<SEC-DOCUMENT>0000064803-21-000011.txt : 20210216
<SEC-HEADER>0000064803-21-000011.hdr.sgml : 20210216
<ACCEPTANCE-DATETIME>20210216064754
ACCESSION NUMBER:		0000064803-21-000011
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		141
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210216
DATE AS OF CHANGE:		20210216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		21632232

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>cvs-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:4a98170d-2b8a-4463-a058-df0f5f10bd13,g:ab909211-91be-459b-b532-dbe2c1c7ff2b,d:c31760c417ad433094d37b2420225748--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:cvs="http://www.cvshealth.com/20201231" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cvs-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF80L2ZyYWc6ZGRmMGIwMjEwODA0NDRlNGIxMDUxNTJhOTRjN2Q0OGEvdGFibGU6NWVjOWRiYjNiYjViNGJkZTg2MzAzMDkzZjJhYzUwMjQvdGFibGVyYW5nZTo1ZWM5ZGJiM2JiNWI0YmRlODYzMDMwOTNmMmFjNTAyNF8zLTEtMS0xLTA_d10da047-1161-4885-afe6-92f05234d9b8">0000064803</ix:nonNumeric><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF80L2ZyYWc6ZGRmMGIwMjEwODA0NDRlNGIxMDUxNTJhOTRjN2Q0OGEvdGFibGU6NWVjOWRiYjNiYjViNGJkZTg2MzAzMDkzZjJhYzUwMjQvdGFibGVyYW5nZTo1ZWM5ZGJiM2JiNWI0YmRlODYzMDMwOTNmMmFjNTAyNF81LTEtMS0xLTA_e186270e-d737-4f6e-b029-93c25f4933f7">2020</ix:nonNumeric><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF80L2ZyYWc6ZGRmMGIwMjEwODA0NDRlNGIxMDUxNTJhOTRjN2Q0OGEvdGFibGU6NWVjOWRiYjNiYjViNGJkZTg2MzAzMDkzZjJhYzUwMjQvdGFibGVyYW5nZTo1ZWM5ZGJiM2JiNWI0YmRlODYzMDMwOTNmMmFjNTAyNF82LTEtMS0xLTA_e5214161-5e97-489c-b29b-dc21f8bd7b24">FY</ix:nonNumeric><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF80L2ZyYWc6ZGRmMGIwMjEwODA0NDRlNGIxMDUxNTJhOTRjN2Q0OGEvdGFibGU6NWVjOWRiYjNiYjViNGJkZTg2MzAzMDkzZjJhYzUwMjQvdGFibGVyYW5nZTo1ZWM5ZGJiM2JiNWI0YmRlODYzMDMwOTNmMmFjNTAyNF83LTEtMS0xLTA_42095482-0f82-4415-b77b-ab235dca2d7f">false</ix:nonNumeric><ix:nonNumeric contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8yMTMzL2ZyYWc6YjcxNDcyZGMxNGI4NDcwM2E4ZTk0NWU3MmNmZTYwNGYvdGFibGU6ZmFhYzQxZmI0OTY3NDNiMWE1MjA4ZDkxNmJjMjdjM2EvdGFibGVyYW5nZTpmYWFjNDFmYjQ5Njc0M2IxYTUyMDhkOTE2YmMyN2MzYV8yLTEtMS0xLTMwNjE_7e343810-80b2-4092-a247-5c76377bfc20">us-gaap:ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8yMTMzL2ZyYWc6YjcxNDcyZGMxNGI4NDcwM2E4ZTk0NWU3MmNmZTYwNGYvdGFibGU6ZmFhYzQxZmI0OTY3NDNiMWE1MjA4ZDkxNmJjMjdjM2EvdGFibGVyYW5nZTpmYWFjNDFmYjQ5Njc0M2IxYTUyMDhkOTE2YmMyN2MzYV8yLTEtMS0xLTMwNjE_b2ab09e6-de12-4f56-9a15-189682067250">us-gaap:ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8yMTMzL2ZyYWc6YjcxNDcyZGMxNGI4NDcwM2E4ZTk0NWU3MmNmZTYwNGYvdGFibGU6ZmFhYzQxZmI0OTY3NDNiMWE1MjA4ZDkxNmJjMjdjM2EvdGFibGVyYW5nZTpmYWFjNDFmYjQ5Njc0M2IxYTUyMDhkOTE2YmMyN2MzYV8yLTEtMS0xLTMwNjE_e463e76d-94f3-45b3-aba1-401ade0a3af5">us-gaap:ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE0LTAtMS0xLTIwNjc3_acac4981-50db-4f80-84d2-20cb232e7d72">us-gaap:AccountingStandardsUpdate201602Member</ix:nonNumeric><ix:nonNumeric contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTAtMS0xLTIwNjc4_147575f9-abf3-431a-a93a-0c6a87ecc03d">us-gaap:AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="ibe752e5f0c414274aa8dd851fe81d462_D20170101-20171231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTUvZnJhZzpjMDFlMWI5NzgyMDg0ZWJjOGUxMWQ3NzYxNDM3NzVkOS90YWJsZTozYTlhODU0OWM3NDU0MzBkODhiZDIxYTRjNTU3NDBlZC90YWJsZXJhbmdlOjNhOWE4NTQ5Yzc0NTQzMGQ4OGJkMjFhNGM1NTc0MGVkXzItMS0xLTEtMTcwMDU_8a9dfaa4-a24a-41fa-84a8-b5098c460208">us-gaap:AccountingStandardsUpdate201409Member</ix:nonNumeric><ix:nonNumeric contextRef="i48c282f0fbe7448d99f6ba30a60ace6c_D20170101-20171231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTUvZnJhZzpjMDFlMWI5NzgyMDg0ZWJjOGUxMWQ3NzYxNDM3NzVkOS90YWJsZTozYTlhODU0OWM3NDU0MzBkODhiZDIxYTRjNTU3NDBlZC90YWJsZXJhbmdlOjNhOWE4NTQ5Yzc0NTQzMGQ4OGJkMjFhNGM1NTc0MGVkXzMtMS0xLTEtMTcwMDU_42df80c9-83b5-4cde-a368-ddc6f8cee619">us-gaap:AccountingStandardsUpdate201802Member</ix:nonNumeric><ix:nonNumeric contextRef="i9e7dfa659f1f4a92a32a74b0958212b4_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2OTY1ODE1NjM0NzI_a2f5f276-1187-4a37-84f0-e7ca761d6280">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i9e7dfa659f1f4a92a32a74b0958212b4_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzE4ODc_a2f5f276-1187-4a37-84f0-e7ca761d6280">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cvs-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i41f59795c714410e9809b7c4aef691c6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ifbc4ad88529244e7ae1cef69ab7110a5_I20210208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-02-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1244a575f4b4f4185b2f04835a5d5dc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4619659f3e0e4e749c1bfe7929426080_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacfc4b890d944c33bd862b4eae13875c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ffa460f969548b583077ff85463f042_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8887a1cd3c8547d681d8baa2a35e51a2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i862fd4d1d6ba4365a8082e4c0ccf9463_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c05067cc57a462d9ae3f15016cd028d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36847bfea20b4065b555edc6977908d0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4db69fd194a4a0081fed80395cfe996_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20db3230df8c4812ac4bf0f95ceda745_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c716e5b99ef43d2a3c07841be0dc4a4_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc9a1b1abab04a16a3b873c907603424_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e063d39bee64f188da6a74f7ebdb608_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i193db80c5bda4fb7aa1cd998bea9026b_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14773d0466f74f54b9cb98d7ad2d00db_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib83b00b1f6e34feeb9987e580b61bb95_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99d5436478ce4110b135201c6608ebd8_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic20621be887c43a9b7de2f03f299252a_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie900981eb1e84a1ba647ba34d76fbbda_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f132d1656cc4ffca90cc7c194f9eb50_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a4dfbfbdb0244b189151eb29a59b6ef_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae582128ff614e3bac0ec6439e7a73c0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2865692d83ef4ec3beffe7dbbdbd7685_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i479bc088fe574cd9bf70b669ad0bde68_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b45a4b6f0e34440abe81173dd958f40_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a8972c93193441eb5d3b821774ebb82_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i633d2d566192435e97ba030a650d9a4d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bf8771a68c449ef90d36d232f370426_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i771cb7ed20844ad7a8c780839f51c6f0_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b8647a195fe4759a2c1d965857302cc_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia07f8a9064884f3da3adf7cb16b994ad_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i182c31bd325c4b0db0263ee586306fe4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7748ca57fc424eaa980cac40c30c5207_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d28dbcffa4047b78489791263cdc3d3_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a9f1919bc174b95976298b74c0d5023_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icec68b3996a444c5a769c70fa0b27d4a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9861fabc3eea4b0aa172430d1406d2ce_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d331567a29463ba17005a8dac8083d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ec57ae1fbdf44c086926cdcbb8ce7ad_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib940e469010141009d1f199a133e402f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i579b801fc47647a9ae9d0a9f745b8002_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaa674d77dad4633b24afc1e676be890_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ebc196b27e547dd9505449bbc3c149c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if00ea0e1726a4c0693ffda7f4456d2ab_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3384c22fbbc4007beae52127a1ca929_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1f2c8e874cd4322964c291da3c8928d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibad41ca6e209411b8aed153ad0ca7b35_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50b94dc3fa4a45d2a882ca93d2edb4a4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id566ff7b0a4d432094d2dd009bd9325d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbb5ad828f3d430ab4e4b7789d96ca96_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7c36f74c88e4d1293588b625bef258b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddbe6826a9f14b02936670ae1a4ac19c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b1fa3d607d64b19b6e722492150bc46_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4052b450116d44169998570f9d72ad8f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaaac464404e4f83b7ae4acc339eae78_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac50116896f44c97b2f61f0fa8211ac1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58512c9652124fb18dc047245e08325f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idef7f894733b48a89d8de562546c4dd5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied30c7ad7aa44d239c4dc814569f41f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if103de66430f477397471c724603a2a4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac8be9403fbc450db4da0a11f9de6385_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i582affc472fa400a9eb5ee9688d05fee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3030715b1c74323bd4bcb2d48199bf3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e943a74976c444798abe05d760b9d08_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9229806f74744b7886032e409d4d844_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42a1c40357754fa8ab8bff9c11bbc401_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8590a938bc284f1db11c769ad6e3a70d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30d444aa6cdc43d59d7fa44cb8d6c3cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i963da7f6c42a4740a9aef503c045ff0b_I20180101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201802Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5212eadada724019b746b479c60caaf0_I20180101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201802Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe752e5f0c414274aa8dd851fe81d462_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48c282f0fbe7448d99f6ba30a60ace6c_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201802Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="store"><xbrli:measure>cvs:store</xbrli:measure></xbrli:unit><xbrli:context id="i1c1af2cb8e024fc0b237288131dfaa08_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="clinic"><xbrli:measure>cvs:clinic</xbrli:measure></xbrli:unit><xbrli:unit id="member"><xbrli:measure>cvs:member</xbrli:measure></xbrli:unit><xbrli:unit id="patient"><xbrli:measure>cvs:patient</xbrli:measure></xbrli:unit><xbrli:unit id="people"><xbrli:measure>cvs:people</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>cvs:Segment</xbrli:measure></xbrli:unit><xbrli:context id="i02d9906f299f46c78575a0dcc95ab970_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ea0930652734afeab89b2f4895835b6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8696070d484a40f2bb7a4f689ad3defb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cvs:FixturesEquipmentAndInternallyDevelopedSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c66b1159478475eadd94b3ae0b2492e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cvs:FixturesEquipmentAndInternallyDevelopedSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i089b48d85e384c799bd89b63783799f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21bafdeb44cc4054a9d59d8f3c997e60_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e60b1b6f4a4dbd88268862a0d22fe5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie669a13e87484bbf8cec205795711fbe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica9c1a9ce292408681c60506f05c7e71_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id09b24f17a054a62a94b835ed727b119_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5737e6e8f2e848bb890ccfdf89d8addd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if57eea73aa9c452f8b32b1d955f87c9c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05dc4ee13c7c4d28aec45e6e732ddc48_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6b3de6701614688b86b94e57bba778a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e7dfa659f1f4a92a32a74b0958212b4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d08e4488aed40f3ab968e76d61f94ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd268c0de8441a3a25145b2c7fdf545_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d5b621fca784ba2afc687cec988fde8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e9687452be744e6ae16597342184c4b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i1ecd36bf6d9f459da73860d5891edad6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dbce9db2d76499fa858862f845f972d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaff454c2b91e4d3a845612cd83bc5a37_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:BrazilSubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37eb583c6b6d47f3b7c106af8367c133_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i426635a6436f4eceb5ae3bf452f2e8ce_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i313e1434cd644196a894b71f3e4d271b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i300a5c4ae7ad4f77b6e0b97f6f8e0cfb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i987983ae1dcf428e845562a5e086c894_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8807d9a1c6eb4ef7a7bb815b14181f74_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebbeab317d23464cb721bf23c9554965_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia39c42c0a78e456cb74db342cf62b094_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4810c04a4634439b6905b74827cb24c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8b1524b485c49609e399b2a230e04c7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd55880281f749318f4691e88cd97168_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i783b1352f68b40d2b4ac2682bc608521_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42aa9378a89545c48dee0fc68567b9a5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad54c820725c447083ff3be1ee37598e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieef46aea24674d5297f52fe96fd3652f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbe2227ce7b3407291809c1a7fef699c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd5d327d52f54f70913e6c6108027d81_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaad598e9ae7248d4b644c5cafe6a51ca_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if63174233acd4168b88c860a242fb85e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61b3eabef1e6460cb656982802e37513_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1a017feef1f44bdbe74396d8046773e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib170695af7314375ae76b557f9da70b3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33407e182d1347caaf77663336da82fb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15b2e86a75f2415d8bf8685add0dd173_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69c3bc4b998f4337814af2804581a932_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c72ee7a1ff04724b5d9c64969981c00_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eefd35256b74eb588b983fc0ce03cee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i615e8d8d64e049b2baa6aa868316807d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e5738b83cac44c8a207d99440f8125c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice6658f59817451f8226605da85f4b71_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic572f6f25fb641d68b501e02911341dd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i905d30d3d5c2417fa14d71aa765d04ac_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc535c0378834b1dba6be6c404915f1d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75ffe98b0bd943648691587a5bd133e0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ff00ef80a974f5eb5b735f33880f18d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc9115de5fde4c4880875ae246f420e0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5478933c3dbd44f28b9d5a0b50d6db7f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i883ea853b3fe48ebb9fada798636ba5b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c68a89f8e4c4e81a8576d27b3744e59_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee4e7fda3ff44e1cae0013e4824f88ca_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a9e992c01b8401c841b3eae8f16e94d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i317b21ec3df84f079f10f3a3cb5996c8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a391b68fb7b4d8f843138cd71f2707b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie48e36cfbbf8422186962d2169fc4edd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie727763f57214c94a1c11e4313718b07_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f10e0c26b5b4685a3da73b5a6d6cdfe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98c09f3cf15740fcb2085a4ea7a6b757_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id31407870d8c4fbe93fa0ef67d5f1bd1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaceaf6ce0c0649e59587194b8562c088_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2c64df3e01c472b98a154efeaba9606_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d705300d5f44592abe5c5834931363a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i637cbce7eef743f392772d2447f3fb0f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03cfffc1fd2442cb99a34979e3c58111_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6948fd96583f49168479c7bb034889d2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a2861a5e8ba4e20bd8eaceed653d6dd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19549f30d57c482c9aefda9c7a91347c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2700a9f4cb9448a3ad808275ab50ef5c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9db376e2f088449494413724fca2e556_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i647cd1db2a7b4b81b35d2e32684b1fd1_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92201227633d42428e8654713a1183c3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i013b860d7dc4425abe6f741f311f6b69_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i691b329bada44592bc51fab7186d983a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbecb39a71a1469892eb85b5117dd313_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bbabdb50ce14e3e9d0aa6b2731c0077_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i521a13bc74694ab2bcde000a0cfa3d7b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8edc8623a1824b2192d1cd1f2197d2df_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee713b77e09b40658fff6dc3733ade2a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa5cde79d4cc48c894fc26a3d00d4c4c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cbb8e25253e442da025fb09f9ffb8fc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c61f360659541ec934371fdc19fdbfe_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c5fc5617f60483f850c62403eee0116_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ace05bc406f4b35bd7d939aba14ba8d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f39b6fd2b4740dcb546b4ea89d46660_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36564f45ec67407d93ad909645376841_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia751108dc0164471ae32975e51995a36_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c87d411f5b34673b9973adc00d3637d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bcade8977e24f33a1be8dd5bbb6e4ae_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0afe948f657f4d75a79b6884ce991c1e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50ea2b4a55ee4369beeefd0c2170a8cf_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9be25d61dc7c486faee71c20d5fbb1f8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7219da47c7214a83bc6666bb4b2abb50_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c3e56e0202f45e1ad53f61ac55f0d3b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e56f64001404d73b3c695a3b5ae8845_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibda6ee66f0de4117add908957e89dd30_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i138a42c6cd5e4913b5eb2ad3288f6b8a_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacafa6a2e9244f43ab295d89abdb066f_D20201022-20201022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-22</xbrli:startDate><xbrli:endDate>2020-10-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia508c5dcbe174753b2ea381d7ec1a3bc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30eb50f669aa417d98981c15d603526d_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia29ce83052be481eb35a86ede34ef887_D20140101-20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="payment"><xbrli:measure>cvs:payment</xbrli:measure></xbrli:unit><xbrli:context id="i6fe88e3b7af243da9625e02cfbb5d718_I20141031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2014-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80d59f9f341b4a83b98d2b3b1b87310e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59ea7852fec74a64bb6d3f7c2754512d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a0cfcdaf6c54b489a9c3eea04ed3a37_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcf15c27df834ce98c7f1da46d42a14a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3267481b2aa4488bb857353dc51ca8f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i373b58235285416bb437fdca972f274b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i343f3e71f5b546c7ac384b8289428e7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dc57d39a4f04908be65c7bad08c6849_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>cvs:state</xbrli:measure></xbrli:unit><xbrli:context id="i8168693bd43e42ad9a06d56bbef64902_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb3ef261af8c4ac5882b054e927e2644_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:AetnaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bda1e1ef73b4b7b83d6f7ff5925839f_D20181128-20181128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:AetnaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-28</xbrli:startDate><xbrli:endDate>2018-11-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8f88d1feca14fab9af82ff64e292817_D20181128-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:AetnaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-28</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d28d9feed044ba598796ea48b01c29b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:AetnaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6292fcfab69c48809cd6df0bbb16e7ba_D20200731-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-31</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i686d61205fb142b1bc16e360c062d7f1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie10ef6a4cf20405a8bbbdaffe804df04_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:BrazilSubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15adb3671036492cbdf9d10285213988_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:DrogariaOnofreLtdaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69096b9bb0844234beb55f386ccdbcdd_D20180102-20180102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:RXCrossroadsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-02</xbrli:startDate><xbrli:endDate>2018-01-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c5ea305571c4ec78c8dbf812bcf4b08_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:RXCrossroadsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46cc0ed8444447369f7ffb60b023dfe9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b98a93f0276459b890b573fb626a088_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id67b9d5fd1cd48469659ac7a217ebce6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2ac54c8ef3a4dbaa343b9df3e53741c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9da7e2dfa74045cdb18889001920c71c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5230461e9b449448da7c51080282d09_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if36ae6ba3e364496829160fdbe5c179f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a19c71845964210be53c6d425920e0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2afaaa9709c42e3912403cd458a7e31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3c9a60aa719471988bfddae88c14375_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa76c57927554320b220d6cae72d2d1e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e6f0f08a7b48b197075141b6b6b948_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7862ac46b00d47789bc1df87115c0653_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f07a8fe7175442fbcc819fecef5c309_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ecf8dcd90f14826a44fd5403301707d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i676e7b8c5a05475e91e66c6e8684f644_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70ae98000fd546eea670504ba0d63d0a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c483eeffe6d4d83b95ee855c212d24f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>cvs:security</xbrli:measure></xbrli:unit><xbrli:context id="i7ed3ea2d008c4900b6da8ca08af14359_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac96be526caf4447bbf555aac1a17ecd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2862acbf1b084e6790226fec4b8bacae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id096a5fb170740c39d0deca267bf7d45_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i994b426c1b84462e8430c20afa88eb28_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if373b00647a647d492b359b2cc518799_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e506a799edf42b6a5cab4f7c3320e36_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a9206a1aaa548579a9355991549eb38_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdd643de24674532b6eb565b63aa23ac_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6781fba553a4bf7935fdce6921489c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6ec62eeb545418f935cd6789b8f043a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a5f6618b0fa465f9f1f9beb794efccb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i387442e37b5e42a49e054c4423e257a8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b8d4e422a0b456caf45c84c95a13c63_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib60bdc4640d3430dba09cf14bed10e42_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29175412719d4ae0bbdcfa90a2791097_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i443be5ac12ab477899d6c78b902bfd1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3350229ccf0473d9d352076764201b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2808c5a9454a47638feaed23f05ffd75_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9ded9eecf3545abad11c717bcf28ef4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99bc2416240a4a1ebcd6963cab1df746_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01cb405c32b64ca890eabde91b0981d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c5b042ce36e4d5f8c31048f338d0da0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5431d9662eca4651a20170ff92cb9ea6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafd0d1d240b7439788501063223cefba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dc8b1810ba64a5fa3916ea6c09b3e81_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63fa7e4e54554cac9b950e535b9ca5a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1643fa3fa2c44337b623c38b9b1c7cc9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32903e0797f349ad863b6da5b59eb0d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic485b0b1dfd5472cb9fc36c196433b4e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8e442f3b9594715b2fb6548ebca61e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01033fcb93704a4391a3e7fbe27e7af2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3682b33721ec4514903d622b539be8a7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cb4368415fd4f45ae4f3029eb9e6097_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88e6a24a77d9465bad6519907e24343a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09f545523cd149f2a426aa336810452a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i822d645dd6e24c729f04ce2895f1a93f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i062d253ff7ef401a835b48533522c00e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide073f4bb27c48c7840435bb8f104221_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0bc39dee46c4714ac0b0fab972c4ccf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i473b0c0209924e7cb5e5f5f0cb1e4669_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69e2a8048cc94bfa86c33501b14cf008_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic55e9a14e25049ec9335dfd7e9cc5e2c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d53390437704160bfb47a2ae8120e70_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79abeff81ecb4f2ba2b425357fdac880_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7deafc4a256c48d8ad86736b4e5311e4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6510e58a12864cabbb5f5d397cdcc6e0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e8f84bde226406fb2371bdc5972636d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4aea11f47ef497bb4cfae564490a9ff_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia03d8280e504476eac041f0e93f83065_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94e42d46c2d6436ca7b0109d263897d7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a3f3595ae134cc981ca1d3c18836706_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bb8e2da802b450082ce3f9ebeddbb9f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb976174df584566912d1ce975916216_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e03fbfce9af49f1aa6114c65a6c2f53_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76d11217f0a44658a8c9c461abf28597_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i971973c567634c73ab4ea2e84ce6b0dd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c310256123047cd9dfe888f312658ec_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88616ec7a1ad44c3a2a4dd7cd79f5196_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a4cbded6e7742669126ef8fc6075ffd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2c70dda95db46be820b218ae77d9e96_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id96a55c4463044b5bf44723d5c1ccf62_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i877d4580f0694cb4be370136b4865d7a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08f62f5e177e435b841ab3f7d3b09c13_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic98ccfb571144f1c97c0ad662c696d05_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0daf6c04fb1344edb25e56b236c0dc57_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib258da2c83ef4d81899c8b052d2499ba_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf33732bb1b44dafa8da81b701b2c146_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieed1e5fc77c944bf8c6cb12c1362e77f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45581d71f4fc45f68574e3690202b39e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47f137d0f6d243babd97d6cefb992373_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b85ad0009a8404f91f09c0c56c9e0a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d7ca48c598f45cb8d641ff3cfd83dc3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb6ec27882864945abe2ffe9bd523656_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4463ae62a9024501b5a957f93ffd509c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f180321401b43afb4ccf64eefc9ed72_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieae65b64f43641bd80854962068ff2bf_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icef7b09090ab4ce78a8ecf8b2b4586e1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i739d9512c32a42c2bc64e5f94d64b6a8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i851d4aa7d40b44b789763f7863bce518_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i439d5bbe06ca42518920801c888d40c2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8dd6959068f4e5490c721fc82461ad7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc5fbdda1ccb46f0bf05959e53345921_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3489e4cdcead49faa7307339be45ea56_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i054b8f52f436443db1807cf26d0d4567_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i458385d44006411896bb4794dbc65c9b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9f2ffe7a0ba474fb811572f2e0ea7e0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4508cc8f56f04ee9a7567e40b8da3c28_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id19caab13c4e4bc38082d1bdf6bc13ea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e22f02c654244d596daa5e51b729587_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c4a870a8354489ab03c6ca49ffdd338_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i344a6a9cd51e4e43b0ca2ddc7cb48feb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60bdcc978cfc484baf04fe7970cd32e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3a9c7ec5cd043a1b1452b0017077321_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i535e58cf8ebd41cb8d7240e4b1e35f50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ddc060d200a4e2aa0952f43df4f21a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e8fea1acd9244a5a882955ae4ed486a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice331df2b98e46fea9be5f51151c8e6b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8a89f2686564b389cdb4fe8539d10e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8edb5e9988eb4dcfadaa6febf64f603c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a5669faf591465099f3db3909bf4908_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2db80d0e7344f35840de60bfea8a22a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide99961030a64271a6dfda0a74b2fd14_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie311d074225743679534438cd7b7490f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8564e44c4d0940d883bb0a3d95fd9e7e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61b53e87d1454d1f831fd5c70d5c60fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia77b398de41746a9bea32d7c8add5469_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadfe4530ccf44844a620422f79befd12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia44caf607a4b4de3b75eb6df51116b96_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id18c3b096aa54a56ab5aebddae95e201_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i150ad433496a404098a477e3ea7c9713_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bfb0024ebcf4bc0a0df96fc6053933d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05c28a6dc98643f2af8af4f866a43aeb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0e0cef498104e4498bc6b4cb58dea9c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48f0fd6cea0b4f2ea1af31f0b858cf48_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4ed896778474633bf168b8f5368a64d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37858238ff4b4357b90cb98696708c18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba2f946e677c41e6a1dd57f66196e517_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81b92da379164d05a04e73b67319b43e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4de0232daf44e89b664bfe4fd000aeb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ed66fb799214fc2bf98dc256cfdda0d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie604f7e6063c410db0270a579e5c2e1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i824ec462d55041558ba9c29476131800_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i427b6fb3db3448e2808f061a08c25372_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ec6476033e246a18cda5819f01ab27f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8539ee32c9a54080a31d12e525e306c0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dad6865b2654a9b907c9347d91993df_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78f5a494a7494280953e08b74b394c16_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9710be21b74c4c1599f063414aaf6404_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9d5661cc4d149c7b8bb9325f15773b2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56d284138b914afab3d80a561bb6eb39_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d9f485c9030494899f777cd715f8fa7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1085bdeb3b104e208f4620803d5c8e4d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e2f247e22d446e691e08e44f6068a66_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf6bb670dc3c4e049ca389440de1255e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1419625a52b4c7f99601b13d3fffd3b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49d58ae32a674ec7a25b0cab1c107c50_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fe5b5a213bc48a9a839453f8eec37aa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdd142883292428c9379bdc65620fa8e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d59fc608e9943a9a082f64bd8966e7d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10d143f8d4624b888878df58de333010_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84acf5a3b4b74531b1bc2f9b3cebfa9f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14c435d7631b4ba8ada299ff02b1fa00_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27193b7a6df549ac80433361247ff541_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1e2ac0b66c2497880c1e0d940d086ae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i099b6050d3584f5fb00e807ed1227a99_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaee970ac587c4ba29630fb7caf93ece4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89a55680a0a4433a9c10cba73488c4a4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib79362fb767e403b8719ea6a27dfc263_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ee3a9120196416f8296ed0519c6e205_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i917d8b2ba01740e38b71a44126058fb3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i909a12cdf2aa40dda0c82baf62b9869d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia22f84d3693548b99878a1e34770cf19_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c603ece9bf403fb66246ce8f442203_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67c1ffa9b4a64076853256c4949fc411_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee9c609f9b8541b4a685e9d0fd26d249_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7980aa14ee0540c882652c696d24ce39_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9553185d57414893ad62b80064c4476b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb48192210564ac4a732e153ced3f314_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43a7de1365ad4a64915e5f9da6e4dd39_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2c1a17b1b7b4bc6b1eed4e29b39070f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60f83ba007004358b8f859c6f7774937_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i488b7e7f18e24adab3814dcb16ac304c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie354c2c65a4c4f7abcb39006882cccc7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bacd808153c4072ae90e6431d9f3e8b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9af5df3294d4476b83876447a5baef98_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i244c2d6efb77428f9129af9df189e973_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c34bf51a0004f2da4f3173e1abb80a8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89a12d5819e147e7bc86f9b529bb3c15_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i281d455fefd94775a95b6168db361569_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if101d6a0ae7e4064a00c572a41fb9b2d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5b578dc25944a4fbe4f6a957829e2d8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04dac01b07d44177a2aaf98a61848abf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id19a4d6575054945aa1e86e5f0871e33_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib042e1b736b6487fa6a695c2e0d0ef4e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id59f0110266f4824ba6157134876f465_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6557af605d654a8e8081d5968b6b3548_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i100418be515a4d90809febbdcf54309f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib991f27f97f044478758250bf930edc1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57f9fd12efa94170971353c862b9029d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6543aefea2e4d4f81c09b28b2913051_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cf3dd46c89b44d5bdbd281a784aaa95_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6180b9fbac5241d0a8dc3af2706fcd51_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6438f449279451c82fc37e0afbb67db_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28d236f896774150b7f1bc5f4da496b8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8ddf588ddb0403491b152484f71c14c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i871f5afdae7444e99dd2730c1cf0cee9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibee9411da7c14a77a36a1bac009e2718_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fe2ce5da7414160ae14468a18322af4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff428bc79a6944198cdd6baa0d71d0b1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c958b1240244ab49139ba6f5f3c28d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a35d7e4fc984bbd812c51700e1979e2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia00b03bec0a84260b8fe2013746a2f95_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i280afee039b24b5c9a7ca13a82b422e7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0e7bd646c054ce0b4531b2eb42e4c6c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie69e76ed83f946baa094f2cc5d6eed7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7305113d58334ee181e867ee40fba5ea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i460c17b4dd6047799d283a4d6ac8e89e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03b2619a7c974ff2a2f5ae867e8f37e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i151d6d04ea0b4c4d8082b77226a45d78_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24eb76bad3d44b72b3d464f255226436_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc128aa047224725a06bd6f71841db12_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54973a0f47c84614ac6eac855bff8c4a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4c1904e935648538c8d82dcc767f325_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bb3afb7703f41758890d49de4633ba9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42c5a9f858b74f68b1093b16815b1cce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cfe1fb048044ccaa0da17032f0b6155_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff5a46ba7a27414b9d1202b7ad24b91e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i844180dee7354a88a31506e0b8d33a2d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19b103cf575b42eba2237027ca0840ed_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia86e094601974260bb883cef037fa44f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide3c87bc14d942c99faa1f30e965d4f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65c51381aa1a459fa5e530ac9f5de9f2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91b1952fb7784e7f9e6499530764f7ad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountFinancialAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c56d1167edd4939801f422a336b0abc_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f780e49e5ac454294cb92045dbbedba_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i328ef57235b84be59c08ccc5a5935e02_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5423b7aeb71b4180a07350c4973d0d2f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i015c0f06a5d5429bb1541c67f66811a0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i052772f862ef450c8eb33c1ce00be32b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i115aa53eff704e2796feb2dab7050983_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc25230039c44ea89e091836ed33b5f4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c1e3b4bd52240c6a3a87ca6634cc223_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19aec03053a346be962dfd329ffc858e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedba146ac9454388b30cd9e975a457e9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21b8848a0b0848d0b1ef073195fcf232_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i412092e3efa64b64bfb4e908a7aecf6f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f1c041ab6e1476e81c0a2cce0548fb0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e630250890a4d9da4b21f7c24765041_D20180401-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i890b640f721945cabfe705407b55dc08_D20180701-20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81f108a20d3a4e71b79be5b539cf2fb3_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i821644c913b3489eb143ff3327e94045_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84badfbc307d4be689f1bf6c6f45530f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ba3c6a5d60545c7aa5e44bfe6800541_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67ce92b07cf64792b2f3329459fc557a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id50415e8993440b4b0cc0fa2104abfda_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc0b012207df4d0a9822ad6163fa473c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75becaee1c754117a23d47d9390aa79a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72cdd4168bda4feba177b3eb839e391b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2e3c68b19214ed09360896c5196bd2e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i591aef778e8f4b08a9c034e1f397fd90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:AboveMarketLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i491553d39bb44be899dcfc0772b9b2d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:AboveMarketLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21fdbe08c4894113b384b8256579df43_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i584138b84e0c44e79759aa9dc3e98131_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie44e4bdd6e20403284243fce9600ca50_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2c72804fb3f40038ae0de7cee82c6ea_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie01b8cdceadc4bdc8efc4a1dccc006f8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63d8ba5cb3cf4c23924e487351249b95_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbfa84e1dd6d488fb10bc33f97246d8f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d00c64ee40f49f090f5ef6179642e56_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6f52fb91cf7425c82f7676b531c4967_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:AboveMarketLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34f48c975e2748a8ab2b5a10d3e41319_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:AboveMarketLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdcdd6decfad41b9858abc5ec839199a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13bbb4efccc14c5c82049f643d62aa08_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc7172c9ddcb4248bce1ae1aa4280d25_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i029b000534014642b4477f76ec44b138_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70084b42bcb34cf790dad3c2e153d003_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib071f664e4424c34825859add41556cc_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbd9a72694e74fb1953ac9de25db565c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0a759204965465a8c57fcb74fea946b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a55f9c69cd1488f89f0c37551af36cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e2b65bba50242fd9c8370770a4be117_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab2819dc76894f5995f2436bdfa0b59f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf1e85cb6e5d4ed281db988a9eb5b755_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2689c30da3241379d3461455317d9fb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadc52b1e6e6f4e7e82de9d1c0a987c54_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if59595395c854ba7b06e3bf1c79b2167_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dc84e117e964242bed54b2fad5b0376_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39ca9c0893574888b90454ef444cf1b0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb51aad0627040f1899c9ab4dbda4d6f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia44aee29de0d4077a6f00b78e9d6263e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJuly2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88f639376b55490690a36f10a9be2811_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJuly2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id01a6d6a45694726a6f06c733cf6bd6f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59044fa83a6d4afea18e5166e0f463e8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82faa3a8c7e745008aa3175817187e10_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2e6fb4f07b74b628115f0ccc6d9da66_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dc856455e7b400ab7c24c5df6647e6f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a9b18d3bdf747699de43dbe6ce0bd3a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b59429fddec4142a6db54bed9ab055a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d340447641846a9a431c822fbec5ddc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i676ade2029cd42ddb0666570247f7159_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6a6f27fcb634d5a8284be453046e3da_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63be7ab398194c9282444fbe7e010250_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id602ed76bb1141efaf6bf5a490a87c42_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c0d5087b6064f70b84a0c6522dde077_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b68adadc076455fb9d9fe54b81b2afb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4f845bef7bb4551b019ead11e5321e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51052298202549029f99a9aa30364e50_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i556ba81c12d2465ab03865c19ccdd639_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ed4c4a68c7f4d81b36909b27c56373c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i171c4fd932814c18abf98b03dd0d5aa6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0047ef3047aa4d01b3b1461ca8ad2376_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i734cf172fc0a4bb394897c043bd538c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i186e6bd3f8c243f290f2d7379452ca08_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icecaee365bf9466885c2e04672491901_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2942eb9beaf4f7cb5866f52e34c56a2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e657c55e1f64967b1ffeccd58ae062b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e950cbfa319445c8d4b8cb106e4f1ce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53be593e004440969eaadd34053626fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f30d489cf5246259fd164aec13a5624_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd43c50e8ca4414ea2cecb99247ff8e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0573e87a0f0c42ed97784d5b5ea32460_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dde33d57ede4cd2b5f5a4f7c72f3c92_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97fa105db68d4c46a1f39c9e528fa813_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1ea528658e74bf787c41152af9d8121_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2694eec161064921894d65f27aa8ab17_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb4bb36351fe4c6f9d1a0eae2a188257_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79094d4adfd5425ea0d62b733c026eca_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6fd5b2064a242a6b820eafdcbbe9428_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4dacf9fff2540b993923fdc63acc6b3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8450bfd94fac484aba4e77c9fc4efd2f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5874afefc4a74dd6ad08f344c1f53ec9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dd4c17f4c144cf297f7e26ae28bd94d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i866a5d43855e486f8cc0c68a5b4620bb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08df6665d2524a33a4be6561924aefca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24c2a1537a164fc5874c6fa1eea075b4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idddb1de105474de39bd0e7760adec57d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie92a12c2190d4335847859245937972b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ca0fb7a5b484776ba687c307ef197ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point3PercentAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i050c35f0329b4b58a86438fbafa04846_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point3PercentAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe8c3f3d18834cf7b9b94d15988c16aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica41313a27ea4d7ca02bb73da16225a1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bb1c419c09e4bb19d54039c47abe8e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8e397dcb8d14af0a33b647343c389f2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a1d49c0ec7e47f4a5602ea8cc802eef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5782efa7db249b6b23113dc33fb76a7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i212780690b054480b1d4b16a1ce55e8f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point75PercentAugust2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82893487b53a40c3a443264c005a3544_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point75PercentAugust2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i014f1a1c658f4a5e88082091afbc10b5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point875PercentFebruary2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28e1dfeab22c474fbf87dbcc1a78ae98_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point875PercentFebruary2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3262bc6e373b449b95e2a2364d10c2ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id20e06cc938d415a953c7aa4bdf9cc8b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8948ebc60ee549319fa423f9c9ca71ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i133831fe5f40404ebaf46e33ca52ac9b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i353b9ef71c8f47328eb48db1a68abf98_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9bdbcde47724dd2a5dc223d8b0d9fb9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic196591389f249e3a85fa825d6428142_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7d67544c4ed4204b542c36dc455c469_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2552168ebcaf4d87b5f4441f01768b71_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d273705308749c995ee3575c0e5b372_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i867a6232fb7244249412521e5001679b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if44fd76e6acf41a9b3352d5c1ce68f96_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1044e6b95e9d4af7a0760d5a5f5c5d96_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point7PercentAugust2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84cdd9e17651455894397e2cc826487c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point7PercentAugust2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a05340b9e204506b8228431b5765c0a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ad9df9ebf4746febbda2d5944fecaa3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fa943d2d2b64256b7f438c6bd342aa4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d024add61ae4a83bd4faf2b2187bffd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacb0304ddc414bc9ba515d05b822e59f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i063d082f54bf4a70a10b63c68204c506_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib365a66162e74ae1a131e17260d3c309_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic58975dfc3894919a505a5a72c8de2e1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bb283ec93234091a925868aa3c3d104_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4515473601e42ccb48a414ff823ea6f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb5c311b199b423a93de6b1490f41256_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f477f50197a44379a3e15ab264fb450_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a9f776493394d3aa1b9afef76079abb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38882d76fbd94254a2babd6873e24f9e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e5d522c3502448f88a84c21bcdd8997_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ff770766b8f4090a02e18b7734a5a58_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea2cca2aa63645ea8d47444ec2a4b2ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f4c74c7d7384526865bf4ee6224633b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia69df1d43019455c8f2e992b4d61f9cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6471700783d4a9ba371feacbe010756_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i436a5971435f44fba2581c308d881259_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2a81421b67049b4b9bda55d847576dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay122021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib876b3c3e46f46e0981a6a45069067a3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay122021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9c68e7d2e424fc59a03e33749acacea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay182022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i624a08d2669d4bc19ebfeec612b82b2b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay182022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8809cf477a8743d9bb985128a2794821_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay172023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbb693e747254191aa459c5a8372bb85_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay172023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic05b162415354eb4a957e1d4b5f6f6c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia57b5877fbea405eb22d66a6eaf931b6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab6686fec59a41f4a0c718105fed5c6d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07faa68d499941c1be4ba68ed832a9f1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f6bebf211ae4518a4a23f58e6f388a0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95fd067686e94117b1c847c8a8c039eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8c5eaacbdf242339dd3eee02265fbc6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f88871020ec4730bb5d033335c7942c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3459ed386a61404c94e9479d6015ffbe_I20201216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99166279d10146f28c4d4195c226385f_I20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad8877d2fdd8467888b253ca40d5a80b_I20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88e8304eaa26409d8a604190defc89b5_I20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94f9c1f9d7704805bcabb81136732a71_D20200821-20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-21</xbrli:startDate><xbrli:endDate>2020-08-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i445f32d7eda447d4a2c49f251b316594_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3625DueApril2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f587ced64ac42339b971d523874e02d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes375DueApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i459a1521a0b34aa48757c591eb7efefc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4125DueApril2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaffd5e9b361c427a883e24208cf16157_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes425DueApril2050Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5a40055293c4fe79da45605991de624_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3754da4dc0974763892869cfb72c7345_I20190815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie91d7fd162c249529beb9e9eb9f7e7a7_I20190815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb2dc5274bad4e428d1e8ae87786fedc_I20190815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifaa8ac73798d48a8aaab4ac171cb2721_D20190815-20190815"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-15</xbrli:startDate><xbrli:endDate>2019-08-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95a7e367f856452c8f2160336066176a_D20190701-20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3267d33afe6d45e6b4528df8d62df448_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibca2e87104be46389dc5a70a0864d1a3_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9f05d6d28af4ae0878d9c571f979793_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28dabe1fc51c4dfa95740ee0bce67f39_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f5ce01da4b6464cad8f27d28f832fe6_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i854b7b5601cc4ad2ae0c167f72910032_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3512931fe12944039d4fea37efaabf11_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00d2c3f9c025419cb3e6849ea5f357fd_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b3bd8ed75a4dcba9f7489cefb5e348_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib154687a8b3a4739af34791842da6702_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e0292e851e64435a7435abc06f22dd9_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f4b2227a9a84f6aaa20022126390e84_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19a7d9778cad44b39b5aedbba6e986eb_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacb6befda8dc4cad8d7d488e77940523_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77619d991c0342398aac18ff9a3beda1_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie86e314ed8c34b84b73378a6b9f4d9fb_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93c1191afd7245a2b1def8168a0950e2_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2792f74c0d9748799688efc0b0fec153_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f532518f6a74de889d917417c28eeb3_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cvs:FloatingRateNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice888eb6a699499fa3f39bf466abe7a3_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fdb87438a4048388482de54f9117c58_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57fd64714a6f4ea08771d23076bbabd4_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55a729e2dd93487da789a270476d9892_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4b13a24dc9745c6846d0092832bf57b_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i128e4692b13144ff870ee0ffea794d65_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia712a987f9e947c89a37cdc4169dac3b_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e401817f81448f2a9b9b27b7cc53de0_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56de586fcbb34f1fa9240dc169c67a55_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id05aab78eef84ae1b36d242d69f4a389_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida8160947ef6494a8204e68ccf558244_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie19b4a92f0034466b0dafc7eef0ed131_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d0605006d2241649165adc7e5b9f2ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6fb4454708b484d80f98d957fdbae70_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i199b7cb664dd42c0a4101ffbc59daa25_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b7e0181861a4c0d9e8c70427c9ed30b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5907cfcab6b4aef941e6f756054404d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd81358eeafb4757a5e163b51db96a44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94f76249fb9a452d9893743b90cf37d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60b124872b654d26a4229c8094209469_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee2b654be581464a9cfbd3f508f399e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06e5a033c28d4981a2fdc1ff5bb4e842_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2be7ba94d39d477293bb398aeeeb21bc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie06fb4df6a36490395db8159ed91e626_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92ca0b1a966a481bb230964303d892b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i467e9f5dc8e842b6afcb7be67ac32c9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idebaa114561f4d728604bd981df6517f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5925ffc572454ec9a71d0ef8eb29f390_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01c474448dea429dae5ca6e183b910fc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1552a4f21d8e47278630c328c2dde9c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6d60e6812854952a3585905fbbea41b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d8204427c844531b278a523b96a7dff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e87124deec94812a64890f3add780e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93b5aeda1e154dd9b1c23b1da20f6ee4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id02d21e453d54dae81874530cd9f89dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i377d5f59a8274903ba535a34426c2ccb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dcfb37002f247639c8eb485fc992007_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01e14729da7b4279abc81f285bf7a165_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabe4e2d60e78403dbc51a597cc767f01_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieea92042d53540819af2bae5cd60cb85_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6007e672e02407bbd8bad0315a61ffa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75d0265957df4b58acf5ac2bed8460f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if507a4fe145e42b493db61571bfd2376_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83dbe71df09344f38b1a756f97f3b8a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10c5293ad9994caab33673ec66c3cf31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54427a144ab54136af97359d16305c28_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i788a8b0a6104485c88fb58913f9c1b1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69a36f8e3e0747b5b5d40f18f897e44b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d20ef997413454bb5220829c7a405ef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24b8f1f9efa947c7bffb894e3104cd7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i353f05ec97dd4a7dad6e03d980c8825e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ec36398a8c3460a872ca7a5eec4975a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7d49739667e46e7a8df15497979d8ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8202fb48582644a489621cd494e8d6ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib225d997939f4bb2bd5ea1d2988d1cb4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if874ae14e12a45bca74664b04f2b5666_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0638d5f10c8d47228bce923194d15629_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff889270d69a4541aec6168c327f2898_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if371687561d646ad8eeab5f4be3e9b99_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieabe9e784e6e48c1aa447f7436dba5ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d02faf330be4175b93e19bf97c5db9e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6302fcfa13ad4d1ea6a72dfe007f13bc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5ac1eab026c440588dfa8abb8de73fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67d5ae7d8fcc4926bcf462116cd3f590_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1bf3a33ce5e49e09483d3f1eb323c91_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5b3546e61842e19f00e5e719d97b10_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd3b8f30c29d437ab39023c671b9f5d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83f10752832a454a8ce347de35c34a61_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3677d20c08e4c8ebbebcb282e4db114_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86f58868e0964cd2b2796c0808009103_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b548029e62747ba94fd53b47736ecd4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58de51b364c74e4a85531407fafb309d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85c43bf5e0d844b89bae1a96c978b4f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife531059d400455c8d2de1200f45d2b3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06bafa8c2cdf4929affc318e38df023e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29f1e9cab7554879b559a825763f064c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied8b9a81bd694cde82356583d0495b4a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb86f9a64a874a4aa21ee0d29a5c45c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f1fcbaf310f4df8bd8906a1f02317be_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i080509f1feb54ebcb46eeaa383e8546f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8654f2977f3d468dae935f3fbfbecf0b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if218f96f5bc7440190bb6d1d32469556_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i729a6c49903d4b309e624c0dbef3b76a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1312f09b0894768af1a8551fc6e5b03_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91c8af184e30405da562adf6b2f53803_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05d08625a5eb4640bd0ccc35f6f0113e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5abb09cdc094ad4b2a7a7bb44a3a237_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f89a175a9a14d3e920a746200d35fac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd90fa404f7c46ff85d4bc45bbb37cdd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8a130cfef55481ab1428a6385d3f85a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5df5acb6d9c14d45b450813208569404_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9298abceed34f2693a1b4f218cd1ae5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i189e4eb5f8f84310ab30e1e16b049ded_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id53b84ef08da4bc0be96eeacb61d6fdf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a7783ec39f44c7f950de140ee30ccd3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bae567789f14a93a57bf38399d526bc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5622e8a9b4b94311af248826e87e3fdf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i307b2fc7ef7b489dace816f6d69b35b4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f44abef5a694fda9c5e4cad71fe5401_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c01a675083b46ebafe2d3f0f7ee1ab3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8826db7d3214cdb93b22d4439751850_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84c926b8e33449989a08783eb00e7643_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32101714f9f94576810cf6f379fe4387_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae61a996efae4295867c0dfb1a39a3f2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7622f52a58534a658e934f69b4a9f3fd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cc20f88214b4a889d0644a52d5a3199_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87158720186e40a988f7d80acf1e290f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2a42438d1164e93a25bd2d16276f08b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9913ee60876d48f9a437df7a194a8925_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e944506a5e748718a30ff6c9042ae2c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i656d5ceb239c4aa6a6bacdc5506c6402_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cc901a60d9e43c0aa6809d88598eebe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13907d2d75304f7ba2882e4c00e7720c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i069fbff796464b2d9a15554368b9f668_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i074b986b3d7d4aa2ac22c8e670376a66_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2a5a8651a074b198c987dc214b0dd2b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iead9829071b4481ab63cea328f7f1f8e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f27c04d6477464c8445d1e603a5b16a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee6557a5cac41d48e5c01b08eaaeb97_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9aa9e3cb8794b4aa342f889f8401d1e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39362337f3b44b66bccad215f1c8e8c0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ad099eb0d7146c38442e0cb9d3a8402_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide54b78ac8dd45638fb5a4471bfa5d00_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i846c67b9e9c6476ba16d4a96de44df37_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19f7ea30687c4c7c906cfa2a0496f916_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13374b6df9b64f6aaa07708acc7d5634_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90458e77c8d04c8b86fc7590c59d6025_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d0070b3fe1244aa932248485abfe70a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie317f789360640fb822133fe59211131_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc128ee345d848ff9eea0ec8c49afc99_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iced38e2fa6484ee9861a8081d056eb1e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9945b71b67144ecb9f14a84d87ddc66_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24a8700c68594e30b441940e80331370_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i147b83dbf4614f9c9108afea3b976504_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1029d4685304d2cb2982ca56bfc846b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f7b664efcce4edeb2d0be08f0af7e83_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i146ec2efe7f44c0fbbf0805c2207957f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb71646c58d7445aa5f321233e70747d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i621fa421235e47879a3c82d1e7761526_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie182b182c1e04b5a95f77614cf852dcb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i174d4a2984ab43e49d4c93870e670a82_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab99963cfd9c4db0b3ea89aeae5f9c86_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14643b42fd4744918e6578d8405012b6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i457edd129a59445180d32544cd427fce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if81393ad83d44ce4a232212a8aed80bb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79605292953547d9b320dae3bf8430ac_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbb7812c80d64641a6de43f21593e322_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c89457d6192440fa11287d12cc947df_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80a9f79f4ffe48d1860759d3460e04e8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id82b6a24ba2c4189832ac5c9b3270e8f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52a9e0dcc4a04df6ac84ab2839ff962f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3e054a6e4684760a1317f79ac480b98_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ee306bddc4f4d6b8934f74c4545ea7c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida6f1c68de9d434f969f54fdf8aba608_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54a2fed1212f490e95fe213e7e4ba150_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i237d341b67b849d18d2ee8b7d61ffa52_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i107d385134dc41aea1a97e0c5d0f5916_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fa9c507902c4d0b8fa4479a7c0ed322_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i646a4d5e671b48e3b5e208d65353fdf0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife78fc80a60a4e48b19bed5974ae5428_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i190a83693cb04cfb8d75c0ceecbbe1ba_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1d6b4017f5149b3ae49f0bd1da1940d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife7c0d3bc5f844c3ab8218065d78c108_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39bb7917bc994f0eaf005fd0617cde55_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i958b9417031b48e7a2cb6c08607b666b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0dca0fdd1cc4f1c87ec37e91a251807_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ba1a93762424cd3b76c4ca89d3b3cf3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i706c321b809b483b98aa21c73cf16796_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5510c8c02acc41eb892b3be5a2a9b1b8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81dde339dd0248afbe29f4dc19b3c9be_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8aef86038c9426ca7436114946db2b5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fb8ea69d9ee452abf1af74b33433c67_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idddcc030b53a42e4be0825c74db753da_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09e3fae81cff499099d524e5745e57cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie58dc0862dea4aa2b787686a9637e9e1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i709a7a961b39422984ed1bd0a5689686_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8c098e2a62d48dba96b79e8a470d8af_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2e47c4a3e474047b5600f55bf95c1ac_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i832b22dba7494ed582da21d8a190e7d9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82cc1b96c4d540878bf6fe77d08690d5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic46f812ae4a24778b7506bc4bb600bf2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc6b13b774c2451ebf395531a720b68e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1dd8da2c561447490c876b5d1d43462_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47492e5b6b204ea7abaea7eee818a880_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateInvestmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib81821bf724343ffbd656554419d3a89_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6f4539d5aa54233a40a81686c5e751a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifab6770f74fb4affaa6da71827532dca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4862415f867402e89af424bb29735c0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ee76c7bbbad45d3a4d8ec0ad4b5a14b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27e3f6392d84488594d582d44fa7d68a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac73a717d5c74326808abd0309a3a07d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51951ef33f584792b1899fbe7522c0e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvs:CVSHealth2017IncentiveCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i368dc3028c9348a7b6752c5b2a1288cc_I20181128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvs:AetnaInc2010StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i942a3f87081143089686acdf7d4ee185_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idedbaa2d1d234783b888c78eec015afe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf6ce0645a6645f6b71865a0cd2f6305_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie367a51e740f4a3da15af04b3bf0109a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42d6f09ef96442c986984d00a0124904_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec4fd22ebfb24fdd8219d715c4eefaf5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0df88ade3c94c729995bbc859b11248_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32362d8d9c104060a8a8caf80210e039_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3218ac52d8e4abb8d070125f07b4ed6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d4c72ed7d1844239059f054fea52735_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i840a4dd4fea34ef1a604ab9891347d56_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8044667803dd4f4e94f81a063416a4a6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c18060ad0f74b60bd700240ae354b4a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:ShareBasedPaymentArrangementOptionGrantedIn2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93f5bc2c5d2246fa87aab2340bdaa368_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17808cc9c8d54c05a246d77b12f95dfa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01826b36b4634f7c8bf2af0872e7548a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14abdf015f0f4b9db4fe52c587222dc0_I20161102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dd8180c25fb4a8481234de8c71c1147_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i999deb1ae4c9461bbcddbc5f7a24ed43_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if989d485536c470f8ae4b36308072658_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7eb47ba380c4e5e8af029b7a1dcec29_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76b1b2868c2745ef9a27492b7d5c0054_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia62846c7391548e195bd48645f91d3f9_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice5dfe6468064630ab677c3f80d083bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f0e3ad72e674d79b9416210fc264e80_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie31822396a9a497fb994c84f0ccd13ff_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34d3860039e94245ab240f1f07b53dc4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcf2440c1d0e4e17ac229c0445e4203e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a22940c170b4cf68098d8a1d7db4b07_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b47b478e9b74d6283da9fb27e389a6f_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c96fa94b27d4a2c824b3844e3c8037b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i443408ee77904553aa013c58c381a6e4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57fe03ab102c4593846e42c9794bcb06_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0602d4ebfef644a18655290e8ece6717_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i060f98498d204f6d8a753045e2d7c203_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1125996cace4e93a47589d739fbafd1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5594c4b0291247d29cdc2fcc74572eb4_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9aaef92229504806b1ba8f864dfcc385_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac55eea462b842aab63a774c5b13738c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia21d4a25030943aa870bf85489fc686b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic509b8303359462cb2a1c66d8ff1c410_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i218673f1547f4d87ad2718881dec2f7c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62fa0632829f46fcb2cb4d4b11969265_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2c5e7b4689046d383454e690de48a8f_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie55d01130f004e38a1138732a5796669_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ea3441f923f4cad82455098c9eac4f3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cf5ea89c34f444085bba9feb6d80c49_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19bfa54afd084b37b88cf9c88401e61d_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia39a6a5feda9465cae5cb3ef31577007_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie67e69bf0ba04460ad30b2bfb023aa77_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia10ab0fc32f0402bbbaa42ba5ce15209_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77138741f151409593c0f08b724a0e30_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e098044ef0e47c5bb1938a83a8faa41_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i544dec88053840f8844b00845a1e6704_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i708551cc4c814f7ba31ad03e5c460a9b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib26f4f89c2814e789be0ba11239b5764_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44c7450a0d11477499c9bec9bf025a94_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4a8d6916f6844c2903a012a996567fe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia66f0a48333c4fb8a9fae0a1c2df0fca_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc86caed1ec14c06a5264c5b07d25d2c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:CommonEquivalentSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reinsuranceagreement"><xbrli:measure>cvs:reinsuranceAgreement</xbrli:measure></xbrli:unit><xbrli:context id="id456c1b6d71e415f8fae0b19939047b5_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i283d40b1ef884f6cb9ca2441e0955fad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:HartfordLifeAndAccidentInsuranceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5a32e023950437daba697bb6436ecc3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:HartfordLifeAndAccidentInsuranceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1061114a7fd4ccdb4a85fb5f0f28ab9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:LincolnLifeAnnuityCompanyOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa18411dccbb43738f7c59758dc47e91_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:LincolnLifeAnnuityCompanyOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09460a20d53d4ad4afdab3735a3cc179_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:WellCareHealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81a6a522a6904da1983e84571970a6af_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:WellCareHealthPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a0994e7abf542478298de546eeea26a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:VOYARetirementInsuranceAndAnnuityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc0de1362c31442e9830179e9cf9ff8a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:VOYARetirementInsuranceAndAnnuityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i974ce0ed0b7041fc865280b9d6ba0727_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:AllOtherReinsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8177202559374cd1b60b07d956cf5c08_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:AllOtherReinsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>cvs:lease</xbrli:measure></xbrli:unit><xbrli:context id="i6e2f1b217f52446cb6e5188fdcdf3a24_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fad3343a4d04d8eb3071527460cb5cf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i970d47a28d574ba6aa6a095102442465_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02d01cae12ae4fcfa5db05cc7acbdce2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:AetnaInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b7b7dd14d4443089c85a899cf72296_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74221d409dca4f35b040b2ed0b77e999_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d5bd822a20345d1b479f13bc043f886_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i875e15f3f4444bf9a8d68faf00b3a90d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93d64ebea36e4de88c24cd1d6157c5e8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9f90001385946838987a8d0b03205b3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i027f2373425b4cd295e0f10e2e0aa39a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67879d9b5c0743d68fc0bf8c41903fae_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4c1b7e8f9d543768b0ff3135e5a5f0b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1058e7e5067441cb02129bfd0cc9dad_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i451e6007601e4a3f8f2a01973945700b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:RXCrossroadsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i356e04bbc2764550a470b9863ec4eece_I20180309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:TwoThousandEighteenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-03-09</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTItMS0xLTA_db94551e-003e-40b1-974c-609d700a26b3 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTItMS0xLTA_2514b134-4d79-4553-bfd8-476a7b592485 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTUtMS0xLTA_7ff7c6fa-bb8f-45ab-b419-bb5be4433372 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTUtMS0xLTA_2e6555ea-9d89-4f6a-9188-aec0ac5db97e id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTItMS0xLTA_eb3c5e68-7726-4b79-b649-2ab124a852a1 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTItMS0xLTA_9b8cebe1-0b8a-4e47-b179-f53a706dfa00 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTUtMS0xLTA_1621828b-14e0-446f-a93d-fbdd43a45fa7 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNS0xLTEtMA_d59bffe9-db14-4325-ad7d-ad2ea667f60f id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTUtMS0xLTA_fd8f0b5e-3919-4188-a448-6bbe6f9716ac id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtMi0xLTEtMA_bd15f8ed-fb13-4a71-9515-093b89ab0d04 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctNS0xLTEtMA_065a8a3f-8af2-4885-a8c1-8ca7428e8223 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTUtMS0xLTA_2f2dd26c-e7f9-4dda-9316-d5984a87a00a id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTItMS0xLTA_2435051f-4ce3-42cb-9703-f4ace175a146 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctMi0xLTEtMA_7e7fe2a3-8e1a-42e9-8ece-9da8b40d2dee" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTYtMS0xLTA_31eb6726-7a91-438f-87a5-53f124c07aa8 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTEwLTEtMS0w_01bbd745-65a4-4dca-9dbe-9b32284c852d id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTgtMS0xLTA_f472468a-9d67-42d2-bc8d-2f8e09cf383e id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzIxOTkwMjMyNTc1NjU_31eb6726-7a91-438f-87a5-53f124c07aa8" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzI_0e9483fe-dba2-4c15-a9ca-3961fe592c5e" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTQtMS0xLTA_01d38a2b-d2f4-401a-a290-0c4d6573dc03 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTQtMS0xLTA_5a2c956a-7097-44be-a189-7313063ea5ee id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTQtMS0xLTA_f68504a9-4624-4e2a-a2d6-ed8227e1917d id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTQtMS0xLTA_257c52a8-5b09-4880-9f25-4b0697e3ff7e id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzYtNC0xLTEtMA_04f10832-781d-4849-96a6-73e822af4437 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTQtMS0xLTA_54335d89-aefe-4dc2-abf8-9c0a58c71b35 id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNC0xLTEtMA_16e4fa08-10b4-4101-b231-c5805bb1fb2a" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzE_a591683a-1aec-44ff-a7e0-6cf45389822a" order="1"></ix:relationship></ix:resources></ix:header></div><div id="ic31760c417ad433094d37b2420225748_1"></div><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.468%"><tr><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.376%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8xMzc1_96d11335-b6e5-4772-8d7e-cb84acf0d29b">10-K</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Mark One)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8xMzc2_291fd670-4ef9-4ee9-9296-67a9bc16623b">&#9745;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8yMTc_25ba1d14-97a0-4505-b19a-5bf4dfcc245c"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8yMTc_f16db495-64ce-400b-916f-f4fddfe021f6">December 31</ix:nonNumeric>, 2020</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8xMzc3_615db032-20f9-4bd6-ad6c-894b249c287b">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from _________ to_________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8xMzc4_e4d44dd8-ea01-4dee-b5a6-1ee0ed347922">001-01011</ix:nonNumeric> </span></div><div style="text-align:center"><img src="cvs-20201231_g1.jpg" alt="cvs-20201231_g1.jpg" style="height:14px;margin-bottom:5pt;vertical-align:text-bottom;width:82px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8xMzc5_8f63e1d6-fa55-4df7-bf83-3ed199862cc0">CVS HEALTH CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6ZDllNTBiNDJiOTE3NDU5ZjhhNmY1YjQ4ZmI2Y2VhYTEvdGFibGVyYW5nZTpkOWU1MGI0MmI5MTc0NTlmOGE2ZjViNDhmYjZjZWFhMV8wLTAtMS0xLTA_9f7fc6ab-0262-4f35-800d-29f43f3c8ad8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6ZDllNTBiNDJiOTE3NDU5ZjhhNmY1YjQ4ZmI2Y2VhYTEvdGFibGVyYW5nZTpkOWU1MGI0MmI5MTc0NTlmOGE2ZjViNDhmYjZjZWFhMV8wLTEtMS0xLTA_a64a35de-3d22-4578-a6a4-381f2cc6d300">05-0494040</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:17.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.133%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MTY2MDM5Y2QwZjI2NDVhOWE1YzQ0Y2RmOGVlMzY5MmYvdGFibGVyYW5nZToxNjYwMzljZDBmMjY0NWE5YTVjNDRjZGY4ZWUzNjkyZl8wLTAtMS0xLTA_e855857d-2b27-45be-b084-a31a5ac3c4c3">One CVS Drive,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MTY2MDM5Y2QwZjI2NDVhOWE1YzQ0Y2RmOGVlMzY5MmYvdGFibGVyYW5nZToxNjYwMzljZDBmMjY0NWE5YTVjNDRjZGY4ZWUzNjkyZl8wLTEtMS0xLTA_8a16bfe5-0cdf-4061-8f1d-d3a3e616ee5d">Woonsocket,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MTY2MDM5Y2QwZjI2NDVhOWE1YzQ0Y2RmOGVlMzY5MmYvdGFibGVyYW5nZToxNjYwMzljZDBmMjY0NWE5YTVjNDRjZGY4ZWUzNjkyZl8wLTItMS0xLTA_3ac0a6ae-52a8-432f-8178-8ee367fde74f">Rhode Island</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MTY2MDM5Y2QwZjI2NDVhOWE1YzQ0Y2RmOGVlMzY5MmYvdGFibGVyYW5nZToxNjYwMzljZDBmMjY0NWE5YTVjNDRjZGY4ZWUzNjkyZl8wLTMtMS0xLTA_1b29cfc5-bd15-4594-bb2d-9484079ac787">02895</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.194%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Registrant&#8217;s telephone number, including area code:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6Y2QzZmUzYjI1YTI1NDA2Y2EwZDhmNzczNjY0MDQyYTMvdGFibGVyYW5nZTpjZDNmZTNiMjVhMjU0MDZjYTBkOGY3NzM2NjQwNDJhM18wLTEtMS0xLTA_2f844f8e-1b3b-4e6b-89f5-dd6b31c6d14c">(401)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6Y2QzZmUzYjI1YTI1NDA2Y2EwZDhmNzczNjY0MDQyYTMvdGFibGVyYW5nZTpjZDNmZTNiMjVhMjU0MDZjYTBkOGY3NzM2NjQwNDJhM18wLTItMS0xLTA_75de1f65-0206-41a8-b70d-15fabdf20e08">765-1500</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MGEzNzdkNmVhZWM0NDk0NmI2YTBiZjJkY2I3ZjViZmUvdGFibGVyYW5nZTowYTM3N2Q2ZWFlYzQ0OTQ2YjZhMGJmMmRjYjdmNWJmZV8yLTAtMS0xLTA_c96499ba-2754-4640-b25d-5dd22d0e8cf6">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MGEzNzdkNmVhZWM0NDk0NmI2YTBiZjJkY2I3ZjViZmUvdGFibGVyYW5nZTowYTM3N2Q2ZWFlYzQ0OTQ2YjZhMGJmMmRjYjdmNWJmZV8yLTEtMS0xLTA_015e3764-51c4-4f3f-abaa-63e8befe905e">CVS</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MGEzNzdkNmVhZWM0NDk0NmI2YTBiZjJkY2I3ZjViZmUvdGFibGVyYW5nZTowYTM3N2Q2ZWFlYzQ0OTQ2YjZhMGJmMmRjYjdmNWJmZV8yLTItMS0xLTA_286262ef-21a1-4f57-85bc-89f1b037eed5">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(g) of the Act:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">None</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.197%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.849%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.197%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF8wLTUtMS0xLTA_68e9c390-a7f6-4322-b712-05efc277474c">Yes</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">No</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF8xLTctMS0xLTA_49b45ad6-36eb-4bd9-a948-5659d728b27a">No</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF8yLTUtMS0xLTA_cb6c04c0-056c-40f2-b4bb-4cb446f848f0">Yes</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">No</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF8zLTUtMS0xLTA_589a3fa3-4303-4392-82d8-f193b75e2ab9">Yes</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">No</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF81LTAtMS0xLTA_e5d8b1c7-ddec-4d6d-9386-263d4307e0f2">Large accelerated filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF82LTctMS0xLTA_99e99e0d-7c07-45da-b014-6d07af3f0a09">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF83LTctMS0xLTA_e20a0cd6-7432-4d69-9d9f-5d37fe5ec9af">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C 7262(b)) by the registered public accounting firm that prepared or issued its audit report.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF85LTctMS0xLTE5Mzg4_a478dc0e-8d50-43f1-a0ab-a78bd63ac607">&#9745;</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF85LTQtMS0xLTA_1a22288b-8522-4c89-91fc-d1a3a109062e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">No</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s common stock held by non-affiliates was approximately $<ix:nonFraction unitRef="usd" contextRef="i41f59795c714410e9809b7c4aef691c6_I20200630" decimals="0" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl81OTk_c83d0b4a-7456-4cb5-9be7-8b5e5e1bcd80">84,719,366,378</ix:nonFraction> as of June&#160;30, 2020, based on the closing price of the common stock on the New York Stock Exchange. For purposes of this calculation, only executive officers and directors are deemed to be affiliates of the registrant.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of February&#160;8, 2021, the registrant had <ix:nonFraction unitRef="shares" contextRef="ifbc4ad88529244e7ae1cef69ab7110a5_I20210208" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl84NjU_5662beed-190a-4dd6-b153-5e91484da1b9">1,311,354,926</ix:nonFraction> shares of common stock outstanding.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8xMzgx_a7656bb5-4857-4710-a03e-26432b5caaeb" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following materials are incorporated by reference into this Form 10-K:</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information contained in the definitive proxy statement for CVS Health Corporation&#8217;s 2021 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year ended December 31, 2020 (the &#8220;Proxy Statement&#8221;), is incorporated by reference in Parts III and IV to the extent described therein.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.903%"><tr><td style="width:1.0%"></td><td style="width:20.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.489%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic31760c417ad433094d37b2420225748_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.649%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part&#160;I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_31">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_31">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1B:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_34">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_34">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_37">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_37">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_40">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_40">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_43">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_43">62</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_46">Information about our Executive Officers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_46">63</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part&#160;II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_52">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_52">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_55">Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_55">65</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_58">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_58">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7A:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_91">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_91">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;8:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_94">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_94">100</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_211">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_211">176</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9A:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_214">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_214">176</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9B:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_217">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_217">177</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part&#160;III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;10:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_223">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_223">177</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;11:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_226">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_226">177</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;12:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_229">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_229">177</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;13:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_232">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_232">178</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;14:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_235">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_235">178</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part&#160;IV</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;15:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_241">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_241">179</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_244">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_244">183</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_247">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_247">184</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic31760c417ad433094d37b2420225748_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, references to the terms &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221; used throughout this Annual Report on Form 10-K (this &#8220;10-K&#8221;) refer to CVS Health Corporation (a Delaware corporation) (&#8220;CVS Health&#8221;) and its subsidiaries (collectively, the &#8220;Company&#8221;). References to competitors and other companies throughout this 10-K, including the information incorporated herein by reference, are for illustrative or comparison purposes only and do not indicate that these companies are the Company&#8217;s or any segment&#8217;s only competitors or closest competitors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Private Securities Litigation Reform Act of 1995 (the &#8220;Reform Act&#8221;) provides a &#8220;safe harbor&#8221; for forward-looking statements, so long as (1) those statements are identified as forward-looking, and (2) the statements are accompanied by meaningful cautionary statements that identify important factors that could cause actual results to differ materially from those discussed in the statement. We want to take advantage of these safe harbor provisions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain information contained in this 10-K is forward-looking within the meaning of the Reform Act or SEC rules. This information includes, but is not limited to: &#8220;Outlook for 2021&#8221; of Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) included in Item 7, &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; included in Item 7A, &#8220;Government Regulation&#8221; included in Item 1, and &#8220;Risk Factors&#8221; included in Item 1A. In addition, throughout this 10-K and our other reports and communications, we use the following words or variations or negatives of these words and similar expressions when we intend to identify forward-looking statements:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Anticipates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Believes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Can</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Continue</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Could</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Estimates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Evaluate</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Expects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Explore</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Forecast</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Guidance</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Intends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Likely</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">May</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Might</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Outlook</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Potential</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Predict</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Probable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Projects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Seeks</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Should</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">View</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Will</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">All statements addressing the future operating performance of CVS Health or any segment or any subsidiary and/or future events or developments, including statements relating to the projected impact of coronavirus disease 2019 (&#8220;COVID-19&#8221;) on the Company&#8217;s businesses, investment portfolio, operating results, cash flows and/or financial condition, statements relating to corporate strategy, statements relating to future revenue, operating income or adjusted operating income, earnings per share or adjusted earnings per share, Pharmacy Services segment business, sales results and/or trends and/or operations, Retail/LTC segment business, sales results and/or trends and/or operations, Health Care Benefits segment business, sales results and/or trends, medical cost trends, medical membership, Medicare Part D membership, medical benefit ratios and/or operations, incremental investment spending, interest expense, effective tax rate, weighted-average share count, cash flow from operations, net capital expenditures, cash available for debt repayment, integration synergies, net synergies, integration costs, enterprise modernization, transformation, leverage ratio, cash available for enhancing shareholder value, inventory reduction, turn rate and/or loss rate, debt ratings, the Company&#8217;s ability to attract or retain customers and clients, store development and/or relocations, new product development, and the impact of industry and regulatory developments, as well as statements expressing optimism or pessimism about future operating results or events, are forward-looking statements within the meaning of the Reform Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements rely on a number of estimates, assumptions and projections concerning future events, and are subject to a number of significant risks and uncertainties and other factors that could cause actual results to differ materially from those statements. Many of these risks and uncertainties and other factors are outside our control. Certain of these risks and uncertainties and other factors are described under &#8220;Risk Factors&#8221; included in Item 1A of this 10-K; these are not the only risks and uncertainties we face. There can be no assurance that the Company has identified all the risks that affect it. Additional risks and uncertainties not presently known to the Company or that the Company currently believes to be immaterial also may adversely affect the Company&#8217;s businesses. If any of those risks or uncertainties develops into actual events, those events or circumstances could have a material adverse effect on the Company&#8217;s businesses, operating results, cash flows, financial condition and/or stock price, among other effects. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should not put undue reliance on forward-looking statements. Any forward-looking statement speaks only as of the date of this 10-K, and we disclaim any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.  Business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), is a diversified health services company united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. The Company has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 105 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. We also serve an estimated 34 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2018 (the &#8220;Aetna Acquisition Date&#8221;), the Company acquired Aetna Inc. (&#8220;Aetna&#8221;). As a result of the acquisition of Aetna (the &#8220;Aetna Acquisition&#8221;), the Company added the Health Care Benefits segment. Certain aspects of Aetna&#8217;s operations, including products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products, are included in the Company&#8217;s Corporate/Other segment. The consolidated financial statements reflect Aetna&#8217;s results subsequent to the Aetna Acquisition Date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has severely impacted the economies of the U.S. and other countries around the world. Beginning in March 2020, the effects of the COVID-19 pandemic began to emerge in the U.S. The Company executed preparedness plans to maintain continuity of its operations, including transitioning many office-based colleagues to a remote work environment and installing protective equipment in our retail pharmacies. The Company also provided enhanced benefits to its colleagues, including bonuses to frontline colleagues, dependent care financial assistance, paid sick leave for part-time colleagues and paid time off to colleagues who test positive or are quarantined due to exposure to COVID-19. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strong local presence and scale in communities across the country enabled us to play an indispensable role in the national response to COVID-19, as well as provide seamless support for our customers wherever they needed us: in our CVS locations, in their homes, and virtually. The Company offered COVID-19 diagnostic testing at more than 4,000 CVS Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> locations as of December 31, 2020 and launched critical diagnostic testing for the vulnerable senior population in long-term care facilities in partnership with three states. The Company was also selected to administer COVID-19 vaccines in both long-term care facilities and its retail pharmacies. The Company began administering COVID-19 vaccinations in long-term care facilities and in certain of its retail pharmacies during December 2020 and February 2021, respectively, and expects to play a significant role in COVID-19 vaccine administration in the future. In the Health Care Benefits segment, the Company also expanded benefit coverage to its members, including cost-sharing waivers for COVID-19 related treatments, as well as assistance to members through premium credits, telehealth cost-sharing waivers and other investments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition in the year ended December 31, 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this 10-K.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_16"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care (&#8220;Managed Medicaid&#8221;) plans, plans offered on public health insurance exchanges (&#8220;Public Exchanges&#8221;) and private health insurance exchanges (&#8220;Private Exchanges&#8221; and together with Public Exchanges, &#8220;Insurance Exchanges&#8221;) and other sponsors of health benefit plans throughout the United States. The </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmacy Services segment includes retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. During the year ended December&#160;31, 2020, the Company&#8217;s PBM filled or managed 2.1 billion prescriptions on a 30-day equivalent basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PBM Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company dispenses prescription drugs directly through its mail order dispensing and specialty mail order pharmacies and through pharmacies in its retail network. All prescriptions processed by the Company are analyzed, processed and documented by the Company&#8217;s proprietary prescription management systems. These systems provide essential features and functionality to allow plan members to utilize their prescription drug benefits. These systems also streamline the process by which prescriptions are processed by staff and network pharmacists by enhancing review of various items through automation, including plan eligibility, early refills, duplicate dispensing, appropriateness of dosage, drug interactions or allergies, over-utilization and potential fraud.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Design Offerings and Administration</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company administers pharmacy benefit plans for clients who contract with it to facilitate prescription drug coverage and claims processing for their eligible plan members. The Company assists its PBM clients in designing pharmacy benefit plans that help improve health outcomes while minimizing the costs to the client. The Company also assists PBM clients in monitoring the effectiveness of their plans through frequent, informal communications, the use of proprietary software, as well as through formal annual, quarterly and sometimes monthly performance reviews.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes recommendations to help PBM clients design benefit plans that promote the use of lower cost, clinically appropriate drugs and helps its PBM clients control costs by recommending plan designs that encourage the use of generic equivalents of brand name drugs when such equivalents are available. Clients also have the option, through plan design, to further lower their pharmacy benefit plan costs by setting different member payment levels for different products on their drug lists or &#8220;formularies,&#8221; which helps guide members to choose lower cost alternatives through appropriate financial incentives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Formulary Management</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes an independent panel of doctors, pharmacists and other medical experts, referred to as the CVS Caremark National Pharmacy and Therapeutics Committee, to review and approve the selection of drugs that meet the Company&#8217;s standards of safety and efficacy for inclusion on one of the Company&#8217;s template formularies. The Company&#8217;s formularies provide recommended products in numerous drug classes to help ensure member access to clinically appropriate drugs with alternatives within a class under the client&#8217;s pharmacy benefit plan, while helping to drive the lowest net cost for clients that select one of the Company&#8217;s formularies. To help improve clinical outcomes for members and clients, the Company conducts ongoing, independent reviews of all drugs, including those appearing on the formularies and generic equivalent products. Many of the Company&#8217;s clients choose to adopt a template formulary offering as part of their plan design. PBM clients are given capabilities to offer real time benefits information for a member&#8217;s specific plan design, provided digitally at the point of prescribing, at the pharmacy and directly to members.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail Pharmacy Network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a national network of approximately 66,000 retail pharmacies, consisting of approximately 40,000 chain pharmacies (which includes CVS Pharmacy locations) and approximately 26,000 independent pharmacies, in the United States, including Puerto Rico, the District of Columbia, Guam and the U.S. Virgin Islands. When a customer fills a prescription in a retail pharmacy, the pharmacy sends prescription data electronically to the Company from the point-of-sale. This data interfaces with the Company&#8217;s proprietary prescription management systems, which verify relevant plan member data and eligibility, while also performing a drug utilization review to help evaluate clinical appropriateness and safety and confirming that the pharmacy will receive payment for the prescription. The Company also offers a performance program for non-Medicare customers, which can be implemented with either the Company&#8217;s broad, national network or with any managed network (as allowed by applicable laws and regulations). Under the program, high performing pharmacies are eligible to receive an incremental positive performance payment. The program aligns with key Healthcare Effectiveness Data Information Set measures utilized by the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) and is funded by client fees.&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mail Order Pharmacy Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment operates mail order dispensing pharmacies in the United States. Plan members or their prescribers submit prescriptions or refill requests, primarily for maintenance medications, to these pharmacies, and staff pharmacists review these prescriptions and refill requests with the assistance of the Company&#8217;s prescription management systems. This review may involve communications with the prescriber and, with the prescriber&#8217;s approval when required, can result in generic substitution, therapeutic interchange or other actions designed to help reduce cost and/or improve quality of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treatment. The Company&#8217;s mail order dispensing pharmacies have been awarded Mail Service Pharmacy accreditation from URAC, a health care accrediting organization that establishes quality standards for the health care industry.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Specialty Pharmacy and Infusion Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment operates specialty mail order pharmacies, retail specialty pharmacy stores and branches for infusion and enteral nutrition services in the United States. The specialty mail order pharmacies are used for delivery of advanced medications to individuals with chronic or genetic diseases and disorders. The Company&#8217;s specialty mail order pharmacies also have been awarded Specialty Pharmacy accreditation from URAC. Substantially all of the Company&#8217;s specialty mail order pharmacies also have been accredited by The Joint Commission, which is an independent, not-for-profit organization that accredits and certifies health care programs and organizations in the United States. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clinical Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers multiple clinical programs and services to help clients manage overall pharmacy and health care costs in a clinically appropriate manner. These programs are primarily designed to promote better health outcomes and to help target inappropriate medication utilization and non-adherence to medication, each of which may result in adverse medical events that negatively affect member health and client pharmacy and medical spend. These programs include utilization management (&#8220;UM&#8221;), medication management, quality assurance, adherence and counseling programs to complement the client&#8217;s plan design and clinical strategies. To help address prescription opioid abuse and misuse, the Company introduced an industry-leading UM approach that limits to seven days the supply of opioids dispensed for certain acute prescriptions for patients who are new to therapy, limits the daily dosage of opioids dispensed based on the strength of the opioid and requires the use of immediate-release formulations of opioids before extended-release opioids are dispensed. The Company&#8217;s Pharmacy Advisor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> program facilitates pharmacist counseling, both face-to-face and over the telephone, to help participating plan members with certain chronic diseases, such as diabetes and cardiovascular conditions, to identify gaps in care, adhere to their prescribed medications and manage their health conditions. The Company also has digital connectivity that helps to lower drug costs for patients by providing expanded visibility to lower cost alternatives through enhanced analytics and data sharing. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disease Management Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s clinical programs and services utilize advanced protocols and offer clients convenience in working with health care providers (&#8220;providers&#8221;) and other third parties. The Company&#8217;s UM program covers diseases such as rheumatoid arthritis, Parkinson&#8217;s disease, seizure disorders and multiple sclerosis and is accredited by the National Committee for Quality Assurance (&#8220;NCQA&#8221;), a private, not-for-profit organization that evaluates, accredits and certifies a wide range of health care organizations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s NovoLogix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">online preauthorization tool helps identify and capture cost savings opportunities for specialty drugs billed under the medical benefit by identifying outliers to appropriate dosages and costs, and helps to ensure clinically appropriate use of specialty drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Group Purchasing Organization Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants. The Company also provides various administrative, management and reporting services to pharmaceutical manufacturers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Services Information Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment&#8217;s claim adjudication platform incorporates architecture that centralizes the data generated from filling mail order prescriptions, adjudicating retail pharmacy claims and delivering other solutions to PBM clients. The Health Engagement Engine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology and proprietary clinical algorithms help connect the various parts of the enterprise and serve an essential role in cost management and health improvement, leveraging cloud-native technologies and practices. This capability transforms pharmacy data into actionable interventions at key points of care, including in retail, mail and specialty pharmacies as well as in customer care call center operations, leveraging our enterprise data platform to improve the quality of care. The technology leverages assisted artificial intelligence to deliver insights to the business and bring automation to otherwise manual tasks. Specialty services also connects with our claim adjudication platform and various health plan adjudication platforms with a centralized architecture servicing many clients and members. Operating services, such as Specialty Expedite</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, provide an interconnected onboarding solution for specialty medications and branding solutions ranging from fulfillment to total patient management. These services are managed through our new innovative specialty workflow and web platform.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Services Clients</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Pharmacy Services clients are primarily employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, Managed Medicaid plans and plans offered on Insurance Exchanges and other sponsors of health benefit plans throughout the United States. Pharmaceuticals are provided to eligible members in benefit plans maintained by clients and utilize the Company&#8217;s information systems, among other things, to help perform safety checks, drug interaction screening and identify opportunities for generic substitution. Substantially all of the Pharmacy Services segment&#8217;s revenues are generated from dispensing and managing prescription drugs to eligible members in benefit plans maintained by clients. In 2018, revenues from Aetna accounted for approximately 9.8% of the Company&#8217;s consolidated total revenues. On the Aetna Acquisition Date, Aetna became a wholly-owned subsidiary of CVS Health. Subsequent to the Aetna Acquisition Date, revenues from Aetna continue to be reported in the Pharmacy Services segment; however, these revenues are eliminated in the consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Services Seasonality</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of Pharmacy Services segment revenues are not seasonal in nature. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Services Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the primary competitive factors in the pharmacy services industry include: (i)&#160;the ability to negotiate favorable discounts from drug manufacturers as well as to negotiate favorable discounts from, and access to, retail pharmacy networks; (ii)&#160;the ability to identify and apply effective cost management programs utilizing clinical strategies, including&#160;the development and utilization of preferred formularies; (iii)&#160;the ability to market PBM products and services; (iv)&#160;the commitment to provide flexible, clinically-oriented services to clients and be responsive to clients&#8217; needs; (v)&#160;the quality, scope and costs of products and services offered to clients and their members; and (vi) operational excellence in delivering services. The Pharmacy Services segment has a significant number of competitors offering PBM services, including large, national PBM companies (e.g., Prime Therapeutics and MedImpact), PBMs owned by large national health plans (e.g., the Express Scripts business of Cigna Corporation and the OptumRx business of UnitedHealth) and smaller standalone PBMs. </span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December&#160;31, 2020, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. During the year ended December&#160;31, 2020, the Retail/LTC segment filled 1.5 billion prescriptions on a 30-day equivalent basis. For the year ended December&#160;31, 2020, the Company dispensed approximately 27.1% of the total retail pharmacy prescriptions in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retail/LTC Products and Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A typical retail store sells prescription drugs and a wide assortment of high-quality, nationally advertised brand name and proprietary brand merchandise. Front store categories include over-the-counter drugs, consumer health products, beauty products and personal care products. LTC operations include distribution of prescription drugs and related consulting and ancillary services. The Company purchases merchandise from numerous manufacturers and distributors. The Company believes that competitive sources are readily available for substantially all of the products carried in its retail stores and the loss of any one supplier would not likely have a material effect on the Retail/LTC segment. The Company&#8217;s MinuteClinic locations offer a variety of health care services.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retail/LTC revenues by major product group are as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage&#160;of&#160;Revenues</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front store and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy includes LTC sales and sales in pharmacies within Target Corporation (&#8220;Target&#8221;) and other retail stores.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">&#8220;Other&#8221; represents less than 10% of the &#8220;Front store and other&#8221; revenue category.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmacy revenues represented approximately three-fourths of Retail/LTC segment revenues in each of 2020, 2019 and 2018. The Company believes that retail pharmacy operations will continue to represent a critical part of the Company&#8217;s business due to industry demographics, e.g., an aging American population consuming a greater number of prescription drugs, prescription drugs being used more often as the first line of defense for managing illness, the introduction of new pharmaceutical products, the need for vaccinations and Medicare Part&#160;D growth. The Company believes the retail pharmacy business benefits from investment in both people and technology, as well as innovative collaborations with health plans, PBMs and providers. Given the nature of prescriptions, consumers want their prescriptions filled accurately by professional pharmacists using the latest tools and technology, and ready when promised. Consumers also need medication management programs and better information to help them get the most out of their health care dollars. To assist consumers with these needs, the Company has introduced integrated pharmacy health care services that provide an earlier, easier and more effective approach to engaging consumers in behaviors that can help lower costs, improve health and save lives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Front Store</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front store revenues reflect the Company&#8217;s strategy of innovating with new and unique products and services, using innovative personalized marketing and adjusting the mix of merchandise to match customers&#8217; needs and preferences. A key component of the front store strategy is the ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;card program, which is one of the largest and most successful retail loyalty programs in the United States. The ExtraCare program allows the Company to balance marketing efforts so it can reward its best customers by providing them with automatic sale prices, customized coupons, ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;rewards and other benefits. The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. The Company continues to launch and enhance new and exclusive brands to create unmatched offerings in beauty products and deliver other unique product offerings, including a full range of high-quality CVS Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and other proprietary brand products that are only available through CVS stores. The Company currently carries approximately 6,000 CVS Health and proprietary brand products, which accounted for approximately 24% of front store revenues during 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MinuteClinic</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company operated approximately 1,100 MinuteClinic&#160;locations in the United States. The clinics are staffed by nurse practitioners and physician assistants who utilize nationally established guidelines to deliver a variety of health care services. Payors value these clinics because they provide convenient, high-quality, cost-effective care, in many cases offering an attractive alternative to more expensive sites of care.&#160;MinuteClinic is collaborating with the Pharmacy Services and Health Care Benefits segments to help meet the needs of CVS Caremark&#8217;s client plan members and the Company&#8217;s health plan members by offering programs that can improve member health and lower costs. MinuteClinic also maintains relationships with leading hospitals, clinics and physicians in the communities we serve to support and enhance quality, access and continuity of care. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">On-site Pharmacies</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also operates a limited number of pharmacies located at client sites, which provide certain health plan members and customers with a convenient alternative for filling their prescriptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Diagnostic Testing</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides medical diagnostic testing primarily through its COVID-19 testing sites located at CVS Pharmacy locations as well as in long-term care facilities, at community-based testing sites in underserved areas, large-scale rapid test sites in select states, and through its Return Ready</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">solution.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Care Pharmacy Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment provides LTC pharmacy services through the Omnicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> business. Omnicare&#8217;s customers consist of skilled nursing facilities, assisted living facilities, independent living communities, hospitals, correctional facilities, and other health care service providers. The Company provides pharmacy consulting, including monthly patient drug therapy evaluations, to assist in compliance with state and federal regulations and provide proprietary clinical and health management programs. It also provides pharmaceutical case management services for retirees, employees and dependents who have drug benefits under corporate-sponsored health care programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Community Location Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The addition of new community locations has played, and will continue to play, a key role in the Company&#8217;s continued growth and success. The Company&#8217;s community location development program focuses on three areas: entering new service areas, adding locations within existing service areas and relocating to more convenient sites. During 2020, the Company opened approximately 55 new community locations, relocated approximately 20 locations, converted approximately 600 locations into HealthHUB</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and closed approximately 90 locations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operated over 650 HealthHUB locations as of December 31, 2020. HealthHUBs have a redesigned format that provide enhanced services, offer a care concierge and focus on health and wellness products. HealthHUBs are designed to meet consumer needs and improve the customer experience by providing care that complements physician practices and hospital systems, enabling improved health outcomes and reducing overall health care costs. The Company expects to continue HealthHUB conversions through 2021 and into 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the last five years, the Company opened approximately 640 new and relocated retail pharmacies, and acquired approximately 225 locations. The Company believes that continuing to assess the appropriateness of its national footprint and identifying more accessible locations are essential components of competing effectively in the current health care environment. As a result, the Company believes that its community location development program is an integral part of its ability to meet the needs of customers and maintain its leadership position in the pharmacy marketplace given the changing health care landscape. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retail/LTC Information Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has continued to invest in information systems to enable it to deliver exceptional customer service, enhance safety and quality, and expand patient care services while lowering operating costs. The proprietary WeCARE Workflow tool supports pharmacy teams by prioritizing work to meet customer expectations, facilitating prescriber outreach, and seamlessly integrating clinical programs. This solution delivers improved efficiency and enhances customer experience, as well as provides a framework to accommodate the evolution of pharmacy practice and the expansion of clinical programs. Our Health Engagement Engine technology and data science clinical algorithms enable the Company to help identify opportunities for pharmacists to deliver face-to-face counseling regarding patient health and safety matters, including medication adherence issues, gaps in care and management of certain chronic health conditions. The Company&#8217;s digital strategy is to empower the consumer to navigate their pharmacy experience and manage their condition through integrated online and mobile solutions that offer utility and convenience. The Company&#8217;s LTC digital technology suite, Omniview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, improves the efficiency of customers&#8217; operations with tools that include executive dashboards, pre-admission pricing, electronic ordering of prescription refills, proof-of-delivery tracking, access to patient profiles, receipt and management of facility bills, and real-time validation of Medicare Part D coverage, among other capabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retail/LTC Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of the Retail/LTC segment&#8217;s businesses is dependent upon the Company&#8217;s ability to establish and maintain contractual relationships with pharmacy benefit managers and other payors on acceptable terms. Substantially all of the Retail/LTC segment&#8217;s pharmacy revenues are derived from pharmacy benefit managers, managed care organizations (&#8220;MCOs&#8221;), government funded health care programs, commercial employers and other third-party payors. No single Retail/LTC payor accounted for 10% or more of the Company&#8217;s consolidated total revenues in 2020, 2019 or 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retail/LTC Seasonality</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of Retail/LTC segment revenues, particularly pharmacy revenues, generally are not seasonal in nature. However, front store revenues tend to be higher during the December holiday season. In addition, both pharmacy and front store revenues are affected by the timing and severity of the cough, cold and flu season. Uncharacteristic or extreme weather conditions also can adversely affect consumer shopping patterns and Retail/LTC revenues, expenses and operating results.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the quarterly earnings progression was also impacted by COVID-19. During March 2020, the Company experienced greater use of 90-day prescriptions, early refills of maintenance medications and increased front store volume as consumers prepared for the COVID-19 pandemic. Subsequent to March 2020, the Company experienced reduced customer traffic in its retail pharmacies and MinuteClinic locations due to shelter-in-place orders as well as reduced new therapy prescriptions as a result of the COVID-19 pandemic. Beginning in the third quarter, the Company saw an increase in diagnostic testing related to the COVID-19 pandemic and in December 2020, the Company began administering COVID-19 vaccinations in long-term care facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retail/LTC Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The retail pharmacy business is highly competitive. The Company believes that it competes principally on the basis of: (i)&#160;store location and convenience, (ii)&#160;customer service and satisfaction, (iii)&#160;product selection and variety, and (iv)&#160;price. In the areas it serves, the Company competes with other drugstore chains (e.g., Walgreens and Rite Aid), supermarkets, discount retailers (e.g., Walmart), independent pharmacies, restrictive pharmacy networks, membership clubs,&#160;internet companies (e.g., Amazon), and retail health clinics (including urgent care centers), as well as mail order dispensing pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LTC pharmacy services are highly regional or local in nature, and within a given geographic area of operation, highly competitive. The Company&#8217;s largest LTC pharmacy competitor nationally is PharMerica. The Company also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities and local retail pharmacies. Some states have enacted &#8220;freedom of choice&#8221; or &#8220;any willing provider&#8221; requirements as part of their state Medicaid programs or in separate legislation, which may increase the competition that the Company faces in providing services to long-term care facility residents in these states.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_22"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers, serving an estimated 34 million people as of December&#160;31, 2020. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology (&#8220;HIT&#8221;) products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. For periods prior to the Aetna Acquisition Date, the Health Care Benefits segment was comprised only of the Company&#8217;s SilverScript</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> PDP business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Products and Services </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk of medical and dental care costs) as &#8220;ASC.&#8221; Health Care Benefits products and services consist of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Commercial Medical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Health Care Benefits segment offers point-of-service (&#8220;POS&#8221;), preferred provider organization (&#8220;PPO&#8221;), health maintenance organization (&#8220;HMO&#8221;) and indemnity benefit (&#8220;Indemnity&#8221;) plans. Commercial medical products also include health savings accounts (&#8220;HSAs&#8221;) and consumer-directed health plans that combine traditional POS or PPO and/or dental coverage, subject to a deductible, with an accumulating benefit account (which may be funded by the plan sponsor and/or the member in the case of HSAs). Principal products and services are targeted specifically to large multi-site national, mid-sized and small employers, individual insureds and expatriates. The Company offers medical stop loss insurance coverage for certain employers who elect to self-insure their health benefits. Under medical stop loss insurance products, the Company assumes risk for costs associated with large individual claims and/or aggregate loss experience within an employer&#8217;s plan above a pre-set annual threshold.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Government Medical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In select geographies, the Health Care Benefits segment offers Medicare Advantage plans, Medicare Supplement plans and prescription drug coverage for Medicare beneficiaries; participates in Medicaid and subsidized Children&#8217;s Health Insurance Programs (&#8220;CHIP&#8221;); and participates in demonstration projects for members who are eligible for both Medicare and Medicaid (&#8220;Duals&#8221;). These Government Medical products are further described below:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare Advantage: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through annual contracts with CMS, the Company offers HMO and PPO products for eligible individuals in certain geographic areas through the Medicare Advantage program. Members typically receive enhanced benefits over traditional fee-for-service Medicare coverage (&#8220;Original Medicare&#8221;), including reduced cost-sharing for preventive care, vision and other services. The Company offered network-based HMO and/or PPO plans in 45 states and Washington, D.C. in 2020. The Company has expanded to 46 states and Washington, D.C. for 2021. For certain qualifying employer groups, the Company&#160;offers Medicare PPO products nationally. When combined with the Company&#8217;s PDP product,&#160;these national PPO plans&#160;form an integrated national Insured Medicare product for employers that provides medical and pharmacy benefits.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare PDP: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a national provider of drug benefits under the Medicare Part D prescription drug program. All Medicare eligible individuals are eligible to participate in this voluntary prescription drug plan. Members typically receive coverage for certain prescription drugs, usually subject to a deductible, co-insurance and/or co-payment. On November 30, 2018, the Company completed the sale of Aetna&#8217;s standalone PDPs to WellCare Health Plans, Inc. effective December 31, 2018. The Company provided administrative services to, and retained the financial results of, the divested plans through 2019. Subsequent to 2019, the Company no longer retains the financial results of the divested plans. </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare Supplement: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain Medicare eligible members, the Company offers&#160;supplemental&#160;coverage for certain health care costs not covered by&#160;Original Medicare. The products included in the Medicare Supplement portfolio help to cover&#160;some of the&#160;gaps in Original Medicare, and include coverage for Medicare&#160;deductibles and coinsurance&#160;amounts. The Company offered a&#160;wide selection of Medicare Supplement products in 49 states and Washington, D.C. in 2020.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medicaid and CHIP:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company offers health care management services to individuals eligible for Medicaid and CHIP under multi-year contracts with government agencies in various states that are subject to annual appropriations. CHIP are state-subsidized insurance programs that provide benefits for families with uninsured children. The Company offered these services on an Insured or ASC basis in 16 states in 2020.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Duals: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides health coverage to beneficiaries who are dually eligible for both Medicare and Medicaid coverage. These members must meet certain income and resource requirements in order to qualify for this coverage. The Company coordinates 100% of the care for these members and may provide them with additional services in order to manage their health care costs. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Specialty and Strategic Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Health Care Benefits segment has a portfolio of additional health products and services that complement its medical products such as dental plans, behavioral health and employee assistance products, provider network access and vision products. The Company also has a portfolio of transformative products and services aimed at creating a holistic and integrated approach to individual health and wellness. These products and services complement the Commercial Medical and Government Medical products and aim to provide innovative solutions, create integrated experience offerings and enable enhanced care delivery to customers. </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Provider Networks </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contracts with physicians, hospitals and other providers for services they provide to the Company&#8217;s members. The Company uses a variety of techniques designed to help encourage appropriate utilization of medical services (&#8220;utilization&#8221;) and maintain affordability of quality coverage. In addition to contracts with providers for negotiated rates of reimbursement, these techniques include creating risk sharing arrangements that align economic incentives with providers, the development and implementation of guidelines for the appropriate utilization and the provision of data to providers to enable them to improve health care quality. At December&#160;31, 2020, the Company&#8217;s underlying nationwide provider network had approximately 1.4 million participating providers. Other providers in the Company&#8217;s provider networks also include laboratory, imaging, urgent care and other freestanding health facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Quality Assessment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS uses a 5-star rating system to monitor Medicare health care and drug plans and ensure that they meet CMS&#8217;s quality standards. CMS uses this rating system to provide Medicare beneficiaries with a tool that they can use to compare the overall quality of care and level of customer service of companies that provide Medicare health care and drug plans. The rating system considers a variety of measures adopted by CMS, including quality of preventative services, chronic illness management and overall customer satisfaction. See &#8220;Health Care Benefits Pricing&#8221; below in this Item 1 for further discussion of star ratings. The Company seeks Health Plan accreditation for Aetna HMO plans from the NCQA. Health care plans seeking accreditation must pass a rigorous, comprehensive review and must annually report on their performance.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aetna Life Insurance Company (&#8220;ALIC&#8221;), a wholly-owned subsidiary of the Company, has received nationwide NCQA PPO Health Plan accreditation. As of December&#160;31, 2020, all of the Company&#8217;s Commercial HMO and all of ALIC&#8217;s PPO members who were eligible participated in HMOs or PPOs that are accredited by the NCQA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provider selection and credentialing/re-credentialing policies and procedures are consistent with NCQA and URAC, as well as state and federal, requirements. In addition, the Company is certified under the NCQA Credentials Verification Organization (&#8220;CVO&#8221;) certification program for all certification options and has URAC CVO accreditation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality assessment programs for contracted providers who participate in the Company&#8217;s networks begin with the initial review of health care practitioners. Practitioners&#8217; licenses and education are verified, and their work history is collected by the Company or in some cases by the practitioner&#8217;s affiliated group or organization. The Company generally requires participating hospitals to be certified by CMS or accredited by The Joint Commission, the American Osteopathic Association, or Det Norske Veritas Healthcare.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers quality and outcome measurement programs, quality improvement programs, and health care data analysis systems to providers and purchasers of health care services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Information Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment currently operates and supports an end-to-end suite of information technology platforms to support member engagement, enrollment, health benefit administration, care management, service operations, financial reporting and analytics.&#160;The multiple platforms are supported by an integration layer to facilitate the transfer of real-time data.&#160;There is continued focus and investment in enterprise data platforms, cloud capabilities, digital products to offer innovative solutions and a seamless experience to the Company&#8217;s members through mobile and web channels.&#160;The Company is making concerted investments in emerging technology capabilities such as voice, artificial intelligence and robotics to further automate, reduce cost and improve the experience for all of its constituents. The Health Care Benefits segment is utilizing the full breadth of the Company&#8217;s assets to build enterprise technology that will help guide our members through their health care journey, provide them a high level of service, enable healthier outcomes and encourage them to take next best actions to lead healthier lives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Customers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical membership is dispersed throughout the United States, and the Company also serves medical members in certain countries outside the United States. The Company offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, many of which are available nationwide. Depending on the product, the Company markets to a range of customers including employer groups, individuals, college students, part-time and hourly workers, health plans, providers, governmental units, government-sponsored plans, labor groups and expatriates. For additional information on medical membership, see &#8220;Health Care Benefits Segment&#8221; in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (the &#8220;MD&amp;A&#8221;) included in Item 7 of this 10-K. </span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company markets both Commercial Insured and ASC products and services primarily to employers that sponsor the Company&#8217;s products for the benefit of their employees and their employees&#8217; dependents. Frequently, larger employers offer employees a choice among coverage options, from which the employee makes his or her selection during a designated annual open enrollment period. Typically, employers pay all of the monthly premiums to the Company and, through payroll deductions, obtain reimbursement from employees for a percentage of the premiums that is determined by each employer. Some Health Care Benefits products are sold directly to employees of employer groups on a fully employee-funded basis. In some cases, the Company bills the covered individual directly. </span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers Insured Medicare coverage on an individual basis as well as through employer groups to their retirees. Medicaid and CHIP members are enrolled on an individual basis. The Company also offers Insured health care coverage to members who are dually-eligible for both Medicare and Medicaid. </span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits products are sold through: the Company&#8217;s sales personnel; independent brokers, agents and consultants who assist in the production and servicing of business; and Private Exchanges. For large plan sponsors, independent consultants and brokers are frequently involved in employer health plan selection decisions and sales. In some instances, the Company may pay commissions, fees and other amounts to brokers, agents, consultants and sales representatives who place business with the Company. In certain cases, the customer pays the broker for services rendered, and the Company may facilitate that arrangement by collecting the funds from the customer and transmitting them to the broker. The Company </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">supports marketing and sales efforts with an advertising program that may include television, radio, billboards, print media and social media, supplemented by market research and direct marketing efforts.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. federal government is a significant customer of the Health Care Benefits segment through contracts with CMS for coverage of Medicare-eligible individuals and federal employee-related benefit programs. Other than the contracts with CMS, the Health Care Benefits segment is not dependent upon a single customer or a few customers the loss of which would have a significant effect on the earnings of the segment. The loss of business from any one, or a few, independent brokers or agents would not have a material adverse effect on the earnings of the Health Care Benefits segment. In both 2020 and 2019, Health Care Benefits segment revenues from the federal government accounted for 13% of the Company&#8217;s consolidated total revenues. Contracts with CMS for coverage of Medicare-eligible individuals in the Health Care Benefits segment accounted for approximately 92% of the Company&#8217;s consolidated revenues from the federal government in both 2020 and 2019. No single Health Care Benefits customer accounted for 10% or more of the Company&#8217;s consolidated total revenues in 2018.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Pricing</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Commercial Insured plans, contracts containing the pricing and other terms of the relationship are generally established in advance of the policy period and typically have a duration of one year. Fees under ASC plans are generally fixed for a period of one year.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, a fixed premium rate is determined at the beginning of the policy period for Commercial Insured plans. The Company typically cannot recover unanticipated increases in health care and other benefit costs in the current policy period; however, it may consider prior experience for a product in the aggregate or for a specific customer, among other factors, in determining premium rates for future policy periods. Where required by state laws, premium rates are filed and approved by state regulators prior to contract inception. Future operating results could be adversely affected if the premium rates requested are not approved or are adjusted downward or their approval is delayed by state or federal regulators. </span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has Medicare Advantage and PDP contracts with CMS to provide HMO, PPO and prescription drug coverage to Medicare beneficiaries in certain geographic areas. Under these annual contracts, CMS pays the Company a fixed per member (or &#8220;capitation&#8221;) payment and/or a portion of the premium, both of which are based on membership and adjusted for demographic and health risk factors. CMS also considers inflation, changes in utilization patterns and average per capita fee-for-service Medicare costs in the calculation of the fixed capitation payment or premium. PDP contracts also provide a risk-sharing arrangement with CMS to limit the Company&#8217;s exposure to unfavorable expenses or benefit from favorable expenses. Amounts payable to the Company under the Medicare arrangements are subject to annual revision by CMS, and the Company elects to participate in each Medicare service area or region on an annual basis. Premiums paid to the Company for Medicare products are subject to federal government reviews and audits, which can result, and have resulted, in retroactive and prospective premium adjustments and refunds to the government and/or members. In addition to payments received from CMS, some Medicare Advantage products and all PDP products require a supplemental premium to be paid by the member or sponsoring employer. In some cases these supplemental premiums are adjusted based on the member&#8217;s income and asset levels. Compared to Commercial Medical products, Medicare contracts generate higher per member per month revenues and higher health care and other benefit costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) ties a portion of each Medicare Advantage plan&#8217;s reimbursement to the plan&#8217;s &#8220;star ratings.&#8221; Plans must have a star rating of four or higher (out of five) to qualify for bonus payments. CMS released the Company&#8217;s 2021 star ratings in October 2020. The Company&#8217;s 2021 star ratings will be used to determine which of the Company&#8217;s Medicare Advantage plans have ratings of four stars or higher and qualify for bonus payments in 2022. Based on the Company&#8217;s membership at December&#160;31, 2020, 83% of the Company&#8217;s Medicare Advantage members were in plans with 2021 star ratings of at least 4.0 stars, consistent with 83% of the Company&#8217;s Medicare Advantage members being in plans with 2020 star ratings of at least 4.0 stars based on the Company&#8217;s membership at December 31, 2019.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rates for Medicare Supplement products are regulated at the state level and vary by state and plan.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Insured Medicaid contracts, state government agencies pay the Company fixed monthly rates per member that vary by state, line of business and demographics; and the Company arranges, pays for and manages the health care services provided to Medicaid beneficiaries. These rates are subject to change by each state, and, in some instances, provide for adjustment for health risk factors. CMS requires these rates to be actuarially sound. The Company also receives fees from customers where it provides services under ASC Medicaid contracts. ASC Medicaid contracts generally are for periods of more than one year, and certain of them contain performance incentives and limited financial risk sharing with respect to certain medical, financial </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and operational metrics. Under these arrangements, performance is evaluated annually, with associated financial incentive opportunities, and financial risk share obligations are typically limited to a percentage of the fees otherwise payable to the Company. Payments to the Company under Medicaid contracts are subject to the annual appropriation process in the applicable state.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Duals contracts, the rate setting process is generally established by CMS in partnership with the state government agency participating in the demonstration project. Both CMS and the state government agency may seek premium and other refunds under certain circumstances, including if the Company fails to comply with CMS regulations or other contractual requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers HMO and consumer-directed medical and dental plans to federal employees under the Federal Employees Health Benefits (&#8220;FEHB&#8221;) Program and the Federal Employees Dental and Vision Insurance Program. Premium rates and fees for those plans are subject to federal government review and audit, which can result, and have resulted, in retroactive and prospective premium and fee adjustments and refunds to the government and/or members. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2014, the ACA imposed significant new industry-wide fees, assessments and taxes, including an annual levy known as the health insurer fee (the &#8220;HIF&#8221;). The HIF applies for both 2020 and 2018 and was temporarily suspended for 2019. In December 2019, the HIF was repealed for calendar years after 2020. For additional information on the ACA fees, assessments and taxes, see Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this 10-K. The Company&#8217;s goal is to collect premiums and fees where possible, or solve for, all of the ACA-related fees, assessments and taxes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Seasonality</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods prior to the Aetna Acquisition Date, the Health Care Benefits segment was comprised only of the Company&#8217;s SilverScript PDP business. The quarterly earnings and operating cash flows of the PDP business are impacted by the Medicare Part D benefit design and changes in the composition of PDP membership. The Medicare Part D standard benefit design results in coverage that varies with a member&#8217;s cumulative annual out-of-pocket costs. The benefit design generally results in employers or other entities that sponsor the Company&#8217;s products (&#8220;plan sponsors&#8221;) sharing a greater portion of the responsibility for total prescription drug costs in the early part of the year. As a result, the PDP pay percentage or benefit ratio generally decreases and operating income generally increases as the year progresses. For periods subsequent to the Aetna Acquisition, the Health Care Benefits segment&#8217;s quarterly operating income progression is also impacted by (i) the seasonality of benefit costs which generally increase during the year as Insured members progress through their annual deductibles and out-of-pocket expense limits and (ii) the seasonality of operating expenses, which are generally the highest during the fourth quarter due primarily to spending to support readiness for the start of the upcoming plan year and marketing associated with Medicare annual enrollment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the quarterly earnings progression was also impacted by COVID-19. Beginning in mid-March, the health care system experienced a significant reduction in utilization that is discretionary and the cancellation of elective medical procedures. Utilization remained below historical levels through April, began to recover in May and June and reached more normal levels in the third and fourth quarters, with select geographies impacted by COVID-19 waves. The impact of the deferral of non-essential care was partially offset by COVID-19 testing and treatment costs, as well as planned COVID-19 related investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health care benefits industry is highly competitive, primarily due to a large number of for-profit and not-for-profit competitors, competitors&#8217; marketing and pricing and a proliferation of competing products, including new products that are continually being introduced into the marketplace. New entrants into the marketplace, as well as consolidation within the industry, have contributed to and are expected to intensify the competitive environment. In addition, the rapid pace of change as the industry evolves towards a consumer-focused retail marketplace, including Insurance Exchanges, and the increased use of technology to interact with members, providers and customers, increase the risks the Company currently faces from new entrants and disruptive actions by existing competitors compared to prior periods.</span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the significant factors that distinguish competing health plans include the perceived overall quality (including accreditation status), quality of service, comprehensiveness of coverage, cost (including premium rates, provider discounts and member out-of-pocket costs), product design, financial stability and ratings, breadth and quality of provider networks, ability to offer different provider network options, providers available in such networks, and quality of member support and care management programs. The Company believes that it is competitive on each of these factors. The </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s ability to increase the number of persons covered by its health plans or to increase Health Care Benefits segment revenues is affected by its ability to differentiate itself from its competitors on these factors. Competition may also affect the availability of services from providers, including primary care physicians, specialists and hospitals.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insured products compete with local and regional health care benefits plans, health care benefits and other plans sponsored by other large commercial health care benefit insurance companies, health system owned health plans, new entrants into the marketplace and numerous for-profit and not-for-profit organizations operating under licenses from the Blue Cross and Blue Shield Association. The largest competitor in Medicare products is Original Medicare. Additional Health Care Benefits segment competitors include other types of medical and dental provider organizations, various specialty service providers (including PBM services providers), health care consultants, financial services companies, integrated health care delivery organizations (networks of providers who also coordinate administrative services for and assume insurance risk of their members), third party administrators (&#8220;TPAs&#8221;), HIT companies and, for certain plans, programs sponsored by the federal or state governments. Emerging competitors include start up health care benefits plans, technology companies, provider-owned health plans, new joint ventures (including not-for-profit joint ventures among firms from multiple industries), technology firms, financial services firms that are distributing competing products on their proprietary Private Exchanges, and consulting firms that are distributing competing products on their proprietary Private Exchanges, as well as non-traditional distributors such as retail companies. The Company&#8217;s ability to increase the number of persons enrolled in Insured Commercial Medical products also is affected by the desire and ability of employers to self-fund their health coverage.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment&#8217;s ASC plans compete primarily with other large commercial health care benefit companies, numerous for-profit and not-for-profit organizations operating under licenses from the Blue Cross and Blue Shield Association and TPAs.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment&#8217;s international products compete with local, global and U.S.-based health plans and commercial health care benefit insurance companies, many of whom are licensed in more geographies and have a longer operating history, better brand recognition and greater marketplace presence in one or more geographies.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provider solutions and HIT marketplaces and products are evolving rapidly. The Company competes for provider solutions and HIT business with other large health plans and commercial health care benefit insurance companies as well as information technology companies and companies that specialize in provider solutions and HIT. Many information technology product competitors have longer operating histories, better brand recognition, greater marketplace presence and more experience in developing innovative products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to competitive pressures affecting the Company&#8217;s ability to obtain new customers or retain existing customers, the Health Care Benefits segment&#8217;s medical membership has been and may continue to be adversely affected by adverse and/or uncertain economic conditions and reductions in workforce by existing customers due to adverse and/or uncertain general economic conditions, especially in the United States and industries where such membership is concentrated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Reinsurance</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">currently has</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">several reinsurance agreements with non-affiliated insurers that relate to Health Care Benefits insurance policies. The Company entered into these contracts to reduce the risk of catastrophic losses which in turn reduces capital and surplus requirements. The Company frequently evaluates reinsurance opportunities and refines its reinsurance and risk management strategies on a regular basis.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_25"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_28"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Strategy</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health is a different kind of health care company. As a diversified health services company, CVS Health is focused on its purpose of helping people on their path to better health. In an increasingly connected and digital world, the Company is meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. This broad reach differentiates CVS Health and fosters an increased level of engagement with customers across the country. Through our innovative new products and services that help manage chronic conditions, our HealthHUB care destinations, and our digital solutions, we are making health care more accessible, more affordable and simply better. The Company believes its strategy oriented around the consumer and being present for all the meaningful moments in health will drive long-term sustainable value and place the Company at the forefront of the evolution of health care.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Generic Sourcing Venture</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and Cardinal Health, Inc. (&#8220;Cardinal&#8221;) each have a 50% ownership in Red Oak Sourcing, LLC (&#8220;Red Oak&#8221;), a generic pharmaceutical sourcing entity. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak. Red Oak does not own or hold inventory on behalf of either company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Working Capital Practices</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company funds the growth of its businesses through a combination of cash flow from operations, commercial paper and other short-term borrowings, proceeds from sale-leaseback transactions and long-term borrowings. For additional information on the Company&#8217;s working capital practices, see &#8220;Liquidity and Capital Resources&#8221; in the MD&amp;A included in Item 7 of this 10-K. The majority of the Retail/LTC segment non-pharmacy revenues are paid in cash, or with debit or credit cards. Managed care organizations, pharmacy benefit managers, government funded health care programs, commercial employers and other third party insurance programs, which represent the vast majority of the Company&#8217;s consolidated pharmacy revenues, typically settle in less than 30 days. The remainder of the Company&#8217;s consolidated pharmacy revenues are paid in cash, or with debit or credit cards. Employer groups, individuals, college students, part-time and hourly workers, health plans, providers, governmental units, government-sponsored plans (with the exception of Medicare Part D services, which are described below), labor groups and expatriates, which represent the vast majority of Health Care Benefits segment revenues, typically settle in less than 30 days. As a provider of Medicare Part D services, the Company contracts annually with CMS.&#160;Utilization of services each plan year results in the accumulation of either a receivable from or a payable to CMS. The timing of settlement of the receivable or payable with CMS takes several quarters, which impacts working capital from year to year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At CVS Health, we share a single, clear purpose: helping people on their path to better health. We devote significant time and attention to the attraction, development and retention of colleagues to deliver high levels of service to our customers. Our commitment to them includes a competitive rewards package and programs that support our diverse range of colleagues in rewarding and fulfilling careers. As of December&#160;31, 2020, we employed nearly 300,000 colleagues primarily in the United States including in all 50 states, the District of Columbia and Puerto Rico, approximately 71% of whom were full-time. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe engaged colleagues produce stronger business results and are more likely to build a career with the Company. Each year we conduct an internal engagement survey that provides colleagues with an opportunity to share their opinions and experiences with respect to their role, their team and the enterprise to help our Board of Directors (the &#8220;Board&#8221;) and our management identify areas where we can improve colleague experience. The survey covers a broad range of topics including development and opportunities, diversity management, recognition, performance, well-being, compliance and continuous improvement. In 2020, greater than 80% of our colleagues participated in the engagement survey, of which greater than 80% responded that they were actively engaged.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board and our chief executive officer (&#8220;CEO&#8221;) provide oversight of our human capital strategy, which consists of the following categories: total rewards; diversity, equity and inclusion; colleague development; and health and safety.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Rewards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize how vital our colleagues are to our success and strive to offer comprehensive and competitive wages and benefits to meet the varying needs of our colleagues and their families. The benefits and programs include annual bonuses, 401(k) plans, stock awards, an employee stock purchase plan, health care and insurance benefits, paid time off, flexible work schedules, family leave, dependent care resources, colleague assistance programs and tuition assistance, among many others, depending on eligibility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, we provided enhanced pay and benefits, including bonuses to frontline colleagues, dependent care financial assistance, paid sick leave for part-time colleagues and paid time off to colleagues who test positive or are quarantined due to exposure. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity, Equity &amp; Inclusion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that a diverse workforce creates a healthier, stronger and more sustainable company. We aim to attract, retain and support a diverse workforce that reflects the many customers, patients, members and communities we serve. Our Diversity Management Leadership Council, a cross-functional group of senior leaders appointed by our CEO, works with our Strategic Diversity Management leadership team to intentionally embed diversity across all facets of our business. For our efforts, we have been recognized as a DiversityInc Top 50 Company, named to Bloomberg&#8217;s 2019 Gender-Equality Index and earned a 100 percent score on the Disability Equality Index, meaning the company is recognized as a &#8220;Best Place to Work for Disability Inclusion.&#8221; The Company discloses information on our diversity, equity and inclusion strategy, programs and progress in our annual Corporate Social Responsibility (&#8220;CSR&#8221;) Report.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a foundation of equity, we continuously focus on increasing underrepresented populations across our business. In 2020, 70% of our total colleague population and 52% of our colleagues at the manager level and above self-reported as female. In addition, in 2020 our colleagues reported their race/ethnicity as: White (53%), Black/African American (16%), Hispanic/Latino (15%), Asian (11%) and Other (5%). The appendix to our CSR Report includes additional data on the diversity of our workforce.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diversity management strategy emphasizes workplace representation, inclusion and belonging, talent acquisition and management and a diverse marketplace. We support 15 Colleague Resource Groups (&#8220;CRGs&#8221;) that include more than 22,000 colleagues across the enterprise. These groups represent a wide range of professional, cultural, ethical and personal affinities and interests, as well as formal mentoring programs. Our CRGs provide our colleagues with an opportunity to connect and network with one another through a particular affinity, culture or interest. Each of our CRGs is sponsored by a senior leader. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Colleague Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a number of resources and programs that attract, engage, develop, advance and retain colleagues. Training and development provides colleagues the support they need to perform well in their current role while planning and preparing for future roles. We offer an online orientation program that pairs new hires with seasoned colleagues and the training continues throughout a colleague&#8217;s career through in-person, virtual and self-paced learning at all levels. We also provide mentoring, tools and workshops for colleagues to manage their career development. We offer a variety of management and leadership programs that develop incumbent diverse and other high potential colleagues. Our broad training practices include updated, tech-enabled tools and keep our colleagues informed of new developments in our industry that are relevant to their roles. During the year ended December 31, 2020, our colleagues completed nearly 12&#160;million training courses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our colleague development program also promotes the importance of compliance across our business. Our colleagues demonstrate this commitment through our annual Code of Conduct training, which 100% of active colleagues completed in 2020. In 2020, we launched more than 75 different training courses as part of our annual Enterprise Compliance Training Program.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health &amp; Safety</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a strong commitment to providing a safe working environment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize Safety Service Plans to analyze data and concentrate on key areas of risk to reduce the chance of workplace incidents. We focus on identifying causes and improving performance when workplace incidents occur. We also engage leaders in promoting a culture of safety. With safety task forces in place at each distribution center, we empower leaders and safety business partners to identify policies, procedures and processes that could improve their own operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from the outset of the COVID-19 pandemic, we took a comprehensive approach to managing occupational health and safety challenges presented by the pandemic. We implemented social distancing practices and enhanced cleaning protocols at all of our locations. We launched a COVID-19 command center to coordinate responsive actions to reports of COVID-positivity among colleagues, including contact tracing, sanitizing and collaborating with public health officials. We distributed personal protective equipment based on our safety professionals&#8217; assessment of various activities our colleagues perform. We added engineering controls and enhanced safety features in our retail locations, including protective panels at pharmacy counters and front store checkout stations. We developed travel, work from home, self-quarantine, wellness check, and other HR-related guidance to help colleagues maintain their health and safety while continuing to support the essential operations of the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has registered and/or applied to register a variety of trademarks and service marks used throughout its businesses, as well as domain names, and relies on a combination of copyright, patent, trademark and trade secret laws, in addition to contractual restrictions, to establish and protect the Company&#8217;s proprietary rights. The Company regards its intellectual property as having significant value in the Pharmacy Services, Retail/LTC and Health Care Benefits segments. The Company is not aware of any facts that could materially impact the continuing use of any of its intellectual property.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_2174"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operations are subject to comprehensive federal, state and local laws and regulations and comparable multiple levels of international regulation in the jurisdictions in which it does business. There also continues to be a heightened level of review and/or audit by federal, state and international regulators of the health&#160;and related benefits industry&#8217;s business and reporting practices. In addition, many of the Company&#8217;s PBM clients and the Company&#8217;s payors in the Retail/LTC segment, including insurers, Medicare plans, Managed Medicaid plans and MCOs, are themselves subject to extensive regulations that affect the design and implementation of prescription drug benefit plans that they sponsor. Similarly, the Company&#8217;s LTC clients, such as skilled nursing facilities, are subject to government regulations, including many of the same government regulations to which the Company is subject. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and rules governing the Company&#8217;s businesses and interpretations of those laws and rules continue to expand and become more restrictive each year and are subject to frequent change. The application of these complex legal and regulatory requirements to the detailed operation of the Company&#8217;s businesses creates areas of uncertainty. Further, there are numerous proposed health care, financial services and other laws and regulations at the federal, state and international levels, some of which could adversely affect the Company&#8217;s businesses if they are enacted. The Company cannot predict whether pending or future federal or state legislation or court proceedings, including fundamental changes to the dynamics of one or more of the industries in which it competes, such as the federal or one or more state governments fundamentally restructuring the Commercial, Medicare or Medicaid marketplace or reducing payments to the Company under or financing for Medicare, Medicaid, dual eligible or special needs programs, increasing its involvement in drug reimbursement, pricing, purchasing, and/or importation or changing the laws governing PBMs, will change various aspects of the industries in which it competes or the health care industry generally or the impact those changes will have on the Company&#8217;s businesses, operating results, cash flows and/or stock price, but the effects could be materially adverse. The Company has internal control policies and procedures and conducts training and compliance programs for its employees to deter prohibited practices. However, if the Company&#8217;s employees or agents fail to comply with applicable laws governing its international or other operations, it may face investigations, prosecutions and other legal proceedings and actions which could result in civil penalties, administrative remedies and criminal sanctions. Any failure or alleged failure to comply with applicable laws and regulations summarized below, or any adverse applications or interpretations of, or changes in, the laws and regulations affecting the Company and/or its businesses, could have a material adverse effect on the Company&#8217;s operating results, financial condition, cash flows and/or stock price. See Item 3 of this 10-K, &#8220;Legal Proceedings,&#8221; for further information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i) future enactment of new health care or other laws or regulations; (ii) the interpretation or application of existing laws or regulations, including the laws and regulations described in this Government Regulation section, as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii) pending or future federal or state governmental investigations of one or more of the Company&#8217;s </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv) pending or future government audits, investigations or enforcement actions against the Company; (v) adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi) adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Families First Coronavirus Response Act (the &#8220;Families First Act&#8221;) and the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) were enacted in March 2020. Each of the Families First Act and the CARES Act requires the Company to provide coverage for COVID-19 related medical services, in many cases without member cost-sharing, in its Insured Health Care Benefits products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act also provides relief funding to providers to reimburse them for health care related expenses incurred in preventing, preparing for and/or responding to COVID-19 (provided no other source is obligated to reimburse those expenses) or lost health care related revenues that are attributable to COVID-19. Under the CARES Act, the Company receives reimbursement for uninsured patients in connection with COVID-19 testing and vaccination as well as monoclonal antibody treatment. Aside from such reimbursement, the Company did not request any funding under the CARES Act. However, in the second quarter of 2020, the Company received $43 million from the CARES Act provider relief fund, all of which was returned to the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) during the second quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act also allows for the deferral of the payment of the employer share of Social Security taxes effective March 27, 2020. The Company has elected to defer its Social Security tax payments in accordance with this provision, and will remit the associated payments in two equal installments on or about December 31, 2021 and December 31, 2022, as required under the CARES Act. The Company deferred approximately $670&#160;million of its Social Security tax payments during the year ended December 31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Families First Act and the CARES Act, the Company is experiencing an unprecedented level of new laws, regulations, directives and orders from federal, state, county and municipal authorities related to the COVID-19 pandemic, most of which have been issued on an emergency basis with immediate, or in some instances retroactive, effect. These governmental actions include, but are not limited to, requirements to waive member cost-sharing associated with COVID-19 testing and treatment, provide coverage for additional COVID-19-related services, expand the use of telemedicine, suspend precertification or other UM mechanisms (including review of claims for medical necessity), allow earlier or longer renewal of prescriptions, extend grace periods for payments of premiums or limit coverage termination based on non-payment of premiums or fees, modify health benefits coverage eligibility rules to help maintain employee eligibility, and facilitate, accelerate or advance payments to providers. For example, in December 2020, as part of a COVID-19 relief package, Congress enacted a 3.75% payment increase to providers through the Medicare Physician Fee Schedule, which Medicare Advantage plans often use as a benchmark for provider contracts. As a result, in many instances the Company will be contractually required to pass on this payment to its providers, which was not anticipated at the time of bidding. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related governmental actions have required the Company to close or significantly limit operations at traditional office worksites and affected the hours of operation of MinuteClinic locations and the Company&#8217;s pharmacies. In some instances, the Company has taken permitted proactive actions consistent with more general regulatory directives, such as expanding home delivery of prescription medications, extending hours of operation for member assistance lines and liberalizing certain other terms of coverage. Similar directives have affected the Company&#8217;s international operations. The Company anticipates additional mandates and directives from domestic and foreign federal, state, county and local authorities throughout the continuation of the COVID-19 pandemic and for some time thereafter, some of which may result in permanent changes in the Company&#8217;s operations or the health care and other benefits cost and other risks assumed by the Company. Further, although the Company has seen regulators relax certain requirements in light of the COVID-19 pandemic, such as temporary suspension of certain audits and extensions of certain filing deadlines, failure to provide regulatory relief or accommodations in other areas may result in increased costs or reduced revenue for the Company. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of this governmental activity on the U.S. economy, consumer, customer and health care provider behavior and health care utilization patterns is beyond our knowledge and control. As a result, the financial and/or operational impact these COVID-19 related governmental actions and inactions will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the collective impact could be material and adverse. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to Multiple Segments of the Company&#8217;s Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Laws Related to Reimbursement by Government Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company is subject to various federal and state laws concerning its submission of claims and other information to Medicare, Medicaid and other federal and state government-sponsored health care programs. Potential sanctions for violating these laws include recoupment or reduction of government reimbursement amounts, civil penalties, treble damages, and exclusion from participation in government health care programs. Such laws include the federal False Claims Act (the &#8220;False Claims Act&#8221;), the federal anti-kickback statute (the &#8220;AKS&#8221;), state false claims acts and anti-kickback statutes in most states, the federal &#8220;Stark Law&#8221; and related state laws. In particular, the False Claims Act prohibits intentionally submitting, conspiring to submit, or causing to be submitted, false claims, records, or statements to the federal government, or intentionally failing to return overpayments, in connection with reimbursement by federal government programs. In addition, any claim for government reimbursement also violates the False Claims Act where it results from a violation of the AKS. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both federal and state false claims laws permit private individuals to file </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or &#8220;whistleblower&#8221; lawsuits on behalf of the federal or state government. Participants in the health and related benefits industry, including the Company, frequently are subject to actions under the False Claims Act or similar state laws. The federal Stark Law generally prohibits physicians from referring Medicare or Medicaid beneficiaries for certain services, including outpatient prescription drugs, to any entity with which the physician, or an immediate family member of the physician, has a financial relationship. The Stark Law further prohibits the entity receiving a prohibited referral from presenting a claim for reimbursement by Medicare or Medicaid for services furnished pursuant to the prohibited referral. Various states have enacted similar laws.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The ACA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The United States Supreme Court is expected to rule on the constitutionality of the ACA by June 2021. If the ACA is deemed unconstitutional, there will likely be significant changes to the laws and rules that govern the Company&#8217;s businesses. If the ACA is deemed constitutional, there may nevertheless be continued efforts to invalidate, modify, repeal or replace it or portions of it, and the Company expects aspects of the ACA to continue to significantly impact its business operations and operating results, including pricing, medical benefit ratios (&#8220;MBRs&#8221;) and the geographies in which the Company&#8217;s products are available.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA made broad-based changes to the U.S. health care system. While most of the significant aspects of the ACA became effective during or prior to 2014, parts of the ACA continue to evolve through the promulgation of executive orders, legislation, regulations and guidance as well as ongoing litigation. Additional changes to the ACA and those regulations and guidance at the federal and/or state level are likely, and those changes are likely to be significant. Growing federal and state budgetary pressures make it more likely that any changes, including changes at the state level in response to changes to, or invalidation, repeal or replacement of, the ACA and/or changes in the funding levels and/or payment mechanisms of federally supported benefit programs, will be adverse to us. For example, if any elements of the ACA are invalidated or repealed at the federal level, the Company expects that some states would seek to enact similar requirements, such as prohibiting pre-existing condition exclusions, prohibiting rescission of insurance coverage, requiring coverage for dependents up to age 26, requiring guaranteed renewability of insurance coverage and prohibiting lifetime limits on insurance coverage.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. In October 2020, the Company received the $313&#160;million in funds it was owed under the ACA&#8217;s risk corridor program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expansion of health care coverage contemplated by the ACA is being funded in part by reductions to the reimbursements the Company and other health plans are paid by the federal government for Medicare members, among other sources. While not all-inclusive, the following are some of the recent key funding changes related to the ACA (assuming it continues to be implemented in its current form). The Company continues to evaluate these provisions and the related regulations and regulatory guidance to determine the impact that they will have on its business operations and operating results:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The repeal of the annual non-tax deductible industry-wide HIF for calendar years after 2020. The HIF was $15.5 billion and $14.3 billion for 2020 and 2018, respectively, and suspended for 2019.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The repeal of the non-tax deductible 40% excise tax on employer-sponsored health care benefits above a certain threshold that was scheduled to begin in 2022.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reduced federal matching funds for Medicaid expansion. Starting in 2017, the federal matching rate declined slightly each year until it reached 90 percent in 2020, and will remain there.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA also specifies minimum medical loss ratios (&#8220;MLRs&#8221;) for Commercial and Medicare Insured products, specifies features required to be included in commercial benefit designs, limits commercial individual and small group rating and pricing practices, encourages additional competition (including potential incentives for new participants to enter the marketplace) and significantly increases federal and state oversight of health plans, including regulations and processes that could delay or limit the Company&#8217;s ability to appropriately increase its health plan premium rates. This in turn could adversely affect the Company&#8217;s ability to continue to participate in certain product lines and/or geographies that it serves today.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential repeal of the ACA, ongoing legislative, regulatory and administrative policy changes to the ACA, the results of federal and state level elections, pending litigation challenging the constitutionality of the ACA or funding for the law and federal budget negotiations continue to create uncertainty about the ultimate impact of the ACA. Given the inherent difficulty of foreseeing the nature and scope of future changes to the ACA and how states, businesses and individuals will respond to those changes, the Company cannot predict the impact on it of future changes to the ACA. It is reasonably possible that invalidation, repeal or replacement of or other changes to the ACA and/or states&#8217; responses to such changes, in the aggregate, could have a significant adverse effect on the Company&#8217;s businesses, operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage products compete directly with Original Medicare and Medicare Advantage products offered by other Medicare Advantage organizations and Medicare Supplement products offered by other insurers. The Company&#8217;s Medicare PDP and Medicare Supplement products are products that Medicare beneficiaries who are enrolled in Original Medicare purchase to enhance their Original Medicare coverage.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to expand the number of counties in which it offers Medicare products. The Company has expanded its Medicare service area and products in 2021 and is seeking to substantially grow its Medicare membership, revenue and operating results over the next several years, including through growth in Medicare Supplement products. The anticipated organic expansion of the Medicare service area and Medicare products offered and the Medicare-related provisions of the ACA significantly increase the Company&#8217;s exposure to funding and regulation of, and changes in government policy with respect to and/or funding or regulation of, the various Medicare programs in which the Company participates, including changes in the amounts payable to us under those programs and/or new reforms or surcharges on existing programs. For example, the ACA requires minimum MLRs for Medicare Advantage and Medicare Part D plans of 85%. If a Medicare Advantage or Medicare Part D contract pays minimum MLR rebates for three consecutive years, it will become ineligible to enroll new members. If a Medicare Advantage or Medicare Part D contract pays such rebates for five consecutive years, it will be terminated by CMS. Due to potential lower utilization of medical services by Medicare beneficiaries during the COVID-19 pandemic, it is possible certain Medicare Advantage contracts may not meet the 85% MLR for consecutive years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage and PDP products are heavily regulated by CMS. The regulations and contractual requirements applicable to the Company and other private participants in Medicare programs are complex, expensive to comply with and subject to change. For example, in the second quarter of 2014, CMS issued a final rule implementing the ACA requirements that Medicare Advantage and PDP plans report and refund to CMS overpayments that those plans receive from CMS. The precise interpretation, impact and legality of this rule are not clear and are subject to pending litigation. Payments the Company receives from CMS for its Medicare Advantage and Part D businesses also are subject to risk adjustment based on the health status of the individuals enrolled. Elements of that risk adjustment mechanism continue to be challenged by the U.S. Department of Justice (the &#8220;DOJ&#8221;), the Office of the Inspector General of the HHS (the &#8220;OIG&#8221;) and CMS itself. Substantial changes in the risk adjustment mechanism, including changes that result from enforcement or audit actions, could materially affect the amount of the Company&#8217;s Medicare reimbursement, require the Company to raise prices or reduce the benefits offered to Medicare beneficiaries, and potentially limit the Company&#8217;s (and the industry&#8217;s) participation in the Medicare program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested significant resources to comply with Medicare standards, and its Medicare compliance efforts will continue to require significant resources. CMS may seek premium and other refunds, prohibit the Company from continuing to market and/or enroll members in or refuse to passively enroll members in one or more of the Company&#8217;s Medicare or Medicare-Medicaid demonstration (historically known as &#8220;dual eligible&#8221;) plans, exclude us from participating in one or more Medicare, dual eligible or dual eligible special needs plan programs and/or institute other sanctions and/or civil monetary penalties against the Company if it fails to comply with CMS regulations or its Medicare contractual requirements. The Company&#8217;s Medicare Supplement products are regulated at the state level and subject to similar significant compliance requirements and risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare Advantage and PDP beneficiaries. For example, CMS conducts risk adjustment data validation (&#8220;RADV&#8221;) audits of a subset of Medicare Advantage contracts for each contract year. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various years for RADV audit, and the number of RADV audits continues to increase. The OIG also is auditing the Company&#8217;s risk adjustment data and that of other companies, and the Company expects CMS and the OIG to continue auditing risk adjustment data. The Company also has received Civil Investigative Demands (&#8220;CIDs&#8221;) from, and provided documents and information to, the Civil Division of the DOJ in connection with a current investigation of its patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 26, 2018, CMS issued proposed rules related to, among other things, changes to the RADV audit methodology established by CMS in 2012. CMS projects that the changes to the RADV audit methodology would increase its recoveries from Medicare Advantage plans as a result of RADV audits. CMS has requested comments on the proposed rules, including whether the proposed RADV rule change should apply retroactively to audits of Medicare Advantage plans for contract year 2011 and forward. The Company is evaluating the potential adverse effect, which could be material, on the Company&#8217;s operating results, financial condition, and cash flows if the proposed RADV rule change were adopted as proposed. CMS also has announced that its goal is to subject all Medicare Advantage contracts to either a comprehensive or a targeted RADV audit for each contract year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of each Medicare Advantage plan&#8217;s reimbursement is tied to the plan&#8217;s &#8220;star ratings.&#8221; The star rating system considers a variety of measures adopted by CMS, including quality of preventative services, chronic illness management, compliance and overall customer satisfaction. Only Medicare Advantage plans with an overall star rating of four or more stars (out of five stars) are eligible for a quality bonus in their basic premium rates. As a result, the Company&#8217;s Medicare Advantage plans&#8217; operating results in 2021 and going forward will be significantly affected by their star ratings. The Company&#8217;s star ratings and past performance scores are adversely affected by the compliance issues that arise each year in its Medicare operations. CMS released the Company&#8217;s 2021 star ratings in October 2020. The Company&#8217;s 2021 star ratings will be used to determine which of its Medicare Advantage plans have ratings of four stars or higher and qualify for bonus payments in 2022. Based on the Company&#8217;s membership at December 31, 2020, 83% of the Company&#8217;s Medicare Advantage members were in plans with 2021 star ratings of at least 4.0 stars. CMS also gives PDPs star ratings which affect each PDP&#8217;s enrollment. Medicare Advantage and PDP plans that are rated less than three stars for three consecutive years are subject to contract termination by CMS. CMS continues to revise its star ratings system to make it harder to achieve four stars or more. Despite the Company&#8217;s success in achieving high 2021 star ratings and other quality measures and the continuation of its improvement efforts, there can be no assurances that it will be successful in maintaining or improving its star ratings in future years. Accordingly, the Company&#8217;s Medicare Advantage plans may not be eligible for full level quality bonuses, which could adversely affect the benefits such plans can offer, reduce membership and/or reduce profit margins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, the Company projects the benchmark payment rates in CMS&#8217;s April 2020 final notice detailing final Medicare Advantage benchmark payment rates for 2021 will increase funding for the Company&#8217;s Medicare Advantage business, excluding the impact of the HIF in 2020, by approximately 1.8% in 2021 compared to 2020. This 2021 rate increase only partially offsets the challenge the Company faces from the impact of the increasing cost of medical care (including prescription medications) and CMS local and national coverage decisions that require the Company to pay for services and supplies that are not factored into the Company&#8217;s bids. The federal government may seek to impose restrictions on the configuration of pharmacy or other provider networks for Medicare Advantage and/or PDP plans, or otherwise restrict the ability of these plans to alter benefits, negotiate prices or establish other terms to improve affordability or maintain viability of products. The Company currently believes that the payments it has received and will receive in the near term are adequate to justify the Company&#8217;s continued participation in the Medicare Advantage and PDP programs, although there are economic and political pressures to continue to reduce spending on the program, and this outlook could change. In January 2021, CMS issued its final notice detailing final 2022 Medicare Advantage benchmark payment rates. Final 2022 Medicare Advantage rates resulted in an increase in industry benchmark rates of approximately 4.1%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Going forward, the Company expects CMS, the OIG, the DOJ, other federal agencies and the U.S. Congress to continue to scrutinize closely each component of the Medicare program (including Medicare Advantage, PDPs, demonstration projects such as Medicare-Medicaid plans and provider network access and adequacy), modify the terms and requirements of the program and possibly seek to recast or limit private insurers&#8217; roles. It is not possible to predict the outcome of this Congressional or regulatory activity, any of which could materially and adversely affect the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in November 2020, the HHS released the final Rebate Rule (the &#8220;Rebate Rule&#8221;), which eliminates the regulatory safe harbor from prosecution under the AKS for rebates from pharmaceutical companies to PBMs in Medicare Part D, replacing it with two far narrower safe harbors designed to directly benefit patients with high out-of-pocket costs and to change the way PBMs are compensated. The new safe harbors are (i) for rebates which are passed on to the patient at the point of sale and (ii) for flat service fee payments made to PBMs which cannot be tied to the list prices of drugs. The Pharmaceutical Care </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management Association (the &#8220;PCMA&#8221;), which represents PBMs, has filed a suit in an effort to block the Rebate Rule, claiming that the Rebate Rule would lead to higher premiums in Medicare Part D and was adopted in an unlawful manner. It is unclear whether the Rebate Rule will be enforceable, whether pharmaceutical companies will respond by reducing list prices, whether list prices in the private market may also be reduced, and what the resulting impact will be to PBMs or the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">340B Drug Pricing Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The 340B Drug Pricing Program allows eligible covered entities to purchase prescription drugs from manufacturers at a steep discount, and is overseen by the HHS and the Health Resources and Services Administration (&#8220;HRSA&#8221;). In 2020, a number of pharmaceutical manufacturers began programs that limited covered entities&#8217; participation in the program through contract pharmacies arrangements, which the Company has with some covered entities. Enforcement from HHS and HRSA to curb these manufacturer practices will significantly impact the Company&#8217;s participation in the program in the future. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Remuneration Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Federal law prohibits, among other things, an entity from knowingly and willfully offering, paying, soliciting or receiving, subject to certain exceptions and &#8220;safe harbors,&#8221; any remuneration to induce the referral of individuals or the purchase, lease or order of items or services for which payment may be made under Medicare, Medicaid or certain other federal and state health care programs. A number of states have similar laws, some of which are not limited to services paid for with government funds. Sanctions for violating these federal and state anti-remuneration laws may include imprisonment, criminal and civil fines, and exclusion from participation in Medicare, Medicaid and other federal and state government-sponsored health care programs. Companies involved in public health care programs such as Medicare and/or Medicaid are required to maintain compliance programs to detect and deter fraud, waste and abuse, and are often the subject of fraud, waste and abuse investigations and audits. The Company has invested significant resources to comply with Medicare and Medicaid program standards. Ongoing vigorous law enforcement and the highly technical regulatory scheme mean that the Company&#8217;s compliance efforts in this area will continue to require significant resources.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust and Unfair Competition </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The U.S. Federal Trade Commission (&#8220;FTC&#8221;) investigates and prosecutes practices that are &#8220;unfair trade practices&#8221; or &#8220;unfair methods of competition.&#8221; Numerous lawsuits have been filed throughout the United States against pharmaceutical manufacturers, retail pharmacies and/or PBMs under various federal and state antitrust and unfair competition laws challenging, among other things: (i) brand name drug pricing and rebate practices of pharmaceutical manufacturers, (ii) the maintenance of retail or specialty pharmacy networks by PBMs, and (iii) various other business practices of PBMs and retail pharmacies. To the extent that the Company appears to have actual or potential market power in a relevant market or CVS Pharmacy, CVS Specialty or MinuteClinic plays a unique or expanded role in a Pharmacy Services or Health Care Benefits segment product offering, the Company&#8217;s business arrangements and uses of confidential information may be subject to heightened scrutiny from an anti-competitive perspective and possible challenge by state and/or federal regulators and/or private parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Privacy and Confidentiality Requirements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Many of the Company&#8217;s activities involve the receipt, use and disclosure by the Company of personally identifiable information (&#8220;PII&#8221;) as permitted in accordance with applicable federal and state privacy and data security laws, which require organizations to provide appropriate privacy and security safeguards for such information. In addition to PII, the Company uses and discloses de-identified data for analytical and other purposes when permitted. Additionally, there are industry standards for handling credit card data known as the Payment Card Industry Data Security Standard, which are a set of requirements designed to help ensure that entities that process, store or transmit credit card information maintain a secure environment. Certain states have incorporated these requirements into state laws or enacted other requirements relating to the use and/or disclosure of PII.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Health Insurance Portability and Accountability Act of 1996 and the regulations issued thereunder (collectively, &#8220;HIPAA&#8221;), as further modified by the American Recovery and Reinvestment Act of 2009 (&#8220;ARRA&#8221;) impose extensive requirements on the way in which health plans, providers, health care clearinghouses (known as &#8220;covered entities&#8221;) and their business associates use, disclose and safeguard protected health information (&#8220;PHI&#8221;). Further, ARRA requires the Company and other covered entities to report any breaches of PHI to impacted individuals and to the HHS and to notify the media in any states where 500 or more people are impacted by the unauthorized release or use of or access to PHI. Criminal penalties and civil sanctions may be imposed for failing to comply with HIPAA standards. The Health Information Technology for Economic and Clinical Health Act (the &#8220;HITECH Act&#8221;), enacted as part of ARRA, amended HIPAA to impose additional restrictions on third-party funded communications using PHI and the receipt of remuneration in exchange for PHI. The HITECH Act also extended HIPAA privacy and security requirements and penalties directly to business associates. HHS has begun to audit health plans, providers and other parties to enforce HIPAA compliance, including with respect to data security. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to HIPAA, state health privacy laws apply to the extent they are more protective of individual privacy than is HIPAA, including laws that place stricter controls on the release of information relating to specific diseases or conditions and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requirements to notify members of unauthorized release or use of or access to PHI. States also have adopted regulations to implement provisions of the Financial Modernization Act of 1999 (also known as the Gramm-Leach-Bliley Act (&#8220;GLBA&#8221;)) which generally require insurers, including health insurers, to provide customers with notice regarding how their non-public personal health and financial information is used and the opportunity to &#8220;opt out&#8221; of certain disclosures before the insurer shares such information with a non-affiliated third party. Like HIPAA, GLBA sets a &#8220;floor&#8221; standard, allowing states to adopt more stringent requirements governing privacy protection. Complying with additional state requirements requires us to make additional investments beyond those the Company has made to comply with HIPAA and GLBA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybersecurity Information Sharing Act of 2015 encourages organizations to share cyber threat indicators with the federal government and, among other things, directs HHS to develop a set of voluntary cybersecurity best practices for organizations in the health care industry. In addition, states have begun to enact more comprehensive privacy laws and regulations addressing consumer rights to data access, deletion, protection or transparency, such as the California Consumer Privacy Act (&#8220;CCPA&#8221;). States also are starting to issue regulations and proposed regulations specifically related to cybersecurity, such as the regulations issued by the New York Department of Financial Services. Complying with conflicting cybersecurity regulations, which may differ from state to state, requires significant resources. In addition, differing approaches to state privacy and/or cyber-security regulation and varying enforcement philosophies may materially and adversely affect the Company&#8217;s ability to standardize its products and services across state lines. Widely-reported large scale commercial data breaches in the United States and abroad increase the likelihood that additional data security legislation will be considered by additional states. These legislative and regulatory developments will impact the design and operation of the Company&#8217;s businesses, its privacy and security strategy and its web-based and mobile assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, each Public Exchange is required to adhere to privacy and security standards with respect to PII, and to impose privacy and security standards that are at least as protective of PII as those the Public Exchange has implemented for itself or non-Public Exchange entities, which include insurers offering plans through the Public Exchange and their designated downstream entities, including PBMs and other business associates. These standards may differ from, and be more stringent than, HIPAA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consumer Protection Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The federal government has many consumer protection laws, such as the Federal Trade Commission Act, the Federal Postal Service Act and the Consumer Product Safety Act. Most states also have similar consumer protection laws and a growing number of states regulate subscription programs. In addition, the federal government and most states have adopted laws and/or regulations requiring places of public accommodation, health care services and other goods and services to be accessible to people with disabilities. These consumer protection and accessibility laws and regulations have been the basis for investigations, lawsuits and multistate settlements relating to, among other matters, the marketing of loyalty programs, and health care products and services, pricing accuracy, expired front store products, financial incentives provided by drug manufacturers to pharmacies in connection with therapeutic interchange programs, disclosures related to how personal data is used and protected and the accessibility of goods and services to people with disabilities. As a result of the Company&#8217;s direct-to-consumer activities, including mobile and web-based solutions offered to members and to other consumers, the Company also is subject to federal and state regulations applicable to electronic communications and to other general consumer protection laws and regulations. For example, the CCPA became effective in 2020, and additional federal and state regulation of consumer privacy protection may be proposed or enacted in 2020. The Company expects these new laws and regulations to impact the design of its products and services and the management and operation of its businesses and to increase its compliance costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transparency in Coverage Rule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In October 2020, the HHS released a final rule requiring health insurers to disclose negotiated prices of drugs, medical services, supplies and other covered items to the public. The rule requires group health plans and health insurance issuers in the individual and group markets to disclose cost-sharing information upon request, to a participant, beneficiary, or enrollee, which, unless otherwise indicated, for the purpose of the final rules includes an authorized representative, and require plans and issuers to disclose in-network provider rates, historical out-of-network allowed amounts and the associated billed charges, and negotiated rates for prescription drugs. Disclosure of data in a machine readable file is required beginning in January 2022, and insurers are required to have a consumer tool in place by January 2023. The public disclosure of insurer- or PBM-negotiated price concessions may result in drug manufacturers lowering discounts or rebates, resulting in higher drug costs for patients and impacting the ability of the Company to negotiate drug prices and provide competitive products and services to consumers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Telemarketing and Other Outbound Contacts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Certain federal and state laws, such as the Telephone Consumer Protection Act and the Telemarketing Sales Rule, give the FTC, the Federal Communications Commission and state attorneys general the ability to regulate, and bring enforcement actions relating to, telemarketing practices and certain automated outbound contacts such as phone calls, texts or emails. Under certain circumstances, these laws provide consumers with a private right of action. Violations of these laws could result in substantial statutory penalties and other sanctions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy and Professional Licensure and Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company is subject to a variety of intersecting federal and state statutes and regulations that govern the wholesale distribution of drugs; operation of retail, specialty, infusion, LTC and mail order pharmacies; licensure of facilities and professionals, including pharmacists, technicians, nurses and other health care professionals; registration of facilities with the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;) and analogous state agencies that regulate controlled substances; packaging, storing, shipping and tracking of pharmaceuticals; repackaging of drug products; labeling, medication guides and other consumer disclosures; interactions with prescribers and health care professionals; compounding of prescription medications; dispensing of controlled and non-controlled substances; counseling of patients; transfers of prescriptions; advertisement of prescription products and pharmacy services; security; inventory control; recordkeeping; reporting to Boards of Pharmacy, the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), the U.S. Consumer Product Safety Commission, the DEA and related state agencies; and other elements of pharmacy practice. Pharmacies are highly regulated and have contact with a wide variety of federal, state and local agencies with various powers to investigate, inspect, audit or solicit information, including Boards of Pharmacy and Nursing, the DEA, the FDA, the DOJ, HHS and others. Many of these agencies have broad enforcement powers, conduct audits on a regular basis, can impose substantial fines and penalties, and may revoke the license, registration or program enrollment of a facility or professional. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">State Insurance, HMO and Insurance Holding Company Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of states regulate affiliated groups of insurers and HMOs such as the Company under holding company statutes. These laws may, among other things, require prior regulatory approval of dividends and material intercompany transfers of assets and transactions between the regulated companies and their affiliates, including their parent holding companies. The Company expects the states in which its insurance and HMO subsidiaries are licensed to continue to expand their regulation of the corporate governance and internal control activities of its insurance companies and HMOs. Changes to state insurance, HMO and/or insurance holding company laws or regulations or changes to the interpretation of those laws or regulations, including due to regulators&#8217; increasing concerns regarding insurance company and/or HMO solvency due, among other things, to past and expected payor insolvencies, could negatively affect the Company&#8217;s businesses in various ways, including through increases in solvency fund assessments, requirements that the Company hold greater levels of capital and/or delays in approving dividends from regulated subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PBM offerings of prescription drug coverage under certain risk arrangements may be subject to laws and regulations in various states. Such laws may require that the party at risk become licensed as an insurer, establish reserves or otherwise demonstrate financial viability. Laws that may apply in such cases include insurance laws and laws governing MCOs and limited prepaid health service plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The states of domicile of the Company&#8217;s regulated subsidiaries have statutory risk-based capital (&#8220;RBC&#8221;) requirements for health and other insurance companies and HMOs based on the National Association of Insurance Commissioners&#8217; Risk-Based Capital for Insurers Model Act (the &#8220;RBC Model Act&#8221;). These RBC requirements are intended to assess the capital adequacy of life and health insurers and HMOs, taking into account the risk characteristics of a company&#8217;s investments and products. The RBC Model Act sets forth the formula for calculating RBC requirements, which are designed to take into account asset risks, insurance risks, interest rate risks and other relevant risks with respect to an individual company&#8217;s business. In general, under these laws, an insurance company or HMO must submit a report of its RBC level to the insurance department or insurance commissioner of its state of domicile for each calendar year. At December&#160;31, 2020, the RBC level of each of the Company&#8217;s insurance and HMO subsidiaries was above the level that would require regulatory action.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding restrictions on certain payments of dividends or other distributions by the Company&#8217;s HMO and insurance company subsidiaries, see Note 12 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; included in Item 8 of this 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holding company laws for the states of domicile of certain of the Company&#8217;s subsidiaries also restrict the ability of any person to obtain control of an insurance company or HMO without prior regulatory approval. Under those statutes, without such approval (or an exemption), no person may acquire any voting security of an insurance holding company (such as the Company&#8217;s ultimate parent company, CVS Health) that controls an insurance company or HMO, or merge with such a holding company, if as a result of such transaction such person would control the insurance holding company. Control is generally defined as the direct or indirect power to direct or cause the direction of the management and policies of a person and is presumed to exist if a person directly or indirectly owns or controls 10% or more of the voting securities of another person.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states have laws that prohibit submitting a false claim or making a false record or statement in order to secure reimbursement from an insurance company. These state laws vary, and violation of them may lead to the imposition of civil or criminal penalties.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Agreements and Mandates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company and/or its various affiliates are subject to certain consent decrees, settlement and other agreements, corrective action plans and corporate integrity agreements with various federal, state and local authorities relating to such matters as privacy practices, controlled substances, PDPs, expired products, environmental and safety matters, marketing and advertising practices, PBM, LTC and other pharmacy operations and various other business practices. Certain of these agreements contain ongoing reporting, monitoring and/or other compliance requirements for the Company. Failure to meet the Company&#8217;s obligations under these agreements could result in civil or criminal remedies, financial penalties, administrative remedies, and/or exclusion from participation in federal health care programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental and Safety Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company&#8217;s businesses are subject to various federal, state and local laws, regulations and other requirements pertaining to protection of the environment, public health and employee safety, including, for example, regulations governing the management of hazardous substances, the cleaning up of contaminated sites, and the maintenance of safe working conditions in the Company&#8217;s retail locations, distribution centers and other facilities. Governmental agencies at the federal, state and local levels continue to focus on the retail and health care sectors&#8217; compliance with such laws and regulations, and have at times pursued enforcement activities. Any failure to comply with these regulations could result in fines or other sanctions by government authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ERISA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;), provides for comprehensive federal regulation of certain employee pension and benefit plans, including private employer and union sponsored health plans and certain other plans that contract with us to provide PBM services. In general, the Company assists plan sponsors in the administration of their health benefit plans, including the prescription drug benefit portion of those plans, in accordance with the plan designs adopted by the plan sponsors. In addition, the Company may have fiduciary duties where it has specifically contracted with a plan sponsor to accept limited fiduciary responsibility, such as for the adjudication of initial prescription drug benefit claims and/or the appeals of denied claims under a plan. In addition to its fiduciary provisions, ERISA imposes civil and criminal liability on service providers to health plans and certain other persons if certain forms of illegal remuneration are made or received. These provisions of ERISA are broadly written and their application to specific business practices is often uncertain.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s health and related benefits and large case pensions products and services and related fees also are subject to potential issues raised by judicial interpretations relating to ERISA. Under those interpretations, together with U.S. Department of Labor (&#8220;DOL&#8221;) regulations, the Company may have ERISA fiduciary duties with respect to PBM members and/or certain general account assets held under contracts that are not guaranteed benefit policies. As a result, certain transactions related to those general account assets are subject to conflict of interest and other restrictions, and the Company must provide certain disclosures to policyholders annually. The Company must comply with these restrictions or face substantial penalties. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, ERISA generally preempts all state and local laws that relate to employee benefit plans, but the extent of the pre-emption continues to be reviewed by courts, including the U.S. Supreme Court. For example, in December 2020, the U.S. Supreme Court upheld an Arkansas law that, among other things, mandates a particular pricing methodology, establishes an appeals process for a pharmacy when the reimbursement is below the pharmacy&#8217;s acquisition cost, permits a pharmacy to reverse and rebill if they cannot procure the drug from its wholesaler at a price equal to or less than the reimbursement rate, prohibits a PBM from reimbursing a pharmacy less than the amount it reimburses an affiliate on a per unit basis, and permits a pharmacy to decline to dispense if the reimbursement is lower than the pharmacy&#8217;s acquisition cost.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Legislative Initiatives and Regulatory Initiatives </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The U.S. federal and state governments, as well as governments in other countries where the Company does business, continue to enact and seriously consider many broad-based legislative and regulatory proposals that have had a material impact on or could materially impact various aspects of the health care and related benefits system and the Company&#8217;s businesses, operating results and/or cash flows. For example:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Under the Budget Control Act of 2011 and the American Taxpayer Relief Act of 2012 significant, automatic across-the-board budget cuts (known as sequestration) began in March 2013, including Medicare spending cuts of not more than 2% of total program costs per year through 2024. Since then, Congress has extended and modified sequestration a number of times. Currently, the CARES Act suspended Medicare sequestration from May 2020 to the end of December 2020 and extended mandatory sequestration to 2030. The Consolidated Appropriations Act of 2021 extended the temporary suspension of Medicare sequestration through the end of March 2021. Significant uncertainty remains as to whether and how the U.S. Congress will proceed with actions that create additional federal revenue and/or with entitlement reform. The Company cannot predict future federal Medicare or federal or state Medicaid funding levels or the impact that future federal or state budget actions or entitlement program reform, if it occurs, will have on the Company&#8217;s businesses, operations or operating results, but the effects could be materially adverse, particularly on the Company&#8217;s Medicare and/or Medicaid revenues, MBRs and operating results.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The European Union&#8217;s (&#8220;EU&#8217;s&#8221;) General Data Protection Regulation (&#8220;GDPR&#8221;) began to apply across the EU during 2018.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other significant legislative and/or regulatory measures which are or recently have been under consideration include the following:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Eliminating payment of manufacturer&#8217;s rebates on prescription drugs to PBMs, PDPs and Managed Medicaid organizations in connection with federally funded health care programs. </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Imposing requirements and restrictions on the design and/or administration of pharmacy benefit plans offered by the Company&#8217;s and its clients&#8217; health plans and/or its PBM clients and/or the services the Company provides to those clients, including prohibiting &#8220;differential&#8221; or &#8220;spread&#8221; pricing in PBM contracts; restricting or eliminating the use of formularies for prescription drugs; restricting the Company&#8217;s ability to require members to obtain drugs through a home delivery or specialty pharmacy; restricting the Company&#8217;s ability to place certain specialty or other drugs in the higher cost tiers of its pharmacy formularies; restricting the Company&#8217;s ability to make changes to drug formularies and/or clinical programs; limiting or eliminating rebates on pharmaceuticals; requiring the use of up front purchase price discounts on pharmaceuticals in lieu of rebates; restricting the Company&#8217;s ability to configure its health plan and retail pharmacy provider networks, including use of CVS Pharmacy locations; and restricting or eliminating the use of certain drug pricing methodologies.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increasing federal or state government regulation of, or involvement in, the pricing and/or purchasing of drugs.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restricting the Company&#8217;s ability to limit providers&#8217; participation in its networks and/or remove providers from its networks by imposing network adequacy requirements or otherwise (including in its Medicare and Commercial Health Care Benefits products).</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Imposing assessments on (or to be collected by) health plans or health carriers that may or may not be passed through to their customers. These assessments may include assessments for insolvency, the uninsured, uncompensated care, Medicaid funding or defraying health care provider medical malpractice insurance costs.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandating coverage by the Company&#8217;s and its clients&#8217; health plans for additional conditions and/or specified procedures, drugs or devices (e.g., high cost pharmaceuticals, experimental pharmaceuticals and oral chemotherapy regimens).</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulating electronic connectivity.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandating or regulating the disclosure of provider fee schedules, manufacturer&#8217;s rebates and other data about the Company&#8217;s payments to providers and/or payments the Company receives from pharmaceutical manufacturers.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandating or regulating disclosure of provider outcome and/or efficiency information.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescribing or limiting members&#8217; financial responsibility for health care or other covered services they utilize, including restricting &#8220;surprise&#8221; bills by providers and by specifying procedures for resolving &#8220;surprise&#8221; bills.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescribing payment levels for health care and other covered services rendered to the Company&#8217;s members by providers who do not have contracts with the Company.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assessing the medical device status of HIT products and/or solutions, mobile consumer wellness tools and clinical decision support tools, which may require compliance with FDA requirements in relation to some of these products, solutions and/or tools.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restricting the ability of employers and/or health plans to establish or impose member financial responsibility.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Amending or supplementing ERISA to impose greater requirements on PBMs or the administration of employer-funded benefit plans or limit the scope of current ERISA pre-emption, which would among other things expose the Company and other health plans to expanded liability for punitive and other extra-contractual damages and additional state regulation.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is uncertain whether the Company can counter the potential adverse effects of such potential legislation or regulation on its operating results or cash flows, including whether it can recoup, through higher premium rates, expanded membership or other measures, the increased costs of mandated coverage or benefits, assessments, fees, taxes or other increased costs, including the cost of modifying its systems to implement any enacted legislation or regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s businesses also may be affected by other legislation and regulations. The Dodd-Frank Wall Street Reform and Consumer Protection Act creates incentives for whistleblowers to speak directly to the government rather than utilizing internal compliance programs and reduces the burden of proof under the Foreign Corrupt Practices Act of 1977 (the &#8220;FCPA&#8221;). There also are laws and regulations that set standards for the escheatment of funds to states.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health savings accounts, health reimbursement arrangements and flexible spending accounts and certain of the tax, fee and subsidy provisions of the ACA also are regulated by the U.S. Department of the Treasury and the Internal Revenue Service.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also may be adversely affected by court and regulatory decisions that expand or revise the interpretations of existing statutes and regulations or impose medical malpractice or bad faith liability. Federal and state courts, including the U.S. Supreme Court, continue to consider cases, and federal and state regulators continue to issue regulations and interpretations, addressing bad faith liability for denial of medical claims, the scope of ERISA&#8217;s fiduciary duty requirements, the scope of the False Claims Act and the pre-emptive effect of ERISA on state laws.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Audits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Company is subject to audits of many of its contracts, including its PBM client contracts, its PBM rebate contracts, its PBM network contracts, its contracts relating to Medicare Advantage and/or Medicare Part D, the agreements the Company&#8217;s pharmacies enter into with other payors, its Medicaid contracts and its customer contracts. Because some of the Company&#8217;s contracts are with state or federal governments or with entities contracted with state or federal agencies, audits of these contracts are often regulated by the federal or state agencies responsible for administering federal or state benefits programs, including those which operate Medicaid fee for service plans, Managed Medicaid plans, Medicare Part D plans or Medicare Advantage organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Employee Health Benefits Program </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Company&#8217;s subsidiaries contract with the Office of Personnel Management (the &#8220;OPM&#8221;) to provide managed health care services under the FEHB program in their service areas. These contracts with the OPM and applicable government regulations establish premium rating arrangements for this program. OPM regulations require that community-rated FEHB plans meet a FEHB program-specific minimum MLR by plan code and market. Managing to these rules is complicated by the simultaneous application of the minimum MLR standards and associated premium rebate requirements of the ACA. The Company also has a contractual arrangement with carriers for the FEHB program, such as the BlueCross BlueShield Association, to provide pharmacy services to federal employees, postal workers, annuitants, and their dependents under the Government-wide Service Benefit Plan, as authorized by the FEHB Act and as part of the FEHB program. Additionally, the Company manages certain FEHB plans on a &#8220;cost-plus&#8221; basis. These arrangements subject the Company to certain aspects of the FEHB Act, and other federal regulations, such as the FEHB Acquisition Regulation, that otherwise would not be applicable to the Company. The OPM also is auditing the Company and its other contractors to, among other things, verify that plans meet their applicable FEHB program-specific MLR and the premiums established under the OPM&#8217;s Insured contracts and costs allocated pursuant to the OPM&#8217;s cost-based contracts are in compliance with the requirements of the applicable FEHB program. The OPM may seek premium refunds or institute other sanctions against the Company if it fails to comply with the FEHB program requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical Services Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Company provides clinical services to health plans, PBMs and providers for a variety of complex and common medical conditions, including arranging for certain members to participate in disease management programs. State laws regulate the practice of medicine, the practice of pharmacy, the practice of nursing and certain other clinical activities. Clinicians engaged in a professional practice in connection with the provision of clinical services must satisfy applicable state licensing requirements and must act within their scope of practice.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Third Party Administration and Other State Licensure Laws </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Many states have licensure or registration laws governing certain types of administrative organizations, such as PPOs, TPAs and companies that provide utilization review services. Several states also have licensure or registration laws governing the organizations that provide or administer consumer card programs (also known as cash card or discount card programs).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has insurance licenses in several foreign jurisdictions and does business directly or through local affiliations in numerous countries around the world. The Company has taken steps to be able to continue to serve customers in the European Economic Area following the United Kingdom&#8217;s exit from the EU (&#8220;Brexit&#8221;). However, the impact of Brexit on the Company&#8217;s international business and operating results is uncertain. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s international operations are subject to different, and sometimes more stringent, legal and regulatory requirements, which vary widely by jurisdiction, including anti-corruption laws; economic sanctions laws; various privacy, insurance, tax, tariff and trade laws and regulations; corporate governance, privacy, data protection (including the EU&#8217;s General Data Protection Regulation which began to apply across the EU during 2018), data mining, data transfer, labor and employment, intellectual property, consumer protection and investment laws and regulations; discriminatory licensing procedures; compulsory cessions of reinsurance; required localization of records and funds; higher premium and income taxes; limitations on dividends and repatriation of capital; and requirements for local participation in an insurer&#8217;s ownership. In addition, the expansion of the Company&#8217;s operations into foreign countries increases the Company&#8217;s exposure to the anti-bribery, anti-corruption and anti-money laundering provisions of U.S. law, including the FCPA, and corresponding foreign laws, including the U.K. Bribery Act 2010 (the &#8220;UK Bribery Act&#8221;). </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Corruption Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The FCPA prohibits offering, promising or authorizing others to give anything of value to a foreign government official to obtain or retain business or otherwise secure a business advantage. The Company also is subject to applicable anti-corruption laws of the jurisdictions in which it operates. In many countries outside the United States, health care professionals are employed by the government. Therefore, the Company&#8217;s dealings with them are subject to regulation under the FCPA. Violations of the FCPA and other anti-corruption laws may result in severe criminal and civil sanctions as well as other penalties, and there continues to be a heightened level of FCPA enforcement activity by the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) and the DOJ. The UK Bribery Act is an anti-corruption law that is broader in scope than the FCPA and applies to all companies with a nexus to the United Kingdom. Disclosures of FCPA violations may be shared with the UK authorities, thus potentially exposing companies to liability and potential penalties in multiple jurisdictions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Money Laundering Regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Certain lines of the Company&#8217;s businesses are subject to Treasury anti-money laundering regulations. Those lines of business have implemented anti-money laundering policies designed to ensure their compliance with the regulations. The Company also is subject to anti-money laundering laws in non-U.S. jurisdictions where it operates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Office of Foreign Assets Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company also is subject to regulation by the Office of Foreign Assets Control of the U.S. Department of Treasury (&#8220;OFAC&#8221;). OFAC administers and enforces economic and trade sanctions based on U.S. foreign policy and national security goals against targeted foreign countries and regimes, terrorists, international narcotics traffickers, those engaged in activities related to the proliferation of weapons of mass destruction, and other threats to the national security, foreign policy or economy of the United States. In addition, the Company is subject to similar regulations in the non-U.S. jurisdictions in which it operates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FDA Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA regulates the Company&#8217;s compounding pharmacy and clinical research operations. The FDA also generally has authority to, among other things, regulate the manufacture, distribution, sale and labeling of medical devices (including hemodialysis devices such as the device the Company is developing and mobile medical devices) and many products sold through retail pharmacies, including prescription drugs, over-the-counter medications, cosmetics, dietary supplements and certain food items. In addition, the FDA regulates the Company&#8217;s activities as a distributor of store brand products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to the Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws and regulations discussed above that may affect multiple segments of the Company&#8217;s business, the Company is subject to federal, state and local statutes and regulations governing the operation of its Pharmacy Services segment specifically. Among these are the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PBM Laws and Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Legislation and/or regulations seeking to regulate PBM activities in a comprehensive manner have been proposed or enacted in a number of states. This legislation could adversely affect the Company&#8217;s ability to conduct business on commercially reasonable terms in states where the legislation is in effect and the Company&#8217;s ability to standardize its PBM products and services across state lines. In addition, certain quasi-regulatory organizations, including the National Association of Boards of Pharmacy and the National Association of Insurance Commissioners (&#8220;NAIC&#8221;) and the National Council of Insurance Legislators, have issued model regulations or may propose future regulations concerning PBMs and/or PBM activities. Similarly, credentialing organizations such as NCQA and URAC may establish voluntary standards regarding PBM, mail order pharmacy and/or specialty pharmacy activities. While the actions of these quasi-regulatory or standard-setting organizations do not have the force of law, they may influence states to adopt their requirements or recommendations and influence client requirements for PBM, mail order pharmacy and/or specialty pharmacy services. Moreover, any standards established by these organizations could also impact the Company&#8217;s health plan clients and/or the services provided to those clients and/or the Company&#8217;s health plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s PBM activities also are regulated directly and indirectly at the federal and state levels, including being subject to the False Claims Act and state false claims acts and the AKS and state anti-kickback laws. These laws and regulations govern, and proposed legislation and regulations may govern and/or further restrict, critical PBM practices, including disclosure, receipt and retention of rebates and other payments received from pharmaceutical manufacturers; use of, administration of and/or changes to drug formularies, maximum allowable cost (&#8220;MAC&#8221;) list pricing, average wholesale prices (&#8220;AWP&#8221;) and/or clinical programs; the offering to plan sponsors of pricing that includes retail network &#8220;differential&#8221; or &#8220;spread&#8221; (i.e., a difference between the drug price charged to the plan sponsor by a PBM and the price paid by the PBM to the dispensing provider); disclosure of data to third parties; drug UM practices; the level of duty a PBM owes its customers; configuration of pharmacy networks; the operations of the Company&#8217;s pharmacies (including audits of its pharmacies); disclosure of negotiated provider reimbursement rates; disclosure of fees associated with administrative service agreements and patient care programs that are attributable to members&#8217; drug utilization; and registration or licensing of PBMs. Failure by the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company or one of its PBM services suppliers to comply with these laws or regulations could result in material fines and/or sanctions and could have a material adverse effect on the Company&#8217;s operating results and/or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s PBM service contracts, including those in which the Company assumes certain risks under performance guarantees or similar arrangements, are generally not subject to insurance regulation by the states. However, state departments of insurance are increasing their oversight of PBM activities due to legislation passing in a number of states requiring PBMs to register or obtain a license with the department. Rulemaking is either underway or has already taken place in a number of states with the areas of focus on licensure requirements, pharmacy reimbursement for generics (MAC reimbursement) and pharmacy audits - most of which fall under the state insurance code.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Most-Favored-Nations Rule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In November 2020, HHS released the Most-Favored-Nations Rule (the &#8220;MFN Rule&#8221;), which requires CMS to take a most-favored-nation approach in calculating payment for Medicare Part B drugs. The MFN Rule will test paying Part B drugs at comparable amounts to the lowest adjusted price paid by any country in the Organization for Economic Co-operation and Development that has a Gross Domestic Product (&#8220;GDP&#8221;) per capita that is at least 60% of the U.S. GDP per capita. The MFN Rule will also test a redesign of the percentage add-on payment structure under Medicare Part B to remove incentives for use of higher-cost drugs through a flat per-dose add-on payment, and will include a financial hardship exemption for participants. The mandatory MFN Rule will operate for seven years, from January 1, 2021 to December 31, 2027. Over the course of the model, CMS will monitor and evaluate the impact of the MFN Rule on beneficiary access to drugs, program costs, and the quality of care for beneficiaries. Further, CMS commits to assess initial impacts of the MFN Rule on quality of care, including access to drugs, prior to beginning performance year 5. Multiple pharmaceutical manufacturers have sued HHS over the rule, and it is currently delayed due to a temporary restraining order prohibiting CMS from implementing it. If implemented, the MFN Rule may impact the ability of the Company to negotiate drug prices and provide competitive products and services to consumers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Network Access Legislation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Medicare Part D and a majority of states now have some form of legislation affecting the Company&#8217;s (and its health plans&#8217; and its health plan clients&#8217;) ability to limit access to a pharmacy provider network or remove pharmacy network providers. For example, certain &#8220;any willing provider&#8221; legislation may require the Company or its clients to admit a nonparticipating pharmacy if such pharmacy is willing and able to meet the plan&#8217;s price and other applicable terms and conditions for network participation. These laws could negatively affect the services and economic benefits achievable through a limited pharmacy provider network. Also, a majority of states now have some form of legislation affecting the Company&#8217;s ability (and the Company&#8217;s and its client health plans&#8217; ability) to conduct audits of network pharmacies regarding claims submitted to the Company for payment. These laws could negatively affect the Company&#8217;s ability to recover overpayments of claims submitted by network pharmacies that the Company identifies through pharmacy audits. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Pricing Legislation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - A number of states have passed legislation regulating the Company&#8217;s ability to manage and establish MACs for generic prescription drugs. MAC methodology is a common cost management practice used by private and public payors (including CMS) to pay pharmacies for dispensing generic prescription drugs. MAC prices specify the allowable reimbursement by a PBM for a particular strength and dosage of a generic drug that is available from multiple manufacturers but sold at different prices. State legislation can regulate the disclosure of MAC prices and MAC price methodologies, the kinds of drugs that a PBM can pay for at a MAC price, and the rights of pharmacies to appeal a MAC price established by a PBM. These laws could negatively affect the Company&#8217;s ability to establish MAC prices for generic drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formulary and Plan Design Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- A number of government entities regulate the administration of prescription drug benefits. HHS regulates how Medicare Part D formularies are developed and administered, including requiring the inclusion of all drugs in certain classes and categories, subject to limited exceptions. Under the ACA, CMS imposes drug coverage requirements for health plans required to cover essential health benefits, including plans offered through federal or state Public Exchanges. Additionally, the NAIC and health care accreditation agencies like NCQA and URAC have developed model acts and standards for formulary development that are often incorporated into government requirements. Many states regulate the scope of prescription drug coverage, as well as the delivery channels to receive prescriptions, for insurers, MCOs and Medicaid managed care plans. The increasing government regulation of formularies could significantly affect the Company&#8217;s ability to develop and administer formularies, pharmacy networks and other plan design features on behalf of its insurer, MCO and other clients. Similarly, some states prohibit health plan sponsors from implementing certain restrictive pharmacy benefit plan design features. This regulation could limit or preclude (i) limited networks, (ii) a requirement to use particular providers, (iii) copayment differentials among providers and (iv) formulary tiering practices. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to the Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws and regulations discussed above that may affect multiple segments of the Company&#8217;s business, the Company is subject to federal, state and local statutes and regulations governing the operation of its Retail/LTC segment specifically. Among these are the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail Medical Clinics </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- States regulate retail medical clinics operated by nurse practitioners or physician assistants through physician oversight, clinic and lab licensure requirements and the prohibition of the corporate practice of medicine. A number of states have implemented or proposed laws or regulations that impact certain components of retail medical clinic operations such as physician oversight, signage, third party contracting requirements, bathroom facilities, and scope of services. These laws and regulations may affect the operation and expansion of the Company&#8217;s owned and managed retail medical clinics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Laws - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other federal, state and local laws and regulations also impact the Company&#8217;s retail operations, including laws and regulations governing the practice of optometry, the practice of audiology, the provision of dietician services and the sale of durable medical equipment, contact lenses, eyeglasses, hearing aids and alcohol.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to the Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws and regulations discussed above that may affect multiple segments of the Company&#8217;s business, the Company is subject to federal, state, local and international statutes and regulations governing its Health Care Benefits segment specifically. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Differing approaches to state insurance regulation and varying enforcement philosophies may materially and adversely affect the Company&#8217;s ability to standardize its Health Care Benefits products and services across state lines. These laws and regulations, including the ACA, restrict how the Company conducts its business and result in additional burdens and costs to the Company. Significant areas of governmental regulation include premium rates and rating methodologies, underwriting rules and procedures, required benefits, sales and marketing activities, provider rates of payment, restrictions on health plans&#8217; ability to limit providers&#8217; participation in their networks and/or remove providers from their networks and financial condition (including reserves and minimum capital or risk based capital requirements). These laws and regulations are different in each jurisdiction and vary from product to product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each health insurer and HMO must file periodic financial and operating reports with the states in which it does business. In addition, health insurers and HMOs are subject to state examination and periodic license renewal. Applicable laws also restrict the ability of the Company&#8217;s regulated subsidiaries to pay dividends, and certain dividends require prior regulatory approval. In addition, some of the Company&#8217;s businesses and related activities may be subject to PPO, MCO, utilization review or TPA-related licensure requirements and regulations. These licensure requirements and regulations differ from state to state, but may contain provider network, contracting, product and rate, financial and reporting requirements. There also are laws and regulations that set specific standards for the Company&#8217;s delivery of services, payment of claims, fraud prevention, protection of consumer health information, and payment for covered benefits and services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Required Regulatory Approvals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company must obtain and maintain regulatory approvals to price, market and administer many of its Health Care Benefits products. Supervisory agencies, including CMS, the Center for Consumer Information and Insurance Oversight and the DOL, as well as state health, insurance, managed care and Medicaid agencies, have broad authority to take one or more of the following actions:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Grant, suspend and revoke the Company&#8217;s licenses to transact business;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Suspend or exclude the Company from participation in government programs;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Suspend or limit the Company&#8217;s authority to market products;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulate many aspects of the products and services the Company offers, including the pricing and underwriting of many of its products and services;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assess damages, fines and/or penalties;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Terminate the Company&#8217;s contract with the government agency and/or withhold payments from the government agency to the Company;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Impose retroactive adjustments to premiums and require the Company to pay refunds to the government, customers and/or members;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restrict the Company&#8217;s ability to conduct acquisitions or dispositions;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Require the Company to maintain minimum capital levels in its subsidiaries and monitor its solvency and reserve adequacy;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulate the Company&#8217;s investment activities on the basis of quality, diversification and other quantitative criteria; and/or</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Exclude the Company&#8217;s plans from participating in Public Exchanges if they are deemed to have a history of &#8220;unreasonable&#8221; premium rate increases or fail to meet other criteria set by HHS or the applicable state.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operations, current and past business practices, current and past contracts, and accounts and other books and records are subject to routine, regular and special investigations, audits, examinations and reviews by, and from time to time the Company receives subpoenas and other requests for information from, federal, state and international supervisory and enforcement agencies, attorneys general and other state, federal and international governmental authorities and legislators. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Product Pricing and Underwriting Restrictions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Pricing and underwriting regulation by states limits the Company&#8217;s underwriting and rating practices and those of other health insurers, particularly for small employer groups, and varies by state. In general, these limitations apply to certain customer segments and limit the Company&#8217;s ability to set prices for new or renewing groups, or both, based on specific characteristics of the group or the group&#8217;s prior claim experience. In some states, these laws and regulations restrict the Company&#8217;s ability to price for the risk it assumes and/or reflect reasonable costs in the Company&#8217;s pricing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA expanded the premium rate review process by, among other things, requiring the Company&#8217;s Commercial Insured rates to be reviewed for &#8220;reasonableness&#8221; at either the state or the federal level. HHS established a federal premium rate review process that generally applies to proposed premium rate increases equal to or exceeding a federally (or lower state) specified threshold. HHS&#8217;s rate review process imposes additional public disclosure requirements as well as additional review on filings requesting premium rate increases equal to or exceeding this &#8220;reasonableness&#8221; threshold. These combined state and federal review requirements may prevent, further delay or otherwise affect the Company&#8217;s ability to price for the risk it assumes, which could adversely affect its MBRs and operating results, particularly during periods of increased utilization of medical services and/or medical cost trend or when such utilization and/or trend exceeds the Company&#8217;s projections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA also specifies minimum MLRs of 85% for large group Commercial products and 80% for individual and small group Commercial products. Because the ACA minimum MLRs are structured as &#8220;floors&#8221; for many of their requirements, states have the latitude to enact more stringent rules governing these restrictions. For Commercial products, states have and may adopt higher minimum MLR requirements, use more stringent definitions of &#8220;medical loss ratio,&#8221; incorporate minimum MLR requirements into prospective premium rate filings, require prior approval of premium rates or impose other requirements related to minimum MLR. Minimum MLR requirements and similar actions further limit the level of margin the Company can earn in its Insured Commercial products while leaving the Company exposed to medical costs that are higher than those reflected in its pricing. The Company also may be subject to significant fines, penalties, premium refunds and litigation if it fails to comply with minimum MLR laws and regulations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company requested increases in its premium rates in its Commercial Health Care Benefits business for 2020 (including as a result of the reinstatement of the HIF for 2020 following the temporary suspension of the HIF for 2019) and expects to continue to request increases in those rates for 2021 and beyond in order to adequately price for projected medical cost trends, required expansions of coverage and rating limits, and significant assessments, fees and taxes imposed by the federal and state governments, including as a result of the ACA. The Company&#8217;s rates also must be adequate to reflect adverse selection in its products, particularly in small group Commercial products. These rate increases may be significant and thus heighten the risks of adverse publicity, adverse regulatory action and adverse selection and the likelihood that the Company&#8217;s requested premium rate increases will be denied, reduced or delayed, which could lead to operating margin compression.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the laws and regulations governing the Company&#8217;s pricing and underwriting practices also limit the differentials in premium rates insurers and other carriers may charge between new and renewal business, and/or between groups based on differing characteristics. They may also require that carriers disclose to customers the basis on which the carrier establishes new business and renewal premium rates and limit the ability of a carrier to terminate customers&#8217; coverage. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicaid Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is seeking to substantially grow its Medicaid, dual eligible and dual eligible special needs plan businesses over the next several years. As a result, the Company also is increasing its exposure to changes in government policy with respect to and/or regulation of the various Medicaid, dual eligible and dual eligible special needs plan programs in which the Company participates, including changes in the amounts payable to the Company under those programs.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2017, Managed Medicaid products, including those the Company offers, are subject to a minimum federal MLR of 85%. A Medicaid managed care quality rating system and provider network adequacy requirements also apply to Medicaid products. Because the federal minimum MLR is structured as a &#8220;floor,&#8221; states have the latitude to enact more stringent rules governing these restrictions. For Managed Medicaid products, states may adopt higher minimum MLR requirements, use more stringent definitions of &#8220;medical loss ratio&#8221; or impose other requirements related to minimum MLR. Minimum MLR requirements and similar actions further limit the level of margin the Company can earn in its Insured Medicaid products while leaving the Company exposed to medical costs that are higher than those reflected in its pricing. The Company also may be subject to significant fines, penalties, premium refunds and litigation if it fails to comply with minimum MLR laws and regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The future of the ACA, and the impact of Medicaid expansion under the ACA, are uncertain. States may opt out of the elements of the ACA requiring expansion of Medicaid coverage without losing their current federal Medicaid funding. To date, a number of states and the District of Columbia have expanded Medicaid coverage to the higher eligibility levels contemplated by the ACA. In addition, the election of new governors and/or state legislatures may impact states&#8217; previous decisions regarding Medicaid expansion. Proposals for substantial changes to federal funding of state Medicaid programs are likely to be considered in 2020 and beyond, including the possibility of converting federal Medicaid support to block grants (such as the block grant option outlined by CMS on January 30, 2020) and per capita caps on federal funding. Uncertainty regarding federal funding is causing and will continue to cause states to re-evaluate their Medicaid expansions and consider new assessments, fees and/or taxes on health plans. That re-evaluation and any changes to federal funding of state Medicaid programs may adversely affect Medicaid payment rates, the Company&#8217;s revenues and its Medicaid membership.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The economic aspects of the Medicaid, dual eligible and dual eligible special needs plan business vary from state to state and are subject to frequent change. Medicaid premiums are paid by each state and differ from state to state. The federal government and certain states also are considering proposals and legislation for Medicaid and dual eligible program reforms or redesigns, including restrictions on the collection of manufacturer&#8217;s rebates on pharmaceuticals by Medicaid MCOs and their contracted PBMs, further program, population and/or geographic expansions of risk-based managed care, increasing beneficiary cost-sharing or payment levels, and changes to benefits, reimbursement, eligibility criteria, provider network adequacy requirements (including requiring the inclusion of specified high cost providers in the Company&#8217;s networks) and program structure. In some states, current Medicaid and dual eligible funding and premium revenue may not be adequate for the Company to continue program participation. The Company&#8217;s Medicaid and dual eligible contracts with states (or sponsors of Medicaid managed care plans) are subject to cancellation by the state (or the sponsors of the managed care plans) after a short notice period without cause (e.g., when a state discontinues a managed care program) or in the event of insufficient state funding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicaid, dual eligible and dual eligible special needs plan products also are heavily regulated by CMS and state Medicaid agencies, which have the right to audit the Company&#8217;s performance to determine compliance with CMS contracts and regulations. The Company&#8217;s Medicaid products, dual eligible products and CHIP contracts also are subject to complex federal and state regulations and oversight by state Medicaid agencies regarding the services provided to Medicaid enrollees, payment for those services, network requirements (including mandatory inclusion of specified high-cost providers), and other aspects of these programs, and by external review organizations which audit Medicaid plans on behalf of state Medicaid agencies. The laws, regulations and contractual requirements applicable to the Company and other participants in Medicaid and dual eligible programs, including requirements that the Company submit encounter data to the applicable state agency, are extensive, complex and subject to change. The Company has invested significant resources to comply with these standards, and its Medicaid and dual eligible program compliance efforts will continue to require significant resources. CMS and/or state Medicaid agencies may fine the Company, withhold payments to the Company, seek premium and other refunds, terminate the Company&#8217;s existing contracts, elect not to award the Company new contracts or not to renew the Company&#8217;s existing contracts, prohibit the Company from continuing to market and/or enroll members in or refuse to automatically assign members to one or more of the Company&#8217;s Medicaid or dual eligible products, exclude the Company from participating in one or more Medicaid or dual eligible programs and/or institute other sanctions and/or civil monetary penalties against the Company if it fails to comply with CMS or state regulations or contractual requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict whether pending or future federal or state legislation or court proceedings will change various aspects of the Medicaid program, nor can it predict the impact those changes will have on its business operations or operating results, but the effects could be materially adverse.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal and State Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Company is subject to extensive financial and business reporting requirements, including penalties for inaccuracies and/or omissions, at both the federal and state level. The Company&#8217;s ability to comply with certain of these requirements depends on receipt of information from third parties that may not be readily available or reliably provided in all instances. The Company is and will continue to be required to modify its information systems, dedicate significant resources </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and incur significant expenses to comply with these requirements. However, the Company cannot eliminate the risks of unavailability of or errors in its reports.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Design and Administration and Sales Practices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - State and/or federal regulatory scrutiny of health care benefit product design and administration and marketing and advertising practices, including the filing of insurance policy forms, the adequacy of provider networks, the accuracy of provider directories, and the adequacy of disclosure regarding products and their administration, is increasing as are the penalties being imposed for inappropriate practices. Medicare, Medicaid and dual eligible products and products offering more limited benefits in particular continue to attract increased regulatory scrutiny.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guaranty Fund Assessments/Solvency Protection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer governed health plans established under the ACA. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation was incorporated in Delaware in 1996. The corporate office is located at One CVS Drive, Woonsocket, Rhode Island 02895, telephone (401)&#160;765-1500. CVS Health&#8217;s common stock is listed on the New York Stock Exchange under the trading symbol &#8220;CVS.&#8221; General information about the Company is available through the Company&#8217;s website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://www.cvshealth.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company&#8217;s financial press releases and filings with the SEC are available free of charge within the Investors section of the Company&#8217;s website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://investors.cvshealth.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, the SEC maintains an internet site that contains reports, proxy and information statements and other information regarding issuers, such as the Company, that file electronically with the SEC. The address of that website is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://www.sec.gov. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information on or linked to the Company&#8217;s website is neither a part of nor incorporated by reference in this 10-K or any of the Company&#8217;s other SEC filings. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with guidance provided by the SEC regarding use by a company of its websites and social media channels as a means to disclose material information to investors and to comply with its disclosure obligations under SEC Regulation FD, CVS Health Corporation (the &#8220;Registrant&#8221;) hereby notifies investors, the media and other interested parties that it intends to continue to use its media and investor relations website (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://investors.cvshealth.com/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and its Twitter feed (@CVSHealthIR) to publish important information about the Registrant, including information that may be deemed material to investors. The list of social media channels that the Registrant uses may be updated on its media and investor relations website from time to time. The Registrant encourages investors, the media, and other interested parties to review the information the Registrant posts on its website and social media channels as described above, in addition to information announced by the Registrant through its SEC filings, press releases and public conference calls and webcasts. </span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider each of the following risks and uncertainties and all of the other information set forth in this 10-K. These risks and uncertainties and other factors may affect forward-looking statements, including those we make in this 10-K or elsewhere, such as in news releases or investor or analyst calls, meetings or presentations, on our websites or through our social media channels. The risks and uncertainties described below are not the only ones we face. There can be no assurance that we have identified all the risks that affect us. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial also may adversely affect our businesses. Any of these risks or uncertainties could cause our actual results to differ materially from our expectations and the expected results discussed in our forward-looking statements. You should not consider past results to be an indication of future performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the following risks or uncertainties develops into actual events or if the circumstances described in the risks or uncertainties occur or continue to occur, those events or circumstances could have a material adverse effect on our businesses, operating results, cash flows, financial condition and/or stock price, among other effects on us. You should read the following section in conjunction with the MD&amp;A, included in Item 7 of this 10-K, our consolidated financial statements and the related notes, included in Item 8 of this 10-K, and our &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in this 10-K.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the principal risks we face: </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to COVID-19</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of COVID-19 on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be material and adverse.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of COVID-19 and the related testing and vaccination may result in us not being able to accurately forecast health care and other benefit costs, and we are uncertain that future health care and other benefits costs will not exceed our projections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Businesses</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Each of our segments operates in a highly competitive and evolving business environment.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A change in our Health Care Benefits product mix may adversely affect our profit margins.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Negative public perception of the industries in which we operate can adversely affect our businesses, operating results, cash flows and prospects.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure to maintain or improve our relationships with our retail and specialty pharmacy customers may adversely affect our operating results.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face risks relating to the availability, pricing and safety profiles of prescription drugs that we purchase and sell.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to accurately forecast health care and other benefit costs.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If actual claims in our Insured Health Care Benefits products exceed our estimates, our operating results could be materially adversely affected, and our ability to take timely corrective actions to limit future costs may be limited.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are exposed to risks relating to the solvency of other insurers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks From Changes in Public Policy and Other Legal and Regulatory Risks</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to potential changes in public policy, laws and regulations, including reform of the U.S. health care system, which can adversely affect our businesses. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to comply with applicable laws and regulations, we could be subject to significant adverse regulatory actions or suffer brand and reputational harm.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our compliance or other systems and processes fail or are deemed inadequate, we may suffer brand and reputational harm and become subject to regulatory actions and/or litigation.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The litigation and other adverse legal proceedings that we face are costly to defend, may result in changes in our business practices, harm our brand and reputation and adversely affect our businesses and operating results.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The governmental audits, investigations and reviews to which we are subject could result in changes to our business practices and also could result in material refunds, fines, penalties, civil and/or criminal liabilities and other sanctions.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our litigation and regulatory risk profile are changing as we offer new products and services.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face unique regulatory and other challenges in our Medicare and Medicaid businesses.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Programs funded in whole or in part by the U.S. federal government account for a significant portion of our revenues, and we expect that percentage to increase.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to obtain adequate premium rate increases in our Insured Health Care Benefits products, which would have an adverse effect on our revenues, MBRs and operating results.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Minimum MLR rebate requirements limit the level of margin we can earn in our Insured Health Care Benefits products while leaving us exposed to higher than expected medical costs.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operating results may be adversely affected by changes in laws and policies governing employers and by union organizing activity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Associated with Mergers, Acquisitions, and Divestitures </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to successfully integrate companies we acquire.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The acquisitions, joint ventures, strategic alliances and other inorganic growth opportunities we pursue may be unsuccessful.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In order to complete a proposed acquisition, we may be required to divest certain portions of our business, for which we may not be able to obtain favorable pricing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Operations</span></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure to meet customer expectations may harm our brand and reputation, our ability to retain and grow our customer base and membership and our operating results and cash flows.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We can provide no assurance that we or our vendors will be able to detect, prevent or contain the effects of cyber attacks or other information security (including cybersecurity) risks or threats in the future.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our use and disclosure of members&#8217;, customers&#8217; and other constituents&#8217; sensitive information is subject to complex regulations at multiple levels, and we would be adversely affected if we or our business associates or other vendors fail to adequately protect members&#8217;, customers&#8217; or other constituents&#8217; sensitive information.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product liability, product recall or personal injury issues could damage our reputation and have a significant adverse effect on our businesses, operating results, cash flows and/or financial condition.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face significant competition in attracting and retaining talented employees, and managing succession for, and retention of, key executives is critical to our success.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sales of our products and services are dependent on our ability to attract and motivate internal sales personnel and independent third-party brokers, consultants and agents. </span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure of our businesses to effectively collaborate could prevent us from maximizing our operating results.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The failure or disruption of our information technology systems or infrastructure to support our businesses could adversely affect our reputation, businesses, operating results and cash flows.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pursuing multiple initiatives simultaneously presents challenges to maintaining, continuing to develop and improve an effective information technology system. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to payment-related risks that could increase our operating costs, expose us to fraud or theft, subject us to potential liability and disrupt our business operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Both our and our vendors&#8217; operations are subject to a variety of business continuity hazards and risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risks</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We would be adversely affected if we do not effectively deploy our capital. Downgrades or potential downgrades in our credit ratings could adversely affect our brand and reputation, businesses, operating results, cash flows and financial condition.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Goodwill and other intangible assets could, in the future, become impaired.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adverse conditions in the U.S. and global capital markets can significantly and adversely affect the value of our investments.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our significant indebtedness has increased our consolidated interest expense and could adversely affect our business flexibility and increase our borrowing costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Relationships with Manufacturers, Providers, Suppliers and Vendors</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face risks relating to the market availability, pricing, suppliers and safety profiles of prescription drugs and other products that we purchase and sell.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operating results may be adversely affected if we are unable to contract with providers on competitive terms and develop and maintain attractive networks with high quality providers.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our service providers fail to meet their contractual obligations to us or to comply with applicable laws or regulations, we may be exposed to brand and reputational harm, litigation and/or regulatory action.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may experience increased medical and other benefit costs, litigation risk and customer and member dissatisfaction when providers that do not have contracts with us render services to our Health Care Benefits members.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continuing consolidation and integration among providers and other suppliers may increase our medical and other covered benefits costs, make it difficult for us to compete in certain geographies and create new competitors.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The spread of, impact of and response to COVID-19 underscores and amplifies certain risks we face. The impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be material and adverse.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 has spread to every state in the U.S., has been declared a pandemic by the World Health Organization and has severely impacted, and is expected to continue to severely impact, the economies of the U.S. and other countries around the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The legislative and regulatory environment governing our businesses is dynamic and changing frequently, including the Families First Act, the CARES Act and mandated increases to the medical services we must pay for without a corresponding increase in the premiums we receive in our Health Care Benefits Insured products. As a result of COVID-19, including legislative and/or regulatory responses to COVID-19, the premiums we charge in our Insured Health Care Benefits products may prove to be insufficient to cover the cost of medical services delivered to our Insured medical members, which may increase significantly as a result of higher utilization rates of medical facilities and services and other increases in associated hospital and pharmaceutical costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state and local governmental policies and initiatives to reduce the transmission of COVID-19, including shelter-in-place orders and social distancing directives, may not effectively combat the severity and/or duration of the COVID-19 pandemic and have resulted in, among other things, a reduction in utilization that is discretionary, the cancellation of elective medical procedures, reduced customer traffic and front store sales in our retail pharmacies, our customers being ordered to close or severely curtail their operations, the adoption of work-from-home policies and a reduction in diagnostic reporting due to reductions in health care provider visits and restrictions on our access to providers&#8217; medical records, all of which impact our businesses. Among other impacts of these policies and initiatives on our businesses, we expect changes in medical claims submission patterns and an adverse impact on (i) drug utilization due to the reduction in discretionary visits with providers; (ii) front store sales as a result of reduced customer traffic in our retail pharmacies due to shelter-in-place orders and COVID-19 related unemployment; (iii) medical membership in our Health Care Benefits segment and covered lives in our PBM clients due to reductions in workforce at our existing customers (including due to business failures) as well as reduced willingness to change benefits providers by prospective customers; (iv) benefit costs due to COVID-19 related support programs we have put in place for our medical members and mandated increases to the medical services we must pay for without a corresponding increase in the premiums we receive in our Insured Health Care Benefits products; and (v) the amount, timing and collectability of payments to the Company from customers, clients, government payers and members as a result of the impact of COVID-19 on them. Over time, these policies and initiatives also may cause us to experience increased benefit costs and/or decreased revenues in our Health Care Benefits segment if, as a result of our medical members not seeing their providers as a result of COVID-19, we are unable to implement clinical initiatives to manage benefit costs and chronic conditions of our medical members and appropriately document their risk profiles.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in response to COVID-19, during the first half of 2020, we began to offer our medical members expanded benefit coverage and became obligated by governmental action to provide other additional coverage. This expanded benefit coverage is being provided without a corresponding increase in the premiums we receive in our Insured Health Care Benefits products. We also are taking actions designed to help provide financial and administrative relief for the health care provider community. Such measures and any further steps we take or are required to take to expand or otherwise modify the services delivered to our Health Care Benefits members, provide relief for the health care provider community, or in connection with the relaxation of shelter-in-place orders and social distancing directives and other restrictions on movement and economic activity intended to reduce the spread of COVID-19, including the potential for widespread testing and vaccination, as a component of lifting those measures, could adversely impact our benefit costs, MBR and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The various initiatives we have implemented to slow and/or reduce the impact of COVID-19, such as colleagues working remotely and installing protective equipment in our retail pharmacies, and the COVID-19-related support programs we have put in place for our customers, medical members and colleagues have increased our operating expenses and reduced the efficiency of our operations. Our operating results will continue to be adversely affected so long as these initiatives continue or if they are expanded. In addition, the adverse economic conditions in the U.S. and abroad caused by COVID-19 have had, and may continue to have, an adverse impact on our net investment income and the value of our investment portfolio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of COVID-19, or actions taken to mitigate its spread, could have material and adverse effects on our ability to operate our businesses effectively, including as a result of the complete or partial closure of facilities, labor shortages and/or financial difficulties experienced by third-party service providers. Disruptions in our supply chains, our distribution chains and/</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or public and private infrastructure, including communications and financial services, could materially and adversely impact our business operations. We have transitioned a significant subset of our colleagues to a remote work environment in an effort to mitigate the spread of COVID-19, as have a significant number of our third-party service providers, which may amplify certain risks to our businesses, including an increased demand for information technology resources, increased risk of phishing and other cybersecurity attacks, increased risk of unauthorized dissemination of sensitive personal information or proprietary or confidential information about us or our medical members or other third-parties and increased risk of business interruptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the FDA has authorized some COVID-19 vaccines for emergency use, the COVID-19 pandemic continues to evolve and the severity and duration of the pandemic and scope and intensity of the governmental response to it are unknown at this time. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A number of factors, many of which are beyond our control, including COVID-19 and related testing and vaccination, contribute to rising health care and other benefit costs. We may not be able to accurately forecast health care and other benefit costs, which could adversely affect our Health Care Benefits segment&#8217;s operating results. There can be no assurance that future health care and other benefits costs will not exceed our projections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of COVID-19, the current economic environment is adverse and less predictable than recently experienced, which has caused and may continue to cause unanticipated and significant volatility in our health care and other benefits costs, including COVID-19 related testing and vaccination and post-acute care skilled nursing facility and behavioral health costs. On January 21, 2021, the President of the United States issued an executive order to support government efforts to expand access, availability and use of COVID-19 diagnostic, screening and surveillance and addressed the cost of COVID-19 testing by facilitating COVID-19 testing free of charge to those who lack comprehensive health insurance and clarifying group health plans&#8217; and health insurance issuers&#8217; obligations to provide coverage for COVID-19 testing. In addition, the timing of vaccine administration to the general public and related costs as well as the identification of new, more infectious strains of the COVID-19 virus and whether the vaccines will be effective against such new strains are uncertain and may impact our MBR. Premiums for our Insured Health Care Benefits products, which comprised 92% of our Health Care Benefits revenues for 2020, are priced in advance based on our forecasts of health care and other benefit costs during a fixed premium period, which is generally twelve months. These forecasts are typically developed several months before the fixed premium period begins, are influenced by historical data (and recent historical data in particular), are dependent on our ability to anticipate and detect medical cost trends and changes in our members&#8217; behavior and health care utilization patterns and medical claim submission patterns and require a significant degree of judgment. For example, our revenue on Medicare policies is based on bids submitted in June of the year before the contract year. Cost increases in excess of our projections cannot be recovered in the fixed premium period through higher premiums. As a result, our profits are particularly sensitive to the accuracy of our forecasts of the increases in health care and other benefit costs that we expect to occur and our ability to anticipate and detect medical cost trends. For 2021, those forecasts include adjustments made to pricing based on prospective expectations for liabilities due to testing, vaccines, direct COVID-19 treatment and deferred care. Risk-adjusted revenue has been adjusted for deferred care, and forecasted enrollment considers assumptions about the economic environment, though COVID-19 related impacts remain uncertain. During periods such as 2020 and 2021 when health care and other benefit costs, utilization and/or medical costs trends experience significant volatility and medical claim submission patterns are changing rapidly as a result of COVID-19, accurately detecting, forecasting, managing, reserving and pricing for our (and our self-insured customers&#8217;) medical cost trends and incurred and future health care and other benefits costs is more challenging. There can be no assurance regarding the accuracy of the health care or other benefit cost projections reflected in our pricing, and our health care and other benefit costs (including COVID-19 related testing and vaccination and post-acute care skilled nursing facility and behavioral health costs) are affected by COVID-19 and other external events over which we have no control. Even relatively small differences between predicted and actual health care and other benefit costs as a percentage of premium revenues can result in significant adverse changes in our Health Care Benefits segment&#8217;s operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of factors contribute to rising health care and other benefit costs, including COVID-19, previously uninsured members entering the health care system, changes in members&#8217; behavior and health care utilization patterns, turnover in our membership, additional government mandated benefits or other regulatory changes (including under the Families First Act and the CARES Act), changes in the health status of our members, the aging of the population and other changing demographic characteristics, advances in medical technology, increases in the number and cost of prescription drugs (including specialty </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pharmacy drugs and ultra-high cost drugs and therapies), direct-to-consumer marketing by drug manufacturers, the increasing influence of social media on our members&#8217; health care utilization and other behaviors, changes in health care practices and general economic conditions (such as inflation and employment levels). In addition, government-imposed limitations on Medicare and Medicaid reimbursements to health plans and providers have caused the private sector to bear a greater share of increasing health care and other benefits costs over time, and future amendments or repeal or replacement of the ACA that increase the uninsured population may amplify this problem. Other factors that affect our health care and other benefit costs include epidemics or other pandemics, changes as a result of the ACA, changes to or the discontinuation of the ACA and other changes in the regulatory environment, the evolution toward a consumer driven business model, new technologies, influenza-related health care costs (which may be substantial), clusters of high-cost cases, health care provider and member fraud, and numerous other factors that are or may be beyond our control.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, if we are not able to accurately and promptly anticipate and detect medical cost trends or accurately estimate the cost of incurred but not yet reported claims or reported claims that have not been paid, our ability to take timely corrective actions to limit future health care costs and reflect our current benefit cost experience in our pricing process may be limited, which would further amplify the extent of any adverse impact on our operating results. These risks are particularly acute during periods such as 2020 and 2021 when health care and other benefit costs, utilization and/or medical cost trends experience significant volatility and medical claim submission patterns are changing rapidly as a result of COVID-19. Such risks are further magnified by the ACA and other existing and future legislation and regulations that limit our ability to price for our projected and/or experienced increases in utilization and/or medical cost trends.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that future health care and other benefits costs will not exceed our projections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse economic conditions in the U.S. and abroad can materially and adversely impact our businesses, operating results, cash flows and financial condition, and we do not expect these conditions to improve in the near future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic, the availability and cost of credit and other capital, higher unemployment rates and other factors have contributed to adverse conditions in the global economy and significantly diminished expectations for the global economy, and particularly the U.S. economy, at least through the end of 2020 and possibly longer. Our customers, medical providers and the other companies with which we do business are generally headquartered in the U.S.; however, many of our largest customers are global companies with operations around the world. As a result, adverse economic conditions in the U.S. and abroad, including those caused by COVID-19, can materially and adversely impact our businesses, operating results, cash flows and financial condition, including:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our Pharmacy Services segment, by causing drug utilization to decline, reducing demand for PBM services and adversely affecting the financial health of our PBM clients.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our Retail/LTC segment, by causing drug utilization to decline, changing consumer purchasing power, preferences and/or spending patterns leading to reduced consumer demand for products sold in our stores and adversely affecting the financial health of our LTC pharmacy customers.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By causing our existing customers to reduce workforces (including due to business failures), which would reduce our revenues, the number of covered lives in our PBM clients and/or the number of members our Health Care Benefits segment serves.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By causing our clients and customers and potential clients and customers, particularly those with the most employees or members, and state and local governments, to force us to compete more vigorously on factors such as price and service, including service, discount and other performance guarantees, to retain or obtain their business.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By causing customers and potential customers of our Retail/LTC and Health Care Benefits segments to purchase fewer products and/or products that generate less profit for us than the ones they currently purchase or otherwise would have purchased.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By causing customers and potential customers of our Health Care Benefits segment, particularly smaller employers and individuals, to forego obtaining or renewing their health and other coverage with us.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our Health Care Benefits segment, by causing unanticipated increases and volatility in utilization of medical and other covered services, including COVID-19 related testing, vaccination and behavioral health services, by our medical members, changes in medical claim submission patterns and/or increases in medical unit costs and/or provider behavior, each of which would increase our costs and limit our ability to accurately detect, forecast, manage, reserve and price for our (and our self-insured customers&#8217;) medical cost trends and incurred and future health care and other benefits costs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By increasing medical unit costs and causing changes in provider behavior in our Health Care Benefits segment as hospitals and other providers attempt to maintain revenue levels in their efforts to adjust to their own COVID-19-related and other economic challenges.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By weakening the ability or perceived ability of the issuers and/or guarantors of the debt or other securities we hold in our investment portfolio to perform on their obligations to us, which could result in defaults in those securities and has reduced, and may further reduce, the value of those securities and has created, and may continue to create, net realized capital losses for us that reduce our operating results.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By weakening the ability of our customers, including self-insured customers in our Health Care Benefits segment, medical providers and the other companies with which we do business as well as our medical members to perform their obligations to us or causing them not to perform those obligations, either of which could reduce our operating results.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By weakening the ability of our former subsidiaries and/or their purchasers to satisfy their lease obligations that we have guaranteed and causing the Company to be required to satisfy those obligations.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By weakening the financial condition of other insurers, including long-term care insurers and life insurers, which increases the risk that we will receive significant assessments for obligations of insolvent insurers to policyholders and claimants.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By causing, over time, inflation that could cause interest rates to increase and thereby increase our interest expense and reduce our operating results, as well as decrease the value of the debt securities we hold in our investment portfolio, which would reduce our operating results and/or adversely affect our financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, reductions in workforce by our customers can cause unanticipated increases in the health care and other benefits costs of our Health Care Benefits segment. For example, our business associated with members who have elected to receive benefits under Consolidated Omnibus Budget Reconciliation Act (known as &#8220;COBRA&#8221;) typically has an MBR that is significantly higher than our overall Commercial MBR.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Businesses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Each of our segments operates in a highly competitive and evolving business environment; and gross margins in the industries in which we compete may decline.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our segments, Pharmacy Services, which includes our pharmacy benefit management (&#8220;PBM&#8221;) business, Retail/LTC, and Health Care Benefits, operates in a highly competitive and evolving business environment. Specifically:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As competition increases in the geographies in which we operate, including competition from new entrants, a significant increase in price compression and/or reimbursement pressures could occur, and this could require us to reevaluate our pricing structures to remain competitive.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The competitive success of our Pharmacy Services segment is dependent on our ability to establish and maintain contractual relationships with network pharmacies as PBM clients evaluate adopting narrow or restricted retail pharmacy networks. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The competitive success of our Retail/LTC segment and our specialty pharmacy operations is dependent on our ability to establish and maintain contractual relationships with PBMs and other payors on acceptable terms as the payors&#8217; clients evaluate adopting narrow or restricted retail pharmacy networks. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our PBM business, we maintain contractual relationships with brand name drug manufacturers that provide for purchase discounts and/or rebates on drugs dispensed by pharmacies in our retail network and by our specialty and mail order pharmacies (all or a portion of which may be passed on to clients). Manufacturer&#8217;s rebates often depend on a PBM&#8217;s ability to meet contractual requirements, including the placement of a manufacturer&#8217;s products on the PBM&#8217;s formularies. If we lose our relationship with one or more drug manufacturers, or if the discounts or rebates provided by drug manufacturers decline, our operating results, cash flows and/or prospects could be adversely affected. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The PBM industry has been experiencing price compression as a result of competitive pressures and increased client demands for lower prices, increased revenue sharing, including sharing in a larger portion of rebates received from drug manufacturers, enhanced service offerings and/or higher service levels. Marketplace dynamics and regulatory changes also have adversely affected our ability to offer plan sponsors pricing that includes the use of retail &#8220;differential&#8221; or &#8220;spread,&#8221; which could adversely affect our future profitability, and we expect these trends to continue.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our retail pharmacy, specialty pharmacy and LTC pharmacy operations have been affected by reimbursement pressure caused by competition, including client demands for lower prices, generic drug pricing, earlier than expected generic drug introductions and network reimbursement pressure. If we are unable to increase our prices to reflect, or otherwise mitigate </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the impact of, increasing costs, our profitability will be adversely affected. If we are unable to limit our price increases, we may lose customers to competitors with more favorable pricing, adversely affecting our revenues and operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A shift in the mix of our pharmacy prescription volume towards programs offering lower reimbursement rates as a result of competition or otherwise could adversely affect our margins, including the ongoing shift in pharmacy mix towards 90-day prescriptions at retail and the ongoing shift in pharmacy mix towards Medicare Part D prescriptions.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">PBM client contracts often are for a period of approximately three years. However, PBM clients may require early or periodic re-negotiation of pricing prior to contract expiration. PBM clients are generally well informed, can move between us and our competitors and often seek competing bids prior to expiration of their contracts. We are therefore under pressure to contain price increases despite being faced with increasing drug costs and increasing operating costs. If we are unable to increase our prices to reflect, or otherwise mitigate the impact of, increasing costs, our profitability will be adversely affected. If we are unable to limit our price increases, we may lose customers to competitors with more favorable pricing, adversely affecting our revenues and operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The operating results and margins of our LTC business are further affected by the increased efforts of health care payors to negotiate reduced or capitated pricing arrangements and by the financial health of, and purchases and sales of, our LTC customers.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our Health Care Benefits segment we are seeking to substantially grow our Medicaid, dual eligible and dual eligible special needs plan membership over the next several years. In many instances, to acquire and retain our government customers&#8217; business, we must bid against our competitors in a highly competitive environment. Winning bids often are challenged successfully by unsuccessful bidders, and may also be withdrawn or cancelled by the issuing agency.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Customer contracts in our Health Care Benefits segment are generally for a period of one year, and our customers have considerable flexibility in moving between us and our competitors. One of the key factors on which we compete for customers, especially in uncertain economic environments, is overall cost. We are therefore under pressure to contain premium price increases despite being faced with increasing health care and other benefit costs and increasing operating costs. If we are unable to increase our prices to reflect, or otherwise mitigate the impact of, increasing costs, our profitability will be adversely affected. If we are unable to limit our price increases, we may lose members to competitors with more favorable pricing, adversely affecting our revenues and operating results. In response to rising prices, our customers may elect to self-insure or to reduce benefits in order to limit increases in their benefit costs. Alternatively, our customers may purchase different types of products from us that are less profitable. Such elections may result in reduced membership in our more profitable Insured products and/or lower premiums for our Insured products, which may adversely affect our revenues and operating results, although such elections also may reduce our health care and other benefit costs. In addition, our Medicare, Medicaid and CHIP products are subject to termination without cause, periodic re-bid, rate adjustment and program redesign, as customers seek to contain their benefit costs, particularly in an uncertain economy, and our exposure to this risk is increasing as we grow our Government products membership. These actions may adversely affect our membership, revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We requested increases in our premium rates in our Commercial Health Care Benefits business for 2021 and expect to continue to request increases in those rates for 2022 and beyond in order to adequately price for projected medical cost trends, required expansions of coverage and rating limits, and significant assessments, fees and taxes imposed by federal and state governments, including as a result of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;). Our rates also must be adequate to reflect the risk that our products will be selected by people with a higher risk profile or utilization rate than the pool of participants we anticipated when we established pricing for the applicable products (also known as &#8220;adverse selection&#8221;), particularly in small group Commercial products. These rate increases may be significant and thus heighten the risks of adverse publicity, adverse regulatory action and adverse selection and the likelihood that our requested premium rate increases will be denied, reduced or delayed, which could lead to operating margin compression.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, competitors in each of our businesses may offer services and pricing terms that we may not be willing or able to offer. Competition also may come from new entrants and other sources in the future. Unless we can demonstrate enhanced value to our clients through innovative product and service offerings in the rapidly changing health care industry, we may be unable to remain competitive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptive innovation by existing or new competitors could alter the competitive landscape in the future and require us to accurately identify and assess such alterations and make timely and effective changes to our strategies and business model to compete effectively. For example, decisions to buy our Pharmacy Services and Health Care Benefits products and services increasingly are made or influenced by consumers, either through direct purchasing (e.g., Medicare Advantage plans and PDPs) or through public health insurance exchanges (&#8220;Public Exchanges&#8221;) and private health insurance exchanges (together with Public Exchanges, collectively, &#8220;Insurance Exchanges&#8221;) that allow individual choice. Consumers also are increasingly seeking to access consumer goods and health care products and services locally and through other direct channels such as mobile </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">devices and websites. To compete effectively in the consumer-driven marketplace, we will be required to develop or acquire new capabilities, attract new talent and develop new service and distribution relationships that respond to consumer needs and preferences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in marketplace dynamics or the actions of competitors or manufacturers, including industry consolidation, the emergence of new competitors and strategic alliances, and decisions to exclude us from new narrow or restricted retail pharmacy networks could materially and adversely affect our businesses, operating results, cash flows and/or prospects. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A change in our Health Care Benefits product mix may adversely affect our profit margins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Insured Health Care Benefits products that involve greater potential risk generally tend to be more profitable than our ASC products. Historically, smaller employer groups have been more likely to purchase Insured Health Care Benefits products because such purchasers are generally unable or unwilling to bear greater liability for health care expenditures, although over the last several years even relatively small employers have moved to ASC products. We also serve, and expect to grow our business with, government-sponsored programs, including Medicare and Medicaid, that are subject to competitive bids and have lower profit margins than our Commercial Insured Health Care Benefits products. A shift of enrollees from more profitable products to less profitable products could have a material adverse effect on the Health Care Benefits segment&#8217;s operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Negative public perception of the industries in which we operate, or of our industries&#8217; or our practices, can adversely affect our businesses, operating results, cash flows and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our brand and reputation are two of our most important assets, and the industries in which we operate have been and are negatively perceived by the public from time to time. Negative publicity may come as a result of adverse media coverage, litigation against us and other industry participants, the ongoing public debates over drug pricing, PBMs, government involvement in drug pricing and purchasing, the future of the ACA, &#8220;surprise&#8221; medical bills, governmental hearings and/or investigations, actual or perceived shortfalls regarding our industries&#8217; or our own products and/or business practices (including PBM operations, drug pricing and insurance coverage determinations) and social media and other media relations activities.  Negative publicity also may come from a failure to meet customer expectations for consistent, high quality and accessible care. This risk may increase as we continue to offer products and services that make greater use of data and as our business model becomes more focused on delivering health care to consumers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, by working with the U.S. government in the distribution and administration of the COVID-19 vaccine, the Company may be subject to negative publicity related to the government&#8217;s actions in response to COVID-19 that are outside of the ability of the Company to control.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Negative public perception and/or publicity of our industries in general, or of us or our key vendors, brokers or product distribution networks in particular, can further increase our costs of doing business and adversely affect our operating results and our stock price by:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adversely affecting our brand and reputation;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adversely affecting our ability to market and sell our products and/or services and/or retain our existing customers and members;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requiring us to change our products and/or services; </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing or restricting the revenue we can receive for our products and/or services; and/or</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing or significantly changing the regulatory and legislative requirements with which we must comply.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We must maintain and improve our relationships with our retail and specialty pharmacy customers and increase the demand for our products and services, including proprietary brands.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our businesses depends in part on customer loyalty, superior customer service and our ability to persuade customers to frequent our retail stores and online sites and to purchase products in additional categories and our proprietary brands. Failure to timely identify or effectively respond to changing consumer preferences and spending patterns, and evolving demographic mixes in the communities we serve, an inability to expand the products being purchased by our clients and customers, or the failure or inability to obtain or offer particular categories of products could adversely affect our relationship with our customers and clients and the demand for our products and services and could result in excess inventories of products.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer our retail customers proprietary brand products that are available exclusively at our retail stores and through our online retail sites. The sale of proprietary products subjects us to unique risks including potential product liability risks, mandatory or voluntary product recalls, potential supply chain and distribution chain disruptions for raw materials and finished products, our ability to successfully protect our intellectual property rights and the rights of applicable third parties, and other risks generally encountered by entities that source, market and sell private-label products. We also face similar risks for the other products we sell in our retail operations, including supply chain and distribution chain disruption risk. Any failure to adequately address some or all of these risks could have an adverse effect on our retail business, operating results, cash flows and/or financial condition. Additionally, an increase in the sales of our proprietary brands may adversely affect our sales of products owned by our suppliers and adversely impact certain of our supplier relationships. Our ability to locate qualified, economically stable suppliers who satisfy our requirements, and to acquire sufficient products in a timely and effective manner, is critical to ensuring, among other things, that customer confidence is not diminished. Any failure to develop sourcing relationships with a broad and deep supplier base could adversely affect our operating results and erode customer loyalty.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also could be adversely affected if we fail to identify or effectively respond to changes in marketplace dynamics. For example, specialty pharmacy represents a significant and growing proportion of prescription drug spending in the U.S., a significant portion of which is dispensed outside of traditional retail pharmacies. Because our specialty pharmacy business focuses on complex and high-cost medications, many of which are made available by manufacturers to a limited number of pharmacies (so-called limited distribution drugs) that serve a relatively limited universe of patients, the future growth of our specialty pharmacy business depends largely upon expanding our access to key drugs and penetration in certain treatment categories. Any contraction of our base of patients or reduction in demand for the prescriptions we currently dispense could have an adverse effect on our specialty pharmacy business, operating results and cash flows.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks relating to the availability, pricing and safety profiles of prescription drugs that we purchase and sell.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The profitability of our Retail/LTC and Pharmacy Services segments is dependent upon the utilization of prescription drug products. We dispense significant volumes of brand name and generic drugs from our retail, LTC, specialty and mail order pharmacies, and the retail pharmacies in our PBM&#8217;s network also dispense significant volumes of brand name and generic drugs. Our revenues, operating results and cash flows may decline if physicians cease writing prescriptions for drugs or the utilization of drugs is reduced, including due to:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased safety risk profiles or regulatory restrictions;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacturing or other supply issues;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain products being withdrawn by their manufacturers or transitioned to over-the-counter products; </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future FDA rulings restricting the supply or increasing the cost of products;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the introduction of new and successful prescription drugs or lower-priced generic alternatives to existing brand name products; or </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inflation in the price of brand name drugs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, increased utilization of generic drugs (which normally yield a higher gross profit rate than equivalent brand name drugs) has resulted in pressure to decrease reimbursement payments to retail, mail order, specialty and LTC pharmacies for generic drugs, causing a reduction in our margins on sales of generic drugs. Consolidation within the generic drug manufacturing industry and other external factors may enhance the ability of manufacturers to sustain or increase pricing of generic drugs and diminish our ability to negotiate reduced generic drug acquisition costs. Any inability to offset increased brand name or generic prescription drug acquisition costs or to modify our activities to lessen the financial impact of such increased costs could have a significant adverse effect on our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A number of factors, many of which are beyond our control, contribute to rising health care and other benefit costs. We may not be able to accurately forecast health care and other benefit costs, which could adversely affect our Health Care Benefits segment&#8217;s operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums for our Insured Health Care Benefits products, which comprised 92% of our Health Care Benefits revenues for 2020, are priced in advance based on our forecasts of health care and other benefit costs during a fixed premium period, which is generally one year. These forecasts are typically developed several months before the fixed premium period begins, are influenced by historical data (and recent historical data in particular), are dependent on our ability to anticipate and detect medical cost trends and changes in our members&#8217; behavior and health care utilization patterns and require a significant degree of judgment. For example, our revenue on Medicare policies is based on bids submitted in June of the year before the contract year. Cost increases in excess of our projections cannot be recovered in the fixed premium period through higher premiums. As </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a result, our profits are particularly sensitive to the accuracy of our forecasts and our ability to anticipate and detect medical cost trends. Even relatively small differences between predicted and actual health care and other benefit costs as a percentage of premium revenues can result in significant adverse changes in our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of factors contribute to rising health care and other benefit costs, including previously uninsured members entering the health care system, changes in members&#8217; behavior and health care utilization patterns, turnover in our membership, additional government mandated benefits or other regulatory changes, changes in the health status of our members, the aging of the population and other changing demographic characteristics, advances in medical technology, increases in the number and cost of prescription drugs (including specialty pharmacy drugs and ultra-high cost drugs and therapies), direct-to-consumer marketing by drug manufacturers, the increasing influence of social media on our members&#8217; health care utilization and other behaviors, changes in health care practices and general economic conditions (such as inflation and employment levels). In addition, government-imposed limitations on Medicare and Medicaid reimbursements to health plans and providers have caused the private sector to bear a greater share of increasing health care and other benefits costs over time, and future amendments or repeal or replacement of the ACA that increase the uninsured population may exacerbate this problem. Other factors that affect our health care and other benefit costs include changes as a result of the ACA, changes to the ACA and other changes in the regulatory environment, the evolution toward a consumer driven business model, new technologies, influenza related health care costs (which may be substantial and higher than we project), clusters of high-cost cases, epidemics or pandemics, health care provider and member fraud, and numerous other factors that are or may be beyond our control. For example, the 2020-2021 influenza season was impacted by efforts taken to reduce the spread of COVID-19; and the 2019-2020 influenza season had an earlier than average start and had a higher incidence of influenza than the 2018-2019 influenza season. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Health Care Benefits segment&#8217;s operating results and competitiveness depend in large part on our ability to appropriately manage future health care and other benefit costs through underwriting criteria, product design, provider network configuration, negotiation of favorable provider contracts and medical management programs. Our medical cost management programs may not be successful and may have a smaller impact on health care and benefit costs than we expect. The factors described above may adversely affect our ability to predict and manage health care and other benefit costs, which can adversely affect our competitiveness and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The reserves we hold for expected claims in our Insured Health Care Benefits products are based on estimates that involve an extensive degree of judgment and are inherently variable. Any reserve, including a premium deficiency reserve, may be insufficient. If actual claims exceed our estimates, our operating results could be materially adversely affected, and our ability to take timely corrective actions to limit future costs may be limited.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A large portion of health care claims are not submitted to us until after the end of the quarter in which services are rendered by providers to our members. Our reported health care costs payable for any particular period reflect our estimates of the ultimate cost of such claims as well as claims that have been reported to us but not yet paid. We also must estimate the amount of rebates payable under the MLR rules of the ACA, CMS and the OPM and the amounts payable by us to, and receivable by us from, the United States federal government under the ACA&#8217;s remaining premium stabilization program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates of health care costs payable are based on a number of factors, including those derived from historical claim experience, but this estimation process also makes use of extensive judgment. Considerable variability is inherent in such estimates, and the accuracy of the estimates is highly sensitive to changes in medical claims submission and processing patterns and/or procedures, turnover and other changes in membership, changes in product mix, changes in the utilization of medical and/or other covered services, including prescription drugs, changes in medical cost trends, changes in our medical management practices and the introduction of new benefits and products. We estimate health care costs payable periodically, and any resulting adjustments, including premium deficiency reserves, are reflected in current-period operating results within benefit costs. For example, as of December 31, 2020 and 2019, we established a premium deficiency reserve of $11 million and $4 million, respectively, related to Medicaid products in the Health Care Benefits segment. A worsening (or improvement) of health care cost trend rates or changes in claim payment patterns from those that we assumed in estimating health care costs payable as of December 31, 2020 would cause these estimates to change in the near term, and such a change could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, if we are not able to accurately and promptly anticipate and detect medical cost trends or accurately estimate the cost of incurred but not yet reported claims or reported claims that have not been paid, our ability to take timely corrective actions to limit future health care costs and reflect our current benefit cost experience in our pricing process may be limited, which would further exacerbate the extent of any adverse impact on our operating results. These risks are particularly acute during and following periods when utilization of medical and/or other covered services and/or medical cost trends are below recent historical levels and in products where there is significant turnover in our membership each year, and such risks are </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">further magnified by the ACA and other legislation and regulations that limit our ability to price for our projected and/or experienced increases in utilization and/or medical cost trends.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results are affected by the health of the economy in general and in the geographies we serve.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses are affected by the U.S. economy and consumer confidence in general and in the geographies we serve, including various economic factors, including inflation and changes in consumer purchasing power, preferences and/or spending patterns. An unfavorable, uncertain or volatile economic environment could cause a decline in drug utilization, an increase in health care utilization and dampen demand for PBM services as well as consumer demand for products sold in our retail stores. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our customers&#8217; operating and financial performance deteriorates, or they are unable to make scheduled payments or obtain adequate financing, our customers may not be able to pay timely, or may delay payment of, amounts owed to us. Any inability of our customers to pay us for our products and services may adversely affect our businesses, operating results and cash flows. In addition, both state and federal government sponsored payers, as a result of budget deficits or spending reductions, may suspend payments or seek to reduce their health care expenditures resulting in our customers delaying payments to us or renegotiating their contracts with us. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, economic conditions including interest rate fluctuations, changes in capital market conditions and regulatory changes may affect our ability to obtain necessary financing on acceptable terms, our ability to secure suitable store locations under acceptable terms, our ability to execute sale-leaseback transactions under acceptable terms and the value of our investment portfolio. Adverse changes in the U.S. economy, consumer confidence and economic conditions could have an adverse effect on our businesses and financial results. This adverse effect could be further exacerbated by the increasing prevalence of high deductible health plans and health plan designs favoring co-insurance over co-payments as members and other consumers may decide to postpone, or not to seek, medical treatment which may lead them to incur more expensive medical treatment in the future and/or decrease our prescription volumes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our Health Care Benefits membership remains concentrated in certain U.S. geographies and in certain industries. Unfavorable changes in health care or other benefit costs or reimbursement rates or increased competition in those geographic areas where our membership is concentrated could therefore have a disproportionately adverse effect on our Health Care Benefits segment&#8217;s operating results. Our Health Care Benefits membership has been and may continue to be affected by workforce reductions by our customers due to adverse and/or uncertain general economic conditions, especially in the U.S. geographies and industries where our membership is concentrated. As a result, we may not be able to profitably grow and diversify our Health Care Benefits membership geographically, by product type or by customer industry, and our revenues and operating results may be disproportionately affected by adverse changes affecting our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to risks relating to the solvency of other insurers.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to assessments under guaranty fund laws existing in all states for obligations of insolvent insurance companies (including long-term care insurers), HMOs, ACA co-ops and other payors to policyholders and claimants. For example, in the first quarter of 2017, Aetna recorded a discounted estimated liability expense of $231 million pretax for our estimated share of future assessments for long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries. Guaranty funds are maintained by state insurance commissioners to protect policyholders and claimants in the event that an insurer, HMO, ACA co-op and/or other payor becomes insolvent or is unable to meet its financial obligations. These funds are usually financed by assessments against insurers regulated by a state. Future assessments may have an adverse effect on our operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Extreme events, or the threat of extreme events, could materially increase our health care (including behavioral health) costs.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nuclear, biological or other attacks, whether as a result of war or terrorism, other man-made disasters, natural disasters, epidemics, pandemics and other extreme events can affect the U.S. economy in general, our industries and us specifically. In particular, such extreme events or the threat of such extreme events could result in significant health care (including behavioral health) costs, which also would be affected by the government&#8217;s actions and the responsiveness of public health agencies and other insurers. Such extreme events or the threat of such extreme events also could disrupt our supply chains and/or our distribution chains for the products we sell. In addition, our employees and those of our vendors are concentrated in certain large, metropolitan areas which may be particularly exposed to these events. Such events could adversely affect our businesses, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operating results and cash flows, and, in the event of extreme circumstances, our financial condition or viability, particularly if our responses to such events are less adequate than those of our competitors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks From Changes in Public Policy and Other Legal and Regulatory Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to potential changes in public policy, laws and regulations, including reform of the U.S. health care system, which can adversely affect our businesses. Entitlement program reform, if it occurs, could have a material adverse effect on our businesses, operations and/or operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The political environment in which we operate remains uncertain. It is reasonably possible that our business operations and operating results could be materially adversely affected by legislative, regulatory and public policy changes at the federal or state level, increased government involvement in drug reimbursement, pricing, purchasing and/or importation and/or increased regulation of PBMs, including: changes to the Medicare or Medicaid programs (including the block grant option outlined by CMS on January 30, 2020, the &#8220;block grant option&#8221;) or the regulatory environment for health care and related benefits, including the ACA; changes to laws or regulations governing drug reimbursement and/or pricing; changes to the laws and regulations governing PBMs&#8217;, PDPs&#8217; and/or Managed Medicaid organizations&#8217; interactions with government funded health care programs; changes to laws and/or regulations governing drug manufacturers&#8217; rebates; changes to laws and/or regulations governing reimbursements paid to pharmacists by and/or reporting required by PBMs; changes to immigration policies and/or other public policy initiatives. It is not possible to predict whether or when any such changes will occur or what form any such changes may take (including through the use of U.S. Presidential Executive Orders). Other significant changes to health care and related benefits system legislation or regulation as well as changes with respect to tax and trade policies, tariffs and other government regulations affecting trade between the United States and other countries also are possible and could adversely affect our businesses. If we fail to respond adequately to such changes, including by implementing strategic and operational initiatives, or do not respond as effectively as our competitors, our businesses, operations and operating results may be materially adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to efforts to amend, repeal or replace the ACA and related regulations, we expect the federal and state governments to continue to enact and seriously consider many broad-based legislative and regulatory proposals that will or could materially impact various aspects of the health care and related benefits system and our businesses. Potential modification to the ACA, including changes in enforcement and/or funding that further destabilize the Public Exchanges, as well as significant changes to Medicaid funding (including the block grant option) could impact the number of Americans with health insurance and, consequently, prescription drug coverage. Further changes to federal health care and related benefits laws, including the ACA, drug reimbursement and pricing laws, laws governing PBMs and/or laws governing PBMs&#8217;, PDPs&#8217; and/or Managed Medicaid organizations&#8217; interactions with government funded health care programs, are probable. We cannot predict the effect, if any, that new health care and related benefits legislation, future changes to the ACA or the implementation of or failure to implement the outstanding provisions of ACA, may have on our Pharmacy Services, retail pharmacy, LTC pharmacy and/or Health Care Benefits operations and/or operating results. The federal and many state governments also are considering changes in the interpretation, enforcement and/or application of existing programs, laws and regulations, including changes to payments under and funding of Medicare and Medicaid programs and increased regulation of PBMs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, changes in existing federal or state laws or regulations or the adoption of new laws or regulations relating to additional regulation of PBMs (including formulary management or other PBM services), drug pricing or purchasing, patent term extensions and/or purchase discount and/or rebate arrangements with drug manufacturers also could reduce the discounts or rebates we receive. Changes in existing federal or state laws or regulations or the adoption of new laws or regulations relating to claims processing and billing, including our ability to use MAC lists and collect transmission fees, also could adversely affect our profitability. For example, on October 29, 2020, the HHS released a final rule requiring health insurers to disclose drug pricing and cost-sharing information. The final rule requires group health plans and health insurance issuers in the individual and group markets to disclose cost-sharing information upon request, to a participant, beneficiary, or enrollee, which, unless otherwise indicated, for the purpose of the final rules includes an authorized representative, and requires plans and issuers to disclose in-network provider rates, historical out-of-network allowed amounts and the associated billed charges, and</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">negotiated rates for prescription drugs. The public disclosure of insurer- or PBM-negotiated price concessions may result in drug manufacturers lowering discounts or rebates, resulting in higher drug costs for patients and impacting the ability of the Company to negotiate drug prices and provide competitive products and services to consumers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in November 2020, the HHS released the Rebate Rule, which eliminates the regulatory safe harbor from prosecution under the AKS for rebates from pharmaceutical companies to PBMs in Medicare Part D and in Medicaid MCOs, replacing it with two far narrower safe harbors designed to directly benefit patients with high out-of-pocket costs and to change the way PBMs are compensated. The new safe harbors are (i) for rebates which are passed on to the patient at the point of sale </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and (ii) for flat service fee payments made to PBMs which cannot be tied to the list prices of drugs. The PCMA, which represents PBMs, has filed a suit in an effort to block the Rebate Rule, claiming that the Rebate Rule would lead to higher premiums in Medicare Part D and was adopted in an unlawful manner. It is unclear whether the Rebate Rule will be enforceable, whether pharmaceutical companies will respond by reducing list prices, whether list prices in the private market may also be reduced, and what the resulting impact will be to PBMs or the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the enactment or content of new legislation or regulations or changes to existing laws or regulations or their enforcement, interpretation or application, or the effect they will have on our business operations or operating results, which could be materially adverse. Even if we could predict such matters, it is not possible to eliminate the adverse impact of public policy changes that would fundamentally change the dynamics of one or more of the industries in which we compete. Examples of such changes include: the federal or one or more state governments fundamentally restructuring or reducing the funding available for Medicare, Medicaid, dual eligible or dual eligible special needs plan programs, increasing its involvement in drug reimbursement, pricing, purchasing and/or importation, changing the laws and regulations governing PBMs&#8217;, PDPs&#8217; and/or Managed Medicaid organizations&#8217; interactions with government funded health care programs, changing the tax treatment of health or related benefits, or repealing or otherwise significantly altering the ACA. The likelihood of adverse changes remains high due to state and federal budgetary pressures, and our businesses and operating results could be materially and adversely affected by such changes, even if we correctly predict their occurrence. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on these matters, see &#8220;Government Regulation&#8221; included in Item 1 of this 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with applicable laws and regulations, many of which are highly complex, we could be subject to significant adverse regulatory actions or suffer brand and reputational harm.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses are subject to extensive regulation and oversight by state, federal and international governmental authorities. The laws and regulations governing our operations and interpretations of those laws and regulations are increasing in number and complexity, change frequently and can be inconsistent or conflict with one another. In general, these laws and regulations are designed to benefit and protect customers, members and providers rather than us or our investors. In addition, the governmental authorities that regulate our businesses have broad latitude to make, interpret and enforce the laws and regulations that govern us and continue to interpret and enforce those laws and regulations more strictly and more aggressively each year. We also must follow various restrictions on certain of our businesses and the payment of dividends by certain of our subsidiaries put in place by certain state regulators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our Pharmacy Services and Retail/LTC operations, products and services are subject to:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the clinical quality, patient safety and other risks inherent in the dispensing, packaging and distribution of drugs and other health care products and services, including claims related to purported dispensing and other operational errors (any failure by our Pharmacy Services and/or Retail/LTC operations to adhere to the laws and regulations applicable to the dispensing of drugs could subject us to civil and criminal penalties);</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state anti-kickback and other laws that govern our relationship with drug manufacturers, customers and consumers;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance requirements under ERISA, including fiduciary obligations in connection with the development and implementation of items such as drug formularies and preferred drug listings; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state legislative proposals and/or regulatory activity that could adversely affect pharmacy benefit industry practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Health Care Benefits products are highly regulated, particularly those that serve Medicare, Medicaid, dual eligible, dual eligible special needs and small group Commercial customers and members. The laws and regulations governing participation in Medicare Advantage, Medicare Part D, Medicaid, dual eligible and dual eligible special needs plan programs are complex, are subject to interpretation and can expose us to penalties for non-compliance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scope of the practices and activities that are prohibited by federal and state false claims acts is the subject of pending litigation. Claims under federal and state false claims acts can be brought by the government or by private individuals on behalf of the government through a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or &#8220;whistleblower&#8221; suit, and we are a defendant in a number of such proceedings. If we are convicted of fraud or other criminal conduct in the performance of a government program or if there is an adverse decision against us under the False Claims Act, we may be temporarily or permanently suspended from participating in government health care programs, including Medicare Advantage, Medicare Part D, Medicaid, dual eligible and dual eligible special needs plan programs, and we also may be required to pay significant fines and/or other monetary penalties. Whistleblower suits have </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulted in significant settlements between governmental agencies and health care companies. The significant incentives and protections provided to whistleblowers under applicable law increase the risk of whistleblower suits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to comply with laws and regulations that apply to government programs, we could be subject to criminal fines, civil penalties, premium refunds, prohibitions on marketing or active or passive enrollment of members, corrective actions, termination of our contracts or other sanctions which could have a material adverse effect on our ability to participate in Medicare Advantage, Medicare Part D, Medicaid, dual eligible, dual eligible special needs plan and other programs and on our operating results, cash flows and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses, profitability and growth also may be adversely affected by (i) judicial and regulatory decisions that change and/or expand the interpretations of existing statutes and regulations, impose medical or bad faith liability, increase our responsibilities under ERISA or the remedies available under ERISA, or reduce the scope of ERISA pre-emption of state law claims or (ii) other legislation and regulations. For example, in December 2020, the U.S. Supreme Court upheld an Arkansas law that, among other things, mandates a particular pricing methodology, establishes an appeals process for a pharmacy when the reimbursement is below the pharmacy&#8217;s acquisition cost, permits a pharmacy to reverse and rebill if they cannot procure the drug from its wholesaler at a price equal to or less than the reimbursement rate, prohibits a PBM from reimbursing a pharmacy less than the amount it reimburses an affiliate on a per unit basis, and permits a pharmacy to decline to dispense if the reimbursement is lower than the pharmacy&#8217;s acquisition cost. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our compliance or other systems and processes fail or are deemed inadequate, we may suffer brand and reputational harm and become subject to regulatory actions and/or litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to being subject to extensive and complex regulations, many of our contracts with customers include detailed requirements. In order to be eligible to offer certain products or bid on certain contracts, we must demonstrate that we have robust systems and processes in place that are designed to maintain compliance with all applicable legal, regulatory and contractual requirements. These systems and processes frequently are reviewed and audited by our customers and regulators. If our systems and processes designed to maintain compliance with applicable legal and contractual requirements, and to prevent and detect instances of, or the potential for, non-compliance fail or are deemed inadequate, we may suffer brand and reputational harm and be subject to regulatory actions, litigation and other proceedings which may result in damages, fines, suspension or loss of licensure, suspension or exclusion from participation in government programs and/or other penalties, any of which could adversely affect our businesses, operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We routinely are subject to litigation and other adverse legal proceedings, including class actions and qui tam actions. Many of these proceedings seek substantial damages which may not be covered by insurance. These proceedings are costly to defend, may result in changes in our business practices, harm our brand and reputation and adversely affect our businesses and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PBM, retail pharmacy, mail order pharmacy, specialty pharmacy, LTC pharmacy and health care and related benefits are highly regulated industries whose participants frequently are subject to litigation and other adverse legal proceedings. We are currently subject to various litigation and arbitration matters, investigations, regulatory audits, inspections, government inquiries, and regulatory and other legal proceedings, both inside and outside the U.S. Outside the U.S., contractual rights, tax positions and applicable regulations may be subject to interpretation or uncertainty to a greater degree than in the U.S. Litigation related to our provision of professional services in our medical clinics, pharmacies and LTC operations is increasing as we expand our services along the continuum of health care.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation, and particularly securities, derivative, collective or class action and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> litigation, is often expensive and disruptive. Many of the legal proceedings against us seek substantial damages (including non-economic or punitive damages and treble damages), and certain of these proceedings also seek changes in our business practices. While we currently have insurance coverage for some potential liabilities, other potential liabilities may not be covered by insurance, insurers may dispute coverage and/or the amount of our insurance may not be enough to cover the damages awarded or costs incurred. In addition, some types of damages, like punitive damages, may not be covered by insurance, and in some jurisdictions the coverage of punitive damages is prohibited. Insurance coverage for all or some forms of liability also may become unavailable or prohibitively expensive in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outcome of litigation and other adverse legal proceedings is always uncertain, and outcomes that are not justifiable by the evidence or existing law or regulation can and do occur, and the costs incurred frequently are substantial regardless of the outcome. Litigation and other adverse legal proceedings could materially adversely affect our businesses, operating results and/or cash flows because of brand and reputational harm to us caused by such proceedings, the cost of defending such proceedings, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the cost of settlement or judgments against us, or the changes in our operations that could result from such proceedings. See Item 3 of this 10-K for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We frequently are subject to regular and special governmental audits, investigations and reviews that could result in changes to our business practices and also could result in material refunds, fines, penalties, civil liabilities, criminal liabilities and other sanctions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As one of the largest national retail, mail order, specialty and LTC pharmacy, PBM and health care and related benefits providers, we frequently are subject to regular and special governmental market conduct and other audits, investigations and reviews by, and we receive subpoenas and other requests for information from, various federal and state agencies, regulatory authorities, attorneys general, committees, subcommittees and members of the U.S. Congress and other state, federal and international governmental authorities. For example, we have received CIDs from, and provided documents and information to, the Civil Division of the DOJ in connection with a current investigation of our patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. CMS and the OIG also are auditing the risk adjustment-related data of certain of our Medicare Advantage plans, and the number of such audits continues to increase. Several such audits, investigations and reviews by governmental authorities currently are pending, some of which may be resolved in 2021, the results of which may be adverse to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state governments have made investigating and prosecuting health care and other insurance fraud, waste and abuse a priority. Fraud, waste and abuse prohibitions encompass a wide range of activities, including kickbacks for referral of members, billing for unnecessary medical and/or other covered services, improper marketing and violations of patient privacy rights. The regulations and contractual requirements applicable to us and other industry participants are complex and subject to change, making it necessary for us to invest significant resources in complying with our regulatory and contractual requirements. Ongoing vigorous law enforcement and the highly technical regulatory scheme mean that our compliance efforts in this area will continue to require significant resources. In addition, our medical costs and the medical expenses of our Health Care Benefits ASC customers may be adversely affected if we do not prevent or detect fraudulent activity by providers and/or members.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regular and special governmental audits, investigations and reviews by federal, state and international regulators could result in changes to our business practices, and also could result in significant or material premium refunds, fines, penalties, civil liabilities, criminal liabilities or other sanctions, including suspension or exclusion from participation in government programs and suspension or loss of licensure. Any of these audits, investigations or reviews could have a material adverse effect on our businesses, operating results, cash flows and/or financial condition or result in significant liabilities and negative publicity for us. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Legal and Regulatory Proceedings&#8221; in Note 16 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; included in Item 8 of this 10-K for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our litigation and regulatory risk profile are changing as we offer new products and services and expand in business areas beyond our historical core businesses of Pharmacy Services, Retail/LTC and Health Care Benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we focused primarily on providing Pharmacy Services, Retail/LTC and Health Care Benefits products and services. As a result of our transformation program and other innovation initiatives, we are expanding our presence in the health care space and plan to offer new products and services (such as the home hemodialysis device we are developing) which present a different litigation and regulatory risk profile than the products and services that we historically have offered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increased volume of business in areas beyond our historical core businesses and new products and services subject us to litigation and regulatory risks that are different from the risks of providing Pharmacy Services, Retail/LTC and Health Care Benefits products and services and increase significantly our exposure to other risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face unique regulatory and other challenges in our Medicare and Medicaid businesses.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are seeking to substantially grow the Medicare and Medicaid membership in our Health Care Benefits segment in 2020 and over the next several years. We face unique regulatory and other challenges that may inhibit the growth and profitability of those businesses.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In April 2020, CMS issued a final notice detailing final Medicare Advantage benchmark payment rates for 2021 (the &#8220;Final Notice&#8221;). Overall, we project the benchmark rates in the Final Notice will increase funding for our Medicare Advantage </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">business, excluding the impact of the HIF in 2020, by approximately 1.8% in 2021 compared to 2020. This 2021 rate increase only partially offsets the challenge we face from the impact of the increasing cost of medical care (including prescription medications) and CMS local and national coverage decisions that require us to pay for services and supplies that are not factored into our bids and creates continued pressure on our Medicare Advantage operating results. In January 2021, CMS issued its final notice detailing final 2022 Medicare Advantage benchmark payment rates. Final 2022 Medicare Advantage rates resulted in an increase in industry benchmark rates of approximately 4.1%. We cannot predict future Medicare funding levels, the impact of future federal budget actions or ensure that such changes or actions will not have an adverse effect on our Medicare operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The organic expansion of our Medicare Advantage and Medicare Part D service area is subject to the ability of CMS to process our requests for service area expansions and our ability to build cost competitive provider networks in the expanded service areas that meet applicable network adequacy requirements. CMS&#8217; decisions on our requests for service area expansions also may be affected adversely by compliance issues that arise each year in our Medicare operations. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CMS regularly audits our performance to determine our compliance with CMS&#8217;s regulations and our contracts with CMS and to assess the quality of the services we provide to our Medicare members. As a result of these audits, we may be subject to significant or material retroactive adjustments to and/or withholding of certain premiums and fees, fines, criminal liability, civil monetary penalties, CMS imposed sanctions (including suspension or exclusion from participation in government programs) or other restrictions on our Medicare, Medicaid and other businesses, including suspension or loss of licensure. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Star ratings&#8221; from CMS for our Medicare Advantage plans will continue to have a significant effect on our plans&#8217; operating results. Since 2015, only Medicare Advantage plans with a star rating of four or higher (out of five) are eligible for a quality bonus in their basic premium rates. CMS continues to change its rating system to make achieving and maintaining a four or higher star rating more difficult. Our star ratings and past performance scores are adversely affected by the compliance issues that arise each year in our Medicare operations. If our star ratings fall below four for a significant portion of our Medicare Advantage membership or do not match the performance of our competitors or the star rating quality bonuses are reduced or eliminated, our revenues, operating results and cash flows may be significantly adversely affected.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Payments we receive from CMS for our Medicare Advantage and Part D businesses also are subject to risk adjustment based on the health status of the individuals we enroll. Elements of that risk adjustment mechanism continue to be challenged by the DOJ, the OIG and CMS itself. Substantial changes in the risk adjustment mechanism, including changes that result from enforcement or audit actions, could materially affect the amount of our Medicare reimbursement, require us to raise prices or reduce the benefits we offer to Medicare beneficiaries, and potentially limit our (and the industry&#8217;s) participation in the Medicare program.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes to the ability of PBMs to have pharmacy performance programs in place for clients and report payments via direct and indirect reporting mechanisms could impact the Pharmacy Services business.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare Part D has resulted in increased utilization of prescription medications and puts pressure on our pharmacy gross margin rates due to regulatory and competitive pressures. Further, as a result of the ACA and changes to the retiree drug subsidy rules, clients of our PBM business could decide to discontinue providing prescription drug benefits to their Medicare-eligible members. To the extent this phenomenon occurs, the adverse effects of increasing customer migration into Medicare Part D may outweigh the benefits we realize from growth of our Medicare Part D products. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our Medicare Part D operating results and our ability to expand our Medicare Part D business could be adversely affected if: the cost and complexity of Medicare Part D exceed management&#8217;s expectations or prevent effective program implementation or administration; changes to the regulations regarding how drug costs are reported for Medicare Part D are implemented in a manner that adversely affects the profitability of our Medicare Part D business; changes to the applicable regulations impact our ability to retain fees from third parties including network pharmacies; the government alters Medicare Part D program requirements or reduces funding because of the higher-than-anticipated cost to taxpayers of Medicare Part D or for other reasons; the government mandated use of point-of-sale manufacturer&#8217;s rebates effective in 2022 continues; the government makes changes to how pharmacy pay-for-performance is calculated; or reinsurance thresholds are reduced below their current levels.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have experienced challenges in obtaining complete and accurate encounter data for our Medicaid products due to difficulties with providers and third-party vendors submitting claims in a timely fashion in the proper format, and with state agencies in coordinating such submissions. As states increase their reliance on encounter data, these difficulties could affect the Medicaid premium rates we receive and how Medicaid membership is assigned to us, which could have a material adverse effect on our Medicaid operating results and cash flows and/or our ability to bid for, and continue to participate in, certain Medicaid programs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal funding for expanded Medicaid coverage began to decrease in 2017. This reduction is causing states to re-evaluate funding for their Medicaid expansions. That re-evaluation may adversely affect Medicaid payment rates, our Medicaid membership in those states, our revenues, our MLRs and our operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to report and correct errors discovered through our own auditing procedures or during a CMS audit or otherwise fail to comply with the applicable laws and regulations, we could be subject to fines, civil monetary penalties or other sanctions, including fines and penalties under the False Claims Act, which could have a material adverse effect on our ability to participate in Medicare Advantage, Part D or other government programs, and on our operating results, cash flows and financial condition. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the second quarter of 2014, CMS issued a final rule implementing ACA requirements that Medicare Advantage and PDP plans report and refund to CMS overpayments that those plans receive from CMS. However, CMS&#8217;s statements in formalized guidance regarding &#8220;overpayments&#8221; to Medicare Advantage plans appear to be inconsistent with CMS&#8217;s prior RADV audit guidance. These statements appear to equate each Medicare Advantage risk adjustment data error with an &#8220;overpayment&#8221; without reconciliation to the principles underlying the fee for service adjustment comparison contemplated by CMS&#8217;s RADV audit methodology. The precise interpretation, impact and legality of the final rule are not clear and are subject to pending litigation. If Medicare Advantage plans were not paid based on payment model principles that align with the requirements of the Social Security Act or such payments were not implemented correctly, it could have a material adverse effect on our operating results, cash flows and/or financial condition.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain of our Medicaid contracts require the submission of complete and correct encounter data. The accurate and timely reporting of encounter data is increasingly important to the success of our Medicaid programs because more states are using encounter data to determine compliance with performance standards and, in part, to set premium rates. We have expended and may continue to expend additional effort and incur significant additional costs to collect accurate, or to correct inaccurate or incomplete, encounter data and have been and could be exposed to premium withholding, operating sanctions and financial fines and penalties for noncompliance. We have experienced challenges in obtaining complete and accurate encounter data due to difficulties with providers and third-party vendors submitting claims in a timely fashion in the proper format, and with state agencies in coordinating such submissions. As states increase their reliance on encounter data, these difficulties could affect the Medicaid premium rates we receive and how Medicaid membership is assigned to us, which could have a material adverse effect on our Medicaid operating results and cash flows and/or our ability to bid for, and continue to participate in, certain Medicaid programs.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our businesses that dispense drugs also face challenges in the Medicaid space. The ACA made several significant changes to Medicaid rebates and to reimbursement rates. One of these changes was to revise the definition of the Average Manufacturer Price, a pricing element common to most payment formulas, and the reimbursement formula for generic drugs. This change has adversely affected the reimbursements we receive when we dispense prescription drugs to Medicaid recipients.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Programs funded in whole or in part by the U.S. federal government account for a significant portion of our revenues, and we expect that percentage to increase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Programs funded in whole or in part by the U.S. federal government account for a significant portion of our revenues, and we expect that percentage to increase. As our government funded businesses grow, our exposure to changes in federal and state government policy with respect to and/or regulation of the various government funded programs in which we participate also increases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues from government funded programs, including in Health Care Benefits&#8217; Medicare, Medicaid, dual eligible and dual eligible special needs plan businesses and from government customers in its Commercial business, are dependent on annual funding by the federal government and/or applicable state or local governments. Federal, state and local governments have the right to cancel or not to renew their contracts with us on short notice without cause or if funds are not available. Funding for these programs is dependent on many factors outside our control, including general economic conditions, continuing government efforts to contain health care costs and budgetary constraints at the federal or applicable state or local level and general political issues and priorities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. federal government and our other government customers also may reduce funding for health care or other programs, cancel or decline to renew contracts with us, or make changes that adversely affect the number of persons eligible for certain programs, the services provided to enrollees in such programs, our premiums and our administrative and health care and other benefit costs, any of which could have a material adverse effect on our businesses, operating results and cash flows. When federal funding is delayed, suspended or curtailed, we continue to receive, and we remain liable for and are required to fund, claims from providers for providing services to beneficiaries of federally funded health benefits programs in which we participate. An extended federal government shutdown or a delay by Congress in raising the federal government&#8217;s debt ceiling </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also could lead to a delay, reduction, suspension or cancellation of federal government spending and a significant increase in interest rates that could, in turn, have a material adverse effect on the value of our investment portfolio, our ability to access the capital markets and our businesses, operating results, cash flows and liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Possible changes in industry pricing benchmarks and drug pricing generally can adversely affect our PBM and Retail/LTC businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that the pharmaceutical industry or regulators may evaluate and/or develop an alternative pricing reference to replace AWP or Wholesale Acquisition Cost (&#8220;WAC&#8221;), which are the pricing references used for many of our PBM and LTC client contracts, drug purchase agreements, retail network contracts, specialty payor agreements and other contracts with third party payors in connection with the reimbursement of drug payments. In addition, many state Medicaid fee-for-service programs have established pharmacy network payments on the basis of Actual Acquisition Cost (&#8220;AAC&#8221;). The use of an AAC basis in FFS Medicaid could have an impact on reimbursement practices in Health Care Benefits&#8217; Commercial and other Government products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future changes to the use of AWP, WAC or to other published pricing benchmarks used to establish drug pricing, including changes in the basis for calculating reimbursement by federal and state health care programs and/or other payors, could impact the reimbursement we receive from Medicare and Medicaid programs, the reimbursement we receive from our PBM clients and other payors and/or our ability to negotiate rebates and/or discounts with drug manufacturers, wholesalers, PBMs and retail pharmacies. A failure or inability to fully offset any increased prices or costs or to modify our operations to mitigate the impact of such increases could have a material adverse effect on our operating results. Additionally, any future changes in drug prices could be significantly different than our projections. We cannot predict the effect of these possible changes on our businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to obtain adequate premium rate increases in our Insured Health Care Benefits products, which would have an adverse effect on our revenues, MBRs and operating results and could magnify the adverse impact of increases in health care and other benefit costs and of ACA assessments, fees and taxes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium rates for our Insured Health Care Benefits products generally must be filed with state insurance regulators and are subject to their approval, which creates risk for us in the current political and regulatory environment. The ACA generally requires a review by HHS in conjunction with state regulators of premium rate increases that exceed a federally specified threshold (or lower state-specific thresholds set by states determined by HHS to have adequate processes). Rate reviews can magnify the adverse impact on our operating margins, MBRs and operating results of increases in health care and other benefit costs, increased utilization of covered services, and ACA assessments, fees and taxes, by restricting our ability to reflect these increases and/or these assessments, fees and taxes in our pricing. Further, our ability to reflect ACA assessments, fees and taxes in our Medicare, Medicaid and CHIP premium rates is limited.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2013, HHS has issued determinations to health plans that their premium rate increases were &#8220;unreasonable,&#8221; and we continue to experience challenges to appropriate premium rate increases in certain states. Regulators or legislatures in several states have implemented or are considering limits on premium rate increases, either by enforcing existing legal requirements more stringently or proposing different regulatory standards. Regulators or legislatures in several states also have conducted hearings on proposed premium rate increases, which can result, and in some instances have resulted, in substantial delays in implementing proposed rate increases even if they ultimately are approved. Our plans can be excluded from participating in small group Public Exchanges if they are deemed to have a history of &#8220;unreasonable&#8221; rate increases. Any significant rate increases we may request heighten the risks of adverse publicity, adverse regulatory action and adverse selection and the likelihood that our requested premium rate increases will be denied, reduced or delayed, which could adversely affect our MBRs and lead to operating margin compression.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate continued regulatory and legislative action to increase regulation of premium rates in our Insured Health Care Benefits products. We may not be able to obtain rates that are actuarially justified or that are sufficient to make our policies profitable in one or more product lines or geographies. If we are unable to obtain adequate premium rates and/or premium rate increases, it could materially and adversely affect our operating margins and MBRs and our ability to earn adequate returns on Insured Health Care Benefits products in one or more states or cause us to withdraw from certain geographies and/or products.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Minimum MLR rebate requirements limit the level of margin we can earn in our Insured Health Care Benefits products while leaving us exposed to higher than expected medical costs. Challenges to our minimum MLR rebate methodology and/or reports could adversely affect our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA&#8217;s minimum MLR rebate requirements limit the level of margin we can earn in Health Care Benefits&#8217; Commercial Insured and Medicare Insured businesses. CMS minimum MLR rebate regulations limit the level of margin we can earn in our Medicaid Insured business. Certain portions of our Health Care Benefits Medicaid and Federal Employees Health Benefits (&#8220;FEHB&#8221;) program business also are subject to minimum MLR rebate requirements in addition to but separate from those imposed by the ACA. Minimum MLR rebate requirements leave us exposed to medical costs that are higher than those reflected in our pricing. The process supporting the management and determination of the amount of MLR rebates payable is complex and requires judgment, and the minimum MLR reporting requirements are detailed. CMS has also proposed, but not yet finalized, a definition of &#8220;prescription drug price concessions&#8221; for commercial MLR calculation purposes, which would make additional PBM information available to plans and the HHS, potentially further complicating the MLR calculation process. Federal and state auditors are challenging our Commercial Health Care Benefits business&#8217; compliance with the ACA&#8217;s minimum MLR requirements as well as our FEHB plans&#8217; compliance with OPM&#8217;s FEHB program-specific minimum MLR requirements. Our Medicare and Medicaid contracts also are subject to minimum MLR audits. If a Medicare Advantage or Medicare Part D contract pays minimum MLR rebates for three consecutive years, it will become ineligible to enroll new members. If a Medicare Advantage or Medicare Part D contract pays such rebates for five consecutive years, it will be terminated by CMS. Additional challenges to our methodology and/or reports relating to minimum MLR and related rebates by federal and state regulators and private litigants are reasonably possible. The outcome of these audits and additional challenges could adversely affect our operating results. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may be adversely affected by changes in laws and policies governing employers and by union organizing activity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal and certain state legislatures continue to consider and pass legislation that increases our costs of doing business, including increased minimum wages and requiring employers to provide paid sick leave or paid family leave. In addition, our employee-related operating costs may be increased by union organizing activity. If we are unable to reflect these increased expenses in our pricing or otherwise modify our operations to mitigate the effects of such increases, our operating results will be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face international political, legal and compliance, operational, regulatory, economic and other risks that may be more significant than in our domestic operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We significantly expanded our international operations as a result of the Aetna Acquisition. As a result of our expanded international operations, we face political, legal, compliance, operational, regulatory, economic and other risks that we do not face or that are more significant than in our domestic operations. These risks vary widely by country and include varying regional and geopolitical business conditions and demands, government intervention and censorship, discriminatory regulation, nationalization or expropriation of assets and pricing constraints. Our international products need to meet country-specific customer and member preferences as well as country-specific legal requirements, including those related to licensing, data privacy, data storage and data protection.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations increase our exposure to, and require us to devote significant management resources to implement controls and systems to comply with, the privacy and data protection laws of non-U.S. jurisdictions, such as the EU&#8217;s GDPR, and the anti-bribery, anti-corruption and anti-money laundering laws of the United States (including the FCPA) and the United Kingdom (including the UK Bribery Act) and similar laws in other jurisdictions. Implementing our compliance policies, internal controls and other systems upon our expansion into new countries and geographies may require the investment of considerable management time and financial and other resources over several years before any significant revenues or profits are generated. Violations of these laws and regulations could result in fines, criminal sanctions against us, our officers or employees, restrictions or outright prohibitions on the conduct of our business, and significant brand and reputational harm. We must regularly reassess the size, capability and location of our global infrastructure and make appropriate changes, and must have effective change management processes and internal controls in place to address changes in our businesses and operations. Our success depends, in part, on our ability to anticipate these risks and manage these difficulties, and the failure to do so could have a material adverse effect on our brand, reputation, businesses, operating results and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations require us to overcome logistical and other challenges based on differing languages, cultures, legal and regulatory schemes and time zones. Our international operations encounter labor laws, standards and customs that can be difficult and make employee relationships less flexible than in our domestic operations and expensive to modify or terminate. In </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">some countries we are required to, or choose to, operate with local business associates, which requires us to manage our relationships with these third parties and may reduce our operational flexibility and ability to quickly respond to business challenges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some countries we may be exposed to currency exchange controls or other restrictions that prevent us from transferring funds internationally or converting local currencies into U.S. dollars or other currencies. Fluctuations in foreign currency exchange rates may adversely affect our revenues, operating results and cash flows from our international operations. Some of our operations are, and are increasingly likely to be, in emerging markets where these risks are heightened. Any measures we may implement to reduce the effect of volatile currencies and other risks on our international operations may not be effective.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Associated with Mergers, Acquisitions, and Divestitures </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to successfully integrate companies we acquire.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of any acquisition we complete, we will need to successfully integrate the products, services and related assets, as well as internal controls into our business operations. If an acquisition is consummated, the integration of the acquired business, its products, services and related assets into our company also may be complex and time-consuming and, if the integration is not fully successful, we may not achieve the anticipated benefits, operating and cost synergies and/or growth opportunities of an acquisition. Potential difficulties that may be encountered in the integration process include the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Integrating personnel, operations and systems (including internal control environments and compliance policies), while maintaining focus on producing and delivering consistent, high quality products and services;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Coordinating geographically dispersed organizations;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disrupting management&#8217;s attention from our ongoing business operations;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Retaining existing customers and attracting new customers; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Managing inefficiencies associated with integrating our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An inability to realize the full extent of the anticipated benefits, operating and cost synergies, innovations and operations efficiencies or growth opportunities of an acquisition, as well as any delays or additional expenses encountered in the integration process, could have a material adverse effect on our businesses and operating results. Furthermore, acquisitions, even if successfully integrated, may fail to further our business strategy as anticipated, expose us to increased competition or challenges with respect to our products, services or service areas, and expose us to additional liabilities associated with an acquired business including risks and liabilities associated with litigation involving the acquired business. Any one of these challenges or risks could impair our ability to realize any benefit from our acquisitions after we have expended resources on them.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to continue to pursue acquisitions, joint ventures, strategic alliances and other inorganic growth opportunities, which may be unsuccessful, cause us to assume unanticipated liabilities, disrupt our existing businesses, be dilutive or lead us to assume significant debt, among other things.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to pursue acquisitions, joint ventures, strategic alliances and other inorganic growth opportunities as part of our growth strategy. In addition to the integration risks noted above, some other risks we face with respect to acquisitions and other inorganic growth strategies include:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we frequently compete with other firms, some of which may have greater financial and other resources and a greater tolerance for risk, to acquire attractive companies;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the acquired, alliance and/or joint venture businesses may not perform as projected;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the goodwill or other intangible assets established as a result of our acquisitions may be incorrectly valued or may become impaired; for example, in 2018 we took $6.1 billion of goodwill impairment charges related to our LTC reporting unit within the Retail/LTC segment;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may assume unanticipated liabilities, including those that were not disclosed to us or which we underestimated;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the acquired businesses, or the pursuit of other inorganic growth strategies, could disrupt or compete with our existing businesses, distract management, result in the loss of key employees, divert resources, result in tax costs or inefficiencies and make it difficult to maintain our current business standards, controls, information technology systems, policies, procedures and performance;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">as we did in the Aetna Acquisition, we may finance future acquisitions and other inorganic growth strategies by issuing common stock for some or all of the purchase price, which would dilute the ownership interests of our stockholders;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">as we did in the Aetna Acquisition, we may incur significant debt in connection with acquisitions (whether to finance acquisitions or by assuming debt from the businesses we acquire);</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not have the expertise to manage and profitably grow the businesses we acquire, and we may need to rely on the retention of key personnel and other suppliers of businesses we acquire, which may be difficult or impossible to accomplish;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may enter into merger or purchase agreements but, due to reasons within or outside our control, fail to complete the related transactions, which could result in termination fees or other penalties that could be material, cause material disruptions to our businesses and operations and adversely affect our brand and reputation;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in order to complete a proposed acquisition, we may be required to divest certain portions of our business, for which we may not be able to obtain favorable pricing;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">as is the case with the Aetna Acquisition and our acquisition of Omnicare, Inc., we may be involved in litigation related to mergers or acquisitions, including for matters that occurred prior to the applicable closing, which may be costly to defend and may result in adverse rulings against us that could be material; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the integration into our businesses of the businesses and entities we acquire may affect the way in which existing laws and regulations apply to us, including subjecting us to laws and regulations that did not previously apply to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, joint ventures present risks that are different from acquisitions, including selection of appropriate joint venture parties, initial and ongoing governance of the joint venture, joint venture compliance activities (including compliance with applicable CMS requirements), growing the joint venture&#8217;s business in a manner acceptable to all the parties, including other providers in the networks that include joint ventures, maintaining positive relationships among the joint venture parties and the joint venture&#8217;s customers, and member and business disruption that may occur upon joint venture termination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to meet customer expectations may harm our brand and reputation, our ability to retain and grow our customer base and membership and our operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to attract and retain customers and members is dependent upon providing cost effective, quality customer service operations (such as call center operations, PBM functions, retail pharmacy and LTC services, retail, mail order and specialty pharmacy prescription delivery, claims processing, customer case installation and online access and tools) that meet or exceed our customers&#8217; and members&#8217; expectations, either directly or through vendors. As we seek to reduce general and administrative expenses, we must balance the potential impact of cost-saving measures on our customers and other services and performances. If we misjudge the effects of such measures, customers and other services may be adversely affected. We depend on third parties for certain of our customer service, PBM and prescription delivery operations. If we or our vendors fail to provide service that meets our customers&#8217; and members&#8217; expectations, we may have difficulty retaining or profitably growing our customer base and/or membership, which could adversely affect our operating results. For example, noncompliance with any privacy or security laws or regulations or any security breach involving us or one of our third-party vendors could have a material adverse effect on our businesses, operating results, brand and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our vendors have experienced and continue to experience cyber attacks. We can provide no assurance that we or our vendors will be able to detect, prevent or contain the effects of such attacks or other information security (including cybersecurity) risks or threats in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our vendors have experienced diverse cyber attacks and expect to continue to experience cyber attacks going forward. As examples, the Company and its vendors have experienced attempts to gain access to systems, denial of service attacks, attempted malware infections, account takeovers, scanning activity, and phishing emails. Attacks can originate from external criminals, terrorists, nation states, or internal actors. The Company is dedicating and will continue to dedicate significant resources and incur significant expenses to maintain and update on an ongoing basis the systems and processes that are designed to mitigate the information security risks it faces and protect the security of its computer systems, software, networks and other technology assets against attempts by unauthorized parties to obtain access to confidential information, disrupt or degrade service, or cause other damage. The impact of cyber attacks has not been material to the Company&#8217;s operations or operating results through December 31, 2020. The Board and its Audit Committee and Nominating and Corporate Governance Committee are regularly informed regarding the Company&#8217;s information security policies, practices and status. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A compromise of our information security controls or of those businesses with whom we interact, which results in confidential information being accessed, obtained, damaged, or used by unauthorized or improper persons, could harm our reputation and expose us to regulatory actions and claims from customers and clients, financial institutions, payment card associations and other persons, any of which could adversely affect our businesses, operating results and financial condition. Because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and may not immediately produce signs of intrusion, we may be unable to anticipate these techniques or to implement adequate preventative measures. Moreover, a data security breach could require that we expend significant resources related to our information systems and infrastructure, and could distract management and other key personnel from performing their primary operational duties. We also could be adversely affected by any significant disruption in the systems of third parties we interact with, including key payors and vendors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs of attempting to protect against the foregoing risks and the costs of responding to a cyber-incident are significant. Large scale data breaches at other entities increase the challenge we and our vendors face in maintaining the security of our information technology systems and proprietary information and of our customers&#8217;, members&#8217; and other constituents&#8217; sensitive information. Following a cyber-incident, our and/or our vendors&#8217; remediation efforts may not be successful, and a cyber-incident could result in interruptions, delays or cessation of service, and loss of existing or potential customers and members. In addition, breaches of our and/or our vendors&#8217; security measures and the unauthorized dissemination of sensitive personal information or proprietary information or confidential information about us, our customers, our members or other third-parties, could expose our customers&#8217;, members&#8217; and other constituents&#8217; private information and our customers, members and other constituents to the risk of financial or medical identity theft, or expose us or other third parties to a risk of loss or misuse of this information, and result in investigations, regulatory enforcement actions, material fines and penalties, loss of customers, litigation or other actions which could have a material adverse effect on our brand, reputation, businesses, operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data governance failures can adversely affect our reputation, businesses and prospects. Our use and disclosure of members&#8217;, customers&#8217; and other constituents&#8217; sensitive information is subject to complex regulations at multiple levels. We would be adversely affected if we or our business associates or other vendors fail to adequately protect members&#8217;, customers&#8217; or other constituents&#8217; sensitive information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information systems are critical to the operation of our businesses. We collect, process, maintain, retain, evaluate, utilize and distribute large amounts of personal health and financial information and other confidential and sensitive data about our customers, members and other constituents in the ordinary course of our businesses. Some of our information systems rely upon third party systems, including cloud service providers, to accomplish these tasks. The use and disclosure of such information is regulated at the federal, state and international levels, and these laws, rules and regulations are subject to change and increased enforcement activity, such as the California Consumer Privacy Act which went into effect January 1, 2020, the EU&#8217;s GDPR which began to apply across the EU during 2018 and the audit program implemented by HHS under HIPAA. In some cases, such laws, rules and regulations also apply to our vendors and/or may hold us liable for any violations by our vendors. International laws, rules and regulations governing the use and disclosure of such information are generally more stringent than U.S. laws and regulations, and they vary from jurisdiction to jurisdiction. Noncompliance with any privacy or security laws or regulations, or any security breach, cyber attack or cybersecurity breach, and any incident involving the theft, misappropriation, loss or other unauthorized disclosure of, or access to, sensitive or confidential customer, member or other constituent information, whether by us, by one of our business associates or vendors or by another third party, could require us to expend significant resources to remediate any damage, could interrupt our operations and could adversely affect our brand and reputation, membership and operating results and also could expose and/or has exposed us to mandatory disclosure to the media, litigation (including class action litigation), governmental investigations and enforcement proceedings, material fines, penalties and/or remediation costs, and compensatory, special, punitive and statutory damages, consent orders, adverse actions against our licenses to do business and/or injunctive relief, any of which could adversely affect our businesses, operating results, cash flows or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses depend on our customers&#8217;, members&#8217; and other constituents&#8217; willingness to entrust us with their health related and other sensitive personal information. Events that adversely affect that trust, including inadequate disclosure to our members or customers of our uses of their information, failing to keep our information technology systems and our customers&#8217;, members&#8217; and other constituents&#8217; sensitive information secure from significant attack, theft, damage, loss or unauthorized disclosure or access, whether as a result of our action or inaction (including human error) or that of our business associates, vendors or other third parties, could adversely affect our brand and reputation, membership and operating results and also could expose and/or has exposed us to mandatory disclosure to the media, litigation (including class action litigation), governmental investigations and enforcement proceedings, material fines, penalties and/or remediation costs, and compensatory, special, punitive and statutory damages, consent orders, adverse actions against our licenses to do business and/or injunctive relief, any of which </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">could adversely affect our businesses, operating results, cash flows or financial condition. Large scale data breaches at other entities increase the challenge we and our vendors face in maintaining the security of our information technology systems and proprietary information and of our customers&#8217;, members&#8217; and other constituents&#8217; sensitive information. There can be no assurance that additional such failures will not occur, or if any do occur, that we will detect them or that they can be sufficiently remediated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product liability, product recall or personal injury issues could damage our reputation and have a significant adverse effect on our businesses, operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products that we sell could become subject to contamination, product tampering, mislabeling, recall or other damage. In addition, errors in the dispensing and packaging of drugs and consuming drugs in a manner that is not prescribed could lead to serious injury or death. Product liability or personal injury claims may be asserted against us with respect to any of the drugs or other products we sell or services we provide. For example, we are a defendant in hundreds of litigation proceedings relating to opioids and the sale of products containing talc. Our businesses involve the provision of professional services, including by pharmacists, physician assistants, nurses and nurse practitioners, which exposes us to professional liability claims. Should a product or other liability issue arise, the coverage available under our insurance programs and the indemnification amounts available to us from third parties may not be adequate to protect us against the financial impact of the related claims. We also may not be able to maintain our existing levels of insurance on acceptable terms in the future. A product liability or personal injury issue or judgment against us or a product recall could damage our reputation and have a significant adverse effect on our businesses, operating results and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to our success, and our failure to do so could adversely affect our businesses, operating results and/or future performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to attract and retain qualified and experienced employees is essential to meet our current and future goals and objectives. There is no guarantee we will be able to attract and retain such employees or that competition among potential employers will not result in increased compensation and/or benefits costs. If we are unable to retain existing employees or attract additional employees, or we experience an unexpected loss of leadership, we could experience a material adverse effect on our businesses, operating results and/or future performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our failure to adequately plan for succession of senior management and other key management roles or the failure of key employees to successfully transition into new roles could have a material adverse effect on our businesses, operating results and/or future performance. The succession plans we have in place and our employment arrangements with certain key executives do not guarantee the services of these executives will continue to be available to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of our products and services are dependent on our ability to attract and motivate internal sales personnel and independent third-party brokers, consultants and agents. New distribution channels create new disintermediation risk. We may be subject to penalties or other regulatory actions as a result of the marketing practices of brokers and agents selling our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are sold primarily through our sales personnel, who frequently work with independent brokers, consultants and agents who assist in the production and servicing of business. The independent brokers, consultants and agents generally are not dedicated to us exclusively and may frequently recommend and/or market health care benefits products of our competitors. Accordingly, we must compete intensely for their services and allegiance. Our sales could be adversely affected if we are unable to attract, retain or motivate sales personnel and third-party brokers, consultants and agents, or if we do not adequately provide support, training and education to this sales network regarding our complex product portfolio, or if our sales strategy is not appropriately aligned across distribution channels. This risk is heightened as we develop, operate and expand our consumer-oriented products and services and we expand in the health care space and our business model evolves to include a greater focus on consumers and direct-to-consumer sales, such as competing for sales on Insurance Exchanges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New distribution channels for our products and services continue to emerge, including Private Exchanges operated by health care consultants and technology companies. These channels may make it more difficult for us to directly engage consumers and other customers in the selection and management of their health care benefits, in health care utilization and in the effective navigation of the health care system. We also may be challenged by new technologies and marketplace entrants that could interfere with our existing relationships with customers and health plan members in these areas.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there have been several investigations regarding the marketing practices of brokers and agents selling health care and other insurance products and the payments they receive. These investigations have resulted in enforcement actions against companies in our industry and brokers and agents marketing and selling those companies&#8217; products. For example, CMS and state departments of insurance have increased their scrutiny of the marketing practices of brokers and agents who market Medicare products. These investigations and enforcement actions could result in penalties and the imposition of corrective action plans and/or changes to industry practices, which could adversely affect our ability to market our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure of our businesses to effectively collaborate could prevent us from maximizing our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To maximize our overall enterprise value, our various businesses need to collaborate effectively. Our businesses need to be aligned in order to prioritize goals and coordinate the design of new products intended to utilize the offerings of multiple businesses, including our transformation and enterprise modernization programs. In addition, misaligned incentives, information siloes, ineffective product development and failure of our corporate governance policies or procedures, for example significant financial decisions being made at an inappropriate level in our organization, also could prevent us from maximizing our operating results and/or achieving our financial and other projections. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The failure or disruption of our information technology systems or the failure of our information technology infrastructure to support our businesses could adversely affect our reputation, businesses, operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information systems are subject to damage or interruption from power outages, facility damage, computer and telecommunications failures, computer viruses, security breaches (including credit card or personally identifiable information breaches), cyber attacks, vandalism, catastrophic events and human error. If our information systems are damaged, fail to work properly or otherwise become unavailable, we may incur substantial costs to repair or replace them, and may experience reputational damage, loss of critical information, customer disruption and interruptions or delays in our ability to perform essential functions and implement new and innovative services. In addition, compliance with changes in U.S. and foreign laws and regulations, including privacy and information security laws and standards, may cause us to incur significant expense due to increased investment in technology and the development of new operational processes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business success and operating results depend in part on effective information technology systems and on continuing to develop and implement improvements in technology. Pursuing multiple initiatives simultaneously could make this continued development and implementation significantly more challenging.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many aspects of our operations are dependent on our information systems and the information collected, processed, stored, and handled by these systems. We rely heavily on our computer systems to manage our ordering, pricing, point-of-sale, pharmacy fulfillment, inventory replenishment, claims processing, customer loyalty and subscription programs, finance and other processes. Throughout our operations, we collect, process, maintain, retain, evaluate, utilize and distribute large amounts of confidential and sensitive data and information, including personally identifiable information and protected health information, that our customers, members and other constituents provide to purchase products or services, enroll in programs or services, register on our websites, interact with our personnel, or otherwise communicate with us. In addition, for these operations, we depend in part on the secure transmission of confidential information over public networks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have many different information and other technology systems supporting our businesses (including as a result of our acquisitions). Our businesses depend in large part on these systems to adequately price our products and services; accurately establish reserves, process claims and report operating results; and interact with providers, employer plan sponsors, customers, members, consumers and vendors in an efficient and uninterrupted fashion. In addition, recent trends toward greater consumer engagement in health care require new and enhanced technologies, including more sophisticated applications for mobile devices. Certain of our technology systems (including software) are older, legacy systems that are less flexible, less efficient and require a significant ongoing commitment of capital and human resources to maintain, protect and enhance them and to integrate them with our other systems. We must re-engineer and reduce the number of these systems to meet changing consumer and vendor preferences and needs, improve our productivity and reduce our operating expenses. We also need to develop or acquire new technology systems, contract with new vendors or modify certain of our existing systems to support the consumer-oriented and transformation products and services we are developing, operating and expanding and/or to meet current and developing industry and regulatory standards, including to keep pace with continuing changes in information processing technology and emerging cybersecurity risks and threats. If we fail to achieve these objectives, our ability to profitably grow our business and/or our operating results may be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, information technology and other technology and process improvement projects, including our transformation and enterprise modernization programs, frequently are long-term in nature and may take longer to complete and cost more than we </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expect and may not deliver the benefits we project once they are complete. If we do not effectively and efficiently secure, manage, integrate and enhance our technology portfolio (including vendor sourced systems), we could, among other things, have problems determining health care and other benefit cost estimates and/or establishing appropriate pricing, meeting the needs of customers, consumers, providers, members and vendors, developing and expanding our consumer-oriented products and services or keeping pace with industry and regulatory standards, and our operating results may be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to payment-related risks that could increase our operating costs, expose us to fraud or theft, subject us to potential liability and disrupt our business operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accept payments using a variety of methods, including cash, checks, credit cards, debit cards, gift cards, mobile payments and potentially other technologies in the future. Acceptance of these payment methods subjects us to rules, regulations, contractual obligations and compliance requirements, including payment network rules and operating guidelines, data security standards and certification requirements, and rules governing electronic funds transfers. These requirements may change in the future, which could make compliance more difficult or costly. For certain payment options, including credit and debit cards, we pay interchange and other fees, which could increase periodically thereby raising our operating costs. We rely on third parties to provide payment processing services, including the processing of credit cards, debit cards, and various other forms of electronic payment. If these vendors are unable to provide these services to us, or if their systems are compromised, our operations could be disrupted. The payment methods that we offer also expose us to potential fraud and theft by persons seeking to obtain unauthorized access to, or exploit any weaknesses in, the payment systems we use. If we fail to abide by applicable rules or requirements, or if data relating to our payment systems is compromised due to a breach or misuse, we may be responsible for any costs incurred by payment card issuing banks and other third parties or subject to fines and higher transaction fees. In addition, our reputation and ability to accept certain types of payments could each be harmed resulting in reduced sales and adverse effects on our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Both our and our vendors&#8217; operations are subject to a variety of business continuity hazards and risks, any of which could interrupt our operations or otherwise adversely affect our performance and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our vendors are subject to business continuity hazards and other risks, including natural disasters, utility and other mechanical failures, acts of war or terrorism, acts of civil unrest, disruption of communications, data security and preservation, disruption of supply or distribution, safety regulation and labor difficulties. The occurrence of any of these or other events to us or our vendors might disrupt or shut down our operations or otherwise adversely affect our operations. We also may be subject to certain liability claims in the event of an injury or loss of life, or damage to property, resulting from such events. Although we have developed procedures for crisis management and disaster recovery and business continuity plans and maintain insurance policies that we believe are customary and adequate for our size and industry, our insurance policies include limits and exclusions and, as a result, our coverage may be insufficient to protect against all potential hazards and risks incident to our businesses. In addition, our crisis management and disaster recovery procedures and business continuity plans may not be effective. Should any such hazards or risks occur, or should our insurance coverage be inadequate or unavailable, our businesses, operating results, cash flows and financial condition could be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We would be adversely affected if we do not effectively deploy our capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Downgrades or potential downgrades in our credit ratings, should they occur, could adversely affect our brand and reputation, businesses, operating results, cash flows and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations generate significant capital, and we have the ability to raise additional capital. The manner in which we deploy our capital, including investments in our businesses, our operations (such as information technology and other strategic and capital projects), dividends, acquisitions, share and/or debt repurchases, repayment of debt, reinsurance or other capital uses, impacts our financial strength, claims paying ability and credit ratings issued by nationally-recognized statistical rating organizations. Credit ratings issued by nationally-recognized statistical rating organizations are broadly distributed and generally used throughout our industries. Our ratings reflect each rating organization&#8217;s opinion of our financial strength, operating performance and ability to meet our debt obligations or obligations to our insureds. We believe our credit ratings and the financial strength and claims paying ability of our principal insurance and HMO subsidiaries are important factors in marketing our Health Care Benefits products to certain of our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the ratings organizations reviews our ratings periodically, and there can be no assurance that our current ratings will be maintained in the future. In connection with the completion of the Aetna Acquisition, each of Standard &amp; Poor&#8217;s, Moody&#8217;s and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fitch downgraded certain of our debt, financial strength and/or other credit ratings. Downgrades in our ratings could adversely affect our businesses, operating results, cash flows and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and other intangible assets could, in the future, become impaired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and December 31, 2019, we had $110.7 billion and $112.9 billion, respectively, of goodwill and other intangible assets. Goodwill and indefinitely-lived intangible assets are subject to annual impairment reviews, or more frequent reviews if events or circumstances indicate that the carrying value may not be recoverable. When evaluating goodwill for potential impairment, we compare the fair value of our reporting units to their respective carrying amounts. We estimate the fair value of our reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, a goodwill impairment loss is recognized in an amount equal to the excess to the extent of the goodwill balance. Estimated fair values could change if, for example, there are changes in the business climate, industry-wide changes, changes in the competitive environment, adverse legal or regulatory actions or developments, changes in capital structure, cost of debt, interest rates, capital expenditure levels, operating cash flows or market capitalization. Because of the significance of our goodwill and intangible assets, any future impairment of these assets could require material noncash charges to our operating results, which also could have a material adverse effect on our financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse conditions in the U.S. and global capital markets can significantly and adversely affect the value of our investments in debt and equity securities, mortgage loans, alternative investments and other investments, and our operating results and/or our financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global capital markets, including credit markets, continue to experience volatility and uncertainty. As an insurer, we have a substantial investment portfolio that supports our policy liabilities and surplus and is comprised largely of debt securities of issuers located in the U.S. As a result, the income we earn from our investment portfolio is largely driven by the level of interest rates in the U.S., and to a lesser extent the international financial markets; and volatility, uncertainty and/or disruptions in the global capital markets, particularly the U.S. credit markets, and governments&#8217; monetary policy, particularly U.S. monetary policy, can significantly and adversely affect the value of our investment portfolio, our operating results and/or our financial condition by:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significantly reducing the value and/or liquidity of the debt securities we hold in our investment portfolio and creating realized capital losses that reduce our operating results and/or unrealized capital losses that reduce our shareholders&#8217; equity;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">keeping interest rates low on high-quality short-term or medium-term debt securities (such as we have experienced during recent years) and thereby materially reducing our net investment income and operating results as the proceeds from securities in our investment portfolio that mature or are otherwise disposed of continue to be reinvested in lower yielding securities;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing the fair values of our investments if interest rates rise;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">causing non-performance of or defaults on their obligations to us by third parties, including customers, issuers of securities in our investment portfolio, mortgage borrowers and/or reinsurance and/or derivatives counterparties;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">making it more difficult to value certain of our investment securities, for example if trading becomes less frequent, which could lead to significant period-to-period changes in our estimates of the fair values of those securities and cause period-to-period volatility in our net income and shareholders&#8217; equity;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing our ability to issue short-term debt securities at attractive interest rates, thereby increasing our interest expense and decreasing our operating results; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing our ability to issue other securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we seek, within guidelines we deem appropriate, to match the duration of our assets and liabilities and to manage our credit and counterparty exposures, a failure adequately to do so could adversely affect our net income and our financial condition and, in extreme circumstances, our cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred and assumed significant indebtedness which has increased our consolidated interest expense and could adversely affect our business flexibility and increase our borrowing costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to complete the Aetna Acquisition, we incurred acquisition-related debt financing of approximately $45.0 billion and assumed Aetna&#8217;s existing indebtedness with a fair value of approximately $8.1 billion. Our substantial indebtedness and elevated debt-to-equity ratio have the effect, among other things, of reducing our flexibility to respond to changing business and economic conditions and increasing our interest expense compared to pre-Aetna Acquisition periods. In addition, the amount of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cash required to service our increased indebtedness levels and thus the demands on our cash resources are greater than the amount of cash flows required to service our indebtedness prior to the Aetna Acquisition. We have suspended share repurchases until we reach our desired debt-to-equity ratio. The increased levels of indebtedness also could reduce funds available to engage in investments in product development, capital expenditures, dividend payments and other activities and may create competitive disadvantages for us relative to other companies with lower debt levels.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Relationships with Manufacturers, Providers, Suppliers and Vendors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks relating to the market availability, pricing, suppliers and safety profiles of prescription drugs and other products that we purchase and sell.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Retail/LTC segment and our mail order and specialty pharmacy operations generate revenues in significant part by dispensing prescription drugs. Our PBM business generates revenues primarily by contracting with clients to provide prescription drugs and related health care services to plan members. As a result, we are dependent on our relationships with prescription drug manufacturers and suppliers. We acquire a substantial amount of our mail order and specialty pharmacies&#8217; prescription drug supply from a limited number of suppliers. Certain of our agreements with such suppliers are short-term and cancelable by either party without cause. In addition, these agreements may allow the supplier to distribute through channels other than us. Certain of these agreements also allow pricing and other terms to be adjusted periodically for changing market conditions or required service levels. A termination or modification to any of these relationships could adversely affect our prescription drug supply and have a material adverse effect on our businesses, operating results and financial condition. Moreover, many products distributed by our pharmacies are manufactured with ingredients that are susceptible to supply shortages. In some cases, we depend upon a single source of supply. Any such supply shortages or loss of any such single source of supply could adversely affect our operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Much of the branded and generic drug product that we sell in our pharmacies, and much of the other merchandise we sell, is manufactured in whole or in substantial part outside of the United States. In most cases, the products or merchandise are imported by others and sold to us. As a result, significant changes in tax or trade policies, tariffs or trade relations between the United States and other countries, such as the imposition of unilateral tariffs on imported products, could result in significant increases in our costs, restrict our access to suppliers, depress economic activity, and have a material adverse effect on our businesses, operating results and cash flows. In addition, other countries may change their business and trade policies and such changes, as well as any negative sentiments towards the United States in response to increased import tariffs and other changes in U.S. trade regulations, could adversely affect our businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our suppliers are independent entities subject to their own operational and financial risks that are outside our control. If our current suppliers were to stop selling prescription drugs to us or delay delivery, including as a result of supply shortages, supplier production disruptions, supplier quality issues, closing or bankruptcies of our suppliers, or for other reasons, we may be unable to procure alternatives from other suppliers in a timely and efficient manner and on acceptable terms, or at all. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may be adversely affected if we are unable to contract with providers on competitive terms and develop and maintain attractive networks with high quality providers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are seeking to enhance our health care provider networks by entering into joint ventures and other collaborative risk-sharing arrangements with providers. Providers&#8217; willingness to enter these arrangements with us depends upon, among other things, our ability to provide them with up to date quality of care data to support these value-based contracts. These arrangements are designed to give providers incentives to engage in population health management and optimize delivery of health care to our members. These arrangements also may allow us to expand into new geographies, target new customer groups, increase membership and reduce medical costs and, if we provide technology or other services to the relevant health system or provider organization, may contribute to our revenue and earnings from alternative sources. If such arrangements do not result in the lower medical costs that we project or if we fail to attract providers to such arrangements, or are less successful at implementing such arrangements than our competitors, our medical costs may not be competitive and may be higher than we project, our attractiveness to customers may be reduced, we may lose or be unable to grow medical membership, and our ability to profitably grow our business and/or our operating results may be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe joint ventures, accountable care organizations (&#8220;ACOs&#8221;) and other non-traditional health care provider organizational structures present opportunities for us, the implementation of our joint ventures and other non-traditional structure strategies may not achieve the intended results, which could adversely affect our operating results and cash flows. Among other things, joint ventures require us to maintain collaborative relationships with our counterparties, continue to gain access to provider rates that make the joint ventures economically sustainable and devote significant management time to the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operation and management of the joint ventures. We may not be able to achieve these objectives in one or more of our joint ventures, which could adversely affect our operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our service providers fail to meet their contractual obligations to us or to comply with applicable laws or regulations, we may be exposed to brand and reputational harm, litigation and/or regulatory action. This risk is particularly high in our Medicare, Medicaid, dual eligible and dual eligible special needs plan programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We contract with various third parties to perform certain functions and services and provide us with certain information technology systems. Our arrangements with these third parties may expose us to public scrutiny, adversely affect our brand and reputation, expose us to litigation or regulatory action, and otherwise make our operations vulnerable if we fail to adequately oversee, monitor and regulate their performance or if they fail to meet their contractual obligations to us or to comply with applicable laws or regulations. For example, certain of our vendors have been responsible for releases of sensitive information of our members and employees, which has caused us to incur additional expenses and given rise to regulatory actions and litigation against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks are particularly high in our Medicare, Medicaid, dual eligible and dual eligible special needs plan programs, where third parties perform medical management and other member related services for us. Any failure of our or these third parties&#8217; prevention, detection or control systems related to regulatory compliance, compliance with our internal policies, data security and/or cybersecurity or any incident involving the theft, misappropriation, loss or other unauthorized disclosure of, or access to, members&#8217;, customers&#8217; or other constituents&#8217; sensitive information could require us to expend significant resources to remediate any damage, interrupt our operations and adversely affect our brand and reputation and also expose us to whistleblower, class action and other litigation, other proceedings, prohibitions on marketing or active or passive enrollment of members, corrective actions, fines, sanctions and/or penalties, any of which could adversely affect our businesses, operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience increased medical and other benefit costs, litigation risk and customer and member dissatisfaction when providers that do not have contracts with us render services to our Health Care Benefits members.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some providers that render services to our Health Care Benefits members do not have contracts with us. In those cases, we do not have a pre-established understanding with these providers as to the amount of compensation that is due to them for services rendered to our members. In some states, the amount of compensation due to these nonparticipating providers is defined by law or regulation, but in most instances it is either not defined or it is established by a standard that is not clearly translatable into dollar terms. In such instances providers may believe that they are underpaid for their services and may either litigate or arbitrate their dispute with us or try to recover the difference between what we have paid them and the amount they charged us from our members, which may result in customer and member dissatisfaction. For example, in October 2018, an arbitrator awarded certain claimant hospitals approximately $150 million in a proceeding relating to Aetna&#8217;s out-of-network benefit payment and administration practices, and in March 2019 that award was reduced to approximately $86 million. Such disputes may cause us to pay higher medical or other benefit costs than we projected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Continuing consolidation and integration among providers and other suppliers may increase our medical and other covered benefits costs, make it difficult for us to compete in certain geographies and create new competitors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hospitals and other providers and health systems continue to consolidate across the health care industry. While this consolidation could increase efficiency and has the potential to improve the delivery of health care services, it also reduces competition and the number of potential contracting parties in certain geographies. These health systems also are increasingly forming and considering forming health plans to directly offer health insurance in competition with us, a process that has been accelerated by the ACA. In addition, ACOs (including Commercial and Medicaid-only ACOs developed as a result of state Medicaid laws), practice management companies, consolidation among and by integrated health systems and other changes in the organizational structures that physicians, hospitals and other providers adopt continues to change the way these providers interact with us and the competitive landscape in which we operate. These changes may increase our medical and other covered benefits costs, may affect the way we price our products and services and estimate our medical and other covered benefits costs and may require us to change our operations, including by withdrawing from certain geographies where we do not have a significant presence across our businesses or are unable to collaborate or contract with providers on acceptable terms. Each of these changes may adversely affect our businesses and operating results.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_34"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B.  Unresolved Staff Comments.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no unresolved SEC Staff Comments.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_37"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.  Properties.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s principal office is an owned building complex located in Woonsocket, Rhode Island, which totals approximately one million square feet. The Company also leases office space in other locations in the United States. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment includes owned or leased mail service dispensing pharmacies, call centers, on-site pharmacy stores, retail specialty pharmacy stores, specialty mail service pharmacies and branches for infusion and enteral services throughout the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Retail/LTC segment operated the following properties:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Approximately 8,115 retail stores, of which approximately 5% were owned. Net selling space for retail stores was approximately 80.1 million square feet as of December&#160;31, 2020. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Approximately 1,845 retail pharmacies within retail chains, as well as approximately 80 clinics in Target Corporation (&#8220;Target&#8221;) stores;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Owned distribution centers and leased distribution facilities throughout the United States totaling approximately 10.5 million square feet; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Owned and leased LTC pharmacies throughout the United States and an owned LTC repackaging facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain business dispositions completed between 1995 and 1997, the Company continues to guarantee lease obligations for 76 former stores. The Company is indemnified for these guarantee obligations by the respective initial purchasers. These guarantees generally remain in effect for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. For additional information on these guarantees, see &#8220;Lease Guarantees&#8221; in Note 16 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; included in Item 8 of this 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment&#8217;s principal office is an owned building complex located in Hartford, Connecticut, which totals approximately 1.7 million square feet. The Health Care Benefits segment also owns or leases office space in other locations in the United States and several other countries. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that the Company&#8217;s owned and leased facilities are suitable and adequate to meet the Company&#8217;s anticipated needs. At the end of the existing lease terms, management believes the leases can be renewed or replaced by alternative space. For additional information on the right-of-use assets and lease liabilities associated with the Company&#8217;s leases, see Note 6 &#8216;&#8216;Leases&#8217;&#8217; included in Item 8 of this 10-K.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_40"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.  Legal Proceedings.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.  Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in Note 16 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; included in Item 8 of this 10-K is incorporated herein by reference.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.  Environmental Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 103 of SEC Regulation S-K requires disclosure of environmental legal proceedings with a governmental authority if management reasonably believes that the proceedings involve potential monetary sanctions of $1 million or more. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is in the process of negotiating with the New York State Department of Environmental Conservation to resolve claims of alleged historical noncompliance with hazardous waste regulations in connection with LTC pharmacies in the State of New York. These proceedings are not material to the Company&#8217;s business or financial condition.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_43"></div><div style="padding-right:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.  Mine Safety Disclosures.</span></div><div style="padding-right:72pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information about our Executive Officers </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the name, age and biographical information for each of the Registrant&#8217;s executive officers as of February&#160;16, 2021. In each case the officer&#8217;s term of office extends to the date of the meeting of the Board following the next annual meeting of stockholders of CVS Health. Previous positions and responsibilities held by each of the executive officers over the past five years or more are indicated below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Eva C. Boratto</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 54, Executive Vice President and Chief Financial Officer of CVS Health Corporation since November 2018; Executive Vice President - Controller and Chief Accounting Officer of CVS Health Corporation from March 2017 through November 2018; Senior Vice President - Controller and Chief Accounting Officer of CVS Health Corporation from July 2013 through February 2017. Ms. Boratto is also a member of the board of directors of United Parcel Service, Inc., an international package delivery and supply chain management company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Troyen A. Brennan, M.D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., age 66, Executive Vice President and Chief Medical Officer of CVS Health Corporation since November&#160;2008; Executive Vice President and Chief Medical Officer of Aetna Inc. from February&#160;2006 through November&#160;2008.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;James D. Clark</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 56, Senior Vice President - Controller and Chief Accounting Officer of CVS Health Corporation since November 2018; Vice President - Finance and Accounting of CVS Pharmacy, Inc. from September 2009 through October 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Daniel P. Finke</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 50, Executive Vice President of CVS Health Corporation and President of Health Care Benefits since February 2021; Executive Vice President, Commercial Business and Markets of Aetna from February 2020 through January 2021; Executive Vice President, Consumer Health and Service of Aetna from June 2018 through January 2020; Senior Vice President, Network and Clinical Services of Aetna from January 2016 through May 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Laurie P. Havanec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 60, Executive Vice President and Chief People Officer of CVS Health Corporation since February 2021; Executive Vice President and Chief People Officer, Otis Worldwide Corporation, an elevator, escalator and moving walkway manufacturer, from October 2019 through January 2021; Corporate Vice President, Talent of United Technologies Corporation, a multinational manufacturing conglomerate, from April 2019 through October 2019; Vice President - HR, Institution Businesses of Aetna from 2013 through March 2017.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Alan M. Lotvin, M.D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., age 59, Executive Vice President of CVS Health Corporation and President of CVS Caremark since March 2020; Executive Vice President - Transformation of CVS Health Corporation from June 2018 through February 2020; Executive Vice President - Specialty Pharmacy, CVS Caremark from November 2012 through May 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Karen S. Lynch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 58, President and Chief Executive Officer of CVS Health Corporation since February 2021; Executive Vice President of CVS Health Corporation from November 2018 through January 2021; President of Aetna from January 2015 through January 2021; Executive Vice President, Local and Regional Businesses of Aetna from February 2013 through December 2014; and a director of CVS Health Corporation since February 2021. Ms. Lynch is also a member of the board of directors of U.S. Bancorp, a banking and financial services company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Neela Montgomery</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 46, Executive Vice President of CVS Health Corporation and President of Retail/Pharmacy since November 2020; Chief Executive Officer of Crate &amp; Barrel Holdings, a retailer of furniture, kitchenware and other home essentials, from August 2017 through August 2020; Executive Board Member of Otto Group GmbH, a German e-commerce company, from November 2014 through July 2017. Ms. Montgomery is also a member of the board of directors of Logitech International SA, a Swiss-American manufacturer of computer peripherals and software.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Thomas M. Moriarty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 57, Executive Vice President and General Counsel of CVS Health Corporation since October&#160;2012; Chief Policy and External Affairs Officer since March 2017; Chief Strategy Officer from March 2014 through February 2017.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Jonathan C. Roberts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 65, Executive Vice President and Chief Operating Officer of CVS Health Corporation since March 2017; Executive Vice President of CVS Health Corporation and President of CVS Caremark from September&#160;2012 through February 2017.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_52"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.  Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health&#8217;s common stock is listed on the New York Stock Exchange under the symbol &#8220;CVS.&#8221; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health has paid cash dividends every quarter since becoming a public company. Future dividends will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; included in Item 8 of this 10-K for information regarding CVS Health&#8217;s dividends.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders of Common Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;8, 2021, there were 26,078 registered holders of the registrant&#8217;s common stock according to the records maintained by the registrant&#8217;s transfer agent.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase program has been authorized by the Board:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;billions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2016 (&#8220;2016 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time. During the three months ended December&#160;31, 2020, the Company did not repurchase any shares of common stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; included in Item 8 of this 10-K for additional information regarding the Company&#8217;s share repurchases.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares the cumulative total shareholder return on CVS Health&#8217;s common stock (assuming reinvestment of dividends) with the cumulative total return on the S&amp;P 500 Index, the S&amp;P 500 Food and Staples Retailing Industry Group Index and the S&amp;P 500 Healthcare Sector Group Index from December 31, 2015 through December 31, 2020. The graph assumes a $100 investment in shares of CVS Health&#8217;s common stock on December 31, 2015.</span></div><div style="text-align:center"><img src="cvs-20201231_g2.jpg" alt="cvs-20201231_g2.jpg" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CVS Health Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Food &amp; Staples Retail Group Index </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Health Care Group Index </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes CVS Health.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes five companies (COST, KR, SYY, WBA, WMT).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes 63 companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-ended values of each investment shown in the preceding graph are based on share price appreciation plus dividends, with the dividends reinvested as of the last business day of the month during which such dividends were ex-dividend. The calculations exclude trading commissions and taxes. Total shareholder returns from each investment can be calculated from the year-end investment values shown beneath the graph. </span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_55"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Reserved</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_58"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. (&#8220;MD&amp;A&#8221;) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with the audited consolidated financial statements and related notes included in Item 8 of this 10-K, &#8220;Risk Factors&#8221; included in Item 1A of this 10-K and the &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in this 10-K.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), is a diversified health services company united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. The Company has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 105 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. We also serve an estimated 34 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2018 (the &#8220;Aetna Acquisition Date&#8221;), the Company acquired Aetna Inc. (&#8220;Aetna&#8221;). As a result of the acquisition of Aetna (the &#8220;Aetna Acquisition&#8221;), the Company added the Health Care Benefits segment. Certain aspects of Aetna&#8217;s operations, including products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products, are included in the Company&#8217;s Corporate/Other segment. The consolidated financial statements reflect Aetna&#8217;s results subsequent to the Aetna Acquisition Date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges and private health insurance exchanges and other sponsors of health benefit plans throughout the United States. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2020, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. For the year ended December 31, 2020, the Company dispensed approximately 27.1% of the total retail pharmacy prescriptions in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; For periods prior to the Aetna Acquisition Date, the Health Care Benefits segment was comprised only of the Company&#8217;s SilverScript</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> PDP business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as large case pensions and long-term care insurance products.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has severely impacted the economies of the U.S. and other countries around the world. Beginning in March 2020, the effects of the COVID-19 pandemic began to emerge in the U.S. The Company executed preparedness plans to maintain continuity of its operations, including transitioning many office-based colleagues to a remote work environment and installing protective equipment in our retail pharmacies. The Company also provided enhanced benefits to its colleagues, including bonuses to frontline colleagues, dependent care financial assistance, paid sick leave for part-time colleagues and paid time off to colleagues who test positive or are quarantined due to exposure to COVID-19. Our strong local presence and scale in communities across the country enabled us to play an indispensable role in the national response to COVID-19, as well as provide seamless support for our customers wherever they needed us: in our CVS locations, in their homes, and virtually. The COVID-19 pandemic had a significant impact on the Company&#8217;s operating results for the year ended December 31, 2020, primarily in the Company&#8217;s Health Care Benefits and Retail/LTC segments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in mid-March, the health system experienced a significant reduction in utilization of medical services (&#8220;utilization&#8221;) that is discretionary and the cancellation of elective medical procedures. Utilization remained below historical levels through April, began to recover in May and June and reached more normal levels in the third and fourth quarters, with select geographies impacted by COVID-19 waves. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to COVID-19, the Company expanded benefit coverage to its members. These expanded benefits included cost-sharing waivers for COVID-19 related treatments, as well as assistance to members through premium credits, telehealth cost-sharing waivers and other investments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 also resulted in a shift in the Company&#8217;s medical membership during the year. The Company experienced declines in Commercial membership due to reductions in workforce at our existing customers, substantially offset by increases in Medicaid membership primarily as a result of the suspension of eligibility redeterminations and increased unemployment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company experienced increased prescription volume due to the greater use of 90-day prescriptions and early refills of maintenance medications, as well as increased front store volume as consumers prepared for the COVID-19 pandemic. Beginning in the second quarter and continuing throughout the remainder of the year, the Company experienced reduced customer traffic in its retail pharmacies and MinuteClinic locations due to shelter-in-place orders as well as reduced new therapy prescriptions and decreased long-term care prescription volume as a result of the COVID-19 pandemic. In addition, the Company incurred incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts and waived fees associated with prescription home delivery and associated front store products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company also played a key role in supporting the local communities in which it operates. The Company offered COVID-19 diagnostic testing at more than 4,000 CVS Pharmacy locations as of December 31, 2020. In addition, the Company launched critical diagnostic testing for the vulnerable senior population in long-term care facilities in partnership with three states. The Company was also selected to administer COVID-19 vaccines in both long-term care facilities and its retail pharmacies. The Company began administering COVID-19 vaccinations in long-term care facilities and in certain of its retail pharmacies during December 2020 and February 2021, respectively, and expects to play a significant role in COVID-19 vaccine administration in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_64"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information summarizes the Company&#8217;s results of operations for 2020 compared to 2019. For discussion of the Company&#8217;s results of operations for 2019&#160;compared to&#160;2018,&#160;see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on February 18, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Consolidated Financial Results</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 vs. 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,579&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,930&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,197&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,795&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,789&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,558&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,231&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,924&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,000.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,201&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(596)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(596)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(533.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to CVS Health</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,179&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,634&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(594)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,228&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,216.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2020 compared to 2019</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $11.9 billion or 4.6% in 2020 compared to 2019. The increase in total revenues was primarily driven by growth in the Health Care Benefits and Retail/LTC segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this MD&amp;A for additional information about the revenues of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $1.6 billion or 4.8% in 2020 compared to 2019. Operating expenses as a&#160;percentage of total revenues remained consistent at 13.1% in both 2020 and 2019. The increase in operating expenses was primarily due to the reinstatement of the non-deductible health insurer fee (&#8220;HIF&#8221;) which was $1.0 billion for 2020, incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts and increased operating expenses associated with growth in the business. The increase in operating expenses was partially offset by (i) a $269 million pre-tax gain on the sale of the Workers&#8217; Compensation business, which occurred on July 31, 2020, (ii) the absence of $231&#160;million of store rationalization charges and a $205&#160;million pre-tax&#160;loss on the sale of the Company&#8217;s Brazilian subsidiary, Drogaria </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Onofre Ltda. (&#8220;Onofre&#8221;), both recorded in the year ended December 31, 2019, and (iii) the favorable impact of enterprise-wide cost savings initiatives in 2020. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this MD&amp;A for additional information about the operating expenses of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased $1.9 billion or 16.1% in 2020 compared to 2019. The increase in operating income was primarily due to:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased operating income in the Health Care Benefits segment, primarily as a result of the COVID-19 pandemic, pre-tax income of $307&#160;million associated with the receipt of amounts owed to the Company under the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) risk corridor program that was previously fully reserved for as payment was uncertain, and the $269 million pre-tax gain on the sale of the Workers&#8217; Compensation business;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased operating income in the Pharmacy Services segment, primarily related to improved purchasing economics; and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The favorable impact of enterprise-wide cost savings initiatives in 2020, partially offset by:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Decreased operating income in the Retail/LTC segment, primarily as a result of continued reimbursement pressure and the net adverse impact of the COVID-19 pandemic, partially offset by the absence of $231&#160;million of store rationalization charges and the $205&#160;million pre-tax loss on the sale of Onofre, both recorded in 2019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this MD&amp;A for additional information about the operating income of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased $128 million in 2020 compared to 2019, primarily due to lower average debt in 2020. See &#8220;Liquidity and Capital Resources&#8221; later in this report for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on early extinguishment of debt</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During 2020, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of $6.0 billion of its outstanding senior notes pursuant to its tender offers for such senior notes in August 2020, which resulted in a loss on early extinguishment of debt of $766&#160;million, and the repayment of $4.5&#160;billion of its outstanding senior notes pursuant to its tender offers for such senior notes in December 2020, which resulted in a loss on early extinguishment of debt of $674&#160;million. During 2019, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of $4.0 billion of its outstanding senior notes pursuant to its tender offers for such senior notes in August 2019, which resulted in a loss on early extinguishment of debt of $79&#160;million. See Note 8 &#8216;&#8216;Borrowings and Credit Agreements&#8217;&#8217; included in Item 8 of this 10-K for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other income increased $82 million in 2020 compared to 2019. Other income represents pension plan asset returns in excess of interest cost on pension plan obligations. The increase in other income in 2020 was primarily due to lower discount rates in 2020 compared to 2019 when determining the interest cost on the Company&#8217;s pension plan obligations as well as strong plan asset returns. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s effective income tax rate remained consistent at 26.3% in both 2020 and 2019, with the impact of the non-deductible HIF offset by the favorable resolution of certain tax matters in the year ended December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss from discontinued operations</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#8216;n Things and Bob&#8217;s Stores, each of which subsequently filed for bankruptcy. The Company&#8217;s loss from discontinued operations in 2020 primarily includes lease-related costs required to satisfy these lease guarantees.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">See &#8220;Discontinued Operations&#8221; in Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; and &#8220;Lease Guarantees&#8221; in Note 16 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; included in Item 8 of this 10-K for additional information about the Company&#8217;s discontinued operations and the Company&#8217;s lease guarantees, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_2146"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outlook for 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to 2021, the Company believes you should consider the following important information:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy Services segment is expected to benefit from continued growth in specialty pharmacy and our ability to drive further improvements in purchasing economics, partially offset by continued price compression.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Retail/LTC segment is expected to benefit from increased prescription volume, diagnostic testing and improved generic drug purchasing, partially offset by continued reimbursement pressure and operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts. The projected adjusted prescription growth is expected to be driven by the continued successful execution of our patient care programs, the anticipated return of provider visits as we move through the year and vaccination administration. While lower front store traffic has persisted into the first quarter of 2021, we expect front store traffic to increase as we move through the year. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Care Benefits segment is expected to benefit from Medicare membership growth, partially offset by membership declines in our Medicaid products, the adverse impact of the COVID-19 pandemic and the removal of the HIF. The projected MBR is expected to increase compared to 2020, reflecting the return to more normal levels of utilization, the removal of the HIF, lower Medicare risk adjustment revenue and the continued shift in business mix. The COVID-19 pandemic is expected to adversely impact earnings in 2021 due to the regulatory changes included in the Consolidated Appropriations Act of 2021; testing, treatment and vaccination costs; and lower Medicare risk adjustment revenue.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company is expected to benefit from the continuation of its enterprise-wide cost savings initiatives that are expected to ramp as we move through the year. Key drivers include:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The ongoing digitalization of our business along with technology improvements in our operations, </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Office real estate reductions associated with workforce management changes and </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Productivity/operational efficiency initiatives within each of the Company&#8217;s segments. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Based upon current tax legislation, the Company expects its effective income tax rate to decrease primarily due to the removal of the HIF in 2021. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company expects changes to its business environment to continue as elected and other government officials at the national and state levels continue to propose and enact significant modifications to public policy and existing laws and regulations that govern or impact the Company&#8217;s businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s current expectations described above are forward-looking statements. Please see &#8220;Risk Factors&#8221; included in Item 1A of this 10-K and the &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in this 10-K for information regarding important factors that may cause the Company&#8217;s actual results to differ from those currently projected and/or otherwise materially affect the Company.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Analysis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of segment operating results is presented based on the Company&#8217;s reportable segments in accordance with the accounting guidance for segment reporting and is consistent with the segment disclosure in Note 17 &#8216;&#8216;Segment Reporting&#8217;&#8217; included in Item 8 of this 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Pharmacy Services, Retail/LTC and Health Care Benefits, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,714)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(856)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Total revenues of the Pharmacy Services segment include approximately $10.9 billion, $11.5 billion and $11.4 billion of retail co-payments for 2020, 2019 and 2018, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this 10-K for additional information about retail co-payments.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Intersegment eliminations relate to&#160;intersegment revenue generating activities that occur between the Pharmacy Services segment, the Retail/LTC segment and/or the Health Care Benefits segment.  </span></div><div style="padding-left:13.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of operating income to adjusted operating income for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,640&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,641)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of fully reserved ACA risk corridor receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,483)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store rationalization charges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(805)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(769)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related transaction and integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on financing for the Aetna Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (8)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,955&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,403&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(856)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(769)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, 2019 and 2018, acquisition-related transaction and integration costs relate to the Aetna Acquisition. In 2018, acquisition-related integration costs also relate to the acquisition of Omnicare, Inc. (&#8220;Omnicare&#8221;). The acquisition-related transaction and integration costs are reflected in the Company&#8217;s consolidated statements of operations in operating expenses within the Corporate/Other segment and the Retail/LTC segment.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment. In 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income. In 2018, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of the Company&#8217;s RxCrossroads subsidiary for $725&#160;million on January 2, 2018. The losses on divestiture in 2019 and 2018 are reflected in the Company&#8217;s consolidated statements of operations in operating expenses within the Retail/LTC segment.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the Company received $313&#160;million owed to it under the ACA&#8217;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#8217;s minimum medical loss ratio (&#8220;MLR&#8221;) rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2019, the store rationalization charges relate to the planned closure of 46 underperforming retail pharmacy stores in the second quarter of 2019 and the planned closure of 22 underperforming retail pharmacy stores in the first quarter of 2020. The store rationalization charges primarily relate to operating lease right-of-use asset impairment charges and are reflected in the Company&#8217;s consolidated statement of operations in operating expenses within the Retail/LTC segment.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2018, the goodwill impairments relate to the LTC reporting unit within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2018, impairment of long-lived assets primarily relates to the impairment of property and equipment within the Retail/LTC segment and is reflected in operating expenses in the Company&#8217;s consolidated statement of operations.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2018, the Company recorded interest income of $536 million on the proceeds of the $40 billion of unsecured senior notes it issued in March 2018 to partially fund the Aetna Acquisition. All amounts are for the periods prior to the close of the Aetna Acquisition, which occurred on November 28, 2018, and were recorded within the Corporate/Other segment.</span></div><div style="text-indent:6.75pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Pharmacy Services segment&#8217;s performance for the respective periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 vs. 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,950</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,946</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,285</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,938</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,491</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,736</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,755&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,245</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,777</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,454</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,607</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,955</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by distribution channel):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,755</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,167</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,710)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,071</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,141</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims processed:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,112.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,889.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,790.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,601.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">See &#8220;Segment Analysis&#8221; above in this MD&amp;A for a reconciliation of operating income (GAAP measure) to adjusted operating income for the Pharmacy Services segment.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2020 compared to 2019</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $447 million, or 0.3%, to $141.9 billion in 2020 compared to 2019. The increase was primarily driven by growth in specialty pharmacy and brand inflation, partially offset by continued price compression and changes in net new business mix.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Pharmacy Services segment include selling, general and administrative expenses; depreciation and amortization expense; and expenses related to specialty retail pharmacies, which include store and administrative payroll, employee benefits and occupancy costs.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $72 million, or 4.8%, in 2020 compared to 2019 primarily driven by lower amortization expense in 2020, partially offset by incremental operating expenses associated with growth in the business, including investments in the Company&#8217;s growth initiatives.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 1.0% and 1.1% in 2020 and 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased $719 million, or 15.2%, and adjusted operating income increased $559 million, or 10.9%, in 2020 compared to 2019. The increase in both operating income and adjusted operating income was primarily driven by improved purchasing economics and growth in specialty pharmacy, partially offset by continued price compression. The increase in operating income also was driven by lower amortization expense in 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Pharmacy Services segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s efforts to (i)&#160;retain existing clients, (ii)&#160;obtain new business and (iii)&#160;maintain or improve the rebates and/or discounts the Company receives from manufacturers, wholesalers and retail pharmacies continue to have an impact on operating income and adjusted operating income. In particular, competitive pressures in the PBM industry have caused the Company and other PBMs to continue to share with clients a larger portion of rebates and/or discounts received from pharmaceutical manufacturers. In addition, marketplace dynamics and regulatory changes have limited the Company&#8217;s ability to offer plan sponsors pricing that includes retail network &#8220;differential&#8221; or &#8220;spread,&#8221; and the Company expects these trends to continue. The &#8220;differential&#8221; or &#8220;spread&#8221; is any difference between the drug price charged to plan sponsors, including Medicare Part&#160;D plan sponsors, by a PBM and the price paid for the drug by the PBM to the dispensing provider.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy claims processed</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total pharmacy claims processed represents the number of prescription claims processed through our pharmacy benefits manager and dispensed by either our retail network pharmacies or our own mail and specialty pharmacies. Management uses this metric to understand variances between actual claims processed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of pharmacy claim volume on segment total revenues and operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pharmacy network claims processed on a 30-day equivalent basis increased 5.1% to 1.8 billion claims in 2020 compared to 1.7 billion claims in 2019. The increase in pharmacy network claims processed was primarily driven by net new business.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s mail choice claims processed on a 30-day equivalent basis increased 4.1% to 322.8 million claims in 2020 compared to 310.2 million claims in 2019. The increase in mail choice claims was primarily driven by net new business and the continued adoption of Maintenance Choice offerings. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Pharmacy Services segment&#8217;s generic drug prescriptions processed or filled by its total prescriptions processed or filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy Services segment&#8217;s total generic dispensing rate remained consistent at 88.2% in both 2020 and 2019. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Retail/LTC segment&#8217;s performance for the respective periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 vs. 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,944</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,729</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,175</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,198</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,608</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,989</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,590&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,619&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,284</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,688</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,906</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,149</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,274</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,127</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,314</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,640</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,793</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,403</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(559)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(698)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by major goods/service lines):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,176</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,442</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,179</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,655</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,422</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,055</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescriptions filled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,339.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same store sales increase: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:22.5pt;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.93pt">See &#8220;Segment Analysis&#8221; above in this MD&amp;A for a reconciliation of operating income (GAAP measure) to adjusted operating income for the Retail/LTC segment.</span></div><div style="padding-left:22.5pt;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.93pt">Includes an adjustment to convert 90&#8209;day prescriptions to the equivalent of three 30&#8209;day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product&#160;days supplied compared to a normal prescription.</span></div><div style="padding-left:22.5pt;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.93pt">Same store sales and prescription volume represent the change in revenues and prescriptions filled in the Company&#8217;s retail pharmacy stores that have been operating for greater than one year, expressed as a percentage that indicates the increase or decrease relative to the comparable prior period. Same store metrics exclude revenues from MinuteClinic, revenues and prescriptions from LTC operations and, in 2019 and 2018, revenues and prescriptions from stores in Brazil. Management uses these metrics to evaluate the performance of existing stores on a comparable basis and to inform future decisions regarding existing stores and new locations. Same-store metrics provide management and investors with information useful in understanding the portion of current revenues and prescriptions resulting from organic growth in existing locations versus the portion resulting from opening new stores.</span></div><div style="padding-left:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2020 compared to 2019</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $4.6 billion, or 5.3%, to $91.2 billion in 2020 compared to 2019. The increase was primarily driven by increased prescription volume, COVID-19 diagnostic testing and brand inflation, partially offset by continued reimbursement pressure and the impact of recent generic introductions.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy same store sales increased 7.0% in 2020 compared to 2019. The increase was driven by the 4.7% increase in pharmacy same store prescription volume on a 30-day equivalent basis, pharmacy drug mix and brand inflation. These increases were partially offset by continued reimbursement pressure and the impact of recent generic introductions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Front store same store sales increased 0.9% in 2020 compared to 2019. The increase was primarily due to increases in consumer health and general merchandise sales.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other revenues increased 83.7% in 2020 compared to 2019. The increase was primarily due to increased diagnostic testing in response to the COVID-19 pandemic in 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Retail/LTC segment include store payroll, store employee benefits, store occupancy costs, selling expenses, advertising expenses, depreciation and amortization expense and certain administrative expenses.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $147 million, or 0.8%, in 2020 compared to 2019. The increase was primarily due to incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts, the increased volume described above and investments in the business in 2020. The increase was partially offset by the absence of $231 million of store rationalization charges in connection with the planned closure of underperforming retail pharmacy stores and the $205 million pre-tax loss on the sale of Onofre, both recorded in 2019, as well as the impact of cost savings initiatives in 2020. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 20.0% in 2020 compared to 20.9% in 2019. The decrease in operating expenses as a percentage of total revenues was primarily driven by the increases in total revenues described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income decreased $153 million, or 2.6%, and adjusted operating income decreased $559 million, or 8.3%, in 2020 compared to 2019. The decrease in both operating income and adjusted operating income was primarily due to continued reimbursement pressure and the net impact of the COVID-19 pandemic, partially offset by the increased pharmacy volume described above and improved generic drug purchasing. The COVID-19 pandemic resulted in reduced operating income and adjusted operating income in 2020 as a result of decreased customer traffic in the segment&#8217;s retail pharmacies and MinuteClinic locations and incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts, partially offset by COVID-19 diagnostic testing. The decrease in operating income also was partially offset by the absence of the $231 million of store rationalization charges and the $205 million pre-tax loss on the sale of Onofre, both recorded in 2019.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Retail/LTC segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The segment&#8217;s pharmacy operating income and adjusted operating income have been adversely affected by the efforts of managed care organizations, PBMs and governmental and other third-party payors to reduce their prescription drug costs, including the use of restrictive networks, as well as changes in the mix of business within the pharmacy portion of the Retail/LTC segment. If the reimbursement pressure accelerates, the segment may not be able to grow revenues, and its operating income and adjusted operating income could be adversely affected.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The increased use of generic drugs has positively impacted the segment&#8217;s operating income and adjusted operating income but has resulted in third-party payors augmenting their efforts to reduce reimbursement payments to retail pharmacies for prescriptions. This trend, which the Company expects to continue, reduces the benefit the segment realizes from brand-to-generic drug conversions.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescriptions filled</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled represents the number of prescriptions dispensed through the Retail/LTC segment&#8217;s pharmacies. Management uses this metric to understand variances between actual prescriptions dispensed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of prescription volume on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled increased 3.4% on a 30-day equivalent basis in 2020 compared to 2019 primarily driven by the continued adoption of patient care programs, partially offset by reduced new therapy prescriptions as a result of the COVID-19 pandemic and decreased long-term care prescription volume.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Retail/LTC segment&#8217;s generic drug prescriptions filled by its total prescriptions filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Retail/LTC segment&#8217;s generic dispensing rate remained consistent at 88.3% in both 2020 and 2019. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For periods prior to November 28, 2018 (the Aetna Acquisition Date), the Health Care Benefits segment was comprised only of the Company&#8217;s SilverScript PDP business. The following table summarizes the Health Care Benefits segment&#8217;s performance for the respective periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 vs. 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages and basis points (&#8220;bps&#8221;)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,301</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,180</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,270</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,974</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,467</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,604</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,962</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,863</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,083</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,092</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,678</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,991</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MBR (Benefit costs as a % of premium revenues) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(330)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,218</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,873</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,769</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,166</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,639</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,202</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenues (by business):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,928</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,818</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,091</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,110</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,727</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,373</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,213</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,089</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(840)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,124</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:22.5pt;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.93pt">For periods prior to the Aetna Acquisition Date, the Health Care Benefits segment was comprised only of the Company&#8217;s SilverScript PDP business. Accordingly, the MBR for the year ended December 31, 2018 is not meaningful (&#8220;NM&#8221;) and is not directly comparable to the MBRs for the years ended December&#160;31, 2020 and 2019.</span></div><div style="padding-left:22.5pt;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.93pt">See &#8220;Segment Analysis&#8221; above in this MD&amp;A for a reconciliation of operating income (GAAP measure) to adjusted operating income for the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2020 compared to 2019</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $5.9 billion, or 8.4%, to $75.5 billion in 2020 compared to 2019 primarily driven by membership growth in the Health Care Benefits segment&#8217;s Government products, the favorable impact of the reinstatement of the HIF for 2020 and the receipt of $313&#160;million owed to the Company under the ACA&#8217;s risk corridor program. These increases were partially offset by the divestitures of Aetna&#8217;s standalone PDPs (which the Company retained the financial results of through 2019) and Workers&#8217; Compensation business, membership declines in the segment&#8217;s Commercial products and COVID-19 related investments benefiting customers in 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Ratio (&#8220;MBR&#8221;)</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical benefit ratio is calculated as benefit costs divided by premium revenues and represents the percentage of premium revenues spent on medical benefits for the Company&#8217;s Insured members. Management uses MBR to assess the underlying business performance and underwriting of its insurance products, understand variances between actual results and expected results and identify trends in period-over-period results. MBR provides management and investors with information useful in assessing the operating results of the Company&#8217;s Insured Health Care Benefits products.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Care Benefits segment&#8217;s MBR decreased 330 basis points from 84.2% to 80.9% in 2020 compared to 2019. The decrease was primarily due to (i) the impact of the COVID-19 pandemic, which resulted in reduced benefit costs due </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the deferral of elective procedures and other discretionary utilization, partially offset by COVID-19 related investments, testing and treatment costs, (ii) the reinstatement of the HIF for 2020 and (iii) the receipt of amounts owed to the Company under the ACA&#8217;s risk corridor program in 2020. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Health Care Benefits segment include selling, general and administrative expenses and depreciation and amortization expenses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $1.3 billion in 2020 compared to 2019. The increase in operating expenses was primarily due to the reinstatement of the HIF which was $1.0 billion for 2020 and incremental operating expenses to support the increased membership described above, including operating expenses to support additional Medicaid members onboarded during the first quarter of 2020. The increase was partially offset by the divestitures of Aetna&#8217;s standalone PDPs and Workers&#8217; Compensation business, the $269 million pre-tax gain on the sale of the Workers&#8217; Compensation business and the impact of cost savings initiatives in 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income and adjusted operating income increased $1.5 billion and $1.0 billion, respectively, in 2020 compared to 2019. The increase in both operating income and adjusted operating income was primarily driven by the impact of the COVID-19 pandemic, partially offset by the divestitures of Aetna&#8217;s standalone PDPs and Workers&#8217; Compensation business. The COVID-19 pandemic resulted in reduced benefit costs due to the deferral of elective procedures and other discretionary utilization, partially offset by COVID-19 related investments, testing and treatment costs. Operating income also includes pre-tax income of $307&#160;million associated with the receipt of amounts owed to the Company under the ACA&#8217;s risk corridor program and the $269 million pre-tax gain on the sale of the Workers&#8217; Compensation business in 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s medical membership as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical membership:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical membership</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,267&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,191&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,717&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,908&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental membership information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Prescription Drug Plan (standalone) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="margin-bottom:0.3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents the Company&#8217;s SilverScript PDP membership only. Excludes 2.5 million members as of December 31, 2019 related to Aetna&#8217;s standalone PDPs that were sold effective December 31, 2018. The Company retained the financial results of the divested plans through 2019 through a reinsurance agreement. Subsequent to 2019, the Company no longer retains the financial results of the divested plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Membership</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership represents the number of members covered by the Company&#8217;s Insured and ASC medical products and related services at a specified point in time. Management uses this metric to understand variances between actual medical membership and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of medical membership on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership as of December&#160;31, 2020 of 23.4 million increased 504 thousand compared with December&#160;31, 2019, primarily reflecting increases in Medicaid and Medicare products, partially offset by declines in Commercial products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Update</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) issued its final notice detailing final 2021 Medicare Advantage benchmark payment rates (the &#8220;Final Notice&#8221;). Overall the Company projects the benchmark rates in the Final Notice will increase funding for its Medicare Advantage business, excluding the impact of the HIF in 2020, by approximately 1.8% in 2021 compared to 2020. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 15, 2021, CMS issued its Final Notice detailing final 2022 Medicare Advantage benchmark payment rates. Final 2022 Medicare Advantage rates resulted in an increase in industry benchmark rates of approximately 4.1%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA ties a portion of each Medicare Advantage plan&#8217;s reimbursement to the plan&#8217;s &#8220;star ratings.&#8221; Plans must have a star rating of four or higher (out of five) to qualify for bonus payments. CMS released the Company&#8217;s 2021 star ratings in October 2020. The Company&#8217;s 2021 star ratings will be used to determine which of the Company&#8217;s Medicare Advantage plans have ratings of four stars or higher and qualify for bonus payments in 2022. Based on the Company&#8217;s membership at December 31, 2020, 83% of the Company&#8217;s Medicare Advantage members were in plans with 2021 star ratings of at least four stars, consistent with 83% of the Company&#8217;s Medicare Advantage members being in plans with 2020 star ratings of at least four stars based on the Company&#8217;s membership at December 31, 2019.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Corporate/Other segment&#8217;s performance for the respective periods:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 vs. 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,195.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,389</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,641)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,483)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(805)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(678)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(856)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this MD&amp;A for a reconciliation of operating loss (GAAP measure) to adjusted operating loss for the Corporate/Other segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2020 compared to 2019</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues primarily relate to products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products, that were acquired in the Aetna Acquisition. In 2018, revenues relate primarily to interest income on the proceeds from the financing of the Aetna Acquisition.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues decreased $86 million in 2020 compared to 2019. The decrease was primarily driven by lower net investment income including an $80 million decrease in net realized capital gains in 2020 compared to 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses within the Corporate/Other segment consist of management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs. Subsequent to the Aetna Acquisition Date, segment operating expenses also include operating costs to support the Company&#8217;s large case pensions and long-term care insurance products.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $136 million in 2020 compared to 2019. The increase was primarily driven by incremental operating expenses associated with the Company&#8217;s investments in transformation and its COVID-19 pandemic response efforts, as well as increased charitable contributions in 2020. The increase was partially offset by a $148 million decrease in acquisition-related integration costs compared to the prior year.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_85"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a level of liquidity sufficient to allow it to meet its cash needs in the short-term. Over the long term, the Company manages its cash and capital structure to maximize shareholder return, maintain its financial condition and maintain flexibility for future strategic initiatives. The Company continuously assesses its regulatory capital requirements, working capital needs, debt and leverage levels, debt maturity schedule, capital expenditure requirements, dividend payouts, potential share repurchases and future investments or acquisitions. The Company believes its operating cash flows, commercial paper program, credit facilities, sale-leaseback program, as well as any potential future borrowings, will be sufficient to fund these future payments and long-term initiatives. As of&#160;December&#160;31, 2020, the Company had approximately&#160;$7.9 billion&#160;in cash and cash equivalents, approximately&#160;$2.2 billion&#160;of which was held by the parent company or nonrestricted subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has severely impacted global economic activity and during the first half of the year caused significant volatility and negative pressure in the capital markets. As a result of the uncertainty generated by COVID-19, on March 31, 2020, the Company issued $4.0 billion aggregate principal amount of unsecured senior notes to enhance its liquidity and strengthen its capital. As markets stabilized, in August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers, while issuing $4.0 billion aggregate principal amount of unsecured senior notes. In December 2020, the Company purchased $4.5&#160;billion of its outstanding senior notes through cash tender offers, while issuing $2.0 billion aggregate principal amount of unsecured senior notes. The Company will continue to monitor the severity and duration of the pandemic and its impact on the U.S. and global economies, consumer behavior and health care utilization patterns and our businesses, results of operations, financial condition, and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in cash, cash equivalents and restricted cash for the years ended December&#160;31, 2020, 2019 and 2018 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019 vs. 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,865&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,865&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,534)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,339)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,285)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,195)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,946&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,850)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,669)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,176&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(736)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2020 compared to 2019</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash provided by operating activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $3.0 billion in 2020 compared to 2019 due primarily to higher operating income in the Health Care Benefits segment and the deferral of approximately $670&#160;million of certain payroll tax payments to future years, as permitted in response to the COVID-19 pandemic.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in investing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $2.2 billion in 2020 compared to 2019 primarily due to increased net purchases of investments and an increase in cash used for acquisitions, partially offset by $840 million in proceeds from the sale of the Workers&#8217; Compensation business. In addition, cash used in investing activities reflected the following activity:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross capital expenditures remained relatively consistent at approximately $2.4 billion and $2.5 billion in 2020 and 2019, respectively. During 2020, approximately 62% of the Company&#8217;s total capital expenditures were for technology and other corporate initiatives, 30% were for store, fulfillment and support facilities expansion and improvements and 8% were for new store construction. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in financing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased slightly to $8.2 billion in 2020 compared to $7.9 billion in 2019. The increase in cash used in finance activities primarily related to an increase in net debt repaid during 2020 compared to 2019.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in net cash used in investing activities for the years ended December&#160;31, 2020, 2019 and 2018 was the following store development activity: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stores (beginning of year)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,921&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New and acquired stores </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closed stores </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stores (end of year)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,962&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,921&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relocated stores </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes retail drugstores and pharmacies within retail chains, primarily in Target Corporation (&#8220;Target&#8221;) stores.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Relocated stores are not included in new and acquired stores or closed stores totals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any commercial paper outstanding as of December 31, 2020 or 2019. In connection with its commercial paper program, the Company maintains a $1.0 billion 364-day unsecured back-up revolving credit facility, which expires on May&#160;12, 2021, a $1.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 18, 2022, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 17, 2023 and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2024. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of December&#160;31, 2020 and 2019, there were no borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the Aetna Acquisition Date, a subsidiary of the Company is a member of the Federal Home Loan Bank of Boston (the &#8220;FHLBB&#8221;). As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of December&#160;31, 2020 was approximately $925 million. At both December&#160;31, 2020 and 2019, there were no outstanding advances from the FHLBB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020, the Company issued $750&#160;million aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027 and $1.25&#160;billion aggregate principal amount of 1.875% unsecured senior notes due February 28, 2031 for total proceeds of approximately $1.99&#160;billion, net of discounts and underwriting fees. The $750&#160;million aggregate principal amount of 1.3% unsecured senior notes represent a further issuance of the Company&#8217;s 1.3% unsecured senior notes due August 21, 2027 initially issued in an aggregate principal amount of $1.5&#160;billion on August 21, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2020, the Company issued $1.5&#160;billion aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027, $1.25&#160;billion aggregate principal amount of 1.75% unsecured senior notes due August 21, 2030 and $1.25&#160;billion aggregate principal amount of 2.7% unsecured senior notes due August 21, 2040 (collectively, the &#8220;August 2020 Notes&#8221;) for total proceeds of approximately $3.97&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2020, the Company issued $750&#160;million aggregate principal amount of 3.625% unsecured senior notes due April 1, 2027, $1.5&#160;billion aggregate principal amount of 3.75% unsecured senior notes due April 1, 2030, $1.0&#160;billion aggregate principal amount of 4.125% unsecured senior notes due April 1, 2040 and $750&#160;million aggregate principal amount of 4.25% unsecured senior notes due April 1, 2050 (collectively, the &#8220;March 2020 Notes&#8221;) for total proceeds of approximately $3.95&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds of these offerings were used for general corporate purposes, which may include working capital, capital expenditures, as well as the repurchase and/or repayment of indebtedness.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the March 2020 Notes. In connection with the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issuance of the March 2020 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $7&#160;million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $5&#160;million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes.  See Note 13 &#8216;&#8216;Other Comprehensive Income&#8217;&#8217; included in Item 8 of this 10-K for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 15, 2019, the Company issued $1.0 billion aggregate principal amount of 2.625% unsecured senior notes due August 15, 2024, $750 million aggregate principal amount of 3% unsecured senior notes due August 15, 2026 and $1.75 billion aggregate principal amount of 3.25% unsecured senior notes due August 15, 2029 (collectively, the &#8220;2019 Notes&#8221;) for total proceeds of approximately $3.46 billion, net of discounts and underwriting fees. The net proceeds of the 2019 Notes were used to repay certain of the Company&#8217;s outstanding debt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in July 2019, the Company entered into several interest rate swap and treasury lock transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the 2019 Notes. In connection with the issuance of the 2019 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $25 million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $18 million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the 2019 Notes. See Note 13 &#8216;&#8216;Other Comprehensive Income&#8217;&#8217; included in Item 8 of this 10-K for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company purchased $4.5&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $113&#160;million of its 4.0% senior notes due 2023, $1.4&#160;billion of its 3.7% senior notes due 2023, $1.0&#160;billion of its 4.1% senior notes due 2025 and $2.0&#160;billion of its 4.3% senior notes due 2028. In connection with the purchase of such senior notes, the Company paid a premium of $619&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $45&#160;million of unamortized deferred financing costs and incurred $10&#160;million in fees, for a total loss on early extinguishment of debt of $674&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, the Company purchased $4.0 billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $1.3&#160;billion of its 3.125% senior notes due 2020, $723&#160;million of its floating rate notes due 2020, $328&#160;million of its 4.125% senior notes due 2021, $297&#160;million of 4.125% senior notes due 2021 issued by Aetna, $413&#160;million of 5.45% senior notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna, and $962&#160;million of its 3.35% senior notes due 2021. In connection with the purchase of such senior notes, the Company paid a premium of $76 million in excess of the aggregate principal amount of the senior notes that were purchased, incurred $8 million in fees and recognized a net gain of $5 million on the write-off of net unamortized deferred financing premiums, for a net loss on early extinguishment of debt of $79 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 &#8216;&#8216;Borrowings and Credit Agreements&#8217;&#8217; and Note 12 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; included in Item 8 of this 10-K for additional information about debt issuances, debt repayments, share repurchases and dividend payments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities, unsecured senior notes and unsecured floating rate notes (see Note 8 &#8216;&#8216;Borrowings and Credit Agreements&#8217;&#8217; included in Item 8 of this 10-K) contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of December&#160;31, 2020, the Company was in compliance with all of its debt covenants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company&#8217;s long-term debt was rated &#8220;Baa2&#8221; by Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) and &#8220;BBB&#8221; by Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;), and its commercial paper program was rated &#8220;P-2&#8221; by Moody&#8217;s and &#8220;A-2&#8221; by S&amp;P. The outlook on the Company&#8217;s long-term debt is &#8220;Stable&#8221; by S&amp;P. In December 2020, Moody&#8217;s changed the outlook on the Company&#8217;s long-term debt from &#8220;Negative&#8221; to &#8220;Stable.&#8221; In assessing the Company&#8217;s credit strength, the Company believes that both Moody&#8217;s and S&amp;P considered, among other things, the Company&#8217;s capital structure and financial policies as well as its consolidated balance sheet, its historical acquisition activity and other financial information. Although the Company currently believes its long-term debt ratings will remain investment grade, it cannot guarantee the future actions of Moody&#8217;s and/or S&amp;P. The Company&#8217;s debt ratings have a direct impact on its future borrowing costs, access to capital markets and new store operating lease costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Programs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020, 2019 and 2018,  the Company did not repurchase any shares of common stock. See Note 12 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; included in Item 8 of this 10-K for additional information on the Company&#8217;s share repurchase program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quarterly Cash Dividend</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, 2019 and 2018, the quarterly cash dividend was $0.50 per share. CVS Health has paid cash dividends every quarter since becoming a public company and expects to maintain its quarterly dividend of $0.50 per share throughout 2021. Future dividends will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Cash Requirements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes certain estimated future cash requirements under the Company&#8217;s various contractual obligations at December&#160;31, 2020, in total and disaggregated into current and long-term obligations. The table below does not include future payments of claims to health care providers or pharmacies because certain terms of these payments are not determinable at December&#160;31, 2020 (for example, the timing and volume of future services provided under fee-for-service arrangements and future membership levels for capitated arrangements). </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual lease obligations with Target </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payments on long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities on the consolidated balance sheets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Future policy benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid claims</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) (6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,374&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,957&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,970&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Refer to Note 6 &#8216;&#8216;Leases&#8217;&#8217; included in Item 8 of this 10-K for additional information regarding the maturity of lease liabilities under operating and finance leases. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; included in Item 8 of this 10-K for additional information regarding the lease arrangements with Target. Amounts related to such operating and finance leases are reflected within the operating lease liabilities and finance lease liabilities in the table above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings are reflected in the table above assuming equivalent stores continue to operate through the term of the arrangements. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Refer to Note 8 &#8216;&#8216;Borrowings and Credit Agreements&#8217;&#8217; included in Item 8 of this 10-K for additional information regarding the maturities of debt principal. Interest payments on long-term debt are calculated using outstanding balances and interest rates in effect on December&#160;31, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Payments of other long-term liabilities exclude Separate Accounts liabilities of approximately $4.9 billion because these liabilities are supported by assets that are legally segregated and are not subject to claims that arise out of the Company&#8217;s business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total payments of future policy benefits, unpaid claims and policyholders&#8217; funds include $763 million, $2.0 billion and $210 million, respectively, of reserves for contracts subject to reinsurance. The Company expects the assuming reinsurance carrier to fund these obligations and has reflected these amounts as reinsurance recoverable assets on the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Customer funds associated with group life and health contracts of approximately $2.9 billion have been excluded from the table above because such funds may be used primarily at the customer&#8217;s discretion to offset future premiums and/or for refunds, and the timing of the related cash flows cannot be determined. Additionally, net unrealized capital gains on debt securities supporting experience-rated products of $135 million, before tax, have been excluded from the table above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restrictions on Certain Payments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, health maintenance organizations (&#8220;HMOs&#8221;) and insurance companies are subject to further regulations that, among other things, may require those companies to maintain certain levels of equity (referred to as surplus) and restrict the amount of dividends and other distributions that may be paid to their equity holders. These regulations are not directly applicable to CVS Health as a holding company, since CVS Health is not an HMO or an insurance company. In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies. The additional regulations and undertakings applicable to the Company&#8217;s HMO and insurance company subsidiaries are not expected to affect the Company&#8217;s ability to service the Company&#8217;s debt, meet other financing obligations or pay dividends, or the ability of any of the Company&#8217;s subsidiaries to service their debt or other financing obligations. Under applicable regulatory requirements and undertakings, at December&#160;31, 2020, the maximum amount of dividends that may be paid by the Company&#8217;s insurance and HMO subsidiaries without prior approval by regulatory authorities was $2.9 billion in the aggregate. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains capital levels in its operating subsidiaries at or above targeted and/or required capital levels and dividends amounts in excess of these levels to meet liquidity requirements, including the payment of interest on debt and stockholder dividends. In addition, at the Company&#8217;s discretion, it uses these funds for other purposes such as funding share and debt repurchase programs, investments in new businesses and other purposes considered advisable. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, the Company held investments of $524 million and $537 million, respectively, that are not accounted for as Separate Accounts assets but are legally segregated and are not subject to claims that arise out of the Company&#8217;s business. See Note 3 &#8216;&#8216;Investments&#8217;&#8217; included in Item 8 of this 10-K for additional information on investments related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Solvency Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The National Association of Insurance Commissioners (the &#8220;NAIC&#8221;) utilizes risk-based capital (&#8220;RBC&#8221;) standards for insurance companies that are designed to identify weakly-capitalized companies by comparing each company&#8217;s adjusted surplus to its required surplus (the &#8220;RBC Ratio&#8221;). The RBC Ratio is designed to reflect the risk profile of insurance companies. Within certain ratio ranges, regulators have increasing authority to take action as the RBC Ratio decreases. There are four levels of regulatory action, ranging from requiring an insurer to submit a comprehensive financial plan for increasing its RBC to the state insurance commissioner to requiring the state insurance commissioner to place the insurer under regulatory control. At December&#160;31, 2020, the RBC Ratio of each of the Company&#8217;s primary insurance subsidiaries was above the level that would require regulatory action. The RBC framework described above for insurers has been extended by the NAIC to health organizations, including HMOs. Although not all states had adopted these rules at December&#160;31, 2020, at that date, each of the Company&#8217;s active HMOs had a surplus that exceeded either the applicable state net worth requirements or, where adopted, the levels that would require regulatory action under the NAIC&#8217;s RBC rules. External rating agencies use their own capital models and/or RBC standards when they determine a company&#8217;s rating.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the consolidated financial statements in conformity with generally accepted accounting principles, which require management to make certain estimates and apply judgment. Estimates and judgments are based on historical experience, current trends and other factors that management believes to be important at the time the consolidated financial statements are prepared. On a regular basis, the Company reviews its accounting policies and how they are applied and disclosed in the consolidated financial statements. While the Company believes the historical experience, current trends and other factors considered by management support the preparation of the consolidated financial statements in conformity with generally accepted accounting principles, actual results could differ from estimates, and such differences could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant accounting policies are discussed in Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this 10-K. Management believes the following accounting policies include a higher degree of judgment and/or complexity and, thus, are considered to be critical accounting policies. The Company has discussed the development and selection of these critical accounting policies with the Audit Committee of the Board (the &#8220;Audit Committee&#8221;), and the Audit Committee has reviewed the disclosures relating to them.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment sells prescription drugs directly through its mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network. The Company&#8217;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the dispensing of prescription drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions dispensed indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#8220;Drug Discounts&#8221; and &#8220;Guarantees&#8221; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#8220;retail co-payments&#8221;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Pharmacy Services segment:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by mail service dispensing pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by third party pharmacies in the Company&#8217;s retail pharmacy network and associated administrative fees are recognized at the Company&#8217;s point-of-sale, which is when the claim is adjudicated by the Company&#8217;s online claims processing system and the Company has transferred control of the prescription drug and performed all of its performance obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Drug Discounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue net of manufacturers&#8217; rebates earned by its clients based on their plan members&#8217; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#8217; rebates earned by its clients. The estimates are based on the best available data at period-end </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#8217; rebate amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retail Pharmacy</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer returns are not material to the Company&#8217;s operating results or financial condition. Sales taxes are not included in revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loyalty and Other Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer loyalty program, ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consists of two components, ExtraSavings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-term Care</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of Long-term Care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#8217;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-In Medical Clinics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided by the Company&#8217;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which reflect contracted rates per employee and the number of covered employees recorded in the Company&#8217;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise. A significant difference in the actual level of retroactivity compared to estimated levels would have a significant effect on the Company&#8217;s operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Premium Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the MLR rebate requirements of the ACA is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#8217;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#8217;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#8217;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Medicare Part D </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include insurance premiums earned by the Company&#8217;s PDPs, which are determined based on the PDP&#8217;s annual bid and related contractual arrangements with CMS. The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairments of Debt Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews its debt securities to determine whether a decline in fair value below the cost basis or carrying value has occurred. If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. The Company analyzes all facts and circumstances believed to be relevant for each investment when performing this analysis, in accordance with applicable accounting guidance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company recorded yield-related impairment losses on debt securities of $49 million. During the year ended December&#160;31, 2020, the Company did not record credit-related impairment losses on debt securities. During the year ended December 31, 2019, the Company recorded other-than-temporary impairment (&#8220;OTTI&#8221;) losses on debt securities of $24 million. There were no material OTTI losses on debt securities for the year ended December 31, 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks inherent in assessing the impairment of a debt security include the risk that market factors may differ from projections and the risk that facts and circumstances factored into the Company&#8217;s assessment may change with the passage of time. Unexpected changes to market factors and circumstances that were not present in past reporting periods are among the factors that may result in a current period decision to sell debt securities that were not impaired in prior reporting periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vendor Allowances and Purchase Discounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vendor and manufacturer receivables were $9.8 billion and $7.9 billion as of December&#160;31, 2020 and 2019, respectively, the majority of which relate to purchase discounts and vendor allowances as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i)&#160;a direct discount at the time of purchase, (ii)&#160;a discount for the prompt payment of invoices or (iii)&#160;when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30&#160;days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#8217;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Pharmacy Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vendor allowances received by the Retail/LTC segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any such allowances received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon purchase volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes a receivable for vendor income that is earned but not yet received based on historical trends and data. The majority of vendor receivables are collected within the following fiscal quarter. Historically, adjustments to the Company&#8217;s vendor receivables resulting from the reconciliation of receivables recognized to the amounts collected have not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have not been any material changes in the way the Company accounts for vendor allowances or purchase discounts during the past three&#160;years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or net realizable value using the weighted average cost method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of ending inventory is reduced for estimated inventory losses that have occurred during the interim period between physical inventory counts. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. The Company&#8217;s accounting for inventory contains uncertainty since management must use judgment to estimate the inventory losses that have occurred during the interim period between physical inventory counts. When estimating these losses, a number of factors are considered which include historical physical inventory results on a location-by-location basis and current physical inventory loss trends.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total reserve for estimated inventory losses covered by this critical accounting policy was $369 million and $401 million as of December&#160;31, 2020 and 2019, respectively. Although management believes there is sufficient current and historical information available to record reasonable estimates for estimated inventory losses, it is possible that actual results could differ. In order to help investors assess the aggregate risk, if any, associated with the inventory-related uncertainties discussed above, a ten&#160;percent (10%)&#160;pre-tax change in estimated inventory losses, which is a reasonably likely change, would increase or decrease the total reserve for estimated inventory losses by approximately $37 million as of December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although management believes that the estimates discussed above are reasonable and the related calculations conform to generally accepted accounting principles, actual results could differ from such estimates, and such differences could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right-of-Use Assets and Lease Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#8217;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. </span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Asset Impairment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recoverability of Definite-Lived Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such an asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted and without interest charges). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the asset group&#8217;s carrying value that exceeds the asset group&#8217;s estimated future cash flows (discounted and with interest charges).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The long-lived asset impairment loss calculation contains uncertainty since management must use judgment to estimate each asset group&#8217;s future sales, profitability and cash flows. When preparing these estimates, the Company considers historical results and current operating trends and consolidated sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including general economic and regulatory conditions, efforts of third party organizations to reduce their prescription drug costs and/or increased member co-payments, the continued efforts of competitors to gain market share and consumer spending patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material impairment charges recognized on long-lived assets in the year ended December 31, 2020. During the year ended December 31, 2019, the Company recorded store rationalization charges of $231 million, primarily related to operating lease right-of-use asset impairment charges. During the year ended December 31, 2018, the Company recognized a $43 million long-lived asset impairment charge, primarily related to the impairment of property and equipment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recoverability of Goodwill</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of amounts paid for acquisitions over the fair value of the net identifiable assets acquired. Goodwill is subject to annual impairment reviews, or more frequent reviews if events or circumstances indicate that the carrying value may not be recoverable. Goodwill is tested for impairment on a reporting unit basis. The impairment test is performed by comparing the reporting unit&#8217;s fair value with its net book value (or carrying amount), including goodwill. The fair value of the reporting units is estimated using a combination of a discounted cash flow method and a market multiple method. If the net book value (carrying amount) of the reporting unit exceeds its fair value, the reporting unit&#8217;s goodwill is considered to be impaired, and an impairment is recognized in an amount equal to the excess.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of the fair value of the reporting units requires the Company to make significant assumptions and estimates. These assumptions and estimates primarily include the selection of appropriate peer group companies; control premiums and valuation multiples appropriate for acquisitions in the industries in which the Company competes; discount rates; terminal growth rates; and forecasts of revenue, operating income, depreciation and amortization, income taxes, capital expenditures and future working capital requirements. When determining these assumptions and preparing these estimates, the Company considers each reporting unit&#8217;s historical results and current operating trends; consolidated revenues, profitability and cash flow results and forecasts; and industry trends. The Company&#8217;s estimates can be affected by a number of factors, including general economic and regulatory conditions; the risk-free interest rate environment; the Company&#8217;s market capitalization; efforts of customers and payers to reduce costs, including their prescription drug costs, and/or increase member co-payments; the continued efforts of competitors to gain market share, consumer spending patterns and the Company&#8217;s ability to achieve its revenue growth projections and execute on its cost reduction initiatives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Goodwill Impairment Test</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company performed its required annual impairment test of goodwill. The results of this impairment test indicated that there was no impairment of goodwill as of the testing date. The goodwill impairment test resulted in the fair values of all of the Company&#8217;s reporting units exceeding their carrying values by significant margins, with the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exception of the Commercial Business and LTC reporting units, which exceeded their carrying values by approximately 6% and 12%, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Aetna Acquisition in November 2018, the Company added the Health Care Benefits segment which included the Commercial Business reporting unit. The transaction was accounted for using the acquisition method of accounting which requires, among other things, the assets acquired and liabilities assumed to be recognized at their fair values at the date of acquisition. As a result, at the time of the acquisition the fair value of the Commercial Business reporting unit was equal to its carrying value. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced declines in its Commercial Insured medical membership subsequent to the closing date of the Aetna Acquisition and may continue to do so for a number of reasons, including as a result of the competitive Commercial business environment. In addition, COVID-19 has had and may continue to have an adverse impact on medical membership in the Commercial business due to reductions in workforce at existing customers (including due to business failures) as well as reduced willingness to change benefit providers by prospective customers. The Company&#8217;s fair value estimate is sensitive to significant assumptions including changes in medical membership, revenue growth rate, operating income and the discount rate. Although the Company believes the financial projections used to determine the fair value of the Commercial Business reporting unit in the third quarter of 2020 were reasonable and achievable, the challenges described above may affect the Company&#8217;s ability to increase medical membership or operating income in the Commercial Business reporting unit at the rate estimated when such goodwill impairment test was performed and may continue to do so. As of December 31, 2020, the goodwill balance in the Commercial Business reporting unit was $26.5 billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LTC reporting unit continues to experience industry-wide challenges that have impacted management&#8217;s ability to grow the business at the rate that was originally estimated when the Company acquired Omnicare in 2015. Those challenges included lower client retention rates, lower occupancy rates in skilled nursing facilities, the deteriorating financial health of numerous skilled nursing facility customers which resulted in a number of customer bankruptcies in 2018, and continued facility reimbursement pressures. COVID-19 has also had an adverse impact on the financial health of the Company&#8217;s long-term care facility customers due to declines in occupancy rates and increased operating expenses. A number of these customers have relied on supplemental liquidity sources such as grants and advance Medicare payments under programs expanded or created under the CARES Act to maintain adequate liquidity during the COVID-19 pandemic and may require additional sources of liquidity throughout the duration of the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes the financial projections used to determine the fair value of the LTC reporting unit in the third quarter of 2020 were reasonable and achievable, the LTC reporting unit has faced challenges that affect the Company&#8217;s ability to grow the LTC reporting unit&#8217;s business at the rate estimated when such goodwill impairment test was performed and may continue to do so. These challenges and some of the key assumptions included in the Company&#8217;s financial projections to determine the estimated fair value of the LTC reporting unit include client retention rates; occupancy rates in skilled nursing facilities; the financial health of skilled nursing facility customers; facility reimbursement pressures; the Company&#8217;s ability to extract cost savings from labor productivity and other initiatives; the geographies impacted and the severity and duration of COVID-19; COVID-19&#8217;s impact on health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to COVID-19. The fair value of the LTC reporting unit also is dependent on market multiples of peer group companies and the risk-free interest rate environment, which impacts the discount rate used in the discounted cash flow valuation method. If the LTC reporting unit does not achieve its forecasts, it is reasonably possible in the near term that the goodwill of the LTC reporting unit could be deemed to be impaired by a material amount. As of December 31, 2020, the goodwill balance in the LTC reporting unit was $431 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic severely impacted global economic activity in 2020, including the businesses of some of the Company&#8217;s customers, and during the first half of the year caused significant volatility and negative pressure in the capital markets. In addition to adversely affecting the Company&#8217;s businesses, which may have a material adverse impact on the Company&#8217;s profitability and cash flows, these developments may adversely affect the timing and collectability of payments to the Company from customers, clients, government payers and members as a result of the impact of COVID-19 on them. For further information regarding the potential adverse impact of COVID-19 on the Company, please see &#8220;Risk Factors&#8221; included in Item 1A of this report. The COVID-19 pandemic continues to evolve. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">us. If the Company&#8217;s businesses, results of operations, financial condition and/or cash flows are materially adversely affected, the goodwill of the LTC and Commercial Business reporting units could be deemed to be impaired by a material amount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 Goodwill Impairment Test</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2019, the Company performed its required annual impairment test of goodwill. The results of this impairment test indicated that there was no impairment of goodwill as of the testing date. The goodwill impairment test resulted in the fair values of all of the Company&#8217;s reporting units exceeding their carrying values by significant margins, with the exception of the Commercial Business and LTC reporting units, which exceeded their carrying values by approximately 4% and 9%, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2018 Goodwill Impairment Tests</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; included in Item 8 of this 10-K, during 2018, the LTC reporting unit experienced industry-wide challenges that impacted management&#8217;s ability to grow the business at the rate that was originally estimated when the Company acquired Omnicare and when the 2017 annual goodwill impairment test was performed. Those challenges include lower client retention rates, lower occupancy rates in skilled nursing facilities, the deteriorating financial health of numerous skilled nursing facility customers which resulted in a number of customer bankruptcies in 2018, and continued facility reimbursement pressures. Following the update of its current and long-term forecast, in June 2018, management determined that there were indicators that the LTC reporting unit&#8217;s goodwill may be impaired and, accordingly, management performed an interim goodwill impairment test as of June 30, 2018. The results of that interim impairment test showed that the fair value of the LTC reporting unit was lower than the carrying value, resulting in a $3.9 billion pre-tax goodwill impairment charge in the second quarter of 2018. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2018, the Company performed its required annual impairment tests of goodwill and concluded there was no impairment of goodwill. The goodwill impairment tests showed that the fair values of the Pharmacy Services and Retail Pharmacy reporting units exceeded their carrying values by significant margins and the fair value of the LTC reporting unit exceeded its carrying value by approximately 2%. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the LTC reporting unit missed its forecast primarily due to operational issues and customer liquidity issues, including one significant customer bankruptcy. Additionally, LTC management submitted updated projected financial results which showed significant additional deterioration primarily due to continued industry and operational challenges, which also caused management to make further updates to its long-term forecast beyond 2019. Based on these updated projections, management determined that there were indicators that the LTC reporting unit&#8217;s goodwill may be further impaired and, accordingly, management performed an interim goodwill impairment test during the fourth quarter of 2018. The results of that interim impairment test showed that the fair value of the LTC reporting unit was lower than the carrying value, resulting in an additional&#160;$2.2 billion pre-tax goodwill impairment charge in the fourth quarter of 2018. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, the fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method. In addition to the lower financial projections, changes in risk-free interest rates and lower market multiples of peer group companies also contributed to the amount of the 2018 goodwill impairment charges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recoverability of Indefinite-Lived Intangible Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are subject to annual impairment reviews, or more frequent reviews if events or circumstances indicate that their carrying value may not be recoverable. Indefinite-lived intangible assets are tested by comparing the estimated fair value of the asset to its carrying value. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indefinite-lived intangible asset impairment loss calculation contains uncertainty since management must use judgment to estimate fair value based on the assumption that, in lieu of ownership of an intangible asset, the Company would be willing to pay a royalty in order to utilize the benefits of the asset. Fair value is estimated by discounting the hypothetical royalty payments to their present value over the estimated economic life of the asset. These estimates can be affected by a number of factors including general economic conditions, availability of market information and the profitability of the Company. There were no impairment losses recognized on indefinite-lived intangible assets in any of the years ended December&#160;31, 2020, 2019 or 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Costs Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At&#160;December&#160;31, 2020 and 2019, 77% and 73% respectively, of health care costs payable are estimates of the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. The remainder of health care costs payable is primarily comprised of pharmacy and capitation payables, other amounts due to providers pursuant to risk sharing agreements and accruals for state assessments. The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this 10-K for additional information on the Company&#8217;s reserving methodology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020 and 2019, the Company observed an increase in completion factors relative to those assumed at the prior year end. After considering the claims paid in 2020 and 2019 with dates of service prior to the fourth quarter of the previous year, the Company observed assumed incurred claim weighted average completion factors that were 4 and 27 basis points higher, respectively, than previously estimated, resulting in a decrease of $35 million and $240 million in 2020 and 2019, respectively, in health care costs payable that related to the prior year. The Company has considered the pattern of changes in its completion factors when determining the completion factors used in its estimates of IBNR as of December&#160;31, 2020. However, based on historical claim experience, it is reasonably possible that the Company&#8217;s estimated weighted average completion factors may vary by plus or minus 11 basis points from the Company&#8217;s assumed rates, which could impact health care costs payable by approximately plus or minus $140 million pretax.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also during 2020 and 2019, the Company observed that health care costs for claims with claim incurred dates of three months or less before the financial statement date were lower than previously estimated. Specifically, after considering the claims paid in 2020 and 2019 with claim incurred dates for the fourth quarter of the previous year, the Company observed health care costs that were 4.0% and 3.2% lower, respectively, for each fourth quarter than previously estimated, resulting in a reduction of $394 million and $284 million in 2020 and 2019, respectively, in health care costs payable that related to prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management considers historical health care cost trend rates together with its knowledge of recent events that may impact current trends when developing estimates of current health care cost trend rates. When establishing reserves as of December&#160;31, 2020, the Company increased its assumed health care cost trend rates for the most recent three months by 9.6% from health care cost trend rates recently observed. Assumed health care cost trend rates during the fourth quarter of 2020 are elevated compared to historical levels due to the impact of COVID-19 pandemic on utilization during 2020. Specifically, beginning in mid-March, the health system experienced a significant reduction in utilization that is discretionary and the cancellation of elective medical procedures. Utilization remained below historical levels through April, began to recover in May and June and reached more normal levels in the third and fourth quarters, with select geographies impacted by COVID-19 waves. Based on historical claim experience, it is reasonably possible that the Company&#8217;s estimated health care cost trend rates may vary by plus or minus 3.5% from the assumed rates, which could impact health care costs payable by plus or minus $404 million pretax.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method. Deferred tax assets and liabilities are established for any temporary differences between financial and tax reporting bases and are adjusted as needed to reflect changes in the enacted tax rates expected to be in effect when the temporary differences reverse. Such adjustments are recorded in the period in which changes in tax laws are enacted, regardless of when they are effective. Deferred tax assets are reduced, if necessary, by a valuation allowance to the extent future realization of those losses, deductions or other tax benefits is sufficiently uncertain.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required in determining the provision for income taxes and the related taxes payable and deferred tax assets and liabilities since, in the ordinary course of business, there are transactions and calculations where the ultimate tax outcome is uncertain. Additionally, the Company&#8217;s tax returns are subject to audit by various domestic and foreign tax authorities that could result in material adjustments based on differing interpretations of the tax laws. Although management believes that its estimates are reasonable and are based on the best available information at the time the provision is prepared, actual results could differ from these estimates resulting in a final tax outcome that may be materially different from that which is reflected in the consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax benefit from an uncertain tax position is recognized only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the related tax authority. Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision. Significant judgment is required in determining uncertain tax positions. The Company has established accruals for uncertain tax positions using its judgment and adjusts these accruals, as warranted, due to changing facts and circumstances.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this 10-K for a description of new accounting pronouncements applicable to the Company.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A.  Quantitative and Qualitative Disclosures About Market Risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s earnings and financial condition are exposed to interest rate risk, credit quality risk, market valuation risk, foreign currency risk, commodity risk and operational risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Interest Rate and Credit Quality Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages interest rate risk by seeking to maintain a tight match between the durations of assets and liabilities when appropriate.&#160;The Company manages credit quality risk by seeking to maintain high average credit quality ratings and diversified sector exposure within its debt securities portfolio.&#160;In connection with its investment and risk management objectives, the Company also uses derivative financial instruments whose market value is at least partially determined by, among other things, levels of or changes in interest rates (short-term or long-term), duration, prepayment rates, equity markets or credit ratings/spreads.&#160;The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.&#160;These instruments, viewed separately, subject the Company to varying degrees of interest rate, equity price and credit risk.&#160;However, when used for hedging, the Company expects these instruments to reduce overall risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment portfolio supported the following products at December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.428%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience-rated products </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,687&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment risks associated with experience-rated products generally do not impact the Company&#8217;s operating results. The risks associated with investments supporting experience-rated pension and annuity products in the large case pensions business in the Company&#8217;s Corporate/Other segment are assumed by the contract holders and not by the Company (subject to, among other things, certain minimum guarantees).&#160;Assets supporting experience-rated products may be subject to contract holder or participant withdrawals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt securities in the Company&#8217;s investment portfolio had an average credit quality rating of A at both December&#160;31, 2020 and 2019 with approximately $6.3 billion and $4.4 billion rated AAA at December&#160;31, 2020 and 2019, respectively.&#160;The debt securities that were rated below investment grade (that is, having a credit quality rating below BBB-/Baa3) were $1.9 billion and $1.2 billion at December&#160;31, 2020 and 2019, respectively (of which 2% and 4% at December&#160;31, 2020 and 2019, respectively, supported experience-rated products).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, the Company held $321 million and $333 million, respectively, of municipal debt securities that were guaranteed by third parties, representing 2% of total investments at both December&#160;31, 2020 and 2019.&#160;These securities had an average credit quality rating of AA at both December&#160;31, 2020 and 2019 with the guarantee. These securities had an average credit quality rating of A and A+ at December&#160;31, 2020 and 2019, respectively, without the guarantee.&#160;The Company does not have any significant concentration of investments with third party guarantors (either direct or indirect).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally classifies debt securities as available for sale, and carries them at fair value on the consolidated balance sheets.&#160;At both December&#160;31, 2020 and 2019, less than 1% of debt securities were valued using inputs that reflect the Company&#8217;s assumptions (categorized as Level 3 inputs in accordance with accounting principles generally accepted in the United States of America).&#160;See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; included in Item 8 of this 10-K for additional information on the methodologies and key assumptions used to determine the fair value of investments. For additional information related to investments, see Note 3 &#8216;&#8216;Investments&#8217;&#8217; included in Item 8 of this 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews debt securities in its portfolio to determine whether a decline in fair value below the cost basis or carrying value has occurred.&#160;If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. The amount of the credit-related component is recorded as an allowance </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. The impairment of debt securities is considered a critical accounting policy.&#160;See &#8216;&#8216;Critical Accounting Policies - Impairments of Debt Securities&#8221; in the MD&amp;A included in Item 7 of this 10-K for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Market Valuation Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly evaluates its risk from market-sensitive instruments by examining, among other things, levels of or changes in interest rates (short-term or long-term), duration, prepayment rates, equity markets and/or credit ratings/spreads. The Company also regularly evaluates the appropriateness of investments relative to management-approved investment guidelines (and operates within those guidelines) and the business objectives of its portfolios.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a quarterly basis, the Company reviews the impact of hypothetical net losses in its investment portfolio on the Company&#8217;s consolidated near-term financial condition, operating results and cash flows assuming the occurrence of certain reasonably possible changes in near-term market rates and prices. Interest rate changes (whether resulting from changes in treasury yields or credit spreads or other factors) represent the most material risk exposure category for the Company.&#160;The Company has estimated the impact on the fair value of market sensitive instruments based on the net present value of cash flows using a representative set of likely future interest rate scenarios. The assumptions used were as follows: an immediate increase of 100 basis points in interest rates (which the Company believes represents a moderately adverse scenario) for long-term debt issued by the Company, as well as its interest rate sensitive investments and an immediate decrease of 15% in prices for publicly traded domestic equity securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming an immediate increase of 100 basis points in interest rates, the theoretical decline in the fair values of market sensitive instruments at December&#160;31, 2020 is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The fair value of long-term debt issued by the Company would decline by approximately $5.3 billion ($6.7 billion pretax). Changes in the fair value of long-term debt do not impact the Company&#8217;s operating results or financial condition.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The theoretical reduction in the fair value of interest rate sensitive investments partially offset by the theoretical reduction in the fair value of interest rate sensitive liabilities would result in a net decline in fair value of approximately $490 million ($615 million pretax) related to continuing non-experience-rated products. Reductions in the fair value of investment securities would be reflected as an unrealized loss in equity, as the Company classifies these debt securities as available for sale. The Company does not record liabilities at fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the value of the Company&#8217;s publicly traded domestic equity securities were to decline by 15%, this would result in a net decline in fair value of $5&#160;million ($7&#160;million pretax).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on overall exposure to interest rate risk and equity price risk, the Company believes that these changes in market rates and prices would not materially affect consolidated near-term financial condition, operating results or cash flows as of December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Foreign Currency and Commodity Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, the Company did not have any material foreign currency exchange rate or commodity derivative instruments in place and believes its exposure to foreign currency exchange rate risk is not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, 5.5% and 6.1%, respectively, of the Company&#8217;s investment portfolio was comprised of investments that have exposure to the oil and gas industry, with more than half that amount comprised of investment grade rated debt securities. These exposures are experiencing varied degrees of financial strains in the current depressed oil and gas price environment, and the likelihood of the Company&#8217;s portfolio incurring additional realized capital losses on these exposures may increase if such depressed prices persist and/or decline further.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Operational Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also faces certain operational risks. Those risks include risks related to the COVID-19 pandemic and risks related to information security, including cybersecurity. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of COVID-19, or actions taken to mitigate its spread, could have material and adverse effects on our ability to operate our businesses effectively, including as a result of the complete or partial closure of facilities or labor shortages. Disruptions in our supply chains, our distribution chains and/or public and private infrastructure, including communications, financial services and supply chains, could materially and adversely impact our business operations. We have transitioned a significant subset of our colleagues to a remote work environment in an effort to mitigate the spread of COVID-19, as have a significant number of our third-party service providers, which may amplify certain risks to our businesses, including an increased demand for information technology resources, increased risk of phishing and other cyber attacks, increased risk of unauthorized dissemination of sensitive personal information or proprietary or confidential information about us or our medical members or other third-parties and increased risk of business interruptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its vendors have experienced diverse cyber attacks and expect to continue to experience cyber attacks going forward. As examples, the Company and its vendors have experienced attempts to gain access to systems, denial of service attacks, attempted malware infections, account takeovers, scanning activity and phishing emails. Attacks can originate from external criminals, terrorists, nation states or internal actors. The Company is dedicating and will continue to dedicate significant resources and incur significant expenses to maintain and update on an ongoing basis the systems and processes that are designed to mitigate the information security risks it faces and protect the security of its computer systems, software, networks and other technology assets against attempts by unauthorized parties to obtain access to confidential information, disrupt or degrade service or cause other damage. The impact of cyber attacks has not been material to the Company&#8217;s operations or operating results through December&#160;31, 2020. The Board and its Audit Committee and Nominating and Corporate Governance Committee are regularly informed regarding the Company&#8217;s information security policies, practices and status.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.  Financial Statements and Supplementary Data.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Consolidated Financial Statements</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_97">Consolidated Statements of Operations for the years ended December 31, 2020, 2019 and 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_97">101</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_100">Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2020, 2019 and 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_100">102</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_103">Consolidated Balance Sheets as of December 31, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_103">103</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_109">Consolidated Statements of Cash Flows for the years ended December 31, 2020, 2019 and 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_109">104</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_112">Consolidated Statements of Shareholders&#8217; Equity for the years ended December 31, 2020, 2019 and 2018</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_112">106</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_118">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_118">107</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_202">Reports of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_202">172</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_94">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1244a575f4b4f4185b2f04835a5d5dc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMy0xLTEtMS0w_7088fe52-c46c-40d9-b90c-4f52446cdbc7">190,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4619659f3e0e4e749c1bfe7929426080_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMy0zLTEtMS0w_a89ae496-45cb-4774-a4e3-919fabf576eb">185,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfc4b890d944c33bd862b4eae13875c_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMy01LTEtMS0w_4d0ad08d-ef2c-4369-91b4-c743220f07f2">183,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNC0xLTEtMS0w_4664306f-c906-4407-8afb-a18fa0b76ed5">69,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNC0zLTEtMS0w_ead1f5a4-ea47-4aa0-9cde-a9dbe2fa0f49">63,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNC01LTEtMS0w_1d1149ab-6391-4952-b182-eadddc4380b1">8,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8887a1cd3c8547d681d8baa2a35e51a2_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNS0xLTEtMS0w_596c5c22-5cc3-4bb2-845f-f7925c35bd29">7,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i862fd4d1d6ba4365a8082e4c0ccf9463_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNS0zLTEtMS0w_a776c302-87e6-44e6-8ee0-14d607868587">7,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c05067cc57a462d9ae3f15016cd028d_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNS01LTEtMS0w_96e00fae-ce77-41a5-8f34-5698e818e08b">1,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNi0xLTEtMS0w_80ab37b0-6b2b-46c9-ac02-2e68454dd34a">798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNi0zLTEtMS0w_ea2108d8-0867-4315-9fa0-03d3d0cfb834">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNi01LTEtMS0w_8acd8e33-86ac-46d3-be65-21434354a2a4">660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNy0xLTEtMS0w_bf55b031-7cf3-4070-8e2b-a05b675d5144">268,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNy0zLTEtMS0w_01e3ab2b-a098-4966-88a8-c66f51af51a8">256,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNy01LTEtMS0w_3dacc44a-5acf-4660-bcbf-b90924857778">194,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfOS0xLTEtMS0w_14525226-6a40-4a85-ade0-296ef187f248">163,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfOS0zLTEtMS0w_0b60b6e6-9cc6-46a5-8421-04f784606c88">158,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfOS01LTEtMS0w_b63e9a2e-dc7b-4366-8357-277d9a00033c">156,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTAtMS0xLTEtMA_086d8487-20eb-4f97-b378-437ed6e83490">55,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTAtMy0xLTEtMA_fcce39f6-2073-4b90-80a8-e5d1aaf4e596">52,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTAtNS0xLTEtMA_23243b64-9b84-4777-8685-15d9fe81d1cc">6,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTEtMS0xLTEtMA_8c804133-2650-48b9-a985-eb92a75e91f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTEtMy0xLTEtMA_e2dd8091-dfbf-42aa-988d-84d67f4a06bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTEtNS0xLTEtMA_a921c00f-2fbf-40df-b713-a770b08a567e">6,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:OperatingExpensesExcludingGoodwillImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTItMS0xLTEtMA_fce528da-7a8a-4b56-aade-a3681e8762a8">35,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:OperatingExpensesExcludingGoodwillImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTItMy0xLTEtMA_5bb83529-94b8-4b24-915b-0bfd2f5c701a">33,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:OperatingExpensesExcludingGoodwillImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTItNS0xLTEtMA_c7f814e2-c5b4-4346-a43c-0b7a6e613e39">21,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTMtMS0xLTEtMA_e0d60756-ce8a-40e3-be66-105ab782c3f5">254,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTMtMy0xLTEtMA_f6f89a03-8a7d-471a-8edf-42cf2a759bae">244,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTMtNS0xLTEtMA_8b034346-6977-4946-b9d5-8c7c88ea3fe8">190,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTQtMS0xLTEtMA_2b1c2b39-e903-49ba-bf3e-3448f4bd8716">13,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTQtMy0xLTEtMA_54b98a80-eea4-40c3-a9e3-456b55538106">11,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTQtNS0xLTEtMA_acd074a2-2e51-40c5-bee2-68619fdfa225">4,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTUtMS0xLTEtMA_a8ce887a-a9e2-4217-aa01-36fba7c10d3c">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTUtMy0xLTEtMA_10e1d301-f0cf-495b-8e37-b948057b772c">3,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTUtNS0xLTEtMA_54a756ab-20e5-474e-8bc9-fde5dd41d614">2,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTYtMS0xLTEtMA_f071d68a-bbdb-4f06-9dd0-52d3c7eb8761">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTYtMy0xLTEtMA_ffa688d4-0159-4bd0-9eb8-80bdb78ec03f">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTYtNS0xLTEtMA_70d2dcbc-a9cd-4f87-9539-0e30adbc1790">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTctMS0xLTEtMA_433fa6f1-d1ed-4135-9230-9b7b76c534e4">206</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTctMy0xLTEtMA_59e41072-47ea-464f-8ff5-e180b3ab59ab">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTctNS0xLTEtMA_b69d51f9-1b85-4044-b7c9-32fc9d2ce407">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTgtMS0xLTEtMA_5e24f72a-60c7-4856-bd95-5aa6357f5283">9,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTgtMy0xLTEtMA_d7a85b8d-0f52-428c-97b0-bfa96c82b092">8,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTgtNS0xLTEtMA_b081e483-c4a7-4d91-baf5-36f870368cfe">1,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTktMS0xLTEtMA_f7dd085c-1e43-457b-b2d4-e7f967d9c42f">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTktMy0xLTEtMA_e87feee9-9c3f-479a-84ff-ad023dd4f942">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTktNS0xLTEtMA_292ebc83-9ab7-4c0c-be22-78ea9677f8f3">2,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjAtMS0xLTEtMA_cda17fea-7d15-451d-8b54-ad7bbd61e288">7,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjAtMy0xLTEtMA_0521c654-5344-4077-8347-ebf606ddd7ae">6,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjAtNS0xLTEtMA_6eae977c-12b4-4c8e-ba69-a4432612bbf8">596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjEtMS0xLTEtMA_d6e6b0ea-d6bc-4079-b00f-3c62cc9feb5a">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjEtMy0xLTEtMA_49612bc8-69e1-4140-8ee7-3500ccfc36cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjEtNS0xLTEtMA_e85d6cd1-366c-4e78-918a-a7d419e22e41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjItMS0xLTEtMA_3edeb1a8-76ad-4e2e-bc92-a15709e691d0">7,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjItMy0xLTEtMA_7dfd08bf-50bf-4f6f-8487-4cceba28a3a5">6,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjItNS0xLTEtMA_1911c967-9fda-4829-a95a-4e7d5af1ed1d">596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjMtMS0xLTEtMA_263d434f-8170-421d-83af-97dc5ac1fff2">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjMtMy0xLTEtMA_3bb7afd4-f292-451f-a4b3-0b4509db99d8">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjMtNS0xLTEtMA_2584c35b-3aa0-4848-aafe-c75889d37196">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to CVS Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjQtMS0xLTEtMA_c9b12151-a16d-4fc3-a925-8b7693955a13">7,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjQtMy0xLTEtMA_b4503f95-bb44-4843-94ab-0a15cc5c95aa">6,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjQtNS0xLTEtMA_a1b8181d-616a-4d77-8ba5-21cb2712f1f6">594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to CVS Health</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjctMS0xLTEtMA_c7882d2c-679b-4c56-8f43-2a01c14a1b52">5.49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjctMy0xLTEtMA_aaa03f32-fd71-4525-aa54-db7d5d6a6b1d">5.10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjctNS0xLTEtMA_93e9460d-eb80-4da6-8403-dc9106b2d26e">0.57</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjgtMS0xLTEtMA_65661061-e549-487b-8130-a712364d6e62">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjgtMy0xLTEtMA_1ae0418b-6270-4909-8e14-2a61643e0e5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjgtNS0xLTEtMA_905ecbe7-e0d8-49dc-970c-01b2e99c6a8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to CVS Health</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjktMS0xLTEtMA_1efb2490-3122-49c2-a3cc-dde218f2059b">5.48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjktMy0xLTEtMA_cbabe04f-5e6a-43aa-87b1-cf55aebdb45d">5.10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjktNS0xLTEtMA_94076329-0a09-47e5-a39d-e109af425a4d">0.57</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average basic shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzAtMS0xLTEtMA_6899e612-7d38-41e9-a407-14d51430040f">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzAtMy0xLTEtMA_c6335f20-6046-4e26-a558-edf5972a5a93">1,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzAtNS0xLTEtMA_fb70dd46-8e35-4e99-a422-12e432b08c70">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzItMS0xLTEtMA_ec4fa5a2-2622-469d-8d3b-651fe105a302">5.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzItMy0xLTEtMA_e2a7ee7e-1b6d-46e4-a11e-51b9dcf97900">5.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzItNS0xLTEtMA_fd0cc01d-eac4-4939-a086-08a62b87197b">0.57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to CVS Health</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzMtMS0xLTEtMA_187e614b-406a-43e2-b2d3-44e5a2ee65d3">0.01</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzMtMy0xLTEtMA_8335cfd4-e078-4f11-8f36-b4f1f824cf12">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="2" format="ixt:zerodash" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzMtNS0xLTEtMA_6b4beb7b-d598-4c24-8116-7a9348767ed5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzQtMS0xLTEtMA_16c5a74a-e964-4431-bae1-74a43d55055f">5.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzQtMy0xLTEtMA_e02323a0-adcc-4b57-8f30-ff91f17679a3">5.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzQtNS0xLTEtMA_3bb86572-f2b0-4b17-8d10-be713afe95e3">0.57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average diluted shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzUtMS0xLTEtMA_b5ff59d4-97fe-43a1-8150-f6b639130ac2">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzUtMy0xLTEtMA_f1aa1846-4587-496a-81b0-b9c1efd22512">1,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzUtNS0xLTEtMA_9e509213-630e-4158-aea5-6ca7570d4c2d">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzYtMS0xLTEtMA_1e58bcb8-a219-4f17-b9e3-08c4e24ab24f">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzYtMy0xLTEtMA_5684cba1-8523-4f6f-b519-62d87dcc863a">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzYtNS0xLTEtMA_f669f478-30ae-494c-bb64-09f30724b500">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_94">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income (Loss)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzItMS0xLTEtMA_3edeb1a8-76ad-4e2e-bc92-a15709e691d0">7,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzItMy0xLTEtMA_7dfd08bf-50bf-4f6f-8487-4cceba28a3a5">6,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzItNS0xLTEtMA_1911c967-9fda-4829-a95a-4e7d5af1ed1d">596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized investment gains </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzQtMS0xLTEtMA_3ba3226a-ab19-4d5e-9379-ee5be9f97bae">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzQtMy0xLTEtMA_b522810e-33cc-4d33-afe2-19508e8694ac">677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzQtNS0xLTEtMA_83242673-f8c0-41c4-9ed9-755fe66c9c33">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzUtMS0xLTEtMA_73992999-93d9-4d83-a91a-9a5fa1455ccd">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzUtMy0xLTEtMA_2ed0aac1-ce99-499a-92f1-b80b7f9ede1f">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzUtNS0xLTEtMA_57de81bc-b76f-491c-a185-a00c07444572">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzYtMS0xLTEtMA_81c49058-5427-47c0-92a7-0a9a1d98ee29">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzYtMy0xLTEtMA_3bff7a6c-5b9d-4f2c-af0c-4ef1229cb813">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzYtNS0xLTEtMA_602d9532-2ec5-45a4-8c65-046136431c8e">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefits </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzctMS0xLTEtMA_f97bd2ba-b8cd-4e1a-a7f0-07ee9ca84c05">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzctMy0xLTEtMA_1e509cc2-9177-42a1-a8b3-99a13fbb005e">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzctNS0xLTEtMA_0f699c31-7d7e-4408-aeb2-af5a5e29c8fa">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzgtMS0xLTEtMA_3416bc4d-f53c-4c08-8f57-8bd75737468f">395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzgtMy0xLTEtMA_1bf5fc46-92b0-48a4-8c67-a9d7e4180bb5">917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzgtNS0xLTEtMA_66c37c9c-fc3e-42d1-8b00-72d3a9f4e36e">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzktMS0xLTEtMA_5bf08791-a936-43fa-a5d1-409cc9927a7c">7,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzktMy0xLTEtMA_b68d8513-7236-4f90-a97f-1d9089bbc433">7,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzktNS0xLTEtMA_7738de94-0144-4be7-9c44-29ffd2000ee0">322</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzEwLTEtMS0xLTA_ca764c0b-3ae0-4732-b39a-78786ac67846">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzEwLTMtMS0xLTA_dfacb3f1-2d71-4c78-a82c-bda7828d9c45">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzEwLTUtMS0xLTA_32b5029e-50b8-476b-8053-0f460ede8b8d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to CVS Health</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzExLTEtMS0xLTA_62e88b31-5024-4fad-9c5d-77bcde32e347">7,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzExLTMtMS0xLTA_f65634a6-edf5-44cd-8766-791e69cdfb15">7,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzExLTUtMS0xLTA_ddd9d92e-e206-4842-a3c9-64e26d455be8">320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_94">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMtMS0xLTEtMA_617c4e50-7a35-4483-bdcc-d804eb569ece">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMtMy0xLTEtMA_90924d1e-1d78-4cdd-991c-5ae392b706da">5,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQtMS0xLTEtMA_27b8f8db-77a3-40a5-ba00-f140ead7993b">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQtMy0xLTEtMA_d21254f9-e9cb-424c-987f-f96b82c17143">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzUtMS0xLTEtMA_0f2e4ce8-4b92-4deb-baad-792d302b1113">21,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzUtMy0xLTEtMA_eb36f716-79bf-49d6-a297-ccd4ea06148e">19,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzYtMS0xLTEtMA_f85555c6-2354-4557-a4a3-8eb4074a20fb">18,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzYtMy0xLTEtMA_a2c35c2c-354d-4e16-9fb4-52af1e0d11ab">17,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzctMS0xLTEtMA_8714f085-9d74-4665-9839-1734c5593a9a">5,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzctMy0xLTEtMA_e2d8d68f-1a76-4870-86fd-6ab6c49820db">5,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzgtMS0xLTEtMA_b9093761-dc3c-4fe0-8f62-25cbe888060d">56,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzgtMy0xLTEtMA_b65c9b30-0003-49c7-bdd7-030573042362">50,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzktMS0xLTEtMA_2ca5bbf1-7e2d-45c8-8de8-5adcacb778ee">20,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzktMy0xLTEtMA_a9d298b7-9864-4940-984b-4aa174f74f17">17,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzEwLTEtMS0xLTA_505e0764-9d0c-4e1a-a864-91c0398c382b">12,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzEwLTMtMS0xLTA_83eb2ae3-2e25-4513-9142-f2e39a469449">12,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzExLTEtMS0xLTA_cbc2b2f2-0373-44f3-9b54-cb74f39be00c">20,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzExLTMtMS0xLTA_73f87535-4b0e-42bf-9009-ac6a0f6bc305">20,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzEyLTEtMS0xLTA_8856b16f-c960-49ff-889a-dc84c28f0fc1">79,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzEyLTMtMS0xLTA_e85f5e81-8b64-4f6e-8c23-5ca4ccafc90a">79,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzEzLTEtMS0xLTA_b1abccc8-328e-4997-b26e-6617d314d1a2">31,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzEzLTMtMS0xLTA_fbb1b43e-cb0b-400b-9bca-e77a42bb3db7">33,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE0LTEtMS0xLTA_ddeacab4-e9d0-4c5a-8d33-8bef8780dbcc">4,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE0LTMtMS0xLTA_8f3e6d65-e74b-4176-baa1-044beb2a0768">4,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE1LTEtMS0xLTA_0afc2b04-2e9f-4ae4-9991-2ac6b2049693">4,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE1LTMtMS0xLTA_86b5ce90-8cb6-43f0-8b06-2510cc9ea17f">4,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE2LTEtMS0xLTA_c1008a0d-1cda-4807-9f04-cae160ce8ccf">230,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE2LTMtMS0xLTA_55d0ad0e-62e9-4250-93c4-1540a6484338">222,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE5LTEtMS0xLTA_5e717915-1dda-4778-ad60-dcb1b0fec045">11,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE5LTMtMS0xLTA_87861a1c-2b1c-4d57-801d-05fd4e6b8311">10,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PharmacyClaimsandDiscountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIwLTEtMS0xLTA_53e948b4-a11a-45bc-88dc-d49a3c275e51">15,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PharmacyClaimsandDiscountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIwLTMtMS0xLTA_1baca93c-fa87-44dd-a1b2-dc4ec440c654">13,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIxLTEtMS0xLTA_4e78c373-0614-4116-9a3a-57b1041c4d83">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIxLTMtMS0xLTA_da8ef50f-e13a-426a-8e5c-9de8f37a9609">6,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherPolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIyLTEtMS0xLTA_fe3ffc2b-c5bc-477a-b8e9-e1e39c200f9c">4,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherPolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIyLTMtMS0xLTA_170e20aa-10cd-4563-ac81-be9b133cbc51">2,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIzLTEtMS0xLTA_b1c5eb1d-86de-4d21-aead-9b0bdf575bf9">14,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIzLTMtMS0xLTA_c324d84c-7f7e-4409-b1a5-9b3b240ccee2">12,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:OtherInsuranceLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI0LTEtMS0xLTA_652e7d67-3020-4f29-83d1-ed7696d7f408">1,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:OtherInsuranceLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI0LTMtMS0xLTA_ba73f567-a647-4b74-812f-d24c1bf25de5">1,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI1LTEtMS0xLTA_d47cccb8-464d-453c-9ebf-1bedc9ff34d7">1,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI1LTMtMS0xLTA_fb542fd9-1301-4c4f-9930-09e1f252a680">1,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI3LTEtMS0xLTA_49be91c6-a577-4107-8fb3-3e394b87e55a">5,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI3LTMtMS0xLTA_bfeabce0-0027-4aab-8c9e-ee75db3a8341">3,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI4LTEtMS0xLTA_ab47996d-be99-4d34-abf1-c15df6c233c0">62,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI4LTMtMS0xLTA_7847357f-f1a2-4604-bc5e-4ab0528f32f2">53,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI5LTEtMS0xLTA_360daf77-09a9-4be9-9c48-0ee7065e3a88">18,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI5LTMtMS0xLTA_51967e69-1f3f-473b-a409-3385272461c2">18,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMwLTEtMS0xLTA_40496f2d-2d44-42b0-9916-a97543f3f655">59,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMwLTMtMS0xLTA_139c906e-9878-447c-aca5-bd1cfe417ca5">64,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMxLTEtMS0xLTA_0f724970-088d-428b-8010-2a01555047c9">6,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMxLTMtMS0xLTA_1ec85955-0781-4959-a5a6-7593f1926d64">7,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMyLTEtMS0xLTA_124d62fe-4bc5-4cf2-b37e-aeae43296702">4,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMyLTMtMS0xLTA_f77ec6a8-a012-4ab8-b82b-8e349d23fbcc">4,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:OtherInsuranceLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMzLTEtMS0xLTA_e73152cd-d0bf-4cea-8c71-a7ba73415a56">7,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:OtherInsuranceLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMzLTMtMS0xLTA_3336d9fc-e615-4414-bd32-58b7d507ef10">7,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM0LTEtMS0xLTA_6ab82cce-74ea-418f-86e9-a980c18eacef">2,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM0LTMtMS0xLTA_b3ea4c6e-a9e6-4fd4-80d9-3b3c544a3292">2,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM1LTEtMS0xLTA_544cad90-275e-4431-b506-a971a111ad8b">161,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM1LTMtMS0xLTA_ec04e78d-5b0b-428c-aa3c-c211f9912e74">158,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 16)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM2LTEtMS0xLTA_af957eaa-a0e1-487f-80ca-3cbd0a558d86"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM2LTMtMS0xLTA_288d7695-c7b9-4bbe-99c1-7eba647857ae"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzU3_b800f890-3106-4efa-bf50-96c502904ee1"><ix:nonFraction unitRef="usdPerShare" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzU3_ee025347-8390-4d7e-8bf6-1bbd12ae55f2">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzY1_617d709f-fac6-4a59-8590-51eb69b03b55"><ix:nonFraction unitRef="shares" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzY1_be2e39af-0c82-41e2-bf5d-65fb91b8cb65">0.1</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzcw_8e63a96d-c0db-470b-8796-71b7de0b49b7"><ix:nonFraction unitRef="shares" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzcw_c0b07ad7-e7cc-444b-9730-1c4e4199f94f"><ix:nonFraction unitRef="shares" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzcw_e3f977e9-c43c-47c7-bf92-116c8fb38058"><ix:nonFraction unitRef="shares" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzcw_f95fbd4d-8d12-43fa-81f0-2e887f95ec01">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued or outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTEtMS0xLTA_ef51cbf1-d0c2-461d-bc22-e864e34b44b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTMtMS0xLTA_aa78e1e3-89e8-4449-98ff-fb7ae54f0b35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTQx_545deb20-485b-4af0-b51d-60780b23c05f"><ix:nonFraction unitRef="usdPerShare" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTQx_d4bdcc1d-e5a9-4343-8553-e131bb9f31ce">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTUw_9de9e30f-36ae-494c-ba13-d49d967e5b3d"><ix:nonFraction unitRef="shares" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTUw_c9bdcd9f-b3dc-46a8-b931-76961f608a8b">3,200</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxODg4_331c0608-9db6-494b-96c3-2b2c8ebd4a0c">1,733</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTEz_587aae3e-1e75-44e4-bd0c-ac51759d247b">1,310</ix:nonFraction> shares outstanding at December 31, 2020 and <ix:nonFraction unitRef="shares" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTI1_2c6a8a9e-8cfe-4faf-914e-91e6ad13b37c">1,727</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTMz_99192a4e-84e1-4e49-815d-854bb5f235d8">1,302</ix:nonFraction> shares outstanding at December 31, 2019 and capital surplus</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTEtMS0xLTA_2fa4a73d-c9ee-4d4c-9185-4d0b8f656393">46,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTMtMS0xLTA_3f92b207-b576-4a03-a765-83c924ab957d">45,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost: <ix:nonFraction unitRef="shares" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoyOTMwMTMwMjEzNzE0OThlODQwMjMzMTIzYWQzZjJhMF8xNjQ5MjY3NDQxNzU0_34b06697-c910-4b97-b82c-d166c06d005d">423</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoyOTMwMTMwMjEzNzE0OThlODQwMjMzMTIzYWQzZjJhMF8xNjQ5MjY3NDQxNzM4_77b7a6ec-b809-47f2-86ad-553db8ae673d">425</ix:nonFraction> shares at December 31, 2020 and 2019</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQxLTEtMS0xLTA_38c0abf6-603d-492d-8203-165ae624296f">28,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQxLTMtMS0xLTA_03294cb8-ea26-4bd1-af6e-aff53c2e623e">28,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQyLTEtMS0xLTA_1c1f7f5f-f31f-4a99-a83f-643b049ebb07">49,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQyLTMtMS0xLTA_3574e78c-4a7e-495c-b7ef-bc527db56325">45,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQzLTEtMS0xLTA_e831b9e8-e89d-458b-a1d6-4f534c4a971b">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQzLTMtMS0xLTA_85d4cea3-6abd-4e5f-8435-4af8fb0c5965">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ0LTEtMS0xLTA_5e515a3d-3ddd-4c66-9e65-283733f4d55d">69,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ0LTMtMS0xLTA_6b69332b-0b40-4db2-aa0a-f158d98c4077">63,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ1LTEtMS0xLTA_92073843-1bed-4995-bdd2-04b6a65da388">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ1LTMtMS0xLTA_4f108bf4-1c76-413a-b712-be5094143bd7">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ2LTEtMS0xLTA_5feb225a-b9d8-41f4-85e7-80ecb7ffe4ef">69,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ2LTMtMS0xLTA_2d97738a-eb12-4972-a04d-3b776961ac8d">64,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ3LTEtMS0xLTA_41adb6d1-ff6b-404f-bada-9c4fd71552f2">230,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ3LTMtMS0xLTA_5a49f343-57d2-4225-ae68-3f88017d1c0b">222,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_94">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts from customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMtMS0xLTEtMA_916c728b-7127-4f3b-934a-8cd7b578e0ce">264,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMtMy0xLTEtMA_3148f932-9e16-40c1-9ecd-fa4680265fae">248,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMtNS0xLTEtMA_cc889e55-aad6-4ebc-9948-9607157fcd45">186,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzQtMS0xLTEtMA_e4c98613-61d0-4347-bc43-e8685be707ca">158,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzQtMy0xLTEtMA_472e4c3e-6cbc-47cf-a324-6a7ded1f1969">149,655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzQtNS0xLTEtMA_fe6051b2-e58d-49ef-9661-7316c2d7dc01">148,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance benefits paid </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInsuranceBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzUtMS0xLTEtMA_76cd9db1-1440-4b62-a486-219303280e8c">55,124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInsuranceBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzUtMy0xLTEtMA_1153190b-d821-4799-b286-a1978faf51b6">52,242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInsuranceBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzUtNS0xLTEtMA_a0e82ce5-b750-4e39-bdca-efc2d5d60e22">6,897</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid to other suppliers and employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToSuppliersAndEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzYtMS0xLTEtMA_1b4ad823-5fd9-4be7-bac0-7e8419f02377">29,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToSuppliersAndEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzYtMy0xLTEtMA_1a35c7eb-a72f-453a-ab2a-e0c41722aab8">28,932</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToSuppliersAndEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzYtNS0xLTEtMA_48d0cda6-3235-4da7-8114-2548621c3521">17,234</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and investment income received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzctMS0xLTEtMA_1c08b1fb-3234-4e65-94d4-edac550e91cf">894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzctMy0xLTEtMA_971b624e-acbd-445d-a653-89a4f78636fe">955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzctNS0xLTEtMA_7b228937-913a-46de-ae93-053cc9fe5b80">644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzgtMS0xLTEtMA_3d87ce02-427b-4187-92ce-0a10bee4acda">2,904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzgtMy0xLTEtMA_995a6102-3724-427c-be66-5548787d945a">2,954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzgtNS0xLTEtMA_ad891c55-4a8f-456b-ae23-f95f1573f88f">2,803</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzktMS0xLTEtMA_4019e3ce-2769-4a56-9aa7-b27a27ea8c5f">2,929</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzktMy0xLTEtMA_bb1e3d01-fc18-4a69-8da3-f458be042a72">2,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzktNS0xLTEtMA_eb7b4238-3048-41ed-b9d2-f016a8dcfe65">2,383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzEwLTEtMS0xLTA_9ad8cdd7-52ff-4a52-a57d-4f789e91aa1d">15,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzEwLTMtMS0xLTA_0f08cd9e-b4a4-4d50-9d2f-49a32c68be68">12,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzEwLTUtMS0xLTA_92e11a25-d0dc-4e0a-9401-2eced3712099">8,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzEzLTEtMS0xLTA_fd76d942-cd0d-4a79-9a0b-1c7c14faacec">6,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzEzLTMtMS0xLTA_18179cfe-f2dc-459b-8866-ef3f67872c79">7,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzEzLTUtMS0xLTA_fb3ae9c4-f59f-41b4-8d19-39074ba5954f">817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE0LTEtMS0xLTA_048b1a2b-1195-4c26-83e1-e6a72b8eaa5b">9,639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE0LTMtMS0xLTA_2b46c4f6-7c9c-47dd-a4ec-887cbeeec21c">7,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE0LTUtMS0xLTA_ef09fa88-96af-42db-9a71-95659c2dabbc">692</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE1LTEtMS0xLTA_aa834688-ca9c-4488-bac7-803c9bc92a93">2,437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE1LTMtMS0xLTA_2b36ce50-6462-4459-b7a2-361ce6914931">2,457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE1LTUtMS0xLTA_ca6cda71-0b38-4fc4-88fb-01e08ba2f6a9">2,037</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale-leaseback transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE2LTEtMS0xLTA_44f8825b-8760-47f0-a320-bd117cb693c7">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE2LTMtMS0xLTA_bd781b6a-ed82-4a4b-b08f-547ecc111eee">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE2LTUtMS0xLTA_541b60d6-82ea-4021-b543-4069bfd8bb9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (net of cash acquired)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE3LTEtMS0xLTA_8e85cbe9-bbf4-49dc-bd6c-9ee76254bba9">866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE3LTMtMS0xLTA_a107de0b-d22f-49ff-9034-3c0868123941">444</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE3LTUtMS0xLTA_65e7c63d-b010-4e2a-8697-9ecb8ea533f0">42,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of subsidiaries and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE4LTEtMS0xLTA_29e0312d-f6d7-4baa-81f0-2d19c33d17be">840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE4LTMtMS0xLTA_e68c19c2-b954-408f-8fa6-e7a37f66c6e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE4LTUtMS0xLTA_8bec95f0-a642-4473-b1a4-32968d368a42">832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE5LTEtMS0xLTA_c4a91000-dd5e-4807-9a1b-97108ecc36ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE5LTMtMS0xLTA_df819d79-1e0e-4bd3-9502-1e6d7f6cfeb6">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE5LTUtMS0xLTA_e0de93d8-f256-48fd-8292-1d7bacb23e27">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzIwLTEtMS0xLTA_405101e8-ef6f-4ef5-b088-20d862ad1105">5,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzIwLTMtMS0xLTA_5290dbef-1742-4111-923c-03b17c81c18c">3,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzIwLTUtMS0xLTA_7de25b6f-15bd-4a83-8e5b-14c4fd7fcb76">43,285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net repayments of short-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzIzLTEtMS0xLTA_2766220e-1024-44fb-8f71-fbb39e9b5c8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzIzLTMtMS0xLTA_42db853e-acee-412c-8ed9-bb1bcadf0e87">720</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzIzLTUtMS0xLTA_01608fe9-ab57-46ac-ab5b-c3af9b165cad">556</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI0LTEtMS0xLTA_5e9ac7e3-8750-459b-bbb7-541c5890d0f8">9,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI0LTMtMS0xLTA_1d196906-6220-4570-87eb-7328991c4694">3,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI0LTUtMS0xLTA_57ad5532-cf4c-488c-b9fe-ddb41ef7cbf0">44,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI1LTEtMS0xLTA_5ed82076-9a69-4d18-a573-a2c370a7c3ba">15,631</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI1LTMtMS0xLTA_7e915dd4-f768-4f30-8b9f-5a1ac41a15b3">8,336</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI1LTUtMS0xLTA_ce4530a5-16db-40bd-ae3d-2dbf4b215a3d">5,522</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI2LTEtMS0xLTA_0b46d4da-7b9f-42b4-9a3d-7ab886ef8edd">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI2LTMtMS0xLTA_9bdd4481-edb0-40ad-9288-e0f32d68fda1">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI2LTUtMS0xLTA_27f97ba9-9465-4a69-af14-9c3ccf4bb292">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI4LTEtMS0xLTA_e586f8a9-d96c-4b9e-9423-ffc2a971cb48">2,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI4LTMtMS0xLTA_dca2369c-f6e1-433b-94bd-1b5cb39c8811">2,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI4LTUtMS0xLTA_082c2ae1-dca7-4b90-bfcd-f21f4a4ec38b">2,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI5LTEtMS0xLTA_fd6a06c1-b5b3-4fcb-a105-7f33a3f2739b">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI5LTMtMS0xLTA_5374cfba-e2e5-45d7-bb8b-ed5887469b7a">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI5LTUtMS0xLTA_d5e9556b-e69d-42cc-9b77-015d7324c0b9">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMwLTEtMS0xLTA_e8cc4ccd-729f-48c7-9621-df5237238499">88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMwLTMtMS0xLTA_9f1befb0-c63f-430a-9ae8-de0ac133b305">112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMwLTUtMS0xLTA_f33a301d-a39c-47cc-833d-95b1447ffab2">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMxLTEtMS0xLTA_fc38f3b7-7d9a-41a6-961c-61db83811c64">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMxLTMtMS0xLTA_edb1c3c7-d483-4c87-b0d5-a10c114c593b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMxLTUtMS0xLTA_348e3e88-f563-4f5f-9fb0-92fa4398af90">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMyLTEtMS0xLTA_1f21fe01-5c02-41f1-85b9-57b1f0eac5ed">8,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMyLTMtMS0xLTA_5d24c81f-8cbd-4340-bffc-80e49702a4ea">7,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMyLTUtMS0xLTA_71add6b8-b915-430c-ba4c-79bc6c6a85a9">36,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMzLTEtMS0xLTA_fc6e1f77-07bd-4ebf-8b85-c88830d3ca21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMzLTMtMS0xLTA_bd4fce45-2a50-4ae0-acea-4c59591f0cdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMzLTUtMS0xLTA_3f9e473d-7ca9-40c4-91e3-bcce4e98720f">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM0LTEtMS0xLTA_f42dd76a-2dd5-4f90-b1c5-d6e062b703a0">2,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM0LTMtMS0xLTA_29050b2e-9c7a-4090-b3f8-f5f0cd10a7ce">1,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM0LTUtMS0xLTA_bbf0ec0a-ba82-4b41-9b6c-3045f4c7a924">2,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the beginning of the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM1LTEtMS0xLTA_28bf55b7-5d7e-4698-851f-9da66a672233">5,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM1LTMtMS0xLTA_e67e2e7b-7345-4e81-923c-0bc56efb6295">4,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20db3230df8c4812ac4bf0f95ceda745_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM1LTUtMS0xLTA_d86aa8f6-cd53-48af-841f-b7b8321708bd">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM2LTEtMS0xLTA_c53aadf3-8d5e-4d1d-ad73-01a304ce8856">8,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM2LTMtMS0xLTA_6ed17a22-a149-4585-aa9d-72732b2c4f02">5,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM2LTUtMS0xLTA_1e80cece-9b1b-4fe1-97ef-373a7086c7f6">4,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_94">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzMtMS0xLTEtMA_3edeb1a8-76ad-4e2e-bc92-a15709e691d0">7,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzMtMy0xLTEtMA_7dfd08bf-50bf-4f6f-8487-4cceba28a3a5">6,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzMtNS0xLTEtMA_8d6d3df7-8317-41d9-bed7-5bed420d24c3">596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzUtMS0xLTEtMA_3617b5af-8cd8-41a8-950e-3fe2da258f23">4,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzUtMy0xLTEtMA_1673bba8-9d2c-48ad-bb9f-f3d73197851b">4,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzUtNS0xLTEtMA_2063779e-2354-477c-8660-00761ee70670">2,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzYtMS0xLTEtMA_9a64ea68-68d2-4d78-abb4-8a3fb3ea3094">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzYtMy0xLTEtMA_a200bb29-1ee1-4ed9-90f4-76093497aa8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzYtNS0xLTEtMA_0d696957-0e41-498c-a96f-a28418ebc08c">6,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzgtMS0xLTEtMA_56760175-3ae0-43af-a676-7ae5c5fdf401">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzgtMy0xLTEtMA_3143b16c-374d-4f3d-972d-a330dc677486">453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzgtNS0xLTEtMA_e2245b90-0d85-40fd-a632-cb8b5842bef2">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on sale of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzktMS0xLTEtMA_101dd34e-e3fd-495d-87eb-72bb40e014e7">269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzktMy0xLTEtMA_02fcadef-0aa5-4312-a9c0-618f6d08f18b">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzktNS0xLTEtMA_c56b778e-505b-492c-a906-737383f378ef">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzEwLTEtMS0xLTA_f2595eac-44c7-4912-ac80-ada27908ed36">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzEwLTMtMS0xLTA_532a35c4-51d7-47f2-9501-54f6c308aaab">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzEwLTUtMS0xLTA_35d2461f-f9c7-4fc1-9ce1-76da7757c6be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzExLTEtMS0xLTA_dbba0319-4c03-42b7-95b8-76cbf18f2b7e">570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzExLTMtMS0xLTA_13dd3c50-0984-4c13-8348-4c5bc953c283">654</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzExLTUtMS0xLTA_9ae3ad9e-8278-4aee-9780-74d11d4c8f45">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzEyLTEtMS0xLTA_58e56d86-38b1-4cd7-8b05-dd4e1c9374aa">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzEyLTMtMS0xLTA_17a3e8d5-a108-4f58-adcb-81015efa542f">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzEyLTUtMS0xLTA_82b463ec-cadc-4c33-a626-5f92a3fe285d">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE0LTEtMS0xLTA_17ea04fe-2219-4b15-8fe2-c101d2adb868">1,510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE0LTMtMS0xLTA_23939d3e-20f1-4d85-8780-84197d1f369b">2,158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE0LTUtMS0xLTA_d839eddd-84a0-4e01-a103-d9eebd3e9975">1,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE1LTEtMS0xLTA_e113e440-7285-48df-b8eb-6b225fcda64e">973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE1LTMtMS0xLTA_20b63fd9-46cf-4a2c-91d8-bd23256c17cb">1,075</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE1LTUtMS0xLTA_f5f912e0-d837-4f1e-bab6-696dc1e8dc4d">1,153</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE2LTEtMS0xLTA_55b366b5-2e2b-4116-8dc3-66ae548aef77">364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE2LTMtMS0xLTA_549ac684-a965-4e82-b662-886bc6f1f6f8">614</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE2LTUtMS0xLTA_9e934f02-7273-4bfa-9392-4277308c5703">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE3LTEtMS0xLTA_d77ee65b-133d-4945-b0b6-d0f2717489b1">2,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE3LTMtMS0xLTA_6cabfce0-28ad-4203-bf93-18ab4b269f8d">3,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE3LTUtMS0xLTA_0e8b865d-0d60-48fa-980b-0c5b1a555d9f">2,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE4LTEtMS0xLTA_743880eb-e14e-4989-9533-40048374fd52">231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE4LTMtMS0xLTA_eff5da63-b67b-4ed3-900c-27b361a52027">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE4LTUtMS0xLTA_6b9c1277-b52a-4fd7-a49b-288ec582c54e">311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE5LTEtMS0xLTA_c813deb6-05ca-4e0d-bbd5-f3d7afd605e6">2,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE5LTMtMS0xLTA_d98848d8-c72b-40f8-a7ac-46057d52bd61">1,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE5LTUtMS0xLTA_49c45a64-b4e4-4827-a349-e47bca6d8c31">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzIwLTEtMS0xLTA_2c105afc-e0bb-4166-9c73-1dc3509c28d6">15,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzIwLTMtMS0xLTA_e171ace1-f2d2-4667-96dc-a06f24e4844a">12,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzIwLTUtMS0xLTA_eb27d124-d1d9-442f-87d4-7793be87c318">8,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_94">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Shareholders&#8217; Equity</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to CVS Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surplus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>CVS Health<br/>Shareholders&#8217; <br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling <br/>Interests </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2017</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c716e5b99ef43d2a3c07841be0dc4a4_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtMS0xLTEtMA_887e5719-a51c-45c7-ad9f-00b444b8a275">1,712</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifc9a1b1abab04a16a3b873c907603424_I20171231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtMi0xLTEtMA_bd15f8ed-fb13-4a71-9515-093b89ab0d04">698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e063d39bee64f188da6a74f7ebdb608_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNC0xLTEtMA_16e4fa08-10b4-4101-b231-c5805bb1fb2a">32,096</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc9a1b1abab04a16a3b873c907603424_I20171231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNS0xLTEtMA_d59bffe9-db14-4325-ad7d-ad2ea667f60f">37,796</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i193db80c5bda4fb7aa1cd998bea9026b_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNi0xLTEtMA_00c99425-043b-47a2-95cf-03406baae617">43,556</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14773d0466f74f54b9cb98d7ad2d00db_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNy0xLTEtMA_3a38c2de-d1a0-4a1c-ba8b-cde1fdfb13df">165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib83b00b1f6e34feeb9987e580b61bb95_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtOC0xLTEtMA_b6a39168-518b-4a6c-b60c-852cdffd7a5c">37,691</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99d5436478ce4110b135201c6608ebd8_I20171231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtOS0xLTEtMA_79243c1d-6a73-4b12-aa52-ead9a162b4e4">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20db3230df8c4812ac4bf0f95ceda745_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtMTAtMS0xLTA_21cd0722-815d-49b7-874f-f953717d5c07">37,695</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adoption of new accounting standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic20621be887c43a9b7de2f03f299252a_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtNi0xLTEtNjA3_b62a2af9-95ac-469a-99b0-0b1c81ab2257">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie900981eb1e84a1ba647ba34d76fbbda_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtNy0xLTEtNjA3_8230c267-f94f-4e54-a63d-5204ca4b2869">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f132d1656cc4ffca90cc7c194f9eb50_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtOC0xLTEtNjA3_999f653d-544c-4faf-9bce-c39d61c7b44d">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a4dfbfbdb0244b189151eb29a59b6ef_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtMTAtMS0xLTYwNw_add9a4c1-8090-4e76-b88c-ee5d313958e8">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae582128ff614e3bac0ec6439e7a73c0_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtNi0xLTEtMA_d5db607b-568f-42b7-b6d4-5692ddceaa30">594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtOC0xLTEtMA_9ad223c4-5510-43a8-9e85-b82cabf1268e">594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2865692d83ef4ec3beffe7dbbdbd7685_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtOS0xLTEtMA_b5fccb3a-3382-4a5f-96be-50fe4ee561fa">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtMTAtMS0xLTA_d5fcbb2d-6e3b-4829-8d0a-c05bca9fe38d">596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income (Note 13)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i479bc088fe574cd9bf70b669ad0bde68_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzUtNy0xLTEtMA_a4f36910-0b46-4227-8b9c-6c35cabba2dd">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzUtOC0xLTEtMA_45c2ab0b-f70e-4131-8d73-0d4e1c1be0da">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzUtMTAtMS0xLTA_7ddfe897-085c-4a60-9f34-edbf7d16ddc7">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common shares issued to acquire Aetna</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4b45a4b6f0e34440abe81173dd958f40_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctMi0xLTEtNjMw_d50a71af-940e-4010-aa72-0c9b28bd1abf">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8972c93193441eb5d3b821774ebb82_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctNC0xLTEtNjMw_16fe42b0-ede0-4629-a559-5776601a1fa9">12,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b45a4b6f0e34440abe81173dd958f40_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctNS0xLTEtNjMw_93c25e5e-9e62-4262-89b5-b26bec99477d">9,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctOC0xLTEtNjMw_a1b8a581-bc8a-4ed9-996d-9aa8735242b7">22,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctMTAtMS0xLTYzNQ_c3384f1c-4eda-4903-89e4-8ba64c1ab364">22,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i633d2d566192435e97ba030a650d9a4d_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzYtMS0xLTEtMA_f042239f-050c-4928-a598-ac089474ae9a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a8972c93193441eb5d3b821774ebb82_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzYtNC0xLTEtMA_04f10832-781d-4849-96a6-73e822af4437">421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzYtOC0xLTEtMA_80ff30f0-d036-40d3-b8e5-d79e2d32f152">421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzYtMTAtMS0xLTA_0e5c2651-00ee-4bf2-b232-c9fe00a95eb2">421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4b45a4b6f0e34440abe81173dd958f40_D20180101-20181231" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctMi0xLTEtMA_7e7fe2a3-8e1a-42e9-8ece-9da8b40d2dee">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b45a4b6f0e34440abe81173dd958f40_D20180101-20181231" decimals="-6" sign="-" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctNS0xLTEtMA_065a8a3f-8af2-4885-a8c1-8ca7428e8223">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231" decimals="-6" sign="-" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctOC0xLTEtMA_fec9e366-c993-4c21-958c-aeef9af57ee1">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctMTAtMS0xLTA_381971fd-ba5b-412a-b9ba-1a0ddba9bcc9">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae582128ff614e3bac0ec6439e7a73c0_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzgtNi0xLTEtMA_f1eaac42-599d-4efc-b91b-3d96d2d731de">2,045</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzgtOC0xLTEtMA_c5d24405-0eba-4920-a758-2d2c119c6628">2,045</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzgtMTAtMS0xLTA_d067b1ef-442a-4204-a97d-6663a0d63e2e">2,045</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Acquisition of noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2865692d83ef4ec3beffe7dbbdbd7685_D20180101-20181231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTktMS0xLTYyMQ_f46cfc8b-222f-4ef0-b8d5-058c0b8c850d">329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTEwLTEtMS02MjE_f9fd82dd-fced-474a-97e6-a22ef1b0407d">329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2865692d83ef4ec3beffe7dbbdbd7685_D20180101-20181231" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzktOS0xLTEtMA_156fb14d-433d-4a22-9ae7-a7c1e08a54d6">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzktMTAtMS0xLTA_470beb11-3939-4364-9440-55d34f3452b9">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bf8771a68c449ef90d36d232f370426_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTEtMS0xLTA_df8d5b1e-3974-4b20-9223-a96cb79ebebb">1,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i771cb7ed20844ad7a8c780839f51c6f0_I20181231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTItMS0xLTA_2514b134-4d79-4553-bfd8-476a7b592485">425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8647a195fe4759a2c1d965857302cc_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTQtMS0xLTA_54335d89-aefe-4dc2-abf8-9c0a58c71b35">45,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i771cb7ed20844ad7a8c780839f51c6f0_I20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTUtMS0xLTA_fd8f0b5e-3919-4188-a448-6bbe6f9716ac">28,228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07f8a9064884f3da3adf7cb16b994ad_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTYtMS0xLTA_0a69a8f0-43bb-4351-8459-2815b3669976">40,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i182c31bd325c4b0db0263ee586306fe4_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTctMS0xLTA_4ebdc84f-2861-4cd4-83f7-124f5253e59e">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7748ca57fc424eaa980cac40c30c5207_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTgtMS0xLTA_37aaa462-6d33-41ac-81d8-82a7aa630c82">58,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d28dbcffa4047b78489791263cdc3d3_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTktMS0xLTA_6bd4a2d8-bdba-444d-8b17-836eb728efa4">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTEwLTEtMS0w_24716ef3-487a-4846-83c9-bbaa4e3fc20f">58,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE0LTAtMS0xLTIwNjc3_acac4981-50db-4f80-84d2-20cb232e7d72"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(4)</span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9f1919bc174b95976298b74c0d5023_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTYtMS0xLTA_31eb6726-7a91-438f-87a5-53f124c07aa8">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icec68b3996a444c5a769c70fa0b27d4a_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTgtMS0xLTA_f472468a-9d67-42d2-bc8d-2f8e09cf383e">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9861fabc3eea4b0aa172430d1406d2ce_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTEwLTEtMS0w_01bbd745-65a4-4dca-9dbe-9b32284c852d">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d331567a29463ba17005a8dac8083d_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEyLTYtMS0xLTA_26b4b9ec-783f-44ae-89bc-ffa839db3a7c">6,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec57ae1fbdf44c086926cdcbb8ce7ad_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEyLTgtMS0xLTA_126ccb36-400e-457e-b4da-4ebc19a6aec5">6,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib940e469010141009d1f199a133e402f_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEyLTktMS0xLTA_3f59256b-864c-4213-8691-3d4f47638c2e">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEyLTEwLTEtMS0w_77bcb6a0-d480-4d53-92eb-4188319c6f74">6,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income (Note 13)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579b801fc47647a9ae9d0a9f745b8002_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEzLTctMS0xLTA_56a8fd3e-e290-4fa8-8998-adf7b9586a80">917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec57ae1fbdf44c086926cdcbb8ce7ad_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEzLTgtMS0xLTA_a78bd4dd-d766-41c7-b456-f85720b0f8fa">917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEzLTEwLTEtMS0w_2d3dc5d1-0172-42e9-8839-92277e14b8a3">917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idaa674d77dad4633b24afc1e676be890_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTEtMS0xLTA_22380353-05fb-4d71-8998-ba03148e0a9a">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4ebc196b27e547dd9505449bbc3c149c_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTItMS0xLTA_79572c17-8c16-4874-aa6a-341e8dd7db9e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if00ea0e1726a4c0693ffda7f4456d2ab_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTQtMS0xLTA_5a2c956a-7097-44be-a189-7313063ea5ee">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ec57ae1fbdf44c086926cdcbb8ce7ad_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTgtMS0xLTA_37fcb297-1e29-47a3-8512-9fbdab5ed9d0">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTEwLTEtMS0w_27fbbd42-e7d7-41d1-af5b-c76381205ff5">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4ebc196b27e547dd9505449bbc3c149c_D20190101-20191231" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTItMS0xLTA_eb3c5e68-7726-4b79-b649-2ab124a852a1">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ebc196b27e547dd9505449bbc3c149c_D20190101-20191231" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTUtMS0xLTA_2f2dd26c-e7f9-4dda-9316-d5984a87a00a">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec57ae1fbdf44c086926cdcbb8ce7ad_D20190101-20191231" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTgtMS0xLTA_ba7bc357-4b0f-4914-bef5-5331e8cec41a">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTEwLTEtMS0w_ca68eabe-90b2-49eb-b7e7-3dad16bad14f">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59d331567a29463ba17005a8dac8083d_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE3LTYtMS0xLTA_1e05dc3d-5cd2-451f-a052-4f0241a59083">2,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ec57ae1fbdf44c086926cdcbb8ce7ad_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE3LTgtMS0xLTA_19e306bd-5649-4128-aacc-74854db372a1">2,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE3LTEwLTEtMS0w_6e7af525-d187-4338-a97d-b3cafb39fc84">2,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib940e469010141009d1f199a133e402f_D20190101-20191231" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE5LTktMS0xLTA_859025c6-ecd0-4352-8051-21cc1725176b">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE5LTEwLTEtMS0w_99f694ae-2596-422e-ae82-9cf5d080c6f9">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3384c22fbbc4007beae52127a1ca929_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTEtMS0xLTA_9051dafc-2d3b-45a4-9bbf-286b445d201b">1,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic1f2c8e874cd4322964c291da3c8928d_I20191231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTItMS0xLTA_2435051f-4ce3-42cb-9703-f4ace175a146">425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad41ca6e209411b8aed153ad0ca7b35_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTQtMS0xLTA_f68504a9-4624-4e2a-a2d6-ed8227e1917d">45,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1f2c8e874cd4322964c291da3c8928d_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTUtMS0xLTA_1621828b-14e0-446f-a93d-fbdd43a45fa7">28,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b94dc3fa4a45d2a882ca93d2edb4a4_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTYtMS0xLTA_98f1bde6-41c3-48c9-a656-615be182db16">45,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id566ff7b0a4d432094d2dd009bd9325d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTctMS0xLTA_ef2c4ca5-d53c-48a7-a82e-65d193fce248">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb5ad828f3d430ab4e4b7789d96ca96_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTgtMS0xLTA_2586179f-f8fc-4573-a5c6-bd1066fc9b66">63,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7c36f74c88e4d1293588b625bef258b_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTktMS0xLTA_02c390c8-ce67-4364-bd64-45700c14ba07">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTEwLTEtMS0w_81ac5e42-facb-4335-8d31-000bfedfcfd0">64,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTAtMS0xLTIwNjc4_147575f9-abf3-431a-a93a-0c6a87ecc03d">Adoption of new accounting standard (Note 1)</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddbe6826a9f14b02936670ae1a4ac19c_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIxLTYtMS0xLTA_42dade65-73ce-4d63-97f4-7e32c3a17957">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b1fa3d607d64b19b6e722492150bc46_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIxLTgtMS0xLTA_32d4e5bd-5a8c-4d84-b303-bf8b9b056f6f">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4052b450116d44169998570f9d72ad8f_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIxLTEwLTEtMS0w_7ff207ab-7e1e-417a-81db-3755b3334986">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaaac464404e4f83b7ae4acc339eae78_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIyLTYtMS0xLTA_ef51f163-bb12-4bc5-ae6a-ac47fa6bd057">7,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac50116896f44c97b2f61f0fa8211ac1_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIyLTgtMS0xLTA_7a980b56-cedd-47e8-b17f-6a38a51dea80">7,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58512c9652124fb18dc047245e08325f_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIyLTktMS0xLTA_fc842a3b-e633-4a53-a90e-508d62f48c40">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIyLTEwLTEtMS0w_6793318c-5261-4cb2-9bcb-a48849db4b06">7,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income (Note 13)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idef7f894733b48a89d8de562546c4dd5_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIzLTctMS0xLTA_feeac7c3-3851-4cee-9906-3453f218cb98">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac50116896f44c97b2f61f0fa8211ac1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIzLTgtMS0xLTA_c2a6aa76-f40f-47af-a13d-412fe48b45b7">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIzLTEwLTEtMS0w_c891babf-2543-4117-9a21-d74b2f1da7a3">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied30c7ad7aa44d239c4dc814569f41f9_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTEtMS0xLTA_c2700f6d-1cea-424a-b55c-bf5743a28752">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if103de66430f477397471c724603a2a4_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTItMS0xLTA_5852c8da-7472-4465-9b6a-1e4830d46909">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac8be9403fbc450db4da0a11f9de6385_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTQtMS0xLTA_257c52a8-5b09-4880-9f25-4b0697e3ff7e">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac50116896f44c97b2f61f0fa8211ac1_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTgtMS0xLTA_f516c586-e8e7-4ba0-ba7f-57ff2bbc2dc5">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTEwLTEtMS0w_ed2477b1-a303-4881-8870-d73b041b74b0">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if103de66430f477397471c724603a2a4_D20200101-20201231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTItMS0xLTA_9b8cebe1-0b8a-4e47-b179-f53a706dfa00">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if103de66430f477397471c724603a2a4_D20200101-20201231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTUtMS0xLTA_2e6555ea-9d89-4f6a-9188-aec0ac5db97e">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac50116896f44c97b2f61f0fa8211ac1_D20200101-20201231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTgtMS0xLTA_caf596b2-0a48-42b7-bdfe-7eeca6306d34">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTEwLTEtMS0w_1ef18408-8a30-4786-99ca-6e4f7bb73f3b">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieaaac464404e4f83b7ae4acc339eae78_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI2LTYtMS0xLTA_c20710c8-aa16-4b86-b6e5-a0430fe8eb1a">2,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac50116896f44c97b2f61f0fa8211ac1_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI2LTgtMS0xLTA_d6dd5e94-2423-4441-ad8b-41036f5beb45">2,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI2LTEwLTEtMS0w_bcbb10fe-a2be-40ae-94c8-25bc0b9468cd">2,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58512c9652124fb18dc047245e08325f_D20200101-20201231" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI3LTktMS0xLTA_9ecf3645-9128-42bf-a8c5-93f05856cc8c">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI3LTEwLTEtMS0w_9c547cfe-58d7-4dfa-ae42-ba92e52d2211">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i582affc472fa400a9eb5ee9688d05fee_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTEtMS0xLTA_7e715c0b-73c1-4a92-9a7a-31ecc8734791">1,733</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie3030715b1c74323bd4bcb2d48199bf3_I20201231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTItMS0xLTA_db94551e-003e-40b1-974c-609d700a26b3">423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e943a74976c444798abe05d760b9d08_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTQtMS0xLTA_01d38a2b-d2f4-401a-a290-0c4d6573dc03">46,513</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3030715b1c74323bd4bcb2d48199bf3_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTUtMS0xLTA_7ff7c6fa-bb8f-45ab-b419-bb5be4433372">28,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9229806f74744b7886032e409d4d844_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTYtMS0xLTA_3be1d002-0047-4486-96ef-13787764e00d">49,640</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42a1c40357754fa8ab8bff9c11bbc401_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTctMS0xLTA_475288f1-c4cf-4405-9376-5e1be98c1d90">1,414</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8590a938bc284f1db11c769ad6e3a70d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTgtMS0xLTA_e10652ef-dddf-4447-a8a3-3515e61cc075">69,389</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d444aa6cdc43d59d7fa44cb8d6c3cc_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTktMS0xLTA_8610272b-6b45-4cad-ab06-4a9553eb5247">312</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTEwLTEtMS0w_8f05007b-b6f2-4c1a-bf5f-f439822a8ca4">69,701</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8" footnoteRole="http://www.xbrl.org/2003/role/footnote">Treasury shares include <ix:nonFraction unitRef="shares" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzEyNg_0bf798c6-0eb4-4ca3-9f33-9baad8ade9fe"><ix:nonFraction unitRef="shares" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzEyNg_31fa1019-cac1-4448-b975-959cc6b438b7"><ix:nonFraction unitRef="shares" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzEyNg_a3c69594-9346-435d-8c87-1e99bf13f866">1</ix:nonFraction></ix:nonFraction></ix:nonFraction> million shares held in trust for each of the years ended December 31, 2020, 2019 and 2018. Treasury stock includes $<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzIzNg_5f8f45d3-a1eb-4a00-bfef-1ba91b1712b1"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzIzNg_c481ae89-0c97-452a-9b3b-d94c7dff5d71"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzIzNg_f96be4f3-730f-402e-a2d6-f7c419ee137c">29</ix:nonFraction></ix:nonFraction></ix:nonFraction> million related to shares held in trust for each of the years ended December 31, 2020, 2019 and 2018. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information.</ix:footnote></span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzE_a591683a-1aec-44ff-a7e0-6cf45389822a" footnoteRole="http://www.xbrl.org/2003/role/footnote">Common stock and capital surplus includes the par value of common stock of $<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzUxMw_ae9435f2-f6c7-4915-8a90-7d30058bc199"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzUxMw_ce28d1db-787f-4351-8cc6-955866b5d297"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzUxMw_f48c3587-bf65-4307-b871-e44ad84d1c07">17</ix:nonFraction></ix:nonFraction></ix:nonFraction> million as of December 31, 2020, 2019 and 2018.</ix:footnote></span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzI_0e9483fe-dba2-4c15-a9ca-3961fe592c5e" continuedAt="idaaab899ad324344a75dcb4fb32c9274" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, which resulted in a reduction to retained earnings of $<ix:nonFraction unitRef="usd" contextRef="i963da7f6c42a4740a9aef503c045ff0b_I20180101" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzcxOQ_10889b9b-cabc-4b03-8a67-ac101c5948bb">13</ix:nonFraction> million and the adoption of ASU 2018-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, which resulted in a reduction to accumulated other comprehensive income of $<ix:nonFraction unitRef="usd" contextRef="i5212eadada724019b746b479c60caaf0_I20180101" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4Xzk3OA_bd82f588-d256-40cf-98c9-f2930f4410d7">7</ix:nonFraction> million and an increase to retained earnings of $<ix:nonFraction unitRef="usd" contextRef="i5212eadada724019b746b479c60caaf0_I20180101" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzEwMjE_82c56a0f-7ce6-4c50-91d0-e6ee48da7103">7</ix:nonFraction> million, each during the year ended December 31, 2018.</span></ix:footnote></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-11.25pt"><ix:continuation id="idaaab899ad324344a75dcb4fb32c9274"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 842), which resulted in an increase to retained earnings of $<ix:nonFraction unitRef="usd" contextRef="i0a9f1919bc174b95976298b74c0d5023_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzIxOTkwMjMyNTc1NjU_31eb6726-7a91-438f-87a5-53f124c07aa8">178</ix:nonFraction> million during the year ended December 31, 2019.</span></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_94">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_121"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDA1_cff3389d-f69f-4167-8b73-510c45973322" continuedAt="i9b30b493d9214ddf963d4e5f8f334295" escape="true">Significant Accounting Policies </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9b30b493d9214ddf963d4e5f8f334295" continuedAt="i41328ad31c5d46cf8bfde6e342ffd0c9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company&#8221;), has more than <ix:nonFraction unitRef="store" contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:NumberOfStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzE4Mg_a0dbde93-734f-4ef8-bc36-ba5480cf9454">9,900</ix:nonFraction> retail locations, approximately <ix:nonFraction unitRef="clinic" contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231" decimals="-2" format="ixt:numdotdecimal" name="cvs:NumberofWalkInMedicalClinics" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxNw_0f42dee4-d1a2-4926-937c-b4860890906d">1,100</ix:nonFraction> walk-in medical clinics, a leading pharmacy benefits manager with approximately <ix:nonFraction unitRef="member" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:NumberOfPlanMembers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzMwMA_bdb41c6a-3fe2-4b71-8b24-49ee5f98eded">105</ix:nonFraction> million plan members, a dedicated senior pharmacy care business serving more than <ix:nonFraction unitRef="patient" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="cvs:NumberofPatientsServedperYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzM3Nw_38dbc3da-122e-4518-94fd-2f9796c370c5">one million</ix:nonFraction> patients per year and expanding specialty pharmacy services. The Company also serves an estimated <ix:nonFraction unitRef="people" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:NumberOfPeopleServed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQ3Nw_ac029b0d-8f0e-4971-8196-4124a7b6dd5e">34</ix:nonFraction> million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic has severely impacted the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition in the year ended December 31, 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2018 (the &#8220;Aetna Acquisition Date&#8221;), the Company acquired Aetna Inc. (&#8220;Aetna&#8221;). As a result of the acquisition of Aetna (the &#8220;Aetna Acquisition&#8221;), the Company added the Health Care Benefits segment. Certain aspects of Aetna&#8217;s operations, including products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products, are included in the Company&#8217;s Corporate/Other segment. The consolidated financial statements reflect Aetna&#8217;s results subsequent to the Aetna Acquisition Date. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTU0_01eef069-657e-46e5-9ef3-84992c77919d" continuedAt="i68e50904aefe410caacfb25e6b1b4c60" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIwOTg_422e2df1-6c37-4c37-829f-6a7f475c4f62">four</ix:nonFraction> reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other, which are described below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#8220;Public Exchanges&#8221;) and private health insurance exchanges and other sponsors of health benefit plans throughout the United States. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2020, the Retail/LTC segment operated more than <ix:nonFraction unitRef="store" contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NumberOfStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzM3NTQ_d9b28e95-fdb1-4b83-9f1a-c114d76262f4">9,900</ix:nonFraction> retail locations, approximately <ix:nonFraction unitRef="clinic" contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231" decimals="0" format="ixt:numdotdecimal" name="cvs:NumberofWalkInMedicalClinics" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzM3ODk_b5607a25-a137-4a2d-ad8f-3e87ef32ba3a">1,100</ix:nonFraction> MinuteClinic locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i41328ad31c5d46cf8bfde6e342ffd0c9" continuedAt="id8402eeacdc943c6a98fe1f18a42a097"><ix:continuation id="i68e50904aefe410caacfb25e6b1b4c60"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; For periods prior to the Aetna Acquisition Date, the Health Care Benefits segment was comprised only of the Company&#8217;s SilverScript</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> PDP business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDA3_e1dea56a-9716-440a-afe5-75624e5f6abf" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDIz_761ff74e-be40-4b84-af0e-a2932c3fcf77" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTU1_a690f670-03c9-4a5a-912a-5f16db756e35" continuedAt="i7ac69968800a4f68917fafc4027d6f8a" escape="true">Use of Estimates</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7ac69968800a4f68917fafc4027d6f8a">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTQy_a959a07d-b093-446e-b251-515470e028ca" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash included in other current assets on the consolidated balance sheets represents amounts held in escrow accounts in connection with certain recent acquisitions. Restricted cash included in other assets on the consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTMz_e4fe8f16-b275-422b-a942-baae837a6227" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzEtMS0xLTEtMA_617c4e50-7a35-4483-bdcc-d804eb569ece">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzEtMy0xLTEtMA_90924d1e-1d78-4cdd-991c-5ae392b706da">5,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzEtNS0xLTEtMA_68d8746f-9a9d-4c4e-ba15-3f6d8ed14abc">4,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzItMS0xLTEtMA_f9e6a436-836b-4157-bd41-3ad334a49269">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzItMy0xLTEtMA_bea9c1d0-6365-4dd8-b004-4e540f64af45">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzItNS0xLTEtMA_7604a648-5891-43e1-acc8-2ce78b54d75f">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzMtMS0xLTEtMA_9cad9521-3593-4f6a-b932-dd9f9f13bf78">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzMtMy0xLTEtMA_533afffa-ad39-4e8f-ac2d-c610d1621254">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzMtNS0xLTEtMA_8c2d0723-3822-4485-9410-237f01b9558e">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzQtMS0xLTEtMA_144fce41-4c83-4383-9f4c-566d31bae2b0">8,130</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzQtMy0xLTEtMA_621d14c9-5036-4d39-afbf-c4c002e4f068">5,954</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzQtNS0xLTEtMA_378bbf65-ef4a-4b8b-a700-f9ec1930369b">4,295</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id8402eeacdc943c6a98fe1f18a42a097" continuedAt="ia4c1f6c5a7ee4034b47306b0cb20f10f"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTk5_5a90bafd-6455-4ce1-91fe-6d1ab31f6628" continuedAt="i1abf7b435a6c46e787e35affef821f8d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; for additional information on how the Company estimates the fair value of these investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#8217;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia4c1f6c5a7ee4034b47306b0cb20f10f" continuedAt="i1b520f05a255416a9b88dbb691f639bf"><ix:continuation id="i1abf7b435a6c46e787e35affef821f8d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist primarily of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#8217;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#8217;s investments through its review or prior to receiving the limited partnership&#8217;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using a discounted future cash flow analysis in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment income on the Company&#8217;s investments is recorded when earned and is reflected in the Company&#8217;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#8217; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#8217;s net income (as long as the contract&#8217;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#8217; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#8217; accounts through a charge to benefit costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#8217; equity, net of tax, as a component of accumulated other comprehensive income. Unrealized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDQw_01c9014f-74c6-4981-831a-1a13b4d30de7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1b520f05a255416a9b88dbb691f639bf" continuedAt="i8acb51786a72416ab3fec42c51771cfb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTYz_75c32d8c-e95d-4b9d-9c9f-8073a721b999" continuedAt="i8624afee00fd4488aa16176c18d16978" escape="true">Accounts Receivable</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8624afee00fd4488aa16176c18d16978">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations.</ix:continuation> <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTYy_16d70ab6-746a-48cc-9abd-65353dc62b90" continuedAt="i8540585e8b6f45da8eb266b0c7a2e926" escape="true">Accounts receivable, net is composed of the following at December&#160;31, 2020 and 2019:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i8540585e8b6f45da8eb266b0c7a2e926"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzEtMS0xLTEtMA_96e5fa16-ae2e-4841-9c16-de47258571b0">7,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzEtMy0xLTEtMA_9daf0c54-b232-4a4e-a721-acc941fe9a79">6,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:VendorandManufacturerReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzItMS0xLTEtMA_e4e1d7a8-9e9d-4ac8-86b0-8deeeb53a30e">9,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:VendorandManufacturerReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzItMy0xLTEtMA_4c117aa9-7459-40b0-a42f-cddfcf404682">7,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsReceivableAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzMtMS0xLTEtMA_74b2469d-1090-4c01-913d-bdade8b4dcc2">2,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsReceivableAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzMtMy0xLTEtMA_bb5b9c50-7ec8-42bb-aba6-c9f9c9a26227">2,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzQtMS0xLTEtMA_c51ab0f9-5f49-4b9c-a7b0-835bae57e44b">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzQtMy0xLTEtMA_c6595779-ad4f-4003-9775-aab645204fdd">2,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzUtMS0xLTEtMA_c47f7917-75cf-4c51-9fd0-ca99d1b5f791">21,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzUtMy0xLTEtMA_ebda0f6d-635c-4ac6-b90f-de1e2bbbd130">19,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MjQ1MzM_4a972593-144a-4fd8-ac64-a234152358a4">358</ix:nonFraction>&#160;million as of December&#160;31, 2020. When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days. The Company&#8217;s allowance for doubtful accounts was $<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzU0OTc1NTgzMDI4MzY_b3c9d7da-50e6-4abd-9d16-53d7f94090c5">319</ix:nonFraction>&#160;million as of December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDE4_5a09d129-7842-4596-aeba-0303a3666c4a" continuedAt="ic8247fac5c834c4b88791a104d41ea7e" escape="true">Inventories </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic8247fac5c834c4b88791a104d41ea7e">Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ReinsuranceAccountingPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDI3_7f0c737d-9df5-445a-89ef-8c4c9aeb61a5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance Recoverables </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2020, the Company&#8217;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTI3_eab0673f-f987-431b-bd00-84ad71087823" continuedAt="i72b830846daf471da24cdf5b7e75e8e1" escape="true">Health Care Contract Acquisition Costs</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i72b830846daf471da24cdf5b7e75e8e1">Insurance products included in the Health Care Benefits segment are cancelable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. Acquisition costs for certain long-duration insurance contracts are deferred and are recorded as other current assets or other assets on the consolidated balance sheets and are amortized over the estimated life of the contracts. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations.</ix:continuation> At December&#160;31, 2020 and 2019, the balance of deferred acquisition costs was $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIwNTAy_d7602e7e-54fa-4695-b2aa-0c39ae7cf1ec">546</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredPolicyAcquisitionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIwNTA5_cccaa52a-7f63-4457-9358-ff995c3c73a3">271</ix:nonFraction> million, respectively, comprised primarily of commissions paid on Medicare Supplement products within the Health Care Benefits segment. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDQ4_9774c54a-5237-4d36-bfdd-2c3007717ecc" continuedAt="ib1b2e0247a66454b88ff91ebc679a038" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from <ix:nonNumeric contextRef="i02d9906f299f46c78575a0dcc95ab970_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxMDEz_8aedd29b-bfd8-4ddb-ad8f-a6ffe3922915">1</ix:nonNumeric> to <ix:nonNumeric contextRef="i9ea0930652734afeab89b2f4895835b6_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxMDE5_0babba13-7bf3-4ebc-832e-2efd86e6f794">40</ix:nonNumeric> years for buildings, building improvements and leasehold improvements and <ix:nonNumeric contextRef="i8696070d484a40f2bb7a4f689ad3defb_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxMDk2_4285c40e-cb89-40b4-b10c-ec349c8f682c">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i1c66b1159478475eadd94b3ae0b2492e_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxMTAy_970046aa-cc13-44fc-a79e-933b7639fbfd">10</ix:nonNumeric> years for fixtures, equipment and internally developed </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8acb51786a72416ab3fec42c51771cfb" continuedAt="i240bfd2525694c9c8bdbfd772c6545be"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib1b2e0247a66454b88ff91ebc679a038">software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDU1_ce4f9680-a863-478f-8267-1e0ad86f28b3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consists of the following at December&#160;31, 2020 and 2019: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i089b48d85e384c799bd89b63783799f0_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzEtMS0xLTEtMA_6b360884-8213-46c8-903d-809048b0e58a">2,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21bafdeb44cc4054a9d59d8f3c997e60_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzEtMy0xLTEtMA_75b9cc1b-294c-4312-86e0-6d1b563a85c9">1,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e60b1b6f4a4dbd88268862a0d22fe5_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzItMS0xLTEtMA_752bea1a-1b20-438c-8720-9a64b9630e7e">3,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie669a13e87484bbf8cec205795711fbe_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzItMy0xLTEtMA_9b9e8f25-9531-42c6-8f04-153d27af6056">3,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica9c1a9ce292408681c60506f05c7e71_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzMtMS0xLTEtMA_64456834-b166-4003-b418-6fc0b6bea156">13,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id09b24f17a054a62a94b835ed727b119_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzMtMy0xLTEtMA_17576931-1745-4e2f-b3de-ee2f8830b055">12,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5737e6e8f2e848bb890ccfdf89d8addd_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzQtMS0xLTEtMA_1548b648-d06f-40c8-8d81-c29175776085">6,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if57eea73aa9c452f8b32b1d955f87c9c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzQtMy0xLTEtMA_f88399bb-8c30-495f-8cb9-15cb774e7e9c">5,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05dc4ee13c7c4d28aec45e6e732ddc48_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzUtMS0xLTEtMA_5e57ae82-7380-4cdd-809f-d9457e505220">6,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6b3de6701614688b86b94e57bba778a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzUtMy0xLTEtMA_57d66e85-4701-4dec-b970-e1f1f8c53e39">5,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzYtMS0xLTEtMA_4f060742-1ef5-4ad2-afb6-1cf31e15789e">31,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzYtMy0xLTEtMA_5451ae7a-bdc8-401c-b57f-225d6b8d8a57">28,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzctMS0xLTEtMA_4638e520-1f74-4c59-974e-01248586c208">18,700</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzctMy0xLTEtMA_1d5c106c-3e4b-4319-a10e-a860c74510ac">16,890</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzgtMS0xLTEtMA_998334d2-5e64-4be2-990f-061d6811c448">12,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzgtMy0xLTEtMA_24a44d5f-bf13-463d-8ac8-34f098fa830c">12,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense (which includes the amortization of property and equipment under finance or capital leases) totaled $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxNjc3_0cd4903f-7f21-45e0-a6af-caa710fcbaff">2.1</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxNzIw_d20e9a2b-4085-4848-ad12-bd5744efbd5f">1.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3Mjk5OTc_b4c6b89c-f94c-4604-bc58-da122b564e0f">1.7</ix:nonFraction> billion for the years ended December&#160;31, 2020, 2019 and 2018, respectively. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about finance leases. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDAx_96555e15-b1b4-407a-a7e5-297057b3967a" continuedAt="i8de5e43c1350419a86723d87415c8356" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right-of-Use Assets and Lease Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#8217;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases typically contain options that permit renewals for additional periods of up to <ix:nonNumeric contextRef="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231" format="ixt-sec:durwordsen" name="cvs:LesseeOperatingAndFinanceLeasesRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIyODcy_73067bfc-970e-4bcb-8643-964e058bf750">five years</ix:nonNumeric> each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8de5e43c1350419a86723d87415c8356">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about right-of-use assets and lease liabilities.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTU3_0cda6aa8-31d9-42a2-ae12-023b17ee0a28" continuedAt="iff521a1f2b254d3f8fdf14d8b2c4c73d" escape="true">Goodwill </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iff521a1f2b254d3f8fdf14d8b2c4c73d">The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently if necessary, as further described below.</ix:continuation> See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about goodwill. </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i240bfd2525694c9c8bdbfd772c6545be" continuedAt="if929146fadd6401bbde84373674820d5"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTI4_ae60c6b6-9388-4afc-b313-aacdb45671f3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#8220;VOBA&#8221;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Other than VOBA, definite-lived intangible assets are amortized using the straight-line method. VOBA is amortized over the expected life of the acquired contracts in proportion to estimated premiums. Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently if necessary, as further described in &#8220;Long-Lived Asset Impairment&#8221; below.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about intangible assets. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDUw_6e0a493a-8f70-40a5-b4e3-c871d424886e" continuedAt="i8e158ed628474407a3fce7ae24152a57" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Asset Impairment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted and without interest charges). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the asset group&#8217;s carrying value that exceeds the asset group&#8217;s estimated future cash flows (discounted and with interest charges). There were <ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="cvs:StoreRationalizationCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjMzOTc0MjY_a18383e4-86aa-470f-bbba-aceef86c3d7b">no</ix:nonFraction> material impairment charges recognized on long-lived assets in the year ended December&#160;31, 2020. During the year ended December 31, 2019, the Company recorded store rationalization charges of $<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:StoreRationalizationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzI3MzMy_0857ce25-167c-4afc-ae14-881c8a972b4e">231</ix:nonFraction> million, primarily related to operating lease right-of-use asset impairment charges. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about the right-of-use asset impairment charges. During the year ended December 31, 2018, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TangibleAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjMzOTc1Njc_373c55c5-57e3-4bf8-9158-c0bce70ef29e">43</ix:nonFraction> million long-lived asset impairment charge, primarily related to the impairment of property and equipment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of both 2020 and 2019, the Company performed its required annual goodwill impairment tests and concluded there were <ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MTkyNzU_1503ba47-e2b4-4cf5-9b29-8e338670dd07"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MTkyNzU_1a34321f-a753-48c9-804d-3ceb077a5e24">no</ix:nonFraction></ix:nonFraction> goodwill impairments as of the testing dates or during the years ended December&#160;31, 2020 and 2019. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about goodwill impairment charges recorded during the year ended December 31, 2018.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8e158ed628474407a3fce7ae24152a57">Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value.</ix:continuation> There were <ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzI4OTU3_18c43e98-a296-4e28-a436-b49ad9bdef8a"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzI4OTU3_838de5e2-46be-468a-80f7-1a11e1783682"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzI4OTU3_88487aac-9c26-4046-94a2-3d2dccbac281">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment losses recognized on indefinite-lived intangible assets in any of the years ended December&#160;31, 2020, 2019 or 2018.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:PolicyholderAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTc4_41224446-9a30-43db-bb32-3d9a7959c67b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if929146fadd6401bbde84373674820d5" continuedAt="i8fe6252cf4d14ab3b25575e014bc1486"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:HealthCareCostsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDU2_93d3e9b9-7916-49c1-86c8-62510b58fc00" continuedAt="i56a58b5275684c9781412f267080c5b8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Costs Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#8217;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#8220;IBNR&#8221;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#8217;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of IBNR in 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#8220;completion factors.&#8221; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within <ix:nonNumeric contextRef="i9e7dfa659f1f4a92a32a74b0958212b4_D20200101-20201231" format="ixt-sec:durwordsen" name="cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzMzMTY3_2aba46ee-a84b-4581-8ec2-cd02d19d0a61">six months</ix:nonNumeric> of the date of service, but it can take up to <ix:nonNumeric contextRef="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231" format="ixt-sec:durmonth" name="cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzMzMjE2_41dc24cd-2e79-4e0c-8f98-59727891be5c">48</ix:nonNumeric> months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#8217;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#8217;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#8217;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#8217;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#8217;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#8217;s business. The health status of the Company&#8217;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#8217;s health care cost trend rate.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8fe6252cf4d14ab3b25575e014bc1486" continuedAt="i9346d2d29baf45bd843dee48fe3b3090"><ix:continuation id="i56a58b5275684c9781412f267080c5b8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2020; however, actual claim payments may differ from the Company&#8217;s estimates. A worsening (or improvement) of the Company&#8217;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2020 would cause these estimates to change in the near term, and such a change could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#8217;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#8217;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#8217;s health care costs payable, see Note 7 &#8216;&#8216;Health Care Costs Payable.&#8217;&#8217; The Company&#8217;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTg2_fe053d63-3d74-4afc-853b-657d7a9ce2c4" continuedAt="i46b739015aac4479acde97f54c48d339" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Insurance Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unpaid Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#8217;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#8217;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#8217;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#8217;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of unpaid claims IBNR in 2020. As of December&#160;31, 2020, unpaid claims balances of $<ix:nonFraction unitRef="usd" contextRef="i8d08e4488aed40f3ab968e76d61f94ae_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityforUnpaidClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQwMzUw_01b47111-8cbc-41b7-be72-e27e7c1822a4">532</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iddd268c0de8441a3a25145b2c7fdf545_I20201231" decimals="-8" format="ixt:numdotdecimal" name="cvs:LiabilityforUnpaidClaims" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQwMzU3_9d24a709-21c1-4b49-82cf-40ad1781cf7d">1.5</ix:nonFraction> billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2019, unpaid claims balances of $<ix:nonFraction unitRef="usd" contextRef="i2d5b621fca784ba2afc687cec988fde8_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityforUnpaidClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQwNDk4_e32b83a5-0f06-4623-96d6-0380c77d874a">704</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2e9687452be744e6ae16597342184c4b_I20191231" decimals="-8" format="ixt:numdotdecimal" name="cvs:LiabilityforUnpaidClaims" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQwNTA1_9c950590-45c6-4bf2-941b-b9c14795c91d">1.8</ix:nonFraction> billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Policy Benefits</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i46b739015aac4479acde97f54c48d339">Future policy benefits consist primarily of reserves for limited payment pension and annuity contracts and long-term care insurance contracts. Reserves for limited payment pension and annuity contracts are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality, retirement, expense and interest rate experience. Such assumptions generally vary by plan, year of issue and policy duration. Assumed interest rates on such contracts ranged from <ix:nonFraction unitRef="number" contextRef="i9e7dfa659f1f4a92a32a74b0958212b4_D20200101-20201231" decimals="3" name="cvs:LimitedPaymentsContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQxMzU4_e1181e69-2158-40f6-928f-3da39ddc1b31">3.3</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231" decimals="3" name="cvs:LimitedPaymentsContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQxMzY0_4e1570d0-ba85-45ec-8b19-8d048df8b11e">11.3</ix:nonFraction>% in the year ended December 31, 2020 and from <ix:nonFraction unitRef="number" contextRef="i1ecd36bf6d9f459da73860d5891edad6_D20190101-20191231" decimals="3" name="cvs:LimitedPaymentsContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzA1NzM_5a2de318-c812-4df0-a5bd-1b085c7fbd0d">3.5</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i1dbce9db2d76499fa858862f845f972d_D20190101-20191231" decimals="3" name="cvs:LimitedPaymentsContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzA1OTA_6fe64d7a-dd87-486a-b534-b604bb3de015">11.3</ix:nonFraction>% in the year ended December 31, 2019. The Company periodically reviews mortality assumptions against both industry standards and its experience. Reserves for long-duration long-term care contracts represent the Company&#8217;s estimate of the present value of future benefits to be paid to or on behalf of policyholders less the present value of future net premiums. The assumed interest rate on such contracts was <ix:nonFraction unitRef="number" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="3" name="cvs:AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQxODM1_238f5c91-727e-400f-8724-bc5f1ec79f36"><ix:nonFraction unitRef="number" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="3" name="cvs:AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQxODM1_91c0138f-c9ef-4322-ac8d-12c450fbd44b">5.1</ix:nonFraction></ix:nonFraction>% in both the years ended December 31, 2020 and 2019. The Company&#8217;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity and interest rate assumptions.</ix:continuation> As of December&#160;31, 2020, future policy benefits </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9346d2d29baf45bd843dee48fe3b3090" continuedAt="i4a93267975c64e4aa329439b116ec33d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">balances of $<ix:nonFraction unitRef="usd" contextRef="i8d08e4488aed40f3ab968e76d61f94ae_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForFuturePolicyBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQyMTMw_3a81b1c9-de26-444c-9324-c01f0db2b459">462</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iddd268c0de8441a3a25145b2c7fdf545_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LiabilityForFuturePolicyBenefits" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQyMTM3_516ba0ab-0e60-463d-b8dc-baa62a815f58">5.5</ix:nonFraction> billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2019, future policy benefits balances of $<ix:nonFraction unitRef="usd" contextRef="i2d5b621fca784ba2afc687cec988fde8_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForFuturePolicyBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQyMjg3_e0f85e8e-6e4c-423d-bb74-1ed0e04cdc73">508</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2e9687452be744e6ae16597342184c4b_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LiabilityForFuturePolicyBenefits" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQyMjk0_63442200-cb7e-4ffc-b85c-9a4e6f7cb60d">5.6</ix:nonFraction> billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="cvs:InsurancePremiumDeficiencyReservePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTgx_557bd336-25d9-4c6e-92ce-0fb79988372f" continuedAt="i5e074208442d44308ac9f779e0d643b8" escape="true">Premium Deficiency Reserves</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5e074208442d44308ac9f779e0d643b8">The Company evaluates its insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is considered in the calculation of premium deficiency losses for short-duration contracts. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#8217;s method of acquiring, servicing and measuring the profitability of such contracts.</ix:continuation> As of December&#160;31, 2020 and 2019, the Company established a premium deficiency reserve of $<ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQzMTg5_d9f320e9-f525-4df3-bf98-cdc7bfee46f2">11</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQzMTk2_6cdbcb83-0e73-4044-85c6-ee3cd7669480">4</ix:nonFraction> million, respectively, related to Medicaid products in the Health Care Benefits segment. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:AllocationsToPolicyholdersPolicies" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDI5_8d593347-b954-4446-869c-448f75cd9071" continuedAt="i021098622d044b8a93d817dd91332fe6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policyholders&#8217; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus  interest credited thereon, net of experience-rated adjustments. In 2020, interest rates for pension and annuity investment contracts ranged from <ix:nonFraction unitRef="number" contextRef="i9e7dfa659f1f4a92a32a74b0958212b4_D20200101-20201231" decimals="3" name="cvs:PensionAndAnnuityInvestmentContractsInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQzNzAw_7e3a702a-153d-4214-9970-4b91706aa263">4.1</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231" decimals="3" name="cvs:PensionAndAnnuityInvestmentContractsInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQzNzA2_f1393506-ed42-42b8-8afd-a90fa8c729b6">5.1</ix:nonFraction>%. In 2019, interest rates for pension and annuity investment contracts ranged from <ix:nonFraction unitRef="number" contextRef="i1ecd36bf6d9f459da73860d5891edad6_D20190101-20191231" decimals="3" name="cvs:PensionAndAnnuityInvestmentContractsInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzAyODU_238f745e-8223-47b4-b3aa-7f987ce63dcc">3.5</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i1dbce9db2d76499fa858862f845f972d_D20190101-20191231" decimals="3" name="cvs:PensionAndAnnuityInvestmentContractsInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzAyOTI_34b04459-820a-45c7-86ea-0a3a9d30f28b">5.2</ix:nonFraction>%. Reserves for contracts subject to experience rating reflect the Company&#8217;s rights as well as the rights of policyholders and plan participants. The Company also holds funds for health savings accounts (&#8220;HSAs&#8221;) on behalf of members associated with high deductible health plans. These amounts are held to pay for qualified health care expenses incurred by these members. The HSA balances were approximately $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-8" format="ixt:numdotdecimal" name="cvs:HeathSavingsAccountBalance" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQ0MjU1_47050374-1c64-4e76-8d6e-16f5bab80f90">2.7</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-8" format="ixt:numdotdecimal" name="cvs:HeathSavingsAccountBalance" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQ0MjYy_0b487829-7ffb-427f-b954-05b807971937">2.2</ix:nonFraction> billion at December&#160;31, 2020 and 2019, respectively, and are reflected in other current assets with a corresponding liability in policyholders&#8217; funds. </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i021098622d044b8a93d817dd91332fe6">Policyholders&#8217; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#8217; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:SelfInsuranceReservePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDQ3_0d37ce60-bb58-436b-a162-91721429f511" continuedAt="ic796256a57c64f14a411216a76eb5775" escape="true">Self-Insurance Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic796256a57c64f14a411216a76eb5775">The Company is self-insured for certain losses related to general liability, workers&#8217; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#8217;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#8217;s historical claims experience.</ix:continuation> At December&#160;31, 2020 and 2019, self-insurance liabilities totaled $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SelfInsuranceReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQ1Mzcw_4060bfd5-d28f-4794-a939-8155335f8ad3">927</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SelfInsuranceReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQ1Mzc3_1a4956b8-b32a-4a13-b126-acd99d14bba0">856</ix:nonFraction> million, respectively, and were recorded as accrued expenses on the consolidated balance sheets.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDA4_b1489c18-19be-4344-8f70-ffc5e52d9f76" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income (loss).</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses from foreign currency transactions and the effects of foreign currency remeasurements were not material in the years ended December&#160;31, 2020 or 2018. On July 1, 2019, the Company sold its Brazilian subsidiary, Drogaria Onofre Ltda. (&#8220;Onofre&#8221;) for an immaterial amount. The Company recorded a loss on the divestiture, which included the elimination of the subsidiary&#8217;s $<ix:nonFraction unitRef="usd" contextRef="iaff454c2b91e4d3a845612cd83bc5a37_D20190701-20190701" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQ2NzAy_fe37828d-a430-4f7b-969e-1b5144fa7a7e">154</ix:nonFraction> million cumulative translation adjustment from accumulated other comprehensive income during the year ended December 31, 2019.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4a93267975c64e4aa329439b116ec33d" continuedAt="i3354413d73d842a0bb8c711f188cff87"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTk1_58eeea71-583a-4f56-9821-066ac0fc429c" continuedAt="i131a22afe10746a6bd74397faaf29e85" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment sells prescription drugs directly through its mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network. The Company&#8217;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the dispensing of prescription drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions dispensed indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#8220;Drug Discounts&#8221; and &#8220;Guarantees&#8221; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#8220;retail co-payments&#8221;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Pharmacy Services segment:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by mail service dispensing pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by third party pharmacies in the Company&#8217;s retail pharmacy network and associated administrative fees are recognized at the Company&#8217;s point-of-sale, which is when the claim is adjudicated by the Company&#8217;s online claims processing system and the Company has transferred control of the prescription drug and performed all of its performance obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Drug Discounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue net of manufacturers&#8217; rebates earned by its clients based on their plan members&#8217; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#8217; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#8217; rebate amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3354413d73d842a0bb8c711f188cff87" continuedAt="ia81f969f6e0a4b3aaa99450b5ec8c5c0"><ix:continuation id="i131a22afe10746a6bd74397faaf29e85" continuedAt="ic435e90a043d4573a0cd708e2985d475"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retail Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer returns are not material to the Company&#8217;s operating results or financial condition. Sales taxes are not included in revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loyalty and Other Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer loyalty program, ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consists of two components, ExtraSavings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-term Care</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of Long-term Care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#8217;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-In Medical Clinics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided by the Company&#8217;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which reflect contracted rates per employee and the number of covered employees </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia81f969f6e0a4b3aaa99450b5ec8c5c0" continuedAt="i9cfda2d13a124862b8ab8d3faa423dc1"><ix:continuation id="ic435e90a043d4573a0cd708e2985d475" continuedAt="i8caaedf9f0884c1f801ac9c9ddb58288"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded in the Company&#8217;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Premium Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#8220;MLR&#8221;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#8220;ACA&#8221;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#8217;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#8217;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#8217;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Medicare Part D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include insurance premiums earned by the Company&#8217;s PDPs, which are determined based on the PDP&#8217;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9cfda2d13a124862b8ab8d3faa423dc1" continuedAt="i94dfd5563da5407997cf272a2c4cc79b"><ix:continuation id="i8caaedf9f0884c1f801ac9c9ddb58288" continuedAt="if041095487ff4bc8aeb704f1fb712ead"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTY2_a6427d56-232b-4f52-8b77-ddbd8161a3d3" continuedAt="i760c6ee76395407687d398a0d465a20f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37eb583c6b6d47f3b7c106af8367c133_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMtMS0xLTEtMA_1aadb1f7-79ac-4564-b4c5-1bc02071e568">141,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426635a6436f4eceb5ae3bf452f2e8ce_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMtMy0xLTEtMA_47d77f33-da4d-44d3-afad-850a3704cb73">70,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313e1434cd644196a894b71f3e4d271b_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMtNS0xLTEtMA_0d6fb73c-bb15-4fd1-a55b-e5c4c688a572">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300a5c4ae7ad4f77b6e0b97f6f8e0cfb_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMtNy0xLTEtMA_3373a893-b8db-4f65-b0dc-93e04489e69a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i987983ae1dcf428e845562a5e086c894_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMtOS0xLTEtMA_02d4cc1e-f6a3-4c76-80e7-20fb86b70515">40,003</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8807d9a1c6eb4ef7a7bb815b14181f74_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMtMTEtMS0xLTA_5fb96f27-eac6-43b2-bcd2-598608c7a940">171,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebbeab317d23464cb721bf23c9554965_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQtMS0xLTEtMA_430559f1-6911-4730-952d-bc177bda09ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia39c42c0a78e456cb74db342cf62b094_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQtMy0xLTEtMA_78fc36d5-5fad-4c67-979a-d70ddc3ba5fa">19,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4810c04a4634439b6905b74827cb24c_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQtNS0xLTEtMA_003875ac-f6ed-4d0c-a95c-79165be5f11b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b1524b485c49609e399b2a230e04c7_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQtNy0xLTEtMA_30b097e0-f8c0-498f-b1ba-659b1a4fff60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd55880281f749318f4691e88cd97168_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQtOS0xLTEtMA_c643e9d4-ed1d-4e2a-b9f9-7b8afbd83d49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i783b1352f68b40d2b4ac2682bc608521_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQtMTEtMS0xLTA_75521c51-5c28-4f4e-8b76-b213109d7f41">19,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42aa9378a89545c48dee0fc68567b9a5_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzUtMS0xLTEtMA_55dbd325-1a09-4a70-beec-e478b85a7ef0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad54c820725c447083ff3be1ee37598e_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzUtMy0xLTEtMA_3ee8876c-5dd3-4a5a-b7f5-e58eff394710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef46aea24674d5297f52fe96fd3652f_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzUtNS0xLTEtMA_5403c702-6b67-45dd-8470-9f6663a09804">69,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbe2227ce7b3407291809c1a7fef699c_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzUtNy0xLTEtMA_3c99fea2-6abb-4d94-b934-7fec1d6e90e5">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd5d327d52f54f70913e6c6108027d81_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzUtOS0xLTEtMA_3585e459-cfa4-4029-806d-c5060d932078">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaad598e9ae7248d4b644c5cafe6a51ca_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzUtMTEtMS0xLTA_f6a69894-f642-4afd-8adc-5fd8b42c01ef">69,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzYtMS0xLTEtMA_8f610992-2670-4424-9e29-4b5b84c4e92a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzYtMy0xLTEtMA_db993e4b-9f17-4a9a-aa96-24d9d049c68f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzYtNS0xLTEtMA_5392fabd-272b-4a95-8ded-1955df2e3ddf">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzYtNy0xLTEtMA_79cb0803-666a-4baf-a699-7531e34d6737">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzYtOS0xLTEtMA_24b3fbcd-ab02-47a8-966d-b3fd127259f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzYtMTEtMS0xLTA_8ed42f05-25fb-4cb1-8747-54b34bedfb9c">798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b3eabef1e6460cb656982802e37513_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzctMS0xLTEtMA_54024b9e-2860-4079-9c21-e78dc3920381">822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1a017feef1f44bdbe74396d8046773e_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzctMy0xLTEtMA_1a6e5511-c321-4dea-84b8-3e3f409c9c01">1,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib170695af7314375ae76b557f9da70b3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzctNS0xLTEtMA_5aa28c4f-9d91-42b5-994a-bfd26f5908be">5,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33407e182d1347caaf77663336da82fb_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzctNy0xLTEtMA_9cf14a02-aa5a-4f17-9362-58e5042ce3c1">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15b2e86a75f2415d8bf8685add0dd173_D20200101-20201231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzctOS0xLTEtMA_950e695e-1469-4150-ad3a-8c3ac01fcd8c">320</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c3bc4b998f4337814af2804581a932_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzctMTEtMS0xLTA_9390c098-916d-4563-918f-e83af6a8bcb8">7,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzgtMS0xLTEtMA_218baa3b-d4bd-431e-953d-939fbed4130a">141,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzgtMy0xLTEtMA_4f695125-544d-4bd4-9f61-ff3911a780e7">91,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzgtNS0xLTEtMA_94dbbc6a-abb8-4cb0-a17e-d7b086183896">75,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzgtNy0xLTEtMA_9763c613-c2e9-42c3-a0aa-83dbe4d4af52">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzgtOS0xLTEtMA_6ca82945-79ab-4d16-a7a9-04f0cc8657b3">40,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzgtMTEtMS0xLTA_9d2bce85-fb48-439c-bf61-ba241c96f45c">268,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c72ee7a1ff04724b5d9c64969981c00_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzExLTEtMS0xLTA_6cfe4090-e69a-46fb-bb0b-0294bcac5c9c">85,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eefd35256b74eb588b983fc0ce03cee_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzEyLTEtMS0xLTA_78f18563-20d8-4b29-9862-8388490f7cb4">56,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i615e8d8d64e049b2baa6aa868316807d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzEzLTEtMS0xLTA_9c4f1958-e1d4-4e4d-b6a3-a2b96abf639a">822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE0LTEtMS0xLTA_80c02901-ba24-4580-a0c0-adc4262a567c">141,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e5738b83cac44c8a207d99440f8125c_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE4LTEtMS0xLTA_5d4cd995-5db2-49a7-b34e-76da1257f8ea">140,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6658f59817451f8226605da85f4b71_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE4LTMtMS0xLTA_ab6f731b-2384-4908-96a8-d32e95b6b4e0">66,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic572f6f25fb641d68b501e02911341dd_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE4LTUtMS0xLTA_edb68950-adc3-447c-b20a-4e8988739a54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i905d30d3d5c2417fa14d71aa765d04ac_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE4LTctMS0xLTA_df2edb93-2f6a-4432-903f-fd9ace09d6fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc535c0378834b1dba6be6c404915f1d_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE4LTktMS0xLTA_c2efee71-f4df-437f-ac21-8b3fe4fd49b7">41,413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75ffe98b0bd943648691587a5bd133e0_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE4LTExLTEtMS0w_55e5db6b-1e19-4b5d-9555-4f25eea9b9ee">165,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff00ef80a974f5eb5b735f33880f18d_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE5LTEtMS0xLTA_b0f8a808-8c39-4a2d-bb48-b1966e89ed29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc9115de5fde4c4880875ae246f420e0_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE5LTMtMS0xLTA_538ecf82-721c-4f5e-8522-7b74975e35f8">19,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5478933c3dbd44f28b9d5a0b50d6db7f_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE5LTUtMS0xLTA_dc07aae4-d9b7-4166-adae-8757b53e30a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i883ea853b3fe48ebb9fada798636ba5b_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE5LTctMS0xLTA_4fd7eda0-454a-4267-a337-1f79e6eae9c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c68a89f8e4c4e81a8576d27b3744e59_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE5LTktMS0xLTA_fe374543-8564-4724-b18b-afbf85a517ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee4e7fda3ff44e1cae0013e4824f88ca_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE5LTExLTEtMS0w_b0c6874b-ffd1-4a30-abc7-bf8b4cb2b27f">19,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a9e992c01b8401c841b3eae8f16e94d_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIwLTEtMS0xLTA_0d3be75e-8630-43d3-b267-fdff0aea6c03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i317b21ec3df84f079f10f3a3cb5996c8_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIwLTMtMS0xLTA_8d3386c7-4f5d-4791-81d8-e47af06d427b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a391b68fb7b4d8f843138cd71f2707b_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIwLTUtMS0xLTA_020839c2-4977-4838-a7f4-2489dea24509">63,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie48e36cfbbf8422186962d2169fc4edd_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIwLTctMS0xLTA_11a35dc1-beeb-480a-879f-1859750aa010">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie727763f57214c94a1c11e4313718b07_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIwLTktMS0xLTA_f3ff4657-420b-4510-bd93-036420f81b48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f10e0c26b5b4685a3da73b5a6d6cdfe_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIwLTExLTEtMS0w_ce86c453-4659-4001-83f4-cb182e26451e">63,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIxLTEtMS0xLTA_46be0bcb-8dd8-4d94-8cd3-c678efa08d5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIxLTMtMS0xLTA_b4d25b17-548a-487d-a312-30e92f10c96d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIxLTUtMS0xLTA_27cd018c-7376-482c-82a3-af4e12282e8b">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIxLTctMS0xLTA_b3b6a16e-deee-4198-a210-7b8c6c7ff95a">412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIxLTktMS0xLTA_94fbee50-f229-4837-8397-25793474e1b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIxLTExLTEtMS0w_1ed7ea89-fc82-4c90-a329-512aa841e1a3">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c09f3cf15740fcb2085a4ea7a6b757_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIyLTEtMS0xLTA_1910947a-e2eb-4f67-91be-f15bbef6e8d3">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id31407870d8c4fbe93fa0ef67d5f1bd1_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIyLTMtMS0xLTA_dee6562c-8301-4b5c-bf2e-93b5c934f87c">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaceaf6ce0c0649e59587194b8562c088_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIyLTUtMS0xLTA_9ca54563-07d4-4571-83fd-8e8c0d1562c3">5,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2c64df3e01c472b98a154efeaba9606_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIyLTctMS0xLTA_7ababbdc-57a7-4cee-befa-4ba45a1ccbc1">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d705300d5f44592abe5c5834931363a_D20190101-20191231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIyLTktMS0xLTA_1240fc2a-b676-4018-9ad1-2161a525c8c1">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i637cbce7eef743f392772d2447f3fb0f_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIyLTExLTEtMS0w_569c38bb-36cf-4f5f-befd-b747626b3b9e">7,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIzLTEtMS0xLTA_4b09fcdf-8486-4722-aa59-931859fe1d7a">141,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIzLTMtMS0xLTA_a99a41b2-5f91-40c9-9154-89fc68991ee1">86,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIzLTUtMS0xLTA_745b1aac-3ce1-4bde-8792-106ca6d50d7f">69,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIzLTctMS0xLTA_773de77e-1ae3-4ca4-bd35-a9db60d2e800">512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIzLTktMS0xLTA_8d9284f6-02a5-4a12-bcb6-fe342a01da4d">41,439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIzLTExLTEtMS0w_1d2d2ef4-c79c-4cb2-aedd-946822dc4e53">256,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1) </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03cfffc1fd2442cb99a34979e3c58111_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzI2LTEtMS0xLTA_31e17619-7e70-4973-8d79-126a4dd5b3ec">88,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6948fd96583f49168479c7bb034889d2_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzI3LTEtMS0xLTA_aa85bacf-6285-4b0c-9d7d-8efab19d6be2">52,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a2861a5e8ba4e20bd8eaceed653d6dd_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzI4LTEtMS0xLTA_1affa67d-2ec0-48a3-985c-d3c2d71f1c62">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzI5LTEtMS0xLTA_cd693de9-0a3d-4967-a2f1-890331f634b1">141,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19549f30d57c482c9aefda9c7a91347c_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMzLTEtMS0xLTg5Mw_b5243715-bd6b-4963-98be-08d93171f515">134,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2700a9f4cb9448a3ad808275ab50ef5c_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMzLTMtMS0xLTg5Mw_e41ef279-5072-49d0-a3ad-4c780deb67f2">64,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db376e2f088449494413724fca2e556_D20180101-20181231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMzLTUtMS0xLTg5Mw_74e010ba-672e-4fd3-a1ca-50b72af1647d">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i647cd1db2a7b4b81b35d2e32684b1fd1_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMzLTctMS0xLTg5Mw_4aa22203-7794-4896-aa7d-cfd0eb715bc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92201227633d42428e8654713a1183c3_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMzLTktMS0xLTg5Mw_d19d38f9-efa4-4f12-ada2-9ef6666769d7">33,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013b860d7dc4425abe6f741f311f6b69_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMzLTExLTEtMS04OTM_a3972eda-872c-4961-8c6a-b54eaa9ee45c">164,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i691b329bada44592bc51fab7186d983a_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM0LTEtMS0xLTg5Mw_19477bc5-36cb-4794-a677-4a614cc41eac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbecb39a71a1469892eb85b5117dd313_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM0LTMtMS0xLTg5Mw_d282033e-38ec-4e5b-a7ea-d10c80c6d180">19,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bbabdb50ce14e3e9d0aa6b2731c0077_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM0LTUtMS0xLTg5Mw_d803c66b-3927-48ee-9754-3fcc9cf53e5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521a13bc74694ab2bcde000a0cfa3d7b_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM0LTctMS0xLTg5Mw_1b6bf068-7991-4abb-a38a-3ab8cb71d9e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8edc8623a1824b2192d1cd1f2197d2df_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM0LTktMS0xLTg5Mw_114e5f3b-c83b-49fb-b791-3cf12cd9b5d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee713b77e09b40658fff6dc3733ade2a_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM0LTExLTEtMS04OTM_b60870bb-c907-42bb-8763-ca5478e7ffe4">19,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa5cde79d4cc48c894fc26a3d00d4c4c_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM1LTEtMS0xLTg5Mw_81a99de8-11c2-42f5-8578-fff8b484d297">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cbb8e25253e442da025fb09f9ffb8fc_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM1LTMtMS0xLTg5Mw_698eb390-d578-421c-8738-1c1ce08ea27c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c61f360659541ec934371fdc19fdbfe_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM1LTUtMS0xLTg5Mw_606ff353-1beb-44fa-9a6e-089612665c25">8,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5fc5617f60483f850c62403eee0116_D20180101-20181231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM1LTctMS0xLTg5Mw_40cf1a87-1a4f-4620-880b-f0151057f5e9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ace05bc406f4b35bd7d939aba14ba8d_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM1LTktMS0xLTg5Mw_6612f535-63ad-4f3e-989d-c6654e590289">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f39b6fd2b4740dcb546b4ea89d46660_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM1LTExLTEtMS04OTM_18d91b39-0768-48e4-95c0-5e8222e7c356">8,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM2LTEtMS0xLTg5Mw_2c32818f-8386-4c4f-8394-db27f77a2b61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM2LTMtMS0xLTg5Mw_dd5e6b97-2d52-4e92-8e36-db1d7eab1769">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM2LTUtMS0xLTg5Mw_5cc571b0-b185-4355-b3a9-0f89ac487696">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM2LTctMS0xLTg5Mw_08f01f8c-c239-4ec7-a3eb-3aa7bc77228f">602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM2LTktMS0xLTg5Mw_386f2df6-74ce-45fd-a5c6-17632a2ac679">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM2LTExLTEtMS04OTM_c57766e0-d1d9-484e-82ee-6dc12f819c6d">660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c87d411f5b34673b9973adc00d3637d_D20180101-20181231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM3LTEtMS0xLTg5Mw_e2a1dbb1-54dc-4013-ab3e-fadfef5e3dbc">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bcade8977e24f33a1be8dd5bbb6e4ae_D20180101-20181231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM3LTMtMS0xLTg5Mw_95f193b1-eb2c-4aa0-a209-fb6219f46b4b">755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afe948f657f4d75a79b6884ce991c1e_D20180101-20181231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM3LTUtMS0xLTg5Mw_3c26f8f0-6d5b-4aeb-8099-5a77bee46050">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50ea2b4a55ee4369beeefd0c2170a8cf_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM3LTctMS0xLTg5Mw_b6dc95cc-14ba-4a1e-a57c-5207568aa6be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be25d61dc7c486faee71c20d5fbb1f8_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM3LTktMS0xLTg5Mw_a951e114-7527-418d-82ae-06ff4059e8ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7219da47c7214a83bc6666bb4b2abb50_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM3LTExLTEtMS04OTM_65333c47-44ee-4a8e-84de-42b9dd4c482d">1,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM4LTEtMS0xLTg5Mw_a466c862-79f9-4476-8890-289c5a55f2a3">134,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM4LTMtMS0xLTg5Mw_27a0d49c-9c93-479a-80a0-95a239ff0d76">83,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM4LTUtMS0xLTg5Mw_8ccbde46-42ca-46f5-8e20-d94b2ab5dcd0">8,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM4LTctMS0xLTg5Mw_6200eb43-1ce9-48b9-b9b0-a6dcda353789">606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM4LTktMS0xLTg5Mw_35dd5eff-837d-4086-80e0-8e4e2bfa44b7">33,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM4LTExLTEtMS04OTM_2719273f-fc54-4eee-be8b-339b144e9aff">194,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3e56e0202f45e1ad53f61ac55f0d3b_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQxLTEtMS0xLTg5Nw_77e08f9c-16b0-4360-a54d-760723c83643">87,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e56f64001404d73b3c695a3b5ae8845_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQyLTEtMS0xLTg5Nw_1dea41dd-b309-4c0d-b842-4ea9fb0765b5">47,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda6ee66f0de4117add908957e89dd30_D20180101-20181231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQzLTEtMS0xLTg5Nw_27e10e0e-6958-47d3-9b18-2593f8023901">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQ0LTEtMS0xLTg5Nw_19d7ad2d-eee0-4b77-a4fb-d883300dcd44">134,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i94dfd5563da5407997cf272a2c4cc79b" continuedAt="ie7e5c5f5e2a447a2a5a975160bcfe3d8"><ix:continuation id="if041095487ff4bc8aeb704f1fb712ead"><ix:continuation id="i760c6ee76395407687d398a0d465a20f"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">program. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Certain prior year amounts have been reclassified for consistency with the current period presentation.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDI4_285eaf46-1025-4dbc-a0a4-3f41682323d7" continuedAt="i5af1ced8a52a4d07b9383f3e8cebcd06" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToyN2JjZDc3YmNkYjA0YzcxYTM2OWFiOWMxMjg1ZDQ0MC90YWJsZXJhbmdlOjI3YmNkNzdiY2RiMDRjNzFhMzY5YWI5YzEyODVkNDQwXzEtMS0xLTEtMA_96e5fa16-ae2e-4841-9c16-de47258571b0">7,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToyN2JjZDc3YmNkYjA0YzcxYTM2OWFiOWMxMjg1ZDQ0MC90YWJsZXJhbmdlOjI3YmNkNzdiY2RiMDRjNzFhMzY5YWI5YzEyODVkNDQwXzEtMy0xLTEtMA_9daf0c54-b232-4a4e-a721-acc941fe9a79">6,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToyN2JjZDc3YmNkYjA0YzcxYTM2OWFiOWMxMjg1ZDQ0MC90YWJsZXJhbmdlOjI3YmNkNzdiY2RiMDRjNzFhMzY5YWI5YzEyODVkNDQwXzItMS0xLTEtMA_a64d45f0-32ac-4917-90b7-a200fab09f08">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToyN2JjZDc3YmNkYjA0YzcxYTM2OWFiOWMxMjg1ZDQ0MC90YWJsZXJhbmdlOjI3YmNkNzdiY2RiMDRjNzFhMzY5YWI5YzEyODVkNDQwXzItMy0xLTEtMA_4af146e5-6019-4702-a9e6-b1a6bc355e3d">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020 and 2019, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i5af1ced8a52a4d07b9383f3e8cebcd06"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzEtMS0xLTEtMA_1c19dca6-0cf3-4281-a09c-de14aa1dde25">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzEtMy0xLTEtMA_0a076eab-d346-47de-8c7d-2bb5aee46294">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzMtMS0xLTEtMA_0e9aab5b-9155-4bbb-9c6c-ed1fc1e100db">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzMtMy0xLTEtMA_9e599549-1178-49bf-9283-250a2a18109d">365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="cvs:ContractWithCustomerLiabilityRedemptionAndBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzQtMS0xLTEtMA_799a495d-d0e0-46a4-8276-dd42992dbcf4">359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="cvs:ContractWithCustomerLiabilityRedemptionAndBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzQtMy0xLTEtMA_d6f3105a-23f7-40ee-985d-4bdec02550ef">359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzUtMS0xLTEtMA_ccf76068-2cf2-47ef-83e2-236192e0f522">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzUtMy0xLTEtMA_d75ba377-0a2e-4be1-a849-f9159af47e41">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="padding-right:4.5pt"><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTM3_ba132f85-97bd-465c-a334-78ed79b7882e" continuedAt="i25a77691d5294e5fa226067eeadbd936" escape="true"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for cost of products sold as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#8217;s mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network, (ii) shipping and handling costs, and (iii) the operating costs of the Company&#8217;s mail service dispensing pharmacies and client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#8217; benefit plans from the Company&#8217;s mail service dispensing pharmacies, net of any volume-related or other discounts (see &#8220;Vendor Allowances and Purchase Discounts&#8221; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#8217;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i25a77691d5294e5fa226067eeadbd936">Cost of products sold includes: the cost of merchandise sold during the reporting period, including prescription drug costs, and the related purchasing costs, warehousing and delivery costs (including depreciation and amortization) and actual and estimated inventory losses.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTY3_38eaba55-b08d-4c42-a232-9159f0ecb676" continuedAt="i915d2e08a2344cec986ea8dde922e7c1" escape="true"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vendor Allowances and Purchase Discounts </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for vendor allowances and purchase discounts as follows: </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie7e5c5f5e2a447a2a5a975160bcfe3d8" continuedAt="ia42308be2f74474c8f58991a77747b63"><ix:continuation id="i915d2e08a2344cec986ea8dde922e7c1" continuedAt="i14e69f623b5f413dae854fb27e98a892"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:durday" name="cvs:PharmacyRebatePeriod" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzY1NTU2_f3cac2be-4dff-403d-b8cb-69889d0c3360">30</ix:nonNumeric> days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#8217;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Pharmacy Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i14e69f623b5f413dae854fb27e98a892">Vendor allowances received by the Retail/LTC segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon purchase volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#8217;s consolidated financial statements in any of the periods presented.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:HealthCareEntitiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDMx_7f241ef1-0bbb-4b6d-866a-b70985076d40" continuedAt="ifc443406f57641a29f163ad83d6b0d87" escape="true"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurer Fee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2014, the ACA has imposed an annual premium-based health insurer fee (&#8220;HIF&#8221;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company has been required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In the years ended December&#160;31, 2020 and 2018, operating expenses included $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:HealthInsurerFee" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzEwNzM_98e65cc7-4269-445f-bd1b-93f5d729beb2">1.0</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:HealthInsurerFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzExMzc_689767c4-82f0-4cac-99b1-cf7fe6cd4bbd">157</ix:nonFraction> million, respectively, related to the Company&#8217;s share of the HIF. There was <ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="cvs:HealthInsurerFee" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzY4MjMw_57bb4fd7-cc19-4ef6-9c6b-005dbd653c43">no</ix:nonFraction> expense related to the HIF in 2019, since there was a one-year suspension of the HIF for 2019. In December 2019, the HIF was repealed for calendar years after 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#8217;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Corridor</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) based on their ratio of allowable costs to target costs (as defined by the ACA). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed a lawsuit in August 2019 to recover the $<ix:nonFraction unitRef="usd" contextRef="i138a42c6cd5e4913b5eb2ad3288f6b8a_I20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainContingencyUnrecordedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MDM4MTg_541197b2-97fc-47b8-9fd2-10efbf466fa4">313</ix:nonFraction>&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia42308be2f74474c8f58991a77747b63" continuedAt="i85856e3f6c4045c68228208af35ed03b"><ix:continuation id="ifc443406f57641a29f163ad83d6b0d87"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company received the $<ix:nonFraction unitRef="usd" contextRef="iacafa6a2e9244f43ab295d89abdb066f_D20201022-20201022" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MDM4NTU_3c0f91c9-23d3-42f1-8c97-f1d8833a652b">313</ix:nonFraction>&#160;million it was owed under the ACA&#8217;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December&#160;31, 2020. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $<ix:nonFraction unitRef="usd" contextRef="ia508c5dcbe174753b2ea381d7ec1a3bc_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MjgwODc_e9840c15-c8c8-42b3-936c-28320ea2225e">307</ix:nonFraction> million and after-tax income of $<ix:nonFraction unitRef="usd" contextRef="ia508c5dcbe174753b2ea381d7ec1a3bc_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MDM5Mjc_a41333d1-7b55-4b43-9058-d88a14fdcdd8">223</ix:nonFraction>&#160;million during the year ended December&#160;31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2019, the Company did not record any ACA risk corridor receivables because payment was uncertain.</span></div></ix:continuation><div><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDQy_643ae02f-a8fb-4c6b-a35f-37c189398d63" continuedAt="ia74a0593f0f54d8aa18bdcbff793397a" escape="true">Advertising Costs </ix:nonNumeric></span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia74a0593f0f54d8aa18bdcbff793397a">Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzY5Mzg5_0e1a408d-72b6-4851-a921-f49ac1479069">461</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzY5Mzkz_3b5a43d3-df77-4c9c-8409-4d9d84f3df5d">396</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzY5NDAw_67183176-35a0-4f7d-8e70-9b2bd6b37e70">364</ix:nonFraction> million in 2020, 2019 and 2018, respectively.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDIw_0f422597-8df9-4abe-b8dd-4ea152b5c193" continuedAt="icae3196d09a04d2ca1b00af789046e7c" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icae3196d09a04d2ca1b00af789046e7c">Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2OTY1ODE1NjM0NzI_a2f5f276-1187-4a37-84f0-e7ca761d6280">three</span> to <ix:nonNumeric contextRef="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2OTY1ODE1NjM0Nzk_691b4819-b028-4d40-9831-49efada44469">five years</ix:nonNumeric>) using the straight-line method.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDIx_f9a4c8f8-093c-4023-bd28-82415496e280" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Tax Cuts and Jobs Act (the &#8220;TCJA&#8221;) was enacted on December 22, 2017. Among numerous changes to existing tax laws, the TCJA permanently reduced the federal corporate income tax rate from 35% to 21% effective January 1, 2018. The effects of changes in tax rates on deferred tax balances are required to be taken into consideration in the period in which the changes are enacted, regardless of when they are effective. As</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a result of the reduction of the corporate income tax rate under the TCJA, the Company estimated the revaluation of its net deferred tax liabilities and recorded a provisional income tax benefit of approximately $<ix:nonFraction unitRef="usd" contextRef="i30eb50f669aa417d98981c15d603526d_D20170101-20171231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjMzOTgzMDE_cd15098e-dda1-463e-86be-e0f5be1dcd81">1.5</ix:nonFraction>&#160;billion for year ended December 31, 2017. In 2018, the Company completed its process of determining the TCJA&#8217;s final impact and recorded an additional income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzcxMjU0_93240894-1857-458f-b228-1c9400e8ec0e">100</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#8217;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTI5_a7fde9a1-26fb-40d2-b502-4dc279ce5c8d" continuedAt="i13f2d22a9bae49a48628695ffb5bd913" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors defined benefit pension plans (&#8220;pension plans&#8221;) and other postretirement employee benefit plans (&#8220;OPEB plans&#8221;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit cost (income) for the Company&#8217;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i85856e3f6c4045c68228208af35ed03b" continuedAt="i2498b0b1d2f14758b798312dbfca5930"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i13f2d22a9bae49a48628695ffb5bd913">period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit cost (income) are included in other income in the consolidated statements of operations.</ix:continuation></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTcy_266db162-804c-4cde-8239-be75e8413bf1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings (Loss) per Common Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (loss) per share is computed using the two-class method. The Company calculates basic earnings (loss) per share based on the weighted average number of common shares outstanding for the period. See Note 14 &#8216;&#8216;Earnings (Loss) Per Share&#8217;&#8217; for additional information.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="cvs:SharesHeldInTrustPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDMy_4788d7b2-0d38-46e5-b4cf-3f5a84ff2ea7" continuedAt="i7d5a4228b0e44a868abf72fbc39b01ae" escape="true">Shares Held in Trust</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7d5a4228b0e44a868abf72fbc39b01ae">The Company maintains grantor trusts, which held approximately <ix:nonFraction unitRef="shares" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:CommonStockSharesHeldInEmployeeTrustShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc0MDA3_0e165a54-c14b-4ebb-af60-e59a3d23c7dd"><ix:nonFraction unitRef="shares" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:CommonStockSharesHeldInEmployeeTrustShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc0MDA3_bcaa8b9b-cb98-4497-84ba-5c49d76b0fee">one million</ix:nonFraction></ix:nonFraction> shares of its common stock at both December&#160;31, 2020 and 2019. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTMw_41bb6433-c6ee-4d45-9f9f-3af52b420520" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Primary Beneficiary</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company and Cardinal Health, Inc. (&#8220;Cardinal&#8221;) established Red Oak Sourcing, LLC (&#8220;Red Oak&#8221;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own <ix:nonFraction unitRef="number" contextRef="ia29ce83052be481eb35a86ede34ef887_D20140101-20141231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc1MjQ0_5a34840c-8e08-4576-87f0-81de61ba8382">50</ix:nonFraction>%. The Red Oak arrangement has an initial term of <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:duryear" name="cvs:Initialcontractualterm" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzU0OTc1NTgzMDI4OTk_448e01e9-ae53-487f-a3be-5a7d72d643e9">10</ix:nonNumeric> years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Retail/LTC segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal is required to pay the Company <ix:nonFraction unitRef="payment" contextRef="i6fe88e3b7af243da9625e02cfbb5d718_I20141031" decimals="INF" name="cvs:NumberOfQuarterlyPaymentsFromVariableInterestEntity" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2MDU5_1c789561-e722-4529-a1a1-104b3f211bac">39</ix:nonFraction> quarterly payments beginning in October 2014. As milestones are met, the quarterly payments increase. The Company received from Cardinal $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:ProceedsFromVariableInterestEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2MTk5_261ca473-9aa6-4104-aeb2-f230782a076d"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:ProceedsFromVariableInterestEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2MTk5_c7ed2626-d4cd-4832-b686-2947c03e340c"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:ProceedsFromVariableInterestEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2MTk5_f929ce3f-af24-41c8-81f1-1c97dc32d4f4">183</ix:nonFraction></ix:nonFraction></ix:nonFraction> million during each of the years ended December&#160;31, 2020, 2019 and 2018. The payments reduce the Company&#8217;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold. Revenues associated with Red Oak expenses reimbursed by Cardinal for the years ended December&#160;31, 2020, 2019 and 2018, and amounts due to or due from Cardinal at December&#160;31, 2020 and 2019 were immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Other Variable Interest Holder</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hedge fund and private equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Real estate partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not the primary beneficiary of these VIEs because the nature of the Company&#8217;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#8217;s income or losses in net income (loss).&#160;The Company&#8217;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i2498b0b1d2f14758b798312dbfca5930" continuedAt="i1d58b48f101b46b280cb1f555ed4ee6b"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDQ2_d9c4e750-7c53-40e7-9333-4c63f105a2fc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total amount of other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2020 and 2019 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge fund investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80d59f9f341b4a83b98d2b3b1b87310e_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzEtMS0xLTEtMA_5451396b-2f9f-43af-aff3-73138832e99f">342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59ea7852fec74a64bb6d3f7c2754512d_I20191231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzEtMy0xLTEtMA_c8e9e6cf-b4d9-4015-b4db-d65ed51251ac">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a0cfcdaf6c54b489a9c3eea04ed3a37_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzItMS0xLTEtMA_1f76c1fa-be5d-4664-a150-50473641718a">547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf15c27df834ce98c7f1da46d42a14a_I20191231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzItMy0xLTEtMA_9982a05d-707d-4b4d-8725-ed0d5d45cebd">538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate partnerships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3267481b2aa4488bb857353dc51ca8f9_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzMtMS0xLTEtMA_9b9a2690-bd43-4e5c-b6ee-257b396b6506">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i373b58235285416bb437fdca972f274b_I20191231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzMtMy0xLTEtMA_0155d126-b934-44bf-b8f4-6a64a45904a8">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343f3e71f5b546c7ac384b8289428e7c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzQtMS0xLTEtMA_d2bde341-eb69-407d-9d07-5484de7f33c8">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dc57d39a4f04908be65c7bad08c6849_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzQtMy0xLTEtMA_4124c557-f1f4-45b3-a39c-b2852bec8e21">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDYw_465bcb58-761e-4cb3-9305-b1472b0513f8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4NTQx_56b208e9-dae4-4222-a7a4-b5bfd04a448c">56</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4NTQ1_0a1285ac-edf0-4bfd-9c95-68c5712d302a">32</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4NTUy_9a08364c-fac4-4a78-b301-a9b70bb6672a">45</ix:nonFraction> million in the years ended December&#160;31, 2020, 2019 and 2018, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in <ix:nonFraction unitRef="state" contextRef="i8168693bd43e42ad9a06d56bbef64902_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfStatesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4ODUy_e341220b-4131-4e0c-b9ed-563f79c07a9c">four</ix:nonFraction> states. Heartland paid the Company $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4ODkw_d7a9eeb5-9845-4086-926c-ca1110acbb81">77</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4ODk0_37f716fe-7819-48e4-8455-8d0636329c8f">96</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4OTAx_912edf8d-e883-4d51-aa04-ebb840bf13da">135</ix:nonFraction> million for pharmaceutical inventory purchases during the years ended December&#160;31, 2020, 2019 and 2018, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020 and 2019, the Company made charitable contributions of&#160;$<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MDc2NTE_aa8825d9-6da6-4dae-a3a7-f92c8efdbdcc">50</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc5MzIy_1750fd80-1eb3-4026-8750-f747a97de7a5">30</ix:nonFraction> million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2020 and 2019.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:DiscontinuedOperationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTUz_5a77cb4e-4fb6-4f4d-814c-6c10c03ecbb4" continuedAt="iaf69285cc3624605827c2f305ae31984" escape="true">Discontinued Operations</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaf69285cc3624605827c2f305ae31984">In connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#8216;n Things and Bob&#8217;s Stores, each of which subsequently filed for bankruptcy. The Company&#8217;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees.</ix:continuation> See &#8220;Lease Guarantees&#8221; in Note 16 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the results of discontinued operations for the year ended December&#160;31, 2020. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDM3_ba8e03b4-9f07-419d-aedd-d355346f9a88" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZjRiNDE4Nzk0NWI0MTRmOTYxNjY0NDIwODZlZDYwYy90YWJsZXJhbmdlOjhmNGI0MTg3OTQ1YjQxNGY5NjE2NjQ0MjA4NmVkNjBjXzEtMS0xLTEtMA_b98f3f6a-7cf9-48af-b4eb-7cc9cba64eae">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZjRiNDE4Nzk0NWI0MTRmOTYxNjY0NDIwODZlZDYwYy90YWJsZXJhbmdlOjhmNGI0MTg3OTQ1YjQxNGY5NjE2NjQ0MjA4NmVkNjBjXzItMS0xLTEtMA_ca8d840f-11bf-4e84-84c7-44f200a6779f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZjRiNDE4Nzk0NWI0MTRmOTYxNjY0NDIwODZlZDYwYy90YWJsZXJhbmdlOjhmNGI0MTg3OTQ1YjQxNGY5NjE2NjQ0MjA4NmVkNjBjXzMtMS0xLTEtMA_899b57ab-50d6-4c7b-9427-282213dd1038">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results from discontinued operations were immaterial for the years ended December 31, 2019 and 2018.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTc2_1edb8b32-5915-4814-854f-5fe5d684b3e6" continuedAt="i01bd54e90da5477c8073836c8ba7e554" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 326). This standard requires the use of a forward-looking expected credit loss impairment model for trade and other receivables, held-to-maturity debt securities, loans and other instruments. This standard also requires impairments and recoveries for available-for-sale debt securities to be recorded through an allowance account and revises certain disclosure requirements. The Company adopted this new accounting standard on January 1, 2020. The Company adopted the credit loss impairment model on a modified retrospective basis and recorded a $<ix:nonFraction unitRef="usd" contextRef="ieb3ef261af8c4ac5882b054e927e2644_I20200101" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzI2Mjc_b4048791-3932-4458-a85b-11f56ff6b97f">3</ix:nonFraction> million cumulative effect adjustment to reduce retained earnings as of the adoption date. The Company adopted the available-for-sale debt security impairment model on a prospective </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1d58b48f101b46b280cb1f555ed4ee6b"><ix:continuation id="i01bd54e90da5477c8073836c8ba7e554"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and other - Internal-Use Software </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 350-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This standard requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in Topic 350-40 to determine which implementation costs to capitalize as assets. The Company adopted this new accounting guidance on January 1, 2020 on a prospective basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#8217;s consolidated operating results, cash flows, financial condition and related disclosures.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_127"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzU2Mzc_e24f3fee-5352-49ff-b6c1-cef12c84134e" continuedAt="i477777da251241a28a0c5e9e708ff7f9" escape="true">Acquisitions and Divestitures </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i477777da251241a28a0c5e9e708ff7f9" continuedAt="i0ff50622aaab447d954c0ee8426c3dda"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition of Aetna</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the Aetna Acquisition Date, the Company acquired <ix:nonFraction unitRef="number" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzExMg_4630f83b-26a1-45b5-b060-981f44de83a6">100</ix:nonFraction>% of the outstanding shares and voting interests of Aetna for a combination of cash and stock. Under the terms of the merger agreement, Aetna shareholders received $<ix:nonFraction unitRef="usdPerShare" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="INF" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzI3Nw_90d5349f-ad70-42c0-a1d7-7e70cb9073c8">145.00</ix:nonFraction> in cash and <ix:nonFraction unitRef="usdPerShare" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="INF" name="cvs:BusinessCombinationPerShareExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzI5Mg_5959060a-94e8-4cd6-8a58-4c63d82d65fe">0.8378</ix:nonFraction> CVS Health shares for each Aetna share. The transaction valued Aetna at approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="0" name="cvs:BusinessCombinationAcquisitionValuePerSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzM4MQ_2b914438-64d6-4e38-9ccf-07684011906f">212</ix:nonFraction> per share or approximately $<ix:nonFraction unitRef="usd" contextRef="i2bda1e1ef73b4b7b83d6f7ff5925839f_D20181128-20181128" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzQxMQ_7e6e59fa-2b58-42b5-bb1c-f461ea4cb183">70</ix:nonFraction> billion. Including the assumption of Aetna&#8217;s debt, the total value of the transaction was approximately $<ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-9" format="ixt:numdotdecimal" name="cvs:BusinessCombinationAcquisitionAssignedValueOfAcquiree" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzUxMA_70bcfca0-9890-453f-b47d-c51775086312">78</ix:nonFraction> billion. The Company financed the cash portion of the purchase price through a combination of cash on hand and by issuing approximately $<ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzY0MQ_25d103cf-4602-43b1-9d71-71adaa1ec4db">45</ix:nonFraction> billion of new debt, including senior notes and term loans. The Company acquired Aetna to help improve the consumer health care experience by combining Aetna&#8217;s health care benefits products and services with CVS Health&#8217;s more than <ix:nonFraction unitRef="store" contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:NumberOfStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzg3MQ_a0dbde93-734f-4ef8-bc36-ba5480cf9454">9,900</ix:nonFraction> retail locations, approximately <ix:nonFraction unitRef="clinic" contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231" decimals="-2" format="ixt:numdotdecimal" name="cvs:NumberofWalkInMedicalClinics" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzkwNg_0f42dee4-d1a2-4926-937c-b4860890906d">1,100</ix:nonFraction> walk-in medical clinics and integrated pharmacy capabilities with the goal of becoming the new, trusted front door to health care.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0ff50622aaab447d954c0ee8426c3dda" continuedAt="ia3faf5c0acbb48a9924d5f2446f6b51e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction has been accounted for using the acquisition method of accounting which requires, among other things, the assets acquired and liabilities assumed to be recognized at their fair values at the date of acquisition. <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzU2NDU_66b72676-08d6-479d-8c93-6c3d1a5e7da6" continuedAt="i73ed02546aca4cc18d2b99498a3046a3" escape="true">The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i73ed02546aca4cc18d2b99498a3046a3"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.988%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzEtMS0xLTEtMA_d94f4c57-9ae1-46ca-a4a4-f6dc4c19b95c">6,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzItMS0xLTEtMA_a8be9a1f-ba22-4375-bc81-89a0046de5e9">4,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzMtMS0xLTEtMA_d7a49563-d99f-43bb-8675-07c5d2bc46ad">3,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments (current and long-term)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzQtMS0xLTEtMA_f37c2009-ec97-40c0-a0ea-80fd75b3e8ab">17,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzUtMS0xLTEtMA_a79f15ff-4624-4e67-a84f-eb60c276a78e">47,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzYtMS0xLTEtMA_7df8cc95-0c7e-4783-955e-25bf15ff1ca5">22,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzctMS0xLTEtMA_9ad46191-3201-4e66-93b6-b06e56f41209">8,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzgtMS0xLTEtMA_1e09777f-6832-4863-bcc1-1f5e9e0fa96a">111,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzktMS0xLTEtMA_6af22f3b-3a81-4d71-b5df-b381d929d877">5,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzEwLTEtMS0xLTA_96ba5bd7-fa58-4fdd-a3d1-a01783740172">9,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt (current and long-term)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzExLTEtMS0xLTA_6cfc735b-3ee1-4979-b022-97a0a49b5abb">8,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzEyLTEtMS0xLTA_e6ce5b93-ce83-4ceb-8fe1-efeb6ffc1c35">4,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzEzLTEtMS0xLTA_3da94794-c212-4c83-b1d5-7b3e546b13a8">13,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzE0LTEtMS0xLTA_1487ba56-fc2a-4238-9a0a-c592d82bd69e">41,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzE1LTEtMS0xLTA_15bad4db-0774-456e-8f23-df970486c09d">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzE2LTEtMS0xLTA_67abc7a9-8881-4671-9730-847bceaf7cd5">69,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s assessment of the fair value of assets acquired and liabilities assumed was finalized during the fourth quarter of 2019. Measurement period adjustments to assets acquired and liabilities assumed during the&#160;year ended&#160;December 31, 2019&#160;primarily were due to additional information received related to certain intangible asset valuations and contingencies and the related impact on the accounting for income taxes and goodwill. There were no material income statement measurement period adjustments recorded during the&#160;year ended&#160;December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated operating results for the year ended December&#160;31, 2018, included $<ix:nonFraction unitRef="usd" contextRef="ie8f88d1feca14fab9af82ff64e292817_D20181128-20181231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzIwODQ_554f46ba-e43e-4236-8179-a3a71aaec86c">5.6</ix:nonFraction> billion of revenues and $<ix:nonFraction unitRef="usd" contextRef="ie8f88d1feca14fab9af82ff64e292817_D20181128-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzIxMDM_69824231-6779-4a75-8379-4c3e8d7440f7">146</ix:nonFraction> million of income before income tax provision associated with the operating results of Aetna from the Aetna Acquisition Date to December&#160;31, 2018. During the year ended December 31, 2018, the Company incurred transaction costs of $<ix:nonFraction unitRef="usd" contextRef="i1d28d9feed044ba598796ea48b01c29b_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzIzMzY_1e77070d-ab9f-4e67-b687-fed96df80a25">147</ix:nonFraction> million associated with the Aetna Acquisition that were recorded within operating expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Information</span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzU2NDA_e521a1b8-71ef-435a-8224-a2b9ee9d044a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma information presents a summary of the Company&#8217;s combined operating results for the year ended December&#160;31, 2018 as if the Aetna acquisition and the related financing transactions had occurred on January 1, 2018. The following pro forma financial information is not necessarily indicative of the Company&#8217;s operating results as they would have been had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including differences between the assumptions used to prepare the pro forma financial information, basic shares outstanding and dilutive equivalents, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.444%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share data</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTo4M2JlMWMxNjhiNTY0OWI4YWQwN2MzYTI4ODgwNzUwMC90YWJsZXJhbmdlOjgzYmUxYzE2OGI1NjQ5YjhhZDA3YzNhMjg4ODA3NTAwXzItMS0xLTEtMA_01bc2de0-8c90-4e71-80ca-c8099f953b1a">243,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTo4M2JlMWMxNjhiNTY0OWI4YWQwN2MzYTI4ODgwNzUwMC90YWJsZXJhbmdlOjgzYmUxYzE2OGI1NjQ5YjhhZDA3YzNhMjg4ODA3NTAwXzMtMS0xLTEtMA_d3278028-dadf-4fbd-a54b-d5bd834bbf58">1,152</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share from continuing operations attributable to CVS Health </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTo4M2JlMWMxNjhiNTY0OWI4YWQwN2MzYTI4ODgwNzUwMC90YWJsZXJhbmdlOjgzYmUxYzE2OGI1NjQ5YjhhZDA3YzNhMjg4ODA3NTAwXzQtMS0xLTEtMA_2a2f93e6-4a15-4edd-9e0a-5391b43a083f">0.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share from continuing operations attributable to CVS Health</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="2" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTo4M2JlMWMxNjhiNTY0OWI4YWQwN2MzYTI4ODgwNzUwMC90YWJsZXJhbmdlOjgzYmUxYzE2OGI1NjQ5YjhhZDA3YzNhMjg4ODA3NTAwXzUtMS0xLTEtMA_1bd9ac02-5c3f-46b8-abf0-eafc4e193b6e">0.88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia3faf5c0acbb48a9924d5f2446f6b51e" continuedAt="ib3adb6f36bcc403e89d06b4a0e83b7ba"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma results for the year ended December&#160;31, 2018 include adjustments related to the following purchase accounting and acquisition-related items:</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elimination of intercompany transactions between CVS Health and Aetna;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elimination of estimated foregone interest income associated with (i) cash assumed to have been used to partially fund the Aetna Acquisition and (ii) adjusting the amortized cost of Aetna&#8217;s investment portfolio to fair value as of the completion of the Aetna Acquisition;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elimination of historical intangible asset, deferred acquisition cost and capitalized software amortization expense and addition of amortization expense based on the values of identified intangible assets;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Additional interest expense from (i) the long-term debt issued to partially fund the Aetna Acquisition and (ii) the amortization of the fair value adjustment to assumed long-term debt.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Additional depreciation expense related to the adjustment of Aetna&#8217;s property and equipment to fair value;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjustments to align CVS Health&#8217;s and Aetna&#8217;s accounting policies;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elimination of transaction related costs; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Tax effects of the adjustments noted above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Workers&#8217; Compensation Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, the Company sold its Workers&#8217; Compensation business for approximately $<ix:nonFraction unitRef="usd" contextRef="i6292fcfab69c48809cd6df0bbb16e7ba_D20200731-20200731" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzIxOTkwMjMyNjMxMDY_df6d95dd-9e68-489c-9bb7-9f25b45d26c7">850</ix:nonFraction>&#160;million. The results of this business have historically been reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $<ix:nonFraction unitRef="usd" contextRef="i686d61205fb142b1bc16e360c062d7f1_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzc2OTY1ODE0MDIxNDQ_20714f19-f14a-44ff-abd4-88c1373c17c2">269</ix:nonFraction> million in the year ended December&#160;31, 2020, which is reflected as a reduction in operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Brazilian Subsidiary</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2019, the Company sold its Brazilian subsidiary, Onofre, for an immaterial amount. Onofre operated <ix:nonFraction unitRef="store" contextRef="ie10ef6a4cf20405a8bbbdaffe804df04_I20190701" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzQ2MzA_c03138ea-d4a2-4165-b42e-2c65e9a252b5">50</ix:nonFraction> retail pharmacy stores, the results of which historically had been reported within the Retail/LTC segment. The Company recorded a pre-tax loss on the divestiture of $<ix:nonFraction unitRef="usd" contextRef="i15adb3671036492cbdf9d10285213988_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzQ3OTg_25964665-6a3a-43e1-8e47-7cfe4fc2fc09">205</ix:nonFraction> million in the year ended December 31, 2019, which primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#8217;s consolidated statement of operations within the Retail/LTC segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of RxCrossroads Subsidiary</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib3adb6f36bcc403e89d06b4a0e83b7ba">On January 2, 2018, the Company sold its RxCrossroads subsidiary, the results of which had historically been reported within the Retail/LTC segment, to McKesson Corporation for $<ix:nonFraction unitRef="usd" contextRef="i69096b9bb0844234beb55f386ccdbcdd_D20180102-20180102" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzUzMDk_de622593-5f31-42a2-8bf7-ff0ee7e26212">725</ix:nonFraction> million. The Company recorded a pre-tax loss on the divestiture of $<ix:nonFraction unitRef="usd" contextRef="i7c5ea305571c4ec78c8dbf812bcf4b08_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzIxOTkwMjMyNjMzMDY_24c6e5ed-2d30-403a-a92d-adcbe7d8d671">86</ix:nonFraction> million in the year ended December 31, 2018 which was reflected in operating expenses in the Company&#8217;s consolidated statement of operations within the Retail/LTC segment.</ix:continuation> </span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_130"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MTM_4fe1bd5b-b3ab-4276-8b51-25ed8aab987f" continuedAt="if81c77c4e5a8441fbdaaae0923245e5a" escape="true">Investments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if81c77c4e5a8441fbdaaae0923245e5a" continuedAt="if4624f2ac909469694dee9af4290265d"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="cvs:TotalInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MjY_dd3e879e-1db1-4b72-b1a1-201265587c04" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46cc0ed8444447369f7ffb60b023dfe9_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzItMS0xLTEtMA_8648fbd3-a93e-4ad4-bd64-40294b01ea14">2,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46cc0ed8444447369f7ffb60b023dfe9_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzItMy0xLTEtMA_f79f7b14-4be5-423d-b645-55e3df5d9d08">18,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46cc0ed8444447369f7ffb60b023dfe9_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzItNS0xLTEtMA_32a31413-c9b6-4c61-a054-6c6e5c4f9955">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b98a93f0276459b890b573fb626a088_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzItNy0xLTEtMA_4835a9cd-ec0d-4885-9bd3-423ed3d886d6">2,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b98a93f0276459b890b573fb626a088_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzItOS0xLTEtMA_11c99a24-72f2-4161-9142-5c27195afdec">14,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b98a93f0276459b890b573fb626a088_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzItMTEtMS0xLTA_63c087f9-1a29-493a-b016-a1ed74f910ab">16,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67b9d5fd1cd48469659ac7a217ebce6_I20201231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzMtMS0xLTEtMA_a4c52691-da97-4eb5-ac1e-df04304c49a7">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67b9d5fd1cd48469659ac7a217ebce6_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzMtMy0xLTEtMA_db2db764-13e7-4bb7-aa4f-dd7a08a00876">821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67b9d5fd1cd48469659ac7a217ebce6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzMtNS0xLTEtMA_4e72ac5e-08eb-48ea-9e24-ba858d8e2258">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ac54c8ef3a4dbaa343b9df3e53741c_I20191231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzMtNy0xLTEtMA_0ab52796-279e-43e5-80c4-5a48dd8169fc">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ac54c8ef3a4dbaa343b9df3e53741c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzMtOS0xLTEtMA_82ccb48a-ff33-436e-8a1d-54826fcaad16">1,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ac54c8ef3a4dbaa343b9df3e53741c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzMtMTEtMS0xLTA_465b79a9-29e2-465c-a4ad-ae88cc219903">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da7e2dfa74045cdb18889001920c71c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzQtMS0xLTEtMA_a7edc7c8-b633-470c-a9ba-f6673c04168a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da7e2dfa74045cdb18889001920c71c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzQtMy0xLTEtMA_fb26d540-0cf9-4ad8-bce3-3c5755047d46">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da7e2dfa74045cdb18889001920c71c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzQtNS0xLTEtMA_166f2124-7bfb-40bb-9a9e-141a73211b79">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5230461e9b449448da7c51080282d09_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzQtNy0xLTEtMA_c4aef8cc-3a79-4f14-9a34-6f8638361db4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5230461e9b449448da7c51080282d09_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzQtOS0xLTEtMA_659856ef-32e9-4b6c-a3c3-dbb2a9766cbf">1,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5230461e9b449448da7c51080282d09_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzQtMTEtMS0xLTA_af85ce81-eb61-43d0-8731-df6c7c452c49">1,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzUtMS0xLTEtMA_0d442db2-31c8-4024-aa93-c37265aee1c6">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzUtMy0xLTEtMA_e7a33b23-c302-4756-8a36-ee52946a776b">20,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzUtNS0xLTEtMA_f86db9ce-7c07-4da4-81aa-4f80123b84cc">23,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzUtNy0xLTEtMA_a3a2c141-db70-4114-ab58-5d365f9ece88">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzUtOS0xLTEtMA_77bd9216-980b-4dac-96ce-3e0735ed7a63">17,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzUtMTEtMS0xLTA_070e6517-239e-4c18-b1d8-f3fcc0b39160">19,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, the Company held investments of $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestrictedInvestmentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEzNA_03fc4234-de99-4c7d-ba0c-5f9f9b858f95">524</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestrictedInvestmentsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzE0MQ_ea6cdeca-3c7e-4ff3-abc7-427629964dac">537</ix:nonFraction> million, respectively, related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract. The conversion occurred prior to the Aetna Acquisition. These investments are included in the total investments of large case pensions supporting non-experience-rated products. Although these investments are not accounted for as Separate Accounts assets, they are legally segregated and are not subject to claims that arise out of the Company&#8217;s business and only support future policy benefits obligations under that group annuity contract. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="if4624f2ac909469694dee9af4290265d" continuedAt="i11b5110b1c01421e85f4ca5a08d4ab79"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4Mjc_6528f4a2-e281-45c6-9ec4-19c319b52707" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.701%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzMtNS0xLTEtMTEzNA_c1257545-6b66-409d-9ff5-ea753979fd34">2,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzMtMy0xLTEtMA_fa8cf7d2-866f-4d51-8bb6-97fd08f23623">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzMtNS0xLTEtMA_a4b34937-b393-499f-939e-38a35b385849">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzMtNy0xLTEtMA_fc728133-5cae-418d-bd1f-0e4280ddfeab">2,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzQtNS0xLTEtMTEzNA_768f1d34-85bb-4865-9708-6667b15d95e8">2,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzQtMy0xLTEtMA_ba637936-83ed-4b9f-a059-e5d13c434a88">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzQtNS0xLTEtMA_f0a83a60-3229-4d39-ba71-8246668c4882">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzQtNy0xLTEtMA_82262999-6367-4369-85c1-0e3adb1897cf">2,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzUtNS0xLTEtMTEzNA_47809627-0662-444d-a01d-ce0130259972">7,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzUtMy0xLTEtMA_13f13330-a3a3-4249-a2a5-62cf8cc00a90">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzUtNS0xLTEtMA_bfdc2e42-c0ef-4c49-bfbe-86b05e2e3064">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzUtNy0xLTEtMA_c8d8d623-0f7a-48a9-8afc-66976f746f45">8,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzYtNS0xLTEtMTEzNA_0086c75d-c66c-423a-bef4-c157b290dde3">2,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzYtMy0xLTEtMA_c5b7c350-b79d-4325-b775-d708fcc69a97">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzYtNS0xLTEtMA_804c3052-42a0-4475-bca9-4c9c601e1015">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzYtNy0xLTEtMA_d4341eff-7fea-4c14-8afa-8ff09c23776f">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzctNS0xLTEtMTEzNA_41841331-4fc4-4911-917d-62552cd17f9e">673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzctMy0xLTEtMA_78d56d17-deb2-48f2-82b5-bfc9baed031f">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzctNS0xLTEtMA_0d9c2077-96d2-497f-8ef1-4ada3906c04f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzctNy0xLTEtMA_40457892-adf8-4029-a74c-3b3fc6c8a5db">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzgtNS0xLTEtMTEzNA_d9ab6a64-af97-4b73-bd25-a48252428f92">962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzgtMy0xLTEtMA_e5874ca7-4a34-4880-97a2-9917d3e33257">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzgtNS0xLTEtMA_35562dc5-d85f-47e9-b2f3-a94ae50e0136">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzgtNy0xLTEtMA_342058e9-caf8-4aaf-89c2-473a67e63cc7">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzktNS0xLTEtMTEzNA_58d286b6-7b37-49f0-91a8-a64d522c8e73">2,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzktMy0xLTEtMA_0816eb63-b80a-4af9-84cf-76d2db3d090a">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzktNS0xLTEtMA_ecb5949a-d1ae-4908-b9c3-1228d23b2ec9">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzktNy0xLTEtMA_fbad9ea6-f760-4f9e-8444-f740dc1d50bd">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2afaaa9709c42e3912403cd458a7e31_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzEwLTUtMS0xLTExMzQ_071086b8-4cda-43d5-97fe-abd2c9985d7b">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2afaaa9709c42e3912403cd458a7e31_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzEwLTMtMS0xLTA_607d9be9-f400-4c84-931f-2ccb109224c2">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2afaaa9709c42e3912403cd458a7e31_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzEwLTUtMS0xLTA_467d4bd5-9218-4bc0-b7f7-4be37af19ab0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2afaaa9709c42e3912403cd458a7e31_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzEwLTctMS0xLTA_d1188fd4-d164-41c1-9498-46af5caa7e2d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzExLTUtMS0xLTExMzk_74fb10de-0901-4114-8617-6fa097e208b2">19,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzExLTMtMS0xLTA_71886b95-6b39-48a6-83b2-5c93c7455376">1,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzExLTUtMS0xLTA_4414e1c9-6e20-4fad-acbb-90b267f4729f">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzExLTctMS0xLTA_0f649a0f-450a-46d0-98ce-110caf6fc3d4">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE1LTUtMS0xLTExNDI_f9f8f60a-47a3-4774-9788-40a9210565ae">1,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE1LTMtMS0xLTA_445c2c90-8dad-4f1f-8fea-2e9926356737">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE1LTUtMS0xLTA_c749b904-13f3-4415-98da-2afb1caa47f0">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE1LTctMS0xLTA_34cdad35-9c20-451f-a832-cf84dce5d7e0">1,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE2LTUtMS0xLTExNDI_2c74b41e-48ce-43c4-ac53-f094811652b4">2,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE2LTMtMS0xLTA_06d46a6c-7804-4fe0-bca7-962595b71fae">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE2LTUtMS0xLTA_c9c99f16-b2cd-42c2-bb32-d051d3f5f5fa">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE2LTctMS0xLTA_54df960c-cc76-4b19-8986-4df26a07c406">2,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE3LTUtMS0xLTExNDI_6cad7906-7724-497e-b45a-fab4b5175b9e">7,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE3LTMtMS0xLTA_81f50761-a078-4323-93c8-693ce639d4f6">573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE3LTUtMS0xLTA_32550256-9d6b-4865-bf7c-3a628f87f929">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE3LTctMS0xLTA_ed80c49a-5915-4ef8-9dc2-8be91eaaed8f">7,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE4LTUtMS0xLTExNDI_afa1e72f-a678-4fdc-9d92-9eee67c10a9d">2,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE4LTMtMS0xLTA_136e2697-c85b-484f-bd5a-cc99ebf3a767">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE4LTUtMS0xLTA_09ede9a1-e47b-47b8-898f-13fa9ac448c8">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE4LTctMS0xLTA_854be920-ea55-4b8b-b293-2f6d75c8a538">2,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE5LTUtMS0xLTExNDI_baa1bc6a-80db-4314-8798-9a0c802e2713">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE5LTMtMS0xLTA_f5fd8ea2-7b64-4ffd-963c-ef06482d879d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE5LTUtMS0xLTA_fce4ea08-b1dd-4dec-a0e5-5c0ac08aa134">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE5LTctMS0xLTA_f993e9e3-4996-4e47-ae93-f9c79d3850dd">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIwLTUtMS0xLTExNDI_3399d14f-36dd-449c-8141-5cdb232d1b45">654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIwLTMtMS0xLTA_c19f5736-7674-4498-9270-0d8e18caba55">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIwLTUtMS0xLTA_03a25157-5acf-4ef3-b396-9c6c10f9ecb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIwLTctMS0xLTA_77337ca7-5ce6-4aa0-a13f-0c0f3dd02a85">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIxLTUtMS0xLTExNDI_da140a54-35e4-47af-bf05-3f9b335b7355">1,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIxLTMtMS0xLTA_030db6a7-7967-4fa1-9e65-e1e95d266ac2">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIxLTUtMS0xLTA_7f57ac90-a211-4c40-b33e-8c11b036e42f">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIxLTctMS0xLTA_1405e756-e266-4042-9b98-aa5c7ce9b214">1,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f07a8fe7175442fbcc819fecef5c309_I20191231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIyLTUtMS0xLTExNDI_241bcee7-46db-4db0-ae12-7c2dc45f3c4d">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f07a8fe7175442fbcc819fecef5c309_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIyLTMtMS0xLTA_b375dbda-94e6-4e83-a792-88d8acd90b5e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f07a8fe7175442fbcc819fecef5c309_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIyLTUtMS0xLTA_d6d21e13-92b9-4fa3-913a-a2642a9c54a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f07a8fe7175442fbcc819fecef5c309_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIyLTctMS0xLTA_82175cf0-d0f0-475a-a1d7-39b5afb7f470">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIzLTUtMS0xLTExNDI_2a3793cc-fc34-4a2e-baf7-dad1c78b5fb1">15,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIzLTMtMS0xLTA_d9783e18-c523-4370-b91f-827a0b2a5ca8">1,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIzLTUtMS0xLTA_0749790c-6e49-495a-9a73-e007a2f60410">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIzLTctMS0xLTA_aa8218a8-8690-4c1c-ad5a-e725612de298">16,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective January 1, 2020, the Company adopted the available-for-sale debt security impairment model under ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments -Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 326). The new impairment model requires the write down of amortized cost through an allowance for credit losses, rather than through a reduction of the amortized cost basis of the available-for-sale debt security. There was <ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzIxOTkwMjMyNjgwNDg_ef5f73da-0dd3-414f-8285-b28bd3e11b13">no</ix:nonFraction> allowance for credit losses recorded on available-for-sale debt securities at December&#160;31, 2020. As the Company adopted the new available-for-sale debt security impairment model on a prospective basis, there was no allowance for credit losses recorded on available-for-sale debt securities at December 31, 2019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results.&#160;At December&#160;31, 2020, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEwNDQ_654cc5ed-6c99-492f-82c7-7ed677f40198">919</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEwODI_18144ba4-878b-4717-ad11-165460732bff">135</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEwODk_d45bcf5a-527b-4be7-8ca9-8a10b24e7a18">no</ix:nonFraction> gross unrealized capital losses and at December&#160;31, 2019, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i2ecf8dcd90f14826a44fd5403301707d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzExNzM_943643c3-ba3e-44f8-b8f6-7ca1e99b7478">965</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i2ecf8dcd90f14826a44fd5403301707d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEyMTE_91675451-b709-458b-b6a7-a64e4ef1db00">83</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="i2ecf8dcd90f14826a44fd5403301707d_I20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEyNTM_dbc6f691-20fe-4a5d-8a6c-2f2770894ef8">no</ix:nonFraction> gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i11b5110b1c01421e85f4ca5a08d4ab79" continuedAt="ib27b4dd3ff214ce68413fbd576bb006f"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MzE_86fe17ec-54a5-4234-a28f-c7e3c50fa8c4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at December&#160;31, 2020 are shown below by contractual maturity.&#160;&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzItMS0xLTEtMA_fbf2c0fb-2c27-4b35-ad1f-e00e627d70ae">1,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzItMy0xLTEtMA_eca607d5-fecd-47be-a834-1d7ae9405d12">1,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzMtMS0xLTEtMA_93291ef1-f7c1-437f-845c-965311b9de75">6,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzMtMy0xLTEtMA_ed72d453-e27e-4fd9-81ca-465c73750a65">6,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzQtMS0xLTEtMA_88e12cd4-a052-4f4a-9586-beff0789d485">3,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzQtMy0xLTEtMA_e7d0876d-ab8d-46d2-8b59-8e18978f9520">4,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzUtMS0xLTEtMA_4eac8034-0468-41b8-91f1-6e2dba89fc75">4,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzUtMy0xLTEtMA_08265e83-d72e-4c3b-b9c6-5514ee20807c">4,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzYtMS0xLTEtMA_3cff4d66-edb0-407e-8308-9bf08b11d02b">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzYtMy0xLTEtMA_f49ed962-2d94-4d81-a9be-148b7d7f175d">705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzctMS0xLTEtMA_07c17a51-bdfa-4505-b13f-a491e129e08e">962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzctMy0xLTEtMA_2d0a4285-d8be-418e-8b5a-b81b1c6b5acf">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzgtMS0xLTEtMA_14272890-c998-4e4b-bf4d-13dbfda69fc3">2,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzgtMy0xLTEtMA_35370964-f1c4-4f67-bd5c-f9bc5873bab3">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzktMS0xLTEtMA_8ca1bdda-95a0-4544-92c5-4dad083b6081">19,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzktMy0xLTEtMA_28aad065-af3b-441a-8b4d-12e63101a737">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage-Backed and Other Asset-Backed Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s residential mortgage-backed securities at December&#160;31, 2020 were issued by the Government National Mortgage Association, the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation and carry agency guarantees and explicit or implicit guarantees by the U.S. Government.&#160;At December&#160;31, 2020, the Company&#8217;s residential mortgage-backed securities had an average credit quality rating of AAA and a weighted average duration of <ix:nonNumeric contextRef="i676e7b8c5a05475e91e66c6e8684f644_D20200101-20201231" format="ixt-sec:duryear" name="cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzIyMzk_bb156071-027e-4a28-8dba-14f19cecb3b3">2.4</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States. Significant market observable inputs used to value these securities include loss severity and probability of default.&#160;At December&#160;31, 2020, these securities had an average credit quality rating of AAA and a weighted average duration of <ix:nonNumeric contextRef="i70ae98000fd546eea670504ba0d63d0a_D20200101-20201231" format="ixt-sec:duryear" name="cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzI1ODc_0a172d70-829e-412e-a3d0-885e4ab605d7">6.1</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card receivables, home equity loans and commercial loans). Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default.&#160;At December&#160;31, 2020, these securities had an average credit quality rating of AA and a weighted average duration of <ix:nonNumeric contextRef="i4c483eeffe6d4d83b95ee855c212d24f_D20200101-20201231" format="ixt-sec:duryear" name="cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzMwMTA_be8cebb1-5ad1-4752-a57e-2b771d75e77c">1.1</ix:nonNumeric> years.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib27b4dd3ff214ce68413fbd576bb006f" continuedAt="i488d44edc9eb4784bc76a40ec54eb35f"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MzI_a22757de-6fde-43f2-8faf-5c1e9eb25c34" continuedAt="ieb117f5262df4d00be7ae21979592f09" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at December&#160;31, 2020 and 2019 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/> Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/> Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/> Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtMS0xLTEtMA_42812586-59df-458c-a7a4-1b96175bf366">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtMy0xLTEtMA_cb1ffbb5-e7bf-4443-9492-c346ae35f627">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtNS0xLTEtMA_db964fe0-4bcc-4ded-abbe-7b892a3f9741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtNy0xLTEtMA_064b0b5c-ff3c-41b0-8900-d71aab314bb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtOS0xLTEtMA_21c3c087-820f-4e96-9a2f-1ebf3fb15710">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtMTEtMS0xLTA_a6f945a9-639f-469f-aabd-11d30583d4a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtMTMtMS0xLTA_169ea7de-b9ec-4904-b258-d74b17dfab79">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtMTUtMS0xLTA_6b6627ea-02d0-45b7-8f62-8ebf21aa0572">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtMTctMS0xLTA_694a0c18-2b5f-4b59-ba44-5feacfa6bc73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtMS0xLTEtMA_a8813031-e855-432e-b677-8737ca64798b">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtMy0xLTEtMA_d96231a0-5c2b-4f57-be95-0741966b7965">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtNS0xLTEtMA_2a621b5a-41db-4a66-bbef-05b93d6e3129">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtNy0xLTEtMA_3e24d3d9-bc1c-4460-a1b3-6c704f5a8493">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtOS0xLTEtMA_23e24ea3-9abe-4c8c-b829-d674c31e65c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtMTEtMS0xLTA_b6f0978f-ed79-4015-a4ba-8898d3cefc8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtMTMtMS0xLTA_11993778-370f-46ec-b6ab-f7d69e921038">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtMTUtMS0xLTA_22240681-abfc-4ee7-9c57-02d0d8403063">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtMTctMS0xLTA_d2eaf29f-97af-448c-b7c2-16a3ffee1f0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtMS0xLTEtMA_550c2502-3688-4c68-9b9c-5f13fa4c2be8">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtMy0xLTEtMA_f2a86c5e-3cfa-4023-a899-b0e400964836">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtNS0xLTEtMA_755f18b9-91c9-4ac9-8dda-80eefb537866">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtNy0xLTEtMA_1fbad2e9-f12f-41f9-9982-22b790687f05">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtOS0xLTEtMA_17374c62-f953-460f-b686-95e1cc84171c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtMTEtMS0xLTA_16fdfa1a-90f3-4e8e-a35c-462b078403e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtMTMtMS0xLTA_52d8cd40-6e70-467b-8c91-fbd3d551595e">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtMTUtMS0xLTA_529ad857-f956-4213-b676-1428919e9300">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtMTctMS0xLTA_ec766eea-08d3-4836-867e-c72e59441810">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctMS0xLTEtMA_939905c9-75e8-427e-98fb-923be4667c1a">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctMy0xLTEtMA_bf860b52-7822-4cde-a2c9-385ea18bc587">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctNS0xLTEtMA_040ed471-20a1-4e70-a00d-60e6aea53938">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctNy0xLTEtMA_80e0ff11-3941-44db-967b-ba9db3bf34a0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctOS0xLTEtMA_975f9eb4-ed28-48d5-b100-6640b2b7027c">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctMTEtMS0xLTA_ecc938d9-94b8-477b-bd38-86d33b815a30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctMTMtMS0xLTA_7616530f-fcf0-473d-a089-3065dd482faa">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctMTUtMS0xLTA_6aa961b7-703d-4e8b-9c59-cd867a22c49f">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctMTctMS0xLTA_c0ac1197-a598-4472-9e46-c711d1dd8609">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtMS0xLTEtMA_4f019339-407b-42ba-b727-8688cb826070">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtMy0xLTEtMA_d4b5f02e-4cb3-47b7-a1d7-b5ca7932adac">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtNS0xLTEtMA_cad0bf5d-0363-47a6-a928-018f90912f86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtNy0xLTEtMA_f49851b5-dc95-44fd-a478-430d8fda0c28">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtOS0xLTEtMA_0fbb481e-7c31-4a68-8c7a-eb9940eb260c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtMTEtMS0xLTA_8c14d3c8-57f6-46ab-ae6e-3dad6cb8e08c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtMTMtMS0xLTA_4925eee9-5116-417d-952a-cca3f25349b8">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtMTUtMS0xLTA_c81c940c-1c24-46c2-8394-933896180677">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtMTctMS0xLTA_7f5e3670-8626-4b59-8c91-89210802daf5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktMS0xLTEtMA_29ffc6f6-c82a-4e9a-ad4c-8bdb6dba6783">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktMy0xLTEtMA_9f4d060f-7847-462f-9df5-bf1ca1051ea7">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktNS0xLTEtMA_11e125ec-4fd5-48fa-af6d-e1e38e4f8e1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktNy0xLTEtMA_498d70a9-7443-45d7-9868-4cdd1c21c7a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktOS0xLTEtMA_0806da98-e2ad-4eae-a6dc-da15e57bd08d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktMTEtMS0xLTA_56c37097-e63e-49cf-b027-d8b2d195485e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktMTMtMS0xLTA_2ab7a1bc-137a-4f0e-bec9-37ae93109606">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktMTUtMS0xLTA_586bc4bb-4d46-4147-a659-21ae326f9d74">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktMTctMS0xLTA_574a5145-0472-4746-91b6-e05e170c6ef9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTEtMS0xLTA_85a2c5d8-4751-4c1b-80b5-7d0488518c90">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTMtMS0xLTA_6c63c255-0c56-4d7d-92eb-fbc7e081ddeb">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTUtMS0xLTA_023dd851-93ca-4df0-b1eb-806f6b37f19a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTctMS0xLTA_4bb85fef-e5d5-4154-a5f0-18000155778e">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTktMS0xLTA_77cf8ccf-1d6e-4aed-a830-a5727daa5022">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTExLTEtMS0w_3eed5de3-7b4f-4496-95ad-451ba3be672c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTEzLTEtMS0w_f9a430bb-c487-469c-a440-280ee5af6c8d">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTE1LTEtMS0w_308dca11-520a-42e2-9158-75504fa3f956">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTE3LTEtMS0w_d9bc2969-045d-46e3-ae64-86a667fd021c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTEtMS0xLTA_cace02ba-5699-4e13-8897-ee6374a590c4">468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTMtMS0xLTA_0f625de6-318b-472c-a2e1-cb428a0eb837">869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTUtMS0xLTA_81086dd6-cf3c-48cd-82a6-6e23889bde32">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTctMS0xLTA_36934914-db61-42a8-947d-6946181355de">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTktMS0xLTA_703a6b1e-0e13-4be8-ad8c-172eb663b48a">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTExLTEtMS0w_0faf84f0-6c77-4731-93e6-85616fbe5beb">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTEzLTEtMS0w_ffb782a6-f16a-4e1c-aec9-7a948ea1f497">527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTE1LTEtMS0w_6390b48f-ea39-47f5-881e-82b4d197728d">915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTE3LTEtMS0w_00e2f4dd-6436-424c-8f01-c1f6ef126c94">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTEtMS0xLTA_87c92971-0d13-4320-9bc1-0a10399b8b7c">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTMtMS0xLTA_bd9780de-8917-4d2d-96be-bd4f96c9790b">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTUtMS0xLTA_3953ddf6-8f4c-40a2-87e6-d1e1bd4af4d3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTctMS0xLTA_bf218856-519d-4844-ab51-ffa41699a414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTktMS0xLTA_a0c21f35-adb5-42cd-898c-810b0681b001">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTExLTEtMS0w_8ebaec85-d563-4a14-b276-dcdbefcfb744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTEzLTEtMS0w_de45632c-60b9-495a-b7c8-41566b26a974">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTE1LTEtMS0w_d124e38a-fea1-4b67-9a66-06b4dde089f5">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTE3LTEtMS0w_cbd5a035-16a6-44b8-8203-8db262151ef1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTEtMS0xLTA_fc96e2e9-5338-491d-a23f-5886e2d6d37e">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTMtMS0xLTA_e7b65bdf-2658-445f-ac39-4afeb65250ae">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTUtMS0xLTA_59713b98-3c0f-43e8-953a-996bce9b772d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTctMS0xLTA_c13d86c1-0fb6-468a-ae9d-26496c4df119">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTktMS0xLTA_9b14664d-6751-4511-8e30-84e8a1389e61">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTExLTEtMS0w_cd529200-94fa-42a2-8d37-946e65036e30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTEzLTEtMS0w_66058a56-15e5-4ad8-b595-890880c0d64f">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTE1LTEtMS0w_f860fcc3-f7a2-4162-9e7f-7f692dfebf45">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3c9a60aa719471988bfddae88c14375_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTE3LTEtMS0w_7b8b49e5-e1ac-499e-8828-de1bc4f7ce10">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTEtMS0xLTA_bcbf9506-21bc-41d0-86de-46dcafe3c064">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTMtMS0xLTA_d37f7285-2345-4be2-88cd-1bfd906ea634">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTUtMS0xLTA_720a920f-f146-4e2c-98a5-b092fbf51fac">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTctMS0xLTA_9891a545-6176-4963-be5c-f121c019e95b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTktMS0xLTA_e2ed23d9-22e4-43a0-a6f2-f9227a34922b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTExLTEtMS0w_959531eb-1c83-450c-b6c8-d663b89d4150">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTEzLTEtMS0w_18a746b7-0448-4b43-a44d-0b1d77bbcf14">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTE1LTEtMS0w_e97068cd-f108-48db-b8d3-829a74e911f6">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTE3LTEtMS0w_0f97fc80-f5be-4ce8-812c-04a873d6566c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTEtMS0xLTA_39b12e9e-ba89-4b08-afd5-6d348b40b795">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTMtMS0xLTA_301d251c-25c3-4564-ace2-824fa5925bd0">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTUtMS0xLTA_bf034373-b73f-47a1-bee1-45899eaf11aa">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTctMS0xLTA_d4cec547-3234-4ebc-b4ea-8180429ae8ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTktMS0xLTA_cafb974e-1cc1-45be-a005-d823e5611e33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTExLTEtMS0w_37e8dc1f-693b-4139-894d-7f7a11bd11c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTEzLTEtMS0w_8d985d5d-c5cd-4941-8dcc-fdce29f3fe43">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTE1LTEtMS0w_ae917944-1afb-43ff-8c0c-85545c8d9b5b">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTE3LTEtMS0w_fa8ee60d-e3d4-4dce-95b5-8d83bd013e41">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTEtMS0xLTA_245fd56a-3632-4bee-a64d-12fc7d492896">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTMtMS0xLTA_f47265a1-8015-40f8-948c-27f61f821b05">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTUtMS0xLTA_2cf33108-7b92-464f-9a4f-ca56af033523">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTctMS0xLTA_b537ae05-9aa5-4e99-a78a-55d3e820fdd3">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTktMS0xLTA_d24ecbc1-68f0-4339-b5b8-a2d74fb4777f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTExLTEtMS0w_e64f94f9-f2e9-4368-8530-57dba2ff44d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTEzLTEtMS0w_bd35be3e-f505-4176-b22c-5086d585d3fc">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTE1LTEtMS0w_3210a9c2-6d6f-4dc8-88d6-012edd3eb6a3">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTE3LTEtMS0w_780c5b02-8766-4e45-a97d-1e88ca0140b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTEtMS0xLTExMDU_8ac876b4-e00c-4c75-9d86-ef8e737562f4">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTMtMS0xLTExMDU_c0e6478d-866f-45af-9ecb-dcd59c0d0041">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTUtMS0xLTExMDU_1350a5cb-d3d9-4d7b-97e3-1191c39e62d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTctMS0xLTExMDU_a1ca3402-f2b3-4982-96af-7992cf4e584f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTktMS0xLTExMDU_77da021d-641e-47af-a7b9-68639fa454ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTExLTEtMS0xMTA1_41f503fd-9824-4dbc-a50e-4b1c6283065c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTEzLTEtMS0xMTA1_64535fbb-9191-4f43-aa13-5e14a5f04779">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTE1LTEtMS0xMTA1_92e59fd3-8f40-44a0-8b15-ee6a9474aad2">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTE3LTEtMS0xMTA1_fc12ce3d-64b7-4e67-a8e0-ceae1a9ca9ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTEtMS0xLTA_16a796cb-871a-4bb1-aa9a-a637025b8adf">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTMtMS0xLTA_b9216b4b-2f82-47e1-a879-7e3b42dc934b">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTUtMS0xLTA_0ca6d39f-4f31-46d5-a557-0c6d231dd83b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTctMS0xLTA_03fea508-fed6-4bcc-89e2-01afe824f5d7">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTktMS0xLTA_c3936ff2-3d1b-4159-9ecc-a9f0028cced7">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTExLTEtMS0w_ef61aa63-7d87-477e-8e7e-b581d2d1bcf4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTEzLTEtMS0w_2c919f33-9216-4cd7-9ce4-17ac8f536ea9">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTE1LTEtMS0w_d41cfa7a-b1c2-4985-b3ab-b66aacb7dc1e">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTE3LTEtMS0w_ad336a47-9f72-4d05-ac13-34f6b7b53740">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTEtMS0xLTA_fcb3a33a-ff77-4fba-8f76-1a8449177ea5">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTMtMS0xLTA_76bb6460-4329-4a7e-9fd1-bc4baad1616f">982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTUtMS0xLTA_d879f9da-d77e-4b1a-bcb1-745a443dd267">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTctMS0xLTA_30f76960-d0d5-46a3-ac93-9a48b5988d96">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTktMS0xLTA_595f0a77-d90e-4ef3-a28b-f013a6ad8d69">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTExLTEtMS0w_5183c176-d121-46e3-a76c-7b1b93775331">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTEzLTEtMS0w_7cded46e-ba45-4341-ad5c-870d5027e533">722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTE1LTEtMS0w_378d9b42-d5ab-44c5-b4d4-d17ed550dc04">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTE3LTEtMS0w_91f33866-9abf-4e56-845c-8066e971b6c4">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. As of December&#160;31, 2020, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i488d44edc9eb4784bc76a40ec54eb35f" continuedAt="i97674ecf74df4d549bbf86098838f76a"><ix:continuation id="ieb117f5262df4d00be7ae21979592f09"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.432%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting experience-<br/>rated products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting remaining<br/>products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzMtMS0xLTEtMA_54d4b443-b641-45f0-ba79-e9041a345934">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzMtMy0xLTEtMA_7c6f4d3f-bd45-4697-ab6e-affbb5cfb69e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzMtNS0xLTEtMA_c0d0f3c3-e3bb-4fc2-bc3e-3f29d086eabb">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzMtNy0xLTEtMA_daee8d10-9feb-4894-aa74-6876ce4cf952">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzMtOS0xLTEtMA_1528e00f-ff2a-449d-9dab-7e9100ac426e">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzMtMTEtMS0xLTA_e1e30465-9b72-4875-bc84-148f8589be37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzQtMS0xLTEtMA_be8c5805-32e1-464a-9aef-b7935c159a24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzQtMy0xLTEtMA_9a7195ca-f7a6-4b39-bdda-0efedb42e083">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzQtNS0xLTEtMA_7b6f3770-4146-4295-a918-0792f7f1e7bf">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzQtNy0xLTEtMA_da01697c-f2b4-4a41-8070-a148d1c68443">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzQtOS0xLTEtMA_4532222f-214c-40e6-ba09-ed4ddbcc503c">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzQtMTEtMS0xLTA_0567d91e-e046-438a-8186-ff1745cf5ca8">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzUtMS0xLTEtMA_36c2cb1d-a62c-48e7-b69e-876386900865">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzUtMy0xLTEtMA_63aae4b7-c2b1-4bdd-a539-21f53405a724">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzUtNS0xLTEtMA_1a192fb5-1c68-4c38-8980-6b2387e26a0a">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzUtNy0xLTEtMA_11bbeb68-9b85-4094-8b97-7d380bcdfaf4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzUtOS0xLTEtMA_13f0e5d6-dc7a-4100-9500-4d0931bb6a9a">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzUtMTEtMS0xLTA_febf5705-904b-4e55-8f24-1fabd1bff26e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzYtMS0xLTEtMA_785df94d-e068-484d-afce-f0156b6d66ba">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzYtMy0xLTEtMA_ee9ff35f-cce1-456b-bd39-2977fe53de80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzYtNS0xLTEtMA_c7873ed0-f5ab-4cbb-a3c7-1457910cc24a">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzYtNy0xLTEtMA_be608823-5c29-4ffd-aee1-5023bae44fd4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzYtOS0xLTEtMA_607888cb-4bc4-4804-b00b-2455fe6cc69a">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzYtMTEtMS0xLTA_3f0b4cd3-9a36-4fe4-8550-ecad77b5a9d0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac96be526caf4447bbf555aac1a17ecd_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzctMS0xLTEtMA_9473a863-a2aa-4565-a13d-9c8a7af1e51b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac96be526caf4447bbf555aac1a17ecd_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzctMy0xLTEtMA_d070aaba-25f4-4486-9b38-4909a094e0dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2862acbf1b084e6790226fec4b8bacae_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzctNS0xLTEtMA_3e34f13c-a693-410b-aa9c-f13e8331e033">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2862acbf1b084e6790226fec4b8bacae_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzctNy0xLTEtMA_8284e7f8-f00b-40dd-b74a-b63a970742af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzctOS0xLTEtMA_e373f135-f7a4-478f-97c3-c86fa0a28779">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzctMTEtMS0xLTA_fb2a91a4-a517-492b-bfd2-af257c7c8340">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id096a5fb170740c39d0deca267bf7d45_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzgtMS0xLTEtMA_f6fa41ee-f214-49c3-a5fe-245241148a4b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id096a5fb170740c39d0deca267bf7d45_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzgtMy0xLTEtMA_297f4210-8749-4ae3-8fad-504f52286b0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i994b426c1b84462e8430c20afa88eb28_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzgtNS0xLTEtMA_c0a0c7f7-acbc-42ab-936c-886cabae3e7f">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i994b426c1b84462e8430c20afa88eb28_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzgtNy0xLTEtMA_49ade2b5-0d1f-4e93-a956-d8fa5dd25431">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzgtOS0xLTEtMA_a2e9fa80-f820-4f22-8b34-4c1bb653ee22">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzgtMTEtMS0xLTA_bed485da-9ab4-4b34-90d3-eae4c534714b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if373b00647a647d492b359b2cc518799_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzktMS0xLTEtMA_8ed653af-d2b5-418c-96de-649095e8a241">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if373b00647a647d492b359b2cc518799_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzktMy0xLTEtMA_4a3b586b-8796-401c-bc78-0ba594ded72e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e506a799edf42b6a5cab4f7c3320e36_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzktNS0xLTEtMA_dde46c57-ee3a-4229-bbbe-b7c48396c56e">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e506a799edf42b6a5cab4f7c3320e36_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzktNy0xLTEtMA_0d7c392d-53e7-4ba4-a434-c8571bbe7f1c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzktOS0xLTEtMA_ef50ca9f-4b12-4e17-aec5-b346a0c8b242">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a19c71845964210be53c6d425920e0f_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzktMTEtMS0xLTA_bc02beee-3b97-4d88-900a-e29266c7f9a8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzEwLTEtMS0xLTA_20f6de12-e011-4f78-81b2-9c824658b8d9">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzEwLTMtMS0xLTA_3f43164e-aa94-4bc5-9b52-116af20be12e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzEwLTUtMS0xLTA_2d73b64b-3c2b-4a28-a2d1-d0fd1337ad47">901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzEwLTctMS0xLTA_2ea287b4-ae1f-4a60-9921-9a66a434910d">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzEwLTktMS0xLTA_88a39a78-1828-488c-b09d-8460b23efee0">915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzEwLTExLTEtMS0w_ccd7c06a-1ea1-44c5-ba37-1805986b1d30">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="cvs:ActivityInMortgageLoanPortfolioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4NDI_abfa28e5-89ba-499c-877d-2fd07dc9578e" continuedAt="i6bc360ea81214ce7a1b231feb2051f11" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2020 and 2019, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a9206a1aaa548579a9355991549eb38_D20200101-20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo0ZGZmZjEzOTVjMGE0M2NjOTM1MWVmNTM0YTY4ZGQ1Zi90YWJsZXJhbmdlOjRkZmZmMTM5NWMwYTQzY2M5MzUxZWY1MzRhNjhkZDVmXzEtMS0xLTEtMA_4dc8d2f2-ac9e-4408-a9be-8816790e27cf">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdd643de24674532b6eb565b63aa23ac_D20190101-20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo0ZGZmZjEzOTVjMGE0M2NjOTM1MWVmNTM0YTY4ZGQ1Zi90YWJsZXJhbmdlOjRkZmZmMTM5NWMwYTQzY2M5MzUxZWY1MzRhNjhkZDVmXzEtMy0xLTEtMA_4b37ada6-82e0-424b-a641-f5c149720cf9">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a9206a1aaa548579a9355991549eb38_D20200101-20201231" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo0ZGZmZjEzOTVjMGE0M2NjOTM1MWVmNTM0YTY4ZGQ1Zi90YWJsZXJhbmdlOjRkZmZmMTM5NWMwYTQzY2M5MzUxZWY1MzRhNjhkZDVmXzItMS0xLTEtMA_b0287014-6948-4c5b-8a1c-bb6185bac362">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdd643de24674532b6eb565b63aa23ac_D20190101-20191231" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo0ZGZmZjEzOTVjMGE0M2NjOTM1MWVmNTM0YTY4ZGQ1Zi90YWJsZXJhbmdlOjRkZmZmMTM5NWMwYTQzY2M5MzUxZWY1MzRhNjhkZDVmXzItMy0xLTEtMA_2abc933f-4e1a-4de6-b9ad-7a39abf73473">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a9206a1aaa548579a9355991549eb38_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo0ZGZmZjEzOTVjMGE0M2NjOTM1MWVmNTM0YTY4ZGQ1Zi90YWJsZXJhbmdlOjRkZmZmMTM5NWMwYTQzY2M5MzUxZWY1MzRhNjhkZDVmXzMtMS0xLTEtMA_d2c27d1a-d261-4560-9ab3-028fc2ed6b8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdd643de24674532b6eb565b63aa23ac_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo0ZGZmZjEzOTVjMGE0M2NjOTM1MWVmNTM0YTY4ZGQ1Zi90YWJsZXJhbmdlOjRkZmZmMTM5NWMwYTQzY2M5MzUxZWY1MzRhNjhkZDVmXzMtMy0xLTEtMA_1a7f7ca2-97de-45eb-bf23-bcbc9f13f80e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i97674ecf74df4d549bbf86098838f76a" continuedAt="i55a5757ba61c48b68dc30019d051ff71"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MjI_9f5ad8b0-be28-4454-810a-48fde436d44f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon the Company&#8217;s assessments at December&#160;31, 2020 and 2019, the amortized cost basis of the Company&#8217;s mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.950%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6781fba553a4bf7935fdce6921489c1_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtMS0xLTEtNTA4MQ_ea61db33-b758-4bef-bcac-3c6163a5c98e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6ec62eeb545418f935cd6789b8f043a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtMy0xLTEtNTA4MQ_ee693972-e944-4c94-b93a-28f797b19651">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5f6618b0fa465f9f1f9beb794efccb_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtNS0xLTEtNTA4MQ_01130018-8923-4e34-85aa-f5d1d842878f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i387442e37b5e42a49e054c4423e257a8_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtNy0xLTEtNTA4MQ_f14054de-2faf-4f48-8b5d-29f77ab67d8c">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b8d4e422a0b456caf45c84c95a13c63_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtOS0xLTEtNTA4MQ_0d9908e6-6f68-4a9e-8917-f7373369d2d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib60bdc4640d3430dba09cf14bed10e42_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtMTEtMS0xLTUwODE_b88a09e0-58c5-44f1-9bec-a73d2328c3e6">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29175412719d4ae0bbdcfa90a2791097_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtMTMtMS0xLTUwODE_2e81859c-912e-4b5b-b171-f0e3ef820b0e">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i443be5ac12ab477899d6c78b902bfd1e_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtMS0xLTEtNTA4MQ_3b1c59e4-1bc9-49b2-9d32-fdf509633e77">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3350229ccf0473d9d352076764201b9_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtMy0xLTEtNTA4MQ_7bf9e5a7-9fad-49c1-8cc9-a85c9234c660">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2808c5a9454a47638feaed23f05ffd75_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtNS0xLTEtNTA4MQ_6d4e2a1b-57f0-4242-8556-8599c697683d">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ded9eecf3545abad11c717bcf28ef4_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtNy0xLTEtNTA4MQ_e9d51daf-3e2f-4589-8f55-20cbd6a26fbf">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99bc2416240a4a1ebcd6963cab1df746_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtOS0xLTEtNTA4MQ_9e1e89d9-1302-4899-802b-0a6abe7c3def">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01cb405c32b64ca890eabde91b0981d7_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtMTEtMS0xLTUwODE_9825cac4-c540-4d68-a621-d0d495797555">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c5b042ce36e4d5f8c31048f338d0da0_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtMTMtMS0xLTUwODE_8620bd1e-26d7-4389-b9a1-ce8b928e2dc7">952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5431d9662eca4651a20170ff92cb9ea6_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtMS0xLTEtNTA4MQ_68883046-ea29-4cc6-b32a-9267f918dea9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafd0d1d240b7439788501063223cefba_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtMy0xLTEtNTA4MQ_5d684639-2b9a-489a-9aa9-20da66b79b58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc8b1810ba64a5fa3916ea6c09b3e81_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtNS0xLTEtNTA4MQ_2a6efda2-3bcb-4118-bcbf-4acbadcadb89">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63fa7e4e54554cac9b950e535b9ca5a5_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtNy0xLTEtNTA4MQ_ad5f5fc0-0d53-4aa7-9870-4e5ce232370b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1643fa3fa2c44337b623c38b9b1c7cc9_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtOS0xLTEtNTA4MQ_cd0062c8-4d95-424e-90be-f0b11ac1557b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32903e0797f349ad863b6da5b59eb0d9_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtMTEtMS0xLTUwODE_1e9d7d44-e722-4f03-ad74-cc63abd3ac26">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic485b0b1dfd5472cb9fc36c196433b4e_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtMTMtMS0xLTUwODE_8a54d946-6289-494f-86f0-36ac5387586b">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8e442f3b9594715b2fb6548ebca61e8_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtMS0xLTEtNTA4MQ_08e74fe9-b508-479b-83a8-28a31e426c4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01033fcb93704a4391a3e7fbe27e7af2_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtMy0xLTEtNTA4MQ_d2c94d1e-2310-497a-9c7c-abafb2648e91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3682b33721ec4514903d622b539be8a7_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtNS0xLTEtNTA4MQ_9af32ffd-42ff-463b-a759-1bd2ce3e614c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb4368415fd4f45ae4f3029eb9e6097_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtNy0xLTEtNTA4MQ_4f3dc693-39b0-4bd2-87be-0286a96ac778">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88e6a24a77d9465bad6519907e24343a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtOS0xLTEtNTA4MQ_b3486a19-7caf-46db-8228-98befbc163ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09f545523cd149f2a426aa336810452a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtMTEtMS0xLTUwODE_411dffa2-4754-40e5-b7bf-b804c6e3ab2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i822d645dd6e24c729f04ce2895f1a93f_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtMTMtMS0xLTUwODE_5957152b-4833-4d94-95e3-894f04622a4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i062d253ff7ef401a835b48533522c00e_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctMS0xLTEtNTA4MQ_8822550d-4f74-47c1-8f37-58e8121cb4fa">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide073f4bb27c48c7840435bb8f104221_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctMy0xLTEtNTA4MQ_d7e67c1f-6a74-4b00-8aa9-758dcedcec81">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0bc39dee46c4714ac0b0fab972c4ccf_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctNS0xLTEtNTA4MQ_47dc4ec7-296e-4514-bc34-5b2cea437ac9">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473b0c0209924e7cb5e5f5f0cb1e4669_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctNy0xLTEtNTA4MQ_c359042c-b1f0-4e96-91fc-d0df58a7513b">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69e2a8048cc94bfa86c33501b14cf008_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctOS0xLTEtNTA4MQ_a4c88db0-5216-42d4-b57b-48023fa6342d">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic55e9a14e25049ec9335dfd7e9cc5e2c_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctMTEtMS0xLTUwODE_61854c07-9ca1-4fcb-a238-93c81aadae03">560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctMTMtMS0xLTUwODE_9651ed05-7bc7-49f0-8d5f-7fecb1fe4733">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79abeff81ecb4f2ba2b425357fdac880_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEwLTMtMS0xLTUwODQ_261b63d2-c908-4d4a-88fa-e020f68a0d86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7deafc4a256c48d8ad86736b4e5311e4_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEwLTUtMS0xLTUwODQ_774b5d8d-6959-4aa4-8c8f-ef1f59497186">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6510e58a12864cabbb5f5d397cdcc6e0_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEwLTctMS0xLTUwODQ_ee0d19e3-52ec-4396-9ffb-9222cdf71023">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e8f84bde226406fb2371bdc5972636d_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEwLTktMS0xLTUwODQ_b295b60a-7910-4887-bef9-16e40be10829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4aea11f47ef497bb4cfae564490a9ff_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEwLTExLTEtMS01MDg0_db35d02e-0508-4ce7-8844-8e714689dc22">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia03d8280e504476eac041f0e93f83065_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEwLTEzLTEtMS01MDg0_091ecd3c-4578-4fc8-abc2-de6486542a4e">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e42d46c2d6436ca7b0109d263897d7_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzExLTMtMS0xLTUwODQ_9f50875d-ded1-4228-b9f8-11a2cc1cfa3f">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a3f3595ae134cc981ca1d3c18836706_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzExLTUtMS0xLTUwODQ_7223ab3b-ac89-41b1-b5b9-f2270ac314ae">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bb8e2da802b450082ce3f9ebeddbb9f_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzExLTctMS0xLTUwODQ_04c89343-06fd-42c1-bd38-78e7f2c857af">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb976174df584566912d1ce975916216_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzExLTktMS0xLTUwODQ_301798bf-b45c-494a-95ae-9ad525c96cf3">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e03fbfce9af49f1aa6114c65a6c2f53_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzExLTExLTEtMS01MDg0_e2b1a5f4-81b5-4290-9bb5-129baa5558e3">611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d11217f0a44658a8c9c461abf28597_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzExLTEzLTEtMS01MDg0_140704d3-293d-45d9-9e90-c79ab663174a">1,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i971973c567634c73ab4ea2e84ce6b0dd_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEyLTMtMS0xLTUwODQ_a4453bea-c364-42ee-aefb-5652f8ec1328">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c310256123047cd9dfe888f312658ec_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEyLTUtMS0xLTUwODQ_c9c6b35d-f5d3-4b5c-9c4b-0e81304c9bd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88616ec7a1ad44c3a2a4dd7cd79f5196_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEyLTctMS0xLTUwODQ_76acf58b-9030-4edd-92e5-bac7e0f9936a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a4cbded6e7742669126ef8fc6075ffd_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEyLTktMS0xLTUwODQ_a514b47c-be2d-43fb-a00d-b99c7a092fdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c70dda95db46be820b218ae77d9e96_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEyLTExLTEtMS01MDg0_5467bb64-c3c2-408b-9330-6d410cb444ee">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id96a55c4463044b5bf44723d5c1ccf62_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEyLTEzLTEtMS01MDg0_106026b2-88c9-4162-9edd-31aae728c598">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877d4580f0694cb4be370136b4865d7a_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEzLTMtMS0xLTUwODQ_127e24f6-cf31-4801-ac1e-1b727b9c0e81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f62f5e177e435b841ab3f7d3b09c13_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEzLTUtMS0xLTUwODQ_70fd1003-a890-4a57-9d8c-2e82f9d497b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic98ccfb571144f1c97c0ad662c696d05_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEzLTctMS0xLTUwODQ_3b2cee69-1ca0-412e-af89-0948ee76b3fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0daf6c04fb1344edb25e56b236c0dc57_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEzLTktMS0xLTUwODQ_c04acac3-eb89-4526-b7e3-a7e59af0a1b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib258da2c83ef4d81899c8b052d2499ba_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEzLTExLTEtMS01MDg0_16cf1ac0-4b60-4d5c-9fe5-22e9cb08c7f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf33732bb1b44dafa8da81b701b2c146_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEzLTEzLTEtMS01MDg0_f846215a-900c-4b67-b3bb-4055229db4fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieed1e5fc77c944bf8c6cb12c1362e77f_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzE0LTMtMS0xLTUwODQ_64a85fe7-9945-4d5f-bb10-c2fdee5d78e7">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45581d71f4fc45f68574e3690202b39e_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzE0LTUtMS0xLTUwODQ_e377a1da-7f5f-42f9-859b-4c774788fb44">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47f137d0f6d243babd97d6cefb992373_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzE0LTctMS0xLTUwODQ_2d785337-fe4d-4d93-afc7-8b5e7e7a8cfc">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b85ad0009a8404f91f09c0c56c9e0a5_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzE0LTktMS0xLTUwODQ_c8a800d8-983d-40d2-9f43-73915b83ea34">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d7ca48c598f45cb8d641ff3cfd83dc3_I20191231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzE0LTExLTEtMS01MDg0_726107d1-a46f-42ac-9d2f-e895697cf7fe">666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6ec27882864945abe2ffe9bd523656_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzE0LTEzLTEtMS01MDg0_5537fc66-8ef9-421d-8112-0bf22c080bb4">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:continuation id="i6bc360ea81214ce7a1b231feb2051f11"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 scheduled mortgage loan principal repayments were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzEtMS0xLTEtMA_7966a039-ce45-40aa-8537-c3b9d7c0561b">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzItMS0xLTEtMA_2ddeacac-8b39-4784-a146-0aa0f773570e">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzMtMS0xLTEtMA_603af48e-870b-4f6b-b914-cb18a5d7cfa9">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzQtMS0xLTEtMA_dc34ea04-6ed0-4f41-ba37-3998b1d58454">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzUtMS0xLTEtMA_ce928a99-097a-4446-bdbb-e9db5ce46dc2">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzYtMS0xLTEtMA_b11623fc-7725-4472-a1d5-b9b56d279a5f">288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzctMS0xLTEtMA_74436f8c-cb50-4b56-ad2f-bb0c9312d5a5">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:InvestmentIncomeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MzQ_2e581d67-57f1-4da0-8df1-b0dc75ce178e" continuedAt="i4033be3177bc4009858db398db1a0592" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the years ended December 31, 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4463ae62a9024501b5a957f93ffd509c_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzEtMS0xLTEtMA_e19eeeeb-f5cc-42c8-9ac9-067bb56cc95e">598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f180321401b43afb4ccf64eefc9ed72_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzEtMy0xLTEtMA_47f82bb9-a622-47a5-b913-44fbede22373">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieae65b64f43641bd80854962068ff2bf_D20180101-20181231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzEtNS0xLTEtMTIwOA_2f1b7dfe-59f6-4295-83b7-7c83231c3342">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icef7b09090ab4ce78a8ecf8b2b4586e1_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzItMS0xLTEtMA_6e3a3904-b1b2-4586-984e-6649bb60f7f6">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739d9512c32a42c2bc64e5f94d64b6a8_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzItMy0xLTEtMA_1fd13bff-a1dc-425e-a065-7129296522b2">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i851d4aa7d40b44b789763f7863bce518_D20180101-20181231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzItNS0xLTEtMTIwOA_c1b62570-6da4-4d22-90dd-f0974725a319">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i439d5bbe06ca42518920801c888d40c2_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzMtMS0xLTEtMA_dd796717-a885-40be-af8a-13c2d153e031">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8dd6959068f4e5490c721fc82461ad7_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzMtMy0xLTEtMA_03694a54-2943-4cc8-8405-dbfd7718b8e6">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5fbdda1ccb46f0bf05959e53345921_D20180101-20181231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzMtNS0xLTEtMTIwOA_731558ec-58cc-4f07-8867-e82cc17da22a">593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzQtMS0xLTEtMA_6379dc87-6d4c-470e-b2f2-a82311a9753e">781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzQtMy0xLTEtMA_9d545d77-2c49-43c6-81e2-cc1905d72868">854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzQtNS0xLTEtMTIwOA_b7866a8b-0428-45b6-8760-f199927b7221">660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzUtMS0xLTEtMA_2f40a9e9-3428-44bf-833c-b4ce4897f2a3">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzUtMy0xLTEtMA_31411c38-0f59-4b28-9c03-beac8b090845">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzUtNS0xLTEtMTIwOA_dcc93b58-deb6-42a9-a887-961c1408c559">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzYtMS0xLTEtMA_aa8a4b4e-1746-4b34-a79d-550b295811b9">746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzYtMy0xLTEtMA_369508a1-3f53-412f-a45a-1fe80b09e005">812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzYtNS0xLTEtMTIwOA_9788e3c9-0651-4d55-9fef-db8e011b5291">657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzctMS0xLTEtMA_dc95e5fc-772d-45fe-ad46-0f30239bed19">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzctMy0xLTEtMA_755e8239-feb0-46ca-8144-7610443aaacc">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzctNS0xLTEtMTIwOA_522e68be-0714-4448-8228-15990d40e1fb">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzgtMS0xLTEtMA_26a12c69-6d8c-4bc3-be79-7445322f8991">798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzgtMy0xLTEtMA_263a3f0b-fa98-46ab-ba35-c957af0d7e11">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzgtNS0xLTEtMTIxNQ_755a8fa5-8b76-4fa8-92fd-ac0036f18557">660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital gains are net of yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzIxOTkwMjMyNjczNTA_4395e9c3-c0c4-4330-a78d-909c4a79b904">49</ix:nonFraction> million for the year ended December&#160;31, 2020. There were <ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt-sec:numwordsen" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzIxOTkwMjMyNjc5MzU_be15d859-5a77-446f-ba0f-37a9699ef636">no</ix:nonFraction> credit-related losses on debt securities in the year ended December&#160;31, 2020. Net realized capital gains are net of other-than-temporary impairment (&#8220;OTTI&#8221;) losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzIxOTkwMjMyNjc0MjM_28d1db15-54a7-4364-9b73-d73ea8640c7e">24</ix:nonFraction> million for the year ended December 31, 2019. There were <ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzU5NTM_5e871851-f7c6-41c8-aac0-3dcb0e5e1514">no</ix:nonFraction> material OTTI losses on debt securities for the year ended December 31, 2018.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i4033be3177bc4009858db398db1a0592" continuedAt="i9f0584adc7e942339b8996df01bb27bc">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i9f0584adc7e942339b8996df01bb27bc">Net investment income includes $<ix:nonFraction unitRef="usd" contextRef="i3489e4cdcead49faa7307339be45ea56_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzYwNjQ_be705036-ba4d-4f4f-b929-3b5fb1448d0a">42</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i054b8f52f436443db1807cf26d0d4567_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzYwNzE_357e641b-9509-4c17-8042-47993041f78a">44</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i458385d44006411896bb4794dbc65c9b_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEwOTk1MTE2MzY5Nzg_99eee749-6503-47ac-936c-1706f86de110">4</ix:nonFraction> million for the years ended December 31, 2020, 2019 and 2018, respectively, related to investments supporting experience-rated products.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="i55a5757ba61c48b68dc30019d051ff71"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital gains and losses recognized during the year ended December 31, 2020 related to investments in equity securities held as of December 31, 2020 were not material.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MjM_458d9c0d-4d47-4c5a-a8f4-9fa92c44572b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available for sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2020, 2019 and subsequent to the Aetna Acquisition Date in 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzEtMS0xLTEtMA_94661ee3-7a64-46a9-a4d3-1b083fab7110">3,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzEtMy0xLTEtMA_0032c344-26da-4f77-b6e6-414b2e310b7f">4,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzEtNS0xLTEtMTI2MA_513b3e49-8b4b-4a63-b127-d75af8c09f3c">389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzItMS0xLTEtMA_788bae4d-e61b-45b1-82b2-4f8843210f1b">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzItMy0xLTEtMA_28790ebe-1c6c-419c-b4ce-17ffc328c31a">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzItNS0xLTEtMTI2MA_ee1d0523-f2c5-412a-8409-9cf0756500a7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzMtMS0xLTEtMA_64d14424-c50b-452f-abfb-6641d1b0fd85">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzMtMy0xLTEtMA_51f13340-51b7-421e-939d-7fa6b3796b24">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzMtNS0xLTEtMTI2MA_54a80701-c52b-4990-8abf-7550ca18f652">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_133"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzExMDE4_c5a02de3-684c-435a-80bc-7f54b4eeb790" continuedAt="iae6c4a1ca3bc41f0b4c4fcb24a763ba4" escape="true">Fair Value</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iae6c4a1ca3bc41f0b4c4fcb24a763ba4" continuedAt="ieb2700cbaf384e67b3a9de6c538c9924"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;In this note, the Company provides details on the fair value of financial assets and liabilities and how it determines those fair values.&#160;The Company presents this information for those financial instruments that are measured at fair value for which the change in fair value impacts net income (loss) attributable to CVS Health or other comprehensive income separately from other financial assets and liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s financial instruments are measured at fair value on the consolidated balance sheets.&#160;The fair values of these instruments are based on valuations that include inputs that can be classified within one of three levels of a hierarchy established by GAAP.&#160;&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities are classified based upon the lowest level of input that is significant to the valuation.&#160;When quoted prices in active markets for identical assets and liabilities are available, the Company uses these quoted market prices to determine the fair value of financial assets and liabilities and classifies these assets and liabilities in Level 1.&#160;In other cases where a quoted market price for identical assets and liabilities in an active market is either not available or not observable, the Company estimates fair value using valuation methodologies based on available and observable market information or by using a matrix pricing model.&#160;These financial assets and liabilities are classified in Level 2.&#160;If quoted market prices are not available, the Company determines fair value using broker quotes or an internal analysis of each investment&#8217;s financial performance and cash flow projections.&#160;Thus, financial assets and liabilities may be classified in Level 3 even though there may be some significant inputs that may be observable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the valuation methodologies used for the Company&#8217;s financial assets and liabilities that are measured at fair value, including the general classification of such assets and liabilities pursuant to the valuation hierarchy.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. When quoted prices are available in an active market, cash equivalents are classified in Level 1 of the fair value hierarchy. Fair values of cash equivalent instruments that do not trade on a regular basis in active markets are classified as Level 2.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Where quoted prices are available in an active market, debt securities are classified in Level 1 of the fair value hierarchy.&#160;The Company&#8217;s&#160;Level 1 debt securities consist primarily of U.S. Treasury securities.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt"><span><br/></span></div><ix:continuation id="ieb2700cbaf384e67b3a9de6c538c9924" continuedAt="ib2d4fd2079bb49b1b72d7a44015c5408"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s Level 2 debt securities are obtained using models, such as matrix pricing, which use quoted market prices of debt securities with similar characteristics or discounted cash flows to estimate fair value. The Company reviews these prices to ensure they are based on observable market inputs that include quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets and inputs that are observable that are not prices (such as interest rates and credit risks). The Company also reviews the methodologies and the assumptions used to calculate prices from these observable inputs. On a quarterly basis, the Company selects a sample of its Level 2 debt securities&#8217; prices and compares them to prices provided by a secondary source. Variances over a specified threshold are identified and reviewed to confirm the price provided by the primary source represents an appropriate estimate of fair value. In addition, the Company&#8217;s internal investment team consistently compares the prices obtained for select Level 2 debt securities to the team&#8217;s own independent estimates of fair value for those securities.&#160;The Company obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December&#160;31, 2020 or 2019. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also values certain debt securities using Level 3 inputs.&#160;For Level 3 debt securities, fair values are determined by outside brokers or, in the case of certain private placement securities, are priced internally.&#160;Outside brokers determine the value of these debt securities through a combination of their knowledge of the current pricing environment and market flows.&#160;The Company did not have any broker quoted debt securities for the years ended December&#160;31, 2020 and 2019. For some private placement securities, the Company&#8217;s internal staff determines the value of these debt securities by analyzing spreads of corporate and sector indices as well as interest spreads of comparable public bonds.&#160;Examples of these private placement Level 3 debt securities include certain U.S. and foreign securities and certain tax-exempt municipal securities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company currently has two classifications of equity securities:&#160;those that are publicly traded and those that are privately placed.&#160;Publicly-traded equity securities are classified in Level 1 because quoted prices are available for these securities in an active market.&#160;For privately placed equity securities, there is no active market; therefore, these securities are classified in Level 3 because the Company prices these securities through an internal analysis of each investment&#8217;s financial statements and cash flow projections. Significant unobservable inputs consist of earnings and revenue multiples, discount for lack of marketability and comparability adjustments. An increase or decrease in any of these unobservable inputs would have resulted in a change in the fair value measurement. </span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib2d4fd2079bb49b1b72d7a44015c5408" continuedAt="i5ec8d2293a2445b2984098024ea061f9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no financial liabilities measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2020 or 2019. <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzExMDEx_b7c545ca-0a7f-4f04-95ec-35df1cfbccfd" continuedAt="i22206bff32cd437aa32d10dab47cd5e0" escape="true">Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2020 and 2019 were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i22206bff32cd437aa32d10dab47cd5e0"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f2ffe7a0ba474fb811572f2e0ea7e0_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzItMS0xLTEtMA_9f711256-4b4a-4481-aaaa-8352055d7788">4,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4508cc8f56f04ee9a7567e40b8da3c28_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzItMy0xLTEtMA_2abaa062-2869-4794-b03c-fa478e7627b4">3,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19caab13c4e4bc38082d1bdf6bc13ea_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzItNS0xLTEtMA_4e81f966-d5d1-4182-9449-f3ca10da7a8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e22f02c654244d596daa5e51b729587_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzItNy0xLTEtMA_60648591-1343-484a-8342-bd78e9d7aa5f">8,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c4a870a8354489ab03c6ca49ffdd338_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzQtMS0xLTEtMA_17382e17-fdc1-4f3f-833f-71e615a90fd9">2,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344a6a9cd51e4e43b0ca2ddc7cb48feb_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzQtMy0xLTEtMA_56224da5-b1ba-4609-ae94-3258ff8279f5">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60bdcc978cfc484baf04fe7970cd32e6_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzQtNS0xLTEtMA_1d15f08c-3aa4-473f-9a30-f60c81049437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3a9c7ec5cd043a1b1452b0017077321_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzQtNy0xLTEtMA_7df5d963-12d5-4de3-b71c-b182350bca6a">2,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i535e58cf8ebd41cb8d7240e4b1e35f50_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzUtMS0xLTEtMA_7dd37ac1-6856-4e2c-8df5-dbb8b806bf90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ddc060d200a4e2aa0952f43df4f21a9_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzUtMy0xLTEtMA_84ff948b-dd08-4e0c-a799-bfa0428a23da">2,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e8fea1acd9244a5a882955ae4ed486a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzUtNS0xLTEtMA_bac76adc-9854-4eab-a6a6-29d7eda42829">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice331df2b98e46fea9be5f51151c8e6b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzUtNy0xLTEtMA_511b1ca1-bc18-47b3-9633-324124d4364c">2,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a89f2686564b389cdb4fe8539d10e8_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzYtMS0xLTEtMA_56bb8415-cf6a-4e26-ab31-62258396566e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8edb5e9988eb4dcfadaa6febf64f603c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzYtMy0xLTEtMA_fd3e5fb7-1c38-4269-a822-09ceb142b1a5">8,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a5669faf591465099f3db3909bf4908_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzYtNS0xLTEtMA_44ef6511-a453-46d8-8c08-826fcfdb43e1">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2db80d0e7344f35840de60bfea8a22a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzYtNy0xLTEtMA_4b2c1ef8-08e6-493d-8555-c33a9b536c40">8,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide99961030a64271a6dfda0a74b2fd14_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzctMS0xLTEtMA_5ec3c5c9-9938-4d32-99bd-3ee5b4f019c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie311d074225743679534438cd7b7490f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzctMy0xLTEtMA_1bcb4c2f-4a43-4387-a9b7-09c02a501771">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8564e44c4d0940d883bb0a3d95fd9e7e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzctNS0xLTEtMA_022045a5-5d5c-4135-a2e5-4e5ddd794b9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61b53e87d1454d1f831fd5c70d5c60fb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzctNy0xLTEtMA_959a808d-016e-409b-91b8-c42e342d2c5b">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia77b398de41746a9bea32d7c8add5469_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzgtMS0xLTEtMA_11f8d187-e5b4-424e-9ac1-4976dba78023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadfe4530ccf44844a620422f79befd12_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzgtMy0xLTEtMA_02ad91ab-390b-4f10-86ec-56827099d680">705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia44caf607a4b4de3b75eb6df51116b96_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzgtNS0xLTEtMA_7ea3d46f-cc43-4533-afbb-6c201966dbec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id18c3b096aa54a56ab5aebddae95e201_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzgtNy0xLTEtMA_36430706-33cf-44af-9a07-243f29c270e4">705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150ad433496a404098a477e3ea7c9713_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzktMS0xLTEtMA_2db74c03-1373-482d-ab16-d299695d0c89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfb0024ebcf4bc0a0df96fc6053933d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzktMy0xLTEtMA_15244496-52b0-47c8-92f5-04bb254c2593">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05c28a6dc98643f2af8af4f866a43aeb_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzktNS0xLTEtMA_f5c40f73-11c5-4830-bdc0-8e3a38be84d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0e0cef498104e4498bc6b4cb58dea9c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzktNy0xLTEtMA_207b3c14-6422-4119-84a3-fc2e5c7ac0a6">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f0fd6cea0b4f2ea1af31f0b858cf48_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEwLTEtMS0xLTA_cf4dcac8-9d73-483e-9ec8-be97b895df9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ed896778474633bf168b8f5368a64d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEwLTMtMS0xLTA_6aed8fb0-a7ac-4594-a4b0-75c982274d6b">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37858238ff4b4357b90cb98696708c18_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEwLTUtMS0xLTA_35011c50-1758-4670-ae9c-03e2ce38789e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2f946e677c41e6a1dd57f66196e517_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEwLTctMS0xLTA_8b044ca3-7b8c-422a-b2ff-438739733403">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81b92da379164d05a04e73b67319b43e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzExLTEtMS0xLTA_6c55405b-187c-4a87-81c1-7608d3b2ba79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4de0232daf44e89b664bfe4fd000aeb_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzExLTMtMS0xLTA_dff9f1ea-2bb1-4cff-8872-d42988affdca">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed66fb799214fc2bf98dc256cfdda0d_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzExLTUtMS0xLTA_4dd47a3c-f89b-419a-a759-adb7623dbc14">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie604f7e6063c410db0270a579e5c2e1e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzExLTctMS0xLTA_af8123b4-1005-421f-ac85-334308037b1a">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f2ffe7a0ba474fb811572f2e0ea7e0_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEyLTEtMS0xLTA_9f5014c9-cde1-48b0-9ccf-643548061d1f">2,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4508cc8f56f04ee9a7567e40b8da3c28_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEyLTMtMS0xLTA_a80f62d3-0a2c-4112-a769-fe6ea75c2052">18,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19caab13c4e4bc38082d1bdf6bc13ea_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEyLTUtMS0xLTA_7946a3e9-7847-4ecb-a693-c0ffc42908b1">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e22f02c654244d596daa5e51b729587_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEyLTctMS0xLTA_b499c8fe-da29-407b-9b4c-2e5177549ff9">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f2ffe7a0ba474fb811572f2e0ea7e0_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEzLTEtMS0xLTA_1fc9fba9-1df8-436d-aec8-e9c3a6e4a460">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4508cc8f56f04ee9a7567e40b8da3c28_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEzLTMtMS0xLTA_04179dbd-be90-44f0-884c-233cf665901a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19caab13c4e4bc38082d1bdf6bc13ea_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEzLTUtMS0xLTA_0b940db4-cb99-4d4c-ad18-29fef24bcdd0">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e22f02c654244d596daa5e51b729587_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEzLTctMS0xLTA_cdd1f5a5-31a2-4b8a-8a06-77a5925874b2">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f2ffe7a0ba474fb811572f2e0ea7e0_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE0LTEtMS0xLTA_d02fd5c5-a08e-4a71-92a3-1d695faae986">6,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4508cc8f56f04ee9a7567e40b8da3c28_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE0LTMtMS0xLTA_fb0fe952-a462-4862-b2a1-f4ac6c9db55b">22,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19caab13c4e4bc38082d1bdf6bc13ea_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE0LTUtMS0xLTA_fea349cb-7207-4d87-bd0d-e1bc73f64d6c">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e22f02c654244d596daa5e51b729587_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE0LTctMS0xLTA_e6da550b-cfa9-4fb0-aae1-363e922633fa">29,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824ec462d55041558ba9c29476131800_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE3LTEtMS0xLTA_1c6abd73-d7d8-4ef1-8632-3e1480e22261">3,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i427b6fb3db3448e2808f061a08c25372_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE3LTMtMS0xLTA_95b54da8-e01f-481b-96fd-2b70eb5a7af0">2,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec6476033e246a18cda5819f01ab27f_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE3LTUtMS0xLTA_8cba8661-62a0-4894-9dda-1e56cfd1e0e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE3LTctMS0xLTA_c26f94cc-5b07-4906-8842-f392a39362f3">5,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8539ee32c9a54080a31d12e525e306c0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE5LTEtMS0xLTA_c7b0d4ea-bbef-4c55-911b-6a06a0111b9f">1,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dad6865b2654a9b907c9347d91993df_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE5LTMtMS0xLTA_866b1f22-6444-4c1d-9885-c75136abac11">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78f5a494a7494280953e08b74b394c16_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE5LTUtMS0xLTA_309859da-d48a-4454-861b-2670cf81cade">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9710be21b74c4c1599f063414aaf6404_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE5LTctMS0xLTA_1e145344-5df5-4a5b-aa28-d4643306a1e2">1,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9d5661cc4d149c7b8bb9325f15773b2_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIwLTEtMS0xLTA_75caeed4-0264-4c72-bf7c-5dfbc191aeeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56d284138b914afab3d80a561bb6eb39_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIwLTMtMS0xLTA_fb336c00-7582-46f2-a107-45c19fed34d9">2,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9f485c9030494899f777cd715f8fa7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIwLTUtMS0xLTA_ad4e61cb-2dd3-4ccd-985e-a7b8a3e21822">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1085bdeb3b104e208f4620803d5c8e4d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIwLTctMS0xLTA_55e527fe-3b41-4ed5-85f0-9c195f0830a3">2,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e2f247e22d446e691e08e44f6068a66_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIxLTEtMS0xLTA_4dea33b3-25ff-4260-abdc-17feec13414c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf6bb670dc3c4e049ca389440de1255e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIxLTMtMS0xLTA_dc39a0d7-7081-4b2b-bd97-04b0eda2c3b8">7,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1419625a52b4c7f99601b13d3fffd3b_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIxLTUtMS0xLTA_25d06da9-6d54-4dbc-9fc4-8b91b9c1249b">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49d58ae32a674ec7a25b0cab1c107c50_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIxLTctMS0xLTA_673ac561-fba5-4330-890c-abea51a06c47">7,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe5b5a213bc48a9a839453f8eec37aa_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIyLTEtMS0xLTA_733341a3-360d-4e68-ae4b-3edf8cfb067f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd142883292428c9379bdc65620fa8e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIyLTMtMS0xLTA_fa44c8cf-de27-49a4-9856-dd914bc1553f">2,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d59fc608e9943a9a082f64bd8966e7d_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIyLTUtMS0xLTA_7f6ec279-d3ff-42e8-b8b7-9a67d8005eaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d143f8d4624b888878df58de333010_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIyLTctMS0xLTA_13ceef73-becf-4a97-a8f8-05a82467d596">2,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84acf5a3b4b74531b1bc2f9b3cebfa9f_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIzLTEtMS0xLTA_8e44b7c2-75e9-4457-a659-8906c0ff1d9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14c435d7631b4ba8ada299ff02b1fa00_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIzLTMtMS0xLTA_2fe34af6-5e58-4c6e-b751-1848859fd4fd">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27193b7a6df549ac80433361247ff541_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIzLTUtMS0xLTA_e06b5e85-26e3-4e55-ae3d-31557941b6b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e2ac0b66c2497880c1e0d940d086ae_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIzLTctMS0xLTA_7620bd85-3ee5-4933-b800-dd97183caf38">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099b6050d3584f5fb00e807ed1227a99_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI0LTEtMS0xLTA_9ced34bd-345a-4a26-b138-c0ae55ee0c90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee970ac587c4ba29630fb7caf93ece4_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI0LTMtMS0xLTA_4871dff7-c68d-4523-b926-8f1997103d13">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89a55680a0a4433a9c10cba73488c4a4_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI0LTUtMS0xLTA_256e98b0-980c-4d8e-98ec-335f79e1383e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib79362fb767e403b8719ea6a27dfc263_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI0LTctMS0xLTA_8ec564ff-14e4-4505-a9e9-bf7c43604b69">700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee3a9120196416f8296ed0519c6e205_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI1LTEtMS0xLTA_c1f12456-3dd7-4a28-96d6-0197d5b56de2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i917d8b2ba01740e38b71a44126058fb3_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI1LTMtMS0xLTA_896f0df2-608c-4dc7-9ca5-e355105e32ca">1,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i909a12cdf2aa40dda0c82baf62b9869d_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI1LTUtMS0xLTA_121fd8d1-9e0c-4ef1-a2ac-6c8acaecb615">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia22f84d3693548b99878a1e34770cf19_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI1LTctMS0xLTA_51c972a9-9148-415b-aa91-934b22d043d2">1,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c603ece9bf403fb66246ce8f442203_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI2LTEtMS0xLTA_04e87abb-3fc9-4747-b24f-3b1014606285">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67c1ffa9b4a64076853256c4949fc411_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI2LTMtMS0xLTA_bd6e947a-e602-411e-8c6d-108a1577875b">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee9c609f9b8541b4a685e9d0fd26d249_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI2LTUtMS0xLTA_1d4919d0-abfc-48e2-9afd-fe66566b5a28">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7980aa14ee0540c882652c696d24ce39_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI2LTctMS0xLTA_590591d6-1211-4aa2-b146-8904b8ac5b92">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824ec462d55041558ba9c29476131800_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI3LTEtMS0xLTA_c955acea-1e91-4730-99d3-272e02a8cb07">1,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i427b6fb3db3448e2808f061a08c25372_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI3LTMtMS0xLTA_d600febc-ec97-4ae5-a358-57281ce1cc3f">15,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec6476033e246a18cda5819f01ab27f_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI3LTUtMS0xLTA_f920ccb8-1000-4320-8dec-18e096750a34">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI3LTctMS0xLTA_8876a7de-768b-489d-a078-83373a205fec">16,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824ec462d55041558ba9c29476131800_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI4LTEtMS0xLTA_08cfeeec-87e2-48eb-9c86-b755dbc86954">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i427b6fb3db3448e2808f061a08c25372_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI4LTMtMS0xLTA_b4bc1c6f-d057-4d23-8b22-f8a23b8062b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec6476033e246a18cda5819f01ab27f_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI4LTUtMS0xLTA_3cbe8a88-8016-4160-861b-6fff31084dff">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI4LTctMS0xLTA_baa0a3a8-9258-4a9c-967c-c1a307e9d592">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824ec462d55041558ba9c29476131800_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI5LTEtMS0xLTA_e7253084-47cf-48c5-a164-8f1ce3875ed6">5,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i427b6fb3db3448e2808f061a08c25372_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI5LTMtMS0xLTA_31df646d-4392-465a-8226-791412b40fe5">17,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec6476033e246a18cda5819f01ab27f_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI5LTUtMS0xLTA_c63617f6-1000-4aa6-8966-a2d0e194add0">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI5LTctMS0xLTA_64726f5f-549b-4144-b28a-4975e591a624">22,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5ec8d2293a2445b2984098024ea061f9" continuedAt="ied2b13bf729148ebbc1aa58ae522fc34"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzU0OTc1NTgxNTQ2MTk_07845073-497f-4b61-877b-58db98c6a269" continuedAt="ief49a41e73f1447988134cc73ead5bf3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2020 were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:40.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/> and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1085bdeb3b104e208f4620803d5c8e4d_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzEtMS0xLTEtNTIyNg_8df80b1e-1210-43a4-976c-583165aa6bd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49d58ae32a674ec7a25b0cab1c107c50_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzEtMy0xLTEtNTIyNg_0766bc04-d2d9-4545-a06c-251659202940">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9553185d57414893ad62b80064c4476b_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzEtNS0xLTEtNTIyNg_00ad5702-1b48-441c-a808-4c5a6b967dd6">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7980aa14ee0540c882652c696d24ce39_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzEtNy0xLTEtNTIyNg_7f6ee45c-5b00-419d-ab24-017e265197c5">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzEtOS0xLTEtNTIyNg_d7647bbf-fc01-4b4f-a85b-edc8105e44ba">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb48192210564ac4a732e153ced3f314_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzMtMS0xLTEtNTIyNg_b171f48d-b048-4136-b002-4f9fb6a72638">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzMtMy0xLTEtNTIyNg_435749a0-f1d1-4a7b-966c-d8f1b211be4b">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzMtNS0xLTEtNTIyNg_ac33a919-24c7-4c99-8e02-d6eda526cfd5">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzMtNy0xLTEtNTIyNg_d58cc4e5-cc81-45bd-9f96-da1ff1323651">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzMtOS0xLTEtNTIyNg_2bb94483-e113-4571-829e-78f7b997fd37">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb48192210564ac4a732e153ced3f314_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzQtMS0xLTEtNTIyNg_21d63dc6-018b-40c8-bccf-0bee7bce9371">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzQtMy0xLTEtNTIyNg_b4298ad2-2ae7-4a28-a7cc-b50f450c8dcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzQtNS0xLTEtNTIyNg_395bd35a-cae8-4b70-b4cc-6bcd5a0ab854">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzQtNy0xLTEtNTIyNg_63cd24f3-5338-40de-ad1d-1f86327b3ac8">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzQtOS0xLTEtNTIyNg_edcc49f6-a5a7-4e2a-92c9-69e1bbb5f7e2">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb48192210564ac4a732e153ced3f314_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzUtMS0xLTEtNTIyNg_65aa1208-e18c-4b78-bdb6-2b68f09ebbce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzUtMy0xLTEtNTIyNg_25aa0347-3d82-4c22-902c-e3bb2e60ecd3">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzUtNS0xLTEtNTIyNg_39b63cdb-63e0-479b-b659-5654f495baab">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzUtNy0xLTEtNTIyNg_dd404977-a350-47ed-b8c0-8bc028d0c777">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzUtOS0xLTEtNTIyNg_7c04e864-a24f-4383-9703-6eea1d703591">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb48192210564ac4a732e153ced3f314_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzYtMS0xLTEtNTIyNg_529f301d-885e-4664-bf6e-5da14ec1a749">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzYtMy0xLTEtNTIyNg_11c3a933-712b-4bd6-97c5-77283f83a513">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzYtNS0xLTEtNTIyNg_b5d909cb-7b1e-42a6-920f-7b9d4bbdc915">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzYtNy0xLTEtNTIyNg_363028ec-b336-413e-b5e7-a924f7014413">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzYtOS0xLTEtNTIyNg_4b78b579-e6f5-41e5-b12b-54fe9d41b2a1">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb48192210564ac4a732e153ced3f314_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzctMS0xLTEtNTIyNg_59c4f32f-5ead-4fb3-a6b6-1ed999be8e80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzctMy0xLTEtNTIyNg_993f61dd-d59e-469a-94fb-f4213a3289a1">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzctNS0xLTEtNTIyNg_5be050f0-932f-4a9b-8a0d-bfbf1c6dabbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzctNy0xLTEtNTIyNg_bcf1fc27-d322-4aa6-b929-8db859bacd9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzctOS0xLTEtNTIyNg_60354691-3fd2-4036-8adc-3c46c240b18e">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb48192210564ac4a732e153ced3f314_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzgtMS0xLTEtNTIyNg_5e2bae14-8f7c-45ff-a577-ca66a9bee573">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzgtMy0xLTEtNTIyNg_92661447-bae2-41c3-b9ad-072f7cc96ebe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzgtNS0xLTEtNTIyNg_ee2304cb-db46-448a-b60f-3e03dfe3770e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzgtNy0xLTEtNTIyNg_4a2ecb78-0cd0-43e3-b7b3-01de45fb5d71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzgtOS0xLTEtNTIyNg_7a5c6d84-7986-4c90-9e53-c164f54700ed">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice331df2b98e46fea9be5f51151c8e6b_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzktMS0xLTEtNTIyNg_36894318-2a26-472a-95d2-9a8afbb1172c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2db80d0e7344f35840de60bfea8a22a_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzktMy0xLTEtNTIyNg_3e6b8f73-2a50-45d8-ae6a-fde0ba8f46dc">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43a7de1365ad4a64915e5f9da6e4dd39_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzktNS0xLTEtNTIyNg_266f76a7-f6fa-4622-b9d7-d1d336089bd0">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie604f7e6063c410db0270a579e5c2e1e_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzktNy0xLTEtNTIyNg_77adf5ac-f5d3-47db-9862-6301c7982d5f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e22f02c654244d596daa5e51b729587_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzktOS0xLTEtNTIyNg_bc762556-10ab-4d6b-83ca-cd5bc5e3010d">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2Xzc2OTY1ODE0MDkwNjc_ebc3915b-73f7-4757-be20-7bae8d16b9dd">4</ix:nonFraction> million during the year ended December 31, 2020. </span></div><div><span><br/></span></div><ix:continuation id="ief49a41e73f1447988134cc73ead5bf3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2c1a17b1b7b4bc6b1eed4e29b39070f_I20181231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzEtMS0xLTEtMA_e95a19ed-08c3-43ec-9b04-d022e34821a4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f83ba007004358b8f859c6f7774937_I20181231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzEtMy0xLTEtMA_9f5f0adc-c9ef-4628-bea3-49a1717913a3">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488b7e7f18e24adab3814dcb16ac304c_I20181231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzEtNS0xLTEtMA_514fdca8-57ee-4d7b-ac38-3865f0580f07">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie354c2c65a4c4f7abcb39006882cccc7_I20181231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzEtNy0xLTEtMA_90108b2a-9527-436e-a8d8-a3c171e4d73b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bacd808153c4072ae90e6431d9f3e8b_I20181231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzEtOS0xLTEtMA_79888682-8230-4377-8468-d59a3e012077">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af5df3294d4476b83876447a5baef98_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzMtMS0xLTEtMA_e12d98d6-cebd-49bf-81d3-e72644d34432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i244c2d6efb77428f9129af9df189e973_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzMtMy0xLTEtMA_f7142316-6813-40ec-b211-993f2930f6f6">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzMtNS0xLTEtMA_f743e325-beba-40cf-93bb-3183cc8a2fb0">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzMtNy0xLTEtMA_1b6c0076-5e32-45c9-ab0c-55162f063144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzMtOS0xLTEtMA_5b8fe4c2-f2cd-44d1-bb98-4bd311f907c5">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af5df3294d4476b83876447a5baef98_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzQtMS0xLTEtMA_486768e2-b02a-40a9-8292-df6b6bc5170e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i244c2d6efb77428f9129af9df189e973_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzQtMy0xLTEtMA_4bb72281-dd4d-4309-af37-70378b8f1d78">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzQtNS0xLTEtMA_3f379676-c547-46f0-ae35-6e091229430d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzQtNy0xLTEtMA_365edac1-8607-4219-87e9-25a45e3318ee">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzQtOS0xLTEtMA_b2beed9a-a282-49b6-b137-ffdfe627f517">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af5df3294d4476b83876447a5baef98_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzUtMS0xLTEtMA_db21f9d9-9975-4965-b8ca-c48293957487">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i244c2d6efb77428f9129af9df189e973_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzUtMy0xLTEtMA_91732837-14e5-48e1-aeb3-18827ddfcdeb">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzUtNS0xLTEtMA_1caddfcc-9db2-4bb5-9452-6373e1720895">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzUtNy0xLTEtMA_0f05b955-dd3a-4431-9e01-368a64eca121">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzUtOS0xLTEtMA_c22945a5-f801-46e5-b374-89e48c8bc6d1">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af5df3294d4476b83876447a5baef98_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzYtMS0xLTEtMA_e6df9015-ba11-43e9-a8ad-0c2aa1b8c0b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i244c2d6efb77428f9129af9df189e973_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzYtMy0xLTEtMA_8e59e107-ab6e-46ef-ad7c-066043aa9074">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzYtNS0xLTEtMA_778b58b1-2a9c-492d-8b00-0b2e0e154e9a">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzYtNy0xLTEtMA_230d5a8e-69b6-4c6d-b413-1c65fcda8fe2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzYtOS0xLTEtMA_8a77d57f-09fc-4a55-8c40-1030345a7bf6">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af5df3294d4476b83876447a5baef98_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzctMS0xLTEtMA_2d189481-0208-4f0a-a654-c516f6ce8753">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i244c2d6efb77428f9129af9df189e973_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzctMy0xLTEtMA_4b33f0cc-a576-43c1-8da0-5322cacd401b">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzctNS0xLTEtMA_ca4ddfcc-dc4a-4ffc-80e3-2789819d4e82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzctNy0xLTEtMA_f4c2bc7e-0e6f-4028-a7ec-f58382a25eee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzctOS0xLTEtMA_ecaeb76a-f6c7-4857-b0a6-403f3c389707">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af5df3294d4476b83876447a5baef98_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzgtMS0xLTEtMA_ebf62fb2-e8e4-4986-8fce-e694a36dfb00">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i244c2d6efb77428f9129af9df189e973_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzgtMy0xLTEtMA_e3905008-a472-48a6-8be6-fa456a4d6b4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzgtNS0xLTEtMA_0c9f5d87-83bb-449f-850f-e31b80e50cc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzgtNy0xLTEtMA_07897e1b-eea4-41fe-acd7-36f2ba28d662">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzgtOS0xLTEtMA_5884afe8-e754-4d74-8fa2-6b21833c8936">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d143f8d4624b888878df58de333010_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzktMS0xLTEtMA_b61ac64f-f605-488f-aa52-0e11a9ba78ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49d58ae32a674ec7a25b0cab1c107c50_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzktMy0xLTEtMA_7abfe62d-a382-4973-a3ba-00f46300c3a1">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9553185d57414893ad62b80064c4476b_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzktNS0xLTEtMA_f0de2c37-7008-4a45-97fe-d491af1f6021">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7980aa14ee0540c882652c696d24ce39_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzktNy0xLTEtMA_174a5922-5e89-4f03-b418-6e0edde3fb7e">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzktOS0xLTEtMA_0f439dd2-d873-4293-9be4-4484b7618ab5">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers into Level 3</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c34bf51a0004f2da4f3173e1abb80a8_D20200101-20201231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpkNjgzOGZiNGJmOTg0ZTgzOWVlNzU5M2I2NzZmZjBmZS90YWJsZXJhbmdlOmQ2ODM4ZmI0YmY5ODRlODM5ZWU3NTkzYjY3NmZmMGZlXzEtMS0xLTEtNTI5Ng_4ebf5f52-e4bf-46f2-987c-790d833b4920">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89a12d5819e147e7bc86f9b529bb3c15_D20190101-20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpkNjgzOGZiNGJmOTg0ZTgzOWVlNzU5M2I2NzZmZjBmZS90YWJsZXJhbmdlOmQ2ODM4ZmI0YmY5ODRlODM5ZWU3NTkzYjY3NmZmMGZlXzEtMS0xLTEtMA_6690f030-68d1-4ed6-94dc-10b8ac91ad32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c34bf51a0004f2da4f3173e1abb80a8_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpkNjgzOGZiNGJmOTg0ZTgzOWVlNzU5M2I2NzZmZjBmZS90YWJsZXJhbmdlOmQ2ODM4ZmI0YmY5ODRlODM5ZWU3NTkzYjY3NmZmMGZlXzItMS0xLTEtNTI5Ng_1cf31bfa-d950-451e-9d74-cf8e41377e7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89a12d5819e147e7bc86f9b529bb3c15_D20190101-20191231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpkNjgzOGZiNGJmOTg0ZTgzOWVlNzU5M2I2NzZmZjBmZS90YWJsZXJhbmdlOmQ2ODM4ZmI0YmY5ODRlODM5ZWU3NTkzYjY3NmZmMGZlXzItMS0xLTEtMA_01b098de-97f7-45d1-93ea-f0f9f2bda8e7">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers out of Level 3</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c34bf51a0004f2da4f3173e1abb80a8_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpkNjgzOGZiNGJmOTg0ZTgzOWVlNzU5M2I2NzZmZjBmZS90YWJsZXJhbmdlOmQ2ODM4ZmI0YmY5ODRlODM5ZWU3NTkzYjY3NmZmMGZlXzMtMS0xLTEtNTI5Ng_94fe0583-e82c-4866-8f3d-11343f4efd2b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89a12d5819e147e7bc86f9b529bb3c15_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpkNjgzOGZiNGJmOTg0ZTgzOWVlNzU5M2I2NzZmZjBmZS90YWJsZXJhbmdlOmQ2ODM4ZmI0YmY5ODRlODM5ZWU3NTkzYjY3NmZmMGZlXzMtMS0xLTEtMA_2f7d2066-0511-4030-9f10-419ac64a8017">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ied2b13bf729148ebbc1aa58ae522fc34" continuedAt="if3e242233df844b99be72652842c0472"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Not Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzExMDE1_55db5dfe-1afa-4bde-8d56-4add8fc66eb1" continuedAt="i27663a3a33e64f35aefad2ba59324600" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281d455fefd94775a95b6168db361569_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzQtMS0xLTEtMA_c7d66712-1989-4c53-8997-e7e92e3f291f">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if101d6a0ae7e4064a00c572a41fb9b2d_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzQtMy0xLTEtMA_eac43f8b-2693-41b9-8216-a95fb740c75e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b578dc25944a4fbe4f6a957829e2d8_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzQtNS0xLTEtMA_466d7881-6787-4e01-85e3-364fbbb8b0c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04dac01b07d44177a2aaf98a61848abf_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzQtNy0xLTEtMA_27e0ece1-ac3e-4526-9022-1ddd7ac8b6d3">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19a4d6575054945aa1e86e5f0871e33_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzQtOS0xLTEtMA_caa9fa07-f6e1-408e-bf88-d40e3abc1020">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281d455fefd94775a95b6168db361569_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzUtMS0xLTEtMA_68d1ddfd-2882-4b01-997c-6d0539809a12">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281d455fefd94775a95b6168db361569_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzgtMS0xLTEtMA_d6ff5032-0aa7-4cce-b715-d97111b90d03">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if101d6a0ae7e4064a00c572a41fb9b2d_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzgtMy0xLTEtMA_5be8e9e9-fc99-48fa-826d-8132a7fb6684">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b578dc25944a4fbe4f6a957829e2d8_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzgtNS0xLTEtMA_fc86895e-7fb4-472d-b277-9a84d0c566c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04dac01b07d44177a2aaf98a61848abf_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzgtNy0xLTEtMA_8be67263-8154-4adb-b833-35422cad9e73">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19a4d6575054945aa1e86e5f0871e33_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzgtOS0xLTEtMA_3318bf70-1ba7-4952-a8e8-5c196402b9a5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281d455fefd94775a95b6168db361569_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzktMS0xLTEtMA_31b18b6a-8942-4dfa-8ab5-4c2a073c838a">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if101d6a0ae7e4064a00c572a41fb9b2d_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzktMy0xLTEtMA_6f4f5305-8a65-4fe6-a5bd-3b7310921403">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b578dc25944a4fbe4f6a957829e2d8_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzktNS0xLTEtMA_d5cf3fc8-8c55-4f75-a45a-1fd59a897965">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04dac01b07d44177a2aaf98a61848abf_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzktNy0xLTEtMA_d0b09bbb-3208-45f2-ae83-4b317980684a">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19a4d6575054945aa1e86e5f0871e33_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzktOS0xLTEtMA_6ea63ac7-cff5-4846-a618-3a2e2b829092">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281d455fefd94775a95b6168db361569_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzEwLTEtMS0xLTA_5ddb4b82-70c1-4697-b831-6d6a7316f66b">64,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if101d6a0ae7e4064a00c572a41fb9b2d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzEwLTMtMS0xLTA_df9f38ac-c325-4c1f-974b-0956b3373af8">75,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b578dc25944a4fbe4f6a957829e2d8_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzEwLTUtMS0xLTA_86b8364a-de11-4787-8182-d06d18857630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04dac01b07d44177a2aaf98a61848abf_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzEwLTctMS0xLTA_536eac07-eb7f-4d0e-8019-93cbc3f82ffb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19a4d6575054945aa1e86e5f0871e33_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzEwLTktMS0xLTA_98c8562d-3870-4002-9750-c47b504bc00c">75,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib042e1b736b6487fa6a695c2e0d0ef4e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE0LTEtMS0xLTUzMjM_8e9bbafc-2725-4576-b054-6cb3f86e2855">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id59f0110266f4824ba6157134876f465_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE0LTMtMS0xLTUzMjM_bbe1c8f9-82ac-440c-a530-ee07876e08a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6557af605d654a8e8081d5968b6b3548_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE0LTUtMS0xLTUzMjM_e50cd0d7-99cb-46a8-8f25-38c5cd262a02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100418be515a4d90809febbdcf54309f_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE0LTctMS0xLTUzMjM_91789bb8-5ddd-40b1-807a-c886511d3d46">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib991f27f97f044478758250bf930edc1_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE0LTktMS0xLTUzMjM_18e584c8-6efb-4e25-931e-24238eed8ede">1,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib042e1b736b6487fa6a695c2e0d0ef4e_I20191231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE1LTEtMS0xLTUzMjM_4edb3bf9-76da-4c40-babd-803fd16473fc">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib042e1b736b6487fa6a695c2e0d0ef4e_I20191231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE4LTEtMS0xLTUzMjM_44bee085-231d-4146-91ea-857acf8075cb">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id59f0110266f4824ba6157134876f465_I20191231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE4LTMtMS0xLTUzMjM_ca996949-2c35-4d2c-8932-12c32b805151">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6557af605d654a8e8081d5968b6b3548_I20191231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE4LTUtMS0xLTUzMjM_77a94b5e-bae8-496a-a085-82b2e55115a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100418be515a4d90809febbdcf54309f_I20191231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE4LTctMS0xLTUzMjM_2f18c49d-7449-4547-afed-66e33cfde03b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib991f27f97f044478758250bf930edc1_I20191231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE4LTktMS0xLTUzMjM_525ab0cc-ef52-4e65-96dc-8129666c8cdd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib042e1b736b6487fa6a695c2e0d0ef4e_I20191231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE5LTEtMS0xLTUzMjM_6a08578c-42db-4172-8d6a-d51140427999">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id59f0110266f4824ba6157134876f465_I20191231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE5LTMtMS0xLTUzMjM_75bd4fba-ffba-4a63-8584-f579c797da7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6557af605d654a8e8081d5968b6b3548_I20191231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE5LTUtMS0xLTUzMjM_7a6dee22-8e20-4b53-a23f-1eee5c038640">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100418be515a4d90809febbdcf54309f_I20191231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE5LTctMS0xLTUzMjM_a7978e70-89f0-4184-89e3-4791ba76d5b9">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib991f27f97f044478758250bf930edc1_I20191231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE5LTktMS0xLTUzMjM_8d6ed9bb-c418-43cf-b7fa-105184c56d33">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib042e1b736b6487fa6a695c2e0d0ef4e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzIwLTEtMS0xLTUzMjM_01ff142e-e5b3-4ce1-8c98-7427f091b98e">68,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id59f0110266f4824ba6157134876f465_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzIwLTMtMS0xLTUzMjM_4b5bbf03-68e1-4c8a-a301-5937cd2f5046">74,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6557af605d654a8e8081d5968b6b3548_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzIwLTUtMS0xLTUzMjM_59f3ba28-1e24-4d9c-952d-208c3447aa6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100418be515a4d90809febbdcf54309f_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzIwLTctMS0xLTUzMjM_b95869dc-225f-42d1-be65-aeb53d37f0d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib991f27f97f044478758250bf930edc1_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzIwLTktMS0xLTUzMjM_578ad9bf-4c62-4ff7-a028-90f67bacc12b">74,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i27663a3a33e64f35aefad2ba59324600" continuedAt="i1f689d5457f941cc8b8e1cf0f7eac03f">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i1f689d5457f941cc8b8e1cf0f7eac03f">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information regarding the valuation of cost method investments.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Net investment income and capital gains and losses on Separate Accounts assets accrue directly to such contract holders.&#160;The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses.&#160;Deposits, withdrawals, net investment income and realized and unrealized capital gains and losses on Separate Accounts assets are not reflected in the consolidated statements of operations, shareholders&#8217; equity or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets include debt and equity securities.&#160;The valuation methodologies used for these assets are similar to the methodologies described above in this Note 4 &#8216;&#8216;Fair Value.&#8217;&#8217;&#160;Separate Accounts assets also include investments in common/collective trusts that are carried at fair value. Common/collective trusts invest in other investment funds otherwise known as the underlying funds. The Separate Accounts&#8217; interests in the common/collective trust funds are based on the fair values of the investments of the underlying funds and therefore are classified in Level 2. The assets in the underlying funds primarily consist of equity securities. Investments in common/collective trust funds are valued at their respective net asset value (&#8220;NAV&#8221;) per share/unit on the valuation date.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if3e242233df844b99be72652842c0472" continuedAt="i9c16b8c943d34d7d93310c692d4a86a9"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzExMDEy_ba9b5e5f-a976-42f3-a213-d9182e2be2c2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts financial assets at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57f9fd12efa94170971353c862b9029d_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItMS0xLTEtMA_5aca846e-9c9a-41d6-9987-f9b6dd5d4d43">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6543aefea2e4d4f81c09b28b2913051_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItMy0xLTEtMA_6f226ee9-156b-4f86-8b38-81be9bf06b9b">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cf3dd46c89b44d5bdbd281a784aaa95_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItNS0xLTEtMA_d08741a9-6616-42f1-9c60-e72701d6564b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6180b9fbac5241d0a8dc3af2706fcd51_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItNy0xLTEtMA_c7ee7345-86ad-40a7-adec-76ac256bfa6b">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6438f449279451c82fc37e0afbb67db_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItOS0xLTEtMA_f12e9d6f-e05f-4e50-9336-74a92ab8c877">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d236f896774150b7f1bc5f4da496b8_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItMTEtMS0xLTA_e7d540ab-41f9-49cf-894a-70ee55935bcc">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8ddf588ddb0403491b152484f71c14c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItMTMtMS0xLTA_1aea6561-7602-4f61-aa22-78022e2f1fe0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i871f5afdae7444e99dd2730c1cf0cee9_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItMTUtMS0xLTA_ee450717-a895-4d2b-bca3-9185a113844c">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee9411da7c14a77a36a1bac009e2718_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtMS0xLTEtMA_39212496-98af-4c53-98f0-a5916eb78ce2">1,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe2ce5da7414160ae14468a18322af4_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtMy0xLTEtMA_06e39a5b-9a62-4b79-a218-f8980086af30">2,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff428bc79a6944198cdd6baa0d71d0b1_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtNS0xLTEtMA_b240e795-d151-4b59-8e50-35364c07416c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c958b1240244ab49139ba6f5f3c28d4_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtNy0xLTEtMA_84c2f2e0-04f0-495c-812c-f7556d2541bb">4,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a35d7e4fc984bbd812c51700e1979e2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtOS0xLTEtMA_7b949e82-2628-4bec-811f-4870d72c1992">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00b03bec0a84260b8fe2013746a2f95_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtMTEtMS0xLTA_0b47d035-6c89-4594-9cda-2700b11c041a">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280afee039b24b5c9a7ca13a82b422e7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtMTMtMS0xLTA_a2f2b7d8-a6c8-49ba-8579-19d5acdc406d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e7bd646c054ce0b4531b2eb42e4c6c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtMTUtMS0xLTA_84af7dd5-9cc1-4ba1-a967-a56f80fb8a72">3,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie69e76ed83f946baa094f2cc5d6eed7c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtMS0xLTEtMA_d1177b22-2694-4173-b450-8a456b6f565f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7305113d58334ee181e867ee40fba5ea_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtMy0xLTEtMA_48439101-8ad2-4297-88cd-670c84e80723">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460c17b4dd6047799d283a4d6ac8e89e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtNS0xLTEtMA_ddb56351-96d3-4355-976a-dfe88d19c480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03b2619a7c974ff2a2f5ae867e8f37e9_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtNy0xLTEtMA_d26ea3fe-2eb7-4bb7-a3bc-cf5ecd26ac76">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i151d6d04ea0b4c4d8082b77226a45d78_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtOS0xLTEtMA_8c49b657-b8da-4937-9289-cc6e1b4f4506">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24eb76bad3d44b72b3d464f255226436_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtMTEtMS0xLTA_7cb78493-4daf-44c1-b9ed-86a759a540e0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc128aa047224725a06bd6f71841db12_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtMTMtMS0xLTA_2d7c35f7-a188-423a-aa3b-9a5126e3351d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54973a0f47c84614ac6eac855bff8c4a_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtMTUtMS0xLTA_59043808-62f4-4239-833d-0ba36fe00410">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c1904e935648538c8d82dcc767f325_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtMS0xLTEtMA_e9b92b91-6c2f-44c0-baf3-2750ba693576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb3afb7703f41758890d49de4633ba9_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtMy0xLTEtMA_c42f4764-1dc8-40ea-a0aa-62d2d03282b1">563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42c5a9f858b74f68b1093b16815b1cce_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtNS0xLTEtMA_5b67ae50-01ec-4fbf-a783-0ba94b32ad27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cfe1fb048044ccaa0da17032f0b6155_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtNy0xLTEtMA_6b21de57-6dd4-4600-962f-169d8daf919f">563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff5a46ba7a27414b9d1202b7ad24b91e_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtOS0xLTEtMA_c4bbfa64-4a9d-4e12-a6a0-79822851dfbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i844180dee7354a88a31506e0b8d33a2d_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtMTEtMS0xLTA_8d6c50ce-0eb0-417f-81a1-fa4fbd350b18">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b103cf575b42eba2237027ca0840ed_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtMTMtMS0xLTA_667cc9f6-e9e5-4992-8c08-a71422ec184b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia86e094601974260bb883cef037fa44f_I20191231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtMTUtMS0xLTA_42cb95fe-c308-4517-89bf-7cb4ad6fef64">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f2ffe7a0ba474fb811572f2e0ea7e0_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtMS0xLTEtMA_d849eed7-7092-4f33-83c1-6c883e019d5b">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4508cc8f56f04ee9a7567e40b8da3c28_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtMy0xLTEtMA_6a2ab1b1-4433-452e-b64e-287995939316">3,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id19caab13c4e4bc38082d1bdf6bc13ea_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtNS0xLTEtMA_a56fea4e-6248-41fe-a416-04b4c83a2199">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e22f02c654244d596daa5e51b729587_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtNy0xLTEtMA_f4098678-97b8-4eb0-86c2-8ca182d931ed">4,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i824ec462d55041558ba9c29476131800_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtOS0xLTEtMA_f09f9978-2248-43d9-b785-f704e02ced28">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i427b6fb3db3448e2808f061a08c25372_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtMTEtMS0xLTA_9960fcf6-c78b-4c3d-8aea-c43a368f0d36">3,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec6476033e246a18cda5819f01ab27f_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtMTMtMS0xLTA_85157085-232b-476b-b409-f639cf3d34db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtMTUtMS0xLTA_d890d2c4-0fe0-4a4c-9bab-9e0dd11e9957">4,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="ide3c87bc14d942c99faa1f30e965d4f6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzIxOTkwMjMyNzE2Mjk_55b82151-f52c-4d2a-ac91-8228feede386">29</ix:nonFraction> million of other receivables at December&#160;31, 2020.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2020 and 2019, the Company had <ix:nonFraction unitRef="usd" contextRef="i65c51381aa1a459fa5e530ac9f5de9f2_D20190101-20191231" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzIxOTkwMjMyNzE2NTY_f9448eef-10d1-48d8-9675-8adabbb2e133"><ix:nonFraction unitRef="usd" contextRef="i91b1952fb7784e7f9e6499530764f7ad_D20200101-20201231" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzIxOTkwMjMyNzE2NTY_fedbe1d3-2795-4717-aaaa-fd27ad8531f9">no</ix:nonFraction></ix:nonFraction> gross transfers of Separate Accounts financial assets into or out of Level 3.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offsetting Financial Assets and Liabilities</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9c16b8c943d34d7d93310c692d4a86a9">Certain financial assets and liabilities are offset in the Company&#8217;s consolidated balance sheets or are subject to master netting arrangements or similar agreements with the applicable counterparty. Financial assets subject to offsetting and enforceable master netting arrangements were $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeCollateralObligationToReturnSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzEwOTk1MTE2NDM0NjQ_8775f6b8-185b-42c4-9f1c-5f07f66c0bd0">2</ix:nonFraction> million as of December 31, 2020. Financial liabilities subject to offsetting and enforceable master netting arrangements were $<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilityCollateralRightToReclaimCashOffset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzEwOTg0_d55f32e1-4847-4fae-9dbd-2467b2754064">3</ix:nonFraction> million as of December 31, 2019.</ix:continuation> </span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_136"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzcxNzc_cf4458f1-b523-4811-952d-11cd051ac67e" continuedAt="ifaf095279a30490c86dedd35987e2747" escape="true">Goodwill and Other Intangibles</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifaf095279a30490c86dedd35987e2747" continuedAt="if49ff42859d549ed8e19d657776e01c6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzcxNzk_830bcf1c-a5d9-43f8-8fe9-446286d96c4a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c56d1167edd4939801f422a336b0abc_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEtMS0xLTEtMA_4f243c72-6c4f-45f7-ae35-4d8a19224ced">23,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f780e49e5ac454294cb92045dbbedba_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEtMy0xLTEtMA_d4c0fe5c-37ae-4eba-825a-7d76f8b3e3e7">10,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i328ef57235b84be59c08ccc5a5935e02_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEtNS0xLTEtMA_ab4f38a5-3ee9-4234-8fe4-3ed60a5e2863">44,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEtNy0xLTEtMA_99f5d881-9129-452d-b518-4bda2a5c9ab6">78,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment realignment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5423b7aeb71b4180a07350c4973d0d2f_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzItMS0xLTEtMA_ab89ec4a-a88a-4f0e-a549-2230ecb1d20f">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i015c0f06a5d5429bb1541c67f66811a0_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzItMy0xLTEtMA_7cb13d88-2552-4754-ac69-0401577c1217">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052772f862ef450c8eb33c1ce00be32b_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzItNS0xLTEtMA_e25d66a7-2db7-43ab-8922-35370321223f">194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzItNy0xLTEtMA_78cda02d-2baa-4b46-9965-2b6e4343e2c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5423b7aeb71b4180a07350c4973d0d2f_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzMtMS0xLTEtMA_c6cea720-6174-4976-8cef-cd87532be297">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i015c0f06a5d5429bb1541c67f66811a0_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzMtMy0xLTEtMA_3f966c6d-97df-4044-980b-28cf2564b548">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052772f862ef450c8eb33c1ce00be32b_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzMtNS0xLTEtMA_74245589-1ec5-4f9a-94fb-7494818120c0">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzMtNy0xLTEtMA_60faf03f-1421-49f2-9df1-3978cd8a9e27">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5423b7aeb71b4180a07350c4973d0d2f_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzQtMS0xLTEtMA_56c76da7-8579-4d17-8bf9-abd1fa6594e3">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i015c0f06a5d5429bb1541c67f66811a0_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzQtMy0xLTEtMA_d168c5e9-4c9e-4797-9aa0-85273081c567">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052772f862ef450c8eb33c1ce00be32b_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzQtNS0xLTEtMA_8778db97-08f4-4d6b-bb6c-938e14f7af3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzQtNy0xLTEtMA_84a7ab67-e471-476a-ac2c-218a49c27fba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i115aa53eff704e2796feb2dab7050983_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzYtMS0xLTEtMA_6755286c-8891-4b31-8efb-1a646f638070">23,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc25230039c44ea89e091836ed33b5f4_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzYtMy0xLTEtMA_de350619-f71d-473e-a3e8-87cbaa7658a0">10,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c1e3b4bd52240c6a3a87ca6634cc223_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzYtNS0xLTEtMA_6a5f6ab7-3cd8-458e-9d23-ac2abce21072">45,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzYtNy0xLTEtMA_1d8de532-89e3-4982-807d-bf9874856ec9">79,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19aec03053a346be962dfd329ffc858e_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzctMS0xLTEtMA_637be21f-307c-4ed0-a4b3-80690cfc170e">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedba146ac9454388b30cd9e975a457e9_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzctMy0xLTEtMA_91990cce-7363-4e9a-8c92-a16425b117c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b8848a0b0848d0b1ef073195fcf232_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzctNS0xLTEtMA_5c44e9c8-ac1a-4c3a-b300-fc7a5363233d">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzctNy0xLTEtMA_87d60858-87e0-4935-bb2c-25ad6f05739c">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture of Workers&#8217; Compensation business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19aec03053a346be962dfd329ffc858e_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzgtMS0xLTEtMA_aac1d919-8007-4a7e-a156-fd5754899444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedba146ac9454388b30cd9e975a457e9_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzgtMy0xLTEtMA_842773fc-16f4-4a44-a313-585f1a508c62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21b8848a0b0848d0b1ef073195fcf232_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzgtNS0xLTEtMA_d1c79b11-a34b-4d70-9d75-5d6b3d4159d2">505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzgtNy0xLTEtMA_ad1a38a2-22ba-48ec-bb68-89dbf07d668c">505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412092e3efa64b64bfb4e908a7aecf6f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEwLTEtMS0xLTA_15472f8d-153e-46dd-aaef-ba5d7460b179">23,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEwLTMtMS0xLTA_a81f09f6-052a-45bf-86c2-caac78f5563a">10,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1c041ab6e1476e81c0a2cce0548fb0_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEwLTUtMS0xLTA_09bb4e02-ccd5-430f-bfa6-193c172fd9ec">45,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEwLTctMS0xLTA_441cf1ee-854b-4b1b-92c9-10242e71430f">79,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the decrease in the carrying amount of goodwill was primarily driven by the divestiture of the Workers&#8217; Compensation business, partially offset by goodwill associated with immaterial acquisitions. During the year ended December&#160;31, 2019, the increase in the carrying amount of goodwill was primarily driven by purchase accounting adjustments associated with the Aetna Acquisition. See Note 2 &#8216;&#8216;Acquisitions and Divestitures&#8217;&#8217; for further discussion regarding the Workers&#8217; Compensation business divestiture and the Aetna Acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, the Company also realigned the composition of its segments to correspond with changes to its operating model and to reflect how the Chief Operating Decision Maker (the &#8220;CODM&#8221;) reviews information and manages the business. As a result of this realignment, the Company reallocated the associated goodwill balance to the Pharmacy Services and Health Care Benefits segments based on a relative fair value approach. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of both 2020 and 2019, the Company performed its required annual impairment tests of goodwill. The results of these impairment tests indicated that there was no impairment of goodwill. At both December&#160;31, 2020 and 2019, cumulative goodwill impairments were $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzIxOTkwMjMyNzk4MjM_1573def0-7441-4cf2-a529-9740ac6bfcf1"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzIxOTkwMjMyNzk4MjM_e0f6c120-c8c1-49a6-821e-d918e7e2cc83">6.1</ix:nonFraction></ix:nonFraction> billion.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="if49ff42859d549ed8e19d657776e01c6" continuedAt="i8ec196ca540841df866c12c06cf280d0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LTC reporting unit has experienced industry-wide challenges that have impacted management&#8217;s ability to grow the business at the rate that was originally estimated when the Company acquired Omnicare, Inc. (&#8220;Omnicare&#8221;) in 2015. Those challenges include lower client retention rates, lower occupancy rates in skilled nursing facilities, the deteriorating financial health of numerous skilled nursing facility customers which resulted in a number of customer bankruptcies in 2018, and continued facility reimbursement pressures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the update of its current and long-term forecasts in June 2018, management determined that there were indicators that the LTC reporting unit&#8217;s goodwill may be impaired and, accordingly, management performed an interim goodwill impairment test as of June 30, 2018. The results of that interim impairment test showed that the fair value of the LTC reporting unit was lower than the carrying value, resulting in a $<ix:nonFraction unitRef="usd" contextRef="i4e630250890a4d9da4b21f7c24765041_D20180401-20180630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzIxOTkwMjMyNzgxNDM_6c2d843f-df3d-484c-923e-231e226d00e1">3.9</ix:nonFraction> billion pre-tax goodwill impairment charge in the second quarter of 2018. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2018, the Company performed its required annual impairment tests of goodwill and concluded there was <ix:nonFraction unitRef="usd" contextRef="i890b640f721945cabfe705407b55dc08_D20180701-20180930" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzIxOTkwMjMyNzk1NTA_dc619779-01b1-4e3a-8c91-68e6a337f6af">no</ix:nonFraction> impairment of goodwill or trade names. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the LTC reporting unit missed its forecast primarily due to operational issues and customer liquidity issues, including one significant customer bankruptcy. Additionally, LTC management submitted updated projected financial results which showed significant additional deterioration primarily due to continued industry and operational challenges including lower occupancy rates in skilled nursing facilities, significant deterioration in the financial health of numerous skilled nursing facility customers and continued facility reimbursement pressures. Based on these updated projections, management determined that there were indicators that the LTC reporting unit&#8217;s goodwill may be further impaired and, accordingly, management performed an interim goodwill impairment test during the fourth quarter of 2018. The results of that interim impairment test showed that the fair value of the LTC reporting unit was lower than the carrying value, resulting in an additional $<ix:nonFraction unitRef="usd" contextRef="i81f108a20d3a4e71b79be5b539cf2fb3_D20181001-20181231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzIxOTkwMjMyNzkzOTQ_bd5f2690-7de0-41c6-954c-06c2ef82b427">2.2</ix:nonFraction> billion pre-tax goodwill impairment charge in the fourth quarter of 2018. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the remaining goodwill balance in the LTC reporting unit was $<ix:nonFraction unitRef="usd" contextRef="i821644c913b3489eb143ff3327e94045_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzIxOTkwMjMyNzk1Mzk_4bc8c5ae-7ac3-4b06-8cd0-0dc1ed9f2b9f">431</ix:nonFraction> million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="cvs:FinitelivedandindefinitelivedintangibleassetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzcxNzQ_31b91e6a-9096-4f44-98c5-4fd910ce2e93" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s intangible assets as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except weighted average life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzItMS0xLTEtMA_266c67f6-332f-4c4d-bdf7-d160f2cdadb5">10,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzItNS0xLTEtMA_238d46e4-1044-4431-b4d3-c6a3c78e033c">10,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84badfbc307d4be689f1bf6c6f45530f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzMtMS0xLTEtMA_2558f878-a4d3-4722-b6fb-f219439bdd49">24,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84badfbc307d4be689f1bf6c6f45530f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzMtMy0xLTEtMA_b015df07-7caa-40c6-81b6-2e8c392a6035">8,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84badfbc307d4be689f1bf6c6f45530f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzMtNS0xLTEtMA_a1e849ed-e23c-4247-b635-6e367cbdf82e">16,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0ba3c6a5d60545c7aa5e44bfe6800541_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzMtNy0xLTEtMA_e00c0614-01e1-49db-bf50-89795a3b231e">14.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67ce92b07cf64792b2f3329459fc557a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzQtMS0xLTEtMA_c27f4e42-d5bd-4ad6-a1d6-4e8ea14950dd">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67ce92b07cf64792b2f3329459fc557a_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzQtMy0xLTEtMA_92da6508-aeb7-4a3d-a175-08a002766983">739</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67ce92b07cf64792b2f3329459fc557a_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzQtNS0xLTEtMA_b48bbf34-3fa9-4f4e-875f-9d143e6227a9">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id50415e8993440b4b0cc0fa2104abfda_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzQtNy0xLTEtMA_7a8668f5-1ed8-4119-bc6e-ef2529b3681d">3.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc0b012207df4d0a9822ad6163fa473c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzUtMS0xLTEtMA_ca51503a-fb3a-48d9-91dd-3b6219c2c8ea">4,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc0b012207df4d0a9822ad6163fa473c_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzUtMy0xLTEtMA_48ec29ae-459a-4083-8dc0-3e382ed62e81">440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc0b012207df4d0a9822ad6163fa473c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzUtNS0xLTEtMA_2f8bf9bc-27f8-4288-9da9-bc8a689e1dbf">3,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i75becaee1c754117a23d47d9390aa79a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzUtNy0xLTEtMA_4f0236b1-3800-4663-8876-7b5a5af9b8ba">20.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72cdd4168bda4feba177b3eb839e391b_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzYtMS0xLTEtMA_8be2093e-0ea3-4d24-88b4-93ba902b2771">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72cdd4168bda4feba177b3eb839e391b_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzYtMy0xLTEtMA_f12b303f-ffa9-4bf0-bdf4-fad140f33b4b">119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72cdd4168bda4feba177b3eb839e391b_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzYtNS0xLTEtMA_aaefe6f7-e217-4379-b9b8-05f9334e34bd">471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2e3c68b19214ed09360896c5196bd2e_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzYtNy0xLTEtMA_e8f09e6f-ebfa-47fc-b02e-70a9a23ec135">20.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i591aef778e8f4b08a9c034e1f397fd90_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzctMS0xLTEtMA_1b2d895a-7312-4486-90fd-f6f1e4ef887b">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i591aef778e8f4b08a9c034e1f397fd90_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzctMy0xLTEtMA_e4fe2094-e405-48a4-9fd1-625492003e4f">260</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i591aef778e8f4b08a9c034e1f397fd90_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzctNS0xLTEtMA_c31f5f10-0244-4cb5-9302-469d64c943bb">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i491553d39bb44be899dcfc0772b9b2d0_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzctNy0xLTEtMA_8b9a74ce-d809-4a53-b20e-f89a7c061c5e">7.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzgtMS0xLTEtMA_bcb28c1b-e952-40d3-a9b0-4dde081a6eaa">41,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzgtMy0xLTEtMA_a490bd5c-bc3b-4f4f-aed0-80fa316f0eda">10,481</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzgtNS0xLTEtMA_0958dfcf-b5dc-4981-8aec-0874a3e74787">31,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzgtNy0xLTEtMA_5c88af4d-d15a-41fb-9bbd-37a25d024a2c">15.2</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzExLTEtMS0xLTA_fc1044ff-65ae-4fc2-b9bb-0c021c94ba33">10,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzExLTUtMS0xLTA_24815eb1-62b7-4cd2-8a0b-a8ee0029b134">10,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21fdbe08c4894113b384b8256579df43_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEyLTEtMS0xLTA_f28a9668-7925-4d6d-973b-2d869dc8d78f">25,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21fdbe08c4894113b384b8256579df43_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEyLTMtMS0xLTA_ba56cf81-36ce-48e4-888d-c4932c235221">8,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21fdbe08c4894113b384b8256579df43_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEyLTUtMS0xLTA_c37d1304-a3db-406f-9cf1-3df274f988cb">17,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i584138b84e0c44e79759aa9dc3e98131_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEyLTctMS0xLTA_8f3e9862-c691-49e1-b221-d19c06b4fc45">14.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie44e4bdd6e20403284243fce9600ca50_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEzLTEtMS0xLTA_166ac20a-5489-4879-892c-efca0265d34a">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie44e4bdd6e20403284243fce9600ca50_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEzLTMtMS0xLTA_9dfd3812-ed99-4097-9c49-8c635b300eb5">386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie44e4bdd6e20403284243fce9600ca50_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEzLTUtMS0xLTA_89fbca86-36bd-4b4c-8538-a15ba3f9b3b1">674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2c72804fb3f40038ae0de7cee82c6ea_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEzLTctMS0xLTA_6600d264-2901-4be9-8fa0-94c5e66273fe">3.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie01b8cdceadc4bdc8efc4a1dccc006f8_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE0LTEtMS0xLTA_97bd08cd-2502-479d-a041-389cceae70ac">4,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie01b8cdceadc4bdc8efc4a1dccc006f8_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE0LTMtMS0xLTA_0b8706a6-7185-469f-ab55-91c88d9548eb">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie01b8cdceadc4bdc8efc4a1dccc006f8_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE0LTUtMS0xLTA_a87d8b12-677f-4b1f-8e6b-c23159f2254d">3,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i63d8ba5cb3cf4c23924e487351249b95_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE0LTctMS0xLTA_488ce357-9d15-4aaf-8245-382bc88c49a7">20.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfa84e1dd6d488fb10bc33f97246d8f_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE1LTEtMS0xLTA_cd77c113-896c-4ae6-bf04-d32194cdd861">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbfa84e1dd6d488fb10bc33f97246d8f_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE1LTMtMS0xLTA_73af072d-cceb-458c-81e7-549182e821d3">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfa84e1dd6d488fb10bc33f97246d8f_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE1LTUtMS0xLTA_29100147-84cd-459c-9748-46da52505c18">527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9d00c64ee40f49f090f5ef6179642e56_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE1LTctMS0xLTA_66cbe99f-2aa8-4cf3-9d2a-5333c3760e6f">20.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6f52fb91cf7425c82f7676b531c4967_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE2LTEtMS0xLTA_3ef65dfa-9aae-44b7-9483-bff3f7fc54f4">364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6f52fb91cf7425c82f7676b531c4967_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE2LTMtMS0xLTA_4379686b-aaf5-4481-8f15-6ecac93a0237">232</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6f52fb91cf7425c82f7676b531c4967_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE2LTUtMS0xLTA_63ab13d4-bb1a-4ad5-9544-59d5fb156ba3">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i34f48c975e2748a8ab2b5a10d3e41319_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE2LTctMS0xLTA_f83f923f-2d5f-473a-ba47-e6560b67f586">8.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE3LTEtMS0xLTA_35146bbe-f5d8-4f60-98c6-f221d5f68f5d">42,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE3LTMtMS0xLTA_f7f4d6a5-50fc-45d2-9b6b-f575622242fc">9,038</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE3LTUtMS0xLTA_e6f766fe-80c0-44f5-bd53-d3ec52c71dee">33,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE3LTctMS0xLTA_cc3a4862-d85c-402a-bb7e-85b5f17f7fd5">15.1</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i8ec196ca540841df866c12c06cf280d0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets totaled $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzY5Nzg_2bad6232-d1a0-4868-b2c1-b8db7fbb4b35">2.3</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzY5ODI_f388f14c-ebac-4001-96fe-3d6fa3721095">2.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzY5ODk_c337f771-32e6-47f9-8eb4-6b96feb6279d">1.0</ix:nonFraction> billion for the years ended December 31, 2020, 2019 and 2018, respectively. <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzcxNzY_5729f99f-1702-4c7c-8d52-00a051f15bfd" continuedAt="i1edfd54a6b7749ba8640bf529fac7d88" escape="true">The projected annual amortization expense for the Company&#8217;s intangible assets for the next five&#160;years is as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i1edfd54a6b7749ba8640bf529fac7d88"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2MzkzNDg0YTQ4ZTA0NzAxOWNjZTc5NWE0ODRhZWZkOC90YWJsZXJhbmdlOjYzOTM0ODRhNDhlMDQ3MDE5Y2NlNzk1YTQ4NGFlZmQ4XzEtMS0xLTEtMA_4089336a-3960-40eb-bb4d-5c817a8c10f8">2,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2MzkzNDg0YTQ4ZTA0NzAxOWNjZTc5NWE0ODRhZWZkOC90YWJsZXJhbmdlOjYzOTM0ODRhNDhlMDQ3MDE5Y2NlNzk1YTQ4NGFlZmQ4XzItMS0xLTEtMA_ed8f2246-6318-4f42-95c6-35e9874dcc8c">1,842</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2MzkzNDg0YTQ4ZTA0NzAxOWNjZTc5NWE0ODRhZWZkOC90YWJsZXJhbmdlOjYzOTM0ODRhNDhlMDQ3MDE5Y2NlNzk1YTQ4NGFlZmQ4XzMtMS0xLTEtMA_1b772683-77a2-4f14-a9c2-37757802b535">1,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2MzkzNDg0YTQ4ZTA0NzAxOWNjZTc5NWE0ODRhZWZkOC90YWJsZXJhbmdlOjYzOTM0ODRhNDhlMDQ3MDE5Y2NlNzk1YTQ4NGFlZmQ4XzQtMS0xLTEtMA_53346899-9493-40f1-a534-6a585ffd52f0">1,770</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2MzkzNDg0YTQ4ZTA0NzAxOWNjZTc5NWE0ODRhZWZkOC90YWJsZXJhbmdlOjYzOTM0ODRhNDhlMDQ3MDE5Y2NlNzk1YTQ4NGFlZmQ4XzUtMS0xLTEtMA_e7baa017-a135-475d-92a8-87c4a1115c60">1,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_142"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NjI_bb310ba4-dd5f-455d-ac34-64c6d1c5ca9d" continuedAt="i9c4125b7b89c4bb99410f232135744f3" escape="true"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NjM_524184ff-8f78-4af8-aac9-e917c8ab7cc7" continuedAt="ib6ae821b938d461ebc1f8ffab3e1eb85" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9c4125b7b89c4bb99410f232135744f3" continuedAt="i5ad9fef8170846ccb0b5f0478bf7c891"><ix:continuation id="ib6ae821b938d461ebc1f8ffab3e1eb85" continuedAt="i375d778f8b2e4fb1bd915e06c1e17525"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 842) (&#8220;ASC 842&#8221;) on January 1, 2019 on a modified retrospective basis. As a result, the Company&#8217;s lease disclosures as of and for the years ended December 31, 2020 and 2019 are reported under ASC 842. Comparative financial information for the year ended December 31, 2018 has not been restated and continues to be reported under ASC 840, the lease accounting standard in effect for that period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disclosure Subsequent to the Adoption of the New Lease Accounting Standard (ASU 2016-02) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of <ix:nonNumeric contextRef="icdcdd6decfad41b9858abc5ec839199a_D20200101-20201231" format="ixt-sec:duryear" name="cvs:LesseeOperatingAndFinanceLeasesTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzcxNQ_af461f9b-982b-4542-a92c-9ad2b2898bf1">15</ix:nonNumeric> to <ix:nonNumeric contextRef="i13bbb4efccc14c5c82049f643d62aa08_D20200101-20201231" format="ixt-sec:duryear" name="cvs:LesseeOperatingAndFinanceLeasesTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzcyMQ_f06b9f14-dd7f-4392-8c20-ae2927d5fce6">25</ix:nonNumeric> years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of <ix:nonNumeric contextRef="idc7172c9ddcb4248bce1ae1aa4280d25_D20200101-20201231" format="ixt-sec:duryear" name="cvs:LesseeOperatingAndFinanceLeasesTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzg1MQ_22215cbb-1644-4090-93a2-43ad4d5e91b5">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i029b000534014642b4477f76ec44b138_D20200101-20201231" format="ixt-sec:duryear" name="cvs:LesseeOperatingAndFinanceLeasesTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzg1Nw_68b4c8aa-faa5-4f74-9d04-a0239be491e6">10</ix:nonNumeric> years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NjU_46fa2f80-9845-495b-9c07-c26d4e527225" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzEtMS0xLTEtMA_820fba4b-4244-4c19-81ce-b66887c9c619">2,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzEtMy0xLTEtNDU1_a8b921b4-1dcf-45b3-8637-c48df061bd0d">2,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzMtMS0xLTEtMA_de173554-e012-44a4-8cd1-ff5f0dc4f3c9">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzMtMy0xLTEtNDU1_49f1c32e-0891-47ce-bf07-9ffc834f247c">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzQtMS0xLTEtMA_099d6d61-84fd-43d4-9394-c6c917ba505e">58</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzQtMy0xLTEtNDU1_cc69f342-d161-4794-87c0-f123df9d280b">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="cvs:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzUtMS0xLTEtMA_ee559a6c-674c-4f75-afac-683af5022052">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="cvs:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzUtMy0xLTEtNDU1_356aefae-45e9-4f22-9339-97fa7a92d539">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzYtMS0xLTEtMA_84882e3b-be70-484a-883c-627ecfe2cfc8">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzYtMy0xLTEtNDU1_3b78e14c-57bb-45a9-bec5-c0a3d98c75f9">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzctMS0xLTEtMA_a255f7ac-725c-4052-a28f-7e1f3b1ffe3a">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzctMy0xLTEtNDU1_c886bfd6-3801-4a6d-b727-6499f03e72e6">581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzgtMS0xLTEtMA_00ea2fb5-bdbc-4331-995d-92d64d527285">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzgtMy0xLTEtNDU1_d24a793c-a039-463b-b1e6-6acb3bba9483">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzktMS0xLTEtMA_9b05e6a8-a16e-432c-91ce-9ec6ced942d1">3,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzktMy0xLTEtNDU1_6491003a-4124-4c14-83d6-061d84e5f9c1">3,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2020 and 2019 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzItMS0xLTEtMA_e991ac0d-75b9-489e-9ce3-db974d2596f0">2,724</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzItMy0xLTEtNDc4_a894d5ee-e430-4c0f-b1fa-18b9ae731a0f">2,701</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for interest portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzMtMS0xLTEtMA_11936a71-b230-4ce3-942e-60d503b7d359">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzMtMy0xLTEtNDc4_de3290fa-f62e-41bc-b900-e0a30d452499">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows paid for principal portion of finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzQtMS0xLTEtMA_cf85b18b-e7df-414b-9e62-2235763c7d80">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzQtMy0xLTEtNDc4_1781988e-7d89-4c4f-833d-c056e7515153">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzYtMS0xLTEtMA_5ce4445d-a3ed-47d9-90d3-d2f966384920">1,679</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzYtMy0xLTEtNDc4_8173f4ff-5dee-462b-934d-49c8e9b19000">1,824</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzctMS0xLTEtMA_435fac33-78ea-4dec-8471-14cad79acf5d">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzctMy0xLTEtNDc4_f18cf519-2840-4efa-967b-f961da8187c9">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i5ad9fef8170846ccb0b5f0478bf7c891" continuedAt="if4d590d1bebf4d10b2e1169a613099d5"><ix:continuation id="i375d778f8b2e4fb1bd915e06c1e17525" continuedAt="i0cc663a703814dac8e6b9175ff0e751e"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="cvs:LesseeLeaseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NTk_0eb4767a-933b-4c60-ba25-f244106d28cd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December&#160;31, 2020 and 2019 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except remaining lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzItMS0xLTEtMA_d36ab2a1-ec7c-4faa-899c-04d54efc53e4">20,729</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzItMy0xLTEtNTEy_f42da14b-5498-4df4-9acf-ca49ff147148">20,860</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzQtMS0xLTEtMA_3176bbcb-093e-4386-8502-892f8da1a582">1,638</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzQtMy0xLTEtNTEy_b8aad93c-6f7c-46cb-b93e-aa7707c7baa9">1,596</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzUtMS0xLTEtMA_4bfbbd08-1f19-415a-b436-33ce0cc9498f">18,757</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzUtMy0xLTEtNTEy_27af33f0-230f-4c58-b3bd-e86bcb4e4e72">18,926</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzYtMS0xLTEtMA_f1e60d7f-fd24-4d82-9c79-985974e8f0a8">20,395</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzYtMy0xLTEtNTEy_baa14bff-be04-4c31-b7af-be0925ccf1fc">20,522</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:FinanceLeaseRightOfUseAssetGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzktMS0xLTEtMA_1312ec8c-dadf-44ff-9252-52d91886f122">1,107</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzktMy0xLTEtNTEy_fd65b58e-6860-4a47-af1e-5e4a5d2882e5">790</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzEwLTEtMS0xLTA_dca94209-996a-4cbe-959d-dbe251aaa184">106</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzEwLTMtMS0xLTUxMg_9c23247a-290e-4dbc-95a5-d4a10a4926dc">38</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:FinanceLeaseRightOfUseAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzExLTEtMS0xLTA_9d1a1d96-137d-49b5-8d80-788c690fe774">1,001</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzExLTMtMS0xLTUxMg_d842a24c-c80b-4ee7-ad65-afc7f14f7c1e">752</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt 0 7pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzEzLTEtMS0xLTA_4d22a635-d68a-4c12-a5cf-2d80e3a8aeb2">33</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzEzLTMtMS0xLTUxMg_5c862be1-7b0c-465f-9fe7-cc40dccb1e79">27</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE0LTEtMS0xLTA_398278d6-7157-40c0-a6d0-b3cf1e8ad912">1,050</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE0LTMtMS0xLTUxMg_0576ac29-ab8b-4fa9-b20d-d2582ffe23c7">781</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE1LTEtMS0xLTA_e66c16d4-7c79-4e28-968f-151538da92fe">1,083</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE1LTMtMS0xLTUxMg_b6f99cb6-853b-4759-b046-ac9c6650b3fe">808</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE4LTEtMS0xLTA_952e938e-95a0-493f-bf7d-b2edda3c9390">13.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE4LTMtMS0xLTUyMQ_08a1e856-28ee-4309-92b1-ec5f6e3b6e1c">13.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE5LTEtMS0xLTA_a041b996-cab3-425a-ab7e-eedaa3278eac">20.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE5LTMtMS0xLTUyMQ_6c48b784-da49-4d02-ab80-a60a97d42b2c">20.5</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzIyLTEtMS0xLTA_13cecf60-3c27-4099-bb22-37328f142a70">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzIyLTMtMS0xLTUyMQ_bfbb80b4-d47c-4c43-8b22-f9716e966daf">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzIzLTEtMS0xLTA_46d37a3f-3aaf-4381-939b-567d8b3bcc5b">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzIzLTMtMS0xLTUyMQ_359a8ea2-6e08-4d6a-8a9e-b27d81ce3526">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NTY_a1f8f30b-6abf-4d7a-9159-e8cdd43c91b9" escape="true"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NjA_e7f358b0-7d45-4565-a0f0-fac4727446ce" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzEtMS0xLTEtMA_99141321-2b05-40fb-b506-d6bff40cc321">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzEtMy0xLTEtMA_b7e96381-3b63-4b48-a24c-6c9194fadab8">2,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LesseeLiabilityPaymentsYearOne" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzEtNS0xLTEtMA_83047e78-1ec2-44d5-b3fb-3f760add3cbf">2,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzItMS0xLTEtMA_ee6b8df0-bc58-4ad3-b9e3-141a1a8d17e3">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzItMy0xLTEtMA_73d8d122-5cee-4d29-9d4d-be936c943939">2,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LesseeLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzItNS0xLTEtMA_180189fe-d231-4598-9f23-b13961f09f99">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzMtMS0xLTEtMA_6bcb67a5-85d3-41f0-a75e-bd72415be6ec">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzMtMy0xLTEtMA_82fa941b-d8aa-405a-8f46-3f04358067e9">2,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LesseeLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzMtNS0xLTEtMA_726a1609-6c6c-4da8-85e1-76ec47e6c220">2,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzQtMS0xLTEtMA_4875065d-6d55-4546-9ad7-e3d51f766752">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzQtMy0xLTEtMA_aec9a1b4-5673-4145-8e39-6dadcc6b2bf3">2,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LesseeLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzQtNS0xLTEtMA_352d3cd7-4e7f-4fd1-ba20-ad056e671b6c">2,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzUtMS0xLTEtMA_32db5195-fccc-4145-a103-720b808631cb">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzUtMy0xLTEtMA_feff16ff-8824-4327-ad1c-46898b058e9a">2,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LesseeLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzUtNS0xLTEtMA_768141b6-bb19-478b-8536-dc44249ffe5a">2,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzYtMS0xLTEtMA_ba228a7f-5729-4959-b2b3-aa3ec89b2d02">1,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzYtMy0xLTEtMA_2acb985a-4594-4c94-971f-1db944ca0799">15,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LesseeLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzYtNS0xLTEtMA_84c81476-75ba-4c3c-b023-e95f351ff6f9">16,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzctMS0xLTEtMA_12b00960-7e06-487b-8acc-7b98cac33927">1,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzctMy0xLTEtMA_f3ded2f8-6124-4215-a425-53242c0fee40">27,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LesseeLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzctNS0xLTEtMA_fb8cf953-1740-46ec-ae4c-156960c2a15b">28,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzgtMS0xLTEtMA_1e8bb604-ff2f-4a6c-a44e-f8837072925c">729</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzgtMy0xLTEtMA_cc318040-b6eb-45f0-99c4-2b48ff28c1ed">6,747</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LesseeLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzgtNS0xLTEtMA_4770a0ea-02dd-4adc-a1da-fbeab3d5d2fd">7,476</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzktMS0xLTEtMA_4f99c4a8-a281-48f9-a1f9-fbe2b5c59572">1,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzktMy0xLTEtMA_1189726f-244a-4681-8974-b0b1fb09f1cd">20,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzktNS0xLTEtMA_13530e53-4707-4e2d-9f0a-67f2a25f0f75">21,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzIzODI_4b1b4546-b265-405c-a415-1733c024c385">306</ix:nonFraction> million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-8" format="ixt:numdotdecimal" name="cvs:OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzI2OTA_541b61f4-35ff-4237-b4bf-807c0ef87534">2.3</ix:nonFraction> billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div></ix:nonNumeric></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Transactions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if4d590d1bebf4d10b2e1169a613099d5"><ix:continuation id="i0cc663a703814dac8e6b9175ff0e751e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a guarantee of lease payments, in connection with the sale-leaseback transactions. Proceeds from sale-leaseback transactions totaled $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzM1MDk_d6e6544d-7dc7-43a8-84ca-9b897ddde931">101</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzEwOTk1MTE2MzU3ODE_368ff538-c868-43ce-a308-d081ddd3276a">5</ix:nonFraction> million in the years ended December 31, 2020 and 2019, respectively. Gains from sale-leaseback transactions totaled $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzIxOTkwMjMyNjY2NzM_6de7f26c-3b5e-4685-98d0-5f70a2de20a8">3</ix:nonFraction> million in the year ended December 31, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzIxOTkwMjMyNjcwMzU_2ec71e7f-9880-4f13-89d6-8fb8abafe060">no</ix:nonFraction> material gains from sale-leaseback transactions in the year ended December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Store Rationalization Charges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2019, the Company performed a review of its retail stores and determined it would close <ix:nonFraction unitRef="store" contextRef="i70084b42bcb34cf790dad3c2e153d003_D20190101-20190331" decimals="INF" name="cvs:NumberOfUnderPerformingStoresPlannedClosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzM2Njg_1f286a97-cf1a-4832-90b8-0a82a11b4240">46</ix:nonFraction> underperforming retail pharmacy stores during the second quarter of 2019. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Accordingly, an interim long-lived asset impairment test was performed. The results of the impairment test indicated that the fair value of each store asset group was lower than the carrying value. The fair value was determined using a discounted cash flow method based on estimated sublease income. In the three months ended March 31, 2019, the Company recorded a store rationalization charge of $<ix:nonFraction unitRef="usd" contextRef="i70084b42bcb34cf790dad3c2e153d003_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="cvs:StoreRationalizationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzQzMTc_e845af78-b611-4bed-aaea-994ffaa528a5">135</ix:nonFraction> million, primarily related to these operating lease right-of-use asset impairment charges, which was recorded within operating expenses in the Retail/LTC segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2019, in connection with its annual budgeting process, the Company performed an updated review of its retail stores and determined it would close an additional <ix:nonFraction unitRef="store" contextRef="ib071f664e4424c34825859add41556cc_D20190701-20190930" decimals="INF" name="cvs:NumberOfUnderPerformingStoresPlannedClosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzQ2NjQ_ec3d36d8-c1f6-4ca2-8666-167945ae1185">22</ix:nonFraction> underperforming retail pharmacy stores during the first quarter of 2020. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Accordingly, an interim long-lived asset impairment test was performed. The results of the impairment test indicated that the fair value of each store asset group was lower than the carrying value. The fair value was determined using a discounted cash flow method based on estimated sublease income. In the three months ended September&#160;30, 2019, the Company recorded a store rationalization charge of $<ix:nonFraction unitRef="usd" contextRef="ib071f664e4424c34825859add41556cc_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="cvs:StoreRationalizationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzUzMTY_0ac4a114-0e29-4faf-97ce-77420170e047">96</ix:nonFraction> million, primarily related to these operating lease right-of-use asset impairment charges, which was recorded within operating expenses in the Retail/LTC segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparative Disclosure Prior to the Adoption of the New Lease Accounting Standard (ASU 2016-02)</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NjE_d9871d2c-fd6e-454b-92aa-e58b3cc30344" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s net rental expense for operating leases for the&#160;year ended December&#160;31, 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.158%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum rentals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseMinimumRentals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo0MGZjNDBiODIwMGQ0MzFmODE0OWM5MTllZTE0Zjg2ZC90YWJsZXJhbmdlOjQwZmM0MGI4MjAwZDQzMWY4MTQ5YzkxOWVlMTRmODZkXzEtMS0xLTEtMA_c47d5946-4146-4fd4-8af6-dd1ae0394288">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent rentals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:OperatingLeasesRentExpenseContingentRentals" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo0MGZjNDBiODIwMGQ0MzFmODE0OWM5MTllZTE0Zjg2ZC90YWJsZXJhbmdlOjQwZmM0MGI4MjAwZDQzMWY4MTQ5YzkxOWVlMTRmODZkXzItMS0xLTEtMA_d580815f-eccd-4b74-a1f0-06e60179bcdd">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:OperatingLeasesRentExpenseGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo0MGZjNDBiODIwMGQ0MzFmODE0OWM5MTllZTE0Zjg2ZC90YWJsZXJhbmdlOjQwZmM0MGI4MjAwZDQzMWY4MTQ5YzkxOWVlMTRmODZkXzMtMS0xLTEtMA_cef13b04-376a-4753-94d0-04ed3a8bc2e4">2,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:OperatingLeasesRentExpenseSubleaseRentals1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo0MGZjNDBiODIwMGQ0MzFmODE0OWM5MTllZTE0Zjg2ZC90YWJsZXJhbmdlOjQwZmM0MGI4MjAwZDQzMWY4MTQ5YzkxOWVlMTRmODZkXzQtMS0xLTEtMA_d9453226-7f16-4365-bb65-12feb09b4774">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total rental expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo0MGZjNDBiODIwMGQ0MzFmODE0OWM5MTllZTE0Zjg2ZC90YWJsZXJhbmdlOjQwZmM0MGI4MjAwZDQzMWY4MTQ5YzkxOWVlMTRmODZkXzUtMS0xLTEtMA_0352b884-228e-4603-91f3-3822594d0e85">2,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_145"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzQxODA_6c85ec78-a897-430c-a4c3-4958b298a344" continuedAt="if5249985ec634706baf7b0f4344ce305" escape="true">Health Care Costs Payable</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if5249985ec634706baf7b0f4344ce305" continuedAt="i94329bced23041ec822e1fd4ce7b4ac6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is information about incurred and cumulative paid health care claims development as of December&#160;31, 2020, net of reinsurance, and the total IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for information on how the Company estimates IBNR reserves and health care costs payable as well as changes to those methodologies, if any. The Company&#8217;s estimate of IBNR liabilities is primarily based on trend and completion factors. Claim frequency is not used in the calculation of the Company&#8217;s liability. In addition, it is impracticable to disclose claim frequency information for health care claims due to the Company&#8217;s inability to gather consistent claim frequency information across its multiple claims processing systems. Any claim frequency count disclosure would not be comparable across the Company&#8217;s different claim processing systems and would not be consistent from period to period based on the volume of claims processed through each system. As a result, health care claim count frequency is not included in the disclosures below.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzQxODI_910c60a1-9837-44e7-9866-188f1ab1c63c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about incurred and paid health care claims development for the year ended December 31, 2019 is presented as required unaudited supplemental information.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.031%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Incurred Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd9a72694e74fb1953ac9de25db565c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzMtMS0xLTEtMA_46d8b80f-f2c4-4b6b-87f5-a9db3a142748">51,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a759204965465a8c57fcb74fea946b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzMtMy0xLTEtMA_223058ee-1d6a-4d79-806d-b41fcbf5f542">51,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a55f9c69cd1488f89f0c37551af36cb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzQtMy0xLTEtMA_669f9c32-5abe-45d8-9fed-23a7cd2c10d4">54,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzUtMy0xLTEtMA_5f777c81-1d57-49e4-8de4-524f170982d2">105,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative Paid Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd9a72694e74fb1953ac9de25db565c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzEwLTEtMS0xLTA_9df873a3-4473-471a-bdf7-5d0b03accc8d">44,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a759204965465a8c57fcb74fea946b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzEwLTMtMS0xLTA_f52ba57a-9d55-4c48-99e1-aa51d9192164">50,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a55f9c69cd1488f89f0c37551af36cb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzExLTMtMS0xLTA_ceebf706-9528-4fa1-a1a6-370c60535089">47,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzEyLTMtMS0xLTA_c749b92f-dfa6-4a25-bd79-58c2b11ddc36">97,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding liabilities for health care costs payable prior to 2019, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzEzLTMtMS0xLTA_dbdcb389-a5de-4bc8-a88d-80824ca691ae">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outstanding liabilities for health care costs payable, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzE0LTMtMS0xLTA_54178be9-d00e-48fd-8389-5f79c8cb7062">7,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company&#8217;s liabilities for IBNR plus expected development on reported claims totaled approximately $<ix:nonFraction unitRef="usd" contextRef="i0f1c041ab6e1476e81c0a2cce0548fb0_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzE3NTI_2d00a976-57f4-42de-93fe-0c4c674ae1e2">6.1</ix:nonFraction> billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at December&#160;31, 2020 related to the current calendar year.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzQxODM_fdc2ccfe-1746-4314-b418-0c3b62390d70" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the December&#160;31, 2020 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-duration health care costs payable, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo0NDVjMWJhZDlmNTk0MDJlYjZhNjQ1Y2I1ZjdjMjA3NC90YWJsZXJhbmdlOjQ0NWMxYmFkOWY1OTQwMmViNmE2NDVjYjVmN2MyMDc0XzEtMS0xLTEtMA_54178be9-d00e-48fd-8389-5f79c8cb7062">7,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo0NDVjMWJhZDlmNTk0MDJlYjZhNjQ1Y2I1ZjdjMjA3NC90YWJsZXJhbmdlOjQ0NWMxYmFkOWY1OTQwMmViNmE2NDVjYjVmN2MyMDc0XzItMS0xLTEtMA_b079dafa-8ffc-42c5-a35f-e9b1c064b2c2">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo0NDVjMWJhZDlmNTk0MDJlYjZhNjQ1Y2I1ZjdjMjA3NC90YWJsZXJhbmdlOjQ0NWMxYmFkOWY1OTQwMmViNmE2NDVjYjVmN2MyMDc0XzMtMS0xLTEtMA_e02d0360-4e93-4076-9c61-09f23781f753">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines other than short duration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo0NDVjMWJhZDlmNTk0MDJlYjZhNjQ1Y2I1ZjdjMjA3NC90YWJsZXJhbmdlOjQ0NWMxYmFkOWY1OTQwMmViNmE2NDVjYjVmN2MyMDc0XzQtMS0xLTEtMA_74a05dea-d9da-4a72-a449-059b0368385f">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total health care costs payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo0NDVjMWJhZDlmNTk0MDJlYjZhNjQ1Y2I1ZjdjMjA3NC90YWJsZXJhbmdlOjQ0NWMxYmFkOWY1OTQwMmViNmE2NDVjYjVmN2MyMDc0XzUtMS0xLTEtMA_ef03db72-f297-4f73-b43e-c65c591c3425">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i94329bced23041ec822e1fd4ce7b4ac6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Aetna Acquisition on November 28, 2018, the Company&#8217;s health care costs payable balance was immaterial and related to unpaid pharmacy claims for its SilverScript PDP. <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzQxODQ_1ff4ffbb-db5c-475d-879d-c3cd44a19d03" continuedAt="id1ebe25b746a45bfa11a9a78a867de58" escape="true">The following table shows the components of the change in health care costs payable during the years ended December 31, 2020, 2019 and 2018:</ix:nonNumeric></span></div><ix:continuation id="id1ebe25b746a45bfa11a9a78a867de58"><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.160%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEtMS0xLTEtMA_28e71a67-f140-4c7b-a658-622264ef319a">6,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEtMy0xLTEtMA_cf1b7f00-9d6a-4104-8697-85829a4c3548">6,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2b65bba50242fd9c8370770a4be117_I20171231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEtNS0xLTEtMTUzMw_ca324eed-8db3-407b-8059-11a0319b0443">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzItMS0xLTEtMA_3d30aef8-10d6-4b6f-ba91-bfb1275be76a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzItMy0xLTEtMA_bf659b73-ff74-4030-8925-bd6dd4c604fd">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2b65bba50242fd9c8370770a4be117_I20171231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzItNS0xLTEtMTUzMw_4bd3e94f-cf58-481f-8b71-7e8d67c7ecf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzMtMS0xLTEtMA_808564f5-a4fb-42a8-92d6-69502484b0eb">6,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzMtMy0xLTEtMA_3dc2fd92-98e7-4c87-998b-91e02f3e27fe">6,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2b65bba50242fd9c8370770a4be117_I20171231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzMtNS0xLTEtMTUzMw_8d68e7ea-bdc8-420a-8019-83253864f5fb">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzQtMS0xLTEtMA_d1c5e323-3bdf-4767-83ab-ff75288ee2eb">414</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzQtMy0xLTEtMA_c35d13ac-fb17-4e62-a020-8bd54a0f9608">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzQtNS0xLTEtMTUzMw_3cfd0223-4a8b-4b57-9325-0fcbe8cdcf0f">5,357</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from pharmacy claims and discounts payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzUtMS0xLTEtMA_c80e8c64-cfe0-49fc-a5e6-6303224d483d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzUtMy0xLTEtMA_1d5c3a12-c0f7-4829-9719-60567362d268">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzUtNS0xLTEtMTUzOA_d7238db6-e1e2-4cac-8640-f380114185ae">776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzctMS0xLTEtMA_2e1ee4d4-9934-41bb-866e-c282295a5a48">55,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzctMy0xLTEtMA_3387bdb2-0c5e-467f-8c78-96172f50f012">52,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzctNS0xLTEtMTUzMw_2e84ea56-8c38-4f6f-85bb-7d907d4d808b">6,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzgtMS0xLTEtMA_fa591501-c520-45a9-9f04-d56c374f29db">429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzgtMy0xLTEtMA_e3afe50b-c076-4230-8f08-0bc3adbcef10">524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzgtNS0xLTEtMTUzMw_9cb0086b-c404-487b-8664-066f5186f032">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzktMS0xLTEtMA_c5b7596e-7958-46d7-9ad4-cc153aa4bb74">55,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzktMy0xLTEtMA_d1f48c0e-ec67-44ca-bdd0-61f9f5774e1a">52,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzktNS0xLTEtMTUzMw_75c04bdd-6f46-4ab3-8b7e-31ecea76f540">6,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzExLTEtMS0xLTA_77318733-5e88-495d-bc1e-ae4c849be85e">48,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzExLTMtMS0xLTA_0feed5f6-c8ca-43fa-8571-82c8f35a1a0e">46,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzExLTUtMS0xLTE1MzM_bf41b668-2024-4c93-9598-c608cd761e0e">6,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEyLTEtMS0xLTA_b121d8c8-e35c-429b-8849-460cdf0d75da">6,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEyLTMtMS0xLTA_dad855d4-7881-479a-bae1-5444a0163e76">5,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEyLTUtMS0xLTE1MzM_87e6b972-90ed-4c31-a270-76a7d8aa415b">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEzLTEtMS0xLTA_3ef13c0d-3dd4-42bb-ad30-dd48f15b4115">54,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEzLTMtMS0xLTA_ef50341c-3d4e-487b-89c4-432be89bbc9b">51,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEzLTUtMS0xLTE1MzM_f4b9997f-c881-471f-8102-cc9c0e0d1243">6,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE0LTEtMS0xLTA_d9f320e9-f525-4df3-bf98-cdc7bfee46f2">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE0LTMtMS0xLTA_6cdbcb83-0e73-4044-85c6-ee3cd7669480">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE0LTUtMS0xLTE1MzM_5d5cf548-77c3-48a7-a45d-ae4c0d555898">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE1LTEtMS0xLTA_5dc50a86-0a1a-4fb1-b6e8-78578f8dcf5b">7,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE1LTMtMS0xLTA_5fd2f710-0330-4425-8d01-1fd19dd0fec3">6,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE1LTUtMS0xLTE1MzM_d201f3ba-eae9-4237-a42c-369cd44ca589">6,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE2LTEtMS0xLTA_e8ba4083-492e-4b57-82ed-63898bbf032b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE2LTMtMS0xLTA_67c252cc-8cea-4457-b699-dfd150e315c4">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE2LTUtMS0xLTE1MzM_f7952aae-5908-48f4-a6f5-8e24eb46470e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE3LTEtMS0xLTA_22de718f-4975-4a1b-8e1b-6fb999bea697">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE3LTMtMS0xLTA_6d3e3d9e-4de9-4920-9d03-88a4722629a1">6,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE3LTUtMS0xLTE1MzM_bf152ca9-53da-4498-8987-6d50454a528a">6,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of the Aetna Acquisition Date, the Company reclassified $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzEwOTk1MTE2MzIxMjc_e23926ee-b29a-481c-a0e7-e3b98a016810">776</ix:nonFraction> million of the Pharmacy Services segment&#8217;s unpaid retail pharmacy claims to third parties from pharmacy claims and discounts payable to health care costs payable as the third party liability was incurred to support the Health Care Benefits segment&#8217;s insured members.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the years ended December&#160;31, 2020, 2019 and 2018 in the table above exclude (i) $<ix:nonFraction unitRef="usd" contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzI5NDM_d9f320e9-f525-4df3-bf98-cdc7bfee46f2">11</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzI5NTA_6cdbcb83-0e73-4044-85c6-ee3cd7669480">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzEwOTk1MTE2MzIwNjY_5d5cf548-77c3-48a7-a45d-ae4c0d555898">16</ix:nonFraction> million, respectively, for a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $<ix:nonFraction unitRef="usd" contextRef="i21b8848a0b0848d0b1ef073195fcf232_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzIxOTkwMjMyNjA0MDI_8f764331-756d-4fa8-ba60-795551d60061">41</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i052772f862ef450c8eb33c1ce00be32b_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzMwNjQ_5ad64813-8f99-4c92-8591-43ae52f55c9c">41</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iab2819dc76894f5995f2436bdfa0b59f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzEwOTk1MTE2MzIwODg_bd0b90aa-9f7e-44ce-8488-c0d54f40004e">4</ix:nonFraction> million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and (iii) $<ix:nonFraction unitRef="usd" contextRef="idf1e85cb6e5d4ed281db988a9eb5b755_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzIxOTkwMjMyNjAzOTg_3344f79c-97c9-4ec6-ae1e-1b8b7fb111cd">221</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie2689c30da3241379d3461455317d9fb_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzMyNDU_eda6a2a3-b6fb-471d-bbdb-368cdb0efcd8">285</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iadc52b1e6e6f4e7e82de9d1c0a987c54_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzEwOTk1MTE2MzIxMTQ_cabf8734-a72e-4e96-97fd-6b4184b65552">22</ix:nonFraction> million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $<ix:nonFraction unitRef="usd" contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzM0ODU_fa591501-c520-45a9-9f04-d56c374f29db">429</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzM4NDgyOTA3MDE4NDk_e3afe50b-c076-4230-8f08-0bc3adbcef10">524</ix:nonFraction> million in 2020 and 2019, respectively, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year. This development does not directly correspond to an increase in the Company&#8217;s operating results as these reductions were offset by estimated current period health care costs when the Company established the estimate of the current year health care costs payable.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_148"></div><div style="margin-bottom:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzgyNDYzMzcyMjY5MTU_91572412-5fee-4c5d-a365-bd11c81ce22e" continuedAt="i1ea579da77034bb79dbc31bec939bca2" escape="true">Borrowings and Credit Agreements</ix:nonNumeric></span></div><ix:continuation id="i1ea579da77034bb79dbc31bec939bca2" continuedAt="i2df0993f396f464d89050c3b36610bec"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzg1MDI_fce932ec-9f05-4508-ac0a-ab1a446e47b6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.452%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if59595395c854ba7b06e3bf1c79b2167_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzctMC0xLTEtMC90ZXh0cmVnaW9uOjI1NzVhNjRjNjRhNzQ5MTY5NTNiYTk4MDViZDgwOTY3XzEwOTk1MTE2Mjc4MjA_0a430a26-4bc7-47d9-8233-eab89e390787">3.125</ix:nonFraction>% senior notes due March 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if59595395c854ba7b06e3bf1c79b2167_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzctMS0xLTEtMA_6f7d1a4e-8789-4b57-ab7e-e564a86a4ffc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dc84e117e964242bed54b2fad5b0376_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzctMy0xLTEtMA_11cee9fb-aa74-4aba-8bfa-fc563c6213ff">723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating rate notes due March 2020 (<ix:nonFraction unitRef="number" contextRef="i39ca9c0893574888b90454ef444cf1b0_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzgtMC0xLTEtMC90ZXh0cmVnaW9uOjI1OTYzYzI3Nzk4NDQwOThhZTBiZGMxZjU1MTgxNzRhXzEwOTk1MTE2Mjc4ODQ_4ebbd23c-d335-403d-a323-95251a954373">2.515</ix:nonFraction>% at December 31, 2019)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb51aad0627040f1899c9ab4dbda4d6f_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzgtMS0xLTEtMA_4b763cea-1969-476f-a7f2-edecfd1d4b11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ca9c0893574888b90454ef444cf1b0_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzgtMy0xLTEtMA_93a89d37-70c6-47fb-a8d0-fec807f89f2e">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia44aee29de0d4077a6f00b78e9d6263e_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzktMC0xLTEtMC90ZXh0cmVnaW9uOjI1Y2FmMDdiNDI4NDRiNGRhNDBkNGJhMzYzM2M2MWVmXzEwOTk1MTE2Mjc4MTU_11bee481-7808-4d64-92d9-d0dae4ef49f2">2.8</ix:nonFraction>% senior notes due July 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia44aee29de0d4077a6f00b78e9d6263e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzktMS0xLTEtMA_3fa0f974-6ff1-4470-801e-4b5521ed6df4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88f639376b55490690a36f10a9be2811_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzktMy0xLTEtMA_982ca5ba-3a9c-42b2-9d6a-42e27edcf287">2,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id01a6d6a45694726a6f06c733cf6bd6f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjphOGVmNmFjOGZhMzU0MGIxOWU4NWM2MDI5YWRlMTZhMl8xMDk5NTExNjI3ODE4_3f5f3069-2d0d-4eeb-83ec-00e8ed4f69ef">3.35</ix:nonFraction>% senior notes due March 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01a6d6a45694726a6f06c733cf6bd6f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEwLTEtMS0xLTA_9505bb59-158d-421d-9db2-a920d7e6d62f">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59044fa83a6d4afea18e5166e0f463e8_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEwLTMtMS0xLTA_0747888e-72c5-430c-80a4-5f73c71c93e6">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating rate notes due March 2021 (<ix:nonFraction unitRef="number" contextRef="i82faa3a8c7e745008aa3175817187e10_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjpjM2Y2NzRjZDM1NWQ0Y2FlYTBmNzM2ZDQ2YjIxODUwZl8xMDk5NTExNjI3ODcz_afc6a305-373f-4228-a4b4-406cc7241a03">0.950</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if2e6fb4f07b74b628115f0ccc6d9da66_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjpjM2Y2NzRjZDM1NWQ0Y2FlYTBmNzM2ZDQ2YjIxODUwZl8xMDk5NTExNjI3ODg1_e43a5e6d-b475-44ae-9dd5-ef0073f8e3c3">2.605</ix:nonFraction>% at December 31, 2020 and 2019, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82faa3a8c7e745008aa3175817187e10_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzExLTEtMS0xLTA_cd6c66f2-05aa-4d59-89cf-e054c19a8790">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2e6fb4f07b74b628115f0ccc6d9da66_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzExLTMtMS0xLTA_f1f22d79-18b6-43b3-a707-6bacab34c20b">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1dc856455e7b400ab7c24c5df6647e6f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjozOGQxMzg1ZjQ5Mzc0OTViYmI2NDFiN2MyNGRiOTRlMF8xMDk5NTExNjI3ODE4_b45402ec-57ab-4fba-9e34-5130c356b11b">4.125</ix:nonFraction>% senior notes due May 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc856455e7b400ab7c24c5df6647e6f_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEyLTEtMS0xLTA_61a5a0f7-6b71-48af-bd3e-3b7335a0be85">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a9b18d3bdf747699de43dbe6ce0bd3a_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEyLTMtMS0xLTA_39260c7f-cac1-4bd5-a15f-77ec29d6368b">222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b59429fddec4142a6db54bed9ab055a_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEzLTAtMS0xLTAvdGV4dHJlZ2lvbjplNjZjYWEyYTQ1Nzg0MzBlYjVmMzUwZWQ5OTBmOTBjN18xMDk5NTExNjI3ODE5_2be08f96-659e-4de8-8b19-a3fc94467399">2.125</ix:nonFraction>% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b59429fddec4142a6db54bed9ab055a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEzLTEtMS0xLTA_c7636b63-2d7b-4772-863f-55cf9771c0e5">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d340447641846a9a431c822fbec5ddc_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEzLTMtMS0xLTA_0d4812ff-7c52-410e-a735-a0aa5fe14b2d">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i676ade2029cd42ddb0666570247f7159_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWIyMGYxMjQ5MGE0MjNhODNkOWYwYjc5YzNmNDU3YV8xMDk5NTExNjI3ODE5_1eefb8d6-9354-4eb2-a8e0-9996eeaef24e">4.125</ix:nonFraction>% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i676ade2029cd42ddb0666570247f7159_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE0LTEtMS0xLTA_22818c74-3031-4dc6-9e59-55399cac0b0d">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6a6f27fcb634d5a8284be453046e3da_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE0LTMtMS0xLTA_7eb9e74e-26c1-4f1e-b200-2ff355114a44">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63be7ab398194c9282444fbe7e010250_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWRiYTAxNjExYzM0YjZiYTA5OWMwYTgxODIzMTZlNF8xMDk5NTExNjI3ODE3_6549bcb7-de39-49b1-903f-5c4e8657df74">5.45</ix:nonFraction>% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63be7ab398194c9282444fbe7e010250_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE1LTEtMS0xLTA_bbeaea99-4eeb-4381-bd32-bfc7539fe95d">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id602ed76bb1141efaf6bf5a490a87c42_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE1LTMtMS0xLTA_421843fc-d6bb-4a3c-a027-0670958f013a">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c0d5087b6064f70b84a0c6522dde077_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjoxZTBmOWNhYmMwM2M0NzAwYmUwODc4ODczNGU4ZjM3MV8xNjQ5MjY3NDQxNzAz_4810fc02-bf9d-4a28-9829-551d3e9b4c5c">3.5</ix:nonFraction>% senior notes due July 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c0d5087b6064f70b84a0c6522dde077_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE3LTEtMS0xLTA_59e33d96-e2d1-41b5-8a46-7d3960d52338">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b68adadc076455fb9d9fe54b81b2afb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE3LTMtMS0xLTA_8f9c62e7-39ad-44e0-a99f-eaf86979ab07">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4f845bef7bb4551b019ead11e5321e3_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjo2N2YwMDljNjQxNWE0YmY1YmZjZDIyZTg3N2ZhMTI2M18xNjQ5MjY3NDQxNzEw_a8ee90a7-c7fb-492a-b52c-de5001a341fb">2.75</ix:nonFraction>% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f845bef7bb4551b019ead11e5321e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE4LTEtMS0xLTA_1520fbf9-d891-4eea-a9ce-b00ff9bc6916">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51052298202549029f99a9aa30364e50_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE4LTMtMS0xLTA_47b4ed83-35ad-41e9-b8f7-dab2a8688115">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i556ba81c12d2465ab03865c19ccdd639_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE5LTAtMS0xLTAvdGV4dHJlZ2lvbjpmODBlNGNjMjA0ZjE0ZWU2YTFhZjQzODkwMmUzZTIwZF8xNjQ5MjY3NDQxNzA5_043ffa4c-04cd-42b5-9835-32ce4a439b88">2.75</ix:nonFraction>% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i556ba81c12d2465ab03865c19ccdd639_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE5LTEtMS0xLTA_09d370ae-a825-4fee-8976-763beedf6f26">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed4c4a68c7f4d81b36909b27c56373c_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE5LTMtMS0xLTA_4180715a-eea8-4a3a-969d-c8c1fa48eefb">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i171c4fd932814c18abf98b03dd0d5aa6_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIwLTAtMS0xLTAvdGV4dHJlZ2lvbjpiYTdmN2Y3NjNkMTI0N2FmODllYWQ4N2VmZDg3ODEyNF8xNjQ5MjY3NDQxNzA5_cbef8380-45be-4362-b3fe-88370db98c1a">4.75</ix:nonFraction>% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171c4fd932814c18abf98b03dd0d5aa6_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIwLTEtMS0xLTA_728c7117-cbc4-4fbf-a973-6fdcc41cceb9">399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0047ef3047aa4d01b3b1461ca8ad2376_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIwLTMtMS0xLTA_216cc232-99da-408d-b6d2-e9b2b25c15d4">399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i734cf172fc0a4bb394897c043bd538c6_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIxLTAtMS0xLTAvdGV4dHJlZ2lvbjoyZTg0NWE2NjJhYmY0MDgwOTkwNWFlZTdkZDFjN2I5OF8xNjQ5MjY3NDQxNzA0_68f29769-da99-498f-848b-7a2134a3863f">3.7</ix:nonFraction>% senior notes due March 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i734cf172fc0a4bb394897c043bd538c6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIxLTEtMS0xLTA_999561e2-b624-4cf8-ac56-f65c098aa757">2,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i186e6bd3f8c243f290f2d7379452ca08_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIxLTMtMS0xLTA_80472e90-ba41-4c4e-a453-a1246ae0c0af">6,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icecaee365bf9466885c2e04672491901_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIyLTAtMS0xLTAvdGV4dHJlZ2lvbjo0ZDYyMDdiZTY2MmI0NjIxOGE3M2Y4OTMxOWQ2ODU5Ml8xNjQ5MjY3NDQxNzAz_4b89945b-adfe-495c-9874-45fe4a40fc1c">2.8</ix:nonFraction>% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icecaee365bf9466885c2e04672491901_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIyLTEtMS0xLTA_8d6b8565-45de-4139-bb46-6c795853a972">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2942eb9beaf4f7cb5866f52e34c56a2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIyLTMtMS0xLTA_572e0b5d-971c-44c0-84d6-49758430d0ad">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0e657c55e1f64967b1ffeccd58ae062b_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIzLTAtMS0xLTAvdGV4dHJlZ2lvbjphZDA2N2Y2MzM5Y2M0OWQzYjIyMmNkMjY2YjE4ZDc1N18xNjQ5MjY3NDQxNzAz_a3250ea7-e926-4326-a00a-869ee5cab845">4</ix:nonFraction>% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e657c55e1f64967b1ffeccd58ae062b_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIzLTEtMS0xLTA_232e7586-d215-438c-8e25-d4310ed4ef73">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e950cbfa319445c8d4b8cb106e4f1ce_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIzLTMtMS0xLTA_2d9d0e53-ddb3-499e-bb9d-2648f46dcb73">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53be593e004440969eaadd34053626fb_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI1LTAtMS0xLTAvdGV4dHJlZ2lvbjo4MWYwODQyYmQyOTE0ZGRjYjgwNmFkOTE1YmYyOWM4Ml8xNjQ5MjY3NDQxNzA5_8aa29822-68a8-4f16-a353-55f80d39e83f">3.375</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53be593e004440969eaadd34053626fb_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI1LTEtMS0xLTA_bd518ffd-fc9e-4cbb-84a2-e687beb62695">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f30d489cf5246259fd164aec13a5624_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI1LTMtMS0xLTA_68fa01fe-500a-4eba-a94b-6087c6deaa3f">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibd43c50e8ca4414ea2cecb99247ff8e7_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI2LTAtMS0xLTE2MzgvdGV4dHJlZ2lvbjo3MTM0OTExNjUyM2Y0OTZjYTQzOTg3NzVkYjAxMWUxMl8xNjQ5MjY3NDQxNzA5_41f492f0-3484-47db-afc7-c84daa019602">2.625</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd43c50e8ca4414ea2cecb99247ff8e7_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI2LTEtMS0xLTE2NDI_786eced9-7798-4c24-b870-0a028e03a0ce">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0573e87a0f0c42ed97784d5b5ea32460_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI2LTMtMS0xLTE2NDI_447164fe-ea44-42dc-a83f-2bdf3c91077b">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dde33d57ede4cd2b5f5a4f7c72f3c92_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI2LTAtMS0xLTAvdGV4dHJlZ2lvbjpkNmNiMTU2MGQ2NGU0YzJmYThlM2FmMmJmZjgwZDIzM18xNjQ5MjY3NDQxNzA3_6725456e-3835-436e-b992-387d5bb00dc4">3.5</ix:nonFraction>% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dde33d57ede4cd2b5f5a4f7c72f3c92_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI2LTEtMS0xLTA_ae9e5f27-4339-4bea-b3d7-db3210d2916b">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fa105db68d4c46a1f39c9e528fa813_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI2LTMtMS0xLTA_77e36a61-1996-4ae9-a3bd-8dc8ebd11467">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if1ea528658e74bf787c41152af9d8121_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI3LTAtMS0xLTAvdGV4dHJlZ2lvbjo1Y2U4YTJkMGJmYjk0ZmY1OWJlZDgyZGQ2OWU2MmQ3M18xNjQ5MjY3NDQxNzAz_f2739af3-5f01-4eca-b6c3-f6dfec3f87bf">5</ix:nonFraction>% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1ea528658e74bf787c41152af9d8121_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI3LTEtMS0xLTA_b955d108-e831-41eb-9e61-f1df9cb09503">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2694eec161064921894d65f27aa8ab17_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI3LTMtMS0xLTA_0e9662b6-44a6-4cb2-b711-aba4097b312f">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibb4bb36351fe4c6f9d1a0eae2a188257_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI4LTAtMS0xLTAvdGV4dHJlZ2lvbjowZWE3YmI2MWMzNzg0OWNiYTMxMWNkYTNlN2VjZjAxY18xNjQ5MjY3NDQxNzA2_967c7c3a-04d1-4a35-83a6-639ab5565997">4.1</ix:nonFraction>% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4bb36351fe4c6f9d1a0eae2a188257_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI4LTEtMS0xLTA_80961288-4762-4ad4-82a0-6f63754754fb">950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79094d4adfd5425ea0d62b733c026eca_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI4LTMtMS0xLTA_7cb25597-7205-4e6e-b3fa-c97f321c4c39">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie6fd5b2064a242a6b820eafdcbbe9428_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI5LTAtMS0xLTAvdGV4dHJlZ2lvbjoxM2U4ZGJmYzcyOWE0OTkzODdiMWYzYzRjMGQwNDBmMV8xNjQ5MjY3NDQxNzA3_3e7fcc7b-8e43-438a-bfdd-b9f79aede312">3.875</ix:nonFraction>% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6fd5b2064a242a6b820eafdcbbe9428_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI5LTEtMS0xLTA_bde3c94d-1465-4c8c-83b4-fc6e1b551f1c">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4dacf9fff2540b993923fdc63acc6b3_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI5LTMtMS0xLTA_7bf43725-fd98-43f3-9f7a-59c7c97c38c0">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8450bfd94fac484aba4e77c9fc4efd2f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmRmZDM0NDQ3ZWY0Nzc0OWQxMmI3MjUxOGM3OWJkY18xNjQ5MjY3NDQxNzA3_6661b335-2551-4705-a1c2-0f10124b73d1">2.875</ix:nonFraction>% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8450bfd94fac484aba4e77c9fc4efd2f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMwLTEtMS0xLTA_cc531d09-dce2-4666-9132-d5fdb70ee2f4">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5874afefc4a74dd6ad08f344c1f53ec9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMwLTMtMS0xLTA_9abfd0b1-f3b2-4725-93c0-7fe0deb1546d">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9dd4c17f4c144cf297f7e26ae28bd94d_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjo5YTBkZGJjYjQyNzA0NDAxOWM4OGRlMjRlNzMyMGQ4Nl8xNjQ5MjY3NDQxNzAx_d454eff0-af94-462d-abb8-85b0f28c52a4">3</ix:nonFraction>% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd4c17f4c144cf297f7e26ae28bd94d_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMxLTEtMS0xLTA_f89557f6-0066-4406-a28b-67474f19a7fa">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866a5d43855e486f8cc0c68a5b4620bb_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMxLTMtMS0xLTA_712816c9-3ebd-4118-9ff0-c0e48a25126f">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i08df6665d2524a33a4be6561924aefca_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMyLTAtMS0xLTE2NDgvdGV4dHJlZ2lvbjo5MmYwNDU2OWQxMDE0NGQzYjA5MTQzNjFlYWU2NTVlMl8xNjQ5MjY3NDQxNzA3_0ce75747-0746-46d5-a488-b49756cc5251">3.625</ix:nonFraction>% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08df6665d2524a33a4be6561924aefca_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMyLTEtMS0xLTE2NDg_92c375e0-958c-4cbd-8831-77db2ed134b3">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24c2a1537a164fc5874c6fa1eea075b4_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMyLTMtMS0xLTE2NDg_ececff0b-c3be-47c6-a138-b06bcd8b19b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idddb1de105474de39bd0e7760adec57d_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjowZGQ2YjhlNGMwMTA0ZjI0YjYzYzE3Y2YyNmRhMzg0MV8xNjQ5MjY3NDQxNzA1_a6d263ad-0f7e-4181-9eb5-7696eb86a71d">6.25</ix:nonFraction>% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idddb1de105474de39bd0e7760adec57d_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMyLTEtMS0xLTA_549b7b60-d033-436e-8f96-b5076a2897a6">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie92a12c2190d4335847859245937972b_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMyLTMtMS0xLTA_1696807f-86d9-4dfd-ba0e-5804026eebc2">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4ca0fb7a5b484776ba687c307ef197ce_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM0LTAtMS0xLTE2NTIvdGV4dHJlZ2lvbjozMjZhMTUzZmE3M2E0NjU0YmVmZGFlMWRiNzY5NTU4MF8xNjQ5MjY3NDQxNzA1_1458eba7-0033-4aaf-8d12-716e5fb5efb4">1.3</ix:nonFraction>% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca0fb7a5b484776ba687c307ef197ce_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM0LTEtMS0xLTE2NTI_cc62c425-4cb4-4338-a939-a99d14db34d2">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i050c35f0329b4b58a86438fbafa04846_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM0LTMtMS0xLTE2NTI_0186f1ef-209f-4112-9752-c91dac7c0ead">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibe8c3f3d18834cf7b9b94d15988c16aa_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjpiYmU0ZWVmNWE3NGI0OGU1OWI2YTc1MmQyMzZjOGI2OV8xNjQ5MjY3NDQxNzA0_fc0d6e69-4929-49f8-bf4c-7d23048a7ee0">4.3</ix:nonFraction>% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8c3f3d18834cf7b9b94d15988c16aa_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMzLTEtMS0xLTA_f240d250-3448-4397-9392-19a3e84338e8">7,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica41313a27ea4d7ca02bb73da16225a1_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMzLTMtMS0xLTA_dc06df2d-c06f-464c-b5f4-8a9904f520a6">9,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bb1c419c09e4bb19d54039c47abe8e8_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjowYWMyZmY2ZDVhMzM0NWQxYWJiZDZlZmZjYzRiYzkyNV8xNjQ5MjY3NDQxNzA3_a65ae8b0-76a0-4316-9f04-b3139b6e6037">3.25</ix:nonFraction>% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bb1c419c09e4bb19d54039c47abe8e8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM0LTEtMS0xLTA_060e987a-4816-434b-bb7c-0528c89c3f69">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8e397dcb8d14af0a33b647343c389f2_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM0LTMtMS0xLTA_d7211ff6-a9b1-47e4-ada5-66496d9e80be">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a1d49c0ec7e47f4a5602ea8cc802eef_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM3LTAtMS0xLTE2NTYvdGV4dHJlZ2lvbjpmZjYzNzExOTgzYmU0NjVmOTRmMTZhMDc5ZmJhNWFhMl8xNjQ5MjY3NDQxNzA2_010be136-5596-4570-af7b-20ea8bd9d6e0">3.75</ix:nonFraction>% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1d49c0ec7e47f4a5602ea8cc802eef_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM3LTEtMS0xLTE2NTY_bfd6bdaa-9458-425c-a004-219ddf0c1e36">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5782efa7db249b6b23113dc33fb76a7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM3LTMtMS0xLTE2NTY_085d9134-a3ec-42cc-8421-33e8f7127618">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i212780690b054480b1d4b16a1ce55e8f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM4LTAtMS0xLTE2NTYvdGV4dHJlZ2lvbjoyZWVjZjJlMDhkNzc0Y2I5Yjg2MTRmNzhjNzQ5OThhM18xNjQ5MjY3NDQxNzA3_d594dc28-ed7b-404d-90dd-6d95dce884a1">1.75</ix:nonFraction>% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i212780690b054480b1d4b16a1ce55e8f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM4LTEtMS0xLTE2NTY_7d67fd9d-2992-47eb-a7ee-dfe2dd4f51cc">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82893487b53a40c3a443264c005a3544_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM4LTMtMS0xLTE2NTY_c28e4caa-17f1-4d23-9883-1beec4f2cb54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i014f1a1c658f4a5e88082091afbc10b5_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQwLTAtMS0xLTY1OTUvdGV4dHJlZ2lvbjpkZGRkZmY4ZTdkZTY0ZjAyODRjMDNmMDczZDE1ZjdmZV8yMTk5MDIzMjU1NTk5_bb58cee9-53bc-402e-ad57-ea2f1ba23075">1.875</ix:nonFraction>% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014f1a1c658f4a5e88082091afbc10b5_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQwLTEtMS0xLTY2MDA_a3eb03ad-bc70-4334-8e73-97bab01182ad">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e1dfeab22c474fbf87dbcc1a78ae98_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQwLTMtMS0xLTY2MDA_2a6570ff-c825-4bef-b6b7-46473c1c4312">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3262bc6e373b449b95e2a2364d10c2ee_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM1LTAtMS0xLTAvdGV4dHJlZ2lvbjoyZjJlMjQ5YTY3YmI0MWEwYTY1YjUyM2YxYzg2ZjBmM18xNjQ5MjY3NDQxNzA3_97ec334c-c175-470a-8faf-2a4eb6cc965b">4.875</ix:nonFraction>% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3262bc6e373b449b95e2a2364d10c2ee_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM1LTEtMS0xLTA_d128635c-6582-41b7-909f-144de072061c">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id20e06cc938d415a953c7aa4bdf9cc8b_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM1LTMtMS0xLTA_f20476a9-7619-42b4-a787-3b6adbdabe25">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8948ebc60ee549319fa423f9c9ca71ae_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5OTE3ZDQzMGJkZTc0NzM4YjMwOTJiMTgwZDdjZWFlNF8xMDk5NTExNjI3ODE5_3943b3a7-27a6-4598-b320-db9c4cf4a137">6.625</ix:nonFraction>% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8948ebc60ee549319fa423f9c9ca71ae_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM2LTEtMS0xLTA_b71825d0-2de3-456c-9f75-44453c631c1b">771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i133831fe5f40404ebaf46e33ca52ac9b_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM2LTMtMS0xLTA_49f0e521-71bc-4f71-a773-dca07bdcf7ca">771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i353b9ef71c8f47328eb48db1a68abf98_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZDdmMjE1YzcxODY0OTcxYmM4Y2JlMTMwZmFlMmNmM18xMDk5NTExNjI3ODIx_46558b3e-4ff1-45aa-8a97-0a74def25975">6.75</ix:nonFraction>% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i353b9ef71c8f47328eb48db1a68abf98_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM3LTEtMS0xLTA_fc3eadeb-3a2f-4438-ad32-065d77f76bf5">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9bdbcde47724dd2a5dc223d8b0d9fb9_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM3LTMtMS0xLTA_6608fa07-7e8f-4cdb-9f41-92d44a29de77">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic196591389f249e3a85fa825d6428142_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjoxOTljNzYwNmVhZWM0OTI4OWIyNWNmYTA1ZjcyNzFkZV8xMDk5NTExNjI3ODE4_14f08dde-7437-4bf7-b2b7-6b7f51fd5dda">4.78</ix:nonFraction>% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic196591389f249e3a85fa825d6428142_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM4LTEtMS0xLTA_ce73c233-578c-44f4-a929-94a620efd236">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d67544c4ed4204b542c36dc455c469_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM4LTMtMS0xLTA_dd74e312-bc84-45f7-80cd-45b7b072ae27">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2552168ebcaf4d87b5f4441f01768b71_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjoyMDI2NWMzY2E4ZTE0ZjYwYTFjOTgzMzJmZTZlN2ZlN18xMDk5NTExNjI3ODI0_c781ceae-5977-4736-9a88-589cbb2d3cdc">6.125</ix:nonFraction>% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2552168ebcaf4d87b5f4441f01768b71_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM5LTEtMS0xLTA_e508c8a1-c282-4a5a-ba42-500c1c4d05f6">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d273705308749c995ee3575c0e5b372_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM5LTMtMS0xLTA_8bf6d4f3-8f1f-43ff-94f3-8d8b0dd8e44a">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i867a6232fb7244249412521e5001679b_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ0LTAtMS0xLTE2NjAvdGV4dHJlZ2lvbjo4YTgyNDNmYTUxNzM0OWNhYWUxNjg4M2NjOGJmODljZV8xMDk5NTExNjI3ODIw_9cbd8d65-a2b4-420f-b3e9-aac5847d62e9">4.125</ix:nonFraction>% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i867a6232fb7244249412521e5001679b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ0LTEtMS0xLTE2NjA_1776dff0-82ae-4eaf-8f9b-811205d07279">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if44fd76e6acf41a9b3352d5c1ce68f96_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ0LTMtMS0xLTE2NjA_0fffd866-c2e3-4688-a347-9c2272fa3462">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1044e6b95e9d4af7a0760d5a5f5c5d96_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ1LTAtMS0xLTE2NjAvdGV4dHJlZ2lvbjo3Y2ZhM2M2MDZhZGI0MTUxOGNjY2RkYWNhNzJmMmMyNF8xMDk5NTExNjI3ODE3_370259c7-9006-4ec4-b862-d9be55f3e612">2.7</ix:nonFraction>% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1044e6b95e9d4af7a0760d5a5f5c5d96_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ1LTEtMS0xLTE2NjA_c5680b34-c7ad-477f-8a66-0558b596b047">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84cdd9e17651455894397e2cc826487c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ1LTMtMS0xLTE2NjA_dacd1240-fdf5-44f6-8dd7-7d29e343edf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a05340b9e204506b8228431b5765c0a_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjphM2E1Y2E2Zjk0ODY0NDlkYTc1ZTAyOTg4ZGUwMjM3MF8xMDk5NTExNjI3ODE2_9182fce4-1bde-4db9-a5b9-26e0cd96e906">5.75</ix:nonFraction>% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a05340b9e204506b8228431b5765c0a_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQwLTEtMS0xLTA_b5d08da1-19a8-495d-b7ef-499a9f8720b2">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ad9df9ebf4746febbda2d5944fecaa3_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQwLTMtMS0xLTA_c44b8688-526f-4c7d-8beb-9434451d42c4">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1fa943d2d2b64256b7f438c6bd342aa4_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNTcyOWRjYzVlNDI0YzI0OTdjM2NhNDZjNWE5MmVmNl8xMDk5NTExNjI3ODE0_f19caa8f-4e97-4e7f-aa04-11e6901639e1">4.5</ix:nonFraction>% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa943d2d2b64256b7f438c6bd342aa4_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQxLTEtMS0xLTA_be489fe8-61dc-4df7-be1f-4247aab2e9f4">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d024add61ae4a83bd4faf2b2187bffd_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQxLTMtMS0xLTA_06c1f978-ca68-4475-80c2-c8cc2813c5eb">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iacb0304ddc414bc9ba515d05b822e59f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMTU5ZTc2NjJmMjI0YmVmYjdjNTc0NDAyODdkZGVmNl8xMDk5NTExNjI3ODIz_ee8dc6e6-0912-4d3e-b692-5adf32d0626f">4.125</ix:nonFraction>% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb0304ddc414bc9ba515d05b822e59f_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQyLTEtMS0xLTA_00aa0f1b-adc2-4daa-ac6c-262e31d8b4d4">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063d082f54bf4a70a10b63c68204c506_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQyLTMtMS0xLTA_84facd23-03a8-4e63-85f7-a6752db65317">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib365a66162e74ae1a131e17260d3c309_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQzLTAtMS0xLTAvdGV4dHJlZ2lvbjplM2NlZGUwOGMxMWY0MDQyYWQ1MWEwYTY5YTFmMDZjN18xMDk5NTExNjI3ODE5_4d937e94-0cab-490c-a354-256b096b5416">5.3</ix:nonFraction>% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib365a66162e74ae1a131e17260d3c309_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQzLTEtMS0xLTA_6eeae75c-2980-4bda-a5bf-1a67e4c71a12">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic58975dfc3894919a505a5a72c8de2e1_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQzLTMtMS0xLTA_55876277-4e60-4820-b5e5-5e38e971b003">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4bb283ec93234091a925868aa3c3d104_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ0LTAtMS0xLTAvdGV4dHJlZ2lvbjo0YTJhMDkwNmMwNTY0MWM3Yjk2MTZjMmU1NTk1NTE2Zl8xMDk5NTExNjI3ODE4_ae86d911-28a1-4932-979c-86e24810a278">4.75</ix:nonFraction>% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb283ec93234091a925868aa3c3d104_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ0LTEtMS0xLTA_de8efa2c-ffef-4d3e-b1bd-3cedb5ec5b54">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4515473601e42ccb48a414ff823ea6f_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ0LTMtMS0xLTA_8184ecc8-6515-469a-8aa7-6c42eda2154e">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icb5c311b199b423a93de6b1490f41256_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ1LTAtMS0xLTAvdGV4dHJlZ2lvbjowYTFkNjhiM2M3ODc0Y2Q2ODZkOTA5NmY4YTgzNjY3N18xMDk5NTExNjI3ODE5_e30cd8fc-284f-42d0-aa79-fa5547a60471">5.125</ix:nonFraction>% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5c311b199b423a93de6b1490f41256_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ1LTEtMS0xLTA_cf03f7c0-ebb0-49e7-b0d2-0a2592ce2578">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f477f50197a44379a3e15ab264fb450_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ1LTMtMS0xLTA_c9f71be6-9206-4833-b445-2d48b774da9b">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7a9f776493394d3aa1b9afef76079abb_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5Mzg2ZTk2ZWVjNTA0MGM1YWFkZGNkOTc2MDQyMzEyN18xMDk5NTExNjI3ODIx_b6b0afaa-8e88-418b-80d6-6bce0e0218f6">3.875</ix:nonFraction>% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9f776493394d3aa1b9afef76079abb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ2LTEtMS0xLTA_0c3ac47e-63a1-43c9-81d3-9885406bb435">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38882d76fbd94254a2babd6873e24f9e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ2LTMtMS0xLTA_74fd3d90-7da6-467d-8323-dd7ffe0d07f8">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e5d522c3502448f88a84c21bcdd8997_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ3LTAtMS0xLTAvdGV4dHJlZ2lvbjozZTlhNGJjZjZhMjM0ZjBmOWRlYzUzZjZhYzc5NDU2Nl8xMDk5NTExNjI3ODE4_4d3a2ab3-2347-4a36-a2a0-74993bd61d9a">5.05</ix:nonFraction>% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e5d522c3502448f88a84c21bcdd8997_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ3LTEtMS0xLTA_91a928d1-b59d-4d78-83b8-b963f2790e23">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ff770766b8f4090a02e18b7734a5a58_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ3LTMtMS0xLTA_5efb8c95-c44f-4acb-9da4-8afe72381eeb">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea2cca2aa63645ea8d47444ec2a4b2ad_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU0LTAtMS0xLTE2NjQvdGV4dHJlZ2lvbjpjNTMwMmMxZjA0ZDM0MzVmYWEwMDBkMzBmOGEzYmU5Nl8xMDk5NTExNjI3ODE4_ccb0a357-d8ad-4146-a4d6-8f2c21a0c4c4">4.25</ix:nonFraction>% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2cca2aa63645ea8d47444ec2a4b2ad_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU0LTEtMS0xLTE2NjQ_d3ed497d-58f8-428d-9eff-f4a129eaa095">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f4c74c7d7384526865bf4ee6224633b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU0LTMtMS0xLTE2NjQ_3d9d4c9a-8497-4a00-b474-71d11a4628f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ4LTEtMS0xLTA_adb10bf6-b971-4111-b8d3-613cbe5eb1da">1,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ4LTMtMS0xLTA_9f01a857-4475-4784-91ce-2d565486e2b0">808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69df1d43019455c8f2e992b4d61f9cb_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ5LTEtMS0xLTA_a10c2c82-8133-4f7e-b776-db43068384f4">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6471700783d4a9ba371feacbe010756_I20191231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ5LTMtMS0xLTA_3652adcb-c4fa-428c-8f5c-73ec6d376c95">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LongtermDebtGrossAndLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUwLTEtMS0xLTA_e145dbea-3094-426a-907d-446350d631b5">65,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LongtermDebtGrossAndLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUwLTMtMS0xLTA_b5dc9e1a-e6ab-4f55-b052-c6c84ad05990">69,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUxLTEtMS0xLTA_ffe04e30-665f-47ba-bcc2-59d74c1db26a">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUxLTMtMS0xLTA_e833a4d6-5649-47c3-8dd6-8144aa93d2fd">262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUyLTEtMS0xLTA_4aed2700-417f-4a48-ae3f-cb518c469271">909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUyLTMtMS0xLTA_c361d13f-ef6a-4ed5-b188-0911397c9e74">1,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUzLTEtMS0xLTA_732e48b0-112c-414c-b600-45b36e7fbd84">64,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUzLTMtMS0xLTA_f1fec528-cf9b-485c-a748-6f2863d56b49">68,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU2LTEtMS0xLTA_d89b3fe3-4c48-4009-8a58-949b6ebe73f6">5,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU2LTMtMS0xLTA_0fff9adc-11cf-4bb0-b97d-ce9f49416bc7">3,781</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU3LTEtMS0xLTA_43f3a1a6-2679-437b-91e6-7768bac413a3">59,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU3LTMtMS0xLTA_0a5aa792-cf31-4431-91e5-9e0fbdc9782c">64,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2df0993f396f464d89050c3b36610bec" continuedAt="ie35e2f3d9ed34cafac6ca6595377ebe2"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzg1MDc_32b17fef-af8c-44c7-9e69-f8e2e3c3eb22" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzEtMS0xLTEtMA_945a748d-d5bd-4d28-803e-37b03629d10c">5,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzItMS0xLTEtMA_4936f0ea-a0c3-4738-81d7-566c67763aa0">4,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzMtMS0xLTEtMA_373295c6-acde-4dbc-8db9-73d8403d6b08">4,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzQtMS0xLTEtMA_f6b151d7-11af-44cc-bc7a-39746456ffa5">2,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzUtMS0xLTEtMA_0dd75aa5-bbc3-46f0-93f6-66565b6ce966">3,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzYtMS0xLTEtMA_b0ff1a7c-58ac-464a-b906-e2d45db4aa0f">44,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzctMS0xLTEtMA_79953f25-bd15-4a31-aa81-7396eef7b348">64,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzgtMS0xLTEtMA_adb10bf6-b971-4111-b8d3-613cbe5eb1da">1,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:LongtermDebtGrossAndLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzktMS0xLTEtMA_b3275831-2d15-4b4b-ae27-c5f4fd17c00d">65,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for a summary of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">maturities of the Company&#8217;s finance lease liabilities.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did <ix:nonFraction unitRef="usd" contextRef="i436a5971435f44fba2581c308d881259_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzQ4NA_f9ff6670-0b40-451b-b438-6e5d46917062">no</ix:nonFraction>t have any commercial paper outstanding as of December 31, 2020 or 2019. In connection with its commercial paper program, the Company maintains a $<ix:nonFraction unitRef="usd" contextRef="ic2a81421b67049b4b9bda55d847576dc_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzc0MA_1830fb0f-4951-4c54-9998-ed1eb18f64b3">1.0</ix:nonFraction> billion <ix:nonNumeric contextRef="ib876b3c3e46f46e0981a6a45069067a3_D20200101-20201231" format="ixt-sec:durday" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzc0Mw_e68cab50-a443-4978-968f-b713ee542c6a">364</ix:nonNumeric>-day unsecured back-up revolving credit facility, which expires on May&#160;12, 2021, a $<ix:nonFraction unitRef="usd" contextRef="ie9c68e7d2e424fc59a03e33749acacea_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzgyOA_47d9e42d-1bf3-4c56-bba2-81e3e36793f7">1.0</ix:nonFraction> billion, <ix:nonNumeric contextRef="i624a08d2669d4bc19ebfeec612b82b2b_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzU0OTc1NTgxNjY5MTA_1afc910e-c27a-4efb-89f4-ac43c57dbc44">five-year</ix:nonNumeric> unsecured back-up revolving credit facility, which expires on May 18, 2022, a $<ix:nonFraction unitRef="usd" contextRef="i8809cf477a8743d9bb985128a2794821_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzkxOA_21439427-b549-46cc-9681-ce350599c3f1">2.0</ix:nonFraction> billion, <ix:nonNumeric contextRef="ibbb693e747254191aa459c5a8372bb85_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzU0OTc1NTgxNjg4ODE_8acef578-d68d-4968-b42f-1bbe7029cbc7">five-year</ix:nonNumeric> unsecured back-up revolving credit facility, which expires on May 17, 2023 and a $<ix:nonFraction unitRef="usd" contextRef="ic05b162415354eb4a957e1d4b5f6f6c4_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzEwMTE_3f1477ed-b453-4e97-9ad2-6a19803e37cd">2.0</ix:nonFraction> billion, <ix:nonNumeric contextRef="ia57b5877fbea405eb22d66a6eaf931b6_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzU0OTc1NTgxNjY5MTE_a67aefce-c211-427b-8fdc-70575577f08e">five-year</ix:nonNumeric> unsecured back-up revolving credit facility, which expires on May 16, 2024. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately <ix:nonFraction unitRef="number" contextRef="iab6686fec59a41f4a0c718105fed5c6d_D20200101-20201231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzEzMTU_ed58df64-46ff-4d35-bc17-14d4c2b116f3">0.03</ix:nonFraction>%, regardless of usage. As of December&#160;31, 2020 and 2019, there were <ix:nonFraction unitRef="usd" contextRef="i07faa68d499941c1be4ba68ed832a9f1_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShortTermBorrowings" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzEzNjg_4e284a48-acf4-454b-a36e-62f696143d1d"><ix:nonFraction unitRef="usd" contextRef="i3f6bebf211ae4518a4a23f58e6f388a0_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShortTermBorrowings" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzEzNjg_b60e9af9-d66d-4496-a569-2554a76a12d7">no</ix:nonFraction></ix:nonFraction> borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the Aetna Acquisition Date, a subsidiary of the Company is a member of the FHLBB. As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of December&#160;31, 2020 was approximately $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM0ODg_4ea4d36d-ec53-4202-b735-7b2e07004b44">925</ix:nonFraction> million. At both December&#160;31, 2020 and 2019, there were <ix:nonFraction unitRef="usd" contextRef="i95fd067686e94117b1c847c8a8c039eb_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShortTermBorrowings" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM1MjI_e06041d7-1331-49a7-8c50-09a6cfb736db">no</ix:nonFraction> outstanding advances from the FHLBB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="ia8c5eaacbdf242339dd3eee02265fbc6_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzM1MTI_cb287d69-3f6e-4795-a59f-ce8c642b7fe0">750</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ia8c5eaacbdf242339dd3eee02265fbc6_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzM1MzU_55572e56-7e2b-4787-98b2-f848f556af4b">1.3</ix:nonFraction>% unsecured senior notes due August 21, 2027 and $<ix:nonFraction unitRef="usd" contextRef="i5f88871020ec4730bb5d033335c7942c_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzM2MDg_2cc58c61-41fa-4c2c-87e6-6a4ad6d26c69">1.25</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i5f88871020ec4730bb5d033335c7942c_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzM2MzY_2abaa016-2f41-4d50-874f-72ed97d8e218">1.875</ix:nonFraction>% unsecured senior notes due February 28, 2031 for total proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzM2NTM_069130b7-a3f8-48f9-90eb-bbd38bca69a2">1.99</ix:nonFraction>&#160;billion, net of discounts and underwriting fees. The $<ix:nonFraction unitRef="usd" contextRef="i3459ed386a61404c94e9479d6015ffbe_I20201216" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzgyNDYzMzcyMjY5MDI_971b1307-eece-404d-adb6-50630f55d5db">750</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ia8c5eaacbdf242339dd3eee02265fbc6_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDIxNjk_55572e56-7e2b-4787-98b2-f848f556af4b">1.3</ix:nonFraction>% unsecured senior notes represent a further issuance of the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="i3459ed386a61404c94e9479d6015ffbe_I20201216" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzM5NjQ_d625ae2e-11f6-4df1-95f3-e231cf5113ad">1.3</ix:nonFraction>% unsecured senior notes due August 21, 2027 initially issued in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i99166279d10146f28c4d4195c226385f_I20200821" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzQwNjM_116a85e0-6270-4040-8e39-26449babc5c9">1.5</ix:nonFraction>&#160;billion on August 21, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i99166279d10146f28c4d4195c226385f_I20200821" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTEwNzI_116a85e0-6270-4040-8e39-26449babc5c9">1.5</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i3459ed386a61404c94e9479d6015ffbe_I20201216" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTEwOTE_d625ae2e-11f6-4df1-95f3-e231cf5113ad">1.3</ix:nonFraction>% unsecured senior notes due August 21, 2027, $<ix:nonFraction unitRef="usd" contextRef="iad8877d2fdd8467888b253ca40d5a80b_I20200821" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTExMTE_7823e59b-0eaf-461b-b86e-429b4b875b5b">1.25</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="iad8877d2fdd8467888b253ca40d5a80b_I20200821" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTExMzI_3727b1ab-b8ad-4200-a6d6-29bf18ae7c68">1.75</ix:nonFraction>% unsecured senior notes due August 21, 2030 and $<ix:nonFraction unitRef="usd" contextRef="i88e8304eaa26409d8a604190defc89b5_I20200821" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTExNTM_15ed2c5e-9f6c-4cc5-aa81-321888f281d0">1.25</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i88e8304eaa26409d8a604190defc89b5_I20200821" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTExNzM_799fdd10-e23c-45a1-9291-aa3d02c1de12">2.7</ix:nonFraction>% unsecured senior notes due August 21, 2040 (collectively, the &#8220;August 2020 Notes&#8221;) for total proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i94f9c1f9d7704805bcabb81136732a71_D20200821-20200821" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTExOTM_8a1cd679-8e10-4e8f-ae7c-dd1a72019010">3.97</ix:nonFraction>&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i445f32d7eda447d4a2c49f251b316594_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM1MDM_f4b93bd9-81fc-4c55-afb0-e2924f98ea29">750</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i445f32d7eda447d4a2c49f251b316594_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM1MjQ_c1919730-cf8b-4ea4-a5e3-5693d129c844">3.625</ix:nonFraction>% unsecured senior notes due April 1, 2027, $<ix:nonFraction unitRef="usd" contextRef="i0f587ced64ac42339b971d523874e02d_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM1NDU_c7017788-6dd1-49e3-afe8-9d3faacbb847">1.5</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i0f587ced64ac42339b971d523874e02d_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM1NjU_19af21f9-1168-4196-ad69-c48edad14820">3.75</ix:nonFraction>% unsecured senior notes due April 1, 2030, $<ix:nonFraction unitRef="usd" contextRef="i459a1521a0b34aa48757c591eb7efefc_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM1ODU_5030f743-a02a-445a-b701-13c2cd8c8246">1.0</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i459a1521a0b34aa48757c591eb7efefc_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM2MDY_f83dd3a4-5cf1-4f16-ad12-1c24938d961f">4.125</ix:nonFraction>% unsecured senior notes due April 1, 2040 and $<ix:nonFraction unitRef="usd" contextRef="iaffd5e9b361c427a883e24208cf16157_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM2Mjc_cd914c85-8921-44b3-a665-fa4d21432208">750</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="iaffd5e9b361c427a883e24208cf16157_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM2NDc_f3f8b4af-6784-41a4-9da6-f5876e28138a">4.25</ix:nonFraction>% unsecured senior notes due April 1, 2050 (collectively, the &#8220;March 2020 Notes&#8221;) for total proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="id5a40055293c4fe79da45605991de624_D20200101-20200331" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM2Njg_8e7a4203-c3be-44c0-a8e5-b8e6a678974b">3.95</ix:nonFraction>&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds of these offerings were used for general corporate purposes, which may include working capital, capital expenditures, as well as the repurchase and/or repayment of indebtedness.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie35e2f3d9ed34cafac6ca6595377ebe2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the March 2020 Notes. In connection with the issuance of the March 2020 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $<ix:nonFraction unitRef="usd" contextRef="id5a40055293c4fe79da45605991de624_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM2OTQ_097f0b68-9bed-4b01-aacd-6f5779705de6">7</ix:nonFraction>&#160;million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $<ix:nonFraction unitRef="usd" contextRef="id5a40055293c4fe79da45605991de624_D20200101-20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM4MTA_4ed5bfb0-6f7a-4792-81ae-36c4e17444c3">5</ix:nonFraction>&#160;million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 13 &#8216;&#8216;Other Comprehensive Income&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 15, 2019, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i3754da4dc0974763892869cfb72c7345_I20190815" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM2MzU_efaa0554-6503-465c-9288-5fa895858603">1.0</ix:nonFraction> billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i3754da4dc0974763892869cfb72c7345_I20190815" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM2Njg_aa6edc57-3f84-4f9d-8b7b-8bad11f2bd26">2.625</ix:nonFraction>% unsecured senior notes due August 15, 2024, $<ix:nonFraction unitRef="usd" contextRef="ie91d7fd162c249529beb9e9eb9f7e7a7_I20190815" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM3MTU_f5987389-d0c4-43e4-915d-d97408182cbc">750</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ie91d7fd162c249529beb9e9eb9f7e7a7_I20190815" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM3NDg_98511d1a-bd03-4aed-bc25-9f811fbdb1f3">3</ix:nonFraction>% unsecured senior notes due August 15, 2026 and $<ix:nonFraction unitRef="usd" contextRef="idb2dc5274bad4e428d1e8ae87786fedc_I20190815" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM3OTg_9657b81f-69bb-4374-9160-3b8e8587068b">1.75</ix:nonFraction> billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="idb2dc5274bad4e428d1e8ae87786fedc_I20190815" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4MzE_9d17d0b6-b18e-46e1-82d4-7fe1608e905e">3.25</ix:nonFraction>% unsecured senior notes due August 15, 2029 (collectively, the &#8220;2019 Notes&#8221;) for total proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="ifaa8ac73798d48a8aaab4ac171cb2721_D20190815-20190815" decimals="7" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM5NDY_d5e063be-f134-468a-9c76-30aa0b2153fb">3.46</ix:nonFraction> billion, net of discounts and underwriting fees. The net proceeds of the 2019 Notes were used to repay certain of the Company&#8217;s outstanding debt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in July 2019, the Company entered into several interest rate swap and treasury lock transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the 2019 Notes. In connection with the issuance of the 2019 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $<ix:nonFraction unitRef="usd" contextRef="i95a7e367f856452c8f2160336066176a_D20190701-20190731" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzQ1ODc_2b3d5da7-e4ad-42c0-a35b-ed0c2dc1c35f">25</ix:nonFraction> million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $<ix:nonFraction unitRef="usd" contextRef="i95a7e367f856452c8f2160336066176a_D20190701-20190731" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzQ2ODE_0236c279-9b59-4962-b014-6e2dc76d420f">18</ix:nonFraction> million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the 2019 Notes. See Note 13 &#8216;&#8216;Other Comprehensive Income&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company purchased $<ix:nonFraction unitRef="usd" contextRef="i3267d33afe6d45e6b4528df8d62df448_D20201201-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDMzNDE_e2a0d8fe-f220-460a-93b8-4e6965f08f1a">4.5</ix:nonFraction>&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $<ix:nonFraction unitRef="usd" contextRef="ibca2e87104be46389dc5a70a0864d1a3_D20201201-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDMzNTU_01e9070b-cb69-47d7-be9d-f3ccbbdd06a1">113</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="i0e657c55e1f64967b1ffeccd58ae062b_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDMzNjk_e8050a13-e9c7-4b12-989a-10b7620ab0d3">4.0</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="id9f05d6d28af4ae0878d9c571f979793_D20201201-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDMzNzU_7ccd8b03-d935-48f2-a738-f10348355594">1.4</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i734cf172fc0a4bb394897c043bd538c6_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDMzODk_9ddcb8b6-ab2c-46b8-9084-e8942e931575">3.7</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="i28dabe1fc51c4dfa95740ee0bce67f39_D20201201-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDMzOTU_104a26b6-7757-4ee8-85c9-0b0d4d163398">1.0</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="ibb4bb36351fe4c6f9d1a0eae2a188257_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0MDk_e3873c2e-dd57-4c59-b934-fd8172c21f36">4.1</ix:nonFraction>% senior notes due 2025 and $<ix:nonFraction unitRef="usd" contextRef="i9f5ce01da4b6464cad8f27d28f832fe6_D20201201-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0MTU_4da0b8fc-a2ce-421c-8f39-36f1a678f311">2.0</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i854b7b5601cc4ad2ae0c167f72910032_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0Mjk_cc25488c-2d24-4605-a660-d5150f038f6c">4.3</ix:nonFraction>% senior notes due 2028. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="i3512931fe12944039d4fea37efaabf11_D20201201-20201231" decimals="INF" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0MzU_fdc8c39a-ffbc-42db-973e-9e75ba63bfed">619</ix:nonFraction>&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $<ix:nonFraction unitRef="usd" contextRef="i3512931fe12944039d4fea37efaabf11_D20201201-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0NTk_2104b717-276e-49c3-9c63-be2d3fb79064">45</ix:nonFraction>&#160;million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="i3512931fe12944039d4fea37efaabf11_D20201201-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtExtinguishmentFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0NDc_f3b17a9e-b23c-4853-b411-c517cf5190db">10</ix:nonFraction>&#160;million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="i3512931fe12944039d4fea37efaabf11_D20201201-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0NzE_4e7ae48f-3b73-404f-a47c-cd6599093fc6">674</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $<ix:nonFraction unitRef="usd" contextRef="i00d2c3f9c025419cb3e6849ea5f357fd_D20200801-20200831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQxNTk_cd38a1f2-c687-4fd2-abcd-26583294200a">6.0</ix:nonFraction>&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $<ix:nonFraction unitRef="usd" contextRef="i55b3bd8ed75a4dcba9f7489cefb5e348_D20200801-20200831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQxNzM_992750ec-d932-430a-a8b5-8701b946c9af">723</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="ib154687a8b3a4739af34791842da6702_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQxODc_f75e1ff0-d2bc-4df9-ad0c-33bd08a0e0fc">4.0</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="i6e0292e851e64435a7435abc06f22dd9_D20200801-20200831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQxOTM_d59558c5-940b-4eee-bbdd-c7039d91c884">2.3</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i3f4b2227a9a84f6aaa20022126390e84_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyMDc_0dcf5de7-fe5b-439e-b772-1e8bafadbc55">3.7</ix:nonFraction>% senior notes due 2023 and $<ix:nonFraction unitRef="usd" contextRef="i19a7d9778cad44b39b5aedbba6e986eb_D20200801-20200831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyMTM_a9152dd0-aafb-49ab-b5fe-4b4d109d2e15">3.0</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="iacb6befda8dc4cad8d7d488e77940523_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyMjc_9b0a76ef-c536-40ae-90f5-90a1e17df813">4.1</ix:nonFraction>% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="i77619d991c0342398aac18ff9a3beda1_D20200801-20200831" decimals="INF" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyMzM_9e59dbfb-43f8-4cad-bff6-56489bb993a2">706</ix:nonFraction>&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $<ix:nonFraction unitRef="usd" contextRef="i77619d991c0342398aac18ff9a3beda1_D20200801-20200831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyNDc_ed1d4755-3fa5-4821-9362-907f91712bd5">47</ix:nonFraction>&#160;million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="i77619d991c0342398aac18ff9a3beda1_D20200801-20200831" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtExtinguishmentFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyNzQ_ccdb2cee-63b6-4e61-814f-9e87fa3d7aa0">13</ix:nonFraction>&#160;million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="i77619d991c0342398aac18ff9a3beda1_D20200801-20200831" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyNjA_e0631aab-2b5c-427e-99f0-70d3124889e1">766</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, the Company purchased $<ix:nonFraction unitRef="usd" contextRef="ie86e314ed8c34b84b73378a6b9f4d9fb_D20190801-20190831" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDI0NzI_17e99162-43c4-458a-81b6-4954f5f351ea">4.0</ix:nonFraction> billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $<ix:nonFraction unitRef="usd" contextRef="i93c1191afd7245a2b1def8168a0950e2_D20190801-20190831" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQzMDA_530ca064-6fa2-45e0-8a59-6b68d47a094d">1.3</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i2792f74c0d9748799688efc0b0fec153_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQzMjE_1ad0d30f-67fe-4a80-bfc1-c07d57fa3858">3.125</ix:nonFraction>% senior notes due 2020, $<ix:nonFraction unitRef="usd" contextRef="i7f532518f6a74de889d917417c28eeb3_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQzNDI_2f17d007-0552-4509-a8ad-72566ffc7b52">723</ix:nonFraction>&#160;million of its floating rate notes due 2020, $<ix:nonFraction unitRef="usd" contextRef="ice888eb6a699499fa3f39bf466abe7a3_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQzNjk_dc77b050-0cc8-4b41-9f0d-c87e7ca00108">328</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="i4fdb87438a4048388482de54f9117c58_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQzOTA_1477bd8b-d9d4-4e98-8273-0e0d3f2e6bf5">4.125</ix:nonFraction>% senior notes due 2021, $<ix:nonFraction unitRef="usd" contextRef="i57fd64714a6f4ea08771d23076bbabd4_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQ0MTE_fca43b52-d09e-4c30-9374-8a84bea8c052">297</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i55a729e2dd93487da789a270476d9892_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQ0MzI_76ef155d-cbb8-48c6-8682-5688e4888195">4.125</ix:nonFraction>% senior notes due 2021 issued by Aetna, $<ix:nonFraction unitRef="usd" contextRef="ia4b13a24dc9745c6846d0092832bf57b_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQ0NTM_2e5fa967-6b9c-4b39-bb9d-eafb6185b234">413</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i128e4692b13144ff870ee0ffea794d65_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQ0NzM_8ecbac69-5eed-4794-b373-0a09e80301cc">5.45</ix:nonFraction>% senior notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna, and $<ix:nonFraction unitRef="usd" contextRef="ia712a987f9e947c89a37cdc4169dac3b_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQ0OTM_5661026c-c3c7-409d-aefe-98e030525611">962</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="i9e401817f81448f2a9b9b27b7cc53de0_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQ1MTM_698aac16-4e31-4dd3-b89e-9ad708118b35">3.35</ix:nonFraction>% senior notes due 2021. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="i56de586fcbb34f1fa9240dc169c67a55_D20190801-20190831" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDI1NDQ_4d060845-82ad-41a7-9031-217b38ca7f07">76</ix:nonFraction> million in excess of the aggregate principal amount of the senior notes that were purchased, incurred $<ix:nonFraction unitRef="usd" contextRef="i56de586fcbb34f1fa9240dc169c67a55_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtExtinguishmentFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDI1NTA_aea185ac-d5b0-48c4-a1d7-1bf92813f6b0">8</ix:nonFraction> million in fees and recognized a net gain of $<ix:nonFraction unitRef="usd" contextRef="i56de586fcbb34f1fa9240dc169c67a55_D20190801-20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDI1NTY_b87f288c-b991-4d8a-a0a9-41604f6bb25e">5</ix:nonFraction> million on the write-off of net unamortized deferred financing premiums, for a net loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="i56de586fcbb34f1fa9240dc169c67a55_D20190801-20190831" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDI1NjI_70e89ef8-4a90-4cf7-a3c7-d7fd2af3c967">79</ix:nonFraction> million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities, unsecured senior notes and unsecured floating rate notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of December&#160;31, 2020, the Company was in compliance with all of its debt covenants.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_154"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDYz_95ad5489-7dfb-4475-bb20-9b952ddc9056" continuedAt="i83483a03dedd44039dbd0a21df2025a5" escape="true">Pension Plans and Other Postretirement Benefits</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i83483a03dedd44039dbd0a21df2025a5" continuedAt="i7dfd52a7a7244792aec79dc3c6aaf642"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company sponsors several active 401(k) savings plans that cover all employees who meet plan eligibility requirements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes matching contributions consistent with the provisions of the respective plans. At the participant&#8217;s option, account balances, including the Company&#8217;s matching contribution, can be invested among various investment options under each plan. The CVS Health Future Fund 401(k) Plan offers the Company&#8217;s common stock fund as an investment option. The Company also maintains nonqualified, unfunded deferred compensation plans for certain key employees. The plans provide participants the opportunity to defer portions of their eligible compensation and for certain nonqualified plans, participants receive matching contributions equivalent to what they could have received under the CVS Health Future Fund 401(k) Plan absent certain restrictions and limitations under the Internal Revenue Code. The Company&#8217;s contributions under its defined contribution plans were $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExMTk_041c263f-5c4a-4e0d-85d3-7956a014393b">520</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExMjM_3b483fbc-3083-4937-ad8c-4f83377260bb">550</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExMzA_46a4531a-114b-4634-85cd-7dbda31daeaf">334</ix:nonFraction> million in the years ended December 31, 2020, 2019 and 2018, respectively. The Company&#8217;s contributions for the years ended December&#160;31, 2019 and 2018 include contributions to the Aetna 401(k) Plan subsequent to the Aetna Acquisition Date. On January 1, 2020, the Aetna 401(k) Plan was merged into the CVS Health Future Fund 401(k) Plan. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2018, the Company completed the Aetna Acquisition. Aetna sponsors a tax-qualified defined benefit pension plan that was frozen in 2010. Aetna also sponsors a nonqualified supplemental pension plan that was frozen in 2007. Aetna&#8217;s pension plan benefit obligations and the fair value of plan assets were remeasured as of the Aetna Acquisition Date. The Company also sponsors several other defined benefit pension plans that are unfunded nonqualified supplemental retirement plans. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Benefit Obligation and Plan Assets</span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDU4_0e4e030d-2048-490f-911f-7aba46c3bebf" escape="true"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDcy_fe4f4d05-a501-46cc-967e-e37d364353d4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables outline the change in pension benefit obligation and plan assets over the specified periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzItMS0xLTEtMA_c6942f53-e926-43dc-ae10-f18f3fd4aa4e">6,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8160947ef6494a8204e68ccf558244_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzItMy0xLTEtMA_a8d48415-8acf-422b-9d3b-95412f2c92f0">5,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzQtMS0xLTEtMA_4b64ced7-6563-4142-a15c-b7c02cf8a4d7">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzQtMy0xLTEtMA_c5865076-308d-4081-b56f-074ecf2d8000">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzUtMS0xLTEtMA_f5c93ec0-c593-4c26-b631-6ad7c0fffd91">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzUtMy0xLTEtMA_111c55c1-c851-40f4-ba18-ce8bb6f19e9d">530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzYtMS0xLTEtMA_278ea5a1-7b8b-442e-b848-6aa6d188c691">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzYtMy0xLTEtMA_fba42cd2-3f2a-4437-94a1-eb50de0b9200">357</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzctMS0xLTEtMA_e2207ded-c6f8-4b08-b34f-3ca78425adeb">6,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzctMy0xLTEtMA_e93fd035-9015-4711-9f55-8696e86d416c">6,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzEwLTEtMS0xLTA_a2baa7ec-39e8-4d2b-bce9-77403a06e7f4">6,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8160947ef6494a8204e68ccf558244_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzEwLTMtMS0xLTA_beb9fa91-476d-4c54-a926-e45d89229cd9">5,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzEyLTEtMS0xLTA_e1f74d0a-85c2-47c6-a522-d06bf921f17d">783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzEyLTMtMS0xLTA_8588bc56-7f6e-4178-b54f-ae870feaba97">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzEzLTEtMS0xLTA_19589502-6ea5-4658-b244-bb6692b3164b">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzEzLTMtMS0xLTA_5d1a06a5-dc8a-4f43-affd-c5f93b002a79">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzE0LTEtMS0xLTA_ed0479be-a9f8-481b-955c-c6de3dd37e9f">358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzE0LTMtMS0xLTA_ecf4875f-9848-4cea-9ed3-35d2a8743b27">357</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzE1LTEtMS0xLTA_f80e4165-e0df-4e3b-8e12-e75c9f3be17a">6,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzE1LTMtMS0xLTA_427e541d-c400-4ee4-89b6-0fd62d60a180">6,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzE3LTEtMS0xLTA_a13cc03f-6416-48b3-b37d-dbf3d69014c4">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzE3LTMtMS0xLTA_2fe69ea6-1381-41ee-bd75-b551b2254ae3">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the pension benefit obligation during the years ended December&#160;31, 2020 and 2019 was primarily driven by the change in the discount rate during each respective period.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7dfd52a7a7244792aec79dc3c6aaf642" continuedAt="if3bca34f10294f0a9fe2044754735a33"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDcz_2e86a49d-7e11-4e81-9c2e-a553f9a8192b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2020 and 2019 for the pension plans consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets reflected in other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzEtMS0xLTEtMA_23e191a5-42fa-4dba-a5a2-f2ddd99e7337">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzEtMy0xLTEtMA_07c3521e-5dc8-4d2f-ba1d-051fdd2d93c1">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities reflected in accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzItMS0xLTEtMA_4f95cbae-19ed-4c6b-96eb-6174bbe284c4">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzItMy0xLTEtMA_a9aec4fd-3e4a-4555-a031-f4f484901122">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities reflected in other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzMtMS0xLTEtMA_6142f055-b9fd-4208-bfeb-24b75b39a56d">285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzMtMy0xLTEtMA_a75c333e-0cc1-4026-b254-06a593a3595a">313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzQtMS0xLTEtMA_d7c5500e-98b9-4d61-bb27-765df46fe674">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzQtMy0xLTEtMA_a4159896-06a6-42da-a81b-0a3b72d8fe97">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Cost (Income)</span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDc0_58b94f78-1ab3-454e-a679-3e8e79e50182" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) for the years ended December&#160;31, 2020, 2019 and 2018 are shown below:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of net periodic benefit cost (income):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzItMS0xLTEtMA_2885dd58-2234-4fcf-9bed-08cdbf0f78bd">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzItMy0xLTEtMA_f6f8ff72-47c0-47ac-bb30-a32f082320e1">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzItNS0xLTEtMA_edbb97fc-0005-4114-94af-7930a6632525">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzMtMS0xLTEtMA_465e481f-d178-4d6b-86d8-e8b69cc63079">388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzMtMy0xLTEtMA_0badc51d-65d8-4b82-912a-41d3f4c9b4c8">357</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzMtNS0xLTEtMA_8069db49-f518-4c68-af55-2f54559aaf65">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzQtMS0xLTEtMA_893e0579-d433-4c63-9d16-e8bd2dee027c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzQtMy0xLTEtMA_bf2f62f8-ff45-41df-9b90-9fe04236ac0c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzQtNS0xLTEtMA_23167549-7c3f-4e42-9c2f-a3ddc2861dc3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzYtMS0xLTEtMA_19ebbbd0-578b-456b-9af7-dad1596a03c3">218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzYtMy0xLTEtMA_381ff18f-584a-4c6a-a074-cf2c4500ea41">131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzYtNS0xLTEtMA_58cd0561-3e2b-4134-8bee-6a8116db04b5">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plan Assumptions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a series of actuarial assumptions to determine its benefit obligation and net periodic benefit cost (income), the most significant of which include discount rates and expected return on plan assets assumptions. </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discount Rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate is determined using a yield curve as of the annual measurement date. The yield curve consists of a series of individual discount rates, with each discount rate corresponding to a single point in time, based on high-quality bonds. Projected benefit payments are discounted to the measurement date using the corresponding rate from the yield curve that is consistent with the maturity profile of the expected liability cash flows.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Return on Plan Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected long-term rate of return on plan assets is determined by using the plan&#8217;s target allocation and return expectations based on many factors including forecasted long-term capital market real returns and the inflationary outlook on a plan by plan basis. See &#8220;Pension Plan Assets&#8221; below for additional details regarding the pension plan assets as of December 31, 2020 and 2019.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also considers other assumptions including mortality, interest crediting rate, termination and retirement rates and cost of living adjustments. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDY2_ed0cf6f9-7eca-4486-a8f7-7b658399a7f5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpjYjRjYzBkNmEzZGM0MjIxODFhZjMwZTFhZmVmNWQ5MC90YWJsZXJhbmdlOmNiNGNjMGQ2YTNkYzQyMjE4MWFmMzBlMWFmZWY1ZDkwXzEtMS0xLTEtMA_a5200901-f8ce-4d2b-b03b-1ec6a72f78c8">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpjYjRjYzBkNmEzZGM0MjIxODFhZjMwZTFhZmVmNWQ5MC90YWJsZXJhbmdlOmNiNGNjMGQ2YTNkYzQyMjE4MWFmMzBlMWFmZWY1ZDkwXzEtMy0xLTEtMA_a24b0d25-e534-44c0-9024-183aff108097">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo5NjY5MzBmNDIzNTk0YmViYjA0ZmJiN2JjMGUzNzc1My90YWJsZXJhbmdlOjk2NjkzMGY0MjM1OTRiZWJiMDRmYmI3YmMwZTM3NzUzXzEtMS0xLTEtMA_bcd1dd4d-e5bc-4c44-b4e4-d2125f2a7353">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo5NjY5MzBmNDIzNTk0YmViYjA0ZmJiN2JjMGUzNzc1My90YWJsZXJhbmdlOjk2NjkzMGY0MjM1OTRiZWJiMDRmYmI3YmMwZTM3NzUzXzEtMy0xLTEtMA_a2526a41-c308-40c9-b56a-f40599041129">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo5NjY5MzBmNDIzNTk0YmViYjA0ZmJiN2JjMGUzNzc1My90YWJsZXJhbmdlOjk2NjkzMGY0MjM1OTRiZWJiMDRmYmI3YmMwZTM3NzUzXzEtNS0xLTEtMA_07bd24bf-1244-4c43-8903-5b8051b165e0">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo5NjY5MzBmNDIzNTk0YmViYjA0ZmJiN2JjMGUzNzc1My90YWJsZXJhbmdlOjk2NjkzMGY0MjM1OTRiZWJiMDRmYmI3YmMwZTM3NzUzXzItMS0xLTEtMA_2f43017d-c416-449d-bf03-0e005b05485b">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo5NjY5MzBmNDIzNTk0YmViYjA0ZmJiN2JjMGUzNzc1My90YWJsZXJhbmdlOjk2NjkzMGY0MjM1OTRiZWJiMDRmYmI3YmMwZTM3NzUzXzItMy0xLTEtMA_225cd486-fa86-4398-a93b-e9c4c3638c15">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo5NjY5MzBmNDIzNTk0YmViYjA0ZmJiN2JjMGUzNzc1My90YWJsZXJhbmdlOjk2NjkzMGY0MjM1OTRiZWJiMDRmYmI3YmMwZTM3NzUzXzItNS0xLTEtMA_47afc15d-4038-4a00-a302-34ab509a9e7e">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if3bca34f10294f0a9fe2044754735a33" continuedAt="ie902507399eb491da55ee32ea3d565b2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plan Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Aetna Acquisition Date, the Company&#8217;s pension plan assets primarily include debt and equity securities held in separate accounts, common/collective trusts and real estate investments. The valuation methodologies used to value these debt and equity securities and common/collective trusts are similar to the methodologies described in Note 4 &#8220;Fair Value.&#8221; Pension plan assets also include investments in other assets that are carried at fair value. The following is a description of the valuation methodologies used to value real estate investments and these additional investments, including the general classification pursuant to the fair value hierarchy.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Real estate investments are valued by independent third party appraisers. The appraisals comply with the Uniform Standards of Professional Appraisal Practice, which include, among other things, the income, cost, and sales comparison approaches to estimating property value. Therefore, these investments are classified in Level 3.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private equity and hedge fund limited partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Private equity and hedge fund limited partnerships are carried at fair value which is estimated using the NAV per unit as reported by the administrator of the underlying investment fund as a practical expedient to fair value. Therefore, these investments have been excluded from the fair value table below.</span></div><div style="padding-left:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDc1_06dd66f5-0a1a-4930-b1ac-1dd4fcab43df" continuedAt="ie1ba20ecc79f46cb9dfc8d29951269aa" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2020 were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19b4a92f0034466b0dafc7eef0ed131_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEtMS0xLTEtMA_b1fb18e7-e771-407c-a861-53786dd969ac">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d0605006d2241649165adc7e5b9f2ca_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEtMy0xLTEtMA_0ab89b30-34f0-446c-aeac-c702fb7e3a8b">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6fb4454708b484d80f98d957fdbae70_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEtNS0xLTEtMA_768e85a5-25fa-419b-b336-15bed9112c33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i199b7cb664dd42c0a4101ffbc59daa25_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEtNy0xLTEtMA_8c46a297-8544-4ddb-b227-63ff56450796">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b7e0181861a4c0d9e8c70427c9ed30b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzMtMS0xLTEtMA_efba05cb-76e8-45a3-b967-d5fe55efb9ef">575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5907cfcab6b4aef941e6f756054404d_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzMtMy0xLTEtMA_3345fe38-dcee-48e2-824f-8eb63798d6f0">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd81358eeafb4757a5e163b51db96a44_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzMtNS0xLTEtMA_600671b9-ac61-47a5-80ca-7e245becc7dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94f76249fb9a452d9893743b90cf37d9_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzMtNy0xLTEtMA_1beee20f-de61-4981-9fa8-ca702180a910">611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60b124872b654d26a4229c8094209469_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzQtMS0xLTEtMA_f2858e5c-de87-46df-bd0b-31e01c297eab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee2b654be581464a9cfbd3f508f399e7_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzQtMy0xLTEtMA_cd049727-d0e0-46de-810a-ba3bdef7f32e">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06e5a033c28d4981a2fdc1ff5bb4e842_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzQtNS0xLTEtMA_c10e12ec-e46f-48ee-90a1-8d67fd6cd2e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be7ba94d39d477293bb398aeeeb21bc_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzQtNy0xLTEtMA_927f7280-1184-4f2a-8d90-59e0702e0517">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie06fb4df6a36490395db8159ed91e626_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzUtMS0xLTEtMA_287e9fda-15f9-4bc1-9eda-4fca485e59ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ca0b1a966a481bb230964303d892b0_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzUtMy0xLTEtMA_3a40a443-48bf-4507-b134-f2bfea0f6aa9">2,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467e9f5dc8e842b6afcb7be67ac32c9d_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzUtNS0xLTEtMA_081f7edc-32a5-4638-a5d8-bf2decfd22ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idebaa114561f4d728604bd981df6517f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzUtNy0xLTEtMA_3e119c66-be53-40df-8452-2ca5fb592060">2,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5925ffc572454ec9a71d0ef8eb29f390_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzYtMS0xLTEtMA_efb89c64-f633-401d-b2e4-4657d19dc947">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01c474448dea429dae5ca6e183b910fc_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzYtMy0xLTEtMA_98b5e0aa-eca2-409c-a505-509fbc3051d8">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1552a4f21d8e47278630c328c2dde9c6_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzYtNS0xLTEtMA_edce3774-6b55-4d21-930d-1a705338c8ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d60e6812854952a3585905fbbea41b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzYtNy0xLTEtMA_e401b54a-a712-4e02-805e-368a165feea5">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8204427c844531b278a523b96a7dff_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzctMS0xLTEtMA_d2ca8b99-f544-42b2-91c2-ec5b3bef692a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e87124deec94812a64890f3add780e7_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzctMy0xLTEtMA_03cd6723-8e0f-4a5a-8cf0-9d8bab67e8ab">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93b5aeda1e154dd9b1c23b1da20f6ee4_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzctNS0xLTEtMA_bc19343a-ea8b-4e76-9204-2ba5cd7535b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id02d21e453d54dae81874530cd9f89dc_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzctNy0xLTEtMA_3bfd8e7b-9b5d-44a8-ba2a-bf7d8f0510c0">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i377d5f59a8274903ba535a34426c2ccb_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzgtMS0xLTEtMA_a8238516-f6f5-4a31-bc44-c7c2ab6959dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dcfb37002f247639c8eb485fc992007_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzgtMy0xLTEtMA_8a5035c5-b1c2-4a93-9d38-829dbbd7862c">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e14729da7b4279abc81f285bf7a165_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzgtNS0xLTEtMA_6ba710ba-a25e-4f27-97f8-e66764f27f80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabe4e2d60e78403dbc51a597cc767f01_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzgtNy0xLTEtMA_30e031fe-4552-4e38-9092-923c45c1b581">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieea92042d53540819af2bae5cd60cb85_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzktMS0xLTEtMA_d93c2972-556c-496c-9b3c-6b66e81d0f4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6007e672e02407bbd8bad0315a61ffa_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzktMy0xLTEtMA_f8fc4791-3e30-443d-b3c4-0d47d5427cb1">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75d0265957df4b58acf5ac2bed8460f2_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzktNS0xLTEtMA_189eaf9a-0601-48b3-9e6c-6c303061475a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if507a4fe145e42b493db61571bfd2376_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzktNy0xLTEtMA_e34e0052-e9fa-434c-8f05-7f4bbdb25037">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83dbe71df09344f38b1a756f97f3b8a9_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEwLTEtMS0xLTA_bc21b439-159a-4357-9721-d540c38fb535">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c5293ad9994caab33673ec66c3cf31_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEwLTMtMS0xLTA_b967c690-c9d6-4c3b-a1e5-9b5fbae68556">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54427a144ab54136af97359d16305c28_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEwLTUtMS0xLTA_eb35acf3-c1f8-49e5-a478-a4a9d47c1be5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i788a8b0a6104485c88fb58913f9c1b1e_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEwLTctMS0xLTA_42c14fb8-e61c-48aa-b20f-1a803456a07a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69a36f8e3e0747b5b5d40f18f897e44b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzExLTEtMS0xLTA_a0208c59-b094-4a14-9b2f-4747f52f2330">575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d20ef997413454bb5220829c7a405ef_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzExLTMtMS0xLTA_8293089b-7c7b-411a-bfca-3d76e27ff78b">2,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b8f1f9efa947c7bffb894e3104cd7a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzExLTUtMS0xLTA_86b6fadc-3e20-4860-b6fa-97cb84f81408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i353f05ec97dd4a7dad6e03d980c8825e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzExLTctMS0xLTA_ed8ef088-e303-4955-a2a7-0bf13f5ef7de">3,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ec36398a8c3460a872ca7a5eec4975a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEzLTEtMS0xLTA_09712cf4-4cd7-4ed3-8668-0de721efd97c">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7d49739667e46e7a8df15497979d8ab_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEzLTMtMS0xLTA_749cc5e4-919a-4e07-ab18-6943d3af4846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8202fb48582644a489621cd494e8d6ed_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEzLTUtMS0xLTA_fcd4fa72-4a80-49cd-9d40-282d3f7c05ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib225d997939f4bb2bd5ea1d2988d1cb4_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEzLTctMS0xLTA_2ce3d718-0897-4e32-9034-d2fa5e8ea992">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if874ae14e12a45bca74664b04f2b5666_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE0LTEtMS0xLTA_4d1b2bb6-26d6-43bd-9de5-85c7f1e01b23">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0638d5f10c8d47228bce923194d15629_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE0LTMtMS0xLTA_a8f32f1d-2e40-4e99-96e4-41e0627db1ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff889270d69a4541aec6168c327f2898_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE0LTUtMS0xLTA_dc58890b-5341-4a12-b38c-069756298db2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if371687561d646ad8eeab5f4be3e9b99_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE0LTctMS0xLTA_18e10110-1ca2-44c2-9df3-40da9759b663">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieabe9e784e6e48c1aa447f7436dba5ec_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE1LTEtMS0xLTA_03939233-a184-4588-90ff-6dfe20cfc6af">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d02faf330be4175b93e19bf97c5db9e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE1LTMtMS0xLTA_1744b974-6a0c-4d45-a9ab-a86c00ee9fcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6302fcfa13ad4d1ea6a72dfe007f13bc_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE1LTUtMS0xLTA_258dc9cb-9f46-4b56-8278-258ccefcb2a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5ac1eab026c440588dfa8abb8de73fa_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE1LTctMS0xLTA_40e34a41-c7c8-47fc-bf10-afb1f1171b7d">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67d5ae7d8fcc4926bcf462116cd3f590_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE2LTEtMS0xLTA_e73f2339-b755-40b4-9acd-aa7293e80631">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bf3a33ce5e49e09483d3f1eb323c91_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE2LTMtMS0xLTA_39820a31-e233-4f94-a740-8e1e062453d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b5b3546e61842e19f00e5e719d97b10_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE2LTUtMS0xLTA_01a5422c-5eef-4970-808f-160c1231a423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd3b8f30c29d437ab39023c671b9f5d5_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE2LTctMS0xLTA_3bcaef36-5e05-4e12-9404-ba4fd59be5d3">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83f10752832a454a8ce347de35c34a61_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE4LTEtMS0xLTA_520cbb86-e8c9-4b27-bc03-57e96110076b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3677d20c08e4c8ebbebcb282e4db114_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE4LTMtMS0xLTA_6fa8ffdb-ec3a-41a0-9c37-9b29317476b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86f58868e0964cd2b2796c0808009103_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE4LTUtMS0xLTA_08a4f404-4a49-40c2-8487-cd4a9c75df9f">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b548029e62747ba94fd53b47736ecd4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE4LTctMS0xLTA_43c5082d-8487-4183-a48d-900660d66044">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58de51b364c74e4a85531407fafb309d_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE5LTEtMS0xLTA_13151902-36f9-4626-bf33-e0435b57b305">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85c43bf5e0d844b89bae1a96c978b4f4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE5LTMtMS0xLTA_71233c21-4ee4-4c0a-bde5-a3c80231cd47">266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife531059d400455c8d2de1200f45d2b3_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE5LTUtMS0xLTA_f87c52c4-8db6-4ca2-9ef7-d91f7860b2a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06bafa8c2cdf4929affc318e38df023e_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE5LTctMS0xLTA_b05b3483-fce4-4b70-b41a-016bf2de56d8">266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29f1e9cab7554879b559a825763f064c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIwLTEtMS0xLTA_6839eeb8-c659-4853-a591-0c489aeda9b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied8b9a81bd694cde82356583d0495b4a_I20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIwLTMtMS0xLTA_8e365b87-66b8-40b8-850a-e3f40746f5bc">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb86f9a64a874a4aa21ee0d29a5c45c6_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIwLTUtMS0xLTA_4b62da50-6c35-49d3-8d10-04cb4450f255">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f1fcbaf310f4df8bd8906a1f02317be_I20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIwLTctMS0xLTA_e77c1578-d600-4c39-b2e0-7ce983d3481d">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i080509f1feb54ebcb46eeaa383e8546f_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIxLTEtMS0xLTA_780d8110-f863-407e-a4b5-7962f8b3e677">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8654f2977f3d468dae935f3fbfbecf0b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIxLTMtMS0xLTA_b56d78eb-9bae-4a69-a838-7a39aa42dfb5">263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if218f96f5bc7440190bb6d1d32469556_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIxLTUtMS0xLTA_582c76aa-3e8d-42dc-8867-e43824bddba8">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i729a6c49903d4b309e624c0dbef3b76a_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIxLTctMS0xLTA_7980425f-6708-4bfb-8080-8b00e0830cb2">606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1312f09b0894768af1a8551fc6e5b03_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIyLTEtMS0xLTA_df7fcdb6-20dd-471b-834e-4799b0ca988a">2,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c8af184e30405da562adf6b2f53803_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIyLTMtMS0xLTA_f28d07a7-b638-4baa-9b7a-d08a9acbf4cd">3,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05d08625a5eb4640bd0ccc35f6f0113e_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIyLTUtMS0xLTA_81dd0225-ac89-4a00-9fac-2ba1a719e408">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5abb09cdc094ad4b2a7a7bb44a3a237_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIyLTctMS0xLTA_95f860e1-2f6f-4be5-b84b-378449c11cab">5,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $<ix:nonFraction unitRef="usd" contextRef="i7f89a175a9a14d3e920a746200d35fac_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzYyMDM_9e951060-c803-47f2-9e3f-b9f3ea6db00d">84</ix:nonFraction> million of equity securities and $<ix:nonFraction unitRef="usd" contextRef="icd90fa404f7c46ff85d4bc45bbb37cdd_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzYyMzE_33aff0d0-a5a7-490b-9717-8082c4b080d2">182</ix:nonFraction> million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="ie8a130cfef55481ab1428a6385d3f85a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzIxOTkwMjMyNzY0MTc_1a8bf4ea-ae88-4ecb-917c-7c3ca4b943d2">142</ix:nonFraction> million of other receivables as well as $<ix:nonFraction unitRef="usd" contextRef="i5df5acb6d9c14d45b450813208569404_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzYyNjQ_4a5c7aeb-ab63-429a-9999-394438346ef8">624</ix:nonFraction> million of private equity limited partnership investments and $<ix:nonFraction unitRef="usd" contextRef="ia9298abceed34f2693a1b4f218cd1ae5_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzYzMjE_479e19b0-6f4e-4621-8731-2791f8e36d02">214</ix:nonFraction> million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie902507399eb491da55ee32ea3d565b2" continuedAt="i63dbf729003c42788f6606b177b9baee"><ix:continuation id="ie1ba20ecc79f46cb9dfc8d29951269aa"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2019 were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i189e4eb5f8f84310ab30e1e16b049ded_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEtMS0xLTEtMA_99d8393f-7e27-4e0f-92b6-ba03fa436b3b">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53b84ef08da4bc0be96eeacb61d6fdf_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEtMy0xLTEtMA_ab7bc462-33d9-4780-987a-ec84e1ae161b">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a7783ec39f44c7f950de140ee30ccd3_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEtNS0xLTEtMA_7b282e7c-ceb0-4557-a3b5-cabfed9359ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bae567789f14a93a57bf38399d526bc_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEtNy0xLTEtMA_908d5a0d-301b-438c-a7b2-38275d4ba10f">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5622e8a9b4b94311af248826e87e3fdf_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzMtMS0xLTEtMA_83abf321-796f-49a4-b513-e18b527c2f5f">592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i307b2fc7ef7b489dace816f6d69b35b4_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzMtMy0xLTEtMA_99470d53-9308-4932-83ef-e75182d294a0">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f44abef5a694fda9c5e4cad71fe5401_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzMtNS0xLTEtMA_6f7255aa-fce6-42b3-ac5a-db195d547212">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c01a675083b46ebafe2d3f0f7ee1ab3_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzMtNy0xLTEtMA_48abc11d-c912-4097-87dd-32743e3713cf">623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8826db7d3214cdb93b22d4439751850_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzQtMS0xLTEtMA_7ba1d989-a4f0-4208-b95a-80a03b41b89d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84c926b8e33449989a08783eb00e7643_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzQtMy0xLTEtMA_3bb626ce-b34f-400b-928e-16a89da0c7b4">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32101714f9f94576810cf6f379fe4387_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzQtNS0xLTEtMA_dd82b253-5f84-44bb-90a5-9eca876df185">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae61a996efae4295867c0dfb1a39a3f2_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzQtNy0xLTEtMA_485050b4-d1af-4f47-bc6f-55fafeaffe51">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7622f52a58534a658e934f69b4a9f3fd_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzUtMS0xLTEtMA_ecb1ea70-ac7a-4725-9e9c-6d2d6995fcdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc20f88214b4a889d0644a52d5a3199_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzUtMy0xLTEtMA_16a0f1fd-1f31-49b5-bc35-d9064a697ba1">1,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87158720186e40a988f7d80acf1e290f_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzUtNS0xLTEtMA_5bc5e7ee-8661-4f42-977a-18ac4c3781f0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2a42438d1164e93a25bd2d16276f08b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzUtNy0xLTEtMA_250a27ab-8c00-4909-aebb-4bdc9e726932">1,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9913ee60876d48f9a437df7a194a8925_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzYtMS0xLTEtMA_6d1aac4f-bc3d-403d-b46b-5d596fed7166">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e944506a5e748718a30ff6c9042ae2c_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzYtMy0xLTEtMA_3a9b6369-ed5c-4e32-8170-807eb398a9aa">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656d5ceb239c4aa6a6bacdc5506c6402_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzYtNS0xLTEtMA_74dc2c42-f976-4964-933f-d46db178b20d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cc901a60d9e43c0aa6809d88598eebe_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzYtNy0xLTEtMA_ada87595-f8ef-442d-8de2-6c99d39aeb85">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13907d2d75304f7ba2882e4c00e7720c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzctMS0xLTEtMA_72d9f6a2-36a1-494d-b84d-57b8e1778c3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i069fbff796464b2d9a15554368b9f668_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzctMy0xLTEtMA_290e0d35-af9a-4693-a56a-ae0d0bca9be0">385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i074b986b3d7d4aa2ac22c8e670376a66_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzctNS0xLTEtMA_ae5ae793-1e5b-435b-89d3-5ccff410f449">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a5a8651a074b198c987dc214b0dd2b_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzctNy0xLTEtMA_f5666ef1-01f5-47c2-bf83-3f9ab7d3c64a">385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iead9829071b4481ab63cea328f7f1f8e_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzgtMS0xLTEtMA_e9fcc4af-05bc-4086-99ce-9cf399d4d73c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f27c04d6477464c8445d1e603a5b16a_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzgtMy0xLTEtMA_5452560a-73cf-4773-bf10-9f23d8bf6e8b">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee6557a5cac41d48e5c01b08eaaeb97_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzgtNS0xLTEtMA_5299be38-fa74-484e-b6b2-e687996cbbd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9aa9e3cb8794b4aa342f889f8401d1e_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzgtNy0xLTEtMA_ea8cf886-0b1b-4a12-8fee-3ed1e76b383c">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39362337f3b44b66bccad215f1c8e8c0_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzktMS0xLTEtMA_33a2694b-9ba0-4673-91b0-988010cc2525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad099eb0d7146c38442e0cb9d3a8402_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzktMy0xLTEtMA_1fc2f023-fa22-456c-a4a6-e06ca4e82051">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide54b78ac8dd45638fb5a4471bfa5d00_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzktNS0xLTEtMA_159356fb-fad6-4c65-b90e-ce2d105fcbc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i846c67b9e9c6476ba16d4a96de44df37_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzktNy0xLTEtMA_3c583176-4a88-42f3-9ca3-3add0b227cd3">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19f7ea30687c4c7c906cfa2a0496f916_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEwLTEtMS0xLTA_bb838899-63a7-4502-b52c-56dd110a7c22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13374b6df9b64f6aaa07708acc7d5634_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEwLTMtMS0xLTA_be50f4dd-06bd-40f9-a7fc-51522f3d0383">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90458e77c8d04c8b86fc7590c59d6025_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEwLTUtMS0xLTA_abb02097-76ab-4c26-8667-417a264f20c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0070b3fe1244aa932248485abfe70a_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEwLTctMS0xLTA_ef51b1b3-29b5-4299-abb1-dcbd36616d73">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie317f789360640fb822133fe59211131_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzExLTEtMS0xLTA_e1841500-1021-4a99-96ff-8cf3a7fd7801">592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc128ee345d848ff9eea0ec8c49afc99_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzExLTMtMS0xLTA_1ada5601-7e2e-4115-a363-a14157d6b778">2,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iced38e2fa6484ee9861a8081d056eb1e_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzExLTUtMS0xLTA_f41946e8-a6fe-4c01-9d8d-d7492c15d5cd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9945b71b67144ecb9f14a84d87ddc66_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzExLTctMS0xLTA_ea95ef90-4998-4261-8e60-74189b8a84e4">3,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24a8700c68594e30b441940e80331370_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEzLTEtMS0xLTA_6983e4b5-46eb-4760-b152-ed24579c5054">931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i147b83dbf4614f9c9108afea3b976504_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEzLTMtMS0xLTA_615ecc50-fa59-4c02-b7de-6cc4b6d1fe2c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1029d4685304d2cb2982ca56bfc846b_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEzLTUtMS0xLTA_19e98e50-326e-410e-8f9e-1bdc0af03f90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f7b664efcce4edeb2d0be08f0af7e83_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEzLTctMS0xLTA_cae481ec-c03f-4afc-bcfa-d0c08dda2728">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i146ec2efe7f44c0fbbf0805c2207957f_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE0LTEtMS0xLTA_dfc300b0-3c53-461d-8953-7fce51c7328c">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb71646c58d7445aa5f321233e70747d_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE0LTMtMS0xLTA_6601af23-7b28-4497-a992-ba8c42447005">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i621fa421235e47879a3c82d1e7761526_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE0LTUtMS0xLTA_54cfaaf6-a09b-4bd2-9f9e-21bb5e7f40bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie182b182c1e04b5a95f77614cf852dcb_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE0LTctMS0xLTA_b46cbaff-2e72-4e2b-bfa7-49c3dcd2e8fe">481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i174d4a2984ab43e49d4c93870e670a82_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE1LTEtMS0xLTA_6d3dec62-f3a2-4ddd-b403-770fd6dd8e37">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab99963cfd9c4db0b3ea89aeae5f9c86_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE1LTMtMS0xLTA_3432ca7b-04e5-45c0-a047-01bf1069c80f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14643b42fd4744918e6578d8405012b6_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE1LTUtMS0xLTA_140d2df2-4704-4bd5-bd34-51a7e6bfc3bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i457edd129a59445180d32544cd427fce_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE1LTctMS0xLTA_1a16f384-1312-45a7-b845-8698ba1b1cb0">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if81393ad83d44ce4a232212a8aed80bb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE2LTEtMS0xLTA_204e016f-375c-41f8-b71d-d45726a3a6e3">1,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79605292953547d9b320dae3bf8430ac_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE2LTMtMS0xLTA_c71c667e-5c67-44af-a0f8-7ee40cef3429">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbb7812c80d64641a6de43f21593e322_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE2LTUtMS0xLTA_0be52315-751d-48eb-8003-25668e150e8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c89457d6192440fa11287d12cc947df_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE2LTctMS0xLTA_3bfef242-5ca9-45d1-b949-0853f21535d8">1,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80a9f79f4ffe48d1860759d3460e04e8_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE4LTEtMS0xLTA_ef83074a-fe28-4fe0-bf83-3607ed0ae418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id82b6a24ba2c4189832ac5c9b3270e8f_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE4LTMtMS0xLTA_840159eb-a15b-4c03-b002-3dc01c34ed3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52a9e0dcc4a04df6ac84ab2839ff962f_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE4LTUtMS0xLTA_5e56f628-3556-4635-8cbf-7b4732f2f36a">353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3e054a6e4684760a1317f79ac480b98_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE4LTctMS0xLTA_eb62ee51-fd33-4c8a-b0f3-4d8249a210c0">353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ee306bddc4f4d6b8934f74c4545ea7c_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE5LTEtMS0xLTA_34de9c6d-df01-474c-a6f5-627ca38ef613">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida6f1c68de9d434f969f54fdf8aba608_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE5LTMtMS0xLTA_5fb7df08-a681-474e-8e91-9056abc0a3e7">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54a2fed1212f490e95fe213e7e4ba150_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE5LTUtMS0xLTA_34f6e2d1-89f4-4f45-890f-50a8f595e68d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i237d341b67b849d18d2ee8b7d61ffa52_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE5LTctMS0xLTA_1cc295de-9679-4498-acd4-450e3c53d9aa">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i107d385134dc41aea1a97e0c5d0f5916_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIwLTEtMS0xLTA_44bae813-7a09-4d47-9fa4-e2a7c4df40f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fa9c507902c4d0b8fa4479a7c0ed322_I20191231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIwLTMtMS0xLTA_922c91b3-1ae4-4cc6-9a1a-d5cffa6f476c">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i646a4d5e671b48e3b5e208d65353fdf0_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIwLTUtMS0xLTA_13065489-5123-4cca-bd77-cf0cee1b7b79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife78fc80a60a4e48b19bed5974ae5428_I20191231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIwLTctMS0xLTA_945d3e80-a495-40d3-9a0a-b9fc87c40603">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i190a83693cb04cfb8d75c0ceecbbe1ba_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIxLTEtMS0xLTA_5f0a7d53-4452-4d8c-84cf-cff5a2d5da93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1d6b4017f5149b3ae49f0bd1da1940d_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIxLTMtMS0xLTA_cfc7f1bc-74b5-418b-8134-000bed44c086">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7c0d3bc5f844c3ab8218065d78c108_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIxLTUtMS0xLTA_08e6258c-a53f-4aba-9d62-181f2e1cfd2c">353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39bb7917bc994f0eaf005fd0617cde55_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIxLTctMS0xLTA_6f4e3e34-16ad-48b8-b6cb-4f292f2dfc02">639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958b9417031b48e7a2cb6c08607b666b_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIyLTEtMS0xLTA_c29d5d46-eccf-40f5-ab3d-47be6fa51a19">2,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0dca0fdd1cc4f1c87ec37e91a251807_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIyLTMtMS0xLTA_ba3fc3c0-b473-46ab-b77a-83a4ad206cc5">3,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba1a93762424cd3b76c4ca89d3b3cf3_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIyLTUtMS0xLTA_61328f29-4683-4a3c-87ef-cc7413f7577a">354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i706c321b809b483b98aa21c73cf16796_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIyLTctMS0xLTA_c4ac861b-95e9-4215-8a03-337ceac3c965">5,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $<ix:nonFraction unitRef="usd" contextRef="i5510c8c02acc41eb892b3be5a2a9b1b8_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzY3MjQ_4d6a749c-c552-4b26-ac56-98cb0e0e6954">137</ix:nonFraction> million of equity securities and $<ix:nonFraction unitRef="usd" contextRef="i81dde339dd0248afbe29f4dc19b3c9be_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzY3NTI_bf66decb-bb46-43a3-b3f9-0e4e17af4aa6">151</ix:nonFraction> million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="ic8aef86038c9426ca7436114946db2b5_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzY3ODU_4cb0277a-f313-4e9c-8f1c-2588ec2e7b3f">540</ix:nonFraction> million of private equity limited partnership investments and $<ix:nonFraction unitRef="usd" contextRef="i4fb8ea69d9ee452abf1af74b33433c67_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzY4NDI_a104c131-8812-4519-af32-936f5acbf61c">184</ix:nonFraction> million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDY4_bacc8f02-172c-42b6-ac3e-4f379914477f" continuedAt="iea58c4869add4665abffbcd69b66b175" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balance of Level 3 pension plan assets during 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. corporate<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52a9e0dcc4a04df6ac84ab2839ff962f_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzItMS0xLTEtMA_947861c8-9293-4f1e-b26d-40b19c271c12">353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87158720186e40a988f7d80acf1e290f_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzItMy0xLTEtMA_b323a6c9-16bb-47cd-b930-56aba3709b2f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba1a93762424cd3b76c4ca89d3b3cf3_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzItNS0xLTEtMA_61b9b7ab-a371-4926-a250-77e3616ff610">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idddcc030b53a42e4be0825c74db753da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzMtMS0xLTEtMA_b7f673f3-b48a-4cfd-a0f0-8e0200ded17d">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e3fae81cff499099d524e5745e57cb_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzMtMy0xLTEtMA_09c3b0e9-38a2-43b0-a868-c8f56182cf86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie58dc0862dea4aa2b787686a9637e9e1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzMtNS0xLTEtMA_fb13fdbe-6c06-45c7-b904-5b4537cb529a">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idddcc030b53a42e4be0825c74db753da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzQtMS0xLTEtMA_415567c6-e145-4a85-8186-e59492dfbe6d">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e3fae81cff499099d524e5745e57cb_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzQtMy0xLTEtMA_a8b184c0-f8b7-4ee7-8f98-d99d78593613">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie58dc0862dea4aa2b787686a9637e9e1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzQtNS0xLTEtMA_28a6b4e5-85b6-4a76-8341-b541aed7bc7e">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idddcc030b53a42e4be0825c74db753da_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzUtMS0xLTEtMA_4241e81b-e18e-4344-be40-510d681652f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09e3fae81cff499099d524e5745e57cb_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzUtMy0xLTEtMA_5139b843-070d-488e-9567-3460e635b976">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie58dc0862dea4aa2b787686a9637e9e1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzUtNS0xLTEtMA_78c81e98-fc30-4d3f-a946-a9c6ed226031">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86f58868e0964cd2b2796c0808009103_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzYtMS0xLTEtMA_dcb95653-1920-49c9-b97f-2c8f16f08cde">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467e9f5dc8e842b6afcb7be67ac32c9d_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzYtMy0xLTEtMA_d4b462f9-c69e-4374-962e-3a95e6b3ea2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05d08625a5eb4640bd0ccc35f6f0113e_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzYtNS0xLTEtMA_db222c06-5e32-484c-8f1a-72901b9bfc59">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i63dbf729003c42788f6606b177b9baee" continuedAt="ia89252272d4042f094be289a100a20fd"><ix:continuation id="iea58c4869add4665abffbcd69b66b175"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balance of Level 3 pension plan assets during 2019 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. corporate<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i709a7a961b39422984ed1bd0a5689686_I20181231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzItMS0xLTEtNTg3MQ_f9ba286a-0e19-4715-b752-7a8790f37ddd">425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8c098e2a62d48dba96b79e8a470d8af_I20181231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzItMy0xLTEtNTg3MQ_51ac0d6f-8ede-481b-be6a-6ba475a24739">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2e47c4a3e474047b5600f55bf95c1ac_I20181231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzItNS0xLTEtNTg3MQ_5bbc556a-dcf4-4a96-a376-d03ccee6297c">430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832b22dba7494ed582da21d8a190e7d9_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzMtMS0xLTEtNTg3MQ_864f8c72-3fa6-4cd0-861b-dea2f76d70cf">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82cc1b96c4d540878bf6fe77d08690d5_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzMtMy0xLTEtNTg3MQ_09da1983-d11a-4431-b0f1-3444c16e6dc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46f812ae4a24778b7506bc4bb600bf2_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzMtNS0xLTEtNTg3MQ_166a49d6-cddd-42b8-86cf-b8b29b123c2b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i832b22dba7494ed582da21d8a190e7d9_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzQtMS0xLTEtNTg3MQ_45da6595-fb47-4a82-98a7-fa0dff047902">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82cc1b96c4d540878bf6fe77d08690d5_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzQtMy0xLTEtNTg3MQ_670df743-b2f5-4143-8d42-96b3f6b60728">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic46f812ae4a24778b7506bc4bb600bf2_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzQtNS0xLTEtNTg3MQ_ca3790e7-3c07-4991-b2df-ed6ddb64f54a">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832b22dba7494ed582da21d8a190e7d9_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzUtMS0xLTEtNTg3MQ_5f4dc794-3b9e-4109-bf40-e32d8fa4b6d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82cc1b96c4d540878bf6fe77d08690d5_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzUtMy0xLTEtNTg3MQ_03790344-285e-44f1-83a9-05418ddc6a00">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46f812ae4a24778b7506bc4bb600bf2_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzUtNS0xLTEtNTg3MQ_9a3ae2b3-3be1-49d5-b9a7-936a0620b96d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52a9e0dcc4a04df6ac84ab2839ff962f_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzYtMS0xLTEtNTg3MQ_e8e45976-06a8-4015-a38a-e0bf9242ffb2">353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87158720186e40a988f7d80acf1e290f_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzYtMy0xLTEtNTg3MQ_b131ea26-b4ed-41ea-ba24-fb421dcd90b4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba1a93762424cd3b76c4ca89d3b3cf3_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzYtNS0xLTEtNTg3MQ_5ffee53e-3ffd-4f84-ac02-5a41163b0494">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pension plan invests in a diversified mix of assets designed to generate returns that will enable the plan to meet its future benefit obligations. The risk of unexpected investment and actuarial outcomes is regularly evaluated. This evaluation is performed through forecasting and assessing ranges of investment outcomes over short- and long-term horizons and by assessing the pension plan&#8217;s liability characteristics. Complementary investment styles and strategies are utilized by professional investment management firms to further improve portfolio and operational risk characteristics. Public and private equity investments are used primarily to increase overall plan returns. Real estate investments are viewed favorably for their diversification benefits and above-average dividend generation. Fixed income investments provide diversification benefits and liability hedging attributes that are desirable, especially in falling interest rate environments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, target investment allocations for the Company&#8217;s pension plan were: <ix:nonFraction unitRef="number" contextRef="icc6b13b774c2451ebf395531a720b68e_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzg0NTk_9cfb88b5-afb0-408c-8edb-fc2636d8e34a">20</ix:nonFraction>% in equity securities, <ix:nonFraction unitRef="number" contextRef="ic1dd8da2c561447490c876b5d1d43462_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzg0ODQ_1b26a4d6-5bb6-4b63-a16c-7e704446c18b">68</ix:nonFraction>% in fixed income and debt securities, <ix:nonFraction unitRef="number" contextRef="i47492e5b6b204ea7abaea7eee818a880_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzg1MDc_6b955e97-b7d5-4884-855a-fd0e2e55d23a">6</ix:nonFraction>% in real estate, <ix:nonFraction unitRef="number" contextRef="ib81821bf724343ffbd656554419d3a89_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzg1MjY_571cce00-ca4a-4dce-bee8-50fe2d786b6f">3</ix:nonFraction>% in private equity limited partnerships and <ix:nonFraction unitRef="number" contextRef="ia6f4539d5aa54233a40a81686c5e751a_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzg1NzI_d763182b-9229-4a4d-a18f-4dc942cd3e2a">3</ix:nonFraction>% in hedge funds. Actual asset allocations may differ from target allocations due to tactical decisions to overweight or underweight certain assets or as a result of normal fluctuations in asset values. Asset allocations are consistent with stated investment policies and, as a general rule, periodically rebalanced back to target asset allocations. Asset allocations and investment performance are formally reviewed periodically throughout the year by the pension plan&#8217;s Investment Subcommittee. Forecasting of asset and liability growth is performed at least annually.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally contributes to its tax-qualified pension plan based on minimum funding requirements determined under applicable federal laws and regulations. Employer contributions related to the nonqualified supplemental pension plans generally represent payments to retirees for current benefits. The Company contributed $<ix:nonFraction unitRef="usd" contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzk0ODc_e6ecf3e7-bbc1-4a0f-aa52-5afd15f3b6de">25</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzk0OTE_64e2c436-1a53-4663-9637-3d9fbb8820b5">25</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzk0OTg_467bf798-667f-42ea-8e14-f5f704cfb6ab">12</ix:nonFraction> million to its pension plans during 2020, 2019 and 2018, respectively. No contributions are required for the tax-qualified pension plan in 2021. The Company expects to make an immaterial amount of contributions for all other pension plans in 2021. <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDYx_69e023ee-e5dd-4970-82b2-4d5830b8bca7" continuedAt="if4784b8beb3141268cb12d0abf8f0ad5" escape="true">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2020: </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="if4784b8beb3141268cb12d0abf8f0ad5" continuedAt="iaca353168f7449cfbbf4889ba1891693"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZToyYzU0OWNjYzllNmQ0ZWZmYjFmYWY4NTRhM2UyM2MzNi90YWJsZXJhbmdlOjJjNTQ5Y2NjOWU2ZDRlZmZiMWZhZjg1NGEzZTIzYzM2XzEtMS0xLTEtMA_34818847-4814-4e02-850a-ec33e068347d">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZToyYzU0OWNjYzllNmQ0ZWZmYjFmYWY4NTRhM2UyM2MzNi90YWJsZXJhbmdlOjJjNTQ5Y2NjOWU2ZDRlZmZiMWZhZjg1NGEzZTIzYzM2XzItMS0xLTEtMA_61057dc1-5684-40c7-bc58-3adc7997c482">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZToyYzU0OWNjYzllNmQ0ZWZmYjFmYWY4NTRhM2UyM2MzNi90YWJsZXJhbmdlOjJjNTQ5Y2NjOWU2ZDRlZmZiMWZhZjg1NGEzZTIzYzM2XzMtMS0xLTEtMA_50300aba-d132-4981-b180-797ab0a9e745">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZToyYzU0OWNjYzllNmQ0ZWZmYjFmYWY4NTRhM2UyM2MzNi90YWJsZXJhbmdlOjJjNTQ5Y2NjOWU2ZDRlZmZiMWZhZjg1NGEzZTIzYzM2XzQtMS0xLTEtMA_6a34faeb-7842-4ec8-a93a-337b698715a4">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZToyYzU0OWNjYzllNmQ0ZWZmYjFmYWY4NTRhM2UyM2MzNi90YWJsZXJhbmdlOjJjNTQ5Y2NjOWU2ZDRlZmZiMWZhZjg1NGEzZTIzYzM2XzUtMS0xLTEtMA_76f7f3c2-3032-4c89-9217-29fc3b823055">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZToyYzU0OWNjYzllNmQ0ZWZmYjFmYWY4NTRhM2UyM2MzNi90YWJsZXJhbmdlOjJjNTQ5Y2NjOWU2ZDRlZmZiMWZhZjg1NGEzZTIzYzM2XzYtMS0xLTEtMA_d44e16c9-6287-459d-8d59-2358518ba139">1,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiemployer Pension Plans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover its union-represented employees. The risks of participating in these multiemployer plans are different from single-employer pension plans in the following respects: (i) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (ii) if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers, and (iii) if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the applicable plan, which is referred to as a withdrawal liability. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia89252272d4042f094be289a100a20fd" continuedAt="ia81ae3531e3b4104b6718163dfd21853"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the multiemployer pension plans in which the Company participates are individually significant to the Company. The Company&#8217;s contributions to multiemployer pension plans were $<ix:nonFraction unitRef="usd" contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEwOTgy_0ed4a1b0-4101-4b2c-872b-d88748da2804">19</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEwOTg2_99efca21-1ce3-4b9b-a63d-5426dcaae3ea">18</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEwOTkz_da385283-dd9f-4e9d-bf6b-9d80994dfb9a">18</ix:nonFraction> million in 2020, 2019 and 2018, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Postretirement Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides postretirement health care and life insurance benefits to certain retirees who meet eligibility requirements. During 2018, the Company acquired additional OPEB plans in connection with the Aetna Acquisition. The Company&#8217;s funding policy is generally to pay covered expenses as they are incurred. For retiree medical plan accounting, the Company reviews external data and its own historical trends for health care costs to determine the health care cost trend rates. As of December&#160;31, 2020 and 2019, the Company&#8217;s other postretirement benefits had an accumulated postretirement benefit obligation of $<ix:nonFraction unitRef="usd" contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExNjY1_596ac223-03c9-44d0-a2c7-8a5b751577d3">226</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib4862415f867402e89af424bb29735c0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExNjcy_141beec8-594a-420a-8061-ae8a034d2eb7">246</ix:nonFraction> million, respectively. Net periodic benefit costs related to these other postretirement benefits were $<ix:nonFraction unitRef="usd" contextRef="i4ee76c7bbbad45d3a4d8ec0ad4b5a14b_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExNzY5_085d7d6c-d3aa-411e-aabd-bef2c1568ccb">12</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i27e3f6392d84488594d582d44fa7d68a_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExNzcz_e05be6cf-6ae6-403e-9bd4-d59f0ee850d3">7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iac73a717d5c74326808abd0309a3a07d_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExNzgw_4aa1f4c6-4613-467b-9ab5-af8f91b5c0d4">2</ix:nonFraction> million in 2020, 2019 and 2018, respectively. </span></div><div><span><br/></span></div><ix:continuation id="iaca353168f7449cfbbf4889ba1891693"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2020: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:86.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpmMmM0ODc2M2U0NmY0MzE2YjVlNmRlMmVkOTMxMzZiOC90YWJsZXJhbmdlOmYyYzQ4NzYzZTQ2ZjQzMTZiNWU2ZGUyZWQ5MzEzNmI4XzEtMS0xLTEtMA_7337f7c4-3c80-4866-a9b8-64d67039bc62">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpmMmM0ODc2M2U0NmY0MzE2YjVlNmRlMmVkOTMxMzZiOC90YWJsZXJhbmdlOmYyYzQ4NzYzZTQ2ZjQzMTZiNWU2ZGUyZWQ5MzEzNmI4XzItMS0xLTEtMA_2cd95dc4-a4a6-4495-8cb5-d4b585a5d6f4">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpmMmM0ODc2M2U0NmY0MzE2YjVlNmRlMmVkOTMxMzZiOC90YWJsZXJhbmdlOmYyYzQ4NzYzZTQ2ZjQzMTZiNWU2ZGUyZWQ5MzEzNmI4XzMtMS0xLTEtMA_55de620f-acf7-4a9f-b715-c2cb8a6647da">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpmMmM0ODc2M2U0NmY0MzE2YjVlNmRlMmVkOTMxMzZiOC90YWJsZXJhbmdlOmYyYzQ4NzYzZTQ2ZjQzMTZiNWU2ZGUyZWQ5MzEzNmI4XzQtMS0xLTEtMA_c02f9139-6e0e-43c1-adb5-2848adcebc02">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpmMmM0ODc2M2U0NmY0MzE2YjVlNmRlMmVkOTMxMzZiOC90YWJsZXJhbmdlOmYyYzQ4NzYzZTQ2ZjQzMTZiNWU2ZGUyZWQ5MzEzNmI4XzUtMS0xLTEtMA_7e7a2d79-a214-4556-a51d-3d4d2b94aa9e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpmMmM0ODc2M2U0NmY0MzE2YjVlNmRlMmVkOTMxMzZiOC90YWJsZXJhbmdlOmYyYzQ4NzYzZTQ2ZjQzMTZiNWU2ZGUyZWQ5MzEzNmI4XzYtMS0xLTEtMA_dfd892cd-126c-4f19-949f-eb3e82d7a195">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia81ae3531e3b4104b6718163dfd21853">Pursuant to various collective bargaining agreements, the Company also contributes to multiemployer health and welfare plans that cover certain union-represented employees. The plans provide postretirement health care and life insurance benefits to certain employees who meet eligibility requirements. The Company&#8217;s contributions to multiemployer health and welfare plans totaled $<ix:nonFraction unitRef="usd" contextRef="i4ee76c7bbbad45d3a4d8ec0ad4b5a14b_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDA3_725c7c99-a162-4409-ba63-fd8225c196ee">54</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i27e3f6392d84488594d582d44fa7d68a_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDEx_fdbbfb90-804d-4955-84cd-fb5e8b50445f">57</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iac73a717d5c74326808abd0309a3a07d_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDE4_3a84c32c-591e-490c-a54f-6ba727b82fe4">58</ix:nonFraction> million in 2020, 2019 and 2018, respectively.</ix:continuation> </span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_160"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQzOTQ_0b4d8c5a-92f8-4de5-ae48-90a57343326f" continuedAt="ie296ddc8384243c5b8da70066df826c2" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie296ddc8384243c5b8da70066df826c2" continuedAt="id6e64332e1fd4e20b8306c7621310fd5"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQzOTY_78a759ed-9554-484e-8675-c6b4aae4322f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzItMS0xLTEtMA_be2df563-368e-4692-8385-f4238dfc77d6">2,615</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzItMy0xLTEtMA_3f264655-1bd8-4bfd-8800-b722a0366eee">2,450</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzItNS0xLTEtMA_a408c619-49b5-44e2-a422-700ca02fc8c6">1,480</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzMtMS0xLTEtMA_914e4381-ae92-4fbe-9292-f74be94590b5">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzMtMy0xLTEtMA_889212bb-b84b-4db2-b962-d251c8a91773">565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzMtNS0xLTEtMA_2c5200a9-e830-43e9-a1be-95ab129e0f89">499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzQtMS0xLTEtMA_e8797d70-fd0f-4d12-ad3b-73983a9ea5d9">3,133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzQtMy0xLTEtMA_4bea0e78-e255-4f95-9cb9-daa29725a55b">3,015</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzQtNS0xLTEtMA_9606b023-e508-4c62-a9a7-77c4b91d27d1">1,979</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzYtMS0xLTEtMA_93b6e1e5-b546-422f-88a3-47c4ffaf951d">450</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzYtMy0xLTEtMA_82dfdb3e-2490-4c40-9724-32df1c5ff762">535</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzYtNS0xLTEtMA_b54edfef-f089-4ce5-a83b-94def3777746">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzctMS0xLTEtMA_c7357fd2-0f12-43fe-afda-813f1f8b2a8b">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzctMy0xLTEtMA_07c43e43-4611-49da-97b4-0ef65ef32af0">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzctNS0xLTEtMA_11592f86-c535-4ecb-a67c-c0c978598f72">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzgtMS0xLTEtMA_d38f09d3-bc1f-4bb3-b951-7709e361fb0d">564</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzgtMy0xLTEtMA_8d7cb873-bd7a-4364-b062-412fc0968eaa">649</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzgtNS0xLTEtMA_a32eb60b-8cac-476e-8d12-c8d8de7c0439">23</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzktMS0xLTEtMA_77ce4696-cb02-4d72-862d-f224a4451000">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzktMy0xLTEtMA_bf1eb7e8-763d-4842-95b1-1e06d6116bfc">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzktNS0xLTEtMA_3e0b4bc3-6e4a-4f43-b814-c1767e26a103">2,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The TCJA was enacted on December 22, 2017. Among numerous changes to existing tax laws, the TCJA permanently reduced the federal corporate income tax rate from 35% to 21% effective on January 1, 2018. The effects of changes in tax rates on deferred tax balances are required to be taken into consideration in the period in which the changes are enacted, regardless of when they are effective. As a result of the reduction of the corporate income tax rate under the TCJA, the Company estimated the revaluation of its net deferred tax liabilities and recorded a provisional income tax benefit of approximately $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-8" sign="-" format="ixt:numdotdecimal" name="cvs:TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzc1NQ_849b4b50-13bd-4898-8849-cde75baf9dcc">1.5</ix:nonFraction> billion for </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id6e64332e1fd4e20b8306c7621310fd5" continuedAt="i44a2bc7883ce4b62a81b406d052e022b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year ended December 31, 2017. In 2018, the Company completed its process of determining the TCJA&#8217;s final impact and recorded an additional income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzkyMw_b9481248-a78d-41b6-a536-a7f5f66c2d40">100</ix:nonFraction> million.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQzOTE_3eceae67-7e80-406a-b082-cd927a297f77" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of the statutory income tax rate to the Company&#8217;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzEtMS0xLTEtMA_cab8ae3b-5b61-4cf9-a91c-330a3f626e9f">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzEtMy0xLTEtMA_053b3ea0-f27e-48b8-a380-998e0fa28448">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzEtNS0xLTEtMA_dadcf7ba-fb61-47c0-ac16-036eb98c462d">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzItMS0xLTEtMA_2bd8c425-79bf-44bf-8e21-69224b3a5ea9">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzItMy0xLTEtMA_c90f136c-7178-4a2c-915b-af58641b9f96">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzItNS0xLTEtMA_1c49d99e-aca3-416c-bcb4-af0ea0a948e6">27.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of the Tax Cuts and Jobs Act</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzMtMS0xLTEtMA_308dce3c-9303-4c6b-806e-4ab0f0ae940f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzMtMy0xLTEtMA_c7671b6e-1538-4ff6-95a7-c91ad27364f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzMtNS0xLTEtMA_25dd13e3-6eac-4d2e-80d2-9b4c608bf5f2">7.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurer fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="3" name="cvs:HealthInsurerFeeTaxEffectPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzQtMS0xLTEtMA_7c3c2f96-06bb-4534-bf3c-1f1bf30d14ac">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="3" format="ixt:zerodash" name="cvs:HealthInsurerFeeTaxEffectPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzQtMy0xLTEtMA_3a4acefb-1f73-41ef-82df-abef8d24bfa6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="3" name="cvs:HealthInsurerFeeTaxEffectPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzQtNS0xLTEtMA_6e3c3f67-e161-4b85-8cb8-2de8688355aa">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzUtMS0xLTEtMA_26d88b4f-809c-45c9-9de8-9a6bd66b9548">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzUtMy0xLTEtMA_347c364c-5d1c-4c05-bdb2-68db880dce15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzUtNS0xLTEtMA_6387634c-1dcb-495f-82e1-8660670e72c5">89.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis difference upon disposition of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzYtMS0xLTEtMA_32b62329-a1f9-43e2-9429-c58ba720ba7d">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzYtMy0xLTEtMA_3d814d87-7d5d-4162-825e-66136fd7f796">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzYtNS0xLTEtMA_d32d0f80-0161-4cfb-8502-b2d85c9105a5">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzctMS0xLTEtMA_02063aff-e719-4a26-8549-6abed1eea129">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzctMy0xLTEtMA_651f41b8-a01a-4dcb-a511-08421cb5e0b4">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzctNS0xLTEtMA_3fb93326-4446-4a69-a68d-b596e3d0a718">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzgtMS0xLTEtMA_fe03f73b-edc1-4ff3-b95e-e8ef4187a05c">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzgtMy0xLTEtMA_01357108-23e6-4d27-ab69-04830bb10ef0">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzgtNS0xLTEtMA_78713954-0825-401a-ba92-4ab63bd5b7aa">142.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQzODc_543246c1-21e2-4142-b2ee-a832c75edf1e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of the Company&#8217;s deferred income tax assets and liabilities as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:78.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzItMS0xLTEtMA_95e5938d-0d53-44bf-bbd5-a8421f250039">5,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzItMy0xLTEtMA_a7ece961-e196-41c9-b35a-88aee06425f8">5,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzMtMS0xLTEtMA_8be6e90e-350d-4142-b95d-685f174a4a84">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzMtMy0xLTEtMA_545a169f-ce84-4ebe-adf1-aaf0f73c5220">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzQtMS0xLTEtMA_cec22008-0fc2-4ac9-a647-2a315f859d59">238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzQtMy0xLTEtMA_e020a912-5a73-4fe7-a8e1-934f7e8a3922">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debts and other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzUtMS0xLTEtMA_ef18f77d-a822-493d-b1ee-5a8457dfe922">395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzUtMy0xLTEtMA_1c936135-743e-4029-a98d-e8da9cd855d4">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzYtMS0xLTEtMA_d0b8840a-5f55-4bb3-a96a-b7f68e24d6c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzYtMy0xLTEtMA_4dad1f8c-6c5d-4c8c-8aa1-3f0ec38e2370">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and capital loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzctMS0xLTEtMA_87c0b47a-feb6-4449-a3da-af5d9e0d688d">568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzctMy0xLTEtMA_c6d3c931-569c-4c6f-9558-83afd3a06aae">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzgtMS0xLTEtMA_788893c1-9f6f-4a47-9a33-f99b336ab4d1">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzgtMy0xLTEtMA_2653de83-3b77-4959-b4f6-215fe62dce85">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzktMS0xLTEtMA_84fe76b0-2381-4cc3-8ca7-d9ef72257d53">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzktMy0xLTEtMA_0f5aa1ff-0b99-4ddb-8150-42ee29b72c81">430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll tax deferral</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-5" name="cvs:DeferredTaxAssetsPayrollTaxDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzEwLTEtMS0xLTA_18273ebc-9359-486b-b553-4c77d7b6cc96">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-5" format="ixt:zerodash" name="cvs:DeferredTaxAssetsPayrollTaxDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzEwLTMtMS0xLTA_93a6128e-8552-4117-b506-901e71f7f43f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzExLTEtMS0xLTA_2e39ad07-f7a0-46b2-8816-48c5643a485e">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzExLTMtMS0xLTA_8193e9cd-58fe-4ef0-9b41-e1e0781a57dc">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzEyLTEtMS0xLTA_b1139b23-b845-4f8d-a9b4-20e6fa706a4e">454</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzEyLTMtMS0xLTA_1947ef87-8744-44db-925b-14a0127faecd">374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzEzLTEtMS0xLTA_ba77dea2-fe1c-455d-a55a-7c9bff4d286f">7,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzEzLTMtMS0xLTA_c46b3c1a-d9e3-47fc-9918-13775f7b3d26">7,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-5" sign="-" name="cvs:DeferredTaxLiabilitiesRetirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE1LTEtMS0xLTE2MDIx_85d21d08-b6c0-4bf7-a13d-365ac373505c">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-5" format="ixt:zerodash" name="cvs:DeferredTaxLiabilitiesRetirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE1LTMtMS0xLTE2MDIx_e79334f8-8538-4d2d-b9e3-cc58567f4095">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE1LTEtMS0xLTA_a97b1a6f-f9ed-45e5-a8a9-0eb92e242f54">421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE1LTMtMS0xLTA_7ffccd90-12ff-48b3-b187-b9d6f4c8edd9">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE3LTEtMS0xLTE2MDI3_30f33073-4f30-4ab3-b488-e1e873d38d96">5,368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE3LTMtMS0xLTE2MDI3_1101097f-ffc7-4007-9168-e6b726baa686">5,464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DeferredTaxLiabilitiesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE2LTEtMS0xLTA_35b8867f-19ed-447b-a2d3-8259da378cf8">8,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DeferredTaxLiabilitiesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE2LTMtMS0xLTA_35fc0406-f536-46a3-b4ea-a39810312524">8,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE3LTEtMS0xLTA_88667517-7abb-4946-8e79-4c9aeff2e1ae">14,568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE3LTMtMS0xLTA_2c2ffb71-1d36-4175-a70a-2648e18514bc">14,603</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE4LTEtMS0xLTA_7e538ca6-aaa3-4107-a41d-08ba780d810b">6,794</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE4LTMtMS0xLTA_578eb3e6-1379-4649-8a95-64286b00f442">7,294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company had net operating and capital loss carryovers of $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzEzMjY_87c0b47a-feb6-4449-a3da-af5d9e0d688d">568</ix:nonFraction> million, which expire between 2021 and 2040. The Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and the Company&#8217;s recent operating results. The Company established a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzE2NTQ_b1139b23-b845-4f8d-a9b4-20e6fa706a4e">454</ix:nonFraction> million because it does not consider it more likely than not that these deferred tax assets will be recovered.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i44a2bc7883ce4b62a81b406d052e022b"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQzOTk_a0de1fc2-16ce-439b-89a3-4f8bebb6bc73" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2020, 2019 and 2018 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzEtMS0xLTEtMA_2ff420cf-e4d1-44e4-a368-e463551020cd">655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzEtMy0xLTEtMA_58e026a9-ace1-4cfc-a708-478672776083">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20db3230df8c4812ac4bf0f95ceda745_I20171231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzEtNS0xLTEtMA_a5995949-66ae-4c62-85c6-660929b9515d">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzItMS0xLTEtMA_7303b035-ae74-4f52-ba5c-56636b79efd3">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzItMy0xLTEtMA_75b39435-6329-4213-8aa5-f3a94b39fd06">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzItNS0xLTEtMA_dd1d5fe0-250d-4766-859c-9ccc92060d16">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzMtMS0xLTEtMA_531aa8e3-826c-426f-a41f-c46c6f4d9ee4">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzMtMy0xLTEtMA_fb30ac5c-f197-469d-afb7-902a6112d018">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzMtNS0xLTEtMA_631e97a0-1f08-4e03-be3f-7613397cf7fe">324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzQtMS0xLTEtMA_85067183-d53f-4583-8c51-2bba2726c9d0">56</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzQtMy0xLTEtMA_24afbbfa-bba1-4893-a80e-756750fd9881">111</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzQtNS0xLTEtMA_3fb112c6-924d-4044-9f6c-9ecea753444d">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of statutes of limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzUtMS0xLTEtMA_2315c046-dea6-4795-9c3e-a84858b34bd1">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzUtMy0xLTEtMA_4626fda2-b156-4103-aa8c-07f49ee09b20">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzUtNS0xLTEtMA_76fdf916-1207-4ff0-90e2-9bb850ea73f0">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzYtMS0xLTEtMA_d9e2a77e-fce1-40be-b8a3-851c44cf98ab">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzYtMy0xLTEtMA_9a38d0ff-45e5-43bc-99b2-da51f40bbe5e">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzYtNS0xLTEtMA_842775f1-aec2-4950-9756-3f04180cc1d3">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzctMS0xLTEtMA_546b9363-2ac0-4961-ab13-dadcf573c14e">768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzctMy0xLTEtMA_2f79ca14-cf52-461d-a752-84be6e0600e9">655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzctNS0xLTEtMA_32599dee-7a96-4ec6-9a68-41ed46cce1eb">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the balance of unrecognized tax benefits during 2018 was mainly due to the Aetna Acquisition.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and most of its subsidiaries are subject to U.S. federal income tax as well as income tax of numerous state and local jurisdictions. The Company participated in the Compliance Assurance Process through 2019, which is a program made available by the U.S. Internal Revenue Service (&#8220;IRS&#8221;) to certain qualifying large taxpayers, under which participants work collaboratively with the IRS to identify and resolve potential tax issues through open, cooperative and transparent interaction prior to the annual filing of their federal income tax returns. The IRS has completed its examinations of the Company&#8217;s consolidated U.S. federal income tax returns for tax years 2013 and 2018. The IRS has substantially completed its examinations of the Company&#8217;s consolidated U.S. federal income tax returns for tax years 2014 through 2017 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries are also currently under income tax examinations by a number of state and local tax authorities. As of December&#160;31, 2020, no examination has resulted in any proposed adjustments that would result in a material change to the Company&#8217;s operating results, financial condition or liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all material state and local income tax matters have been concluded for fiscal years through 2014. Certain state exams are likely to be concluded and certain state statutes of limitations will lapse in 2021, but the change in the balance of the Company&#8217;s uncertain tax positions is projected to be immaterial. In addition, it is reasonably possible that the Company&#8217;s unrecognized tax benefits could change within the next twelve months due to the anticipated conclusion of various examinations with the IRS for various years. An estimate of the range of the possible change cannot be made at this time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records interest expense related to unrecognized tax benefits and penalties in the income tax provision. The Company accrued interest expense of approximately $<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQwMjA_4fa9ba20-1479-4f94-84d7-0d56f47ae9f4">34</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQwMjQ_6ee50a76-f79a-4f4d-97da-50deb9761ddb">49</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQwMzE_dd5a05d3-0c38-4b68-b7bc-99ef0030e646">19</ix:nonFraction> million in 2020, 2019 and 2018, respectively. The Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQwOTY_d4fe4df9-928a-4b1c-85af-b8ccef67df41">121</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQxMDM_c7b81f2e-7127-4328-9fde-870923440cca">173</ix:nonFraction> million accrued for interest and penalties as of December&#160;31, 2020 and 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the total amount of unrecognized tax benefits that, if recognized, would affect the Company&#8217;s effective income tax rate is approximately $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQzMjE_e97082f8-3a8a-4cba-9262-0ab955526bf3">651</ix:nonFraction> million, after considering the federal benefit of state income taxes.</span></div></ix:continuation><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_163"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4MzY_26545c4f-3bb1-40a3-ac2d-a59088f121b9" continuedAt="i18a8836ffbe04c04878656a3c362beb3" escape="true">Stock Incentive Plans</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i18a8836ffbe04c04878656a3c362beb3" continuedAt="i7b825ff705dd4feb8725f4baa89f48e2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the CVS Health 2017 Incentive Compensation Plan (&#8220;ICP&#8221;) provide for grants of annual incentive and long-term performance awards to executive officers and other officers and employees of the Company or any subsidiary of the Company, as well as equity compensation to outside directors of CVS Health. Payment of such annual incentive and long-term performance awards will be in cash, stock, other awards or other property, at the discretion of the Management Planning and Development Committee (the &#8220;MP&amp;D Committee&#8221;) of CVS Health&#8217;s Board of Directors (the &#8220;Board&#8221;). The ICP allows for a maximum of <ix:nonFraction unitRef="shares" contextRef="i51951ef33f584792b1899fbe7522c0e5_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzYzOQ_4e58d23d-ef3e-4f4a-8df7-8d19a0955be5">58</ix:nonFraction> million shares of CVS Health common stock to be reserved and available for grants. As of December&#160;31, 2020, there were approximately <ix:nonFraction unitRef="shares" contextRef="i51951ef33f584792b1899fbe7522c0e5_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzEwMjA_d5a4f825-160c-44b0-bf46-fde799dfcf0e">38</ix:nonFraction> million shares of CVS Health common stock available for future grants under the ICP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the Aetna Acquisition Date, approximately <ix:nonFraction unitRef="shares" contextRef="i368dc3028c9348a7b6752c5b2a1288cc_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzExNDk_dc9109c8-565e-4b55-83c7-2ddffc22ac9b">22</ix:nonFraction> million shares of Aetna common stock subject to awards outstanding under the Amended Aetna Inc. 2010 Stock Incentive Plan (&#8220;SIP&#8221;) were assumed by CVS Health. In addition, in accordance with the merger agreement, shares which were available for future issuance under the SIP were converted into approximately <ix:nonFraction unitRef="shares" contextRef="i368dc3028c9348a7b6752c5b2a1288cc_I20181128" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzE0NTI_24cbff38-f329-4fe9-8a13-d33e6e89b2c4">32</ix:nonFraction> million shares of CVS Health common stock reserved and available for issuance pursuant to future awards. Subsequent to the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7b825ff705dd4feb8725f4baa89f48e2" continuedAt="i0a7f597c586a4a268b933445b0d75d92"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expiration of the SIP on May 21, 2020, the ICP is the only compensation plan under which the Company grants stock options, restricted stock and other stock-based awards to its employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzE4ODc_a2f5f276-1187-4a37-84f0-e7ca761d6280">three</span> to <ix:nonNumeric contextRef="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzE4OTM_691b4819-b028-4d40-9831-49efada44469">five years</ix:nonNumeric>) using the straight-line method. <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4MzQ_8edd9942-3731-407c-baa4-0cde4d3a52d6" continuedAt="id18157097516406d8a71bc453c8a02bb" escape="true">The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2020, 2019 and 2018:</ix:nonNumeric></span></div><ix:continuation id="id18157097516406d8a71bc453c8a02bb"><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights (&#8220;SARs&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzEtMS0xLTEtMA_3afaf223-016d-4d18-b5e4-20d2acfadb7f">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzEtMy0xLTEtMA_10e9b588-361f-48ae-af9c-647ac80a214a">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzEtNS0xLTEtMA_ec9b36ce-2db6-440c-ade8-9617cf2a1037">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzItMS0xLTEtMA_3f4b4138-4028-46f7-b41a-7c9d915df5db">329</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idedbaa2d1d234783b888c78eec015afe_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzItMy0xLTEtMA_a7558256-fddc-4823-a55f-b038d9aecab2">377</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf6ce0645a6645f6b71865a0cd2f6305_D20180101-20181231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzItNS0xLTEtMA_0f8b7fb9-2b0b-484f-92f2-51ede3a75132">210</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzMtMS0xLTEtMA_f7498c50-ee78-4add-985b-f9f6faa92b3c">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzMtMy0xLTEtMA_c5ebd2da-53e0-4126-9ff0-76d098705183">453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzMtNS0xLTEtMA_bd90fa78-de74-43d9-b036-00405dc829d9">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the ESPP.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Stock-based compensation for the&#160;year ended December&#160;31, 2018 includes $<ix:nonFraction unitRef="usd" contextRef="ie367a51e740f4a3da15af04b3bf0109a_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzIxNjU_811be6d2-f42c-43be-832d-c3ad9da268a9">14</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i42d6f09ef96442c986984d00a0124904_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzIxNzI_61d721fe-6ec2-416a-ad26-daf79838e0e2">27</ix:nonFraction> million associated with accelerated vesting of SARs and restricted stock replacement awards, respectively, issued to Aetna employees who were terminated subsequent to the Aetna Acquisition.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Employee Stock Purchase Plan (&#8220;ESPP&#8221;) provides for the purchase of up to <ix:nonFraction unitRef="shares" contextRef="iec4fd22ebfb24fdd8219d715c4eefaf5_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzI0MDg_84d00265-08c0-4397-b616-5bc87a948bc6">60</ix:nonFraction> million shares of CVS Health common stock. Under the ESPP, eligible employees may purchase common stock at the end of each six&#160;month offering period at a purchase price equal to <ix:nonFraction unitRef="number" contextRef="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzI1ODE_ec1b1326-9da6-4525-a3b8-9718b357a16c">90</ix:nonFraction>% of the lower of the fair market value on the first day or the last day of the offering period. During 2020, approximately <ix:nonFraction unitRef="shares" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzI3MDQ_2d716a48-7fc4-4b50-943f-fe9bca06aa4d">3</ix:nonFraction> million shares of common stock were purchased under the provisions of the ESPP at an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="2" name="cvs:StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzI4MDE_d51fc14a-838a-4238-ab5c-adb42b6b3214">53.85</ix:nonFraction> per share. As of December&#160;31, 2020, approximately <ix:nonFraction unitRef="shares" contextRef="iec4fd22ebfb24fdd8219d715c4eefaf5_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzI4Mzk_81115a23-8ed0-465c-ac0e-2bcaf5166281">34</ix:nonFraction> million shares of common stock were available for issuance under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock-based compensation associated with the ESPP is estimated on the date of grant (the first day of the six&#160;month offering period) using the Black-Scholes option pricing model.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4MjY_25f3826f-a948-4ad0-b651-f2f694ad41c0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzEtMS0xLTEtMA_c70a8ab6-027b-4570-8949-1d5556e4834f">1.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic0df88ade3c94c729995bbc859b11248_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzEtMy0xLTEtMA_207f79d6-d988-4d83-87e6-c2e92d418133">1.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32362d8d9c104060a8a8caf80210e039_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzEtNS0xLTEtMA_2216c532-174d-474d-bb2b-9299c66f3de9">1.45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzItMS0xLTEtMA_83b2016b-48f2-4298-ab9b-8225a8cb39a9">37.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic0df88ade3c94c729995bbc859b11248_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzItMy0xLTEtMA_bfa4f2ae-a323-4ede-8c5c-4a1ae6918c7c">27.96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32362d8d9c104060a8a8caf80210e039_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzItNS0xLTEtMA_fa13aad5-a71e-4f80-a6e2-ef0bbea06565">28.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzMtMS0xLTEtMA_76aa10e1-f0b9-48ac-813a-8c386ad5c645">0.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic0df88ade3c94c729995bbc859b11248_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzMtMy0xLTEtMA_8b79216c-57ef-4c3c-af79-ff2e6cacf384">2.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32362d8d9c104060a8a8caf80210e039_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzMtNS0xLTEtMA_9615bf75-78b3-4a56-813a-75f5598b8b6d">1.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzQtMS0xLTEtMA_37dd4eee-7c21-4bcd-ac13-bb62c18ef5fd">0.5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic0df88ade3c94c729995bbc859b11248_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzQtMy0xLTEtMA_bf053da5-f1f1-45a8-b9c5-8680c32a44e6">0.5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i32362d8d9c104060a8a8caf80210e039_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzQtNS0xLTEtMA_8cdbf333-8942-4ec9-a986-04d69cf742f5">0.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzUtMS0xLTEtMA_43725172-0451-43ab-8cbd-a83b3b1e2e96">13.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic0df88ade3c94c729995bbc859b11248_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzUtMy0xLTEtMA_98d8983c-2c9f-4b3d-a5db-46d322abd877">10.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i32362d8d9c104060a8a8caf80210e039_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzUtNS0xLTEtMA_e3a37593-88bb-4830-a7e6-e77edb2825ea">12.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health&#8217;s daily stock price over the previous six&#160;month period.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life is based on the semi-annual purchase period.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units and Performance Stock Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s restricted stock units and performance stock units are considered nonvested share awards and require no payment from the employee. The fair value of the restricted stock units is based on the market price of CVS Health common stock on the grant date and is recognized on a straight-line basis over the vesting period. For each restricted stock unit granted, employees receive one share of common stock, net of taxes, at the end of the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s performance stock units contain performance vesting conditions in addition to a service vesting condition. Vesting of the Company&#8217;s performance stock units is dependent upon the degree to which the Company achieves its performance goals, which are generally set for a three-year performance period and are approved at the time of grant by the MP&amp;D Committee. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0a7f597c586a4a268b933445b0d75d92" continuedAt="i81305c83a7a141e48668faa2c9a862b7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of performance stock units granted with service and performance vesting conditions is based on the market price of CVS Health common stock on the grant date and is recognized over the vesting period. Certain of the performance stock units also contain a market vesting condition based on the performance of CVS Health common stock relative to a comparator group. The fair value of these performance stock units is determined using a Monte Carlo simulation as of the grant date and is recognized over the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2018, the Company completed the Aetna Acquisition. All unvested Aetna performance stock unit and restricted stock unit awards as of the Aetna Acquisition Date were converted into replacement CVS Health restricted stock awards. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="ib3218ac52d8e4abb8d070125f07b4ed6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU0OTE_076673bb-9480-43c6-bccf-da764a3be88f">493</ix:nonFraction> million of total unrecognized compensation cost related to the Company&#8217;s restricted stock units and performance stock units that are expected to vest. These costs are expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU3MTM_2fe37d7b-ffb7-41e8-9827-f873beb37010">2.3</ix:nonNumeric> years. The total fair value of restricted stock units vested during 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU3OTY_6140cd81-f655-45cc-a556-321f8e0b284e">229</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="idedbaa2d1d234783b888c78eec015afe_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU4MDA_7d504374-0bb3-40ad-beb3-a90c3f18a707">265</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibf6ce0645a6645f6b71865a0cd2f6305_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU4MDc_47e9bffc-59aa-45ce-a857-073e4a91ad80">262</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4Mjg_bd8f0330-7a98-48de-8c82-4513af267a60" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In thousands, except weighted average grant date fair value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d4c72ed7d1844239059f054fea52735_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzEtMS0xLTEtMA_ace5b8ca-d3f0-4b08-aef2-8cebd98c270c">13,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8d4c72ed7d1844239059f054fea52735_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzEtMy0xLTEtMA_b965375a-3298-4ba9-be1e-59ef59e657c0">61.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzItMS0xLTEtMA_4ed4cc87-9b00-4f30-af17-cad0586885c6">6,849</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzItMy0xLTEtMA_93a25252-fbd8-48f7-803e-080d9c7cd0ea">58.38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzMtMS0xLTEtMA_38940eae-844a-4d1d-9a2b-26ef4e98756b">3,793</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzMtMy0xLTEtMA_a2243d43-594b-442e-a350-1b4feb3132d9">60.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzQtMS0xLTEtMA_483bf563-5ff0-4d6a-b490-7210ed1c1640">1,357</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzQtMy0xLTEtMA_c9404b7d-95ba-4e22-8b19-4b803b89a51b">59.10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3218ac52d8e4abb8d070125f07b4ed6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzUtMS0xLTEtMA_a3f68f86-48a0-41ae-8a51-e8b47743c8cb">14,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib3218ac52d8e4abb8d070125f07b4ed6_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzUtMy0xLTEtMA_1e903989-764a-4b8b-95f3-87c89ed5eb99">58.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options and SARs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All stock option grants are awarded at fair value on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. Stock options granted generally become exercisable over a <ix:nonNumeric contextRef="i840a4dd4fea34ef1a604ab9891347d56_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU0OTc1NTgxNDg4NDU_f8752a0f-5233-482c-916c-2380d5fb563a">four-year</ix:nonNumeric> period from the grant date. Stock options granted through 2018 generally expire <ix:nonNumeric contextRef="i8044667803dd4f4e94f81a063416a4a6_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzYzODg_1a9fde3f-c07e-46fd-a95d-594fad8fb2f5">seven years</ix:nonNumeric> after the grant date. Stock options granted subsequent to 2018 generally expire <ix:nonNumeric contextRef="i4c18060ad0f74b60bd700240ae354b4a_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzY0NTA_70a5d6a0-5e67-43c4-806e-fa2c710c5c43">ten years</ix:nonNumeric> after the grant date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2018, the Company completed the Aetna Acquisition. All unvested Aetna SARs outstanding as of the Aetna Acquisition Date were converted into replacement CVS Health SARs. The replacement SARs granted will be settled in CVS Health common stock, net of taxes, based on the appreciation of the stock price on the exercise date over the market price on the date of grant. The fair value of SARs is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. SARs generally become exercisable over a <ix:nonNumeric contextRef="i93f5bc2c5d2246fa87aab2340bdaa368_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU0OTc1NTgxNDg4NDY_55dd0912-ec3a-4693-a73d-7e7ae999aabb">three-year</ix:nonNumeric> period from the grant date. SARs generally expire <ix:nonNumeric contextRef="i93f5bc2c5d2246fa87aab2340bdaa368_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzcxNDI_cfbf2d23-fb71-4edd-bb38-2d11a04361c7">ten years</ix:nonNumeric> after the grant date.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4Mjk_1f5b8760-a619-47f9-abb7-3243783eee9b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from stock options exercised (including ESPP)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzEtMS0xLTEtMA_8daa2974-a9b5-4d6f-85a7-93df08bb0864">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzEtMy0xLTEtMA_de86810f-63fa-4049-a9eb-f57f91601689">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzEtNS0xLTEtMA_1fbccea9-2237-4652-bdb1-986e9a2311c6">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes for net share settlement of equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzItMS0xLTEtMA_2f6166e7-e303-4c98-9337-35315bd598e5">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzItMy0xLTEtMA_bb16fe87-cd6c-42b0-990d-24a97854cc14">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzItNS0xLTEtMA_336f8400-49fb-44b0-918a-ada8e6a47569">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of stock options and SARs exercised </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzMtMS0xLTEtMA_0cfdad83-e096-46e6-8c9c-cc2133bf0ce2">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzMtMy0xLTEtMA_1e554c5d-8677-4ea4-8aeb-57adef3d8af2">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzMtNS0xLTEtMA_3694ac4d-0c34-4341-833f-72df6010b7d1">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of stock options and SARs vested </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="-6" name="cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzQtMS0xLTEtMA_77319a18-35b9-4777-8675-68f1bb92318b">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231" decimals="-6" name="cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzQtMy0xLTEtMA_173b26f7-1792-4877-ab2e-5e1e967b6d99">467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231" decimals="-6" name="cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzQtNS0xLTEtMA_96cb93ea-17e5-4377-8ecb-d9b37e1824e7">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i81305c83a7a141e48668faa2c9a862b7"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4MTk_eac359b7-f326-4878-904f-5750fd7d9605" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option and SAR is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzEtMS0xLTEtMA_5604d36b-631e-460f-aba0-26a890a718d3">3.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzEtMy0xLTEtMA_7d421d79-6b25-40f3-ac28-1d36ef5674eb">3.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzEtNS0xLTEtMA_d86fe39c-2883-4762-bfcd-71d674c25727">2.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzItMS0xLTEtMA_6a8514f2-6a9c-48ec-aa11-9858972f5f01">25.22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzItMy0xLTEtMA_36a1336a-e098-4df3-b061-9b5a52cde173">21.76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzItNS0xLTEtMA_2f3dbf9e-1c53-4ca9-a68d-bbd80e349664">21.27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzMtMS0xLTEtMA_45ef7d1f-7bc1-4d21-9de6-cd4ddb466384">0.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzMtMy0xLTEtMA_ff03d586-6974-4bba-a660-c8cf89237467">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzMtNS0xLTEtMA_825b0a3a-bd66-4917-abe1-921679e26c21">2.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzQtMS0xLTEtMA_b27c5d93-196c-4ff1-ace1-30c515d397f5">6.3</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzQtMy0xLTEtMA_ab8a657e-4966-48b3-8be3-992c55baa5f4">6.3</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzQtNS0xLTEtMA_5fbaa7ea-7635-41e4-8d08-aa967983003d">4.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzUtMS0xLTEtMA_05c3d790-c254-4087-a3f2-3399b207045a">8.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzUtMy0xLTEtMA_6ead59b1-90bd-4e87-b926-59c5ca37c8c5">6.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzUtNS0xLTEtMA_59e938c4-a9bb-43bc-8591-c02719f8cd94">24.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is based on annual dividends paid and the fair market value of CVS Health stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health&#8217;s daily stock price over a period equal to the expected life of each option or SAR grant after adjustments for infrequent events such as stock splits.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options or SARs being valued.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life represents the number of&#160;years the options or SARs are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the weighted-average grant date fair value in 2018 was due to the issuance of the replacement SARs in connection with the Aetna Acquisition in the year ended December 31, 2018. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, unrecognized compensation expense related to unvested stock options and SARs totaled $<ix:nonFraction unitRef="usd" contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg0NjM_45f103ab-fbb8-4ae0-9dbc-4130987d1797">45</ix:nonFraction> million, which the Company expects to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg1NDQ_7df3796e-b411-4570-9792-e680ae5c7d03">1.8</ix:nonNumeric> years. After considering anticipated forfeitures, the Company expects approximately <ix:nonFraction unitRef="shares" contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg2MjU_ff4be79d-5969-4959-91d0-55d56a742caa">10</ix:nonFraction> million of the unvested stock options and SARs to vest over the requisite service period.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4MjU_5bf8b7ad-bbbc-43c9-85e1-7f42d686eba2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s stock option and SAR activity for the&#160;year ended December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands, except weighted average exercise price and remaining contractual term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01826b36b4634f7c8bf2af0872e7548a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzEtMS0xLTEtMA_10dd62f1-c165-4388-870c-4e12e5cd6e35">23,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i01826b36b4634f7c8bf2af0872e7548a_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzEtMy0xLTEtMA_22d74182-2c00-469c-aa0e-f22957f4e3c6">69.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzItMS0xLTEtMA_4a59035c-43da-4ec0-859e-19c9eb22e555">4,759</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzItMy0xLTEtMA_a696cdb2-7516-44c8-851d-f7a96bb271df">58.50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzMtMS0xLTEtMA_9da2c60e-8a36-43e1-aa61-4d8515042bb0">2,601</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzMtMy0xLTEtMA_3b08cc2e-e8a3-46e1-a543-b0d3b4a07af5">52.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzQtMS0xLTEtMA_9dc5e8f7-3de4-45de-97c8-3f4e1d409930">1,164</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzQtMy0xLTEtMA_d733758e-0b13-4a25-9a03-0e99d1ec851c">57.61</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzUtMS0xLTEtMA_143a0957-c422-4d4c-9850-34f374390043">941</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzUtMy0xLTEtMA_a41b7188-af75-41d5-9d54-da063d565af6">83.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzYtMS0xLTEtMA_49f6204e-178d-47d4-ba97-05630938234b">23,955</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzYtMy0xLTEtMA_691a43fe-0bd1-416a-bbe8-3cfcc9c73f10">69.62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzYtNS0xLTEtMA_e8186946-ceb3-44aa-90b3-aaff5a0feb30">4.86</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzYtNy0xLTEtMA_2d72f981-405e-4f61-9eec-96a0eab03ccf">185,487</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzctMS0xLTEtMA_3cb9e044-dc5b-4db5-b61a-c8712a7e98e1">13,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzctMy0xLTEtMA_3195fb1e-f8eb-43fc-af0b-7b38f7d761ab">78.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzctNS0xLTEtMA_e25e87b0-31f0-496a-9d46-3fbdda092d6c">2.79</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzctNy0xLTEtMA_8a3682ed-50ff-4c52-8c2e-50107283be3f">78,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at end of year and expected to vest in the future</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzgtMS0xLTEtMA_e64bbf37-2bea-4ea2-bfca-f0ff9f063a28">23,448</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzgtMy0xLTEtMA_6097375a-e5dd-48e2-8713-cadccfe0262a">69.87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzgtNS0xLTEtMA_73731be3-7974-49c7-8dd1-36089825ed6e">4.78</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzgtNy0xLTEtMA_0b3a16f8-a83b-45ac-abcc-05821b5f432e">180,102</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_169"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzQxNzA_7b8b021f-b435-415b-921a-febfff834aaf" continuedAt="id1e6db9d75704374adb29c3a9fb134cc" escape="true">Shareholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id1e6db9d75704374adb29c3a9fb134cc" continuedAt="i5f86d82c796a4582a7292716382e9bf8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzQxNjc_b1fdc09a-e51d-4bb0-8152-bb288436d2b0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase program has been authorized by the Board:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2016 (&#8220;2016 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14abdf015f0f4b9db4fe52c587222dc0_I20161102" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo4YjMxNTM0MjFlNDU0ZmUzOWNmY2MzMjIxZWI5MDhmYy90YWJsZXJhbmdlOjhiMzE1MzQyMWU0NTRmZTM5Y2ZjYzMyMjFlYjkwOGZjXzEtMS0xLTEtMA_b6e06b68-ef33-4e3c-b937-9de50fea45b1">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd8180c25fb4a8481234de8c71c1147_I20201231" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo4YjMxNTM0MjFlNDU0ZmUzOWNmY2MzMjIxZWI5MDhmYy90YWJsZXJhbmdlOjhiMzE1MzQyMWU0NTRmZTM5Y2ZjYzMyMjFlYjkwOGZjXzEtMy0xLTEtMA_ba7dce60-a7d0-4140-8233-d1be358125a1">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5f86d82c796a4582a7292716382e9bf8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020, 2019 and 2018, the Company did not repurchase any shares of common stock pursuant to the 2016 Repurchase Program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly cash dividend declared by the Board was $<ix:nonFraction unitRef="usdPerShare" contextRef="i999deb1ae4c9461bbcddbc5f7a24ed43_I20200930" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_077707cd-2fba-4f5d-b394-fd68abf6c632"><ix:nonFraction unitRef="usdPerShare" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_121cc61f-9e20-4a9b-bf96-9bdca474dc1f"><ix:nonFraction unitRef="usdPerShare" contextRef="if989d485536c470f8ae4b36308072658_I20190930" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_182f1c34-d2aa-48e4-81be-55b123c47f2d"><ix:nonFraction unitRef="usdPerShare" contextRef="id7eb47ba380c4e5e8af029b7a1dcec29_I20200331" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_4767a0e0-0749-4148-aa97-48ee23139caa"><ix:nonFraction unitRef="usdPerShare" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_5bb5a8f1-1f2c-4d59-9f6e-2c030d527a66"><ix:nonFraction unitRef="usdPerShare" contextRef="id7eb47ba380c4e5e8af029b7a1dcec29_I20200331" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_6c74c54d-94ed-4c50-8c00-ea422ad97745"><ix:nonFraction unitRef="usdPerShare" contextRef="i41f59795c714410e9809b7c4aef691c6_I20200630" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_6edea0f4-3c4b-43ea-b167-8b9ae53d8af0"><ix:nonFraction unitRef="usdPerShare" contextRef="i999deb1ae4c9461bbcddbc5f7a24ed43_I20200930" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_763ba24a-450b-43e3-9c1e-ef504ab66b3d"><ix:nonFraction unitRef="usdPerShare" contextRef="i76b1b2868c2745ef9a27492b7d5c0054_I20190630" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_9390a2d1-d056-46be-983b-4e09ae5d0f99"><ix:nonFraction unitRef="usdPerShare" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_9c3c556a-23dd-4ae8-8a19-99cd6f053c57"><ix:nonFraction unitRef="usdPerShare" contextRef="ia62846c7391548e195bd48645f91d3f9_I20190331" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_ac2a19cf-65aa-48f0-9ba8-d6cf407806f0"><ix:nonFraction unitRef="usdPerShare" contextRef="i41f59795c714410e9809b7c4aef691c6_I20200630" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_db58ed4f-aee6-4868-bff6-709c71bafc3f">0.50</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per share in 2020 and 2019. CVS Health has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Requirements</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2018, the Company completed the Aetna Acquisition. Aetna&#8217;s insurance business operations are conducted through subsidiaries that principally consist of HMOs and insurance companies. The Company&#8217;s HMO and insurance subsidiaries report their financial statements in accordance with accounting practices prescribed by state regulatory authorities which may differ from GAAP. The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2020, 2019 and 2018 for the Company&#8217;s insurance and HMO subsidiaries were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory net income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo1NzZjMDM3MjEwNzk0ZTgwOWExYjRiYWI1NDgwM2MyNS90YWJsZXJhbmdlOjU3NmMwMzcyMTA3OTRlODA5YTFiNGJhYjU0ODAzYzI1XzEtMS0xLTEtMTE2MTc_e1cff4f2-acf6-40ac-b144-29c381de5f00">3,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo1NzZjMDM3MjEwNzk0ZTgwOWExYjRiYWI1NDgwM2MyNS90YWJsZXJhbmdlOjU3NmMwMzcyMTA3OTRlODA5YTFiNGJhYjU0ODAzYzI1XzEtMy0xLTEtMTEyNzk_37b43fba-0e10-4383-954a-dc1257e719fd">2,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated statutory capital and surplus</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice5dfe6468064630ab677c3f80d083bf_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo1NzZjMDM3MjEwNzk0ZTgwOWExYjRiYWI1NDgwM2MyNS90YWJsZXJhbmdlOjU3NmMwMzcyMTA3OTRlODA5YTFiNGJhYjU0ODAzYzI1XzItMS0xLTEtMTEyODM_747b66db-e0e4-4742-a906-9ace31462b64">13,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f0e3ad72e674d79b9416210fc264e80_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo1NzZjMDM3MjEwNzk0ZTgwOWExYjRiYWI1NDgwM2MyNS90YWJsZXJhbmdlOjU3NmMwMzcyMTA3OTRlODA5YTFiNGJhYjU0ODAzYzI1XzItMy0xLTEtMTEyNzk_0045217e-cae1-4315-9852-8dd017b9132d">10,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie31822396a9a497fb994c84f0ccd13ff_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo1NzZjMDM3MjEwNzk0ZTgwOWExYjRiYWI1NDgwM2MyNS90YWJsZXJhbmdlOjU3NmMwMzcyMTA3OTRlODA5YTFiNGJhYjU0ODAzYzI1XzItNS0xLTEtMTEyODY_fc92dc21-35bf-473d-83e2-14dde18b8be3">10,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Statutory net income of the Company&#8217;s insurance and HMO subsidiaries for the year ended December 31, 2018 (which includes Aetna and its subsidiaries from November 28, 2018 to December 31, 2018) is not material (&#8220;NM&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s insurance and HMO subsidiaries paid $<ix:nonFraction unitRef="usd" contextRef="i34d3860039e94245ab240f1f07b53dc4_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIxOTkwMjMyNjIwODE_18fdd7f4-1e9b-421d-89bb-e97cda189ccc">3.1</ix:nonFraction> billion of gross dividends to the Company for the year ended December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, HMOs and insurance companies are subject to further regulations that, among other things, may require those companies to maintain certain levels of equity and restrict the amount of dividends and other distributions that may be paid to their equity holders. In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies. <ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:StatutoryAccountingPracticesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzQxNjI_ca43db22-5e40-4edc-a845-ccd950505ebb" continuedAt="iaefce6feedaa47778cab2822b160eb59" escape="true">At December&#160;31, 2020, these amounts were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="iaefce6feedaa47778cab2822b160eb59"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:88.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated minimum statutory surplus required by regulators</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZToyZDAxZWVjZjVjYjg0ZWE2OTgzMGY2OTcyMjEyYTk0Mi90YWJsZXJhbmdlOjJkMDFlZWNmNWNiODRlYTY5ODMwZjY5NzIyMTJhOTQyXzEtMS0xLTEtMA_6f1267ec-680b-4c7a-b01f-06a11d390eaf">5,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments on deposit with regulatory bodies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" name="us-gaap:AssetsHeldByInsuranceRegulators" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZToyZDAxZWVjZjVjYjg0ZWE2OTgzMGY2OTcyMjEyYTk0Mi90YWJsZXJhbmdlOjJkMDFlZWNmNWNiODRlYTY5ODMwZjY5NzIyMTJhOTQyXzItMS0xLTEtMA_448efa6f-8870-4fba-9c2c-1306f82abb94">712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated maximum dividend distributions permitted in 2021 without prior regulatory approval</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZToyZDAxZWVjZjVjYjg0ZWE2OTgzMGY2OTcyMjEyYTk0Mi90YWJsZXJhbmdlOjJkMDFlZWNmNWNiODRlYTY5ODMwZjY5NzIyMTJhOTQyXzMtMS0xLTEtMA_5c065120-e4a8-45fe-b2aa-0ef0dc07ea11">2,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, noncontrolling interests were $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzY1OTcwNjk3NzIyNjk_92073843-1bed-4995-bdd2-04b6a65da388">312</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzY1OTcwNjk3NzIyODE_4f108bf4-1c76-413a-b712-be5094143bd7">306</ix:nonFraction> million, respectively, primarily related to third party interests in the Company&#8217;s operating entities.&#160;The noncontrolling entities&#8217; share is included in total shareholders</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> equity on the consolidated balance sheets.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">160</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_175"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90ZXh0cmVnaW9uOjIxOTY0YjVjZjI2NjRlZWFiYjRmZjc0ODZiYjJiNjE2XzE1MTY_1c96aff1-5c04-4cfb-87c8-2bb2bec74213" continuedAt="if2a6b6f5f92241f398bc0c62da5bddd2" escape="true">Other Comprehensive Income</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if2a6b6f5f92241f398bc0c62da5bddd2" continuedAt="i87af385a10ef438b91247cc539983dd4"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90ZXh0cmVnaW9uOjIxOTY0YjVjZjI2NjRlZWFiYjRmZjc0ODZiYjJiNjE2XzE1MTk_28431518-4293-428a-b384-ea2b9db7c7ac" continuedAt="id26fbd9eb9544c81a6b68b2d8728b942" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income in 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcf2440c1d0e4e17ac229c0445e4203e_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMtMS0xLTEtMA_d6f83408-5a9c-4d42-a1f6-5f32c7b16ba0">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a22940c170b4cf68098d8a1d7db4b07_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMtMy0xLTEtMA_c3bd6724-a2be-4d82-afab-894864bfe95f">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b47b478e9b74d6283da9fb27e389a6f_I20171231" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMtNS0xLTEtMA_e2a431b4-a3b8-4e6e-8d6e-64e2c15a201a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i4c96fa94b27d4a2c824b3844e3c8037b_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzQtMC0xLTEtMC90ZXh0cmVnaW9uOmNhMzFkZmIzMTlkNzQ3NGRiZDU0NTg1ZWIyMDFkMWZiXzY1OTcwNjk3NjY3NTg_35656b4f-5f08-479b-ad56-00424065ce30">497</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i443408ee77904553aa013c58c381a6e4_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzQtMC0xLTEtMC90ZXh0cmVnaW9uOmNhMzFkZmIzMTlkNzQ3NGRiZDU0NTg1ZWIyMDFkMWZiXzY1OTcwNjk3NjY3Njk_18fc0c52-122c-4a7f-8d11-fd6bdc5ab41b">927</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i57fe03ab102c4593846e42c9794bcb06_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzQtMC0xLTEtMC90ZXh0cmVnaW9uOmNhMzFkZmIzMTlkNzQ3NGRiZDU0NTg1ZWIyMDFkMWZiXzY1OTcwNjk3NjY3NzY_ed0a4137-1793-47ef-a078-ab9eafd9b71f">132</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c96fa94b27d4a2c824b3844e3c8037b_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzQtMS0xLTEtMA_21a76a8a-e22d-4957-bbf4-0bc6147e1511">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i443408ee77904553aa013c58c381a6e4_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzQtMy0xLTEtMA_75daa015-2823-48ca-8e8e-35f50c5858b8">763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57fe03ab102c4593846e42c9794bcb06_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzQtNS0xLTEtMA_2c249641-4430-40ba-ae44-4a580308124e">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i4c96fa94b27d4a2c824b3844e3c8037b_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzUtMC0xLTEtMC90ZXh0cmVnaW9uOjgyY2NmMDg2MTljNTQ0Mjg5MGI4ZDQxMzIwN2U3MDdkXzY1OTcwNjk3NjY3OTU_c39805b8-417c-427a-b93f-42d73fbcebfc">31</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i443408ee77904553aa013c58c381a6e4_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzUtMC0xLTEtMC90ZXh0cmVnaW9uOjgyY2NmMDg2MTljNTQ0Mjg5MGI4ZDQxMzIwN2U3MDdkXzY1OTcwNjk3NjY3ODU_a3f97222-3f96-4bdc-9d0c-c072312e68c1">105</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i57fe03ab102c4593846e42c9794bcb06_D20180101-20181231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzUtMC0xLTEtMC90ZXh0cmVnaW9uOjgyY2NmMDg2MTljNTQ0Mjg5MGI4ZDQxMzIwN2U3MDdkXzY1OTcwNjk3NjY3OTE_ac12a4dd-8900-40bb-93f0-026d37c3f95e">1</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c96fa94b27d4a2c824b3844e3c8037b_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzUtMS0xLTEtMA_9fb0c607-4e66-4c1a-9630-69c4116171ab">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i443408ee77904553aa013c58c381a6e4_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzUtMy0xLTEtMA_a7fbe144-7410-445b-8331-76568cfa3a40">86</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57fe03ab102c4593846e42c9794bcb06_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzUtNS0xLTEtMA_c5dcc39e-543a-4356-b790-37cc63093cef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c96fa94b27d4a2c824b3844e3c8037b_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzYtMS0xLTEtMA_5555bb8a-93d4-4f25-b4d0-22f7676a295f">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i443408ee77904553aa013c58c381a6e4_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzYtMy0xLTEtMA_76deef47-d3f7-48cf-b0b3-e4a51be5e7f9">677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57fe03ab102c4593846e42c9794bcb06_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzYtNS0xLTEtMA_e44e078f-808d-4069-bc8c-a5611dfe76c0">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0602d4ebfef644a18655290e8ece6717_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzctMS0xLTEtMA_3172744c-1ead-4671-ad55-5f195d5fa378">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcf2440c1d0e4e17ac229c0445e4203e_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzctMy0xLTEtMA_338f46ce-a2a2-4faa-bb72-e3482cfaf81c">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a22940c170b4cf68098d8a1d7db4b07_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzctNS0xLTEtMA_ff339ccb-ee0a-4e7c-99c7-9106b2ee05f3">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i060f98498d204f6d8a753045e2d7c203_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEwLTEtMS0xLTA_83184aa2-b948-472b-b5bb-7f9a370bea7e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1125996cace4e93a47589d739fbafd1_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEwLTMtMS0xLTA_dada9a02-ca3a-43ce-8021-149feb1c45f8">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5594c4b0291247d29cdc2fcc74572eb4_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEwLTUtMS0xLTA_0c3e891f-1dfc-44f9-80f8-e60f45c4d4c4">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aaef92229504806b1ba8f864dfcc385_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzExLTEtMS0xLTA_8c028892-8289-4155-9a4f-6edb12ca330a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac55eea462b842aab63a774c5b13738c_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzExLTMtMS0xLTA_0f01720f-bbb2-4fa4-bbd4-00c953299ce3">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia21d4a25030943aa870bf85489fc686b_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzExLTUtMS0xLTA_2e91e771-649d-46c3-8c0b-a1615e0cca4c">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aaef92229504806b1ba8f864dfcc385_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEyLTEtMS0xLTA_83e9f9f1-f8b2-499a-8ce0-ea831077d824">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac55eea462b842aab63a774c5b13738c_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEyLTMtMS0xLTA_8cca8dc7-9c94-4248-a3d4-c974c35aaf63">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia21d4a25030943aa870bf85489fc686b_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEyLTUtMS0xLTA_55f875d6-74e0-4dea-ab9d-e4b56164abf6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aaef92229504806b1ba8f864dfcc385_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEzLTEtMS0xLTA_8f32e440-5e7d-4f97-a54f-e1ad80470905">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac55eea462b842aab63a774c5b13738c_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEzLTMtMS0xLTA_59ab3c1f-96fa-4a29-be3d-6f15132d143a">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia21d4a25030943aa870bf85489fc686b_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEzLTUtMS0xLTA_fefd8c27-7cfe-4994-9741-9654caac35e1">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic509b8303359462cb2a1c66d8ff1c410_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE0LTEtMS0xLTA_0e127e2f-27e5-4397-9f7f-864d1104b1b2">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i060f98498d204f6d8a753045e2d7c203_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE0LTMtMS0xLTA_0204bb39-08c0-4bf8-851c-1fe5bc9176d2">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1125996cace4e93a47589d739fbafd1_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE0LTUtMS0xLTA_7cd6bf0e-a034-4093-9a14-1046478cf707">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i218673f1547f4d87ad2718881dec2f7c_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE3LTEtMS0xLTA_c019e658-55b2-4ba8-9f4d-db0fc5851cae">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62fa0632829f46fcb2cb4d4b11969265_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE3LTMtMS0xLTA_ed2297d1-a648-43d5-893b-f244754d86a9">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2c5e7b4689046d383454e690de48a8f_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE3LTUtMS0xLTA_729a78f5-2968-4fb9-9e26-8bec3ae2062b">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE4LTEtMS0xLTA_a52852dc-c80a-4761-8fb9-0a9bba84deb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE4LTMtMS0xLTA_52fa2760-1232-4145-8daa-0c5ae9d516c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE4LTUtMS0xLTA_dbb182bc-c835-4307-aa6a-216fca07ef92">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE5LTAtMS0xLTAvdGV4dHJlZ2lvbjphYmI5MTc4NTVlODU0ZTI3YjZjZDZlYzA1N2RkMGZiZl82NTk3MDY5NzY2Nzc0_900753d2-ce89-4e89-a0b4-87b4d7b31caa">7</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE5LTAtMS0xLTAvdGV4dHJlZ2lvbjphYmI5MTc4NTVlODU0ZTI3YjZjZDZlYzA1N2RkMGZiZl82NTk3MDY5NzY2Nzgy_8b843e5d-5f63-43d8-9ffd-26d31811a5f0">25</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE5LTAtMS0xLTAvdGV4dHJlZ2lvbjphYmI5MTc4NTVlODU0ZTI3YjZjZDZlYzA1N2RkMGZiZl82NTk3MDY5NzY2Nzg5_4e182705-27e3-497a-91a1-55b213450e74">465</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE5LTEtMS0xLTA_1cb6328f-c485-4899-bd3b-f8145c44b1de">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE5LTMtMS0xLTA_6ad11b9c-c14f-4dfb-a4f5-d2caa49d9a6f">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE5LTUtMS0xLTA_782487d1-b2d1-4cda-ac7c-555278257591">344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIwLTAtMS0xLTAvdGV4dHJlZ2lvbjplY2ViMjdkY2U4MzA0ODkwOTNiNDg5M2JkNjU1YWNlMl82NTk3MDY5NzY2Nzg0_997132d4-dfbb-4da7-92a1-771dc7a6feef">35</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIwLTAtMS0xLTAvdGV4dHJlZ2lvbjplY2ViMjdkY2U4MzA0ODkwOTNiNDg5M2JkNjU1YWNlMl82NTk3MDY5NzY2Nzky_c234a458-d60a-4957-8f0f-e06ac2270b99">20</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIwLTAtMS0xLTAvdGV4dHJlZ2lvbjplY2ViMjdkY2U4MzA0ODkwOTNiNDg5M2JkNjU1YWNlMl82NTk3MDY5NzY2ODAw_58be0045-fef6-4553-9c16-f6677eddc0d2">19</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIwLTEtMS0xLTA_cee61e3c-e6ab-4a92-950f-dbd00e8537a8">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIwLTMtMS0xLTA_c75c253f-ac4c-4b25-ad2b-767635a956b8">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIwLTUtMS0xLTA_3d545bff-65bc-4d84-9fdc-cecee6d3e8b5">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIxLTEtMS0xLTA_573d3072-f7d5-43f5-b55a-3d2c4181c900">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIxLTMtMS0xLTA_2f8c400e-457e-462a-bdeb-58c285ee6475">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIxLTUtMS0xLTA_c736f33a-5c0f-497d-a7d4-d6b81d7d2671">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie55d01130f004e38a1138732a5796669_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIyLTEtMS0xLTA_3cb3054b-d648-48c9-996c-f6c94d0f7b53">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i218673f1547f4d87ad2718881dec2f7c_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIyLTMtMS0xLTA_105c8cbf-5349-46b2-8c71-d858c63c72c0">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62fa0632829f46fcb2cb4d4b11969265_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIyLTUtMS0xLTA_a6b01480-bed1-4b23-8153-9a45c12e3df7">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ea3441f923f4cad82455098c9eac4f3_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI1LTEtMS0xLTA_b00b643b-8f2f-4fb6-875c-5d59d2c0a814">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cf5ea89c34f444085bba9feb6d80c49_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI1LTMtMS0xLTA_27ad476e-297b-4450-a23c-68d158115321">149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19bfa54afd084b37b88cf9c88401e61d_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI1LTUtMS0xLTA_62438afa-d102-4c1e-95fe-17686f3216a4">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI2LTEtMS0xLTA_2cd84892-58bf-4961-a939-380fb4efc719">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI2LTMtMS0xLTA_c40a2eae-ebb9-4a33-8e54-640c78b0db70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI2LTUtMS0xLTA_8682a200-a698-4dca-ae1d-35bcf87eadcc">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI3LTAtMS0xLTAvdGV4dHJlZ2lvbjplM2JkNWIwODNmNjI0OTQ1YmJmODA4MjZmZWYyMDhjMV82NTk3MDY5NzY2Nzcz_5fdab4ef-6b3e-4829-ba88-f47262fc6c5e">30</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI3LTAtMS0xLTAvdGV4dHJlZ2lvbjplM2JkNWIwODNmNjI0OTQ1YmJmODA4MjZmZWYyMDhjMV82NTk3MDY5NzY2Nzgw_7df3e7f0-a091-426c-9201-a1727626f00a">162</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI3LTAtMS0xLTAvdGV4dHJlZ2lvbjplM2JkNWIwODNmNjI0OTQ1YmJmODA4MjZmZWYyMDhjMV82NTk3MDY5NzY2Nzg5_655a778c-5cc2-4f89-a644-b356b3f46d3e">178</ix:nonFraction>) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI3LTEtMS0xLTA_ac3857c6-55a0-476c-b5d6-1f305dca015a">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI3LTMtMS0xLTA_f904ad15-7df8-42db-b644-b7d75dbc2293">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI3LTUtMS0xLTA_4eca5a4e-d7af-4a73-ae72-e64e8b1a3a04">132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjZGExMjIzY2NlM2Y0NGQzYmVhMDNmMGMwM2ZjY2ZkZF82NTk3MDY5NzY2Nzc1_cf18b873-a376-4cd4-a160-7c17bd1809b9">7</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjZGExMjIzY2NlM2Y0NGQzYmVhMDNmMGMwM2ZjY2ZkZF82NTk3MDY5NzY2Nzgz_c72d124f-74ff-44dd-b4f7-f99a4514b4e6">12</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjZGExMjIzY2NlM2Y0NGQzYmVhMDNmMGMwM2ZjY2ZkZF82NTk3MDY5NzY2Nzg5_b7c6bdfe-e7b0-4052-9a14-4d59d6e732cc">11</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI4LTEtMS0xLTA_317a0d55-3641-4417-995b-fd5ab5d25593">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI4LTMtMS0xLTA_ecbb3879-69ff-4b38-9120-fd6d430c6f1c">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI4LTUtMS0xLTA_fae7f6da-3b21-44c6-be42-62a2ff9050f3">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI5LTEtMS0xLTA_48ecf4be-41b2-4d81-bbd7-e85d5931e188">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI5LTMtMS0xLTA_52cab899-1bfe-4453-a7dc-a3ee18c184b6">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI5LTUtMS0xLTA_23588eec-e32e-41e8-bcea-73d4b96252a3">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia39a6a5feda9465cae5cb3ef31577007_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMwLTEtMS0xLTA_0934ae0b-7ec6-4f79-a033-530c716d8b3f">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ea3441f923f4cad82455098c9eac4f3_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMwLTMtMS0xLTA_f393a183-a638-4695-9b9b-4b2517170679">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cf5ea89c34f444085bba9feb6d80c49_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMwLTUtMS0xLTA_7c15c0ad-ea1b-4ec2-bde0-82c33a9fbbcc">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of year accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie67e69bf0ba04460ad30b2bfb023aa77_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMyLTEtMS0xLTA_82afa36d-3823-4bc6-a17b-a0ede7aa328d">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia10ab0fc32f0402bbbaa42ba5ce15209_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMyLTMtMS0xLTA_1b81fa3e-a1fb-4823-a4da-7d8ab1d11001">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77138741f151409593c0f08b724a0e30_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMyLTUtMS0xLTA_d21e9752-e97e-45b2-805a-f4956e895b66">165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e098044ef0e47c5bb1938a83a8faa41_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMzLTEtMS0xLTA_1526bdb8-0625-4954-a455-5d50633ca9c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544dec88053840f8844b00845a1e6704_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMzLTMtMS0xLTA_86d2dd12-7f66-4fd0-b30d-4a51732ab36f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i708551cc4c814f7ba31ad03e5c460a9b_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMzLTUtMS0xLTA_1a1d48ca-adf7-4d3e-9e3c-692a1d0e9427">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzM0LTEtMS0xLTA_3416bc4d-f53c-4c08-8f57-8bd75737468f">395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzM0LTMtMS0xLTA_1bf5fc46-92b0-48a4-8c67-a9d7e4180bb5">917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzM0LTUtMS0xLTA_66c37c9c-fc3e-42d1-8b00-72d3a9f4e36e">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of year accumulated other comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib26f4f89c2814e789be0ba11239b5764_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzM1LTEtMS0xLTA_d52355d4-e2f9-4034-8d5f-f479d561a0fb">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie67e69bf0ba04460ad30b2bfb023aa77_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzM1LTMtMS0xLTA_4e0780c7-3138-4a61-90ec-d2578b3c779c">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia10ab0fc32f0402bbbaa42ba5ce15209_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzM1LTUtMS0xLTA_85685ca9-5297-4953-b04b-a12169157e94">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive loss represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of ASU 2018-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Income Statement Reporting Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Topic 220); Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">during the year ended December 31, 2018.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i87af385a10ef438b91247cc539983dd4"><ix:continuation id="id26fbd9eb9544c81a6b68b2d8728b942"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify approximately $<ix:nonFraction unitRef="usd" contextRef="ie55d01130f004e38a1138732a5796669_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90ZXh0cmVnaW9uOjIxOTY0YjVjZjI2NjRlZWFiYjRmZjc0ODZiYjJiNjE2XzExODY_e2e3412c-24d5-4bfe-9af0-89f96bd0d166">13</ix:nonFraction> million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_181"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90ZXh0cmVnaW9uOjJhYTMwYjM0ZGE0MjQwZGM4OWM2ZWI3NzVmMWZjMTFjXzEzMTI_2b3fad80-bcd0-4507-b0f0-6c3a2c29972b" continuedAt="i6a426c05a57941b0820ad57db31116cc" escape="true">Earnings (Loss) Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6a426c05a57941b0820ad57db31116cc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (loss) per share is computed using the two-class method. For periods in which the Company reports net income, diluted earnings per share is determined by using the weighted average number of common and dilutive common equivalent shares outstanding during the period, unless the effect is antidilutive. SARs and options to purchase <ix:nonFraction unitRef="shares" contextRef="i44c7450a0d11477499c9bec9bf025a94_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90ZXh0cmVnaW9uOjJhYTMwYjM0ZGE0MjQwZGM4OWM2ZWI3NzVmMWZjMTFjXzM3Mw_634768e6-80d0-4fb8-a6e9-b2b31c326975">15</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ic4a8d6916f6844c2903a012a996567fe_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90ZXh0cmVnaW9uOjJhYTMwYjM0ZGE0MjQwZGM4OWM2ZWI3NzVmMWZjMTFjXzY1OTcwNjk3NjgwMjQ_85bf51d4-a076-4105-8768-cca65b32747e">17</ix:nonFraction>&#160;million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the years ended December&#160;31, 2020 and 2019, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, options to purchase <ix:nonFraction unitRef="shares" contextRef="ia66f0a48333c4fb8a9fae0a1c2df0fca_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90ZXh0cmVnaW9uOjJhYTMwYjM0ZGE0MjQwZGM4OWM2ZWI3NzVmMWZjMTFjXzcyMw_555bea70-7129-4468-aecd-400b7df6eebf">13</ix:nonFraction> million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share, for the year ended December&#160;31, 2018. In addition, due to the loss from continuing operations attributable to CVS Health in the year ended December 31, 2018, <ix:nonFraction unitRef="shares" contextRef="icc86caed1ec14c06a5264c5b07d25d2c_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90ZXh0cmVnaW9uOjJhYTMwYjM0ZGE0MjQwZGM4OWM2ZWI3NzVmMWZjMTFjXzk4Nw_0b9124dc-a55d-472a-a5dc-ba6137246510">3</ix:nonFraction> million potentially dilutive common equivalent shares were excluded from the calculation of diluted earnings per share, as the impact of these shares was antidilutive for that period.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90ZXh0cmVnaW9uOjJhYTMwYjM0ZGE0MjQwZGM4OWM2ZWI3NzVmMWZjMTFjXzEzMTM_ffa4a6a9-e95e-47b0-b84f-88263b786314" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings (loss) per share from continuing operations for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings (loss) per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzItMS0xLTEtMA_cda17fea-7d15-451d-8b54-ad7bbd61e288">7,201</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzItMy0xLTEtMA_0521c654-5344-4077-8347-ebf606ddd7ae">6,631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzItNS0xLTEtMA_96890304-6350-4e0e-8dad-af3d5021289b">596</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzMtMS0xLTEtMA_f8bf3f97-767d-4f45-aaba-0cebd7a35eb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzMtMy0xLTEtMA_5316344b-234d-4c8e-be94-6da255c94ccd">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzMtNS0xLTEtMA_9a6f7cd6-6a7f-440b-9f38-e0efaa4ec7cf">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzQtMS0xLTEtMA_e3969c3c-012d-4518-9831-fdf563ea8a0f">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzQtMy0xLTEtMA_13633cd6-25c1-4b7b-8503-5fa1b1344e1e">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzQtNS0xLTEtMA_489c025c-5b59-44e8-8465-60b7dde7405e">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzUtMS0xLTEtMA_aedd2958-38b9-4690-895f-3474353f0da3">7,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzUtMy0xLTEtMA_6f387338-732b-45a1-8c92-31b411d55140">6,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzUtNS0xLTEtMA_330c5b10-1ae8-4164-a900-4dd8f808ae3d">597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings (loss) per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzgtMS0xLTEtMA_6899e612-7d38-41e9-a407-14d51430040f">1,309</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzgtMy0xLTEtMA_c6335f20-6046-4e26-a558-edf5972a5a93">1,301</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzgtNS0xLTEtMA_fb70dd46-8e35-4e99-a422-12e432b08c70">1,044</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzktMS0xLTEtMA_841ba298-0657-419b-a46d-307590a762ac">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzktMy0xLTEtMA_4dff1ced-d5e4-4b9d-8da4-893c16b0a358">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzktNS0xLTEtMA_bbb1f13e-ac52-4fed-85db-07a5df29da37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzEwLTEtMS0xLTA_b5ff59d4-97fe-43a1-8150-f6b639130ac2">1,314</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzEwLTMtMS0xLTA_f1aa1846-4587-496a-81b0-b9c1efd22512">1,305</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzEwLTUtMS0xLTA_9e509213-630e-4158-aea5-6ca7570d4c2d">1,044</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share from continuing operations:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzEzLTEtMS0xLTA_c7882d2c-679b-4c56-8f43-2a01c14a1b52">5.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzEzLTMtMS0xLTA_aaa03f32-fd71-4525-aa54-db7d5d6a6b1d">5.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzEzLTUtMS0xLTA_93e9460d-eb80-4da6-8403-dc9106b2d26e">0.57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzE0LTEtMS0xLTA_ec4fa5a2-2622-469d-8d3b-651fe105a302">5.47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzE0LTMtMS0xLTA_e2a7ee7e-1b6d-46e4-a11e-51b9dcf97900">5.08</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzE0LTUtMS0xLTA_fd0cc01d-eac4-4939-a086-08a62b87197b">0.57</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_184"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ReinsuranceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90ZXh0cmVnaW9uOmE3NjdmYmE1Y2U0YzRmOWQ4MmVmY2MyNDVkMzUyNjVmXzIzMDM_e95f3b12-6b7c-4d9f-9b02-b685b129d54d" continuedAt="i17b2b1c8e0444bd999c10fc148d09e84" escape="true">Reinsurance</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i17b2b1c8e0444bd999c10fc148d09e84" continuedAt="i21d49725650d4f8399dd1247db05578d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured.</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2018, the Company completed the sale of Aetna&#8217;s standalone Medicare Part D prescription drug plans to a subsidiary of WellCare Health Plans, Inc. (&#8220;WellCare&#8221;), effective December 31, 2018. In connection with that sale, subsidiaries of WellCare and Aetna entered into reinsurance agreements under which WellCare ceded to Aetna 100% of the insurance risk related to the divested standalone Medicare Part D prescription drug plans for the 2019 PDP plan year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company entered into <ix:nonFraction unitRef="reinsuranceagreement" contextRef="id456c1b6d71e415f8fae0b19939047b5_D20210101-20210131" decimals="INF" format="ixt-sec:numwordsen" name="cvs:NumberofReinsuranceContractsEnteredInto" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90ZXh0cmVnaW9uOmE3NjdmYmE1Y2U0YzRmOWQ4MmVmY2MyNDVkMzUyNjVmXzkxMg_6ab5ee69-1df3-4f35-8bd7-55938097071c">two</ix:nonFraction> <ix:nonNumeric contextRef="id456c1b6d71e415f8fae0b19939047b5_D20210101-20210131" format="ixt-sec:durwordsen" name="cvs:FourYearsReinsuranceAgreementWithUnrelatedInsurer" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90ZXh0cmVnaW9uOmE3NjdmYmE1Y2U0YzRmOWQ4MmVmY2MyNDVkMzUyNjVmXzU0OTc1NTgxNDEyMDc_00b29eaa-cf9a-4f6b-b015-d094613a2eb0">four-year</ix:nonNumeric> reinsurance agreements with an unrelated reinsurer that allow it to reduce required capital and provide collateralized excess of loss reinsurance coverage on a portion of the Health Care Benefits segment&#8217;s group Commercial Insured business.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">162</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i21d49725650d4f8399dd1247db05578d"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90ZXh0cmVnaW9uOmE3NjdmYmE1Y2U0YzRmOWQ4MmVmY2MyNDVkMzUyNjVmXzIzMTA_57b7214c-f23d-4fb6-a302-04818513d853" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reinsurer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hartford Life and Accident Insurance Company</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i283d40b1ef884f6cb9ca2441e0955fad_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzItMS0xLTEtMA_017b7eaf-1fc7-4d54-9104-5608b5f60067">2,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a32e023950437daba697bb6436ecc3_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzItMy0xLTEtMA_2ced14d0-126a-44ef-8d7a-ff837721b4d8">3,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Life &amp; Annuity Company of New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1061114a7fd4ccdb4a85fb5f0f28ab9_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzMtMS0xLTEtMA_d39df03f-bb60-4f21-91c8-8241748ffc19">406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa18411dccbb43738f7c59758dc47e91_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzMtMy0xLTEtMA_de0d1c24-cb84-444c-b8d9-b47fa6048078">413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WellCare Health Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09460a20d53d4ad4afdab3735a3cc179_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzQtMS0xLTEtMA_7fda18e7-0213-426b-ac7c-11d7081941fc">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a6a522a6904da1983e84571970a6af_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzQtMy0xLTEtMA_67da0f98-69be-40d4-8196-e690a258b4cb">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOYA Retirement Insurance and Annuity Company </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0994e7abf542478298de546eeea26a_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzUtMS0xLTEtMA_d7ac99a7-1c89-4fd6-a175-861d40e60938">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc0de1362c31442e9830179e9cf9ff8a_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzUtMy0xLTEtMA_1f05227f-59c3-4368-8495-f8c52ffe43fe">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i974ce0ed0b7041fc865280b9d6ba0727_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzYtMS0xLTEtMA_2115798d-0b36-4f98-9570-0393cbec8d89">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8177202559374cd1b60b07d956cf5c08_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzYtMy0xLTEtMA_4c5dfb97-694e-41e3-a612-fe1998caef79">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzctMS0xLTEtMA_f1f87114-2ca5-4629-af21-b976a43967f2">3,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzctMy0xLTEtMA_fdba6e66-3aae-47ee-8a80-a04ef75bc2e1">4,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90ZXh0cmVnaW9uOmE3NjdmYmE1Y2U0YzRmOWQ4MmVmY2MyNDVkMzUyNjVmXzIzMDc_1a992277-ca93-40d4-9ff4-85d04feb5522" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DirectPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzEtMS0xLTEtMA_f2b017b4-ff34-436e-a755-507a324a23ab">69,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DirectPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzEtMy0xLTEtMA_f893813b-e806-4082-b5db-11ca7ba98fe8">62,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DirectPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzEtNS0xLTEtMjA5Ng_2a624f78-2532-49d9-bde2-d464dc95a6d9">8,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:AssumedPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzItMS0xLTEtMA_15a503b1-f1ec-4d3d-ad50-a3ddde14c6e6">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssumedPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzItMy0xLTEtMA_fa2f2093-36e9-4bcb-a418-8c51f4a6d320">2,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:AssumedPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzItNS0xLTEtMjA5Ng_56266ae1-c48d-43fd-baf2-c8db5fcd4c5f">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:CededPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzMtMS0xLTEtMA_5700f981-6510-46fe-bc4b-6a083dae86da">825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CededPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzMtMy0xLTEtMA_ee798ff3-d77b-4ea6-bcdf-427e5f3f3992">1,954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:CededPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzMtNS0xLTEtMjA5Ng_692bc9d0-913e-4872-a706-3244192ce3e4">219</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzQtMS0xLTEtMA_48a49e3b-e0dd-4c2e-bb71-841919ef6f02">69,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzQtMy0xLTEtMA_26c3d939-9dcd-486d-b412-0307b6e09617">63,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzQtNS0xLTEtMjA5Ng_c4c007f2-c11a-4759-b573-ecb744fb85cb">8,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:EffectsOfReinsuranceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90ZXh0cmVnaW9uOmE3NjdmYmE1Y2U0YzRmOWQ4MmVmY2MyNDVkMzUyNjVmXzIzMDE_1ea2804b-5dd8-42e4-bb07-bdc642e8102f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of reinsurance on benefit costs for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzEtMS0xLTEtMA_ab56abe2-7e09-4ec0-8f3a-46cd8f273cbc">56,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzEtMy0xLTEtMA_fbfcf726-3237-4b64-9ad8-f379a0f149e5">52,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzEtNS0xLTEtMjEwMg_ff246903-7492-4cdd-9f02-ff0e38e9a7d5">6,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzItMS0xLTEtMA_a3cf7f11-eab8-4987-9670-040bc2f1f6fa">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzItMy0xLTEtMA_ed63d90d-ac04-4b45-a67a-f3c76b49fe82">1,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzItNS0xLTEtMjEwMg_384e53ac-3f7b-4b88-ad88-fa220bb4d687">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzMtMS0xLTEtMA_d4391678-ec5e-4618-a4ad-19b37c77e2c8">727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzMtMy0xLTEtMA_227ea516-4dac-4c75-9281-36614db2884b">1,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzMtNS0xLTEtMjEwMg_ca9ca9ea-dd21-4560-b949-051782cf8844">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzQtMS0xLTEtMA_5486a7be-83c9-423f-8322-7b7389667296">55,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzQtMy0xLTEtMA_7a1636dd-2fe7-4e00-a24e-8df949bcec0c">52,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzQtNS0xLTEtMjEwMg_53eb520d-ebca-4f72-8409-791f0cfb8d1b">6,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is not a material difference between premiums on a written basis versus an earned basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has various agreements with unrelated reinsurers that do not qualify for reinsurance accounting under GAAP, and consequently are accounted for using deposit accounting. The Company entered into these contracts to reduce the risk of catastrophic loss which in turn reduces the Company&#8217;s capital and surplus requirements. Total deposit assets and liabilities related to reinsurance agreements that do not qualify for reinsurance accounting under GAAP were not material as of December&#160;31, 2020 or 2019.</span></div></ix:continuation><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_190"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzMyMDE1_1f9f67bd-639d-4b09-922b-82ec78d74b0f" continuedAt="ic491faa80ed24921be52c259acf81012" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic491faa80ed24921be52c259acf81012" continuedAt="i2167b6df530845edaa5f3d6713bdcf87"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the following significant guarantee arrangements at December&#160;31, 2020:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ASC Claim Funding Accounts - The Company has arrangements with certain banks for the processing of claim payments for its ASC customers. The banks maintain accounts to fund claims of the Company&#8217;s ASC customers. The customer is </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2167b6df530845edaa5f3d6713bdcf87" continuedAt="i11bb6c8670024f70b49632536b5e6e4c"><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">responsible for funding the amount paid by the bank each day. In these arrangements, the Company guarantees that the banks will not sustain losses if the responsible ASC customer does not properly fund its account. The aggregate maximum exposure under these arrangements is generally limited to $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GuaranteeObligationsMaximumExposure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzY0Ng_7dd9f703-3c95-497a-9a73-93bb30b28d2d">250</ix:nonFraction> million. The Company can limit its exposure to these guarantees by suspending the payment of claims for ASC customers that have not adequately funded the amount paid by the bank. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Separate Accounts Assets - Certain Separate Accounts assets associated with the large case pensions business in the Corporate/Other segment represent funds maintained as a contractual requirement to fund specific pension annuities that the Company has guaranteed. Minimum contractual obligations underlying the guaranteed benefits in these Separate Accounts were approximately $<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-8" format="ixt:numdotdecimal" name="cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzExOTg_45309032-c7e9-4306-8f72-c466e0e9d9da"><ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-8" format="ixt:numdotdecimal" name="cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzExOTg_4d23f9e1-1ce9-47ec-bfa8-832481015cd0">1.4</ix:nonFraction></ix:nonFraction> billion at both December&#160;31, 2020 and 2019. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information on Separate Accounts. Contract holders assume all investment and mortality risk and are required to maintain Separate Accounts balances at or above a specified level. The level of required funds is a function of the risk underlying the Separate Account&#8217;s investment strategy. If contract holders do not maintain the required level of Separate Accounts assets to meet the annuity guarantees, the Company would establish an additional liability. Contract holders&#8217; balances in the Separate Accounts at December&#160;31, 2020 exceeded the value of the guaranteed benefit obligation. As a result, the Company was not required to maintain any additional liability for its related guarantees at December&#160;31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of December&#160;31, 2020, the Company guaranteed <ix:nonFraction unitRef="lease" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="INF" name="cvs:GuarantorObligationsNumberofLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzI4Nzc_91396640-2781-4dcf-bbda-ee2918c03f82">76</ix:nonFraction> such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the consolidated balance sheets), with the maximum remaining lease term extending through 2030.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">164</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i11bb6c8670024f70b49632536b5e6e4c" continuedAt="i4d41328207b94e78abf8dcd741cd3399"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total guaranty fund assessments liability was $<ix:nonFraction unitRef="usd" contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GuarantyLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzU4Nzk_949f6b3d-9b98-421e-adb0-80eb34932edd">78</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36847bfea20b4065b555edc6977908d0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GuarantyLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzU4ODY_b850b149-6c76-48e2-9ac4-5160a02110d0">84</ix:nonFraction> million at December&#160;31, 2020 and 2019, respectively, and was recorded in accrued expenses on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CMS, state insurance and health and welfare departments, state attorneys general, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;) and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4d41328207b94e78abf8dcd741cd3399" continuedAt="i98335924c3ed47e3a8dd034d1cc6effd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other requests for documents and information from, and is being investigated by, Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re National Prescription Opiate Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the U.S. Department of Justice (the &#8220;DOJ&#8221;) served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations in connection with an investigation concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The Company has been cooperating with the government with respect to this subpoena.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Mohajer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed complaints-in-intervention in these two previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases. With respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint, all states and Washington, D.C. have declined to intervene at this time. The government&#8217;s investigation related to these complaints included the previously disclosed CID that the Company received in October 2015 from the SDNY concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The complaints allege that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mohajer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relators have amended their complaint to include claims based on similar theories related to certain skilled nursing facilities. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena..</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i98335924c3ed47e3a8dd034d1cc6effd" continuedAt="i5b97661a946c4a88aa0b48bc811c84cb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">whom the Company does not have a contract (&#8220;out-of-network providers&#8221;). Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#8217;s post-payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#8220;HHS-OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange-related or other audits by CMS, HHS-OIG or otherwise, including audits of the Company&#8217;s MLR rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i5b97661a946c4a88aa0b48bc811c84cb" continuedAt="i4768b799eb0b488f959cda6172fecd38"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the Company received a CID from the Office of the Washington Attorney General, Medicaid Fraud Control Division, on behalf of the State of Washington and all other states, as well as the District of Columbia, Puerto Rico and the U.S. Virgin Islands. The investigation involves, among other things, possible retention of overpayments and possible submission of false claims for Medicaid reimbursement relating to drugs prescribed by providers who were excluded by the applicable federal and/or state Medicaid programs. The Company is cooperating with the government with respect to this investigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. Since filing, several of the cases have been consolidated, and the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), was recently dismissed with prejudice. The Company and its current and former officers and directors are defending themselves against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, two ERISA class actions were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna, and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The district court consolidated the actions and the Company has moved to dismiss the amended and consolidated class action complaint. The Company also received a related document request pursuant to ERISA &#167; 104(b), to which the Company has responded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health care company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4768b799eb0b488f959cda6172fecd38"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">federal government, withholding of premium payments to the Company by government agencies, assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i) future enactment of new health care or other laws or regulations; (ii) the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii) pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv) pending or future government audits, investigations or enforcement actions against the Company; (v) adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi) adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div></ix:continuation><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_196"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzU3MDg_933a180f-a647-480e-a4de-7889c849455f" continuedAt="i33bb76b3784a4d83882ff4cfc89ef492" escape="true">Segment Reporting</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i33bb76b3784a4d83882ff4cfc89ef492" continuedAt="i66ab619bb382411eb1e8bab82005f3a4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzQx_e40b1bae-851f-4ab4-b563-769a91cac303">three</ix:nonFraction> operating segments, Pharmacy Services, Retail/LTC and Health Care Benefits, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the CODM evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliation of consolidated operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020 and 2019, revenues from the federal government accounted for <ix:nonFraction unitRef="number" contextRef="i6e2f1b217f52446cb6e5188fdcdf3a24_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzcxMTg_b84a9d8b-5d62-45d9-b898-e51e0d3326b9">14</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i4fad3343a4d04d8eb3071527460cb5cf_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzcxMjM_707433a9-3e3b-4ee1-894b-bf04fd5bab64">13</ix:nonFraction>%, respectively, of the Company&#8217;s consolidated total revenues, primarily related to contracts with CMS for coverage of Medicare-eligible individuals within the Health Care Benefits segment. Revenues from the federal government were less than <ix:nonFraction unitRef="number" contextRef="i970d47a28d574ba6aa6a095102442465_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzU0OTc1NTgxNjEyMTU_b1f0826c-ebae-49b4-8d44-eada4426713b">10</ix:nonFraction>% of the Company&#8217;s consolidated revenues in 2018. In 2018, approximately <ix:nonFraction unitRef="number" contextRef="i02d01cae12ae4fcfa5db05cc7acbdce2_D20180101-20181231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIwMDY_acd6d803-ec8f-4a91-8870-1a620b116332">9.8</ix:nonFraction>% of the Company&#8217;s consolidated revenues were from Aetna, which was a Pharmacy Services segment client. On the Aetna Acquisition Date, Aetna became a wholly-owned subsidiary of CVS Health. Subsequent to the Aetna Acquisition Date, transactions with Aetna continue to be reported within the Pharmacy Services segment, but are eliminated in the Company&#8217;s consolidated financial statements. </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i66ab619bb382411eb1e8bab82005f3a4" continuedAt="id2d08ec5f0814bdca46a92dfbc58be44"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzU3MDM_c72dc9af-9eaf-41e8-87ac-cee7e311e988" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzItMS0xLTEtMA_cb2ebc1d-0f64-4287-a8de-372fb9c1881c">132,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzItMy0xLTEtMA_e0a9da3c-8f0d-4a7e-91ea-a4540aaf72f6">60,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzItNS0xLTEtMA_a9febfcc-0b0f-41f2-b669-97bc0a32d566">74,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzItNy0xLTEtMA_d7cdf7a0-c761-4819-8ea1-25742ed4ea3f">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzItMTEtMS0xLTA_b2c9ad38-aaf3-48fa-8522-06493a981e67">267,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11b7b7dd14d4443089c85a899cf72296_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtMS0xLTEtMTg4MQ_ba5953fd-1df8-4c06-9c38-6b58a958853b">9,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74221d409dca4f35b040b2ed0b77e999_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtMy0xLTEtMTg4MQ_189bae10-fed8-4404-a8d6-c24e7c95e06f">30,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d5bd822a20345d1b479f13bc043f886_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtNS0xLTEtMTg4MQ_47f4a746-0271-47cd-8998-280d581957f7">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtOS0xLTEtMTg4MQ_d4514283-9db2-44d2-8ce2-bfc884138afb">40,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtMS0xLTEtMA_8f610992-2670-4424-9e29-4b5b84c4e92a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtMy0xLTEtMA_db993e4b-9f17-4a9a-aa96-24d9d049c68f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtNS0xLTEtMA_5392fabd-272b-4a95-8ded-1955df2e3ddf">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtNy0xLTEtMA_79cb0803-666a-4baf-a699-7531e34d6737">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtOS0xLTEtMA_24b3fbcd-ab02-47a8-966d-b3fd127259f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtMTEtMS0xLTA_24a2c441-5cc4-44c9-aaff-d9a2c5fdaa09">798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzQtMS0xLTEtMA_58497f92-b549-4f4e-bafa-ccc190b246ba">141,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzQtMy0xLTEtMA_a9ef9c96-e605-407e-a59b-084a1ae6520b">91,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzQtNS0xLTEtMA_e0e6ddae-ec80-4348-abdb-993c9c46bb80">75,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzQtNy0xLTEtMA_cfacf59b-776f-477a-98e6-acf6223ef992">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzQtOS0xLTEtMA_f2ade516-09ef-4053-bc0e-62ec1b96023c">40,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzQtMTEtMS0xLTA_56fbc0ce-16c7-4b68-84b9-5aa758371d37">268,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzUtMS0xLTEtMA_a07ab2e5-eee2-4e1d-9e8d-ead0da921517">5,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzUtMy0xLTEtMA_090bc3b0-e437-494b-94dc-6ea6e0888c60">6,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzUtNS0xLTEtMA_ee3e7758-7a97-490e-a5fd-3456ddd369a9">6,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzUtNy0xLTEtMA_33f3ada2-c0b4-4254-9d28-1aab9ec7ead2">1,306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzUtOS0xLTEtMA_087c40ff-da09-4cb7-9429-a94a65508009">708</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzUtMTEtMS0xLTA_20e5d505-6316-46be-9825-c65f2a621e6a">16,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzYtMS0xLTEtMA_8f6769e2-5295-4f96-bf68-4d8b27c1ffcc">612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzYtMy0xLTEtMA_92c5c508-7d2b-4f4a-b5d4-5efa72cf8e00">1,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzYtNS0xLTEtMA_7f0ece49-8cc6-4149-b92c-f747f6bf5ad1">1,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzYtNy0xLTEtMA_7c30b750-4e50-4985-b69b-e65addf6e25d">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzYtOS0xLTEtMA_ae4e756f-523c-4375-b1c6-859fe22fa7d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzYtMTEtMS0xLTA_b66f5c3c-cfa7-4c89-b23f-170a2bd4db62">4,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzktMS0xLTEtMA_94cbb91d-f63e-4f8e-b4cc-5548f51c875a">130,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzktMy0xLTEtMA_317dfe14-a080-44c8-b8bc-8cb0c508f4cb">56,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzktNS0xLTEtMA_a6a6fa21-0ad2-4a3e-8195-d41fad737981">68,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzktNy0xLTEtMA_dd8294ce-8c3d-4aa0-aa54-7386f42ae27f">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzktMTEtMS0xLTA_7cab36fc-ea7c-40fe-a7e4-08719f8fade7">255,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875e15f3f4444bf9a8d68faf00b3a90d_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTEtMS0xLTE4OTA_7e2dc9c1-f6f8-457b-8fb9-95fcd0d7be7e">11,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93d64ebea36e4de88c24cd1d6157c5e8_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTMtMS0xLTE4OTA_73e4c287-2e52-45d2-803d-b000468ddf6f">30,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f90001385946838987a8d0b03205b3_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTUtMS0xLTE4OTA_91e65e5e-5ad4-4545-920f-179438991c5b">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTktMS0xLTE4OTA_ed295ca5-fe8d-4eb7-97b3-2546c05be2e2">41,439</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEwLTEtMS0xLTA_fa8b438e-4921-42c2-b820-b02cdec1d8bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEwLTMtMS0xLTA_4ee940c5-6763-4e61-9f7b-03fb1b05798a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEwLTUtMS0xLTA_6ee42fdb-ffcd-4db9-9cfc-80a74ead7045">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEwLTctMS0xLTA_cd7025bb-3ead-4012-9307-89f7238e6642">412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEwLTktMS0xLTA_723f5089-f86a-4c1f-85aa-9da46229c869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEwLTExLTEtMS0w_b8f59ce7-75ba-40ef-8bea-3dfadf4f84a0">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTEtMS0xLTA_bd3f67e8-44c4-4249-b741-ace671cc1270">141,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTMtMS0xLTA_b5680843-7bcf-4931-8030-fdd1df13384e">86,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTUtMS0xLTA_f92ef8ac-6c05-4d33-bb95-340614d81182">69,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTctMS0xLTA_645d9703-aa9a-45fe-bde0-00e6a00eedb3">512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTktMS0xLTA_5f677a1f-e304-44c4-97a4-8adff707572a">41,439</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTExLTEtMS0w_3daf8fef-3a94-4e0f-bd1f-deaa2d20663a">256,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEyLTEtMS0xLTA_b630ab82-2ddd-4236-9420-1cdaabcef44f">5,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEyLTMtMS0xLTA_1317a024-2a24-4bed-b11d-9dd5be32bf74">6,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEyLTUtMS0xLTA_518cfd12-cf2e-4ac6-8021-89aea8181b81">5,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEyLTctMS0xLTA_8103e3ef-ace8-4863-81ed-d0983c42df41">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEyLTktMS0xLTA_1358ae0f-7578-449f-b336-6c1637ab344b">697</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEyLTExLTEtMS0w_33427fba-4f81-44e8-aea3-2d7afbdb2450">15,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEzLTEtMS0xLTA_8363790b-ef90-46a0-971a-c1f5a4506dca">766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEzLTMtMS0xLTA_746a329f-0976-466d-b7c9-7e0df5eeeda1">1,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEzLTUtMS0xLTA_8eb18607-b43a-4b3e-9f78-bd5ef4275330">1,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEzLTctMS0xLTA_eabae611-e04c-4627-998f-bdda7e3c98de">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEzLTktMS0xLTA_31678cd9-2de9-4e99-8c47-a1e9da029fe7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEzLTExLTEtMS0w_c01b3ef5-ac9c-4caa-b9d1-658d99d1097e">4,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE2LTEtMS0xLTA_017a0fd1-b5eb-4e20-89d7-b6f58816c078">130,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE2LTMtMS0xLTA_36833839-3104-4198-86a7-54e1f82cd8e9">54,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE2LTUtMS0xLTA_ec7ca21b-b49d-4ff2-b98f-1448c609fde1">8,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE2LTctMS0xLTA_90717c36-f553-4c39-8f56-f124d8d86116">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE2LTExLTEtMS0w_5c87d8ca-1841-49b8-8b1a-9b5171756d5e">193,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i027f2373425b4cd295e0f10e2e0aa39a_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTEtMS0xLTE4OTc_94d39d34-9aca-49d4-9649-abe13f94391a">4,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67879d9b5c0743d68fc0bf8c41903fae_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTMtMS0xLTE4OTc_8a02f157-d6fc-4181-a113-5597a15a52dc">28,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c1b7e8f9d543768b0ff3135e5a5f0b_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTUtMS0xLTE4OTc_b21c3b0c-c56d-4c52-8514-5b1ad9333b64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTktMS0xLTE4OTc_6faf1b40-9e91-4414-a188-4544f1808d64">33,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE3LTEtMS0xLTA_1e0879e2-5b9a-485d-b996-6e5220e523f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE3LTMtMS0xLTA_f3bccff6-413e-47ad-865b-11ad969cb279">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE3LTUtMS0xLTA_4c7ac5cc-d1f9-46c9-8469-bade26c48e00">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE3LTctMS0xLTA_1235bd89-416c-488d-a74a-daa90373adc0">602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE3LTktMS0xLTA_83af842e-065a-4b11-9726-fac63bff1a76">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE3LTExLTEtMS0w_8fbeb7a5-47c3-421e-9698-fd86bbba5c7e">660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE4LTEtMS0xLTA_7b52dc1e-7b1e-4b30-bc5e-cc650f26799d">134,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE4LTMtMS0xLTA_4d87ec2c-a035-46ba-945a-bb73c747e588">83,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE4LTUtMS0xLTA_4d9b5aa8-aadf-49b3-826a-d5847a73de71">8,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE4LTctMS0xLTA_4efbc770-4d59-4f5f-834b-87e063148944">606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE4LTktMS0xLTA_a0635ddf-ecbb-4569-aa3c-277e3c23d4eb">33,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE4LTExLTEtMS0w_7c4941bf-8bc0-46b9-af4d-8dd3c3854a7b">194,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTEtMS0xLTA_f4bb288d-559d-486a-bcc1-55477c72e09e">4,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTMtMS0xLTA_ad197305-9d61-4c00-ab2c-8bda63f46745">7,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTUtMS0xLTA_7f536ba2-e2d4-45f9-98b0-719c57d00ead">528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTctMS0xLTA_e58a5c66-db38-45fd-abf9-4970f9de0329">856</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTktMS0xLTA_064fd1d6-180d-477f-b92a-3fe9136f6926">769</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTExLTEtMS0w_203ad57a-8900-4709-b392-aee98e37b503">11,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzIwLTEtMS0xLTA_e2da6bb1-e7bd-47e0-91b8-d4116a706ebd">710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzIwLTMtMS0xLTA_f5933fe6-f0a7-46d4-8046-15903a08d281">1,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzIwLTUtMS0xLTA_4728dfab-84be-442d-950a-1978aebc2cf7">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzIwLTctMS0xLTA_d5ee4051-6506-4832-9824-f0cf6e835b9f">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzIwLTktMS0xLTA_fbdad40d-dd37-46dc-9b35-896cf68dde05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzIwLTExLTEtMS0w_0541287a-0682-457b-9a85-5d27fb28f064">2,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Total revenues of the Pharmacy Services segment include approximately $<ix:nonFraction unitRef="usd" contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231" decimals="-8" format="ixt:numdotdecimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzI1MDU_0b455d80-cc34-4784-9dd8-fc876372b429">10.9</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231" decimals="-8" format="ixt:numdotdecimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzI1MDk_4706c5cb-cc71-43d3-b3d6-10b35fd8c78e">11.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231" decimals="-8" format="ixt:numdotdecimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzI1MTY_f6ab68a7-ca30-469c-b33d-83f6d3c67c23">11.4</ix:nonFraction> billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of retail co-payments for 2020, 2019 and 2018, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information about retail co-payments.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id2d08ec5f0814bdca46a92dfbc58be44"><ix:nonNumeric contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzU3MDU_4f55c9ab-051a-4c82-ba4b-45f22c23da76" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzEtMS0xLTEtMA_e80af6a9-a16d-4a86-8275-ec383706b1cc">13,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzEtMy0xLTEtMA_5ddc43db-dab4-49cd-b114-983571b570e3">11,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzEtNS0xLTEtMA_a89c4c74-e25f-4a55-b432-d010a3f3feb3">4,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzItMS0xLTEtMA_a318e32c-95a1-4c67-9bc5-7064e20a4b67">2,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzItMy0xLTEtMA_1f140631-ce1c-47a0-843d-674803369f87">2,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzItNS0xLTEtMA_86804177-82b4-41bd-9519-373efdaa48d5">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related transaction and integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzMtMS0xLTEtMA_7cdb169c-9d90-41d5-aa17-adc6585b98a0">332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzMtMy0xLTEtMA_2ba0666f-2acf-4f9a-b37e-1e847ad73fa0">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzMtNS0xLTEtMA_190b30a9-e4a5-4717-8d74-6a3edd481971">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtMS0xLTEtNjI1OQ_622f72ab-7310-4939-a18e-2197e1b8981b">269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtMy0xLTEtNjI1OQ_5eaeb186-3d81-42a5-bd90-2c2f1255aa99">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtNS0xLTEtNjI1OQ_55bf3333-389b-405b-b2b8-ffd3267dd903">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of fully reserved ACA risk corridor receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtMS0xLTEtMjYzMw_45198185-5a69-4af3-8b65-eb2a0f92e8c5">307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtMy0xLTEtMjYzNw_a321b3f3-a56c-4bd9-b78c-0f91b801ee1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtNS0xLTEtMjY0MQ_0b8ac302-2555-4dbe-b5a8-cf5833051bb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store rationalization charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="cvs:StoreRationalizationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtMS0xLTEtMA_ecbd2666-6ba3-4949-b2dd-8c00694b582c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" name="cvs:StoreRationalizationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtMy0xLTEtMA_afd96f1d-9b67-4a6c-85a3-650d54ff0104">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="cvs:StoreRationalizationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtNS0xLTEtMA_3e9d2f1d-b94e-4bfe-8b17-dc0d69799373">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzYtMS0xLTEtMA_80fe7343-0a0f-40df-b77f-f364429b41fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzYtMy0xLTEtMA_7f1e3bc0-1125-4d1d-9f1c-455acd838108">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1058e7e5067441cb02129bfd0cc9dad_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzYtNS0xLTEtMA_2abb458c-e874-4589-8f5a-9ca9fb464f55">6,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TangibleAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzctMS0xLTEtMA_6614de97-88bd-466b-9be1-5a0c05aceb90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:TangibleAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzctMy0xLTEtMA_c1102dfb-6009-416c-afe5-33047f44eafb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" name="us-gaap:TangibleAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzctNS0xLTEtMA_373c55c5-57e3-4bf8-9158-c0bce70ef29e">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on financing for the Aetna Acquisition </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzgtMS0xLTEtMA_bfbc37de-2f17-4304-8926-abe7dc695526">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzgtMy0xLTEtMA_d641aa4c-428f-4c1f-82ff-35a4856ef9f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzgtNS0xLTEtMA_8c4d79b9-4c59-4fe7-9dda-86abc1a34d43">536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzktMS0xLTEtMA_369e2367-3ad6-493b-b466-8f23fef0d0a2">16,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzktMy0xLTEtMA_33427fba-4f81-44e8-aea3-2d7afbdb2450">15,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzktNS0xLTEtMA_203ad57a-8900-4709-b392-aee98e37b503">11,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.   </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, 2019 and 2018, acquisition-related transaction and integration costs relate to the Aetna Acquisition. In 2018, acquisition-related integration costs also relate to the acquisition of Omnicare. The acquisition-related transaction and integration costs are reflected in the Company&#8217;s consolidated statements of operations in operating expenses within the Corporate/Other segment and the Retail/LTC segment.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $<ix:nonFraction unitRef="usd" contextRef="i6292fcfab69c48809cd6df0bbb16e7ba_D20200731-20200731" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzMwOTA_19850f02-0368-43e5-9619-18b5f656bed0">850</ix:nonFraction>&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment. In 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income. In 2018, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of the Company&#8217;s RxCrossroads subsidiary for $<ix:nonFraction unitRef="usd" contextRef="i451e6007601e4a3f8f2a01973945700b_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzMxMTc_0621e2ed-be0c-4297-9737-ccc4e70cbb83">725</ix:nonFraction>&#160;million on January 2, 2018. The losses on divestiture of subsidiary are reflected in the Company&#8217;s consolidated statements of operations in operating expenses within the Retail/LTC segment.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the Company received $<ix:nonFraction unitRef="usd" contextRef="i138a42c6cd5e4913b5eb2ad3288f6b8a_I20190831" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainContingencyUnrecordedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzY1OTcwNjk3NzkyNTc_541197b2-97fc-47b8-9fd2-10efbf466fa4">313</ix:nonFraction>&#160;million owed to it under the ACA&#8217;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $<ix:nonFraction unitRef="usd" contextRef="ia508c5dcbe174753b2ea381d7ec1a3bc_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzc5MDk_e9840c15-c8c8-42b3-936c-28320ea2225e">307</ix:nonFraction>&#160;million in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2019, the store rationalization charges relate to the planned closure of <ix:nonFraction unitRef="store" contextRef="i70084b42bcb34cf790dad3c2e153d003_D20190101-20190331" decimals="INF" name="cvs:NumberOfUnderPerformingStoresPlannedClosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzcwNzU_803f80f5-2335-4d4e-8d9a-93691afc9264">46</ix:nonFraction> underperforming retail pharmacy stores in the second quarter of 2019 and the planned closure of <ix:nonFraction unitRef="store" contextRef="ib071f664e4424c34825859add41556cc_D20190701-20190930" decimals="INF" name="cvs:NumberOfUnderPerformingStoresPlannedClosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzcwNzk_03041368-d6f0-4108-9ba6-392fe097afbf">22</ix:nonFraction> underperforming retail pharmacy stores in the first quarter of 2020. The store rationalization charges primarily relate to operating lease right-of-use asset impairment charges and are reflected in the Company&#8217;s consolidated statement of operations in operating expenses within the Retail/LTC segment.   </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2018, the goodwill impairments relate to the LTC reporting unit within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2018, impairment of long-lived assets primarily relates to the impairment of property and equipment within the Retail/LTC segment and is reflected in operating expenses in the Company&#8217;s consolidated statement of operations. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2018, the Company recorded interest income of $<ix:nonFraction unitRef="usd" contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzY1OTcwNjk3NzYwMDM_8c4d79b9-4c59-4fe7-9dda-86abc1a34d43">536</ix:nonFraction> million on the proceeds of the $<ix:nonFraction unitRef="usd" contextRef="i356e04bbc2764550a470b9863ec4eece_I20180309" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzU0MzY_a40aa4af-77fa-47e2-b821-e088501db10e">40</ix:nonFraction> billion of unsecured senior notes it issued in March 2018 to partially fund the Aetna Acquisition. All amounts are for the periods prior to the close of the Aetna Acquisition, which occurred on November 28, 2018, and were recorded within the Corporate/Other segment.</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:6.75pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_202"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_94">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited CVS Health Corporation&#8217;s internal control over financial reporting as of December&#160;31, 2020, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, CVS Health Corporation (the Company) maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2020, based on the COSO criteria.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2020 consolidated financial statements of the Company and our report dated February&#160;16, 2021, expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;16, 2021 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_205"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of CVS Health Corporation (the Company) as of December&#160;31, 2020 and 2019, the related consolidated statements of operations, comprehensive income (loss), shareholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2020, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2020, in conformity with U.S. generally accepted accounting principles. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December&#160;31, 2020, based on criteria established in Internal Control-Integrated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February&#160;16, 2021, expressed an unqualified opinion thereon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.305%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">Impairment of goodwill of the Commercial Business reporting unit</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, the Company&#8217;s goodwill related to the Commercial Business reporting unit was $26.5 billion. As discussed in Note 1 to the consolidated financial statements, goodwill is not amortized, but rather is subject to an annual impairment review, or more frequent reviews, if events and circumstances indicate an impairment exists. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing management's annual goodwill impairment test related to the Commercial Business reporting unit was complex and highly judgmental due to the significant estimation required to determine the fair value of the reporting unit. In particular, the fair value estimate was sensitive to changes in significant assumptions, such as the discount rate, projected revenue and projected operating income that are forward-looking and affected by future economic and market conditions.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s annual goodwill impairment review process, including controls over management&#8217;s review of the significant assumptions described above.<br/><br/>To test the estimated fair value of the Commercial Business reporting unit, we performed audit procedures that included, among others, assessing methodologies and testing the significant assumptions discussed above and the underlying data used by the Company in its analysis. We compared the significant assumptions to the reporting unit&#8217;s historical results and third-party industry data. We performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the reporting unit that would result from changes in the key assumptions. We involved valuation specialists to assist in our assessment of the methodology and significant assumptions (such as the discount rate), used by the Company. In addition, we tested management&#8217;s reconciliation of the fair value of all reporting units to the market capitalization of the Company.  </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Valuation of health care costs payable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, the incurred but not reported (&#8220;IBNR&#8221;) liabilities represented $6.1 billion of $7.9  billion of health care costs payable. As discussed in Note 1 to the financial statements, the Company&#8217;s liability for health care costs payable includes estimated payments for (1) services rendered to members but not yet reported and (2) claims that have been reported but not yet paid, each as of the financial statement date (collectively, &#8220;IBNR&#8221;). The estimated IBNR liability is developed utilizing actuarial principles and assumptions that include historical and projected claim submission and processing patterns, historical and assumed medical cost trends, historical utilization of medical services, claim inventory levels, changes in membership and product mix, seasonality and other relevant factors to record the actuarial best estimate of health care costs payable. There is significant uncertainty inherent in determining management&#8217;s actuarial best estimate of health care costs payable. In particular, the estimate is sensitive to the assumed completion factors and the assumed health care cost trend rates. <br/><br/>Auditing management&#8217;s actuarial best estimate of IBNR reserves for health care costs payable for its products and services involved a high degree of subjectivity in evaluating management&#8217;s assumptions used in the valuation process.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the process for estimating IBNR reserves. This included, among others, controls over the completeness and accuracy of data used in the actuarial projections, the transfer of data between underlying source systems, and the review and approval processes that management has in place for the actuarial principles and assumptions used in estimating the health care costs payable.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To test IBNR reserves, our audit procedures included, among others, testing the completeness and accuracy of the underlying claim and membership data used in the calculation of IBNR reserves. We involved actuarial specialists to assist with our audit procedures, which included, among others, evaluating the methodologies applied by the Company in determining the actuarially determined liability, evaluating management&#8217;s actuarial principles and assumptions used in their analysis based on historical claim experience, and independently calculating a range of reserve estimates for comparison to management&#8217;s actuarial best estimate of the liability for health care costs payable. Additionally, we performed a review of the prior period liabilities for incurred but not paid claims to subsequent claims development.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">174</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2007.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;16, 2021</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">175</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_211"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.  Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.</span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_214"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A.  Controls and Procedures.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures (as defined in Rules&#160;13a-15 (f)&#160;and 15d-15(f) under the Securities Exchange Act of 1934) as of December&#160;31, 2020, have concluded that as of such date the Company&#8217;s disclosure controls and procedures were adequate and effective at a reasonable assurance level and designed to ensure that material information relating to the Company and its consolidated subsidiaries would be made known to such officers on a timely basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s report on internal control over financial reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial r</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eporting. The Company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the Company&#8217;s consolidated financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company&#8217;s assets that could have a material effect on the Company&#8217;s consolidated financial statements. In order to ensure the Company&#8217;s internal control over financial reporting is effective, management regularly assesses such control and did so most recently for its financial reporting as of December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management conducted an assessment of the effectiveness of the Company&#8217;s internal control over financial reporting based on the criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control-Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework). This evaluation included review of the documentation, evaluation of the design effectiveness and testing of the operating effectiveness of controls. The Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s system of internal control over financial reporting is enhanced by periodic reviews by the Company&#8217;s internal auditors, written policies and procedures and a written Code of Conduct adopted by CVS Health&#8217;s Board of Directors, applicable to all employees of the Company. In addition, the Company has an internal Disclosure Committee, comprised of management from each functional area within the Company, which performs a separate review of disclosure controls and procedures. There are inherent limitations in the effectiveness of any system of internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on management&#8217;s assessment, management concluded that the Company&#8217;s internal control over financial reporting is effective and provides reasonable assurance that assets are safeguarded and that the financial records are reliable for preparing financial statements as of December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst&#160;&amp; Young LLP, the Company&#8217;s independent registered public accounting firm, is appointed by CVS Health&#8217;s Board of Directors and ratified by CVS Health&#8217;s stockholders. They were engaged to render an opinion regarding the fair presentation of the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s consolidated financial statements as well as conducting an audit of internal control over financial reporting. Their reports included in Item 8 of this Form 10-K are based upon audits conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in internal control over financial reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no change in the Company&#8217;s internal control over financial reporting identified in connection with the evaluation required by paragraph (d)&#160;of Rule&#160;13a-15 or Rule&#160;15d-15 that occurred during the fourth quarter ended December&#160;31, 2020 that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">176</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_217"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B.  Other Information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No events have occurred during the fourth quarter ended December&#160;31, 2020 that would require disclosure under this item.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_220"></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_223"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10.  Directors, Executive Officers and Corporate Governance.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning the Executive Officers of CVS Health Corporation is included in Part I of this 10-K pursuant to General Instruction G to Form 10-K. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sections of the Proxy Statement under the captions &#8220;Committees of the Board as of the Annual Meeting,&#8221; &#8220;Code of Conduct,&#8221; &#8220;Audit Committee Report,&#8221; and &#8220;Biographies of our Incumbent Board Nominees&#8221; are incorporated herein by reference. </span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_226"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11.  Executive Compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sections of the Proxy Statement under the captions &#8220;Non-Employee Director Compensation&#8221; and &#8220;Executive Compensation and Related Matters,&#8221; including &#8220;Letter from the Management Planning and Development Committee,&#8221; &#8220;Compensation Committee Report,&#8221; &#8220;Compensation Discussion and Analysis&#8221; and &#8220;Compensation of Named Executive Officers&#8221; are incorporated herein by reference.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_229"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sections of the Proxy Statement under the captions &#8220;Share Ownership of Directors and Certain Executive Officers&#8221; and &#8220;Share Ownership of Principal Stockholders&#8221; are incorporated herein by reference. Those sections contain information concerning security ownership of certain beneficial owners and management and related stockholder matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the registrant&#8217;s common stock that may be issued upon the exercise of options, warrants and rights under all of the Company&#8217;s equity compensation plans as of December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">securities&#160;to&#160;be</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">issued&#160;upon</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">exercise&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">outstanding</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">options,&#160;warrants</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">and&#160;rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) (2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>average&#160;exercise<br/>price&#160;of<br/>outstanding<br/>options,&#160;warrants<br/>and&#160;rights<br/>(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of&#160;securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">remaining&#160;available&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">future&#160;issuance&#160;under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">equity&#160;compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">plans&#160;(excluding</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">securities&#160;reflected&#160;in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">first&#160;column)&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(c)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by stockholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by stockholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.18&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,856&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Shares in thousands.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Consists of: (i) 21,796 shares of common stock underlying outstanding options, (ii) 779 shares of common stock issuable upon the exercise of outstanding stock appreciation rights (&#8220;SARs&#8221;) and (iii) 16,181 shares of common stock issuable on the vesting of outstanding restricted stock units, deferred stock units and performance stock units, assuming target level performance in the case of performance stock units. The number of shares included with respect to outstanding SARs is the number of shares of CVS Health common stock that would have been issued had the SARs been exercised based on the closing price per share of CVS Health common stock on December 31, 2020, as reported on the NYSE, which was $68.30.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Consists of the CVS Health 2017 Incentive Compensation Plan.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Consists of the Amended Aetna Inc. 2010 Stock Incentive Plan (the &#8220;Aetna Stock Plan&#8221;). The Aetna Stock Plan expired on May 21, 2020, therefore there are no securities available for future issuance under this plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Aetna Stock Plan was last approved by Aetna&#8217;s shareholders at Aetna&#8217;s 2017 Annual Meeting on May 19, 2017. The Company elected to continue to grant awards under the Aetna Stock Plan to employees of Aetna and its subsidiaries following the completion of the Aetna Acquisition. The Aetna Stock Plan was designed to promote the Company&#8217;s interests and those of its stockholders and to further align the interests of stockholders and employees by tying awards to total return to stockholders, enabling plan participants to acquire additional equity interests in the Company and providing compensation opportunities dependent upon the Company&#8217;s performance. The Aetna Stock Plan was not submitted to the Company&#8217;s stockholders and expired on May 21, 2020. Under the Aetna Stock Plan, eligible participants could be granted stock options to purchase shares of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health common stock, SARs, time-vesting and/or performance-vesting incentive stock or incentive units and other stock-based awards.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_232"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13.  Certain Relationships and Related Transactions, and Director Independence.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sections of the Proxy Statement under the captions &#8220;Independence Determinations for Directors&#8221; and &#8220;Related Person Transaction Policy&#8221; are incorporated herein by reference.</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_235"></div><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14.  Principal Accountant Fees and Services.</span></div><div style="padding-right:2.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The section of the Proxy Statement under the caption &#8220;Item 2: Ratification of Appointment of Independent Registered Public Accounting Firm for 2021&#8221; is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">178</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_238"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_241"></div><div style="-sec-extract:summary;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15.  Exhibits, Financial Statement Schedules.</span></div><div style="padding-right:2.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as part of this 10-K:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Financial Statements. See &#8220;Index to Consolidated Financial Statements&#8221; in Item 8 of this 10-K.</span></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Financial Statement Schedules. All financial statement schedules are omitted because they are not applicable, not required under the instructions, or the information is included in the consolidated financial statements or related notes.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Exhibits. The exhibits listed in the &#8220;Index to Exhibits&#8221; in this Item 15 are filed or incorporated by reference as part of this 10-K. Exhibits marked with an asterisk (*)&#160;are management contracts or compensatory plans or arrangements. Exhibits other than those listed are omitted because they are not required to be listed or are not applicable. Pursuant to Item 601(b)(4)(iii) of Regulation S-K, the Registrant hereby agrees to furnish to the Securities and Exchange Commission a copy of any omitted instrument that is not required to be listed.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Plan of acquisition, reorganization, arrangement, liquidation or succession</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000030/exhibit21agreementandplano.htm">Agreement and Plan of Merger, dated as of May 20, 2015, among CVS Pharmacy, Inc., Tree Merger Sub, Inc. and Omnicare, Inc. (incorporated by reference to Exhibit&#160;2.1 to the Registrant&#8217;s Current Report on Form&#160;8-K filed May 21, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex23.htm">Master Transaction Agreement dated as of October 22, 2017, by and between Aetna Inc. and Hartford Life and Accident Insurance Company (incorporated by reference to Exhibit 2.3 to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312517361800/d444237dex21.htm">Agreement and Plan of Merger, dated as of December 3, 2017, among CVS Health Corporation, Hudson Merger Sub Corp. and Aetna Inc. (incorporated by reference to Exhibit&#160;2.1 to the Registrant&#8217;s Current Report on Form&#160;8-K filed December 5, 2017).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Articles of Incorporation and Bylaws</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518184593/d456958dex31c.htm">Restated Certificate of Incorporation of the Registrant dated June 4, 2018 (incorporated by reference to Exhibit&#160;3.1C of Registrant&#8217;s Current Report on Form&#160;8-K filed June 5, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000094787120000619/ss177554_ex0301.htm">By-Laws of the Registrant, as amended and restated July 8, 2020 (incorporated by reference to Exhibit&#160;3.1 to the Registrant&#8217;s Current Report on Form&#160;8-K filed July 10, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Instruments defining the rights of security holders, including indentures</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/0000950103-96-001174.txt">Specimen common stock certificate (incorporated by reference to Exhibit 4.1 to the Registration Statement of the Registrant ((then known as CVS Corporation) as successor to Melville Corporation) on Form 8-B filed November 4, 1996).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000095010306001962/ex0401.htm">Senior Indenture dated August 15, 2006, between the Registrant and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed August 15, 2006).</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex42.htm">Form of the Registrant&#8217;s 2021 Floating Rate Note (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex44.htm">Form of the Registrant&#8217;s 2021 Note (incorporated by reference to Exhibit 4.4 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex45.htm">Form of the Registrant&#8217;s 2023 Note (incorporated by reference to Exhibit 4.5 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex46.htm">Form of the Registrant&#8217;s 2025 Note (incorporated by reference to Exhibit 4.6 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex47.htm">Form of the Registrant&#8217;s 2028 Note (incorporated by reference to Exhibit 4.7 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex48.htm">Form of the Registrant&#8217;s 2038 Note (incorporated by reference to Exhibit 4.8 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex49.htm">Form of the Registrant&#8217;s 2048 Note (incorporated by reference to Exhibit 4.9 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">179</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312519222479/d791446dex41.htm">Form of the Registrant&#8217;s 2024 Note (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed August 15, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312519222479/d791446dex42.htm">Form of the Registrant&#8217;s 2026 Note (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed August 15, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312519222479/d791446dex43.htm">Form of the Registrant&#8217;s 2029 Note (incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s Current Report on Form 8-K filed August 15, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520092890/d876921dex41.htm">Form of the Registrant&#8217;s 2027 Note (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on March 31, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520092890/d876921dex42.htm">Form of the Registrant&#8217;s 2030 Note (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on March 31, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520092890/d876921dex43.htm">Form of the Registrant&#8217;s 2040 Note (incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s Current Report on Form 8-K filed on March 31, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520092890/d876921dex44.htm">Form of the Registrant&#8217;s 2050 Note (incorporated by reference to Exhibit 4.4 to the Registrant&#8217;s Current Report on Form 8-K filed on March 31, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520227082/d54415dex41.htm">Form of the Registrant&#8217;s 2027 Note (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on August 21, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520227082/d54415dex42.htm">Form of the Registrant&#8217;s 2030 Note (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on August 21, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520227082/d54415dex43.htm">Form of the Registrant&#8217;s 2040 Note (incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s Current Report on Form 8-K filed on August 21, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520319098/d57932dex41.htm">Form of the Registrant&#8217;s 2027 Note (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on December 16, 2020). </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520319098/d57932dex42.htm">Form of the Registrant&#8217;s 2031 Note (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on December 16, 2020). </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit422-2020.htm">Material terms of outstanding securities that are registered under Section 12 of the 1934 Act as required by Item 202(a)-(d) and (f) of Regulation S-K.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Material Contracts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000155837017006198/cvs-20170630ex1026f1efc.htm">Five Year Credit Agreement, dated as of May 18, 2017, by and among the Registrant, the lenders party thereto and The Bank of New York Mellon, as Administrative Agent (incorporated by reference to Exhibit&#160;10.2 to the Registrant&#8217;s Quarterly Report on Form&#160;10-Q for the fiscal quarter ended June 30, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312517373753/d508259dex103.htm">Amendment No. 1 to Five Year Credit Agreement dated as of December 15, 2017, to the Five Year Credit Agreement dated as of May 18, 2017, by and among the Registrant, the lenders party thereto and The Bank of New York Mellon, as Administrative Agent (incorporated by reference to Exhibit&#160;10.3 to the Registrant&#8217;s Current Report on Form&#160;8-K filed December 19, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000155837018006683/cvs-20180630ex1045acd05.htm">Amendment No. 2 to Five Year Credit Agreement dated as of May 17, 2018, to the Five Year Credit Agreement dated as of May 18, 2017, by and among the Registrant, the lenders party thereto and The Bank of New York Mellon, as Administrative Agent (incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000039/ex104-06302019.htm">Amendment No. 3, dated as of May 16, 2019, to the Five Year Credit Agreement dated as of May 18, 2017, by and among the Registrant, the lenders party thereto and The Bank of New York Mellon, as Administrative Agent (incorporated by reference to Exhibit 10.4 of the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000155837018006683/cvs-20180630ex102e86994.htm">Five Year Credit Agreement dated as of May 17, 2018, by and among the Registrant, the lenders party thereto and The Bank of New York Mellon, as Administrative Agent (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000039/ex103-06302019.htm">Amendment No. 1, dated as of May 16, 2019, to the Five Year Credit Agreement dated as of May 17, 2018, by and among the Registrant, the lenders party thereto and The Bank of New York Mellon, as Administrative Agent (incorporated by reference to Exhibit 10.3 of the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/a06302020ex101.htm">364-Day Credit Agreement dated as of May 13, 2020 by and among the Registrant, the lenders party thereto, Barclays Bank PLC and JPMorgan Chase Bank, N.A., as Co-Syndication Agents, Goldman Sachs Bank USA, and Wells Fargo Bank, National Association, as Co-Documentation Agents, and Bank of America, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000039/ex102-06302019.htm">Five Year Credit Agreement dated as of May 16, 2019 by and among the Registrant, the lenders party thereto and Bank of America, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.2 of the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2019).</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">180</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312509163865/dex106.htm">The Registrant&#8217;s Supplemental Retirement Plan I for Select Senior Management, as amended and restated as of December 31, 2008 (incorporated by reference to Exhibit 10.6 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2009).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480314000008/ex1025restrictivecovenanta.htm">Form of Enterprise Non-Competition, Non-Disclosure and Developments Agreement between the Registrant and certain of the Registrant&#8217;s executive officers (incorporated by reference to Exhibit 10.25 of the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2013).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/exhibit1011-2019.htm">The Registrant&#8217;s Deferred Stock Compensation Plan, as amended and restated (incorporated by reference to Exhibit 10.11 to the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000094787120000499/ss173456-ex9902.htm">The Registrant&#8217;s 2007 Employee Stock Purchase Plan, as amended (incorporated by reference to Exhibit&#160;99.2 to the Registrant&#8217;s Registration Statement on Form&#160;S-8 filed May 19, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480316000074/a1028universal409adefiniti.htm">Universal 409A Definition Document, as amended (incorporated by reference to Exhibit&#160;10.28 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/exhibit1014-2019.htm">The Registrant&#8217;s Deferred Compensation Plan, as amended and restated (incorporated by reference to Exhibit 10.14 to the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480317000006/ex1025partnershipequitypro.htm">The Registrant&#8217;s Partnership Equity Program, as amended (incorporated by reference to Exhibit&#160;10.25 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480317000006/ex1027performance-basedres.htm">The Registrant&#8217;s Performance-Based Restricted Stock Unit Plan, as amended (incorporated by reference to Exhibit&#160;10.27 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000094787120000499/ss173456-ex9901.htm">The Registrant&#8217;s 2017 Incentive Compensation Plan, as amended (incorporated by reference to Exhibit 99.1 to the Registrant&#8217;s Registration Statement on Form S-8 filed May 19, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000155837017006198/cvs-20170630ex1043fff6d.htm">The Registrant&#8217;s Executive Incentive Plan, as amended (incorporated by reference to Exhibit&#160;10.4 to the Registrant&#8217;s Quarterly Report on Form&#160;10-Q for the fiscal quarter ended June 30, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000155837017006198/cvs-20170630ex105a3120c.htm">The Registrant&#8217;s Long-Term Incentive Plan, as amended (incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000008/ex1029formofnon-qualifieds.htm">Form&#160;of Non-Qualified Stock Option Agreement between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit&#160;10.29 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2014).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000008/ex1030formofrestrictedstoc.htm">Form&#160;of Restricted Stock Unit Agreement - Annual Grant - between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit&#160;10.30 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2014).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000008/ex1031formofpbrsagreement.htm">Form&#160;of Performance-Based Restricted Stock Unit Agreement between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit&#160;10.31 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2014).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000008/ex1032pepcompanymatchingpr.htm">Form&#160;of Partnership Equity Program Participant Purchased RSUs, Company Matching RSUs and Company Matching Options Agreement (Pre-Tax) (incorporated by reference to Exhibit&#160;10.32 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2014).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000008/ex1033pepcompanymatchingpo.htm">Form&#160;of Partnership Equity Program Participant Purchased RSUs, Company Matching RSUs and Company Matching Options Agreement (Post-Tax) (incorporated by reference to Exhibit&#160;10.33 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2014).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000155837018003777/cvs-20180331ex10150a8df.htm">Form of Performance Stock Unit Agreement - Annual Grant between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000155837018003777/cvs-20180331ex102304379.htm">Form of Performance Stock Unit Agreement (LTIP) - Annual Grant between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/a09302020ex101.htm">Form of Performance Stock Unit Agreement - Annual Grant between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/exhibit1027-2019.htm">The Registrant&#8217;s Management Incentive Plan (incorporated by reference to Exhibit 10.27 to the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex1037.htm">The Registrant&#8217;s Severance Plan for Non-Store Employees amended as of November 28, 2018 (incorporated by reference to Exhibit 10.37 to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex1038.htm">The Registrant&#8217;s Performance-Based Restricted Stock Unit Program, as amended (incorporated by reference to Exhibit 10.38 to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex1039.htm">Form&#160;of Non-Qualified Stock Option Agreement between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.39 to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018).</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">181</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex1040.htm">Form&#160;of Restricted Stock Unit Agreement - Annual Grant - between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.40 to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex1041.htm">Form&#160;of Performance-Based Restricted Stock Unit Agreement between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.41 to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex1042.htm">Form&#160;of Partnership Equity Program Participant Purchased RSUs, Company Matching RSUs and Company Matching Options Agreement (Pre-Tax) (incorporated by reference to Exhibit 10.42 to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480314000008/ex1031peppost-taxagreement.htm">Form&#160;of Partnership Equity Program Participant Purchased RSUs, Company Matching RSUs and Company Matching Options Agreement (Post-Tax) (incorporated by reference to Exhibit&#160;10.31 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2013).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000039/ex105-06302019.htm">Form of Performance Stock Unit Agreement - Annual Grant between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.5 of the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2019).</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312509041089/dex1038.htm">Amended and Restated Employment Agreement between the Registrant and Larry Merlo (incorporated by reference to Exhibit&#160;10.38 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2008).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000110465913011354/a12-28799_1ex10d31.htm">Amendment dated as of December&#160;21, 2012 to the Amended and Restated Employment Agreement between the Registrant and Larry Merlo (incorporated by reference to Exhibit&#160;10.31 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2012).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480317000006/ex1037ceooptionagreement16.htm">Form&#160;of Non-Qualified Stock Option Agreement - Annual Grant between the Registrant and Larry Merlo (incorporated by reference to Exhibit&#160;10.37 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480317000006/ex1038ceorsuagreement16.htm">Form&#160;of Restricted Stock Unit Agreement - Annual Grant between the Registrant and Larry Merlo (incorporated by reference to Exhibit&#160;10.38 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000002/exhibit101amendmentdatedja.htm">Amendment dated January 22, 2015 to Nonqualified Stock Option Agreements between the Registrant and Larry Merlo (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed January 23, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000039/ex105-06302019.htm">Form of Performance Stock Unit Agreement - Annual Grant between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000021/ex101.htm">Change in Control Agreement effective as of July 19, 2010 between the Registrant and Eva Boratto (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/exhibit1048-2019.htm">Restrictive Covenant Agreement dated June 21, 2019 between the Registrant and Eva Boratto (incorporated by reference to Exhibit 10.48 to the registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000110465913011354/a12-28799_1ex10d33.htm">Change in Control Agreement dated December&#160;22, 2008 between the Registrant and Jonathan Roberts (incorporated by reference to Exhibit&#160;10.33 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2012).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000110465913011354/a12-28799_1ex10d34.htm">Amendment dated as of December&#160;31, 2012 to the Change in Control Agreement dated December&#160;22, 2008 between the Registrant and Jonathan Roberts (incorporated by reference to Exhibit&#160;10.34 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2012).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480317000006/ex1044robertsrsuagreement16.htm">Restricted Stock Unit Agreement - Annual Grant dated April 1, 2016 between the Registrant and Jonathan Roberts (incorporated by reference to Exhibit&#160;10.44 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.48*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480317000006/ex1045robertsrestrictiveco.htm">Restrictive Covenant Agreement dated May 20, 2016 between the Registrant and Jonathan Roberts (incorporated by reference to Exhibit&#160;10.45 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.49*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000023/ex101changeincontrolagreem.htm">Change in Control Agreement dated October 1, 2012 between the Registrant and Thomas Moriarty (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/exhibit1056-2019.htm">Restrictive Covenant Agreement dated July 8, 2019 between the Registrant and Thomas Moriarty (incorporated by reference to Exhibit 10.56 of the Registrant's Annual Report on form 10-K for the fiscal year ended December 31, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1051-2020.htm">Amended and Restated Employment Agreement dated November 5, 2020 between the Registrant and Karen S. Lynch.</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">182</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1052-2020.htm">Restrictive Covenant Agreement dated November 6, 2020 between the Registrant and Karen S. Lynch.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.53*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Descriptions of certain arrangements not embodied in formal documents as described under the heading &#8220;Non-Employee Director Compensation&#8221; are incorporated herein by reference to the Proxy Statement (when filed). </span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiaries of the registrant</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit211-2020.htm">Subsidiaries of CVS Health Corporation.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consents of experts and counsel</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231-2020.htm">Consent of Ernst&#160;&amp; Young LLP.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rule 13a-14(a)/15d-14(a) Certifications</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-2020.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-2020.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Section 1350 Certifications</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-2020.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-2020.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interactive Data File</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the CVS Health Corporation Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2020 formatted in Inline XBRL: (i)&#160;the Consolidated Statements of Operations, (ii) the Consolidated Statements of Comprehensive Income (Loss), (iii)&#160;the Consolidated Balance Sheets, (iv)&#160;the Consolidated Statements of Cash Flows, (v) the Consolidated Statements of Shareholders&#8217; Equity and (vi)&#160;the related Notes to Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - The cover page from the Company's Annual Report on Form 10-K for the year ended December 31, 2020, formatted in Inline XBRL (included as Exhibit 101).</span></td></tr></table></div><div><span><br/></span></div><div id="ic31760c417ad433094d37b2420225748_244"></div><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16.  Form 10-K Summary.</span></div><div style="padding-right:2.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">183</span></div></div></div><div id="ic31760c417ad433094d37b2420225748_247"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ic31760c417ad433094d37b2420225748_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CVS HEALTH CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ EVA C. BORATTO</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eva C. Boratto</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ FERNANDO AGUIRRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fernando Aguirre</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ C. DAVID BROWN II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">C. David Brown II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ EVA C. BORATTO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eva C. Boratto</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Officer (Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ JAMES D. CLARK</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President - Controller and Chief</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">James D. Clark</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounting Officer (Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ ALECIA A. DECOUDREAUX</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Alecia A. DeCoudreaux</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ NANCY-ANN M. DEPARLE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nancy-Ann M. DeParle</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;DAVID W. DORMAN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair of the Board and Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">David W. Dorman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ ROGER N. FARAH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Roger N. Farah</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ ANNE M. FINUCANE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Anne M. Finucane</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ EDWARD J. LUDWIG</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Edward J. Ludwig</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ KAREN S. LYNCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Karen S. Lynch</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Executive Officer) and Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ LARRY J. MERLO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Larry J. Merlo</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ JEAN-PIERRE MILLON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Jean-Pierre Millon</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ MARY L. SCHAPIRO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Mary L. Schapiro</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ WILLIAM C. WELDON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">William C. Weldon</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ TONY L. WHITE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 16, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tony L. White</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.22
<SEQUENCE>2
<FILENAME>exhibit422-2020.htm
<DESCRIPTION>EX-4.22
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie63134c13da74cf4a099c88a50075343_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 4.22</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF COMMON STOCK REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font><br></font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following description (this &#8220;Description&#8221;) of the terms of the common stock of CVS Health Corporation (&#8220;CVS Health&#8221;) is a summary only and is qualified by reference to the relevant provisions of Delaware law and the Restated Certificate of Incorporation (the &#8220;Charter&#8221;) and the By-Laws (the &#8220;By-Laws&#8221;) of CVS Health.&#160;Copies of the Charter and the By-Laws&#160;are incorporated by reference as exhibits to the Annual Report on Form 10-K to which this Description is an exhibit.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Authorized Capital Stock</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Charter as of February 16, 2021, the authorized capital stock of CVS Health consisted of (i)&#160;3,200,000,000 shares of common stock, par value of $0.01 per share (&#8220;common stock&#8221;), (ii)&#160;120,619 shares of cumulative preferred stock, par value $0.01 per share (&#8220;preferred stock&#8221;), and (iii)&#160;50,000,000 shares of preference stock, par value $1.00 per share (&#8220;preference stock&#8221;).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of shares of common stock are entitled to one vote per share on all matters voted on by CVS Health stockholders, including elections of directors. Except as otherwise required by law, or by the provisions of the preferred stock or the preference stock, or provided in any resolution adopted by the CVS Health board of directors (the &#8220;board&#8221;) with respect to any subsequently created class or series of shares of CVS Health, the holders of the shares of common stock exclusively possess all voting power. The Charter precludes cumulative voting in the election of directors. The Charter provides for a majority vote standard for uncontested elections of directors, and a plurality of votes standard for contested elections of directors. Subject to any rights of any outstanding series of preferred stock or preference stock, (i) the holders of shares of common stock are entitled to such dividends as may be declared from time to time by the board from funds available therefor, (ii)&#160;no dividends may be declared, paid, or set aside for payment on shares of common stock unless full cumulative dividends are paid on any outstanding preference stock and any other preferred stock issued and outstanding at such time that is designated to have such dividend preference and (iii)&#160;upon dissolution the holders of shares of common stock are entitled to receive pro rata all assets of CVS Health available for distribution to such holders, subject to any liquidation preferences designated to any preferred stock or preference stock that may be issued and outstanding at such time of liquidation.</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Preemptive Rights</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Charter provides that no holder of any shares of CVS Health of any class or series may have any preemptive right to purchase or subscribe to any shares of CVS Health or any security convertible into shares of CVS Health of any class or series.</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provisions Relating to Amendments to CVS Health&#8217;s Charter and&#160;By-Laws</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, stockholders have the right to adopt, amend or repeal the certificate of incorporation and&#160;by-laws&#160;of a corporation. However, Delaware law requires that any amendment to the Charter also be approved by the board. Under Delaware law, unless a higher vote is required in a corporation&#8217;s certificate of incorporation, amendments to the corporation&#8217;s certificate of incorporation will be adopted upon receiving at a properly convened meeting the affirmative vote of a majority of the votes cast by all stockholders entitled to vote thereon, and if any class or series is entitled to vote thereon as a class, the affirmative vote of a majority of the votes cast in each class vote.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the&#160;By-Laws&#160;may be amended by the board with respect to all matters not exclusively reserved by law to the stockholders. Amendments to the&#160;By-Laws&#160;may be adopted and approved by the affirmative vote of the holders of record of a majority of the outstanding shares of stock of CVS Health entitled to vote at any annual or special meeting, or by the affirmative vote of a majority of the directors cast at any regular or special meeting, at which a quorum is present.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Statutory and Charter Provisions</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain provisions of the Charter and By-Laws summarized in the following paragraphs may be deemed to have an antitakeover effect and may delay, defer or prevent a tender offer or takeover attempt.  </font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential Issuances of Preferred Stock and Preference Stock</font></div><div style="margin-bottom:3pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February 16, 2021, the Charter authorized 120,619 shares of preferred stock, par value $0.01 per share and 50,000,000 shares of preference stock, par value $1.00 per share. The Charter also authorizes the board to issue shares of preferred stock or preference stock, from time to time, in such class or classes, and such series within any class, and with such designations, preferences and relative, participating, optional or other special rights, and qualifications, limitations or restrictions thereof as the board may determine, including, for example, (i)&#160;the designation of the class or series&#59; (ii)&#160;the number of shares of the class or series, which number the board may thereafter (except where otherwise provided in the designation of any subsequently authorized class or series) increase or decrease (but not below the number of shares thereof then outstanding)&#59; (iii)&#160;whether dividends, if any, will be cumulative or noncumulative and the dividend rate of the class or series&#59; (iv)&#160;the dates on which dividends, if any, will be payable&#59; (v)&#160;the redemption rights and price or prices, if any, for shares of the class or series&#59; (vi)&#160;the terms and amounts of any sinking fund provided for the purchase or redemption of shares of the class or series&#59; (vii)&#160;the amounts payable on shares of the class or series in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of CVS Health&#59; (viii)&#160;whether the shares of the class or series will be convertible into shares of any other class or series, or any other security, of CVS Health or any other corporation, and, if so, the specification of such other class or series or such other security, the conversion price or prices or rate or rates, any adjustments thereof, the date or dates as of which such shares will be convertible and all other terms and conditions upon which such conversion may be made&#59; (ix)&#160;restrictions on the issuance of shares of the same class or series or of any other class or series&#59; and (x)&#160;the voting rights, if any, of the holders of such class or series. The authorized capital stock of CVS Health, including preferred stock, preference stock and common stock, will be available for issuance without further action by CVS Health stockholders, unless such action is required by applicable law or the rules of any stock exchange or automated quotation system on which CVS Health&#8217;s securities may be listed or traded. If the approval of CVS Health stockholders is not so required, the board does not intend to seek stockholder approval.</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the board has no intention at the present time of doing so, it could issue a class or series of preferred stock or preference stock that could, depending on the terms of such class or series, impede completion of a merger, tender offer or other takeover attempt that the holders of some, or a majority, of CVS Health shares might believe to be in their best interests or in which CVS Health stockholders might receive a premium for their shares over the then-current market price of such shares.</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential Issuances of Rights to Purchase Securities</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health does not currently have a stockholder rights plan, although the board retains the right to adopt a new plan at a future date. The Charter grants the board exclusive authority to create and issue rights entitling the holders thereof to purchase from CVS Health shares of capital stock or other securities and to elect to repurchase, redeem, terminate or amend any such rights. The times at which and terms upon which such rights are to be issued, repurchased, redeemed, terminated or amended are to be determined exclusively by the board and set forth in the contracts or instruments that evidence any such rights. The authority of the board with respect to such rights includes determining, for example, (i)&#160;the purchase price of the capital stock or other securities or property to be purchased upon exercise of such rights&#59; (ii)&#160;provisions relating to the times at which and the circumstances under which such rights may be exercised or sold or otherwise transferred, either together with or separately from any other shares or other securities of CVS Health&#59; (iii)&#160;provisions which adjust the number or exercise price of such rights or the amount or nature of the shares, other securities or other property receivable upon exercise of such rights in the event of a combination, split or recapitalization of any shares of CVS Health, a change in ownership of CVS Health&#8217;s shares or other securities or a reorganization, merger, consolidation, sale of assets or other occurrence relating to CVS Health or any shares of CVS Health, and provisions restricting the ability of CVS Health to enter into any such transaction absent an assumption by the other party or parties thereto of the obligations of CVS Health under such rights&#59; (iv)&#160;provisions which deny the holder of a specified percentage of the outstanding securities of CVS Health the right to exercise such rights and&#47;or cause such rights held by such holder to become void&#59; (v)&#160;provisions which</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">permit CVS Health to redeem or exchange such rights&#59; and (vi)&#160;the appointment of the rights agent with respect to such rights. This provision is intended to confirm the board&#8217;s exclusive authority to issue, repurchase, redeem, terminate or amend share purchase rights or other rights to purchase shares or securities of CVS Health or any other corporation.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholder Action by Written Consent</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Charter provides that stockholder action may be taken at an annual or special meeting of stockholders or by written consent in lieu of a meeting, but only if such action is taken in accordance with the provisions of the Charter and&#160;By-Laws.&#160;Any person other than CVS Health seeking to have the CVS Health stockholders authorize or take corporate action by written consent without a meeting is required to deliver a written notice signed by holders of record of at least twenty-five percent (25%) of the voting power of the outstanding capital stock of CVS Health entitled to express consent on the relevant action and request that a record date be fixed for such purpose.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholder Vote on Fundamental or Extraordinary Corporate Transactions</font></div><div style="margin-bottom:3pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, a sale, lease or exchange of all or substantially all of CVS Health&#8217;s assets, an amendment to the Charter, a merger or consolidation of CVS Health with another corporation or a dissolution of CVS Health generally requires the affirmative vote of the board and, with limited exceptions, the affirmative vote of a majority of the aggregate voting power of the outstanding stock entitled to vote on the transaction.</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to transactions with related persons (persons who own at least 10% of the outstanding capital stock of CVS Health), the Charter provides that a majority of outstanding shares (excluding those owned by the related person) voting as a single class is required to approve a business combination transaction with a related person, unless (i) such transaction is approved by a majority of continuing directors (directors who are not the related person, or an affiliate or associate thereof (or a representative or nominee of the related person or such affiliate or associate), that is involved in the relevant business combination and (a) who were members of the board immediately prior to the time that such related person became a related person or (b) whose initial election as a director was recommended by the affirmative vote of a least a majority of the continuing directors then in office, provided that, in either such case, such continuing director has continued in office after becoming a continuing director) or (ii) certain fair price requirements are met.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Anti-Takeover Provisions</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health has not opted out of Section 203 of the Delaware General Corporation Law, which provides that, if a person acquires 15% or more of the outstanding voting stock of a Delaware corporation, thereby becoming an &#8220;interested stockholder,&#8221; that person may not engage in certain &#8220;business combinations&#8221; with the corporation, including mergers, purchases and sales of 10% or more of its assets, stock purchases and other transactions pursuant to which the percentage of the corporation&#8217;s stock owned by the interested stockholder increases (other than on a pro rata basis) or pursuant to which the interested stockholder receives a financial benefit from the corporation, for a period of three years after becoming an interested stockholder unless one of the following exceptions applies&#58; (i) the board approved the acquisition of stock pursuant to which the person became an interested stockholder or the transaction that resulted in the person becoming an interested stockholder prior to the time that the person became an interested stockholder&#59; (ii) upon consummation of the transaction that resulted in the person becoming an interested stockholder such person owned at least 85% of the outstanding voting stock of CVS Health, excluding, for purposes of determining the voting stock outstanding, voting stock owned by directors who are also officers and certain employee stock plans&#59; or (iii) the transaction is approved by the board and by the affirmative vote of two-thirds of the outstanding voting stock which is not owned by the interested stockholder. An &#8220;interested stockholder&#8221; also includes the affiliates and associates of a 15% or more owner and any affiliate or associate of CVS Health who was the owner of 15% or more of the outstanding voting stock within the three-year period prior to determine whether a person is an interested stockholder.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.51
<SEQUENCE>3
<FILENAME>exhibit1051-2020.htm
<DESCRIPTION>EX-10.51
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ieef2e3a26c934e97be88a3686ad62f97_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.51</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AMENDED AND RESTATED EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), dated   this 5th day of November 2020, by and between CVS Health Corporation, a Delaware corporation       (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS Health</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and Karen S. Lynch (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) (certain capitalized terms      used herein being defined in Article 6).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Executive is currently employed as Executive Vice President, CVS Health and President, Aetna, pursuant to an employment agreement dated, as of December 10, 2014, which was amended on November 28, 2018 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Original Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Company and Executive desire for Executive to transition from Executive&#8217;s position as Executive Vice President, CVS Health and President, Aetna to the position of President       and Chief Executive Officer of the Company&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, in connection with such transition, the Company and Executive desire to amend   and restate the Original Employment Agreement in its entirety to reflect the prior amendment thereto   and to set forth the revised terms of Executive&#8217;s employment as President and Chief Executive        Officer of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW THEREFORE, in consideration of the foregoing and of the mutual covenants and agreements of the parties set forth in this Agreement, and of other good and valuable consideration,       the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be     legally bound, agree as follows&#58;</font></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 1</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">POSITION&#59; AT-WILL EMPLOYMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 1.01. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Position.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;Effective on the 1st day of February 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), Executive shall commence her duties as President and Chief Executive Officer of CVS Health and shall provide    services to CVS Health and its subsidiaries in accordance with the terms of this Agreement.        Executive acknowledges that Executive&#8217;s employment under this Agreement will be with CVS  Pharmacy, Inc., a Delaware corporation and a subsidiary of CVS Health, and therefore references to      the Company in this Agreement shall also refer to CVS Pharmacy, Inc., unless the context indicates otherwise.  Executive shall be appointed to the Board of Directors of CVS Health Corporation      effective February 1, 2021 and, thereafter, shall be subject to annual re-election by stockholders beginning with the 2021 Annual Meeting of Stockholders.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In such position, Executive shall have such duties, responsibilities and authority, consistent with such position, as shall be determined from time to time by the Board and shall report       to the Board.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During Executive&#8217;s employment with the Company, Executive will devote     substantially all of her business time to the performance of her duties hereunder and will not engage        in any other business, profession or occupation for compensation or otherwise which would conflict    with the rendition of such services either directly or indirectly, without the prior written consent of        </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Board&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that nothing herein shall be deemed to preclude Executive, subject to the prior written consent of the Board, from serving on any business, civic or charitable board, managing    personal investments or participating in CEO leadership events, as long as such activities do not materially interfere with the performance of Executive&#8217;s duties hereunder.  If the Company         concludes that it is desirable, upon the Company&#8217;s request, Executive will resign from any board of directors on which she serves as soon as reasonably practicable considering her fiduciary duty to         such board&#8217;s company or civic or charitable organization, as the case may be.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 1.02. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">At-will Employment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Executive&#8217;s employment under this Agreement shall commence on the Effective Date and shall end on the date Executive&#8217;s employment is terminated, as provided herein.  For the avoidance of doubt, Executive&#8217;s employment with the Company shall at all times be on an at-will basis and nothing in this Agreement shall provide Executive the right to employment for any specified period following the Effective Date.</font></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 2</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">COMPENSATION AND BENEFITS</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 2.01. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Base Salary. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Starting on the Effective Date, the Company shall pay   Executive an annual base salary (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) at the initial annual rate of $1,450,000 payable        in equal monthly installments or otherwise in accordance with the payroll and personnel practices of     the Company from time to time.  The Base Salary shall be reviewed annually by the Board or the Committee for possible increase in the sole discretion of the Board or the Committee, as the case         may be.  Executive&#8217;s Base Salary, as in effect from time to time, may not be reduced by the         Company without Executive&#8217;s consent, except in the event of a ratable reduction affecting all senior officers of the Company.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 2.02. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Incentive Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject in each case to Executive&#8217;s continued employment as contemplated hereby&#58;</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Executive shall be eligible to participate in the Company&#8217;s annual bonus plan for similarly situated executives (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Annual Bonus Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) with a target annual cash bonus opportunity     of 200% of Base Salary (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Executive&#8217;s eligibility and target annual cash bonus opportunity are subject to periodic review and adjustment by the Board or the Committee.  The       Annual Bonus shall be determined in accordance with the terms of the Annual Bonus Plan, and     payment of the Annual Bonus shall be made at the same time that other senior-level executives of the Company receive their incentive awards, which is generally in March following the plan year.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Executive shall be eligible to receive annual equity awards at a level commensurate    with Executive&#8217;s position beginning in calendar year 2021.  For 2021, the cash value of Executive&#8217;s  target annual equity award is $11,000,000.  The composition of annual equity awards is currently        75% Company performance stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and 25% stock options.  As of the date hereof,       PSUs have a three-year cliff vesting period and a two-year post-vesting holding period for net shares      of Company common stock delivered upon settlement, and stock options vest in four equal      installments on the first four anniversaries of the grant date and have a ten-year term.  The        Company&#8217;s annual equity award program components, terms and weightings are reviewed annually       by the Committee and are subject to change.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 2.03. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefits&#59; Perquisites</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Executive shall be eligible for employee benefits that are offered to similarly situated executives of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Executive shall be entitled to use the Company aircraft in accordance with the Company&#8217;s aircraft policy, as approved by the Committee and as in effect from time to time.      Executive shall reimburse the Company for any costs of personal air travel that exceed $250,000 per calendar year.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 2.04. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Business Expenses.</font></div><div style="margin-bottom:0.12pt;text-indent:0.36pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Reasonable travel, entertainment and other business expenses incurred by Executive       in the performance of her duties hereunder shall be reimbursed by the Company in accordance with       the Company&#8217;s policies as in effect from time to time.</font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.02pt">The Company shall provide Executive with appropriate office facilities and support at  the Company&#8217;s headquarters, which shall be Executive&#8217;s principal job location.</font></div><div style="text-indent:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 3</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CERTAIN BENEFITS</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.01. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Certain Events. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Qualifying Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any of the following events&#58;</font></div><div><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The involuntary termination of Executive&#8217;s employment by the Company, other than    (y) for Cause, or (z) by reason of Executive&#8217;s death or Disability&#59; or</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Executive&#8217;s voluntary termination of employment for Good Reason, provided that Executive shall have provided the Company with notice of any event constituting Good Reason no      later than 30 days following the occurrence of such event and such termination occurs within 90 days after the occurrence of any event constituting Good Reason (that has not otherwise been cured by the Company prior to the end of such 90-day period).</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.02. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Separation Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Except to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> Section 5.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Executive shall be entitled to the benefits set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)   upon a termination of employment&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon any termination of employment including by reason of death or Disability, Executive&#8217;s voluntary termination of employment (with or without Good Reason) or upon        involuntary termination of Executive&#8217;s employment by the Company, Executive shall be entitled to&#58;</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Executive&#8217;s earned but unpaid Base Salary and other vested but unpaid cash entitlements (including any earned but unpaid cash Annual Bonus for the performance year prior to       the year in which Executive terminates employment) for the period through and including the date of termination of Executive&#8217;s employment (other than entitlements referenced in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.02(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> below)  (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Accrued Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Executive&#8217;s other vested benefits earned by Executive for the period through   and including the date of Executive&#8217;s termination of employment, which shall be paid in accordance   with the terms of the applicable plans, programs or arrangements (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Accrued Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Upon a Qualifying Event, the Company shall pay Executive in addition to the       amounts set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> above&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Cash compensation through the second anniversary of such Qualifying Event  (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Payment Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) in equal installments during the Payment Period in accordance with the applicable Company payroll, in an aggregate amount equal to two times the sum of (y) the highest      Base Salary in effect during the six-month period immediately prior to the time of such termination        of employment and (z) the Executive&#8217;s target Annual Bonus opportunity for the year of termination        of employment (such payment, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cash Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), on the condition that Executive         has delivered to the Company a release substantially in the form as attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (with such changes as may be required under applicable law) of any employment-related claims, provided     that this release must be signed within 30 days after the Executive&#8217;s separation from service and any payment that otherwise would be made within such 30-day period shall by paid at the expiration of     such 30-day period, subject to Executive&#8217;s execution of such release&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that if  Executive experiences a Qualifying Event within two years following a Change in Control, the Cash Severance Payment shall instead be an aggregate amount equal to two-and-a-half times the sum of         (y) the highest Base Salary in effect during the six-month period immediately prior to the time of        such termination of employment and (z) the Executive&#8217;s target Annual Bonus opportunity for the        year of termination of employment.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;A &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pro-Rata Bonus Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; for the year of Executive&#8217;s termination of employment calculated as Executive&#8217;s Annual Bonus opportunity multiplied by a fraction, the    numerator of which is the number of days in the year through the date of Executive&#8217;s termination of employment and the denominator of which is 365.  The Pro-Rata Bonus Amount shall be based on        the greater of Executive&#8217;s Annual Bonus opportunity at target and the actual funding percentage for      the Annual Bonus Plan for such performance period, as determined by the Committee in its sole discretion.  Payment of this pro-rata bonus amount, if any, shall be made to Executive at the same       time as annual bonuses are paid to senior executives of the Company&#59;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;With respect to equity awards made prior to the Effective Date, Executive shall be treated as eligible for &#8216;retirement&#8217; under the vesting and exercise terms of any such equity award.  For the avoidance of doubt, &#8216;retirement&#8217; treatment for equity awards made prior to the Effective Date shall mean&#58; (1) with respect to restricted stock units (excluding the Closing Sign-On Equity Award), performance stock units and any LTIP awards, pro-rated vesting as of Executive&#8217;s termination of employment date (with any performance criteria deemed achieved based on actual performance as of the end of the applicable performance period) and settlement on the originally scheduled settlement date&#59;   and (2) with respect to stock options and stock appreciation rights, immediate vesting in that portion of the stock option and&#47;or stock appreciation right that would have otherwise vested within one year following Executive&#8217;s termination of employment date and the ability to exercise such stock option     and&#47;or stock appreciation right for five years following Executive&#8217;s termination of employment date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that Executive shall not be permitted to exercise any stock option or stock appreciation right beyond the original term of such award.  Notwithstanding the foregoing, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.02(b)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not apply to the Closing Sign-On Equity Award or equity awards granted following the Effective Date&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;With respect to Company equity awards granted following the Effective Date, Executive shall be treated as &#8216;retirement&#8217; eligible under the vesting and exercise terms of the applicable award agreements relating to Company awards generally applicable to senior-level executives of the Company&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;Continued participation in all medical, health and life insurance plans at the  same benefit and cost sharing level at which Executive and Executive&#8217;s eligible dependents were participating on the date of termination of Executive&#8217;s employment until the earlier of&#58; (1) the 18-    month anniversary of Executive&#8217;s termination of employment date&#59; or (2) the date, or dates,        Executive receives equivalent coverage and benefits under the plans and programs of a subsequent employer (such coverage and benefits to be determined on a coverage-bycoverage, or benefit-by-  benefit, basis)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that (A) if Executive is precluded from continuing Executive&#8217;s participation in any employee benefit plan or program as provided in this clause (v), Executive shall receive cash payments equal on an aftertax basis to the cost to Executive of obtaining the benefits provided under the plan or program in which Executive is unable to participate for the period       specified in this clause (v), (B) such cost shall be deemed to be the lowest reasonable cost that would     be incurred by Executive in obtaining such benefit on an individual basis, and (C) payment of such amounts shall be made quarterly in advance. For the avoidance of doubt, Executive acknowledges        and agrees that Executive shall be responsible for Executive&#8217;s portion of any premiums due in   connection with Executive&#8217;s continued participation in any medical, health and life insurance plans pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.02(b)(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the extent that Executive is a &#8220;Specified Employee&#8221; within the meaning of Section 409A of the     Code at the time of her separation from service, to the extent required by Section 409A and the regulations issued thereunder, the payments to which Executive would otherwise be entitled during       the first six months following her separation of service shall be deferred and accumulated for a         period of six months and paid in a lump sum on the first day of the seventh month with the seventh month&#8217;s payment, with interest on such deferred compensation at the rate paid pursuant to the stable  value fund of the Company&#8217;s 401(k) plan or, if such fund no longer exists, the fund with the      investment criteria most clearly comparable to that of such fund.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;For the avoidance of doubt and consistent with the applicable award agreements,     equity awards made by Aetna before the Closing Effective Date, the Closing Sign-On Equity Award, 2018-2020 LTIP and any supplemental LTIP with respect to the 2018-2020 performance period shall     be treated as follows&#58;  (1) upon an involuntary termination of Executive&#8217;s employment by reason of  death, unvested awards shall become immediately vested (with any performance criteria deemed  achieved based on target performance as of Executive&#8217;s death)&#59; and (2) upon an involuntary     termination of Executive&#8217;s employment by reason of Disability, pro-rated vesting as of Executive&#8217;s termination of employment date (with any performance criteria deemed achieved based on actual performance as of the end of the applicable performance period)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in each case stock   options shall remain exercisable for one year following Executive&#8217;s termination of employment date, except that Executive shall not be permitted to exercise any stock option beyond the original term of   such award.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;If Executive experiences a Qualifying Event within two years following a Change in Control, any outstanding equity awards held by Executive at such time shall be treated in accordance  with the terms of the applicable award agreement governing such equity awards.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 4</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SUCCESSORS AND ASSIGNMENTS</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 4.01.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Successors. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company will require any successor (whether by reason of        a change in control, direct or indirect, by purchase, merger, consolidation, or otherwise) to all or substantially all of the business and&#47;or assets of the Company to expressly assume and agree to      perform the obligations under this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.  The Company&#8217;s     rights hereunder shall not otherwise be assignable without Executive&#8217;s consent.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 4.02. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Assignment by Executive. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement shall inure to the benefit of and        be enforceable by Executive&#8217;s personal or legal representatives, executors, administrators,         successors, heirs, distributees, devisees, and legatees.  If Executive should die or become disabled     while any amount is owed but unpaid to Executive hereunder, all such amounts, unless otherwise provided herein, shall be paid to Executive&#8217;s devisee, legatee, legal guardian or other designee, or if   there is no such designee, to Executive&#8217;s estate.  Executive&#8217;s rights hereunder shall not otherwise be assignable.</font></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 5</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MISCELLANEOUS</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Notices. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any notice required to be delivered hereunder shall be in writing     and shall be addressed</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">if to the Company, to&#58;</font></div><div style="padding-left:72pt;padding-right:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CVS Health Corporation</font></div><div style="padding-left:72pt;padding-right:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">One CVS Drive</font></div><div style="padding-left:72pt;padding-right:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MC 1160 </font></div><div style="padding-left:72pt;padding-right:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Woonsocket, RI 02895</font></div><div style="padding-left:72pt;padding-right:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58;  General Counsel</font></div><div style="padding-left:72pt;padding-right:72pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">if to Executive, to Executive&#8217;s last known address as reflected on the books and records of the     Company or such other address as such party may hereafter specify for the purpose by written notice      to the other party hereto.  With a copy to Thomas A. Hickey, Esq., Gunster, Yoakley &#38; Stuart, P.A.,    777 South Flagler Drive, Suite 500 East, West Palm Beach, FL 33401.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any such notice shall be deemed received on the date of receipt by the recipient thereof if received     prior to 5&#58;00 p.m. in the place of receipt and such day is a business day in the place of receipt.   Otherwise, any such notice shall be deemed not to have been received until the next succeeding    business day in the place of receipt.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.02. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Legal Fees and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company shall pay all legal fees, costs of litigation, arbitration (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, American Arbitration Association and arbitrator fees), prejudgment        interest, and other expenses which are reasonably incurred by Executive as a result of any conflict between the parties pertaining to this Agreement or in connection with the termination of Executive&#8217;s employment if Executive is the prevailing party as determined by the arbitrator.  In addition, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.12pt;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Company shall pay Executive&#8217;s reasonable legal fees and expenses associated with entering this Agreement.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.03. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Arbitration. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except as provided in any agreement referenced in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">       </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">5.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, any dispute or controversy arising under or in connection with this Agreement shall be settled        by arbitration, conducted before a panel of three arbitrators sitting in a location selected by Executive within 50 miles from the location of Executive&#8217;s principal place of employment with the Company,        in accordance with the rules of the American Arbitration Association then in effect.  The decision of     the arbitrators in that proceeding, shall be binding on the Company and Executive.  Judgment may be entered on the award of the arbitrator in any court having jurisdiction.  Notwithstanding the         foregoing of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, each of the parties agrees that, prior to submitting a dispute under this Agreement to arbitration, the parties agree to submit, for a period of sixty (60) days, to voluntary mediation before a jointly selected neutral third party mediator under the Employment Mediation      Rules of the American Arbitration Association to take place in Woonsocket, RI (however, such  mediation or obligation to mediate shall not suspend or otherwise delay any termination of      employment or other action of the Company or affect the Company&#8217;s other rights under this    Agreement).  Except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, each party shall pay its own expenses of such  mediation and&#47;or arbitration and all common expenses of such mediation and&#47;or arbitration shall be   borne equally by Executive and the Company.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.04. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Unfunded Agreement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The obligations of the Company under this      Agreement represent an unsecured, unfunded promise to pay benefits to Executive and&#47;or         Executive&#8217;s beneficiaries, and shall not entitle Executive or such beneficiaries to a preferential claim       to any asset of the Company.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.05. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Non-Exclusivity of Benefits. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless specifically provided herein, neither the provisions of this Agreement nor the benefits provided hereunder shall reduce any amounts otherwise payable, or in any way diminish Executive&#8217;s rights as an employee of the Company, whether existing  now or hereafter, under any compensation and&#47;or benefit plans (qualified or nonqualified), programs, policies, or practices provided by the Company, for which Executive may qualify&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that the Separation Benefits shall be in lieu of any severance benefits under any such plans, programs, policies or practices.  Vested benefits or other amounts which Executive is otherwise      entitled to receive under any plan, policy, practice, or program of the Company (i.e., including, but       not limited to, vested benefits under any qualified or nonqualified retirement plan), at or subsequent        to the date of termination of Executive&#8217;s employment shall be payable in accordance with such plan, policy, practice, or program except as expressly modified by this Agreement.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.06. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Employment Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Nothing herein contained shall interfere with the Company&#8217;s right to terminate Executive&#8217;s employment with the Company at any time, with or        without Cause, subject to the Company&#8217;s obligation to provide Separation Benefits and other benefits provided hereunder, if any.  Executive shall also have the right to terminate her employment with the Company at any time without liability, subject only to her obligations under the employee covenants      or obligations contained in any equity or other awards granted to Executive or any other obligation  agreed to by Executive before or after the Effective Date.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.07. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Mitigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In no event shall Executive be obligated to seek other    employment or take any other action by way of mitigation of the amounts payable to Executive under  any of the provisions of this Agreement nor shall the amount of any payment or benefit hereunder be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.12pt;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">reduced by any compensation earned by Executive as a result of employment by another employer, including, but not limited to, Executive&#8217;s eligibility for any retiree health benefits.</font></div><div><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.08. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Entire Agreement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement represents the entire agreement between Executive and the Company and its affiliates with respect to Executive&#8217;s employment and&#47;or       severance rights, and, as of the Effective Date, supersedes all prior discussions, negotiations, and agreements concerning such rights (including the Original Employment Agreement, as amended).</font></div><div><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.09. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything in this Agreement to the   contrary, the Company shall withhold from any amounts payable under this Agreement all federal,     state, city, or other taxes as are legally required to be withheld.</font></div><div><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Waiver of Rights. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The waiver by either party of a breach of any provision of this Agreement shall not operate or be construed as a continuing waiver or as a consent to or waiver        of any subsequent breach hereof.</font></div><div><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.11. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Severability. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event any provision of the Agreement shall be held     illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Agreement, and the Agreement shall be construed and enforced as if the illegal or invalid provision      had not been included.</font></div><div><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Governing Law. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement shall be governed by, construed and   enforced in accordance with the laws of the State of Rhode Island without reference to principles of conflicts of laws.</font></div><div><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Counterparts. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement may be signed in several counterparts, each     of which shall be an original, with the same effect as if the signatures thereto and hereto were on the  same instrument.</font></div><div><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.14. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Indemnification. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During Executive&#8217;s employment with the Company and       for so long thereafter as Executive may have any liability as a result of her service&#58;  (a) the Company  shall indemnify Executive (and Executive&#8217;s legal representatives or other successors) to the fullest   extent permitted by the Certificate of Incorporation and By-Laws of the Company, as in effect at         such time or on the Effective Date&#59; and (b) Executive shall be entitled to the protection of any     insurance policies that the Company may elect to maintain generally for the benefit of its directors        and officers (and to the extent the Company maintains such an insurance policy or policies,         Executive shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available for any officer or director of the Company), against all     costs, charges and expenses whatsoever incurred or sustained by Executive or Executive&#8217;s legal representatives at the time such costs, charges and expenses are incurred or sustained, in connection    with any action, suit or proceeding to which Executive (or Executive&#8217;s legal representatives or other successors) may be made a party by reason of Executive&#8217;s serving or having served as a director,     officer or employee of the Company, or any subsidiary or Executive&#8217;s serving or having served any   other enterprise as a director, officer, employee or fiduciary at the request of the Company.  For   purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it is understood and agreed that the Company&#8217;s Certificate of   Incorporation provide, and shall continue to provide the maximum indemnification permitted by the Company&#8217;s State of Incorporation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Restrictive Covenant Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  Concurrently with the execution of this Agreement, Executive shall execute the Company&#8217;s Restrictive Covenant Agreement (the       &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restrictive Covenant Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, which shall become effective      upon the Effective Date and shall supersede Executive&#8217;s current Restrictive Covenant Agreement,     dated as of December 8, 2018, which shall remain in full force and effect until such time.  Executive acknowledges that the Company may modify such Restrictive Covenant Agreement in the future in connection with the granting of equity awards and Executive agrees to execute a modified agreement      to the extent the modification is applicable to senior officers of the Company and not in anticipation       of a Change in Control.  Upon request by the Company, Executive agrees to execute a new        Restrictive Covenant Agreement, with substantially similar post-employment non-competition and     non-solicitation periods and limitations as those set forth in the Restrictive Covenant Agreement then applicable to Executive, upon Executive&#8217;s termination of employment in exchange for a one-time        cash payment equal to $10,000, which shall be paid within 30 days of Executive&#8217;s execution of such Restrictive Covenant Agreement.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Stock Ownership Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Executive acknowledges and understands      that the Company has adopted certain stock ownership guidelines for executives and that the       Company expects Executive to own shares of stock in the Company consistent with Executive&#8217;s    position in accordance with such stock ownership guidelines, as approved by the Committee and as         in effect from time to time.</font></div><div style="margin-bottom:8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Section 409A. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If any provision of this Agreement (or any award of  compensation or benefits provided under this Agreement) would cause Executive to incur any    additional tax or interest under Section 409A of the Code, the Company shall reform such provision        to comply with Section 409A and agrees to maintain, to the maximum extent practicable without  violating Section 409A of the Code, the original intent and economic benefit to Executive of the applicable provision.  The Company shall not accelerate the payment of any deferred compensation        in violation of Section 409A of the Code and to the extent required under Section 409A, the        Company shall delay the payment of any deferred compensation for six months following        Executive&#8217;s termination of employment.  When used in connection with any payments subject to    Section 409A required to be made hereunder, the phrase &#8220;termination of employment&#8221; and        correlative terms shall mean separation from service as defined in Section 409A.  Unless such     payments are otherwise exempt from Section 409A, any reimbursements or in-kind benefits provided under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 2.03, 2.04, 3.02 or 5.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of this Agreement shall be administered in accordance with Section 409A, such that&#58;  (a) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during one year shall not affect the expenses eligible for reimbursement or the in-kind    benefits provided in any other year&#59; (b) reimbursement of eligible expenses shall be made on or        before December 31 of the year following the year in which the expense was incurred&#59; and (c) Executive&#8217;s right to reimbursement or in-kind benefits shall not be subject to liquidation or to      exchange for another benefit.  For purposes of Section 409A, Executive&#8217;s right to receive any   installment payments pursuant to this Agreement shall be treated as a right to receive a series of    separate and distinct payments.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5.18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Section 280G. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything in this Agreement to the contrary,       in the event the Separation Benefits described in this Agreement either alone or together with any      other payments and benefits which Executive has the right receive from the Company or any        affiliated company (together with the Separation Benefits, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Total Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) would subject   Executive to an excise tax under Section 4999 of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), then the Company       shall reduce the Separation Benefits (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Benefit Reduction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) by the amount necessary to result in<br> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.12pt;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Executive not being subject to the Excise Tax, if such reduction would result in Executive&#8217;s &#8220;Net     After-Tax Amount&#8221; attributable to the Total Benefits being greater than it would be if no Benefit Reduction was effected. For this purpose &#8220;Net After-Tax Amount&#8221; shall mean the net amount of the  Total Benefits that Executive is entitled to receive under this Agreement or any other agreement, plan     or arrangement of the Company or otherwise after giving effect to all federal, state and local taxes        that would be applicable to such payments, including, but not limited to, the Excise Tax. The determination of whether any such Benefit Reduction shall be effected shall be made by a nationally recognized public accounting firm selected by the Company that is reasonably acceptable to       Executive and is not the audit firm of the potential acquirer in any transaction that would constitute a Change in Control (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Accounting Firm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and such determination shall be binding on both     Executive and the Company.  In the event it is determined that a Benefit Reduction is required, the  parties shall cooperate in all material respects to mitigate the amount of any such reduction.  To the  extent that any Benefit Reduction is required following mitigation, then such reduction shall be done   first by reducing cash severance&#59; then any accelerated vesting of any equity awards shall be reduced       or eliminated or waived, in reverse order of date of grant&#59; and finally any other benefits to which Executive is or may be entitled shall be reduced or eliminated, all as determined by the Accounting   Firm.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.19. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No provision of this Agreement may be altered, modified, or amended      unless such alteration, modification or amendment is agreed to in writing and signed by each of the parties hereto.</font></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 6</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DEFINITIONS</font></div><div><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 6.01. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  For purposes of this Agreement, the following terms shall have  the meanings set forth below.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accounting Firm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 5.18.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accrued Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 3.02.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Accrued Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 3.02.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Aetna</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means Aetna Inc., a Pennsylvania corporation.</font></div><div style="padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in the introductory paragraph of</font></div><div style="padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this Agreement.</font></div><div style="padding-right:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 2.02(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Annual Bonus Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 2.02(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 2.01.</font></div><div style="margin-bottom:12pt;padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Beneficial Owner</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning ascribed to such term in Rule 13d-3 under the Exchange Act (including any successor to such rule).</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Benefit Reduction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 5.18.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company.</font></div><div style="padding-right:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cash Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section </font></div><div style="margin-bottom:12pt;padding-left:0.36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.02(b)(i).</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any one or more of the following&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Executive&#8217;s willful and material breach of Sections 2, 3, 4 or 7 of the Restrictive Covenant Agreement&#59;</font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Executive is convicted of a felony involving moral turpitude&#59; or</font></div><div><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Executive engages in conduct that constitutes willful gross neglect or willful gross misconduct in carrying out Executive&#8217;s duties under this Agreement, resulting, in either case, in    material harm to the financial condition or reputation of the Company.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For purposes of this Agreement, an act or failure to act on Executive&#8217;s part shall be       considered &#8220;willful&#8221; if it was done or omitted to be done by Executive not in good faith and shall not include any act or failure to act resulting from any incapacity of Executive.  For purposes of this definition, wherever the term &#8220;Cause&#8221; is used in plans or other agreements governing Executive&#8217;s    rights, the term used in such plans or other agreements shall be no less favorable to Executive than        the term Cause herein.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A termination for Cause shall not take effect unless the provisions of this paragraph are   complied with.  Executive shall be given written notice by the Company of its intention to terminate Executive for Cause, such notice (i) to state in detail the particular act or acts or failure or failures to      act that constitute the grounds on which the proposed termination for Cause is based&#59; and (ii) to be    given within 90 days of the Company&#8217;s learning of such act or acts or failure or failures to act.    Executive shall have 20 days after the date that such written notice has been given to Executive in    which to cure such conduct, to the extent such cure is possible.  If Executive fails to cure such       conduct, Executive shall then be entitled to a hearing before the Committee at which Executive is   entitled to appear.  Such hearing shall be held within 25 days of such notice to Executive, provided Executive requests such hearing within 10 days of the written notice from the Company of the      intention to terminate Executive for Cause.  If, within five days following such hearing, Executive is furnished written notice by the Board confirming that, in its judgment, grounds for Cause on the basis of the original notice exist, Executive shall thereupon be terminated for Cause.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the occurrence of&#58;  </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">any Person (other than (i) the Company, (ii) any trustee or other fiduciary holding securities under any employee benefit plan of the Company, (iii) any company owned, directly or indirectly, by the stockholders of the Company immediately after the occurrence with respect to       which the evaluation is being made in substantially the same proportions as their ownership of the common stock of the Company immediately prior to such occurrence or (iv) any surviving or       resulting entity from a merger or consolidation referred to in clause (c) below that does not constitute       a Change in Control under clause (c) below) becomes the Beneficial Owner (except that a Person        shall be deemed to be the Beneficial Owner of all shares that any such Person has the right to acquire pursuant to any agreement or arrangement or upon exercise of conversion rights, warrants or options      or otherwise, without regard to the 60 day period referred to in Rule 13d-3 under the Exchange Act), </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:0.27pt;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">directly or indirectly, of securities of the Company or of any subsidiary owning directly or indirectly      all or substantially all of the consolidated assets of the Company (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Significant Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), representing 30% or more of the combined voting power of the Company&#8217;s or such Significant Subsidiary&#8217;s then outstanding securities&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">during any period of 12 consecutive months, individuals who at the beginning of such period constitute the Board, and any new director whose election by the Board or nomination for   election by the Company&#8217;s stockholders was approved by a vote of at least a majority of the directors  then still in office who either were directors at the beginning of the 12 month period or whose        election or nomination for election was previously so approved, cease for any reason to constitute at   least a majority of the Board&#59;</font></div><div style="padding-left:27.7pt;text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the consummation of a merger or consolidation of the Company or any Significant Subsidiary with any other entity, other than a merger or consolidation which would result in the       voting securities of the Company or a Significant Subsidiary outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities       of the surviving or resulting entity) more than 50% of the combined voting power of the surviving or resulting entity outstanding immediately after such merger or consolidation&#59; or</font></div><div style="padding-left:27.7pt;text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the consummation of a transaction (or series of transactions within a 12 month       period) which constitutes the sale or disposition of all or substantially all of the consolidated assets of   the Company but in no event assets having a gross fair market value of less than 40% of the total       gross fair market value of all of the consolidated assets of the Company (other than such a sale or disposition immediately after which such assets will be owned directly or indirectly by the      stockholders of the Company in substantially the same proportions as their ownership of the common stock of the Company immediately prior to such sale or disposition).</font></div><div style="padding-left:27.7pt;text-indent:36pt"><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#3d3d3d;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">For purposes of&#160;</font><font style="color:#262626;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">this definition of Change in Control</font><font style="color:#595959;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">, t</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">he&#160;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">t</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">erm&#160;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">&#8220;Pe</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">rson&#8221;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">&#160;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">shall have the&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">mean</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">i</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">ng ascribed&#160;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">to&#160;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">such&#160;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">term i</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">n&#160;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">Section 3(a)(9) of&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">the Exchange&#160;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">Act and used&#160;</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">i</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">n Sections&#160;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">13(d)</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">&#160;and 14(d) thereof,&#160;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">includ</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">ing&#160;</font><font style="color:#444444;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">&#8220;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">group&#8221; as defined&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">in&#160;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">Section&#160;</font><font style="color:#0f0f0f;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">13</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">(d)</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">&#160;thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Closing Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means November 28, 2018.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Closing Sign-On Equity Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the sign-on equity award granted to Executive on        the Closing Effective Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean the Management Planning and Development Committee of the      Board.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means CVS Health Corporation, a Delaware corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means Long-Term Disability, as such term is defined in the Disability Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Disability Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the long-term disability plan (or any successor disability and&#47;or survivorship plan adopted by the Company) in which Executive participates, as in effect immediately prior to the relevant event (subject to changes in coverage levels applicable to all employees        generally covered by such Disability Plan).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 1.01.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934, as amended from time to time,       or any successor act thereto.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 5.18.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in the introductory paragraph of this  Agreement.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means, without Executive&#8217;s express written consent, the occurrence of any      one or more of the following&#58;  (a)&#160;a reduction by the Company of Executive&#8217;s Base Salary or Annual Bonus from the level in effect immediately prior thereto, except in the event of a ratable reduction affecting all senior officers of the Company&#59; (b)&#160;an assignment of any duties to Executive that is materially inconsistent with Executive&#8217;s duties and responsibilities or a material diminution of Executive&#8217;s duties and responsibilities, in each case as such duties and responsibilities were in effect immediately following the Effective Date&#59; (c)&#160;any failure of a successor of the Company to assume      and agree to perform the Company&#8217;s entire obligations under this Agreement, as required by   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereof, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such successor has received at least ten (10) days written notice      from the Company or Executive of the requirements of such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; (d)&#160;Executive reporting to    any person other than the Board&#59; (e)&#160;removal of Executive as President and Chief Executive Officer        of the Company (other than in connection with a termination of Executive&#8217;s employment for Cause)&#59; (f)&#160;any action or inaction by the Company that constitutes a material breach of the terms of this Agreement&#59; or (g) the Company&#8217;s failure to nominate and recommend Executive for re-election to         the Board. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">LTIP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Company&#8217;s long-term incentive program.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Original Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in the recitals to this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Payment Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 3.02.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Pro-Rata Bonus Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 3.02.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">PSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 2.02(c).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Qualifying Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 3.01.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Restrictive Covenant Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 5.15.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 3.02.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Total Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning accorded such term in Section 5.18.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></div></div><div id="ieef2e3a26c934e97be88a3686ad62f97_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company and Executive have executed this Agreement on this 5th day of November 2020.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:44.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.815%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#47;s&#47; Lisa Bisaccia</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Lisa Bisaccia</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Chief Human Resources Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Acknowledged and Accepted&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">CVS PHARMACY, INC.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#47;s&#47; Lisa Bisaccia</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Lisa Bisaccia</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Chief Human Resources Officer</font></td></tr><tr style="height:69pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">EXECUTIVE</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#47;s&#47; Karen S. Lynch</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Karen S. Lynch</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Exhibit A&#58; Form of Release Agreement</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Exhibit B&#58; Restrictive Covenant Agreement</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:234pt"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:5.95pt;text-indent:-5.95pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.52
<SEQUENCE>4
<FILENAME>exhibit1052-2020.htm
<DESCRIPTION>EX-10.52
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i343fdf5061f0477789462206d78d7f2b_7"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.52</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">CVS Health Corporation</font></div><div style="margin-bottom:16pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">Restrictive Covenant Agreement</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">I, Karen Lynch, enter into this Restrictive Covenant Agreement (&#8220;Agreement&#8221;) with CVS Health Corporation, on its own behalf and on behalf of its subsidiaries and affiliates (&#8220;CVS&#8221; or &#8220;Corporation&#8221;), which is effective as of February 1, 2021 (&#8220;Effective Date&#8221;) and shall supersede my current Restrictive Covenant Agreement, dated as of December 8, 2018 (&#8220;Current Restrictive Covenant Agreement&#8221;), which shall remain in full force and effect until such time. In consideration of the mutual promises in this Agreement, the parties agree as follows&#58;</font></div><div style="margin-bottom:5pt;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">1.&#160;&#160;&#160;&#160;Consideration for Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">In connection with my duties and responsibilities at CVS Health Corporation or one of its subsidiaries or affiliates, including but not limited to CVS Pharmacy, Inc., Aetna, Inc., Caremark, LLC and Coram, LLC (collectively, the &#8220;Corporation&#8221;), the Corporation will provide me with Confidential Information and&#47;or access to the Corporation&#8217;s customers and clients and the opportunity to develop and maintain relationships and goodwill with them.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">In addition, the Corporation has awarded me additional financial compensation, pursuant to my Amended and Restated Employment Agreement, dated as of November 5, 2020 (&#8220;Employment Agreement&#8221;), which is contingent on the execution of this Agreement and compliance with its terms.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">2.&#160;&#160;&#160;&#160;Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">During my employment by the Corporation and during the Non-Competition Period following the termination of my employment for any reason, I will not, directly or indirectly, engage in Competition or provide Consulting or Audit Services within the Restricted Area.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">a.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Engaging in &#8220;Competition&#8221; means providing services to a Competitor of the Corporation (whether as an employee, independent contractor, consultant, principal, agent, partner, officer, director, investor, or shareholder, except as a shareholder of less than one percent of a publicly traded company) that&#58; (i) are the same or similar in function or purpose to the services I provided to the Corporation at any time during the last two years of my employment by the Corporation&#59; or (ii) will likely result in the disclosure of Confidential Information to a Competitor or the use of Confidential Information on behalf of a Competitor. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">If a representative of the Corporation, during my employment or the Non-Competition Period, requests that I identify the company or business to which I will be or am providing services, or with which I will be or am employed, and requests that I provide information about the services that I am or will be providing to such entity, I shall provide the Corporation with a written statement detailing the identity of the entity and the nature of the services that I am or will be providing to such entity with sufficient detail to allow the Corporation to independently assess whether I am or will be in violation of this Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Such statement shall be delivered to the Corporation&#8217;s Chief Human Resources Officer or her authorized delegate via personal delivery</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">or overnight delivery within five calendar days</font><font style="color:#1f497d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">of my receipt of such request.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">b.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Competitor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">A &#8220;Competitor&#8221; for purposes of this Agreement shall mean any person, corporation or other entity that competes with one or more of the business offerings of the Corporation  As of the Effective Date, the Corporation&#8217;s business offerings include&#58; (i) pharmacy benefits management (&#8220;PBM&#8221;), including&#58;  (a) the administration of pharmacy benefits for businesses, government agencies and health plans&#59; (b) mail order pharmacy&#59; (c) specialty pharmacy&#59; (d) the procurement of prescription drugs at a negotiated rate for dispensing&#59; and (e) Medicare Part D </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Page &#124; 1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2020 Karen Lynch RCA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">services&#59; (ii) retail, which includes the sale of prescription drugs, over-the-counter medications, beauty products and cosmetics, digital and traditional photo finishing services, digital and other online offerings, seasonal and other general merchandise, greeting cards, convenience foods and other product lines and services which  are sold by the Corporation&#8217;s retail division (&#8220;Retail&#8221;)&#59; (iii) retail health clinics (&#8220;MinuteClinic&#8221;)&#59;  (iv) the provision of pharmaceutical products and ancillary services, including specialty pharmaceutical products and support services and the provision of related pharmacy consulting, data management services and medical supplies to long-term care facilities, other healthcare service providers and recipients of services from such facilities (&#8220;Long- Term Care&#8221;)&#59; (v) the provision of prescription infusion drugs and related services (&#8220;Infusion&#8221;)&#59; (vi) the provision of insurance (&#8220;Insurance&#8221;) including&#58; (a) health insurance products and services&#59; (b) managed health care products and services&#59; (c) dental, vision, workers compensation and employee assistance program products and services&#59; (d) wellness products and services to employers, government agencies,  health plans, other businesses or third party payers&#59;  (e) other voluntary products that are excepted benefits under HIPAA&#59; (vii) the creation and provision of population health management products and services (&#8220;Health Management&#8221;)&#59; (viii) the administration of (ii) &#8211; (vii) (&#8220;Administration&#8221;)&#59; and (ix) any other business in which Corporation is engaged or imminently will be engaged. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">For the purpose of assessing whether I am engaging in &#8220;Competition&#8221; under Section 2(a)(i) above, a person, corporation or other entity shall not be considered a Retail Competitor if such entity derives annual gross revenues from its business in an amount which is less than 2% of the Corporation&#8217;s gross revenues from Retail, during its most recently completed fiscal year. For avoidance of doubt, this exclusion does not apply to a determination of whether I am engaging in &#8220;Competition&#8221; as set forth in Section 2(a)(ii) above.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">The parties acknowledge that both the Corporation&#8217;s products and services and the entities which compete with the Corporation&#8217;s products and services evolve and an entity will be considered a Competitor if it provides products or services competitive with the products and services provided by the Corporation within the last two years of my employment.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">I agree to this enterprise-wide definition of Competition which may prevent me from providing services to any of the Corporation&#8217;s PBM, Retail, Insurance, Health Management, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">MinuteClinic, Long-Term Care, Administration and&#47;or Infusion Competitors or any combination thereof during the Non-Competition period.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">       </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">c.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Consulting or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Audit Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">&#8220;Consulting or Audit Services&#8221; shall mean any activity which involves providing audit review or other consulting or advisory services with respect to any relationship or prospective relationship between the Corporation and any third party that is likely to result in the use or disclosure of Confidential Information.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">   </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">d.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Non-Competition Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">The &#8220;Non-Competition Period&#8221; shall be the period of 24 months following the termination of my employment with the Corporation for any reason.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">e.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Restricted Area</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">&#8220;Restricted Area&#8221; refers to those states within the United States in which the Corporation conducts its business, as well as the District of Columbia and Puerto Rico.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">To the extent I worked on international projects in Asia, Europe, Brazil or other countries where the Corporation may conduct business, the Restricted Area includes those countries and those countries where the Corporation is actively planning to conduct business. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Page &#124; 2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2020 Karen Lynch RCA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">3.&#160;&#160;&#160;&#160;Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">During the Non-Solicitation Period, which shall be during my employment by the Corporation and for 24 months following the termination of my employment  with the Corporation for any reason, I will not, unless a duly authorized officer of the Corporation gives me written authorization to do so&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">a.&#160;&#160;&#160;&#160;interfere with the Corporation&#8217;s relationship with its Business Partners by soliciting or communicating (regardless of who initiates the communication) with a Business Partner to&#58; (i) induce or encourage the Business Partner to stop doing business or reduce its business with the Corporation, or (ii) buy a product or service that competes with a product or service offered by the Corporation&#8217;s business.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">&#8220;Business Partner&#8221; means&#58; a customer (person or entity), prospective customer (person or entity), healthcare provider, supplier, agency, manufacturer, broker, hospital, hospital system, long-term care facility, and&#47;or pharmaceutical manufacturer with whom the Corporation has a business relationship and with which I had business-related contact or dealings, or about which I received Confidential Information, in the two years prior to the termination of my employment with the Corporation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">A Business Partner does not include a customer, supplier, manufacturer, broker, hospital, hospital system, long-term care facility and&#47;or pharmaceutical manufacturer which has fully and finally ceased doing any business with the Corporation independent of any conduct or communications by me or breach of this Agreement and such full cessation of business has been in effect for at least 1 year prior to my separation from employment with the Corporation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Nothing in this Paragraph 3(a) shall prevent me from working as a staff pharmacist or in another retail position wherein I would be providing or selling prescriptions or other products directly to consumers.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">b.&#160;&#160;&#160;&#160;work on a Corporation account on behalf of a Business Partner or serve as the representative of a Business Partner for the Corporation. </font></div><div><font><br></font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">c.&#160;&#160;&#160;&#160;interfere with the Corporation&#8217;s relationship with any employee or contractor of the Corporation by&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">(i) soliciting or communicating with the employee or contractor to induce or encourage him or her to leave the Corporation&#8217;s employ or engagement (regardless of who first initiates the communication)&#59; (ii) helping another person or entity evaluate such employee or contractor as an employment or contractor candidate&#59; or (iii) otherwise helping any person or entity hire an employee or contractor away from the Corporation.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">4.&#160;&#160;&#160;&#160;Non-Disclosure of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">a.&#160;&#160;&#160;&#160;Subject to Sections 7 and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">8 below, I will not at any time, whether during or after the termination of my employment, disclose to any person or entity any of the Corporation&#8217;s Confidential Information, except as may be appropriately required in the ordinary course of performing my duties as an employee of the Corporation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">The Corporation&#8217;s Confidential Information includes but is not limited to the following non-public information&#58; trade secrets&#59; computer code generated or developed by the Corporation&#59; software or programs and related documentation&#59; strategic compilations and analysis&#59; strategic processes&#59; business or financial methods, practices and plans&#59; non-public costs and prices&#59; operating margins&#59; marketing, merchandising and selling techniques and information&#59; customer lists&#59; provider lists&#59; details of customer agreements&#59; pricing arrangements with pharmaceutical manufacturers, distributors or suppliers including but not limited to any discounts and&#47;or rebates&#59; pharmacy reimbursement rates&#59; premium information&#59; payment rates&#59; contractual forms&#59; expansion strategies&#59; real estate strategies&#59; operating strategies&#59; sources of supply&#59; patient records&#59; business plans&#59; other financial, commercial, business or technical information related to the Corporation and confidential information of third </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Page &#124; 3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2020 Karen Lynch RCA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">parties which is given to the Corporation </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">pursuant to an obligation or agreement to keep such information confidential (collectively, &#8220;Confidential Information&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">I shall not use or attempt to use any Confidential Information on behalf of any person or entity other than the Corporation, or in any manner which may injure or cause loss or may be calculated to injure or cause loss, whether directly or indirectly, to the Corporation. </font><font style="color:#1f497d;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">If, at any time over the last two years of my employment at CVS, my position included access to Confidential Information, as described above, specifically related to the Corporation&#8217;s procurement of prescription drugs, I understand and agree my employment with a pharmaceutical manufacturer, distributor or supplier (&#8220;Pharmaceutical Entity&#8221;)would place a substantial risk of use and&#47;or disclosure of Confidential Information with which I have been or will be entrusted during my employment with the Corporation.  In light of this risk of disclosure, I acknowledge and agree that the Corporation will be entitled to immediate injunctive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">relief to prevent me from disclosing any such Confidential Information in the course of my employment with any such Pharmaceutical Entity.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">I agree that the disclosure of such Confidential Information, to Corporation&#8217;s PBM Competitors with which one may negotiate in the course of employment with such Pharmaceutical Entity, would cause immediate and irreparable harm to the Corporation. For employees residing in Connecticut, these restrictions on use or disclosure of Confidential Information will only apply for three (3) years after the end of my employment where information that does not qualify as a trade secret is concerned&#59; however, the restrictions will continue apply to trade secret information for as long as the information at issue remains qualified as a trade secret.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">b.&#160;&#160;&#160;&#160;During my employment, I shall not make, use, or permit to be used, any materials of any nature relating to any matter within the scope of the business of the Corporation or concerning any of its dealings or affairs other than for the benefit of the Corporation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">I shall not, after the termination of my employment, use or permit to be used any such materials and shall return same in accordance with Section 5 below.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">5.&#160;&#160;&#160;&#160;Ownership and Return of the Corporation&#8217;s Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">On or before my final date of employment with the Corporation, I shall return to the Corporation all property of the Corporation in my possession, custody or control, including but not limited to the originals and copies of any information provided to or acquired by me in connection with the performance of my duties for the Corporation, such as files, correspondence, communications, memoranda, e-mails, slides, records, and all other documents, no matter how produced or reproduced, all computer equipment, communication devices (including but not limited to any mobile phone or other portable digital assistant or device), computer programs and&#47;or files, and all office keys and access cards.  I agree  that all the items described in this Section are the sole property of the Corporation.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">6.&#160;&#160;&#160;&#160;Rights to Inventions, Works</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">a.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">Assignment of Inventions.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">All inventions, original works of authorship, developments, concepts, improvements, designs, discoveries, ideas, trademarks or trade secrets, whether patentable or otherwise protectable under similar law, made, conceived or developed by me, whether alone or jointly with others, from the date of my initial employment by the Corporation and continuing until the end of any period during which I am employed by the Corporation, relating or pertaining in any way to my employment with or the business of the Corporation (collectively referred to as &#8220;Inventions&#8221;) shall be promptly disclosed in writing to the Corporation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">I hereby assign to the Corporation, or its designee, all of my rights, title and interest to such Inventions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">All original works of authorship which are made by me (solely or jointly with others) within the scope of and during the period of my employment with the Corporation and which are protectable by copyright are &#8220;works made for hire,&#8221; as that term is defined in the United States Copyright Act and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Page &#124; 4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2020 Karen Lynch RCA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">as such are the sole property of the Corporation. The decision whether to commercialize or market any Invention developed by me solely or jointly with others is within the Corporation&#8217;s sole discretion and for the Corporation&#8217;s sole benefit and no royalty will be due to me as a result of the Corporation&#8217;s efforts to commercialize or market any such Invention.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">b.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">Inventions Retained and Licensed. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">I have attached hereto as Exhibit A, a list describing all inventions, original works of authorship, developments, improvements, and trade secrets which were made by me prior to my employment with the Corporation (&#8220;Prior Inventions&#8221;), which belong to me and are not assigned to the Corporation hereunder.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">If no such list is attached, I represent that there are no such Prior Inventions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">I will not incorporate, or permit to be incorporated, any Prior Invention owned by me or in which I have an interest into a Corporation product, process or machine without the Corporation&#8217;s prior written consent.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">Notwithstanding the foregoing sentence, if, in the course of my employment with the Corporation, I incorporate into a Corporation product, process or machine a Prior Invention owned by me or in which I have an interest, the Corporation is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention as part of or in connection with such product, process or machine. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">c.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">Patent and Copyright Registrations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">I will assist the Corporation, or its designee, at the Corporation&#8217;s expense, in every proper way to secure the Corporation&#8217;s rights in the Inventions and any copyrights, patents, mask work rights or other intellectual property rights relating thereto, including, but not limited to, the disclosure to the Corporation of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments which the Corporation shall deem necessary in order to apply for and obtain such rights and in order to assign and convey to the Corporation, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">My obligation to execute or cause to be executed, when it is in my power to do so, any such instrument or papers shall continue after my employment ends for any reason and&#47;or after the termination of this Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">If the Corporation is unable because of my mental or physical incapacity or for any other reason to secure my signature to apply for or to pursue any application for any United States or foreign patents or copyright registrations covering Inventions or original works of authorship assigned to the Corporation as above, then I hereby irrevocably designate and appoint the Corporation and its duly authorized officers and agents as my agent and attorney in fact, to act for and in my behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon with the same legal force and effect as if executed by me. </font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">7.&#160;&#160;&#160;&#160;Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">a.&#160;&#160;&#160;&#160;In the event  I receive a subpoena, deposition notice, interview request, or other process or order to testify or produce Confidential Information or any other information or property of the Corporation, I shall promptly&#58; (a) notify the Corporation of the item, document, or information sought by such subpoena, deposition notice, interview request, or other process or order&#59; (b) furnish the Corporation with a copy of said subpoena, deposition notice, interview request, or other process or order&#59; and (c) provide reasonable cooperation with respect to any procedure that the Corporation may initiate to protect Confidential Information or other interests.  If the Corporation objects to the subpoena, deposition notice, interview request, process, or order, I shall cooperate to ensure that there shall be no disclosure until the court or other applicable entity has ruled upon the objection, and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Page &#124; 5</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2020 Karen Lynch RCA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">then only in accordance with the ruling so made.  If no such objection is made despite a reasonable opportunity to do so, I shall be entitled to comply with the subpoena, deposition, notice, interview request, or other process or order provided that I have fulfilled the above obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">b.&#160;&#160;&#160;&#160;I will cooperate fully with the Corporation, its affiliates, and their legal counsel in connection with any action, proceeding, or dispute arising out of matters with which I was directly or indirectly involved while serving as an employee of the Corporation, its predecessors, subsidiaries or affiliates.  This cooperation shall include, but shall not be limited to, meeting with, and providing information to, the Corporation and its legal counsel, maintaining the confidentiality of any past or future privileged communications with the Corporation&#8217;s legal counsel (outside and in-house), and making myself available to testify truthfully by affidavit, in depositions, or in any other forum on behalf of the Corporation.  The Corporation agrees to reimburse me for any reasonable and necessary out-of-pocket costs associated with my cooperation.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">8.&#160;&#160;&#160;&#160;Limitation on Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.  Nothing in this Agreement is intended to or shall interfere with my right to file charges or participate in a proceeding with any appropriate federal, state or local government agency, including the Occupational Safety and Health Administration (&#8220;OSHA&#8221;), National Labor Relations Board (&#8220;NLRB&#8221;) or the Securities and Exchange Commission (&#8220;SEC&#8221;), or to exercise rights under Section 7 of the National Labor Relations Act (&#8220;NLRA&#8221;), or interfere with my  right to file a charge or complaint with or participate or cooperate in an investigation or proceeding with the US Equal Employment Opportunity Commission (&#8220;EEOC&#8221;) or comparable state or local agencies&#59; such agencies have authority to carry out their statutory duties by investigating a charge, issuing a determination, filing a lawsuit, or taking any other action authorized by law.  I retain the right to participate in any such action   and retain the right to communicate with, NLRB, SEC, EEOC, OSHA and comparable state or local agencies and such communication shall not be limited by any provision in this Agreement. Nothing in this Agreement limits my right to receive an award for information provided to a government agency such as the SEC and OSHA.  In addition, nothing in this Agreement is intended to interfere with or restrain the immunity provided under 18 U.S.C. &#167; 1833(b) for confidential disclosures of trade secrets to government officials, or lawyers, solely for the purpose of reporting or investigating a suspected violation of law&#59; or in a sealed filing in court or other proceeding.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">9.&#160;&#160;&#160;&#160;Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.  Any breach of this Agreement by me will cause irreparable damage to the Corporation and, in the event of such breach, the Corporation shall have, in addition to any and all remedies of law, the right to an injunction, specific performance or other equitable relief to prevent the violation of my obligations hereunder, and without providing a bond to the extent permitted by the applicable rules of civil procedure.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">10.&#160;&#160;&#160;&#160;No Right of Continued Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.  This Agreement does not create an obligation on the Corporation or any other person or entity to continue my employment.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">11.&#160;&#160;&#160;&#160;No Conflicting Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.  I represent that the performance of my job duties with the Corporation and my compliance with all of the terms of this Agreement does not and will not breach any agreement to keep in confidence proprietary information acquired by me in confidence or in trust prior to my employment by the Corporation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">12.&#160;&#160;&#160;&#160;Entire Agreement&#47;No Reliance&#47;No Modifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.   Except as provided in this Section 12 and Section 13, this Agreement and any compensation, benefit or equity plan or agreement referred to herein or under which equity was granted, including my Employment Agreement, to the extent </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Page &#124; 6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2020 Karen Lynch RCA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">those other agreements apply to me, set forth the entire agreement between the parties hereto and fully supersede any and all prior and&#47;or supplemental understandings, whether written or oral, between the parties concerning the subject matter of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">, that my Current Restrictive Covenant Agreement shall continue to remain in full force and effect until the Effective Date. I agree and acknowledge that I have not relied on any representations, promises or agreements of any kind in connection with my decision to accept the terms of this Agreement, except for the representations, promises and agreements herein.  This Agreement shall not have any effect on any prior existing agreements between Corporation and me regarding the arbitration of workplace legal disputes and any such agreements remain in full force and effect. Any modification to this Agreement must be made in writing and signed by me and the Corporation&#8217;s Chief Human Resources Officer or her authorized representative.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">13.&#160;&#160;&#160;&#160;Supplementation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">The Restrictive Covenants set forth in this Agreement shall supplement and do not supersede the restrictions agreed to by me in any other agreement or contract I have entered into with the Corporation (including Aetna, Inc.). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">14.&#160;&#160;&#160;&#160;No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.  Any waiver by the Corporation of a breach of any provision of this Agreement, or of any other similar agreement with any other current or former employee of the Corporation, shall not operate or be construed as a waiver of any subsequent breach of such provision or any other provision hereof.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">15.&#160;&#160;&#160;&#160;Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.  The parties hereby agree that each provision herein shall be treated as a separate and independent clause, and the unenforceability of any one clause shall in no way impair the enforceability of any of the other clauses herein.  Moreover, if one or more of the provisions of this Agreement are for any reason held to be excessively broad as to scope, activity, duration, subject or otherwise so as to be unenforceable at law, the parties consent to such provision or provisions being modified or limited by the appropriate judicial body (where allowed by applicable law), so as to be enforceable to the maximum extent compatible with the applicable law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">16.&#160;&#160;&#160;&#160;Survival of Employee&#8217;s Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.  My obligations under this Agreement shall survive the termination of my employment regardless of the manner of such termination and shall be binding upon my heirs, personal representatives, executors, administrators and legal representatives.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">17.&#160;&#160;&#160;&#160;Eligibility for Severance Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">. If my employment with the Corporation terminates under circumstances in which I am eligible for severance under my Employment Agreement, the Corporation will offer me severance in accordance with my Employment Agreement and the length of the Non-Competition Period will match the length of the severance period. I acknowledge that my Employment Agreement sets forth pre-requisites I must meet in order to receive severance, including but not limited to execution and non-revocation of the form of release agreement attached as Exhibit A to my Employment Agreement. In the event that the Corporation fails to comply with its obligations to offer me severance according to my Employment Agreement, then Section 2 of this Agreement shall be of no further effect. I agree that if I decline the Corporation&#8217;s offer of severance, I shall continue to be subject to the restrictions in Section 2.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">18.&#160;&#160;&#160;&#160;Corporation&#8217;s Right to Assign Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.  The Corporation has the right to assign this Agreement to its successors and assigns without the need for further agreement or consent by me, and all covenants and agreements hereunder shall inure to the benefit of and be enforceable by said successors or assigns.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Page &#124; 7</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2020 Karen Lynch RCA</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">19.&#160;&#160;&#160;&#160;Non-Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.  I shall not assign my rights and obligations under this Agreement, in whole or in part, whether by operation of law or otherwise, without the prior written consent of the Corporation, and any such assignment contrary to the terms hereof shall be null and void and of no force or effect.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">20.&#160;&#160;&#160;&#160;Governing Law&#59; Venue&#59; Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">.  This Agreement shall be governed by and construed in accordance with the laws of the state of Rhode Island. I agree that any claim or dispute I may have against the corporation must be resolved by a court located in the state of Rhode Island. The headings of the sections contained in this Agreement are for convenience only and shall not be deemed to control or affect the meaning or construction of any provision of this Agreement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:115%">21.&#160;&#160;&#160;&#160;Tolling.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">In the event I violate one of the time-limited restrictions in this Agreement, I agree that the time period for such violated restriction shall be extended by one day for each day I have violated the restriction, up to a maximum extension equal to the length of the original period of the restricted covenant.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, the undersigned has executed this Agreement as a sealed instrument as of the date set forth below.</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Karen S. Lynch</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Lisa Bisaccia</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Lisa Bisaccia</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Chief Human Resources Officer</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CVS Health Corporation</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Employee ID</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11-6-2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Page &#124; 8</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2020 Karen Lynch RCA</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>5
<FILENAME>exhibit211-2020.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i1c3ca5bcb830452ca18c68bcdeff3b30_57"></div><div style="min-height:61.92pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Subsidiaries of CVS Health Corporation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Listed below are subsidiaries under CVS Health Corporation at December 31, 2020 with their jurisdictions of  organization shown in parentheses. Subsidiaries excluded from the list below are not insurance companies and would not, in the aggregate, constitute a &#8220;significant subsidiary&#8221; of CVS Health Corporation, as that term is defined in Rule 1-02(w) of Regulation S-X.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">CVS Foreign, Inc. (New York)</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Caremark Indemnity Ltd. (Bermuda)</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS International, L.L.C. (Delaware)</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">CVS Pharmacy, Inc. (Rhode Island)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Aetna Inc. (Pennsylvania)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Aetna Health Holdings, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health of California Inc. (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health Inc. (Connecticut) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health Inc. (Florida) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health Inc. (Georgia) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health Inc. (Maine) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health of Michigan Inc. (Michigan) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health Inc. (New Jersey) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health Inc. (New York)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health Inc. (New York)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health Inc. (Pennsylvania)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health Inc. (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of California Inc. (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health of Ohio Inc. (Ohio)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of Texas Inc. (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of Washington, Inc. (Washington)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health Inc. (Georgia) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna HealthAssurance Pennsylvania, Inc. (Pennsylvania)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Dental of California Inc. (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Dental Inc. (New Jersey) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Dental Inc. (Texas) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Rx Home Delivery, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health Management, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Ireland Inc. (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Specialty Pharmacy, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Cofinity, Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">&#64;Credentials Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health Inc. (Pennsylvania)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health Inc. (Connecticut)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of Illinois Inc. (Illinois) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health Premier Plan MMAI Inc. (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of Kansas Inc. (Kansas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health, Inc. (Louisiana)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Florida Inc. (Florida)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health Inc. (Ohio)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of Oklahoma Inc. (Oklahoma)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of Nevada Inc. (Nevada)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health Inc. (New Jersey)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of North Carolina Inc. (North Carolina)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Network Services LLC (Connecticut)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Risk Assurance Company of Connecticut Inc. (Connecticut)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Student Health Agency Inc. (Massachusetts)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.92pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Delaware Physicians Care, Incorporated (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Schaller Anderson Medical Administrators, Incorporated (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Medicaid Administrators LLC (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">iTriage, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Medical Examinations of New York, P.C. (New York)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">bswift LLC (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Prodigy Health Group, Inc. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Niagara Re, Inc. (New York)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Performax, Inc. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Scrip World, LLC (Utah)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Precision Benefit Services, Inc. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">American Health Holding, Inc. (Ohio)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Meritain Health, Inc. (New York)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Administrative Enterprises, Inc. (Arizona)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S Healthcare Holdings, LLC (Ohio)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prime Net, Inc. (Ohio)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Professional Risk Management, Inc. (Ohio)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">ADMINCO, Inc. (Arizona) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna ACO Holdings Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Pharmacy Management Services, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Transplant Network, Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health of Iowa Inc. (Iowa)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Health Care of Nebraska, Inc. (Nebraska)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health Inc. (Louisiana)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">HealthAssurance Pennsylvania, Inc. (Pennsylvania)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Prescription Management Services Inc. (Nevada)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Health and Life Insurance Company (Missouri)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of Kentucky Insurance Company (Kentucky)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Health Care of Virginia, Inc. (Virginia)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Health Care of Missouri, Inc. (Missouri)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of Missouri LLC (Missouri)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Health Care of Illinois, Inc. (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Health Care of West Virginia, Inc. (West Virginia)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry HealthCare Management Corporation (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Health Care of Kansas, Inc. (Kansas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Health Care National Accounts, Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of Michigan Inc. (Michigan)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health of Utah Inc. (Utah)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of Tennessee Inc. (Tennessee)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Health Care National Network, Inc. (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Consumer Advantage, Inc. (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MHNet Specialty Services, LLC (Maryland)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Mental Health Network of New York IPA, Inc. (New York)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Mental Health Associates, Inc. (Louisiana)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MHNet of Florida, Inc. (Florida)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Group Dental Service, Inc. (Maryland)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Group Dental Service of Maryland, Inc. (Maryland)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Florida Health Plan Administrators, LLC (Florida)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Better Health of Florida Inc. (Florida)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Carefree Insurance Services, Inc. (Florida)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coventry Health Plan of Florida, Inc. (Florida)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">First Health Group Corp. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">First Health Life &#38; Health Insurance Company (Texas)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Claims Administration Corp. (Maryland)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Continental Life Insurance Company of Brentwood, Tennessee (Tennessee)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.92pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">American Continental Insurance Company (Tennessee)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Aetna Life Insurance Company (Connecticut)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">AHP Holdings, Inc. (Connecticut) </font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Insurance Company of Connecticut (Connecticut)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">AE Fourteen, Incorporated (Connecticut) </font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Life Assignment Company (Connecticut) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna ACO Holdings Inc. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Innovation Health Holdings, LLC (Delaware)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Innovation Health Insurance Company (Virginia)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Innovation Health Plan, Inc. (Virginia)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Texas Health + Aetna Health Insurance Holding Company LLC (Texas)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Texas Health + Aetna Health Insurance Company (Texas)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Texas Health + Aetna Health Plan Inc. (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Banner Health and Aetna Health Insurance Holding Company LLC (Delaware) </font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Banner Health and Aetna Health Insurance Company (Arizona)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Banner Health and Aetna Health Plan Inc. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Sutter Health and Aetna Insurance Holding Company LLC (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Sutter Health and Aetna Administrative Services LLC (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Sutter Health and Aetna Insurance Company (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Allina Health and Aetna Insurance Holding Company LLC (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Allina Health and Aetna Insurance Company (Minnesota) </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">PE Holdings, LLC (Connecticut) </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Resources LLC (Delaware) </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Canal Place, LLC (Delaware) </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Ventures, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Phoenix Data Solutions LLC (Delaware) </font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Aetna Financial Holdings, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Asset Advisors, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">U.S. Healthcare Properties, Inc. (Pennsylvania) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Capital Management, LLC (Delaware) </font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Partners Diversified Fund, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Workers&#8217; Comp Access, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Behavioral Health, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Managed Care Coordinators, Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Horizon Behavioral Services, LLC (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Employee Assistance Services, LLC (Kentucky)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Health and Human Resource Center, Inc. (California)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Resources for Living, LLC (Texas)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">The Vasquez Group Inc. (Illinois)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Work and Family Benefits, Inc. (New Jersey)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Card Solutions, LLC (Connecticut)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">PayFlex Holdings, Inc. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">PayFlex Systems USA, Inc. (Nebraska)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Aetna Health and Life Insurance Company (Connecticut) </font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Aetna Health Insurance Company (Pennsylvania) </font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Aetna Health Insurance Company of New York (New York)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">AUSHC Holdings, Inc. (Connecticut) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">PHPSNE Parent Corporation (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Active Health Management, Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Health Data &#38; Management Solutions, Inc. (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Integrated Informatics, Inc. (Pennsylvania)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Health Re, Inc. (Vermont)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">ASI Wings, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Health Clinical Trial Services LLC (Connecticut)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Aetna Corporate Services LLC (Delaware)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.92pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Echo Merger Sub, Inc. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Aetna International Inc. (Connecticut)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Life &#38; Casualty (Bermuda) Ltd. (Bermuda)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna International Ex Pat LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Global Holdings Limited (England &#38; Wales)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Insurance (Hong Kong) Limited (Hong Kong)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Virtual Home Healthcare LLC (Dubai)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Minor Health Enterprise Co, Ltd. (Thailand)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Health Care Management Co. Ltd. (Thailand)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Aetna Services (Thailand) Limited (Thailand)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Aetna Health Insurance (Thailand) Public Company Limited (Thailand)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health Insurance (Thailand) Public Company Limited (Thailand)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Holdings (Thailand) Limited (Thailand)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Care Management Co. Ltd. (Thailand)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Minor Health Enterprise Co, Ltd. (Thailand)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Aetna Health Insurance (Thailand) Public Company Limited (Thailand)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Global Benefits (Bermuda) Limited (Bermuda)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Goodhealth Worldwide (Global) Limited (Bermuda)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Global Benefits (Europe) Limited (England &#38; Wales)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Global Benefits (Asia Pacific) Limited (Hong Kong) </font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">PT Aetna Management Consulting (Indonesia)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Goodhealth Worldwide (Asia) Limited (Hong Kong)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Global Benefits Limited (DIFC, UAE)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Global Benefits (Middle East) LLC (UAE) </font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Pt. Aetna Global Benefits Indonesia (Indonesia)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Spinnaker Topco Limited (Bermuda)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Spinnaker Bidco Limited (England and Wales)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Aetna Holdco (UK) Limited (England and Wales)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Aetna Global Benefits (UK) Limited (England and Wales)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Aetna Insurance Company Limited (England and Wales)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Insurance (Singapore) Pte. Ltd. (Singapore)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Health Insurance Company of Europe DAC (Ireland)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna (Shanghai) Enterprise Services Co. Ltd. (China)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna (Beijing) Enterprise Management Services Co., Ltd. (China)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Aetna Global Benefits (Singapore) PTE. LTD. (Singapore)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Indian Health Organisation Private Limited (India)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">PT Aetna Management Consulting (Indonesia)</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CVS Pharmacy, Inc. (continued)</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Alabama CVS Pharmacy, L.L.C. (Alabama)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Alaska CVS Pharmacy, L.L.C. (Alaska)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">American Drug Stores Delaware, L.L.C. (Delaware)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Arkansas CVS Pharmacy, L.L.C. (Arkansas)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CareCenter Pharmacy, L.L.C. (Delaware)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Caremark Rx, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">ACS ACQCO CORP. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Advanced Care Scripts, Inc. (Florida)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CaremarkPCS, L.L.C. (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CaremarkPCS Health, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark IPA, L.L.C. (New York)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Accordant Health Services, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">AdvancePCS SpecialtyRx, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">AdvanceRx.com, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Caremark PhC, L.L.C. (Delaware)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.92pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Caremark Ulysses Holding Corp. (New York)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MemberHealth LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">UAC Holding, Inc. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Caremark, L.L.C. (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Arizona Mail Pharmacy, LLC (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Arizona Specialty Pharmacy, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark California Specialty Pharmacy, L.L.C. (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Florida Mail Pharmacy, LLC (Florida)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Florida Specialty Pharmacy, LLC (Florida)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Hawaii Mail Pharmacy, L.L.C. (Hawaii)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Hawaii Specialty Pharmacy, LLC (Hawaii)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Illinois Mail Pharmacy, LLC (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CVS Caremark Advanced Technology Pharmacy, L.L.C. (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Illinois Specialty Pharmacy, LLC (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Irving Resource Center, LLC (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Kansas Specialty Pharmacy, LLC (Kansas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Logistics, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Louisiana Specialty Pharmacy, LLC (Louisiana)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Maryland Specialty Pharmacy, LLC (Maryland)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Massachusetts Specialty Pharmacy, L.L.C. (Massachusetts)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Michigan Specialty Pharmacy, LLC (Michigan)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Minnesota Specialty Pharmacy, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark New Jersey Specialty Pharmacy, LLC (New Jersey)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark North Carolina Specialty Pharmacy, LLC (North Carolina)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Ohio Specialty Pharmacy, L.L.C. (Ohio)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Pennsylvania Specialty Pharmacy, LLC (Pennsylvania)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Redlands Pharmacy, L.L.C. (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Repack, LLC (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Tennessee Specialty Pharmacy, LLC (Tennessee)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Texas Mail Pharmacy, LLC (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Texas Specialty Pharmacy, LLC (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Washington Specialty Pharmacy, LLC (Washington)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Central Rx Services, LLC (Nevada)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CVS Caremark TN SUTA, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Generation Health, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NovoLogix, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CaremarkPCS Alabama Mail Pharmacy, LLC (Alabama)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Caremark Part D Services, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Eckerd Corporation of Florida, Inc. (Florida)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Express Pharmacy Services of PA, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Ocean Acquisition Sub, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coram LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">T2 Medical, Inc. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Coram Healthcare Corporation of Alabama (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Coram Healthcare Corporation of Florida (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Coram Healthcare Corporation of Greater D.C. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Coram Healthcare Corporation of Greater New York (New York)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Coram Healthcare Corporation of Indiana (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Coram Healthcare Corporation of Mississippi (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Coram Healthcare Corporation of Nevada (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Coram Healthcare Corporation of Northern California (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Coram Healthcare Corporation of Southern California (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Coram Healthcare Corporation of Southern Florida (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Coram Specialty Infusion Services, L.L.C. (Delaware)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coram Rx, LLC (Delaware)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.92pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coram Healthcare Corporation of North Texas (Delaware)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coram Healthcare Corporation of Utah (Delaware)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Coram Healthcare Corporation of Massachusetts (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Coram Alternate Site Services, Inc. (Delaware)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Geneva Woods Management, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Part D Holding Company, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Accendo Insurance Company (Utah)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Silverscript Insurance Company (Tennessee)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Connecticut CVS Pharmacy, L.L.C. (Connecticut)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Coram Clinical Trials, Inc. (Delaware)*</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Cabot Holdings Inc. (Delaware)*</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Shaw Holdings Inc. (Delaware)*</font></div><div style="padding-left:94.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Omnicare, LLC (Delaware)*</font></div><div style="padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Evergreen Pharmaceutical of California, LLC (California)</font></div><div style="padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">JHC Acquisition, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Geneva Woods Pharmacy, LLC (Alaska)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Geneva Woods Health Services, LLC (Delaware)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Geneva Woods Retail Pharmacy LLC (Delaware)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Geneva Woods LTC Pharmacy, LLC</font></div><div style="padding-left:198pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Geneva Woods Pharmacy Wyoming, LLC (Delaware)</font></div><div style="padding-left:198pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Geneva Woods Pharmacy Washington, LLC (Delaware)</font></div><div style="padding-left:198pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Geneva Woods Pharmacy Alaska, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">AMC - Tennessee, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CHP Acquisition, LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Home Pharmacy Services, LLC (Missouri)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CP Acquisition, LLC (Oklahoma)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Managed Healthcare, LLC (Delaware) </font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Medical Arts Health Care, LLC (Georgia)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NIV Acquisition, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">OCR Services, LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Shore Pharmaceutical Providers, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Omnicare of Nevada, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Omnicare Pharmacies of the Great Plains Holding, LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">Omnicare of Nebraska LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Pharmacy Associates of Glenn Falls, LLC (New York)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Sterling Healthcare Services, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Superior Care Pharmacy, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">TCPI Acquisition, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">UC Acquisition, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Weber Medical Systems LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Williamson Drug Company, LLC (Virginia)</font></div><div style="padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Med World Acquisition Corp. (Delaware)</font></div><div style="padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MHHP Acquisition Company, LLC (Delaware)</font></div><div style="padding-left:81pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:135pt"><font><br></font></div><div style="padding-left:135pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:135pt;text-indent:-135pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%"> *Coram Clinical Trials, Inc. &#8211; CVS Pharmacy, Inc. 75%&#47;Aetna Life Insurance Company 25%</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%"> *</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:139%;position:relative;top:-3.15pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%">CVS Cabot Holdings, Inc. &#8211; Coram Clinical Trials, Inc. 99.72%&#47;Aetna Inc. 0.28% </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%"> *CVS Shaw Holdings, Inc. &#8211; Coram Clinical Trials, Inc. 99.72%&#47;Aetna Inc. 0.28% </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:139%"> *Omnicare, LLC &#8211; Aetna Inc. 0.28%&#47;CVS Cabot Holdings, Inc. 49.86%&#47;CVS Shaw Holdings, Inc. 49.86%</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.92pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Omnicare, LLC (continued)</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NeighborCare Pharmacy Services, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">APS Acquisition LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">ASCO HealthCare, LLC (Maryland)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Badger Acquisition LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Badger Acquisition of Minnesota LLC (Delaware)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Merwin Long Term Care, LLC (Minnesota)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Badger Acquisition of Ohio LLC (Delaware) </font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Badger Acquisition of Kentucky LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Best Care LTC Acquisition Company, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Care Pharmaceutical Services, LP (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CCRx Holdings, LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Continuing Care Rx, LLC (Pennsylvania)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">CCRx of North Carolina LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Compscript, LLC (Florida)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Campo&#8217;s Medical Pharmacy, LLC (Louisiana)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">D &#38; R Pharmaceutical Services LLC (Kentucky)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Enloe Drugs, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Evergreen Pharmaceutical, LLC (Washington)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Home Care Pharmacy, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Interlock Pharmacy Systems, LLC (Missouri)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Langsam Health Services, LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">LCPS Acquisition, LLC (Delaware)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Omnicare Pharmacy of Tennessee LLC (Delaware)</font></div><div style="padding-left:144pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.46pt">Lobos Acquisition, LLC (Delaware)</font></div><div style="padding-left:144pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.46pt">Lo-Med Prescription Services, LLC (Ohio) </font></div><div style="padding-left:157.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.09pt">ZS Acquisition Company, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Main Street Pharmacy, L.L.C. (Maryland)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NCS Healthcare of Illinois, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NCS Healthcare of Iowa, LLC (Ohio)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">Martin Health Services, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NCS Healthcare of Kansas, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NCS Healthcare of Kentucky, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NCS Healthcare of Montana, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NCS Healthcare of New Mexico, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NCS Healthcare of South Carolina, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NCS Healthcare of Tennessee, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NCS Healthcare of Ohio, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">NCS Healthcare of Wisconsin, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">North Shore Pharmacy Services LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Omnicare Indiana Partnership Holding Company LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Omnicare of New York, LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">NeighborCare of Indiana, LLC (Indiana)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Grandview Pharmacy, LLC (Indiana)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">NeighborCare of Virginia, LLC (Virginia)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Omnicare Pharmacies of Pennsylvania West LLC (Pennsylvania)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Omnicare Pharmacy and Supply Services LLC (South Dakota)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Omnicare Pharmacy of the Midwest, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Omnicare Property Management, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Pharmacy Consultants, LLC (South Carolina)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">PRN Pharmaceutical Services, LP (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roeschen&#8217;s Healthcare LLC (Wisconsin)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.59pt">PP Acquisition Company LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Specialized Pharmacy Services, LLC (Michigan)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.92pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Value Health Care Services LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">VAPS Acquisition Company, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Westhaven Services Co, LLC (Ohio)</font></div><div style="padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Three Forks Apothecary, LLC (Kentucky)</font></div><div style="margin-bottom:8pt;padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">UNI-Care Health Services of Maine, LLC (New Hampshire)</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CVS Pharmacy, Inc. (continued)</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS 2948 Henderson, L.L.C. (Nevada)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS AL Distribution, L.L.C. (Alabama)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Albany, L.L.C. (New York)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS AOC Services, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CVS AOC Corporation (California)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Care Concierge, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Health Clinical Trial Services LLC (Connecticut)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Health Solutions LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Indiana, L.L.C. (Indiana)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS International, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CCI Foreign, S.&#224; R.L. (R.C.S. Luxembourg)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Beauty Holdings, L.L.C. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pamplona Sa&#250;de e Beleza LTDA (Brazil)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Kidney Care, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CVS Kidney Care Health Services LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CVS Kidney Care Advanced Technologies LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CVS Kidney Care Home Dialysis LLC (Delaware)</font></div><div style="padding-left:103.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">CVS-SHC Kidney Care Home Dialysis of Austin LLC (Delaware)</font></div><div style="padding-left:103.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">CVS-SHC Kidney Care Home Dialysis of Los Angeles LLC (Delaware)</font></div><div style="padding-left:103.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">CVS-SHC Kidney Care Home Dialysis of Philadelphia LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Manchester NH, L.L.C. (New Hampshire)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Media Exchange LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Michigan, L.L.C. (Michigan)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Orlando FL Distribution, L.L.C. (Florida)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS PA Distribution, L.L.C. (Pennsylvania)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Pharmacy Overseas Online, LLC</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS PR Center, Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Puerto Rico CVS Pharmacy, L.L.C. (Puerto Rico)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Puerto Rico, L.L.C. (Puerto Rico)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Caremark Puerto Rico Specialty Pharmacy, L.L.C. (Puerto Rico)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS RS Arizona, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Arizona CVS Stores, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CVS 3268 Gilbert, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CVS 3745 Peoria, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CVS Gilbert 3272, L.L.C. (Arizona)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Rx Services, Inc. (New York)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Busse CVS, L.L.C. (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Goodyear CVS, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Sheffield Avenue CVS, L.L.C. (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">South Wabash CVS, L.L.C. (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Thomas Phoenix CVS, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Washington Lamb CVS, L.L.C. (Nevada)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS SC Distribution, L.L.C. (South Carolina)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS State Capital, L.L.C. (Maine)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS TN Distribution, L.L.C. (Tennessee)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Transportation, L.L.C. (Indiana)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.92pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">CVS Vero FL Distribution, L.L.C. (Florida)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">D.A.W., LLC (Massachusetts)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Delaware CVS Pharmacy, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Digital eHealth, LLC (Rhode Island)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">District of Columbia CVS Pharmacy, L.L.C. (District of Columbia)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Enterprise Patient Safety Organization, LLC (Rhode Island)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">E.T.B., Inc. (Texas)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Garfield Beach CVS, L.L.C. (California)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Georgia CVS Pharmacy, L.L.C. (Georgia)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">German Dobson CVS, L.L.C. (Arizona)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Grand St. Paul CVS, L.L.C. (Minnesota)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Highland Park CVS, L.L.C. (Illinois)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Holiday CVS, L.L.C. (Florida)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Hook-SupeRx, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Idaho CVS Pharmacy, L.L.C. (Idaho)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Iowa CVS Pharmacy, L.L.C. (Iowa)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Kansas CVS Pharmacy, L.L.C. (Kansas)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Kentucky CVS Pharmacy, L.L.C. (Kentucky)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Longs Drug Stores California, L.L.C. (California)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Louisiana CVS Pharmacy, L.L.C. (Louisiana)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Maryland CVS Pharmacy, L.L.C. (Maryland)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Melville Realty Company, Inc. (New York)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">CVS Bellmore Avenue, L.L.C. (New York)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">MinuteClinic, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Alabama, L.L.C. (Alabama)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Arkansas, LLC (Arkansas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Arizona, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Colorado LLC (Colorado)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Florida, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Georgia, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Hawaii, L.L.C. (Hawaii)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Illinois, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Kentucky, L.L.C. (Kentucky)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Louisiana, L.L.C. (Louisiana)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Maine, L.L.C. (Maine)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Maryland, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Massachusetts, LLC (Massachusetts)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Nebraska, L.L.C. (Nebraska)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of New Hampshire, L.L.C. (New Hampshire)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of New Mexico, L.L.C. (New Mexico)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Ohio, LLC (Ohio)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Oklahoma, LLC (Oklahoma)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Oregon, LLC (Oregon)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Pennsylvania, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Rhode Island, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of South Carolina, L.L.C. (South Carolina)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Texas, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Utah, L.L.C. (Utah)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Virginia, LLC (Virginia)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Washington, LLC (Oregon)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Diagnostic of Wisconsin, L.L.C. (Wisconsin)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Online Diagnostic Services, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Physician Practice of Texas (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">MinuteClinic Telehealth Services, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Mississippi CVS Pharmacy, L.L.C. (Mississippi)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:61.92pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Missouri CVS Pharmacy, L.L.C. (Missouri)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Montana CVS Pharmacy, L.L.C. (Montana)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Nebraska CVS Pharmacy, L.L.C. (Nebraska)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">New Jersey CVS Pharmacy, L.L.C. (New Jersey)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">North Carolina CVS Pharmacy, L.L.C. (North Carolina)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Ohio CVS Stores, L.L.C. (Ohio)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Oklahoma CVS Pharmacy, L.L.C. (Oklahoma)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Oregon CVS Pharmacy, L.L.C. (Oregon)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Pennsylvania CVS Pharmacy, L.L.C. (Pennsylvania)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">ProCare Pharmacy Direct, L.L.C. (Ohio)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">ProCare Pharmacy, L.L.C. (Rhode Island)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Red Oak Sourcing, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Rhode Island CVS Pharmacy, L.L.C. (Rhode Island)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">South Carolina CVS Pharmacy, L.L.C. (South Carolina)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Tennessee CVS Pharmacy, L.L.C. (Tennessee)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Utah CVS Pharmacy, L.L.C. (Utah)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Vermont CVS Pharmacy, L.L.C. (Vermont)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Virginia CVS Pharmacy, L.L.C. (Virginia)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Warm Springs Road CVS, L.L.C. (Nevada)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Washington CVS Pharmacy, L.L.C. (Washington)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Wellpartner, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">West Virginia CVS Pharmacy, L.L.C. (West Virginia)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Wisconsin CVS Pharmacy, L.L.C. (Wisconsin)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Woodward Detroit CVS, L.L.C. (Michigan)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Zinc Health Ventures, LLC</font></div><div style="margin-bottom:8pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12pt">Zinc Health Services, LLC</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>exhibit231-2020.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8d41818ebfdd4f4889a741de66e44a62_48"></div><div style="min-height:72pt;width:100%"><div style="padding-left:18pt;text-align:right"><font><br></font></div><div style="padding-left:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consent of Independent Registered Public Accounting Firm</font></div><div style="padding-left:18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="margin-top:12pt;padding-left:27.35pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Registration Statement (Form S-3ASR No. 333-238506) of CVS Health Corporation, and</font></div><div style="margin-bottom:12pt;padding-left:27.35pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Registration Statements (Form S-8 Nos. 333-238507, 333-230035, 333-228622, 333-167746, 333-217853, 333-208805, 333-141481, 333-139470, 333-63664, 333-91253, 333-49407, 333-34927, and 333-28043) of CVS Health Corporation&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of our reports dated February&#160;16, 2021, with respect to the consolidated financial statements of CVS Health Corporation and the effectiveness of internal control over financial reporting of CVS Health Corporation included in this Annual Report (Form 10-K) of CVS Health Corporation for the year ended December&#160;31, 2020.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boston, Massachusetts</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;16, 2021</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:18pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>exhibit311-2020.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i895226b1fd7e47cba2c3a40e09835829_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:5pt;text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen S. Lynch, President and Chief Executive Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 10-K of CVS Health Corporation&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;KAREN S. LYNCH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen S. Lynch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>exhibit312-2020.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5bce8280dc0c4205bd1d0cdb634944f8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="margin-bottom:5pt;text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Eva C. Boratto, Executive Vice President and Chief Financial Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 10-K of CVS Health Corporation&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;EVA C. BORATTO</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eva C. Boratto</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>exhibit321-2020.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i48705ab93e474dd49bf052c960acbd45_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Annual Report of CVS Health Corporation (the &#34;Company&#34;) on Form 10-K for the period ended December&#160;31, 2020 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen S. Lynch, President and Chief Executive Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;KAREN S. LYNCH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen S. Lynch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>exhibit322-2020.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i590aab367eb849658825daf34382657b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2 </font></div><div style="margin-bottom:5pt;text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Annual Report of CVS Health Corporation (the &#34;Company&#34;) on Form 10-K for the period ended December&#160;31, 2020 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Eva C. Boratto, Executive Vice President and Chief Financial Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;EVA C. BORATTO</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eva C. Boratto</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial&#160;Officer</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>cvs-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4a98170d-2b8a-4463-a058-df0f5f10bd13,g:ab909211-91be-459b-b532-dbe2c1c7ff2b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cvshealth.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cvshealth.com/role/CoverPage">
        <link:definition>000010001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations">
        <link:definition>100010002 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>100020003 - Statement - Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheets">
        <link:definition>100030004 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>100040005 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>100050006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows_1" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1">
        <link:definition>100050006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquity" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity">
        <link:definition>100060007 - Statement - Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquityParentheticals" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals">
        <link:definition>100070008 - Statement - Consolidated Statements of Shareholders' Equity (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies">
        <link:definition>210011001 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>220022001 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables">
        <link:definition>230033001 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>240044001 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesRestrictedCashDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails">
        <link:definition>240054002 - Disclosure - Significant Accounting Policies - Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAccountsReceivableDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails">
        <link:definition>240064003 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails">
        <link:definition>240074004 - Disclosure - Significant Accounting Policies - Property Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDisaggregationofRevenueDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails">
        <link:definition>240084005 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesContractBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails">
        <link:definition>240094006 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesVariableInterestEntitiesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails">
        <link:definition>240104007 - Disclosure - Significant Accounting Policies - Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDiscontinuedOperationsDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails">
        <link:definition>240114008 - Disclosure - Significant Accounting Policies - Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestitures" roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestitures">
        <link:definition>210121002 - Disclosure - Acquisitions and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresTables" roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresTables">
        <link:definition>230133002 - Disclosure - Acquisitions and Divestitures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresNarrativeDetails" roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails">
        <link:definition>240144009 - Disclosure - Acquisitions and Divestitures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>240154010 - Disclosure - Acquisitions and Divestitures - Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsandDivestituresProFormaDetails" roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails">
        <link:definition>240164011 - Disclosure - Acquisitions and Divestitures - Pro Forma (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.cvshealth.com/role/Investments">
        <link:definition>210171003 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.cvshealth.com/role/InvestmentsTables">
        <link:definition>230183003 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofTotalInvestmentsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails">
        <link:definition>240194012 - Disclosure - Investments - Schedule of Total Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.cvshealth.com/role/InvestmentsNarrativeDetails">
        <link:definition>240204013 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails">
        <link:definition>240214014 - Disclosure - Investments - Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesbyMaturityDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails">
        <link:definition>240224015 - Disclosure - Investments - Debt Securities by Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails">
        <link:definition>240234016 - Disclosure - Investments - Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionMaturitiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails">
        <link:definition>240244017 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails">
        <link:definition>240254018 - Disclosure - Investments - Mortgage Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansCreditRatingsIndicatorDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
        <link:definition>240264019 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails">
        <link:definition>240274020 - Disclosure - Investments - Schedule of Mortgage Loan Principal Repayments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNetInvestmentIncomeDetails" roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails">
        <link:definition>240284021 - Disclosure - Investments - Net Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsRealizedGainsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails">
        <link:definition>240294022 - Disclosure - Investments - Realized Gains (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.cvshealth.com/role/FairValue">
        <link:definition>210301004 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.cvshealth.com/role/FairValueTables">
        <link:definition>230313004 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFairValueMeasurementsDetails" roleURI="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails">
        <link:definition>240324023 - Disclosure - Fair Value - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueChangesinLevel3FinancialAssetsDetails" roleURI="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails">
        <link:definition>240334024 - Disclosure - Fair Value - Changes in Level 3 Financial Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueGrossTransfersIntoOutOfLevel3Details" roleURI="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details">
        <link:definition>240344025 - Disclosure - Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueCarryingValueandFairValueClassifiedbyLevelDetails" roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
        <link:definition>240354026 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueSeparateAccountsFairValueDetails" roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails">
        <link:definition>240364027 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueOffsettingFinancialLiabilitiesDetails" roleURI="http://www.cvshealth.com/role/FairValueOffsettingFinancialLiabilitiesDetails">
        <link:definition>240374028 - Disclosure - Fair Value - Offsetting Financial Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>210381005 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesTables" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables">
        <link:definition>230393005 - Disclosure - Goodwill and Other Intangibles (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesGoodwillDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails">
        <link:definition>240404029 - Disclosure - Goodwill and Other Intangibles - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesNarrativeDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails">
        <link:definition>240414030 - Disclosure - Goodwill and Other Intangibles - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesIntangibleAssetsDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails">
        <link:definition>240424031 - Disclosure - Goodwill and Other Intangibles - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails">
        <link:definition>240434032 - Disclosure - Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.cvshealth.com/role/Leases">
        <link:definition>210441006 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.cvshealth.com/role/LeasesTables">
        <link:definition>230453006 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.cvshealth.com/role/LeasesNarrativeDetails">
        <link:definition>240464033 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryoftheComponentsofNetLeaseCostDetails" roleURI="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails">
        <link:definition>240474034 - Disclosure - Leases - Summary of the Components of Net Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>240484035 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>240494036 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails">
        <link:definition>240504037 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1">
        <link:definition>240504037 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesRentalExpenseDetails" roleURI="http://www.cvshealth.com/role/LeasesRentalExpenseDetails">
        <link:definition>240514038 - Disclosure - Leases - Rental Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayable" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable">
        <link:definition>210521007 - Disclosure - Health Care Costs Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableTables" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables">
        <link:definition>230533007 - Disclosure - Health Care Costs Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails">
        <link:definition>240544039 - Disclosure - Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableNarrativeDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails">
        <link:definition>240554040 - Disclosure - Health Care Costs Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails">
        <link:definition>240564041 - Disclosure - Health Care Costs Payable - Reconciliation of Health Care Net Incurred and Paid Claims Development to Health Care Costs Payable Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails">
        <link:definition>240574042 - Disclosure - Health Care Costs Payable - Reconciliation of Health Care Costs Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangements" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangements">
        <link:definition>210581008 - Disclosure - Borrowings and Credit Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsTables" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables">
        <link:definition>230593008 - Disclosure - Borrowings and Credit Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsScheduleofDebtDetails" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails">
        <link:definition>240604043 - Disclosure - Borrowings and Credit Arrangements - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsDebtMaturitiesDetails" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails">
        <link:definition>240614044 - Disclosure - Borrowings and Credit Arrangements - Debt Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsShorttermBorrowingsDetails" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails">
        <link:definition>240624045 - Disclosure - Borrowings and Credit Arrangements - Short-term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsLongTermBorrowingsDetails" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails">
        <link:definition>240634046 - Disclosure - Borrowings and Credit Arrangements - Long-Term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefits" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits">
        <link:definition>210641009 - Disclosure - Pension Plans and Other Postretirement Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsTables" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables">
        <link:definition>230653009 - Disclosure - Pension Plans and Other Postretirement Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsNarrativeDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails">
        <link:definition>240664047 - Disclosure - Pension Plans and Other Postretirement Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails">
        <link:definition>240674048 - Disclosure - Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails">
        <link:definition>240684049 - Disclosure - Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails">
        <link:definition>240694050 - Disclosure - Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails">
        <link:definition>240704051 - Disclosure - Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails">
        <link:definition>240714052 - Disclosure - Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails">
        <link:definition>240724053 - Disclosure - Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cvshealth.com/role/IncomeTaxes">
        <link:definition>210731010 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.cvshealth.com/role/IncomeTaxesTables">
        <link:definition>230743010 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxProvisionDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails">
        <link:definition>240754054 - Disclosure - Income Taxes - Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240764055 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveTaxRateReconciliationDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails">
        <link:definition>240774056 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>240784057 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>240794058 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlans" roleURI="http://www.cvshealth.com/role/StockIncentivePlans">
        <link:definition>210801011 - Disclosure - Stock Incentive Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansTables" roleURI="http://www.cvshealth.com/role/StockIncentivePlansTables">
        <link:definition>230813011 - Disclosure - Stock Incentive Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails">
        <link:definition>240824059 - Disclosure - Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansValuationandAssumptionsDetails" roleURI="http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails">
        <link:definition>240834060 - Disclosure - Stock Incentive Plans - Valuation and Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansRestrictedStockActivityDetails" roleURI="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails">
        <link:definition>240844061 - Disclosure - Stock Incentive Plans - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansStockOptionandSARActivityDetails" roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails">
        <link:definition>240854062 - Disclosure - Stock Incentive Plans - Stock Option and SAR Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cvshealth.com/role/ShareholdersEquity">
        <link:definition>210861012 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.cvshealth.com/role/ShareholdersEquityTables">
        <link:definition>230873012 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityRepurchasesDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails">
        <link:definition>240884063 - Disclosure - Shareholders' Equity - Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityDividendsDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails">
        <link:definition>240894064 - Disclosure - Shareholders' Equity - Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityRegulatoryRequirementsDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails">
        <link:definition>240904065 - Disclosure - Shareholders' Equity - Regulatory Requirements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNoncontrollingInterestsDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails">
        <link:definition>240914066 - Disclosure - Shareholders' Equity - Noncontrolling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncome" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome">
        <link:definition>210921013 - Disclosure - Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeTables" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables">
        <link:definition>230933013 - Disclosure - Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeDetails" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails">
        <link:definition>240944067 - Disclosure - Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShare" roleURI="http://www.cvshealth.com/role/EarningsLossPerShare">
        <link:definition>210951014 - Disclosure - Earnings (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShareTables" roleURI="http://www.cvshealth.com/role/EarningsLossPerShareTables">
        <link:definition>230963014 - Disclosure - Earnings (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShareDetails" roleURI="http://www.cvshealth.com/role/EarningsLossPerShareDetails">
        <link:definition>240974068 - Disclosure - Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Reinsurance" roleURI="http://www.cvshealth.com/role/Reinsurance">
        <link:definition>210981015 - Disclosure - Reinsurance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceTables" roleURI="http://www.cvshealth.com/role/ReinsuranceTables">
        <link:definition>230993015 - Disclosure - Reinsurance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceNarrativeDetails" roleURI="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails">
        <link:definition>241004069 - Disclosure - Reinsurance - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceReinsuranceRecoverablesDetails" roleURI="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails">
        <link:definition>241014070 - Disclosure - Reinsurance - Reinsurance Recoverables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceEffectsofReinsuranceDetails" roleURI="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails">
        <link:definition>241024071 - Disclosure - Reinsurance - Effects of Reinsurance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies">
        <link:definition>211031016 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails">
        <link:definition>241044072 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.cvshealth.com/role/SegmentReporting">
        <link:definition>211051017 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.cvshealth.com/role/SegmentReportingTables">
        <link:definition>231063016 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails">
        <link:definition>241074073 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSummarizedFinancialInformationofSegmentsDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails">
        <link:definition>241084074 - Disclosure - Segment Reporting - Summarized Financial Information of Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails">
        <link:definition>241094075 - Disclosure - Segment Reporting - Reconciliation of Operating Earnings to Net Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cvs_SeniorNotes3DueAugust2026Member" abstract="true" name="SeniorNotes3DueAugust2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_TreasuryStockSharesHeldinTrust" abstract="false" name="TreasuryStockSharesHeldinTrust" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueYearFive" abstract="false" name="LesseeLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" abstract="false" name="ContractWithCustomerLiabilityRedemptionAndBreakage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" abstract="true" name="DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LeasesWeightedAverageDiscountRateAbstract" abstract="true" name="LeasesWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes4125DueApril2040Member" abstract="true" name="SeniorNotes4125DueApril2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_CoventryHealthCareWorkersCompensationBusinessMember" abstract="true" name="CoventryHealthCareWorkersCompensationBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_USFederalGovernmentMember" abstract="true" name="USFederalGovernmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LimitedPaymentsContracts" abstract="false" name="LimitedPaymentsContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" abstract="false" name="FinitelivedandindefinitelivedintangibleassetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" abstract="false" name="ContractualObligationsToMaintainLevelsOfSeparateAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberofPatientsServedperYear" abstract="false" name="NumberofPatientsServedperYear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_TotalInvestmentsLineItems" abstract="true" name="TotalInvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_OperatingExpensesExcludingGoodwillImpairments" abstract="false" name="OperatingExpensesExcludingGoodwillImpairments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member" abstract="true" name="ShareBasedPaymentArrangementOptionGrantedIn2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" abstract="false" name="HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_SeniorNotes3.7DueMarch2023Member" abstract="true" name="SeniorNotes3.7DueMarch2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_NumberofReinsuranceContractsEnteredInto" abstract="false" name="NumberofReinsuranceContractsEnteredInto" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_PharmacyClaimsandDiscountsPayableCurrent" abstract="false" name="PharmacyClaimsandDiscountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_RetailLongTermCareSegmentMember" abstract="true" name="RetailLongTermCareSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_EquitySecuritiesDomesticRealEstateMember" abstract="true" name="EquitySecuritiesDomesticRealEstateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_NumberOfPeopleServed" abstract="false" name="NumberOfPeopleServed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_DebtAndEquitySecuritiesAvailableForSaleMember" abstract="true" name="DebtAndEquitySecuritiesAvailableForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" abstract="false" name="DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_DebtExtinguishmentFees" abstract="false" name="DebtExtinguishmentFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LesseeLiabilityUndiscountedExcessAmount" abstract="false" name="LesseeLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense" abstract="false" name="TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansMember" abstract="true" name="MortgageLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsAxis" abstract="true" name="TotalInvestmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_SeniorNotes3.25DueAugust2029Member" abstract="true" name="SeniorNotes3.25DueAugust2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" abstract="false" name="AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cvs_AetnaInc.Member" abstract="true" name="AetnaInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_HealthCareBenefitsSegmentMember" abstract="true" name="HealthCareBenefitsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_VendorandManufacturerReceivables" abstract="false" name="VendorandManufacturerReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" abstract="false" name="OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member" abstract="true" name="ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_BusinessCombinationPerShareExchangeRatio" abstract="false" name="BusinessCombinationPerShareExchangeRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" abstract="false" name="LesseeOperatingAndFinanceLeasesRenewalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_SeniorNotes1Point3PercentAugust2027Member" abstract="true" name="SeniorNotes1Point3PercentAugust2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesNoncurrent" abstract="false" name="OtherInsuranceLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsYearOne" abstract="false" name="LesseeLiabilityPaymentsYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes6.75DueDecember2037Member" abstract="true" name="SeniorNotes6.75DueDecember2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueNovember2042Member" abstract="true" name="SeniorNotes4.125DueNovember2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LongTermCareReportingUnitMember" abstract="true" name="LongTermCareReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_InvestmentIncomeExcludingCapitalGainsorLosses" abstract="false" name="InvestmentIncomeExcludingCapitalGainsorLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" abstract="false" name="DeferredTaxLiabilitiesDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FinanceLeaseRightOfUseAssetNet" abstract="false" name="FinanceLeaseRightOfUseAssetNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DeferredTaxAssetsPayrollTaxDeferral" abstract="false" name="DeferredTaxAssetsPayrollTaxDeferral" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FloatingRateNotesMember" abstract="true" name="FloatingRateNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes1875DueFebruary2031Member" abstract="true" name="SeniorNotes1875DueFebruary2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateLoansFullyRepaid" abstract="false" name="MortgageLoansOnRealEstateLoansFullyRepaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodTwoMember" abstract="true" name="YearOfOriginationPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.875DueJune2026Member" abstract="true" name="SeniorNotes2.875DueJune2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueNovember2024Member" abstract="true" name="SeniorNotes3.5DueNovember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_OutstandingSeniorNotesMember" abstract="true" name="OutstandingSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesMember" abstract="true" name="OtherInsuranceLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_RevolvingCreditFacilityExpiringMay182022Member" abstract="true" name="RevolvingCreditFacilityExpiringMay182022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_RevolvingCreditFacilityExpiringMay172023Member" abstract="true" name="RevolvingCreditFacilityExpiringMay172023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes1Point75PercentAugust2030Member" abstract="true" name="SeniorNotes1Point75PercentAugust2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueMay2021Member" abstract="true" name="SeniorNotes4.125DueMay2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" abstract="true" name="LesseeLeasesLiabilitiesPaymentsDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes2.75DueNovember2022Member" abstract="true" name="SeniorNotes2.75DueNovember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_Categories5and6Member" abstract="true" name="Categories5and6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueYearFour" abstract="false" name="LesseeLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ValueOfBusinessAcquiredMember" abstract="true" name="ValueOfBusinessAcquiredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" abstract="true" name="VOYARetirementInsuranceAndAnnuityCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_HeathSavingsAccountBalance" abstract="false" name="HeathSavingsAccountBalance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Category2To4Member" abstract="true" name="Category2To4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DenominatorForEarningsPerShareCalculationAbstract" abstract="true" name="DenominatorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_OtherAcquiredIntangibleAssetsLineItems" abstract="true" name="OtherAcquiredIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree" abstract="false" name="BusinessCombinationAcquisitionAssignedValueOfAcquiree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" abstract="true" name="LincolnLifeAnnuityCompanyOfNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_HeartlandHealthcareServicesMember" abstract="true" name="HeartlandHealthcareServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_NumberOfPlanMembers" abstract="false" name="NumberOfPlanMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" abstract="true" name="DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3Point625PercentApril2027Member" abstract="true" name="SeniorNotes3Point625PercentApril2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_PharmacyRebatePeriod" abstract="false" name="PharmacyRebatePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_AetnaInc2010StockIncentivePlanMember" abstract="true" name="AetnaInc2010StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LesseeLeaseTableTextBlock" abstract="false" name="LesseeLeaseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cvs_ActivityInMortgageLoanPortfolioTableTextBlock" abstract="false" name="ActivityInMortgageLoanPortfolioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cvs_AdjustedOperatingIncomeLoss" abstract="false" name="AdjustedOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueAfterYearFive" abstract="false" name="LesseeLiabilityPaymentsDueAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" abstract="false" name="StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="cvs_EmployeeStockOptionsandStockAppreciationRightsMember" abstract="true" name="EmployeeStockOptionsandStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FloatingRateNotesDueMarch2020Member" abstract="true" name="FloatingRateNotesDueMarch2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_RevolvingCreditFacilityExpiringMay122021Member" abstract="true" name="RevolvingCreditFacilityExpiringMay122021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_BusinessCombinationAcquisitionValuePerSharesAcquired" abstract="false" name="BusinessCombinationAcquisitionValuePerSharesAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="cvs_SeniorNotes3.125DueMarch2020Member" abstract="true" name="SeniorNotes3.125DueMarch2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_RedeemablePreferredSecuritiesMember" abstract="true" name="RedeemablePreferredSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FloatingRateNotesDueMarch2021Member" abstract="true" name="FloatingRateNotesDueMarch2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3625DueApril2027Member" abstract="true" name="SeniorNotes3625DueApril2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LongtermDebtGrossAndLeaseObligation" abstract="false" name="LongtermDebtGrossAndLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherAcquiredIntangibleAssetsTable" abstract="true" name="OtherAcquiredIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_TreasuryStockValueSharesHeldInTrust" abstract="false" name="TreasuryStockValueSharesHeldInTrust" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" abstract="false" name="FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.8DueJune2023Member" abstract="true" name="SeniorNotes2.8DueJune2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" abstract="true" name="FixturesEquipmentAndInternallyDevelopedSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_NetRevenuesRetailCoPayments" abstract="false" name="NetRevenuesRetailCoPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DeferredTaxLiabilitiesRetirementBenefits" abstract="false" name="DeferredTaxLiabilitiesRetirementBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.375DueAugust2024Member" abstract="true" name="SeniorNotes3.375DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" abstract="false" name="RelatedPartyTransactionCharitableContributionToNonProfitEntity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.8DueJuly2020Member" abstract="true" name="SeniorNotes2.8DueJuly2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FrontStoreRevenueMember" abstract="true" name="FrontStoreRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsDomain" abstract="true" name="TotalInvestmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes2.625DueAugust2024Member" abstract="true" name="SeniorNotes2.625DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFiveMember" abstract="true" name="YearOfOriginationPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_RXCrossroadsMember" abstract="true" name="RXCrossroadsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Initialcontractualterm" abstract="false" name="Initialcontractualterm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_NumberOfUnderPerformingStoresPlannedClosure" abstract="false" name="NumberOfUnderPerformingStoresPlannedClosure" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes4.78DueMarch2038Member" abstract="true" name="SeniorNotes4.78DueMarch2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" abstract="false" name="PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TwoThousandEighteenNotesMember" abstract="true" name="TwoThousandEighteenNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPriorToPeriodFiveMember" abstract="true" name="YearOfOriginationPriorToPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_RevolvingCreditFacilityExpiringMay162024Member" abstract="true" name="RevolvingCreditFacilityExpiringMay162024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDue" abstract="false" name="LesseeLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SupportingRemainingProductsMember" abstract="true" name="SupportingRemainingProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_BrazilSubsidiaryMember" abstract="true" name="BrazilSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_ProviderNetworksMember" abstract="true" name="ProviderNetworksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5DueDecember2024Member" abstract="true" name="SeniorNotes5DueDecember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes3Point75PercentApril2030Member" abstract="true" name="SeniorNotes3Point75PercentApril2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SalesChannelOtherMember" abstract="true" name="SalesChannelOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.45DueJune2021Member" abstract="true" name="SeniorNotes5.45DueJune2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_PremiumsMember" abstract="true" name="PremiumsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes6.125DueSeptember2039Member" abstract="true" name="SeniorNotes6.125DueSeptember2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" abstract="false" name="PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5.75DueMay2041Member" abstract="true" name="SeniorNotes5.75DueMay2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes6.25DueJune2027Member" abstract="true" name="SeniorNotes6.25DueJune2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsTable" abstract="true" name="TotalInvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueJuly2022Member" abstract="true" name="SeniorNotes3.5DueJuly2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" abstract="false" name="ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.3DueMarch2028Member" abstract="true" name="SeniorNotes4.3DueMarch2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" abstract="false" name="FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherAssetBackedSecuritiesMember" abstract="true" name="OtherAssetBackedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueDecember2022Member" abstract="true" name="SeniorNotes4.75DueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" abstract="false" name="FinanceLeaseRightOfUseAssetAccumulatedDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_A2016RepurchaseProgramMember" abstract="true" name="A2016RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueAugust2047Member" abstract="true" name="SeniorNotes3.875DueAugust2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.3DueDecember2043Member" abstract="true" name="SeniorNotes5.3DueDecember2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes175DueAugust2030Member" abstract="true" name="SeniorNotes175DueAugust2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DrogariaOnofreLtdaMember" abstract="true" name="DrogariaOnofreLtdaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" abstract="true" name="RestrictedStockUnitsandPerformanceShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.05DueMarch2048Member" abstract="true" name="SeniorNotes5.05DueMarch2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.125DueJuly2045Member" abstract="true" name="SeniorNotes5.125DueJuly2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" abstract="false" name="ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesCurrent" abstract="false" name="OtherInsuranceLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes425DueApril2050Member" abstract="true" name="SeniorNotes425DueApril2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes43Due2028Member" abstract="true" name="SeniorNotes43Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SharesHeldInTrustPolicyTextBlock" abstract="false" name="SharesHeldInTrustPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodThreeMember" abstract="true" name="YearOfOriginationPeriodThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueJuly2025Member" abstract="true" name="SeniorNotes3.875DueJuly2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Category1Member" abstract="true" name="Category1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_HealthInsurerFeeTaxEffectPercent" abstract="false" name="HealthInsurerFeeTaxEffectPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cvs_SeniorNotes1Point875PercentFebruary2031Member" abstract="true" name="SeniorNotes1Point875PercentFebruary2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_BackUpCreditFacilitiesMember" abstract="true" name="BackUpCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_GuarantorObligationsNumberofLeases" abstract="false" name="GuarantorObligationsNumberofLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" abstract="false" name="DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueMarch2044Member" abstract="true" name="SeniorNotes4.75DueMarch2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes27DueAugust2040Member" abstract="true" name="SeniorNotes27DueAugust2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueJune2021Member" abstract="true" name="SeniorNotes4.125DueJune2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueYearThree" abstract="false" name="LesseeLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Category7Member" abstract="true" name="Category7Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4DueDecember2023Member" abstract="true" name="SeniorNotes4DueDecember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LiabilityforUnpaidClaims" abstract="false" name="LiabilityforUnpaidClaims" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HartfordLifeAndAccidentInsuranceCompanyMember" abstract="true" name="HartfordLifeAndAccidentInsuranceCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFourMember" abstract="true" name="YearOfOriginationPeriodFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OperatingLeasesRentExpenseGross" abstract="false" name="OperatingLeasesRentExpenseGross" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_StoreRationalizationCharges" abstract="false" name="StoreRationalizationCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.1DueMarch2025Member" abstract="true" name="SeniorNotes4.1DueMarch2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_NumberofWalkInMedicalClinics" abstract="false" name="NumberofWalkInMedicalClinics" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithoutFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsTableTextBlock" abstract="false" name="TotalInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cvs_SeniorNotes4Point25PercentApril2050Member" abstract="true" name="SeniorNotes4Point25PercentApril2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeparateAccountFinancialAssetsMember" abstract="true" name="SeparateAccountFinancialAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" abstract="true" name="USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes13DueAugust2027Member" abstract="true" name="SeniorNotes13DueAugust2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_PharmacyRevenueMember" abstract="true" name="PharmacyRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.125June2021Member" abstract="true" name="SeniorNotes2.125June2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodOneMember" abstract="true" name="YearOfOriginationPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_NumeratorForEarningsPerShareCalculationAbstract" abstract="true" name="NumeratorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_CommonEquivalentSharesMember" abstract="true" name="CommonEquivalentSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" abstract="false" name="FourYearsReinsuranceAgreementWithUnrelatedInsurer" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AllOtherReinsurersMember" abstract="true" name="AllOtherReinsurersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_FinanceLeaseRightOfUseAssetGross" abstract="false" name="FinanceLeaseRightOfUseAssetGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_WellCareHealthPlansMember" abstract="true" name="WellCareHealthPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueYearTwo" abstract="false" name="LesseeLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.875DueJuly2035Member" abstract="true" name="SeniorNotes4.875DueJuly2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_PharmacyServicesSegmentMember" abstract="true" name="PharmacyServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.5DueMay2042Member" abstract="true" name="SeniorNotes4.5DueMay2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity" abstract="false" name="NumberOfQuarterlyPaymentsFromVariableInterestEntity" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" abstract="false" name="ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_CVSHealth2017IncentiveCompensationPlanMember" abstract="true" name="CVSHealth2017IncentiveCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_InsuranceAndHmoMember" abstract="true" name="InsuranceAndHmoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PaymentsforInsuranceBenefits" abstract="false" name="PaymentsforInsuranceBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_CommonAndCollectiveTrustsMember" abstract="true" name="CommonAndCollectiveTrustsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_PensionAndAnnuityInvestmentContractsInterest" abstract="false" name="PensionAndAnnuityInvestmentContractsInterest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" abstract="false" name="InsurancePremiumDeficiencyReservePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PremiumDeficiencyReserveLiability" abstract="false" name="PremiumDeficiencyReserveLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3.35DueMarch2021Member" abstract="true" name="SeniorNotes3.35DueMarch2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_LesseeOperatingAndFinanceLeasesTermOfContract" abstract="false" name="LesseeOperatingAndFinanceLeasesTermOfContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" abstract="false" name="NoncontrollinginterestOtherPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SupportingExperienceRatedProductsMember" abstract="true" name="SupportingExperienceRatedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" abstract="true" name="FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_OtherLongTermInsuranceLiabilitiesMember" abstract="true" name="OtherLongTermInsuranceLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes375DueApril2030Member" abstract="true" name="SeniorNotes375DueApril2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_ProceedsFromVariableInterestEntity" abstract="false" name="ProceedsFromVariableInterestEntity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HealthInsurerFee" abstract="false" name="HealthInsurerFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2Point7PercentAugust2040Member" abstract="true" name="SeniorNotes2Point7PercentAugust2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes6.625DueJune2036Member" abstract="true" name="SeniorNotes6.625DueJune2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.75DueDecember2022Member" abstract="true" name="SeniorNotes2.75DueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4Point125PercentApril2040Member" abstract="true" name="SeniorNotes4Point125PercentApril2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>cvs-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4a98170d-2b8a-4463-a058-df0f5f10bd13,g:ab909211-91be-459b-b532-dbe2c1c7ff2b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CoverPage" xlink:type="simple" xlink:href="cvs-20201231.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_38328793-3985-4673-addc-4a224ee324f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6dcfa33d-44ae-4857-a778-ae29bd02915e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38328793-3985-4673-addc-4a224ee324f2" xlink:to="loc_us-gaap_ProfitLoss_6dcfa33d-44ae-4857-a778-ae29bd02915e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b9ad5384-69b1-4cf3-a519-e2d9dee67a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_38328793-3985-4673-addc-4a224ee324f2" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b9ad5384-69b1-4cf3-a519-e2d9dee67a22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_9618729d-679f-48cc-af68-a1b23bd971be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c04c9c20-38fe-4a4f-b20c-cd3ef5a63e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_9618729d-679f-48cc-af68-a1b23bd971be" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c04c9c20-38fe-4a4f-b20c-cd3ef5a63e84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_be7dd68b-8001-41ef-9fc0-425dab5864c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_9618729d-679f-48cc-af68-a1b23bd971be" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_be7dd68b-8001-41ef-9fc0-425dab5864c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairments_3819544a-cec3-4272-a964-594378038131" xlink:href="cvs-20201231.xsd#cvs_OperatingExpensesExcludingGoodwillImpairments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_9618729d-679f-48cc-af68-a1b23bd971be" xlink:to="loc_cvs_OperatingExpensesExcludingGoodwillImpairments_3819544a-cec3-4272-a964-594378038131" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_64a3bb26-b965-4b50-8291-aaefb43e8b06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_9618729d-679f-48cc-af68-a1b23bd971be" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_64a3bb26-b965-4b50-8291-aaefb43e8b06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_18279656-6516-487a-bd39-f2977dc1e0f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b4e8b1e5-c807-4187-97d8-02c09be676b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_18279656-6516-487a-bd39-f2977dc1e0f2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b4e8b1e5-c807-4187-97d8-02c09be676b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ad1ee74f-609e-4e5c-b841-981869d87f6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_18279656-6516-487a-bd39-f2977dc1e0f2" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ad1ee74f-609e-4e5c-b841-981869d87f6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2c6980d3-1b11-4b6b-a04a-3e90993dfb5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f0261b91-aa9f-474e-bf29-f6c105033c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2c6980d3-1b11-4b6b-a04a-3e90993dfb5b" xlink:to="loc_us-gaap_CostsAndExpenses_f0261b91-aa9f-474e-bf29-f6c105033c2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_04539894-ad42-4999-8258-b86ca58aee8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2c6980d3-1b11-4b6b-a04a-3e90993dfb5b" xlink:to="loc_us-gaap_Revenues_04539894-ad42-4999-8258-b86ca58aee8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e90707b5-5f8f-4dbd-8ee3-5ea2d6d2510f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_71cb6c65-e14c-4c28-8e11-db159cc6a164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e90707b5-5f8f-4dbd-8ee3-5ea2d6d2510f" xlink:to="loc_us-gaap_OperatingIncomeLoss_71cb6c65-e14c-4c28-8e11-db159cc6a164" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6ce532ba-4615-426b-8bf3-b0032edb9cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e90707b5-5f8f-4dbd-8ee3-5ea2d6d2510f" xlink:to="loc_us-gaap_InterestExpense_6ce532ba-4615-426b-8bf3-b0032edb9cb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c5806c0d-1802-4a62-9eab-ffd455e7bf2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e90707b5-5f8f-4dbd-8ee3-5ea2d6d2510f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c5806c0d-1802-4a62-9eab-ffd455e7bf2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_84de4442-37d3-4da1-b574-d9a7d0f65688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e90707b5-5f8f-4dbd-8ee3-5ea2d6d2510f" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_84de4442-37d3-4da1-b574-d9a7d0f65688" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_06b39905-914f-45e9-b55f-10921436bd1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_89b5c350-9e29-4fa7-947e-d5e8add74023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_06b39905-914f-45e9-b55f-10921436bd1a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_89b5c350-9e29-4fa7-947e-d5e8add74023" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_e41fabfc-1b12-4104-9ada-37a68aa7f5e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_06b39905-914f-45e9-b55f-10921436bd1a" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_e41fabfc-1b12-4104-9ada-37a68aa7f5e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9167404b-d2dd-47bf-8275-6d930649150c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_65d9fbb6-b2fd-4c6f-954a-0e4c99eac60d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_9167404b-d2dd-47bf-8275-6d930649150c" xlink:to="loc_us-gaap_NetInvestmentIncome_65d9fbb6-b2fd-4c6f-954a-0e4c99eac60d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_6cc8eb46-b07d-4a31-b301-e39b36857e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_9167404b-d2dd-47bf-8275-6d930649150c" xlink:to="loc_us-gaap_PremiumsEarnedNet_6cc8eb46-b07d-4a31-b301-e39b36857e7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_00cab352-5729-4365-bb47-a0747dff241c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_9167404b-d2dd-47bf-8275-6d930649150c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_00cab352-5729-4365-bb47-a0747dff241c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4a71c5da-9499-4e86-a72e-71d51fdb61f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_554e0331-a2c4-44ae-9713-e704697dda60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4a71c5da-9499-4e86-a72e-71d51fdb61f3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_554e0331-a2c4-44ae-9713-e704697dda60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5af05ebb-205e-490f-9499-76d72d0deecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4a71c5da-9499-4e86-a72e-71d51fdb61f3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5af05ebb-205e-490f-9499-76d72d0deecf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_fe191dac-4ec9-4532-9fcc-82eeecfadbbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_84c14a36-79d8-4440-b3f3-27633a41a11e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_fe191dac-4ec9-4532-9fcc-82eeecfadbbc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_84c14a36-79d8-4440-b3f3-27633a41a11e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_7ad84883-aaab-40ca-9836-71f81507bc9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_fe191dac-4ec9-4532-9fcc-82eeecfadbbc" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_7ad84883-aaab-40ca-9836-71f81507bc9a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_045d9e80-e17a-4ffb-a190-26ad5b83a533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_04e2e026-3c86-4e36-abed-99efccfe3c05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_045d9e80-e17a-4ffb-a190-26ad5b83a533" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_04e2e026-3c86-4e36-abed-99efccfe3c05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_f852ae32-74d9-4d33-93f1-f1768a0bca68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_045d9e80-e17a-4ffb-a190-26ad5b83a533" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_f852ae32-74d9-4d33-93f1-f1768a0bca68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7a34ed1e-3703-4761-8225-a4441d504912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_045d9e80-e17a-4ffb-a190-26ad5b83a533" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7a34ed1e-3703-4761-8225-a4441d504912" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c41cf4bb-48fd-496c-9466-76e078988435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_045d9e80-e17a-4ffb-a190-26ad5b83a533" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c41cf4bb-48fd-496c-9466-76e078988435" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b921c2ac-26c0-47d0-96f9-d4b9f1f155c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a01d1d0d-1fb8-4d3d-bd93-7adbdbbc0602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b921c2ac-26c0-47d0-96f9-d4b9f1f155c5" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a01d1d0d-1fb8-4d3d-bd93-7adbdbbc0602" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1ca4fd4f-3f40-4ba8-8d88-5b3ff85f2f57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b921c2ac-26c0-47d0-96f9-d4b9f1f155c5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1ca4fd4f-3f40-4ba8-8d88-5b3ff85f2f57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_376b5c6a-44f7-4580-84aa-94c758c0be8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9aa1836a-aed6-4c4a-834f-0dd298101142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_376b5c6a-44f7-4580-84aa-94c758c0be8e" xlink:to="loc_us-gaap_ProfitLoss_9aa1836a-aed6-4c4a-834f-0dd298101142" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbe0f3fa-0b2b-4351-90bc-291928768508" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_376b5c6a-44f7-4580-84aa-94c758c0be8e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cbe0f3fa-0b2b-4351-90bc-291928768508" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fc66e066-6883-470f-b7f5-3eb8755f10ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8b6f8743-1c8d-40db-afba-60927fe7b5e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fc66e066-6883-470f-b7f5-3eb8755f10ef" xlink:to="loc_us-gaap_Liabilities_8b6f8743-1c8d-40db-afba-60927fe7b5e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3731e6ea-a956-4a72-9e24-53ed61e12f74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fc66e066-6883-470f-b7f5-3eb8755f10ef" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3731e6ea-a956-4a72-9e24-53ed61e12f74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_33699b95-00a9-4c31-bf6c-d8406e541d07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fc66e066-6883-470f-b7f5-3eb8755f10ef" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_33699b95-00a9-4c31-bf6c-d8406e541d07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6d0bd92c-97d7-45ae-a8c5-9ecaa0e729a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fd623592-8292-4e89-9913-965c26155e48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6d0bd92c-97d7-45ae-a8c5-9ecaa0e729a3" xlink:to="loc_us-gaap_StockholdersEquity_fd623592-8292-4e89-9913-965c26155e48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_dd23da14-659c-44d0-87ca-84619f2e359f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6d0bd92c-97d7-45ae-a8c5-9ecaa0e729a3" xlink:to="loc_us-gaap_MinorityInterest_dd23da14-659c-44d0-87ca-84619f2e359f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ddefc9aa-a6df-46d9-826f-ee7495bf2cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9686222b-5fe2-4f0c-b46e-d277d91479d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddefc9aa-a6df-46d9-826f-ee7495bf2cfa" xlink:to="loc_us-gaap_AssetsCurrent_9686222b-5fe2-4f0c-b46e-d277d91479d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_7469067b-34c6-42c4-b3ca-4db7c225c86e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddefc9aa-a6df-46d9-826f-ee7495bf2cfa" xlink:to="loc_us-gaap_LongTermInvestments_7469067b-34c6-42c4-b3ca-4db7c225c86e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5a9933de-5aa3-44c1-915e-43d71af13069" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddefc9aa-a6df-46d9-826f-ee7495bf2cfa" xlink:to="loc_us-gaap_Goodwill_5a9933de-5aa3-44c1-915e-43d71af13069" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a364d75-e6f4-4619-98c9-05856bd6619d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddefc9aa-a6df-46d9-826f-ee7495bf2cfa" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3a364d75-e6f4-4619-98c9-05856bd6619d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_0b335561-ae08-43af-b86d-2ef675789b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddefc9aa-a6df-46d9-826f-ee7495bf2cfa" xlink:to="loc_us-gaap_SeparateAccountAssets_0b335561-ae08-43af-b86d-2ef675789b47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_70276a0e-c06c-4a66-9531-0dc291f2277f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddefc9aa-a6df-46d9-826f-ee7495bf2cfa" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_70276a0e-c06c-4a66-9531-0dc291f2277f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c1dc9ebe-8ce1-483f-b3bb-4567e576b8e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddefc9aa-a6df-46d9-826f-ee7495bf2cfa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c1dc9ebe-8ce1-483f-b3bb-4567e576b8e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_69288848-303b-4208-8a83-e0d10deb72ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddefc9aa-a6df-46d9-826f-ee7495bf2cfa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_69288848-303b-4208-8a83-e0d10deb72ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2d5405a2-3da7-4ed9-a291-952f65cc0d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddefc9aa-a6df-46d9-826f-ee7495bf2cfa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2d5405a2-3da7-4ed9-a291-952f65cc0d50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e0f61e9d-d27b-4762-98b1-80747202404c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_77223ba7-4405-4b4b-aa81-1e672b29c6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e0f61e9d-d27b-4762-98b1-80747202404c" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_77223ba7-4405-4b4b-aa81-1e672b29c6bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_2095552e-73fd-4bf9-9b1e-81f0821b3cdb" xlink:href="cvs-20201231.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e0f61e9d-d27b-4762-98b1-80747202404c" xlink:to="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_2095552e-73fd-4bf9-9b1e-81f0821b3cdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_0eca8496-2f16-490f-acec-bdbbebdfa162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e0f61e9d-d27b-4762-98b1-80747202404c" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_0eca8496-2f16-490f-acec-bdbbebdfa162" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_b8722c07-de75-4e77-a48a-72fb292c0fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e0f61e9d-d27b-4762-98b1-80747202404c" xlink:to="loc_us-gaap_OtherPolicyholderFunds_b8722c07-de75-4e77-a48a-72fb292c0fce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2388d4dc-a10a-4e3e-a831-f10c35433978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e0f61e9d-d27b-4762-98b1-80747202404c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2388d4dc-a10a-4e3e-a831-f10c35433978" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_0d5faa40-0aea-4d68-a1b2-5f61afc181b7" xlink:href="cvs-20201231.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e0f61e9d-d27b-4762-98b1-80747202404c" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_0d5faa40-0aea-4d68-a1b2-5f61afc181b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7b190ed4-01f0-46a6-b871-9dae1af5bd1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e0f61e9d-d27b-4762-98b1-80747202404c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7b190ed4-01f0-46a6-b871-9dae1af5bd1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_b2a90973-bcc1-4767-b18d-fa783854ccbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e0f61e9d-d27b-4762-98b1-80747202404c" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_b2a90973-bcc1-4767-b18d-fa783854ccbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ebb2c9ed-55e6-427c-a2c8-49caaf59c9b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_1db08aac-9456-42d0-9bbf-1699f812635a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ebb2c9ed-55e6-427c-a2c8-49caaf59c9b0" xlink:to="loc_us-gaap_PreferredStockValue_1db08aac-9456-42d0-9bbf-1699f812635a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_cf691885-2cf7-40a7-ad7d-6f243f1acbd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ebb2c9ed-55e6-427c-a2c8-49caaf59c9b0" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_cf691885-2cf7-40a7-ad7d-6f243f1acbd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_5c009ede-c117-4a0e-affa-89b04db70284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ebb2c9ed-55e6-427c-a2c8-49caaf59c9b0" xlink:to="loc_us-gaap_TreasuryStockValue_5c009ede-c117-4a0e-affa-89b04db70284" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d8f5eeeb-1190-4de2-8792-6ee4deb8b401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ebb2c9ed-55e6-427c-a2c8-49caaf59c9b0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d8f5eeeb-1190-4de2-8792-6ee4deb8b401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a058031d-2b37-495e-80ab-c5eecc6c798a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ebb2c9ed-55e6-427c-a2c8-49caaf59c9b0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a058031d-2b37-495e-80ab-c5eecc6c798a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6bc93835-39ff-4079-86ca-5d502ed10b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f75bfe6f-6a27-41df-9de3-64ee58cc8f9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6bc93835-39ff-4079-86ca-5d502ed10b32" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f75bfe6f-6a27-41df-9de3-64ee58cc8f9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_22a72b3f-1213-4232-9d4b-b305927405e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6bc93835-39ff-4079-86ca-5d502ed10b32" xlink:to="loc_us-gaap_ShortTermInvestments_22a72b3f-1213-4232-9d4b-b305927405e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f1530426-f747-4dc7-96e1-cdab03f7be39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6bc93835-39ff-4079-86ca-5d502ed10b32" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f1530426-f747-4dc7-96e1-cdab03f7be39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2fd4778d-b770-4eaf-a78f-4aa138308694" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6bc93835-39ff-4079-86ca-5d502ed10b32" xlink:to="loc_us-gaap_InventoryNet_2fd4778d-b770-4eaf-a78f-4aa138308694" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a957fff5-0413-4a09-811a-86c680d9e94a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6bc93835-39ff-4079-86ca-5d502ed10b32" xlink:to="loc_us-gaap_OtherAssetsCurrent_a957fff5-0413-4a09-811a-86c680d9e94a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c7cb2505-0a81-4bd0-bd6e-0bb5927c882f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_add3b469-f56b-40b9-9795-9c9a72975f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c7cb2505-0a81-4bd0-bd6e-0bb5927c882f" xlink:to="loc_us-gaap_LiabilitiesCurrent_add3b469-f56b-40b9-9795-9c9a72975f40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fafcb9ec-e5e0-4162-8024-8af39ab94d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c7cb2505-0a81-4bd0-bd6e-0bb5927c882f" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fafcb9ec-e5e0-4162-8024-8af39ab94d74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a2124e2a-1efc-4c97-b67c-89db1a0dfe13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c7cb2505-0a81-4bd0-bd6e-0bb5927c882f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a2124e2a-1efc-4c97-b67c-89db1a0dfe13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_9854b878-1977-4593-8242-f81e1610ea72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c7cb2505-0a81-4bd0-bd6e-0bb5927c882f" xlink:to="loc_us-gaap_SeparateAccountsLiability_9854b878-1977-4593-8242-f81e1610ea72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_c3fe8ed1-1e08-4e0b-a1d7-fc34a8edda34" xlink:href="cvs-20201231.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c7cb2505-0a81-4bd0-bd6e-0bb5927c882f" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_c3fe8ed1-1e08-4e0b-a1d7-fc34a8edda34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bf12daa6-09d8-4ea1-9a7d-94fa3c966712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c7cb2505-0a81-4bd0-bd6e-0bb5927c882f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bf12daa6-09d8-4ea1-9a7d-94fa3c966712" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3c65c1a5-7037-472d-bcaa-5d5a10e0ea5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c7cb2505-0a81-4bd0-bd6e-0bb5927c882f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3c65c1a5-7037-472d-bcaa-5d5a10e0ea5b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b7c4a90-c2e2-4c51-a9fd-f6456f128e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_fd294a8c-606f-4f7c-969e-8bf84e924e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b7c4a90-c2e2-4c51-a9fd-f6456f128e9e" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_fd294a8c-606f-4f7c-969e-8bf84e924e6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c51fb519-cc85-445c-940d-e8f84193af1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b7c4a90-c2e2-4c51-a9fd-f6456f128e9e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c51fb519-cc85-445c-940d-e8f84193af1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_8eb916c6-72df-430e-8f59-c4c3cd0fa5ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b7c4a90-c2e2-4c51-a9fd-f6456f128e9e" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_8eb916c6-72df-430e-8f59-c4c3cd0fa5ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_e2c1af78-99ea-4c8b-a4e3-f3de830f9eb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b7c4a90-c2e2-4c51-a9fd-f6456f128e9e" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_e2c1af78-99ea-4c8b-a4e3-f3de830f9eb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_3765de28-fc59-4e99-98ff-2ef1d31b79fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b7c4a90-c2e2-4c51-a9fd-f6456f128e9e" xlink:to="loc_us-gaap_PaymentsOfDividends_3765de28-fc59-4e99-98ff-2ef1d31b79fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_72dcd8f1-6885-41b0-8421-7984c8931b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b7c4a90-c2e2-4c51-a9fd-f6456f128e9e" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_72dcd8f1-6885-41b0-8421-7984c8931b56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_26fcb3f1-d025-4144-88bf-6a24888aebe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b7c4a90-c2e2-4c51-a9fd-f6456f128e9e" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_26fcb3f1-d025-4144-88bf-6a24888aebe3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_aab6f4f8-dd5e-4881-9232-605916c02842" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b7c4a90-c2e2-4c51-a9fd-f6456f128e9e" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_aab6f4f8-dd5e-4881-9232-605916c02842" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_71efeeb2-9d8a-40c2-8dae-18bad8995d0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_ProfitLoss_71efeeb2-9d8a-40c2-8dae-18bad8995d0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1ba6d94f-a9ae-40cf-8a93-d68ed63fe975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1ba6d94f-a9ae-40cf-8a93-d68ed63fe975" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_009d8b23-7fad-4387-bb5a-9864f7c43f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_009d8b23-7fad-4387-bb5a-9864f7c43f7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_40a9ec78-b384-47f1-bf2d-b8eb02beb6c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_ShareBasedCompensation_40a9ec78-b384-47f1-bf2d-b8eb02beb6c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_57632245-a667-4350-b197-51f0c1cd289b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_57632245-a667-4350-b197-51f0c1cd289b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_807505b6-aecb-4132-ac3c-14ef3bff1c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_807505b6-aecb-4132-ac3c-14ef3bff1c47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_bbb108e9-7ed4-4559-bfe4-6eebcc648395" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_bbb108e9-7ed4-4559-bfe4-6eebcc648395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_01a11a71-86f6-45a4-9eb4-769d00c2e656" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_01a11a71-86f6-45a4-9eb4-769d00c2e656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_04cfe916-d5d1-4bcd-9f21-02c38d59fc4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_04cfe916-d5d1-4bcd-9f21-02c38d59fc4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_19941bb9-2391-4b91-a872-0f17e8457198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_19941bb9-2391-4b91-a872-0f17e8457198" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_cca2db2c-5b06-447d-9d7d-b6962b599871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_cca2db2c-5b06-447d-9d7d-b6962b599871" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d768f527-cb36-4ccb-8a66-20771cf6fefa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d768f527-cb36-4ccb-8a66-20771cf6fefa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_d57ab7b3-0332-439a-bf45-db3ca4fae17b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_d57ab7b3-0332-439a-bf45-db3ca4fae17b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_59d2f624-c40d-41c1-a7b7-f79e80a94c8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e7c816b-45dc-4e36-83c5-564f3f8e99c4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_59d2f624-c40d-41c1-a7b7-f79e80a94c8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5756a74b-b990-4303-a5b1-d1ed31bf4d85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_53cd6b5b-3a48-4f13-ac32-5f7f82f12c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5756a74b-b990-4303-a5b1-d1ed31bf4d85" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_53cd6b5b-3a48-4f13-ac32-5f7f82f12c7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0d9e8403-edc3-46c0-b9fb-9a9dad3ada39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5756a74b-b990-4303-a5b1-d1ed31bf4d85" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0d9e8403-edc3-46c0-b9fb-9a9dad3ada39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_2eab3cd7-646c-43df-88ff-f851d35bf378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5756a74b-b990-4303-a5b1-d1ed31bf4d85" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_2eab3cd7-646c-43df-88ff-f851d35bf378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_924e8af2-dddd-426f-aa40-7363fe729981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5756a74b-b990-4303-a5b1-d1ed31bf4d85" xlink:to="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_924e8af2-dddd-426f-aa40-7363fe729981" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6f4771de-4b69-4f8b-a287-321dac376171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5756a74b-b990-4303-a5b1-d1ed31bf4d85" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6f4771de-4b69-4f8b-a287-321dac376171" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_799ac754-092b-44fb-aaa1-915c556742cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5756a74b-b990-4303-a5b1-d1ed31bf4d85" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_799ac754-092b-44fb-aaa1-915c556742cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7a420d10-c113-494c-965b-fbaee98bb8bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5756a74b-b990-4303-a5b1-d1ed31bf4d85" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7a420d10-c113-494c-965b-fbaee98bb8bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a955fdb-01d9-42cb-a20e-663b4ee31fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79eb3ef9-fa0e-4ef2-95f3-1934e9d9798a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a955fdb-01d9-42cb-a20e-663b4ee31fe3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_79eb3ef9-fa0e-4ef2-95f3-1934e9d9798a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2374a28-ae00-48a8-bada-31528fab63d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a955fdb-01d9-42cb-a20e-663b4ee31fe3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e2374a28-ae00-48a8-bada-31528fab63d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0ccb9f14-b80b-424f-8268-1d56e6222753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a955fdb-01d9-42cb-a20e-663b4ee31fe3" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0ccb9f14-b80b-424f-8268-1d56e6222753" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fe8649bf-5e78-4a5e-8bec-764217c9908c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a955fdb-01d9-42cb-a20e-663b4ee31fe3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fe8649bf-5e78-4a5e-8bec-764217c9908c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofCashFlows_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_848072af-a62a-4244-ba1d-c7f845706d6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_714ff45a-1d44-4774-8fa2-8dff02c13a52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_848072af-a62a-4244-ba1d-c7f845706d6d" xlink:to="loc_us-gaap_ProceedsFromCustomers_714ff45a-1d44-4774-8fa2-8dff02c13a52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_77f8cfbc-8aab-4d1c-b42c-16b7c411b0cd" xlink:href="cvs-20201231.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_848072af-a62a-4244-ba1d-c7f845706d6d" xlink:to="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_77f8cfbc-8aab-4d1c-b42c-16b7c411b0cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits_fc6dd379-7df9-44ea-8f90-1c45f813ac92" xlink:href="cvs-20201231.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_848072af-a62a-4244-ba1d-c7f845706d6d" xlink:to="loc_cvs_PaymentsforInsuranceBenefits_fc6dd379-7df9-44ea-8f90-1c45f813ac92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_77fba1c4-9986-4ec3-a46c-d0a472a5a6ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_848072af-a62a-4244-ba1d-c7f845706d6d" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_77fba1c4-9986-4ec3-a46c-d0a472a5a6ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_8d1c23a4-eee4-4769-bac1-392812867cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_848072af-a62a-4244-ba1d-c7f845706d6d" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_8d1c23a4-eee4-4769-bac1-392812867cbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_10f1af69-e064-481a-be10-eef6c098841f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_848072af-a62a-4244-ba1d-c7f845706d6d" xlink:to="loc_us-gaap_InterestPaidNet_10f1af69-e064-481a-be10-eef6c098841f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_dd7e78c4-14f9-471c-995e-e8f4cf3cee12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_848072af-a62a-4244-ba1d-c7f845706d6d" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_dd7e78c4-14f9-471c-995e-e8f4cf3cee12" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6822f98e-d89e-483a-9bc4-794fedb6707c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0625dd6e-92c8-43e4-a876-fddcf48fda7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6822f98e-d89e-483a-9bc4-794fedb6707c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0625dd6e-92c8-43e4-a876-fddcf48fda7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_eee1a3eb-660c-4418-8798-dd694877214f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6822f98e-d89e-483a-9bc4-794fedb6707c" xlink:to="loc_us-gaap_RestrictedCashCurrent_eee1a3eb-660c-4418-8798-dd694877214f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_08b22143-89e3-41dd-9bf8-f5e6e1d3cc38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6822f98e-d89e-483a-9bc4-794fedb6707c" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_08b22143-89e3-41dd-9bf8-f5e6e1d3cc38" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_12ed6b1f-d749-4eac-b4cd-6b2d211ef06e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_30cec2ff-71d9-479c-8aff-efd9ac5cb3c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_12ed6b1f-d749-4eac-b4cd-6b2d211ef06e" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_30cec2ff-71d9-479c-8aff-efd9ac5cb3c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_e57407bb-b3dc-4087-8bb9-2bfe1e656938" xlink:href="cvs-20201231.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_12ed6b1f-d749-4eac-b4cd-6b2d211ef06e" xlink:to="loc_cvs_VendorandManufacturerReceivables_e57407bb-b3dc-4087-8bb9-2bfe1e656938" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_83fd1e99-a86d-4bf2-bf74-8a6d5d72c255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_12ed6b1f-d749-4eac-b4cd-6b2d211ef06e" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_83fd1e99-a86d-4bf2-bf74-8a6d5d72c255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_e9942221-d84d-40d1-bec7-26a9aaefb0f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_12ed6b1f-d749-4eac-b4cd-6b2d211ef06e" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_e9942221-d84d-40d1-bec7-26a9aaefb0f4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f47d5a1c-8924-4d52-b20c-0c9ec01828ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e72cf045-8334-4d82-b598-a7b3b16f96d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f47d5a1c-8924-4d52-b20c-0c9ec01828ee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e72cf045-8334-4d82-b598-a7b3b16f96d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_974f22a8-330c-47bb-9cc2-c02abea9e65f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f47d5a1c-8924-4d52-b20c-0c9ec01828ee" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_974f22a8-330c-47bb-9cc2-c02abea9e65f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesVariableInterestEntitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesDiscontinuedOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ec955023-5414-4be4-9074-2a44d4ffaa3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_b261a65f-84a1-4bb3-8031-74a8c87d5a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ec955023-5414-4be4-9074-2a44d4ffaa3a" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_b261a65f-84a1-4bb3-8031-74a8c87d5a9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_acea5fd0-7eda-4749-89a2-9c753b253757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_ec955023-5414-4be4-9074-2a44d4ffaa3a" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_acea5fd0-7eda-4749-89a2-9c753b253757" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestitures" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestitures"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestitures" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestituresTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestituresTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestituresNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f0e6cf2c-33d8-407d-b83b-408c21abe4ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d0443aa3-ce22-425d-aefc-8e25903cb736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f0e6cf2c-33d8-407d-b83b-408c21abe4ea" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d0443aa3-ce22-425d-aefc-8e25903cb736" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a08c1e46-dd8a-44b1-a029-a7e630a82915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f0e6cf2c-33d8-407d-b83b-408c21abe4ea" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a08c1e46-dd8a-44b1-a029-a7e630a82915" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_26806f01-0d28-474a-b0d3-c63483ccc623" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f0e6cf2c-33d8-407d-b83b-408c21abe4ea" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_26806f01-0d28-474a-b0d3-c63483ccc623" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments_6abb500b-66d5-4ae0-b16a-1c5d2a2cbe8f" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f0e6cf2c-33d8-407d-b83b-408c21abe4ea" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments_6abb500b-66d5-4ae0-b16a-1c5d2a2cbe8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ebeef2fe-ac47-4f54-ac9b-51faf111f766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f0e6cf2c-33d8-407d-b83b-408c21abe4ea" xlink:to="loc_us-gaap_Goodwill_ebeef2fe-ac47-4f54-ac9b-51faf111f766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_76f7c997-07af-4b94-9c41-00ff311c4c98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f0e6cf2c-33d8-407d-b83b-408c21abe4ea" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_76f7c997-07af-4b94-9c41-00ff311c4c98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_d796d515-318d-4a7a-a955-9f9f691550a6" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f0e6cf2c-33d8-407d-b83b-408c21abe4ea" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_d796d515-318d-4a7a-a955-9f9f691550a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e259b62a-8b91-4c92-b1fa-1028f1da5563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet_f36337e3-ce2d-4a33-a704-b9002042e1a2" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e259b62a-8b91-4c92-b1fa-1028f1da5563" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet_f36337e3-ce2d-4a33-a704-b9002042e1a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_5d956244-1c6a-4154-a6b3-a52a66f352dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e259b62a-8b91-4c92-b1fa-1028f1da5563" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_5d956244-1c6a-4154-a6b3-a52a66f352dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_66ea3663-6b6a-47d8-a164-d79144208150" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e259b62a-8b91-4c92-b1fa-1028f1da5563" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_66ea3663-6b6a-47d8-a164-d79144208150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_16c926db-fe8b-42da-9912-183082e96bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e259b62a-8b91-4c92-b1fa-1028f1da5563" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_16c926db-fe8b-42da-9912-183082e96bb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4c96fb0b-fb48-49f5-a9f5-52138847a7bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e259b62a-8b91-4c92-b1fa-1028f1da5563" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4c96fb0b-fb48-49f5-a9f5-52138847a7bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_9fee64a7-f6ae-4409-96c5-b6efa334ee91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_ff17bb19-a77f-4062-abdd-9cb114deab3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_9fee64a7-f6ae-4409-96c5-b6efa334ee91" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_ff17bb19-a77f-4062-abdd-9cb114deab3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0ed65eb7-60ea-4ecf-a0f4-b230ef1ddc23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_9fee64a7-f6ae-4409-96c5-b6efa334ee91" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0ed65eb7-60ea-4ecf-a0f4-b230ef1ddc23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_a28c963d-85a4-4909-9d77-ebb7b056d962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_9fee64a7-f6ae-4409-96c5-b6efa334ee91" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_a28c963d-85a4-4909-9d77-ebb7b056d962" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestituresProFormaDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Investments" xlink:type="simple" xlink:href="cvs-20201231.xsd#Investments"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/Investments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsScheduleofTotalInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_d1bbf865-e2db-4f76-81d9-45a2597a7025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_e3697e20-b532-4a43-ad6d-a5c3ba30ddea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_d1bbf865-e2db-4f76-81d9-45a2597a7025" xlink:to="loc_us-gaap_ShortTermInvestments_e3697e20-b532-4a43-ad6d-a5c3ba30ddea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_2802b8fe-e7a1-484a-a938-4cb35e69b9ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_d1bbf865-e2db-4f76-81d9-45a2597a7025" xlink:to="loc_us-gaap_LongTermInvestments_2802b8fe-e7a1-484a-a938-4cb35e69b9ea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c0de9e63-de45-4c68-afce-0d218275291e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d5163000-85b3-430b-a6c4-37dd7840e5b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c0de9e63-de45-4c68-afce-0d218275291e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d5163000-85b3-430b-a6c4-37dd7840e5b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_ab75a45e-da78-4d30-8e05-e2d8fddfd5ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c0de9e63-de45-4c68-afce-0d218275291e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_ab75a45e-da78-4d30-8e05-e2d8fddfd5ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_4e9c895b-599a-4eef-a4f6-1d146810720f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c0de9e63-de45-4c68-afce-0d218275291e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_4e9c895b-599a-4eef-a4f6-1d146810720f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_edfd422b-c23f-42b1-9d08-43693a1b6160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c0de9e63-de45-4c68-afce-0d218275291e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_edfd422b-c23f-42b1-9d08-43693a1b6160" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_ca7a56a2-2b8c-4a30-b358-452b48108b87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c0de9e63-de45-4c68-afce-0d218275291e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_ca7a56a2-2b8c-4a30-b358-452b48108b87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_1ffa9f9e-a653-471b-9c96-67c3c8a23f52" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_a7490e58-1e85-4ae4-a3ed-2659fd934fa6" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_1ffa9f9e-a653-471b-9c96-67c3c8a23f52" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_a7490e58-1e85-4ae4-a3ed-2659fd934fa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_81cf47ba-8511-4c7d-8b1f-cb1a75a6bf00" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_1ffa9f9e-a653-471b-9c96-67c3c8a23f52" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_81cf47ba-8511-4c7d-8b1f-cb1a75a6bf00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_978d95e7-db3e-43b4-a519-b6c64e590797" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_1ffa9f9e-a653-471b-9c96-67c3c8a23f52" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_978d95e7-db3e-43b4-a519-b6c64e590797" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_8f4e9435-db03-4f03-a777-9d1ea5ddc9cf" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_1ffa9f9e-a653-471b-9c96-67c3c8a23f52" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_8f4e9435-db03-4f03-a777-9d1ea5ddc9cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_7d62d759-8799-4398-ae26-a97755959c7a" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_1ffa9f9e-a653-471b-9c96-67c3c8a23f52" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_7d62d759-8799-4398-ae26-a97755959c7a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_7fdb20b4-bee1-4cff-a165-efbf0c585433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_b1b8c40f-3a6e-4e0f-8c6d-91b4edf8c400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_7fdb20b4-bee1-4cff-a165-efbf0c585433" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_b1b8c40f-3a6e-4e0f-8c6d-91b4edf8c400" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_c22194e5-2d8a-4f67-a973-1fe7bef1f164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_7fdb20b4-bee1-4cff-a165-efbf0c585433" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_c22194e5-2d8a-4f67-a973-1fe7bef1f164" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_6fc0f43b-b56b-402b-8d53-eedf763f568d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_1aa8172b-de2b-4c02-83d6-07413795ffcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_6fc0f43b-b56b-402b-8d53-eedf763f568d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_1aa8172b-de2b-4c02-83d6-07413795ffcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_7e573198-e637-4de6-83fc-ee1f7b51d693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_6fc0f43b-b56b-402b-8d53-eedf763f568d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_7e573198-e637-4de6-83fc-ee1f7b51d693" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5e51e27e-7afc-4610-97e8-851a3603e8e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_1fb32d5b-7f85-4359-a038-6fc6e8c57c4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5e51e27e-7afc-4610-97e8-851a3603e8e3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_1fb32d5b-7f85-4359-a038-6fc6e8c57c4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_33d49854-2910-4e62-890e-73f8cd85fdc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5e51e27e-7afc-4610-97e8-851a3603e8e3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_33d49854-2910-4e62-890e-73f8cd85fdc2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c89d807e-4e58-4220-8395-eb36be61ae29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_0c861532-f392-4325-9288-f01d59c094cf" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c89d807e-4e58-4220-8395-eb36be61ae29" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_0c861532-f392-4325-9288-f01d59c094cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_f55b56d0-4958-4b3c-bb6e-518b205d5286" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c89d807e-4e58-4220-8395-eb36be61ae29" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_f55b56d0-4958-4b3c-bb6e-518b205d5286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_11cc4220-47c3-40bb-b862-4d2b5a54204c" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c89d807e-4e58-4220-8395-eb36be61ae29" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_11cc4220-47c3-40bb-b862-4d2b5a54204c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_5ebb46f6-5394-4213-8daa-1eaf518bd243" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c89d807e-4e58-4220-8395-eb36be61ae29" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_5ebb46f6-5394-4213-8daa-1eaf518bd243" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_b63344c6-234f-4d42-94f2-d5fd8bfa56e8" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_c89d807e-4e58-4220-8395-eb36be61ae29" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_b63344c6-234f-4d42-94f2-d5fd8bfa56e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_07a9b1f6-0e89-4074-a5ad-d24c3d4a2080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_857d64ad-aa2a-4b1b-b530-1fb0674dcfeb" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_07a9b1f6-0e89-4074-a5ad-d24c3d4a2080" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_857d64ad-aa2a-4b1b-b530-1fb0674dcfeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_0f1f7f92-efdf-4245-a609-1de59bb9afde" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_07a9b1f6-0e89-4074-a5ad-d24c3d4a2080" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_0f1f7f92-efdf-4245-a609-1de59bb9afde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_19d67bd2-bf3e-4de9-a40c-cfa1888e9d3a" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_07a9b1f6-0e89-4074-a5ad-d24c3d4a2080" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_19d67bd2-bf3e-4de9-a40c-cfa1888e9d3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_8c1fc781-83a4-490e-a421-d51e536d34ae" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_07a9b1f6-0e89-4074-a5ad-d24c3d4a2080" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_8c1fc781-83a4-490e-a421-d51e536d34ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_c16a8797-7772-4d2d-af69-8cf0046e040b" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_07a9b1f6-0e89-4074-a5ad-d24c3d4a2080" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_c16a8797-7772-4d2d-af69-8cf0046e040b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsMortgageLoansDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_8c3ee364-4152-4991-bb79-4d0e4dc77859" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_36650b62-5260-427f-b4d8-e5f10c86ae45" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_8c3ee364-4152-4991-bb79-4d0e4dc77859" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_36650b62-5260-427f-b4d8-e5f10c86ae45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_1aadf1d9-af06-4de1-b74b-90d2a0fbc4e8" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_8c3ee364-4152-4991-bb79-4d0e4dc77859" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_1aadf1d9-af06-4de1-b74b-90d2a0fbc4e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_8fbaac8e-c50c-4004-b69e-0cb49c756481" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_8c3ee364-4152-4991-bb79-4d0e4dc77859" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_8fbaac8e-c50c-4004-b69e-0cb49c756481" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_4dbb2b5e-8956-416c-9d29-21c634cc0cf3" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_8c3ee364-4152-4991-bb79-4d0e4dc77859" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_4dbb2b5e-8956-416c-9d29-21c634cc0cf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_eceb9a90-c8ac-4773-8506-0fc523ed91cc" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_8c3ee364-4152-4991-bb79-4d0e4dc77859" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_eceb9a90-c8ac-4773-8506-0fc523ed91cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_9b0d7fd6-6e05-4178-bd58-717ae9aac8f9" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_8c3ee364-4152-4991-bb79-4d0e4dc77859" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_9b0d7fd6-6e05-4178-bd58-717ae9aac8f9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_834af4c7-ee25-45c6-8772-180e1c70952d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_9c78a5d6-e7f1-4d31-97ee-b205ef7bf6dc" xlink:href="cvs-20201231.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_834af4c7-ee25-45c6-8772-180e1c70952d" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_9c78a5d6-e7f1-4d31-97ee-b205ef7bf6dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_6c2131b3-03b2-4737-a666-4de7ea8cf6a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_834af4c7-ee25-45c6-8772-180e1c70952d" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_6c2131b3-03b2-4737-a666-4de7ea8cf6a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_2514026f-a90b-4aec-bf14-de849a53c67c" xlink:href="cvs-20201231.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_3d3f4ebd-b525-46de-adb8-9db898d2e9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_2514026f-a90b-4aec-bf14-de849a53c67c" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_3d3f4ebd-b525-46de-adb8-9db898d2e9ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_ec9d472e-648c-46d8-b231-85f1311c1867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_2514026f-a90b-4aec-bf14-de849a53c67c" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_ec9d472e-648c-46d8-b231-85f1311c1867" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsRealizedGainsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValue" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValue"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueFairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_625de7fe-b3fa-4425-a0dc-89fde8f1dff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_544f9ab6-ca41-42ff-8841-df8287548985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_625de7fe-b3fa-4425-a0dc-89fde8f1dff3" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_544f9ab6-ca41-42ff-8841-df8287548985" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dd2271fc-05d4-4986-9c6e-cf0252759b86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_625de7fe-b3fa-4425-a0dc-89fde8f1dff3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_dd2271fc-05d4-4986-9c6e-cf0252759b86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_64a3695b-9b9b-4766-80ee-61db60e722b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_625de7fe-b3fa-4425-a0dc-89fde8f1dff3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_64a3695b-9b9b-4766-80ee-61db60e722b8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueChangesinLevel3FinancialAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueGrossTransfersIntoOutOfLevel3Details"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_9d08a78f-da8d-41cd-86ce-87670cb6f704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_382e023e-ceee-47fc-bcd0-b515522480c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_9d08a78f-da8d-41cd-86ce-87670cb6f704" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_382e023e-ceee-47fc-bcd0-b515522480c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_ecfa2e32-8f2c-4f48-8f7b-b2e520d5854c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_9d08a78f-da8d-41cd-86ce-87670cb6f704" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_ecfa2e32-8f2c-4f48-8f7b-b2e520d5854c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueOffsettingFinancialLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueOffsettingFinancialLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueOffsettingFinancialLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangiblesTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangiblesGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangiblesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangiblesIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7707fbe5-86e6-4be7-9a0f-cfb1868b2d40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_fdab4a96-4a34-40c5-b20a-7f157d4e9bfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7707fbe5-86e6-4be7-9a0f-cfb1868b2d40" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_fdab4a96-4a34-40c5-b20a-7f157d4e9bfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3c189ac7-80d1-4e85-b8ab-7add12d8e186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7707fbe5-86e6-4be7-9a0f-cfb1868b2d40" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3c189ac7-80d1-4e85-b8ab-7add12d8e186" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3882d3c3-8028-4b74-8992-9e9751fee6f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2b510e9e-0aa6-4950-b214-416277911440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3882d3c3-8028-4b74-8992-9e9751fee6f5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2b510e9e-0aa6-4950-b214-416277911440" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_16f039ef-3a05-44d3-b93a-1d858fd4438b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3882d3c3-8028-4b74-8992-9e9751fee6f5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_16f039ef-3a05-44d3-b93a-1d858fd4438b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e70a4864-d013-48d6-8e31-4fba8fb06c21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fee355c3-3d99-407b-bb82-527e8b96094b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e70a4864-d013-48d6-8e31-4fba8fb06c21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_fee355c3-3d99-407b-bb82-527e8b96094b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7afc4540-46ce-4c47-82bb-642f696086ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e70a4864-d013-48d6-8e31-4fba8fb06c21" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7afc4540-46ce-4c47-82bb-642f696086ce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Leases" xlink:type="simple" xlink:href="cvs-20201231.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesSummaryoftheComponentsofNetLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseCost_6b8e42a4-657d-497f-8494-ec84c735c21d" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_bfd78b4f-cc50-4b57-a478-48ff3312dd90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_FinanceLeaseCost_6b8e42a4-657d-497f-8494-ec84c735c21d" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_bfd78b4f-cc50-4b57-a478-48ff3312dd90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_3ae2dff3-57f8-4094-ae48-6555a55edd4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_FinanceLeaseCost_6b8e42a4-657d-497f-8494-ec84c735c21d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_3ae2dff3-57f8-4094-ae48-6555a55edd4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_377fac9c-5b43-4a80-9872-09b936149c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_cad4e1d6-b896-4a7b-b2ae-b19b4345d165" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_377fac9c-5b43-4a80-9872-09b936149c2c" xlink:to="loc_us-gaap_SubleaseIncome_cad4e1d6-b896-4a7b-b2ae-b19b4345d165" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_e050c360-eafd-43bf-b4c8-cd37bab1cc2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_377fac9c-5b43-4a80-9872-09b936149c2c" xlink:to="loc_us-gaap_VariableLeaseCost_e050c360-eafd-43bf-b4c8-cd37bab1cc2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_7c04d70e-b2c6-4acb-81a6-28000a1a1ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_377fac9c-5b43-4a80-9872-09b936149c2c" xlink:to="loc_us-gaap_OperatingLeaseCost_7c04d70e-b2c6-4acb-81a6-28000a1a1ba9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseCost_cce94da6-3c8e-4f25-a379-0fffeeae5c55" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_377fac9c-5b43-4a80-9872-09b936149c2c" xlink:to="loc_cvs_FinanceLeaseCost_cce94da6-3c8e-4f25-a379-0fffeeae5c55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_9d5b708c-e55c-4f59-8b56-63935fe11074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_377fac9c-5b43-4a80-9872-09b936149c2c" xlink:to="loc_us-gaap_ShortTermLeaseCost_9d5b708c-e55c-4f59-8b56-63935fe11074" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_28943c01-37cb-4f85-a00c-dabec740c5e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b4a87388-10a9-4f2b-806f-7f8959f00687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_28943c01-37cb-4f85-a00c-dabec740c5e1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b4a87388-10a9-4f2b-806f-7f8959f00687" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1dba7113-4ba7-41b4-91ab-b01d42326fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_28943c01-37cb-4f85-a00c-dabec740c5e1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1dba7113-4ba7-41b4-91ab-b01d42326fec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetNet_432bdac2-183d-465d-aa32-14dcf198e605" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseRightOfUseAssetNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetGross_4e2a0af4-07a5-4874-a460-d720425f47be" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseRightOfUseAssetGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetNet_432bdac2-183d-465d-aa32-14dcf198e605" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetGross_4e2a0af4-07a5-4874-a460-d720425f47be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_faba6ea8-30f3-4ebb-b1b2-0acfcace4ec4" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetNet_432bdac2-183d-465d-aa32-14dcf198e605" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_faba6ea8-30f3-4ebb-b1b2-0acfcace4ec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_9451ea20-f46e-467e-be23-3125044df8b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_af533e3c-718c-45a5-9184-ba6d686c8c2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_9451ea20-f46e-467e-be23-3125044df8b6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_af533e3c-718c-45a5-9184-ba6d686c8c2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1d7c1599-32f6-46d7-9535-0f913f4aa5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_9451ea20-f46e-467e-be23-3125044df8b6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_1d7c1599-32f6-46d7-9535-0f913f4aa5cc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearThree_03512ced-13c4-4318-8b58-54d61793e0a9" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_a50fed06-0cc9-446e-85c6-47642b7a4a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearThree_03512ced-13c4-4318-8b58-54d61793e0a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_a50fed06-0cc9-446e-85c6-47642b7a4a4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_bff63ed3-ba55-40f6-8360-57b972825348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearThree_03512ced-13c4-4318-8b58-54d61793e0a9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_bff63ed3-ba55-40f6-8360-57b972825348" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_a8cb5ca7-f9da-4e6f-94eb-d01e2e347297" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_668ec273-6b3d-469d-9cc9-11c1d61b2b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_a8cb5ca7-f9da-4e6f-94eb-d01e2e347297" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_668ec273-6b3d-469d-9cc9-11c1d61b2b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5a6b138a-a11b-402f-8b71-82ee8507e739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_a8cb5ca7-f9da-4e6f-94eb-d01e2e347297" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5a6b138a-a11b-402f-8b71-82ee8507e739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cb3bf397-b26b-4cc6-8029-85f11ff64dcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ff841bf8-173a-473f-9a04-9bbcdad34303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cb3bf397-b26b-4cc6-8029-85f11ff64dcf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ff841bf8-173a-473f-9a04-9bbcdad34303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_842650ce-e9fb-4fcd-b0b8-076fe480fc8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_3fe9108f-fbfb-4cd7-9a7d-95478e312a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_842650ce-e9fb-4fcd-b0b8-076fe480fc8f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_3fe9108f-fbfb-4cd7-9a7d-95478e312a0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c4c65a90-1f2d-47ff-ba91-d60459d3d2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_842650ce-e9fb-4fcd-b0b8-076fe480fc8f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c4c65a90-1f2d-47ff-ba91-d60459d3d2c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_a8d0d702-31ab-4eb3-9be1-c9cc7d0bb5f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_842650ce-e9fb-4fcd-b0b8-076fe480fc8f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_a8d0d702-31ab-4eb3-9be1-c9cc7d0bb5f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_c370eb7d-203e-40b3-9e93-4e3eb7bc7040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_842650ce-e9fb-4fcd-b0b8-076fe480fc8f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_c370eb7d-203e-40b3-9e93-4e3eb7bc7040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_e06cf709-66bf-48c6-b9a5-61fa1fcf576c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_842650ce-e9fb-4fcd-b0b8-076fe480fc8f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_e06cf709-66bf-48c6-b9a5-61fa1fcf576c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_99ffe19d-c657-42da-baa3-668ed8ce0c04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_842650ce-e9fb-4fcd-b0b8-076fe480fc8f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_99ffe19d-c657-42da-baa3-668ed8ce0c04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeaseLiability_f2f7ce37-b29a-4c0f-ab54-129ec8f61bb9" xlink:href="cvs-20201231.xsd#cvs_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d9b723b7-f5c6-4bc3-8e66-e88c581458d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LeaseLiability_f2f7ce37-b29a-4c0f-ab54-129ec8f61bb9" xlink:to="loc_us-gaap_FinanceLeaseLiability_d9b723b7-f5c6-4bc3-8e66-e88c581458d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_df4bba8a-0d56-47a7-ae2f-072d5e21eb3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LeaseLiability_f2f7ce37-b29a-4c0f-ab54-129ec8f61bb9" xlink:to="loc_us-gaap_OperatingLeaseLiability_df4bba8a-0d56-47a7-ae2f-072d5e21eb3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDue_fbe069fe-8086-4eac-9a52-a9f1d9a479a2" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_71c304c6-572e-4f85-a1f4-beab2bf876aa" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_fbe069fe-8086-4eac-9a52-a9f1d9a479a2" xlink:to="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_71c304c6-572e-4f85-a1f4-beab2bf876aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeaseLiability_b5c40321-4b0b-4129-af25-4558e5bdba5e" xlink:href="cvs-20201231.xsd#cvs_LeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_fbe069fe-8086-4eac-9a52-a9f1d9a479a2" xlink:to="loc_cvs_LeaseLiability_b5c40321-4b0b-4129-af25-4558e5bdba5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFour_47c09c22-29d8-4022-938a-82b678301b11" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_0cec7787-1d85-4809-8f15-ee314a3e720e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFour_47c09c22-29d8-4022-938a-82b678301b11" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_0cec7787-1d85-4809-8f15-ee314a3e720e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_aeba37ed-fb9b-4ab5-b804-33cfcab478b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFour_47c09c22-29d8-4022-938a-82b678301b11" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_aeba37ed-fb9b-4ab5-b804-33cfcab478b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFive_3e98b1bf-91be-43d5-bff2-9d6e7b9c2bf0" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_24584710-65c5-411c-b50b-ae8af10d3b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFive_3e98b1bf-91be-43d5-bff2-9d6e7b9c2bf0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_24584710-65c5-411c-b50b-ae8af10d3b00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_aa50cc10-4284-4be9-b3d5-22a25b2f8601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFive_3e98b1bf-91be-43d5-bff2-9d6e7b9c2bf0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_aa50cc10-4284-4be9-b3d5-22a25b2f8601" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsYearOne_ac63621b-b0f0-4604-a265-f5c37f91c6ff" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsYearOne"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_bd8e52a8-e9ac-41ce-81d5-fe59211de79b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsYearOne_ac63621b-b0f0-4604-a265-f5c37f91c6ff" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_bd8e52a8-e9ac-41ce-81d5-fe59211de79b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_0d5abc1d-2924-4547-9cc6-26495cb3a747" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_bdd8ffd6-3344-40da-a1c3-b02aa326b999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_0d5abc1d-2924-4547-9cc6-26495cb3a747" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_bdd8ffd6-3344-40da-a1c3-b02aa326b999" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ccccee6a-5d60-4941-ac12-c3649fb5f229" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_0d5abc1d-2924-4547-9cc6-26495cb3a747" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ccccee6a-5d60-4941-ac12-c3649fb5f229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_653c684a-e9e4-4547-ab01-8be0b94683c8" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d4437070-dc14-4b26-94c2-837bb311ad2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_653c684a-e9e4-4547-ab01-8be0b94683c8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d4437070-dc14-4b26-94c2-837bb311ad2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6a97eb69-8047-46f7-89cb-c22ccfffb522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_653c684a-e9e4-4547-ab01-8be0b94683c8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6a97eb69-8047-46f7-89cb-c22ccfffb522" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f72f1c47-32a3-42fd-92ec-668d3035a2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_d4e78e51-530b-49d8-8007-79c1d0596cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f72f1c47-32a3-42fd-92ec-668d3035a2ad" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_d4e78e51-530b-49d8-8007-79c1d0596cee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b85330ce-c307-4b79-bf00-cb8d765bae11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f72f1c47-32a3-42fd-92ec-668d3035a2ad" xlink:to="loc_us-gaap_FinanceLeaseLiability_b85330ce-c307-4b79-bf00-cb8d765bae11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDue_76016924-619a-4e8a-8af4-329f548b50f7" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsYearOne_047237b0-05d3-468d-8143-55387b87db2b" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsYearOne"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_76016924-619a-4e8a-8af4-329f548b50f7" xlink:to="loc_cvs_LesseeLiabilityPaymentsYearOne_047237b0-05d3-468d-8143-55387b87db2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_9f5b409f-4790-4c68-8ff8-96fd504e611b" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_76016924-619a-4e8a-8af4-329f548b50f7" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_9f5b409f-4790-4c68-8ff8-96fd504e611b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearThree_0e6fa493-98b2-4d12-82d5-566ad232c529" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_76016924-619a-4e8a-8af4-329f548b50f7" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearThree_0e6fa493-98b2-4d12-82d5-566ad232c529" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFour_2dc121f9-c44d-4f73-85cb-a6dcbbc7fa08" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_76016924-619a-4e8a-8af4-329f548b50f7" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearFour_2dc121f9-c44d-4f73-85cb-a6dcbbc7fa08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFive_820db295-1224-4eba-9095-94685028ac1b" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_76016924-619a-4e8a-8af4-329f548b50f7" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearFive_820db295-1224-4eba-9095-94685028ac1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_6a8940ca-b532-4676-a9c2-8b2ac417657d" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_76016924-619a-4e8a-8af4-329f548b50f7" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_6a8940ca-b532-4676-a9c2-8b2ac417657d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesRentalExpenseDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesRentalExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesRentalExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeasesRentExpenseGross_40574d03-b25e-4864-82a2-2cb959a1f15c" xlink:href="cvs-20201231.xsd#cvs_OperatingLeasesRentExpenseGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseMinimumRentals_b0731e4c-29ce-4b89-a3fe-18395ead179b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_OperatingLeasesRentExpenseGross_40574d03-b25e-4864-82a2-2cb959a1f15c" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseMinimumRentals_b0731e4c-29ce-4b89-a3fe-18395ead179b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseContingentRentals_1476caa8-c111-446e-85f7-d2ee7e60da6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseContingentRentals"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_OperatingLeasesRentExpenseGross_40574d03-b25e-4864-82a2-2cb959a1f15c" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseContingentRentals_1476caa8-c111-446e-85f7-d2ee7e60da6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_89221cde-29e3-4c61-85af-bb5809657d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_f421377c-7026-4df0-b743-d947f282d1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet_89221cde-29e3-4c61-85af-bb5809657d0b" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_f421377c-7026-4df0-b743-d947f282d1e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeasesRentExpenseGross_43add4b2-3826-4a27-b2b8-533c09c496b1" xlink:href="cvs-20201231.xsd#cvs_OperatingLeasesRentExpenseGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet_89221cde-29e3-4c61-85af-bb5809657d0b" xlink:to="loc_cvs_OperatingLeasesRentExpenseGross_43add4b2-3826-4a27-b2b8-533c09c496b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayable"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_3040f064-ae91-40fc-be46-24a0a520c172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_3b5f99ad-ffa1-4ba8-a5a5-f0ac29cc923e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_3040f064-ae91-40fc-be46-24a0a520c172" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_3b5f99ad-ffa1-4ba8-a5a5-f0ac29cc923e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_78f4a0d2-8dbc-42a4-9442-6df3f9730bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_3040f064-ae91-40fc-be46-24a0a520c172" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_78f4a0d2-8dbc-42a4-9442-6df3f9730bea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_238b6cd4-6fdf-4075-9800-223406ac71bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_3040f064-ae91-40fc-be46-24a0a520c172" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_238b6cd4-6fdf-4075-9800-223406ac71bd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_02acb776-79c7-495d-86e5-fafaa3f3b7a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_05d57b92-2457-4611-b98f-19940970ad34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_02acb776-79c7-495d-86e5-fafaa3f3b7a5" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_05d57b92-2457-4611-b98f-19940970ad34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_da4e9161-3a00-477a-881e-accdecc2ba34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_02acb776-79c7-495d-86e5-fafaa3f3b7a5" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_da4e9161-3a00-477a-881e-accdecc2ba34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_bd195e7a-89b1-40ad-b43b-7694172be2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_08ba335f-0281-427b-8782-fcd2422d19ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_bd195e7a-89b1-40ad-b43b-7694172be2c0" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_08ba335f-0281-427b-8782-fcd2422d19ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_b350ae4c-9f74-4c23-b7d1-6bf176b3fd96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_bd195e7a-89b1-40ad-b43b-7694172be2c0" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_b350ae4c-9f74-4c23-b7d1-6bf176b3fd96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_6e016156-a6f1-4094-aac4-f612643eb613" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_c1996a62-2a0d-4264-b202-f7151aaff986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_6e016156-a6f1-4094-aac4-f612643eb613" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_c1996a62-2a0d-4264-b202-f7151aaff986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_3dd68abc-80fa-4352-94d6-1c50405a1851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_6e016156-a6f1-4094-aac4-f612643eb613" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_3dd68abc-80fa-4352-94d6-1c50405a1851" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangements"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_c57c48eb-7b09-444a-878e-4d3f93f716bf" xlink:href="cvs-20201231.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_a7412e3f-61a3-4011-b5cb-2de5f3fedbdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation_c57c48eb-7b09-444a-878e-4d3f93f716bf" xlink:to="loc_us-gaap_FinanceLeaseLiability_a7412e3f-61a3-4011-b5cb-2de5f3fedbdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ad9492e6-dbd8-43a1-850e-0d4196409dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation_c57c48eb-7b09-444a-878e-4d3f93f716bf" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ad9492e6-dbd8-43a1-850e-0d4196409dca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_3bad3c77-eb0f-439f-8cbc-2c413854a7eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_07c393d1-c5eb-4eed-8961-08c60a0fe899" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_3bad3c77-eb0f-439f-8cbc-2c413854a7eb" xlink:to="loc_us-gaap_FinanceLeaseLiability_07c393d1-c5eb-4eed-8961-08c60a0fe899" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e7f5854d-9f2b-4dd0-8ab9-3261a414ba82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_3bad3c77-eb0f-439f-8cbc-2c413854a7eb" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e7f5854d-9f2b-4dd0-8ab9-3261a414ba82" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsDebtMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e0cb2b32-b23c-4b32-83f9-103fc969deac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b3ebed41-ca3e-4252-bc8b-a2667154cf12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e0cb2b32-b23c-4b32-83f9-103fc969deac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b3ebed41-ca3e-4252-bc8b-a2667154cf12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8a4902df-c0e8-41f5-9904-4b1aa4f6d40a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e0cb2b32-b23c-4b32-83f9-103fc969deac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8a4902df-c0e8-41f5-9904-4b1aa4f6d40a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_cb9f00f6-ed2d-4d16-b0bc-2566fb3184ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e0cb2b32-b23c-4b32-83f9-103fc969deac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_cb9f00f6-ed2d-4d16-b0bc-2566fb3184ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5f8732b1-3a8f-4799-bd17-7bd9a51f423a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e0cb2b32-b23c-4b32-83f9-103fc969deac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5f8732b1-3a8f-4799-bd17-7bd9a51f423a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_ba23176e-a8ac-46ac-966c-c470617a5011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e0cb2b32-b23c-4b32-83f9-103fc969deac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_ba23176e-a8ac-46ac-966c-c470617a5011" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e4047b66-35c1-4285-aa6a-d1c98fb07197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e0cb2b32-b23c-4b32-83f9-103fc969deac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e4047b66-35c1-4285-aa6a-d1c98fb07197" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsShorttermBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsLongTermBorrowingsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefits"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e3a0cc5f-9dec-4239-aeb7-7383c1d358a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_052438d8-371f-4f40-a670-51d8a36aee60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e3a0cc5f-9dec-4239-aeb7-7383c1d358a9" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_052438d8-371f-4f40-a670-51d8a36aee60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_759cb1d1-b4ef-4b1c-8a96-6b8c4692d4cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e3a0cc5f-9dec-4239-aeb7-7383c1d358a9" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_759cb1d1-b4ef-4b1c-8a96-6b8c4692d4cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_6eb166f9-efdc-427f-a584-fd24276b88d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_cf8bb2f4-2b14-4ae5-9e0a-d4ae978bd767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_6eb166f9-efdc-427f-a584-fd24276b88d0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_cf8bb2f4-2b14-4ae5-9e0a-d4ae978bd767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0f6dfbd5-b3c8-4bc2-b479-3ad0391cf9f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_6eb166f9-efdc-427f-a584-fd24276b88d0" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0f6dfbd5-b3c8-4bc2-b479-3ad0391cf9f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f4d92a5b-ccb4-4da9-810a-5c89cb296574" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_6eb166f9-efdc-427f-a584-fd24276b88d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f4d92a5b-ccb4-4da9-810a-5c89cb296574" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_305684ca-163a-46b4-96e7-5d40ceae7a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_7009ae75-b781-4edb-a459-460c2c151c8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_305684ca-163a-46b4-96e7-5d40ceae7a2d" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_7009ae75-b781-4edb-a459-460c2c151c8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_28d87839-046e-4cd2-9dba-bec72bb0b7e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_305684ca-163a-46b4-96e7-5d40ceae7a2d" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_28d87839-046e-4cd2-9dba-bec72bb0b7e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4efa0484-473a-4302-bf16-72760f59d621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_305684ca-163a-46b4-96e7-5d40ceae7a2d" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4efa0484-473a-4302-bf16-72760f59d621" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e54e656a-973d-4d76-9cb2-0d0001713c5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_261301cd-c5a6-463b-beca-18fcedb2d902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e54e656a-973d-4d76-9cb2-0d0001713c5c" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_261301cd-c5a6-463b-beca-18fcedb2d902" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_d1fcdeb4-19bf-41f6-b832-7c65a709c3d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e54e656a-973d-4d76-9cb2-0d0001713c5c" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_d1fcdeb4-19bf-41f6-b832-7c65a709c3d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ae64686f-3da9-4ecb-92ce-46bfe72af296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a84cfd8c-fb02-495f-bb97-0814ef918245" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ae64686f-3da9-4ecb-92ce-46bfe72af296" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a84cfd8c-fb02-495f-bb97-0814ef918245" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_ce8d203d-e68b-4fee-8459-50a0328ab5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ae64686f-3da9-4ecb-92ce-46bfe72af296" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_ce8d203d-e68b-4fee-8459-50a0328ab5ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2e0650a2-141d-4fc7-8ffa-509cfa8d6911" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_dfae9b25-bb60-4dc9-9e96-bbb318631bac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2e0650a2-141d-4fc7-8ffa-509cfa8d6911" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_dfae9b25-bb60-4dc9-9e96-bbb318631bac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06293208-e73b-4ed9-a9bb-c72f1d1d2898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_2e0650a2-141d-4fc7-8ffa-509cfa8d6911" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06293208-e73b-4ed9-a9bb-c72f1d1d2898" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_52c26a56-ea17-4c3b-a66a-14c44fe993b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0f99e094-ac71-48d4-adbd-c78ecd4b9f42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_52c26a56-ea17-4c3b-a66a-14c44fe993b0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0f99e094-ac71-48d4-adbd-c78ecd4b9f42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b3da461d-9715-44d3-9e14-7de7141f9687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_52c26a56-ea17-4c3b-a66a-14c44fe993b0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b3da461d-9715-44d3-9e14-7de7141f9687" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_f266d219-d1c5-4dca-b417-8b97330a07e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_52c26a56-ea17-4c3b-a66a-14c44fe993b0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_f266d219-d1c5-4dca-b417-8b97330a07e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFeeTaxEffectPercent_73ef65ca-e6b5-4335-8f5a-ef03d499babf" xlink:href="cvs-20201231.xsd#cvs_HealthInsurerFeeTaxEffectPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_52c26a56-ea17-4c3b-a66a-14c44fe993b0" xlink:to="loc_cvs_HealthInsurerFeeTaxEffectPercent_73ef65ca-e6b5-4335-8f5a-ef03d499babf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_30dedb23-cf1e-483c-9539-7c2096c67bc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_52c26a56-ea17-4c3b-a66a-14c44fe993b0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_30dedb23-cf1e-483c-9539-7c2096c67bc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_cd95ba72-a6ee-49d1-af3d-33a4a6a2c885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_52c26a56-ea17-4c3b-a66a-14c44fe993b0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_cd95ba72-a6ee-49d1-af3d-33a4a6a2c885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4a2751b0-7758-4ecf-9651-761fc2d2ef2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_52c26a56-ea17-4c3b-a66a-14c44fe993b0" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4a2751b0-7758-4ecf-9651-761fc2d2ef2e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_e5ab4cf4-db6f-4d68-9b5b-476a83341651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_43fc1802-b58b-4d0b-ba7e-c3fd86d4b01c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e5ab4cf4-db6f-4d68-9b5b-476a83341651" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_43fc1802-b58b-4d0b-ba7e-c3fd86d4b01c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_a3933a7c-1813-4abc-86a2-83af14647705" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e5ab4cf4-db6f-4d68-9b5b-476a83341651" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_a3933a7c-1813-4abc-86a2-83af14647705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_1641de5c-c51e-4bc8-a92b-0363317ffa4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e5ab4cf4-db6f-4d68-9b5b-476a83341651" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_1641de5c-c51e-4bc8-a92b-0363317ffa4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f21d2ca8-a508-4a49-901a-feb621fc047d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e5ab4cf4-db6f-4d68-9b5b-476a83341651" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_f21d2ca8-a508-4a49-901a-feb621fc047d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_30594140-c073-4afb-b58c-a6a6687ef0b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e5ab4cf4-db6f-4d68-9b5b-476a83341651" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_30594140-c073-4afb-b58c-a6a6687ef0b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_0c5b6004-bbde-4dba-aefa-f887cea11109" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e5ab4cf4-db6f-4d68-9b5b-476a83341651" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_0c5b6004-bbde-4dba-aefa-f887cea11109" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_2a88bf46-d6c5-4b14-842b-aae8c6f697e7" xlink:href="cvs-20201231.xsd#cvs_DeferredTaxAssetsPayrollTaxDeferral"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e5ab4cf4-db6f-4d68-9b5b-476a83341651" xlink:to="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_2a88bf46-d6c5-4b14-842b-aae8c6f697e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_9e62a0c2-4a12-4033-834d-eb22af6a82b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e5ab4cf4-db6f-4d68-9b5b-476a83341651" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_9e62a0c2-4a12-4033-834d-eb22af6a82b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_7300b241-35e7-443a-a421-e57734e41208" xlink:href="cvs-20201231.xsd#cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e5ab4cf4-db6f-4d68-9b5b-476a83341651" xlink:to="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_7300b241-35e7-443a-a421-e57734e41208" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_7390a207-65d8-4a9d-bea0-9c329b19ac4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e5ab4cf4-db6f-4d68-9b5b-476a83341651" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_7390a207-65d8-4a9d-bea0-9c329b19ac4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_b0f30e82-3746-476f-9c59-02db69c21979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e5ab4cf4-db6f-4d68-9b5b-476a83341651" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_b0f30e82-3746-476f-9c59-02db69c21979" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_99617a8d-fd2e-4d50-9c03-bf15e5a241c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_1a6a2ed0-2034-46bc-a2d6-541042eee1ff" xlink:href="cvs-20201231.xsd#cvs_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_99617a8d-fd2e-4d50-9c03-bf15e5a241c1" xlink:to="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_1a6a2ed0-2034-46bc-a2d6-541042eee1ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_1ead8ecd-c8e2-4080-859e-6928504cc0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_99617a8d-fd2e-4d50-9c03-bf15e5a241c1" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_1ead8ecd-c8e2-4080-859e-6928504cc0cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_104c6d60-9493-4692-bc22-1b1fff39042c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_99617a8d-fd2e-4d50-9c03-bf15e5a241c1" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_104c6d60-9493-4692-bc22-1b1fff39042c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_1e293fb9-4801-4a6e-abd5-8b5c30ae5045" xlink:href="cvs-20201231.xsd#cvs_DeferredTaxLiabilitiesRetirementBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_99617a8d-fd2e-4d50-9c03-bf15e5a241c1" xlink:to="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_1e293fb9-4801-4a6e-abd5-8b5c30ae5045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_09d1c77c-1bf1-4571-974f-8e57137dcd17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_fbae214e-7ef1-403f-a6d7-04ba50f16aff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_09d1c77c-1bf1-4571-974f-8e57137dcd17" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_fbae214e-7ef1-403f-a6d7-04ba50f16aff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e33d5896-5300-49e5-9d15-cf3f3e30b09c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_09d1c77c-1bf1-4571-974f-8e57137dcd17" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e33d5896-5300-49e5-9d15-cf3f3e30b09c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlans" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlans"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansValuationandAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansRestrictedStockActivityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansStockOptionandSARActivityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquity"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityRepurchasesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityDividendsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityRegulatoryRequirementsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityNoncontrollingInterestsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20201231.xsd#OtherComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#OtherComprehensiveIncomeTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#OtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fd00c59e-41f0-4f9a-960b-08c3a1c9def9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_cde5c075-cd9b-4b25-846c-c972ebf2ef42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fd00c59e-41f0-4f9a-960b-08c3a1c9def9" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_cde5c075-cd9b-4b25-846c-c972ebf2ef42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4fa5d13c-6bea-4822-97fa-1e036f8c12a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fd00c59e-41f0-4f9a-960b-08c3a1c9def9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4fa5d13c-6bea-4822-97fa-1e036f8c12a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsLossPerShare" xlink:type="simple" xlink:href="cvs-20201231.xsd#EarningsLossPerShare"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/EarningsLossPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsLossPerShareTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#EarningsLossPerShareTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/EarningsLossPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsLossPerShareDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#EarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/EarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_74752f7e-f801-4af5-9ba3-190290d0e344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_00d88a5c-2157-4b4b-aa3c-61376f3c2449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_74752f7e-f801-4af5-9ba3-190290d0e344" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_00d88a5c-2157-4b4b-aa3c-61376f3c2449" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_60be3df6-e8e4-48fc-9a78-0026aba94987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_74752f7e-f801-4af5-9ba3-190290d0e344" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_60be3df6-e8e4-48fc-9a78-0026aba94987" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6b25e4e1-3588-45a8-ba20-6be22f8c0590" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_74752f7e-f801-4af5-9ba3-190290d0e344" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6b25e4e1-3588-45a8-ba20-6be22f8c0590" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2bdba5b3-e26a-48ec-8f92-0983989c404b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9fa83b19-289c-4ef4-929b-4d08e8d08004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2bdba5b3-e26a-48ec-8f92-0983989c404b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9fa83b19-289c-4ef4-929b-4d08e8d08004" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_15e16b6f-a716-4b6b-a426-4f44cea3a9b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2bdba5b3-e26a-48ec-8f92-0983989c404b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_15e16b6f-a716-4b6b-a426-4f44cea3a9b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Reinsurance" xlink:type="simple" xlink:href="cvs-20201231.xsd#Reinsurance"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/Reinsurance" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#ReinsuranceTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ReinsuranceNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ReinsuranceReinsuranceRecoverablesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ReinsuranceEffectsofReinsuranceDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_f8a0ae14-efe6-41a9-aeef-f4538831cc01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_baa4c8c1-5085-4ee5-9e6f-04a39f1b8eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_f8a0ae14-efe6-41a9-aeef-f4538831cc01" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_baa4c8c1-5085-4ee5-9e6f-04a39f1b8eeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_12c0f9a8-96a6-4c86-a686-5c52a3801a26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_f8a0ae14-efe6-41a9-aeef-f4538831cc01" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_12c0f9a8-96a6-4c86-a686-5c52a3801a26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_47ed8c1c-4eca-404a-9b12-01a735f6f0f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_f8a0ae14-efe6-41a9-aeef-f4538831cc01" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_47ed8c1c-4eca-404a-9b12-01a735f6f0f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_7e67069f-6dea-4121-85d1-95fc72b373ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned_57c056b6-6d9e-46c3-9fbb-8189c56fe055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsEarnedNet_7e67069f-6dea-4121-85d1-95fc72b373ac" xlink:to="loc_us-gaap_DirectPremiumsEarned_57c056b6-6d9e-46c3-9fbb-8189c56fe055" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned_86047dd6-7f5e-4e1d-b076-c254830e5149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsEarnedNet_7e67069f-6dea-4121-85d1-95fc72b373ac" xlink:to="loc_us-gaap_AssumedPremiumsEarned_86047dd6-7f5e-4e1d-b076-c254830e5149" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned_796997e3-c385-4c40-8925-3f909e7010c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededPremiumsEarned"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsEarnedNet_7e67069f-6dea-4121-85d1-95fc72b373ac" xlink:to="loc_us-gaap_CededPremiumsEarned_796997e3-c385-4c40-8925-3f909e7010c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cvs-20201231.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#CommitmentsandContingenciesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReporting"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReporting" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReportingTables"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReportingNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReportingSummarizedFinancialInformationofSegmentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_fb111af7-a610-4604-9497-4ac593be9a92" xlink:href="cvs-20201231.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreRationalizationCharges_2726bca8-efb5-4f6a-987a-304ffee98664" xlink:href="cvs-20201231.xsd#cvs_StoreRationalizationCharges"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss_fb111af7-a610-4604-9497-4ac593be9a92" xlink:to="loc_cvs_StoreRationalizationCharges_2726bca8-efb5-4f6a-987a-304ffee98664" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_8f8f63af-3d69-45dc-91c1-7cff7200bddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss_fb111af7-a610-4604-9497-4ac593be9a92" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_8f8f63af-3d69-45dc-91c1-7cff7200bddb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_e79a4cac-6c15-4d98-b0dd-f6deb95e9d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss_fb111af7-a610-4604-9497-4ac593be9a92" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_e79a4cac-6c15-4d98-b0dd-f6deb95e9d1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c522201d-8ac9-44d8-951b-cf4a146ecc6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss_fb111af7-a610-4604-9497-4ac593be9a92" xlink:to="loc_us-gaap_OperatingIncomeLoss_c522201d-8ac9-44d8-951b-cf4a146ecc6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_70ce6c9c-b6fb-4b50-87f6-53c1ab942f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss_fb111af7-a610-4604-9497-4ac593be9a92" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_70ce6c9c-b6fb-4b50-87f6-53c1ab942f21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d5f6e348-15c4-4c64-a2de-c6c5991f4f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss_fb111af7-a610-4604-9497-4ac593be9a92" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d5f6e348-15c4-4c64-a2de-c6c5991f4f40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_0b276c01-4ec4-4f81-b815-c6edfb3a409a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss_fb111af7-a610-4604-9497-4ac593be9a92" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_0b276c01-4ec4-4f81-b815-c6edfb3a409a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c0ae51ac-8cfd-4c03-b351-7bfddc4bd0f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss_fb111af7-a610-4604-9497-4ac593be9a92" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c0ae51ac-8cfd-4c03-b351-7bfddc4bd0f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_e0d19138-f84f-474c-a87b-8d8e5e9b6a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss_fb111af7-a610-4604-9497-4ac593be9a92" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_e0d19138-f84f-474c-a87b-8d8e5e9b6a0f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>cvs-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4a98170d-2b8a-4463-a058-df0f5f10bd13,g:ab909211-91be-459b-b532-dbe2c1c7ff2b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CoverPage" xlink:type="simple" xlink:href="cvs-20201231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CoverPage" xlink:type="extended" id="i6d95d96ae9cd43bdadb72fe144f2fadb_CoverPage"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="i5547c0c9b36d44a29d1aff915bbfe90b_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_844173e0-c43c-4066-9be8-35a356cbf660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_RevenuesAbstract_844173e0-c43c-4066-9be8-35a356cbf660" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c6ef5b9e-e023-4b5f-b096-2d7e2d3875b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_844173e0-c43c-4066-9be8-35a356cbf660" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c6ef5b9e-e023-4b5f-b096-2d7e2d3875b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_ecc319c5-6faa-497e-a941-6d483b76ec3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_844173e0-c43c-4066-9be8-35a356cbf660" xlink:to="loc_us-gaap_PremiumsEarnedNet_ecc319c5-6faa-497e-a941-6d483b76ec3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_bec2248f-0454-420c-b191-c3363defa87d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_844173e0-c43c-4066-9be8-35a356cbf660" xlink:to="loc_us-gaap_NetInvestmentIncome_bec2248f-0454-420c-b191-c3363defa87d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3e5f0aac-de45-41f5-99c9-79a5949ba6c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_844173e0-c43c-4066-9be8-35a356cbf660" xlink:to="loc_us-gaap_Revenues_3e5f0aac-de45-41f5-99c9-79a5949ba6c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_01b8d6f0-84f9-40b0-9895-8bc8d73ce6db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_01b8d6f0-84f9-40b0-9895-8bc8d73ce6db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_2af614e6-2fd6-43f4-8769-35c25013006d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_2af614e6-2fd6-43f4-8769-35c25013006d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_345aa6e4-6fb0-49f8-b6a5-6b009222b8e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_345aa6e4-6fb0-49f8-b6a5-6b009222b8e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairments_cad408bd-275b-40a4-8946-03c0a948bae8" xlink:href="cvs-20201231.xsd#cvs_OperatingExpensesExcludingGoodwillImpairments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:to="loc_cvs_OperatingExpensesExcludingGoodwillImpairments_cad408bd-275b-40a4-8946-03c0a948bae8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_a50f8e2d-d011-46b0-b28c-3ab599ee16ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:to="loc_us-gaap_CostsAndExpenses_a50f8e2d-d011-46b0-b28c-3ab599ee16ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bb50ccb4-6f0f-415f-9f2a-ee63f74f1e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_OperatingIncomeLoss_bb50ccb4-6f0f-415f-9f2a-ee63f74f1e8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_eaac9524-98ce-4b48-9e26-d3fdca74e1a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_InterestExpense_eaac9524-98ce-4b48-9e26-d3fdca74e1a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1564eafd-021a-42d5-a730-216ad835a697" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1564eafd-021a-42d5-a730-216ad835a697" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b424f028-d28d-43c8-85cc-5da58444d808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b424f028-d28d-43c8-85cc-5da58444d808" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b715c6d5-186b-4de6-ac29-5d9781417c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b715c6d5-186b-4de6-ac29-5d9781417c03" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_568f5d9c-2498-4298-b8a5-97d44cbc9f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_568f5d9c-2498-4298-b8a5-97d44cbc9f7c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_36d12d5b-d0cd-4217-8d10-f04b96971c25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_36d12d5b-d0cd-4217-8d10-f04b96971c25" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1419a9c2-3a70-4840-a752-47a6359bf870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1419a9c2-3a70-4840-a752-47a6359bf870" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fef0db54-a35b-4eff-8b16-ff1351497a26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_ProfitLoss_fef0db54-a35b-4eff-8b16-ff1351497a26" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f15a3c24-3f4f-4242-8ff3-ea5b683e535c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f15a3c24-3f4f-4242-8ff3-ea5b683e535c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_39f14004-4b19-4d92-b960-2a6601451cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_NetIncomeLoss_39f14004-4b19-4d92-b960-2a6601451cb2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_04c08f00-c2c2-4561-afec-5cc0a3a8dfc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_04c08f00-c2c2-4561-afec-5cc0a3a8dfc9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_b316d48b-34e8-4cb4-a0ec-d3e82e0af523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04c08f00-c2c2-4561-afec-5cc0a3a8dfc9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_b316d48b-34e8-4cb4-a0ec-d3e82e0af523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_0c5b335f-1b9b-4eed-8c42-c918326f0770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04c08f00-c2c2-4561-afec-5cc0a3a8dfc9" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_0c5b335f-1b9b-4eed-8c42-c918326f0770" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_85b38d81-91fb-4dd2-bb9a-0c33fa24f298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04c08f00-c2c2-4561-afec-5cc0a3a8dfc9" xlink:to="loc_us-gaap_EarningsPerShareBasic_85b38d81-91fb-4dd2-bb9a-0c33fa24f298" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_859c599f-ce4c-4c42-9afd-05c8628547df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04c08f00-c2c2-4561-afec-5cc0a3a8dfc9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_859c599f-ce4c-4c42-9afd-05c8628547df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_868bc86d-0b9c-4fce-b26c-95be346f6f66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_868bc86d-0b9c-4fce-b26c-95be346f6f66" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3bf6db4b-6f2e-44ae-99ca-1cc3f42e4428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_868bc86d-0b9c-4fce-b26c-95be346f6f66" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3bf6db4b-6f2e-44ae-99ca-1cc3f42e4428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_9582d062-edca-4fe4-a90c-ce977abc68ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_868bc86d-0b9c-4fce-b26c-95be346f6f66" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_9582d062-edca-4fe4-a90c-ce977abc68ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f00974c2-47e4-41b2-8fc0-703e208f7d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_868bc86d-0b9c-4fce-b26c-95be346f6f66" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f00974c2-47e4-41b2-8fc0-703e208f7d54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c2989a6-4104-432a-bfbf-181111ac5324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_868bc86d-0b9c-4fce-b26c-95be346f6f66" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c2989a6-4104-432a-bfbf-181111ac5324" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_3c4acfc3-3c20-453b-8a0c-f3c6b28ac32b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_3c4acfc3-3c20-453b-8a0c-f3c6b28ac32b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_b1eaa767-e2fb-43ce-a03b-d9f18df8bb46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_b1eaa767-e2fb-43ce-a03b-d9f18df8bb46" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_41cb79e6-033b-4ee5-826b-ef24c429f881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_StatementTable_41cb79e6-033b-4ee5-826b-ef24c429f881" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_137479a4-36ca-4905-8e61-200b4ace9cba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_41cb79e6-033b-4ee5-826b-ef24c429f881" xlink:to="loc_srt_ProductOrServiceAxis_137479a4-36ca-4905-8e61-200b4ace9cba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_137479a4-36ca-4905-8e61-200b4ace9cba_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_137479a4-36ca-4905-8e61-200b4ace9cba" xlink:to="loc_srt_ProductsAndServicesDomain_137479a4-36ca-4905-8e61-200b4ace9cba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ceb1ee47-218e-4720-a72b-8327ce992039" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_137479a4-36ca-4905-8e61-200b4ace9cba" xlink:to="loc_srt_ProductsAndServicesDomain_ceb1ee47-218e-4720-a72b-8327ce992039" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_3300c8cb-31f6-4527-8e83-3da842c4e345" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ceb1ee47-218e-4720-a72b-8327ce992039" xlink:to="loc_us-gaap_ProductMember_3300c8cb-31f6-4527-8e83-3da842c4e345" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_b515cd07-ba4d-4153-a5ed-8967ec9d94cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ceb1ee47-218e-4720-a72b-8327ce992039" xlink:to="loc_us-gaap_ServiceMember_b515cd07-ba4d-4153-a5ed-8967ec9d94cc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="i36ceaa8c1dd143fe91550cc8f53cef35_ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="idcee0140d4d04f80a35972484042b0cc_ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i314d26a4b7d4498f97c4c8e4b1291179_ConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="ic24ee7bb317649fd8b5faf0751609e21_ConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended" id="if148fda10dd543cda8b547d8ff5635d7_ConsolidatedStatementsofShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3b7186ee-b2ee-4666-ab06-3adf1aec9a47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b7186ee-b2ee-4666-ab06-3adf1aec9a47" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_f2ed9d0f-f4bc-4ad0-8420-ad0d8a54b9f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_SharesOutstanding_f2ed9d0f-f4bc-4ad0-8420-ad0d8a54b9f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_59c5e056-a581-43ce-a263-b41876351183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_59c5e056-a581-43ce-a263-b41876351183" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b759e129-4449-409b-8aa0-73612b5ef93a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_ProfitLoss_b759e129-4449-409b-8aa0-73612b5ef93a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a039656d-a5e5-4562-867c-69ed4c5942c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a039656d-a5e5-4562-867c-69ed4c5942c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_e383c1ea-f370-43d4-9cff-ddd0ed7d536f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_e383c1ea-f370-43d4-9cff-ddd0ed7d536f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_cb3e3827-498f-47d2-ad28-45b5d6fb8e57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_cb3e3827-498f-47d2-ad28-45b5d6fb8e57" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6921f334-6ccb-4800-9c95-43ee5c67fa4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6921f334-6ccb-4800-9c95-43ee5c67fa4e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2fee7d5b-7baf-484f-859d-3e057b94a2d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2fee7d5b-7baf-484f-859d-3e057b94a2d6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_8bf5fe65-7fd1-4c66-87f1-a7ae02ce006c" xlink:href="cvs-20201231.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_8bf5fe65-7fd1-4c66-87f1-a7ae02ce006c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_e85edf41-10aa-4378-8e8a-eba1c9250e61" xlink:href="cvs-20201231.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_e85edf41-10aa-4378-8e8a-eba1c9250e61" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_aa5febe2-a455-4548-82b0-dc86653c8429" xlink:href="cvs-20201231.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_aa5febe2-a455-4548-82b0-dc86653c8429" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_6ac2fd97-edbd-421c-9f5a-e166482505f9" xlink:href="cvs-20201231.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_6ac2fd97-edbd-421c-9f5a-e166482505f9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_24d3c288-01f7-48c0-b7ff-77cf7de508bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_DividendsCommonStock_24d3c288-01f7-48c0-b7ff-77cf7de508bf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_f3da9cb0-2364-4115-ad29-4d8ace3ddb4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_f3da9cb0-2364-4115-ad29-4d8ace3ddb4f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_94e49863-0cca-4082-a6f5-b55c093dcce0" xlink:href="cvs-20201231.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_94e49863-0cca-4082-a6f5-b55c093dcce0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_375e1fa2-d263-4a21-9547-011fc35fc3f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdd0036b-b205-476e-9ba3-7263e1705377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_6082e439-26cc-4d58-aee2-c223b88e7cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3b7186ee-b2ee-4666-ab06-3adf1aec9a47" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_6082e439-26cc-4d58-aee2-c223b88e7cdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b187ed80-9cdf-4964-af56-25bcbc13d1d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3b7186ee-b2ee-4666-ab06-3adf1aec9a47" xlink:to="loc_us-gaap_StatementTable_b187ed80-9cdf-4964-af56-25bcbc13d1d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b3847598-754f-4365-87ca-29381482f20d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b187ed80-9cdf-4964-af56-25bcbc13d1d2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b3847598-754f-4365-87ca-29381482f20d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b3847598-754f-4365-87ca-29381482f20d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3847598-754f-4365-87ca-29381482f20d" xlink:to="loc_us-gaap_EquityComponentDomain_b3847598-754f-4365-87ca-29381482f20d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3847598-754f-4365-87ca-29381482f20d" xlink:to="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5dcd23d5-5ccb-47f1-8132-a5a512b43d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_CommonStockMember_5dcd23d5-5ccb-47f1-8132-a5a512b43d53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_f3e06e9b-6028-4d43-8fb7-57f971c93275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_TreasuryStockMember_f3e06e9b-6028-4d43-8fb7-57f971c93275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_f8096c7e-5c9a-4ad9-a955-cb5f0c3a1f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_f8096c7e-5c9a-4ad9-a955-cb5f0c3a1f77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c44ce84d-39cf-4f44-a977-a85f2c20a070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_RetainedEarningsMember_c44ce84d-39cf-4f44-a977-a85f2c20a070" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b6406b-c9d9-4643-b0af-41c3785c55ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b6406b-c9d9-4643-b0af-41c3785c55ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_d0c0a2a6-e35b-4c4c-a6f4-fe7011312d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_ParentMember_d0c0a2a6-e35b-4c4c-a6f4-fe7011312d14" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ddd095fd-2681-42c0-b2f9-37ad456f2242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ddd095fd-2681-42c0-b2f9-37ad456f2242" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a090fac4-3ba8-4a9d-96f1-747445e6b0fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b187ed80-9cdf-4964-af56-25bcbc13d1d2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a090fac4-3ba8-4a9d-96f1-747445e6b0fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a090fac4-3ba8-4a9d-96f1-747445e6b0fa_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a090fac4-3ba8-4a9d-96f1-747445e6b0fa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a090fac4-3ba8-4a9d-96f1-747445e6b0fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d643f0bf-43af-4bef-88ec-9ccf0abc54eb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a090fac4-3ba8-4a9d-96f1-747445e6b0fa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d643f0bf-43af-4bef-88ec-9ccf0abc54eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b9ba66b8-a891-4616-9198-ac060eb6c9c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d643f0bf-43af-4bef-88ec-9ccf0abc54eb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b9ba66b8-a891-4616-9198-ac060eb6c9c0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended" id="ie79798b98c894043b99caa5f457f225c_ConsolidatedStatementsofShareholdersEquityParentheticals">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_d9d5b6dc-7448-4e51-9633-8325958353ee" xlink:href="cvs-20201231.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_d9d5b6dc-7448-4e51-9633-8325958353ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_fa4fee4c-e464-41e7-8d06-14f20d66f2eb" xlink:href="cvs-20201231.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_fa4fee4c-e464-41e7-8d06-14f20d66f2eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b55f6b49-52cf-441d-9b26-a9f420d7b9ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_us-gaap_CommonStockValue_b55f6b49-52cf-441d-9b26-a9f420d7b9ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c707af1-95a0-42d7-98a0-7384d1686cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c707af1-95a0-42d7-98a0-7384d1686cec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ab5667ec-acfd-4776-bef4-71b7e7506cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ab5667ec-acfd-4776-bef4-71b7e7506cc5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_aa823933-c5c3-4f95-b626-77622f70ad49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_aa823933-c5c3-4f95-b626-77622f70ad49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_a5b2be30-68ee-480f-bcfc-04b8a990a594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_a5b2be30-68ee-480f-bcfc-04b8a990a594" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f6fa84b1-d5b5-432d-9d04-cfe78f1d334e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_us-gaap_StatementTable_f6fa84b1-d5b5-432d-9d04-cfe78f1d334e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c7cc7f7f-3eba-490d-bee2-adaacc04ed30" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f6fa84b1-d5b5-432d-9d04-cfe78f1d334e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c7cc7f7f-3eba-490d-bee2-adaacc04ed30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c7cc7f7f-3eba-490d-bee2-adaacc04ed30_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c7cc7f7f-3eba-490d-bee2-adaacc04ed30" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c7cc7f7f-3eba-490d-bee2-adaacc04ed30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7120cbae-676e-4b40-a356-66e17ad2ee11" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c7cc7f7f-3eba-490d-bee2-adaacc04ed30" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7120cbae-676e-4b40-a356-66e17ad2ee11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0b9eace5-765f-4535-be8b-79664bb9f94e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7120cbae-676e-4b40-a356-66e17ad2ee11" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0b9eace5-765f-4535-be8b-79664bb9f94e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_821146b0-a29f-41cb-9bf6-792276970806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f6fa84b1-d5b5-432d-9d04-cfe78f1d334e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_821146b0-a29f-41cb-9bf6-792276970806" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_821146b0-a29f-41cb-9bf6-792276970806_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_821146b0-a29f-41cb-9bf6-792276970806" xlink:to="loc_us-gaap_EquityComponentDomain_821146b0-a29f-41cb-9bf6-792276970806_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8b175337-8387-433e-a775-de5249e1aaf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_821146b0-a29f-41cb-9bf6-792276970806" xlink:to="loc_us-gaap_EquityComponentDomain_8b175337-8387-433e-a775-de5249e1aaf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4f38c15b-1310-4351-b8ca-d69f8d251104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8b175337-8387-433e-a775-de5249e1aaf8" xlink:to="loc_us-gaap_RetainedEarningsMember_4f38c15b-1310-4351-b8ca-d69f8d251104" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5185de63-acc8-4224-b2ac-d8e53c4a78da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f6fa84b1-d5b5-432d-9d04-cfe78f1d334e" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5185de63-acc8-4224-b2ac-d8e53c4a78da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_5185de63-acc8-4224-b2ac-d8e53c4a78da_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5185de63-acc8-4224-b2ac-d8e53c4a78da" xlink:to="loc_us-gaap_TypeOfAdoptionMember_5185de63-acc8-4224-b2ac-d8e53c4a78da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_c7fba54f-60c9-4aad-860a-ab7d6e055e42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5185de63-acc8-4224-b2ac-d8e53c4a78da" xlink:to="loc_us-gaap_TypeOfAdoptionMember_c7fba54f-60c9-4aad-860a-ab7d6e055e42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_8838b63e-15d1-4d92-bfdb-512474e39812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_c7fba54f-60c9-4aad-860a-ab7d6e055e42" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_8838b63e-15d1-4d92-bfdb-512474e39812" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201802Member_6f85de0a-6041-40b4-8d5b-a32e34560707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201802Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_c7fba54f-60c9-4aad-860a-ab7d6e055e42" xlink:to="loc_us-gaap_AccountingStandardsUpdate201802Member_6f85de0a-6041-40b4-8d5b-a32e34560707" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="extended" id="iac76a536ed434b94bb1a6d607574ab6a_SignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended" id="id16aa1963e6546d184d817170c215b7a_SignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended" id="i33c2dc94299e4f078424318fb11cb0e3_SignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i2dcde524393b435389b0fb2782b791ae_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_88a5cc16-f350-4dec-98ae-a8224a592bd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_NumberOfStores_88a5cc16-f350-4dec-98ae-a8224a592bd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_31edefcd-3d14-44b9-bbab-57bc1375b463" xlink:href="cvs-20201231.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_31edefcd-3d14-44b9-bbab-57bc1375b463" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPlanMembers_632bfa4c-0a46-4f28-b404-6d32871008fe" xlink:href="cvs-20201231.xsd#cvs_NumberOfPlanMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_NumberOfPlanMembers_632bfa4c-0a46-4f28-b404-6d32871008fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear_52b7c5ed-b1cf-4860-b4a9-0b22fce6312d" xlink:href="cvs-20201231.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_NumberofPatientsServedperYear_52b7c5ed-b1cf-4860-b4a9-0b22fce6312d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_3f86ed81-9396-4749-bf97-1866d843c998" xlink:href="cvs-20201231.xsd#cvs_NumberOfPeopleServed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_NumberOfPeopleServed_3f86ed81-9396-4749-bf97-1866d843c998" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_4e57c611-1a0f-459f-9f04-cc85c9875480" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_NumberOfReportableSegments_4e57c611-1a0f-459f-9f04-cc85c9875480" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_04b8d99b-6df5-48ca-95a3-033792711e65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_04b8d99b-6df5-48ca-95a3-033792711e65" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_c94b704f-939d-43ed-b4a6-cf789646ec4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_c94b704f-939d-43ed-b4a6-cf789646ec4e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b55cc3d2-2eff-4e88-a55a-b4076ccc977a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_Depreciation_b55cc3d2-2eff-4e88-a55a-b4076ccc977a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_873ee638-d17c-43d7-a2c9-8164154cac82" xlink:href="cvs-20201231.xsd#cvs_LesseeOperatingAndFinanceLeasesRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_873ee638-d17c-43d7-a2c9-8164154cac82" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreRationalizationCharges_c5fa1c85-4eb3-41e5-add3-c18a48e0023f" xlink:href="cvs-20201231.xsd#cvs_StoreRationalizationCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_StoreRationalizationCharges_c5fa1c85-4eb3-41e5-add3-c18a48e0023f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_ec656c50-7cff-466e-9213-b2ecbd03289c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_ec656c50-7cff-466e-9213-b2ecbd03289c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_0834b8ae-ab98-4d60-9156-ed794bddf06d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_0834b8ae-ab98-4d60-9156-ed794bddf06d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_e87ba631-dd8a-493f-b3f4-4b6207c4e9b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_e87ba631-dd8a-493f-b3f4-4b6207c4e9b5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_0f345274-8665-42be-8cc3-6515846c449f" xlink:href="cvs-20201231.xsd#cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_0f345274-8665-42be-8cc3-6515846c449f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityforUnpaidClaims_bac41ac3-07ac-480d-8137-047814a8a5d5" xlink:href="cvs-20201231.xsd#cvs_LiabilityforUnpaidClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_LiabilityforUnpaidClaims_bac41ac3-07ac-480d-8137-047814a8a5d5" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LimitedPaymentsContracts_1188e37f-581a-464b-9c44-fa1b045e84aa" xlink:href="cvs-20201231.xsd#cvs_LimitedPaymentsContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_LimitedPaymentsContracts_1188e37f-581a-464b-9c44-fa1b045e84aa" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_8903cebc-d5e2-4362-b929-cfd179efdf8d" xlink:href="cvs-20201231.xsd#cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_8903cebc-d5e2-4362-b929-cfd179efdf8d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_abc4ff1d-0725-4ec0-880a-5e06265625a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_abc4ff1d-0725-4ec0-880a-5e06265625a2" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_eba7fdf8-6d72-40c0-beff-17c16fc6c4e3" xlink:href="cvs-20201231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_eba7fdf8-6d72-40c0-beff-17c16fc6c4e3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PensionAndAnnuityInvestmentContractsInterest_a7b103ab-bd03-4a2c-9152-d639c5a05bb5" xlink:href="cvs-20201231.xsd#cvs_PensionAndAnnuityInvestmentContractsInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_PensionAndAnnuityInvestmentContractsInterest_a7b103ab-bd03-4a2c-9152-d639c5a05bb5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeathSavingsAccountBalance_25614734-f0a1-4482-9dc0-deee196ef234" xlink:href="cvs-20201231.xsd#cvs_HeathSavingsAccountBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_HeathSavingsAccountBalance_25614734-f0a1-4482-9dc0-deee196ef234" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_c3cb3896-6e5a-41b9-bf78-41b6cc0f8858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_SelfInsuranceReserve_c3cb3896-6e5a-41b9-bf78-41b6cc0f8858" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b79512de-f2c4-4d45-b1ea-5849804ca81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b79512de-f2c4-4d45-b1ea-5849804ca81d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6369ea2d-2082-43a6-ada3-c983d4aaa954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6369ea2d-2082-43a6-ada3-c983d4aaa954" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRebatePeriod_8a92c146-d8b6-4a45-8ef7-f75d3ff93427" xlink:href="cvs-20201231.xsd#cvs_PharmacyRebatePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_PharmacyRebatePeriod_8a92c146-d8b6-4a45-8ef7-f75d3ff93427" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee_9a44e54f-502f-4abd-9263-a6c3c61d6a36" xlink:href="cvs-20201231.xsd#cvs_HealthInsurerFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_HealthInsurerFee_9a44e54f-502f-4abd-9263-a6c3c61d6a36" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_90f2ec44-282e-47d2-bbe9-5d6cea392faa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_90f2ec44-282e-47d2-bbe9-5d6cea392faa" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_c3f54399-7eff-452a-ab18-a572798b8218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_c3f54399-7eff-452a-ab18-a572798b8218" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_e6800eb1-703c-40b8-9d17-fc452f171a34" xlink:href="cvs-20201231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_e6800eb1-703c-40b8-9d17-fc452f171a34" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_95fb96d8-3d99-4307-b56f-559071e063ba" xlink:href="cvs-20201231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_95fb96d8-3d99-4307-b56f-559071e063ba" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_9790a039-380d-40c5-9ce9-bf44da266c39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_AdvertisingExpense_9790a039-380d-40c5-9ce9-bf44da266c39" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_12b9b2bb-4113-485a-9b58-64bdcedf0dac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_12b9b2bb-4113-485a-9b58-64bdcedf0dac" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_4ff92eaf-d668-4ad6-9008-4d8b294e491f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_4ff92eaf-d668-4ad6-9008-4d8b294e491f" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_5bec1011-95ee-4a17-9339-3e72390823b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_5bec1011-95ee-4a17-9339-3e72390823b3" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesHeldInEmployeeTrustShares_861ea650-002c-497e-a4b2-035809a83fb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesHeldInEmployeeTrustShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_CommonStockSharesHeldInEmployeeTrustShares_861ea650-002c-497e-a4b2-035809a83fb4" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_5c687107-a190-4f3a-aa70-c442c14b869f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_5c687107-a190-4f3a-aa70-c442c14b869f" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Initialcontractualterm_8fc65c24-e4ef-47b1-9bcf-62beee616a42" xlink:href="cvs-20201231.xsd#cvs_Initialcontractualterm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_Initialcontractualterm_8fc65c24-e4ef-47b1-9bcf-62beee616a42" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity_94f32d7e-1634-4ad3-9f49-bd7b86c46087" xlink:href="cvs-20201231.xsd#cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity_94f32d7e-1634-4ad3-9f49-bd7b86c46087" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsFromVariableInterestEntity_e5806062-1d4a-4f3d-8626-8e9099d6733b" xlink:href="cvs-20201231.xsd#cvs_ProceedsFromVariableInterestEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_ProceedsFromVariableInterestEntity_e5806062-1d4a-4f3d-8626-8e9099d6733b" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_ff143201-d6e0-4cde-9753-de736ae0a78d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_ff143201-d6e0-4cde-9753-de736ae0a78d" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_11f8d2ca-cfe0-4f40-86e8-361386f4e6d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_11f8d2ca-cfe0-4f40-86e8-361386f4e6d9" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_c202a59d-a8c9-42cd-a822-3210c2ce164d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_c202a59d-a8c9-42cd-a822-3210c2ce164d" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_3d54c6e5-10b4-4908-b9ff-725198f2efc2" xlink:href="cvs-20201231.xsd#cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_3d54c6e5-10b4-4908-b9ff-725198f2efc2" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dd754c70-db74-4dac-9046-2e5cccbad08e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dd754c70-db74-4dac-9046-2e5cccbad08e" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4dae117b-2497-4f39-a598-cceaedb4c2ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_srt_ProductOrServiceAxis_4dae117b-2497-4f39-a598-cceaedb4c2ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4dae117b-2497-4f39-a598-cceaedb4c2ee_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4dae117b-2497-4f39-a598-cceaedb4c2ee" xlink:to="loc_srt_ProductsAndServicesDomain_4dae117b-2497-4f39-a598-cceaedb4c2ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_168033a3-1c60-4650-9fd5-bb5c71f3e380" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4dae117b-2497-4f39-a598-cceaedb4c2ee" xlink:to="loc_srt_ProductsAndServicesDomain_168033a3-1c60-4650-9fd5-bb5c71f3e380" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_85392697-f448-4b88-a221-58091b1fd6d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_168033a3-1c60-4650-9fd5-bb5c71f3e380" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_85392697-f448-4b88-a221-58091b1fd6d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a2247651-a317-40ce-a8e5-37ddeb437757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a2247651-a317-40ce-a8e5-37ddeb437757" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a2247651-a317-40ce-a8e5-37ddeb437757_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a2247651-a317-40ce-a8e5-37ddeb437757" xlink:to="loc_us-gaap_SegmentDomain_a2247651-a317-40ce-a8e5-37ddeb437757_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c2c4ff4c-8aa6-47b3-8426-e9e8a2001f57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a2247651-a317-40ce-a8e5-37ddeb437757" xlink:to="loc_us-gaap_SegmentDomain_c2c4ff4c-8aa6-47b3-8426-e9e8a2001f57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_d3186443-b545-4f1b-b395-4c420acc81f2" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c2c4ff4c-8aa6-47b3-8426-e9e8a2001f57" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_d3186443-b545-4f1b-b395-4c420acc81f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_d932d552-0ba5-47e5-a5b8-3ad10935ba11" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c2c4ff4c-8aa6-47b3-8426-e9e8a2001f57" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_d932d552-0ba5-47e5-a5b8-3ad10935ba11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e4ff2537-f1aa-4fa2-a197-ed3f95a4cb2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e4ff2537-f1aa-4fa2-a197-ed3f95a4cb2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e4ff2537-f1aa-4fa2-a197-ed3f95a4cb2a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e4ff2537-f1aa-4fa2-a197-ed3f95a4cb2a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e4ff2537-f1aa-4fa2-a197-ed3f95a4cb2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_326820aa-6cb6-4d02-b33c-1b883aca7b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e4ff2537-f1aa-4fa2-a197-ed3f95a4cb2a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_326820aa-6cb6-4d02-b33c-1b883aca7b5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BrazilSubsidiaryMember_9b2d38d4-0192-4789-9217-4104069e0cb0" xlink:href="cvs-20201231.xsd#cvs_BrazilSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_326820aa-6cb6-4d02-b33c-1b883aca7b5d" xlink:to="loc_cvs_BrazilSubsidiaryMember_9b2d38d4-0192-4789-9217-4104069e0cb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_238af78d-fce9-4f0c-85ac-8fbc4aeb8e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_238af78d-fce9-4f0c-85ac-8fbc4aeb8e03" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_238af78d-fce9-4f0c-85ac-8fbc4aeb8e03_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_238af78d-fce9-4f0c-85ac-8fbc4aeb8e03" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_238af78d-fce9-4f0c-85ac-8fbc4aeb8e03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6ebce91c-3ee5-4711-997f-e34e1235d5a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_238af78d-fce9-4f0c-85ac-8fbc4aeb8e03" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6ebce91c-3ee5-4711-997f-e34e1235d5a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_f1780957-718b-4c03-88e6-9f9f52067a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6ebce91c-3ee5-4711-997f-e34e1235d5a1" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_f1780957-718b-4c03-88e6-9f9f52067a9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22a09e9f-b6cc-4f4f-b843-c4028abc8621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22a09e9f-b6cc-4f4f-b843-c4028abc8621" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_22a09e9f-b6cc-4f4f-b843-c4028abc8621_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22a09e9f-b6cc-4f4f-b843-c4028abc8621" xlink:to="loc_us-gaap_TypeOfAdoptionMember_22a09e9f-b6cc-4f4f-b843-c4028abc8621_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_19f74dbe-8123-45d9-8db4-7517f8410f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22a09e9f-b6cc-4f4f-b843-c4028abc8621" xlink:to="loc_us-gaap_TypeOfAdoptionMember_19f74dbe-8123-45d9-8db4-7517f8410f25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_42241b61-ec9a-4c78-9fea-1cbf47c58e42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_19f74dbe-8123-45d9-8db4-7517f8410f25" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_42241b61-ec9a-4c78-9fea-1cbf47c58e42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f0b718cc-0240-437c-b288-7d618727e24f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_srt_RangeAxis_f0b718cc-0240-437c-b288-7d618727e24f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f0b718cc-0240-437c-b288-7d618727e24f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f0b718cc-0240-437c-b288-7d618727e24f" xlink:to="loc_srt_RangeMember_f0b718cc-0240-437c-b288-7d618727e24f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37d1ac29-abdb-41cc-aeba-a7b09ea8393c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f0b718cc-0240-437c-b288-7d618727e24f" xlink:to="loc_srt_RangeMember_37d1ac29-abdb-41cc-aeba-a7b09ea8393c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bf29a530-5463-40a7-99db-8be9e785e706" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_37d1ac29-abdb-41cc-aeba-a7b09ea8393c" xlink:to="loc_srt_MinimumMember_bf29a530-5463-40a7-99db-8be9e785e706" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2c60409a-464d-47f1-bbe6-468255564da5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_37d1ac29-abdb-41cc-aeba-a7b09ea8393c" xlink:to="loc_srt_MaximumMember_2c60409a-464d-47f1-bbe6-468255564da5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_271d260a-de2b-4354-a17e-0858f1f41785" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_271d260a-de2b-4354-a17e-0858f1f41785" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_271d260a-de2b-4354-a17e-0858f1f41785_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_271d260a-de2b-4354-a17e-0858f1f41785" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_271d260a-de2b-4354-a17e-0858f1f41785_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1945099b-eccd-46c9-b971-fa3ec0c9458b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_271d260a-de2b-4354-a17e-0858f1f41785" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1945099b-eccd-46c9-b971-fa3ec0c9458b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_f181286b-773a-42fa-a6c5-d5b4099c8c13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1945099b-eccd-46c9-b971-fa3ec0c9458b" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_f181286b-773a-42fa-a6c5-d5b4099c8c13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_381a37b5-a1d5-4d52-8af0-6a40b594d209" xlink:href="cvs-20201231.xsd#cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1945099b-eccd-46c9-b971-fa3ec0c9458b" xlink:to="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_381a37b5-a1d5-4d52-8af0-6a40b594d209" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_384ac09f-90a4-45f5-bbe9-434761fba941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_384ac09f-90a4-45f5-bbe9-434761fba941" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_384ac09f-90a4-45f5-bbe9-434761fba941_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_384ac09f-90a4-45f5-bbe9-434761fba941" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_384ac09f-90a4-45f5-bbe9-434761fba941_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6ce9ed9e-9c46-4967-8c01-907765904306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_384ac09f-90a4-45f5-bbe9-434761fba941" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6ce9ed9e-9c46-4967-8c01-907765904306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesMember_3269fbf9-d94f-4817-ae60-3cc70ed4ab1c" xlink:href="cvs-20201231.xsd#cvs_OtherInsuranceLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6ce9ed9e-9c46-4967-8c01-907765904306" xlink:to="loc_cvs_OtherInsuranceLiabilitiesMember_3269fbf9-d94f-4817-ae60-3cc70ed4ab1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_fcbd86f2-dae0-4787-ac36-c5263982d9ee" xlink:href="cvs-20201231.xsd#cvs_OtherLongTermInsuranceLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6ce9ed9e-9c46-4967-8c01-907765904306" xlink:to="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_fcbd86f2-dae0-4787-ac36-c5263982d9ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_86fccd12-bb5e-46ff-bad7-1f3042ac43de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_86fccd12-bb5e-46ff-bad7-1f3042ac43de" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_86fccd12-bb5e-46ff-bad7-1f3042ac43de_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_86fccd12-bb5e-46ff-bad7-1f3042ac43de" xlink:to="loc_us-gaap_EquityComponentDomain_86fccd12-bb5e-46ff-bad7-1f3042ac43de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d5378c8e-e503-4ead-bcdc-091828661458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_86fccd12-bb5e-46ff-bad7-1f3042ac43de" xlink:to="loc_us-gaap_EquityComponentDomain_d5378c8e-e503-4ead-bcdc-091828661458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2f3c5c8e-a1be-43f6-85f6-617a3fe62a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d5378c8e-e503-4ead-bcdc-091828661458" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2f3c5c8e-a1be-43f6-85f6-617a3fe62a8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b8e6cbf2-8468-4ff2-8f1c-be386e54eea2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_dei_LegalEntityAxis_b8e6cbf2-8468-4ff2-8f1c-be386e54eea2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b8e6cbf2-8468-4ff2-8f1c-be386e54eea2_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b8e6cbf2-8468-4ff2-8f1c-be386e54eea2" xlink:to="loc_dei_EntityDomain_b8e6cbf2-8468-4ff2-8f1c-be386e54eea2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_11dcfeab-da6a-4ab5-bd69-493613e883fb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b8e6cbf2-8468-4ff2-8f1c-be386e54eea2" xlink:to="loc_dei_EntityDomain_11dcfeab-da6a-4ab5-bd69-493613e883fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_e286c403-1771-4a79-a92e-bc0f13c7e6a4" xlink:href="cvs-20201231.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_11dcfeab-da6a-4ab5-bd69-493613e883fb" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_e286c403-1771-4a79-a92e-bc0f13c7e6a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_78f72763-45a9-495c-8d97-0e158082edfd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_78f72763-45a9-495c-8d97-0e158082edfd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_78f72763-45a9-495c-8d97-0e158082edfd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_78f72763-45a9-495c-8d97-0e158082edfd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_78f72763-45a9-495c-8d97-0e158082edfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ecc612b9-2865-4434-8a30-61fe558fc556" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_78f72763-45a9-495c-8d97-0e158082edfd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ecc612b9-2865-4434-8a30-61fe558fc556" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_60672be8-caa0-45b9-b2b1-72028e7cc888" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ecc612b9-2865-4434-8a30-61fe558fc556" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_60672be8-caa0-45b9-b2b1-72028e7cc888" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f42957ad-1792-4cd5-a464-64b5574e63aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_srt_LitigationCaseAxis_f42957ad-1792-4cd5-a464-64b5574e63aa" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f42957ad-1792-4cd5-a464-64b5574e63aa_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_f42957ad-1792-4cd5-a464-64b5574e63aa" xlink:to="loc_srt_LitigationCaseTypeDomain_f42957ad-1792-4cd5-a464-64b5574e63aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f9353ad0-6e65-4128-ba20-09c8fb3be104" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_f42957ad-1792-4cd5-a464-64b5574e63aa" xlink:to="loc_srt_LitigationCaseTypeDomain_f9353ad0-6e65-4128-ba20-09c8fb3be104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_b40bee21-b4f4-4faa-8c14-bfd3f44dd92e" xlink:href="cvs-20201231.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f9353ad0-6e65-4128-ba20-09c8fb3be104" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_b40bee21-b4f4-4faa-8c14-bfd3f44dd92e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_af4e6392-3c49-4902-a0aa-fc802cb381fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_LitigationStatusAxis_af4e6392-3c49-4902-a0aa-fc802cb381fa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_af4e6392-3c49-4902-a0aa-fc802cb381fa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_af4e6392-3c49-4902-a0aa-fc802cb381fa" xlink:to="loc_us-gaap_LitigationStatusDomain_af4e6392-3c49-4902-a0aa-fc802cb381fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_643432a1-aa0f-4e58-b4a6-21ba0c47652f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_af4e6392-3c49-4902-a0aa-fc802cb381fa" xlink:to="loc_us-gaap_LitigationStatusDomain_643432a1-aa0f-4e58-b4a6-21ba0c47652f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_6a2ebfec-0459-42b0-b650-87af8c8e6fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_643432a1-aa0f-4e58-b4a6-21ba0c47652f" xlink:to="loc_us-gaap_SettledLitigationMember_6a2ebfec-0459-42b0-b650-87af8c8e6fa3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesRestrictedCashDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails" xlink:type="extended" id="idb4be08ea5ff499aaf14d6cb057d1c49_SignificantAccountingPoliciesRestrictedCashDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended" id="i669393e008d2497b93bc98510d7d1b42_SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended" id="ia8e3c3859c314f67842f9c2414293f08_SignificantAccountingPoliciesPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_473f909c-188d-4363-84c9-59b3c47f90dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9f6c1d71-22ff-48e9-936c-73a7e37b447f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_473f909c-188d-4363-84c9-59b3c47f90dc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9f6c1d71-22ff-48e9-936c-73a7e37b447f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_dddf6a77-325b-4eab-acd9-7a392db3dfd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_473f909c-188d-4363-84c9-59b3c47f90dc" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_dddf6a77-325b-4eab-acd9-7a392db3dfd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5920c9b6-e23d-46e9-8179-02e856e3569b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_473f909c-188d-4363-84c9-59b3c47f90dc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5920c9b6-e23d-46e9-8179-02e856e3569b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8d748042-dbd8-4191-b58c-45d1f9da6901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_473f909c-188d-4363-84c9-59b3c47f90dc" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8d748042-dbd8-4191-b58c-45d1f9da6901" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_28b68074-9bd6-42b6-aaed-60b29063ba07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8d748042-dbd8-4191-b58c-45d1f9da6901" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_28b68074-9bd6-42b6-aaed-60b29063ba07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_28b68074-9bd6-42b6-aaed-60b29063ba07_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_28b68074-9bd6-42b6-aaed-60b29063ba07" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_28b68074-9bd6-42b6-aaed-60b29063ba07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_28b68074-9bd6-42b6-aaed-60b29063ba07" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_8043def5-29af-4872-88fd-48f672ab10f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:to="loc_us-gaap_LandMember_8043def5-29af-4872-88fd-48f672ab10f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_682ce0b3-f765-444b-b96a-956be01fa9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_682ce0b3-f765-444b-b96a-956be01fa9ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_9ee75703-9771-415e-a279-254da277383a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_9ee75703-9771-415e-a279-254da277383a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_679d6232-1aae-4f2c-a97e-00230fa9068a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_679d6232-1aae-4f2c-a97e-00230fa9068a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_8231e885-627e-443f-a5c1-37c70b92f05a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_8231e885-627e-443f-a5c1-37c70b92f05a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended" id="ia4a1c487b4104e2492d83b4f2ef39534_SignificantAccountingPoliciesDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_866bc1c5-a23b-4dea-be6a-660abe72e46d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_070eaf2c-9311-4cb6-9b9b-155b3e575d2a" xlink:href="cvs-20201231.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_866bc1c5-a23b-4dea-be6a-660abe72e46d" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_070eaf2c-9311-4cb6-9b9b-155b3e575d2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_8e2907b1-8f43-414f-a1b0-af5d86540e15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_866bc1c5-a23b-4dea-be6a-660abe72e46d" xlink:to="loc_us-gaap_NetInvestmentIncome_8e2907b1-8f43-414f-a1b0-af5d86540e15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2b2162bf-5365-4691-b42e-1170f85cf93f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_866bc1c5-a23b-4dea-be6a-660abe72e46d" xlink:to="loc_us-gaap_Revenues_2b2162bf-5365-4691-b42e-1170f85cf93f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_866bc1c5-a23b-4dea-be6a-660abe72e46d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a17cb357-1e7e-4919-8f4c-faa1c94eb97a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:to="loc_srt_ConsolidationItemsAxis_a17cb357-1e7e-4919-8f4c-faa1c94eb97a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a17cb357-1e7e-4919-8f4c-faa1c94eb97a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_a17cb357-1e7e-4919-8f4c-faa1c94eb97a" xlink:to="loc_srt_ConsolidationItemsDomain_a17cb357-1e7e-4919-8f4c-faa1c94eb97a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1895540a-aa61-410b-b288-f01cb4568e3e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_a17cb357-1e7e-4919-8f4c-faa1c94eb97a" xlink:to="loc_srt_ConsolidationItemsDomain_1895540a-aa61-410b-b288-f01cb4568e3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e2af05cf-8f94-4381-b972-9ebcb6cd61a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_1895540a-aa61-410b-b288-f01cb4568e3e" xlink:to="loc_us-gaap_OperatingSegmentsMember_e2af05cf-8f94-4381-b972-9ebcb6cd61a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9d736e7f-b02e-49f1-8361-5e87bfd4675a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_1895540a-aa61-410b-b288-f01cb4568e3e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9d736e7f-b02e-49f1-8361-5e87bfd4675a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_a2695117-99bd-4962-9cd4-38cb94dac0ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_1895540a-aa61-410b-b288-f01cb4568e3e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_a2695117-99bd-4962-9cd4-38cb94dac0ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_14a6a9b4-34a3-4ab8-86ef-8030f67d44a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_14a6a9b4-34a3-4ab8-86ef-8030f67d44a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_14a6a9b4-34a3-4ab8-86ef-8030f67d44a1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_14a6a9b4-34a3-4ab8-86ef-8030f67d44a1" xlink:to="loc_us-gaap_SegmentDomain_14a6a9b4-34a3-4ab8-86ef-8030f67d44a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f52dad0c-e9fe-483c-9d4c-73529568aea4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_14a6a9b4-34a3-4ab8-86ef-8030f67d44a1" xlink:to="loc_us-gaap_SegmentDomain_f52dad0c-e9fe-483c-9d4c-73529568aea4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_80caa915-a736-4970-b510-2c255ff040f9" xlink:href="cvs-20201231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f52dad0c-e9fe-483c-9d4c-73529568aea4" xlink:to="loc_cvs_PharmacyServicesSegmentMember_80caa915-a736-4970-b510-2c255ff040f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_7585c2bd-43c9-4c71-bfaf-fc63f9ccbcd0" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f52dad0c-e9fe-483c-9d4c-73529568aea4" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_7585c2bd-43c9-4c71-bfaf-fc63f9ccbcd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_c38de8f5-9bdd-48f3-915b-ed7d71b3379c" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f52dad0c-e9fe-483c-9d4c-73529568aea4" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_c38de8f5-9bdd-48f3-915b-ed7d71b3379c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1fcb015d-67a9-47bd-9bce-c62eac9709fd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:to="loc_srt_ProductOrServiceAxis_1fcb015d-67a9-47bd-9bce-c62eac9709fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1fcb015d-67a9-47bd-9bce-c62eac9709fd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1fcb015d-67a9-47bd-9bce-c62eac9709fd" xlink:to="loc_srt_ProductsAndServicesDomain_1fcb015d-67a9-47bd-9bce-c62eac9709fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ecfcfc6e-fba8-4fcb-8802-227668e18b16" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1fcb015d-67a9-47bd-9bce-c62eac9709fd" xlink:to="loc_srt_ProductsAndServicesDomain_ecfcfc6e-fba8-4fcb-8802-227668e18b16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_5c9f92bc-76fc-42f5-b29c-f754d177e98b" xlink:href="cvs-20201231.xsd#cvs_PharmacyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ecfcfc6e-fba8-4fcb-8802-227668e18b16" xlink:to="loc_cvs_PharmacyRevenueMember_5c9f92bc-76fc-42f5-b29c-f754d177e98b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_0b08c24d-daf0-4602-8c78-7ad802e9e09d" xlink:href="cvs-20201231.xsd#cvs_FrontStoreRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ecfcfc6e-fba8-4fcb-8802-227668e18b16" xlink:to="loc_cvs_FrontStoreRevenueMember_0b08c24d-daf0-4602-8c78-7ad802e9e09d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_50f4fa4d-776d-4846-a4d7-4db0ab7ebdde" xlink:href="cvs-20201231.xsd#cvs_PremiumsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ecfcfc6e-fba8-4fcb-8802-227668e18b16" xlink:to="loc_cvs_PremiumsMember_50f4fa4d-776d-4846-a4d7-4db0ab7ebdde" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_f5901f8e-71ef-4f83-b022-4353083b4fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ecfcfc6e-fba8-4fcb-8802-227668e18b16" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_f5901f8e-71ef-4f83-b022-4353083b4fb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_9a1b9cf7-c1d3-46d0-900f-d3e48810a660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_9a1b9cf7-c1d3-46d0-900f-d3e48810a660" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9a1b9cf7-c1d3-46d0-900f-d3e48810a660_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_9a1b9cf7-c1d3-46d0-900f-d3e48810a660" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9a1b9cf7-c1d3-46d0-900f-d3e48810a660_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_2da3709c-3f38-484f-a05f-46acf9af18fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_9a1b9cf7-c1d3-46d0-900f-d3e48810a660" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_2da3709c-3f38-484f-a05f-46acf9af18fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_7aeff3c4-50ab-41cf-8855-ef276fe69b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_2da3709c-3f38-484f-a05f-46acf9af18fa" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_7aeff3c4-50ab-41cf-8855-ef276fe69b16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_b49644f0-04e9-485e-aed9-cae9c2284d3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_2da3709c-3f38-484f-a05f-46acf9af18fa" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_b49644f0-04e9-485e-aed9-cae9c2284d3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_9e8d6c01-71c1-4c94-9fce-638de04fb88c" xlink:href="cvs-20201231.xsd#cvs_SalesChannelOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_2da3709c-3f38-484f-a05f-46acf9af18fa" xlink:to="loc_cvs_SalesChannelOtherMember_9e8d6c01-71c1-4c94-9fce-638de04fb88c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="extended" id="i6a8808590d1d4680aaa85385e0b7ca23_SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesVariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="extended" id="i92506e15d9f74b90a518487c0a1253e3_SignificantAccountingPoliciesVariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_a342cced-8171-4ecd-8876-93256e4645d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_502e46d3-d068-4984-9d73-aeb4a87cff76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_a342cced-8171-4ecd-8876-93256e4645d8" xlink:to="loc_us-gaap_LongTermInvestments_502e46d3-d068-4984-9d73-aeb4a87cff76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_316a75fc-44aa-44ab-8e98-e8154e4117da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_a342cced-8171-4ecd-8876-93256e4645d8" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_316a75fc-44aa-44ab-8e98-e8154e4117da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_42535371-c3b9-40e2-968d-2ec6239cb0fe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_316a75fc-44aa-44ab-8e98-e8154e4117da" xlink:to="loc_srt_ConsolidatedEntitiesAxis_42535371-c3b9-40e2-968d-2ec6239cb0fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_42535371-c3b9-40e2-968d-2ec6239cb0fe_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_42535371-c3b9-40e2-968d-2ec6239cb0fe" xlink:to="loc_srt_ConsolidatedEntitiesDomain_42535371-c3b9-40e2-968d-2ec6239cb0fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_50536c08-753b-45a7-98be-c3dd0df3399e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_42535371-c3b9-40e2-968d-2ec6239cb0fe" xlink:to="loc_srt_ConsolidatedEntitiesDomain_50536c08-753b-45a7-98be-c3dd0df3399e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_304d5cfc-ef80-4cdb-b479-6365d4f43f9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_50536c08-753b-45a7-98be-c3dd0df3399e" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_304d5cfc-ef80-4cdb-b479-6365d4f43f9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_24993ead-fd9f-4a2e-9d47-12fe4f4b5058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_316a75fc-44aa-44ab-8e98-e8154e4117da" xlink:to="loc_us-gaap_InvestmentTypeAxis_24993ead-fd9f-4a2e-9d47-12fe4f4b5058" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_24993ead-fd9f-4a2e-9d47-12fe4f4b5058_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_24993ead-fd9f-4a2e-9d47-12fe4f4b5058" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_24993ead-fd9f-4a2e-9d47-12fe4f4b5058_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_66066833-9769-42a2-885d-97e22ffcc167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_24993ead-fd9f-4a2e-9d47-12fe4f4b5058" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_66066833-9769-42a2-885d-97e22ffcc167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_23eee109-c225-4815-aa61-354194c99396" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_66066833-9769-42a2-885d-97e22ffcc167" xlink:to="loc_us-gaap_HedgeFundsMember_23eee109-c225-4815-aa61-354194c99396" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_4738b12c-4e39-4621-a57f-1776c3ebfa29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_66066833-9769-42a2-885d-97e22ffcc167" xlink:to="loc_us-gaap_PrivateEquityFundsMember_4738b12c-4e39-4621-a57f-1776c3ebfa29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_0101ab94-0990-44c6-afd4-81622568de8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_66066833-9769-42a2-885d-97e22ffcc167" xlink:to="loc_us-gaap_RealEstateFundsMember_0101ab94-0990-44c6-afd4-81622568de8c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="extended" id="ica60825aab6c4d1290b13d0f17c04b1c_SignificantAccountingPoliciesDiscontinuedOperationsDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestitures" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestitures"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestitures" xlink:type="extended" id="ife02b5e314d94eea8803d1c89eac8cbd_AcquisitionsandDivestitures"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestituresTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestituresTables" xlink:type="extended" id="i5b7b602f470249ad8dc974ff02ac869a_AcquisitionsandDivestituresTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="extended" id="i4e50ca534fa94756beb409bf34ffb315_AcquisitionsandDivestituresNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_df00d589-f038-4ed6-9289-c4c214764ec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_df00d589-f038-4ed6-9289-c4c214764ec0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_1b15b9f4-0710-4517-b5e2-ae443ff4fce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_1b15b9f4-0710-4517-b5e2-ae443ff4fce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPerShareExchangeRatio_3d185624-c06f-45bd-bff7-0d9a45ce31cb" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationPerShareExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_cvs_BusinessCombinationPerShareExchangeRatio_3d185624-c06f-45bd-bff7-0d9a45ce31cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired_05846673-f383-4675-af2c-da9e4d0535b9" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationAcquisitionValuePerSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired_05846673-f383-4675-af2c-da9e4d0535b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_87495bf5-81c9-472c-9d33-ec172a90387b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_87495bf5-81c9-472c-9d33-ec172a90387b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree_0920a4c9-9812-464c-93df-ba2f451b67df" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree_0920a4c9-9812-464c-93df-ba2f451b67df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_68b9c3a8-514b-4ac2-a476-05371e1381b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_LongTermDebt_68b9c3a8-514b-4ac2-a476-05371e1381b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_e36d1843-64be-4453-9c93-458c8bf99922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_NumberOfStores_e36d1843-64be-4453-9c93-458c8bf99922" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_e952ba77-b345-477e-9c9d-17cf0a4948c4" xlink:href="cvs-20201231.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_e952ba77-b345-477e-9c9d-17cf0a4948c4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_6ddb320e-ed54-473b-ae9e-b5451f017984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_6ddb320e-ed54-473b-ae9e-b5451f017984" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_ce7b22b1-bd7e-4618-85fa-c20957c918d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_ce7b22b1-bd7e-4618-85fa-c20957c918d1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_1a8c65ce-a48a-42be-96af-c59dd7c40509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_1a8c65ce-a48a-42be-96af-c59dd7c40509" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_edf7c1c2-08d0-428d-be28-3181530fd5d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_edf7c1c2-08d0-428d-be28-3181530fd5d3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_a8490610-7fad-493b-9af7-7b27bf2d980a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_a8490610-7fad-493b-9af7-7b27bf2d980a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_b2b24ed9-7501-4f2d-bb4a-710ce4214e81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_b2b24ed9-7501-4f2d-bb4a-710ce4214e81" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a84302f4-606b-4936-930c-796e45652b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a84302f4-606b-4936-930c-796e45652b84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a84302f4-606b-4936-930c-796e45652b84_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a84302f4-606b-4936-930c-796e45652b84" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a84302f4-606b-4936-930c-796e45652b84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9a6cd357-0ed0-4f9e-9883-6ea628c98686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a84302f4-606b-4936-930c-796e45652b84" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9a6cd357-0ed0-4f9e-9883-6ea628c98686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_7474094f-1693-48db-adf9-f23a256bf955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9a6cd357-0ed0-4f9e-9883-6ea628c98686" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_7474094f-1693-48db-adf9-f23a256bf955" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ee68ed94-9ca5-4978-9f36-8aac56014fd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ee68ed94-9ca5-4978-9f36-8aac56014fd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ee68ed94-9ca5-4978-9f36-8aac56014fd5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ee68ed94-9ca5-4978-9f36-8aac56014fd5" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ee68ed94-9ca5-4978-9f36-8aac56014fd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7cd83e29-324e-4539-b386-d91f6aab7a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ee68ed94-9ca5-4978-9f36-8aac56014fd5" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7cd83e29-324e-4539-b386-d91f6aab7a0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BrazilSubsidiaryMember_7e6d74cf-b657-4a05-ba40-6db23f46ab7b" xlink:href="cvs-20201231.xsd#cvs_BrazilSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7cd83e29-324e-4539-b386-d91f6aab7a0f" xlink:to="loc_cvs_BrazilSubsidiaryMember_7e6d74cf-b657-4a05-ba40-6db23f46ab7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RXCrossroadsMember_d5277c06-5ad8-4920-9e7b-92ab2e82e7a0" xlink:href="cvs-20201231.xsd#cvs_RXCrossroadsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7cd83e29-324e-4539-b386-d91f6aab7a0f" xlink:to="loc_cvs_RXCrossroadsMember_d5277c06-5ad8-4920-9e7b-92ab2e82e7a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_a8e87246-d5ff-439d-8ade-e9cd2418079c" xlink:href="cvs-20201231.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7cd83e29-324e-4539-b386-d91f6aab7a0f" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_a8e87246-d5ff-439d-8ade-e9cd2418079c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DrogariaOnofreLtdaMember_7a414bf0-420f-40c7-8782-043c82854643" xlink:href="cvs-20201231.xsd#cvs_DrogariaOnofreLtdaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7cd83e29-324e-4539-b386-d91f6aab7a0f" xlink:to="loc_cvs_DrogariaOnofreLtdaMember_7a414bf0-420f-40c7-8782-043c82854643" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f2dfc7a2-3aea-48cd-b64e-c166507b1b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f2dfc7a2-3aea-48cd-b64e-c166507b1b27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f2dfc7a2-3aea-48cd-b64e-c166507b1b27_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f2dfc7a2-3aea-48cd-b64e-c166507b1b27" xlink:to="loc_us-gaap_SegmentDomain_f2dfc7a2-3aea-48cd-b64e-c166507b1b27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_24600666-901e-4a9a-96e1-59b7902198c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f2dfc7a2-3aea-48cd-b64e-c166507b1b27" xlink:to="loc_us-gaap_SegmentDomain_24600666-901e-4a9a-96e1-59b7902198c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_cc4f4f3f-db9e-461d-b476-5f0ccf62d36b" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_24600666-901e-4a9a-96e1-59b7902198c2" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_cc4f4f3f-db9e-461d-b476-5f0ccf62d36b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_962a443f-d152-4b19-8153-8728dbbe02ba" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_24600666-901e-4a9a-96e1-59b7902198c2" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_962a443f-d152-4b19-8153-8728dbbe02ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_459c051c-2f25-4474-8537-227c80d881d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_459c051c-2f25-4474-8537-227c80d881d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_459c051c-2f25-4474-8537-227c80d881d4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_459c051c-2f25-4474-8537-227c80d881d4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_459c051c-2f25-4474-8537-227c80d881d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_26c3d713-8d0d-4186-9fde-44b311121705" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_459c051c-2f25-4474-8537-227c80d881d4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_26c3d713-8d0d-4186-9fde-44b311121705" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc.Member_93bd6d8a-2ff9-48c1-ac5f-6f40a5f12dc3" xlink:href="cvs-20201231.xsd#cvs_AetnaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_26c3d713-8d0d-4186-9fde-44b311121705" xlink:to="loc_cvs_AetnaInc.Member_93bd6d8a-2ff9-48c1-ac5f-6f40a5f12dc3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="i0d9cd7471dd94faca249cf2f93c566fe_AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_81ba05b2-5168-4595-a8b7-1bdb791ad028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_81ba05b2-5168-4595-a8b7-1bdb791ad028" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6156b096-1dd1-452e-a839-4c96ff347b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6156b096-1dd1-452e-a839-4c96ff347b99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_5542bc23-5022-41f0-b328-585552a97b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_5542bc23-5022-41f0-b328-585552a97b83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments_f6d3c48a-fa54-4e85-ad76-0c4d8d3be93a" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments_f6d3c48a-fa54-4e85-ad76-0c4d8d3be93a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_26eb2a29-4392-49b2-9eda-73e4f361dbea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_Goodwill_26eb2a29-4392-49b2-9eda-73e4f361dbea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_732c3985-3e00-4a8e-af1d-d092a10821f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_732c3985-3e00-4a8e-af1d-d092a10821f5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_f618ff85-2678-4e87-9080-7f02c3aa9076" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_f618ff85-2678-4e87-9080-7f02c3aa9076" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_20c672a8-795a-49e7-a8fa-6f7e2c2dfeec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_20c672a8-795a-49e7-a8fa-6f7e2c2dfeec" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet_2dfd2751-5579-4e03-99a1-2dc19c0f4d26" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet_2dfd2751-5579-4e03-99a1-2dc19c0f4d26" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_40134da0-e4b6-4135-b40f-c270504ff7d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_40134da0-e4b6-4135-b40f-c270504ff7d1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_4d1396ac-67fb-4d6c-891a-55e07518da11" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_4d1396ac-67fb-4d6c-891a-55e07518da11" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4b919e13-3371-4573-92da-5d8ca4d6094e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4b919e13-3371-4573-92da-5d8ca4d6094e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6d1ee16c-5173-4075-bb95-2eae5ebe6111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6d1ee16c-5173-4075-bb95-2eae5ebe6111" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9fddbdd2-4a95-4ba4-8422-7b8a07599e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9fddbdd2-4a95-4ba4-8422-7b8a07599e29" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_9c6df5d4-126f-4633-9b83-1fea5f29c171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_9c6df5d4-126f-4633-9b83-1fea5f29c171" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_737685e7-5970-4d6c-b7d5-961474ef9de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_737685e7-5970-4d6c-b7d5-961474ef9de6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_44c4aeb6-38a9-41ad-966b-575fa1c41ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_44c4aeb6-38a9-41ad-966b-575fa1c41ea2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b7ff26dd-6309-46b8-be8e-014bda08fb8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_44c4aeb6-38a9-41ad-966b-575fa1c41ea2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b7ff26dd-6309-46b8-be8e-014bda08fb8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ff26dd-6309-46b8-be8e-014bda08fb8f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b7ff26dd-6309-46b8-be8e-014bda08fb8f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b7ff26dd-6309-46b8-be8e-014bda08fb8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_efab89d7-ab42-432e-aced-d92399ef5255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b7ff26dd-6309-46b8-be8e-014bda08fb8f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_efab89d7-ab42-432e-aced-d92399ef5255" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc.Member_568a3172-432f-4156-8463-9ad87022578f" xlink:href="cvs-20201231.xsd#cvs_AetnaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_efab89d7-ab42-432e-aced-d92399ef5255" xlink:to="loc_cvs_AetnaInc.Member_568a3172-432f-4156-8463-9ad87022578f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestituresProFormaDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails" xlink:type="extended" id="ib99bbc0bf81a4950aad91fef01f468ed_AcquisitionsandDivestituresProFormaDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Investments" xlink:type="simple" xlink:href="cvs-20201231.xsd#Investments"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/Investments" xlink:type="extended" id="i40ac6adc45ec444586b3824ab1994002_Investments"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="extended" id="i3abcfc66fccc4cd9b0a9461f77e41838_InvestmentsTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsScheduleofTotalInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="extended" id="if61dab9b5d714cdba574d2ea0c04a7cb_InvestmentsScheduleofTotalInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_62fc08a1-b6d4-4cfd-8791-8dc27c170b11" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_6486f2a9-bada-4b81-84a4-544edcf8879d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_62fc08a1-b6d4-4cfd-8791-8dc27c170b11" xlink:to="loc_us-gaap_ShortTermInvestments_6486f2a9-bada-4b81-84a4-544edcf8879d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_dfe67c5c-af08-4af4-8aca-9293c2523675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_62fc08a1-b6d4-4cfd-8791-8dc27c170b11" xlink:to="loc_us-gaap_LongTermInvestments_dfe67c5c-af08-4af4-8aca-9293c2523675" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_dec646eb-4544-4e8e-a26b-ce47fdcb4ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_62fc08a1-b6d4-4cfd-8791-8dc27c170b11" xlink:to="loc_us-gaap_Investments_dec646eb-4544-4e8e-a26b-ce47fdcb4ddb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_031de285-d031-40cd-97e8-ab03cdbb9926" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cvs_TotalInvestmentsLineItems_62fc08a1-b6d4-4cfd-8791-8dc27c170b11" xlink:to="loc_cvs_TotalInvestmentsTable_031de285-d031-40cd-97e8-ab03cdbb9926" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_6f9b90dd-e0e6-4047-a368-74e1d0c4e045" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_TotalInvestmentsTable_031de285-d031-40cd-97e8-ab03cdbb9926" xlink:to="loc_cvs_TotalInvestmentsAxis_6f9b90dd-e0e6-4047-a368-74e1d0c4e045" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_6f9b90dd-e0e6-4047-a368-74e1d0c4e045_default" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_TotalInvestmentsAxis_6f9b90dd-e0e6-4047-a368-74e1d0c4e045" xlink:to="loc_cvs_TotalInvestmentsDomain_6f9b90dd-e0e6-4047-a368-74e1d0c4e045_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_23a4ad0b-4ba2-45a1-b674-658e942fc76e" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_TotalInvestmentsAxis_6f9b90dd-e0e6-4047-a368-74e1d0c4e045" xlink:to="loc_cvs_TotalInvestmentsDomain_23a4ad0b-4ba2-45a1-b674-658e942fc76e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_87b6f59b-f0b6-4d06-ac8a-62d7dec46a47" xlink:href="cvs-20201231.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_23a4ad0b-4ba2-45a1-b674-658e942fc76e" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_87b6f59b-f0b6-4d06-ac8a-62d7dec46a47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_22679157-5296-4081-91e2-5e06aac2930a" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_23a4ad0b-4ba2-45a1-b674-658e942fc76e" xlink:to="loc_cvs_MortgageLoansMember_22679157-5296-4081-91e2-5e06aac2930a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_6b30fe15-26cc-4b91-8397-855bcb7eff71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_23a4ad0b-4ba2-45a1-b674-658e942fc76e" xlink:to="loc_us-gaap_OtherInvestmentsMember_6b30fe15-26cc-4b91-8397-855bcb7eff71" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="extended" id="i2d1eb61d47404a3b855f1e4b5a16ce6f_InvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed63319f-12b2-4971-b107-ad4245dab186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsAtFairValue_efd223e6-559b-490b-a96a-50073f2fe6f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed63319f-12b2-4971-b107-ad4245dab186" xlink:to="loc_us-gaap_RestrictedInvestmentsAtFairValue_efd223e6-559b-490b-a96a-50073f2fe6f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_8d6970de-2566-46b0-8e49-e853f2a75448" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed63319f-12b2-4971-b107-ad4245dab186" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_8d6970de-2566-46b0-8e49-e853f2a75448" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_406d1953-b411-406f-b8a5-498eedeed1f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed63319f-12b2-4971-b107-ad4245dab186" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_406d1953-b411-406f-b8a5-498eedeed1f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_50f05b23-55a6-4614-89ba-47fe08f407b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_406d1953-b411-406f-b8a5-498eedeed1f9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_50f05b23-55a6-4614-89ba-47fe08f407b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_50f05b23-55a6-4614-89ba-47fe08f407b1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_50f05b23-55a6-4614-89ba-47fe08f407b1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_50f05b23-55a6-4614-89ba-47fe08f407b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00791404-8be7-498f-8188-e9d14adc3274" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_50f05b23-55a6-4614-89ba-47fe08f407b1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00791404-8be7-498f-8188-e9d14adc3274" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_7ffaeb2f-5a88-4ff3-a834-42ee7a36ecab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00791404-8be7-498f-8188-e9d14adc3274" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_7ffaeb2f-5a88-4ff3-a834-42ee7a36ecab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_70c4bbd9-fcba-4dce-b590-6ba72ab9f454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00791404-8be7-498f-8188-e9d14adc3274" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_70c4bbd9-fcba-4dce-b590-6ba72ab9f454" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_94762c07-47ef-42cf-b400-3772e1848a5d" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00791404-8be7-498f-8188-e9d14adc3274" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_94762c07-47ef-42cf-b400-3772e1848a5d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended" id="i97d219924a214cc1b870b2c8a5a27e4a_InvestmentsDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2c4eb5cd-e5bd-480c-8bba-71b901180a1a" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2c4eb5cd-e5bd-480c-8bba-71b901180a1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7772f15d-6408-4cd1-8679-fd7dfbde5d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7772f15d-6408-4cd1-8679-fd7dfbde5d0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3c4b57ab-f11c-4764-a164-0402809c5c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3c4b57ab-f11c-4764-a164-0402809c5c1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c4e24844-de4b-4705-809d-40579c74fce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c4e24844-de4b-4705-809d-40579c74fce8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_e8ea346f-3d72-4e8d-aeb8-30f079da887e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_e8ea346f-3d72-4e8d-aeb8-30f079da887e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2b133fc7-e6f2-48e3-aefa-740ec4f741c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2b133fc7-e6f2-48e3-aefa-740ec4f741c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_75af1cdf-9589-4500-8cf7-61f61064442f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2b133fc7-e6f2-48e3-aefa-740ec4f741c5" xlink:to="loc_srt_ProductOrServiceAxis_75af1cdf-9589-4500-8cf7-61f61064442f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_75af1cdf-9589-4500-8cf7-61f61064442f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_75af1cdf-9589-4500-8cf7-61f61064442f" xlink:to="loc_srt_ProductsAndServicesDomain_75af1cdf-9589-4500-8cf7-61f61064442f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ad2e2370-83e3-4e8e-9d4c-0d2ab706d561" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_75af1cdf-9589-4500-8cf7-61f61064442f" xlink:to="loc_srt_ProductsAndServicesDomain_ad2e2370-83e3-4e8e-9d4c-0d2ab706d561" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_c5f497ef-bc26-43fc-bd92-73a8579af3b6" xlink:href="cvs-20201231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ad2e2370-83e3-4e8e-9d4c-0d2ab706d561" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_c5f497ef-bc26-43fc-bd92-73a8579af3b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ea5489e7-369e-45ab-99f8-9a6d7e3b8ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2b133fc7-e6f2-48e3-aefa-740ec4f741c5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ea5489e7-369e-45ab-99f8-9a6d7e3b8ee3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea5489e7-369e-45ab-99f8-9a6d7e3b8ee3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ea5489e7-369e-45ab-99f8-9a6d7e3b8ee3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea5489e7-369e-45ab-99f8-9a6d7e3b8ee3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ea5489e7-369e-45ab-99f8-9a6d7e3b8ee3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f59cd7ea-a5af-4be8-8d00-3b351444cddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f59cd7ea-a5af-4be8-8d00-3b351444cddf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_ab0522a7-b45c-451d-ad05-c4824391f061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_ab0522a7-b45c-451d-ad05-c4824391f061" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_35c4e76e-21d7-451a-bd44-ccf71d85d9d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_35c4e76e-21d7-451a-bd44-ccf71d85d9d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_f41ed8d1-b2ff-4634-84ad-0938098659b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_f41ed8d1-b2ff-4634-84ad-0938098659b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_dc15ec40-21bf-4df3-b68f-cc2050bc8c49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_dc15ec40-21bf-4df3-b68f-cc2050bc8c49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_04c71184-f1d3-48ed-a43e-ab20565dd0ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_04c71184-f1d3-48ed-a43e-ab20565dd0ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_c7d378a6-f00a-4a62-b71c-a9587bcc6473" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_c7d378a6-f00a-4a62-b71c-a9587bcc6473" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_25d46e8f-292d-4a80-9dca-92836fd9f70e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_25d46e8f-292d-4a80-9dca-92836fd9f70e" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended" id="i2b1a76a6ff854fecaf85deca52394a4c_InvestmentsDebtSecuritiesbyMaturityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e7c25144-4a03-45c0-98fe-be9d1117559f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e7c25144-4a03-45c0-98fe-be9d1117559f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_b1585758-e31e-44fe-b1c2-23801f8991d4" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_b1585758-e31e-44fe-b1c2-23801f8991d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_304fd6e9-a8af-47a9-b6b9-24e97524b29c" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_304fd6e9-a8af-47a9-b6b9-24e97524b29c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_2feb41da-395f-4fc9-9454-a555e775fbfb" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_2feb41da-395f-4fc9-9454-a555e775fbfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_f0246f8a-5f80-494a-8eed-b68e5427a516" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_f0246f8a-5f80-494a-8eed-b68e5427a516" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_3b45b55c-01f3-4a46-9a64-33af3587479d" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_3b45b55c-01f3-4a46-9a64-33af3587479d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_947d319e-7adf-4e16-8cd9-23f6f28e44c8" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_947d319e-7adf-4e16-8cd9-23f6f28e44c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e7c25144-4a03-45c0-98fe-be9d1117559f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_12f23915-5285-4b8d-9316-bc0a7f1e1fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_12f23915-5285-4b8d-9316-bc0a7f1e1fb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_d9cdac90-e1a9-42cd-a047-d899c882881f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_d9cdac90-e1a9-42cd-a047-d899c882881f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_51050f9f-ca05-455e-ad64-32565f309d70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_51050f9f-ca05-455e-ad64-32565f309d70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_56239ed4-529f-479b-8cdc-a478682d22b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_56239ed4-529f-479b-8cdc-a478682d22b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_6c988cee-598b-49cb-8f21-5721731bf954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_6c988cee-598b-49cb-8f21-5721731bf954" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_aa9f3fa4-663a-4a50-864c-8087bfc830e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_aa9f3fa4-663a-4a50-864c-8087bfc830e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bd3cd4b-9f7c-4753-ad56-468ff3f67d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e7c25144-4a03-45c0-98fe-be9d1117559f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bd3cd4b-9f7c-4753-ad56-468ff3f67d4e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7a6636fb-ae7b-4b4e-9bce-a89d0b2b1bf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bd3cd4b-9f7c-4753-ad56-468ff3f67d4e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7a6636fb-ae7b-4b4e-9bce-a89d0b2b1bf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7a6636fb-ae7b-4b4e-9bce-a89d0b2b1bf1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7a6636fb-ae7b-4b4e-9bce-a89d0b2b1bf1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7a6636fb-ae7b-4b4e-9bce-a89d0b2b1bf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7edb881d-8553-49f9-8a6e-0370454913c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7a6636fb-ae7b-4b4e-9bce-a89d0b2b1bf1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7edb881d-8553-49f9-8a6e-0370454913c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_ec626018-19d1-4e17-a65d-c0793472348d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7edb881d-8553-49f9-8a6e-0370454913c1" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_ec626018-19d1-4e17-a65d-c0793472348d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d4cc2f53-3f3a-453b-bfdc-be908dbb5ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7edb881d-8553-49f9-8a6e-0370454913c1" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d4cc2f53-3f3a-453b-bfdc-be908dbb5ba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_d3c5d5cb-4bb0-4c5b-8eae-c57f7a00a7cf" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7edb881d-8553-49f9-8a6e-0370454913c1" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_d3c5d5cb-4bb0-4c5b-8eae-c57f7a00a7cf" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended" id="i94c977c4b8784fb4ae5fad03f297f567_InvestmentsUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a6d224f4-80a5-4d0c-a621-2098ed6d5249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_012f935e-7cc8-49e5-a334-ec94c7887fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a6d224f4-80a5-4d0c-a621-2098ed6d5249" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_012f935e-7cc8-49e5-a334-ec94c7887fea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_70b09776-ee22-4aa7-8364-929311665554" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_012f935e-7cc8-49e5-a334-ec94c7887fea" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_70b09776-ee22-4aa7-8364-929311665554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_a6d7b02a-c994-4097-8617-a4c01a719d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_012f935e-7cc8-49e5-a334-ec94c7887fea" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_a6d7b02a-c994-4097-8617-a4c01a719d9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_15669778-60b4-40d9-bdc1-2492a021b224" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_012f935e-7cc8-49e5-a334-ec94c7887fea" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_15669778-60b4-40d9-bdc1-2492a021b224" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_db3ce0c5-ef43-4a9f-92cd-f1a372d9f458" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a6d224f4-80a5-4d0c-a621-2098ed6d5249" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_db3ce0c5-ef43-4a9f-92cd-f1a372d9f458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d51f30f6-c362-4a6b-8794-45495d8713f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_db3ce0c5-ef43-4a9f-92cd-f1a372d9f458" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d51f30f6-c362-4a6b-8794-45495d8713f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_59ca6005-cb9a-4e64-be11-cbf46803efd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_db3ce0c5-ef43-4a9f-92cd-f1a372d9f458" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_59ca6005-cb9a-4e64-be11-cbf46803efd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_93a09246-8791-430e-80e6-2e63f32c92a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_db3ce0c5-ef43-4a9f-92cd-f1a372d9f458" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_93a09246-8791-430e-80e6-2e63f32c92a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4ac7116c-27c8-4e5b-a26c-14fa9e486ed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a6d224f4-80a5-4d0c-a621-2098ed6d5249" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4ac7116c-27c8-4e5b-a26c-14fa9e486ed2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ce52aedb-8f54-4e07-8477-0a80309e0440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4ac7116c-27c8-4e5b-a26c-14fa9e486ed2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ce52aedb-8f54-4e07-8477-0a80309e0440" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_03b78be2-bd19-443f-965d-c47b5ca824df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4ac7116c-27c8-4e5b-a26c-14fa9e486ed2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_03b78be2-bd19-443f-965d-c47b5ca824df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_61388076-0290-4dca-8fc2-3e2e18051e77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4ac7116c-27c8-4e5b-a26c-14fa9e486ed2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_61388076-0290-4dca-8fc2-3e2e18051e77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_768e9f3f-967a-4576-85fe-707a6936e2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a6d224f4-80a5-4d0c-a621-2098ed6d5249" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_768e9f3f-967a-4576-85fe-707a6936e2c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d1b8945b-748d-4e71-82df-460e6526f653" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_768e9f3f-967a-4576-85fe-707a6936e2c0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d1b8945b-748d-4e71-82df-460e6526f653" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d1b8945b-748d-4e71-82df-460e6526f653_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d1b8945b-748d-4e71-82df-460e6526f653" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d1b8945b-748d-4e71-82df-460e6526f653_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d1b8945b-748d-4e71-82df-460e6526f653" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cc898473-1fe1-4e0a-a782-2752aaff4b0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cc898473-1fe1-4e0a-a782-2752aaff4b0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_fe3f2bb4-ea6c-4bf8-8536-6acf25375760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_fe3f2bb4-ea6c-4bf8-8536-6acf25375760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_e9d9b3af-af3b-44b3-b7fc-76f331ebb035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_e9d9b3af-af3b-44b3-b7fc-76f331ebb035" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_ef895267-f0a8-45de-815f-6244a2d9d37d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_ef895267-f0a8-45de-815f-6244a2d9d37d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d22b4e03-fb6e-4177-8ba8-e1df109800fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d22b4e03-fb6e-4177-8ba8-e1df109800fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_085bc72e-f4a8-4aa4-9d45-4c1c27a95334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_085bc72e-f4a8-4aa4-9d45-4c1c27a95334" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_05bef420-7125-4860-88a2-2089bba27b46" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_05bef420-7125-4860-88a2-2089bba27b46" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended" id="iea61f0c9424243f0bcaa28b8b80cc39b_InvestmentsUnrealizedLossPositionMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_777e42d1-2ad5-428a-9b83-429cd04b9e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_777e42d1-2ad5-428a-9b83-429cd04b9e10" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_2f9e9b47-1222-4330-996a-4413b3ed3473" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_2f9e9b47-1222-4330-996a-4413b3ed3473" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_f5cfdf0c-2b25-417b-b29b-9a74e1abc83b" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_f5cfdf0c-2b25-417b-b29b-9a74e1abc83b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_27457fef-6e56-4068-a8c4-b561115bdcdc" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_27457fef-6e56-4068-a8c4-b561115bdcdc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_0c258ebc-bf11-447b-846c-a9a33c9f9739" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_0c258ebc-bf11-447b-846c-a9a33c9f9739" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_98f39a91-e862-4ad7-8bdb-13a19931df71" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_98f39a91-e862-4ad7-8bdb-13a19931df71" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7882b202-993c-407b-9f88-cd2eb1daddf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7882b202-993c-407b-9f88-cd2eb1daddf1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_777e42d1-2ad5-428a-9b83-429cd04b9e10" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_26f6d681-01de-4be8-90e7-333ac824f924" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_26f6d681-01de-4be8-90e7-333ac824f924" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_f0dc1d44-6014-4290-b909-54d188459056" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_f0dc1d44-6014-4290-b909-54d188459056" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_48de2767-6692-49e7-a5f9-11eae1abc198" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_48de2767-6692-49e7-a5f9-11eae1abc198" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_0e59f29c-0213-4b71-ab91-6470d4185ff8" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_0e59f29c-0213-4b71-ab91-6470d4185ff8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_e7eae8d6-86ca-4224-b273-f72a09d86933" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_e7eae8d6-86ca-4224-b273-f72a09d86933" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_082b70a9-cfb6-47f4-a2f9-11d293071750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_082b70a9-cfb6-47f4-a2f9-11d293071750" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9bca1465-e4dd-412a-8948-ddb62c08f3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_777e42d1-2ad5-428a-9b83-429cd04b9e10" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9bca1465-e4dd-412a-8948-ddb62c08f3b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_afda5a37-abb7-49f3-ae93-51de0d191665" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9bca1465-e4dd-412a-8948-ddb62c08f3b2" xlink:to="loc_srt_ProductOrServiceAxis_afda5a37-abb7-49f3-ae93-51de0d191665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_afda5a37-abb7-49f3-ae93-51de0d191665_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_afda5a37-abb7-49f3-ae93-51de0d191665" xlink:to="loc_srt_ProductsAndServicesDomain_afda5a37-abb7-49f3-ae93-51de0d191665_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e92f39e8-289d-4973-a2c2-a60c6f72b626" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_afda5a37-abb7-49f3-ae93-51de0d191665" xlink:to="loc_srt_ProductsAndServicesDomain_e92f39e8-289d-4973-a2c2-a60c6f72b626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_e7dfb38c-6da0-4523-a9f3-454de4c8bc9d" xlink:href="cvs-20201231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e92f39e8-289d-4973-a2c2-a60c6f72b626" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_e7dfb38c-6da0-4523-a9f3-454de4c8bc9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_29357372-d93e-48c6-9454-7844170834f3" xlink:href="cvs-20201231.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e92f39e8-289d-4973-a2c2-a60c6f72b626" xlink:to="loc_cvs_SupportingRemainingProductsMember_29357372-d93e-48c6-9454-7844170834f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_93442f5f-fd07-4442-97a6-c9ce6268a5f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9bca1465-e4dd-412a-8948-ddb62c08f3b2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_93442f5f-fd07-4442-97a6-c9ce6268a5f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_93442f5f-fd07-4442-97a6-c9ce6268a5f9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_93442f5f-fd07-4442-97a6-c9ce6268a5f9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_93442f5f-fd07-4442-97a6-c9ce6268a5f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_879fd837-53e3-4378-b081-7458b3e8c9f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_93442f5f-fd07-4442-97a6-c9ce6268a5f9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_879fd837-53e3-4378-b081-7458b3e8c9f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_f1603e0f-0e70-4b7f-8fd2-bd8635df1da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_879fd837-53e3-4378-b081-7458b3e8c9f9" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_f1603e0f-0e70-4b7f-8fd2-bd8635df1da9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_bd7c1881-3443-4310-a684-4bbd5063b72c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_879fd837-53e3-4378-b081-7458b3e8c9f9" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_bd7c1881-3443-4310-a684-4bbd5063b72c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_ae28aff3-1b73-45f8-9c81-9484c1f9deef" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_879fd837-53e3-4378-b081-7458b3e8c9f9" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_ae28aff3-1b73-45f8-9c81-9484c1f9deef" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsMortgageLoansDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended" id="ie06454d1040c4445aaf0e1dac6622f64_InvestmentsMortgageLoansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_2b59505d-fcf7-4857-8000-869621744306" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_827a3588-3484-4a00-8458-3916bf138fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_2b59505d-fcf7-4857-8000-869621744306" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_827a3588-3484-4a00-8458-3916bf138fd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_a39f3fc6-30e9-4677-aa40-e9dcbed6bdbc" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_2b59505d-fcf7-4857-8000-869621744306" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_a39f3fc6-30e9-4677-aa40-e9dcbed6bdbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_9b7d0ee9-ef41-4765-8339-15a3cc882b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_2b59505d-fcf7-4857-8000-869621744306" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_9b7d0ee9-ef41-4765-8339-15a3cc882b28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_8e261f0d-0bf0-432c-aa88-ac5c1271daa6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_2b59505d-fcf7-4857-8000-869621744306" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_8e261f0d-0bf0-432c-aa88-ac5c1271daa6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_ae752961-f328-41d8-b4bc-069573e795d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_8e261f0d-0bf0-432c-aa88-ac5c1271daa6" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_ae752961-f328-41d8-b4bc-069573e795d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ae752961-f328-41d8-b4bc-069573e795d3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_ae752961-f328-41d8-b4bc-069573e795d3" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ae752961-f328-41d8-b4bc-069573e795d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_89dfea59-b971-467e-bf88-0df395c08ac5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_ae752961-f328-41d8-b4bc-069573e795d3" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_89dfea59-b971-467e-bf88-0df395c08ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_457a9edd-4a54-429e-9bcc-796f7b6e4764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_89dfea59-b971-467e-bf88-0df395c08ac5" xlink:to="loc_us-gaap_CommercialRealEstateMember_457a9edd-4a54-429e-9bcc-796f7b6e4764" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended" id="i2895266a71e041a1a103c0efae7bf1b7_InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_6a9b4a02-1ce2-43f7-8f17-dbf02a1cb74c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_99e9ef93-7fa2-4ce3-b45a-d9ac8131afa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6a9b4a02-1ce2-43f7-8f17-dbf02a1cb74c" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_99e9ef93-7fa2-4ce3-b45a-d9ac8131afa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_db50781b-8658-4ecb-886f-a428b8deefa7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6a9b4a02-1ce2-43f7-8f17-dbf02a1cb74c" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_db50781b-8658-4ecb-886f-a428b8deefa7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0cfea529-39b1-43cc-bb43-7c0ebac16419" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_db50781b-8658-4ecb-886f-a428b8deefa7" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0cfea529-39b1-43cc-bb43-7c0ebac16419" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_0cfea529-39b1-43cc-bb43-7c0ebac16419_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0cfea529-39b1-43cc-bb43-7c0ebac16419" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_0cfea529-39b1-43cc-bb43-7c0ebac16419_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ac88d892-3fa1-4eff-8998-23d1d4f70754" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0cfea529-39b1-43cc-bb43-7c0ebac16419" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ac88d892-3fa1-4eff-8998-23d1d4f70754" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_e7f5d05b-624c-43b5-80e4-883fe67e0c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ac88d892-3fa1-4eff-8998-23d1d4f70754" xlink:to="loc_us-gaap_CommercialRealEstateMember_e7f5d05b-624c-43b5-80e4-883fe67e0c1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis_c4b51d80-cf07-4247-abaa-b0331ae8f242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_db50781b-8658-4ecb-886f-a428b8deefa7" xlink:to="loc_us-gaap_InternalCreditAssessmentAxis_c4b51d80-cf07-4247-abaa-b0331ae8f242" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_c4b51d80-cf07-4247-abaa-b0331ae8f242_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_c4b51d80-cf07-4247-abaa-b0331ae8f242" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_c4b51d80-cf07-4247-abaa-b0331ae8f242_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_d3393f6b-ea54-416c-9b42-78bf7685579a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_c4b51d80-cf07-4247-abaa-b0331ae8f242" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_d3393f6b-ea54-416c-9b42-78bf7685579a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_f7f5b681-1687-4f70-ad67-67350aa7c618" xlink:href="cvs-20201231.xsd#cvs_Category1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_d3393f6b-ea54-416c-9b42-78bf7685579a" xlink:to="loc_cvs_Category1Member_f7f5b681-1687-4f70-ad67-67350aa7c618" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_5f4a3e39-71eb-4f3b-81c0-631881318cd4" xlink:href="cvs-20201231.xsd#cvs_Category2To4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_d3393f6b-ea54-416c-9b42-78bf7685579a" xlink:to="loc_cvs_Category2To4Member_5f4a3e39-71eb-4f3b-81c0-631881318cd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_81e593e0-a9fa-4fbb-821e-b5c18d118d08" xlink:href="cvs-20201231.xsd#cvs_Categories5and6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_d3393f6b-ea54-416c-9b42-78bf7685579a" xlink:to="loc_cvs_Categories5and6Member_81e593e0-a9fa-4fbb-821e-b5c18d118d08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_875bba4d-84f3-450e-a75e-027c52093b8a" xlink:href="cvs-20201231.xsd#cvs_Category7Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_d3393f6b-ea54-416c-9b42-78bf7685579a" xlink:to="loc_cvs_Category7Member_875bba4d-84f3-450e-a75e-027c52093b8a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_4cb262e4-df94-4049-84f5-b87810f8cca9" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_db50781b-8658-4ecb-886f-a428b8deefa7" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_4cb262e4-df94-4049-84f5-b87810f8cca9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_4cb262e4-df94-4049-84f5-b87810f8cca9_default" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_4cb262e4-df94-4049-84f5-b87810f8cca9" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_4cb262e4-df94-4049-84f5-b87810f8cca9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_4cb262e4-df94-4049-84f5-b87810f8cca9" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_9bb4149f-8f5f-401f-a9ff-8271d466b5ed" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_9bb4149f-8f5f-401f-a9ff-8271d466b5ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_4b565b1b-5b11-43e6-ae8d-a3d4202809e9" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_4b565b1b-5b11-43e6-ae8d-a3d4202809e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_c1e1f78b-b0d4-4c76-b7aa-4d04b1788c5f" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_c1e1f78b-b0d4-4c76-b7aa-4d04b1788c5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_a8e0b286-80a4-4ac1-a73b-a1fa2515c87a" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_a8e0b286-80a4-4ac1-a73b-a1fa2515c87a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_9b600ea3-9184-4bd8-a5f9-6b94c80de1ed" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_9b600ea3-9184-4bd8-a5f9-6b94c80de1ed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_102aee6e-e93a-404a-b1da-6f4923be3e00" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_102aee6e-e93a-404a-b1da-6f4923be3e00" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" xlink:type="extended" id="i1b5b6bfa8c174f718f62776845448c08_InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_17eef06c-44d3-4264-9d1f-d94f4c37827d" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_17eef06c-44d3-4264-9d1f-d94f4c37827d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_950a8e2e-c17c-470c-a384-4e70d1794623" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_950a8e2e-c17c-470c-a384-4e70d1794623" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_7558ccd8-ce5a-4e48-b6be-29cf77febe97" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_7558ccd8-ce5a-4e48-b6be-29cf77febe97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_7795c278-61d1-44d8-a738-10b4b689703e" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_7795c278-61d1-44d8-a738-10b4b689703e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_1be88a72-c0e1-499f-a25b-83236f31d6cd" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_1be88a72-c0e1-499f-a25b-83236f31d6cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_4b1dddfc-3d16-4340-908a-893cec68224a" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_4b1dddfc-3d16-4340-908a-893cec68224a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_9ce828d1-a824-4239-85f1-382342c228a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_9ce828d1-a824-4239-85f1-382342c228a4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_90994d14-24dc-466d-a2a7-0afd5db7c5c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_90994d14-24dc-466d-a2a7-0afd5db7c5c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f9d549c4-1e68-45f6-858e-a4a6f4fd2ff0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_90994d14-24dc-466d-a2a7-0afd5db7c5c7" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f9d549c4-1e68-45f6-858e-a4a6f4fd2ff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_f9d549c4-1e68-45f6-858e-a4a6f4fd2ff0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f9d549c4-1e68-45f6-858e-a4a6f4fd2ff0" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_f9d549c4-1e68-45f6-858e-a4a6f4fd2ff0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_66390562-e2f8-46b3-9c3a-26fab0b1679a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f9d549c4-1e68-45f6-858e-a4a6f4fd2ff0" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_66390562-e2f8-46b3-9c3a-26fab0b1679a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_f564a70a-b9ee-4f0b-874e-90cdb2fe73dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_66390562-e2f8-46b3-9c3a-26fab0b1679a" xlink:to="loc_us-gaap_CommercialRealEstateMember_f564a70a-b9ee-4f0b-874e-90cdb2fe73dd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended" id="i1b3f0566e9904661ae052f9dc2726b00_InvestmentsNetInvestmentIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_13daa889-c3f4-466c-a46c-9508c32204df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_13daa889-c3f4-466c-a46c-9508c32204df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_941e7739-77c5-482e-a9fb-c00c180fc405" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_941e7739-77c5-482e-a9fb-c00c180fc405" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_67a1618c-e33f-4ccc-881d-9907a6248f76" xlink:href="cvs-20201231.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_67a1618c-e33f-4ccc-881d-9907a6248f76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_41363bd3-e8f2-4991-9a1f-a0c7a156d0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_41363bd3-e8f2-4991-9a1f-a0c7a156d0f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_d425ec95-2bfd-46cc-bcf5-becb77f3559b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_us-gaap_InvestmentIncomeNet_d425ec95-2bfd-46cc-bcf5-becb77f3559b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_70513a56-5421-4122-87b9-f1217d487358" xlink:href="cvs-20201231.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_70513a56-5421-4122-87b9-f1217d487358" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_06aa2aa0-87cb-45ef-90ea-6a98712a2aca" xlink:href="cvs-20201231.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_06aa2aa0-87cb-45ef-90ea-6a98712a2aca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_b1b2bc00-fbb2-453c-889a-d4dc6385a899" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_b1b2bc00-fbb2-453c-889a-d4dc6385a899" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_55aa2043-55f1-4ace-b325-6fdc623eef1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_55aa2043-55f1-4ace-b325-6fdc623eef1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_309b6483-a208-44d6-a831-cd1c7e01f570" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_55aa2043-55f1-4ace-b325-6fdc623eef1d" xlink:to="loc_us-gaap_InvestmentTypeAxis_309b6483-a208-44d6-a831-cd1c7e01f570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_309b6483-a208-44d6-a831-cd1c7e01f570_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_309b6483-a208-44d6-a831-cd1c7e01f570" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_309b6483-a208-44d6-a831-cd1c7e01f570_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_44389894-6bf0-4a89-9ad2-38c973861da2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_309b6483-a208-44d6-a831-cd1c7e01f570" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_44389894-6bf0-4a89-9ad2-38c973861da2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_815e4a54-6f3e-4128-a2fa-e501af2d23f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_44389894-6bf0-4a89-9ad2-38c973861da2" xlink:to="loc_us-gaap_DebtSecuritiesMember_815e4a54-6f3e-4128-a2fa-e501af2d23f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_b2f9ba26-55d8-49c2-97f8-3cd10e809790" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_44389894-6bf0-4a89-9ad2-38c973861da2" xlink:to="loc_cvs_MortgageLoansMember_b2f9ba26-55d8-49c2-97f8-3cd10e809790" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_b63394e6-ae7d-49d2-81fd-fad7e80a2f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_44389894-6bf0-4a89-9ad2-38c973861da2" xlink:to="loc_us-gaap_OtherInvestmentsMember_b63394e6-ae7d-49d2-81fd-fad7e80a2f24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_531ee65b-a5d3-4dca-825d-d2345e75e989" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_55aa2043-55f1-4ace-b325-6fdc623eef1d" xlink:to="loc_srt_ProductOrServiceAxis_531ee65b-a5d3-4dca-825d-d2345e75e989" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_531ee65b-a5d3-4dca-825d-d2345e75e989_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_531ee65b-a5d3-4dca-825d-d2345e75e989" xlink:to="loc_srt_ProductsAndServicesDomain_531ee65b-a5d3-4dca-825d-d2345e75e989_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ef79b953-74e4-482e-a90b-92bbf4a29e25" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_531ee65b-a5d3-4dca-825d-d2345e75e989" xlink:to="loc_srt_ProductsAndServicesDomain_ef79b953-74e4-482e-a90b-92bbf4a29e25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_5201642b-6731-45cf-8142-b4bc295ce61e" xlink:href="cvs-20201231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ef79b953-74e4-482e-a90b-92bbf4a29e25" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_5201642b-6731-45cf-8142-b4bc295ce61e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsRealizedGainsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="extended" id="id5735dd79e254b11b60162669dab9ce2_InvestmentsRealizedGainsDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValue" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValue"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValue" xlink:type="extended" id="idaf5317bab0e4b708643b1dcd9708693_FairValue"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueTables" xlink:type="extended" id="i15e8393152744feb8d13268ee4b93f39_FairValueTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="extended" id="i3397a6eb493a41e88b3dff9ba988df83_FairValueFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e1aeb8cb-80a3-4cef-9604-ee3678d0945a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_9754fe75-9b50-43c7-a11d-3ac6a2a1c00d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e1aeb8cb-80a3-4cef-9604-ee3678d0945a" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_9754fe75-9b50-43c7-a11d-3ac6a2a1c00d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a5745251-913e-4f4d-a28e-06a5a05d1cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9754fe75-9b50-43c7-a11d-3ac6a2a1c00d" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a5745251-913e-4f4d-a28e-06a5a05d1cd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0eb55037-4bbb-4c57-81ca-417477ae1cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9754fe75-9b50-43c7-a11d-3ac6a2a1c00d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0eb55037-4bbb-4c57-81ca-417477ae1cea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3343c547-90c7-43c6-9715-7a3f86abe163" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9754fe75-9b50-43c7-a11d-3ac6a2a1c00d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3343c547-90c7-43c6-9715-7a3f86abe163" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_56e372b4-d342-41b3-9964-9eafab06588c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9754fe75-9b50-43c7-a11d-3ac6a2a1c00d" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_56e372b4-d342-41b3-9964-9eafab06588c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6c1b4ca5-65eb-4b2c-acb1-9945e22ed8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e1aeb8cb-80a3-4cef-9604-ee3678d0945a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6c1b4ca5-65eb-4b2c-acb1-9945e22ed8a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25bee5ef-403a-4a22-a7bb-981d0d1b488a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6c1b4ca5-65eb-4b2c-acb1-9945e22ed8a5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25bee5ef-403a-4a22-a7bb-981d0d1b488a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_25bee5ef-403a-4a22-a7bb-981d0d1b488a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25bee5ef-403a-4a22-a7bb-981d0d1b488a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_25bee5ef-403a-4a22-a7bb-981d0d1b488a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_06f7af41-88f3-487d-8e0d-9de295fcbcf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25bee5ef-403a-4a22-a7bb-981d0d1b488a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_06f7af41-88f3-487d-8e0d-9de295fcbcf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_746d42b4-aa4a-4274-bc63-790c95ebde83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_06f7af41-88f3-487d-8e0d-9de295fcbcf3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_746d42b4-aa4a-4274-bc63-790c95ebde83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_acdf43b6-5686-4ebe-91ec-ac4253f2c534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6c1b4ca5-65eb-4b2c-acb1-9945e22ed8a5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_acdf43b6-5686-4ebe-91ec-ac4253f2c534" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_acdf43b6-5686-4ebe-91ec-ac4253f2c534_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_acdf43b6-5686-4ebe-91ec-ac4253f2c534" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_acdf43b6-5686-4ebe-91ec-ac4253f2c534_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_acdf43b6-5686-4ebe-91ec-ac4253f2c534" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_8282b083-f700-461a-916a-6242b8928288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_8282b083-f700-461a-916a-6242b8928288" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_85c81ec1-2d28-4aa7-9415-8fbfc7fc41af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_85c81ec1-2d28-4aa7-9415-8fbfc7fc41af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_49cc27e2-29a6-4e5e-b8d9-9601a01671ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_49cc27e2-29a6-4e5e-b8d9-9601a01671ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_d5769b94-c68c-499c-8373-995726e9341a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_d5769b94-c68c-499c-8373-995726e9341a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_b1967c2b-f341-4023-bf47-9ec7b253878d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_b1967c2b-f341-4023-bf47-9ec7b253878d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_57e9262d-6d27-4e11-b029-d8193ce37851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_57e9262d-6d27-4e11-b029-d8193ce37851" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_d9a5a385-bd78-41bc-8031-20d1f872abf2" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_d9a5a385-bd78-41bc-8031-20d1f872abf2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_156c3b2a-488c-49ad-83ca-95514c6df37a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_156c3b2a-488c-49ad-83ca-95514c6df37a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b08968a2-dcf7-4c08-b683-5ffec96050fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6c1b4ca5-65eb-4b2c-acb1-9945e22ed8a5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b08968a2-dcf7-4c08-b683-5ffec96050fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b08968a2-dcf7-4c08-b683-5ffec96050fa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b08968a2-dcf7-4c08-b683-5ffec96050fa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b08968a2-dcf7-4c08-b683-5ffec96050fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e3b97d7c-8c43-41f3-88be-092d6f1ff102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b08968a2-dcf7-4c08-b683-5ffec96050fa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e3b97d7c-8c43-41f3-88be-092d6f1ff102" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8db88dbc-020e-449e-92b3-498994bac445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e3b97d7c-8c43-41f3-88be-092d6f1ff102" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8db88dbc-020e-449e-92b3-498994bac445" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5fd26ddc-f33b-4503-b7b2-5a558393e01b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e3b97d7c-8c43-41f3-88be-092d6f1ff102" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5fd26ddc-f33b-4503-b7b2-5a558393e01b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_afa9da23-6e2b-448b-997e-2923e5ef8c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e3b97d7c-8c43-41f3-88be-092d6f1ff102" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_afa9da23-6e2b-448b-997e-2923e5ef8c20" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueChangesinLevel3FinancialAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="extended" id="i47f7e50aab06410998a2ca7f9b379202_FairValueChangesinLevel3FinancialAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340d7138-1137-41d3-8222-93f91b5d1bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340d7138-1137-41d3-8222-93f91b5d1bfd" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1f33dda2-6128-42af-baa6-352e133d907f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1f33dda2-6128-42af-baa6-352e133d907f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9553a842-d912-4813-95ed-45674391fbf9" xlink:href="cvs-20201231.xsd#cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9553a842-d912-4813-95ed-45674391fbf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_246d6e41-d65a-4073-b906-15f785e8bec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9553a842-d912-4813-95ed-45674391fbf9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_246d6e41-d65a-4073-b906-15f785e8bec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ebbfa114-712d-4d81-98e1-56229400faad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9553a842-d912-4813-95ed-45674391fbf9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ebbfa114-712d-4d81-98e1-56229400faad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_859828af-fd94-4d7d-889c-21e0d1ae91a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_859828af-fd94-4d7d-889c-21e0d1ae91a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_8a52af5f-4a68-4eee-ac04-df6211dffe4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_8a52af5f-4a68-4eee-ac04-df6211dffe4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_d50d7f36-7c1d-4a41-b3b4-53d804fbcc51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_d50d7f36-7c1d-4a41-b3b4-53d804fbcc51" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_4e19397b-eab2-48e8-9e1e-7bee8a551440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_4e19397b-eab2-48e8-9e1e-7bee8a551440" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_3a66f94d-62eb-4960-990d-d3efa8ad14ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_9772944a-3def-4a17-8aec-84c6c64fb60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340d7138-1137-41d3-8222-93f91b5d1bfd" xlink:to="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_9772944a-3def-4a17-8aec-84c6c64fb60c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6725d418-e92f-4c65-94ab-7986380a64d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340d7138-1137-41d3-8222-93f91b5d1bfd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6725d418-e92f-4c65-94ab-7986380a64d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_fc3184fb-86c7-4153-9d1e-b57363db1c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6725d418-e92f-4c65-94ab-7986380a64d7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_fc3184fb-86c7-4153-9d1e-b57363db1c62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fc3184fb-86c7-4153-9d1e-b57363db1c62_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fc3184fb-86c7-4153-9d1e-b57363db1c62" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fc3184fb-86c7-4153-9d1e-b57363db1c62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fc3184fb-86c7-4153-9d1e-b57363db1c62" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_720d15e4-1afe-4c7f-a8e1-9b92ef9544ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_720d15e4-1afe-4c7f-a8e1-9b92ef9544ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_50a4da1e-1b2c-45d5-8144-44a1974d1e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_50a4da1e-1b2c-45d5-8144-44a1974d1e8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_f443df82-6f31-4109-8fcf-ebce809e2b20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_f443df82-6f31-4109-8fcf-ebce809e2b20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_6fedc77b-05d1-478c-8760-596cfb10f004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:to="loc_us-gaap_EquitySecuritiesMember_6fedc77b-05d1-478c-8760-596cfb10f004" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_826f5a8c-69f3-496e-ad72-a5323ab2ac7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_826f5a8c-69f3-496e-ad72-a5323ab2ac7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7c2cb892-5507-44ae-a9af-dfcfadd9fca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6725d418-e92f-4c65-94ab-7986380a64d7" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7c2cb892-5507-44ae-a9af-dfcfadd9fca1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7c2cb892-5507-44ae-a9af-dfcfadd9fca1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7c2cb892-5507-44ae-a9af-dfcfadd9fca1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7c2cb892-5507-44ae-a9af-dfcfadd9fca1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f7955f2e-09f2-4a39-b399-b628faa44f95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7c2cb892-5507-44ae-a9af-dfcfadd9fca1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f7955f2e-09f2-4a39-b399-b628faa44f95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_121c5b90-d46f-4e2e-a261-a7ac5e30ab48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f7955f2e-09f2-4a39-b399-b628faa44f95" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_121c5b90-d46f-4e2e-a261-a7ac5e30ab48" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueGrossTransfersIntoOutOfLevel3Details"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="extended" id="i845c651aefc345649817c7f512673a90_FairValueGrossTransfersIntoOutOfLevel3Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8cb322df-c2e4-41f6-9889-8afbcab1bee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_140824b6-1ecf-47e4-aa10-7619c5855ab6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8cb322df-c2e4-41f6-9889-8afbcab1bee0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_140824b6-1ecf-47e4-aa10-7619c5855ab6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_5f1b0f9c-b946-4a9f-98ee-b602c69c7f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8cb322df-c2e4-41f6-9889-8afbcab1bee0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_5f1b0f9c-b946-4a9f-98ee-b602c69c7f59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_dd6ed2a2-dd3b-4544-bd3d-56b1de555dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8cb322df-c2e4-41f6-9889-8afbcab1bee0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_dd6ed2a2-dd3b-4544-bd3d-56b1de555dfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86e6f6e1-3096-4dfb-a1db-881b646ba02a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8cb322df-c2e4-41f6-9889-8afbcab1bee0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86e6f6e1-3096-4dfb-a1db-881b646ba02a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f9385490-37df-4022-a111-f79737da6ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86e6f6e1-3096-4dfb-a1db-881b646ba02a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f9385490-37df-4022-a111-f79737da6ca5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f9385490-37df-4022-a111-f79737da6ca5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f9385490-37df-4022-a111-f79737da6ca5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f9385490-37df-4022-a111-f79737da6ca5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_53e48176-c922-4cbc-a91c-12bb9d66c0da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f9385490-37df-4022-a111-f79737da6ca5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_53e48176-c922-4cbc-a91c-12bb9d66c0da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5c78a8dc-4c02-476d-bb53-038f6e2a468f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_53e48176-c922-4cbc-a91c-12bb9d66c0da" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5c78a8dc-4c02-476d-bb53-038f6e2a468f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_131fa6be-8759-485b-bae4-dddc5c6fab69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86e6f6e1-3096-4dfb-a1db-881b646ba02a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_131fa6be-8759-485b-bae4-dddc5c6fab69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_131fa6be-8759-485b-bae4-dddc5c6fab69_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_131fa6be-8759-485b-bae4-dddc5c6fab69" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_131fa6be-8759-485b-bae4-dddc5c6fab69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fa3471b-6601-4fe5-aab7-e81363e73ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_131fa6be-8759-485b-bae4-dddc5c6fab69" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fa3471b-6601-4fe5-aab7-e81363e73ac6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ee3e3b78-5f30-48f2-a17b-15b1a7d92cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fa3471b-6601-4fe5-aab7-e81363e73ac6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ee3e3b78-5f30-48f2-a17b-15b1a7d92cc4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended" id="ied54afc1280b477e9ccef1e928befa34_FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30e5443c-092a-4d09-98c8-f3a26bb3d539" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_38c7e6d2-6c80-4bad-ae52-dc6e0b4bec4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30e5443c-092a-4d09-98c8-f3a26bb3d539" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_38c7e6d2-6c80-4bad-ae52-dc6e0b4bec4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_bb7e33f6-dffd-49d8-9d6c-cd913f8dd738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_38c7e6d2-6c80-4bad-ae52-dc6e0b4bec4d" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_bb7e33f6-dffd-49d8-9d6c-cd913f8dd738" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_fa264ace-3130-430d-8871-83a1c7277bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_38c7e6d2-6c80-4bad-ae52-dc6e0b4bec4d" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_fa264ace-3130-430d-8871-83a1c7277bcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_f956b775-8c61-4c14-bcfb-7f14ab03430f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30e5443c-092a-4d09-98c8-f3a26bb3d539" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_f956b775-8c61-4c14-bcfb-7f14ab03430f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_c56a70aa-5ca5-4cc3-8e78-8cf807912353" xlink:href="cvs-20201231.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_f956b775-8c61-4c14-bcfb-7f14ab03430f" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_c56a70aa-5ca5-4cc3-8e78-8cf807912353" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_509e6a47-db58-45f0-bf98-671c058c2d20" xlink:href="cvs-20201231.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_f956b775-8c61-4c14-bcfb-7f14ab03430f" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_509e6a47-db58-45f0-bf98-671c058c2d20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_7573135f-6f63-44f3-a47e-4c40e45d403f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_f956b775-8c61-4c14-bcfb-7f14ab03430f" xlink:to="loc_us-gaap_DebtInstrumentFairValue_7573135f-6f63-44f3-a47e-4c40e45d403f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_680cae35-c629-4291-b79c-9bafafee12a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30e5443c-092a-4d09-98c8-f3a26bb3d539" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_680cae35-c629-4291-b79c-9bafafee12a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_385bf894-7db7-4bb6-8f05-777bdf99b9cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_680cae35-c629-4291-b79c-9bafafee12a3" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_385bf894-7db7-4bb6-8f05-777bdf99b9cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_385bf894-7db7-4bb6-8f05-777bdf99b9cb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_385bf894-7db7-4bb6-8f05-777bdf99b9cb" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_385bf894-7db7-4bb6-8f05-777bdf99b9cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_c46897c6-21b2-46fb-a386-e034bf6b9113" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_385bf894-7db7-4bb6-8f05-777bdf99b9cb" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_c46897c6-21b2-46fb-a386-e034bf6b9113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1d42b0b1-7528-48c6-b595-1b6c226f189b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_c46897c6-21b2-46fb-a386-e034bf6b9113" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1d42b0b1-7528-48c6-b595-1b6c226f189b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_70ff0984-a389-4db7-a660-3e4a33120b68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1d42b0b1-7528-48c6-b595-1b6c226f189b" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_70ff0984-a389-4db7-a660-3e4a33120b68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_34316835-9d21-48ba-8061-bbae7be18aba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1d42b0b1-7528-48c6-b595-1b6c226f189b" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_34316835-9d21-48ba-8061-bbae7be18aba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136d38c9-29c0-4f35-b0b5-5dd888ad82c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_680cae35-c629-4291-b79c-9bafafee12a3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136d38c9-29c0-4f35-b0b5-5dd888ad82c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_136d38c9-29c0-4f35-b0b5-5dd888ad82c5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136d38c9-29c0-4f35-b0b5-5dd888ad82c5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_136d38c9-29c0-4f35-b0b5-5dd888ad82c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1798ed6d-796a-4feb-a68e-2ac2c0d74c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136d38c9-29c0-4f35-b0b5-5dd888ad82c5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1798ed6d-796a-4feb-a68e-2ac2c0d74c86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_336ced11-5edf-46fc-90f6-05817c1cf768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1798ed6d-796a-4feb-a68e-2ac2c0d74c86" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_336ced11-5edf-46fc-90f6-05817c1cf768" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72c73953-dc30-455f-b929-4f6327d3d389" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_680cae35-c629-4291-b79c-9bafafee12a3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72c73953-dc30-455f-b929-4f6327d3d389" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72c73953-dc30-455f-b929-4f6327d3d389_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72c73953-dc30-455f-b929-4f6327d3d389" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_72c73953-dc30-455f-b929-4f6327d3d389_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad09f32d-0a15-4b3c-a515-c1f2ddc80b6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72c73953-dc30-455f-b929-4f6327d3d389" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad09f32d-0a15-4b3c-a515-c1f2ddc80b6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3db24d08-7bf3-49b5-97dd-59fe47a6d53a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad09f32d-0a15-4b3c-a515-c1f2ddc80b6a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3db24d08-7bf3-49b5-97dd-59fe47a6d53a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_49677ab7-55c7-44a4-a52e-c1fd777c684d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad09f32d-0a15-4b3c-a515-c1f2ddc80b6a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_49677ab7-55c7-44a4-a52e-c1fd777c684d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3b7d53a2-81a9-4e04-8dd8-e9ca7139e060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad09f32d-0a15-4b3c-a515-c1f2ddc80b6a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3b7d53a2-81a9-4e04-8dd8-e9ca7139e060" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended" id="i3c165cae22f84c7b9e7c2dad57430e13_FairValueSeparateAccountsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9608b969-cb81-422b-b165-5d274bc83e05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_1fc56c78-7422-431d-a49b-3239ab9489c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9608b969-cb81-422b-b165-5d274bc83e05" xlink:to="loc_us-gaap_SeparateAccountAssets_1fc56c78-7422-431d-a49b-3239ab9489c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_227c1379-2252-47d1-b3c5-350da56d0f53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9608b969-cb81-422b-b165-5d274bc83e05" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_227c1379-2252-47d1-b3c5-350da56d0f53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9608b969-cb81-422b-b165-5d274bc83e05" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e0d811a5-1f75-4d8b-8815-1982700c8861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e0d811a5-1f75-4d8b-8815-1982700c8861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e0d811a5-1f75-4d8b-8815-1982700c8861_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e0d811a5-1f75-4d8b-8815-1982700c8861" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e0d811a5-1f75-4d8b-8815-1982700c8861_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_209d2fa3-d6ab-4aa2-b2af-69e4dd1f0806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e0d811a5-1f75-4d8b-8815-1982700c8861" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_209d2fa3-d6ab-4aa2-b2af-69e4dd1f0806" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_62d54a7b-bb63-4c79-92ec-3a1d2d8a876e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_209d2fa3-d6ab-4aa2-b2af-69e4dd1f0806" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_62d54a7b-bb63-4c79-92ec-3a1d2d8a876e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7b55cf5a-f1c0-4386-8849-9a5cdee16585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7b55cf5a-f1c0-4386-8849-9a5cdee16585" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7b55cf5a-f1c0-4386-8849-9a5cdee16585_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7b55cf5a-f1c0-4386-8849-9a5cdee16585" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7b55cf5a-f1c0-4386-8849-9a5cdee16585_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bcb5873a-2ebe-40e7-9108-e2394f4e511a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7b55cf5a-f1c0-4386-8849-9a5cdee16585" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bcb5873a-2ebe-40e7-9108-e2394f4e511a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ebab0975-9218-49bf-90f3-4f4942a02e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bcb5873a-2ebe-40e7-9108-e2394f4e511a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ebab0975-9218-49bf-90f3-4f4942a02e3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d37adfd2-a854-4d30-94ab-04ef3ab3b5b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bcb5873a-2ebe-40e7-9108-e2394f4e511a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d37adfd2-a854-4d30-94ab-04ef3ab3b5b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a5aa8431-99d7-463e-a88d-c94fb1a0e4c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bcb5873a-2ebe-40e7-9108-e2394f4e511a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a5aa8431-99d7-463e-a88d-c94fb1a0e4c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_666a794e-97e2-4f29-a408-298412c32f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_666a794e-97e2-4f29-a408-298412c32f31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_666a794e-97e2-4f29-a408-298412c32f31_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_666a794e-97e2-4f29-a408-298412c32f31" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_666a794e-97e2-4f29-a408-298412c32f31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_666a794e-97e2-4f29-a408-298412c32f31" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_e1fae1c7-d590-426d-99f1-de2af19ffa65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_e1fae1c7-d590-426d-99f1-de2af19ffa65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_f1fd4caa-80be-4e0a-825a-1327b7102f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:to="loc_us-gaap_DebtSecuritiesMember_f1fd4caa-80be-4e0a-825a-1327b7102f09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_9a7fd509-772a-4311-b897-863f30246b0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:to="loc_us-gaap_EquitySecuritiesMember_9a7fd509-772a-4311-b897-863f30246b0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_1b524ca6-2645-4b4f-b109-38127669d5aa" xlink:href="cvs-20201231.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_1b524ca6-2645-4b4f-b109-38127669d5aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountFinancialAssetsMember_9087a8b3-4c08-4847-b437-384d5b3888da" xlink:href="cvs-20201231.xsd#cvs_SeparateAccountFinancialAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:to="loc_cvs_SeparateAccountFinancialAssetsMember_9087a8b3-4c08-4847-b437-384d5b3888da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9d920820-cfa8-4a67-a6c8-c930721bf770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9d920820-cfa8-4a67-a6c8-c930721bf770" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9d920820-cfa8-4a67-a6c8-c930721bf770_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9d920820-cfa8-4a67-a6c8-c930721bf770" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9d920820-cfa8-4a67-a6c8-c930721bf770_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_18d2f513-76d1-45bd-8525-01d4a16bfd10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9d920820-cfa8-4a67-a6c8-c930721bf770" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_18d2f513-76d1-45bd-8525-01d4a16bfd10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_75da932c-7249-471c-8396-4f5124b4b477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_18d2f513-76d1-45bd-8525-01d4a16bfd10" xlink:to="loc_us-gaap_AccountsReceivableMember_75da932c-7249-471c-8396-4f5124b4b477" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueOffsettingFinancialLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueOffsettingFinancialLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueOffsettingFinancialLiabilitiesDetails" xlink:type="extended" id="icf3d52eca62940ec9cc3044220768641_FairValueOffsettingFinancialLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended" id="ia5ebba6c32cf47838651d565eb0d2944_GoodwillandOtherIntangibleAssets"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangiblesTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables" xlink:type="extended" id="i74b4233e1d3446a79859f94bb29536c9_GoodwillandOtherIntangiblesTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangiblesGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="extended" id="i8abee9d9cc0445fabac7209be6eaab2f_GoodwillandOtherIntangiblesGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_28442db1-2dd0-4ba0-97d1-c6fd02c229cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_28442db1-2dd0-4ba0-97d1-c6fd02c229cb" xlink:to="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8f849676-4268-4fad-8846-a32ccc4155a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_Goodwill_8f849676-4268-4fad-8846-a32ccc4155a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_c12136b0-09bf-450f-97e5-fc4bf98a7a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_GoodwillTransfers_c12136b0-09bf-450f-97e5-fc4bf98a7a62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_52f37609-734b-4cb5-b53d-5cf7dd60e61a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_52f37609-734b-4cb5-b53d-5cf7dd60e61a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_4baa93d2-4749-4e87-9311-45f464f9b98b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_4baa93d2-4749-4e87-9311-45f464f9b98b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_5e96a393-ebd9-4c51-91df-1142675ffe4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_5e96a393-ebd9-4c51-91df-1142675ffe4b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_a82cefb8-aca0-45d4-ba57-f5460338a141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_a82cefb8-aca0-45d4-ba57-f5460338a141" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9090be42-424c-4046-b684-5d476eafe4c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_de052ff9-1cad-4db2-a5b8-1a8e5bdabb9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_28442db1-2dd0-4ba0-97d1-c6fd02c229cb" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_de052ff9-1cad-4db2-a5b8-1a8e5bdabb9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_19a3d7c7-e02c-449a-893e-c3ecee098f88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_de052ff9-1cad-4db2-a5b8-1a8e5bdabb9d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_19a3d7c7-e02c-449a-893e-c3ecee098f88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_19a3d7c7-e02c-449a-893e-c3ecee098f88_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_19a3d7c7-e02c-449a-893e-c3ecee098f88" xlink:to="loc_us-gaap_SegmentDomain_19a3d7c7-e02c-449a-893e-c3ecee098f88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a6fae981-2b07-41f6-aabb-54c9ee9f3b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_19a3d7c7-e02c-449a-893e-c3ecee098f88" xlink:to="loc_us-gaap_SegmentDomain_a6fae981-2b07-41f6-aabb-54c9ee9f3b84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_2a9f8379-7fc5-41de-9bb7-4c411eb75597" xlink:href="cvs-20201231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a6fae981-2b07-41f6-aabb-54c9ee9f3b84" xlink:to="loc_cvs_PharmacyServicesSegmentMember_2a9f8379-7fc5-41de-9bb7-4c411eb75597" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_07dead9d-1870-4111-b11f-6e6f8987c037" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a6fae981-2b07-41f6-aabb-54c9ee9f3b84" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_07dead9d-1870-4111-b11f-6e6f8987c037" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_b5892489-a3ad-4083-b6b0-7cb2835e8f03" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a6fae981-2b07-41f6-aabb-54c9ee9f3b84" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_b5892489-a3ad-4083-b6b0-7cb2835e8f03" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangiblesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="extended" id="i67aded681c434a5eb51bba88976256de_GoodwillandOtherIntangiblesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_3d585135-37c6-46e8-986d-c556492e02f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_18db4998-de81-448b-883a-d59707d04d24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d585135-37c6-46e8-986d-c556492e02f0" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_18db4998-de81-448b-883a-d59707d04d24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8a9ee82d-4244-4f0b-9094-8219cefeb61d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d585135-37c6-46e8-986d-c556492e02f0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8a9ee82d-4244-4f0b-9094-8219cefeb61d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_98a3c63e-fafb-4aa8-b4f3-ecccdef361d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3d585135-37c6-46e8-986d-c556492e02f0" xlink:to="loc_us-gaap_Goodwill_98a3c63e-fafb-4aa8-b4f3-ecccdef361d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_3d585135-37c6-46e8-986d-c556492e02f0" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_17d2ed19-790a-43f6-8b2d-387067b947d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_17d2ed19-790a-43f6-8b2d-387067b947d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_17d2ed19-790a-43f6-8b2d-387067b947d5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_17d2ed19-790a-43f6-8b2d-387067b947d5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_17d2ed19-790a-43f6-8b2d-387067b947d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c5ff1cb5-bf32-43e3-b72d-2000abec01d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_17d2ed19-790a-43f6-8b2d-387067b947d5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c5ff1cb5-bf32-43e3-b72d-2000abec01d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_b89955c5-fa7f-4f46-895e-232b20d4b7f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c5ff1cb5-bf32-43e3-b72d-2000abec01d6" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_b89955c5-fa7f-4f46-895e-232b20d4b7f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9b360bcf-ac69-42b4-921d-0b6cf5bc2673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9b360bcf-ac69-42b4-921d-0b6cf5bc2673" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9b360bcf-ac69-42b4-921d-0b6cf5bc2673_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9b360bcf-ac69-42b4-921d-0b6cf5bc2673" xlink:to="loc_us-gaap_SegmentDomain_9b360bcf-ac69-42b4-921d-0b6cf5bc2673_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_03d62520-3d35-41ac-a644-e8ee4d74c51d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9b360bcf-ac69-42b4-921d-0b6cf5bc2673" xlink:to="loc_us-gaap_SegmentDomain_03d62520-3d35-41ac-a644-e8ee4d74c51d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_e816c7c2-6f4f-4342-900e-180da322bfc5" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_03d62520-3d35-41ac-a644-e8ee4d74c51d" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_e816c7c2-6f4f-4342-900e-180da322bfc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_b228d35a-ff7a-4d10-b31f-67762ab4772a" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_03d62520-3d35-41ac-a644-e8ee4d74c51d" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_b228d35a-ff7a-4d10-b31f-67762ab4772a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_e0099eea-46b7-440f-af50-abe0cf4625bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:to="loc_us-gaap_ReportingUnitAxis_e0099eea-46b7-440f-af50-abe0cf4625bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_e0099eea-46b7-440f-af50-abe0cf4625bc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_e0099eea-46b7-440f-af50-abe0cf4625bc" xlink:to="loc_us-gaap_ReportingUnitDomain_e0099eea-46b7-440f-af50-abe0cf4625bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_63eb3ccc-bfc6-4146-b034-6be228b4b3a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_e0099eea-46b7-440f-af50-abe0cf4625bc" xlink:to="loc_us-gaap_ReportingUnitDomain_63eb3ccc-bfc6-4146-b034-6be228b4b3a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember_41a8b7fe-7dd2-46eb-9eaf-39641c629aab" xlink:href="cvs-20201231.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_63eb3ccc-bfc6-4146-b034-6be228b4b3a2" xlink:to="loc_cvs_LongTermCareReportingUnitMember_41a8b7fe-7dd2-46eb-9eaf-39641c629aab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d6128305-86d8-4e37-b705-7c10882ed1da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d6128305-86d8-4e37-b705-7c10882ed1da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6128305-86d8-4e37-b705-7c10882ed1da_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d6128305-86d8-4e37-b705-7c10882ed1da" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d6128305-86d8-4e37-b705-7c10882ed1da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_977a3610-2dc0-4032-8ac7-f54918cca5c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d6128305-86d8-4e37-b705-7c10882ed1da" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_977a3610-2dc0-4032-8ac7-f54918cca5c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_5abc32de-ce5d-4ea6-bfcc-757bec9804e4" xlink:href="cvs-20201231.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_977a3610-2dc0-4032-8ac7-f54918cca5c2" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_5abc32de-ce5d-4ea6-bfcc-757bec9804e4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangiblesIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="extended" id="ib73be29a359446a3b9e8d3d782c85494_GoodwillandOtherIntangiblesIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:href="cvs-20201231.xsd#cvs_OtherAcquiredIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ac9e2a18-f1bd-4538-9e71-427bd273e9b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ac9e2a18-f1bd-4538-9e71-427bd273e9b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_35ef123e-9dd9-4682-92ec-3ded26523466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_35ef123e-9dd9-4682-92ec-3ded26523466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0d9eafab-9138-4f4e-87cb-1bce4354ea77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0d9eafab-9138-4f4e-87cb-1bce4354ea77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d58c4735-0a83-4e58-964a-7c3d3d7b295b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d58c4735-0a83-4e58-964a-7c3d3d7b295b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e993223a-ded6-4275-a51a-a4c68500d1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e993223a-ded6-4275-a51a-a4c68500d1c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ba624a18-6c7d-48d5-975d-afaeef20b926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ba624a18-6c7d-48d5-975d-afaeef20b926" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_ce2387cc-3943-4a97-a9d1-99cea6470587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_ce2387cc-3943-4a97-a9d1-99cea6470587" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_abbd17af-37f8-465a-ab08-ec0db21aa4e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_abbd17af-37f8-465a-ab08-ec0db21aa4e5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsTable_ceaebe20-c59a-48af-9485-6ba095e59f5f" xlink:href="cvs-20201231.xsd#cvs_OtherAcquiredIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_cvs_OtherAcquiredIntangibleAssetsTable_ceaebe20-c59a-48af-9485-6ba095e59f5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fed4b0c0-d57a-4064-935e-57837e56538c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_ceaebe20-c59a-48af-9485-6ba095e59f5f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fed4b0c0-d57a-4064-935e-57837e56538c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fed4b0c0-d57a-4064-935e-57837e56538c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fed4b0c0-d57a-4064-935e-57837e56538c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fed4b0c0-d57a-4064-935e-57837e56538c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fed4b0c0-d57a-4064-935e-57837e56538c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_c2cc9af8-e1ae-4fff-8062-c76bd490160e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_c2cc9af8-e1ae-4fff-8062-c76bd490160e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_3978d752-f640-4a77-a406-8083592c9b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_3978d752-f640-4a77-a406-8083592c9b6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProviderNetworksMember_de1e1516-6b79-4998-8d45-02961efb808f" xlink:href="cvs-20201231.xsd#cvs_ProviderNetworksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:to="loc_cvs_ProviderNetworksMember_de1e1516-6b79-4998-8d45-02961efb808f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ValueOfBusinessAcquiredMember_015a6b8d-778b-4cdd-b149-993ac173cf85" xlink:href="cvs-20201231.xsd#cvs_ValueOfBusinessAcquiredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:to="loc_cvs_ValueOfBusinessAcquiredMember_015a6b8d-778b-4cdd-b149-993ac173cf85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AboveMarketLeasesMember_5e8abe5b-cea5-4add-ac84-bc7f2c698578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AboveMarketLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:to="loc_us-gaap_AboveMarketLeasesMember_5e8abe5b-cea5-4add-ac84-bc7f2c698578" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" xlink:type="extended" id="i8b80316b29c848f6b7579f96f4fb0b07_GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Leases" xlink:type="simple" xlink:href="cvs-20201231.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/Leases" xlink:type="extended" id="i9d1dc779605244b498422634c0513183_Leases"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/LeasesTables" xlink:type="extended" id="i4dc1081708b44930ac2145bfb618d984_LeasesTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i875c95ab884840f79c97a0b14a709a51_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeOperatingAndFinanceLeasesTermOfContract_fbf5cbcf-4b0a-4aec-bd92-d12393181909" xlink:href="cvs-20201231.xsd#cvs_LesseeOperatingAndFinanceLeasesTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:to="loc_cvs_LesseeOperatingAndFinanceLeasesTermOfContract_fbf5cbcf-4b0a-4aec-bd92-d12393181909" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_9f5cb9cb-6a24-4ee6-9d87-c39cc59f5b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:to="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_9f5cb9cb-6a24-4ee6-9d87-c39cc59f5b0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_ecbd578d-4f60-47f9-b633-6472caedbd62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_ecbd578d-4f60-47f9-b633-6472caedbd62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfUnderPerformingStoresPlannedClosure_3633b3e3-67d8-42d4-b20f-77826cc39273" xlink:href="cvs-20201231.xsd#cvs_NumberOfUnderPerformingStoresPlannedClosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:to="loc_cvs_NumberOfUnderPerformingStoresPlannedClosure_3633b3e3-67d8-42d4-b20f-77826cc39273" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreRationalizationCharges_55c184bf-6711-4b0c-8a92-17b8b9878f18" xlink:href="cvs-20201231.xsd#cvs_StoreRationalizationCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:to="loc_cvs_StoreRationalizationCharges_55c184bf-6711-4b0c-8a92-17b8b9878f18" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_efce7c8a-a816-4d21-a9a2-e52bc014d467" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_efce7c8a-a816-4d21-a9a2-e52bc014d467" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_14247930-b78c-4982-b473-70a002324913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_efce7c8a-a816-4d21-a9a2-e52bc014d467" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_14247930-b78c-4982-b473-70a002324913" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_14247930-b78c-4982-b473-70a002324913_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_14247930-b78c-4982-b473-70a002324913" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_14247930-b78c-4982-b473-70a002324913_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84da3553-8110-469f-8f6f-816ca1e7623d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_14247930-b78c-4982-b473-70a002324913" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84da3553-8110-469f-8f6f-816ca1e7623d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_511b37f2-ca5b-40b2-9476-147360751628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84da3553-8110-469f-8f6f-816ca1e7623d" xlink:to="loc_us-gaap_BuildingMember_511b37f2-ca5b-40b2-9476-147360751628" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_2ed3b357-3b49-4980-a586-b67eb60a0cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84da3553-8110-469f-8f6f-816ca1e7623d" xlink:to="loc_us-gaap_EquipmentMember_2ed3b357-3b49-4980-a586-b67eb60a0cee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e184493e-a7ab-4709-9ac6-de9c4866f81a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_efce7c8a-a816-4d21-a9a2-e52bc014d467" xlink:to="loc_srt_RangeAxis_e184493e-a7ab-4709-9ac6-de9c4866f81a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e184493e-a7ab-4709-9ac6-de9c4866f81a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e184493e-a7ab-4709-9ac6-de9c4866f81a" xlink:to="loc_srt_RangeMember_e184493e-a7ab-4709-9ac6-de9c4866f81a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_984388f4-ff23-46d3-a262-c05a064a3a7d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e184493e-a7ab-4709-9ac6-de9c4866f81a" xlink:to="loc_srt_RangeMember_984388f4-ff23-46d3-a262-c05a064a3a7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a108188d-c1d1-40b5-ac1a-2a47c254ab16" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_984388f4-ff23-46d3-a262-c05a064a3a7d" xlink:to="loc_srt_MinimumMember_a108188d-c1d1-40b5-ac1a-2a47c254ab16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_38341bc3-07c1-4eda-88a8-dc6c94b434e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_984388f4-ff23-46d3-a262-c05a064a3a7d" xlink:to="loc_srt_MaximumMember_38341bc3-07c1-4eda-88a8-dc6c94b434e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a36db6c7-ff4d-4a92-b3b4-537a098af268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_efce7c8a-a816-4d21-a9a2-e52bc014d467" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a36db6c7-ff4d-4a92-b3b4-537a098af268" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a36db6c7-ff4d-4a92-b3b4-537a098af268_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a36db6c7-ff4d-4a92-b3b4-537a098af268" xlink:to="loc_us-gaap_SegmentDomain_a36db6c7-ff4d-4a92-b3b4-537a098af268_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3549b935-f602-461d-9990-b33261ca32c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a36db6c7-ff4d-4a92-b3b4-537a098af268" xlink:to="loc_us-gaap_SegmentDomain_3549b935-f602-461d-9990-b33261ca32c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_01ce1a4b-f681-4e3e-a56a-4dcb08be804c" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3549b935-f602-461d-9990-b33261ca32c1" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_01ce1a4b-f681-4e3e-a56a-4dcb08be804c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesSummaryoftheComponentsofNetLeaseCostDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="extended" id="i35b6e90543ea48ba994fa8fd46470e68_LeasesSummaryoftheComponentsofNetLeaseCostDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended" id="idb02d54ca0294c869db63b72e72f532c_LeasesSupplementalCashFlowInformationDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="i1bd0489233934ad6839435ce2229bc72_LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="extended" id="i433f07a6355647aaa77c2ce101606c3d_LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesRentalExpenseDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesRentalExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/LeasesRentalExpenseDetails" xlink:type="extended" id="i7c49f1e752b14c7ca7d81452b3676738_LeasesRentalExpenseDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayable"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="extended" id="iec949a9d3bf3481e96de2333cead6de3_HealthCareCostsPayable"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="extended" id="ie06435873f2e439ea61256090dbfef4b_HealthCareCostsPayableTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="extended" id="ifa3ab2b32f4b4db397b80d61656d17f9_HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_a699c941-69bc-41fa-bcf5-e2f52207609e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_137a7faf-96e6-4857-8d2b-007a736f84e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_a699c941-69bc-41fa-bcf5-e2f52207609e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_137a7faf-96e6-4857-8d2b-007a736f84e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_e3924f36-1f14-41f2-8e6c-b06244f3f4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_a699c941-69bc-41fa-bcf5-e2f52207609e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_e3924f36-1f14-41f2-8e6c-b06244f3f4a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_eddb6f28-5938-4c85-bc6b-b5c728b26c7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_a699c941-69bc-41fa-bcf5-e2f52207609e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_eddb6f28-5938-4c85-bc6b-b5c728b26c7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_172addf7-883b-4487-89ba-d2c84281aeff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_a699c941-69bc-41fa-bcf5-e2f52207609e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_172addf7-883b-4487-89ba-d2c84281aeff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_4cb7057f-7d26-493b-a8fa-841234138bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_a699c941-69bc-41fa-bcf5-e2f52207609e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_4cb7057f-7d26-493b-a8fa-841234138bb1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_555392ba-c7e1-46c3-948d-bf04f90fc73a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_4cb7057f-7d26-493b-a8fa-841234138bb1" xlink:to="loc_srt_ProductOrServiceAxis_555392ba-c7e1-46c3-948d-bf04f90fc73a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_555392ba-c7e1-46c3-948d-bf04f90fc73a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_555392ba-c7e1-46c3-948d-bf04f90fc73a" xlink:to="loc_srt_ProductsAndServicesDomain_555392ba-c7e1-46c3-948d-bf04f90fc73a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fc4b8c43-742f-4bc6-92b0-da1aff65ed44" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_555392ba-c7e1-46c3-948d-bf04f90fc73a" xlink:to="loc_srt_ProductsAndServicesDomain_fc4b8c43-742f-4bc6-92b0-da1aff65ed44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_46fdc338-fdf0-4430-9405-9252ae61e1d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_fc4b8c43-742f-4bc6-92b0-da1aff65ed44" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_46fdc338-fdf0-4430-9405-9252ae61e1d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f9d7d24b-8376-4128-a5e3-a2428adb50c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_4cb7057f-7d26-493b-a8fa-841234138bb1" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f9d7d24b-8376-4128-a5e3-a2428adb50c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f9d7d24b-8376-4128-a5e3-a2428adb50c2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f9d7d24b-8376-4128-a5e3-a2428adb50c2" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f9d7d24b-8376-4128-a5e3-a2428adb50c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f8694f38-d5e6-45ac-b87c-d4298dee60f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f9d7d24b-8376-4128-a5e3-a2428adb50c2" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f8694f38-d5e6-45ac-b87c-d4298dee60f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_a047c783-47ec-4f32-87e3-4a5f459d6f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f8694f38-d5e6-45ac-b87c-d4298dee60f7" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_a047c783-47ec-4f32-87e3-4a5f459d6f6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_6ff2d03f-a5cb-46e1-b339-aff6722395b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f8694f38-d5e6-45ac-b87c-d4298dee60f7" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_6ff2d03f-a5cb-46e1-b339-aff6722395b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended" id="ic5d90cba1da248bfbf6d503ad0025b0a_HealthCareCostsPayableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4eba0457-6ab4-4cc0-97b5-d32432e5a2ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_38709e37-efcf-4ccb-8d60-4addacb35b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4eba0457-6ab4-4cc0-97b5-d32432e5a2ff" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_38709e37-efcf-4ccb-8d60-4addacb35b2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_cafe711b-2eb5-4dd0-8bdc-51b6ba7b0226" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4eba0457-6ab4-4cc0-97b5-d32432e5a2ff" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_cafe711b-2eb5-4dd0-8bdc-51b6ba7b0226" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_183c449b-6507-470a-bac0-c5f68f671832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4eba0457-6ab4-4cc0-97b5-d32432e5a2ff" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_183c449b-6507-470a-bac0-c5f68f671832" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b067917c-3de5-4ed2-968e-8ef654b065b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_183c449b-6507-470a-bac0-c5f68f671832" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b067917c-3de5-4ed2-968e-8ef654b065b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b067917c-3de5-4ed2-968e-8ef654b065b6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b067917c-3de5-4ed2-968e-8ef654b065b6" xlink:to="loc_us-gaap_SegmentDomain_b067917c-3de5-4ed2-968e-8ef654b065b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bc1bd11c-6bfd-43a5-bc00-fe8ab9bea2d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b067917c-3de5-4ed2-968e-8ef654b065b6" xlink:to="loc_us-gaap_SegmentDomain_bc1bd11c-6bfd-43a5-bc00-fe8ab9bea2d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_e1e74217-0fff-4947-8ccd-25834e051d23" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bc1bd11c-6bfd-43a5-bc00-fe8ab9bea2d3" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_e1e74217-0fff-4947-8ccd-25834e051d23" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" xlink:type="extended" id="iaca7ca9cd5c048e9a709f597071fc116_HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_24d707df-7486-4d66-b140-dabc933944c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_24d707df-7486-4d66-b140-dabc933944c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1fe9ec03-5517-462a-a9b9-fde6e0a1e431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1fe9ec03-5517-462a-a9b9-fde6e0a1e431" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_7a13a3d5-83c7-475a-bdff-ea40c60d4d00" xlink:href="cvs-20201231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_7a13a3d5-83c7-475a-bdff-ea40c60d4d00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_eb3ba479-cd78-4ce5-8380-24d270fc6c05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_eb3ba479-cd78-4ce5-8380-24d270fc6c05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_433d552c-eaff-4c16-8a0a-e25584016962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_433d552c-eaff-4c16-8a0a-e25584016962" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_bb8fa63a-d9b0-4d85-b0f7-1d45e13820a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_bb8fa63a-d9b0-4d85-b0f7-1d45e13820a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_83ca7bb7-ba59-4dcf-8855-7922e970a00c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_bb8fa63a-d9b0-4d85-b0f7-1d45e13820a6" xlink:to="loc_srt_ProductOrServiceAxis_83ca7bb7-ba59-4dcf-8855-7922e970a00c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_83ca7bb7-ba59-4dcf-8855-7922e970a00c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_83ca7bb7-ba59-4dcf-8855-7922e970a00c" xlink:to="loc_srt_ProductsAndServicesDomain_83ca7bb7-ba59-4dcf-8855-7922e970a00c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b7d6ff1c-7056-4f04-a86e-397c15f772ba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_83ca7bb7-ba59-4dcf-8855-7922e970a00c" xlink:to="loc_srt_ProductsAndServicesDomain_b7d6ff1c-7056-4f04-a86e-397c15f772ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_f6390a22-db05-43b6-aba4-e96bbe2e8092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b7d6ff1c-7056-4f04-a86e-397c15f772ba" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_f6390a22-db05-43b6-aba4-e96bbe2e8092" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" xlink:type="extended" id="ie71a8e00aa294a7b99832937730cd3f1_HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_54d50c02-b895-4fec-8fdb-cd573acd235d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_54d50c02-b895-4fec-8fdb-cd573acd235d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_32247a70-1e58-483f-9067-ffc2ce51e38d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_32247a70-1e58-483f-9067-ffc2ce51e38d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ff5a3cb4-1fc4-4bfa-b409-dd2f98aa327a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ff5a3cb4-1fc4-4bfa-b409-dd2f98aa327a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_9d49a619-072a-4887-812c-478874cbf07f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_9d49a619-072a-4887-812c-478874cbf07f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_fbfefdc3-b4e7-408d-80fd-4bef504c95e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_fbfefdc3-b4e7-408d-80fd-4bef504c95e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification_34f6874e-fbc9-4142-a2c5-56183844f952" xlink:href="cvs-20201231.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification_34f6874e-fbc9-4142-a2c5-56183844f952" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_70d51287-70cd-4084-9ea1-c2abafb62fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_70d51287-70cd-4084-9ea1-c2abafb62fc5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_5b521707-9565-4c31-a51d-c1c6275594b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_70d51287-70cd-4084-9ea1-c2abafb62fc5" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_5b521707-9565-4c31-a51d-c1c6275594b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_90672ae8-ee3f-4015-ab0e-56e4518f8dcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_70d51287-70cd-4084-9ea1-c2abafb62fc5" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_90672ae8-ee3f-4015-ab0e-56e4518f8dcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_4a0bc506-4a3f-47b6-86c6-0b0404403684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_70d51287-70cd-4084-9ea1-c2abafb62fc5" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_4a0bc506-4a3f-47b6-86c6-0b0404403684" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_e294f43c-649e-49de-b174-7e43d14cc510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_e294f43c-649e-49de-b174-7e43d14cc510" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_465d39c3-5023-4292-87a9-f850eafff3b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_e294f43c-649e-49de-b174-7e43d14cc510" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_465d39c3-5023-4292-87a9-f850eafff3b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d726ad5b-481d-404d-a1b6-73e1a35109ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_e294f43c-649e-49de-b174-7e43d14cc510" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d726ad5b-481d-404d-a1b6-73e1a35109ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f0a334ee-1b96-4cbe-acc2-fa098bc62334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_e294f43c-649e-49de-b174-7e43d14cc510" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f0a334ee-1b96-4cbe-acc2-fa098bc62334" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_67c9987d-876a-41de-ac68-c7dc8ea4cf60" xlink:href="cvs-20201231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_67c9987d-876a-41de-ac68-c7dc8ea4cf60" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_8a5a5c8c-72be-4c5e-aff1-cc917609c83c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_a8933022-7931-479e-bf8a-0888d1a8da10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1de7a762-595a-4b7b-a3b4-add7c82d285a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_a6e626d1-fed7-4226-9164-e7d4b4cd4eee" xlink:href="cvs-20201231.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_54d50c02-b895-4fec-8fdb-cd573acd235d" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_a6e626d1-fed7-4226-9164-e7d4b4cd4eee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5f2e7a6f-9620-44b7-9a73-60e52b2e5dcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_54d50c02-b895-4fec-8fdb-cd573acd235d" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5f2e7a6f-9620-44b7-9a73-60e52b2e5dcc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_81196050-52ce-4131-ac4c-a420f0a92359" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5f2e7a6f-9620-44b7-9a73-60e52b2e5dcc" xlink:to="loc_srt_ProductOrServiceAxis_81196050-52ce-4131-ac4c-a420f0a92359" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_81196050-52ce-4131-ac4c-a420f0a92359_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_81196050-52ce-4131-ac4c-a420f0a92359" xlink:to="loc_srt_ProductsAndServicesDomain_81196050-52ce-4131-ac4c-a420f0a92359_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_39549858-4462-4af5-a65c-d6e713caa929" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_81196050-52ce-4131-ac4c-a420f0a92359" xlink:to="loc_srt_ProductsAndServicesDomain_39549858-4462-4af5-a65c-d6e713caa929" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_b2e0ffcf-305f-4248-aa7a-1e3f6eed6d7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_39549858-4462-4af5-a65c-d6e713caa929" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_b2e0ffcf-305f-4248-aa7a-1e3f6eed6d7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_564a0371-7063-4e1e-a2e1-ffd5b847157e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5f2e7a6f-9620-44b7-9a73-60e52b2e5dcc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_564a0371-7063-4e1e-a2e1-ffd5b847157e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_564a0371-7063-4e1e-a2e1-ffd5b847157e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_564a0371-7063-4e1e-a2e1-ffd5b847157e" xlink:to="loc_us-gaap_SegmentDomain_564a0371-7063-4e1e-a2e1-ffd5b847157e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b0d36f1c-6fbf-4bff-8e16-1e52ef1c7dfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_564a0371-7063-4e1e-a2e1-ffd5b847157e" xlink:to="loc_us-gaap_SegmentDomain_b0d36f1c-6fbf-4bff-8e16-1e52ef1c7dfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_0b88ef5b-fa2b-4f9d-9a24-49356e3c6f29" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b0d36f1c-6fbf-4bff-8e16-1e52ef1c7dfb" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_0b88ef5b-fa2b-4f9d-9a24-49356e3c6f29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_7f132b23-518c-4f81-b33e-67f80d4d0f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b0d36f1c-6fbf-4bff-8e16-1e52ef1c7dfb" xlink:to="loc_us-gaap_CorporateAndOtherMember_7f132b23-518c-4f81-b33e-67f80d4d0f84" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangements"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangements" xlink:type="extended" id="ida32bf1dc1ad4eed84bcd52c3bdd1952_BorrowingsandCreditArrangements"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended" id="ic80ffcc075c84fefa0929adb01529592_BorrowingsandCreditArrangementsTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails" xlink:type="extended" id="i31e7310f87ab46c1aaa034134528ebab_BorrowingsandCreditArrangementsScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d3f9cc42-acb3-45c5-b561-766e0be9fdd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d3f9cc42-acb3-45c5-b561-766e0be9fdd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_a6d0b359-2ba0-43d5-b752-860c9689b1be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_DebtInstrumentTerm_a6d0b359-2ba0-43d5-b752-860c9689b1be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e5d8cae7-1d74-4784-82f7-1472e2f781e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e5d8cae7-1d74-4784-82f7-1472e2f781e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b231ddfe-4cd1-4bd7-8ac6-fc9766e7ea55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_FinanceLeaseLiability_b231ddfe-4cd1-4bd7-8ac6-fc9766e7ea55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_578f031d-89b3-4565-8586-c94e0d33dc81" xlink:href="cvs-20201231.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_578f031d-89b3-4565-8586-c94e0d33dc81" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_fb174783-fcc7-49a5-bf86-de138769a8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_fb174783-fcc7-49a5-bf86-de138769a8c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_5a985762-5972-447c-9c1b-ba6682594d1b" xlink:href="cvs-20201231.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_5a985762-5972-447c-9c1b-ba6682594d1b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_b58d4bee-d2bc-4c58-a3bf-f7eeffbecaaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_b58d4bee-d2bc-4c58-a3bf-f7eeffbecaaf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9a261c52-b732-4772-ba3f-df597b68deec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9a261c52-b732-4772-ba3f-df597b68deec" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8ce13cde-70dd-4462-a67a-555861655231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8ce13cde-70dd-4462-a67a-555861655231" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2d05f0aa-4623-49df-9470-fb381708964c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_DebtInstrumentTable_2d05f0aa-4623-49df-9470-fb381708964c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7c8c7e5e-1f98-41a0-9deb-5e0dbdeb3c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2d05f0aa-4623-49df-9470-fb381708964c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7c8c7e5e-1f98-41a0-9deb-5e0dbdeb3c8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7c8c7e5e-1f98-41a0-9deb-5e0dbdeb3c8c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7c8c7e5e-1f98-41a0-9deb-5e0dbdeb3c8c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7c8c7e5e-1f98-41a0-9deb-5e0dbdeb3c8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e4fab533-09ee-4e84-ad80-84d3823fc7a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7c8c7e5e-1f98-41a0-9deb-5e0dbdeb3c8c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e4fab533-09ee-4e84-ad80-84d3823fc7a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7b7fcd3a-42d3-494a-b4f7-ef56d34fa083" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e4fab533-09ee-4e84-ad80-84d3823fc7a5" xlink:to="loc_us-gaap_SeniorNotesMember_7b7fcd3a-42d3-494a-b4f7-ef56d34fa083" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_01ab6bda-673f-41c4-9e8f-dd7f0e7d68e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e4fab533-09ee-4e84-ad80-84d3823fc7a5" xlink:to="loc_us-gaap_NotesPayableToBanksMember_01ab6bda-673f-41c4-9e8f-dd7f0e7d68e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_c36e1d06-9ea4-4a6a-943c-3f2649271175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e4fab533-09ee-4e84-ad80-84d3823fc7a5" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_c36e1d06-9ea4-4a6a-943c-3f2649271175" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2ba503e4-2cb7-4b2c-b06e-348e510a58f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2d05f0aa-4623-49df-9470-fb381708964c" xlink:to="loc_us-gaap_DebtInstrumentAxis_2ba503e4-2cb7-4b2c-b06e-348e510a58f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2ba503e4-2cb7-4b2c-b06e-348e510a58f8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2ba503e4-2cb7-4b2c-b06e-348e510a58f8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2ba503e4-2cb7-4b2c-b06e-348e510a58f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2ba503e4-2cb7-4b2c-b06e-348e510a58f8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member_bc126b0f-39c5-4be5-86d8-1695e94f9d56" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.125DueMarch2020Member_bc126b0f-39c5-4be5-86d8-1695e94f9d56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member_2369a957-6e99-484b-a6f6-297237fb1f6c" xlink:href="cvs-20201231.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_FloatingRateNotesDueMarch2020Member_2369a957-6e99-484b-a6f6-297237fb1f6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJuly2020Member_cc9b6cb2-498f-460c-a575-64fc2c1632f7" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.8DueJuly2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.8DueJuly2020Member_cc9b6cb2-498f-460c-a575-64fc2c1632f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_0a4e48de-8310-48d6-8972-4ef3d09a3e9a" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_0a4e48de-8310-48d6-8972-4ef3d09a3e9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2021Member_ced28175-2184-4c8c-85e7-a3d2e35e368b" xlink:href="cvs-20201231.xsd#cvs_FloatingRateNotesDueMarch2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_FloatingRateNotesDueMarch2021Member_ced28175-2184-4c8c-85e7-a3d2e35e368b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_0bbad6ac-0300-4fc8-bc1b-cc25eb2176bb" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_0bbad6ac-0300-4fc8-bc1b-cc25eb2176bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.125June2021Member_b4cf013b-07b9-4f59-83bb-6e031e2e8a3d" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.125June2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.125June2021Member_b4cf013b-07b9-4f59-83bb-6e031e2e8a3d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_cb7b4235-48de-400e-ab33-f66ef83f9538" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_cb7b4235-48de-400e-ab33-f66ef83f9538" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_b95576c9-fd09-4a14-b108-98645aebaa60" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_b95576c9-fd09-4a14-b108-98645aebaa60" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_b1557ab3-7d52-46d2-a531-6345c8d76a20" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_b1557ab3-7d52-46d2-a531-6345c8d76a20" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_3ddd5334-7ea9-44be-abee-20479d0fde0a" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_3ddd5334-7ea9-44be-abee-20479d0fde0a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_b2d835e0-2c84-4d47-aadb-3940fd7a896e" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_b2d835e0-2c84-4d47-aadb-3940fd7a896e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_a8c1bbf6-ab64-4a03-b76a-9e560ad06056" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_a8c1bbf6-ab64-4a03-b76a-9e560ad06056" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_040f2c69-873f-4543-bb3b-16d7560e0a84" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_040f2c69-873f-4543-bb3b-16d7560e0a84" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_77fdb6b8-b1a4-44f3-8313-5c73e98024d6" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_77fdb6b8-b1a4-44f3-8313-5c73e98024d6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_19562611-4323-44a6-8ef8-386ee57a1144" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_19562611-4323-44a6-8ef8-386ee57a1144" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_88290a84-4cc4-4560-bc3d-caeaff27219e" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_88290a84-4cc4-4560-bc3d-caeaff27219e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_e9d693f0-c210-4a86-aa07-ed70c10e78e0" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_e9d693f0-c210-4a86-aa07-ed70c10e78e0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_21a3ca0e-be6e-439d-8862-79f809d7bf08" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_21a3ca0e-be6e-439d-8862-79f809d7bf08" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_1dd3815f-87c9-4e4e-a322-a57da8db0536" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_1dd3815f-87c9-4e4e-a322-a57da8db0536" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_cb46a097-3eb7-497c-826a-b8fa5159f7b7" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_cb46a097-3eb7-497c-826a-b8fa5159f7b7" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_bee46cd8-55b3-452d-b360-b6bc375b8b17" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_bee46cd8-55b3-452d-b360-b6bc375b8b17" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_ac9d44c6-98bd-43d8-9516-1ae81bd4d714" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_ac9d44c6-98bd-43d8-9516-1ae81bd4d714" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_4ec588c9-783e-44d1-8096-9c192c957d94" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_4ec588c9-783e-44d1-8096-9c192c957d94" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point625PercentApril2027Member_89ac2c60-9649-4d9c-8913-7a7602d64a66" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3Point625PercentApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3Point625PercentApril2027Member_89ac2c60-9649-4d9c-8913-7a7602d64a66" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_748d5397-27b6-4251-8867-b0ccb5459a39" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_748d5397-27b6-4251-8867-b0ccb5459a39" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point3PercentAugust2027Member_6130a6b2-9d1b-43a2-a93c-cf141350c594" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes1Point3PercentAugust2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes1Point3PercentAugust2027Member_6130a6b2-9d1b-43a2-a93c-cf141350c594" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_6c72c0f6-7582-4c76-9ebe-938992922e47" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_6c72c0f6-7582-4c76-9ebe-938992922e47" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_0b8e92ad-98f1-446e-80a8-dfb8da8042e5" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_0b8e92ad-98f1-446e-80a8-dfb8da8042e5" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point75PercentApril2030Member_ee3ecd3d-4367-497d-856f-49f6f1cc6515" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3Point75PercentApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3Point75PercentApril2030Member_ee3ecd3d-4367-497d-856f-49f6f1cc6515" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point75PercentAugust2030Member_d8bed8bc-1f98-4369-ae1f-522a9399f82d" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes1Point75PercentAugust2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes1Point75PercentAugust2030Member_d8bed8bc-1f98-4369-ae1f-522a9399f82d" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member_62774d5d-fda4-4891-ad99-7be5e8a665d6" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes1Point875PercentFebruary2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member_62774d5d-fda4-4891-ad99-7be5e8a665d6" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_d3b418ab-1dd4-4ca5-9872-8c0d1152c68b" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_d3b418ab-1dd4-4ca5-9872-8c0d1152c68b" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_57c32de6-96e9-419a-be3d-b0fc4e61d586" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_57c32de6-96e9-419a-be3d-b0fc4e61d586" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_6b44d7e8-8708-4f52-a2f6-5ee626c61358" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_6b44d7e8-8708-4f52-a2f6-5ee626c61358" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_3cd8f37c-fbf7-4d1e-96a3-1bee1da8d4e7" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_3cd8f37c-fbf7-4d1e-96a3-1bee1da8d4e7" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_22b36d3e-c49c-4274-b1ff-3ea865b9eb0c" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_22b36d3e-c49c-4274-b1ff-3ea865b9eb0c" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point125PercentApril2040Member_05d19ac9-35b4-4695-b439-c37202170175" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4Point125PercentApril2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4Point125PercentApril2040Member_05d19ac9-35b4-4695-b439-c37202170175" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point7PercentAugust2040Member_6edc3a0a-e382-41ea-bdf1-eefbe8604386" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2Point7PercentAugust2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2Point7PercentAugust2040Member_6edc3a0a-e382-41ea-bdf1-eefbe8604386" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_15649e4b-a3e7-4e50-bd2d-952f3d65080f" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_15649e4b-a3e7-4e50-bd2d-952f3d65080f" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_21fcb20c-8d81-416f-88eb-23cf3febab87" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_21fcb20c-8d81-416f-88eb-23cf3febab87" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_01341c02-5017-4e2a-84dc-6758a5f1629e" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_01341c02-5017-4e2a-84dc-6758a5f1629e" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_99372241-69e4-4d6f-ad57-e25709912444" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_99372241-69e4-4d6f-ad57-e25709912444" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_57fb8b54-878b-4ada-803e-dea3382f36e6" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_57fb8b54-878b-4ada-803e-dea3382f36e6" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_6398eceb-7151-4686-b9f5-42d2f85b93fa" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_6398eceb-7151-4686-b9f5-42d2f85b93fa" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_f9dbe947-ec4b-4331-859a-f57fdadcaee4" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_f9dbe947-ec4b-4331-859a-f57fdadcaee4" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_0fd132c1-056d-43e9-88d3-171edaea388c" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_0fd132c1-056d-43e9-88d3-171edaea388c" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point25PercentApril2050Member_e7f61e76-72a9-4114-b1ff-7e5f717aca25" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4Point25PercentApril2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4Point25PercentApril2050Member_e7f61e76-72a9-4114-b1ff-7e5f717aca25" xlink:type="arc" order="47"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsDebtMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails" xlink:type="extended" id="i7348d31c099e4b55ab7772d7b9039512_BorrowingsandCreditArrangementsDebtMaturitiesDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsShorttermBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails" xlink:type="extended" id="i1c965fc6590a48698be4ff2ba761713f_BorrowingsandCreditArrangementsShorttermBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_821e8c21-432a-4f32-be4a-d47568f83541" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_ShortTermBorrowings_821e8c21-432a-4f32-be4a-d47568f83541" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ce195431-6e75-4dca-9572-22632b99c0c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ce195431-6e75-4dca-9572-22632b99c0c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e42b7e5b-8645-45b8-89eb-159f01583c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_DebtInstrumentTerm_e42b7e5b-8645-45b8-89eb-159f01583c57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c58baab1-b658-41b0-8b7c-4dcde68aa9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c58baab1-b658-41b0-8b7c-4dcde68aa9f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_75add392-cf40-4154-946b-b774871512ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_75add392-cf40-4154-946b-b774871512ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_83764566-1a04-4a29-8b9e-772b9013108b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_83764566-1a04-4a29-8b9e-772b9013108b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_51024c6f-ff50-482e-80b4-f6ff47f73155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_51024c6f-ff50-482e-80b4-f6ff47f73155" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_b6aa1d86-a108-4077-82ed-9f44a4db18a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_b6aa1d86-a108-4077-82ed-9f44a4db18a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_ca0c5ea5-e993-4875-83e5-d0d764ffa912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b6aa1d86-a108-4077-82ed-9f44a4db18a3" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_ca0c5ea5-e993-4875-83e5-d0d764ffa912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_ca0c5ea5-e993-4875-83e5-d0d764ffa912_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_ca0c5ea5-e993-4875-83e5-d0d764ffa912" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_ca0c5ea5-e993-4875-83e5-d0d764ffa912_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_8c5e3ff0-1bef-4f09-80a6-6db1863a3976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_ca0c5ea5-e993-4875-83e5-d0d764ffa912" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_8c5e3ff0-1bef-4f09-80a6-6db1863a3976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6239d5b8-494f-4fa2-a351-42a5fea5cef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_8c5e3ff0-1bef-4f09-80a6-6db1863a3976" xlink:to="loc_us-gaap_CommercialPaperMember_6239d5b8-494f-4fa2-a351-42a5fea5cef5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_c663892f-8c10-43b9-b1c1-ad24a349e98a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_8c5e3ff0-1bef-4f09-80a6-6db1863a3976" xlink:to="loc_us-gaap_LineOfCreditMember_c663892f-8c10-43b9-b1c1-ad24a349e98a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember_2182cbb5-422a-49aa-88ed-6fb298f14e05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_8c5e3ff0-1bef-4f09-80a6-6db1863a3976" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMember_2182cbb5-422a-49aa-88ed-6fb298f14e05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1d99972c-09a2-406d-ba01-219121f21687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b6aa1d86-a108-4077-82ed-9f44a4db18a3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1d99972c-09a2-406d-ba01-219121f21687" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1d99972c-09a2-406d-ba01-219121f21687_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1d99972c-09a2-406d-ba01-219121f21687" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1d99972c-09a2-406d-ba01-219121f21687_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a66113a6-d8c9-45d3-98bc-9be8cda2011c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1d99972c-09a2-406d-ba01-219121f21687" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a66113a6-d8c9-45d3-98bc-9be8cda2011c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_15e676c8-c2cd-4df9-b854-cab5b05d8c38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a66113a6-d8c9-45d3-98bc-9be8cda2011c" xlink:to="loc_us-gaap_NotesPayableToBanksMember_15e676c8-c2cd-4df9-b854-cab5b05d8c38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_af3e56ab-be5d-4db5-9e58-a8b74dea2f87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a66113a6-d8c9-45d3-98bc-9be8cda2011c" xlink:to="loc_us-gaap_SeniorNotesMember_af3e56ab-be5d-4db5-9e58-a8b74dea2f87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c6952dd7-f399-436f-b0d5-18324a5ab00b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b6aa1d86-a108-4077-82ed-9f44a4db18a3" xlink:to="loc_us-gaap_DebtInstrumentAxis_c6952dd7-f399-436f-b0d5-18324a5ab00b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c6952dd7-f399-436f-b0d5-18324a5ab00b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c6952dd7-f399-436f-b0d5-18324a5ab00b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c6952dd7-f399-436f-b0d5-18324a5ab00b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_36d0a6c9-4130-4720-997b-ab93001f8b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c6952dd7-f399-436f-b0d5-18324a5ab00b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_36d0a6c9-4130-4720-997b-ab93001f8b88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BackUpCreditFacilitiesMember_4c82c02e-21d7-4f4c-992f-7461f1c2b789" xlink:href="cvs-20201231.xsd#cvs_BackUpCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_36d0a6c9-4130-4720-997b-ab93001f8b88" xlink:to="loc_cvs_BackUpCreditFacilitiesMember_4c82c02e-21d7-4f4c-992f-7461f1c2b789" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay122021Member_5763a251-d47b-4cf3-bf66-e5036c3292f7" xlink:href="cvs-20201231.xsd#cvs_RevolvingCreditFacilityExpiringMay122021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_4c82c02e-21d7-4f4c-992f-7461f1c2b789" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay122021Member_5763a251-d47b-4cf3-bf66-e5036c3292f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay182022Member_ed1b498e-29bb-4a39-a0ed-67d4bdc6c420" xlink:href="cvs-20201231.xsd#cvs_RevolvingCreditFacilityExpiringMay182022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_4c82c02e-21d7-4f4c-992f-7461f1c2b789" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay182022Member_ed1b498e-29bb-4a39-a0ed-67d4bdc6c420" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay172023Member_5bf8f5f2-61dd-4b07-82c1-6be8b661aaad" xlink:href="cvs-20201231.xsd#cvs_RevolvingCreditFacilityExpiringMay172023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_4c82c02e-21d7-4f4c-992f-7461f1c2b789" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay172023Member_5bf8f5f2-61dd-4b07-82c1-6be8b661aaad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay162024Member_bcb9322c-82ac-4243-b4a1-e7baa8a327e1" xlink:href="cvs-20201231.xsd#cvs_RevolvingCreditFacilityExpiringMay162024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_4c82c02e-21d7-4f4c-992f-7461f1c2b789" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay162024Member_bcb9322c-82ac-4243-b4a1-e7baa8a327e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TwoThousandEighteenNotesMember_b2e312cd-525c-41bc-a045-48c67ce91dfe" xlink:href="cvs-20201231.xsd#cvs_TwoThousandEighteenNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_36d0a6c9-4130-4720-997b-ab93001f8b88" xlink:to="loc_cvs_TwoThousandEighteenNotesMember_b2e312cd-525c-41bc-a045-48c67ce91dfe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsLongTermBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails" xlink:type="extended" id="if7f56ba85fa1462b8de91f6f5c79cfa6_BorrowingsandCreditArrangementsLongTermBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8d99a18b-f822-4d3a-8469-92bb2c6412dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8d99a18b-f822-4d3a-8469-92bb2c6412dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_470470b0-340f-4965-a622-8f885a0889d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_470470b0-340f-4965-a622-8f885a0889d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_862e97de-c58b-41a4-a70b-45096746059a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_862e97de-c58b-41a4-a70b-45096746059a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_a8268e9b-41cc-4987-8cbe-fbe0e0d9bbc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_a8268e9b-41cc-4987-8cbe-fbe0e0d9bbc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_509385e4-6e7f-46c0-9bae-b6d9a023b5ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_509385e4-6e7f-46c0-9bae-b6d9a023b5ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_6ed38c02-8679-4ae5-b633-a3f8ad7afe9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_6ed38c02-8679-4ae5-b633-a3f8ad7afe9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_b937c154-9b1d-4517-a485-6fbc008448c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_b937c154-9b1d-4517-a485-6fbc008448c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_23d73e71-f8d8-49f8-8f80-af4c3cc3b625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_23d73e71-f8d8-49f8-8f80-af4c3cc3b625" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees_eaaf6ff1-1196-4b3d-8bf0-9b4b0ad60c47" xlink:href="cvs-20201231.xsd#cvs_DebtExtinguishmentFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_cvs_DebtExtinguishmentFees_eaaf6ff1-1196-4b3d-8bf0-9b4b0ad60c47" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_98e530fd-fe08-4170-9993-cc201f92271c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_98e530fd-fe08-4170-9993-cc201f92271c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_13640f44-7e8c-4ea9-a8aa-5a8dcb322289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_13640f44-7e8c-4ea9-a8aa-5a8dcb322289" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_57e8a52d-03b5-44be-ad99-db97cfe68e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_DebtInstrumentTerm_57e8a52d-03b5-44be-ad99-db97cfe68e06" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6a7433c0-8da8-477d-ab7f-3c352ba5d97a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_6a7433c0-8da8-477d-ab7f-3c352ba5d97a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_e1b8f38d-7fce-4451-a3d0-278384e44130" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_e1b8f38d-7fce-4451-a3d0-278384e44130" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bb9a68d4-5915-47a8-8c1e-0320b2667a14" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:to="loc_srt_RangeAxis_bb9a68d4-5915-47a8-8c1e-0320b2667a14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bb9a68d4-5915-47a8-8c1e-0320b2667a14_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bb9a68d4-5915-47a8-8c1e-0320b2667a14" xlink:to="loc_srt_RangeMember_bb9a68d4-5915-47a8-8c1e-0320b2667a14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_70d284fc-5652-4a09-bf11-bb657dc65165" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bb9a68d4-5915-47a8-8c1e-0320b2667a14" xlink:to="loc_srt_RangeMember_70d284fc-5652-4a09-bf11-bb657dc65165" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_47fb64e1-6d53-44ab-a997-a55ef6971600" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_70d284fc-5652-4a09-bf11-bb657dc65165" xlink:to="loc_srt_MinimumMember_47fb64e1-6d53-44ab-a997-a55ef6971600" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_01c9ae98-a6ad-4550-bbe6-189913427256" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_70d284fc-5652-4a09-bf11-bb657dc65165" xlink:to="loc_srt_MaximumMember_01c9ae98-a6ad-4550-bbe6-189913427256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3cff89a3-85ae-4ef4-8fbb-6c0275e48a43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3cff89a3-85ae-4ef4-8fbb-6c0275e48a43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3cff89a3-85ae-4ef4-8fbb-6c0275e48a43_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3cff89a3-85ae-4ef4-8fbb-6c0275e48a43" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3cff89a3-85ae-4ef4-8fbb-6c0275e48a43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c968cd66-c880-4ad0-aea5-e69ee5eec756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3cff89a3-85ae-4ef4-8fbb-6c0275e48a43" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c968cd66-c880-4ad0-aea5-e69ee5eec756" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc.Member_aaaea049-aeee-4bda-86ee-d2559b74903b" xlink:href="cvs-20201231.xsd#cvs_AetnaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c968cd66-c880-4ad0-aea5-e69ee5eec756" xlink:to="loc_cvs_AetnaInc.Member_aaaea049-aeee-4bda-86ee-d2559b74903b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c8f19703-e7b9-4630-ac79-27c8b6e3a6de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c8f19703-e7b9-4630-ac79-27c8b6e3a6de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c8f19703-e7b9-4630-ac79-27c8b6e3a6de_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c8f19703-e7b9-4630-ac79-27c8b6e3a6de" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c8f19703-e7b9-4630-ac79-27c8b6e3a6de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c5d87609-cbff-4d4d-af09-2616b0439fa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c8f19703-e7b9-4630-ac79-27c8b6e3a6de" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c5d87609-cbff-4d4d-af09-2616b0439fa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ed8f92c9-f1fc-45ed-96be-3812e046a7bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c5d87609-cbff-4d4d-af09-2616b0439fa5" xlink:to="loc_us-gaap_SeniorNotesMember_ed8f92c9-f1fc-45ed-96be-3812e046a7bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_1acbb81a-0271-42b2-9052-a047ad7236a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c5d87609-cbff-4d4d-af09-2616b0439fa5" xlink:to="loc_us-gaap_NotesPayableToBanksMember_1acbb81a-0271-42b2-9052-a047ad7236a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesMember_f6581470-0cbb-426e-ab3b-fcac8fb97548" xlink:href="cvs-20201231.xsd#cvs_FloatingRateNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c5d87609-cbff-4d4d-af09-2616b0439fa5" xlink:to="loc_cvs_FloatingRateNotesMember_f6581470-0cbb-426e-ab3b-fcac8fb97548" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4dbd4c0d-e88d-4bd8-92fb-280e7896de40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:to="loc_us-gaap_DebtInstrumentAxis_4dbd4c0d-e88d-4bd8-92fb-280e7896de40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4dbd4c0d-e88d-4bd8-92fb-280e7896de40_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4dbd4c0d-e88d-4bd8-92fb-280e7896de40" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4dbd4c0d-e88d-4bd8-92fb-280e7896de40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4dbd4c0d-e88d-4bd8-92fb-280e7896de40" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_4f9ed565-ff9a-452d-9135-672b848ddd62" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_4f9ed565-ff9a-452d-9135-672b848ddd62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member_be899ca8-7174-4151-9b45-a250789dda45" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes1875DueFebruary2031Member_be899ca8-7174-4151-9b45-a250789dda45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_3aecb70a-2d46-4cec-8d60-8b51bcfa3d4f" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_3aecb70a-2d46-4cec-8d60-8b51bcfa3d4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_745b94a4-d2e1-493a-88a2-b93a1eec01d8" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_745b94a4-d2e1-493a-88a2-b93a1eec01d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3625DueApril2027Member_fe4b4db4-940c-49fd-970d-ed1e8bb67fef" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3625DueApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes3625DueApril2027Member_fe4b4db4-940c-49fd-970d-ed1e8bb67fef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes375DueApril2030Member_6d13e643-3a7a-464d-873c-9c36f8c9e178" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes375DueApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes375DueApril2030Member_6d13e643-3a7a-464d-873c-9c36f8c9e178" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4125DueApril2040Member_bd69f149-b056-4825-9321-b03170eaeacd" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4125DueApril2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes4125DueApril2040Member_bd69f149-b056-4825-9321-b03170eaeacd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes425DueApril2050Member_8057baad-f0fc-4561-a449-c0a016260766" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes425DueApril2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes425DueApril2050Member_8057baad-f0fc-4561-a449-c0a016260766" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_769c38e6-4365-4795-8614-4fb12dde6e29" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_769c38e6-4365-4795-8614-4fb12dde6e29" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_a04e3f05-5bdc-402d-9713-672694986ec1" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_a04e3f05-5bdc-402d-9713-672694986ec1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_e57e7765-dc1d-4503-9650-776800010e4e" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_e57e7765-dc1d-4503-9650-776800010e4e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember_b61dab74-e105-49cd-a930-e4bd2fe86f32" xlink:href="cvs-20201231.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_OutstandingSeniorNotesMember_b61dab74-e105-49cd-a930-e4bd2fe86f32" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_928f45ff-4346-409e-a9c6-a9aea48ce831" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_928f45ff-4346-409e-a9c6-a9aea48ce831" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_9f0f5432-9500-4f7f-a861-bfd6bcfc8ae6" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_9f0f5432-9500-4f7f-a861-bfd6bcfc8ae6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_c542b143-d2f8-45f9-9d50-4c4e77c9972e" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_c542b143-d2f8-45f9-9d50-4c4e77c9972e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes43Due2028Member_61aecd63-34b5-4d1c-8817-396c6b9d5779" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes43Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes43Due2028Member_61aecd63-34b5-4d1c-8817-396c6b9d5779" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member_fabae6ed-f4ac-453d-b18c-3262ebc767ea" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes3.125DueMarch2020Member_fabae6ed-f4ac-453d-b18c-3262ebc767ea" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member_616d2052-8bc1-4229-abd7-e5a0da51b17f" xlink:href="cvs-20201231.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_FloatingRateNotesDueMarch2020Member_616d2052-8bc1-4229-abd7-e5a0da51b17f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_4efb3852-cae1-44a6-bbbc-66240a34ab96" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_4efb3852-cae1-44a6-bbbc-66240a34ab96" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_1e2c663f-e3ac-4bed-a2b5-e5f7934b6118" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_1e2c663f-e3ac-4bed-a2b5-e5f7934b6118" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_1fbd2651-f934-49ba-8002-6becb3aedb99" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_1fbd2651-f934-49ba-8002-6becb3aedb99" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_bafae25a-6a4b-4c8b-b7d6-a2e9e584a751" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_bafae25a-6a4b-4c8b-b7d6-a2e9e584a751" xlink:type="arc" order="21"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefits"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits" xlink:type="extended" id="ifabf194f0c81447e9ecc5108205863be_PensionPlansandOtherPostretirementBenefits"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables" xlink:type="extended" id="i725b5c9ed1c24561bbbb3b35a79dbd44_PensionPlansandOtherPostretirementBenefitsTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="extended" id="ieef5674eb13b40e4818019a6d3e57e1d_PensionPlansandOtherPostretirementBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_11fa1f75-b774-49f4-bd69-56a3dd266b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_11fa1f75-b774-49f4-bd69-56a3dd266b22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_f3f8c538-acfc-4268-9538-9ad65abac7b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_f3f8c538-acfc-4268-9538-9ad65abac7b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_704ccf8c-be48-40eb-ac9a-8ee3b6513055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_704ccf8c-be48-40eb-ac9a-8ee3b6513055" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_9004fdd8-4c92-48a7-a928-3bd282364042" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlanPensionInsignificantPlanContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_9004fdd8-4c92-48a7-a928-3bd282364042" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5742bc45-bad8-43ad-a64b-0dab1376eeb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5742bc45-bad8-43ad-a64b-0dab1376eeb2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_cb06a4fc-2f83-4349-a87e-6b4af781aecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_cb06a4fc-2f83-4349-a87e-6b4af781aecf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_24e053c7-c6c5-4bee-aae1-ac85c091d470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_24e053c7-c6c5-4bee-aae1-ac85c091d470" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_6e272f39-0655-47ba-9a66-9eb8b3d3cd48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_24e053c7-c6c5-4bee-aae1-ac85c091d470" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_6e272f39-0655-47ba-9a66-9eb8b3d3cd48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6e272f39-0655-47ba-9a66-9eb8b3d3cd48_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_6e272f39-0655-47ba-9a66-9eb8b3d3cd48" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6e272f39-0655-47ba-9a66-9eb8b3d3cd48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_95264a86-07e4-42a5-9594-e3bc194043a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_6e272f39-0655-47ba-9a66-9eb8b3d3cd48" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_95264a86-07e4-42a5-9594-e3bc194043a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_74b7572b-435b-4530-bbd9-f02e029f2202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_95264a86-07e4-42a5-9594-e3bc194043a6" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_74b7572b-435b-4530-bbd9-f02e029f2202" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ab463fb4-da2a-4612-84af-d32475a7c546" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_95264a86-07e4-42a5-9594-e3bc194043a6" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ab463fb4-da2a-4612-84af-d32475a7c546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a085238f-57ce-4612-b682-671d43519836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_24e053c7-c6c5-4bee-aae1-ac85c091d470" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a085238f-57ce-4612-b682-671d43519836" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_a085238f-57ce-4612-b682-671d43519836_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a085238f-57ce-4612-b682-671d43519836" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_a085238f-57ce-4612-b682-671d43519836_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a085238f-57ce-4612-b682-671d43519836" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_a5b4fe85-b8b8-405a-9956-f65093a38cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:to="loc_us-gaap_EquitySecuritiesMember_a5b4fe85-b8b8-405a-9956-f65093a38cfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_9b1d0401-ccab-46d4-af83-5fc3a64ec2f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:to="loc_us-gaap_DebtSecuritiesMember_9b1d0401-ccab-46d4-af83-5fc3a64ec2f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentMember_ed8539fc-908b-4274-83fd-3ee580253ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealEstateInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:to="loc_us-gaap_RealEstateInvestmentMember_ed8539fc-908b-4274-83fd-3ee580253ff0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_ac1e33be-502f-4c26-be97-a232531fa217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:to="loc_us-gaap_PrivateEquityFundsMember_ac1e33be-502f-4c26-be97-a232531fa217" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_3998eb11-a0b3-4ff3-9210-02a76f590db0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:to="loc_us-gaap_HedgeFundsMember_3998eb11-a0b3-4ff3-9210-02a76f590db0" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="extended" id="i56394a220bf54526b2c551094ccfaa79_PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18b7c1ad-0a2b-4166-a248-0f10cec49f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18b7c1ad-0a2b-4166-a248-0f10cec49f99" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_6b21df25-ed01-4f9e-a28e-4c7cb000d291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_6b21df25-ed01-4f9e-a28e-4c7cb000d291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_bddf777e-3f33-4430-9a36-442a39db9b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_bddf777e-3f33-4430-9a36-442a39db9b88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_78cde5dd-d725-4c1f-9a6e-ee4d11fc9982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_78cde5dd-d725-4c1f-9a6e-ee4d11fc9982" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_115c1946-3ec2-4663-a815-07905ce7a64a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_115c1946-3ec2-4663-a815-07905ce7a64a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_922a3f8b-5f47-430f-9da0-31dc09c5ceba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18b7c1ad-0a2b-4166-a248-0f10cec49f99" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6cd9a5a1-b0c1-40b1-8efe-604487ce8492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6cd9a5a1-b0c1-40b1-8efe-604487ce8492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_3eab48db-4c77-4d86-a887-fc2e28d801b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_3eab48db-4c77-4d86-a887-fc2e28d801b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_c651755a-bb0a-4bc6-bd46-e9cc4ba745c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_c651755a-bb0a-4bc6-bd46-e9cc4ba745c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_8adcfe2e-2b42-4dff-aedd-5f5170650e94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_8adcfe2e-2b42-4dff-aedd-5f5170650e94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5c5378e9-62a3-4d62-8133-4a8abc081e60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_64e2bb71-d53d-4a49-a527-75ea7f0ee7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18b7c1ad-0a2b-4166-a248-0f10cec49f99" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_64e2bb71-d53d-4a49-a527-75ea7f0ee7fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_b990b26c-1125-4135-8b51-49e49654b503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18b7c1ad-0a2b-4166-a248-0f10cec49f99" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_b990b26c-1125-4135-8b51-49e49654b503" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_ae56ec64-ed55-4ec4-a636-39a4420c3979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_b990b26c-1125-4135-8b51-49e49654b503" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_ae56ec64-ed55-4ec4-a636-39a4420c3979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_22d732c7-f3a9-4578-98bd-dba114343047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_b990b26c-1125-4135-8b51-49e49654b503" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_22d732c7-f3a9-4578-98bd-dba114343047" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d6bcc8bf-4e03-4ef1-bb2d-4fb019a54ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_b990b26c-1125-4135-8b51-49e49654b503" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d6bcc8bf-4e03-4ef1-bb2d-4fb019a54ba7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7d43bf1e-5a7f-4dc9-83fe-7c3a81a44ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_b990b26c-1125-4135-8b51-49e49654b503" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7d43bf1e-5a7f-4dc9-83fe-7c3a81a44ae7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_234cbe34-61ae-4cb4-9e03-2b03569894b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18b7c1ad-0a2b-4166-a248-0f10cec49f99" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_234cbe34-61ae-4cb4-9e03-2b03569894b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_5b7789dc-8112-44c9-b7eb-fadbe0a01d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_234cbe34-61ae-4cb4-9e03-2b03569894b8" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_5b7789dc-8112-44c9-b7eb-fadbe0a01d5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_5b7789dc-8112-44c9-b7eb-fadbe0a01d5e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5b7789dc-8112-44c9-b7eb-fadbe0a01d5e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_5b7789dc-8112-44c9-b7eb-fadbe0a01d5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b8d72440-97b1-4263-bc8e-4e96ac818e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5b7789dc-8112-44c9-b7eb-fadbe0a01d5e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b8d72440-97b1-4263-bc8e-4e96ac818e3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_daa778ab-4bca-4cfe-a48b-e6151e072ffe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b8d72440-97b1-4263-bc8e-4e96ac818e3c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_daa778ab-4bca-4cfe-a48b-e6151e072ffe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="extended" id="i7e8e8b8a959048c0ad427ef3ac6a1d9e_PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9f6e691-8a52-4816-a73f-704680a6ea0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7b60a3b0-90a7-49ed-aa71-10b6e1a91c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9f6e691-8a52-4816-a73f-704680a6ea0f" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7b60a3b0-90a7-49ed-aa71-10b6e1a91c74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_9b99b3db-e5df-4846-bf61-2af0a9256d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7b60a3b0-90a7-49ed-aa71-10b6e1a91c74" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_9b99b3db-e5df-4846-bf61-2af0a9256d90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2292ed74-73c1-4138-a705-35739e1ca88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7b60a3b0-90a7-49ed-aa71-10b6e1a91c74" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2292ed74-73c1-4138-a705-35739e1ca88c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9bc4896d-323c-487b-8137-5d1c45e21f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7b60a3b0-90a7-49ed-aa71-10b6e1a91c74" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9bc4896d-323c-487b-8137-5d1c45e21f2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a574b23a-79cd-47be-bf85-87382f97d0ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7b60a3b0-90a7-49ed-aa71-10b6e1a91c74" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a574b23a-79cd-47be-bf85-87382f97d0ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e7911d6-ffc2-42be-b1d9-2ef6ca54df74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9f6e691-8a52-4816-a73f-704680a6ea0f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e7911d6-ffc2-42be-b1d9-2ef6ca54df74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_5fc3cc90-e6dd-4006-8077-cf4b87111d97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e7911d6-ffc2-42be-b1d9-2ef6ca54df74" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_5fc3cc90-e6dd-4006-8077-cf4b87111d97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_5fc3cc90-e6dd-4006-8077-cf4b87111d97_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5fc3cc90-e6dd-4006-8077-cf4b87111d97" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_5fc3cc90-e6dd-4006-8077-cf4b87111d97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6153b750-dff8-4f9c-831b-e0009de56eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5fc3cc90-e6dd-4006-8077-cf4b87111d97" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6153b750-dff8-4f9c-831b-e0009de56eeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_92cedced-45b8-4b63-9cd5-b2de62b05ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6153b750-dff8-4f9c-831b-e0009de56eeb" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_92cedced-45b8-4b63-9cd5-b2de62b05ef2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" xlink:type="extended" id="ie66d25eca8ca47dc89e9692da39151e6_PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="extended" id="i012a27a59e7d4849bcec25df23e7a6ec_PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53eaf016-7442-4b37-b1ec-2725eb02a52f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_60a0e8c6-a476-415d-8160-6710aacd016c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53eaf016-7442-4b37-b1ec-2725eb02a52f" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_60a0e8c6-a476-415d-8160-6710aacd016c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_bce5bd24-f0a0-48eb-bbed-1237096d82bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53eaf016-7442-4b37-b1ec-2725eb02a52f" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_bce5bd24-f0a0-48eb-bbed-1237096d82bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36feda71-8977-4fb6-bc7f-9030f35afdd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53eaf016-7442-4b37-b1ec-2725eb02a52f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36feda71-8977-4fb6-bc7f-9030f35afdd6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e9d827d2-2098-407e-b5a7-020051298c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36feda71-8977-4fb6-bc7f-9030f35afdd6" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e9d827d2-2098-407e-b5a7-020051298c5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e9d827d2-2098-407e-b5a7-020051298c5a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e9d827d2-2098-407e-b5a7-020051298c5a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e9d827d2-2098-407e-b5a7-020051298c5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6618d13f-4fd2-4467-809d-47b4102cde9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e9d827d2-2098-407e-b5a7-020051298c5a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6618d13f-4fd2-4467-809d-47b4102cde9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_5b6305c9-10ff-4c60-9ecf-04014c1afc9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6618d13f-4fd2-4467-809d-47b4102cde9d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_5b6305c9-10ff-4c60-9ecf-04014c1afc9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67381ef5-9472-4dc3-b2d7-11835861e15d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36feda71-8977-4fb6-bc7f-9030f35afdd6" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67381ef5-9472-4dc3-b2d7-11835861e15d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_67381ef5-9472-4dc3-b2d7-11835861e15d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67381ef5-9472-4dc3-b2d7-11835861e15d" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_67381ef5-9472-4dc3-b2d7-11835861e15d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67381ef5-9472-4dc3-b2d7-11835861e15d" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_5efb0e38-e570-4d15-89ba-9fd3aff99e81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_5efb0e38-e570-4d15-89ba-9fd3aff99e81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_36429914-3e03-4e68-ac9b-a24e410d180f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_36429914-3e03-4e68-ac9b-a24e410d180f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_ae096efb-2602-4ca8-851c-895e7dc0cab6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_ae096efb-2602-4ca8-851c-895e7dc0cab6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_333e1885-6cde-467d-aabd-8ff7c3b7e1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_333e1885-6cde-467d-aabd-8ff7c3b7e1ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_b78e3401-306f-4049-8193-3a4f8a3cb684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_b78e3401-306f-4049-8193-3a4f8a3cb684" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3694f3cc-645a-478a-838d-73b4a06028f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3694f3cc-645a-478a-838d-73b4a06028f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_eeb3138a-9ca1-4ee7-a23c-813953e46f33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_eeb3138a-9ca1-4ee7-a23c-813953e46f33" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_cec518d8-1b2b-4621-a61d-11e8fe0a05f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_cec518d8-1b2b-4621-a61d-11e8fe0a05f7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedeemablePreferredSecuritiesMember_5ab64bea-6d17-4fda-afe7-bf7f9a57b9ef" xlink:href="cvs-20201231.xsd#cvs_RedeemablePreferredSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_cvs_RedeemablePreferredSecuritiesMember_5ab64bea-6d17-4fda-afe7-bf7f9a57b9ef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_984a8afc-d4a6-496a-a85f-4a42d312138e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_EquitySecuritiesMember_984a8afc-d4a6-496a-a85f-4a42d312138e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_0a339b9f-bc62-42bd-a541-c8988291d747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_984a8afc-d4a6-496a-a85f-4a42d312138e" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_0a339b9f-bc62-42bd-a541-c8988291d747" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_5efac992-c6b2-40a1-8b98-ee71776e967e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_984a8afc-d4a6-496a-a85f-4a42d312138e" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_5efac992-c6b2-40a1-8b98-ee71776e967e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EquitySecuritiesDomesticRealEstateMember_ee9a1a0a-c572-40de-b755-adc29784f03f" xlink:href="cvs-20201231.xsd#cvs_EquitySecuritiesDomesticRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_984a8afc-d4a6-496a-a85f-4a42d312138e" xlink:to="loc_cvs_EquitySecuritiesDomesticRealEstateMember_ee9a1a0a-c572-40de-b755-adc29784f03f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_8c4c9b00-6dcf-43c7-83c2-e5660d7f911b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_OtherInvestmentsMember_8c4c9b00-6dcf-43c7-83c2-e5660d7f911b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_1059634e-83b1-492d-8203-60b02ca0f28b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentsMember_8c4c9b00-6dcf-43c7-83c2-e5660d7f911b" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_1059634e-83b1-492d-8203-60b02ca0f28b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_59bf6701-1284-4603-a223-b36546ff1732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentsMember_8c4c9b00-6dcf-43c7-83c2-e5660d7f911b" xlink:to="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_59bf6701-1284-4603-a223-b36546ff1732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDerivativeMember_654bd0e8-077d-40f8-8722-9bcedd287e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDerivativeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentsMember_8c4c9b00-6dcf-43c7-83c2-e5660d7f911b" xlink:to="loc_us-gaap_DefinedBenefitPlanDerivativeMember_654bd0e8-077d-40f8-8722-9bcedd287e58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_12933ffd-71ee-4e74-a661-f083d25444d4" xlink:href="cvs-20201231.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_12933ffd-71ee-4e74-a661-f083d25444d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_21285af3-2592-4662-bf8f-0146be682580" xlink:href="cvs-20201231.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_21285af3-2592-4662-bf8f-0146be682580" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_02771717-0b45-4943-a118-bd9799bc4b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_PrivateEquityFundsMember_02771717-0b45-4943-a118-bd9799bc4b59" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_dcebf070-6f05-4307-a625-2bffafa25efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_HedgeFundsMember_dcebf070-6f05-4307-a625-2bffafa25efc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_74321724-096d-4f76-a5e7-8f6fa248d5e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_AccountsReceivableMember_74321724-096d-4f76-a5e7-8f6fa248d5e2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d769889c-9483-4932-82ef-d155901eb30b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36feda71-8977-4fb6-bc7f-9030f35afdd6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d769889c-9483-4932-82ef-d155901eb30b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d769889c-9483-4932-82ef-d155901eb30b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d769889c-9483-4932-82ef-d155901eb30b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d769889c-9483-4932-82ef-d155901eb30b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d769889c-9483-4932-82ef-d155901eb30b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e084591c-e010-44a8-9881-5dee8654f892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e084591c-e010-44a8-9881-5dee8654f892" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_186190ee-87b8-4e1a-b09c-3a8a9c7fc300" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_186190ee-87b8-4e1a-b09c-3a8a9c7fc300" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_2e41236a-8f90-4494-9aaf-043108aea96c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_2e41236a-8f90-4494-9aaf-043108aea96c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_7ff533ff-9024-439c-929d-ce9c950d6eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_7ff533ff-9024-439c-929d-ce9c950d6eb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_2e1555f1-8589-46ff-9e07-6b87db771ada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_2e1555f1-8589-46ff-9e07-6b87db771ada" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="extended" id="ie32a7443bb3a4a48bd281b038ae045bd_PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_64b55bba-8a20-42e5-8045-393e3cc81721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_64b55bba-8a20-42e5-8045-393e3cc81721" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_26d2069c-35ca-47d4-a663-0a31934bfbca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_26d2069c-35ca-47d4-a663-0a31934bfbca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_eb3d9653-6e1f-4d63-bf04-8f934ef946c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_eb3d9653-6e1f-4d63-bf04-8f934ef946c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_f3ef9c77-4439-4cef-8f12-5c6633c43025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:to="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_f3ef9c77-4439-4cef-8f12-5c6633c43025" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_5f386080-1390-440e-8bcb-97be9a49e056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:to="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_5f386080-1390-440e-8bcb-97be9a49e056" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_74d26913-5851-4fd7-88bc-1db6d01f1f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b2945775-e4e3-4ffc-aad6-1a0f204b4644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_64b55bba-8a20-42e5-8045-393e3cc81721" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b2945775-e4e3-4ffc-aad6-1a0f204b4644" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d024f00f-5d3a-42b3-a875-ce1a357a307d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b2945775-e4e3-4ffc-aad6-1a0f204b4644" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d024f00f-5d3a-42b3-a875-ce1a357a307d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d024f00f-5d3a-42b3-a875-ce1a357a307d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d024f00f-5d3a-42b3-a875-ce1a357a307d" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d024f00f-5d3a-42b3-a875-ce1a357a307d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_4e047fb4-37ab-42d7-843e-21283dea7f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d024f00f-5d3a-42b3-a875-ce1a357a307d" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_4e047fb4-37ab-42d7-843e-21283dea7f59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_ba6a9cd7-f332-468f-ae2e-ad5ec3eb2977" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_4e047fb4-37ab-42d7-843e-21283dea7f59" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_ba6a9cd7-f332-468f-ae2e-ad5ec3eb2977" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_c65e54da-3f50-4077-9e2d-14b1cbc63905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_4e047fb4-37ab-42d7-843e-21283dea7f59" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_c65e54da-3f50-4077-9e2d-14b1cbc63905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4396a747-274d-405e-a276-72e19bdaa0ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b2945775-e4e3-4ffc-aad6-1a0f204b4644" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4396a747-274d-405e-a276-72e19bdaa0ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4396a747-274d-405e-a276-72e19bdaa0ef_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4396a747-274d-405e-a276-72e19bdaa0ef" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4396a747-274d-405e-a276-72e19bdaa0ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40e9b465-1efd-441c-9877-5f28c6867be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4396a747-274d-405e-a276-72e19bdaa0ef" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40e9b465-1efd-441c-9877-5f28c6867be1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c99e7af3-0001-4ae3-a77e-cb7061bfd78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40e9b465-1efd-441c-9877-5f28c6867be1" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c99e7af3-0001-4ae3-a77e-cb7061bfd78a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_f9de45bf-5941-4c8a-9bb2-058981d43e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b2945775-e4e3-4ffc-aad6-1a0f204b4644" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_f9de45bf-5941-4c8a-9bb2-058981d43e29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_f9de45bf-5941-4c8a-9bb2-058981d43e29_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f9de45bf-5941-4c8a-9bb2-058981d43e29" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_f9de45bf-5941-4c8a-9bb2-058981d43e29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2714596b-fa07-4f66-9cbc-edf5af2e334a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f9de45bf-5941-4c8a-9bb2-058981d43e29" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2714596b-fa07-4f66-9cbc-edf5af2e334a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_30d0f47d-e0d4-4657-b925-b99d65357d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_2714596b-fa07-4f66-9cbc-edf5af2e334a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_30d0f47d-e0d4-4657-b925-b99d65357d1b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="extended" id="i14c043375ff2434fb831f5ade02b7745_PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_99192698-b5dd-4e42-a209-4013d6b1673a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_99192698-b5dd-4e42-a209-4013d6b1673a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_b0c55843-af05-4e59-821f-e97f7631b0a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_b0c55843-af05-4e59-821f-e97f7631b0a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_fbc4e659-5abf-458d-9c39-5b510c97c7c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_fbc4e659-5abf-458d-9c39-5b510c97c7c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_cd94e337-7ca2-4bb2-90e6-1aae1c3a7704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_cd94e337-7ca2-4bb2-90e6-1aae1c3a7704" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_3e39b79a-3231-458c-9987-36b3958ecd22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_3e39b79a-3231-458c-9987-36b3958ecd22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_1235b615-7df3-44a6-ae09-e8826328ffe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_1235b615-7df3-44a6-ae09-e8826328ffe8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_297129d9-ccd9-4565-aaa0-377b7f71b259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_297129d9-ccd9-4565-aaa0-377b7f71b259" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_83bba237-f9a4-4872-a7ca-aa3bda69dd27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_297129d9-ccd9-4565-aaa0-377b7f71b259" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_83bba237-f9a4-4872-a7ca-aa3bda69dd27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_83bba237-f9a4-4872-a7ca-aa3bda69dd27_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_83bba237-f9a4-4872-a7ca-aa3bda69dd27" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_83bba237-f9a4-4872-a7ca-aa3bda69dd27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a1eaf5cf-a3bd-445f-b966-141824d55a54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_83bba237-f9a4-4872-a7ca-aa3bda69dd27" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a1eaf5cf-a3bd-445f-b966-141824d55a54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_528a4dfe-5208-424d-bc26-6cf01ed8a4c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a1eaf5cf-a3bd-445f-b966-141824d55a54" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_528a4dfe-5208-424d-bc26-6cf01ed8a4c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8c9a8626-0e4e-4e8f-ad9f-3dc53665475d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a1eaf5cf-a3bd-445f-b966-141824d55a54" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8c9a8626-0e4e-4e8f-ad9f-3dc53665475d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/IncomeTaxes" xlink:type="extended" id="i75c356751dfa49ccb3ffd537882dbc26_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesTables" xlink:type="extended" id="i0df012b471e640cab87b7e9c370580e1_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended" id="if5a6bdceeabc4fa5a63b9086ebfdccf2_IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i440de75e1e2946b6b31645d853748d3a_IncomeTaxesNarrativeDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="extended" id="i00bb9c65a04f427fbafc4722b148db3f_IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="i2164e9da04e5467393f270991ec58bcf_IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended" id="i44ca98b1146746ea8a2cb7ca993092f4_IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlans" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlans"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlans" xlink:type="extended" id="i936131ca63c04a36992f8e03285dec79_StockIncentivePlans"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansTables" xlink:type="extended" id="i2c8340f4e81b4e2eb378baf302438e20_StockIncentivePlansTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="extended" id="i0f734c6969f5483fae419eae3326f353_StockIncentivePlansStockBasedCompensationExpenseandESPPDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c16b76a8-97cf-4753-aca6-aef543274c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c16b76a8-97cf-4753-aca6-aef543274c20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3bf49d46-8502-446c-bb5c-5de3e0d05cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3bf49d46-8502-446c-bb5c-5de3e0d05cce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_15a3a1d9-54a9-4423-af70-f9b166f50c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_15a3a1d9-54a9-4423-af70-f9b166f50c71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0e65da96-e0f4-4b39-9964-ff9d27173e42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0e65da96-e0f4-4b39-9964-ff9d27173e42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_164b4245-67d4-40f4-8bdb-f7d798939da6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_164b4245-67d4-40f4-8bdb-f7d798939da6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_63278a6d-599b-4992-92c8-219a3e07d6a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_63278a6d-599b-4992-92c8-219a3e07d6a2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8539e1a0-01c2-4a9a-be80-28db60a2e505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8539e1a0-01c2-4a9a-be80-28db60a2e505" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_051b4bca-492a-426b-81ba-2c2053281163" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_051b4bca-492a-426b-81ba-2c2053281163" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_d1ed99e1-654f-4e4f-bd46-1ca037bdc04a" xlink:href="cvs-20201231.xsd#cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_d1ed99e1-654f-4e4f-bd46-1ca037bdc04a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_59db2345-2a8d-4db9-af25-4569ae295f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_59db2345-2a8d-4db9-af25-4569ae295f15" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e456f9f4-33a7-4908-8e1c-d99fb4a3a798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e456f9f4-33a7-4908-8e1c-d99fb4a3a798" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ec28a393-20d0-4be3-8218-4f01a170d3e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ec28a393-20d0-4be3-8218-4f01a170d3e2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2795053f-083a-4e60-938f-a5973b322d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2795053f-083a-4e60-938f-a5973b322d53" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_14566a4a-852f-44e8-a5ec-2e1e517dde63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_14566a4a-852f-44e8-a5ec-2e1e517dde63" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_79c0a2e7-ab29-4d6d-8f78-e05ba0f5f686" xlink:href="cvs-20201231.xsd#cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_79c0a2e7-ab29-4d6d-8f78-e05ba0f5f686" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f66f907a-8a3a-4359-b295-0b4933161d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f66f907a-8a3a-4359-b295-0b4933161d2e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c1c2ad99-2e8c-4502-a6cd-7bb58f6bd391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f66f907a-8a3a-4359-b295-0b4933161d2e" xlink:to="loc_us-gaap_PlanNameAxis_c1c2ad99-2e8c-4502-a6cd-7bb58f6bd391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c1c2ad99-2e8c-4502-a6cd-7bb58f6bd391_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_c1c2ad99-2e8c-4502-a6cd-7bb58f6bd391" xlink:to="loc_us-gaap_PlanNameDomain_c1c2ad99-2e8c-4502-a6cd-7bb58f6bd391_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d55dc520-5f42-4aaf-aa70-21e2480dd70c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_c1c2ad99-2e8c-4502-a6cd-7bb58f6bd391" xlink:to="loc_us-gaap_PlanNameDomain_d55dc520-5f42-4aaf-aa70-21e2480dd70c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember_f4711d79-a17c-4060-bb89-5dea35b63e32" xlink:href="cvs-20201231.xsd#cvs_CVSHealth2017IncentiveCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d55dc520-5f42-4aaf-aa70-21e2480dd70c" xlink:to="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember_f4711d79-a17c-4060-bb89-5dea35b63e32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc2010StockIncentivePlanMember_467d1f6f-6ad0-4337-a7cc-91218ff9c2eb" xlink:href="cvs-20201231.xsd#cvs_AetnaInc2010StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d55dc520-5f42-4aaf-aa70-21e2480dd70c" xlink:to="loc_cvs_AetnaInc2010StockIncentivePlanMember_467d1f6f-6ad0-4337-a7cc-91218ff9c2eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3b602236-02e7-40a5-8ee3-2e779aa6bd0e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f66f907a-8a3a-4359-b295-0b4933161d2e" xlink:to="loc_srt_RangeAxis_3b602236-02e7-40a5-8ee3-2e779aa6bd0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3b602236-02e7-40a5-8ee3-2e779aa6bd0e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3b602236-02e7-40a5-8ee3-2e779aa6bd0e" xlink:to="loc_srt_RangeMember_3b602236-02e7-40a5-8ee3-2e779aa6bd0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8a257304-2bb4-435d-b0ce-8da24bdfda93" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3b602236-02e7-40a5-8ee3-2e779aa6bd0e" xlink:to="loc_srt_RangeMember_8a257304-2bb4-435d-b0ce-8da24bdfda93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4a326939-103c-4bb3-ac2a-f0c29396bcbe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8a257304-2bb4-435d-b0ce-8da24bdfda93" xlink:to="loc_srt_MinimumMember_4a326939-103c-4bb3-ac2a-f0c29396bcbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_29bb3526-628e-47c7-86e8-411039ffa736" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8a257304-2bb4-435d-b0ce-8da24bdfda93" xlink:to="loc_srt_MaximumMember_29bb3526-628e-47c7-86e8-411039ffa736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_78ac95fa-ec12-4075-9051-1f91f32de923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f66f907a-8a3a-4359-b295-0b4933161d2e" xlink:to="loc_us-gaap_AwardTypeAxis_78ac95fa-ec12-4075-9051-1f91f32de923" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78ac95fa-ec12-4075-9051-1f91f32de923_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_78ac95fa-ec12-4075-9051-1f91f32de923" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78ac95fa-ec12-4075-9051-1f91f32de923_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_78ac95fa-ec12-4075-9051-1f91f32de923" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_5eae3384-3286-4e37-92c3-588fe9336117" xlink:href="cvs-20201231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:to="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_5eae3384-3286-4e37-92c3-588fe9336117" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_15a014cb-5e58-4764-bdda-8443fefa4b0e" xlink:href="cvs-20201231.xsd#cvs_RestrictedStockUnitsandPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:to="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_15a014cb-5e58-4764-bdda-8443fefa4b0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_a52f1313-6a4f-4edf-97b0-a0a63f3203e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_a52f1313-6a4f-4edf-97b0-a0a63f3203e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_64915bfd-1403-4d3a-9f56-e94af7cfae68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:to="loc_us-gaap_RestrictedStockMember_64915bfd-1403-4d3a-9f56-e94af7cfae68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3eb6e5a3-fc9c-4e5e-8de2-1d4c7040f8ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3eb6e5a3-fc9c-4e5e-8de2-1d4c7040f8ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_4b38067e-fbcf-4b85-b43a-ae40948d096e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:to="loc_us-gaap_EmployeeStockMember_4b38067e-fbcf-4b85-b43a-ae40948d096e" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansValuationandAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails" xlink:type="extended" id="i38fcf3981dcb4b5182fd35edd9aefeef_StockIncentivePlansValuationandAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f145d5d0-4cf5-4326-b7c3-afb3bc243bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f145d5d0-4cf5-4326-b7c3-afb3bc243bde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3d6e23b2-8547-4a4b-806f-12e8b9f92f94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3d6e23b2-8547-4a4b-806f-12e8b9f92f94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d0815836-344d-493c-8794-7af79406d7dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d0815836-344d-493c-8794-7af79406d7dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_38d8352b-7ac5-4b7b-a1f9-37d1f4502fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_38d8352b-7ac5-4b7b-a1f9-37d1f4502fe9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dce838c7-e885-4342-944a-8590e4502ce4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dce838c7-e885-4342-944a-8590e4502ce4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2c21bf7c-20f5-4700-b70f-2d624dda49c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2c21bf7c-20f5-4700-b70f-2d624dda49c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_21e5ad8b-f2ae-475f-873f-be1e1da9c32a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2c21bf7c-20f5-4700-b70f-2d624dda49c0" xlink:to="loc_us-gaap_AwardTypeAxis_21e5ad8b-f2ae-475f-873f-be1e1da9c32a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21e5ad8b-f2ae-475f-873f-be1e1da9c32a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_21e5ad8b-f2ae-475f-873f-be1e1da9c32a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21e5ad8b-f2ae-475f-873f-be1e1da9c32a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2ed27ad-f447-4ebe-9e95-62310bd7ecbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_21e5ad8b-f2ae-475f-873f-be1e1da9c32a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2ed27ad-f447-4ebe-9e95-62310bd7ecbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_4f92df4f-d3c4-4933-81aa-3a5d7d39be38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2ed27ad-f447-4ebe-9e95-62310bd7ecbe" xlink:to="loc_us-gaap_EmployeeStockMember_4f92df4f-d3c4-4933-81aa-3a5d7d39be38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_9203b9fc-5fe8-487c-a964-d0696b89304b" xlink:href="cvs-20201231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2ed27ad-f447-4ebe-9e95-62310bd7ecbe" xlink:to="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_9203b9fc-5fe8-487c-a964-d0696b89304b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="extended" id="id97f070f276644a7ac5e4864e055c7e2_StockIncentivePlansRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f504207a-4197-4093-b3e8-4720e2873eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f504207a-4197-4093-b3e8-4720e2873eb1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7033acfa-d8a9-43a4-b775-0ace37030f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7033acfa-d8a9-43a4-b775-0ace37030f54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9a3dd517-62c1-4cda-9efc-1ecab1055e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9a3dd517-62c1-4cda-9efc-1ecab1055e5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_64acc130-0114-4582-89b5-9a3d18951b3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_64acc130-0114-4582-89b5-9a3d18951b3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c5155cfc-b058-4388-a03d-47e81b342bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c5155cfc-b058-4388-a03d-47e81b342bfe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_39a789ab-be59-4af5-8cb6-2c5071e923db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f504207a-4197-4093-b3e8-4720e2873eb1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_10bf4c74-655c-4844-a1b5-a405184b920d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_10bf4c74-655c-4844-a1b5-a405184b920d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_31ab3538-80f1-467c-bb44-af4955d047e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_31ab3538-80f1-467c-bb44-af4955d047e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_202fd588-a7a8-4b44-8869-7d5cda14a2dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_202fd588-a7a8-4b44-8869-7d5cda14a2dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0b69c0f6-6352-42d7-b725-29e68bedd29f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0b69c0f6-6352-42d7-b725-29e68bedd29f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9b1b59cb-e072-412d-9587-e86d4a2125ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3295aa75-eca0-4285-9ed5-2c4df028ceca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f504207a-4197-4093-b3e8-4720e2873eb1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3295aa75-eca0-4285-9ed5-2c4df028ceca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4134c41f-73af-4309-879b-e627e7d6fdda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3295aa75-eca0-4285-9ed5-2c4df028ceca" xlink:to="loc_us-gaap_AwardTypeAxis_4134c41f-73af-4309-879b-e627e7d6fdda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4134c41f-73af-4309-879b-e627e7d6fdda_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4134c41f-73af-4309-879b-e627e7d6fdda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4134c41f-73af-4309-879b-e627e7d6fdda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_195b2696-36a2-4c11-b70f-774a6f862e4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4134c41f-73af-4309-879b-e627e7d6fdda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_195b2696-36a2-4c11-b70f-774a6f862e4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_db435b2e-b05d-4ed8-8ff7-a110e995b975" xlink:href="cvs-20201231.xsd#cvs_RestrictedStockUnitsandPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_195b2696-36a2-4c11-b70f-774a6f862e4d" xlink:to="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_db435b2e-b05d-4ed8-8ff7-a110e995b975" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansStockOptionandSARActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="extended" id="i1f598f0c2c504f1d8683ec641b26df10_StockIncentivePlansStockOptionandSARActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_be08844d-93da-4f60-9fce-9ca0b370dcf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_be08844d-93da-4f60-9fce-9ca0b370dcf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_e1b8fadd-963e-4525-b63a-7a511bc45fba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_e1b8fadd-963e-4525-b63a-7a511bc45fba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f26335b6-36d6-4b46-94aa-f20f377e85ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f26335b6-36d6-4b46-94aa-f20f377e85ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1ac0899e-98a5-47bd-9ce4-08505550f281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1ac0899e-98a5-47bd-9ce4-08505550f281" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_a3d4b9d2-6e43-4ea7-8087-0e9e36450c32" xlink:href="cvs-20201231.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_a3d4b9d2-6e43-4ea7-8087-0e9e36450c32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6fe68cbe-fa87-44e1-90ae-721cab8f522b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6fe68cbe-fa87-44e1-90ae-721cab8f522b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_37865414-c6da-44d6-b8a7-566cee8e3582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_37865414-c6da-44d6-b8a7-566cee8e3582" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_85e26ff2-a2fb-4007-bd27-0c0172936001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_85e26ff2-a2fb-4007-bd27-0c0172936001" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_131c430f-1299-4793-88f4-84965257245a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_131c430f-1299-4793-88f4-84965257245a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_5c97115d-0e0b-47c9-80e3-0112d9a8724e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_5c97115d-0e0b-47c9-80e3-0112d9a8724e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_85fe6b76-3ce6-4357-92bf-47df842bfd26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cc11ede9-1a25-4d27-a774-8c1737e2f915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cc11ede9-1a25-4d27-a774-8c1737e2f915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_420c049d-9616-4761-aac9-38a4fae4ec29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_420c049d-9616-4761-aac9-38a4fae4ec29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a591973f-f65d-4905-8711-651f093fe046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a591973f-f65d-4905-8711-651f093fe046" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8dd33a5f-b14c-476e-9c41-fbbbcc5a7071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8dd33a5f-b14c-476e-9c41-fbbbcc5a7071" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_77d04326-d800-4c50-a2f3-823c778701cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_77d04326-d800-4c50-a2f3-823c778701cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_be44f5e2-6ae0-4ceb-a224-b461f6875826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_febbacbc-c818-4221-b0a3-b9380e85a322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_febbacbc-c818-4221-b0a3-b9380e85a322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a58d4dc0-0a0d-4609-8353-23ac242bea4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a58d4dc0-0a0d-4609-8353-23ac242bea4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_39a31b2c-786a-4d08-83e5-7cb9d6fc2775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_39a31b2c-786a-4d08-83e5-7cb9d6fc2775" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_7af74455-34d6-4b63-b9b6-ec6d1620ff83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_7af74455-34d6-4b63-b9b6-ec6d1620ff83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4749609b-ba24-4e4c-9ed4-bdaf36c61094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4749609b-ba24-4e4c-9ed4-bdaf36c61094" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_20b456c2-dad9-4cf8-98aa-3f526551c985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_20b456c2-dad9-4cf8-98aa-3f526551c985" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_97509201-cbe3-4969-9343-f3dfbd519040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_97509201-cbe3-4969-9343-f3dfbd519040" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1253e5fb-6398-4cf1-9653-8fe1d0cb35b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1253e5fb-6398-4cf1-9653-8fe1d0cb35b3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_25c25e43-6a9e-4eb3-aa49-f0a00fc695b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_25c25e43-6a9e-4eb3-aa49-f0a00fc695b7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_7b5751a1-07ea-458b-82ef-ec40c6360a3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_7b5751a1-07ea-458b-82ef-ec40c6360a3a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41d30528-5551-4ec3-91f0-1b6b381ac13e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41d30528-5551-4ec3-91f0-1b6b381ac13e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6e36bf6f-672a-4641-87e1-1d5448998a66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41d30528-5551-4ec3-91f0-1b6b381ac13e" xlink:to="loc_us-gaap_AwardTypeAxis_6e36bf6f-672a-4641-87e1-1d5448998a66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e36bf6f-672a-4641-87e1-1d5448998a66_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6e36bf6f-672a-4641-87e1-1d5448998a66" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e36bf6f-672a-4641-87e1-1d5448998a66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109a4bf1-5bf1-43ff-925d-57250f408868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6e36bf6f-672a-4641-87e1-1d5448998a66" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109a4bf1-5bf1-43ff-925d-57250f408868" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member_2eafdf65-3377-4fb0-b3ac-787c9ce89a6a" xlink:href="cvs-20201231.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109a4bf1-5bf1-43ff-925d-57250f408868" xlink:to="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member_2eafdf65-3377-4fb0-b3ac-787c9ce89a6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member_457a5522-4727-473e-9319-c7e3615165fe" xlink:href="cvs-20201231.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109a4bf1-5bf1-43ff-925d-57250f408868" xlink:to="loc_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member_457a5522-4727-473e-9319-c7e3615165fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_6e21a83b-1875-40db-8206-b33da9910615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109a4bf1-5bf1-43ff-925d-57250f408868" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_6e21a83b-1875-40db-8206-b33da9910615" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_d77bf9b5-e5e9-4d1e-97d1-40f9a767647f" xlink:href="cvs-20201231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109a4bf1-5bf1-43ff-925d-57250f408868" xlink:to="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_d77bf9b5-e5e9-4d1e-97d1-40f9a767647f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="extended" id="i6a9366989a0846e4a46d780f94bc06b7_ShareholdersEquity"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="extended" id="icd81477f7c50431bac2824c8caa9637a_ShareholdersEquityTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails" xlink:type="extended" id="if0bdf684b2214ad4b71e03554ceb69c8_ShareholdersEquityRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9b2afcc6-8990-40c3-a700-bb7b9614497e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3e6096b2-cf34-4b14-95cc-f65cac872578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9b2afcc6-8990-40c3-a700-bb7b9614497e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3e6096b2-cf34-4b14-95cc-f65cac872578" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_39accda4-8b8c-4234-937c-edffd60be429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9b2afcc6-8990-40c3-a700-bb7b9614497e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_39accda4-8b8c-4234-937c-edffd60be429" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_0fcdea26-a3cf-4b35-9e2a-93ba44330b71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9b2afcc6-8990-40c3-a700-bb7b9614497e" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_0fcdea26-a3cf-4b35-9e2a-93ba44330b71" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_22121c8b-4078-4a85-8aaf-6241dabd77f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_0fcdea26-a3cf-4b35-9e2a-93ba44330b71" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_22121c8b-4078-4a85-8aaf-6241dabd77f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_22121c8b-4078-4a85-8aaf-6241dabd77f8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_22121c8b-4078-4a85-8aaf-6241dabd77f8" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_22121c8b-4078-4a85-8aaf-6241dabd77f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_3733a8c3-ba4f-44b2-9f0f-23154cb32898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_22121c8b-4078-4a85-8aaf-6241dabd77f8" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_3733a8c3-ba4f-44b2-9f0f-23154cb32898" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember_36b008f1-958e-45c9-a0ae-8cedb81b30ae" xlink:href="cvs-20201231.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_3733a8c3-ba4f-44b2-9f0f-23154cb32898" xlink:to="loc_cvs_A2016RepurchaseProgramMember_36b008f1-958e-45c9-a0ae-8cedb81b30ae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityDividendsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="extended" id="id6650f1f01e6486b8b33fd58215874d6_ShareholdersEquityDividendsDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityRegulatoryRequirementsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="extended" id="i3c113711471042d388e909ebba10cc99_ShareholdersEquityRegulatoryRequirementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_e2aa0def-859b-4736-94ad-4abd13a436dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_e2aa0def-859b-4736-94ad-4abd13a436dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_b3dc0067-ba5c-457b-80b2-d3ff1805a89b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_b3dc0067-ba5c-457b-80b2-d3ff1805a89b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_062a203f-3b0d-4cc4-9afc-1d24023c97c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_062a203f-3b0d-4cc4-9afc-1d24023c97c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_964df043-0a7e-46bd-aa8d-4d6406758e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_964df043-0a7e-46bd-aa8d-4d6406758e51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators_24f8925f-39f2-4864-88c6-69f4a5eebb5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_AssetsHeldByInsuranceRegulators_24f8925f-39f2-4864-88c6-69f4a5eebb5c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_87b5ed43-7423-4549-8202-1f06cbd3f31e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_87b5ed43-7423-4549-8202-1f06cbd3f31e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable_20269336-bc6a-44f7-bbd1-3ed30ce3ded3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_StatutoryAccountingPracticesTable_20269336-bc6a-44f7-bbd1-3ed30ce3ded3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c8187f99-fba1-430b-8c2a-4adf581d72ed" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_20269336-bc6a-44f7-bbd1-3ed30ce3ded3" xlink:to="loc_dei_LegalEntityAxis_c8187f99-fba1-430b-8c2a-4adf581d72ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c8187f99-fba1-430b-8c2a-4adf581d72ed_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c8187f99-fba1-430b-8c2a-4adf581d72ed" xlink:to="loc_dei_EntityDomain_c8187f99-fba1-430b-8c2a-4adf581d72ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_28ca942b-bb6e-4758-8c80-ccb30a97d278" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c8187f99-fba1-430b-8c2a-4adf581d72ed" xlink:to="loc_dei_EntityDomain_28ca942b-bb6e-4758-8c80-ccb30a97d278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsuranceAndHmoMember_3c2098cc-82a7-4f6d-ab60-8b85bca63be3" xlink:href="cvs-20201231.xsd#cvs_InsuranceAndHmoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_28ca942b-bb6e-4758-8c80-ccb30a97d278" xlink:to="loc_cvs_InsuranceAndHmoMember_3c2098cc-82a7-4f6d-ab60-8b85bca63be3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityNoncontrollingInterestsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails" xlink:type="extended" id="i095746df0a234e61a8a212e4a4a08587_ShareholdersEquityNoncontrollingInterestsDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20201231.xsd#OtherComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="extended" id="i8e4a54744cee47a582ce8024cf37cf7a_OtherComprehensiveIncome"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#OtherComprehensiveIncomeTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="extended" id="i80abfffcca2740aebbbb7fccb78872e6_OtherComprehensiveIncomeTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#OtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended" id="i5991101166c249369c2473a67242cce0_OtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d4f20cc3-9b84-4793-8236-8d399113ecca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d4f20cc3-9b84-4793-8236-8d399113ecca" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fc784e55-a06a-4ecf-abab-7f1b1a770c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fc784e55-a06a-4ecf-abab-7f1b1a770c87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect_60abc6e7-3955-4471-807a-caa3bd8ca89f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect_60abc6e7-3955-4471-807a-caa3bd8ca89f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b324e3bf-93fd-4e64-b9b7-1747e2ea4408" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b324e3bf-93fd-4e64-b9b7-1747e2ea4408" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_70f1e61f-ddb5-4ad2-aaa3-009cc2ae3064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_70f1e61f-ddb5-4ad2-aaa3-009cc2ae3064" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f67cd13f-edc8-4868-b871-806c7ad3e6d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f67cd13f-edc8-4868-b871-806c7ad3e6d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_07ed6f9f-1ff0-48b4-b4cf-a1f3d78b22a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_7732c65a-835c-4132-ace7-eed4352bc4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d4f20cc3-9b84-4793-8236-8d399113ecca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_7732c65a-835c-4132-ace7-eed4352bc4a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f990e010-bdf1-4390-807c-6fa8b39f228d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d4f20cc3-9b84-4793-8236-8d399113ecca" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f990e010-bdf1-4390-807c-6fa8b39f228d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_ec3de1d7-5b9b-4f74-bce9-f1a35ed724b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d4f20cc3-9b84-4793-8236-8d399113ecca" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_ec3de1d7-5b9b-4f74-bce9-f1a35ed724b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_65e62139-3a3b-41b6-820f-5d0dcb9bd2e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d4f20cc3-9b84-4793-8236-8d399113ecca" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_65e62139-3a3b-41b6-820f-5d0dcb9bd2e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b24ca1a7-8084-46c1-b8ee-f39a70b0f5cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_65e62139-3a3b-41b6-820f-5d0dcb9bd2e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b24ca1a7-8084-46c1-b8ee-f39a70b0f5cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b24ca1a7-8084-46c1-b8ee-f39a70b0f5cf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b24ca1a7-8084-46c1-b8ee-f39a70b0f5cf" xlink:to="loc_us-gaap_EquityComponentDomain_b24ca1a7-8084-46c1-b8ee-f39a70b0f5cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b24ca1a7-8084-46c1-b8ee-f39a70b0f5cf" xlink:to="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_4b0e0662-2fbe-4495-9c07-1db4a527c555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_4b0e0662-2fbe-4495-9c07-1db4a527c555" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_47fab5ea-cdc2-4fdb-873d-9ec3f889fa7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_47fab5ea-cdc2-4fdb-873d-9ec3f889fa7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_72ce4eb6-16ae-4ad1-915f-ecdb4beb880d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_72ce4eb6-16ae-4ad1-915f-ecdb4beb880d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_6394161a-1921-41dd-89e6-aeef32153275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_6394161a-1921-41dd-89e6-aeef32153275" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_e657aee0-b14e-41d7-88d2-1e3fad8f85dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_e657aee0-b14e-41d7-88d2-1e3fad8f85dc" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsLossPerShare" xlink:type="simple" xlink:href="cvs-20201231.xsd#EarningsLossPerShare"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/EarningsLossPerShare" xlink:type="extended" id="i95d8853daed346378516ae430b42db15_EarningsLossPerShare"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsLossPerShareTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#EarningsLossPerShareTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/EarningsLossPerShareTables" xlink:type="extended" id="ibc400b234ac44edcb542ff102893b47c_EarningsLossPerShareTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsLossPerShareDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#EarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/EarningsLossPerShareDetails" xlink:type="extended" id="i0adc0e9ae4144d16b2f19ea3b60a9138_EarningsLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1a9529bb-93a4-4f16-b50f-478fb6b22212" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ec60b113-e01b-4e73-89f0-57e665cee257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1a9529bb-93a4-4f16-b50f-478fb6b22212" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ec60b113-e01b-4e73-89f0-57e665cee257" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb99cb52-72b6-49d3-9349-c88892058d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1a9529bb-93a4-4f16-b50f-478fb6b22212" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb99cb52-72b6-49d3-9349-c88892058d1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_65dd10cf-5897-4ef6-abb3-be88b2443a27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb99cb52-72b6-49d3-9349-c88892058d1f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_65dd10cf-5897-4ef6-abb3-be88b2443a27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_65dd10cf-5897-4ef6-abb3-be88b2443a27_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_65dd10cf-5897-4ef6-abb3-be88b2443a27" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_65dd10cf-5897-4ef6-abb3-be88b2443a27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ab2d07-f620-4991-a18a-01a1c24e0044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_65dd10cf-5897-4ef6-abb3-be88b2443a27" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ab2d07-f620-4991-a18a-01a1c24e0044" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fd6fc78f-1936-405c-9443-e26e0626195d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ab2d07-f620-4991-a18a-01a1c24e0044" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fd6fc78f-1936-405c-9443-e26e0626195d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonEquivalentSharesMember_4d77ad2c-8f1e-4fb6-a0fc-44624e5925ef" xlink:href="cvs-20201231.xsd#cvs_CommonEquivalentSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ab2d07-f620-4991-a18a-01a1c24e0044" xlink:to="loc_cvs_CommonEquivalentSharesMember_4d77ad2c-8f1e-4fb6-a0fc-44624e5925ef" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Reinsurance" xlink:type="simple" xlink:href="cvs-20201231.xsd#Reinsurance"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/Reinsurance" xlink:type="extended" id="i6bfc56724eff4e23a42f54bf50ccafbd_Reinsurance"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#ReinsuranceTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ReinsuranceTables" xlink:type="extended" id="ibe3058584ba7422f84df5f27dfc85206_ReinsuranceTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ReinsuranceNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="extended" id="i8ede98bdf45745418792be4c368f7b86_ReinsuranceNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_74ea3b1a-9136-4099-900d-99d609607bee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofReinsuranceContractsEnteredInto_87c14767-3c9e-4ed4-b496-198df1684a2a" xlink:href="cvs-20201231.xsd#cvs_NumberofReinsuranceContractsEnteredInto"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_74ea3b1a-9136-4099-900d-99d609607bee" xlink:to="loc_cvs_NumberofReinsuranceContractsEnteredInto_87c14767-3c9e-4ed4-b496-198df1684a2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_41b2c945-0256-4b8d-adc7-f89ab5b92a6b" xlink:href="cvs-20201231.xsd#cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_74ea3b1a-9136-4099-900d-99d609607bee" xlink:to="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_41b2c945-0256-4b8d-adc7-f89ab5b92a6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_749468f4-b609-40d1-8092-c87b18994ba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_74ea3b1a-9136-4099-900d-99d609607bee" xlink:to="loc_us-gaap_SubsequentEventTable_749468f4-b609-40d1-8092-c87b18994ba2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_769dfdbd-bd8f-48bd-af16-51495439b58d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_749468f4-b609-40d1-8092-c87b18994ba2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_769dfdbd-bd8f-48bd-af16-51495439b58d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_769dfdbd-bd8f-48bd-af16-51495439b58d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_769dfdbd-bd8f-48bd-af16-51495439b58d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_769dfdbd-bd8f-48bd-af16-51495439b58d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_09674efa-1643-4b04-a485-e89b99264427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_769dfdbd-bd8f-48bd-af16-51495439b58d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_09674efa-1643-4b04-a485-e89b99264427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_087dd1c0-02a6-4d2d-a0bd-65267f564e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_09674efa-1643-4b04-a485-e89b99264427" xlink:to="loc_us-gaap_SubsequentEventMember_087dd1c0-02a6-4d2d-a0bd-65267f564e7b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ReinsuranceReinsuranceRecoverablesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="extended" id="i3e766e0f736f40f8b27636757ec025e2_ReinsuranceReinsuranceRecoverablesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems_ee390f9c-90f9-4083-830a-e47ba3238687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_d851a6ff-22ef-4ae1-b694-b5b5d3b16f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_ee390f9c-90f9-4083-830a-e47ba3238687" xlink:to="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_d851a6ff-22ef-4ae1-b694-b5b5d3b16f18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable_4a94a19f-6343-44d9-92db-04024048dbd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CededCreditRiskLineItems_ee390f9c-90f9-4083-830a-e47ba3238687" xlink:to="loc_us-gaap_CededCreditRiskTable_4a94a19f-6343-44d9-92db-04024048dbd9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis_9d2575cf-4084-43d0-9a7f-cc4895fed1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_4a94a19f-6343-44d9-92db-04024048dbd9" xlink:to="loc_us-gaap_CededCreditRiskAxis_9d2575cf-4084-43d0-9a7f-cc4895fed1b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_9d2575cf-4084-43d0-9a7f-cc4895fed1b6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CededCreditRiskAxis_9d2575cf-4084-43d0-9a7f-cc4895fed1b6" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_9d2575cf-4084-43d0-9a7f-cc4895fed1b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CededCreditRiskAxis_9d2575cf-4084-43d0-9a7f-cc4895fed1b6" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_6d56348a-382e-4791-9dd0-e987cd83cff6" xlink:href="cvs-20201231.xsd#cvs_HartfordLifeAndAccidentInsuranceCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:to="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_6d56348a-382e-4791-9dd0-e987cd83cff6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_3e52f0d7-62b2-4e7c-a97f-122aec9e559c" xlink:href="cvs-20201231.xsd#cvs_LincolnLifeAnnuityCompanyOfNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:to="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_3e52f0d7-62b2-4e7c-a97f-122aec9e559c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_WellCareHealthPlansMember_941fe80b-3d1a-4318-bc3f-34c512a13c10" xlink:href="cvs-20201231.xsd#cvs_WellCareHealthPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:to="loc_cvs_WellCareHealthPlansMember_941fe80b-3d1a-4318-bc3f-34c512a13c10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_d4c30a80-5aa0-44a2-bbda-ae7fa70b2284" xlink:href="cvs-20201231.xsd#cvs_VOYARetirementInsuranceAndAnnuityCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:to="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_d4c30a80-5aa0-44a2-bbda-ae7fa70b2284" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AllOtherReinsurersMember_477fb4fc-3674-4949-8095-d1f714191904" xlink:href="cvs-20201231.xsd#cvs_AllOtherReinsurersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:to="loc_cvs_AllOtherReinsurersMember_477fb4fc-3674-4949-8095-d1f714191904" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ReinsuranceEffectsofReinsuranceDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="extended" id="if49e4d60eb5e482c87d17d4b8f16083b_ReinsuranceEffectsofReinsuranceDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cvs-20201231.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="extended" id="i2f58459234ec47d4ab5a96534670acc2_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i2127f07600e74031836c540afe64e060_CommitmentsandContingenciesDetails"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReporting"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReporting" xlink:type="extended" id="i3253342fc74a4e0888d52d6276bb65fb_SegmentReporting"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReportingTables"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="extended" id="i763b9049e5aa40979b4321a9444ef09c_SegmentReportingTables"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReportingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended" id="if2c8acb0cb364008a44ef3aafc19f72f_SegmentReportingNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_4c37ad0d-2314-48af-bce7-46a89f75c4dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_17215e62-576e-469e-9171-db700c8dce83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_4c37ad0d-2314-48af-bce7-46a89f75c4dc" xlink:to="loc_us-gaap_NumberOfOperatingSegments_17215e62-576e-469e-9171-db700c8dce83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_79be953d-3a14-404a-aa56-d612271e7b1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_4c37ad0d-2314-48af-bce7-46a89f75c4dc" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_79be953d-3a14-404a-aa56-d612271e7b1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_27baab94-1124-41ec-867b-c5dc7cbc2058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_4c37ad0d-2314-48af-bce7-46a89f75c4dc" xlink:to="loc_us-gaap_ConcentrationRiskTable_27baab94-1124-41ec-867b-c5dc7cbc2058" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_82f87bc9-6bbc-4118-9418-d025cb121ab0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_27baab94-1124-41ec-867b-c5dc7cbc2058" xlink:to="loc_srt_MajorCustomersAxis_82f87bc9-6bbc-4118-9418-d025cb121ab0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_82f87bc9-6bbc-4118-9418-d025cb121ab0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_82f87bc9-6bbc-4118-9418-d025cb121ab0" xlink:to="loc_srt_NameOfMajorCustomerDomain_82f87bc9-6bbc-4118-9418-d025cb121ab0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3f7e9ecb-7d7c-4d66-aa63-4cbfe24a6668" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_82f87bc9-6bbc-4118-9418-d025cb121ab0" xlink:to="loc_srt_NameOfMajorCustomerDomain_3f7e9ecb-7d7c-4d66-aa63-4cbfe24a6668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc.Member_4f274d8b-fe89-4862-84d3-7a1112657332" xlink:href="cvs-20201231.xsd#cvs_AetnaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_3f7e9ecb-7d7c-4d66-aa63-4cbfe24a6668" xlink:to="loc_cvs_AetnaInc.Member_4f274d8b-fe89-4862-84d3-7a1112657332" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USFederalGovernmentMember_c81fb11b-a06b-4787-89b8-875c35975e6d" xlink:href="cvs-20201231.xsd#cvs_USFederalGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_3f7e9ecb-7d7c-4d66-aa63-4cbfe24a6668" xlink:to="loc_cvs_USFederalGovernmentMember_c81fb11b-a06b-4787-89b8-875c35975e6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e11286fc-a273-4476-b8ab-7e7411bb22e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_27baab94-1124-41ec-867b-c5dc7cbc2058" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e11286fc-a273-4476-b8ab-7e7411bb22e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e11286fc-a273-4476-b8ab-7e7411bb22e6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e11286fc-a273-4476-b8ab-7e7411bb22e6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e11286fc-a273-4476-b8ab-7e7411bb22e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_08c7883a-8cdc-42c6-819c-67c3cf072147" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e11286fc-a273-4476-b8ab-7e7411bb22e6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_08c7883a-8cdc-42c6-819c-67c3cf072147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_3944bfcd-a15e-4717-8286-7d7087fb712b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_08c7883a-8cdc-42c6-819c-67c3cf072147" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_3944bfcd-a15e-4717-8286-7d7087fb712b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_63de79da-e650-4a69-9275-0ee07edbdc8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_27baab94-1124-41ec-867b-c5dc7cbc2058" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_63de79da-e650-4a69-9275-0ee07edbdc8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_63de79da-e650-4a69-9275-0ee07edbdc8f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_63de79da-e650-4a69-9275-0ee07edbdc8f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_63de79da-e650-4a69-9275-0ee07edbdc8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_acda3ed8-5f68-4ea2-a645-e8055074923e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_63de79da-e650-4a69-9275-0ee07edbdc8f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_acda3ed8-5f68-4ea2-a645-e8055074923e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_a81f7bb6-f204-4183-8be7-03ce14fa4258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_acda3ed8-5f68-4ea2-a645-e8055074923e" xlink:to="loc_us-gaap_SalesRevenueNetMember_a81f7bb6-f204-4183-8be7-03ce14fa4258" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReportingSummarizedFinancialInformationofSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails" xlink:type="extended" id="i8c376f84144043cdb7a1399a8c23564c_SegmentReportingSummarizedFinancialInformationofSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_b14f19b5-b33d-4241-90fc-d09f3a1300d1" xlink:href="cvs-20201231.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_b14f19b5-b33d-4241-90fc-d09f3a1300d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_137696d9-842f-4fc5-9bdc-59f1cccf518c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_137696d9-842f-4fc5-9bdc-59f1cccf518c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_76d88ecb-5de0-4a12-91ce-2cac1e8cc4d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_us-gaap_NetInvestmentIncome_76d88ecb-5de0-4a12-91ce-2cac1e8cc4d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_694a72e4-4083-4fa5-9b6a-de43df3fb9d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_us-gaap_Revenues_694a72e4-4083-4fa5-9b6a-de43df3fb9d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_baf14011-6d3b-4c51-b069-2166f7095bdf" xlink:href="cvs-20201231.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_baf14011-6d3b-4c51-b069-2166f7095bdf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5bff06e6-db74-4fca-b9b4-b38b6e38b18a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5bff06e6-db74-4fca-b9b4-b38b6e38b18a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_bf48990d-98c6-4312-a834-005932186101" xlink:href="cvs-20201231.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_bf48990d-98c6-4312-a834-005932186101" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ff47053-b0d4-474a-9fc7-bea74c3be568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ff47053-b0d4-474a-9fc7-bea74c3be568" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7981e44a-3d63-4334-b918-2d99862f9e00" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ff47053-b0d4-474a-9fc7-bea74c3be568" xlink:to="loc_srt_ConsolidationItemsAxis_7981e44a-3d63-4334-b918-2d99862f9e00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7981e44a-3d63-4334-b918-2d99862f9e00_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_7981e44a-3d63-4334-b918-2d99862f9e00" xlink:to="loc_srt_ConsolidationItemsDomain_7981e44a-3d63-4334-b918-2d99862f9e00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9774d527-5f78-4b92-8b4d-0e47c1934537" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_7981e44a-3d63-4334-b918-2d99862f9e00" xlink:to="loc_srt_ConsolidationItemsDomain_9774d527-5f78-4b92-8b4d-0e47c1934537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d02ac021-b51f-4be1-accc-249a3b5b4592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9774d527-5f78-4b92-8b4d-0e47c1934537" xlink:to="loc_us-gaap_OperatingSegmentsMember_d02ac021-b51f-4be1-accc-249a3b5b4592" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_bbd0f78c-e275-4904-8107-304053eb5177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9774d527-5f78-4b92-8b4d-0e47c1934537" xlink:to="loc_us-gaap_IntersegmentEliminationMember_bbd0f78c-e275-4904-8107-304053eb5177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_fc39d354-0206-4c04-bbe1-a58a7810c589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_9774d527-5f78-4b92-8b4d-0e47c1934537" xlink:to="loc_us-gaap_CorporateNonSegmentMember_fc39d354-0206-4c04-bbe1-a58a7810c589" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3317a933-aba7-4608-86ce-89bb20da1b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ff47053-b0d4-474a-9fc7-bea74c3be568" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3317a933-aba7-4608-86ce-89bb20da1b36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3317a933-aba7-4608-86ce-89bb20da1b36_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3317a933-aba7-4608-86ce-89bb20da1b36" xlink:to="loc_us-gaap_SegmentDomain_3317a933-aba7-4608-86ce-89bb20da1b36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ee14efa9-1967-487e-bfd5-95f797e9ebfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3317a933-aba7-4608-86ce-89bb20da1b36" xlink:to="loc_us-gaap_SegmentDomain_ee14efa9-1967-487e-bfd5-95f797e9ebfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_07b11a51-3f93-456e-9318-880e6913b6aa" xlink:href="cvs-20201231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ee14efa9-1967-487e-bfd5-95f797e9ebfd" xlink:to="loc_cvs_PharmacyServicesSegmentMember_07b11a51-3f93-456e-9318-880e6913b6aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_b7b1fbdc-d1cd-4027-90d2-dd229e288ac3" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ee14efa9-1967-487e-bfd5-95f797e9ebfd" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_b7b1fbdc-d1cd-4027-90d2-dd229e288ac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_c3a438f6-ebc1-468f-b42a-f05d5c681f82" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ee14efa9-1967-487e-bfd5-95f797e9ebfd" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_c3a438f6-ebc1-468f-b42a-f05d5c681f82" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails" xlink:type="extended" id="i15a6da1b4e65443b8af1426abff0d7bc_SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_af38ed61-4a89-4a64-a772-3a498aa802cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_OperatingIncomeLoss_af38ed61-4a89-4a64-a772-3a498aa802cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_805b4449-3dfd-4989-87ca-f321087617a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_805b4449-3dfd-4989-87ca-f321087617a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_fc0bead6-6b98-4e60-ac77-f77e6f3ae66b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_fc0bead6-6b98-4e60-ac77-f77e6f3ae66b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_ec053e68-ca60-418a-8d34-3830e890a535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_ec053e68-ca60-418a-8d34-3830e890a535" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_057306d0-7bae-4faf-afc9-91fbadc99d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_057306d0-7bae-4faf-afc9-91fbadc99d52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreRationalizationCharges_fb3d5bc4-e2c3-4fae-bbbd-94d1ed33d901" xlink:href="cvs-20201231.xsd#cvs_StoreRationalizationCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_cvs_StoreRationalizationCharges_fb3d5bc4-e2c3-4fae-bbbd-94d1ed33d901" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_743e64b9-1a3a-4f1b-990f-b798ac324d33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_743e64b9-1a3a-4f1b-990f-b798ac324d33" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_0e71f281-9b4f-482f-86c8-7009363b0868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_0e71f281-9b4f-482f-86c8-7009363b0868" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_b049c3fd-b504-484e-a487-25c6ebfad080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_b049c3fd-b504-484e-a487-25c6ebfad080" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_c9d17d7e-5dd6-4253-ae0b-90d8e8e21b85" xlink:href="cvs-20201231.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_c9d17d7e-5dd6-4253-ae0b-90d8e8e21b85" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9459b3ad-c4a4-44c6-85e6-de65db1862bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9459b3ad-c4a4-44c6-85e6-de65db1862bc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_997d6ce2-7c26-44eb-b1b0-095679f10f00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_997d6ce2-7c26-44eb-b1b0-095679f10f00" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_2f69ef69-a2ed-4bbd-b104-e29b7776bffd" xlink:href="cvs-20201231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_2f69ef69-a2ed-4bbd-b104-e29b7776bffd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfUnderPerformingStoresPlannedClosure_d3b6d372-fde0-4612-bf17-b482a5267c7e" xlink:href="cvs-20201231.xsd#cvs_NumberOfUnderPerformingStoresPlannedClosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_cvs_NumberOfUnderPerformingStoresPlannedClosure_d3b6d372-fde0-4612-bf17-b482a5267c7e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3be36799-0120-4931-ac08-6edc66f71269" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3be36799-0120-4931-ac08-6edc66f71269" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ee251d31-3513-40e3-bd10-b6e28c15d7d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_us-gaap_DebtInstrumentAxis_ee251d31-3513-40e3-bd10-b6e28c15d7d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ee251d31-3513-40e3-bd10-b6e28c15d7d4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ee251d31-3513-40e3-bd10-b6e28c15d7d4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ee251d31-3513-40e3-bd10-b6e28c15d7d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f1c0d4a8-dc1c-42c0-a38e-9f84b36f079b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ee251d31-3513-40e3-bd10-b6e28c15d7d4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f1c0d4a8-dc1c-42c0-a38e-9f84b36f079b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TwoThousandEighteenNotesMember_d22f1d82-e7d2-429a-865e-cef750c8c44f" xlink:href="cvs-20201231.xsd#cvs_TwoThousandEighteenNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f1c0d4a8-dc1c-42c0-a38e-9f84b36f079b" xlink:to="loc_cvs_TwoThousandEighteenNotesMember_d22f1d82-e7d2-429a-865e-cef750c8c44f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_246ec571-f3cd-492b-a585-b0c42a3a15c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_246ec571-f3cd-492b-a585-b0c42a3a15c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_246ec571-f3cd-492b-a585-b0c42a3a15c2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_246ec571-f3cd-492b-a585-b0c42a3a15c2" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_246ec571-f3cd-492b-a585-b0c42a3a15c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41c7b4b9-756c-4a9d-9438-ee149d1e6388" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_246ec571-f3cd-492b-a585-b0c42a3a15c2" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41c7b4b9-756c-4a9d-9438-ee149d1e6388" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RXCrossroadsMember_3483da23-b597-4893-bcb4-774cf6d89e2b" xlink:href="cvs-20201231.xsd#cvs_RXCrossroadsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41c7b4b9-756c-4a9d-9438-ee149d1e6388" xlink:to="loc_cvs_RXCrossroadsMember_3483da23-b597-4893-bcb4-774cf6d89e2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_80f19b25-9d18-4073-a180-352085dc5544" xlink:href="cvs-20201231.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41c7b4b9-756c-4a9d-9438-ee149d1e6388" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_80f19b25-9d18-4073-a180-352085dc5544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a23cb319-0f8d-43e1-a1a7-1859d37463b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a23cb319-0f8d-43e1-a1a7-1859d37463b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a23cb319-0f8d-43e1-a1a7-1859d37463b4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a23cb319-0f8d-43e1-a1a7-1859d37463b4" xlink:to="loc_us-gaap_SegmentDomain_a23cb319-0f8d-43e1-a1a7-1859d37463b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a017e82c-7a12-499c-bf30-fa252f749c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a23cb319-0f8d-43e1-a1a7-1859d37463b4" xlink:to="loc_us-gaap_SegmentDomain_a017e82c-7a12-499c-bf30-fa252f749c8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_d27d4acb-c2be-460c-bca8-219e59a7ed7b" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a017e82c-7a12-499c-bf30-fa252f749c8c" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_d27d4acb-c2be-460c-bca8-219e59a7ed7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_e550f9cf-f3bc-423e-95e6-eee51954f7fa" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a017e82c-7a12-499c-bf30-fa252f749c8c" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_e550f9cf-f3bc-423e-95e6-eee51954f7fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_57f0f30c-fa08-4256-ac33-3325fe721c97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_57f0f30c-fa08-4256-ac33-3325fe721c97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_57f0f30c-fa08-4256-ac33-3325fe721c97_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_57f0f30c-fa08-4256-ac33-3325fe721c97" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_57f0f30c-fa08-4256-ac33-3325fe721c97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5e4f15d9-0be5-4906-a040-f029bc72b855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_57f0f30c-fa08-4256-ac33-3325fe721c97" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5e4f15d9-0be5-4906-a040-f029bc72b855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_750327e5-6643-4671-9e64-ae4d8d97d08d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_5e4f15d9-0be5-4906-a040-f029bc72b855" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_750327e5-6643-4671-9e64-ae4d8d97d08d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_715af28b-e610-47fb-aa56-40cd974f0f03" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_srt_LitigationCaseAxis_715af28b-e610-47fb-aa56-40cd974f0f03" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_715af28b-e610-47fb-aa56-40cd974f0f03_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_715af28b-e610-47fb-aa56-40cd974f0f03" xlink:to="loc_srt_LitigationCaseTypeDomain_715af28b-e610-47fb-aa56-40cd974f0f03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c04c467b-a4f0-4b6e-a15c-7792318123e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_715af28b-e610-47fb-aa56-40cd974f0f03" xlink:to="loc_srt_LitigationCaseTypeDomain_c04c467b-a4f0-4b6e-a15c-7792318123e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_bdc46ce1-dd6a-4106-bde9-20c28b364913" xlink:href="cvs-20201231.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_c04c467b-a4f0-4b6e-a15c-7792318123e9" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_bdc46ce1-dd6a-4106-bde9-20c28b364913" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_1edc673c-7248-4da9-a013-2ef975bb8ac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_us-gaap_LitigationStatusAxis_1edc673c-7248-4da9-a013-2ef975bb8ac1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_1edc673c-7248-4da9-a013-2ef975bb8ac1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_1edc673c-7248-4da9-a013-2ef975bb8ac1" xlink:to="loc_us-gaap_LitigationStatusDomain_1edc673c-7248-4da9-a013-2ef975bb8ac1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d71f1a23-ff54-4e63-9ce2-91aaa359db68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_1edc673c-7248-4da9-a013-2ef975bb8ac1" xlink:to="loc_us-gaap_LitigationStatusDomain_d71f1a23-ff54-4e63-9ce2-91aaa359db68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_bdf58c09-76bb-4624-8cd7-e865e9c90c21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_d71f1a23-ff54-4e63-9ce2-91aaa359db68" xlink:to="loc_us-gaap_SettledLitigationMember_bdf58c09-76bb-4624-8cd7-e865e9c90c21" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>cvs-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4a98170d-2b8a-4463-a058-df0f5f10bd13,g:ab909211-91be-459b-b532-dbe2c1c7ff2b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_644f15e2-b9cf-4195-bbb5-11f5951bfa1d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_1584bbbf-f2b1-4383-9cc3-4f5b2867dc49_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target investment allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7c1f8468-dfb0-424a-b06d-f3aca3c6fc6a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic value outstanding at end of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_459134b6-3d24-411c-a660-031ee407f83a_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, municipalities and political subdivisions</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_cf0c3e8e-e2f9-4132-a40f-2500770b2c73_verboseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, municipalities and political subdivisions</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_1f191826-aa10-457e-8141-71ca32c160c3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in benefit obligation:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_472fd98c-04bd-4ae6-bbc0-b7a5750742b8_terseLabel_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_label_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset-Backed Securities [Member]</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:to="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_416c8095-1ede-44d0-8b26-482bf7a073ca_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_714f3bd3-6a46-4fe0-9021-16de8de7f984_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in plan assets:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueMay2021Member_9b68f5d0-bc98-4a83-9ae8-d47a30a3c825_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due May 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueMay2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due May 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueMay2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due May 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueMay2021Member" xlink:to="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_36656c58-7109-49a3-bacb-f1007e8b77d5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_fd13974b-a7be-4b17-aa27-2e94eb698a73_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseCost_0455fff8-27b6-42ac-80fb-4f2218114442_totalLabel_en-US" xlink:label="lab_cvs_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease costs</link:label>
    <link:label id="lab_cvs_FinanceLeaseCost_label_en-US" xlink:label="lab_cvs_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:label id="lab_cvs_FinanceLeaseCost_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseCost" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseCost" xlink:to="lab_cvs_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesTable_5785f5ac-a4f7-4e7d-b839-26592b4629af_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Table]</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesTable_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable" xlink:to="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_8f1093cd-2454-409a-a033-9c56f451642b_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Insurance Liabilities</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:to="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_262536e2-a72c-4852-bf69-3be44a88e70a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase accounting adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_5922e143-68b8-474d-8e60-e5e0c05f8517_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueJune2021Member_eedc3020-051b-45e6-9df9-68d943723e01_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due June 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueJune2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due June 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueJune2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due June 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueJune2021Member" xlink:to="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_8ee70940-47e8-4a28-ab1a-d385ad1e03a3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_64e7eb62-6045-4ee7-b767-ff33bb00e802_negatedTerseLabel_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and breakage</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_label_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Redemption And Breakage</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_documentation_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Redemption And Breakage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:href="cvs-20201231.xsd#cvs_ContractWithCustomerLiabilityRedemptionAndBreakage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:to="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_bf11c356-22b4-4b4f-b6ae-c83cedeb5120_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_15c861ae-d46e-4d0c-8d9f-87ce87f8ab40_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_label_en-US" xlink:label="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:to="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_a62d7706-8314-4d77-b6f2-2c9e77f256f8_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_62c759f6-19f8-41a7-b2b9-06b1eaa2e3bd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6d61a3b8-9d02-4ee3-9c53-d231c2133b6c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_276897cd-9193-40da-8c74-bdd6e2b75572_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.05% senior notes due March 2048</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:to="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b744e75d-2893-46f9-beaf-bc72021949af_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_f04f049f-5707-4077-a42d-a4448216bca9_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due July 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due July 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due July 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueJuly2022Member" xlink:to="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5f0c318c-6e77-4fab-8f34-5450a2d9dca0_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_651b6c12-61e7-4e41-bcf8-070d4d76a57b_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_43f8d0a1-b4d4-42ff-8873-094c29a12cfa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_ee8614cb-5eb6-4c99-b158-1733fde4379c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b128fd02-9a09-4a9a-b769-bbf84643f07f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category7Member_915d98c9-fda3-418a-95de-c2debe3013bd_terseLabel_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7</link:label>
    <link:label id="lab_cvs_Category7Member_label_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 7 [Member]</link:label>
    <link:label id="lab_cvs_Category7Member_documentation_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Category 7</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member" xlink:href="cvs-20201231.xsd#cvs_Category7Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category7Member" xlink:to="lab_cvs_Category7Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceDisclosuresAbstract_2eab99f1-93eb-49b2-b408-d0991c56aca4_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReinsuranceDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract" xlink:to="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_9627065c-8bbf-4a03-9c47-513d10338f36_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2Point7PercentAugust2040Member_c4d1274f-359c-4c73-8489-c0f675330af6_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.7% senior notes due August 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes2Point7PercentAugust2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2 Point 7 Percent, August 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2Point7PercentAugust2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2 Point 7 Percent, August 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2Point7PercentAugust2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:to="lab_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_5108bb82-3730-444a-9236-b3e300bf9d5a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share from continuing operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ced089db-e866-406d-bf8e-ba2817e3f697_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0f4bcc8b-ff26-4c26-bea4-d448a58d39a0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_2e4f9c5a-31e4-4b48-8da1-06470c70f955_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_da21d0d4-e7f7-4794-a6fb-2b73968cf25d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_19b47e6b-020f-4a8b-9ea4-0465c99d5b73_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_fe8886ef-2717-4b3b-b8a8-8d95a5a0cd3d_terseLabel_en-US" xlink:label="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized and unrealized capital gains (losses):</link:label>
    <link:label id="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_label_en-US" xlink:label="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]</link:label>
    <link:label id="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_documentation_en-US" xlink:label="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:href="cvs-20201231.xsd#cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:to="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_fbdd5bbb-930a-4474-aaf8-f8ef4689720a_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_22ecf68a-06c4-4ae9-8418-f40020c4cce1_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_0fbf5694-9a87-4ff9-ad3a-ac5301d9b0ee_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1983e60b-2d7c-44d5-ba40-a3cd37621ad9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_25499b7c-0ffe-4e78-a9fa-2a82b6e3daa5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingExpensesExcludingGoodwillImpairments_4a4ad645-df3a-433b-b555-25adf8e2e1d4_terseLabel_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingGoodwillImpairments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_cvs_OperatingExpensesExcludingGoodwillImpairments_label_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingGoodwillImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Goodwill Impairments</link:label>
    <link:label id="lab_cvs_OperatingExpensesExcludingGoodwillImpairments_documentation_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingGoodwillImpairments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Goodwill Impairments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairments" xlink:href="cvs-20201231.xsd#cvs_OperatingExpensesExcludingGoodwillImpairments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingExpensesExcludingGoodwillImpairments" xlink:to="lab_cvs_OperatingExpensesExcludingGoodwillImpairments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsYearOne_3bcd5ff6-99cb-4c99-a1c1-ee0c51bc0e66_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsYearOne_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Year One</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsYearOne_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsYearOne" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsYearOne" xlink:to="lab_cvs_LesseeLiabilityPaymentsYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_4d64a0b1-411b-45a9-a21e-1f71fbdae1b6_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_e545a8f7-2095-4a9d-ae76-4995ff330132_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows paid for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_9dc3e3c5-79e6-4e8b-bec8-6837710db40f_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_30c6b7c3-0b02-489a-89c6-681cbf36fed7_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_6ed83ef8-28d1-4a8c-b62a-2d0335c48b84_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d79b07cb-ebbf-4e94-a465-5af7651f9234_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentMember_a505b541-e5d4-45e1-b652-7afb8c74146f_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentMember_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealEstateInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentMember" xlink:to="lab_us-gaap_RealEstateInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f05f36e1-165e-4744-befe-cf735d7b73b5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_54b61a7b-e945-45a7-adee-7413fc7ab437_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign securities</link:label>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_572fdc08-2695-4c4a-bcda-a6ddbc176a88_terseLabel_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator for earnings (loss) per share calculation:</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20201231.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a91e254b-5586-4f64-9434-e2a7defd17dc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b119bc75-ab34-4438-9544-31e71934d5ef_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8f2cbfc3-6ec3-4ec7-9425-88647c6e6479_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_708704fa-a1b7-46f8-b5cb-00848bee0fa5_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_480f8b61-4735-4750-8655-a9040a0d42c7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7d1b974a-3d75-462a-b259-4a49878b9596_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_c0241ed9-9297-4b97-bdb4-dbb8daa0f723_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_0fb837a1-ead6-4741-87ec-55119b2915ae_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligations, maximum exposure</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_0b62dcc1-196f-44b9-b68b-ed49a2016d03_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_9945a95e-9f39-414e-92fd-d41b34b28dc9_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_f7696676-fcf0-4e64-a965-8690ac543035_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_c392f8a4-f7fb-4420-9cbd-ab26a4481b4b_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts without a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:href="cvs-20201231.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_319d053a-f51c-4c50-bae7-fa784d08619c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_8c60182a-e77b-43b7-b146-7a27fb597f65_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share from continuing operations, diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_70e39912-9317-4a28-b260-2efa1858c08b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_02a2d1c1-1474-41f0-a0ab-172322e7673a_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_f6dbfef2-be4c-4b89-a41b-245f43ba798c_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseMinimumRentals_86ada928-e6f4-4103-b3c1-03b9b9775fbb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum rentals</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseMinimumRentals_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Minimum Rentals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseMinimumRentals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_9363e913-bcaa-4fc8-ae0f-63e714308e82_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution centers and Corporate Offices</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_37be799c-8a8a-46aa-9be4-631f727058db_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_44c26dbf-8f76-41c1-b433-87802655a68a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_d1a43ee8-103f-4fc6-bc3e-78a60f82e5fb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay182022Member_5b813f41-a8a0-41bc-91c7-c07484cb0b87_terseLabel_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay182022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 18, 2022</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay182022Member_label_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay182022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 18, 2022 [Member]</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay182022Member_documentation_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay182022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 18, 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay182022Member" xlink:href="cvs-20201231.xsd#cvs_RevolvingCreditFacilityExpiringMay182022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RevolvingCreditFacilityExpiringMay182022Member" xlink:to="lab_cvs_RevolvingCreditFacilityExpiringMay182022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_121747a8-508a-43ca-a2f7-76a1d4f76f5d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_c1253f4a-e488-49f3-8924-0c071672f807_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows paid for principal portion of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_05301182-28fc-4530-b3bc-2eabfe8427b4_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income (Loss) by Component</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_567babc5-fe4e-40f6-a31e-5fbfc0106829_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_7f75aada-091a-42b6-afc9-666b5f5c1d13_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_f77a3b64-947e-4d6d-9e7f-eed58e0317bf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_bdf3f7e8-ce3b-4ca9-bc16-7a5d42031357_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_0e87d707-5393-4c7f-b0c5-55aa7aa4d656_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_f3fd03f2-7603-4ff9-a4b3-f810b6b0762d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage ("Less than" - 2018 Federal Government)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_53696cb1-01af-4a55-8f96-700aa6482380_terseLabel_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-related impairment loss (reversal of loss)</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20201231.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b80797c0-bd5d-48ea-a40b-1e89207b8a1e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_97eea806-c7fd-4fe6-928f-49dc3f977c99_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_da249b73-6943-42a9-9c97-b92bfa33c03b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category2To4Member_9013d3ea-e239-44ca-85f6-a604533e673f_terseLabel_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2 to 4</link:label>
    <link:label id="lab_cvs_Category2To4Member_label_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 2 to 4 [Member]</link:label>
    <link:label id="lab_cvs_Category2To4Member_documentation_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member" xlink:href="cvs-20201231.xsd#cvs_Category2To4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category2To4Member" xlink:to="lab_cvs_Category2To4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_8af984e8-ec7a-4f6d-aaed-326450ff1242_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.3% senior notes due December 2043</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:to="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_0db235d9-e731-4912-8539-b17d86238f3b_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Three</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_de2b159c-06e7-481a-ad75-b35c4a710c9d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_0a94f64e-1cf3-41d2-8d52-5571d573ac17_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_7c42bf4f-b2d2-4a31-b2ed-627242f4d7f4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_301f9d68-3e2a-4f39-861d-efadbfefcb2e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_d6e3da0c-074a-4593-8dc3-ea687173a645_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ec0202d5-db30-45f8-b64d-3126ff75687c_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_b992b076-557b-4af9-93ba-63213f286302_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset_cdaec222-5981-415b-8646-eb2a9046d1cb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities subject to offsetting and enforceable master netting arrangements</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Collateral, Right to Reclaim Cash, Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset" xlink:to="lab_us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_b934abd9-a96a-4ab1-bd4e-8e9024f11a20_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_3f9f1df0-1c5d-4add-b844-0c0599fca1a0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_ca7b7204-22a1-4984-88e1-1c689ce2aa52_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_169bfd07-4f22-4429-b127-7cd5e7ea1274_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_87f1aab2-d059-46ae-8b1d-2a018eca521e_terseLabel_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line</link:label>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthInsuranceProductLineMember" xlink:to="lab_us-gaap_HealthInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsDomain_c1c7f5a6-af9a-4049-a04f-dc3faaf250b1_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsDomain_label_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsDomain" xlink:to="lab_cvs_TotalInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_a393563a-284f-4084-9532-12862799b348_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance and Deposit Contracts [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:to="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_6874eef5-128b-4b76-9605-cf521066a585_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings and Credit Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ffed30fd-0031-4cba-9a27-0e78c5156596_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_d567f085-f708-487b-ad8c-8d03b1a51e3f_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Prior To Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Prior To Period Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_32ab286d-4a9a-4c09-94b9-2b6083a40ab1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_15866349-11ba-4ded-9fa9-2f9f2dbab1c9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_7bea567c-7b53-4887-a919-5ceb44e25150_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b72c943f-118a-431f-8df3-bfce65b2ee68_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_7da07081-4f3a-49d7-91a3-aa79955cc2c7_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_cd4285a5-1ff0-429d-a4bb-2faadc63c9a3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment realignment</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b68dc6e9-f3c2-481b-aa4e-963ac9ccc476_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_8ecf7cda-fec0-4abc-be67-5a56bd34787f_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3% senior notes due August 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:to="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_d4022e6e-96d0-49ad-b994-3b9a4af54163_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate/ Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_fe9c8f68-4d64-4c02-a301-7e5556bbd5e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityUndiscountedExcessAmount_c2cf9883-bdb1-48ec-b4f8-39d973b3007f_negatedTotalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cvs_LesseeLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_cvs_LesseeLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:to="lab_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskAxis_211802bb-3bbf-4dd9-9ca4-9835a3c18ccc_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Reinsurer [Axis]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskAxis_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Reinsurer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskAxis" xlink:to="lab_us-gaap_CededCreditRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification_cc26e828-486a-4ddb-a896-785818849f5e_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from pharmacy claims and discounts payable</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification_label_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Reclassification</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification_documentation_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of unpaid retail pharmacy claims to third parties from pharmacy claims and discounts payable to health care costs payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification" xlink:href="cvs-20201231.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification" xlink:to="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_453ef474-cfc4-41ea-8601-a2950fd2625d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_8c748200-0167-49aa-8fd0-c8c7dabd755b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesHeldInEmployeeTrustShares_f4b56eec-a09e-4847-acb9-161f984788a6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesHeldInEmployeeTrustShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares held in trust (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesHeldInEmployeeTrustShares_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesHeldInEmployeeTrustShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Held in Employee Trust, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesHeldInEmployeeTrustShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesHeldInEmployeeTrustShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesHeldInEmployeeTrustShares" xlink:to="lab_us-gaap_CommonStockSharesHeldInEmployeeTrustShares" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_USFederalGovernmentMember_eb22c296-9357-41b3-856e-1c97065fd0cc_terseLabel_en-US" xlink:label="lab_cvs_USFederalGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Federal Government</link:label>
    <link:label id="lab_cvs_USFederalGovernmentMember_label_en-US" xlink:label="lab_cvs_USFederalGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Federal Government [Member]</link:label>
    <link:label id="lab_cvs_USFederalGovernmentMember_documentation_en-US" xlink:label="lab_cvs_USFederalGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Federal Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USFederalGovernmentMember" xlink:href="cvs-20201231.xsd#cvs_USFederalGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_USFederalGovernmentMember" xlink:to="lab_cvs_USFederalGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_02bbafaf-e504-40d5-abac-345ecda7c63f_terseLabel_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of leases guaranteed</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_label_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number of Leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_documentation_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases" xlink:href="cvs-20201231.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_GuarantorObligationsNumberofLeases" xlink:to="lab_cvs_GuarantorObligationsNumberofLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a683f589-31cc-4dc8-9c82-b3772a11dfff_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_bcc1b9ac-d400-469c-b961-870426ce9dca_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_5e891167-cbe0-4ff2-b9f3-26f94a645d3a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value and estimated fair value of certain financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_af5f23d8-145c-4930-ba83-d75dcbde8ed4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_08e66e6b-b143-49cc-a6d8-9a88aeee6a87_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined statutory capital and surplus</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus, Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_b9f56feb-4454-4650-ae14-d4ffb20cedb4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_e5ccf227-dd08-424d-9a68-7956fec9232a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis difference upon disposition of subsidiary</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_7a9fb0c5-0649-4b3a-af3e-7036d56204dc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201802Member_ab292b87-17a9-4226-91b8-bda468772ede_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201802Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201802Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201802Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201802Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201802Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201802Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201802Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_92945eeb-dd2f-4754-ba16-459cdead87bd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_c05f9c10-ca4a-4de0-9d9e-76cf8bb17cfb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and rents</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_b04b945e-93b7-43a7-8cdb-3f5d38d25501_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member_0d67ea4a-0adf-4a75-ad2a-348ff506e085_terseLabel_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 17, 2023</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member_label_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 17, 2023 [Member]</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member_documentation_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 17, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay172023Member" xlink:href="cvs-20201231.xsd#cvs_RevolvingCreditFacilityExpiringMay172023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RevolvingCreditFacilityExpiringMay172023Member" xlink:to="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock_f923b350-26bd-451d-9399-789f5d76d1db_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareCostsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_95c54fcc-8c03-4bce-bc9b-1a2c76f216af_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_033e9cfe-ef8f-4447-b9d3-f33b1da995ce_terseLabel_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services</link:label>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_label_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services Segment [Member]</link:label>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_documentation_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember" xlink:href="cvs-20201231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyServicesSegmentMember" xlink:to="lab_cvs_PharmacyServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_dc0829c1-0d2c-432d-8e4c-42a4a0536e8c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation not yet recognized, options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FrontStoreRevenueMember_ee39c223-5dc7-4678-b2d2-b28e93007751_terseLabel_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_label_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_documentation_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember" xlink:href="cvs-20201231.xsd#cvs_FrontStoreRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FrontStoreRevenueMember" xlink:to="lab_cvs_FrontStoreRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_dd7c8ec6-6a60-432e-8961-669fad1f7cd5_terseLabel_en-US" xlink:label="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four years reinsurance agreement with unrelated insurer</link:label>
    <link:label id="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_label_en-US" xlink:label="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Years Reinsurance Agreement With Unrelated Insurer</link:label>
    <link:label id="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_documentation_en-US" xlink:label="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This line item represents the four years of a reinsurance agreement with an unrelated insurer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:href="cvs-20201231.xsd#cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:to="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskLineItems_6d24258d-857c-4b2f-ac61-ef01f87a4424_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskLineItems_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskLineItems" xlink:to="lab_us-gaap_CededCreditRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_c7140b77-6e09-4612-9533-ec17be5e1706_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_0ec97a48-c0a5-417f-af38-0da1f88bcf31_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_baff0b46-ecf8-4fe1-ba3b-99a4bf887880_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_3387c665-bca6-449c-b239-b66f850d3e5f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1c99a290-3736-4bbd-a667-5f317dc2d642_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued to acquire Aetna</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_089e2cc2-7fa1-4394-bd62-ac8f1a0995a2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e2ce09e1-3ba3-49f3-9397-90a979f2bd08_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_8ccfd8ce-88ac-41be-92a4-6a05d4f8b0ad_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated minimum statutory surplus required by regulators</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_69df6cda-486a-4a22-94e5-5b3008925eb2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_08d42dcf-4281-4771-939f-01392141456b_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance benefits paid</link:label>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_label_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Insurance Benefits</link:label>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_documentation_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Insurance Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits" xlink:href="cvs-20201231.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsforInsuranceBenefits" xlink:to="lab_cvs_PaymentsforInsuranceBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_d29f849e-35b9-497e-beb5-a86b96d1f74c_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_99a4e4c0-6e63-4328-8a60-426f0f7a5781_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthInsurerFee_e82e3812-301b-4418-a2f5-e77362211755_terseLabel_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFee_label_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFee_documentation_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee" xlink:href="cvs-20201231.xsd#cvs_HealthInsurerFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthInsurerFee" xlink:to="lab_cvs_HealthInsurerFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_9893415e-2f01-4bb7-aa5f-4386ca2381a9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_0c3b6125-0c87-4d4c-a616-26a59e8ee8b2_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease costs and supplemental cash flow information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_43e00c90-9ed0-4fbb-8323-84a7aee84c1c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All outstanding liabilities for health care costs payable prior to 2019, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_73b55792-9eba-49b9-84db-56edb8807ab4_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and lease obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c50c06a2-bbb8-4857-9ef9-2ccd66045976_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_e5b3d250-6504-4755-8dd2-88e7ee0d8498_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contracts/relationships and covenants not to compete</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_129a4958-df36-4862-8c66-80d0817cc2c0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_041f7fe2-26fd-44d2-a388-3d2d9fc0f69d_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5ae5af0f-3b7f-4cdb-9d3e-83c39974870c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_9be13937-a69f-491f-8ce5-241a7b4389f6_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_label_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_documentation_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:href="cvs-20201231.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:to="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_a8b60489-84fc-47ef-87e3-1dc1ce6bfe96_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_e74408ab-8dfc-4676-ad72-e4242b790adb_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_8ab568a4-7a0d-4b70-9bbe-1e0ba24a089c_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, unrealized losses</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_c4d3e575-aca9-4783-ba07-5d6a8f3eb58b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d841c7c3-87d8-4f9c-9b3b-e849d03848cc_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_25e5fa91-686a-441d-9d57-13524ad1dac0_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium receivables</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:to="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_94501f0a-5a43-447a-ba81-80b07751f4cf_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c04b1c50-b833-4f82-ad9e-ff3587329db1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_ee27a4ea-fe28-4788-adb0-5e86c30f2a67_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_f2786b4a-1599-413a-9605-568ee3e9b7c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6e6d40c1-bc87-46af-8831-cf841ae2e277_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DrogariaOnofreLtdaMember_4c7842a5-4afc-40bc-b2ad-eaae757828e5_terseLabel_en-US" xlink:label="lab_cvs_DrogariaOnofreLtdaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drogaria onofre Ltda. [Member]</link:label>
    <link:label id="lab_cvs_DrogariaOnofreLtdaMember_label_en-US" xlink:label="lab_cvs_DrogariaOnofreLtdaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drogaria onofre Ltda. [Member]</link:label>
    <link:label id="lab_cvs_DrogariaOnofreLtdaMember_documentation_en-US" xlink:label="lab_cvs_DrogariaOnofreLtdaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drogaria onofre Ltda.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DrogariaOnofreLtdaMember" xlink:href="cvs-20201231.xsd#cvs_DrogariaOnofreLtdaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DrogariaOnofreLtdaMember" xlink:to="lab_cvs_DrogariaOnofreLtdaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_229b320e-0655-4e2f-8166-f576bc8af7a7_terseLabel_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities</link:label>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:to="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_c679328a-0f4c-4800-9de8-35815e215344_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_2b105001-da1e-4896-b5d6-d3f9ef7505a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable and other insurance liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b353aeca-4af5-4463-a4fd-b2af6ae040a6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_99e51acc-e545-440b-8f9f-30c806d210b4_terseLabel_en-US" xlink:label="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Life &amp; Annuity Company of New York</link:label>
    <link:label id="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_label_en-US" xlink:label="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Life &amp; Annuity Company Of New York [Member]</link:label>
    <link:label id="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_documentation_en-US" xlink:label="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Life &amp; Annuity Company Of New York [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:href="cvs-20201231.xsd#cvs_LincolnLifeAnnuityCompanyOfNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:to="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0e55c950-e843-45c8-aaf6-393ec8bc78ff_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_7fa8b4ac-3cbe-489f-aa9b-bda7900ffc02_terseLabel_en-US" xlink:label="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations:</link:label>
    <link:label id="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="cvs-20201231.xsd#cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_d2493eb2-cdde-4c08-9725-b0e56c6bac2e_terseLabel_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-related impairment loss</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20201231.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_422251d6-0e04-4bdc-ac1b-f4399787004c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_65fcfdfa-bf77-4362-abe9-7a898e20975f_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Two</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_2b679bcf-bd34-41ff-b20d-1d8b2e1be45e_verboseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_857ffff5-5343-476d-8297-cfe2fc387d21_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_b41831ea-a2f9-47b0-8b60-193895794f86_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_45475262-a172-4415-a01d-652097f7eb10_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_dc3de590-74c3-43d8-be19-b3b0b6277ac9_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due August 2047</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:to="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalCreditAssessmentDomain_81bef3dd-29e3-4490-bdbd-4bc8b078696f_terseLabel_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Domain]</link:label>
    <link:label id="lab_us-gaap_InternalCreditAssessmentDomain_label_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain" xlink:to="lab_us-gaap_InternalCreditAssessmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_e8cb8f86-911f-4a5a-9e1a-65f13c0dc1af_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Contract Acquisition Costs</link:label>
    <link:label id="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_label_en-US" xlink:label="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:to="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b0f3e310-6dd0-4c99-9244-2fdc48b05390_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_1de800b6-4ae3-471a-9cfb-6d7a3d9c4af3_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_e5bf36e1-2327-4c3a-9035-c35d3f413c78_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.125% senior notes due July 2045</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:to="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3a2b1f05-d25c-45c0-813e-25c787a577bd_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_26283cb8-a563-4354-8ce5-e67a083e98cc_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term vested at end of year and expected to vest in the future</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_d555d044-fd7d-41c3-8174-a24fe7439c00_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d817b435-a49c-40a7-9fa3-f7dbffc5a3f0_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_ae6fd160-3410-458d-9bba-b834a2c8af2b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_69bedd3b-49e2-4bb9-b89c-c3b2dc841c52_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_880af1f1-0d05-459d-b8a4-4ecc6560fe86_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_57134531-55ac-4ff5-bd0c-7adb64dc29af_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_fe8cb4d6-f273-4b79-adc1-ad2dcf22df83_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_81c8db11-b858-4b54-8339-7ce629d162fd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_767cfdab-9e74-481d-827b-09dfb7377a14_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_0ceb801f-03e5-49f1-80e4-cf55d746b8dd_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mail choice</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_9d20e4a3-0fcb-4ea2-9418-6ff9500dad32_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income on financing for the Aetna Acquisition</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_1ec8e362-c83e-4d93-9666-5fb33fc6774c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3Point625PercentApril2027Member_67b50585-1903-46d9-96d2-1a662c207411_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% senior notes due April 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point625PercentApril2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 625 Percent, April 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point625PercentApril2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 625 Percent, April 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3Point625PercentApril2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:to="lab_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_87d3e652-e249-4c56-b3d0-94b19b6ce4a8_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% senior notes due June 2036</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:to="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_f8b47082-da7a-480f-b538-79bb884514f4_terseLabel_en-US" xlink:label="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of direct, assumed and ceded premiums earned</link:label>
    <link:label id="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_label_en-US" xlink:label="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-17, Insurance Companies, Reinsurance [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:to="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_d56015ab-d5cb-42f4-a4ba-cd1dbcba08e9_terseLabel_en-US" xlink:label="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables [Member]</link:label>
    <link:label id="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_label_en-US" xlink:label="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables [Member]</link:label>
    <link:label id="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_documentation_en-US" xlink:label="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:href="cvs-20201231.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:to="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_9d4888e4-d4cc-45af-a2f8-0c1bc37aa650_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherLongTermInsuranceLiabilitiesMember_47f42851-e122-443a-a469-4d62cbc95cb7_terseLabel_en-US" xlink:label="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Insurance Liabilities</link:label>
    <link:label id="lab_cvs_OtherLongTermInsuranceLiabilitiesMember_label_en-US" xlink:label="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Insurance Liabilities [Member]</link:label>
    <link:label id="lab_cvs_OtherLongTermInsuranceLiabilitiesMember_documentation_en-US" xlink:label="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Insurance Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:href="cvs-20201231.xsd#cvs_OtherLongTermInsuranceLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:to="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_8d75780c-c87d-4536-b3a1-8a5d65055372_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_4ad74d42-dcd4-49eb-9a45-feb81253ae48_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share from continuing operations, basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_5455240b-d736-4db2-a182-0b2b4880e467_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_dd186414-8f8c-449a-8ce1-952867b3c852_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_8382ca92-8e35-487c-88c5-20fb4e1f29ab_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalCreditAssessmentAxis_6b449a3b-1727-437f-bfd0-dd968ca63124_terseLabel_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Axis]</link:label>
    <link:label id="lab_us-gaap_InternalCreditAssessmentAxis_label_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis" xlink:to="lab_us-gaap_InternalCreditAssessmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits_d3cbfd14-31d7-43f1-afa0-1868850f9059_terseLabel_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement benefits</link:label>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits_label_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Retirement Benefits</link:label>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits_documentation_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Retirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:href="cvs-20201231.xsd#cvs_DeferredTaxLiabilitiesRetirementBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:to="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_75a3f04a-819b-4c08-a048-2abe89062707_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_955b43d5-cb4d-47d5-9aa3-c8782cea0ef8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_d90c303f-4b8a-4e54-81d9-06f15c815ec0_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares held in trust (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:href="cvs-20201231.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:to="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_415b1113-f873-4476-9d1e-f2a8929e4e42_terseLabel_en-US" xlink:label="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOYA Retirement Insurance and Annuity Company</link:label>
    <link:label id="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_label_en-US" xlink:label="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOYA Retirement Insurance And Annuity Company [Member]</link:label>
    <link:label id="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_documentation_en-US" xlink:label="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOYA Retirement Insurance And Annuity Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:href="cvs-20201231.xsd#cvs_VOYARetirementInsuranceAndAnnuityCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:to="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_4910b702-bd79-48a4-8b63-da55a7286077_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_f79569bf-2752-4c68-95d0-cb76d0aae3c3_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases, sales and settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:to="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_6a694d82-db78-45e8-a54c-e2d580269ab2_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_568b15ca-003d-436b-b7c7-e82d6d02dfcb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium paid in excess of debt principal</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_4d4b2ee8-4c05-4b15-b720-98e6bc36fc35_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related transaction and integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_a97e62e0-d891-400f-90ee-0d6b19d87e41_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CommonEquivalentSharesMember_92b28093-9ce5-48aa-9a40-f0c3585a419b_terseLabel_en-US" xlink:label="lab_cvs_CommonEquivalentSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Equivalent Shares</link:label>
    <link:label id="lab_cvs_CommonEquivalentSharesMember_label_en-US" xlink:label="lab_cvs_CommonEquivalentSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Equivalent Shares [Member]</link:label>
    <link:label id="lab_cvs_CommonEquivalentSharesMember_documentation_en-US" xlink:label="lab_cvs_CommonEquivalentSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Equivalent Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonEquivalentSharesMember" xlink:href="cvs-20201231.xsd#cvs_CommonEquivalentSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CommonEquivalentSharesMember" xlink:to="lab_cvs_CommonEquivalentSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_27fb4f7b-7cc3-41f1-b6f0-ce53956d80c0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.125DueMarch2020Member_77dd7fab-2d40-4326-a43e-d2de166e4657_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.125DueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% senior notes due March 2020</link:label>
    <link:label id="lab_cvs_SeniorNotes3.125DueMarch2020Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.125DueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.125%, Due March 2020 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.125DueMarch2020Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.125DueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.125%, Due March 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.125DueMarch2020Member" xlink:to="lab_cvs_SeniorNotes3.125DueMarch2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_edc056ec-ea61-4c55-a179-4666b7257fd7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, outstanding at beginning of year ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c287bc41-0ba1-48d9-a9c7-500e79d1ecf4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, outstanding at end of year ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_e3c0e297-22f0-4aee-b912-8bd8d7389c01_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable to Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableToBanksMember" xlink:to="lab_us-gaap_NotesPayableToBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4a61afc1-e141-4245-bdf6-e855543d86c4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2ec0e918-47b7-49c5-ae3f-ad490f65251b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ee826d0e-6d08-4618-a655-a91f739c08e8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeOperatingAndFinanceLeasesTermOfContract_019eac89-0731-47fe-b151-d78cb87e1437_terseLabel_en-US" xlink:label="lab_cvs_LesseeOperatingAndFinanceLeasesTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_cvs_LesseeOperatingAndFinanceLeasesTermOfContract_label_en-US" xlink:label="lab_cvs_LesseeOperatingAndFinanceLeasesTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Term Of Contract</link:label>
    <link:label id="lab_cvs_LesseeOperatingAndFinanceLeasesTermOfContract_documentation_en-US" xlink:label="lab_cvs_LesseeOperatingAndFinanceLeasesTermOfContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Term Of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeOperatingAndFinanceLeasesTermOfContract" xlink:href="cvs-20201231.xsd#cvs_LesseeOperatingAndFinanceLeasesTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeOperatingAndFinanceLeasesTermOfContract" xlink:to="lab_cvs_LesseeOperatingAndFinanceLeasesTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_5850be10-f038-4571-bd1f-e3d81ef2ae50_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_a9db7de5-0eae-46d2-9aa0-617070dbaddf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_14bdc3ca-772f-4163-8722-01405d855743_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from stock options exercised (including ESPP)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b92c5fc9-6c79-46e1-83f6-a11dbc82e048_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_61edd56b-fc2d-42a2-b9da-309449992258_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3f786517-536b-4479-bdf1-3d9c7c7bf242_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarized financial information of segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CashFlowLesseeAbstract_0956b353-4565-444f-883f-c25e6fbbf57e_terseLabel_en-US" xlink:label="lab_cvs_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_cvs_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_cvs_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:label id="lab_cvs_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_cvs_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CashFlowLesseeAbstract" xlink:href="cvs-20201231.xsd#cvs_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CashFlowLesseeAbstract" xlink:to="lab_cvs_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_40267d46-0ff1-4417-829e-4b0de9968c84_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_b34ef74d-41dd-48e8-b4a4-bc99fac691b1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_91b4a26d-bbb8-4037-ab77-acd77fb9b92a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_23897c25-2189-4868-b303-5639b5cb9be5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_279ad108-19ef-4beb-b167-b830d8e7aa33_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_f71d5220-a551-4f2f-8699-91491cc497e2_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt securities by contractual maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6529aa2f-a916-4d6f-a1d3-ebf9eb1de0dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountsPolicy_cf693f60-8f9e-41c8-8ef5-968d46a6fc3a_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Accounts</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountsPolicy" xlink:to="lab_us-gaap_PolicyholderAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_682a0915-9b51-45f7-a1f3-39bea55d438d_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_57c10a5a-8bbf-4610-9797-30825510e602_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_e6af8237-b870-41d8-81f1-4f2086c4205c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average assumptions used in determining benefit obligations and net benefit costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_01ec385f-f5e0-4426-bb5d-cdadbfc90f41_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_bc416412-6e8c-40d1-acc9-610312d1a951_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BackUpCreditFacilitiesMember_9034b3eb-6ebd-4802-8b4d-9f03e8171265_terseLabel_en-US" xlink:label="lab_cvs_BackUpCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Back-Up Credit Facilities</link:label>
    <link:label id="lab_cvs_BackUpCreditFacilitiesMember_label_en-US" xlink:label="lab_cvs_BackUpCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Back-Up Credit Facilities [Member]</link:label>
    <link:label id="lab_cvs_BackUpCreditFacilitiesMember_documentation_en-US" xlink:label="lab_cvs_BackUpCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Back-Up Credit Facilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BackUpCreditFacilitiesMember" xlink:href="cvs-20201231.xsd#cvs_BackUpCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BackUpCreditFacilitiesMember" xlink:to="lab_cvs_BackUpCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_28fddea7-eb5d-448e-9898-ac7d874bff26_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in plan assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongTermCareReportingUnitMember_fab172d1-9cc2-487a-9f92-bba7cfed2ca9_terseLabel_en-US" xlink:label="lab_cvs_LongTermCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care Reporting Unit</link:label>
    <link:label id="lab_cvs_LongTermCareReportingUnitMember_label_en-US" xlink:label="lab_cvs_LongTermCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care Reporting Unit [Member]</link:label>
    <link:label id="lab_cvs_LongTermCareReportingUnitMember_documentation_en-US" xlink:label="lab_cvs_LongTermCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember" xlink:href="cvs-20201231.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongTermCareReportingUnitMember" xlink:to="lab_cvs_LongTermCareReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_0c6d1c31-58ab-46fc-a6fd-8349dac9abe5_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized capital gains</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_65f0095c-47e0-410a-af25-53b584e671a1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_92284145-5bd5-4919-a93f-cad8daee5bab_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_90596601-f565-4f1f-b483-f82552e09fdf_terseLabel_en-US" xlink:label="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected to vest (in shares)</link:label>
    <link:label id="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_label_en-US" xlink:label="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number</link:label>
    <link:label id="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_documentation_en-US" xlink:label="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" xlink:href="cvs-20201231.xsd#cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" xlink:to="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c08e0c13-7bb6-4396-bb2e-96e6ef261db4_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangibles</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_1ad7fc07-ea99-47bc-8b48-6479f01e51fe_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_91fcc582-580a-4432-b941-46221cc3f0f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_ad1ca4a9-c01e-46d4-8949-8b9ab68750fb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_521b8f17-392e-4fb7-918f-d37299fc0e83_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_4e4f6793-ec65-49bb-9aac-3cfa1286dccf_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet_9f393976-f405-4cf9-87a0-fdff1b89ee85_terseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable</link:label>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet" xlink:to="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_640ff6f6-98a8-4e55-b717-bc165d6cc44b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7143be03-750d-4480-ba81-6e18da5d2c9e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_11fb408a-edab-4925-b67b-69f3e07aa4bf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax income recognized</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_0c05db66-29f4-4f48-9e5e-b4bd11bc42fc_terseLabel_en-US" xlink:label="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contribution to CVS Health Foundation</link:label>
    <link:label id="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_label_en-US" xlink:label="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Charitable Contribution To Non-Profit Entity</link:label>
    <link:label id="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_documentation_en-US" xlink:label="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Charitable Contribution To Non-Profit Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:href="cvs-20201231.xsd#cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:to="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_52463146-fe9b-4c36-bf0f-fa0e3c19dc51_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative goodwill impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_f9a7a404-859b-49a7-a292-5b51c2d227b9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_9830d9d6-a82c-4888-b826-92369fbb885c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026-2030</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_1458c595-0691-44d8-9e9f-29a5646495fe_terseLabel_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts, Equity Securities</link:label>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_label_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust, Equity Securities [Member]</link:label>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_documentation_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:href="cvs-20201231.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:to="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearTwo_ae0b914f-23f7-423e-a213-a1ed89b541a7_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_ef0a6ceb-3737-47f4-8cc6-5b58fbe955e7_terseLabel_en-US" xlink:label="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds received and tax benefit from share-based payment awards</link:label>
    <link:label id="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Proceeds Received and Tax Benefit from Share-based Payment Awards [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:to="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_0b7d763a-674c-40e9-bc47-32152ec027df_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingencyUnrecordedAmount_88274121-0c2c-4186-bbd5-f56741451c93_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingencyUnrecordedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain contingency, unrecorded amount</link:label>
    <link:label id="lab_us-gaap_GainContingencyUnrecordedAmount_label_en-US" xlink:label="lab_us-gaap_GainContingencyUnrecordedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Unrecorded Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingencyUnrecordedAmount" xlink:to="lab_us-gaap_GainContingencyUnrecordedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_bc6b4a14-29d8-48b3-91bd-1bc49bf74bed_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_2ce8ee5b-e876-42d5-92b2-ea7cb24bdbb3_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HeathSavingsAccountBalance_1564352e-7ae4-4610-b2dd-eb88be8ac29c_terseLabel_en-US" xlink:label="lab_cvs_HeathSavingsAccountBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HSA balances</link:label>
    <link:label id="lab_cvs_HeathSavingsAccountBalance_label_en-US" xlink:label="lab_cvs_HeathSavingsAccountBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heath Savings Account Balance</link:label>
    <link:label id="lab_cvs_HeathSavingsAccountBalance_documentation_en-US" xlink:label="lab_cvs_HeathSavingsAccountBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heath Savings Account Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeathSavingsAccountBalance" xlink:href="cvs-20201231.xsd#cvs_HeathSavingsAccountBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HeathSavingsAccountBalance" xlink:to="lab_cvs_HeathSavingsAccountBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_f7005744-211e-43b8-bfca-ddf1eb7c5c32_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% senior notes due November 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due November 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due November 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.75DueNovember2022Member" xlink:to="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e147f67d-f577-4a3f-be38-46217beb70fc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7c11deac-183b-4aab-b2b6-fb9ef1671c9c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes for net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RedeemablePreferredSecuritiesMember_c5476bca-f84c-4a26-8ba6-95df7553fb83_terseLabel_en-US" xlink:label="lab_cvs_RedeemablePreferredSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred securities</link:label>
    <link:label id="lab_cvs_RedeemablePreferredSecuritiesMember_label_en-US" xlink:label="lab_cvs_RedeemablePreferredSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Securities [Member]</link:label>
    <link:label id="lab_cvs_RedeemablePreferredSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_RedeemablePreferredSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedeemablePreferredSecuritiesMember" xlink:href="cvs-20201231.xsd#cvs_RedeemablePreferredSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RedeemablePreferredSecuritiesMember" xlink:to="lab_cvs_RedeemablePreferredSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_32549fa9-a7c8-4f56-9641-91a92d2cc081_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_173652ef-fd1a-4fa0-9ac6-ac95f4f972da_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available for sale</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssumedPremiumsEarned_ce8cf2a7-da1e-40c1-98f3-7906713da957_terseLabel_en-US" xlink:label="lab_us-gaap_AssumedPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed</link:label>
    <link:label id="lab_us-gaap_AssumedPremiumsEarned_label_en-US" xlink:label="lab_us-gaap_AssumedPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Premiums Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssumedPremiumsEarned" xlink:to="lab_us-gaap_AssumedPremiumsEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_741f61e3-78af-4ebd-a278-b644d763ac46_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life of property plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_8e948c32-8222-4f49-b344-82a611c70f2a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_ad96808f-e726-4cfc-bab1-d4a3ee303edb_terseLabel_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains from sale-leaseback transactions</link:label>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_label_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:to="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_14dfb88c-cf00-48ad-8990-07458a17ab10_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_851dc0e5-5f0e-49c1-9015-1ce6e0d3b702_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_32b58bde-e7d5-48ef-8ede-9e1c70737431_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_65578425-ee2b-467c-94a6-a34f6b09d93c_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_292dccef-74f0-47f0-b9e2-89832eaccb02_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_785ff64d-e139-41d9-b0c8-bb51657881a9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_f754c30a-c86e-4be1-b297-199133157e57_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_149dfc0a-674a-4dcb-9e84-f9c11d9cc469_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_bab81610-d5c9-4f4a-b4ed-4e88b9c16f7a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dcd98ea6-b3b2-4bf4-9f62-9c511f5916f5_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_cafb9591-2011-4a0a-953e-cb17d5e2bc55_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_c36f7546-74c0-4009-9961-c60c1c294d60_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_477c2636-357a-4615-a975-2f7328b06a3c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_83f46d2e-33d9-4197-9cdd-2248ded74464_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_6a799fca-5748-4c0c-9f29-6b1821f1e8df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1e5ef289-6ee7-4883-8e6f-7253bcd45d73_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPlanMembers_786c6d05-baf6-45ce-9795-bde0479d9757_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPlanMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plan members</link:label>
    <link:label id="lab_cvs_NumberOfPlanMembers_label_en-US" xlink:label="lab_cvs_NumberOfPlanMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Plan Members</link:label>
    <link:label id="lab_cvs_NumberOfPlanMembers_documentation_en-US" xlink:label="lab_cvs_NumberOfPlanMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Plan Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPlanMembers" xlink:href="cvs-20201231.xsd#cvs_NumberOfPlanMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPlanMembers" xlink:to="lab_cvs_NumberOfPlanMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c2b16dd9-ce05-436e-970b-22cb980aa1aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_cb4b28e6-6a31-4984-9746-dca0d36fc9e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_1f406cf4-4f96-468c-8f87-14b39f2b8e55_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_89242686-62b0-41b9-98b3-3ae53dd4a231_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_ff34c2a4-d562-4c8f-a906-7c57e194bf1d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.875%, senior notes due February 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.875%, Due February 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.875%, Due February 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1875DueFebruary2031Member" xlink:to="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_edce0517-9aa7-4f4c-933f-33d841148de8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_7ed52755-cc7a-4a79-b264-ac3b55711009_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_e8ba04dd-1a09-46d4-957c-8709edfc4001_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4% senior notes due December 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:to="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_1ed55905-851e-46dc-aa61-eeca8c0a9366_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_c4b9f128-4a86-4a01-853c-43b05597c6bb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIE, ownership percentage</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_4308a531-bd64-411b-b899-f9414a779e3d_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_eb6f3e94-933e-44b1-ad8c-614a34294ac2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_048ff307-9ead-4f8d-9e83-d85899302d1a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_2abab30e-b654-4e06-94fe-1353e5d33a3c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FloatingRateNotesMember_ddf6d70c-aaee-4067-849d-e6ba2fb04583_terseLabel_en-US" xlink:label="lab_cvs_FloatingRateNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes</link:label>
    <link:label id="lab_cvs_FloatingRateNotesMember_label_en-US" xlink:label="lab_cvs_FloatingRateNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes [Member]</link:label>
    <link:label id="lab_cvs_FloatingRateNotesMember_documentation_en-US" xlink:label="lab_cvs_FloatingRateNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesMember" xlink:href="cvs-20201231.xsd#cvs_FloatingRateNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FloatingRateNotesMember" xlink:to="lab_cvs_FloatingRateNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_e1d6b16b-786c-4617-a654-b3c1f4fa288c_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Paid and Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:to="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9e5798c8-8229-405b-a721-7e49f7b45325_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_eb081890-07fa-49d4-a148-b77a9e807383_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_848ae105-4cfd-49bb-9611-e94fcfa1ae90_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders&#8217; funds</link:label>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_label_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Policyholder Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPolicyholderFunds" xlink:to="lab_us-gaap_OtherPolicyholderFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_7c1f0e93-677a-49c8-8b69-32b3b84a0ac2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_2b346644-3826-4768-944a-a00c0ab83ac1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_fe43fefa-8c2d-481d-915a-ca1cdabc9cca_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Claims paid</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_04159e55-bc78-443d-bbb7-c867a7e763d4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_805ef826-8df4-442c-b4fc-8efa7e56178b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_9c6e5a02-8dcb-4f4d-802b-8b90f7da24f8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_9a0d184d-1e97-4ea8-9ee7-2ddbbb18ba84_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_7eab557d-c839-420f-a84e-c0f743efc254_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of operating earnings to net income</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_8379e2bd-9118-4ecc-a6be-bd919f914f03_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_06e3775a-779f-4d27-b3ce-7c03cc266efd_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_fbc3b5a4-fb56-4c9f-91fc-b81893bb5453_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_5d08b5bd-4a32-4470-80ed-a4ea8a96e1a4_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_ec86c962-8655-410f-9687-8c6738b68a69_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% senior notes due August 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.3%, Due August 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.3%, Due August 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes13DueAugust2027Member" xlink:to="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_95151f1a-6a2e-483f-b281-3c3398d6cf8c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and investment income received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Interest and Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_07695b17-9b26-4fef-a7dc-3f6fb742802b_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due March 2044</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:to="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_a792813b-81fe-43a7-8a25-136424096e8d_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:href="cvs-20201231.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_d800f297-d7e3-4bd4-8e7f-051bd371ec33_negatedTerseLabel_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discounts and deferred financing costs</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_label_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_documentation_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:href="cvs-20201231.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:to="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_a965021a-3e01-4306-a09d-deaf4db9386f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4e640438-6b60-4934-93f8-b2370c507688_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_2e28fb72-4cf4-4417-a56e-2c5b23c61f70_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_99b5955e-1ec0-4299-aaaa-b7fdc88b7957_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_c1820078-92e3-43ff-9b60-823f64c68060_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock and Capital Surplus</link:label>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Including Additional Paid in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_01d31601-7603-4e63-9b61-ca2d2e6c2cfb_terseLabel_en-US" xlink:label="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options and Stock Appreciation Rights</link:label>
    <link:label id="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_label_en-US" xlink:label="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember" xlink:href="cvs-20201231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember" xlink:to="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDue_c60b58bf-a1c6-4f7a-827d-ae1209ce5dec_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDue_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDue" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue" xlink:to="lab_cvs_LesseeLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansMember_6a860f2c-a765-4858-8883-8655770ca8a7_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_label_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans [Member]</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_documentation_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansMember" xlink:to="lab_cvs_MortgageLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_78bc725a-2fb6-4e3d-ad10-6cbbac2e06fd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_fd0d6343-defe-4996-bf2e-df6ee771428b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearThree_f9e1b44b-b651-4747-912b-d476c294fec3_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a15bc363-cc41-47e0-85f0-438eab65054c_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a3d32f28-948e-42b0-b612-de44d7f30484_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_a218938d-1650-430d-9f88-b0af11abd373_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_4da8e609-d480-499b-8f4d-042ae7804984_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock percent</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProceedsFromVariableInterestEntity_c83c90d2-5859-4590-888f-cd9868cded47_terseLabel_en-US" xlink:label="lab_cvs_ProceedsFromVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from VIE</link:label>
    <link:label id="lab_cvs_ProceedsFromVariableInterestEntity_label_en-US" xlink:label="lab_cvs_ProceedsFromVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Variable Interest Entity</link:label>
    <link:label id="lab_cvs_ProceedsFromVariableInterestEntity_documentation_en-US" xlink:label="lab_cvs_ProceedsFromVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Variable Interest Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsFromVariableInterestEntity" xlink:href="cvs-20201231.xsd#cvs_ProceedsFromVariableInterestEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProceedsFromVariableInterestEntity" xlink:to="lab_cvs_ProceedsFromVariableInterestEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes43Due2028Member_41092778-0872-4d6e-b8bf-218fe3422a09_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes43Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.3% senior notes due 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes43Due2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes43Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes43Due2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes43Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes43Due2028Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes43Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes43Due2028Member" xlink:to="lab_cvs_SeniorNotes43Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_0f036432-bf11-458b-a304-128925b7c306_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_6f1e34a3-4c07-4d28-be9b-a2305d0546cd_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of the period</link:label>
    <link:label id="lab_us-gaap_Goodwill_6af44448-d00b-452e-94f1-e729efedc184_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of the period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2021Member_ffc27987-aa77-4eca-a8f9-e96e929de78f_terseLabel_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes due March 2021</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2021Member_label_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2021 [Member]</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2021Member_documentation_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2021Member" xlink:href="cvs-20201231.xsd#cvs_FloatingRateNotesDueMarch2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FloatingRateNotesDueMarch2021Member" xlink:to="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e848a1f2-0f43-487a-b84d-751136833182_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_9d93d4aa-2c81-4a05-818f-35ab49078f36_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_label_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsLineItems" xlink:to="lab_cvs_TotalInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesMember_91dc8ce7-fd8d-4180-a5fd-48dc445144a4_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesMember_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities [Member]</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesMember_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesMember" xlink:href="cvs-20201231.xsd#cvs_OtherInsuranceLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesMember" xlink:to="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b80b212a-568f-491c-8954-247cfb4aafea_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_bd5325be-a912-43b0-a559-329f78a7bc52_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e1c68c3a-0de5-409c-835a-7fdcbd8cc893_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and capital loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.35DueMarch2021Member_c1cac97c-3925-49aa-99cb-0c4f53b7c9df_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.35% senior notes due March 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes3.35DueMarch2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.35%, Due March 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.35DueMarch2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.35%, Due March 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.35DueMarch2021Member" xlink:to="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_54ce3608-cc07-47ec-817d-a3ad57bb7c0e_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment expenses</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Investment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_44789c0c-36b0-4426-9300-9064fe5de770_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_713d09bc-6fc5-4ba6-9e2e-a9f2a4ec002a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_80188e5a-9939-499d-ab9c-9ef896b990f4_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issued in acquisition</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_0afdd6b3-6082-44ac-8f9c-23ad1075b016_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on sale of subsidiaries</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_41ae3cd8-9d5e-40c1-9456-b835d250f434_negatedLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of subsidiary</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssets_6fca8e76-f83f-45b3-b681-15c73945138c_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts assets</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssets_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssets" xlink:to="lab_us-gaap_SeparateAccountAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_72dfcd07-7cbc-4b3d-bf35-2889371e306b_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building, building improvements and leasehold improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_b992be82-20d9-4342-9097-8d966e042385_verboseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_3905e561-6a36-4f4c-97bc-4befefacfacc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_00dae8e0-a44b-45d8-bd07-e570bd337136_terseLabel_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other decreases in noncontrolling interests</link:label>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_label_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, Other Period Increase (Decrease)</link:label>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, Other Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:href="cvs-20201231.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:to="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4125DueApril2040Member_7f7e77f1-b1b2-46c6-aed7-f5d26b52ec82_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due April 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes4125DueApril2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due April 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4125DueApril2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due April 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4125DueApril2040Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4125DueApril2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4125DueApril2040Member" xlink:to="lab_cvs_SeniorNotes4125DueApril2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_557ae8e0-7040-40a2-b346-1e27925d428a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c9d8cf99-207f-4549-a49f-fc27755bd9f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_8414c163-5c34-4965-97d1-053ef6de3ff8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_cffe4f87-ca4a-4211-8eb7-222db073a67d_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LimitedPaymentsContracts_d8569898-c1f0-4262-acec-e6b8796e87c9_terseLabel_en-US" xlink:label="lab_cvs_LimitedPaymentsContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed interest rates on limited payment pension contracts on large case pension business (in hundredths)</link:label>
    <link:label id="lab_cvs_LimitedPaymentsContracts_label_en-US" xlink:label="lab_cvs_LimitedPaymentsContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Payments Contracts</link:label>
    <link:label id="lab_cvs_LimitedPaymentsContracts_documentation_en-US" xlink:label="lab_cvs_LimitedPaymentsContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum assumed interest rates on limited payment contracts on large case pensions business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LimitedPaymentsContracts" xlink:href="cvs-20201231.xsd#cvs_LimitedPaymentsContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LimitedPaymentsContracts" xlink:to="lab_cvs_LimitedPaymentsContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8a5dc723-6d6a-4764-90ba-ce6c01845a03_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_0b4c5002-3841-4af5-8ec5-bd7b2cad3ee5_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate account financial assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_1b81baa9-134c-460f-a517-72e06f08a93c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities (included in accrued expenses)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_68044253-e237-4cef-ad03-aab18406608e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31, 2019</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_447cf852-931c-4760-a3b1-a47c08781399_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31, 2020</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_b6d575b6-2cb9-4968-ad31-64cc66128581_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_c02bbd25-5cf9-4d67-871c-5d6783ba387e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_f1a2c4d7-6365-4fa6-8a8a-ad6809b9f397_terseLabel_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available for sale</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_label_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities Available For Sale [Member]</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_documentation_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:href="cvs-20201231.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:to="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5c5432ac-b5b9-46f8-bbe5-eac53fff0a28_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, granted ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_5a911019-e4bd-4ee2-a00a-52d33b2ad961_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_0e8b6480-ebf6-4135-bb37-6163ce50e137_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_d76513e0-19bb-40f7-8daf-e8d5ffbb1ad7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_4ef0f333-74c1-40ee-8144-65fe5be27278_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8f27783a-bfe7-4a87-af80-d719e4091ece_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual pretax amortization for other acquired intangible assets over the next five years</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7b792fae-8d81-48af-8252-e200f17bfb20_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0fe9efe8-8947-4b71-a06e-616a264e273e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_1deb9ca3-0c42-4ad0-94a8-6196cf78d486_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_13ea0b81-59ef-44e2-af29-04d25ac84257_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_02117cda-cf85-4b18-b959-ce71c2afe882_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_b93f6d5c-fd3f-4f9d-8418-4449cd7388c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_97e52198-de84-4da2-a401-745522c3ea22_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt of fully reserved ACA risk corridor receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_95f6c7b4-98d6-4304-bac7-bcb90d27ee77_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_2435701b-3e9c-4efb-bcad-8f68ca09c912_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_368b2070-9854-4d5e-89bb-01eb7794b472_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_aab6f8dd-01a0-4cac-8af5-fb50cafd8cb9_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_0e5f6a52-5ba4-41ee-ad2f-433ca92f7c49_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_44ed60ae-0b60-48bb-a65a-d05954d7bf4a_negatedTerseLabel_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_label_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Accumulated Depreciation</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:to="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_a04be4f2-a8b2-42aa-b95d-43ea21a638b9_totalLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net benefit costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationPerShareExchangeRatio_d038ba5f-ddf3-4ed0-bc92-2a2e308fd402_terseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationPerShareExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per share exchange ratio</link:label>
    <link:label id="lab_cvs_BusinessCombinationPerShareExchangeRatio_label_en-US" xlink:label="lab_cvs_BusinessCombinationPerShareExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Per Share Exchange Ratio</link:label>
    <link:label id="lab_cvs_BusinessCombinationPerShareExchangeRatio_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationPerShareExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Per Share Exchange Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPerShareExchangeRatio" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationPerShareExchangeRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationPerShareExchangeRatio" xlink:to="lab_cvs_BusinessCombinationPerShareExchangeRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_3b38837d-30b8-4cd9-b7ee-161ee47393ac_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_d62f85fc-afbb-43c2-b9d0-39fac606f6ec_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ab92b85e-cfb8-4e60-be4f-fde080070101_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_431e30f2-0b3b-4e86-9a1c-30a24a7c607d_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_c863ed9e-a897-4882-ac3b-4c73585c7fe7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_aa85d8fb-a629-4f61-aaf4-2e082e65b2f4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_005b6c4b-51cb-4cd3-90e4-5effb09a298f_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.75% senior notes due December 2037</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:to="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_aea67141-ecc2-4b49-b2f0-ecb99a56e0a3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3200600a-9327-49ec-9bf8-b88a99804423_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_8015493f-0340-4a5b-9b3b-30bcd8e8e241_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated maximum dividend distributions permitted in 2021 without prior regulatory approval</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_ee9ba5e7-6d74-4782-9108-949177095ec7_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other current assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_c52cb654-4011-401b-ba80-9fe866439b8a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_3e23ea7b-cff0-48f0-84f5-80f24a6099e3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_2986d641-6b79-4831-a6f5-221c0c3a6099_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_ac24f4ee-375d-49ca-adbc-6eac9c90d614_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_63fb875f-9f0f-4c49-8549-3dcde0571bd2_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_c2016294-96fc-4e15-b32e-96b3782ab56b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ValueOfBusinessAcquiredMember_e70beebf-6b23-40bc-b254-188f0a5045bb_terseLabel_en-US" xlink:label="lab_cvs_ValueOfBusinessAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Business Acquired</link:label>
    <link:label id="lab_cvs_ValueOfBusinessAcquiredMember_label_en-US" xlink:label="lab_cvs_ValueOfBusinessAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Business Acquired [Member]</link:label>
    <link:label id="lab_cvs_ValueOfBusinessAcquiredMember_documentation_en-US" xlink:label="lab_cvs_ValueOfBusinessAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Business Acquired [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ValueOfBusinessAcquiredMember" xlink:href="cvs-20201231.xsd#cvs_ValueOfBusinessAcquiredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ValueOfBusinessAcquiredMember" xlink:to="lab_cvs_ValueOfBusinessAcquiredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_96acd401-bc22-4451-9305-aa00c027fcf3_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due July 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:to="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive_43691c7a-5854-4ac8-88bf-3b2de370922d_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due After Year Five</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_c7e488a3-0ea0-4d97-811e-877afad4dd01_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eec6d70f-d9ac-4afd-9b26-eebd1010d506_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LeasesWeightedAverageDiscountRateAbstract_53ead9ae-6320-4707-9501-cedb9e5caa00_terseLabel_en-US" xlink:label="lab_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_cvs_LeasesWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_cvs_LeasesWeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted Average Discount Rate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:href="cvs-20201231.xsd#cvs_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:to="lab_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.45DueJune2021Member_2c824671-98a4-4f9b-969d-af35e6bc0c8e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.45% senior notes due June 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes5.45DueJune2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.45%, Due June 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.45DueJune2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents senior notes due 2021 with a coupon rate of 5.45%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.45DueJune2021Member" xlink:to="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BrazilSubsidiaryMember_763c70dd-ad0f-478c-bcf7-d3e1a395550d_terseLabel_en-US" xlink:label="lab_cvs_BrazilSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil Subsidiary</link:label>
    <link:label id="lab_cvs_BrazilSubsidiaryMember_label_en-US" xlink:label="lab_cvs_BrazilSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil Subsidiary [Member]</link:label>
    <link:label id="lab_cvs_BrazilSubsidiaryMember_documentation_en-US" xlink:label="lab_cvs_BrazilSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BrazilSubsidiaryMember" xlink:href="cvs-20201231.xsd#cvs_BrazilSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BrazilSubsidiaryMember" xlink:to="lab_cvs_BrazilSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_61dd632f-7779-4066-8bd8-09165ed3379c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_15f6c7d3-d816-4a90-8375-c44ba68e653d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_fed297cb-3e8e-472b-808e-5b8cebcc7272_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f246354e-a13f-446c-836b-a401e7eaac6c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPeopleServed_095286b4-c401-4399-adb5-442830100f1f_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of people served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_label_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_documentation_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed" xlink:href="cvs-20201231.xsd#cvs_NumberOfPeopleServed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPeopleServed" xlink:to="lab_cvs_NumberOfPeopleServed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_ac641efa-fb1d-4c4f-a8b2-ab8334393c73_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:to="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_cd983011-8b97-4b49-afcb-47c69c42fdc1_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_5a8de1a5-4956-49d0-8aea-bf84bf443c24_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_2b962646-f53f-4d80-aac2-a80621e3f678_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_ae5754b8-ba28-4229-b45c-e8934d0d7398_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_cbab6aa6-0158-4d8a-b3ef-79446ab2bd50_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAbstract_58ff5adb-b6a6-4a36-be59-5530e204400a_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting [Abstract]</link:label>
    <link:label id="lab_us-gaap_OffsettingAbstract_label_en-US" xlink:label="lab_us-gaap_OffsettingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAbstract" xlink:to="lab_us-gaap_OffsettingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_6dba6524-15d6-4eb4-8756-e4a266f18724_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average duration of securities</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_0314718b-8c68-42fb-b5b0-e7c1e8d63bb6_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_c7cc2078-8af7-48f8-803f-313291c3cdfc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeparateAccountFinancialAssetsMember_339c2fda-6031-4b68-83bd-1ac11777327c_terseLabel_en-US" xlink:label="lab_cvs_SeparateAccountFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Accounts, financial assets</link:label>
    <link:label id="lab_cvs_SeparateAccountFinancialAssetsMember_label_en-US" xlink:label="lab_cvs_SeparateAccountFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Financial Assets [Member]</link:label>
    <link:label id="lab_cvs_SeparateAccountFinancialAssetsMember_documentation_en-US" xlink:label="lab_cvs_SeparateAccountFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountFinancialAssetsMember" xlink:href="cvs-20201231.xsd#cvs_SeparateAccountFinancialAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeparateAccountFinancialAssetsMember" xlink:to="lab_cvs_SeparateAccountFinancialAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f00f7689-623f-4bfe-8bd8-688b9fe9195c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_4ec89949-aa18-4cec-bbc1-c8a05ecbeaf3_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts liabilities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_label_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountsLiability" xlink:to="lab_us-gaap_SeparateAccountsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_dc0a1e0b-7534-4d4b-b224-b76409d034d2_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts with a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:href="cvs-20201231.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_cb88e2be-2b45-44f3-af76-311ee1a340f9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred in acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_81b1aeef-074c-477b-a078-70922b65b717_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due November 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:to="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_941e30a5-6f45-4e82-9d11-62ebbb0efa76_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_51d542fc-870c-479f-9e83-8a78d98ba2d0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_2df1755f-64c4-4761-aa1a-62c6bedfc3c3_terseLabel_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former gain contingency, recognized in current period, net of tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period, Net of Tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_documentation_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:href="cvs-20201231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:to="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_f8c429b1-cb45-4455-b56d-b3412aefa854_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b58a1f00-84c0-4e9b-9651-a3b2d052746a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_a7cf01c7-4be3-48b3-8a6d-6d2184764ed7_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:href="cvs-20201231.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_1bc4d67e-0665-428b-8319-bb11ae1231f0_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_d110e4c6-c0cf-4257-8206-ca84bed5eb40_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% senior notes due December 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due December 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.75DueDecember2022Member" xlink:to="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_8bd03ddf-8ff3-464a-b26a-5e5c782c21a9_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_bfddc56c-3b93-4c51-a9f4-1fb4bb7547ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information about incurred and paid health care claims development</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_942572cc-ab31-439b-9e52-f9f0439f22c4_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_16c03901-c64e-4cbe-897d-4270b022bb9d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease costs</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_bcc1ce1e-90a6-4366-a99e-39fc3077622c_verboseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_586d70d6-c75c-42de-a0f6-cfc328d6b60e_terseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_label_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Deficiency Reserve Liability</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_documentation_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability" xlink:href="cvs-20201231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumDeficiencyReserveLiability" xlink:to="lab_cvs_PremiumDeficiencyReserveLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_e1c043d2-1a57-4894-82be-109d4f690f8f_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:to="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_2cc8d4b1-9e8f-46b8-b973-e240931d75be_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:to="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member_bae00a21-0d40-4bf8-9e13-b70f5b79196e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.875% senior notes due February 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 875 Percent, February 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 875 Percent, February 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes1Point875PercentFebruary2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:to="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_332f07f7-1d17-4a94-8d15-cf78bf2ca1ee_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2a335d6f-ca2a-4e44-9e86-a085a4281575_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and rents</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_a353a4c5-f24a-48ce-93d6-a20df03e37e2_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_a6357a0c-fe8d-4ba7-ae5f-2d76a21860cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LeaseLiability_775c67a9-da75-4d7b-9724-fcd792e2f805_totalLabel_en-US" xlink:label="lab_cvs_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_cvs_LeaseLiability_label_en-US" xlink:label="lab_cvs_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_cvs_LeaseLiability_documentation_en-US" xlink:label="lab_cvs_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeaseLiability" xlink:href="cvs-20201231.xsd#cvs_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LeaseLiability" xlink:to="lab_cvs_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_156e9a19-a1b4-43d7-9618-892bcde6a1b1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_3777e385-0a8c-415e-89f6-e67d1333b005_totalLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Commercial and Consumer, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f6d593c7-4a8d-4ed6-897c-7d53c62c784e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskTable_dd98089e-9e89-47b0-8d08-c19e8490436b_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Table]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskTable_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskTable" xlink:to="lab_us-gaap_CededCreditRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6aaf448c-63ff-493f-a59c-4c647811340c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFour_563e6bfd-1f1d-47f4-9316-058e763dd812_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseContingentRentals_52c5ad92-c413-4871-8b1f-df260710c416_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseContingentRentals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent rentals</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseContingentRentals_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseContingentRentals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Contingent Rentals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseContingentRentals" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseContingentRentals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseContingentRentals" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseContingentRentals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_28df8120-ceeb-4d7e-8b1b-a58fe9713773_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AetnaInc2010StockIncentivePlanMember_7e5440de-2c01-4165-a167-f1ad7cbe6318_terseLabel_en-US" xlink:label="lab_cvs_AetnaInc2010StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna Inc 2010 Stock Incentive Plan</link:label>
    <link:label id="lab_cvs_AetnaInc2010StockIncentivePlanMember_label_en-US" xlink:label="lab_cvs_AetnaInc2010StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna Inc 2010 Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_cvs_AetnaInc2010StockIncentivePlanMember_documentation_en-US" xlink:label="lab_cvs_AetnaInc2010StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna Inc 2010 Stock Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc2010StockIncentivePlanMember" xlink:href="cvs-20201231.xsd#cvs_AetnaInc2010StockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AetnaInc2010StockIncentivePlanMember" xlink:to="lab_cvs_AetnaInc2010StockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_6e3aa197-28ba-496c-9bb5-2026bc5868b2_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due November 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due November 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents senior notes due 2042 with a coupon rate of 4.125%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:to="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_a6c75599-5cba-4afd-a40a-0c47d190b012_terseLabel_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Co-payments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_label_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_documentation_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments" xlink:href="cvs-20201231.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NetRevenuesRetailCoPayments" xlink:to="lab_cvs_NetRevenuesRetailCoPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3b025baf-634f-4344-a2e5-492a2d142646_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3ba4b107-94ca-4d30-8a67-357e3a2ba544_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (Note 13)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingLeasesRentExpenseGross_d0c066ff-5fa4-4339-bf07-55d6fe1332a4_totalLabel_en-US" xlink:label="lab_cvs_OperatingLeasesRentExpenseGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rental expense</link:label>
    <link:label id="lab_cvs_OperatingLeasesRentExpenseGross_label_en-US" xlink:label="lab_cvs_OperatingLeasesRentExpenseGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Gross</link:label>
    <link:label id="lab_cvs_OperatingLeasesRentExpenseGross_documentation_en-US" xlink:label="lab_cvs_OperatingLeasesRentExpenseGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeasesRentExpenseGross" xlink:href="cvs-20201231.xsd#cvs_OperatingLeasesRentExpenseGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingLeasesRentExpenseGross" xlink:to="lab_cvs_OperatingLeasesRentExpenseGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_69cf2793-88d5-452b-90cb-62dc736f24f4_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfUnderPerformingStoresPlannedClosure_aaad7c14-e8ce-4801-982e-547cac9460ec_terseLabel_en-US" xlink:label="lab_cvs_NumberOfUnderPerformingStoresPlannedClosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of under performing stores, planned closure</link:label>
    <link:label id="lab_cvs_NumberOfUnderPerformingStoresPlannedClosure_label_en-US" xlink:label="lab_cvs_NumberOfUnderPerformingStoresPlannedClosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Under Performing Stores, Planned Closure</link:label>
    <link:label id="lab_cvs_NumberOfUnderPerformingStoresPlannedClosure_documentation_en-US" xlink:label="lab_cvs_NumberOfUnderPerformingStoresPlannedClosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Under Performing Stores, Planned Closure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfUnderPerformingStoresPlannedClosure" xlink:href="cvs-20201231.xsd#cvs_NumberOfUnderPerformingStoresPlannedClosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfUnderPerformingStoresPlannedClosure" xlink:to="lab_cvs_NumberOfUnderPerformingStoresPlannedClosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_b844da7a-7919-4808-b229-bf40b6efd7e3_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_4092f29f-0115-45ff-ab48-e616412cc1b8_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_ed6e580d-c5be-4366-8a53-1c28f5a349a3_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate/ Other</link:label>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_label_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateAndOtherMember" xlink:to="lab_us-gaap_CorporateAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_bda2d427-a69a-4d1c-aacc-e51dcf1a0f45_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_c725cdcc-f8de-4b55-8247-e7a0feccfada_terseLabel_en-US" xlink:label="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures, equipment and internally developed software</link:label>
    <link:label id="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_label_en-US" xlink:label="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures, Equipment And Internally Developed Software [Member]</link:label>
    <link:label id="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_documentation_en-US" xlink:label="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures, Equipment And Internally Developed Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:href="cvs-20201231.xsd#cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:to="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6429de96-e6be-434e-bb92-0b1ea6afa0f5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_892e7f16-8891-46ea-bacf-6ab8da7ee1d3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f6aa6cc2-82af-49bb-af0b-68cc4ea71c1a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_a87c38c1-9c70-4f67-9c64-a6609555dc55_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AboveMarketLeasesMember_d8a0578a-c5ef-4591-823f-9a3d5e842dd1_terseLabel_en-US" xlink:label="lab_us-gaap_AboveMarketLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_AboveMarketLeasesMember_label_en-US" xlink:label="lab_us-gaap_AboveMarketLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Above Market Leases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AboveMarketLeasesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AboveMarketLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AboveMarketLeasesMember" xlink:to="lab_us-gaap_AboveMarketLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_8220338f-181b-4078-b35c-6e94d26ded61_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_a1f830eb-476e-4c52-a8c6-e29cd0eb26d6_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on divestiture, pretax</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_5de00fb9-c6e2-4c2c-93bf-1e2ca4f39f21_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on divestiture of subsidiary</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_15a5b503-3247-42a3-98d6-9d24850e6e9a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_ab059cb0-c042-49cf-8674-4b15021f53ea_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_77d84230-d82b-44b4-b5ad-72c395b6ceea_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member_8e47f131-e8f5-4b5e-b981-dc2da6dcb771_terseLabel_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted in 2019</link:label>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member_label_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Granted In 2019 [Member]</link:label>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member_documentation_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Granted In 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member" xlink:href="cvs-20201231.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member" xlink:to="lab_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_decb5d95-1ab2-4e70-829d-737aa0996896_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_e1223208-bf29-40a9-b6b4-97df26981c8d_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined statutory net income</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Net Income Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member_8d7a549f-a596-4cd4-b073-17d43d7603a2_terseLabel_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted prior to 2019</link:label>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member_label_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Granted Prior To 2019 [Member]</link:label>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member_documentation_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Granted Prior To 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member" xlink:href="cvs-20201231.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member" xlink:to="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_e92de37f-828d-40d6-8475-f5fd3442283e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_003bc9ca-e6c3-4b77-bbca-e30b6816eea4_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityforUnpaidClaims_609eddaa-8b4a-420f-b148-4092b07e7a90_terseLabel_en-US" xlink:label="lab_cvs_LiabilityforUnpaidClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for unpaid claims</link:label>
    <link:label id="lab_cvs_LiabilityforUnpaidClaims_label_en-US" xlink:label="lab_cvs_LiabilityforUnpaidClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims</link:label>
    <link:label id="lab_cvs_LiabilityforUnpaidClaims_documentation_en-US" xlink:label="lab_cvs_LiabilityforUnpaidClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the total liability on the balance sheet for unpaid claims for both short-duration and long-duration insurance contracts after reinsurance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityforUnpaidClaims" xlink:href="cvs-20201231.xsd#cvs_LiabilityforUnpaidClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityforUnpaidClaims" xlink:to="lab_cvs_LiabilityforUnpaidClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_50497434-fc53-4fea-9e5e-57b663f7f024_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares, net of ESPP issuances</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20201231.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_fe2cc840-a2ca-44c3-b2ce-357b847d52b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Fair Value, Inputs, Level 1, 2 and 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, 2 and 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:to="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_aaa09f44-c4d2-48e1-b39d-5b78bdafcd87_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_cdfd1971-ee2a-46d0-b13e-f041609d5945_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_f0dc6b7f-c30a-4fda-a1eb-bf564ae0f581_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_7b468c71-77fd-4fd5-8330-0b7c34d4f133_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_ecd8f5f7-83b9-4f49-9300-e6ea248d7775_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_5713f5e3-9862-41c8-97a6-1232345cc918_terseLabel_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting remaining products</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_label_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Remaining Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities in an unrealized capital loss position supporting remaining products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember" xlink:href="cvs-20201231.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingRemainingProductsMember" xlink:to="lab_cvs_SupportingRemainingProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ad5b8cbc-cfda-414d-80af-ce2220f89283_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_37c77497-e39f-4b10-b42e-b7b7132e9880_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsMember_7f9ae42a-d40b-43fc-8f27-6f2e9b52fd15_terseLabel_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_cvs_PremiumsMember_label_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:label id="lab_cvs_PremiumsMember_documentation_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember" xlink:href="cvs-20201231.xsd#cvs_PremiumsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsMember" xlink:to="lab_cvs_PremiumsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_d4d51b64-8888-489a-b16e-b4a7272e6d2f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_79acabac-6b89-470c-b243-631709971b31_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.75% senior notes due May 2041</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:to="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_f94597ff-cb9a-4cc0-a031-5df1798f1f3e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets (liabilities) recognized on the consolidated balance sheet</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_72a0f4a6-8995-40db-9a8e-8cd8d87c0129_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_7f425420-7cf0-4790-9b17-5eabc27f28b6_terseLabel_en-US" xlink:label="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, amount due in excess of remaining estimated economic life</link:label>
    <link:label id="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_label_en-US" xlink:label="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life</link:label>
    <link:label id="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_documentation_en-US" xlink:label="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:href="cvs-20201231.xsd#cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:to="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_7ce021f9-61b6-4b8e-9470-d378d1813af7_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_01bc5033-a442-48bd-abe0-814f36677e96_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_946c49cb-1af7-4e49-a31e-cc5b6b292ed9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on write off of unamortized deferred financing premiums</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_819a4380-b041-4e4f-94bb-e1a1150e950c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_f3bd37ce-5969-4213-89ae-ebde605d7f35_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fb10dffc-4769-404e-ab74-b38dda32980f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_12d5c067-32fa-42eb-9020-b62286914ed3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d1751843-95a3-4197-be88-3385196bf6fd_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_9267d163-ead0-4456-b9a4-9fe6c3895fea_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_b82e9f60-4ea7-4716-8634-3b0b8ada0c60_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_cebf6d24-fe5a-4232-b7c0-26ea134c4ffa_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Direct</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_8f1faf9f-d3af-438d-9e88-9470d63d8a84_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_b36ddc99-15c6-4438-b352-e850a1e72737_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3e8c3e38-bd41-48c9-9780-c9c5e22abc41_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_da217bf7-d008-4540-ad44-1478d4ff61af_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_631451f9-b0b6-45cb-ab12-ee3ee8b951f5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_a5f2e35e-ec94-454f-b6c7-ae603ead3960_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_6b4a0ddf-2abe-42c2-8c81-b57195207b25_terseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt (current and long-term)</link:label>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_fe33913c-8e92-40ff-9842-996d96301bd8_verboseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed debt</link:label>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_label_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:to="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_63616d50-099b-4b2a-9d60-e1dcc107479a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term rate of return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_c9d5d7fc-0987-4d46-8e54-6e9cc96c2468_terseLabel_en-US" xlink:label="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term</link:label>
    <link:label id="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_label_en-US" xlink:label="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Renewal Term</link:label>
    <link:label id="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_documentation_en-US" xlink:label="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:href="cvs-20201231.xsd#cvs_LesseeOperatingAndFinanceLeasesRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:to="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3Point75PercentApril2030Member_66211b5d-8218-4a6e-93d9-bb63dd54e668_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% senior notes due April 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point75PercentApril2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 75 Percent, April 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point75PercentApril2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 75 Percent, April 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3Point75PercentApril2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:to="lab_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_1555b2d0-32f5-4c7a-9543-a5351bf44caf_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_c59e3361-5c39-4b9b-8208-1e57cc6076e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_0d0d84dd-04ca-420f-b1e1-e598e7376260_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:to="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_ade97791-1553-46b8-ab9b-df83bd385291_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_48a326c5-7e21-40a1-b828-9bbf9ab3e8a0_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_d3c8b9e2-5ee8-41ee-9f97-7f216d47f8d9_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_33967370-94e6-4804-8231-9bbf7322807d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_798967db-1dde-44f3-8d1d-21ffd7a7058c_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of year balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e961a1e-bb07-4ef3-8201-ebfa077927e9_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of year balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_40d57b40-7732-4f5b-a702-2d5d3bd2970e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a1c58e6f-553a-4ea0-bb3a-61ece2e80ef1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_b0d11a2c-db0b-482a-9c8d-e7a55180702f_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_6e590a2b-ff03-4e4b-aa64-bd4e908dd2f1_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsAxis_d74eb3f2-c320-4e8f-af06-3bad72a8bb35_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsAxis_label_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsAxis" xlink:to="lab_cvs_TotalInvestmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_110917e3-8a8f-41e0-bf2f-c948838bdba6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_862d5318-59c2-42d9-a3bc-e530f6d64c7d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_2a6fb0f2-f205-401b-8ad5-7970f507f034_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_c18caa2a-ae3e-4967-8d33-c0c9fe73bddf_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_3825eeae-4e74-4007-8589-220e6cb3d1b9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ea7167f5-0191-44ad-b8ac-cf1cd5130c34_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_b9a1b120-e6fa-4d3d-8264-cb16c35efa19_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_733f0abb-bf2a-487b-87b0-fbb22a23a902_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_9108358b-c23e-49d8-bf84-679b7034a1c2_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:href="cvs-20201231.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_69364af6-cdba-4819-b8d9-0e30b9f099b2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of unrecognized tax benefits roll forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_eb9821f7-7013-4ea6-963f-469e7b2ad16a_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7bdb3578-05ba-485a-acf5-7be035660e76_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of long-term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_6ac8ff54-e248-4a53-a65d-824b0c5444a3_terseLabel_en-US" xlink:label="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed interest rates on long-duration group life and long-term care contracts</link:label>
    <link:label id="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_label_en-US" xlink:label="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Interest Rates On Long Duration Group Life And Long Term Care Contracts</link:label>
    <link:label id="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_documentation_en-US" xlink:label="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Interest Rates On Long Duration Group Life And Long Term Care Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" xlink:href="cvs-20201231.xsd#cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" xlink:to="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_6dcdeda3-09ed-4a90-9bb2-2afb24c3ab73_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e4847825-7210-4668-8412-4c902d5aad7c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_1160b4b9-8f0a-4580-a317-e4d1f28c8e56_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of subsidiaries and other assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_e1d79f33-d2ea-49a3-9a2b-d859e1dbf173_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_af592493-bf98-43fe-8f4f-73e2146894de_terseLabel_en-US" xlink:label="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Deficiency Reserves</link:label>
    <link:label id="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_label_en-US" xlink:label="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Premium Deficiency Reserve [Policy Text Block]</link:label>
    <link:label id="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_documentation_en-US" xlink:label="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Premium Deficiency Reserve [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:href="cvs-20201231.xsd#cvs_InsurancePremiumDeficiencyReservePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:to="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_aec4ae15-59c6-4f04-8f6b-66731bc35873_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets, Trademarks</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_c439f785-27c8-4bb0-bcbd-c46ef96488e7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to other suppliers and employees</link:label>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_label_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Suppliers and Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:to="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_875998b1-23d7-4713-ae3b-551e8013ed41_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_287566d2-dfae-456a-940f-f0bc65b9a453_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_b8581947-623b-4eaf-9f85-aa1e66463996_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Other Revenues from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StoreRationalizationCharges_516939b2-78d2-408b-ba9e-deee9dfbf343_verboseLabel_en-US" xlink:label="lab_cvs_StoreRationalizationCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store rationalization charges</link:label>
    <link:label id="lab_cvs_StoreRationalizationCharges_label_en-US" xlink:label="lab_cvs_StoreRationalizationCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store Rationalization Charges</link:label>
    <link:label id="lab_cvs_StoreRationalizationCharges_documentation_en-US" xlink:label="lab_cvs_StoreRationalizationCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store Rationalization Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreRationalizationCharges" xlink:href="cvs-20201231.xsd#cvs_StoreRationalizationCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StoreRationalizationCharges" xlink:to="lab_cvs_StoreRationalizationCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_94ae4693-6015-45c9-b162-8966c78ca714_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Two [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:to="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_380cd706-7509-406d-847c-5a0404f709aa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded</link:label>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_label_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Ceded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:to="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3eb1d552-00a3-46a9-bca0-ac722e1fbf7e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_9171f455-803a-4cd7-a3da-ca56016c8b60_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_1e6d5fae-4542-43b6-8425-c8e42c2c38b9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_da3f6d7b-7bfe-4891-8528-c66ea893b9c6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_fa4e1ecf-74a3-413e-b8a5-a88f691f9f4e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Components of incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0e87eabc-77a6-4cc8-b672-2afd6841a2cd_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_22453051-0d6c-47e0-bd30-d038b60cafc7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b973146b-3b6e-4e79-a06c-c5a022dc0bf0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_02db7266-14c6-41c5-9316-9508b057b739_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_72ce3040-8230-460d-8180-6bbc042a245a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_866ebc0e-d13e-43fe-bed2-e2b7aa259f95_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit of revaluation of net DTL due to TCJA</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b15abc08-568f-45e8-b386-59a3223630bc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_70631019-af71-476d-9ac6-89c905b56aeb_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% senior notes due May 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:to="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_7aed8c30-36c1-49a7-9a2b-23f120f18c6a_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred securities</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockMember" xlink:to="lab_us-gaap_RedeemablePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e89a13f0-e5d0-4981-afd2-becafe78117d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_173e4018-4a61-46c9-9531-d5938f4bf127_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Other Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_72991a81-4185-4060-9c3f-c818d52acc15_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_b068db31-1fde-4f43-871a-91ad850e117c_terseLabel_en-US" xlink:label="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hartford Life and Accident Insurance Company</link:label>
    <link:label id="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_label_en-US" xlink:label="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hartford Life And Accident Insurance Company [Member]</link:label>
    <link:label id="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_documentation_en-US" xlink:label="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hartford Life And Accident Insurance Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:href="cvs-20201231.xsd#cvs_HartfordLifeAndAccidentInsuranceCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:to="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsLineItems_cf4eb52b-0778-4547-8c6b-eb66a0c6b3b8_terseLabel_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets[Line Items]</link:label>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsLineItems_label_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Acquired Intangible Assets [Line Items]</link:label>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:href="cvs-20201231.xsd#cvs_OtherAcquiredIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:to="lab_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_3d8b8e77-6049-4864-a8b8-2d5ebb3b2759_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_83d53249-8f22-4220-92f1-6c8f7533601f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of liability for unpaid claims and claims adjustment expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_510a7d58-c8b6-4cdb-9192-9f0bafde3cd0_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b531315b-6392-47d5-a86e-f9de77a51fe7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_629db034-9708-48ab-a0c5-28b8aedd8feb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Life (years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Weighted Average Period before Next Renewal or Extension</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_ab05cf33-2613-478c-bfc1-4f45b4b4249f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_4f5aaa52-86a4-4a7e-bec8-e66c7ea1c55f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_e66cbe45-2a0d-4e60-af2e-8f2144120560_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_450614c6-0ea9-4805-9e5c-0409dd19ec8a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Policy</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e5f90863-3e21-499f-81a0-47881203e5fc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, expired ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_55842de1-5087-4bee-9073-54b2a413d7a0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross transfers into Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_be991af2-0c5d-4f95-917d-d0301d42a8f2_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities in an unrealized capital loss position</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_b64f1431-c21e-4434-b41d-ebde764dd046_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedInvestmentsAtFairValue_16bcaa4e-0328-462f-8413-322c5b93e224_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedInvestmentsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments related to 2012 contract conversion</link:label>
    <link:label id="lab_us-gaap_RestrictedInvestmentsAtFairValue_label_en-US" xlink:label="lab_us-gaap_RestrictedInvestmentsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Investments, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedInvestmentsAtFairValue" xlink:to="lab_us-gaap_RestrictedInvestmentsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_115f0ef9-baa2-43d3-8a9e-3e2cc49dd4e7_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_a43aa949-5539-415b-b5c5-0fa52ea7f269_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_02c33d93-df15-4448-87ba-9fc21cc57e17_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fe010f7d-0473-452d-8860-43aec53fbd5e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TwoThousandEighteenNotesMember_d8b48e28-24e4-48ad-bb0c-37374a3753dd_terseLabel_en-US" xlink:label="lab_cvs_TwoThousandEighteenNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Senior Notes</link:label>
    <link:label id="lab_cvs_TwoThousandEighteenNotesMember_label_en-US" xlink:label="lab_cvs_TwoThousandEighteenNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eighteen Notes [Member]</link:label>
    <link:label id="lab_cvs_TwoThousandEighteenNotesMember_documentation_en-US" xlink:label="lab_cvs_TwoThousandEighteenNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eighteen Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TwoThousandEighteenNotesMember" xlink:href="cvs-20201231.xsd#cvs_TwoThousandEighteenNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TwoThousandEighteenNotesMember" xlink:to="lab_cvs_TwoThousandEighteenNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_b2c6151c-b7b7-4766-9ad5-5d754be46b21_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_1bd754c0-5333-4d83-8645-e6713b0564de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of variable interest entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_a8d5ea5a-6995-4e60-b02c-927758bc3e4d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total health care costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_488b35a7-57d2-4a15-b20a-959a15314adf_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_354220be-3b77-4c92-b574-88f63290d98b_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_9b92dfcf-8cfc-491f-8fe7-bcaf84dbba91_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of change in health care costs payable</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_9670731f-d6f3-4325-bdfa-c1eb10cb2b0a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_66fc567d-e5ce-402d-b6ca-8f0c01c8fff5_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_f7930d94-460f-4908-91ee-e166631245f6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_269d72f8-5d04-4ee3-b03f-9cf5786d4bdc_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans and Other Postretirement Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ef092103-9db3-4eda-af59-03d9727c8bd5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_b52e30d1-7f90-4a6c-adb1-6c19c62c8563_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_e43a9414-507c-4d03-a6c7-15184c17513b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_7c377198-95a3-4bfb-8767-5bda9ad2f4b4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_fc183490-9031-442d-87bd-d443cec29515_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Assets and Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral_a6489d82-2058-4538-b7e4-74279d2521d9_terseLabel_en-US" xlink:label="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll tax deferral</link:label>
    <link:label id="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral_label_en-US" xlink:label="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Payroll Tax Deferral</link:label>
    <link:label id="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral_documentation_en-US" xlink:label="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Payroll Tax Deferral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:href="cvs-20201231.xsd#cvs_DeferredTaxAssetsPayrollTaxDeferral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:to="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProviderNetworksMember_68602fcd-66e5-4b72-bc97-769de24eacb5_terseLabel_en-US" xlink:label="lab_cvs_ProviderNetworksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider networks</link:label>
    <link:label id="lab_cvs_ProviderNetworksMember_label_en-US" xlink:label="lab_cvs_ProviderNetworksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider networks [Member]</link:label>
    <link:label id="lab_cvs_ProviderNetworksMember_documentation_en-US" xlink:label="lab_cvs_ProviderNetworksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in a business combination or other transaction. This item represents the value ascribed to the relationships with the acquiree's physicians, hospitals and other health care providers network.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProviderNetworksMember" xlink:href="cvs-20201231.xsd#cvs_ProviderNetworksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProviderNetworksMember" xlink:to="lab_cvs_ProviderNetworksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_23f5c157-91ed-4979-ab5f-d16a3ba90995_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_1fc2fc27-74e2-4d3e-a2ed-97cbd6ad62f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectsOfReinsuranceTableTextBlock_141da3b3-851c-4dfc-9d78-4e61266bd0f7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of impact of reinsurance on benefit costs</link:label>
    <link:label id="lab_us-gaap_EffectsOfReinsuranceTableTextBlock_label_en-US" xlink:label="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Reinsurance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectsOfReinsuranceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:to="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_7d49d965-d97a-4ee7-8cd8-b502503501df_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_1edee327-04b9-4982-9f69-cd3e10785e88_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_d3df7231-d0f8-4589-b381-5a4ec48d3644_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit (OPEB) Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_f4730335-43fd-452f-8d41-5d9d2725f49f_terseLabel_en-US" xlink:label="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average purchase price of shares purchased (in dollars per share)</link:label>
    <link:label id="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_label_en-US" xlink:label="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased</link:label>
    <link:label id="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_documentation_en-US" xlink:label="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:href="cvs-20201231.xsd#cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:to="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5bee5f71-3972-4247-9e45-2c1e94c72757_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SharesHeldInTrustPolicyTextBlock_c8241da8-d489-4417-a3d4-2a0e39771b2c_terseLabel_en-US" xlink:label="lab_cvs_SharesHeldInTrustPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Held in Trust</link:label>
    <link:label id="lab_cvs_SharesHeldInTrustPolicyTextBlock_label_en-US" xlink:label="lab_cvs_SharesHeldInTrustPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Held In Trust [Policy Text Block]</link:label>
    <link:label id="lab_cvs_SharesHeldInTrustPolicyTextBlock_documentation_en-US" xlink:label="lab_cvs_SharesHeldInTrustPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Held In Trust [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SharesHeldInTrustPolicyTextBlock" xlink:href="cvs-20201231.xsd#cvs_SharesHeldInTrustPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SharesHeldInTrustPolicyTextBlock" xlink:to="lab_cvs_SharesHeldInTrustPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_945ce3af-9cd1-4f87-a0a5-7422a67a06c6_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_5aba1050-fc01-480b-b44a-abd9d7bd77b1_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_7fc949f0-04a2-4b83-8200-93c3e46b4055_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_125d5261-7fa7-4ced-a38d-917c75bea7c8_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_26853453-644a-47f3-9f50-d2c2f21a4a92_totalLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amortized Cost</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_3e570311-9d15-4381-8c63-ac6a9d1b9c82_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Four</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_611dfbfa-1442-499d-8c20-43bf208a839e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_460c895d-b7cf-43bf-95c6-2708be78a8b7_netLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (GAAP measure)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_b20a49bc-06b9-49cc-b0ac-c8acf7b6d20c_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Asset Impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_316db625-c078-41e6-817c-6d843ac4ebdd_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of contract with customer assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_34eefb10-e886-48f9-8e3f-b9bb0ca19279_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self insurance liabilities</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserve" xlink:to="lab_us-gaap_SelfInsuranceReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5cdc49c2-25d1-4da7-addb-7a5e0c193f3a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_69be78b3-17fd-4086-ae56-98f013d11244_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 16)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_3fde513a-b6da-457c-8d65-c262500a68ba_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_c9566a30-4a82-4f4f-93ed-6b28c1327291_terseLabel_en-US" xlink:label="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases Liabilities Payments Due [Abstract]</link:label>
    <link:label id="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_documentation_en-US" xlink:label="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases Liabilities Payments Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:href="cvs-20201231.xsd#cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:to="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dbced01f-a8c2-4772-8e63-e17ee6055380_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_088f161a-10ff-4ce1-aca9-3410dab92b00_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_123d6805-5dfd-4c21-b738-38cf5fe93a93_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_f18be0bc-a634-4406-9a42-6669b2cc96b5_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares (in shares)</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:href="cvs-20201231.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_72f611ba-ba55-4692-baef-23bff1e15bf6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d359d2ed-219e-4bda-b343-7ada3d6ce1df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2020Member_ad920fdf-c35d-447c-a9db-465ab4bb8593_terseLabel_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes due March 2020</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2020Member_label_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2020 [Member]</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2020Member_documentation_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member" xlink:href="cvs-20201231.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FloatingRateNotesDueMarch2020Member" xlink:to="lab_cvs_FloatingRateNotesDueMarch2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceAccountingPolicy_a65a6a47-89d2-424f-954f-d9fb529cf722_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceAccountingPolicy_label_en-US" xlink:label="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Accounting Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceAccountingPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceAccountingPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceAccountingPolicy" xlink:to="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_4473f5b7-bbb5-4251-98f5-6530b0cd8ab9_terseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InsuranceAndHmoMember_b68c5928-21a0-4f01-b82d-688699da767b_terseLabel_en-US" xlink:label="lab_cvs_InsuranceAndHmoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and HMO</link:label>
    <link:label id="lab_cvs_InsuranceAndHmoMember_label_en-US" xlink:label="lab_cvs_InsuranceAndHmoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and HMO [Member]</link:label>
    <link:label id="lab_cvs_InsuranceAndHmoMember_documentation_en-US" xlink:label="lab_cvs_InsuranceAndHmoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and HMO subsidiaries [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsuranceAndHmoMember" xlink:href="cvs-20201231.xsd#cvs_InsuranceAndHmoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InsuranceAndHmoMember" xlink:to="lab_cvs_InsuranceAndHmoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_44b67b14-67af-412f-b573-87749596e203_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ecaeea3e-c3af-4244-99c5-0de67793b086_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_4c33cd27-0fcd-48e4-9959-a1d93f88c0fc_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_4dcb6502-98e8-4212-8481-b894a2b8bf1f_terseLabel_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail/ LTC</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_label_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_documentation_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RetailLongTermCareSegmentMember" xlink:to="lab_cvs_RetailLongTermCareSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_3e628a38-164a-4b6c-b6c5-37b5f37624a9_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_354fc0ee-6a49-42f2-b24e-04e6343d3834_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RXCrossroadsMember_f5a94921-1c89-47a9-be41-18e2e9338eff_terseLabel_en-US" xlink:label="lab_cvs_RXCrossroadsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RX Crossroads</link:label>
    <link:label id="lab_cvs_RXCrossroadsMember_label_en-US" xlink:label="lab_cvs_RXCrossroadsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RX Crossroads [Member]</link:label>
    <link:label id="lab_cvs_RXCrossroadsMember_documentation_en-US" xlink:label="lab_cvs_RXCrossroadsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RX Crossroads [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RXCrossroadsMember" xlink:href="cvs-20201231.xsd#cvs_RXCrossroadsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RXCrossroadsMember" xlink:to="lab_cvs_RXCrossroadsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_a340799a-5d31-4c22-bc2d-da9eaed7f2af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_48901cf2-4c3f-49b9-a7a5-341bdd37907a_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_1329336e-174e-4604-887d-b43566f1610b_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due December 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due December 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueDecember2022Member" xlink:to="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_8859fcdf-7dc7-4f69-bf7c-215a99df480d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in level 3 financial assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b0c65945-faee-4d02-af4d-aa4ec768ba8b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_08bf87e5-b251-491b-a07d-17c6df23da3f_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_9599c14f-668f-4f37-b079-f28f3f1463de_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_d623a8e5-ab4e-4b2a-9085-40b05daf7004_terseLabel_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for earnings (loss) per share calculation:</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20201231.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_0b4c88aa-8c83-47ca-9fa1-61d9afb5ed71_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.125% senior notes due September 2039</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:to="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_56fb5953-60c5-423c-a4b2-34a1f3b8e359_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: sublease income</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Sublease Rentals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_622f2964-5ae3-4860-815a-f0f170b26b5c_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_045c7edc-0b38-4e9a-803f-94d4e0488548_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_128042ac-d9fe-4467-9646-017abdaeadae_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.s. government securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_ea133fff-fabf-486a-bff7-64e58693d408_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total rental expense, net</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e7b8a1a9-f4bb-432d-ad7f-40d079b5a878_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares exercisable at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_41f9322a-38bf-4e21-9104-baa8b8399b3c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes375DueApril2030Member_d13b613f-b81c-419e-a535-f29e556cae30_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes375DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% senior notes due April 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes375DueApril2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes375DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.75%, Due April 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes375DueApril2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes375DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.75%, Due April 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes375DueApril2030Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes375DueApril2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes375DueApril2030Member" xlink:to="lab_cvs_SeniorNotes375DueApril2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_6017ef30-d6ed-40a0-ab4d-510693600472_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized capital losses included in OCI associated with Level 3 financial assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_label_en-US" xlink:label="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:to="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_8c6ecd3f-fb8b-4911-89b1-d3883b89e49c_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy network</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_fb3a247e-a095-46e2-975e-4dcdd37d632a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c7b5c100-e6c4-496a-8c39-cc4710c937fe_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Products and Services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eae71957-7eb3-403c-8f9e-b0f33837744f_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_04802de6-7c8c-43be-9f9c-7635c178b637_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_9b2c4ee1-4622-4c5f-a3c5-21fed6b08e66_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_a34cfec8-4713-4422-a97d-61d3be0ea7c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_843640dc-37db-47a1-bba4-4d7d67297a9f_terseLabel_en-US" xlink:label="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debts and other allowances</link:label>
    <link:label id="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_label_en-US" xlink:label="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances</link:label>
    <link:label id="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_documentation_en-US" xlink:label="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:href="cvs-20201231.xsd#cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:to="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_0d6e434f-94c8-4c73-83bc-2ec542429d8e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_7660b0af-4bfd-4095-86de-865d3a9a72f2_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividend declared (USD per share)</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_0d451c31-b182-40d1-8d94-ed9fef411300_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Table]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:to="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_a8fb577b-fab3-4521-9e22-a5abc7dbb924_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_8390a7d5-7e33-496d-b5e8-760d4f4eafec_terseLabel_en-US" xlink:label="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases:</link:label>
    <link:label id="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_9350f264-724d-41b7-b26d-e919e2299b57_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued to acquire Aetna (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_285df5c4-413d-469f-87d9-ad378d9fdd64_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% senior notes due August 2029</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:to="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_f71c6775-404f-46d8-bb1a-4c67c881e2a1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share from continuing operations:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_3e25cb2d-d42a-4cd9-9941-958fc5bf58c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_4de704fb-3684-4ce3-8975-070989327022_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5% senior notes due December 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:to="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_a1dfa9b6-254e-4447-8f24-3a8b72c49762_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e3b924fc-9b85-406a-acde-ec981f9274a3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceTextBlock_ae58dea6-09ad-4840-b76a-60ce84e08fac_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance</link:label>
    <link:label id="lab_us-gaap_ReinsuranceTextBlock_label_en-US" xlink:label="lab_us-gaap_ReinsuranceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceTextBlock" xlink:to="lab_us-gaap_ReinsuranceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_037dd6f9-7f33-45f4-bb0c-c0352efc5e16_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_bc183cc5-b729-48da-834d-0e205486378f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofReinsuranceContractsEnteredInto_14533fd6-701b-4f84-a5e6-3ff25946596d_terseLabel_en-US" xlink:label="lab_cvs_NumberofReinsuranceContractsEnteredInto" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reinsurance contracts entered into</link:label>
    <link:label id="lab_cvs_NumberofReinsuranceContractsEnteredInto_label_en-US" xlink:label="lab_cvs_NumberofReinsuranceContractsEnteredInto" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reinsurance Contracts Entered Into</link:label>
    <link:label id="lab_cvs_NumberofReinsuranceContractsEnteredInto_documentation_en-US" xlink:label="lab_cvs_NumberofReinsuranceContractsEnteredInto" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reinsurance contracts entered into with an unrelated insurer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofReinsuranceContractsEnteredInto" xlink:href="cvs-20201231.xsd#cvs_NumberofReinsuranceContractsEnteredInto"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofReinsuranceContractsEnteredInto" xlink:to="lab_cvs_NumberofReinsuranceContractsEnteredInto" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_18845678-85d5-4683-a023-01bedcd06dd7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_978919b2-b275-4c93-98b2-3c4d5245a054_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions used to determine benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_5c95a957-c867-4615-b227-34a199ed6c0d_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future noncancelable subleases, future minimum payments</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_e7b92f74-62ff-4bbc-afce-3649e3ec800f_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_dbc22c7a-3ae3-4a99-b82c-5c43569e5f85_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_729cbfe5-43fd-4b46-914c-05a38e67fb52_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_61d1e5c2-300f-40cf-993d-25486999a72c_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_119d4048-b3c5-4f22-8edd-6a41c9eb3d89_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Initialcontractualterm_944564cd-17f2-401a-b42b-b57d98416a3f_terseLabel_en-US" xlink:label="lab_cvs_Initialcontractualterm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial contractual term</link:label>
    <link:label id="lab_cvs_Initialcontractualterm_label_en-US" xlink:label="lab_cvs_Initialcontractualterm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial contractual term</link:label>
    <link:label id="lab_cvs_Initialcontractualterm_documentation_en-US" xlink:label="lab_cvs_Initialcontractualterm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Initial Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Initialcontractualterm" xlink:href="cvs-20201231.xsd#cvs_Initialcontractualterm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Initialcontractualterm" xlink:to="lab_cvs_Initialcontractualterm" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_b739889d-a2ad-4db7-a5d8-51997e0954b2_terseLabel_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former gain contingency, recognized in current period, before tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period, Before Tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_documentation_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:href="cvs-20201231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:to="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_3d0639da-a5db-4754-8510-d34672bddad2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income of acquiree since acquisition date</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_1b065900-426c-4a8f-b3c3-a28efd9047d2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b8a9451c-4316-48c9-9c61-bdfbf749c743_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_312ee334-7323-4d08-8975-0dc237abcbc7_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, fair value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2971979c-a796-49ca-9c39-bfee53a63aef_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term exercisable at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_26ba3d67-aff3-4e46-b91b-463271e4b528_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Paid Health Care Claims,Net of Reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Categories5and6Member_9071fa34-bdbe-41b4-a7ce-c0d23d953358_terseLabel_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5 and 6</link:label>
    <link:label id="lab_cvs_Categories5and6Member_label_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories 5 and 6 [Member]</link:label>
    <link:label id="lab_cvs_Categories5and6Member_documentation_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Categories 5 and 6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member" xlink:href="cvs-20201231.xsd#cvs_Categories5and6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Categories5and6Member" xlink:to="lab_cvs_Categories5and6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_5b7cdcc6-18a4-4207-a2c0-7763e357882d_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares, net of ESPP issuances (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20201231.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_5c704956-77fd-45fc-af45-8ca2da085901_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8a8e9a67-9fed-4c74-bcd1-2d1ec5ebc324_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of basic and diluted earnings (loss) per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1Point75PercentAugust2030Member_d4ba04fb-1b8a-47a4-b527-b7bb0cfd05a3_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.75% senior notes due August 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point75PercentAugust2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 75 Percent, August 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point75PercentAugust2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 75 Percent, August 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes1Point75PercentAugust2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:to="lab_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5455e841-fd59-4872-bcb3-24d77fffd1d5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_d1478415-db6f-4e97-a02c-ca117a88757e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetNet_6f6c01f7-7e2e-4f9e-99c1-e9c467cf6d70_totalLabel_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetNet_label_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Net</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetNet_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetNet" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseRightOfUseAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetNet" xlink:to="lab_cvs_FinanceLeaseRightOfUseAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_8d7d760c-7180-4a6d-a1f5-94868bb95c35_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of fair value of assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_526612a9-843d-446c-8ccd-fde3bdd3e88c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase programs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_07127691-ffef-4a40-8519-574d03e7d5d8_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.875% senior notes due July 2035</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:to="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_35c4341f-1368-4177-b241-81e02eda73de_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_2a0dbe22-4230-4bb5-890b-9014587f8dcd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_5112edec-b3bf-47ba-8db1-1e1407adeb22_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_WellCareHealthPlansMember_4a31a72d-c59e-4513-8e1c-9a3c21a8f327_terseLabel_en-US" xlink:label="lab_cvs_WellCareHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WellCare Health Plans</link:label>
    <link:label id="lab_cvs_WellCareHealthPlansMember_label_en-US" xlink:label="lab_cvs_WellCareHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WellCare Health Plans [Member]</link:label>
    <link:label id="lab_cvs_WellCareHealthPlansMember_documentation_en-US" xlink:label="lab_cvs_WellCareHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WellCare Health Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_WellCareHealthPlansMember" xlink:href="cvs-20201231.xsd#cvs_WellCareHealthPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_WellCareHealthPlansMember" xlink:to="lab_cvs_WellCareHealthPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_529a1a15-7413-4eb7-99f9-19a5f8ddc512_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in prior years' healthcare costs payable</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_00e0bb2e-399a-445d-b527-623421b059cd_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_22666881-fed8-4bbe-96b7-b324841d814d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_2802dfc3-61e8-4d63-9742-b1186635426c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.25% senior notes due June 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:to="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b88bb0e4-88a8-4355-a6b7-70992bb1dd70_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyRevenueMember_5a7f4ec5-1920-482e-a4f1-eb7194077b79_terseLabel_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_label_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_documentation_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember" xlink:href="cvs-20201231.xsd#cvs_PharmacyRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyRevenueMember" xlink:to="lab_cvs_PharmacyRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_6e733dfc-9326-42f1-808a-69aedb01046c_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1Point3PercentAugust2027Member_451cfc82-5d01-40e8-9fa2-dcf19dab388d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% senior notes due August 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point3PercentAugust2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 3 Percent, August 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point3PercentAugust2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 3 Percent, August 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes1Point3PercentAugust2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:to="lab_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_bd59d1a5-eea0-4a52-8983-c727c60184d8_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.7% senior notes due March 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.7%, Due March 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.7%, Due March 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.7DueMarch2023Member" xlink:to="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_4d2d84e9-5448-48e5-9411-7d05fb17414d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_WeightedAverageRemainingLeaseTermAbstract_fe3f8c89-b89a-4615-b241-696109a5c769_terseLabel_en-US" xlink:label="lab_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_cvs_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_cvs_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:href="cvs-20201231.xsd#cvs_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_2acd45cb-1a64-4c16-a483-abb380b304a6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4Point25PercentApril2050Member_a635706d-85dc-49f9-bf90-4b1d72743e98_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.25% senior notes due April 2050</link:label>
    <link:label id="lab_cvs_SeniorNotes4Point25PercentApril2050Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point 25 Percent, April 2050 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4Point25PercentApril2050Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point 25 Percent, April 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4Point25PercentApril2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:to="lab_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_846e492b-deef-487d-9ead-0af00a330445_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0feed810-1951-42bc-a20f-bd2d12b74373_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_822df789-2623-47c9-9e34-8fb2b3d19023_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.7% senior notes due August 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.7%, Due August 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.7%, Due August 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes27DueAugust2040Member" xlink:to="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_92b5a750-279a-4dcd-8738-62a2232ea092_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_7f66e53a-fef6-4c75-8a65-908be7843ae1_terseLabel_en-US" xlink:label="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases:</link:label>
    <link:label id="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="cvs-20201231.xsd#cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_1bc1f6bb-664f-47d2-9ad7-d589f613f0ef_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_9b9ff129-c3f5-4f07-8e3e-f14fd627a4a3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_9f3d0744-4e18-4d94-8c37-cb6869ab35a9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Included in earnings&#160;</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0be0c31e-139e-453f-8478-5d16a63d3376_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_7dcac00c-2fee-436f-9975-8619971a14cd_terseLabel_en-US" xlink:label="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual obligations underlying the guaranteed benefits</link:label>
    <link:label id="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_label_en-US" xlink:label="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligations To Maintain Levels Of Separate Accounts</link:label>
    <link:label id="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_documentation_en-US" xlink:label="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the contractual obligation to maintain the required level of funding in Separate Accounts necessary to fund specific guaranteed pensions annuities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:href="cvs-20201231.xsd#cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:to="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_5ecec2f2-f300-48d2-9f46-9aa017de5279_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed</link:label>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_label_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:to="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_37128172-3cd8-4adf-9c09-5eccfdc60c9f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_0ff18d33-a3cf-4648-95f7-13c23f8d564f_terseLabel_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting experience- rated products</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_label_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Experience Rated Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting discontinued and experience-rated products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember" xlink:href="cvs-20201231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingExperienceRatedProductsMember" xlink:to="lab_cvs_SupportingExperienceRatedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_fa9205c9-2f95-4570-8639-ca6e416e61c0_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeTextBlock" xlink:to="lab_us-gaap_InvestmentIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_157954d7-945a-4018-8d2c-a47b9927e8ce_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount expected to be reclassified</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_e7bd5a9f-789b-42fa-8118-88e91a12ae7f_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_65738250-5616-45be-ad7e-949b51c20615_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_aa501337-80f3-4488-b435-347f0a4cd2c1_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_adb64061-90f9-4d31-8e1c-ed673ad4d74f_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_050d1261-4b64-4c80-8e0e-6aecda987790_negatedTerseLabel_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_label_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Depreciation and Amortization</link:label>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Depreciation and Amortization - Amount of deferred tax liability attributable to taxable temporary differences from depreciation and amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:href="cvs-20201231.xsd#cvs_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_af62d681-6daa-44eb-82fc-06406a19d918_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_5bd3b735-bbf3-4dd3-bd1c-122fd15de32d_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Reform</link:label>
    <link:label id="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareEntitiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:to="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_5e2db25a-37b3-4127-899e-3e7e81745d57_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows paid for interest portion of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_39459fcf-b68b-4083-95d2-15af192ad1b7_verboseLabel_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds and related gross realized capital gains and losses from the sale of debt securities</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_label_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:href="cvs-20201231.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:to="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock_a1672a96-d3a0-42c2-86fd-2dbc0c6bb2a4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of change in level 3 plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStores_794b7931-c76a-4872-9039-f156fdb28c56_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stores</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_9b689edb-43e5-497b-8f84-ca0a7b7d2fb3_verboseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stores</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_label_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStores" xlink:to="lab_us-gaap_NumberOfStores" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_0ccbd827-896a-486a-aeb8-ba5406fd49b4_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% senior notes due June 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:to="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect_7c1b7dd3-9379-45aa-b066-baa27e72eabd_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption of new accounting standard</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense_ae1644b4-944f-48dd-8b01-17b55cd23907_negatedTerseLabel_en-US" xlink:label="lab_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisional benefit of revaluation of net DTL due to TCJA</link:label>
    <link:label id="lab_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense_label_en-US" xlink:label="lab_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense</link:label>
    <link:label id="lab_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense_documentation_en-US" xlink:label="lab_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense" xlink:href="cvs-20201231.xsd#cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense" xlink:to="lab_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_540b39da-4290-46c6-aedf-eabf6a637de3_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f0cf0d9e-be00-4b61-afc4-bd313ac08cf5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_0a63770c-e4d0-4cd7-8614-da2035ee6b9c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_cc336e10-9759-4764-814a-2bba53229d20_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_9c7f9032-f443-4e14-8122-6d761098c105_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_2e34c4e9-6fdb-46c8-bd78-c5ede8638253_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal After Year Five</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_58f222b4-d31b-49ca-88c6-7b9ef1b60029_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_d50f6a75-f4e4-4d3c-b72d-2158b18d2651_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTTI losses, investments, portion recognized in earnings, net</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_45a6731c-30c1-4f9f-80b4-97c5cd55ebab_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets reflected in other assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_690962ca-9590-4940-a928-ea6baa9e5231_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_dcca72cd-15a6-420d-b994-76421c483313_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AllOtherReinsurersMember_4b213d45-4f83-4769-8987-6930ef335b28_terseLabel_en-US" xlink:label="lab_cvs_AllOtherReinsurersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other</link:label>
    <link:label id="lab_cvs_AllOtherReinsurersMember_label_en-US" xlink:label="lab_cvs_AllOtherReinsurersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Reinsurers [Member]</link:label>
    <link:label id="lab_cvs_AllOtherReinsurersMember_documentation_en-US" xlink:label="lab_cvs_AllOtherReinsurersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Reinsurers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AllOtherReinsurersMember" xlink:href="cvs-20201231.xsd#cvs_AllOtherReinsurersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AllOtherReinsurersMember" xlink:to="lab_cvs_AllOtherReinsurersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_3564c78e-0e81-46e7-8385-c21f7d60590f_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_66d10196-9085-4c27-a2aa-79654a41b95d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.3% senior notes due March 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:to="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_561e0e0c-991d-49b1-aeb0-f22107b3ba09_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_9bd04cf5-c2bb-42cc-8c3b-97616236d743_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_a03e0532-c9bc-4f62-a8ef-d167aeeb6ca7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_ce9d09de-3ae1-473a-8a30-2eb7a9ee81ca_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_ee837bd4-532b-456e-b5da-10a09dcf0614_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_dc03cd70-5ff8-4336-b25d-1d017c649701_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_4cb41ce6-4642-4e8a-b5a8-eb3963cb86eb_terseLabel_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of stock options and SARs vested</link:label>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_label_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value</link:label>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_documentation_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:href="cvs-20201231.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:to="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5cfbc407-937d-4da6-a268-34a81711669f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation not yet recognized, period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_4c189cb1-d990-4854-81f2-c1e883f5e92c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_dcc0ec7b-77be-45a6-b7b9-0d70186349bf_totalLabel_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_b31ac3c8-6282-4606-a38a-d16e1120a950_terseLabel_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_label_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross And Lease Obligation</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_documentation_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross And Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation" xlink:href="cvs-20201231.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation" xlink:to="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLeaseTableTextBlock_608cda63-bfc3-40a8-ac1a-bc1125d463de_terseLabel_en-US" xlink:label="lab_cvs_LesseeLeaseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental balance sheet information</link:label>
    <link:label id="lab_cvs_LesseeLeaseTableTextBlock_label_en-US" xlink:label="lab_cvs_LesseeLeaseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease [Table Text Block]</link:label>
    <link:label id="lab_cvs_LesseeLeaseTableTextBlock_documentation_en-US" xlink:label="lab_cvs_LesseeLeaseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLeaseTableTextBlock" xlink:href="cvs-20201231.xsd#cvs_LesseeLeaseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLeaseTableTextBlock" xlink:to="lab_cvs_LesseeLeaseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_260089b0-7156-4e8a-8cbb-8e3a302d3c47_terseLabel_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_label_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_documentation_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareBenefitsSegmentMember" xlink:to="lab_cvs_HealthCareBenefitsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_db6e6b13-bd5d-4c6c-9274-d6dd32b26436_totalLabel_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (excluding net realized capital gains or losses)</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_label_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains or Losses</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_documentation_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains or Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:href="cvs-20201231.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:to="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c054164c-8e94-451b-bbe3-cfd9d2ed7c2c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuarantyLiabilities_11e5ffdc-e9aa-4ffa-9def-7467bdd3fb4c_terseLabel_en-US" xlink:label="lab_us-gaap_GuarantyLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty liabilities</link:label>
    <link:label id="lab_us-gaap_GuarantyLiabilities_label_en-US" xlink:label="lab_us-gaap_GuarantyLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuarantyLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuarantyLiabilities" xlink:to="lab_us-gaap_GuarantyLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_072d61f2-2553-4579-b5c1-de37ddf9067c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_a7ce453b-62e1-4b88-914a-869ae66d46d8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and pharmacy claims and discounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_fd6488cd-62f4-49ca-ae81-d1fc778b7351_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_b0964c7f-5e8b-49a9-ab2b-4f182f7a3acc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_33fe4000-6fdf-4bb2-8892-af7b1831ffa3_totalLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total outstanding liabilities for health care costs payable, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_23c02655-f80d-4cad-9832-a2d1999f937e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration health care costs payable, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_989f1d72-70f3-49b9-b003-d73b563f9d58_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_2d6b316a-c8cd-433f-8652-0abd0790a9ec_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_ae4ecd64-d64c-4988-9bab-c8d73441a3b0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_35e44f77-c8d1-4e59-bc1e-789055e8ee6a_terseLabel_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_label_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common and Collective Trusts [Member]</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_documentation_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember" xlink:href="cvs-20201231.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CommonAndCollectiveTrustsMember" xlink:to="lab_cvs_CommonAndCollectiveTrustsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_535b5b0b-037a-4982-ab4b-de0674187b36_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetGross_33998afc-8e8b-4bfe-9e48-de4018acf348_terseLabel_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetGross_label_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Gross</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetGross_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetGross" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseRightOfUseAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetGross" xlink:to="lab_cvs_FinanceLeaseRightOfUseAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_970142eb-425b-4974-97f9-384318f99af4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_6c773c83-e427-4df2-b321-932ef9a9bc34_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_63b4d4bb-56d6-41f0-8a25-cad3a0e5b32c_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_fd8e0140-2b9b-4217-b0fe-225d1523ab98_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_c7b154b3-198d-4840-9dbb-feb564bd2665_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_c1b576ea-fa6f-45c4-88b4-02028560e92c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_1e24a5bc-ea3e-4fb9-bbed-2ddb7a15d1d3_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total claims paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_85a6418e-c09d-44ed-b55f-7c1f29ebefb0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_07f4cbf1-14ed-4aa9-bf23-031d17c509d7_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from derivative instruments</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Derivative Instrument, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember_151ff0e3-d848-40ba-9368-a3c83a0478d5_terseLabel_en-US" xlink:label="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Health 2017 Incentive Compensation Plan</link:label>
    <link:label id="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember_label_en-US" xlink:label="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Health 2017 Incentive Compensation Plan [Member]</link:label>
    <link:label id="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember_documentation_en-US" xlink:label="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Health 2017 Incentive Compensation Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:href="cvs-20201231.xsd#cvs_CVSHealth2017IncentiveCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:to="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_da7a3bbc-e80d-4346-8b34-94a2244d82a4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_b11d4be0-80d9-4fb1-a619-08468c313639_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_672cac45-f65f-4295-8dc1-981b03e465ac_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_23c4b66d-4daf-4b92-83e3-d2c101183652_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_c2f0d2ac-3830-440e-a46e-2d240bc47e31_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_7a6f4f6b-fc3c-464c-a019-20e16ae765de_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_02f7f304-a26d-4e79-94ec-f6205d143e90_terseLabel_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes</link:label>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_label_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes [Member]</link:label>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_documentation_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember" xlink:href="cvs-20201231.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OutstandingSeniorNotesMember" xlink:to="lab_cvs_OutstandingSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_72d151cb-57f6-4044-b3a9-e7e43f096d9b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Allowances and Purchase Discounts</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFive_9172cb72-2d5b-491a-ab92-0d48098f9a06_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_7ea9e641-db80-4c21-a540-a0eeeb944256_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_c3092288-28fb-4f69-a1d2-a4d2cd80561b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred Health Care Claims,Net of Reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d50a87a6-a7d6-4772-b909-3480953d321b_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_08aa60c7-1235-4e3b-ba2e-898fa1835db8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f5e75bd0-381c-417b-9835-1212f382ef91_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_22aaa13f-1f57-46fe-b04c-060160779bd1_verboseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_e008705d-8698-4514-9870-f7d7fd551f2d_terseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from external customers</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_documentation_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="cvs-20201231.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_50b50015-2a1e-48f8-8be5-af71caa66d1a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3625DueApril2027Member_e7f15639-24da-4ea2-97be-cdaa0c7ed3f3_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% senior notes due April 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes3625DueApril2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.625%, Due April 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3625DueApril2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.625%, Due April 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3625DueApril2027Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3625DueApril2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3625DueApril2027Member" xlink:to="lab_cvs_SeniorNotes3625DueApril2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_6e436cf6-8469-4934-b4a7-e6b9d2daa608_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_62090315-0767-4ff0-a8ff-53c9f1468efb_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining as of December 31, 2020</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_073c8a34-3d72-4c20-b142-2d79afc87808_terseLabel_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_ecf92dbd-6d0d-459c-8d92-da08dce97838_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairments</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_654b5c4d-3857-4182-9753-c13c99cc2158_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_1031e6f0-0972-4761-9c1e-5323de7fc619_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_efa80458-50f0-4fef-9154-6ecb2ffc7217_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_12c1c6af-531f-44fe-a118-262c59c8d784_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_29dd6954-ebec-42a9-83f9-5b51a465a0c0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_54a1ff19-f1ed-4297-bfa5-2b7aa761ecda_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_8da99ea3-88f3-411c-9fd4-38bd2ff8e720_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of effective income tax rate reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_3b1d5c3d-2796-4398-a692-f619fa6e6bc9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_6c0089bc-db7a-48a1-b8ad-3231ba92e579_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock options and stock appreciation rights award activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_3c3de32a-a200-4d6f-bf63-583de5155bae_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5f7727ea-ce8a-4105-a3bc-1df6c977aa4d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes425DueApril2050Member_75c86965-cc63-4e16-bd1f-c0e5accf4c0a_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes425DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.25% senior notes due April 2050</link:label>
    <link:label id="lab_cvs_SeniorNotes425DueApril2050Member_label_en-US" xlink:label="lab_cvs_SeniorNotes425DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.25%, Due April 2050 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes425DueApril2050Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes425DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.25%, Due April 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes425DueApril2050Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes425DueApril2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes425DueApril2050Member" xlink:to="lab_cvs_SeniorNotes425DueApril2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e910f78d-30a9-462a-8f91-49ed630603b7_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_156476a5-a574-495d-836b-bbaf10442416_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_354b3f62-3286-4558-b106-2d7a06550f7b_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_2e3ad9a3-2deb-4716-826d-94aeab147cf1_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_8a384a36-3be2-4b44-80ef-6626a3c2dac5_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_6a679e53-5629-488a-9a44-e7d2788c0733_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_8a622b08-f607-4ccc-9263-62ed5d4823dc_terseLabel_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_label_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:to="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c40892da-bc69-4320-b10c-3ac5a7a67939_verboseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative translation adjustment from AOCI eliminated upon divestiture</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_bf94ea0d-f1bc-4f4d-9266-2b4e4d75d2f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_693a4f1a-bc4a-4423-a106-1375bc025a76_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_3aeda611-b329-4ddc-895d-e38dc00f062e_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4Point125PercentApril2040Member_dc3904f6-281b-4f2d-8493-439ab2211a70_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due April 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes4Point125PercentApril2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point 125 Percent, April 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4Point125PercentApril2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point 125 Percent, April 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4Point125PercentApril2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:to="lab_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_e7c07de3-9a31-4f73-b54d-23c7e2076251_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Three [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:to="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_bb6f0ae8-1eca-459b-945f-3811e73a8bd7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI before Reclass, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_0b74d5bc-cb00-4be4-b591-fa0579f452c5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_e044fcca-e50a-4bfd-a858-f14b51126c20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_90e88cc9-2f3d-495f-a56e-af74b5e22c05_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net repayments of short-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_fcf1fc54-309c-4ed2-9f77-a763e5d156e9_terseLabel_en-US" xlink:label="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_label_en-US" xlink:label="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:to="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_384b53d0-0df1-45e6-a65c-a352d77a876c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_2428cf54-ea8f-4094-8a2d-fffe704685b2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_1d6fd481-75c3-46cf-a190-b61c32dd5973_terseLabel_en-US" xlink:label="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer plans, plan contributions</link:label>
    <link:label id="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_label_en-US" xlink:label="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Pension, Insignificant, Plan Contribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlanPensionInsignificantPlanContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:to="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_265a261d-bef9-4208-9c38-1eaffe580559_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_560439ba-0523-4b1d-8bcd-76951373cddf_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_7144f2b1-d8f0-46c7-b6a0-25872c69961a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New debt issued in acquisition</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_fcc33120-7056-4a9d-9417-8cd55c2a8ab3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_4f78570d-2571-44c2-99d2-2860cbdae248_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_8bc266e6-251f-4851-ba73-5c258046ba1a_terseLabel_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rewards earnings and gift card issuances</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_label_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_documentation_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:href="cvs-20201231.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:to="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_5b321185-ae7f-404a-8711-dcd013ce65f1_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_d507588a-f967-476c-ae6f-f95b98a3cf57_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_9756fcc5-56e8-4f9c-9645-4dd06bed6e1e_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0d3e3b23-20b7-47ce-9288-2bfa3f718962_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_7e9cd83f-61e6-47a8-b619-2b7e154a78d6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_9039bab5-eb9b-4339-b565-01edcc0e28c4_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_1b7bed2e-a7d1-4e9f-aa7d-4bb266c35c79_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_ac3287a0-8dff-4569-9b82-1b69fd74ea50_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_cdc378ce-2588-4157-b11a-f975b6e9adef_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8d23f1e3-e942-4ddf-8af8-62b07792d2fc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_a4fdd4d6-fed6-40d0-8e99-51c2efe017aa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_7446baf3-bde4-47c5-b323-6f144f2bfc70_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f8c90858-e7b4-40cf-a2bb-a1c30e4a2acf_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_053530d3-e4a6-46b6-ba3a-3f51fa58ed5f_terseLabel_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients served per year</link:label>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_label_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Patients Served per Year</link:label>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_documentation_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Patients Served per Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear" xlink:href="cvs-20201231.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofPatientsServedperYear" xlink:to="lab_cvs_NumberofPatientsServedperYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_c1ce06c7-1efd-400d-8ca1-7278f038a042_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity_303a51fd-f402-4b95-a51e-fcd54192e5cc_terseLabel_en-US" xlink:label="lab_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of quarterly payments from VIE</link:label>
    <link:label id="lab_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity_label_en-US" xlink:label="lab_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Quarterly Payments From Variable Interest Entity</link:label>
    <link:label id="lab_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity_documentation_en-US" xlink:label="lab_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Quarterly Payments From Variable Interest Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity" xlink:href="cvs-20201231.xsd#cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity" xlink:to="lab_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_1372f46b-4bda-46d7-9048-bfbd860fbb3f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TCJA tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9aea5406-0708-47db-a9e4-5c6b07d6ff76_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation not yet recognized, other than options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_72a14ceb-4242-414e-9528-eb864d70f55c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_38c9a228-80dc-45fc-89b2-c5933de6d0f3_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8d7b2830-9f2d-4903-aee0-4556bcfde343_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_d60367eb-2a46-4a81-bcf8-2d1eb7aa13b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededPremiumsEarned_8bdbd0c8-b01c-4bfb-8e93-cdb5cdaef6eb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CededPremiumsEarned" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded</link:label>
    <link:label id="lab_us-gaap_CededPremiumsEarned_label_en-US" xlink:label="lab_us-gaap_CededPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Premiums Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededPremiumsEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededPremiumsEarned" xlink:to="lab_us-gaap_CededPremiumsEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_03527ec1-1c89-4825-81bd-81a14291bfaf_terseLabel_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts, Debt Securities</link:label>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_label_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust, Debt Securities [Member]</link:label>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust, Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:href="cvs-20201231.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:to="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_86e07550-0fc3-494f-8b02-68c28fe72ced_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_36a354a8-411f-4978-839c-e893e5c8ef25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_06084ca9-7078-4a40-b4c3-c5ff01e80ffc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assets (liabilities) recognized in Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_97cab7b8-da1b-4240-98ec-4c667f442cf2_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_69221d02-7317-4310-9351-3ff6e398eb39_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_5b2eec02-3b1e-4b22-82a5-410465541f18_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost (income)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4579f403-3ac3-453c-ac0e-dac7e26c1ad6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, exercised ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_12f0c48d-aac6-4e2d-9b45-ed81e231c85a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_107aee20-2620-4490-991e-da2228925163_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_9538d54b-35d5-4d41-95e1-0e2943c9ca8d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_61d691f1-a11b-40af-a474-236eca7c9cc1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_9a654e08-c211-4186-88db-037b09813dfa_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_108afb0e-fad6-4cda-ab90-766e4fb9470a_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category1Member_31fdb69d-9f44-4489-8576-6b7377598377_terseLabel_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1</link:label>
    <link:label id="lab_cvs_Category1Member_label_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 1 [Member]</link:label>
    <link:label id="lab_cvs_Category1Member_documentation_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 1 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member" xlink:href="cvs-20201231.xsd#cvs_Category1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category1Member" xlink:to="lab_cvs_Category1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_54b35bc6-0c05-47bf-a4ea-f15fe5a76370_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_014a8294-1073-47e0-8629-242fa07a4224_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_84cf6b94-1fe6-4727-8e0b-02e7a3b21977_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in benefit obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_1dbbacf1-8cdb-417d-9126-44e5db4ea500_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and OPEB plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_f5253edb-39d2-413d-a19e-ff8300f92b61_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs recorded in other insurance liabilities</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_label_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_documentation_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:href="cvs-20201231.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:to="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock_a734fb13-4986-4a4b-836d-b4397724dc20_terseLabel_en-US" xlink:label="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock_label_en-US" xlink:label="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite lived and indefinite lived intangible assets [Table Text Block]</link:label>
    <link:label id="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the cost, accumulated amortization and net balance of intangibles assets and amortization period, in total and by major class. Finite-lived intangible assets have a stated useful life over which their gross carrying value is amortized. Indefinite intangible assets have a projected indefinite period of benefit (hence are not amortized).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" xlink:href="cvs-20201231.xsd#cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" xlink:to="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PensionAndAnnuityInvestmentContractsInterest_d8523ff8-3db5-42d0-8c5f-9545b34b1b27_terseLabel_en-US" xlink:label="lab_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate for pension and annuity investment contracts</link:label>
    <link:label id="lab_cvs_PensionAndAnnuityInvestmentContractsInterest_label_en-US" xlink:label="lab_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Annuity Investment Contracts Interest</link:label>
    <link:label id="lab_cvs_PensionAndAnnuityInvestmentContractsInterest_documentation_en-US" xlink:label="lab_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Annuity Investment Contracts Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:href="cvs-20201231.xsd#cvs_PensionAndAnnuityInvestmentContractsInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:to="lab_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_fd55d4c5-ed77-4643-ba7a-ea068a6fcbee_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_42eec9a5-53dc-41cb-a80c-d7bf2d8e07c3_terseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_label_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Assets</link:label>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" xlink:to="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRealEstateMember_d562169f-e5cb-49b0-bd2c-54948c173968_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRealEstateMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:to="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_ae893d83-bddd-41f8-9093-0c67a7c8008e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3, net</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_c0d65ee5-dba8-497c-b139-d95a877a9b2f_totalLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_baa17ea5-8047-42da-8625-f0bd4b44abb8_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross transfers into (out of) level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_28bde12e-a801-4ed6-88bf-071f540aefd6_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_7d983bf7-54a4-42aa-b493-3c4b1b5c8720_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocationsToPolicyholdersPolicies_024fa263-cfc1-4a8e-9f1c-a5bcc5e77152_terseLabel_en-US" xlink:label="lab_us-gaap_AllocationsToPolicyholdersPolicies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders' Funds</link:label>
    <link:label id="lab_us-gaap_AllocationsToPolicyholdersPolicies_label_en-US" xlink:label="lab_us-gaap_AllocationsToPolicyholdersPolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocations to Policyholders, Policies [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocationsToPolicyholdersPolicies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocationsToPolicyholdersPolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocationsToPolicyholdersPolicies" xlink:to="lab_us-gaap_AllocationsToPolicyholdersPolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_95968b42-6956-4332-b7ed-debab612e9cf_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c011b4d9-4ccf-4d30-869c-b47cbdd40283_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_6ee2c527-e957-478f-a4ac-c9a87cec0156_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_662a8bdb-9d3c-4f91-acb6-092fce0ea821_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_b6033a15-e730-49c0-85fd-d8e2720ad5d8_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_4bc07798-b925-4274-9509-c4d939d3fa7f_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_84aa2bd7-2553-475d-a4c1-7d6c7356350a_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_20cb7df6-8d15-4fea-955e-31f343809c6a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_0f67ca10-2b69-402a-8741-47471eb17783_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_9c7126d4-b125-4295-b276-01512a4b729d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_f66c2a9b-1f45-4993-a6b4-aa9aa63c4d33_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_adaa5e58-4bfd-42ed-baf5-cc264a9ad56b_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired_177db7ca-f13a-425e-b742-1cb31c67301f_terseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The assigned value per share of acquiree (in dollars per share)</link:label>
    <link:label id="lab_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired_label_en-US" xlink:label="lab_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Acquisition Value Per Shares Acquired</link:label>
    <link:label id="lab_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The assigned value per share of the acquiree company.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationAcquisitionValuePerSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired" xlink:to="lab_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_645202cb-4c60-4482-8900-cd7818e287a5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_ade8c28b-0bdd-475f-92c5-4285344b3023_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Products Sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_7586efae-3236-43c6-b623-aa60cebffe97_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCosts" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_fbb26abd-50f7-458b-b020-ea6fbf20e379_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_f928397d-c729-4c60-8d2e-c2759493f36e_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation and Transactions and Translations</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_46203b94-a33d-4a0d-a5e0-c6fef16dc38d_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstate" xlink:to="lab_us-gaap_MortgageLoansOnRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_6be0401c-4060-4447-b82a-fa26b02fbe85_verboseLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income (loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_f3af330e-054c-4bca-9d66-8bd41358661c_totalLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_label_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_documentation_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss" xlink:href="cvs-20201231.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss" xlink:to="lab_cvs_AdjustedOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_94c4430e-b223-4ae4-bb46-9bc3d8234e19_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.75% senior notes due August 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.75%, Due August 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.75%, Due August 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes175DueAugust2030Member" xlink:to="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_0d37d48f-a699-4221-bd04-382a0a2c75b8_terseLabel_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal home loan bank advances maximum amount available</link:label>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_label_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank, Advances, General Debt Obligations, Maximum Amount Available</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:to="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_c4dd0f06-9184-4050-9ade-f794ab18e6b3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_088c8182-3593-4d8b-9c89-90cd17739dbe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share from continuing operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_cf679a52-8ba4-4675-b1ae-432a0ecdea2e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_0543d6d8-b193-4d0b-ba79-c00d9db1cb3b_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldByInsuranceRegulators_cd0a2afa-630d-4b21-852a-09dddea77eef_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldByInsuranceRegulators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments on deposit with regulatory bodies</link:label>
    <link:label id="lab_us-gaap_AssetsHeldByInsuranceRegulators_label_en-US" xlink:label="lab_us-gaap_AssetsHeldByInsuranceRegulators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held by Insurance Regulators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldByInsuranceRegulators" xlink:to="lab_us-gaap_AssetsHeldByInsuranceRegulators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_d5e38146-b478-4eeb-8af8-b27187189a1e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule ESPP valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_d2f3fe6e-e180-4f5c-85d6-bece1d097501_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_af9f3b88-7cc6-4539-b4c0-6be8a5e81b4f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_e43dfc0a-c64b-4731-a45d-5ed286618feb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_a6ddce68-f393-4277-a7ed-ecb636a82113_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets, investment within plan asset category, amount</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6dcefa5c-1e70-4729-b5ef-f6161c2d5923_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDerivativeMember_d2eff6fa-34ba-4648-93cc-68ca557740d6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDerivativeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDerivativeMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDerivativeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Derivative [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDerivativeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDerivativeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDerivativeMember" xlink:to="lab_us-gaap_DefinedBenefitPlanDerivativeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay122021Member_4bd9c6d6-0b50-4916-84dd-9f3793bf9d0b_terseLabel_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay122021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 12, 2021</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay122021Member_label_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay122021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 12, 2021 [Member]</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay122021Member_documentation_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay122021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 12, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay122021Member" xlink:href="cvs-20201231.xsd#cvs_RevolvingCreditFacilityExpiringMay122021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RevolvingCreditFacilityExpiringMay122021Member" xlink:to="lab_cvs_RevolvingCreditFacilityExpiringMay122021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b6add4cb-4e46-401b-a184-bd08254d6f8a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_9490feb6-2c3c-4238-83f5-2f0e153e80cb_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance lines other than short duration</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Other Reconciling Item</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_a7545cbe-c87c-4622-a942-c74f1dd46f5b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Disclosure</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:to="lab_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_7477114e-3367-4a1d-8d05-e019fbf2f297_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale-leaseback transactions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lease Payment, Sales-Type and Direct Financing Leases, Investing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:to="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_588f833b-b876-45fc-8b22-cea0daf176fa_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_74e4fac1-f53b-4dd2-8ce9-6af5d3554a2f_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_4d77e32e-e996-40d6-835c-79152f9cefd9_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Five</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_cc5f9d04-5507-4852-98f1-5d2b53fbe3e0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_5635ab31-d271-4fdf-ac01-a892a07cb418_terseLabel_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and manufacturer receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_label_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_documentation_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables" xlink:href="cvs-20201231.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VendorandManufacturerReceivables" xlink:to="lab_cvs_VendorandManufacturerReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_0ba9f412-e74f-4d5d-a86a-d8cd78313fab_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_1eb2ce4d-1bdb-44d6-af0d-19b63931a2e7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_0871d62b-05d9-42c5-abce-3d6e27951028_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_274ec011-bcbd-4e9b-b43d-81e44b8e5ed4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested at end of year and expected to vest in the future (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_d541a435-ec8a-4f15-9704-be0695111cc3_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_07a6e62f-746a-4c1b-be38-6c1ff1c46d43_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4f63b6c2-b8b2-4262-9159-a5bf0103469f_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_271e09e7-60ea-4ff5-af42-f19d94e9eb6a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c5ac43c0-df25-496b-a251-1d229bd4e657_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_907b750d-d99e-438e-bec8-598e486f7518_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_ffd7d0a6-f559-4c08-8076-43dede1e30a6_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. corporate securities</link:label>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_5266555a-96ae-4217-827f-47cbdc4d9279_verboseLabel_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. corporate securities</link:label>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c261c82c-199a-4967-abf4-ce47a8a01b64_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_f648bef1-c460-47a9-879a-29efbd6662c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities reflected in other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5b729f34-2103-4d09-9ffe-684231ae64a8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_b17158c4-bbc4-4c6d-a33c-dcc28e906ee7_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_b88a752d-ac4d-4274-bd63-ba426d0b69dc_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_9b8ba467-9906-4b4d-90d2-62eda740123d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2c757f13-2ec2-4ead-aead-325ed6610f7b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8e0d2acd-c028-4f0c-9e13-e4e0f62da7e1_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_55f3b132-ef68-4644-9ba4-412f1ebac49b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of discontinued operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_3b0a3154-a073-4472-83f5-d7a058cf6b9c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_05f11f20-a7da-4619-8234-135098129ce5_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount awarded from other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_92e09f45-d391-487f-9d46-24d44c1be310_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_2b27cd87-adcc-4ca4-a1a1-70d158799da6_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryAxis_4ec97e02-82d8-4e1f-8b0b-73efa8ee0c17_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Axis]</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryAxis_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis" xlink:to="lab_us-gaap_SeparateAccountAssetCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_8b33bc5e-04e5-49dc-9cc3-68a8dc547496_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_b8711ba9-b16d-426b-9c15-b54bc54aa36d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of the Tax Cuts and Jobs Act</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a3b57423-3195-428d-ae35-9af941edc706_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f57e76df-b041-47c0-b84f-8f91314ad4e1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_97c8251b-2af1-4f15-b41d-2ffcc6cc7a45_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_ca65551e-635c-4124-89ac-e71c9d7da6f7_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.8% senior notes due June 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:to="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_12e5de09-9eb6-4335-82a0-6d45954634cc_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5a16fdc5-85bf-4799-8e7d-870034b241ce_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value exercisable at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_d183eb68-9c80-46fd-9a91-43e41bf2ecb4_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate</link:label>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_label_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialRealEstateMember" xlink:to="lab_us-gaap_CommercialRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_537e480d-0137-4a05-96e7-3fcc37288a33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_f6f3165e-566d-4c6d-9f4d-5a8cd93c2e27_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_33fcc6a2-6c9b-40f4-bcef-26a133e2816c_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsTable_67028f05-6b99-40b6-88a0-d099de1352e1_terseLabel_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Table]</link:label>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsTable_label_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Acquired Intangible Assets [Table]</link:label>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsTable_documentation_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsTable" xlink:href="cvs-20201231.xsd#cvs_OtherAcquiredIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable" xlink:to="lab_cvs_OtherAcquiredIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_4b5c3ba2-6d12-41cb-a509-f8daca135213_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_7965a78d-68eb-41b1-bc98-e2cf64ebd9e0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_639e833a-5ab1-4cad-9ddf-0d1911811b19_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_1ef17aab-6a35-4de3-990a-9d8ce29b62b5_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans fully repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Loans Fully Repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertains to amount of mortgage loans fully repaid.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:to="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_091caba5-299b-4889-be7e-3cc5802f165d_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4555eac6-c352-4ed0-a9c4-0f29573778ab_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6a36af73-bf79-4fde-9fc5-58797a541ac9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_3fc3a72e-f8d5-4466-bc80-cb3641f8b60c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMember_77d0b69f-070a-47e2-9a39-dc3400b730f8_terseLabel_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Advances</link:label>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMember_label_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Advances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:to="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_fc260fad-f0ab-4197-a3bd-a60af7c590a5_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Four [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFourMember" xlink:to="lab_cvs_YearOfOriginationPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c1d183d7-db2e-4725-80c7-6b8b1c2246b1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_d8cdc147-4f57-44eb-bf51-fa0359e0273a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_376bf0c0-b68a-4bb3-824d-a9368df7056d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_68286bab-dd49-4417-a84e-73bec989bf2a_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_6eca42fb-5b10-4f00-8f01-471e999aff40_verboseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal of debt extinguished</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_c1da3807-1ff5-436e-aaa9-8f7f054e28cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_79e3c083-7d12-4063-96a8-0f7b0a302be9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_a1432b76-3d11-4bd2-b474-1e44f670b8d4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_de718e04-b6bd-4bad-8b39-67a773b714e8_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total rental expense, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_216c60cf-5ff9-4b40-acd4-84d4ff3546e7_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_6f9a0ffc-e2eb-4276-b9e5-33bb64c8e7cf_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans foreclosed</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_55f3b1eb-a85c-4a30-8603-0272435147f3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a65cda70-6623-4d54-aeb2-77d4414cac90_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_118f455e-f23a-42ee-bdef-6507694cb2ad_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease to accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_bb54767a-670e-4027-8257-c8b70dbc3d49_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_a1ceb28b-fca9-4df5-bbfe-85540e02b820_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.1% senior notes due March 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:to="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_c5c1a60b-a562-468a-918c-7d8909ec8611_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_e54acda3-c75d-490b-a747-9d1575fc0c4c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of statutes of limitation</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_43f2dfb1-05e1-4e13-bd8f-5b81519053fd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ce07e1f5-2528-46f7-8831-d9f76663ba51_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_77768986-0f6d-4e70-a1c9-72ac7ec2e935_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_667bc590-423c-4abd-a2d3-906baa12c3f7_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_4a7ab4c7-23de-43f6-907a-b685a0b91820_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_5d3713bb-d1e9-4892-87ae-6cd7cc8ad974_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_fa9e9a93-23ff-42e7-a046-45c657db87b8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_39d2f561-59e3-4cc6-ad24-7beeb175923c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_9d5e277f-ac17-4720-98e0-06ceabcaef20_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_728d0b6f-9c0b-45b0-b2ef-721956d7db1c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement benefits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_f83ff160-f042-4039-964c-f7e78efa6f2b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of expected future benefits payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyRebatePeriod_aa610b19-923e-47d1-9b8e-7f8503f72413_terseLabel_en-US" xlink:label="lab_cvs_PharmacyRebatePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy rebate period</link:label>
    <link:label id="lab_cvs_PharmacyRebatePeriod_label_en-US" xlink:label="lab_cvs_PharmacyRebatePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebate Period</link:label>
    <link:label id="lab_cvs_PharmacyRebatePeriod_documentation_en-US" xlink:label="lab_cvs_PharmacyRebatePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebate Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRebatePeriod" xlink:href="cvs-20201231.xsd#cvs_PharmacyRebatePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyRebatePeriod" xlink:to="lab_cvs_PharmacyRebatePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree_b9e04da1-3593-4d0f-a3d8-40e91a8b8ed1_terseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assigned value of acquiree</link:label>
    <link:label id="lab_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree_label_en-US" xlink:label="lab_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Acquisition Assigned Value Of Acquiree</link:label>
    <link:label id="lab_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Acquisition Assigned Value Of Acquiree</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree" xlink:to="lab_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_89034d9b-f83f-40d7-aa6a-45b3f586d462_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_244ea1c7-fa0d-4584-9737-307b21236e0d_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_577520d7-bf69-4519-8060-327df665a39f_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2c96390a-a516-4856-92f0-513a83b5b4f3_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgeFundsMember_c130150d-c5de-4ef6-9eee-51a2fdcdde96_verboseLabel_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge fund investments</link:label>
    <link:label id="lab_us-gaap_HedgeFundsMember_5314e92a-b135-49b9-a87f-b901916df4e1_terseLabel_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Funds</link:label>
    <link:label id="lab_us-gaap_HedgeFundsMember_label_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgeFundsMember" xlink:to="lab_us-gaap_HedgeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_d49cfec6-9cc5-4d84-9482-858117bb38d2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d6dab11f-871b-40f2-861b-6e4c17544249_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_78a0ef48-2416-4f7a-b6b4-c563129e7d60_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares held in trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:href="cvs-20201231.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:to="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_9956504e-5bb2-44e0-b604-e409b66f149d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_81525564-b018-41de-8e4a-757332a82fde_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premiums</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_7aff4a2d-5ee6-413e-aa46-aaf170bf006c_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock_e6c424ae-2674-4906-b9c8-ab16f4d893f6_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory accounting practices disclosure</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:to="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SalesChannelOtherMember_55266b56-8951-479b-b23f-7d05476db018_terseLabel_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_label_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_documentation_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember" xlink:href="cvs-20201231.xsd#cvs_SalesChannelOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SalesChannelOtherMember" xlink:to="lab_cvs_SalesChannelOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_4e186d67-7286-40f1-9dbe-4b47a4ecd1ee_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivateEquityFundsMember_ed96ef0a-f11d-43b8-a713-0116a0cb8ba3_verboseLabel_en-US" xlink:label="lab_us-gaap_PrivateEquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private equity investments</link:label>
    <link:label id="lab_us-gaap_PrivateEquityFundsMember_label_en-US" xlink:label="lab_us-gaap_PrivateEquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Equity Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivateEquityFundsMember" xlink:to="lab_us-gaap_PrivateEquityFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_053d131a-3c83-4042-86aa-6ce1efabd766_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_eea9969a-d52b-47d0-913a-46c3b123d9f7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_9a9fb134-9767-4262-8d89-11ed53f2eb5e_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments_5930c783-5b20-43f0-bfd5-efb7e245addc_terseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments (current and long-term)</link:label>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments_label_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments</link:label>
    <link:label id="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments" xlink:to="lab_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_8aaa4b7c-b1a4-48df-a007-8ca158a56c0b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_1b61ce8c-a8bf-4103-a679-16576e01f18e_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.125June2021Member_e9ed9fa0-09d8-4efb-a052-933a5c1a36ff_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.125June2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% senior notes due June 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes2.125June2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.125June2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125%, June 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.125June2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.125June2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125%, June 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.125June2021Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.125June2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.125June2021Member" xlink:to="lab_cvs_SeniorNotes2.125June2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ee2f4df0-04c6-4d25-a6c4-8adb2991fe83_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b37db6a9-b04d-4204-a36e-6aa2b8fb877a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_6b817384-3442-4c5e-8e2b-ec4178945896_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_74a32731-fc2c-4b2d-9296-1ab2abd00dbd_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_5448d867-b2fb-4fae-821c-a6051d2a3f37_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryDomain_1771406a-76c6-4c40-a408-7f51d63a4be9_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Domain]</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryDomain_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain" xlink:to="lab_us-gaap_SeparateAccountAssetCategoryDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_e338521d-6be7-4be4-a14e-dbd64d36e43e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3869bdd6-f3ad-4506-b691-73d315e3d60c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_875b66db-52b1-46ea-a2b3-1171c285e3d2_terseLabel_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy claims and discounts payable</link:label>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_label_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims and Discounts Payable, Current</link:label>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_documentation_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims and Discounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:href="cvs-20201231.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:to="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_a562283d-4a31-46f6-be19-01716a8286e2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Domestic</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_5410b3cc-8d2f-4362-a95f-13dfbd23f602_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_f56586ac-c99c-4fce-8ced-5b94cff34302_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskReinsurerDomain_fe861c82-dc16-4826-a97a-86bc89b92115_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskReinsurerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Reinsurer [Domain]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskReinsurerDomain_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskReinsurerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Reinsurer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain" xlink:to="lab_us-gaap_CededCreditRiskReinsurerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EquitySecuritiesDomesticRealEstateMember_4ce5d63c-2e21-4d89-aaaa-ee3e93ed0a40_terseLabel_en-US" xlink:label="lab_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic real estate</link:label>
    <link:label id="lab_cvs_EquitySecuritiesDomesticRealEstateMember_label_en-US" xlink:label="lab_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Domestic Real Estate [Member]</link:label>
    <link:label id="lab_cvs_EquitySecuritiesDomesticRealEstateMember_documentation_en-US" xlink:label="lab_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This category includes information about ownership interests or the right to acquire ownership interests in domestic real estate whose ownership interest is represented by shares of common or preferred stock (which is neither mandatorily redeemable no redeemable at the option of the holder), convertible securities, stock rights, or stock warrants categorized by other type.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:href="cvs-20201231.xsd#cvs_EquitySecuritiesDomesticRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:to="lab_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_7664739b-45bb-49f4-a0ec-a7a652266b86_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtExtinguishmentFees_901b3054-3149-4802-9a3c-e6de8e508b0f_terseLabel_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment fees</link:label>
    <link:label id="lab_cvs_DebtExtinguishmentFees_label_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Extinguishment Fees</link:label>
    <link:label id="lab_cvs_DebtExtinguishmentFees_documentation_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Extinguishment Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees" xlink:href="cvs-20201231.xsd#cvs_DebtExtinguishmentFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtExtinguishmentFees" xlink:to="lab_cvs_DebtExtinguishmentFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_b968e4fb-607e-4993-b04d-9dd3495b2f9f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_4f0733bd-9e78-4544-a155-44210c3bfdba_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.8DueJuly2020Member_c23a4644-649c-44fb-9190-3fd8922df47c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJuly2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.8% senior notes due July 2020</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJuly2020Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJuly2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due July 2020 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJuly2020Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJuly2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due July 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJuly2020Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.8DueJuly2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.8DueJuly2020Member" xlink:to="lab_cvs_SeniorNotes2.8DueJuly2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_13bab3bf-8e00-4b4e-96bb-269968784e24_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01: 3,200 shares authorized; 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus</link:label>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stocks, Including Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:to="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_625f355c-25bc-4ce8-8723-520a7e735115_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period One [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodOneMember" xlink:to="lab_cvs_YearOfOriginationPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_52d99cfb-6a0f-420c-a9f0-1814e210e55a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, gross carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_1e48f558-9e5e-4709-92cd-fbcd3bd47d70_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8c3607b1-48fd-405a-9670-21b6825fd987_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_a871c4b2-7a1e-4f8e-b28b-d4ea7c82c94b_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_3a06ca52-40b2-4b0c-bd8d-052b6b754f98_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables (included in accounts receivable, net)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_57c5a6f8-828c-4d8f-aade-7c64ea60af97_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value vested at end of year and expected to vest in the future</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthInsurerFeeTaxEffectPercent_ee8ea0bb-dbc3-4cfb-8280-dc97994129a8_terseLabel_en-US" xlink:label="lab_cvs_HealthInsurerFeeTaxEffectPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFeeTaxEffectPercent_label_en-US" xlink:label="lab_cvs_HealthInsurerFeeTaxEffectPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee Tax Effect, Percent</link:label>
    <link:label id="lab_cvs_HealthInsurerFeeTaxEffectPercent_documentation_en-US" xlink:label="lab_cvs_HealthInsurerFeeTaxEffectPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the tax effect of the health care reform's non-tax deductible health insurer fee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFeeTaxEffectPercent" xlink:href="cvs-20201231.xsd#cvs_HealthInsurerFeeTaxEffectPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthInsurerFeeTaxEffectPercent" xlink:to="lab_cvs_HealthInsurerFeeTaxEffectPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member_c458f729-447c-4a36-90b3-821d85d596aa_terseLabel_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 16, 2024</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member_label_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 16, 2024 [Member]</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member_documentation_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 16, 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay162024Member" xlink:href="cvs-20201231.xsd#cvs_RevolvingCreditFacilityExpiringMay162024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RevolvingCreditFacilityExpiringMay162024Member" xlink:to="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_c75d18cb-bb54-4879-9810-9c0badfbf8e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU and performance share unit activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_3baf9ed3-cf07-4d53-8185-d17f6e59fa77_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Included in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4a70fa47-e6aa-468f-ac76-92fd2d481191_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateFundsMember_70d768ae-7e66-4943-97e9-c1bd569161ff_verboseLabel_en-US" xlink:label="lab_us-gaap_RealEstateFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate partnerships</link:label>
    <link:label id="lab_us-gaap_RealEstateFundsMember_label_en-US" xlink:label="lab_us-gaap_RealEstateFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealEstateFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateFundsMember" xlink:to="lab_us-gaap_RealEstateFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_923e4531-cdf2-4bc5-b824-8129cb880e42_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_592369d7-1503-4df7-83aa-dcce141b3478_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_c74dc48e-2c18-43d2-8af8-d636648fcadb_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c043a097-4f1e-405c-bb18-94898f96c831_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average basic shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e96916fe-129a-45d5-b09f-a1643f92bdbd_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3de8bf19-735b-4a83-bec9-fbe144cc0581_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_064135a6-b171-4e6a-a243-3379dac6c483_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, forfeited ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_03198de0-dbb2-4ed2-8376-a36a099af033_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.78% senior notes due March 2038</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:to="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_d9cde9cf-623b-4904-ad9b-a8734e0136df_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_0bedeecd-76b1-4f68-ac9d-68ec3bc90828_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectPremiumsEarned_550b44fd-13f1-4c98-91ec-d238f0205cd7_terseLabel_en-US" xlink:label="lab_us-gaap_DirectPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_DirectPremiumsEarned_label_en-US" xlink:label="lab_us-gaap_DirectPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Premiums Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectPremiumsEarned" xlink:to="lab_us-gaap_DirectPremiumsEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_ea810327-5ee9-4196-acda-cf51cae62230_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AetnaInc.Member_06dfd838-d038-4f0e-94e2-705f89f53362_verboseLabel_en-US" xlink:label="lab_cvs_AetnaInc.Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna Inc.</link:label>
    <link:label id="lab_cvs_AetnaInc.Member_label_en-US" xlink:label="lab_cvs_AetnaInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna Inc. [Member]</link:label>
    <link:label id="lab_cvs_AetnaInc.Member_documentation_en-US" xlink:label="lab_cvs_AetnaInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc.Member" xlink:href="cvs-20201231.xsd#cvs_AetnaInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AetnaInc.Member" xlink:to="lab_cvs_AetnaInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_686572ef-c533-4350-964c-647e6bb73351_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_c0319e75-9342-4c25-9f9a-2ffc21aeb65b_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_25d24f15-1fc4-4786-a5ed-797b4b8e47d5_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_c16732b4-80f3-43ac-90f1-4d525f897dcf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_bce6bd65-3be6-4381-bdb5-65c038d1b605_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_2625a5f8-318f-4ea0-92c6-6e61e96b79d3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_533b68e5-7894-4ec8-9093-f3c05d6e2a66_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_82c973ff-2259-4055-afa4-ff8af1ac671c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_74bb46b6-0aee-4bc5-9064-7ec4a3a6033a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_label_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:to="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_bab43349-fe0f-4237-9c2d-a8dbc56fa40b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_52604f0f-3b17-4b7a-8fae-8e2f7a5218d6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c8b13bce-da89-441a-a9b8-6576b4ae71b3_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_da4dbc3f-4fd6-4ffb-a2a7-f9a5859a4cf6_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6ed8e18e-bdcb-4871-b618-ec0a10cf9abf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_f6e63e64-4fc4-44a4-bc68-ec735e895f0b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_272342bf-d85a-4901-8000-8440d70c7f7d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_ff31122e-7dd1-453f-a5f4-7c7f6bed3633_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_71705bc9-93f1-4c58-9cd8-02bbb5c75d48_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_0e807000-f11a-48cd-a844-66af4db0f545_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified, pre-tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_ef7035c6-5beb-4799-ac9c-0f49edef42b7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of pro forma financial information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_4210c43a-9afb-4ffd-a021-791a2fc5eaec_verboseLabel_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity in mortgage loan portfolio</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_label_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity in mortgage loan portfolio [Table Text Block]</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Table representing activities in mortgage loan portfolio during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:href="cvs-20201231.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:to="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_bb266106-3680-43f7-9933-2adc4252b0cf_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_bcee3696-1131-472f-a75f-f42f54b933f0_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_eb61ac3d-bc76-463d-b65f-1856d19f9e8b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of stock options and SARs exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_9a435de0-177b-45e5-a604-03e1675ae8b5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue of acquiree since acquisition date</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_0e474253-97c6-4b31-b210-4595c3d0c410_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated compensation cost</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Accelerated Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_daaa2aee-3ba4-420d-93e5-2da19445e0a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_24474f30-9767-4533-91e5-0d5f41d15ee7_terseLabel_en-US" xlink:label="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period after date of service a claim is paid</link:label>
    <link:label id="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_label_en-US" xlink:label="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable, Period After Date Of Services Claims Are Paid</link:label>
    <link:label id="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_documentation_en-US" xlink:label="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable, Period After Date Of Services Claims Are Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:href="cvs-20201231.xsd#cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:to="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_8b045c38-7d46-41c1-ab10-a1ffda75510c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_457d725a-3b9c-41a7-99ba-27159be25b63_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_8bbb3e40-b837-4e61-8d24-84c479afb0b7_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_7df74be9-0324-4c70-aa11-7d62989f8ae6_terseLabel_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of walk-in medical clinics</link:label>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_label_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Walk In Medical Clinics</link:label>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_documentation_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Walk In Medical Clinics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics" xlink:href="cvs-20201231.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofWalkInMedicalClinics" xlink:to="lab_cvs_NumberofWalkInMedicalClinics" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1dd3f4dd-6ee4-4a93-9171-90562a44fd2e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_c9707475-b4f3-4614-a22b-e4636da5b615_terseLabel_en-US" xlink:label="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units</link:label>
    <link:label id="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_label_en-US" xlink:label="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units [Member]</link:label>
    <link:label id="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_documentation_en-US" xlink:label="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" xlink:href="cvs-20201231.xsd#cvs_RestrictedStockUnitsandPerformanceShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" xlink:to="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_27b35f05-643b-40df-8d34-59540b60923e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cb46456c-cf8d-4e4e-8bc6-42308a4bac12_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_06d5f7e9-3953-43d4-b3cd-0467d1598dca_verboseLabel_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan internal credit rating</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_label_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:href="cvs-20201231.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:to="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1fd84a12-3b63-4f20-8de5-1244648852c2_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_07107c46-aba8-432c-8408-b2dded6f9c5c_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_b00087cf-8caf-4f11-bcd2-eb4efcb8ec48_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions used to determine net benefit costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_611e1d7c-905d-4a7e-add9-66bb084be9d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTable_744a2320-69bc-456e-bff8-d26fe682719c_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTable_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTable" xlink:to="lab_cvs_TotalInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_aa751297-dafd-41b4-a86b-504757ebc6e5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_f999e505-a15e-4e97-a5d7-a837b3fcadbd_verboseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investments</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table Text Block]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes total investments, both current and long-term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTableTextBlock" xlink:to="lab_cvs_TotalInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_9f00ef52-c2e2-4a58-8e89-85a962a9963c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested in period, fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCollateralObligationToReturnSecurities_7a88ae10-1bab-443c-a2dd-6bae41c7d47b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCollateralObligationToReturnSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative assets subject to offsetting and enforceable master netting arrangements</link:label>
    <link:label id="lab_us-gaap_DerivativeCollateralObligationToReturnSecurities_label_en-US" xlink:label="lab_us-gaap_DerivativeCollateralObligationToReturnSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Collateral, Obligation to Return Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities" xlink:to="lab_us-gaap_DerivativeCollateralObligationToReturnSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_4c09a5f0-ebbb-490d-9348-992f01fc40df_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_63da6640-7499-42f2-a32e-a42e0727e4f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture of Workers&#8217; Compensation business</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_fe25889f-844c-4d7c-af11-df50311158a8_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_0a2bd83b-4709-48cc-8486-6bb6221424aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_4a6080f1-9721-469a-84b7-a15153c523e2_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_a191ed0e-3d0b-493f-aad9-6e2ed4432788_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_d7e9f163-19f4-4111-9c35-6aa3c079f764_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_2f98658c-fb9f-47f7-bb77-ff168356fb67_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_50b76c2e-19b7-42af-99a8-8951084bdc47_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_90743ad3-5d32-49e8-ae9a-6858be903e12_terseLabel_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business</link:label>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_label_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business [Member]</link:label>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_documentation_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:href="cvs-20201231.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:to="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_4e4d89fd-4a83-44db-b77d-9d74eff9a722_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average contractual term, outstanding at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0ffbd4c8-9357-403d-a3a8-25ad90a496c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_ed7a0990-f966-4b46-91b0-896770ace4db_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities reflected in accrued expenses</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_a55d4b5a-b061-41d4-8096-11d47ec5d79a_terseLabel_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_label_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_documentation_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember" xlink:href="cvs-20201231.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HeartlandHealthcareServicesMember" xlink:to="lab_cvs_HeartlandHealthcareServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_673278f6-cc45-40a5-958c-3aaa1dba312b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts from customers</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCustomers" xlink:to="lab_us-gaap_ProceedsFromCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4362f90f-6f4b-4e03-ae2b-9d8cef88ff8b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price exercisable at end of year ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_5a98ba99-62c2-4a94-982e-ba84209ca407_terseLabel_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program</link:label>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember" xlink:href="cvs-20201231.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2016RepurchaseProgramMember" xlink:to="lab_cvs_A2016RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_61ebd6ae-676f-4e5a-b326-7431dc64f3a1_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_8246fc31-5b27-4dad-8d4b-90810d1c23d5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_7f00375d-0537-4bbe-a47a-d2a984962800_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_c20bd341-669f-4ef2-8958-37b8c570af99_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost: 423 and 425 shares at December 31, 2020 and 2019</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_32d4289d-1bef-4316-87b2-38e53a715fe2_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_ec698979-5d49-46f8-9331-aeacc8f7f475_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_29a588ce-8d5c-4b6f-be32-5287ba1e3028_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cb9fd630-c7d0-4ce4-981d-b837cd7c1fb9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_37828698-0214-4c87-a215-348bf7211e4f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price vested at end of year and expected to vest in the future ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_663ae783-0ebb-4fd2-b29f-ab35565d777c_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_96e6ccf6-fadf-4179-8a5e-fe46bb883966_totalLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_9779b0dd-91e3-49a6-9475-d32549fecbf9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:to="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_17515d30-f4c1-4f22-ab93-ce2f7b0a0170_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_083035f0-0bd9-46f1-a572-8d7375b2183f_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements Recently Adopted and Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_692a4c0f-3ebb-4b6b-88ba-447b834b1b62_terseLabel_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages Held-for-sale, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:to="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_03a401f6-c5ff-4770-af0d-aee70c8067b0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesLineItems_0b933a57-a5a0-41c9-bbb4-404b69f6e45c_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesLineItems_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems" xlink:to="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_74786467-de3d-4a00-96db-979b2dd91ed0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_81535396-140e-4dd2-85e7-95ba8ae5dab9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_a8f4cd9b-de12-4c59-9323-888981d467c7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>cvs-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:4a98170d-2b8a-4463-a058-df0f5f10bd13,g:ab909211-91be-459b-b532-dbe2c1c7ff2b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CoverPage" xlink:type="simple" xlink:href="cvs-20201231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_997bc13d-ad62-4681-ace2-cafca6472b28" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_DocumentType_997bc13d-ad62-4681-ace2-cafca6472b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_fa34a898-0ca9-4f5a-abb3-a9e9dac542cf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_DocumentAnnualReport_fa34a898-0ca9-4f5a-abb3-a9e9dac542cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9e7c87a3-e383-4288-9f12-15b84c44aba8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_DocumentPeriodEndDate_9e7c87a3-e383-4288-9f12-15b84c44aba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e2ed99c8-d2c1-487f-85ff-c9aa2c0b7054" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_DocumentTransitionReport_e2ed99c8-d2c1-487f-85ff-c9aa2c0b7054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_602324e1-6690-4536-bcc9-d4e6bd84349c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityFileNumber_602324e1-6690-4536-bcc9-d4e6bd84349c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_dbdb0205-6126-4905-b183-cd4095d03333" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityRegistrantName_dbdb0205-6126-4905-b183-cd4095d03333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_273ddd9e-2e92-48a2-859f-818a56f032f4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityIncorporationStateCountryCode_273ddd9e-2e92-48a2-859f-818a56f032f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a4dee6a8-0af6-4947-b1d7-88bac46e8004" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityTaxIdentificationNumber_a4dee6a8-0af6-4947-b1d7-88bac46e8004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_70f85bcd-46c2-49e3-abca-a02fd4d0c334" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityAddressAddressLine1_70f85bcd-46c2-49e3-abca-a02fd4d0c334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_4b37becd-b661-4799-9ead-2591f9a6f420" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityAddressCityOrTown_4b37becd-b661-4799-9ead-2591f9a6f420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_df5294e7-45a1-4255-bd4c-8df35f518e98" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityAddressStateOrProvince_df5294e7-45a1-4255-bd4c-8df35f518e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8ff6d27b-35aa-4bf9-8355-12a2b284104e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityAddressPostalZipCode_8ff6d27b-35aa-4bf9-8355-12a2b284104e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_aaa88cd1-2ecf-4858-a1fe-e8377c9bfafd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_CityAreaCode_aaa88cd1-2ecf-4858-a1fe-e8377c9bfafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_22a6c44d-71aa-434b-86f7-1face4db17a6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_LocalPhoneNumber_22a6c44d-71aa-434b-86f7-1face4db17a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ef179acb-5082-47d1-8b88-9154a1ff6a6a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_Security12bTitle_ef179acb-5082-47d1-8b88-9154a1ff6a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_29612144-03bd-4700-b543-7691399bcfbc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_TradingSymbol_29612144-03bd-4700-b543-7691399bcfbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f6fd851c-7073-4e5c-b275-dd65be45e4ab" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_SecurityExchangeName_f6fd851c-7073-4e5c-b275-dd65be45e4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_f1d9a3a9-3c35-406a-bad2-103cd99cb6ac" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_f1d9a3a9-3c35-406a-bad2-103cd99cb6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_b0c48a2b-8166-4621-a88d-6858ce7bca75" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityVoluntaryFilers_b0c48a2b-8166-4621-a88d-6858ce7bca75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_3ea879b4-d034-47ac-a753-2a6b1079a702" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityCurrentReportingStatus_3ea879b4-d034-47ac-a753-2a6b1079a702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_fa4cefc2-d369-4447-8546-eb762d966c60" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityInteractiveDataCurrent_fa4cefc2-d369-4447-8546-eb762d966c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_139f2336-0bc8-4ae1-a35f-9ccad38d1fd8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityFilerCategory_139f2336-0bc8-4ae1-a35f-9ccad38d1fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_ac71c128-106a-43c7-964a-1dd4823ca7eb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntitySmallBusiness_ac71c128-106a-43c7-964a-1dd4823ca7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_90850968-3c47-4994-ad61-a4ba5a03081d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityEmergingGrowthCompany_90850968-3c47-4994-ad61-a4ba5a03081d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_43905476-453e-4183-b2b7-0d719cdc2a66" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_IcfrAuditorAttestationFlag_43905476-453e-4183-b2b7-0d719cdc2a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_af1d316c-2632-4f5b-8c03-38f85dc29be0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityShellCompany_af1d316c-2632-4f5b-8c03-38f85dc29be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_11da38a8-f018-4160-8890-7c1ab6baf8a2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityPublicFloat_11da38a8-f018-4160-8890-7c1ab6baf8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9b464995-e025-4eb6-b723-0d862cd5dfa1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9b464995-e025-4eb6-b723-0d862cd5dfa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_15db31db-35ba-46a1-a942-50a55fe1596b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_15db31db-35ba-46a1-a942-50a55fe1596b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d051fb87-0e53-4e43-a63f-3f182a166cfc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_EntityCentralIndexKey_d051fb87-0e53-4e43-a63f-3f182a166cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4a4d85b2-d102-427f-9e18-38ae62b6a0e1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_CurrentFiscalYearEndDate_4a4d85b2-d102-427f-9e18-38ae62b6a0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f9d0e54e-9ea9-4460-9f70-1c84e640a32e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_DocumentFiscalYearFocus_f9d0e54e-9ea9-4460-9f70-1c84e640a32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3c5d5496-4efa-4a8d-bdeb-064e6db65773" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_DocumentFiscalPeriodFocus_3c5d5496-4efa-4a8d-bdeb-064e6db65773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c2c56363-dc20-4acf-921c-cdb10bad82d4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ea05adb0-9712-4d80-960f-942fde6ea597" xlink:to="loc_dei_AmendmentFlag_c2c56363-dc20-4acf-921c-cdb10bad82d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_fa99d21b-f916-4893-9842-1764ef34b9ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_41cb79e6-033b-4ee5-826b-ef24c429f881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa99d21b-f916-4893-9842-1764ef34b9ff" xlink:to="loc_us-gaap_StatementTable_41cb79e6-033b-4ee5-826b-ef24c429f881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_137479a4-36ca-4905-8e61-200b4ace9cba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_41cb79e6-033b-4ee5-826b-ef24c429f881" xlink:to="loc_srt_ProductOrServiceAxis_137479a4-36ca-4905-8e61-200b4ace9cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ceb1ee47-218e-4720-a72b-8327ce992039" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_137479a4-36ca-4905-8e61-200b4ace9cba" xlink:to="loc_srt_ProductsAndServicesDomain_ceb1ee47-218e-4720-a72b-8327ce992039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_3300c8cb-31f6-4527-8e83-3da842c4e345" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ceb1ee47-218e-4720-a72b-8327ce992039" xlink:to="loc_us-gaap_ProductMember_3300c8cb-31f6-4527-8e83-3da842c4e345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_b515cd07-ba4d-4153-a5ed-8967ec9d94cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ceb1ee47-218e-4720-a72b-8327ce992039" xlink:to="loc_us-gaap_ServiceMember_b515cd07-ba4d-4153-a5ed-8967ec9d94cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_41cb79e6-033b-4ee5-826b-ef24c429f881" xlink:to="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_844173e0-c43c-4066-9be8-35a356cbf660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_RevenuesAbstract_844173e0-c43c-4066-9be8-35a356cbf660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c6ef5b9e-e023-4b5f-b096-2d7e2d3875b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_844173e0-c43c-4066-9be8-35a356cbf660" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c6ef5b9e-e023-4b5f-b096-2d7e2d3875b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_ecc319c5-6faa-497e-a941-6d483b76ec3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_844173e0-c43c-4066-9be8-35a356cbf660" xlink:to="loc_us-gaap_PremiumsEarnedNet_ecc319c5-6faa-497e-a941-6d483b76ec3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_bec2248f-0454-420c-b191-c3363defa87d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_844173e0-c43c-4066-9be8-35a356cbf660" xlink:to="loc_us-gaap_NetInvestmentIncome_bec2248f-0454-420c-b191-c3363defa87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3e5f0aac-de45-41f5-99c9-79a5949ba6c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_844173e0-c43c-4066-9be8-35a356cbf660" xlink:to="loc_us-gaap_Revenues_3e5f0aac-de45-41f5-99c9-79a5949ba6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_01b8d6f0-84f9-40b0-9895-8bc8d73ce6db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_01b8d6f0-84f9-40b0-9895-8bc8d73ce6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_2af614e6-2fd6-43f4-8769-35c25013006d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_2af614e6-2fd6-43f4-8769-35c25013006d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_345aa6e4-6fb0-49f8-b6a5-6b009222b8e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_345aa6e4-6fb0-49f8-b6a5-6b009222b8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingGoodwillImpairments_cad408bd-275b-40a4-8946-03c0a948bae8" xlink:href="cvs-20201231.xsd#cvs_OperatingExpensesExcludingGoodwillImpairments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:to="loc_cvs_OperatingExpensesExcludingGoodwillImpairments_cad408bd-275b-40a4-8946-03c0a948bae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_a50f8e2d-d011-46b0-b28c-3ab599ee16ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb9026cb-4dae-420b-89cf-503752333909" xlink:to="loc_us-gaap_CostsAndExpenses_a50f8e2d-d011-46b0-b28c-3ab599ee16ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bb50ccb4-6f0f-415f-9f2a-ee63f74f1e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_OperatingIncomeLoss_bb50ccb4-6f0f-415f-9f2a-ee63f74f1e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_eaac9524-98ce-4b48-9e26-d3fdca74e1a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_InterestExpense_eaac9524-98ce-4b48-9e26-d3fdca74e1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1564eafd-021a-42d5-a730-216ad835a697" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1564eafd-021a-42d5-a730-216ad835a697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b424f028-d28d-43c8-85cc-5da58444d808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b424f028-d28d-43c8-85cc-5da58444d808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b715c6d5-186b-4de6-ac29-5d9781417c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b715c6d5-186b-4de6-ac29-5d9781417c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_568f5d9c-2498-4298-b8a5-97d44cbc9f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_568f5d9c-2498-4298-b8a5-97d44cbc9f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_36d12d5b-d0cd-4217-8d10-f04b96971c25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_36d12d5b-d0cd-4217-8d10-f04b96971c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1419a9c2-3a70-4840-a752-47a6359bf870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1419a9c2-3a70-4840-a752-47a6359bf870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fef0db54-a35b-4eff-8b16-ff1351497a26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_ProfitLoss_fef0db54-a35b-4eff-8b16-ff1351497a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f15a3c24-3f4f-4242-8ff3-ea5b683e535c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f15a3c24-3f4f-4242-8ff3-ea5b683e535c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_39f14004-4b19-4d92-b960-2a6601451cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_NetIncomeLoss_39f14004-4b19-4d92-b960-2a6601451cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_04c08f00-c2c2-4561-afec-5cc0a3a8dfc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_04c08f00-c2c2-4561-afec-5cc0a3a8dfc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_b316d48b-34e8-4cb4-a0ec-d3e82e0af523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04c08f00-c2c2-4561-afec-5cc0a3a8dfc9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_b316d48b-34e8-4cb4-a0ec-d3e82e0af523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_0c5b335f-1b9b-4eed-8c42-c918326f0770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04c08f00-c2c2-4561-afec-5cc0a3a8dfc9" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_0c5b335f-1b9b-4eed-8c42-c918326f0770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_85b38d81-91fb-4dd2-bb9a-0c33fa24f298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04c08f00-c2c2-4561-afec-5cc0a3a8dfc9" xlink:to="loc_us-gaap_EarningsPerShareBasic_85b38d81-91fb-4dd2-bb9a-0c33fa24f298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_859c599f-ce4c-4c42-9afd-05c8628547df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_04c08f00-c2c2-4561-afec-5cc0a3a8dfc9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_859c599f-ce4c-4c42-9afd-05c8628547df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_868bc86d-0b9c-4fce-b26c-95be346f6f66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_868bc86d-0b9c-4fce-b26c-95be346f6f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3bf6db4b-6f2e-44ae-99ca-1cc3f42e4428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_868bc86d-0b9c-4fce-b26c-95be346f6f66" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_3bf6db4b-6f2e-44ae-99ca-1cc3f42e4428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_9582d062-edca-4fe4-a90c-ce977abc68ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_868bc86d-0b9c-4fce-b26c-95be346f6f66" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_9582d062-edca-4fe4-a90c-ce977abc68ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f00974c2-47e4-41b2-8fc0-703e208f7d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_868bc86d-0b9c-4fce-b26c-95be346f6f66" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f00974c2-47e4-41b2-8fc0-703e208f7d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c2989a6-4104-432a-bfbf-181111ac5324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_868bc86d-0b9c-4fce-b26c-95be346f6f66" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c2989a6-4104-432a-bfbf-181111ac5324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_3c4acfc3-3c20-453b-8a0c-f3c6b28ac32b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_3c4acfc3-3c20-453b-8a0c-f3c6b28ac32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_b1eaa767-e2fb-43ce-a03b-d9f18df8bb46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b66cb7bb-a908-4a11-80f5-3ed87bbf8367" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_b1eaa767-e2fb-43ce-a03b-d9f18df8bb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea1ba1a1-5ceb-467b-b722-da74f21e5301" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8e74da7f-cca3-4e61-9e3c-1df7938b2bee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea1ba1a1-5ceb-467b-b722-da74f21e5301" xlink:to="loc_us-gaap_ProfitLoss_8e74da7f-cca3-4e61-9e3c-1df7938b2bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_43820b94-f11c-4164-b4ed-74a5eb1ec54f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea1ba1a1-5ceb-467b-b722-da74f21e5301" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_43820b94-f11c-4164-b4ed-74a5eb1ec54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_8da3680d-f36e-4e04-87f2-b6e8a3a805d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_43820b94-f11c-4164-b4ed-74a5eb1ec54f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_8da3680d-f36e-4e04-87f2-b6e8a3a805d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_82310768-3872-4650-b9cc-0ca4aee5bdd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_43820b94-f11c-4164-b4ed-74a5eb1ec54f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_82310768-3872-4650-b9cc-0ca4aee5bdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a30680ac-021e-42ce-8991-c4ad2d062361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_43820b94-f11c-4164-b4ed-74a5eb1ec54f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a30680ac-021e-42ce-8991-c4ad2d062361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_293966c0-c6c8-4451-a9e7-a41154126700" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_43820b94-f11c-4164-b4ed-74a5eb1ec54f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_293966c0-c6c8-4451-a9e7-a41154126700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_588b32b1-e0e4-4925-921e-96491ff41e80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_43820b94-f11c-4164-b4ed-74a5eb1ec54f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_588b32b1-e0e4-4925-921e-96491ff41e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dc57a35c-bcfe-497d-8b4e-4ac25572a75a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea1ba1a1-5ceb-467b-b722-da74f21e5301" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dc57a35c-bcfe-497d-8b4e-4ac25572a75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1385a576-4517-498a-b309-39dd3124a85a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea1ba1a1-5ceb-467b-b722-da74f21e5301" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1385a576-4517-498a-b309-39dd3124a85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_032a51b7-e678-4094-a41f-be364703099e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ea1ba1a1-5ceb-467b-b722-da74f21e5301" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_032a51b7-e678-4094-a41f-be364703099e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6f82e980-1de9-4f2c-a197-d5263a83ffaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f82e980-1de9-4f2c-a197-d5263a83ffaa" xlink:to="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_980e4baf-e5c6-4675-ac20-14f96e5b84f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_980e4baf-e5c6-4675-ac20-14f96e5b84f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_54a1e958-89ec-45d0-8dcc-8aa93eec1668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_ShortTermInvestments_54a1e958-89ec-45d0-8dcc-8aa93eec1668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2750fe9c-65c3-476c-b62d-5cd5171a668e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2750fe9c-65c3-476c-b62d-5cd5171a668e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1974faa1-5431-4bf2-b4a1-43343eebffe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_InventoryNet_1974faa1-5431-4bf2-b4a1-43343eebffe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_7f323ad6-68e0-46ca-bdf7-7237b3b94eea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_OtherAssetsCurrent_7f323ad6-68e0-46ca-bdf7-7237b3b94eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7f0cb800-d151-4359-bc6f-06a8d4e56a4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_AssetsCurrent_7f0cb800-d151-4359-bc6f-06a8d4e56a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_c7cb91cc-a41c-430b-b0d7-cb4dcc5da4bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_LongTermInvestments_c7cb91cc-a41c-430b-b0d7-cb4dcc5da4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b99198f1-97b2-431a-a714-7ccbb72a1b9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b99198f1-97b2-431a-a714-7ccbb72a1b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0f7f93a5-15d1-4d17-88ed-7dbc587465fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0f7f93a5-15d1-4d17-88ed-7dbc587465fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2f6a4127-f511-445f-adac-b065e1c324b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_Goodwill_2f6a4127-f511-445f-adac-b065e1c324b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1ddae0f1-f863-4f1f-be52-333ce2869dbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1ddae0f1-f863-4f1f-be52-333ce2869dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_ea58b481-c70c-40d3-9dbf-4c43773d4eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_SeparateAccountAssets_ea58b481-c70c-40d3-9dbf-4c43773d4eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7fd7e50a-bf79-4293-987b-f5421ecd5b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7fd7e50a-bf79-4293-987b-f5421ecd5b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6acceb33-9f73-485a-8ed5-9e112cb16120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_62b9869c-0a42-420e-bc45-abfbe3eded67" xlink:to="loc_us-gaap_Assets_6acceb33-9f73-485a-8ed5-9e112cb16120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f82e980-1de9-4f2c-a197-d5263a83ffaa" xlink:to="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_83110249-9cb4-431f-9eac-eaca8bd8a6f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_83110249-9cb4-431f-9eac-eaca8bd8a6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_8a419c42-56ba-4e0c-afab-fb95e9710afc" xlink:href="cvs-20201231.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_8a419c42-56ba-4e0c-afab-fb95e9710afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_0b7c69e2-4be4-42f4-92aa-6b4fc10165c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_0b7c69e2-4be4-42f4-92aa-6b4fc10165c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_de788b4e-3ca0-4ceb-a351-42a55aa7cc93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_OtherPolicyholderFunds_de788b4e-3ca0-4ceb-a351-42a55aa7cc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_76599026-eb5f-4fc4-9a6c-50e8ae0762cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_76599026-eb5f-4fc4-9a6c-50e8ae0762cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_f222472b-f0bc-4cbb-a3c6-65b9c247dedf" xlink:href="cvs-20201231.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_f222472b-f0bc-4cbb-a3c6-65b9c247dedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_04a4dcc0-5527-4e58-9273-cbc0906d6184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_04a4dcc0-5527-4e58-9273-cbc0906d6184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8e63a71f-23bb-4e52-bd5c-f3c9183070d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8e63a71f-23bb-4e52-bd5c-f3c9183070d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4d53a7d2-5200-41e7-baa9-1c8974549567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_LiabilitiesCurrent_4d53a7d2-5200-41e7-baa9-1c8974549567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_603fabb4-45c9-4d14-8230-468d0ac5e352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_603fabb4-45c9-4d14-8230-468d0ac5e352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4a48355b-49f9-4a0d-997e-b8370ff54d85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_4a48355b-49f9-4a0d-997e-b8370ff54d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c3bea73f-8b3e-4f30-8e8d-cb7795bd9510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c3bea73f-8b3e-4f30-8e8d-cb7795bd9510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_519a80a3-6d21-40fd-86bc-8c2b4f57d98f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_SeparateAccountsLiability_519a80a3-6d21-40fd-86bc-8c2b4f57d98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_1d63d851-3898-4ed0-b3bc-c1fcf7f95f92" xlink:href="cvs-20201231.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_1d63d851-3898-4ed0-b3bc-c1fcf7f95f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4c99c760-e268-409c-b147-b8ea862ebc63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4c99c760-e268-409c-b147-b8ea862ebc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_59976877-4337-4022-8a1d-0b4c319d3888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_4b020f8c-b4f6-4ff2-9379-cf9e99e7add9" xlink:to="loc_us-gaap_Liabilities_59976877-4337-4022-8a1d-0b4c319d3888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_0c4dbabe-b759-4116-b3d9-87f9854cadf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f82e980-1de9-4f2c-a197-d5263a83ffaa" xlink:to="loc_us-gaap_CommitmentsAndContingencies_0c4dbabe-b759-4116-b3d9-87f9854cadf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4bd6ca85-43b4-4e00-bc27-90934787b86b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f82e980-1de9-4f2c-a197-d5263a83ffaa" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4bd6ca85-43b4-4e00-bc27-90934787b86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_04f6f19a-6f46-432e-8475-0b433ba535ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4bd6ca85-43b4-4e00-bc27-90934787b86b" xlink:to="loc_us-gaap_PreferredStockValue_04f6f19a-6f46-432e-8475-0b433ba535ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_b92a0b97-c0c6-46e6-84ac-6aa1a6d42571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4bd6ca85-43b4-4e00-bc27-90934787b86b" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_b92a0b97-c0c6-46e6-84ac-6aa1a6d42571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_7d9872ed-d255-4eae-88f5-110b30734743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4bd6ca85-43b4-4e00-bc27-90934787b86b" xlink:to="loc_us-gaap_TreasuryStockValue_7d9872ed-d255-4eae-88f5-110b30734743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_63b6ba44-dd5b-4702-9199-42de2cbe0dbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4bd6ca85-43b4-4e00-bc27-90934787b86b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_63b6ba44-dd5b-4702-9199-42de2cbe0dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3210b336-a37b-4192-b6fc-cdf9e6c3cc27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4bd6ca85-43b4-4e00-bc27-90934787b86b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3210b336-a37b-4192-b6fc-cdf9e6c3cc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7ab901c2-9382-4814-8557-ed46bd090540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4bd6ca85-43b4-4e00-bc27-90934787b86b" xlink:to="loc_us-gaap_StockholdersEquity_7ab901c2-9382-4814-8557-ed46bd090540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_590a411b-2e49-4b58-b184-bab2af299a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4bd6ca85-43b4-4e00-bc27-90934787b86b" xlink:to="loc_us-gaap_MinorityInterest_590a411b-2e49-4b58-b184-bab2af299a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2f049480-b55f-40fc-8fb8-8eeb1db3e368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4bd6ca85-43b4-4e00-bc27-90934787b86b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2f049480-b55f-40fc-8fb8-8eeb1db3e368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_eb2f8dc3-28d5-4009-b851-9aa95c2898d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6f82e980-1de9-4f2c-a197-d5263a83ffaa" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_eb2f8dc3-28d5-4009-b851-9aa95c2898d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_68b900b7-36e9-4cda-92ae-cf86c9de9055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_40e771f6-84fe-463f-b3a8-7bd7588b2304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_68b900b7-36e9-4cda-92ae-cf86c9de9055" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_40e771f6-84fe-463f-b3a8-7bd7588b2304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_62d03e95-e50d-47d6-a63a-55863aa238ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_68b900b7-36e9-4cda-92ae-cf86c9de9055" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_62d03e95-e50d-47d6-a63a-55863aa238ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_73c1eb96-7902-42ac-9612-d1d30bf900f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_68b900b7-36e9-4cda-92ae-cf86c9de9055" xlink:to="loc_us-gaap_PreferredStockSharesIssued_73c1eb96-7902-42ac-9612-d1d30bf900f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_b05b0baf-9fd5-4ba6-804f-9d7a2eba003b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_68b900b7-36e9-4cda-92ae-cf86c9de9055" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_b05b0baf-9fd5-4ba6-804f-9d7a2eba003b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1e764e8f-4f3c-408c-bebb-0ed60f487680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_68b900b7-36e9-4cda-92ae-cf86c9de9055" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1e764e8f-4f3c-408c-bebb-0ed60f487680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_066ade83-836e-4246-8153-6e57cbfad9c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_68b900b7-36e9-4cda-92ae-cf86c9de9055" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_066ade83-836e-4246-8153-6e57cbfad9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_c3ce9fc8-ff12-492f-b4de-c9fbcbc1c3b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_68b900b7-36e9-4cda-92ae-cf86c9de9055" xlink:to="loc_us-gaap_CommonStockSharesIssued_c3ce9fc8-ff12-492f-b4de-c9fbcbc1c3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3f977498-1132-47c1-8db6-b9bf0ca36c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_68b900b7-36e9-4cda-92ae-cf86c9de9055" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3f977498-1132-47c1-8db6-b9bf0ca36c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_cf815042-d97c-40ec-8561-03cfd2c7680c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_68b900b7-36e9-4cda-92ae-cf86c9de9055" xlink:to="loc_us-gaap_TreasuryStockShares_cf815042-d97c-40ec-8561-03cfd2c7680c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_7edd9fac-5952-4f44-aeaf-65be9efbb0ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0d26e86-0561-4818-813d-40daafaef83d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7edd9fac-5952-4f44-aeaf-65be9efbb0ef" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0d26e86-0561-4818-813d-40daafaef83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_8c4457d3-d603-4a86-8819-3a70bae824c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0d26e86-0561-4818-813d-40daafaef83d" xlink:to="loc_us-gaap_ProceedsFromCustomers_8c4457d3-d603-4a86-8819-3a70bae824c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_fde00ced-95b3-4478-884b-ea6dedfcb9f0" xlink:href="cvs-20201231.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0d26e86-0561-4818-813d-40daafaef83d" xlink:to="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_fde00ced-95b3-4478-884b-ea6dedfcb9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits_3a8f469c-4e2d-43c7-ae7a-72966706e711" xlink:href="cvs-20201231.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0d26e86-0561-4818-813d-40daafaef83d" xlink:to="loc_cvs_PaymentsforInsuranceBenefits_3a8f469c-4e2d-43c7-ae7a-72966706e711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_0f54e4b5-52d1-4ae4-9448-3be1706449cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0d26e86-0561-4818-813d-40daafaef83d" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_0f54e4b5-52d1-4ae4-9448-3be1706449cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_11febd3a-889f-4d26-ad20-09092d5b9f67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0d26e86-0561-4818-813d-40daafaef83d" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_11febd3a-889f-4d26-ad20-09092d5b9f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_d62a3790-21ca-4149-a204-22d1ad654cb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0d26e86-0561-4818-813d-40daafaef83d" xlink:to="loc_us-gaap_InterestPaidNet_d62a3790-21ca-4149-a204-22d1ad654cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_d40b596f-bb7d-4c9e-81bd-c5da5c1d2d72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0d26e86-0561-4818-813d-40daafaef83d" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_d40b596f-bb7d-4c9e-81bd-c5da5c1d2d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d5a006ae-f444-493d-81bf-0d8522f37e15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0d26e86-0561-4818-813d-40daafaef83d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d5a006ae-f444-493d-81bf-0d8522f37e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fc40b004-283e-482c-8012-12c732b32009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7edd9fac-5952-4f44-aeaf-65be9efbb0ef" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fc40b004-283e-482c-8012-12c732b32009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_34a2a047-85ec-4c85-9de5-e2dfea78c887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fc40b004-283e-482c-8012-12c732b32009" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_34a2a047-85ec-4c85-9de5-e2dfea78c887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_d6c7c214-944d-4616-808e-778c62ec35ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fc40b004-283e-482c-8012-12c732b32009" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_d6c7c214-944d-4616-808e-778c62ec35ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_913b97a2-9e07-482e-b975-ccda315d1308" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fc40b004-283e-482c-8012-12c732b32009" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_913b97a2-9e07-482e-b975-ccda315d1308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_ddba79dd-5043-4966-811d-97ce994ad3ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fc40b004-283e-482c-8012-12c732b32009" xlink:to="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_ddba79dd-5043-4966-811d-97ce994ad3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_08cfb4a2-1d4f-45f0-b711-f3ab53160a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fc40b004-283e-482c-8012-12c732b32009" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_08cfb4a2-1d4f-45f0-b711-f3ab53160a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_e7bdf785-407e-4354-b339-9f16236048da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fc40b004-283e-482c-8012-12c732b32009" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_e7bdf785-407e-4354-b339-9f16236048da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ef3d96c6-b72b-4cb9-add6-814dcbfea89d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fc40b004-283e-482c-8012-12c732b32009" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ef3d96c6-b72b-4cb9-add6-814dcbfea89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_66d395f5-a8ee-431d-bb5b-1c5fc7d476b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fc40b004-283e-482c-8012-12c732b32009" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_66d395f5-a8ee-431d-bb5b-1c5fc7d476b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf0593e6-612f-405b-9cc5-1b67906a404c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7edd9fac-5952-4f44-aeaf-65be9efbb0ef" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf0593e6-612f-405b-9cc5-1b67906a404c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_827b7725-8952-49b8-9c2a-a77f9f2e3450" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf0593e6-612f-405b-9cc5-1b67906a404c" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_827b7725-8952-49b8-9c2a-a77f9f2e3450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_3dc97461-fe02-4b13-8507-017cae46e5c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf0593e6-612f-405b-9cc5-1b67906a404c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_3dc97461-fe02-4b13-8507-017cae46e5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_16b19574-6baf-48aa-a080-4a4da0a720b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf0593e6-612f-405b-9cc5-1b67906a404c" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_16b19574-6baf-48aa-a080-4a4da0a720b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_953539ab-84f1-4d09-942a-a722cb3cd99e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf0593e6-612f-405b-9cc5-1b67906a404c" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_953539ab-84f1-4d09-942a-a722cb3cd99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_b150b005-315e-430f-9bed-f352203b3697" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf0593e6-612f-405b-9cc5-1b67906a404c" xlink:to="loc_us-gaap_PaymentsOfDividends_b150b005-315e-430f-9bed-f352203b3697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1bb576dc-ff80-4b31-90a2-5084db7d860a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf0593e6-612f-405b-9cc5-1b67906a404c" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_1bb576dc-ff80-4b31-90a2-5084db7d860a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3a112d06-2046-415f-a193-ac45997aff68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf0593e6-612f-405b-9cc5-1b67906a404c" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3a112d06-2046-415f-a193-ac45997aff68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b8487730-5368-4220-b818-f4cb5a506798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf0593e6-612f-405b-9cc5-1b67906a404c" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b8487730-5368-4220-b818-f4cb5a506798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dc1f91fc-04a9-402a-8309-43f4a0f65bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bf0593e6-612f-405b-9cc5-1b67906a404c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dc1f91fc-04a9-402a-8309-43f4a0f65bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_39b98389-a870-4adc-8c3a-2f180f7534a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7edd9fac-5952-4f44-aeaf-65be9efbb0ef" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_39b98389-a870-4adc-8c3a-2f180f7534a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ceec28c9-4e7c-462d-982e-20dea4b1e0f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7edd9fac-5952-4f44-aeaf-65be9efbb0ef" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ceec28c9-4e7c-462d-982e-20dea4b1e0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8cf63e08-4e02-48ac-91a4-99c9e0593370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7edd9fac-5952-4f44-aeaf-65be9efbb0ef" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8cf63e08-4e02-48ac-91a4-99c9e0593370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5634c4eb-7ccf-409d-b850-63c5e9710a39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7edd9fac-5952-4f44-aeaf-65be9efbb0ef" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5634c4eb-7ccf-409d-b850-63c5e9710a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3231d9e9-00f8-4b1e-8712-0a5d63fe03f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7edd9fac-5952-4f44-aeaf-65be9efbb0ef" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3231d9e9-00f8-4b1e-8712-0a5d63fe03f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f3a1ff38-755c-4c67-99a3-2b00729f69e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3231d9e9-00f8-4b1e-8712-0a5d63fe03f1" xlink:to="loc_us-gaap_ProfitLoss_f3a1ff38-755c-4c67-99a3-2b00729f69e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_182de56a-fe13-4625-aace-7e6a9805d47e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3231d9e9-00f8-4b1e-8712-0a5d63fe03f1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_182de56a-fe13-4625-aace-7e6a9805d47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e8fd19a5-7191-41a9-8d3e-995ad4779768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_182de56a-fe13-4625-aace-7e6a9805d47e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e8fd19a5-7191-41a9-8d3e-995ad4779768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_f7026f59-c0ac-4424-b099-370993540e90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_182de56a-fe13-4625-aace-7e6a9805d47e" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_f7026f59-c0ac-4424-b099-370993540e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_277631a3-bcf8-47a5-8b34-092a87c2c82d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_182de56a-fe13-4625-aace-7e6a9805d47e" xlink:to="loc_us-gaap_ShareBasedCompensation_277631a3-bcf8-47a5-8b34-092a87c2c82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_22cf6b7a-4469-459a-815b-524bf0e1e5f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_182de56a-fe13-4625-aace-7e6a9805d47e" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_22cf6b7a-4469-459a-815b-524bf0e1e5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2bee40b1-310f-45e1-9ea6-c51e5514c885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_182de56a-fe13-4625-aace-7e6a9805d47e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2bee40b1-310f-45e1-9ea6-c51e5514c885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_dd94a5d5-0cb7-4809-a22d-46d2903a2d4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_182de56a-fe13-4625-aace-7e6a9805d47e" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_dd94a5d5-0cb7-4809-a22d-46d2903a2d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_07ba3c23-e474-46ed-b8e6-6e793e589a00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_182de56a-fe13-4625-aace-7e6a9805d47e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_07ba3c23-e474-46ed-b8e6-6e793e589a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_47c1d8f3-ec93-45a0-94b7-479f11312a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_3231d9e9-00f8-4b1e-8712-0a5d63fe03f1" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_47c1d8f3-ec93-45a0-94b7-479f11312a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_53e29cbd-2298-4ac3-987f-4d556d3b098e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_47c1d8f3-ec93-45a0-94b7-479f11312a3c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_53e29cbd-2298-4ac3-987f-4d556d3b098e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f5180207-e259-4c7a-94f4-d4b555960288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_47c1d8f3-ec93-45a0-94b7-479f11312a3c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f5180207-e259-4c7a-94f4-d4b555960288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_aa926c43-0fa2-4cde-9cc1-fa144edccec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_47c1d8f3-ec93-45a0-94b7-479f11312a3c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_aa926c43-0fa2-4cde-9cc1-fa144edccec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8de39060-3382-4731-ac10-3f8b4980cf63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_47c1d8f3-ec93-45a0-94b7-479f11312a3c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8de39060-3382-4731-ac10-3f8b4980cf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_b3292b2a-26cf-4114-a403-04148f732943" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_47c1d8f3-ec93-45a0-94b7-479f11312a3c" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_b3292b2a-26cf-4114-a403-04148f732943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_dd47cfdb-6ee7-4b8a-8147-dbb4247cc074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_47c1d8f3-ec93-45a0-94b7-479f11312a3c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_dd47cfdb-6ee7-4b8a-8147-dbb4247cc074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3f99424-6ea8-4a69-a387-0fa3ef9a91d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_47c1d8f3-ec93-45a0-94b7-479f11312a3c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a3f99424-6ea8-4a69-a387-0fa3ef9a91d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofCashFlows_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3cc38627-d2a2-40b2-ac59-01d74fd9d653" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b187ed80-9cdf-4964-af56-25bcbc13d1d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3cc38627-d2a2-40b2-ac59-01d74fd9d653" xlink:to="loc_us-gaap_StatementTable_b187ed80-9cdf-4964-af56-25bcbc13d1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b3847598-754f-4365-87ca-29381482f20d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b187ed80-9cdf-4964-af56-25bcbc13d1d2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b3847598-754f-4365-87ca-29381482f20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b3847598-754f-4365-87ca-29381482f20d" xlink:to="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5dcd23d5-5ccb-47f1-8132-a5a512b43d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_CommonStockMember_5dcd23d5-5ccb-47f1-8132-a5a512b43d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_f3e06e9b-6028-4d43-8fb7-57f971c93275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_TreasuryStockMember_f3e06e9b-6028-4d43-8fb7-57f971c93275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_f8096c7e-5c9a-4ad9-a955-cb5f0c3a1f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_f8096c7e-5c9a-4ad9-a955-cb5f0c3a1f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c44ce84d-39cf-4f44-a977-a85f2c20a070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_RetainedEarningsMember_c44ce84d-39cf-4f44-a977-a85f2c20a070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b6406b-c9d9-4643-b0af-41c3785c55ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b6406b-c9d9-4643-b0af-41c3785c55ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_d0c0a2a6-e35b-4c4c-a6f4-fe7011312d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_ParentMember_d0c0a2a6-e35b-4c4c-a6f4-fe7011312d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ddd095fd-2681-42c0-b2f9-37ad456f2242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef9eec44-1e90-4881-a84d-33d9d3955408" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ddd095fd-2681-42c0-b2f9-37ad456f2242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a090fac4-3ba8-4a9d-96f1-747445e6b0fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b187ed80-9cdf-4964-af56-25bcbc13d1d2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a090fac4-3ba8-4a9d-96f1-747445e6b0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d643f0bf-43af-4bef-88ec-9ccf0abc54eb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_a090fac4-3ba8-4a9d-96f1-747445e6b0fa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d643f0bf-43af-4bef-88ec-9ccf0abc54eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b9ba66b8-a891-4616-9198-ac060eb6c9c0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d643f0bf-43af-4bef-88ec-9ccf0abc54eb" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b9ba66b8-a891-4616-9198-ac060eb6c9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3b7186ee-b2ee-4666-ab06-3adf1aec9a47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b187ed80-9cdf-4964-af56-25bcbc13d1d2" xlink:to="loc_us-gaap_StatementLineItems_3b7186ee-b2ee-4666-ab06-3adf1aec9a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b7186ee-b2ee-4666-ab06-3adf1aec9a47" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_f2ed9d0f-f4bc-4ad0-8420-ad0d8a54b9f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_SharesOutstanding_f2ed9d0f-f4bc-4ad0-8420-ad0d8a54b9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_59c5e056-a581-43ce-a263-b41876351183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_59c5e056-a581-43ce-a263-b41876351183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b759e129-4449-409b-8aa0-73612b5ef93a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_ProfitLoss_b759e129-4449-409b-8aa0-73612b5ef93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a039656d-a5e5-4562-867c-69ed4c5942c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a039656d-a5e5-4562-867c-69ed4c5942c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_e383c1ea-f370-43d4-9cff-ddd0ed7d536f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_e383c1ea-f370-43d4-9cff-ddd0ed7d536f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_cb3e3827-498f-47d2-ad28-45b5d6fb8e57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_cb3e3827-498f-47d2-ad28-45b5d6fb8e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6921f334-6ccb-4800-9c95-43ee5c67fa4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6921f334-6ccb-4800-9c95-43ee5c67fa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2fee7d5b-7baf-484f-859d-3e057b94a2d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2fee7d5b-7baf-484f-859d-3e057b94a2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_8bf5fe65-7fd1-4c66-87f1-a7ae02ce006c" xlink:href="cvs-20201231.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_8bf5fe65-7fd1-4c66-87f1-a7ae02ce006c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_e85edf41-10aa-4378-8e8a-eba1c9250e61" xlink:href="cvs-20201231.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_e85edf41-10aa-4378-8e8a-eba1c9250e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_aa5febe2-a455-4548-82b0-dc86653c8429" xlink:href="cvs-20201231.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_aa5febe2-a455-4548-82b0-dc86653c8429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_6ac2fd97-edbd-421c-9f5a-e166482505f9" xlink:href="cvs-20201231.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_6ac2fd97-edbd-421c-9f5a-e166482505f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_24d3c288-01f7-48c0-b7ff-77cf7de508bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_DividendsCommonStock_24d3c288-01f7-48c0-b7ff-77cf7de508bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_f3da9cb0-2364-4115-ad29-4d8ace3ddb4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_f3da9cb0-2364-4115-ad29-4d8ace3ddb4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_94e49863-0cca-4082-a6f5-b55c093dcce0" xlink:href="cvs-20201231.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_94e49863-0cca-4082-a6f5-b55c093dcce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_375e1fa2-d263-4a21-9547-011fc35fc3f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_SharesOutstanding_375e1fa2-d263-4a21-9547-011fc35fc3f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdd0036b-b205-476e-9ba3-7263e1705377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_28c24523-07d7-4198-bb5b-a0f05492a6ae" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bdd0036b-b205-476e-9ba3-7263e1705377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_6082e439-26cc-4d58-aee2-c223b88e7cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3b7186ee-b2ee-4666-ab06-3adf1aec9a47" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_6082e439-26cc-4d58-aee2-c223b88e7cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20201231.xsd#ConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_dd0e8c76-e7b9-402f-b88d-0eee13331e6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f6fa84b1-d5b5-432d-9d04-cfe78f1d334e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_dd0e8c76-e7b9-402f-b88d-0eee13331e6b" xlink:to="loc_us-gaap_StatementTable_f6fa84b1-d5b5-432d-9d04-cfe78f1d334e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c7cc7f7f-3eba-490d-bee2-adaacc04ed30" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f6fa84b1-d5b5-432d-9d04-cfe78f1d334e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c7cc7f7f-3eba-490d-bee2-adaacc04ed30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7120cbae-676e-4b40-a356-66e17ad2ee11" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_c7cc7f7f-3eba-490d-bee2-adaacc04ed30" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7120cbae-676e-4b40-a356-66e17ad2ee11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0b9eace5-765f-4535-be8b-79664bb9f94e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_7120cbae-676e-4b40-a356-66e17ad2ee11" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0b9eace5-765f-4535-be8b-79664bb9f94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_821146b0-a29f-41cb-9bf6-792276970806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f6fa84b1-d5b5-432d-9d04-cfe78f1d334e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_821146b0-a29f-41cb-9bf6-792276970806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8b175337-8387-433e-a775-de5249e1aaf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_821146b0-a29f-41cb-9bf6-792276970806" xlink:to="loc_us-gaap_EquityComponentDomain_8b175337-8387-433e-a775-de5249e1aaf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4f38c15b-1310-4351-b8ca-d69f8d251104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8b175337-8387-433e-a775-de5249e1aaf8" xlink:to="loc_us-gaap_RetainedEarningsMember_4f38c15b-1310-4351-b8ca-d69f8d251104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5185de63-acc8-4224-b2ac-d8e53c4a78da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f6fa84b1-d5b5-432d-9d04-cfe78f1d334e" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5185de63-acc8-4224-b2ac-d8e53c4a78da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_c7fba54f-60c9-4aad-860a-ab7d6e055e42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_5185de63-acc8-4224-b2ac-d8e53c4a78da" xlink:to="loc_us-gaap_TypeOfAdoptionMember_c7fba54f-60c9-4aad-860a-ab7d6e055e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_8838b63e-15d1-4d92-bfdb-512474e39812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_c7fba54f-60c9-4aad-860a-ab7d6e055e42" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_8838b63e-15d1-4d92-bfdb-512474e39812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201802Member_6f85de0a-6041-40b4-8d5b-a32e34560707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201802Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_c7fba54f-60c9-4aad-860a-ab7d6e055e42" xlink:to="loc_us-gaap_AccountingStandardsUpdate201802Member_6f85de0a-6041-40b4-8d5b-a32e34560707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f6fa84b1-d5b5-432d-9d04-cfe78f1d334e" xlink:to="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_d9d5b6dc-7448-4e51-9633-8325958353ee" xlink:href="cvs-20201231.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_d9d5b6dc-7448-4e51-9633-8325958353ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_fa4fee4c-e464-41e7-8d06-14f20d66f2eb" xlink:href="cvs-20201231.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_fa4fee4c-e464-41e7-8d06-14f20d66f2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b55f6b49-52cf-441d-9b26-a9f420d7b9ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_us-gaap_CommonStockValue_b55f6b49-52cf-441d-9b26-a9f420d7b9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c707af1-95a0-42d7-98a0-7384d1686cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3c707af1-95a0-42d7-98a0-7384d1686cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ab5667ec-acfd-4776-bef4-71b7e7506cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ab5667ec-acfd-4776-bef4-71b7e7506cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_aa823933-c5c3-4f95-b626-77622f70ad49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_aa823933-c5c3-4f95-b626-77622f70ad49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_a5b2be30-68ee-480f-bcfc-04b8a990a594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c89ec22-bd49-4663-abb3-ca8fcdc9c975" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_a5b2be30-68ee-480f-bcfc-04b8a990a594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a8558ec7-5291-4406-bc0d-16169f39de3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_083e42bd-6210-4712-b91a-b78f9ee39a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a8558ec7-5291-4406-bc0d-16169f39de3a" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_083e42bd-6210-4712-b91a-b78f9ee39a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_4728b3d5-565e-4ba8-b6e0-e2dfc1e152af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_4728b3d5-565e-4ba8-b6e0-e2dfc1e152af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6babc21e-d02c-48d7-87e0-388fc29239cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6babc21e-d02c-48d7-87e0-388fc29239cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_0b9abc4d-14e2-4be8-8e59-34a18f6feffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_0b9abc4d-14e2-4be8-8e59-34a18f6feffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_2152b1d4-e7ae-4d9f-be6a-a48427099d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_UseOfEstimates_2152b1d4-e7ae-4d9f-be6a-a48427099d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_4bb456af-2bd4-4099-983a-bea71ce93d34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_4bb456af-2bd4-4099-983a-bea71ce93d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_e9183770-873c-451b-b73d-3a5ae2aab13f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_e9183770-873c-451b-b73d-3a5ae2aab13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_b3805bdf-e2ab-4697-94a6-98608682070d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_b3805bdf-e2ab-4697-94a6-98608682070d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_faca4fd7-151e-4b2e-8cb9-96b0c02363df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_faca4fd7-151e-4b2e-8cb9-96b0c02363df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_6a2d1059-aa5f-4704-9cfe-792f21c60a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_6a2d1059-aa5f-4704-9cfe-792f21c60a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceAccountingPolicy_f5badd4a-d606-41a4-aaf2-47b2cf5240fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceAccountingPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_ReinsuranceAccountingPolicy_f5badd4a-d606-41a4-aaf2-47b2cf5240fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_2f24f7a9-9756-4e8e-9059-45491b9ce7f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_2f24f7a9-9756-4e8e-9059-45491b9ce7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_b0dba601-d560-4f48-bcca-9f23b5293f85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_b0dba601-d560-4f48-bcca-9f23b5293f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_02d36064-a786-42d4-a0f8-c9787f9f5460" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_02d36064-a786-42d4-a0f8-c9787f9f5460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_47220d08-354f-4a1f-a4d7-7170c5a51b64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_47220d08-354f-4a1f-a4d7-7170c5a51b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_3a00ae78-8442-48e4-aa60-b527f5e2811b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_3a00ae78-8442-48e4-aa60-b527f5e2811b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_655a4c7e-1338-4077-acf8-b19f5a2d2c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_655a4c7e-1338-4077-acf8-b19f5a2d2c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountsPolicy_b17f0d4f-893a-4be3-b78b-b861ff289bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderAccountsPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_PolicyholderAccountsPolicy_b17f0d4f-893a-4be3-b78b-b861ff289bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock_bcfea705-9d33-451d-82b8-617d34addec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareCostsPolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock_bcfea705-9d33-451d-82b8-617d34addec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_11f74f22-5034-4c06-aa98-ec533dc483a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_11f74f22-5034-4c06-aa98-ec533dc483a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_58fb9656-c08e-4356-bf4d-626ec13099a2" xlink:href="cvs-20201231.xsd#cvs_InsurancePremiumDeficiencyReservePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_58fb9656-c08e-4356-bf4d-626ec13099a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocationsToPolicyholdersPolicies_532d97e3-fb73-4a86-904f-7eabf46d7031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocationsToPolicyholdersPolicies"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_AllocationsToPolicyholdersPolicies_532d97e3-fb73-4a86-904f-7eabf46d7031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_6d2275c4-26c8-4e27-98b5-3b617f4967c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_6d2275c4-26c8-4e27-98b5-3b617f4967c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0a255928-3984-4c33-ba9f-fa41f9abf8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0a255928-3984-4c33-ba9f-fa41f9abf8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1fabd680-66eb-47c5-a6f5-26859886ddba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_1fabd680-66eb-47c5-a6f5-26859886ddba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_2e08eb41-2597-4c38-9241-aad78ebd3266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_2e08eb41-2597-4c38-9241-aad78ebd3266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_112c239c-a395-48fb-a9c8-fdc181b475b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_112c239c-a395-48fb-a9c8-fdc181b475b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_981e477b-09df-4409-9403-c8165921bfdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareEntitiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_981e477b-09df-4409-9403-c8165921bfdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_79605bff-3bfa-4cba-937c-725fc71e0038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_79605bff-3bfa-4cba-937c-725fc71e0038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8f3e2aec-55bd-4bc2-9c14-66da59db7002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8f3e2aec-55bd-4bc2-9c14-66da59db7002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_524bb32e-f2e0-4584-a747-936961463fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_524bb32e-f2e0-4584-a747-936961463fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_3cc750e2-1efb-443a-8786-738bfdeb4614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_3cc750e2-1efb-443a-8786-738bfdeb4614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_5df92fbf-5906-492f-8d4c-d25bf5f29f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_5df92fbf-5906-492f-8d4c-d25bf5f29f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SharesHeldInTrustPolicyTextBlock_82f8cdb3-2c80-44bf-bf8e-a02cfdf00d03" xlink:href="cvs-20201231.xsd#cvs_SharesHeldInTrustPolicyTextBlock"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_cvs_SharesHeldInTrustPolicyTextBlock_82f8cdb3-2c80-44bf-bf8e-a02cfdf00d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_f2e996dd-40f6-4118-a18f-24992c6c3de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_f2e996dd-40f6-4118-a18f-24992c6c3de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_58adc70b-3e76-4d8e-a11a-f2c3dde0f7d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_58adc70b-3e76-4d8e-a11a-f2c3dde0f7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_2fb56b68-9c48-41fc-9c11-9d3b7334568c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_2fb56b68-9c48-41fc-9c11-9d3b7334568c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0e1a990e-dd9d-4e1c-8beb-6e26a7e9e807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_89476d1e-e947-453f-a3cf-5628c75c67fd" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0e1a990e-dd9d-4e1c-8beb-6e26a7e9e807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1fd6984a-9f7e-4af5-baaa-7aa620f63931" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_6574ad5c-7a19-4a5a-92d9-0f91bef9a82b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1fd6984a-9f7e-4af5-baaa-7aa620f63931" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_6574ad5c-7a19-4a5a-92d9-0f91bef9a82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_21f00045-a309-4a8e-971c-675cdaa35ef6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1fd6984a-9f7e-4af5-baaa-7aa620f63931" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_21f00045-a309-4a8e-971c-675cdaa35ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d5ec26ea-25ce-4fb1-bfee-cac7c31513d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1fd6984a-9f7e-4af5-baaa-7aa620f63931" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d5ec26ea-25ce-4fb1-bfee-cac7c31513d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_ede83fec-4eae-4ea5-aceb-f57206b0e2ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1fd6984a-9f7e-4af5-baaa-7aa620f63931" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_ede83fec-4eae-4ea5-aceb-f57206b0e2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_a5987c5f-b5d8-4d1a-9fea-291c2c2aa6a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1fd6984a-9f7e-4af5-baaa-7aa620f63931" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_a5987c5f-b5d8-4d1a-9fea-291c2c2aa6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_c2ca2be1-d095-4fe7-b91e-337382ca8acc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1fd6984a-9f7e-4af5-baaa-7aa620f63931" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_c2ca2be1-d095-4fe7-b91e-337382ca8acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_2c106a79-a08c-43d0-86ec-f667eca204f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1fd6984a-9f7e-4af5-baaa-7aa620f63931" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_2c106a79-a08c-43d0-86ec-f667eca204f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_987dc00f-bad7-4803-ac37-a770d069c655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_987dc00f-bad7-4803-ac37-a770d069c655" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4dae117b-2497-4f39-a598-cceaedb4c2ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_srt_ProductOrServiceAxis_4dae117b-2497-4f39-a598-cceaedb4c2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_168033a3-1c60-4650-9fd5-bb5c71f3e380" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4dae117b-2497-4f39-a598-cceaedb4c2ee" xlink:to="loc_srt_ProductsAndServicesDomain_168033a3-1c60-4650-9fd5-bb5c71f3e380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_85392697-f448-4b88-a221-58091b1fd6d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_168033a3-1c60-4650-9fd5-bb5c71f3e380" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_85392697-f448-4b88-a221-58091b1fd6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a2247651-a317-40ce-a8e5-37ddeb437757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a2247651-a317-40ce-a8e5-37ddeb437757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c2c4ff4c-8aa6-47b3-8426-e9e8a2001f57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a2247651-a317-40ce-a8e5-37ddeb437757" xlink:to="loc_us-gaap_SegmentDomain_c2c4ff4c-8aa6-47b3-8426-e9e8a2001f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_d3186443-b545-4f1b-b395-4c420acc81f2" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c2c4ff4c-8aa6-47b3-8426-e9e8a2001f57" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_d3186443-b545-4f1b-b395-4c420acc81f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_d932d552-0ba5-47e5-a5b8-3ad10935ba11" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c2c4ff4c-8aa6-47b3-8426-e9e8a2001f57" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_d932d552-0ba5-47e5-a5b8-3ad10935ba11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e4ff2537-f1aa-4fa2-a197-ed3f95a4cb2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e4ff2537-f1aa-4fa2-a197-ed3f95a4cb2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_326820aa-6cb6-4d02-b33c-1b883aca7b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e4ff2537-f1aa-4fa2-a197-ed3f95a4cb2a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_326820aa-6cb6-4d02-b33c-1b883aca7b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BrazilSubsidiaryMember_9b2d38d4-0192-4789-9217-4104069e0cb0" xlink:href="cvs-20201231.xsd#cvs_BrazilSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_326820aa-6cb6-4d02-b33c-1b883aca7b5d" xlink:to="loc_cvs_BrazilSubsidiaryMember_9b2d38d4-0192-4789-9217-4104069e0cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_238af78d-fce9-4f0c-85ac-8fbc4aeb8e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_238af78d-fce9-4f0c-85ac-8fbc4aeb8e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_6ebce91c-3ee5-4711-997f-e34e1235d5a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_238af78d-fce9-4f0c-85ac-8fbc4aeb8e03" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_6ebce91c-3ee5-4711-997f-e34e1235d5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_f1780957-718b-4c03-88e6-9f9f52067a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_6ebce91c-3ee5-4711-997f-e34e1235d5a1" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_f1780957-718b-4c03-88e6-9f9f52067a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22a09e9f-b6cc-4f4f-b843-c4028abc8621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22a09e9f-b6cc-4f4f-b843-c4028abc8621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_19f74dbe-8123-45d9-8db4-7517f8410f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_22a09e9f-b6cc-4f4f-b843-c4028abc8621" xlink:to="loc_us-gaap_TypeOfAdoptionMember_19f74dbe-8123-45d9-8db4-7517f8410f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_42241b61-ec9a-4c78-9fea-1cbf47c58e42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_19f74dbe-8123-45d9-8db4-7517f8410f25" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_42241b61-ec9a-4c78-9fea-1cbf47c58e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f0b718cc-0240-437c-b288-7d618727e24f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_srt_RangeAxis_f0b718cc-0240-437c-b288-7d618727e24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37d1ac29-abdb-41cc-aeba-a7b09ea8393c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f0b718cc-0240-437c-b288-7d618727e24f" xlink:to="loc_srt_RangeMember_37d1ac29-abdb-41cc-aeba-a7b09ea8393c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bf29a530-5463-40a7-99db-8be9e785e706" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_37d1ac29-abdb-41cc-aeba-a7b09ea8393c" xlink:to="loc_srt_MinimumMember_bf29a530-5463-40a7-99db-8be9e785e706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2c60409a-464d-47f1-bbe6-468255564da5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_37d1ac29-abdb-41cc-aeba-a7b09ea8393c" xlink:to="loc_srt_MaximumMember_2c60409a-464d-47f1-bbe6-468255564da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_271d260a-de2b-4354-a17e-0858f1f41785" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_271d260a-de2b-4354-a17e-0858f1f41785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1945099b-eccd-46c9-b971-fa3ec0c9458b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_271d260a-de2b-4354-a17e-0858f1f41785" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1945099b-eccd-46c9-b971-fa3ec0c9458b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_f181286b-773a-42fa-a6c5-d5b4099c8c13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1945099b-eccd-46c9-b971-fa3ec0c9458b" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_f181286b-773a-42fa-a6c5-d5b4099c8c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_381a37b5-a1d5-4d52-8af0-6a40b594d209" xlink:href="cvs-20201231.xsd#cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1945099b-eccd-46c9-b971-fa3ec0c9458b" xlink:to="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_381a37b5-a1d5-4d52-8af0-6a40b594d209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_384ac09f-90a4-45f5-bbe9-434761fba941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_384ac09f-90a4-45f5-bbe9-434761fba941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6ce9ed9e-9c46-4967-8c01-907765904306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_384ac09f-90a4-45f5-bbe9-434761fba941" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6ce9ed9e-9c46-4967-8c01-907765904306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesMember_3269fbf9-d94f-4817-ae60-3cc70ed4ab1c" xlink:href="cvs-20201231.xsd#cvs_OtherInsuranceLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6ce9ed9e-9c46-4967-8c01-907765904306" xlink:to="loc_cvs_OtherInsuranceLiabilitiesMember_3269fbf9-d94f-4817-ae60-3cc70ed4ab1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_fcbd86f2-dae0-4787-ac36-c5263982d9ee" xlink:href="cvs-20201231.xsd#cvs_OtherLongTermInsuranceLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6ce9ed9e-9c46-4967-8c01-907765904306" xlink:to="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_fcbd86f2-dae0-4787-ac36-c5263982d9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_86fccd12-bb5e-46ff-bad7-1f3042ac43de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_86fccd12-bb5e-46ff-bad7-1f3042ac43de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d5378c8e-e503-4ead-bcdc-091828661458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_86fccd12-bb5e-46ff-bad7-1f3042ac43de" xlink:to="loc_us-gaap_EquityComponentDomain_d5378c8e-e503-4ead-bcdc-091828661458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2f3c5c8e-a1be-43f6-85f6-617a3fe62a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d5378c8e-e503-4ead-bcdc-091828661458" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2f3c5c8e-a1be-43f6-85f6-617a3fe62a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b8e6cbf2-8468-4ff2-8f1c-be386e54eea2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_dei_LegalEntityAxis_b8e6cbf2-8468-4ff2-8f1c-be386e54eea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_11dcfeab-da6a-4ab5-bd69-493613e883fb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b8e6cbf2-8468-4ff2-8f1c-be386e54eea2" xlink:to="loc_dei_EntityDomain_11dcfeab-da6a-4ab5-bd69-493613e883fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_e286c403-1771-4a79-a92e-bc0f13c7e6a4" xlink:href="cvs-20201231.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_11dcfeab-da6a-4ab5-bd69-493613e883fb" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_e286c403-1771-4a79-a92e-bc0f13c7e6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_78f72763-45a9-495c-8d97-0e158082edfd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_78f72763-45a9-495c-8d97-0e158082edfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ecc612b9-2865-4434-8a30-61fe558fc556" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_78f72763-45a9-495c-8d97-0e158082edfd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ecc612b9-2865-4434-8a30-61fe558fc556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_60672be8-caa0-45b9-b2b1-72028e7cc888" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ecc612b9-2865-4434-8a30-61fe558fc556" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_60672be8-caa0-45b9-b2b1-72028e7cc888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f42957ad-1792-4cd5-a464-64b5574e63aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_srt_LitigationCaseAxis_f42957ad-1792-4cd5-a464-64b5574e63aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f9353ad0-6e65-4128-ba20-09c8fb3be104" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_f42957ad-1792-4cd5-a464-64b5574e63aa" xlink:to="loc_srt_LitigationCaseTypeDomain_f9353ad0-6e65-4128-ba20-09c8fb3be104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_b40bee21-b4f4-4faa-8c14-bfd3f44dd92e" xlink:href="cvs-20201231.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f9353ad0-6e65-4128-ba20-09c8fb3be104" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_b40bee21-b4f4-4faa-8c14-bfd3f44dd92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_af4e6392-3c49-4902-a0aa-fc802cb381fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_LitigationStatusAxis_af4e6392-3c49-4902-a0aa-fc802cb381fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_643432a1-aa0f-4e58-b4a6-21ba0c47652f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_af4e6392-3c49-4902-a0aa-fc802cb381fa" xlink:to="loc_us-gaap_LitigationStatusDomain_643432a1-aa0f-4e58-b4a6-21ba0c47652f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_6a2ebfec-0459-42b0-b650-87af8c8e6fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_643432a1-aa0f-4e58-b4a6-21ba0c47652f" xlink:to="loc_us-gaap_SettledLitigationMember_6a2ebfec-0459-42b0-b650-87af8c8e6fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cef73d8f-97fe-42a9-8cda-17a05ee01f2d" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_88a5cc16-f350-4dec-98ae-a8224a592bd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_NumberOfStores_88a5cc16-f350-4dec-98ae-a8224a592bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_31edefcd-3d14-44b9-bbab-57bc1375b463" xlink:href="cvs-20201231.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_31edefcd-3d14-44b9-bbab-57bc1375b463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPlanMembers_632bfa4c-0a46-4f28-b404-6d32871008fe" xlink:href="cvs-20201231.xsd#cvs_NumberOfPlanMembers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_NumberOfPlanMembers_632bfa4c-0a46-4f28-b404-6d32871008fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear_52b7c5ed-b1cf-4860-b4a9-0b22fce6312d" xlink:href="cvs-20201231.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_NumberofPatientsServedperYear_52b7c5ed-b1cf-4860-b4a9-0b22fce6312d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_3f86ed81-9396-4749-bf97-1866d843c998" xlink:href="cvs-20201231.xsd#cvs_NumberOfPeopleServed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_NumberOfPeopleServed_3f86ed81-9396-4749-bf97-1866d843c998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_4e57c611-1a0f-459f-9f04-cc85c9875480" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_NumberOfReportableSegments_4e57c611-1a0f-459f-9f04-cc85c9875480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_04b8d99b-6df5-48ca-95a3-033792711e65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_04b8d99b-6df5-48ca-95a3-033792711e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_c94b704f-939d-43ed-b4a6-cf789646ec4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_c94b704f-939d-43ed-b4a6-cf789646ec4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b55cc3d2-2eff-4e88-a55a-b4076ccc977a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_Depreciation_b55cc3d2-2eff-4e88-a55a-b4076ccc977a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_873ee638-d17c-43d7-a2c9-8164154cac82" xlink:href="cvs-20201231.xsd#cvs_LesseeOperatingAndFinanceLeasesRenewalTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_873ee638-d17c-43d7-a2c9-8164154cac82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreRationalizationCharges_c5fa1c85-4eb3-41e5-add3-c18a48e0023f" xlink:href="cvs-20201231.xsd#cvs_StoreRationalizationCharges"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_StoreRationalizationCharges_c5fa1c85-4eb3-41e5-add3-c18a48e0023f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_ec656c50-7cff-466e-9213-b2ecbd03289c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_ec656c50-7cff-466e-9213-b2ecbd03289c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_0834b8ae-ab98-4d60-9156-ed794bddf06d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_0834b8ae-ab98-4d60-9156-ed794bddf06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_e87ba631-dd8a-493f-b3f4-4b6207c4e9b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_e87ba631-dd8a-493f-b3f4-4b6207c4e9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_0f345274-8665-42be-8cc3-6515846c449f" xlink:href="cvs-20201231.xsd#cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_0f345274-8665-42be-8cc3-6515846c449f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityforUnpaidClaims_bac41ac3-07ac-480d-8137-047814a8a5d5" xlink:href="cvs-20201231.xsd#cvs_LiabilityforUnpaidClaims"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_LiabilityforUnpaidClaims_bac41ac3-07ac-480d-8137-047814a8a5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LimitedPaymentsContracts_1188e37f-581a-464b-9c44-fa1b045e84aa" xlink:href="cvs-20201231.xsd#cvs_LimitedPaymentsContracts"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_LimitedPaymentsContracts_1188e37f-581a-464b-9c44-fa1b045e84aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_8903cebc-d5e2-4362-b929-cfd179efdf8d" xlink:href="cvs-20201231.xsd#cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_8903cebc-d5e2-4362-b929-cfd179efdf8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_abc4ff1d-0725-4ec0-880a-5e06265625a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_abc4ff1d-0725-4ec0-880a-5e06265625a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_eba7fdf8-6d72-40c0-beff-17c16fc6c4e3" xlink:href="cvs-20201231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_eba7fdf8-6d72-40c0-beff-17c16fc6c4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PensionAndAnnuityInvestmentContractsInterest_a7b103ab-bd03-4a2c-9152-d639c5a05bb5" xlink:href="cvs-20201231.xsd#cvs_PensionAndAnnuityInvestmentContractsInterest"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_PensionAndAnnuityInvestmentContractsInterest_a7b103ab-bd03-4a2c-9152-d639c5a05bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeathSavingsAccountBalance_25614734-f0a1-4482-9dc0-deee196ef234" xlink:href="cvs-20201231.xsd#cvs_HeathSavingsAccountBalance"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_HeathSavingsAccountBalance_25614734-f0a1-4482-9dc0-deee196ef234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_c3cb3896-6e5a-41b9-bf78-41b6cc0f8858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_SelfInsuranceReserve_c3cb3896-6e5a-41b9-bf78-41b6cc0f8858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b79512de-f2c4-4d45-b1ea-5849804ca81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b79512de-f2c4-4d45-b1ea-5849804ca81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6369ea2d-2082-43a6-ada3-c983d4aaa954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6369ea2d-2082-43a6-ada3-c983d4aaa954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRebatePeriod_8a92c146-d8b6-4a45-8ef7-f75d3ff93427" xlink:href="cvs-20201231.xsd#cvs_PharmacyRebatePeriod"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_PharmacyRebatePeriod_8a92c146-d8b6-4a45-8ef7-f75d3ff93427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee_9a44e54f-502f-4abd-9263-a6c3c61d6a36" xlink:href="cvs-20201231.xsd#cvs_HealthInsurerFee"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_HealthInsurerFee_9a44e54f-502f-4abd-9263-a6c3c61d6a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_90f2ec44-282e-47d2-bbe9-5d6cea392faa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_90f2ec44-282e-47d2-bbe9-5d6cea392faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_c3f54399-7eff-452a-ab18-a572798b8218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_c3f54399-7eff-452a-ab18-a572798b8218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_e6800eb1-703c-40b8-9d17-fc452f171a34" xlink:href="cvs-20201231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_e6800eb1-703c-40b8-9d17-fc452f171a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_95fb96d8-3d99-4307-b56f-559071e063ba" xlink:href="cvs-20201231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_95fb96d8-3d99-4307-b56f-559071e063ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_9790a039-380d-40c5-9ce9-bf44da266c39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_AdvertisingExpense_9790a039-380d-40c5-9ce9-bf44da266c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_12b9b2bb-4113-485a-9b58-64bdcedf0dac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_12b9b2bb-4113-485a-9b58-64bdcedf0dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_4ff92eaf-d668-4ad6-9008-4d8b294e491f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit_4ff92eaf-d668-4ad6-9008-4d8b294e491f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_5bec1011-95ee-4a17-9339-3e72390823b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_5bec1011-95ee-4a17-9339-3e72390823b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesHeldInEmployeeTrustShares_861ea650-002c-497e-a4b2-035809a83fb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesHeldInEmployeeTrustShares"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_CommonStockSharesHeldInEmployeeTrustShares_861ea650-002c-497e-a4b2-035809a83fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_5c687107-a190-4f3a-aa70-c442c14b869f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_5c687107-a190-4f3a-aa70-c442c14b869f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Initialcontractualterm_8fc65c24-e4ef-47b1-9bcf-62beee616a42" xlink:href="cvs-20201231.xsd#cvs_Initialcontractualterm"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_Initialcontractualterm_8fc65c24-e4ef-47b1-9bcf-62beee616a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity_94f32d7e-1634-4ad3-9f49-bd7b86c46087" xlink:href="cvs-20201231.xsd#cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity_94f32d7e-1634-4ad3-9f49-bd7b86c46087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsFromVariableInterestEntity_e5806062-1d4a-4f3d-8626-8e9099d6733b" xlink:href="cvs-20201231.xsd#cvs_ProceedsFromVariableInterestEntity"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_ProceedsFromVariableInterestEntity_e5806062-1d4a-4f3d-8626-8e9099d6733b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_ff143201-d6e0-4cde-9753-de736ae0a78d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_ff143201-d6e0-4cde-9753-de736ae0a78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_11f8d2ca-cfe0-4f40-86e8-361386f4e6d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_11f8d2ca-cfe0-4f40-86e8-361386f4e6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_c202a59d-a8c9-42cd-a822-3210c2ce164d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_c202a59d-a8c9-42cd-a822-3210c2ce164d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_3d54c6e5-10b4-4908-b9ff-725198f2efc2" xlink:href="cvs-20201231.xsd#cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_3d54c6e5-10b4-4908-b9ff-725198f2efc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dd754c70-db74-4dac-9046-2e5cccbad08e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7159ae56-d4cc-44c9-8143-f45939afa828" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dd754c70-db74-4dac-9046-2e5cccbad08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8184d8be-cb91-4b51-bfd2-0762a6ad9fff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8de1de55-d8cb-41e5-b9da-e7feb63e4fb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8184d8be-cb91-4b51-bfd2-0762a6ad9fff" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8de1de55-d8cb-41e5-b9da-e7feb63e4fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_96edb82a-f5ce-40f6-8fcf-d0112598b970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8184d8be-cb91-4b51-bfd2-0762a6ad9fff" xlink:to="loc_us-gaap_RestrictedCashCurrent_96edb82a-f5ce-40f6-8fcf-d0112598b970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_eecf00df-bcb6-4750-ab82-98c4cbcf00e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8184d8be-cb91-4b51-bfd2-0762a6ad9fff" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_eecf00df-bcb6-4750-ab82-98c4cbcf00e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_961c2df2-7809-40ca-9353-ed1991cb5e68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8184d8be-cb91-4b51-bfd2-0762a6ad9fff" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_961c2df2-7809-40ca-9353-ed1991cb5e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_265829cf-4be3-4e86-b591-6bcd48626989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_eb8b5732-a11c-4651-8124-9c3100047f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_265829cf-4be3-4e86-b591-6bcd48626989" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_eb8b5732-a11c-4651-8124-9c3100047f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_001b3fc5-83ac-4a21-95d9-54bfd582fe68" xlink:href="cvs-20201231.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_265829cf-4be3-4e86-b591-6bcd48626989" xlink:to="loc_cvs_VendorandManufacturerReceivables_001b3fc5-83ac-4a21-95d9-54bfd582fe68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_499a1f4e-ebfa-4739-ba3b-487702123227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_265829cf-4be3-4e86-b591-6bcd48626989" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_499a1f4e-ebfa-4739-ba3b-487702123227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_68433423-3435-40f5-934c-263fd3151512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_265829cf-4be3-4e86-b591-6bcd48626989" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_68433423-3435-40f5-934c-263fd3151512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b2806f72-ec44-44d8-879a-3a940ca183c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_265829cf-4be3-4e86-b591-6bcd48626989" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b2806f72-ec44-44d8-879a-3a940ca183c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_9c1f20bf-0b66-4b7e-9525-54456c03b455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_265829cf-4be3-4e86-b591-6bcd48626989" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_9c1f20bf-0b66-4b7e-9525-54456c03b455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_44a2ad5d-793b-4d56-8d69-e6743179f105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8d748042-dbd8-4191-b58c-45d1f9da6901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_44a2ad5d-793b-4d56-8d69-e6743179f105" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8d748042-dbd8-4191-b58c-45d1f9da6901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_28b68074-9bd6-42b6-aaed-60b29063ba07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8d748042-dbd8-4191-b58c-45d1f9da6901" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_28b68074-9bd6-42b6-aaed-60b29063ba07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_28b68074-9bd6-42b6-aaed-60b29063ba07" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_8043def5-29af-4872-88fd-48f672ab10f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:to="loc_us-gaap_LandMember_8043def5-29af-4872-88fd-48f672ab10f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_682ce0b3-f765-444b-b96a-956be01fa9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_682ce0b3-f765-444b-b96a-956be01fa9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_9ee75703-9771-415e-a279-254da277383a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_9ee75703-9771-415e-a279-254da277383a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_679d6232-1aae-4f2c-a97e-00230fa9068a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_679d6232-1aae-4f2c-a97e-00230fa9068a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_8231e885-627e-443f-a5c1-37c70b92f05a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3035b507-bd50-42ad-974e-7578ef8a11f7" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_8231e885-627e-443f-a5c1-37c70b92f05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_473f909c-188d-4363-84c9-59b3c47f90dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8d748042-dbd8-4191-b58c-45d1f9da6901" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_473f909c-188d-4363-84c9-59b3c47f90dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9f6c1d71-22ff-48e9-936c-73a7e37b447f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_473f909c-188d-4363-84c9-59b3c47f90dc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9f6c1d71-22ff-48e9-936c-73a7e37b447f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_dddf6a77-325b-4eab-acd9-7a392db3dfd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_473f909c-188d-4363-84c9-59b3c47f90dc" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_dddf6a77-325b-4eab-acd9-7a392db3dfd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5920c9b6-e23d-46e9-8179-02e856e3569b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_473f909c-188d-4363-84c9-59b3c47f90dc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5920c9b6-e23d-46e9-8179-02e856e3569b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_dfd7c1bc-5f26-42fd-add9-59999d59479c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dfd7c1bc-5f26-42fd-add9-59999d59479c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a17cb357-1e7e-4919-8f4c-faa1c94eb97a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:to="loc_srt_ConsolidationItemsAxis_a17cb357-1e7e-4919-8f4c-faa1c94eb97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1895540a-aa61-410b-b288-f01cb4568e3e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_a17cb357-1e7e-4919-8f4c-faa1c94eb97a" xlink:to="loc_srt_ConsolidationItemsDomain_1895540a-aa61-410b-b288-f01cb4568e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e2af05cf-8f94-4381-b972-9ebcb6cd61a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_1895540a-aa61-410b-b288-f01cb4568e3e" xlink:to="loc_us-gaap_OperatingSegmentsMember_e2af05cf-8f94-4381-b972-9ebcb6cd61a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9d736e7f-b02e-49f1-8361-5e87bfd4675a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_1895540a-aa61-410b-b288-f01cb4568e3e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9d736e7f-b02e-49f1-8361-5e87bfd4675a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_a2695117-99bd-4962-9cd4-38cb94dac0ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_1895540a-aa61-410b-b288-f01cb4568e3e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_a2695117-99bd-4962-9cd4-38cb94dac0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_14a6a9b4-34a3-4ab8-86ef-8030f67d44a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_14a6a9b4-34a3-4ab8-86ef-8030f67d44a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f52dad0c-e9fe-483c-9d4c-73529568aea4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_14a6a9b4-34a3-4ab8-86ef-8030f67d44a1" xlink:to="loc_us-gaap_SegmentDomain_f52dad0c-e9fe-483c-9d4c-73529568aea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_80caa915-a736-4970-b510-2c255ff040f9" xlink:href="cvs-20201231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f52dad0c-e9fe-483c-9d4c-73529568aea4" xlink:to="loc_cvs_PharmacyServicesSegmentMember_80caa915-a736-4970-b510-2c255ff040f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_7585c2bd-43c9-4c71-bfaf-fc63f9ccbcd0" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f52dad0c-e9fe-483c-9d4c-73529568aea4" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_7585c2bd-43c9-4c71-bfaf-fc63f9ccbcd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_c38de8f5-9bdd-48f3-915b-ed7d71b3379c" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f52dad0c-e9fe-483c-9d4c-73529568aea4" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_c38de8f5-9bdd-48f3-915b-ed7d71b3379c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1fcb015d-67a9-47bd-9bce-c62eac9709fd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:to="loc_srt_ProductOrServiceAxis_1fcb015d-67a9-47bd-9bce-c62eac9709fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ecfcfc6e-fba8-4fcb-8802-227668e18b16" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1fcb015d-67a9-47bd-9bce-c62eac9709fd" xlink:to="loc_srt_ProductsAndServicesDomain_ecfcfc6e-fba8-4fcb-8802-227668e18b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_5c9f92bc-76fc-42f5-b29c-f754d177e98b" xlink:href="cvs-20201231.xsd#cvs_PharmacyRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ecfcfc6e-fba8-4fcb-8802-227668e18b16" xlink:to="loc_cvs_PharmacyRevenueMember_5c9f92bc-76fc-42f5-b29c-f754d177e98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_0b08c24d-daf0-4602-8c78-7ad802e9e09d" xlink:href="cvs-20201231.xsd#cvs_FrontStoreRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ecfcfc6e-fba8-4fcb-8802-227668e18b16" xlink:to="loc_cvs_FrontStoreRevenueMember_0b08c24d-daf0-4602-8c78-7ad802e9e09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_50f4fa4d-776d-4846-a4d7-4db0ab7ebdde" xlink:href="cvs-20201231.xsd#cvs_PremiumsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ecfcfc6e-fba8-4fcb-8802-227668e18b16" xlink:to="loc_cvs_PremiumsMember_50f4fa4d-776d-4846-a4d7-4db0ab7ebdde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_f5901f8e-71ef-4f83-b022-4353083b4fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ecfcfc6e-fba8-4fcb-8802-227668e18b16" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_f5901f8e-71ef-4f83-b022-4353083b4fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_9a1b9cf7-c1d3-46d0-900f-d3e48810a660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_9a1b9cf7-c1d3-46d0-900f-d3e48810a660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_2da3709c-3f38-484f-a05f-46acf9af18fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_9a1b9cf7-c1d3-46d0-900f-d3e48810a660" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_2da3709c-3f38-484f-a05f-46acf9af18fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_7aeff3c4-50ab-41cf-8855-ef276fe69b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_2da3709c-3f38-484f-a05f-46acf9af18fa" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_7aeff3c4-50ab-41cf-8855-ef276fe69b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_b49644f0-04e9-485e-aed9-cae9c2284d3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_2da3709c-3f38-484f-a05f-46acf9af18fa" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_b49644f0-04e9-485e-aed9-cae9c2284d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_9e8d6c01-71c1-4c94-9fce-638de04fb88c" xlink:href="cvs-20201231.xsd#cvs_SalesChannelOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_2da3709c-3f38-484f-a05f-46acf9af18fa" xlink:to="loc_cvs_SalesChannelOtherMember_9e8d6c01-71c1-4c94-9fce-638de04fb88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_866bc1c5-a23b-4dea-be6a-660abe72e46d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c4476954-f760-4de0-930a-e2258e61d680" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_866bc1c5-a23b-4dea-be6a-660abe72e46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_070eaf2c-9311-4cb6-9b9b-155b3e575d2a" xlink:href="cvs-20201231.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_866bc1c5-a23b-4dea-be6a-660abe72e46d" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_070eaf2c-9311-4cb6-9b9b-155b3e575d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_8e2907b1-8f43-414f-a1b0-af5d86540e15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_866bc1c5-a23b-4dea-be6a-660abe72e46d" xlink:to="loc_us-gaap_NetInvestmentIncome_8e2907b1-8f43-414f-a1b0-af5d86540e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2b2162bf-5365-4691-b42e-1170f85cf93f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_866bc1c5-a23b-4dea-be6a-660abe72e46d" xlink:to="loc_us-gaap_Revenues_2b2162bf-5365-4691-b42e-1170f85cf93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f2aa6117-7aaa-473e-a0df-98a37cca9ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_12411e74-1958-4b74-b87c-7daa2a92323a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f2aa6117-7aaa-473e-a0df-98a37cca9ee9" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_12411e74-1958-4b74-b87c-7daa2a92323a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_22a6bde7-5aa7-4ac3-a308-8bcd9cb07ea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f2aa6117-7aaa-473e-a0df-98a37cca9ee9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_22a6bde7-5aa7-4ac3-a308-8bcd9cb07ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_e845c4aa-ae1d-4252-832b-e20d4052f5bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f2aa6117-7aaa-473e-a0df-98a37cca9ee9" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_e845c4aa-ae1d-4252-832b-e20d4052f5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c48bd48a-59e2-47a5-8191-a994182ddada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_e845c4aa-ae1d-4252-832b-e20d4052f5bd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c48bd48a-59e2-47a5-8191-a994182ddada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_f8e8506f-2066-4fd2-a644-4215db157fa9" xlink:href="cvs-20201231.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_e845c4aa-ae1d-4252-832b-e20d4052f5bd" xlink:to="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_f8e8506f-2066-4fd2-a644-4215db157fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_32546c4a-0848-41a5-85cc-4892e69a26c1" xlink:href="cvs-20201231.xsd#cvs_ContractWithCustomerLiabilityRedemptionAndBreakage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_e845c4aa-ae1d-4252-832b-e20d4052f5bd" xlink:to="loc_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_32546c4a-0848-41a5-85cc-4892e69a26c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_22bf988b-3b8a-42ad-8c6d-434e87d7b946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_e845c4aa-ae1d-4252-832b-e20d4052f5bd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_22bf988b-3b8a-42ad-8c6d-434e87d7b946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesVariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_08bf1960-f824-4c01-b288-49516f9b93a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_316a75fc-44aa-44ab-8e98-e8154e4117da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_08bf1960-f824-4c01-b288-49516f9b93a1" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_316a75fc-44aa-44ab-8e98-e8154e4117da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_42535371-c3b9-40e2-968d-2ec6239cb0fe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_316a75fc-44aa-44ab-8e98-e8154e4117da" xlink:to="loc_srt_ConsolidatedEntitiesAxis_42535371-c3b9-40e2-968d-2ec6239cb0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_50536c08-753b-45a7-98be-c3dd0df3399e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_42535371-c3b9-40e2-968d-2ec6239cb0fe" xlink:to="loc_srt_ConsolidatedEntitiesDomain_50536c08-753b-45a7-98be-c3dd0df3399e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_304d5cfc-ef80-4cdb-b479-6365d4f43f9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_50536c08-753b-45a7-98be-c3dd0df3399e" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_304d5cfc-ef80-4cdb-b479-6365d4f43f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_24993ead-fd9f-4a2e-9d47-12fe4f4b5058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_316a75fc-44aa-44ab-8e98-e8154e4117da" xlink:to="loc_us-gaap_InvestmentTypeAxis_24993ead-fd9f-4a2e-9d47-12fe4f4b5058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_66066833-9769-42a2-885d-97e22ffcc167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_24993ead-fd9f-4a2e-9d47-12fe4f4b5058" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_66066833-9769-42a2-885d-97e22ffcc167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_23eee109-c225-4815-aa61-354194c99396" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_66066833-9769-42a2-885d-97e22ffcc167" xlink:to="loc_us-gaap_HedgeFundsMember_23eee109-c225-4815-aa61-354194c99396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_4738b12c-4e39-4621-a57f-1776c3ebfa29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_66066833-9769-42a2-885d-97e22ffcc167" xlink:to="loc_us-gaap_PrivateEquityFundsMember_4738b12c-4e39-4621-a57f-1776c3ebfa29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_0101ab94-0990-44c6-afd4-81622568de8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_66066833-9769-42a2-885d-97e22ffcc167" xlink:to="loc_us-gaap_RealEstateFundsMember_0101ab94-0990-44c6-afd4-81622568de8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_a342cced-8171-4ecd-8876-93256e4645d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_316a75fc-44aa-44ab-8e98-e8154e4117da" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_a342cced-8171-4ecd-8876-93256e4645d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_502e46d3-d068-4984-9d73-aeb4a87cff76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_a342cced-8171-4ecd-8876-93256e4645d8" xlink:to="loc_us-gaap_LongTermInvestments_502e46d3-d068-4984-9d73-aeb4a87cff76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SignificantAccountingPoliciesDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_aa44b739-d83b-4fd1-baf1-b33bfbcd05be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_4281f3ac-5716-4400-8131-864c25df448a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aa44b739-d83b-4fd1-baf1-b33bfbcd05be" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_4281f3ac-5716-4400-8131-864c25df448a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_88d4b53d-84d0-42db-9f1c-7c5cb395b002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aa44b739-d83b-4fd1-baf1-b33bfbcd05be" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_88d4b53d-84d0-42db-9f1c-7c5cb395b002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_0e71c388-de6a-4ea9-9313-25bb98f80050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aa44b739-d83b-4fd1-baf1-b33bfbcd05be" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_0e71c388-de6a-4ea9-9313-25bb98f80050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestitures" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestitures"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_c364f8e4-72fb-4ec7-8bf3-7e4cef8208e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_4d18c181-66b7-415c-a2fa-4e17d999ce42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_c364f8e4-72fb-4ec7-8bf3-7e4cef8208e5" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_4d18c181-66b7-415c-a2fa-4e17d999ce42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestituresTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_96d15f13-d8d1-4b84-bca4-8f83806b157c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_4552c81c-39a8-4360-a215-9cffbb420436" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_96d15f13-d8d1-4b84-bca4-8f83806b157c" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_4552c81c-39a8-4360-a215-9cffbb420436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_b1ed1b77-5c8b-4017-8511-c9aee261d80b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_96d15f13-d8d1-4b84-bca4-8f83806b157c" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_b1ed1b77-5c8b-4017-8511-c9aee261d80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_294648ea-1bf1-4d9d-a81a-626393a47b71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_294648ea-1bf1-4d9d-a81a-626393a47b71" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a84302f4-606b-4936-930c-796e45652b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a84302f4-606b-4936-930c-796e45652b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9a6cd357-0ed0-4f9e-9883-6ea628c98686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a84302f4-606b-4936-930c-796e45652b84" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9a6cd357-0ed0-4f9e-9883-6ea628c98686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_7474094f-1693-48db-adf9-f23a256bf955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9a6cd357-0ed0-4f9e-9883-6ea628c98686" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_7474094f-1693-48db-adf9-f23a256bf955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ee68ed94-9ca5-4978-9f36-8aac56014fd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ee68ed94-9ca5-4978-9f36-8aac56014fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7cd83e29-324e-4539-b386-d91f6aab7a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ee68ed94-9ca5-4978-9f36-8aac56014fd5" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7cd83e29-324e-4539-b386-d91f6aab7a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BrazilSubsidiaryMember_7e6d74cf-b657-4a05-ba40-6db23f46ab7b" xlink:href="cvs-20201231.xsd#cvs_BrazilSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7cd83e29-324e-4539-b386-d91f6aab7a0f" xlink:to="loc_cvs_BrazilSubsidiaryMember_7e6d74cf-b657-4a05-ba40-6db23f46ab7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RXCrossroadsMember_d5277c06-5ad8-4920-9e7b-92ab2e82e7a0" xlink:href="cvs-20201231.xsd#cvs_RXCrossroadsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7cd83e29-324e-4539-b386-d91f6aab7a0f" xlink:to="loc_cvs_RXCrossroadsMember_d5277c06-5ad8-4920-9e7b-92ab2e82e7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_a8e87246-d5ff-439d-8ade-e9cd2418079c" xlink:href="cvs-20201231.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7cd83e29-324e-4539-b386-d91f6aab7a0f" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_a8e87246-d5ff-439d-8ade-e9cd2418079c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DrogariaOnofreLtdaMember_7a414bf0-420f-40c7-8782-043c82854643" xlink:href="cvs-20201231.xsd#cvs_DrogariaOnofreLtdaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7cd83e29-324e-4539-b386-d91f6aab7a0f" xlink:to="loc_cvs_DrogariaOnofreLtdaMember_7a414bf0-420f-40c7-8782-043c82854643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f2dfc7a2-3aea-48cd-b64e-c166507b1b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f2dfc7a2-3aea-48cd-b64e-c166507b1b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_24600666-901e-4a9a-96e1-59b7902198c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f2dfc7a2-3aea-48cd-b64e-c166507b1b27" xlink:to="loc_us-gaap_SegmentDomain_24600666-901e-4a9a-96e1-59b7902198c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_cc4f4f3f-db9e-461d-b476-5f0ccf62d36b" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_24600666-901e-4a9a-96e1-59b7902198c2" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_cc4f4f3f-db9e-461d-b476-5f0ccf62d36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_962a443f-d152-4b19-8153-8728dbbe02ba" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_24600666-901e-4a9a-96e1-59b7902198c2" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_962a443f-d152-4b19-8153-8728dbbe02ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_459c051c-2f25-4474-8537-227c80d881d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_459c051c-2f25-4474-8537-227c80d881d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_26c3d713-8d0d-4186-9fde-44b311121705" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_459c051c-2f25-4474-8537-227c80d881d4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_26c3d713-8d0d-4186-9fde-44b311121705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc.Member_93bd6d8a-2ff9-48c1-ac5f-6f40a5f12dc3" xlink:href="cvs-20201231.xsd#cvs_AetnaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_26c3d713-8d0d-4186-9fde-44b311121705" xlink:to="loc_cvs_AetnaInc.Member_93bd6d8a-2ff9-48c1-ac5f-6f40a5f12dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f304a6af-c0e6-4141-b94f-6a5f247f779f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_df00d589-f038-4ed6-9289-c4c214764ec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_df00d589-f038-4ed6-9289-c4c214764ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_1b15b9f4-0710-4517-b5e2-ae443ff4fce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_1b15b9f4-0710-4517-b5e2-ae443ff4fce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPerShareExchangeRatio_3d185624-c06f-45bd-bff7-0d9a45ce31cb" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationPerShareExchangeRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_cvs_BusinessCombinationPerShareExchangeRatio_3d185624-c06f-45bd-bff7-0d9a45ce31cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired_05846673-f383-4675-af2c-da9e4d0535b9" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationAcquisitionValuePerSharesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired_05846673-f383-4675-af2c-da9e4d0535b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_87495bf5-81c9-472c-9d33-ec172a90387b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_87495bf5-81c9-472c-9d33-ec172a90387b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree_0920a4c9-9812-464c-93df-ba2f451b67df" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree_0920a4c9-9812-464c-93df-ba2f451b67df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_68b9c3a8-514b-4ac2-a476-05371e1381b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_LongTermDebt_68b9c3a8-514b-4ac2-a476-05371e1381b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_e36d1843-64be-4453-9c93-458c8bf99922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_NumberOfStores_e36d1843-64be-4453-9c93-458c8bf99922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_e952ba77-b345-477e-9c9d-17cf0a4948c4" xlink:href="cvs-20201231.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_e952ba77-b345-477e-9c9d-17cf0a4948c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_6ddb320e-ed54-473b-ae9e-b5451f017984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_6ddb320e-ed54-473b-ae9e-b5451f017984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_ce7b22b1-bd7e-4618-85fa-c20957c918d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_ce7b22b1-bd7e-4618-85fa-c20957c918d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_1a8c65ce-a48a-42be-96af-c59dd7c40509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_1a8c65ce-a48a-42be-96af-c59dd7c40509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_edf7c1c2-08d0-428d-be28-3181530fd5d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_edf7c1c2-08d0-428d-be28-3181530fd5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_a8490610-7fad-493b-9af7-7b27bf2d980a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_a8490610-7fad-493b-9af7-7b27bf2d980a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_b2b24ed9-7501-4f2d-bb4a-710ce4214e81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_14e636b5-be5e-4680-a98f-2a3dfc6cedbf" xlink:to="loc_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax_b2b24ed9-7501-4f2d-bb4a-710ce4214e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b1d2b188-a47e-4a60-8c54-3f26ec55652d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_44c4aeb6-38a9-41ad-966b-575fa1c41ea2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b1d2b188-a47e-4a60-8c54-3f26ec55652d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_44c4aeb6-38a9-41ad-966b-575fa1c41ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b7ff26dd-6309-46b8-be8e-014bda08fb8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_44c4aeb6-38a9-41ad-966b-575fa1c41ea2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b7ff26dd-6309-46b8-be8e-014bda08fb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_efab89d7-ab42-432e-aced-d92399ef5255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b7ff26dd-6309-46b8-be8e-014bda08fb8f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_efab89d7-ab42-432e-aced-d92399ef5255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc.Member_568a3172-432f-4156-8463-9ad87022578f" xlink:href="cvs-20201231.xsd#cvs_AetnaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_efab89d7-ab42-432e-aced-d92399ef5255" xlink:to="loc_cvs_AetnaInc.Member_568a3172-432f-4156-8463-9ad87022578f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_44c4aeb6-38a9-41ad-966b-575fa1c41ea2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_81ba05b2-5168-4595-a8b7-1bdb791ad028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_81ba05b2-5168-4595-a8b7-1bdb791ad028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6156b096-1dd1-452e-a839-4c96ff347b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6156b096-1dd1-452e-a839-4c96ff347b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_5542bc23-5022-41f0-b328-585552a97b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_5542bc23-5022-41f0-b328-585552a97b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments_f6d3c48a-fa54-4e85-ad76-0c4d8d3be93a" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments_f6d3c48a-fa54-4e85-ad76-0c4d8d3be93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_26eb2a29-4392-49b2-9eda-73e4f361dbea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_Goodwill_26eb2a29-4392-49b2-9eda-73e4f361dbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_732c3985-3e00-4a8e-af1d-d092a10821f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_732c3985-3e00-4a8e-af1d-d092a10821f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_f618ff85-2678-4e87-9080-7f02c3aa9076" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets_f618ff85-2678-4e87-9080-7f02c3aa9076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_20c672a8-795a-49e7-a8fa-6f7e2c2dfeec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_20c672a8-795a-49e7-a8fa-6f7e2c2dfeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet_2dfd2751-5579-4e03-99a1-2dc19c0f4d26" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet_2dfd2751-5579-4e03-99a1-2dc19c0f4d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_40134da0-e4b6-4135-b40f-c270504ff7d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_40134da0-e4b6-4135-b40f-c270504ff7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_4d1396ac-67fb-4d6c-891a-55e07518da11" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_4d1396ac-67fb-4d6c-891a-55e07518da11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4b919e13-3371-4573-92da-5d8ca4d6094e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4b919e13-3371-4573-92da-5d8ca4d6094e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6d1ee16c-5173-4075-bb95-2eae5ebe6111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6d1ee16c-5173-4075-bb95-2eae5ebe6111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9fddbdd2-4a95-4ba4-8422-7b8a07599e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9fddbdd2-4a95-4ba4-8422-7b8a07599e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_9c6df5d4-126f-4633-9b83-1fea5f29c171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_9c6df5d4-126f-4633-9b83-1fea5f29c171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_737685e7-5970-4d6c-b7d5-961474ef9de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cc4cd24-912f-424c-9669-242e1bbccbc7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_737685e7-5970-4d6c-b7d5-961474ef9de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#AcquisitionsandDivestituresProFormaDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_ed85ed12-9ad9-4d30-b83c-b3d08ef0b532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ef5290d4-f7d3-4917-9b40-340719645135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_ed85ed12-9ad9-4d30-b83c-b3d08ef0b532" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_ef5290d4-f7d3-4917-9b40-340719645135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_1ca14156-969e-4e63-b3fa-cb849cb4eb8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_ed85ed12-9ad9-4d30-b83c-b3d08ef0b532" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_1ca14156-969e-4e63-b3fa-cb849cb4eb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_789e7c02-e56e-4c64-a274-8d0ee76ea174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_ed85ed12-9ad9-4d30-b83c-b3d08ef0b532" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_789e7c02-e56e-4c64-a274-8d0ee76ea174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_f35a9961-947d-4dfe-a534-728b9dd9400c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_ed85ed12-9ad9-4d30-b83c-b3d08ef0b532" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_f35a9961-947d-4dfe-a534-728b9dd9400c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Investments" xlink:type="simple" xlink:href="cvs-20201231.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_87d3bea4-8535-44e3-9627-64c1cbaa8ef1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_ea3210ec-9c59-4131-8cc2-fb60706c29c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_87d3bea4-8535-44e3-9627-64c1cbaa8ef1" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_ea3210ec-9c59-4131-8cc2-fb60706c29c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_ce4d4991-1471-4ca2-9efc-9ab604d2488f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock_72fa860e-478d-42cc-bc83-8960bac91039" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ce4d4991-1471-4ca2-9efc-9ab604d2488f" xlink:to="loc_cvs_TotalInvestmentsTableTextBlock_72fa860e-478d-42cc-bc83-8960bac91039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_f59c11c6-c8d1-4dd9-9102-98de323acef1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ce4d4991-1471-4ca2-9efc-9ab604d2488f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_f59c11c6-c8d1-4dd9-9102-98de323acef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_dec9d50f-21d0-4f16-b624-8ca357c5025c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ce4d4991-1471-4ca2-9efc-9ab604d2488f" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_dec9d50f-21d0-4f16-b624-8ca357c5025c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_002581f4-19dd-4de5-9d0f-cf72eeb3a582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ce4d4991-1471-4ca2-9efc-9ab604d2488f" xlink:to="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_002581f4-19dd-4de5-9d0f-cf72eeb3a582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_9847b704-8f9f-4fc2-b707-4c20ce45f73c" xlink:href="cvs-20201231.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ce4d4991-1471-4ca2-9efc-9ab604d2488f" xlink:to="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_9847b704-8f9f-4fc2-b707-4c20ce45f73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_875c3c7e-5f18-41cd-83a0-e575301017b0" xlink:href="cvs-20201231.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ce4d4991-1471-4ca2-9efc-9ab604d2488f" xlink:to="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_875c3c7e-5f18-41cd-83a0-e575301017b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock_1104cb8c-4c0d-46f6-a941-440dac39ecff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ce4d4991-1471-4ca2-9efc-9ab604d2488f" xlink:to="loc_us-gaap_InvestmentIncomeTextBlock_1104cb8c-4c0d-46f6-a941-440dac39ecff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_40fb0ce4-06e8-4dff-9789-be2c0217d644" xlink:href="cvs-20201231.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_ce4d4991-1471-4ca2-9efc-9ab604d2488f" xlink:to="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_40fb0ce4-06e8-4dff-9789-be2c0217d644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsScheduleofTotalInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_b478f1d2-700a-404a-a847-ff4a50000e68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_031de285-d031-40cd-97e8-ab03cdbb9926" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b478f1d2-700a-404a-a847-ff4a50000e68" xlink:to="loc_cvs_TotalInvestmentsTable_031de285-d031-40cd-97e8-ab03cdbb9926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_6f9b90dd-e0e6-4047-a368-74e1d0c4e045" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_031de285-d031-40cd-97e8-ab03cdbb9926" xlink:to="loc_cvs_TotalInvestmentsAxis_6f9b90dd-e0e6-4047-a368-74e1d0c4e045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_23a4ad0b-4ba2-45a1-b674-658e942fc76e" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsAxis_6f9b90dd-e0e6-4047-a368-74e1d0c4e045" xlink:to="loc_cvs_TotalInvestmentsDomain_23a4ad0b-4ba2-45a1-b674-658e942fc76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_87b6f59b-f0b6-4d06-ac8a-62d7dec46a47" xlink:href="cvs-20201231.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_23a4ad0b-4ba2-45a1-b674-658e942fc76e" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_87b6f59b-f0b6-4d06-ac8a-62d7dec46a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_22679157-5296-4081-91e2-5e06aac2930a" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_23a4ad0b-4ba2-45a1-b674-658e942fc76e" xlink:to="loc_cvs_MortgageLoansMember_22679157-5296-4081-91e2-5e06aac2930a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_6b30fe15-26cc-4b91-8397-855bcb7eff71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_23a4ad0b-4ba2-45a1-b674-658e942fc76e" xlink:to="loc_us-gaap_OtherInvestmentsMember_6b30fe15-26cc-4b91-8397-855bcb7eff71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_62fc08a1-b6d4-4cfd-8791-8dc27c170b11" xlink:href="cvs-20201231.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_031de285-d031-40cd-97e8-ab03cdbb9926" xlink:to="loc_cvs_TotalInvestmentsLineItems_62fc08a1-b6d4-4cfd-8791-8dc27c170b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_6486f2a9-bada-4b81-84a4-544edcf8879d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_62fc08a1-b6d4-4cfd-8791-8dc27c170b11" xlink:to="loc_us-gaap_ShortTermInvestments_6486f2a9-bada-4b81-84a4-544edcf8879d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_dfe67c5c-af08-4af4-8aca-9293c2523675" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_62fc08a1-b6d4-4cfd-8791-8dc27c170b11" xlink:to="loc_us-gaap_LongTermInvestments_dfe67c5c-af08-4af4-8aca-9293c2523675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_dec646eb-4544-4e8e-a26b-ce47fdcb4ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_62fc08a1-b6d4-4cfd-8791-8dc27c170b11" xlink:to="loc_us-gaap_Investments_dec646eb-4544-4e8e-a26b-ce47fdcb4ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_628306ae-c172-421d-91ba-b692d20e694e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_406d1953-b411-406f-b8a5-498eedeed1f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_628306ae-c172-421d-91ba-b692d20e694e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_406d1953-b411-406f-b8a5-498eedeed1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_50f05b23-55a6-4614-89ba-47fe08f407b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_406d1953-b411-406f-b8a5-498eedeed1f9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_50f05b23-55a6-4614-89ba-47fe08f407b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00791404-8be7-498f-8188-e9d14adc3274" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_50f05b23-55a6-4614-89ba-47fe08f407b1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00791404-8be7-498f-8188-e9d14adc3274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_7ffaeb2f-5a88-4ff3-a834-42ee7a36ecab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00791404-8be7-498f-8188-e9d14adc3274" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_7ffaeb2f-5a88-4ff3-a834-42ee7a36ecab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_70c4bbd9-fcba-4dce-b590-6ba72ab9f454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00791404-8be7-498f-8188-e9d14adc3274" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_70c4bbd9-fcba-4dce-b590-6ba72ab9f454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_94762c07-47ef-42cf-b400-3772e1848a5d" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_00791404-8be7-498f-8188-e9d14adc3274" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_94762c07-47ef-42cf-b400-3772e1848a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed63319f-12b2-4971-b107-ad4245dab186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_406d1953-b411-406f-b8a5-498eedeed1f9" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed63319f-12b2-4971-b107-ad4245dab186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsAtFairValue_efd223e6-559b-490b-a96a-50073f2fe6f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed63319f-12b2-4971-b107-ad4245dab186" xlink:to="loc_us-gaap_RestrictedInvestmentsAtFairValue_efd223e6-559b-490b-a96a-50073f2fe6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_8d6970de-2566-46b0-8e49-e853f2a75448" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ed63319f-12b2-4971-b107-ad4245dab186" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_8d6970de-2566-46b0-8e49-e853f2a75448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_7f31d730-e2a2-4603-9f46-42763735691e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2b133fc7-e6f2-48e3-aefa-740ec4f741c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_7f31d730-e2a2-4603-9f46-42763735691e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2b133fc7-e6f2-48e3-aefa-740ec4f741c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_75af1cdf-9589-4500-8cf7-61f61064442f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2b133fc7-e6f2-48e3-aefa-740ec4f741c5" xlink:to="loc_srt_ProductOrServiceAxis_75af1cdf-9589-4500-8cf7-61f61064442f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ad2e2370-83e3-4e8e-9d4c-0d2ab706d561" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_75af1cdf-9589-4500-8cf7-61f61064442f" xlink:to="loc_srt_ProductsAndServicesDomain_ad2e2370-83e3-4e8e-9d4c-0d2ab706d561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_c5f497ef-bc26-43fc-bd92-73a8579af3b6" xlink:href="cvs-20201231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad2e2370-83e3-4e8e-9d4c-0d2ab706d561" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_c5f497ef-bc26-43fc-bd92-73a8579af3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ea5489e7-369e-45ab-99f8-9a6d7e3b8ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2b133fc7-e6f2-48e3-aefa-740ec4f741c5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ea5489e7-369e-45ab-99f8-9a6d7e3b8ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ea5489e7-369e-45ab-99f8-9a6d7e3b8ee3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f59cd7ea-a5af-4be8-8d00-3b351444cddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f59cd7ea-a5af-4be8-8d00-3b351444cddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_ab0522a7-b45c-451d-ad05-c4824391f061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_ab0522a7-b45c-451d-ad05-c4824391f061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_35c4e76e-21d7-451a-bd44-ccf71d85d9d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_35c4e76e-21d7-451a-bd44-ccf71d85d9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_f41ed8d1-b2ff-4634-84ad-0938098659b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_f41ed8d1-b2ff-4634-84ad-0938098659b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_dc15ec40-21bf-4df3-b68f-cc2050bc8c49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_dc15ec40-21bf-4df3-b68f-cc2050bc8c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_04c71184-f1d3-48ed-a43e-ab20565dd0ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_04c71184-f1d3-48ed-a43e-ab20565dd0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_c7d378a6-f00a-4a62-b71c-a9587bcc6473" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_c7d378a6-f00a-4a62-b71c-a9587bcc6473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_25d46e8f-292d-4a80-9dca-92836fd9f70e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05375574-d8b8-49ef-a16e-e57a7121d340" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_25d46e8f-292d-4a80-9dca-92836fd9f70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_2b133fc7-e6f2-48e3-aefa-740ec4f741c5" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2c4eb5cd-e5bd-480c-8bba-71b901180a1a" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2c4eb5cd-e5bd-480c-8bba-71b901180a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7772f15d-6408-4cd1-8679-fd7dfbde5d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7772f15d-6408-4cd1-8679-fd7dfbde5d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3c4b57ab-f11c-4764-a164-0402809c5c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3c4b57ab-f11c-4764-a164-0402809c5c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c4e24844-de4b-4705-809d-40579c74fce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c4e24844-de4b-4705-809d-40579c74fce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_e8ea346f-3d72-4e8d-aeb8-30f079da887e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_17596c91-f8a1-43cc-9fce-d0ab3abc89f7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_e8ea346f-3d72-4e8d-aeb8-30f079da887e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_72072a85-9b6a-4de4-b0ef-e21602c6d401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bd3cd4b-9f7c-4753-ad56-468ff3f67d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_72072a85-9b6a-4de4-b0ef-e21602c6d401" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bd3cd4b-9f7c-4753-ad56-468ff3f67d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7a6636fb-ae7b-4b4e-9bce-a89d0b2b1bf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bd3cd4b-9f7c-4753-ad56-468ff3f67d4e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7a6636fb-ae7b-4b4e-9bce-a89d0b2b1bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7edb881d-8553-49f9-8a6e-0370454913c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7a6636fb-ae7b-4b4e-9bce-a89d0b2b1bf1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7edb881d-8553-49f9-8a6e-0370454913c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_ec626018-19d1-4e17-a65d-c0793472348d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7edb881d-8553-49f9-8a6e-0370454913c1" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_ec626018-19d1-4e17-a65d-c0793472348d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d4cc2f53-3f3a-453b-bfdc-be908dbb5ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7edb881d-8553-49f9-8a6e-0370454913c1" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d4cc2f53-3f3a-453b-bfdc-be908dbb5ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_d3c5d5cb-4bb0-4c5b-8eae-c57f7a00a7cf" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7edb881d-8553-49f9-8a6e-0370454913c1" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_d3c5d5cb-4bb0-4c5b-8eae-c57f7a00a7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e7c25144-4a03-45c0-98fe-be9d1117559f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bd3cd4b-9f7c-4753-ad56-468ff3f67d4e" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e7c25144-4a03-45c0-98fe-be9d1117559f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e7c25144-4a03-45c0-98fe-be9d1117559f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_b1585758-e31e-44fe-b1c2-23801f8991d4" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_b1585758-e31e-44fe-b1c2-23801f8991d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_304fd6e9-a8af-47a9-b6b9-24e97524b29c" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_304fd6e9-a8af-47a9-b6b9-24e97524b29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_2feb41da-395f-4fc9-9454-a555e775fbfb" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_2feb41da-395f-4fc9-9454-a555e775fbfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_f0246f8a-5f80-494a-8eed-b68e5427a516" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_f0246f8a-5f80-494a-8eed-b68e5427a516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_3b45b55c-01f3-4a46-9a64-33af3587479d" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_3b45b55c-01f3-4a46-9a64-33af3587479d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_947d319e-7adf-4e16-8cd9-23f6f28e44c8" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc4415f1-429f-47a0-97e9-76fb5c308aae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_947d319e-7adf-4e16-8cd9-23f6f28e44c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e7c25144-4a03-45c0-98fe-be9d1117559f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_12f23915-5285-4b8d-9316-bc0a7f1e1fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_12f23915-5285-4b8d-9316-bc0a7f1e1fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_d9cdac90-e1a9-42cd-a047-d899c882881f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_d9cdac90-e1a9-42cd-a047-d899c882881f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_51050f9f-ca05-455e-ad64-32565f309d70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_51050f9f-ca05-455e-ad64-32565f309d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_56239ed4-529f-479b-8cdc-a478682d22b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_56239ed4-529f-479b-8cdc-a478682d22b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_6c988cee-598b-49cb-8f21-5721731bf954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_6c988cee-598b-49cb-8f21-5721731bf954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_aa9f3fa4-663a-4a50-864c-8087bfc830e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_df62eacd-efc0-4650-8a9d-2b42715b53a6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_aa9f3fa4-663a-4a50-864c-8087bfc830e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_a934aed2-5368-4469-92ab-2a07436de71f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_768e9f3f-967a-4576-85fe-707a6936e2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_a934aed2-5368-4469-92ab-2a07436de71f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_768e9f3f-967a-4576-85fe-707a6936e2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d1b8945b-748d-4e71-82df-460e6526f653" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_768e9f3f-967a-4576-85fe-707a6936e2c0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d1b8945b-748d-4e71-82df-460e6526f653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d1b8945b-748d-4e71-82df-460e6526f653" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cc898473-1fe1-4e0a-a782-2752aaff4b0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cc898473-1fe1-4e0a-a782-2752aaff4b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_fe3f2bb4-ea6c-4bf8-8536-6acf25375760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_fe3f2bb4-ea6c-4bf8-8536-6acf25375760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_e9d9b3af-af3b-44b3-b7fc-76f331ebb035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_e9d9b3af-af3b-44b3-b7fc-76f331ebb035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_ef895267-f0a8-45de-815f-6244a2d9d37d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_ef895267-f0a8-45de-815f-6244a2d9d37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d22b4e03-fb6e-4177-8ba8-e1df109800fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d22b4e03-fb6e-4177-8ba8-e1df109800fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_085bc72e-f4a8-4aa4-9d45-4c1c27a95334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_085bc72e-f4a8-4aa4-9d45-4c1c27a95334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_05bef420-7125-4860-88a2-2089bba27b46" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16fdaa5b-70b4-4ff9-a775-35cbb9b5cc49" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_05bef420-7125-4860-88a2-2089bba27b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a6d224f4-80a5-4d0c-a621-2098ed6d5249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_768e9f3f-967a-4576-85fe-707a6936e2c0" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a6d224f4-80a5-4d0c-a621-2098ed6d5249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_012f935e-7cc8-49e5-a334-ec94c7887fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a6d224f4-80a5-4d0c-a621-2098ed6d5249" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_012f935e-7cc8-49e5-a334-ec94c7887fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_70b09776-ee22-4aa7-8364-929311665554" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_012f935e-7cc8-49e5-a334-ec94c7887fea" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_70b09776-ee22-4aa7-8364-929311665554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_a6d7b02a-c994-4097-8617-a4c01a719d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_012f935e-7cc8-49e5-a334-ec94c7887fea" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_a6d7b02a-c994-4097-8617-a4c01a719d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_15669778-60b4-40d9-bdc1-2492a021b224" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_012f935e-7cc8-49e5-a334-ec94c7887fea" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_15669778-60b4-40d9-bdc1-2492a021b224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_db3ce0c5-ef43-4a9f-92cd-f1a372d9f458" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a6d224f4-80a5-4d0c-a621-2098ed6d5249" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_db3ce0c5-ef43-4a9f-92cd-f1a372d9f458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d51f30f6-c362-4a6b-8794-45495d8713f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_db3ce0c5-ef43-4a9f-92cd-f1a372d9f458" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d51f30f6-c362-4a6b-8794-45495d8713f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_59ca6005-cb9a-4e64-be11-cbf46803efd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_db3ce0c5-ef43-4a9f-92cd-f1a372d9f458" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_59ca6005-cb9a-4e64-be11-cbf46803efd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_93a09246-8791-430e-80e6-2e63f32c92a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_db3ce0c5-ef43-4a9f-92cd-f1a372d9f458" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_93a09246-8791-430e-80e6-2e63f32c92a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4ac7116c-27c8-4e5b-a26c-14fa9e486ed2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a6d224f4-80a5-4d0c-a621-2098ed6d5249" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4ac7116c-27c8-4e5b-a26c-14fa9e486ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ce52aedb-8f54-4e07-8477-0a80309e0440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4ac7116c-27c8-4e5b-a26c-14fa9e486ed2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_ce52aedb-8f54-4e07-8477-0a80309e0440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_03b78be2-bd19-443f-965d-c47b5ca824df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4ac7116c-27c8-4e5b-a26c-14fa9e486ed2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_03b78be2-bd19-443f-965d-c47b5ca824df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_61388076-0290-4dca-8fc2-3e2e18051e77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_4ac7116c-27c8-4e5b-a26c-14fa9e486ed2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_61388076-0290-4dca-8fc2-3e2e18051e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_f7f17a9c-ffd2-4c81-9aec-54324d7b1230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9bca1465-e4dd-412a-8948-ddb62c08f3b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_f7f17a9c-ffd2-4c81-9aec-54324d7b1230" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9bca1465-e4dd-412a-8948-ddb62c08f3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_afda5a37-abb7-49f3-ae93-51de0d191665" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9bca1465-e4dd-412a-8948-ddb62c08f3b2" xlink:to="loc_srt_ProductOrServiceAxis_afda5a37-abb7-49f3-ae93-51de0d191665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e92f39e8-289d-4973-a2c2-a60c6f72b626" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_afda5a37-abb7-49f3-ae93-51de0d191665" xlink:to="loc_srt_ProductsAndServicesDomain_e92f39e8-289d-4973-a2c2-a60c6f72b626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_e7dfb38c-6da0-4523-a9f3-454de4c8bc9d" xlink:href="cvs-20201231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e92f39e8-289d-4973-a2c2-a60c6f72b626" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_e7dfb38c-6da0-4523-a9f3-454de4c8bc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_29357372-d93e-48c6-9454-7844170834f3" xlink:href="cvs-20201231.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e92f39e8-289d-4973-a2c2-a60c6f72b626" xlink:to="loc_cvs_SupportingRemainingProductsMember_29357372-d93e-48c6-9454-7844170834f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_93442f5f-fd07-4442-97a6-c9ce6268a5f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9bca1465-e4dd-412a-8948-ddb62c08f3b2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_93442f5f-fd07-4442-97a6-c9ce6268a5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_879fd837-53e3-4378-b081-7458b3e8c9f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_93442f5f-fd07-4442-97a6-c9ce6268a5f9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_879fd837-53e3-4378-b081-7458b3e8c9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_f1603e0f-0e70-4b7f-8fd2-bd8635df1da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_879fd837-53e3-4378-b081-7458b3e8c9f9" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_f1603e0f-0e70-4b7f-8fd2-bd8635df1da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_bd7c1881-3443-4310-a684-4bbd5063b72c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_879fd837-53e3-4378-b081-7458b3e8c9f9" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_bd7c1881-3443-4310-a684-4bbd5063b72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_ae28aff3-1b73-45f8-9c81-9484c1f9deef" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_879fd837-53e3-4378-b081-7458b3e8c9f9" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_ae28aff3-1b73-45f8-9c81-9484c1f9deef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_777e42d1-2ad5-428a-9b83-429cd04b9e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9bca1465-e4dd-412a-8948-ddb62c08f3b2" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_777e42d1-2ad5-428a-9b83-429cd04b9e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_777e42d1-2ad5-428a-9b83-429cd04b9e10" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_2f9e9b47-1222-4330-996a-4413b3ed3473" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_2f9e9b47-1222-4330-996a-4413b3ed3473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_f5cfdf0c-2b25-417b-b29b-9a74e1abc83b" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_f5cfdf0c-2b25-417b-b29b-9a74e1abc83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_27457fef-6e56-4068-a8c4-b561115bdcdc" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_27457fef-6e56-4068-a8c4-b561115bdcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_0c258ebc-bf11-447b-846c-a9a33c9f9739" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_0c258ebc-bf11-447b-846c-a9a33c9f9739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_98f39a91-e862-4ad7-8bdb-13a19931df71" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_98f39a91-e862-4ad7-8bdb-13a19931df71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7882b202-993c-407b-9f88-cd2eb1daddf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_00f10930-12a8-4bd6-9c2f-1a873d68f37a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_7882b202-993c-407b-9f88-cd2eb1daddf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_777e42d1-2ad5-428a-9b83-429cd04b9e10" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_26f6d681-01de-4be8-90e7-333ac824f924" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_26f6d681-01de-4be8-90e7-333ac824f924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_f0dc1d44-6014-4290-b909-54d188459056" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_f0dc1d44-6014-4290-b909-54d188459056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_48de2767-6692-49e7-a5f9-11eae1abc198" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_48de2767-6692-49e7-a5f9-11eae1abc198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_0e59f29c-0213-4b71-ab91-6470d4185ff8" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_0e59f29c-0213-4b71-ab91-6470d4185ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_e7eae8d6-86ca-4224-b273-f72a09d86933" xlink:href="cvs-20201231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_e7eae8d6-86ca-4224-b273-f72a09d86933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_082b70a9-cfb6-47f4-a2f9-11d293071750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_7ff49a01-b4e0-4348-9e8c-d7140e631551" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_082b70a9-cfb6-47f4-a2f9-11d293071750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsMortgageLoansDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_8db94de8-7136-429a-956d-f1a23e2792bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_8e261f0d-0bf0-432c-aa88-ac5c1271daa6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_8db94de8-7136-429a-956d-f1a23e2792bc" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_8e261f0d-0bf0-432c-aa88-ac5c1271daa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_ae752961-f328-41d8-b4bc-069573e795d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_8e261f0d-0bf0-432c-aa88-ac5c1271daa6" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_ae752961-f328-41d8-b4bc-069573e795d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_89dfea59-b971-467e-bf88-0df395c08ac5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_ae752961-f328-41d8-b4bc-069573e795d3" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_89dfea59-b971-467e-bf88-0df395c08ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_457a9edd-4a54-429e-9bcc-796f7b6e4764" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_89dfea59-b971-467e-bf88-0df395c08ac5" xlink:to="loc_us-gaap_CommercialRealEstateMember_457a9edd-4a54-429e-9bcc-796f7b6e4764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_2b59505d-fcf7-4857-8000-869621744306" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_8e261f0d-0bf0-432c-aa88-ac5c1271daa6" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_2b59505d-fcf7-4857-8000-869621744306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_827a3588-3484-4a00-8458-3916bf138fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_2b59505d-fcf7-4857-8000-869621744306" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_827a3588-3484-4a00-8458-3916bf138fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_a39f3fc6-30e9-4677-aa40-e9dcbed6bdbc" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_2b59505d-fcf7-4857-8000-869621744306" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_a39f3fc6-30e9-4677-aa40-e9dcbed6bdbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_9b7d0ee9-ef41-4765-8339-15a3cc882b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_2b59505d-fcf7-4857-8000-869621744306" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_9b7d0ee9-ef41-4765-8339-15a3cc882b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_756be6fe-d1f8-485d-b569-d91d278d9695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_db50781b-8658-4ecb-886f-a428b8deefa7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_756be6fe-d1f8-485d-b569-d91d278d9695" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_db50781b-8658-4ecb-886f-a428b8deefa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0cfea529-39b1-43cc-bb43-7c0ebac16419" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_db50781b-8658-4ecb-886f-a428b8deefa7" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0cfea529-39b1-43cc-bb43-7c0ebac16419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ac88d892-3fa1-4eff-8998-23d1d4f70754" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_0cfea529-39b1-43cc-bb43-7c0ebac16419" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ac88d892-3fa1-4eff-8998-23d1d4f70754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_e7f5d05b-624c-43b5-80e4-883fe67e0c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ac88d892-3fa1-4eff-8998-23d1d4f70754" xlink:to="loc_us-gaap_CommercialRealEstateMember_e7f5d05b-624c-43b5-80e4-883fe67e0c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis_c4b51d80-cf07-4247-abaa-b0331ae8f242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_db50781b-8658-4ecb-886f-a428b8deefa7" xlink:to="loc_us-gaap_InternalCreditAssessmentAxis_c4b51d80-cf07-4247-abaa-b0331ae8f242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_d3393f6b-ea54-416c-9b42-78bf7685579a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_c4b51d80-cf07-4247-abaa-b0331ae8f242" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_d3393f6b-ea54-416c-9b42-78bf7685579a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_f7f5b681-1687-4f70-ad67-67350aa7c618" xlink:href="cvs-20201231.xsd#cvs_Category1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_d3393f6b-ea54-416c-9b42-78bf7685579a" xlink:to="loc_cvs_Category1Member_f7f5b681-1687-4f70-ad67-67350aa7c618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_5f4a3e39-71eb-4f3b-81c0-631881318cd4" xlink:href="cvs-20201231.xsd#cvs_Category2To4Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_d3393f6b-ea54-416c-9b42-78bf7685579a" xlink:to="loc_cvs_Category2To4Member_5f4a3e39-71eb-4f3b-81c0-631881318cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_81e593e0-a9fa-4fbb-821e-b5c18d118d08" xlink:href="cvs-20201231.xsd#cvs_Categories5and6Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_d3393f6b-ea54-416c-9b42-78bf7685579a" xlink:to="loc_cvs_Categories5and6Member_81e593e0-a9fa-4fbb-821e-b5c18d118d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_875bba4d-84f3-450e-a75e-027c52093b8a" xlink:href="cvs-20201231.xsd#cvs_Category7Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_d3393f6b-ea54-416c-9b42-78bf7685579a" xlink:to="loc_cvs_Category7Member_875bba4d-84f3-450e-a75e-027c52093b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_4cb262e4-df94-4049-84f5-b87810f8cca9" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_db50781b-8658-4ecb-886f-a428b8deefa7" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_4cb262e4-df94-4049-84f5-b87810f8cca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_4cb262e4-df94-4049-84f5-b87810f8cca9" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_9bb4149f-8f5f-401f-a9ff-8271d466b5ed" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_9bb4149f-8f5f-401f-a9ff-8271d466b5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_4b565b1b-5b11-43e6-ae8d-a3d4202809e9" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_4b565b1b-5b11-43e6-ae8d-a3d4202809e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_c1e1f78b-b0d4-4c76-b7aa-4d04b1788c5f" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_c1e1f78b-b0d4-4c76-b7aa-4d04b1788c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_a8e0b286-80a4-4ac1-a73b-a1fa2515c87a" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_a8e0b286-80a4-4ac1-a73b-a1fa2515c87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_9b600ea3-9184-4bd8-a5f9-6b94c80de1ed" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_9b600ea3-9184-4bd8-a5f9-6b94c80de1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_102aee6e-e93a-404a-b1da-6f4923be3e00" xlink:href="cvs-20201231.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_7470cbae-57a8-4469-b3f0-18c2ad00553c" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_102aee6e-e93a-404a-b1da-6f4923be3e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_6a9b4a02-1ce2-43f7-8f17-dbf02a1cb74c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_db50781b-8658-4ecb-886f-a428b8deefa7" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_6a9b4a02-1ce2-43f7-8f17-dbf02a1cb74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_99e9ef93-7fa2-4ce3-b45a-d9ac8131afa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6a9b4a02-1ce2-43f7-8f17-dbf02a1cb74c" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_99e9ef93-7fa2-4ce3-b45a-d9ac8131afa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8e159c25-cb16-46fc-a32a-9b95eb99a07b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_90994d14-24dc-466d-a2a7-0afd5db7c5c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8e159c25-cb16-46fc-a32a-9b95eb99a07b" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_90994d14-24dc-466d-a2a7-0afd5db7c5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f9d549c4-1e68-45f6-858e-a4a6f4fd2ff0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_90994d14-24dc-466d-a2a7-0afd5db7c5c7" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f9d549c4-1e68-45f6-858e-a4a6f4fd2ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_66390562-e2f8-46b3-9c3a-26fab0b1679a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f9d549c4-1e68-45f6-858e-a4a6f4fd2ff0" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_66390562-e2f8-46b3-9c3a-26fab0b1679a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_f564a70a-b9ee-4f0b-874e-90cdb2fe73dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_66390562-e2f8-46b3-9c3a-26fab0b1679a" xlink:to="loc_us-gaap_CommercialRealEstateMember_f564a70a-b9ee-4f0b-874e-90cdb2fe73dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_90994d14-24dc-466d-a2a7-0afd5db7c5c7" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_17eef06c-44d3-4264-9d1f-d94f4c37827d" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_17eef06c-44d3-4264-9d1f-d94f4c37827d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_950a8e2e-c17c-470c-a384-4e70d1794623" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_950a8e2e-c17c-470c-a384-4e70d1794623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_7558ccd8-ce5a-4e48-b6be-29cf77febe97" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_7558ccd8-ce5a-4e48-b6be-29cf77febe97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_7795c278-61d1-44d8-a738-10b4b689703e" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_7795c278-61d1-44d8-a738-10b4b689703e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_1be88a72-c0e1-499f-a25b-83236f31d6cd" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_1be88a72-c0e1-499f-a25b-83236f31d6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_4b1dddfc-3d16-4340-908a-893cec68224a" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_4b1dddfc-3d16-4340-908a-893cec68224a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_9ce828d1-a824-4239-85f1-382342c228a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_6cc6cf5a-b4b7-490f-b336-0a6f87422e3b" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_9ce828d1-a824-4239-85f1-382342c228a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_2faa456e-4a45-42d4-b5a5-a1d044cd929f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_55aa2043-55f1-4ace-b325-6fdc623eef1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2faa456e-4a45-42d4-b5a5-a1d044cd929f" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_55aa2043-55f1-4ace-b325-6fdc623eef1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_309b6483-a208-44d6-a831-cd1c7e01f570" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_55aa2043-55f1-4ace-b325-6fdc623eef1d" xlink:to="loc_us-gaap_InvestmentTypeAxis_309b6483-a208-44d6-a831-cd1c7e01f570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_44389894-6bf0-4a89-9ad2-38c973861da2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_309b6483-a208-44d6-a831-cd1c7e01f570" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_44389894-6bf0-4a89-9ad2-38c973861da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_815e4a54-6f3e-4128-a2fa-e501af2d23f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_44389894-6bf0-4a89-9ad2-38c973861da2" xlink:to="loc_us-gaap_DebtSecuritiesMember_815e4a54-6f3e-4128-a2fa-e501af2d23f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_b2f9ba26-55d8-49c2-97f8-3cd10e809790" xlink:href="cvs-20201231.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_44389894-6bf0-4a89-9ad2-38c973861da2" xlink:to="loc_cvs_MortgageLoansMember_b2f9ba26-55d8-49c2-97f8-3cd10e809790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_b63394e6-ae7d-49d2-81fd-fad7e80a2f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_44389894-6bf0-4a89-9ad2-38c973861da2" xlink:to="loc_us-gaap_OtherInvestmentsMember_b63394e6-ae7d-49d2-81fd-fad7e80a2f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_531ee65b-a5d3-4dca-825d-d2345e75e989" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_55aa2043-55f1-4ace-b325-6fdc623eef1d" xlink:to="loc_srt_ProductOrServiceAxis_531ee65b-a5d3-4dca-825d-d2345e75e989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ef79b953-74e4-482e-a90b-92bbf4a29e25" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_531ee65b-a5d3-4dca-825d-d2345e75e989" xlink:to="loc_srt_ProductsAndServicesDomain_ef79b953-74e4-482e-a90b-92bbf4a29e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_5201642b-6731-45cf-8142-b4bc295ce61e" xlink:href="cvs-20201231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ef79b953-74e4-482e-a90b-92bbf4a29e25" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_5201642b-6731-45cf-8142-b4bc295ce61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_55aa2043-55f1-4ace-b325-6fdc623eef1d" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_13daa889-c3f4-466c-a46c-9508c32204df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_13daa889-c3f4-466c-a46c-9508c32204df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_941e7739-77c5-482e-a9fb-c00c180fc405" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_941e7739-77c5-482e-a9fb-c00c180fc405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_67a1618c-e33f-4ccc-881d-9907a6248f76" xlink:href="cvs-20201231.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_67a1618c-e33f-4ccc-881d-9907a6248f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_41363bd3-e8f2-4991-9a1f-a0c7a156d0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_41363bd3-e8f2-4991-9a1f-a0c7a156d0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_d425ec95-2bfd-46cc-bcf5-becb77f3559b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_us-gaap_InvestmentIncomeNet_d425ec95-2bfd-46cc-bcf5-becb77f3559b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_70513a56-5421-4122-87b9-f1217d487358" xlink:href="cvs-20201231.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_70513a56-5421-4122-87b9-f1217d487358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_06aa2aa0-87cb-45ef-90ea-6a98712a2aca" xlink:href="cvs-20201231.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_06aa2aa0-87cb-45ef-90ea-6a98712a2aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_b1b2bc00-fbb2-453c-889a-d4dc6385a899" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b8bee21b-e52a-4127-a958-8c5a9dc85597" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_b1b2bc00-fbb2-453c-889a-d4dc6385a899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#InvestmentsRealizedGainsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_5c085335-b887-4eee-aa6d-9a76573d46e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_35708d64-9566-45ff-a25a-ca77431c5ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_5c085335-b887-4eee-aa6d-9a76573d46e1" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_35708d64-9566-45ff-a25a-ca77431c5ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_d7ef72e7-04b1-435d-b4f6-77d1559f5e83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_5c085335-b887-4eee-aa6d-9a76573d46e1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_d7ef72e7-04b1-435d-b4f6-77d1559f5e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_746c75df-3eef-4664-a285-c8702504d798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_5c085335-b887-4eee-aa6d-9a76573d46e1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_746c75df-3eef-4664-a285-c8702504d798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValue" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fec8f55a-9224-4f31-bffa-4c5a8c892774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_d8b035c6-6514-42ed-9f04-955c384dc419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fec8f55a-9224-4f31-bffa-4c5a8c892774" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_d8b035c6-6514-42ed-9f04-955c384dc419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f8610796-da31-45c4-bbb0-d233245dbfb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_af70acfe-108b-42c3-974d-eab33fe04cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f8610796-da31-45c4-bbb0-d233245dbfb2" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_af70acfe-108b-42c3-974d-eab33fe04cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_104fb31a-7977-4c78-b51b-61a7ab0d015c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f8610796-da31-45c4-bbb0-d233245dbfb2" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_104fb31a-7977-4c78-b51b-61a7ab0d015c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_69c6b4da-4553-4140-bedd-177ece78c2be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f8610796-da31-45c4-bbb0-d233245dbfb2" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_69c6b4da-4553-4140-bedd-177ece78c2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_c2131fc1-9b70-42e0-a700-5bd70a2f0076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f8610796-da31-45c4-bbb0-d233245dbfb2" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_c2131fc1-9b70-42e0-a700-5bd70a2f0076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_08e69694-9108-4a1d-ad65-4d1f43037f1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6c1b4ca5-65eb-4b2c-acb1-9945e22ed8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_08e69694-9108-4a1d-ad65-4d1f43037f1f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6c1b4ca5-65eb-4b2c-acb1-9945e22ed8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25bee5ef-403a-4a22-a7bb-981d0d1b488a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6c1b4ca5-65eb-4b2c-acb1-9945e22ed8a5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25bee5ef-403a-4a22-a7bb-981d0d1b488a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_06f7af41-88f3-487d-8e0d-9de295fcbcf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_25bee5ef-403a-4a22-a7bb-981d0d1b488a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_06f7af41-88f3-487d-8e0d-9de295fcbcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_746d42b4-aa4a-4274-bc63-790c95ebde83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_06f7af41-88f3-487d-8e0d-9de295fcbcf3" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_746d42b4-aa4a-4274-bc63-790c95ebde83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_acdf43b6-5686-4ebe-91ec-ac4253f2c534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6c1b4ca5-65eb-4b2c-acb1-9945e22ed8a5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_acdf43b6-5686-4ebe-91ec-ac4253f2c534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_acdf43b6-5686-4ebe-91ec-ac4253f2c534" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_8282b083-f700-461a-916a-6242b8928288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_8282b083-f700-461a-916a-6242b8928288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_85c81ec1-2d28-4aa7-9415-8fbfc7fc41af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_85c81ec1-2d28-4aa7-9415-8fbfc7fc41af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_49cc27e2-29a6-4e5e-b8d9-9601a01671ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_49cc27e2-29a6-4e5e-b8d9-9601a01671ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_d5769b94-c68c-499c-8373-995726e9341a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_d5769b94-c68c-499c-8373-995726e9341a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_b1967c2b-f341-4023-bf47-9ec7b253878d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_b1967c2b-f341-4023-bf47-9ec7b253878d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_57e9262d-6d27-4e11-b029-d8193ce37851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_57e9262d-6d27-4e11-b029-d8193ce37851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_d9a5a385-bd78-41bc-8031-20d1f872abf2" xlink:href="cvs-20201231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_d9a5a385-bd78-41bc-8031-20d1f872abf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_156c3b2a-488c-49ad-83ca-95514c6df37a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8826b18f-602b-4264-8a29-1115a552f059" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_156c3b2a-488c-49ad-83ca-95514c6df37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b08968a2-dcf7-4c08-b683-5ffec96050fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6c1b4ca5-65eb-4b2c-acb1-9945e22ed8a5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b08968a2-dcf7-4c08-b683-5ffec96050fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e3b97d7c-8c43-41f3-88be-092d6f1ff102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b08968a2-dcf7-4c08-b683-5ffec96050fa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e3b97d7c-8c43-41f3-88be-092d6f1ff102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8db88dbc-020e-449e-92b3-498994bac445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e3b97d7c-8c43-41f3-88be-092d6f1ff102" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8db88dbc-020e-449e-92b3-498994bac445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5fd26ddc-f33b-4503-b7b2-5a558393e01b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e3b97d7c-8c43-41f3-88be-092d6f1ff102" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5fd26ddc-f33b-4503-b7b2-5a558393e01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_afa9da23-6e2b-448b-997e-2923e5ef8c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e3b97d7c-8c43-41f3-88be-092d6f1ff102" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_afa9da23-6e2b-448b-997e-2923e5ef8c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e1aeb8cb-80a3-4cef-9604-ee3678d0945a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6c1b4ca5-65eb-4b2c-acb1-9945e22ed8a5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e1aeb8cb-80a3-4cef-9604-ee3678d0945a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_9754fe75-9b50-43c7-a11d-3ac6a2a1c00d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e1aeb8cb-80a3-4cef-9604-ee3678d0945a" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_9754fe75-9b50-43c7-a11d-3ac6a2a1c00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a5745251-913e-4f4d-a28e-06a5a05d1cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9754fe75-9b50-43c7-a11d-3ac6a2a1c00d" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a5745251-913e-4f4d-a28e-06a5a05d1cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0eb55037-4bbb-4c57-81ca-417477ae1cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9754fe75-9b50-43c7-a11d-3ac6a2a1c00d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0eb55037-4bbb-4c57-81ca-417477ae1cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_3343c547-90c7-43c6-9715-7a3f86abe163" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9754fe75-9b50-43c7-a11d-3ac6a2a1c00d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_3343c547-90c7-43c6-9715-7a3f86abe163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_56e372b4-d342-41b3-9964-9eafab06588c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9754fe75-9b50-43c7-a11d-3ac6a2a1c00d" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_56e372b4-d342-41b3-9964-9eafab06588c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueChangesinLevel3FinancialAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6ba36fe8-7333-49c1-9b9f-7d40b74bf05f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6725d418-e92f-4c65-94ab-7986380a64d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6ba36fe8-7333-49c1-9b9f-7d40b74bf05f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6725d418-e92f-4c65-94ab-7986380a64d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_fc3184fb-86c7-4153-9d1e-b57363db1c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6725d418-e92f-4c65-94ab-7986380a64d7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_fc3184fb-86c7-4153-9d1e-b57363db1c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_fc3184fb-86c7-4153-9d1e-b57363db1c62" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_720d15e4-1afe-4c7f-a8e1-9b92ef9544ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_720d15e4-1afe-4c7f-a8e1-9b92ef9544ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_50a4da1e-1b2c-45d5-8144-44a1974d1e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_50a4da1e-1b2c-45d5-8144-44a1974d1e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_f443df82-6f31-4109-8fcf-ebce809e2b20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_f443df82-6f31-4109-8fcf-ebce809e2b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_6fedc77b-05d1-478c-8760-596cfb10f004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:to="loc_us-gaap_EquitySecuritiesMember_6fedc77b-05d1-478c-8760-596cfb10f004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_826f5a8c-69f3-496e-ad72-a5323ab2ac7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_167aa43d-d028-479b-bae8-5cc48acf19cc" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_826f5a8c-69f3-496e-ad72-a5323ab2ac7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7c2cb892-5507-44ae-a9af-dfcfadd9fca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6725d418-e92f-4c65-94ab-7986380a64d7" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7c2cb892-5507-44ae-a9af-dfcfadd9fca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f7955f2e-09f2-4a39-b399-b628faa44f95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7c2cb892-5507-44ae-a9af-dfcfadd9fca1" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f7955f2e-09f2-4a39-b399-b628faa44f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_121c5b90-d46f-4e2e-a261-a7ac5e30ab48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f7955f2e-09f2-4a39-b399-b628faa44f95" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_121c5b90-d46f-4e2e-a261-a7ac5e30ab48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340d7138-1137-41d3-8222-93f91b5d1bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6725d418-e92f-4c65-94ab-7986380a64d7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340d7138-1137-41d3-8222-93f91b5d1bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340d7138-1137-41d3-8222-93f91b5d1bfd" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1f33dda2-6128-42af-baa6-352e133d907f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1f33dda2-6128-42af-baa6-352e133d907f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9553a842-d912-4813-95ed-45674391fbf9" xlink:href="cvs-20201231.xsd#cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9553a842-d912-4813-95ed-45674391fbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_246d6e41-d65a-4073-b906-15f785e8bec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9553a842-d912-4813-95ed-45674391fbf9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_246d6e41-d65a-4073-b906-15f785e8bec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ebbfa114-712d-4d81-98e1-56229400faad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9553a842-d912-4813-95ed-45674391fbf9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_ebbfa114-712d-4d81-98e1-56229400faad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_859828af-fd94-4d7d-889c-21e0d1ae91a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_859828af-fd94-4d7d-889c-21e0d1ae91a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_8a52af5f-4a68-4eee-ac04-df6211dffe4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_8a52af5f-4a68-4eee-ac04-df6211dffe4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_d50d7f36-7c1d-4a41-b3b4-53d804fbcc51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_d50d7f36-7c1d-4a41-b3b4-53d804fbcc51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_4e19397b-eab2-48e8-9e1e-7bee8a551440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_4e19397b-eab2-48e8-9e1e-7bee8a551440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_3a66f94d-62eb-4960-990d-d3efa8ad14ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6a708886-6224-4d0b-8dd0-fe12d94d2ca4" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_3a66f94d-62eb-4960-990d-d3efa8ad14ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_9772944a-3def-4a17-8aec-84c6c64fb60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_340d7138-1137-41d3-8222-93f91b5d1bfd" xlink:to="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_9772944a-3def-4a17-8aec-84c6c64fb60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueGrossTransfersIntoOutOfLevel3Details"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6df6e6b3-7911-49f1-98f9-845bf93cfe63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86e6f6e1-3096-4dfb-a1db-881b646ba02a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6df6e6b3-7911-49f1-98f9-845bf93cfe63" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86e6f6e1-3096-4dfb-a1db-881b646ba02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f9385490-37df-4022-a111-f79737da6ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86e6f6e1-3096-4dfb-a1db-881b646ba02a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f9385490-37df-4022-a111-f79737da6ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_53e48176-c922-4cbc-a91c-12bb9d66c0da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f9385490-37df-4022-a111-f79737da6ca5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_53e48176-c922-4cbc-a91c-12bb9d66c0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5c78a8dc-4c02-476d-bb53-038f6e2a468f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_53e48176-c922-4cbc-a91c-12bb9d66c0da" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5c78a8dc-4c02-476d-bb53-038f6e2a468f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_131fa6be-8759-485b-bae4-dddc5c6fab69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86e6f6e1-3096-4dfb-a1db-881b646ba02a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_131fa6be-8759-485b-bae4-dddc5c6fab69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fa3471b-6601-4fe5-aab7-e81363e73ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_131fa6be-8759-485b-bae4-dddc5c6fab69" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fa3471b-6601-4fe5-aab7-e81363e73ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ee3e3b78-5f30-48f2-a17b-15b1a7d92cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fa3471b-6601-4fe5-aab7-e81363e73ac6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ee3e3b78-5f30-48f2-a17b-15b1a7d92cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8cb322df-c2e4-41f6-9889-8afbcab1bee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_86e6f6e1-3096-4dfb-a1db-881b646ba02a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8cb322df-c2e4-41f6-9889-8afbcab1bee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_140824b6-1ecf-47e4-aa10-7619c5855ab6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8cb322df-c2e4-41f6-9889-8afbcab1bee0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_140824b6-1ecf-47e4-aa10-7619c5855ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_5f1b0f9c-b946-4a9f-98ee-b602c69c7f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8cb322df-c2e4-41f6-9889-8afbcab1bee0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_5f1b0f9c-b946-4a9f-98ee-b602c69c7f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_dd6ed2a2-dd3b-4544-bd3d-56b1de555dfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8cb322df-c2e4-41f6-9889-8afbcab1bee0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_dd6ed2a2-dd3b-4544-bd3d-56b1de555dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5a309793-5183-450f-a734-69b554d55a19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_680cae35-c629-4291-b79c-9bafafee12a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5a309793-5183-450f-a734-69b554d55a19" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_680cae35-c629-4291-b79c-9bafafee12a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_385bf894-7db7-4bb6-8f05-777bdf99b9cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_680cae35-c629-4291-b79c-9bafafee12a3" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_385bf894-7db7-4bb6-8f05-777bdf99b9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_c46897c6-21b2-46fb-a386-e034bf6b9113" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_385bf894-7db7-4bb6-8f05-777bdf99b9cb" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_c46897c6-21b2-46fb-a386-e034bf6b9113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1d42b0b1-7528-48c6-b595-1b6c226f189b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_c46897c6-21b2-46fb-a386-e034bf6b9113" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1d42b0b1-7528-48c6-b595-1b6c226f189b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_70ff0984-a389-4db7-a660-3e4a33120b68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1d42b0b1-7528-48c6-b595-1b6c226f189b" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_70ff0984-a389-4db7-a660-3e4a33120b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_34316835-9d21-48ba-8061-bbae7be18aba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1d42b0b1-7528-48c6-b595-1b6c226f189b" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_34316835-9d21-48ba-8061-bbae7be18aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136d38c9-29c0-4f35-b0b5-5dd888ad82c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_680cae35-c629-4291-b79c-9bafafee12a3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136d38c9-29c0-4f35-b0b5-5dd888ad82c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1798ed6d-796a-4feb-a68e-2ac2c0d74c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_136d38c9-29c0-4f35-b0b5-5dd888ad82c5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1798ed6d-796a-4feb-a68e-2ac2c0d74c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_336ced11-5edf-46fc-90f6-05817c1cf768" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1798ed6d-796a-4feb-a68e-2ac2c0d74c86" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_336ced11-5edf-46fc-90f6-05817c1cf768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72c73953-dc30-455f-b929-4f6327d3d389" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_680cae35-c629-4291-b79c-9bafafee12a3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72c73953-dc30-455f-b929-4f6327d3d389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad09f32d-0a15-4b3c-a515-c1f2ddc80b6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_72c73953-dc30-455f-b929-4f6327d3d389" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad09f32d-0a15-4b3c-a515-c1f2ddc80b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3db24d08-7bf3-49b5-97dd-59fe47a6d53a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad09f32d-0a15-4b3c-a515-c1f2ddc80b6a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3db24d08-7bf3-49b5-97dd-59fe47a6d53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_49677ab7-55c7-44a4-a52e-c1fd777c684d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad09f32d-0a15-4b3c-a515-c1f2ddc80b6a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_49677ab7-55c7-44a4-a52e-c1fd777c684d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3b7d53a2-81a9-4e04-8dd8-e9ca7139e060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ad09f32d-0a15-4b3c-a515-c1f2ddc80b6a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3b7d53a2-81a9-4e04-8dd8-e9ca7139e060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30e5443c-092a-4d09-98c8-f3a26bb3d539" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_680cae35-c629-4291-b79c-9bafafee12a3" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30e5443c-092a-4d09-98c8-f3a26bb3d539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_38c7e6d2-6c80-4bad-ae52-dc6e0b4bec4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30e5443c-092a-4d09-98c8-f3a26bb3d539" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_38c7e6d2-6c80-4bad-ae52-dc6e0b4bec4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_bb7e33f6-dffd-49d8-9d6c-cd913f8dd738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_38c7e6d2-6c80-4bad-ae52-dc6e0b4bec4d" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_bb7e33f6-dffd-49d8-9d6c-cd913f8dd738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_fa264ace-3130-430d-8871-83a1c7277bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_38c7e6d2-6c80-4bad-ae52-dc6e0b4bec4d" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_fa264ace-3130-430d-8871-83a1c7277bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_f956b775-8c61-4c14-bcfb-7f14ab03430f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30e5443c-092a-4d09-98c8-f3a26bb3d539" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_f956b775-8c61-4c14-bcfb-7f14ab03430f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_c56a70aa-5ca5-4cc3-8e78-8cf807912353" xlink:href="cvs-20201231.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_f956b775-8c61-4c14-bcfb-7f14ab03430f" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_c56a70aa-5ca5-4cc3-8e78-8cf807912353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_509e6a47-db58-45f0-bf98-671c058c2d20" xlink:href="cvs-20201231.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_f956b775-8c61-4c14-bcfb-7f14ab03430f" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_509e6a47-db58-45f0-bf98-671c058c2d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_7573135f-6f63-44f3-a47e-4c40e45d403f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_f956b775-8c61-4c14-bcfb-7f14ab03430f" xlink:to="loc_us-gaap_DebtInstrumentFairValue_7573135f-6f63-44f3-a47e-4c40e45d403f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_92f30e12-5404-4d1e-8156-e419db0e327e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_92f30e12-5404-4d1e-8156-e419db0e327e" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e0d811a5-1f75-4d8b-8815-1982700c8861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e0d811a5-1f75-4d8b-8815-1982700c8861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_209d2fa3-d6ab-4aa2-b2af-69e4dd1f0806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_e0d811a5-1f75-4d8b-8815-1982700c8861" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_209d2fa3-d6ab-4aa2-b2af-69e4dd1f0806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_62d54a7b-bb63-4c79-92ec-3a1d2d8a876e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_209d2fa3-d6ab-4aa2-b2af-69e4dd1f0806" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_62d54a7b-bb63-4c79-92ec-3a1d2d8a876e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7b55cf5a-f1c0-4386-8849-9a5cdee16585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7b55cf5a-f1c0-4386-8849-9a5cdee16585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bcb5873a-2ebe-40e7-9108-e2394f4e511a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7b55cf5a-f1c0-4386-8849-9a5cdee16585" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bcb5873a-2ebe-40e7-9108-e2394f4e511a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ebab0975-9218-49bf-90f3-4f4942a02e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bcb5873a-2ebe-40e7-9108-e2394f4e511a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ebab0975-9218-49bf-90f3-4f4942a02e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d37adfd2-a854-4d30-94ab-04ef3ab3b5b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bcb5873a-2ebe-40e7-9108-e2394f4e511a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d37adfd2-a854-4d30-94ab-04ef3ab3b5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a5aa8431-99d7-463e-a88d-c94fb1a0e4c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bcb5873a-2ebe-40e7-9108-e2394f4e511a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a5aa8431-99d7-463e-a88d-c94fb1a0e4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_666a794e-97e2-4f29-a408-298412c32f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_666a794e-97e2-4f29-a408-298412c32f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_666a794e-97e2-4f29-a408-298412c32f31" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_e1fae1c7-d590-426d-99f1-de2af19ffa65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_e1fae1c7-d590-426d-99f1-de2af19ffa65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_f1fd4caa-80be-4e0a-825a-1327b7102f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:to="loc_us-gaap_DebtSecuritiesMember_f1fd4caa-80be-4e0a-825a-1327b7102f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_9a7fd509-772a-4311-b897-863f30246b0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:to="loc_us-gaap_EquitySecuritiesMember_9a7fd509-772a-4311-b897-863f30246b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_1b524ca6-2645-4b4f-b109-38127669d5aa" xlink:href="cvs-20201231.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_1b524ca6-2645-4b4f-b109-38127669d5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountFinancialAssetsMember_9087a8b3-4c08-4847-b437-384d5b3888da" xlink:href="cvs-20201231.xsd#cvs_SeparateAccountFinancialAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_700bee80-4073-44b2-829a-83082ad5d674" xlink:to="loc_cvs_SeparateAccountFinancialAssetsMember_9087a8b3-4c08-4847-b437-384d5b3888da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9d920820-cfa8-4a67-a6c8-c930721bf770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9d920820-cfa8-4a67-a6c8-c930721bf770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_18d2f513-76d1-45bd-8525-01d4a16bfd10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9d920820-cfa8-4a67-a6c8-c930721bf770" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_18d2f513-76d1-45bd-8525-01d4a16bfd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_75da932c-7249-471c-8396-4f5124b4b477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_18d2f513-76d1-45bd-8525-01d4a16bfd10" xlink:to="loc_us-gaap_AccountsReceivableMember_75da932c-7249-471c-8396-4f5124b4b477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9608b969-cb81-422b-b165-5d274bc83e05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_befccf34-8ef9-4f69-83b5-9f911570522b" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9608b969-cb81-422b-b165-5d274bc83e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_1fc56c78-7422-431d-a49b-3239ab9489c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9608b969-cb81-422b-b165-5d274bc83e05" xlink:to="loc_us-gaap_SeparateAccountAssets_1fc56c78-7422-431d-a49b-3239ab9489c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_227c1379-2252-47d1-b3c5-350da56d0f53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_9608b969-cb81-422b-b165-5d274bc83e05" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_227c1379-2252-47d1-b3c5-350da56d0f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueOffsettingFinancialLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#FairValueOffsettingFinancialLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueOffsettingFinancialLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAbstract_11a5b917-43fc-4026-84b5-37b0704c25e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_35704483-79be-4a36-b903-bd2fce0674fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAbstract_11a5b917-43fc-4026-84b5-37b0704c25e1" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_35704483-79be-4a36-b903-bd2fce0674fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset_0c62455f-4360-4ae0-98d2-2018d4b63cc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAbstract_11a5b917-43fc-4026-84b5-37b0704c25e1" xlink:to="loc_us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset_0c62455f-4360-4ae0-98d2-2018d4b63cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c6a4340-07a9-4c40-aa68-73d52aa2d5a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4723a329-ef17-4581-a422-2709e75d9162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c6a4340-07a9-4c40-aa68-73d52aa2d5a1" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4723a329-ef17-4581-a422-2709e75d9162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangiblesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9aefe152-9628-4c4c-92e6-f50090c5d2f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_8726c916-3679-46cc-a43e-b660a6f42c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9aefe152-9628-4c4c-92e6-f50090c5d2f1" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_8726c916-3679-46cc-a43e-b660a6f42c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock_3f68efe6-c021-4891-99c4-8218f52ebc26" xlink:href="cvs-20201231.xsd#cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9aefe152-9628-4c4c-92e6-f50090c5d2f1" xlink:to="loc_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock_3f68efe6-c021-4891-99c4-8218f52ebc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_1c18ae4f-d69c-4ca6-abd5-0bbf9b67addc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9aefe152-9628-4c4c-92e6-f50090c5d2f1" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_1c18ae4f-d69c-4ca6-abd5-0bbf9b67addc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangiblesGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0a1d1e58-4664-428e-ae59-bf809bfd492d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_de052ff9-1cad-4db2-a5b8-1a8e5bdabb9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0a1d1e58-4664-428e-ae59-bf809bfd492d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_de052ff9-1cad-4db2-a5b8-1a8e5bdabb9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_19a3d7c7-e02c-449a-893e-c3ecee098f88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_de052ff9-1cad-4db2-a5b8-1a8e5bdabb9d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_19a3d7c7-e02c-449a-893e-c3ecee098f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a6fae981-2b07-41f6-aabb-54c9ee9f3b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_19a3d7c7-e02c-449a-893e-c3ecee098f88" xlink:to="loc_us-gaap_SegmentDomain_a6fae981-2b07-41f6-aabb-54c9ee9f3b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_2a9f8379-7fc5-41de-9bb7-4c411eb75597" xlink:href="cvs-20201231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a6fae981-2b07-41f6-aabb-54c9ee9f3b84" xlink:to="loc_cvs_PharmacyServicesSegmentMember_2a9f8379-7fc5-41de-9bb7-4c411eb75597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_07dead9d-1870-4111-b11f-6e6f8987c037" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a6fae981-2b07-41f6-aabb-54c9ee9f3b84" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_07dead9d-1870-4111-b11f-6e6f8987c037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_b5892489-a3ad-4083-b6b0-7cb2835e8f03" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a6fae981-2b07-41f6-aabb-54c9ee9f3b84" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_b5892489-a3ad-4083-b6b0-7cb2835e8f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_28442db1-2dd0-4ba0-97d1-c6fd02c229cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_de052ff9-1cad-4db2-a5b8-1a8e5bdabb9d" xlink:to="loc_us-gaap_GoodwillLineItems_28442db1-2dd0-4ba0-97d1-c6fd02c229cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_28442db1-2dd0-4ba0-97d1-c6fd02c229cb" xlink:to="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8f849676-4268-4fad-8846-a32ccc4155a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_Goodwill_8f849676-4268-4fad-8846-a32ccc4155a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_c12136b0-09bf-450f-97e5-fc4bf98a7a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_GoodwillTransfers_c12136b0-09bf-450f-97e5-fc4bf98a7a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_52f37609-734b-4cb5-b53d-5cf7dd60e61a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_52f37609-734b-4cb5-b53d-5cf7dd60e61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_4baa93d2-4749-4e87-9311-45f464f9b98b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_4baa93d2-4749-4e87-9311-45f464f9b98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_5e96a393-ebd9-4c51-91df-1142675ffe4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_5e96a393-ebd9-4c51-91df-1142675ffe4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_a82cefb8-aca0-45d4-ba57-f5460338a141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_a82cefb8-aca0-45d4-ba57-f5460338a141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9090be42-424c-4046-b684-5d476eafe4c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_391c4316-360b-4aca-8053-9931d92ed985" xlink:to="loc_us-gaap_Goodwill_9090be42-424c-4046-b684-5d476eafe4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangiblesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fbd78eea-5e28-480c-a045-42eb280d5625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fbd78eea-5e28-480c-a045-42eb280d5625" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_17d2ed19-790a-43f6-8b2d-387067b947d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_17d2ed19-790a-43f6-8b2d-387067b947d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c5ff1cb5-bf32-43e3-b72d-2000abec01d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_17d2ed19-790a-43f6-8b2d-387067b947d5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c5ff1cb5-bf32-43e3-b72d-2000abec01d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_b89955c5-fa7f-4f46-895e-232b20d4b7f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c5ff1cb5-bf32-43e3-b72d-2000abec01d6" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_b89955c5-fa7f-4f46-895e-232b20d4b7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9b360bcf-ac69-42b4-921d-0b6cf5bc2673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9b360bcf-ac69-42b4-921d-0b6cf5bc2673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_03d62520-3d35-41ac-a644-e8ee4d74c51d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9b360bcf-ac69-42b4-921d-0b6cf5bc2673" xlink:to="loc_us-gaap_SegmentDomain_03d62520-3d35-41ac-a644-e8ee4d74c51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_e816c7c2-6f4f-4342-900e-180da322bfc5" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_03d62520-3d35-41ac-a644-e8ee4d74c51d" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_e816c7c2-6f4f-4342-900e-180da322bfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_b228d35a-ff7a-4d10-b31f-67762ab4772a" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_03d62520-3d35-41ac-a644-e8ee4d74c51d" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_b228d35a-ff7a-4d10-b31f-67762ab4772a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_e0099eea-46b7-440f-af50-abe0cf4625bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:to="loc_us-gaap_ReportingUnitAxis_e0099eea-46b7-440f-af50-abe0cf4625bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_63eb3ccc-bfc6-4146-b034-6be228b4b3a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_e0099eea-46b7-440f-af50-abe0cf4625bc" xlink:to="loc_us-gaap_ReportingUnitDomain_63eb3ccc-bfc6-4146-b034-6be228b4b3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember_41a8b7fe-7dd2-46eb-9eaf-39641c629aab" xlink:href="cvs-20201231.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_63eb3ccc-bfc6-4146-b034-6be228b4b3a2" xlink:to="loc_cvs_LongTermCareReportingUnitMember_41a8b7fe-7dd2-46eb-9eaf-39641c629aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d6128305-86d8-4e37-b705-7c10882ed1da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d6128305-86d8-4e37-b705-7c10882ed1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_977a3610-2dc0-4032-8ac7-f54918cca5c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d6128305-86d8-4e37-b705-7c10882ed1da" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_977a3610-2dc0-4032-8ac7-f54918cca5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_5abc32de-ce5d-4ea6-bfcc-757bec9804e4" xlink:href="cvs-20201231.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_977a3610-2dc0-4032-8ac7-f54918cca5c2" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_5abc32de-ce5d-4ea6-bfcc-757bec9804e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_3d585135-37c6-46e8-986d-c556492e02f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5deb99cc-befa-4e8d-a77b-fdbdf8e71a28" xlink:to="loc_us-gaap_GoodwillLineItems_3d585135-37c6-46e8-986d-c556492e02f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_18db4998-de81-448b-883a-d59707d04d24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d585135-37c6-46e8-986d-c556492e02f0" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_18db4998-de81-448b-883a-d59707d04d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8a9ee82d-4244-4f0b-9094-8219cefeb61d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d585135-37c6-46e8-986d-c556492e02f0" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8a9ee82d-4244-4f0b-9094-8219cefeb61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_98a3c63e-fafb-4aa8-b4f3-ecccdef361d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3d585135-37c6-46e8-986d-c556492e02f0" xlink:to="loc_us-gaap_Goodwill_98a3c63e-fafb-4aa8-b4f3-ecccdef361d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherIntangiblesIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4e3d6f6-df5d-4293-a8c6-9f46fa83f8b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsTable_ceaebe20-c59a-48af-9485-6ba095e59f5f" xlink:href="cvs-20201231.xsd#cvs_OtherAcquiredIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4e3d6f6-df5d-4293-a8c6-9f46fa83f8b5" xlink:to="loc_cvs_OtherAcquiredIntangibleAssetsTable_ceaebe20-c59a-48af-9485-6ba095e59f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fed4b0c0-d57a-4064-935e-57837e56538c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_ceaebe20-c59a-48af-9485-6ba095e59f5f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fed4b0c0-d57a-4064-935e-57837e56538c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fed4b0c0-d57a-4064-935e-57837e56538c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_c2cc9af8-e1ae-4fff-8062-c76bd490160e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_c2cc9af8-e1ae-4fff-8062-c76bd490160e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_3978d752-f640-4a77-a406-8083592c9b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_3978d752-f640-4a77-a406-8083592c9b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProviderNetworksMember_de1e1516-6b79-4998-8d45-02961efb808f" xlink:href="cvs-20201231.xsd#cvs_ProviderNetworksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:to="loc_cvs_ProviderNetworksMember_de1e1516-6b79-4998-8d45-02961efb808f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ValueOfBusinessAcquiredMember_015a6b8d-778b-4cdd-b149-993ac173cf85" xlink:href="cvs-20201231.xsd#cvs_ValueOfBusinessAcquiredMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:to="loc_cvs_ValueOfBusinessAcquiredMember_015a6b8d-778b-4cdd-b149-993ac173cf85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AboveMarketLeasesMember_5e8abe5b-cea5-4add-ac84-bc7f2c698578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AboveMarketLeasesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_215db647-326a-4bd3-8883-a69edfdd56e7" xlink:to="loc_us-gaap_AboveMarketLeasesMember_5e8abe5b-cea5-4add-ac84-bc7f2c698578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:href="cvs-20201231.xsd#cvs_OtherAcquiredIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_ceaebe20-c59a-48af-9485-6ba095e59f5f" xlink:to="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ac9e2a18-f1bd-4538-9e71-427bd273e9b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ac9e2a18-f1bd-4538-9e71-427bd273e9b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_35ef123e-9dd9-4682-92ec-3ded26523466" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_35ef123e-9dd9-4682-92ec-3ded26523466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0d9eafab-9138-4f4e-87cb-1bce4354ea77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0d9eafab-9138-4f4e-87cb-1bce4354ea77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d58c4735-0a83-4e58-964a-7c3d3d7b295b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d58c4735-0a83-4e58-964a-7c3d3d7b295b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e993223a-ded6-4275-a51a-a4c68500d1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e993223a-ded6-4275-a51a-a4c68500d1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ba624a18-6c7d-48d5-975d-afaeef20b926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ba624a18-6c7d-48d5-975d-afaeef20b926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_ce2387cc-3943-4a97-a9d1-99cea6470587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_ce2387cc-3943-4a97-a9d1-99cea6470587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_abbd17af-37f8-465a-ab08-ec0db21aa4e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_d72c02e2-19a0-4436-ad05-a07adc737b7b" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_abbd17af-37f8-465a-ab08-ec0db21aa4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0a5e5b8-dfb2-4889-8b92-4e69810c569f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_f8592da1-4c75-4932-8c3a-914ea359224e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b0a5e5b8-dfb2-4889-8b92-4e69810c569f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_f8592da1-4c75-4932-8c3a-914ea359224e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_79960467-1ca2-4586-bea3-f7ddc34c3785" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_f8592da1-4c75-4932-8c3a-914ea359224e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_79960467-1ca2-4586-bea3-f7ddc34c3785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a6ca57e8-1abf-42c7-9908-9f1085f47a4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_f8592da1-4c75-4932-8c3a-914ea359224e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_a6ca57e8-1abf-42c7-9908-9f1085f47a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a2735bb5-30b9-40ac-82c3-7982a8a873c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_f8592da1-4c75-4932-8c3a-914ea359224e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a2735bb5-30b9-40ac-82c3-7982a8a873c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0ec90583-b1e7-459c-82e5-8792d6241904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_f8592da1-4c75-4932-8c3a-914ea359224e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0ec90583-b1e7-459c-82e5-8792d6241904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_fad89f32-4aa4-42a7-aa4b-e59a9db077c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_f8592da1-4c75-4932-8c3a-914ea359224e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_fad89f32-4aa4-42a7-aa4b-e59a9db077c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Leases" xlink:type="simple" xlink:href="cvs-20201231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7cc83b00-0fbf-40e8-8b04-564703eed910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_8d846eef-97e8-4252-8d19-e6f4556b210d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7cc83b00-0fbf-40e8-8b04-564703eed910" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_8d846eef-97e8-4252-8d19-e6f4556b210d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_eb8244a5-b645-414b-8df6-73c6b7cf8688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7cc83b00-0fbf-40e8-8b04-564703eed910" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_eb8244a5-b645-414b-8df6-73c6b7cf8688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_929e38e2-ba4c-44ab-bc5a-b5ddf1997c01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_787a5da7-b029-4a97-a17f-41d1088e089d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_929e38e2-ba4c-44ab-bc5a-b5ddf1997c01" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_787a5da7-b029-4a97-a17f-41d1088e089d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLeaseTableTextBlock_8daf3c3c-4e2f-41c0-ba53-5338421342a2" xlink:href="cvs-20201231.xsd#cvs_LesseeLeaseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_929e38e2-ba4c-44ab-bc5a-b5ddf1997c01" xlink:to="loc_cvs_LesseeLeaseTableTextBlock_8daf3c3c-4e2f-41c0-ba53-5338421342a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1dc3417d-9179-4f61-b301-2d396dab127a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_929e38e2-ba4c-44ab-bc5a-b5ddf1997c01" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1dc3417d-9179-4f61-b301-2d396dab127a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_d6ca77cd-feac-4877-a400-502938363950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_929e38e2-ba4c-44ab-bc5a-b5ddf1997c01" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_d6ca77cd-feac-4877-a400-502938363950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_0d9ecd87-2d13-46ef-a26c-6663fd73d71f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_929e38e2-ba4c-44ab-bc5a-b5ddf1997c01" xlink:to="loc_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_0d9ecd87-2d13-46ef-a26c-6663fd73d71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5f5d6b7a-1b5c-49fa-9d5e-a6bc772a7a11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_efce7c8a-a816-4d21-a9a2-e52bc014d467" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5f5d6b7a-1b5c-49fa-9d5e-a6bc772a7a11" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_efce7c8a-a816-4d21-a9a2-e52bc014d467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_14247930-b78c-4982-b473-70a002324913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_efce7c8a-a816-4d21-a9a2-e52bc014d467" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_14247930-b78c-4982-b473-70a002324913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84da3553-8110-469f-8f6f-816ca1e7623d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_14247930-b78c-4982-b473-70a002324913" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84da3553-8110-469f-8f6f-816ca1e7623d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_511b37f2-ca5b-40b2-9476-147360751628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84da3553-8110-469f-8f6f-816ca1e7623d" xlink:to="loc_us-gaap_BuildingMember_511b37f2-ca5b-40b2-9476-147360751628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_2ed3b357-3b49-4980-a586-b67eb60a0cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_84da3553-8110-469f-8f6f-816ca1e7623d" xlink:to="loc_us-gaap_EquipmentMember_2ed3b357-3b49-4980-a586-b67eb60a0cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e184493e-a7ab-4709-9ac6-de9c4866f81a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_efce7c8a-a816-4d21-a9a2-e52bc014d467" xlink:to="loc_srt_RangeAxis_e184493e-a7ab-4709-9ac6-de9c4866f81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_984388f4-ff23-46d3-a262-c05a064a3a7d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e184493e-a7ab-4709-9ac6-de9c4866f81a" xlink:to="loc_srt_RangeMember_984388f4-ff23-46d3-a262-c05a064a3a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a108188d-c1d1-40b5-ac1a-2a47c254ab16" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_984388f4-ff23-46d3-a262-c05a064a3a7d" xlink:to="loc_srt_MinimumMember_a108188d-c1d1-40b5-ac1a-2a47c254ab16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_38341bc3-07c1-4eda-88a8-dc6c94b434e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_984388f4-ff23-46d3-a262-c05a064a3a7d" xlink:to="loc_srt_MaximumMember_38341bc3-07c1-4eda-88a8-dc6c94b434e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a36db6c7-ff4d-4a92-b3b4-537a098af268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_efce7c8a-a816-4d21-a9a2-e52bc014d467" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a36db6c7-ff4d-4a92-b3b4-537a098af268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3549b935-f602-461d-9990-b33261ca32c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a36db6c7-ff4d-4a92-b3b4-537a098af268" xlink:to="loc_us-gaap_SegmentDomain_3549b935-f602-461d-9990-b33261ca32c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_01ce1a4b-f681-4e3e-a56a-4dcb08be804c" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3549b935-f602-461d-9990-b33261ca32c1" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_01ce1a4b-f681-4e3e-a56a-4dcb08be804c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_efce7c8a-a816-4d21-a9a2-e52bc014d467" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeOperatingAndFinanceLeasesTermOfContract_fbf5cbcf-4b0a-4aec-bd92-d12393181909" xlink:href="cvs-20201231.xsd#cvs_LesseeOperatingAndFinanceLeasesTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:to="loc_cvs_LesseeOperatingAndFinanceLeasesTermOfContract_fbf5cbcf-4b0a-4aec-bd92-d12393181909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_9f5cb9cb-6a24-4ee6-9d87-c39cc59f5b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:to="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_9f5cb9cb-6a24-4ee6-9d87-c39cc59f5b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_ecbd578d-4f60-47f9-b633-6472caedbd62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_ecbd578d-4f60-47f9-b633-6472caedbd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfUnderPerformingStoresPlannedClosure_3633b3e3-67d8-42d4-b20f-77826cc39273" xlink:href="cvs-20201231.xsd#cvs_NumberOfUnderPerformingStoresPlannedClosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:to="loc_cvs_NumberOfUnderPerformingStoresPlannedClosure_3633b3e3-67d8-42d4-b20f-77826cc39273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreRationalizationCharges_55c184bf-6711-4b0c-8a92-17b8b9878f18" xlink:href="cvs-20201231.xsd#cvs_StoreRationalizationCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_85926f6e-4765-4d0f-9b12-3872eb5ab3ff" xlink:to="loc_cvs_StoreRationalizationCharges_55c184bf-6711-4b0c-8a92-17b8b9878f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesSummaryoftheComponentsofNetLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3ce3e3c3-6fff-44d2-9011-eb14747ae2e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_2db4dd16-8e86-4ba3-99a4-95d39427900f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3ce3e3c3-6fff-44d2-9011-eb14747ae2e1" xlink:to="loc_us-gaap_OperatingLeaseCost_2db4dd16-8e86-4ba3-99a4-95d39427900f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_6ca5844f-93f5-4ea2-83f2-1e4cfa4d23de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3ce3e3c3-6fff-44d2-9011-eb14747ae2e1" xlink:to="loc_us-gaap_LeaseCostAbstract_6ca5844f-93f5-4ea2-83f2-1e4cfa4d23de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c70c7a91-772d-48f8-a894-4703708c3be9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_6ca5844f-93f5-4ea2-83f2-1e4cfa4d23de" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c70c7a91-772d-48f8-a894-4703708c3be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_9212c039-63df-4d0f-af3c-3a75285484a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_6ca5844f-93f5-4ea2-83f2-1e4cfa4d23de" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_9212c039-63df-4d0f-af3c-3a75285484a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseCost_1566dae4-e091-44ef-8d50-56241b956ec4" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_6ca5844f-93f5-4ea2-83f2-1e4cfa4d23de" xlink:to="loc_cvs_FinanceLeaseCost_1566dae4-e091-44ef-8d50-56241b956ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_b9e67783-736d-47c9-8928-6d663e2430bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_6ca5844f-93f5-4ea2-83f2-1e4cfa4d23de" xlink:to="loc_us-gaap_ShortTermLeaseCost_b9e67783-736d-47c9-8928-6d663e2430bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_12e13e9a-1711-4fd9-8410-25e7e91c0ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_6ca5844f-93f5-4ea2-83f2-1e4cfa4d23de" xlink:to="loc_us-gaap_VariableLeaseCost_12e13e9a-1711-4fd9-8410-25e7e91c0ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_1413152a-658b-4b0d-9844-1b842ab4dc36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_6ca5844f-93f5-4ea2-83f2-1e4cfa4d23de" xlink:to="loc_us-gaap_SubleaseIncome_1413152a-658b-4b0d-9844-1b842ab4dc36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_6d84fdbb-cb15-4b70-b985-e1276fbc7f67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_6ca5844f-93f5-4ea2-83f2-1e4cfa4d23de" xlink:to="loc_us-gaap_LeaseCost_6d84fdbb-cb15-4b70-b985-e1276fbc7f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_27967333-bc09-40b9-b596-6bc1866e0e07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CashFlowLesseeAbstract_a14099bc-893c-402e-88a2-a30f13d20d11" xlink:href="cvs-20201231.xsd#cvs_CashFlowLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_27967333-bc09-40b9-b596-6bc1866e0e07" xlink:to="loc_cvs_CashFlowLesseeAbstract_a14099bc-893c-402e-88a2-a30f13d20d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_83af86bd-0c99-4779-b36f-1cfd6e4431c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_CashFlowLesseeAbstract_a14099bc-893c-402e-88a2-a30f13d20d11" xlink:to="loc_us-gaap_OperatingLeasePayments_83af86bd-0c99-4779-b36f-1cfd6e4431c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_764d5216-7bcc-4c60-bdee-e5ff5e1e9ae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_CashFlowLesseeAbstract_a14099bc-893c-402e-88a2-a30f13d20d11" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_764d5216-7bcc-4c60-bdee-e5ff5e1e9ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_29282410-ed55-4120-ad56-0d6093efb818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_CashFlowLesseeAbstract_a14099bc-893c-402e-88a2-a30f13d20d11" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_29282410-ed55-4120-ad56-0d6093efb818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_c8174261-9fd3-4021-8ea0-de12273a9ed0" xlink:href="cvs-20201231.xsd#cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_CashFlowLesseeAbstract_a14099bc-893c-402e-88a2-a30f13d20d11" xlink:to="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_c8174261-9fd3-4021-8ea0-de12273a9ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3c4185c4-95a9-41c2-bfaa-a5aea27c9427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_c8174261-9fd3-4021-8ea0-de12273a9ed0" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3c4185c4-95a9-41c2-bfaa-a5aea27c9427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6114b880-c3a6-47d0-801e-bd8058dac051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_c8174261-9fd3-4021-8ea0-de12273a9ed0" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6114b880-c3a6-47d0-801e-bd8058dac051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9922159f-eaba-4f87-8b7c-c60229c5b251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_64c098b8-8693-429a-91ce-cfe595d9a46b" xlink:href="cvs-20201231.xsd#cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9922159f-eaba-4f87-8b7c-c60229c5b251" xlink:to="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_64c098b8-8693-429a-91ce-cfe595d9a46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_124eebfd-5426-4620-b467-e537c4c927d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_64c098b8-8693-429a-91ce-cfe595d9a46b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_124eebfd-5426-4620-b467-e537c4c927d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8a01cda4-616d-4b62-8049-73a89a95e934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_64c098b8-8693-429a-91ce-cfe595d9a46b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8a01cda4-616d-4b62-8049-73a89a95e934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f999c2b4-c6ef-47e3-95a6-606d4fe80077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_64c098b8-8693-429a-91ce-cfe595d9a46b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f999c2b4-c6ef-47e3-95a6-606d4fe80077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_94bb7e8d-488f-4015-9ebd-1eeb55b59f79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_64c098b8-8693-429a-91ce-cfe595d9a46b" xlink:to="loc_us-gaap_OperatingLeaseLiability_94bb7e8d-488f-4015-9ebd-1eeb55b59f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_76cbd3ff-4a85-4901-9794-0c6f8b596186" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9922159f-eaba-4f87-8b7c-c60229c5b251" xlink:to="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_76cbd3ff-4a85-4901-9794-0c6f8b596186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetGross_9057866a-6009-47b5-aa42-e0ffad78f945" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseRightOfUseAssetGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_76cbd3ff-4a85-4901-9794-0c6f8b596186" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetGross_9057866a-6009-47b5-aa42-e0ffad78f945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_9b296989-7b9a-4f8c-872d-580d80e300d7" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_76cbd3ff-4a85-4901-9794-0c6f8b596186" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_9b296989-7b9a-4f8c-872d-580d80e300d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetNet_f7e74e9c-b55f-408f-a654-8f29a47b44b1" xlink:href="cvs-20201231.xsd#cvs_FinanceLeaseRightOfUseAssetNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_76cbd3ff-4a85-4901-9794-0c6f8b596186" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetNet_f7e74e9c-b55f-408f-a654-8f29a47b44b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_7928de06-f218-4e6f-91fb-9848fa235cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_76cbd3ff-4a85-4901-9794-0c6f8b596186" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_7928de06-f218-4e6f-91fb-9848fa235cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_330e17f4-32e3-4d71-ad87-f674493dd26c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_76cbd3ff-4a85-4901-9794-0c6f8b596186" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_330e17f4-32e3-4d71-ad87-f674493dd26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7bbc45c4-4e64-4df8-b18a-d0eaab25405c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_76cbd3ff-4a85-4901-9794-0c6f8b596186" xlink:to="loc_us-gaap_FinanceLeaseLiability_7bbc45c4-4e64-4df8-b18a-d0eaab25405c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_00ec5f07-5e7f-4974-a78f-c908b0f760f3" xlink:href="cvs-20201231.xsd#cvs_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9922159f-eaba-4f87-8b7c-c60229c5b251" xlink:to="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_00ec5f07-5e7f-4974-a78f-c908b0f760f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8a3f665f-fc75-4fe4-b0b7-742078a5fefe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_00ec5f07-5e7f-4974-a78f-c908b0f760f3" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8a3f665f-fc75-4fe4-b0b7-742078a5fefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_0fd9a2b7-0c6b-4285-ae83-dd4f3e04beaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_00ec5f07-5e7f-4974-a78f-c908b0f760f3" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_0fd9a2b7-0c6b-4285-ae83-dd4f3e04beaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_ba6cbf9f-ae19-4eda-b8f3-1b2981ebe258" xlink:href="cvs-20201231.xsd#cvs_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9922159f-eaba-4f87-8b7c-c60229c5b251" xlink:to="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_ba6cbf9f-ae19-4eda-b8f3-1b2981ebe258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_02e3699e-cf92-4875-a89b-07292a50e411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_ba6cbf9f-ae19-4eda-b8f3-1b2981ebe258" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_02e3699e-cf92-4875-a89b-07292a50e411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_2fb1db38-2275-419f-bd33-4c578a3ac9be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_ba6cbf9f-ae19-4eda-b8f3-1b2981ebe258" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_2fb1db38-2275-419f-bd33-4c578a3ac9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_38a927bd-9bb6-4955-ac89-a47b03988e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6bb2ff3c-8f05-4b20-a931-bb7607af2657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_38a927bd-9bb6-4955-ac89-a47b03988e5b" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6bb2ff3c-8f05-4b20-a931-bb7607af2657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_9fb50fee-01a7-4243-a000-f2d6d25c0972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6bb2ff3c-8f05-4b20-a931-bb7607af2657" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_9fb50fee-01a7-4243-a000-f2d6d25c0972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_65e24bf9-7b45-4b9b-a15c-c2e47997fb58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6bb2ff3c-8f05-4b20-a931-bb7607af2657" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_65e24bf9-7b45-4b9b-a15c-c2e47997fb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_82153225-b2c9-4c2a-b08e-a482ad3b5cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6bb2ff3c-8f05-4b20-a931-bb7607af2657" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_82153225-b2c9-4c2a-b08e-a482ad3b5cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_486bc1b8-c07b-4657-b208-464eaec09c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6bb2ff3c-8f05-4b20-a931-bb7607af2657" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_486bc1b8-c07b-4657-b208-464eaec09c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f8199f5d-8d5a-4f28-ba22-1d80cb286ceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6bb2ff3c-8f05-4b20-a931-bb7607af2657" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f8199f5d-8d5a-4f28-ba22-1d80cb286ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_68012d87-875e-49e8-bb12-1b84607be31f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6bb2ff3c-8f05-4b20-a931-bb7607af2657" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_68012d87-875e-49e8-bb12-1b84607be31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_9d3c773d-cd54-4b2c-b651-099cb3fed865" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6bb2ff3c-8f05-4b20-a931-bb7607af2657" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_9d3c773d-cd54-4b2c-b651-099cb3fed865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_51142f47-724d-4a35-b029-fd19ff21686c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6bb2ff3c-8f05-4b20-a931-bb7607af2657" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_51142f47-724d-4a35-b029-fd19ff21686c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_6e41bf2a-f62d-42a0-9428-50a2ac2511d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_6bb2ff3c-8f05-4b20-a931-bb7607af2657" xlink:to="loc_us-gaap_FinanceLeaseLiability_6e41bf2a-f62d-42a0-9428-50a2ac2511d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_193f1467-b909-454a-87cb-e80ca7f71a88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_38a927bd-9bb6-4955-ac89-a47b03988e5b" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_193f1467-b909-454a-87cb-e80ca7f71a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2d689791-06ce-48da-8674-9a15be21b426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_193f1467-b909-454a-87cb-e80ca7f71a88" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2d689791-06ce-48da-8674-9a15be21b426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_487a5dbc-d4f4-4834-ad84-70370dd7bbc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_193f1467-b909-454a-87cb-e80ca7f71a88" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_487a5dbc-d4f4-4834-ad84-70370dd7bbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c3289aae-618b-4fce-a1b0-eb1bdc57fe9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_193f1467-b909-454a-87cb-e80ca7f71a88" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c3289aae-618b-4fce-a1b0-eb1bdc57fe9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_be087a3c-480c-4403-b4a4-aa9046c76a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_193f1467-b909-454a-87cb-e80ca7f71a88" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_be087a3c-480c-4403-b4a4-aa9046c76a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_a902a7a8-fad9-4549-9675-f2bd04abf919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_193f1467-b909-454a-87cb-e80ca7f71a88" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_a902a7a8-fad9-4549-9675-f2bd04abf919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_db27b27b-1ab1-4232-859d-98342d6d464a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_193f1467-b909-454a-87cb-e80ca7f71a88" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_db27b27b-1ab1-4232-859d-98342d6d464a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ac8418f9-fa37-4c6a-9991-8182d59a5af3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_193f1467-b909-454a-87cb-e80ca7f71a88" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ac8418f9-fa37-4c6a-9991-8182d59a5af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0479fdfb-e97b-44c6-b577-8b657a920f51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_193f1467-b909-454a-87cb-e80ca7f71a88" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0479fdfb-e97b-44c6-b577-8b657a920f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_dee77627-4144-43c6-9437-25c4ce77252d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_193f1467-b909-454a-87cb-e80ca7f71a88" xlink:to="loc_us-gaap_OperatingLeaseLiability_dee77627-4144-43c6-9437-25c4ce77252d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_1b3c7bd9-28ac-4584-a309-3a3bdfa11e84" xlink:href="cvs-20201231.xsd#cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_38a927bd-9bb6-4955-ac89-a47b03988e5b" xlink:to="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_1b3c7bd9-28ac-4584-a309-3a3bdfa11e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsYearOne_4c161540-8cb1-46f8-a427-c88f94bdc10a" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsYearOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_1b3c7bd9-28ac-4584-a309-3a3bdfa11e84" xlink:to="loc_cvs_LesseeLiabilityPaymentsYearOne_4c161540-8cb1-46f8-a427-c88f94bdc10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_57eae7e2-20cb-4192-8fb5-7d1b4fa822b0" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_1b3c7bd9-28ac-4584-a309-3a3bdfa11e84" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_57eae7e2-20cb-4192-8fb5-7d1b4fa822b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearThree_4c2da4a6-5680-4987-83f9-e08ea407f13b" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_1b3c7bd9-28ac-4584-a309-3a3bdfa11e84" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearThree_4c2da4a6-5680-4987-83f9-e08ea407f13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFour_5709416c-f660-4868-8496-f6d689891624" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_1b3c7bd9-28ac-4584-a309-3a3bdfa11e84" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearFour_5709416c-f660-4868-8496-f6d689891624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFive_f5828380-bc0b-4f7f-adc5-75ea6173096a" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_1b3c7bd9-28ac-4584-a309-3a3bdfa11e84" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearFive_f5828380-bc0b-4f7f-adc5-75ea6173096a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_c6c5a62e-4ec8-4a9d-9333-99ba6bff4672" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_1b3c7bd9-28ac-4584-a309-3a3bdfa11e84" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_c6c5a62e-4ec8-4a9d-9333-99ba6bff4672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDue_d0bf6697-8e3a-4977-8220-79a88fdc3836" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_1b3c7bd9-28ac-4584-a309-3a3bdfa11e84" xlink:to="loc_cvs_LesseeLiabilityPaymentsDue_d0bf6697-8e3a-4977-8220-79a88fdc3836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_811fa040-ed6d-4880-bb61-281b57f5376c" xlink:href="cvs-20201231.xsd#cvs_LesseeLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_1b3c7bd9-28ac-4584-a309-3a3bdfa11e84" xlink:to="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_811fa040-ed6d-4880-bb61-281b57f5376c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeaseLiability_15b301bc-fb76-47c0-bb44-18074bfda01e" xlink:href="cvs-20201231.xsd#cvs_LeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_1b3c7bd9-28ac-4584-a309-3a3bdfa11e84" xlink:to="loc_cvs_LeaseLiability_15b301bc-fb76-47c0-bb44-18074bfda01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_a5c58692-6d6d-445b-a32d-0c5b4f547f4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_38a927bd-9bb6-4955-ac89-a47b03988e5b" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_a5c58692-6d6d-445b-a32d-0c5b4f547f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_fb64b494-1d69-4ea8-8654-9a675b90557d" xlink:href="cvs-20201231.xsd#cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_38a927bd-9bb6-4955-ac89-a47b03988e5b" xlink:to="loc_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_fb64b494-1d69-4ea8-8654-9a675b90557d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesRentalExpenseDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#LeasesRentalExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesRentalExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2c6af5d2-30ec-4cd8-9028-3bc90a8c9d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseMinimumRentals_125cf7d8-b333-4fdc-bf49-fdfab79e7ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseMinimumRentals"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2c6af5d2-30ec-4cd8-9028-3bc90a8c9d13" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseMinimumRentals_125cf7d8-b333-4fdc-bf49-fdfab79e7ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseContingentRentals_3dcfb758-d936-415d-8544-04245c86c1f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseContingentRentals"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2c6af5d2-30ec-4cd8-9028-3bc90a8c9d13" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseContingentRentals_3dcfb758-d936-415d-8544-04245c86c1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeasesRentExpenseGross_78757e0c-17ef-493d-8e6c-0d31a18da933" xlink:href="cvs-20201231.xsd#cvs_OperatingLeasesRentExpenseGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2c6af5d2-30ec-4cd8-9028-3bc90a8c9d13" xlink:to="loc_cvs_OperatingLeasesRentExpenseGross_78757e0c-17ef-493d-8e6c-0d31a18da933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_fff4a785-9a9d-4a3c-9738-65d5bb363b25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2c6af5d2-30ec-4cd8-9028-3bc90a8c9d13" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_fff4a785-9a9d-4a3c-9738-65d5bb363b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_271c1652-fddc-47be-9652-404c22c2eed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2c6af5d2-30ec-4cd8-9028-3bc90a8c9d13" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_271c1652-fddc-47be-9652-404c22c2eed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayable"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_b683a948-d8f3-4dc8-92c1-391bae8a8440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_b245c8ab-0950-4263-9c71-7ef4324f259a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_b683a948-d8f3-4dc8-92c1-391bae8a8440" xlink:to="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_b245c8ab-0950-4263-9c71-7ef4324f259a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_7eed4e74-0951-4077-85c7-00eaa27342ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_9814daa8-8332-455b-8ab7-022f7a7f8b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_7eed4e74-0951-4077-85c7-00eaa27342ff" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_9814daa8-8332-455b-8ab7-022f7a7f8b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_80139d94-345c-43b6-9182-88749c4fcbe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_7eed4e74-0951-4077-85c7-00eaa27342ff" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_80139d94-345c-43b6-9182-88749c4fcbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_39496bfb-092f-4b9d-836f-a8da744af48e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_7eed4e74-0951-4077-85c7-00eaa27342ff" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_39496bfb-092f-4b9d-836f-a8da744af48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_cac8c8d1-710b-4a56-8f3a-c51b429cd4b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_4cb7057f-7d26-493b-a8fa-841234138bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cac8c8d1-710b-4a56-8f3a-c51b429cd4b0" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_4cb7057f-7d26-493b-a8fa-841234138bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_555392ba-c7e1-46c3-948d-bf04f90fc73a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_4cb7057f-7d26-493b-a8fa-841234138bb1" xlink:to="loc_srt_ProductOrServiceAxis_555392ba-c7e1-46c3-948d-bf04f90fc73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fc4b8c43-742f-4bc6-92b0-da1aff65ed44" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_555392ba-c7e1-46c3-948d-bf04f90fc73a" xlink:to="loc_srt_ProductsAndServicesDomain_fc4b8c43-742f-4bc6-92b0-da1aff65ed44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_46fdc338-fdf0-4430-9405-9252ae61e1d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_fc4b8c43-742f-4bc6-92b0-da1aff65ed44" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_46fdc338-fdf0-4430-9405-9252ae61e1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f9d7d24b-8376-4128-a5e3-a2428adb50c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_4cb7057f-7d26-493b-a8fa-841234138bb1" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f9d7d24b-8376-4128-a5e3-a2428adb50c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f8694f38-d5e6-45ac-b87c-d4298dee60f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_f9d7d24b-8376-4128-a5e3-a2428adb50c2" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f8694f38-d5e6-45ac-b87c-d4298dee60f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_a047c783-47ec-4f32-87e3-4a5f459d6f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f8694f38-d5e6-45ac-b87c-d4298dee60f7" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_a047c783-47ec-4f32-87e3-4a5f459d6f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_6ff2d03f-a5cb-46e1-b339-aff6722395b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f8694f38-d5e6-45ac-b87c-d4298dee60f7" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_6ff2d03f-a5cb-46e1-b339-aff6722395b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_a699c941-69bc-41fa-bcf5-e2f52207609e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_4cb7057f-7d26-493b-a8fa-841234138bb1" xlink:to="loc_us-gaap_ClaimsDevelopmentLineItems_a699c941-69bc-41fa-bcf5-e2f52207609e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_137a7faf-96e6-4857-8d2b-007a736f84e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_a699c941-69bc-41fa-bcf5-e2f52207609e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_137a7faf-96e6-4857-8d2b-007a736f84e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_e3924f36-1f14-41f2-8e6c-b06244f3f4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_a699c941-69bc-41fa-bcf5-e2f52207609e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_e3924f36-1f14-41f2-8e6c-b06244f3f4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_eddb6f28-5938-4c85-bc6b-b5c728b26c7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_a699c941-69bc-41fa-bcf5-e2f52207609e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_eddb6f28-5938-4c85-bc6b-b5c728b26c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_172addf7-883b-4487-89ba-d2c84281aeff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_a699c941-69bc-41fa-bcf5-e2f52207609e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_172addf7-883b-4487-89ba-d2c84281aeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_85563c68-e2c3-4b6e-acf5-2e063242b4b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_183c449b-6507-470a-bac0-c5f68f671832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_85563c68-e2c3-4b6e-acf5-2e063242b4b8" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_183c449b-6507-470a-bac0-c5f68f671832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b067917c-3de5-4ed2-968e-8ef654b065b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_183c449b-6507-470a-bac0-c5f68f671832" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b067917c-3de5-4ed2-968e-8ef654b065b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bc1bd11c-6bfd-43a5-bc00-fe8ab9bea2d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b067917c-3de5-4ed2-968e-8ef654b065b6" xlink:to="loc_us-gaap_SegmentDomain_bc1bd11c-6bfd-43a5-bc00-fe8ab9bea2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_e1e74217-0fff-4947-8ccd-25834e051d23" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bc1bd11c-6bfd-43a5-bc00-fe8ab9bea2d3" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_e1e74217-0fff-4947-8ccd-25834e051d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4eba0457-6ab4-4cc0-97b5-d32432e5a2ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_183c449b-6507-470a-bac0-c5f68f671832" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4eba0457-6ab4-4cc0-97b5-d32432e5a2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_38709e37-efcf-4ccb-8d60-4addacb35b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4eba0457-6ab4-4cc0-97b5-d32432e5a2ff" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_38709e37-efcf-4ccb-8d60-4addacb35b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_cafe711b-2eb5-4dd0-8bdc-51b6ba7b0226" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4eba0457-6ab4-4cc0-97b5-d32432e5a2ff" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_cafe711b-2eb5-4dd0-8bdc-51b6ba7b0226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_9054ebdb-b2ea-4cc9-a004-91bf3c55ab1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_bb8fa63a-d9b0-4d85-b0f7-1d45e13820a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_9054ebdb-b2ea-4cc9-a004-91bf3c55ab1e" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_bb8fa63a-d9b0-4d85-b0f7-1d45e13820a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_83ca7bb7-ba59-4dcf-8855-7922e970a00c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_bb8fa63a-d9b0-4d85-b0f7-1d45e13820a6" xlink:to="loc_srt_ProductOrServiceAxis_83ca7bb7-ba59-4dcf-8855-7922e970a00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b7d6ff1c-7056-4f04-a86e-397c15f772ba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_83ca7bb7-ba59-4dcf-8855-7922e970a00c" xlink:to="loc_srt_ProductsAndServicesDomain_b7d6ff1c-7056-4f04-a86e-397c15f772ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_f6390a22-db05-43b6-aba4-e96bbe2e8092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b7d6ff1c-7056-4f04-a86e-397c15f772ba" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_f6390a22-db05-43b6-aba4-e96bbe2e8092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_bb8fa63a-d9b0-4d85-b0f7-1d45e13820a6" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_24d707df-7486-4d66-b140-dabc933944c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_24d707df-7486-4d66-b140-dabc933944c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1fe9ec03-5517-462a-a9b9-fde6e0a1e431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_1fe9ec03-5517-462a-a9b9-fde6e0a1e431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_7a13a3d5-83c7-475a-bdff-ea40c60d4d00" xlink:href="cvs-20201231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_7a13a3d5-83c7-475a-bdff-ea40c60d4d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_eb3ba479-cd78-4ce5-8380-24d270fc6c05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_eb3ba479-cd78-4ce5-8380-24d270fc6c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_433d552c-eaff-4c16-8a0a-e25584016962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_8345eb9d-b083-4bc3-8bc1-3ffffb4dc3f2" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_433d552c-eaff-4c16-8a0a-e25584016962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_f9b07ecd-f754-4cc4-8a93-fd70d67f287c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5f2e7a6f-9620-44b7-9a73-60e52b2e5dcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_f9b07ecd-f754-4cc4-8a93-fd70d67f287c" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5f2e7a6f-9620-44b7-9a73-60e52b2e5dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_81196050-52ce-4131-ac4c-a420f0a92359" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5f2e7a6f-9620-44b7-9a73-60e52b2e5dcc" xlink:to="loc_srt_ProductOrServiceAxis_81196050-52ce-4131-ac4c-a420f0a92359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_39549858-4462-4af5-a65c-d6e713caa929" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_81196050-52ce-4131-ac4c-a420f0a92359" xlink:to="loc_srt_ProductsAndServicesDomain_39549858-4462-4af5-a65c-d6e713caa929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_b2e0ffcf-305f-4248-aa7a-1e3f6eed6d7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_39549858-4462-4af5-a65c-d6e713caa929" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_b2e0ffcf-305f-4248-aa7a-1e3f6eed6d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_564a0371-7063-4e1e-a2e1-ffd5b847157e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5f2e7a6f-9620-44b7-9a73-60e52b2e5dcc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_564a0371-7063-4e1e-a2e1-ffd5b847157e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b0d36f1c-6fbf-4bff-8e16-1e52ef1c7dfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_564a0371-7063-4e1e-a2e1-ffd5b847157e" xlink:to="loc_us-gaap_SegmentDomain_b0d36f1c-6fbf-4bff-8e16-1e52ef1c7dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_0b88ef5b-fa2b-4f9d-9a24-49356e3c6f29" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b0d36f1c-6fbf-4bff-8e16-1e52ef1c7dfb" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_0b88ef5b-fa2b-4f9d-9a24-49356e3c6f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_7f132b23-518c-4f81-b33e-67f80d4d0f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b0d36f1c-6fbf-4bff-8e16-1e52ef1c7dfb" xlink:to="loc_us-gaap_CorporateAndOtherMember_7f132b23-518c-4f81-b33e-67f80d4d0f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_54d50c02-b895-4fec-8fdb-cd573acd235d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5f2e7a6f-9620-44b7-9a73-60e52b2e5dcc" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_54d50c02-b895-4fec-8fdb-cd573acd235d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_54d50c02-b895-4fec-8fdb-cd573acd235d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_32247a70-1e58-483f-9067-ffc2ce51e38d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_32247a70-1e58-483f-9067-ffc2ce51e38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ff5a3cb4-1fc4-4bfa-b409-dd2f98aa327a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ff5a3cb4-1fc4-4bfa-b409-dd2f98aa327a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_9d49a619-072a-4887-812c-478874cbf07f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_9d49a619-072a-4887-812c-478874cbf07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_fbfefdc3-b4e7-408d-80fd-4bef504c95e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_fbfefdc3-b4e7-408d-80fd-4bef504c95e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification_34f6874e-fbc9-4142-a2c5-56183844f952" xlink:href="cvs-20201231.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification_34f6874e-fbc9-4142-a2c5-56183844f952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_70d51287-70cd-4084-9ea1-c2abafb62fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_70d51287-70cd-4084-9ea1-c2abafb62fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_5b521707-9565-4c31-a51d-c1c6275594b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_70d51287-70cd-4084-9ea1-c2abafb62fc5" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_5b521707-9565-4c31-a51d-c1c6275594b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_90672ae8-ee3f-4015-ab0e-56e4518f8dcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_70d51287-70cd-4084-9ea1-c2abafb62fc5" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_90672ae8-ee3f-4015-ab0e-56e4518f8dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_4a0bc506-4a3f-47b6-86c6-0b0404403684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_70d51287-70cd-4084-9ea1-c2abafb62fc5" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_4a0bc506-4a3f-47b6-86c6-0b0404403684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_e294f43c-649e-49de-b174-7e43d14cc510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_e294f43c-649e-49de-b174-7e43d14cc510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_465d39c3-5023-4292-87a9-f850eafff3b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_e294f43c-649e-49de-b174-7e43d14cc510" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_465d39c3-5023-4292-87a9-f850eafff3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d726ad5b-481d-404d-a1b6-73e1a35109ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_e294f43c-649e-49de-b174-7e43d14cc510" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d726ad5b-481d-404d-a1b6-73e1a35109ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f0a334ee-1b96-4cbe-acc2-fa098bc62334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_e294f43c-649e-49de-b174-7e43d14cc510" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_f0a334ee-1b96-4cbe-acc2-fa098bc62334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_67c9987d-876a-41de-ac68-c7dc8ea4cf60" xlink:href="cvs-20201231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_67c9987d-876a-41de-ac68-c7dc8ea4cf60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_8a5a5c8c-72be-4c5e-aff1-cc917609c83c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_8a5a5c8c-72be-4c5e-aff1-cc917609c83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_a8933022-7931-479e-bf8a-0888d1a8da10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_a8933022-7931-479e-bf8a-0888d1a8da10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1de7a762-595a-4b7b-a3b4-add7c82d285a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_610c2330-71b2-4ea9-b9a7-2a36cf24f867" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1de7a762-595a-4b7b-a3b4-add7c82d285a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_a6e626d1-fed7-4226-9164-e7d4b4cd4eee" xlink:href="cvs-20201231.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_54d50c02-b895-4fec-8fdb-cd573acd235d" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_a6e626d1-fed7-4226-9164-e7d4b4cd4eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangements"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_49521fb1-15a6-4250-a63f-0df90d826a91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_ff6774cd-636e-4dc9-8f32-3d178b7f5cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_49521fb1-15a6-4250-a63f-0df90d826a91" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_ff6774cd-636e-4dc9-8f32-3d178b7f5cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7de0edb7-001a-4951-9344-2319cb8f1e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0fe26619-a344-4ecd-928e-ed20af659d67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7de0edb7-001a-4951-9344-2319cb8f1e10" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0fe26619-a344-4ecd-928e-ed20af659d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_906d0730-4c5e-4a01-a17f-194c2a26a580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7de0edb7-001a-4951-9344-2319cb8f1e10" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_906d0730-4c5e-4a01-a17f-194c2a26a580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e8d11574-c624-4c3c-a3fd-781606368e52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2d05f0aa-4623-49df-9470-fb381708964c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e8d11574-c624-4c3c-a3fd-781606368e52" xlink:to="loc_us-gaap_DebtInstrumentTable_2d05f0aa-4623-49df-9470-fb381708964c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7c8c7e5e-1f98-41a0-9deb-5e0dbdeb3c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2d05f0aa-4623-49df-9470-fb381708964c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7c8c7e5e-1f98-41a0-9deb-5e0dbdeb3c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e4fab533-09ee-4e84-ad80-84d3823fc7a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7c8c7e5e-1f98-41a0-9deb-5e0dbdeb3c8c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e4fab533-09ee-4e84-ad80-84d3823fc7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7b7fcd3a-42d3-494a-b4f7-ef56d34fa083" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e4fab533-09ee-4e84-ad80-84d3823fc7a5" xlink:to="loc_us-gaap_SeniorNotesMember_7b7fcd3a-42d3-494a-b4f7-ef56d34fa083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_01ab6bda-673f-41c4-9e8f-dd7f0e7d68e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e4fab533-09ee-4e84-ad80-84d3823fc7a5" xlink:to="loc_us-gaap_NotesPayableToBanksMember_01ab6bda-673f-41c4-9e8f-dd7f0e7d68e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_c36e1d06-9ea4-4a6a-943c-3f2649271175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e4fab533-09ee-4e84-ad80-84d3823fc7a5" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_c36e1d06-9ea4-4a6a-943c-3f2649271175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2ba503e4-2cb7-4b2c-b06e-348e510a58f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2d05f0aa-4623-49df-9470-fb381708964c" xlink:to="loc_us-gaap_DebtInstrumentAxis_2ba503e4-2cb7-4b2c-b06e-348e510a58f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2ba503e4-2cb7-4b2c-b06e-348e510a58f8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member_bc126b0f-39c5-4be5-86d8-1695e94f9d56" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.125DueMarch2020Member_bc126b0f-39c5-4be5-86d8-1695e94f9d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member_2369a957-6e99-484b-a6f6-297237fb1f6c" xlink:href="cvs-20201231.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_FloatingRateNotesDueMarch2020Member_2369a957-6e99-484b-a6f6-297237fb1f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJuly2020Member_cc9b6cb2-498f-460c-a575-64fc2c1632f7" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.8DueJuly2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.8DueJuly2020Member_cc9b6cb2-498f-460c-a575-64fc2c1632f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_0a4e48de-8310-48d6-8972-4ef3d09a3e9a" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_0a4e48de-8310-48d6-8972-4ef3d09a3e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2021Member_ced28175-2184-4c8c-85e7-a3d2e35e368b" xlink:href="cvs-20201231.xsd#cvs_FloatingRateNotesDueMarch2021Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_FloatingRateNotesDueMarch2021Member_ced28175-2184-4c8c-85e7-a3d2e35e368b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_0bbad6ac-0300-4fc8-bc1b-cc25eb2176bb" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_0bbad6ac-0300-4fc8-bc1b-cc25eb2176bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.125June2021Member_b4cf013b-07b9-4f59-83bb-6e031e2e8a3d" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.125June2021Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.125June2021Member_b4cf013b-07b9-4f59-83bb-6e031e2e8a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_cb7b4235-48de-400e-ab33-f66ef83f9538" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_cb7b4235-48de-400e-ab33-f66ef83f9538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_b95576c9-fd09-4a14-b108-98645aebaa60" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_b95576c9-fd09-4a14-b108-98645aebaa60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_b1557ab3-7d52-46d2-a531-6345c8d76a20" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_b1557ab3-7d52-46d2-a531-6345c8d76a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_3ddd5334-7ea9-44be-abee-20479d0fde0a" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_3ddd5334-7ea9-44be-abee-20479d0fde0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_b2d835e0-2c84-4d47-aadb-3940fd7a896e" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_b2d835e0-2c84-4d47-aadb-3940fd7a896e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_a8c1bbf6-ab64-4a03-b76a-9e560ad06056" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_a8c1bbf6-ab64-4a03-b76a-9e560ad06056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_040f2c69-873f-4543-bb3b-16d7560e0a84" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_040f2c69-873f-4543-bb3b-16d7560e0a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_77fdb6b8-b1a4-44f3-8313-5c73e98024d6" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_77fdb6b8-b1a4-44f3-8313-5c73e98024d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_19562611-4323-44a6-8ef8-386ee57a1144" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_19562611-4323-44a6-8ef8-386ee57a1144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_88290a84-4cc4-4560-bc3d-caeaff27219e" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_88290a84-4cc4-4560-bc3d-caeaff27219e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_e9d693f0-c210-4a86-aa07-ed70c10e78e0" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_e9d693f0-c210-4a86-aa07-ed70c10e78e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_21a3ca0e-be6e-439d-8862-79f809d7bf08" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_21a3ca0e-be6e-439d-8862-79f809d7bf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_1dd3815f-87c9-4e4e-a322-a57da8db0536" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_1dd3815f-87c9-4e4e-a322-a57da8db0536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_cb46a097-3eb7-497c-826a-b8fa5159f7b7" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_cb46a097-3eb7-497c-826a-b8fa5159f7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_bee46cd8-55b3-452d-b360-b6bc375b8b17" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_bee46cd8-55b3-452d-b360-b6bc375b8b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_ac9d44c6-98bd-43d8-9516-1ae81bd4d714" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_ac9d44c6-98bd-43d8-9516-1ae81bd4d714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_4ec588c9-783e-44d1-8096-9c192c957d94" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_4ec588c9-783e-44d1-8096-9c192c957d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point625PercentApril2027Member_89ac2c60-9649-4d9c-8913-7a7602d64a66" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3Point625PercentApril2027Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3Point625PercentApril2027Member_89ac2c60-9649-4d9c-8913-7a7602d64a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_748d5397-27b6-4251-8867-b0ccb5459a39" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_748d5397-27b6-4251-8867-b0ccb5459a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point3PercentAugust2027Member_6130a6b2-9d1b-43a2-a93c-cf141350c594" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes1Point3PercentAugust2027Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes1Point3PercentAugust2027Member_6130a6b2-9d1b-43a2-a93c-cf141350c594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_6c72c0f6-7582-4c76-9ebe-938992922e47" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_6c72c0f6-7582-4c76-9ebe-938992922e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_0b8e92ad-98f1-446e-80a8-dfb8da8042e5" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_0b8e92ad-98f1-446e-80a8-dfb8da8042e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point75PercentApril2030Member_ee3ecd3d-4367-497d-856f-49f6f1cc6515" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3Point75PercentApril2030Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3Point75PercentApril2030Member_ee3ecd3d-4367-497d-856f-49f6f1cc6515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point75PercentAugust2030Member_d8bed8bc-1f98-4369-ae1f-522a9399f82d" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes1Point75PercentAugust2030Member"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes1Point75PercentAugust2030Member_d8bed8bc-1f98-4369-ae1f-522a9399f82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member_62774d5d-fda4-4891-ad99-7be5e8a665d6" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes1Point875PercentFebruary2031Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member_62774d5d-fda4-4891-ad99-7be5e8a665d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_d3b418ab-1dd4-4ca5-9872-8c0d1152c68b" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_d3b418ab-1dd4-4ca5-9872-8c0d1152c68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_57c32de6-96e9-419a-be3d-b0fc4e61d586" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_57c32de6-96e9-419a-be3d-b0fc4e61d586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_6b44d7e8-8708-4f52-a2f6-5ee626c61358" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_6b44d7e8-8708-4f52-a2f6-5ee626c61358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_3cd8f37c-fbf7-4d1e-96a3-1bee1da8d4e7" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_3cd8f37c-fbf7-4d1e-96a3-1bee1da8d4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_22b36d3e-c49c-4274-b1ff-3ea865b9eb0c" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_22b36d3e-c49c-4274-b1ff-3ea865b9eb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point125PercentApril2040Member_05d19ac9-35b4-4695-b439-c37202170175" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4Point125PercentApril2040Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4Point125PercentApril2040Member_05d19ac9-35b4-4695-b439-c37202170175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point7PercentAugust2040Member_6edc3a0a-e382-41ea-bdf1-eefbe8604386" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2Point7PercentAugust2040Member"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes2Point7PercentAugust2040Member_6edc3a0a-e382-41ea-bdf1-eefbe8604386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_15649e4b-a3e7-4e50-bd2d-952f3d65080f" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_15649e4b-a3e7-4e50-bd2d-952f3d65080f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_21fcb20c-8d81-416f-88eb-23cf3febab87" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_21fcb20c-8d81-416f-88eb-23cf3febab87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_01341c02-5017-4e2a-84dc-6758a5f1629e" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_01341c02-5017-4e2a-84dc-6758a5f1629e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_99372241-69e4-4d6f-ad57-e25709912444" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_99372241-69e4-4d6f-ad57-e25709912444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_57fb8b54-878b-4ada-803e-dea3382f36e6" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_57fb8b54-878b-4ada-803e-dea3382f36e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_6398eceb-7151-4686-b9f5-42d2f85b93fa" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_6398eceb-7151-4686-b9f5-42d2f85b93fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_f9dbe947-ec4b-4331-859a-f57fdadcaee4" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_f9dbe947-ec4b-4331-859a-f57fdadcaee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_0fd132c1-056d-43e9-88d3-171edaea388c" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_0fd132c1-056d-43e9-88d3-171edaea388c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point25PercentApril2050Member_e7f61e76-72a9-4114-b1ff-7e5f717aca25" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4Point25PercentApril2050Member"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c8051724-daff-4e35-81ea-53b6ee3c0712" xlink:to="loc_cvs_SeniorNotes4Point25PercentApril2050Member_e7f61e76-72a9-4114-b1ff-7e5f717aca25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2d05f0aa-4623-49df-9470-fb381708964c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d3f9cc42-acb3-45c5-b561-766e0be9fdd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d3f9cc42-acb3-45c5-b561-766e0be9fdd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_a6d0b359-2ba0-43d5-b752-860c9689b1be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_DebtInstrumentTerm_a6d0b359-2ba0-43d5-b752-860c9689b1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e5d8cae7-1d74-4784-82f7-1472e2f781e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e5d8cae7-1d74-4784-82f7-1472e2f781e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b231ddfe-4cd1-4bd7-8ac6-fc9766e7ea55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_FinanceLeaseLiability_b231ddfe-4cd1-4bd7-8ac6-fc9766e7ea55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_578f031d-89b3-4565-8586-c94e0d33dc81" xlink:href="cvs-20201231.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_578f031d-89b3-4565-8586-c94e0d33dc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_fb174783-fcc7-49a5-bf86-de138769a8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_fb174783-fcc7-49a5-bf86-de138769a8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_5a985762-5972-447c-9c1b-ba6682594d1b" xlink:href="cvs-20201231.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_5a985762-5972-447c-9c1b-ba6682594d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_b58d4bee-d2bc-4c58-a3bf-f7eeffbecaaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_b58d4bee-d2bc-4c58-a3bf-f7eeffbecaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9a261c52-b732-4772-ba3f-df597b68deec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_9a261c52-b732-4772-ba3f-df597b68deec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8ce13cde-70dd-4462-a67a-555861655231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cfc308a6-476a-489d-af66-87b0527de898" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_8ce13cde-70dd-4462-a67a-555861655231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsDebtMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dc88317a-79d8-4533-9789-9ad89b0ea17e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_0231aa52-e9cd-4539-b8df-d469711e1b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dc88317a-79d8-4533-9789-9ad89b0ea17e" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_0231aa52-e9cd-4539-b8df-d469711e1b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1ae8e5bb-b8e2-4cfd-b975-5c79123fb49e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0231aa52-e9cd-4539-b8df-d469711e1b0a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1ae8e5bb-b8e2-4cfd-b975-5c79123fb49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c589612e-5bfe-4500-bf2c-53fc1aa99134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0231aa52-e9cd-4539-b8df-d469711e1b0a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c589612e-5bfe-4500-bf2c-53fc1aa99134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9311e6ff-54f7-4541-a3e2-cdee344cebcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0231aa52-e9cd-4539-b8df-d469711e1b0a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9311e6ff-54f7-4541-a3e2-cdee344cebcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ac792981-b555-4c37-8d2a-c16eb4b7e6b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0231aa52-e9cd-4539-b8df-d469711e1b0a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ac792981-b555-4c37-8d2a-c16eb4b7e6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_670d93fe-a042-41ff-b10f-32bae024f0e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0231aa52-e9cd-4539-b8df-d469711e1b0a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_670d93fe-a042-41ff-b10f-32bae024f0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_ed650532-54f3-49c3-ac6d-c1efed42e631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0231aa52-e9cd-4539-b8df-d469711e1b0a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_ed650532-54f3-49c3-ac6d-c1efed42e631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_625b8f3a-87b8-4df1-96f7-793f18ea0d46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_0231aa52-e9cd-4539-b8df-d469711e1b0a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_625b8f3a-87b8-4df1-96f7-793f18ea0d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_36b322b8-5c5a-4302-be3d-6c5694dd9996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dc88317a-79d8-4533-9789-9ad89b0ea17e" xlink:to="loc_us-gaap_FinanceLeaseLiability_36b322b8-5c5a-4302-be3d-6c5694dd9996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_29c404e2-8428-48d2-b521-1eae7a6b05bb" xlink:href="cvs-20201231.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dc88317a-79d8-4533-9789-9ad89b0ea17e" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_29c404e2-8428-48d2-b521-1eae7a6b05bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsShorttermBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d716db86-f9eb-4d03-a237-8ff245159945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_b6aa1d86-a108-4077-82ed-9f44a4db18a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d716db86-f9eb-4d03-a237-8ff245159945" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_b6aa1d86-a108-4077-82ed-9f44a4db18a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_ca0c5ea5-e993-4875-83e5-d0d764ffa912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b6aa1d86-a108-4077-82ed-9f44a4db18a3" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_ca0c5ea5-e993-4875-83e5-d0d764ffa912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_8c5e3ff0-1bef-4f09-80a6-6db1863a3976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_ca0c5ea5-e993-4875-83e5-d0d764ffa912" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_8c5e3ff0-1bef-4f09-80a6-6db1863a3976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6239d5b8-494f-4fa2-a351-42a5fea5cef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_8c5e3ff0-1bef-4f09-80a6-6db1863a3976" xlink:to="loc_us-gaap_CommercialPaperMember_6239d5b8-494f-4fa2-a351-42a5fea5cef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_c663892f-8c10-43b9-b1c1-ad24a349e98a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_8c5e3ff0-1bef-4f09-80a6-6db1863a3976" xlink:to="loc_us-gaap_LineOfCreditMember_c663892f-8c10-43b9-b1c1-ad24a349e98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember_2182cbb5-422a-49aa-88ed-6fb298f14e05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_8c5e3ff0-1bef-4f09-80a6-6db1863a3976" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMember_2182cbb5-422a-49aa-88ed-6fb298f14e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1d99972c-09a2-406d-ba01-219121f21687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b6aa1d86-a108-4077-82ed-9f44a4db18a3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1d99972c-09a2-406d-ba01-219121f21687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a66113a6-d8c9-45d3-98bc-9be8cda2011c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1d99972c-09a2-406d-ba01-219121f21687" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a66113a6-d8c9-45d3-98bc-9be8cda2011c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_15e676c8-c2cd-4df9-b854-cab5b05d8c38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a66113a6-d8c9-45d3-98bc-9be8cda2011c" xlink:to="loc_us-gaap_NotesPayableToBanksMember_15e676c8-c2cd-4df9-b854-cab5b05d8c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_af3e56ab-be5d-4db5-9e58-a8b74dea2f87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a66113a6-d8c9-45d3-98bc-9be8cda2011c" xlink:to="loc_us-gaap_SeniorNotesMember_af3e56ab-be5d-4db5-9e58-a8b74dea2f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c6952dd7-f399-436f-b0d5-18324a5ab00b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b6aa1d86-a108-4077-82ed-9f44a4db18a3" xlink:to="loc_us-gaap_DebtInstrumentAxis_c6952dd7-f399-436f-b0d5-18324a5ab00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_36d0a6c9-4130-4720-997b-ab93001f8b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c6952dd7-f399-436f-b0d5-18324a5ab00b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_36d0a6c9-4130-4720-997b-ab93001f8b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BackUpCreditFacilitiesMember_4c82c02e-21d7-4f4c-992f-7461f1c2b789" xlink:href="cvs-20201231.xsd#cvs_BackUpCreditFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_36d0a6c9-4130-4720-997b-ab93001f8b88" xlink:to="loc_cvs_BackUpCreditFacilitiesMember_4c82c02e-21d7-4f4c-992f-7461f1c2b789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay122021Member_5763a251-d47b-4cf3-bf66-e5036c3292f7" xlink:href="cvs-20201231.xsd#cvs_RevolvingCreditFacilityExpiringMay122021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_4c82c02e-21d7-4f4c-992f-7461f1c2b789" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay122021Member_5763a251-d47b-4cf3-bf66-e5036c3292f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay182022Member_ed1b498e-29bb-4a39-a0ed-67d4bdc6c420" xlink:href="cvs-20201231.xsd#cvs_RevolvingCreditFacilityExpiringMay182022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_4c82c02e-21d7-4f4c-992f-7461f1c2b789" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay182022Member_ed1b498e-29bb-4a39-a0ed-67d4bdc6c420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay172023Member_5bf8f5f2-61dd-4b07-82c1-6be8b661aaad" xlink:href="cvs-20201231.xsd#cvs_RevolvingCreditFacilityExpiringMay172023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_4c82c02e-21d7-4f4c-992f-7461f1c2b789" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay172023Member_5bf8f5f2-61dd-4b07-82c1-6be8b661aaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay162024Member_bcb9322c-82ac-4243-b4a1-e7baa8a327e1" xlink:href="cvs-20201231.xsd#cvs_RevolvingCreditFacilityExpiringMay162024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_4c82c02e-21d7-4f4c-992f-7461f1c2b789" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay162024Member_bcb9322c-82ac-4243-b4a1-e7baa8a327e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TwoThousandEighteenNotesMember_b2e312cd-525c-41bc-a045-48c67ce91dfe" xlink:href="cvs-20201231.xsd#cvs_TwoThousandEighteenNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_36d0a6c9-4130-4720-997b-ab93001f8b88" xlink:to="loc_cvs_TwoThousandEighteenNotesMember_b2e312cd-525c-41bc-a045-48c67ce91dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b6aa1d86-a108-4077-82ed-9f44a4db18a3" xlink:to="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_821e8c21-432a-4f32-be4a-d47568f83541" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_ShortTermBorrowings_821e8c21-432a-4f32-be4a-d47568f83541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ce195431-6e75-4dca-9572-22632b99c0c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ce195431-6e75-4dca-9572-22632b99c0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e42b7e5b-8645-45b8-89eb-159f01583c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_DebtInstrumentTerm_e42b7e5b-8645-45b8-89eb-159f01583c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c58baab1-b658-41b0-8b7c-4dcde68aa9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c58baab1-b658-41b0-8b7c-4dcde68aa9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_75add392-cf40-4154-946b-b774871512ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_75add392-cf40-4154-946b-b774871512ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_83764566-1a04-4a29-8b9e-772b9013108b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_83764566-1a04-4a29-8b9e-772b9013108b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_51024c6f-ff50-482e-80b4-f6ff47f73155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_74c7041e-6025-4d8a-9a51-bd86340a0927" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_51024c6f-ff50-482e-80b4-f6ff47f73155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#BorrowingsandCreditArrangementsLongTermBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a8566f23-90b6-4c93-8467-53c134f2a6dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a8566f23-90b6-4c93-8467-53c134f2a6dd" xlink:to="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bb9a68d4-5915-47a8-8c1e-0320b2667a14" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:to="loc_srt_RangeAxis_bb9a68d4-5915-47a8-8c1e-0320b2667a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_70d284fc-5652-4a09-bf11-bb657dc65165" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bb9a68d4-5915-47a8-8c1e-0320b2667a14" xlink:to="loc_srt_RangeMember_70d284fc-5652-4a09-bf11-bb657dc65165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_47fb64e1-6d53-44ab-a997-a55ef6971600" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_70d284fc-5652-4a09-bf11-bb657dc65165" xlink:to="loc_srt_MinimumMember_47fb64e1-6d53-44ab-a997-a55ef6971600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_01c9ae98-a6ad-4550-bbe6-189913427256" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_70d284fc-5652-4a09-bf11-bb657dc65165" xlink:to="loc_srt_MaximumMember_01c9ae98-a6ad-4550-bbe6-189913427256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3cff89a3-85ae-4ef4-8fbb-6c0275e48a43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3cff89a3-85ae-4ef4-8fbb-6c0275e48a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c968cd66-c880-4ad0-aea5-e69ee5eec756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3cff89a3-85ae-4ef4-8fbb-6c0275e48a43" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c968cd66-c880-4ad0-aea5-e69ee5eec756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc.Member_aaaea049-aeee-4bda-86ee-d2559b74903b" xlink:href="cvs-20201231.xsd#cvs_AetnaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c968cd66-c880-4ad0-aea5-e69ee5eec756" xlink:to="loc_cvs_AetnaInc.Member_aaaea049-aeee-4bda-86ee-d2559b74903b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c8f19703-e7b9-4630-ac79-27c8b6e3a6de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c8f19703-e7b9-4630-ac79-27c8b6e3a6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c5d87609-cbff-4d4d-af09-2616b0439fa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c8f19703-e7b9-4630-ac79-27c8b6e3a6de" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c5d87609-cbff-4d4d-af09-2616b0439fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ed8f92c9-f1fc-45ed-96be-3812e046a7bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c5d87609-cbff-4d4d-af09-2616b0439fa5" xlink:to="loc_us-gaap_SeniorNotesMember_ed8f92c9-f1fc-45ed-96be-3812e046a7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_1acbb81a-0271-42b2-9052-a047ad7236a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c5d87609-cbff-4d4d-af09-2616b0439fa5" xlink:to="loc_us-gaap_NotesPayableToBanksMember_1acbb81a-0271-42b2-9052-a047ad7236a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesMember_f6581470-0cbb-426e-ab3b-fcac8fb97548" xlink:href="cvs-20201231.xsd#cvs_FloatingRateNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c5d87609-cbff-4d4d-af09-2616b0439fa5" xlink:to="loc_cvs_FloatingRateNotesMember_f6581470-0cbb-426e-ab3b-fcac8fb97548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4dbd4c0d-e88d-4bd8-92fb-280e7896de40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:to="loc_us-gaap_DebtInstrumentAxis_4dbd4c0d-e88d-4bd8-92fb-280e7896de40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4dbd4c0d-e88d-4bd8-92fb-280e7896de40" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_4f9ed565-ff9a-452d-9135-672b848ddd62" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_4f9ed565-ff9a-452d-9135-672b848ddd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member_be899ca8-7174-4151-9b45-a250789dda45" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes1875DueFebruary2031Member_be899ca8-7174-4151-9b45-a250789dda45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_3aecb70a-2d46-4cec-8d60-8b51bcfa3d4f" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_3aecb70a-2d46-4cec-8d60-8b51bcfa3d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_745b94a4-d2e1-493a-88a2-b93a1eec01d8" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_745b94a4-d2e1-493a-88a2-b93a1eec01d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3625DueApril2027Member_fe4b4db4-940c-49fd-970d-ed1e8bb67fef" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3625DueApril2027Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes3625DueApril2027Member_fe4b4db4-940c-49fd-970d-ed1e8bb67fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes375DueApril2030Member_6d13e643-3a7a-464d-873c-9c36f8c9e178" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes375DueApril2030Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes375DueApril2030Member_6d13e643-3a7a-464d-873c-9c36f8c9e178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4125DueApril2040Member_bd69f149-b056-4825-9321-b03170eaeacd" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4125DueApril2040Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes4125DueApril2040Member_bd69f149-b056-4825-9321-b03170eaeacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes425DueApril2050Member_8057baad-f0fc-4561-a449-c0a016260766" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes425DueApril2050Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes425DueApril2050Member_8057baad-f0fc-4561-a449-c0a016260766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_769c38e6-4365-4795-8614-4fb12dde6e29" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_769c38e6-4365-4795-8614-4fb12dde6e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_a04e3f05-5bdc-402d-9713-672694986ec1" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_a04e3f05-5bdc-402d-9713-672694986ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_e57e7765-dc1d-4503-9650-776800010e4e" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_e57e7765-dc1d-4503-9650-776800010e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember_b61dab74-e105-49cd-a930-e4bd2fe86f32" xlink:href="cvs-20201231.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_OutstandingSeniorNotesMember_b61dab74-e105-49cd-a930-e4bd2fe86f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_928f45ff-4346-409e-a9c6-a9aea48ce831" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_928f45ff-4346-409e-a9c6-a9aea48ce831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_9f0f5432-9500-4f7f-a861-bfd6bcfc8ae6" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_9f0f5432-9500-4f7f-a861-bfd6bcfc8ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_c542b143-d2f8-45f9-9d50-4c4e77c9972e" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_c542b143-d2f8-45f9-9d50-4c4e77c9972e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes43Due2028Member_61aecd63-34b5-4d1c-8817-396c6b9d5779" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes43Due2028Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes43Due2028Member_61aecd63-34b5-4d1c-8817-396c6b9d5779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member_fabae6ed-f4ac-453d-b18c-3262ebc767ea" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes3.125DueMarch2020Member_fabae6ed-f4ac-453d-b18c-3262ebc767ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member_616d2052-8bc1-4229-abd7-e5a0da51b17f" xlink:href="cvs-20201231.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_FloatingRateNotesDueMarch2020Member_616d2052-8bc1-4229-abd7-e5a0da51b17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_4efb3852-cae1-44a6-bbbc-66240a34ab96" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_4efb3852-cae1-44a6-bbbc-66240a34ab96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_1e2c663f-e3ac-4bed-a2b5-e5f7934b6118" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_1e2c663f-e3ac-4bed-a2b5-e5f7934b6118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_1fbd2651-f934-49ba-8002-6becb3aedb99" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_1fbd2651-f934-49ba-8002-6becb3aedb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_bafae25a-6a4b-4c8b-b7d6-a2e9e584a751" xlink:href="cvs-20201231.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a648af59-ec01-4b66-ab1e-ab4dee0b15cb" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_bafae25a-6a4b-4c8b-b7d6-a2e9e584a751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_99903a32-b6b8-48cd-8f52-42ce62ba19bc" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8d99a18b-f822-4d3a-8469-92bb2c6412dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8d99a18b-f822-4d3a-8469-92bb2c6412dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_470470b0-340f-4965-a622-8f885a0889d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_470470b0-340f-4965-a622-8f885a0889d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_862e97de-c58b-41a4-a70b-45096746059a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_862e97de-c58b-41a4-a70b-45096746059a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_a8268e9b-41cc-4987-8cbe-fbe0e0d9bbc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_a8268e9b-41cc-4987-8cbe-fbe0e0d9bbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_509385e4-6e7f-46c0-9bae-b6d9a023b5ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_509385e4-6e7f-46c0-9bae-b6d9a023b5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_6ed38c02-8679-4ae5-b633-a3f8ad7afe9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_6ed38c02-8679-4ae5-b633-a3f8ad7afe9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_b937c154-9b1d-4517-a485-6fbc008448c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_b937c154-9b1d-4517-a485-6fbc008448c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_23d73e71-f8d8-49f8-8f80-af4c3cc3b625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_23d73e71-f8d8-49f8-8f80-af4c3cc3b625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees_eaaf6ff1-1196-4b3d-8bf0-9b4b0ad60c47" xlink:href="cvs-20201231.xsd#cvs_DebtExtinguishmentFees"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_cvs_DebtExtinguishmentFees_eaaf6ff1-1196-4b3d-8bf0-9b4b0ad60c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_98e530fd-fe08-4170-9993-cc201f92271c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_98e530fd-fe08-4170-9993-cc201f92271c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_13640f44-7e8c-4ea9-a8aa-5a8dcb322289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_13640f44-7e8c-4ea9-a8aa-5a8dcb322289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_57e8a52d-03b5-44be-ad99-db97cfe68e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_DebtInstrumentTerm_57e8a52d-03b5-44be-ad99-db97cfe68e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6a7433c0-8da8-477d-ab7f-3c352ba5d97a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_6a7433c0-8da8-477d-ab7f-3c352ba5d97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_e1b8f38d-7fce-4451-a3d0-278384e44130" xlink:href="cvs-20201231.xsd#cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5bfa1fcf-4f13-4725-a4c7-db1c31d112c0" xlink:to="loc_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_e1b8f38d-7fce-4451-a3d0-278384e44130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefits"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_65a5add6-7f2e-4408-b0c5-9bf976b3b821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_c1839a5c-070a-46aa-b9d4-6b293b296dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_65a5add6-7f2e-4408-b0c5-9bf976b3b821" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_c1839a5c-070a-46aa-b9d4-6b293b296dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2f4fdad0-ef35-457a-a86f-7c63f2f0de98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_7b5affa9-70c8-46b0-a0f5-ee5a035871dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2f4fdad0-ef35-457a-a86f-7c63f2f0de98" xlink:to="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_7b5affa9-70c8-46b0-a0f5-ee5a035871dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_8607d7f1-43fc-4fde-8136-880e63f81131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2f4fdad0-ef35-457a-a86f-7c63f2f0de98" xlink:to="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_8607d7f1-43fc-4fde-8136-880e63f81131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_dd5adb47-e420-4416-bf0f-48f5597aafb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2f4fdad0-ef35-457a-a86f-7c63f2f0de98" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_dd5adb47-e420-4416-bf0f-48f5597aafb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_abbd10b9-c41a-41ab-a56e-1a0bc4c4a0bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2f4fdad0-ef35-457a-a86f-7c63f2f0de98" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_abbd10b9-c41a-41ab-a56e-1a0bc4c4a0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_e4015e5c-5ac9-426a-8ba2-93923dee962d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2f4fdad0-ef35-457a-a86f-7c63f2f0de98" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_e4015e5c-5ac9-426a-8ba2-93923dee962d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_2b5c1a5f-b8cc-4a83-8dd8-025fa34fa679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2f4fdad0-ef35-457a-a86f-7c63f2f0de98" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_2b5c1a5f-b8cc-4a83-8dd8-025fa34fa679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock_8d700fd7-9021-4b7b-88ea-27841fd4b568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2f4fdad0-ef35-457a-a86f-7c63f2f0de98" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock_8d700fd7-9021-4b7b-88ea-27841fd4b568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_98266946-b401-4760-96c9-1c2e044ff92c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2f4fdad0-ef35-457a-a86f-7c63f2f0de98" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_98266946-b401-4760-96c9-1c2e044ff92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e6e8efb7-29f7-4fed-96d9-1ec9b86a395f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_24e053c7-c6c5-4bee-aae1-ac85c091d470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e6e8efb7-29f7-4fed-96d9-1ec9b86a395f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_24e053c7-c6c5-4bee-aae1-ac85c091d470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_6e272f39-0655-47ba-9a66-9eb8b3d3cd48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_24e053c7-c6c5-4bee-aae1-ac85c091d470" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_6e272f39-0655-47ba-9a66-9eb8b3d3cd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_95264a86-07e4-42a5-9594-e3bc194043a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_6e272f39-0655-47ba-9a66-9eb8b3d3cd48" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_95264a86-07e4-42a5-9594-e3bc194043a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_74b7572b-435b-4530-bbd9-f02e029f2202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_95264a86-07e4-42a5-9594-e3bc194043a6" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_74b7572b-435b-4530-bbd9-f02e029f2202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ab463fb4-da2a-4612-84af-d32475a7c546" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_95264a86-07e4-42a5-9594-e3bc194043a6" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_ab463fb4-da2a-4612-84af-d32475a7c546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a085238f-57ce-4612-b682-671d43519836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_24e053c7-c6c5-4bee-aae1-ac85c091d470" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a085238f-57ce-4612-b682-671d43519836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a085238f-57ce-4612-b682-671d43519836" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_a5b4fe85-b8b8-405a-9956-f65093a38cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:to="loc_us-gaap_EquitySecuritiesMember_a5b4fe85-b8b8-405a-9956-f65093a38cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_9b1d0401-ccab-46d4-af83-5fc3a64ec2f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:to="loc_us-gaap_DebtSecuritiesMember_9b1d0401-ccab-46d4-af83-5fc3a64ec2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentMember_ed8539fc-908b-4274-83fd-3ee580253ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealEstateInvestmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:to="loc_us-gaap_RealEstateInvestmentMember_ed8539fc-908b-4274-83fd-3ee580253ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_ac1e33be-502f-4c26-be97-a232531fa217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:to="loc_us-gaap_PrivateEquityFundsMember_ac1e33be-502f-4c26-be97-a232531fa217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_3998eb11-a0b3-4ff3-9210-02a76f590db0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0945f4fd-2851-4f16-a5e5-4a338bbd3da6" xlink:to="loc_us-gaap_HedgeFundsMember_3998eb11-a0b3-4ff3-9210-02a76f590db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_24e053c7-c6c5-4bee-aae1-ac85c091d470" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_11fa1f75-b774-49f4-bd69-56a3dd266b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_11fa1f75-b774-49f4-bd69-56a3dd266b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_f3f8c538-acfc-4268-9538-9ad65abac7b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_f3f8c538-acfc-4268-9538-9ad65abac7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_704ccf8c-be48-40eb-ac9a-8ee3b6513055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_704ccf8c-be48-40eb-ac9a-8ee3b6513055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_9004fdd8-4c92-48a7-a928-3bd282364042" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlanPensionInsignificantPlanContribution"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_9004fdd8-4c92-48a7-a928-3bd282364042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5742bc45-bad8-43ad-a64b-0dab1376eeb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5742bc45-bad8-43ad-a64b-0dab1376eeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_cb06a4fc-2f83-4349-a87e-6b4af781aecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_ecad2742-ca78-47f8-ad36-c709ee22ef1e" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_cb06a4fc-2f83-4349-a87e-6b4af781aecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_79c9c40a-b133-433b-9b64-c8851c259d23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_234cbe34-61ae-4cb4-9e03-2b03569894b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_79c9c40a-b133-433b-9b64-c8851c259d23" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_234cbe34-61ae-4cb4-9e03-2b03569894b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_5b7789dc-8112-44c9-b7eb-fadbe0a01d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_234cbe34-61ae-4cb4-9e03-2b03569894b8" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_5b7789dc-8112-44c9-b7eb-fadbe0a01d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b8d72440-97b1-4263-bc8e-4e96ac818e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5b7789dc-8112-44c9-b7eb-fadbe0a01d5e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b8d72440-97b1-4263-bc8e-4e96ac818e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_daa778ab-4bca-4cfe-a48b-e6151e072ffe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_b8d72440-97b1-4263-bc8e-4e96ac818e3c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_daa778ab-4bca-4cfe-a48b-e6151e072ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18b7c1ad-0a2b-4166-a248-0f10cec49f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_234cbe34-61ae-4cb4-9e03-2b03569894b8" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18b7c1ad-0a2b-4166-a248-0f10cec49f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18b7c1ad-0a2b-4166-a248-0f10cec49f99" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_6b21df25-ed01-4f9e-a28e-4c7cb000d291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_6b21df25-ed01-4f9e-a28e-4c7cb000d291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_bddf777e-3f33-4430-9a36-442a39db9b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_bddf777e-3f33-4430-9a36-442a39db9b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_78cde5dd-d725-4c1f-9a6e-ee4d11fc9982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_78cde5dd-d725-4c1f-9a6e-ee4d11fc9982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_115c1946-3ec2-4663-a815-07905ce7a64a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_115c1946-3ec2-4663-a815-07905ce7a64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_922a3f8b-5f47-430f-9da0-31dc09c5ceba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_c824bfb9-5e7b-46e6-8300-879535576eef" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_922a3f8b-5f47-430f-9da0-31dc09c5ceba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18b7c1ad-0a2b-4166-a248-0f10cec49f99" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6cd9a5a1-b0c1-40b1-8efe-604487ce8492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6cd9a5a1-b0c1-40b1-8efe-604487ce8492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_3eab48db-4c77-4d86-a887-fc2e28d801b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_3eab48db-4c77-4d86-a887-fc2e28d801b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_c651755a-bb0a-4bc6-bd46-e9cc4ba745c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_c651755a-bb0a-4bc6-bd46-e9cc4ba745c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_8adcfe2e-2b42-4dff-aedd-5f5170650e94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_8adcfe2e-2b42-4dff-aedd-5f5170650e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5c5378e9-62a3-4d62-8133-4a8abc081e60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_b8c48e0a-6f0e-4ddb-af10-f2ec6eb57fef" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5c5378e9-62a3-4d62-8133-4a8abc081e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_64e2bb71-d53d-4a49-a527-75ea7f0ee7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18b7c1ad-0a2b-4166-a248-0f10cec49f99" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_64e2bb71-d53d-4a49-a527-75ea7f0ee7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_b990b26c-1125-4135-8b51-49e49654b503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_18b7c1ad-0a2b-4166-a248-0f10cec49f99" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_b990b26c-1125-4135-8b51-49e49654b503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_ae56ec64-ed55-4ec4-a636-39a4420c3979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_b990b26c-1125-4135-8b51-49e49654b503" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_ae56ec64-ed55-4ec4-a636-39a4420c3979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_22d732c7-f3a9-4578-98bd-dba114343047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_b990b26c-1125-4135-8b51-49e49654b503" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_22d732c7-f3a9-4578-98bd-dba114343047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d6bcc8bf-4e03-4ef1-bb2d-4fb019a54ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_b990b26c-1125-4135-8b51-49e49654b503" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_d6bcc8bf-4e03-4ef1-bb2d-4fb019a54ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7d43bf1e-5a7f-4dc9-83fe-7c3a81a44ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_b990b26c-1125-4135-8b51-49e49654b503" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_7d43bf1e-5a7f-4dc9-83fe-7c3a81a44ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9d9ca431-f16b-4dfe-9b20-cb0a9b625960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e7911d6-ffc2-42be-b1d9-2ef6ca54df74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9d9ca431-f16b-4dfe-9b20-cb0a9b625960" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e7911d6-ffc2-42be-b1d9-2ef6ca54df74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_5fc3cc90-e6dd-4006-8077-cf4b87111d97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e7911d6-ffc2-42be-b1d9-2ef6ca54df74" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_5fc3cc90-e6dd-4006-8077-cf4b87111d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6153b750-dff8-4f9c-831b-e0009de56eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5fc3cc90-e6dd-4006-8077-cf4b87111d97" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6153b750-dff8-4f9c-831b-e0009de56eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_92cedced-45b8-4b63-9cd5-b2de62b05ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6153b750-dff8-4f9c-831b-e0009de56eeb" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_92cedced-45b8-4b63-9cd5-b2de62b05ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9f6e691-8a52-4816-a73f-704680a6ea0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8e7911d6-ffc2-42be-b1d9-2ef6ca54df74" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9f6e691-8a52-4816-a73f-704680a6ea0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7b60a3b0-90a7-49ed-aa71-10b6e1a91c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a9f6e691-8a52-4816-a73f-704680a6ea0f" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7b60a3b0-90a7-49ed-aa71-10b6e1a91c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_9b99b3db-e5df-4846-bf61-2af0a9256d90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7b60a3b0-90a7-49ed-aa71-10b6e1a91c74" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_9b99b3db-e5df-4846-bf61-2af0a9256d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2292ed74-73c1-4138-a705-35739e1ca88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7b60a3b0-90a7-49ed-aa71-10b6e1a91c74" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2292ed74-73c1-4138-a705-35739e1ca88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9bc4896d-323c-487b-8137-5d1c45e21f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7b60a3b0-90a7-49ed-aa71-10b6e1a91c74" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9bc4896d-323c-487b-8137-5d1c45e21f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a574b23a-79cd-47be-bf85-87382f97d0ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_7b60a3b0-90a7-49ed-aa71-10b6e1a91c74" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a574b23a-79cd-47be-bf85-87382f97d0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_10ca7c3a-7b87-4b88-845e-d252283dd191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_5a357b01-1dd1-4f46-bfdf-5e53682b12d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_10ca7c3a-7b87-4b88-845e-d252283dd191" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_5a357b01-1dd1-4f46-bfdf-5e53682b12d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_9d7fb2d6-faa0-414f-9500-b0d5410aa9ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_5a357b01-1dd1-4f46-bfdf-5e53682b12d2" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_9d7fb2d6-faa0-414f-9500-b0d5410aa9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_2c5641ce-745f-4ab1-94d6-be9321b60f8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_10ca7c3a-7b87-4b88-845e-d252283dd191" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_2c5641ce-745f-4ab1-94d6-be9321b60f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_1bc44b8f-e53e-49d8-8605-91e2df26e185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_2c5641ce-745f-4ab1-94d6-be9321b60f8d" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_1bc44b8f-e53e-49d8-8605-91e2df26e185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_c2208f9b-a72a-470f-8bf8-380fe389ae28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_2c5641ce-745f-4ab1-94d6-be9321b60f8d" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_c2208f9b-a72a-470f-8bf8-380fe389ae28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cc993513-b67f-4a21-997f-bde422c5dd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36feda71-8977-4fb6-bc7f-9030f35afdd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cc993513-b67f-4a21-997f-bde422c5dd0d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36feda71-8977-4fb6-bc7f-9030f35afdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_e9d827d2-2098-407e-b5a7-020051298c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36feda71-8977-4fb6-bc7f-9030f35afdd6" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_e9d827d2-2098-407e-b5a7-020051298c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6618d13f-4fd2-4467-809d-47b4102cde9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_e9d827d2-2098-407e-b5a7-020051298c5a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6618d13f-4fd2-4467-809d-47b4102cde9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_5b6305c9-10ff-4c60-9ecf-04014c1afc9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_6618d13f-4fd2-4467-809d-47b4102cde9d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_5b6305c9-10ff-4c60-9ecf-04014c1afc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67381ef5-9472-4dc3-b2d7-11835861e15d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36feda71-8977-4fb6-bc7f-9030f35afdd6" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67381ef5-9472-4dc3-b2d7-11835861e15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_67381ef5-9472-4dc3-b2d7-11835861e15d" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_5efb0e38-e570-4d15-89ba-9fd3aff99e81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_5efb0e38-e570-4d15-89ba-9fd3aff99e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_36429914-3e03-4e68-ac9b-a24e410d180f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_36429914-3e03-4e68-ac9b-a24e410d180f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_ae096efb-2602-4ca8-851c-895e7dc0cab6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_ae096efb-2602-4ca8-851c-895e7dc0cab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_333e1885-6cde-467d-aabd-8ff7c3b7e1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_333e1885-6cde-467d-aabd-8ff7c3b7e1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_b78e3401-306f-4049-8193-3a4f8a3cb684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_b78e3401-306f-4049-8193-3a4f8a3cb684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3694f3cc-645a-478a-838d-73b4a06028f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_3694f3cc-645a-478a-838d-73b4a06028f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_eeb3138a-9ca1-4ee7-a23c-813953e46f33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_eeb3138a-9ca1-4ee7-a23c-813953e46f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_cec518d8-1b2b-4621-a61d-11e8fe0a05f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_cec518d8-1b2b-4621-a61d-11e8fe0a05f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedeemablePreferredSecuritiesMember_5ab64bea-6d17-4fda-afe7-bf7f9a57b9ef" xlink:href="cvs-20201231.xsd#cvs_RedeemablePreferredSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_b9d4c3af-9c42-4551-a380-78201f3eeac9" xlink:to="loc_cvs_RedeemablePreferredSecuritiesMember_5ab64bea-6d17-4fda-afe7-bf7f9a57b9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_984a8afc-d4a6-496a-a85f-4a42d312138e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_EquitySecuritiesMember_984a8afc-d4a6-496a-a85f-4a42d312138e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_0a339b9f-bc62-42bd-a541-c8988291d747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_984a8afc-d4a6-496a-a85f-4a42d312138e" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_0a339b9f-bc62-42bd-a541-c8988291d747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_5efac992-c6b2-40a1-8b98-ee71776e967e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_984a8afc-d4a6-496a-a85f-4a42d312138e" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_5efac992-c6b2-40a1-8b98-ee71776e967e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EquitySecuritiesDomesticRealEstateMember_ee9a1a0a-c572-40de-b755-adc29784f03f" xlink:href="cvs-20201231.xsd#cvs_EquitySecuritiesDomesticRealEstateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_984a8afc-d4a6-496a-a85f-4a42d312138e" xlink:to="loc_cvs_EquitySecuritiesDomesticRealEstateMember_ee9a1a0a-c572-40de-b755-adc29784f03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_8c4c9b00-6dcf-43c7-83c2-e5660d7f911b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_OtherInvestmentsMember_8c4c9b00-6dcf-43c7-83c2-e5660d7f911b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_1059634e-83b1-492d-8203-60b02ca0f28b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentsMember_8c4c9b00-6dcf-43c7-83c2-e5660d7f911b" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_1059634e-83b1-492d-8203-60b02ca0f28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_59bf6701-1284-4603-a223-b36546ff1732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentsMember_8c4c9b00-6dcf-43c7-83c2-e5660d7f911b" xlink:to="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_59bf6701-1284-4603-a223-b36546ff1732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDerivativeMember_654bd0e8-077d-40f8-8722-9bcedd287e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDerivativeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentsMember_8c4c9b00-6dcf-43c7-83c2-e5660d7f911b" xlink:to="loc_us-gaap_DefinedBenefitPlanDerivativeMember_654bd0e8-077d-40f8-8722-9bcedd287e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_12933ffd-71ee-4e74-a661-f083d25444d4" xlink:href="cvs-20201231.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_12933ffd-71ee-4e74-a661-f083d25444d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_21285af3-2592-4662-bf8f-0146be682580" xlink:href="cvs-20201231.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_21285af3-2592-4662-bf8f-0146be682580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_02771717-0b45-4943-a118-bd9799bc4b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_PrivateEquityFundsMember_02771717-0b45-4943-a118-bd9799bc4b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_dcebf070-6f05-4307-a625-2bffafa25efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_HedgeFundsMember_dcebf070-6f05-4307-a625-2bffafa25efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_74321724-096d-4f76-a5e7-8f6fa248d5e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_46e348a9-05e3-4ae3-bea3-495626fdf066" xlink:to="loc_us-gaap_AccountsReceivableMember_74321724-096d-4f76-a5e7-8f6fa248d5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d769889c-9483-4932-82ef-d155901eb30b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36feda71-8977-4fb6-bc7f-9030f35afdd6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d769889c-9483-4932-82ef-d155901eb30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d769889c-9483-4932-82ef-d155901eb30b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e084591c-e010-44a8-9881-5dee8654f892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e084591c-e010-44a8-9881-5dee8654f892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_186190ee-87b8-4e1a-b09c-3a8a9c7fc300" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_186190ee-87b8-4e1a-b09c-3a8a9c7fc300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_2e41236a-8f90-4494-9aaf-043108aea96c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_2e41236a-8f90-4494-9aaf-043108aea96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_7ff533ff-9024-439c-929d-ce9c950d6eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_7ff533ff-9024-439c-929d-ce9c950d6eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_2e1555f1-8589-46ff-9e07-6b87db771ada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3633ad86-83c8-4065-9bb2-85dd599fbd04" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_2e1555f1-8589-46ff-9e07-6b87db771ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53eaf016-7442-4b37-b1ec-2725eb02a52f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_36feda71-8977-4fb6-bc7f-9030f35afdd6" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53eaf016-7442-4b37-b1ec-2725eb02a52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_60a0e8c6-a476-415d-8160-6710aacd016c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53eaf016-7442-4b37-b1ec-2725eb02a52f" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_60a0e8c6-a476-415d-8160-6710aacd016c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_bce5bd24-f0a0-48eb-bbed-1237096d82bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_53eaf016-7442-4b37-b1ec-2725eb02a52f" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_bce5bd24-f0a0-48eb-bbed-1237096d82bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94f12f29-8488-433f-8929-83c83ba2aa45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b2945775-e4e3-4ffc-aad6-1a0f204b4644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_94f12f29-8488-433f-8929-83c83ba2aa45" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b2945775-e4e3-4ffc-aad6-1a0f204b4644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d024f00f-5d3a-42b3-a875-ce1a357a307d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b2945775-e4e3-4ffc-aad6-1a0f204b4644" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d024f00f-5d3a-42b3-a875-ce1a357a307d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_4e047fb4-37ab-42d7-843e-21283dea7f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d024f00f-5d3a-42b3-a875-ce1a357a307d" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_4e047fb4-37ab-42d7-843e-21283dea7f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_ba6a9cd7-f332-468f-ae2e-ad5ec3eb2977" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_4e047fb4-37ab-42d7-843e-21283dea7f59" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_ba6a9cd7-f332-468f-ae2e-ad5ec3eb2977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_c65e54da-3f50-4077-9e2d-14b1cbc63905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_4e047fb4-37ab-42d7-843e-21283dea7f59" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_c65e54da-3f50-4077-9e2d-14b1cbc63905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4396a747-274d-405e-a276-72e19bdaa0ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b2945775-e4e3-4ffc-aad6-1a0f204b4644" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4396a747-274d-405e-a276-72e19bdaa0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40e9b465-1efd-441c-9877-5f28c6867be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_4396a747-274d-405e-a276-72e19bdaa0ef" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40e9b465-1efd-441c-9877-5f28c6867be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c99e7af3-0001-4ae3-a77e-cb7061bfd78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40e9b465-1efd-441c-9877-5f28c6867be1" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c99e7af3-0001-4ae3-a77e-cb7061bfd78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_f9de45bf-5941-4c8a-9bb2-058981d43e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b2945775-e4e3-4ffc-aad6-1a0f204b4644" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_f9de45bf-5941-4c8a-9bb2-058981d43e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2714596b-fa07-4f66-9cbc-edf5af2e334a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_f9de45bf-5941-4c8a-9bb2-058981d43e29" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2714596b-fa07-4f66-9cbc-edf5af2e334a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_30d0f47d-e0d4-4657-b925-b99d65357d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_2714596b-fa07-4f66-9cbc-edf5af2e334a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_30d0f47d-e0d4-4657-b925-b99d65357d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_64b55bba-8a20-42e5-8045-393e3cc81721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_b2945775-e4e3-4ffc-aad6-1a0f204b4644" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_64b55bba-8a20-42e5-8045-393e3cc81721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_64b55bba-8a20-42e5-8045-393e3cc81721" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_26d2069c-35ca-47d4-a663-0a31934bfbca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_26d2069c-35ca-47d4-a663-0a31934bfbca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_eb3d9653-6e1f-4d63-bf04-8f934ef946c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_eb3d9653-6e1f-4d63-bf04-8f934ef946c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_f3ef9c77-4439-4cef-8f12-5c6633c43025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:to="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_f3ef9c77-4439-4cef-8f12-5c6633c43025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_5f386080-1390-440e-8bcb-97be9a49e056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:to="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_5f386080-1390-440e-8bcb-97be9a49e056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_74d26913-5851-4fd7-88bc-1db6d01f1f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_1f7c51fd-34bd-47ae-8eab-693f3d9f6d5a" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_74d26913-5851-4fd7-88bc-1db6d01f1f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_58b58adf-f0ed-47d3-9216-97c911dbd8fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_297129d9-ccd9-4565-aaa0-377b7f71b259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_58b58adf-f0ed-47d3-9216-97c911dbd8fe" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_297129d9-ccd9-4565-aaa0-377b7f71b259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_83bba237-f9a4-4872-a7ca-aa3bda69dd27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_297129d9-ccd9-4565-aaa0-377b7f71b259" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_83bba237-f9a4-4872-a7ca-aa3bda69dd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a1eaf5cf-a3bd-445f-b966-141824d55a54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_83bba237-f9a4-4872-a7ca-aa3bda69dd27" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a1eaf5cf-a3bd-445f-b966-141824d55a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_528a4dfe-5208-424d-bc26-6cf01ed8a4c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a1eaf5cf-a3bd-445f-b966-141824d55a54" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_528a4dfe-5208-424d-bc26-6cf01ed8a4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8c9a8626-0e4e-4e8f-ad9f-3dc53665475d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a1eaf5cf-a3bd-445f-b966-141824d55a54" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8c9a8626-0e4e-4e8f-ad9f-3dc53665475d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_297129d9-ccd9-4565-aaa0-377b7f71b259" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_99192698-b5dd-4e42-a209-4013d6b1673a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_99192698-b5dd-4e42-a209-4013d6b1673a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_b0c55843-af05-4e59-821f-e97f7631b0a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_b0c55843-af05-4e59-821f-e97f7631b0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_fbc4e659-5abf-458d-9c39-5b510c97c7c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_fbc4e659-5abf-458d-9c39-5b510c97c7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_cd94e337-7ca2-4bb2-90e6-1aae1c3a7704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_cd94e337-7ca2-4bb2-90e6-1aae1c3a7704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_3e39b79a-3231-458c-9987-36b3958ecd22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_3e39b79a-3231-458c-9987-36b3958ecd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_1235b615-7df3-44a6-ae09-e8826328ffe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_51d5fc3c-bcee-44cc-82f4-fcb225462b8f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_1235b615-7df3-44a6-ae09-e8826328ffe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_97384ffc-3143-4014-989d-3b1f9e9269e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_31b6effd-61bf-4644-97c6-9d2c75ec94da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_97384ffc-3143-4014-989d-3b1f9e9269e4" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_31b6effd-61bf-4644-97c6-9d2c75ec94da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_411035c5-8dce-4785-826a-4ae47de45372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0a20a794-20f2-46ef-8fb6-efd4c75b90f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_411035c5-8dce-4785-826a-4ae47de45372" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0a20a794-20f2-46ef-8fb6-efd4c75b90f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a56f6a1a-311f-4b1a-b6e8-6def8ef6c1e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_411035c5-8dce-4785-826a-4ae47de45372" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a56f6a1a-311f-4b1a-b6e8-6def8ef6c1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_97f2616e-c354-4132-9459-95ed9e617b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_411035c5-8dce-4785-826a-4ae47de45372" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_97f2616e-c354-4132-9459-95ed9e617b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_b7f5ff5f-81d3-4b3d-8c84-0133bb0c53c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_411035c5-8dce-4785-826a-4ae47de45372" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_b7f5ff5f-81d3-4b3d-8c84-0133bb0c53c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_63b9b833-196f-4d57-9b59-06ddf427dac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_5848ec91-db2a-43b3-bdd9-45e98c5e8321" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_63b9b833-196f-4d57-9b59-06ddf427dac3" xlink:to="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_5848ec91-db2a-43b3-bdd9-45e98c5e8321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7884f5f3-c3f5-4107-8a90-0fef3d9a2f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_5848ec91-db2a-43b3-bdd9-45e98c5e8321" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7884f5f3-c3f5-4107-8a90-0fef3d9a2f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4ebee3af-6f7a-41de-80db-1bcdaff43154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7884f5f3-c3f5-4107-8a90-0fef3d9a2f40" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4ebee3af-6f7a-41de-80db-1bcdaff43154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ae4bfd20-0706-46ee-8fad-a825b67df2fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7884f5f3-c3f5-4107-8a90-0fef3d9a2f40" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ae4bfd20-0706-46ee-8fad-a825b67df2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8c331664-649b-4004-bc98-7995ebeeae6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7884f5f3-c3f5-4107-8a90-0fef3d9a2f40" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8c331664-649b-4004-bc98-7995ebeeae6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_e1d3c412-198d-4921-8dd7-b137e09dc7d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_5848ec91-db2a-43b3-bdd9-45e98c5e8321" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_e1d3c412-198d-4921-8dd7-b137e09dc7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c0210020-edc9-4fbb-bb2b-c910103211d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_e1d3c412-198d-4921-8dd7-b137e09dc7d7" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c0210020-edc9-4fbb-bb2b-c910103211d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_70e20133-83a6-4cab-8008-a18a078517b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_e1d3c412-198d-4921-8dd7-b137e09dc7d7" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_70e20133-83a6-4cab-8008-a18a078517b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06e570e3-3b62-4060-bfb3-9c97ca6556e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_e1d3c412-198d-4921-8dd7-b137e09dc7d7" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_06e570e3-3b62-4060-bfb3-9c97ca6556e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1d52fbdb-1be4-469d-b425-4d0bda1999a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_5848ec91-db2a-43b3-bdd9-45e98c5e8321" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1d52fbdb-1be4-469d-b425-4d0bda1999a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2c768064-cd7d-4d3a-9360-cd4f44c0124a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense_26c00b79-e0e3-45c7-9c36-bfab27c2acf1" xlink:href="cvs-20201231.xsd#cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2c768064-cd7d-4d3a-9360-cd4f44c0124a" xlink:to="loc_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense_26c00b79-e0e3-45c7-9c36-bfab27c2acf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_3134d499-810e-4a86-a85d-860c903efdeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2c768064-cd7d-4d3a-9360-cd4f44c0124a" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit_3134d499-810e-4a86-a85d-860c903efdeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d9c0c5d9-7c3d-408b-9c4e-672362deda91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2c768064-cd7d-4d3a-9360-cd4f44c0124a" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d9c0c5d9-7c3d-408b-9c4e-672362deda91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d4dda37c-64c8-4fcf-900a-c9a190a09dac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2c768064-cd7d-4d3a-9360-cd4f44c0124a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d4dda37c-64c8-4fcf-900a-c9a190a09dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_9feb86c7-6f1f-489d-a9ae-624ee55392be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2c768064-cd7d-4d3a-9360-cd4f44c0124a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_9feb86c7-6f1f-489d-a9ae-624ee55392be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_e1f172b2-41e1-4cb7-867b-a9123f042f80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2c768064-cd7d-4d3a-9360-cd4f44c0124a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_e1f172b2-41e1-4cb7-867b-a9123f042f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_416b1653-2667-4028-94e3-5a6f2824590f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2c768064-cd7d-4d3a-9360-cd4f44c0124a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_416b1653-2667-4028-94e3-5a6f2824590f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3adb7842-26f6-458f-bfa4-ad2665d08585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_b1894ac2-7c5c-4f15-af02-56a4d0605e54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3adb7842-26f6-458f-bfa4-ad2665d08585" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_b1894ac2-7c5c-4f15-af02-56a4d0605e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3dbf0e27-f82f-47ce-9993-75a9c0ba6255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_b1894ac2-7c5c-4f15-af02-56a4d0605e54" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3dbf0e27-f82f-47ce-9993-75a9c0ba6255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0e47dd45-533c-4308-ae79-aa24b7b8f1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_b1894ac2-7c5c-4f15-af02-56a4d0605e54" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_0e47dd45-533c-4308-ae79-aa24b7b8f1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_e7d00e56-36eb-44c2-8b37-c680af70c74f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_b1894ac2-7c5c-4f15-af02-56a4d0605e54" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_e7d00e56-36eb-44c2-8b37-c680af70c74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFeeTaxEffectPercent_4d711470-dc40-4780-bbce-dfda620a7708" xlink:href="cvs-20201231.xsd#cvs_HealthInsurerFeeTaxEffectPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_b1894ac2-7c5c-4f15-af02-56a4d0605e54" xlink:to="loc_cvs_HealthInsurerFeeTaxEffectPercent_4d711470-dc40-4780-bbce-dfda620a7708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_e18c42b2-b50e-4ec0-8e57-8dfd7f9becb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_b1894ac2-7c5c-4f15-af02-56a4d0605e54" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_e18c42b2-b50e-4ec0-8e57-8dfd7f9becb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_255851d6-8381-442e-b473-f394bf60c39a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_b1894ac2-7c5c-4f15-af02-56a4d0605e54" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_255851d6-8381-442e-b473-f394bf60c39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4f5d2f8f-03f8-48e0-9c21-c94e82c4d55c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_b1894ac2-7c5c-4f15-af02-56a4d0605e54" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_4f5d2f8f-03f8-48e0-9c21-c94e82c4d55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3d75b4f0-a62a-4e4e-b8ec-c77b6811ec49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_b1894ac2-7c5c-4f15-af02-56a4d0605e54" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_3d75b4f0-a62a-4e4e-b8ec-c77b6811ec49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d6edbad7-d9a8-4945-bed0-b2b7f8208bc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_b899e52a-101f-4a2f-9b74-eaa55853af7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d6edbad7-d9a8-4945-bed0-b2b7f8208bc8" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_b899e52a-101f-4a2f-9b74-eaa55853af7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_b899e52a-101f-4a2f-9b74-eaa55853af7d" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_8a177a4e-636a-4d6e-aef3-34a1de0c65c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_8a177a4e-636a-4d6e-aef3-34a1de0c65c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_4f866c9a-c692-496e-a18e-e0b116b63805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_4f866c9a-c692-496e-a18e-e0b116b63805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_0c0d8ebd-a8df-4aeb-966f-51e3dc449d71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_0c0d8ebd-a8df-4aeb-966f-51e3dc449d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_9eb66b92-d938-4480-8140-e13794fbbe18" xlink:href="cvs-20201231.xsd#cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:to="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_9eb66b92-d938-4480-8140-e13794fbbe18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_d7880b67-3332-4930-8eb8-14ea7278b4f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_d7880b67-3332-4930-8eb8-14ea7278b4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3ef0b5f1-8f79-439e-8542-ff341a37ebc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3ef0b5f1-8f79-439e-8542-ff341a37ebc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_546082bf-e38c-46ee-8f35-9c3296d0c720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_546082bf-e38c-46ee-8f35-9c3296d0c720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_14546abb-7f2f-44fe-af74-a0196dcc7fa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_14546abb-7f2f-44fe-af74-a0196dcc7fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_4c19ca68-d36d-403f-8887-f6c37599bcd7" xlink:href="cvs-20201231.xsd#cvs_DeferredTaxAssetsPayrollTaxDeferral"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:to="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_4c19ca68-d36d-403f-8887-f6c37599bcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_803360f2-fddd-41eb-8f28-3bc82d71c75e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_803360f2-fddd-41eb-8f28-3bc82d71c75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f51f8fb6-a9dc-4d70-94da-13ce1a564d18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_f51f8fb6-a9dc-4d70-94da-13ce1a564d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_3fc964b8-82fe-4df4-b80c-e7344bfeb9ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_1f07966b-c686-4f8d-a176-f99138739493" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_3fc964b8-82fe-4df4-b80c-e7344bfeb9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_61d51c14-1876-4966-a9a0-26e8b12e9a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_b899e52a-101f-4a2f-9b74-eaa55853af7d" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_61d51c14-1876-4966-a9a0-26e8b12e9a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_ce060251-45e1-44ce-b2e6-7e9dff77d8de" xlink:href="cvs-20201231.xsd#cvs_DeferredTaxLiabilitiesRetirementBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_61d51c14-1876-4966-a9a0-26e8b12e9a8a" xlink:to="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_ce060251-45e1-44ce-b2e6-7e9dff77d8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_1cb544e6-5a4e-4370-b51a-6ff4c4f78b7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_61d51c14-1876-4966-a9a0-26e8b12e9a8a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_1cb544e6-5a4e-4370-b51a-6ff4c4f78b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_faa176d3-d9bf-4bb8-b0d3-46f07e074dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_61d51c14-1876-4966-a9a0-26e8b12e9a8a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_faa176d3-d9bf-4bb8-b0d3-46f07e074dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_20b1c7fd-566f-4ae1-aa1c-483e1d125b86" xlink:href="cvs-20201231.xsd#cvs_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_61d51c14-1876-4966-a9a0-26e8b12e9a8a" xlink:to="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_20b1c7fd-566f-4ae1-aa1c-483e1d125b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_15eaaf1e-f070-4c15-9048-844b64116fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_b899e52a-101f-4a2f-9b74-eaa55853af7d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_15eaaf1e-f070-4c15-9048-844b64116fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_1626c204-076f-4122-a823-128dcbfabaf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_b899e52a-101f-4a2f-9b74-eaa55853af7d" xlink:to="loc_us-gaap_DeferredTaxLiabilities_1626c204-076f-4122-a823-128dcbfabaf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c2029776-d36c-495c-a884-422e40d29205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1d01345c-f3da-40df-9b8e-b15c1c4b3195" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c2029776-d36c-495c-a884-422e40d29205" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1d01345c-f3da-40df-9b8e-b15c1c4b3195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ce70a170-ac6d-42b7-b49b-6f1c41168c83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1d01345c-f3da-40df-9b8e-b15c1c4b3195" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ce70a170-ac6d-42b7-b49b-6f1c41168c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5cf6ed4c-b38f-4efb-94e1-1ef31174ea2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1d01345c-f3da-40df-9b8e-b15c1c4b3195" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5cf6ed4c-b38f-4efb-94e1-1ef31174ea2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_d14f8be4-7b29-44bf-9dbd-375b47209e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1d01345c-f3da-40df-9b8e-b15c1c4b3195" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_d14f8be4-7b29-44bf-9dbd-375b47209e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_4ca64746-ea52-4dbd-8127-bd02e7331e61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1d01345c-f3da-40df-9b8e-b15c1c4b3195" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_4ca64746-ea52-4dbd-8127-bd02e7331e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2fa9aa0c-037f-4e42-a83e-874eebec8f58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1d01345c-f3da-40df-9b8e-b15c1c4b3195" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_2fa9aa0c-037f-4e42-a83e-874eebec8f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_ddd65222-0f3a-43af-a977-bc7949b6aadd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1d01345c-f3da-40df-9b8e-b15c1c4b3195" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_ddd65222-0f3a-43af-a977-bc7949b6aadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_268b778a-58a7-4e54-96aa-3edfad523a7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1d01345c-f3da-40df-9b8e-b15c1c4b3195" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_268b778a-58a7-4e54-96aa-3edfad523a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlans" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlans"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6a59ecba-a72c-4c24-988e-217a99192698" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_921e836f-5738-4b20-a60c-64ddb9e19edf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6a59ecba-a72c-4c24-988e-217a99192698" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_921e836f-5738-4b20-a60c-64ddb9e19edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37783758-6c43-4416-95e6-b184a1b86f46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_991bd89e-df61-409b-992c-a45eb8b3491c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37783758-6c43-4416-95e6-b184a1b86f46" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_991bd89e-df61-409b-992c-a45eb8b3491c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_59bd652f-e7c2-4533-a33b-2624db38d9a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37783758-6c43-4416-95e6-b184a1b86f46" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_59bd652f-e7c2-4533-a33b-2624db38d9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_5ac535a7-d72c-4df6-9ae2-5024466ac239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37783758-6c43-4416-95e6-b184a1b86f46" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_5ac535a7-d72c-4df6-9ae2-5024466ac239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_36085df2-9975-4f42-8e97-3ee654ea3586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37783758-6c43-4416-95e6-b184a1b86f46" xlink:to="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_36085df2-9975-4f42-8e97-3ee654ea3586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_88409e9f-cc25-4039-98ba-96bb0326b288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37783758-6c43-4416-95e6-b184a1b86f46" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_88409e9f-cc25-4039-98ba-96bb0326b288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_2a5c25a5-55b4-4a07-81e6-85c7908afbf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_37783758-6c43-4416-95e6-b184a1b86f46" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_2a5c25a5-55b4-4a07-81e6-85c7908afbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b87ba0c0-8395-45b1-852c-272219c2bb2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f66f907a-8a3a-4359-b295-0b4933161d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b87ba0c0-8395-45b1-852c-272219c2bb2d" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f66f907a-8a3a-4359-b295-0b4933161d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c1c2ad99-2e8c-4502-a6cd-7bb58f6bd391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f66f907a-8a3a-4359-b295-0b4933161d2e" xlink:to="loc_us-gaap_PlanNameAxis_c1c2ad99-2e8c-4502-a6cd-7bb58f6bd391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d55dc520-5f42-4aaf-aa70-21e2480dd70c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_c1c2ad99-2e8c-4502-a6cd-7bb58f6bd391" xlink:to="loc_us-gaap_PlanNameDomain_d55dc520-5f42-4aaf-aa70-21e2480dd70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember_f4711d79-a17c-4060-bb89-5dea35b63e32" xlink:href="cvs-20201231.xsd#cvs_CVSHealth2017IncentiveCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d55dc520-5f42-4aaf-aa70-21e2480dd70c" xlink:to="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember_f4711d79-a17c-4060-bb89-5dea35b63e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc2010StockIncentivePlanMember_467d1f6f-6ad0-4337-a7cc-91218ff9c2eb" xlink:href="cvs-20201231.xsd#cvs_AetnaInc2010StockIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d55dc520-5f42-4aaf-aa70-21e2480dd70c" xlink:to="loc_cvs_AetnaInc2010StockIncentivePlanMember_467d1f6f-6ad0-4337-a7cc-91218ff9c2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3b602236-02e7-40a5-8ee3-2e779aa6bd0e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f66f907a-8a3a-4359-b295-0b4933161d2e" xlink:to="loc_srt_RangeAxis_3b602236-02e7-40a5-8ee3-2e779aa6bd0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8a257304-2bb4-435d-b0ce-8da24bdfda93" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3b602236-02e7-40a5-8ee3-2e779aa6bd0e" xlink:to="loc_srt_RangeMember_8a257304-2bb4-435d-b0ce-8da24bdfda93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4a326939-103c-4bb3-ac2a-f0c29396bcbe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8a257304-2bb4-435d-b0ce-8da24bdfda93" xlink:to="loc_srt_MinimumMember_4a326939-103c-4bb3-ac2a-f0c29396bcbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_29bb3526-628e-47c7-86e8-411039ffa736" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8a257304-2bb4-435d-b0ce-8da24bdfda93" xlink:to="loc_srt_MaximumMember_29bb3526-628e-47c7-86e8-411039ffa736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_78ac95fa-ec12-4075-9051-1f91f32de923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f66f907a-8a3a-4359-b295-0b4933161d2e" xlink:to="loc_us-gaap_AwardTypeAxis_78ac95fa-ec12-4075-9051-1f91f32de923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_78ac95fa-ec12-4075-9051-1f91f32de923" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_5eae3384-3286-4e37-92c3-588fe9336117" xlink:href="cvs-20201231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:to="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_5eae3384-3286-4e37-92c3-588fe9336117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_15a014cb-5e58-4764-bdda-8443fefa4b0e" xlink:href="cvs-20201231.xsd#cvs_RestrictedStockUnitsandPerformanceShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:to="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_15a014cb-5e58-4764-bdda-8443fefa4b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_a52f1313-6a4f-4edf-97b0-a0a63f3203e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_a52f1313-6a4f-4edf-97b0-a0a63f3203e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_64915bfd-1403-4d3a-9f56-e94af7cfae68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:to="loc_us-gaap_RestrictedStockMember_64915bfd-1403-4d3a-9f56-e94af7cfae68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3eb6e5a3-fc9c-4e5e-8de2-1d4c7040f8ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3eb6e5a3-fc9c-4e5e-8de2-1d4c7040f8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_4b38067e-fbcf-4b85-b43a-ae40948d096e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0050e30-5ffb-45bd-8a0a-fffaa264aa00" xlink:to="loc_us-gaap_EmployeeStockMember_4b38067e-fbcf-4b85-b43a-ae40948d096e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f66f907a-8a3a-4359-b295-0b4933161d2e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c16b76a8-97cf-4753-aca6-aef543274c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c16b76a8-97cf-4753-aca6-aef543274c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3bf49d46-8502-446c-bb5c-5de3e0d05cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_3bf49d46-8502-446c-bb5c-5de3e0d05cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_15a3a1d9-54a9-4423-af70-f9b166f50c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_15a3a1d9-54a9-4423-af70-f9b166f50c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0e65da96-e0f4-4b39-9964-ff9d27173e42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0e65da96-e0f4-4b39-9964-ff9d27173e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_164b4245-67d4-40f4-8bdb-f7d798939da6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_164b4245-67d4-40f4-8bdb-f7d798939da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_63278a6d-599b-4992-92c8-219a3e07d6a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_63278a6d-599b-4992-92c8-219a3e07d6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8539e1a0-01c2-4a9a-be80-28db60a2e505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8539e1a0-01c2-4a9a-be80-28db60a2e505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_051b4bca-492a-426b-81ba-2c2053281163" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_051b4bca-492a-426b-81ba-2c2053281163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_d1ed99e1-654f-4e4f-bd46-1ca037bdc04a" xlink:href="cvs-20201231.xsd#cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_d1ed99e1-654f-4e4f-bd46-1ca037bdc04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_59db2345-2a8d-4db9-af25-4569ae295f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_59db2345-2a8d-4db9-af25-4569ae295f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e456f9f4-33a7-4908-8e1c-d99fb4a3a798" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e456f9f4-33a7-4908-8e1c-d99fb4a3a798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ec28a393-20d0-4be3-8218-4f01a170d3e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ec28a393-20d0-4be3-8218-4f01a170d3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2795053f-083a-4e60-938f-a5973b322d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2795053f-083a-4e60-938f-a5973b322d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_14566a4a-852f-44e8-a5ec-2e1e517dde63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_14566a4a-852f-44e8-a5ec-2e1e517dde63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_79c0a2e7-ab29-4d6d-8f78-e05ba0f5f686" xlink:href="cvs-20201231.xsd#cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_863868e9-90d6-4d70-b5b6-ed97569bb490" xlink:to="loc_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_79c0a2e7-ab29-4d6d-8f78-e05ba0f5f686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansValuationandAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e6d1d282-38c3-4e10-ad65-325964b9ad35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2c21bf7c-20f5-4700-b70f-2d624dda49c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e6d1d282-38c3-4e10-ad65-325964b9ad35" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2c21bf7c-20f5-4700-b70f-2d624dda49c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_21e5ad8b-f2ae-475f-873f-be1e1da9c32a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2c21bf7c-20f5-4700-b70f-2d624dda49c0" xlink:to="loc_us-gaap_AwardTypeAxis_21e5ad8b-f2ae-475f-873f-be1e1da9c32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2ed27ad-f447-4ebe-9e95-62310bd7ecbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_21e5ad8b-f2ae-475f-873f-be1e1da9c32a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2ed27ad-f447-4ebe-9e95-62310bd7ecbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_4f92df4f-d3c4-4933-81aa-3a5d7d39be38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2ed27ad-f447-4ebe-9e95-62310bd7ecbe" xlink:to="loc_us-gaap_EmployeeStockMember_4f92df4f-d3c4-4933-81aa-3a5d7d39be38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_9203b9fc-5fe8-487c-a964-d0696b89304b" xlink:href="cvs-20201231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c2ed27ad-f447-4ebe-9e95-62310bd7ecbe" xlink:to="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_9203b9fc-5fe8-487c-a964-d0696b89304b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2c21bf7c-20f5-4700-b70f-2d624dda49c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f145d5d0-4cf5-4326-b7c3-afb3bc243bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f145d5d0-4cf5-4326-b7c3-afb3bc243bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3d6e23b2-8547-4a4b-806f-12e8b9f92f94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3d6e23b2-8547-4a4b-806f-12e8b9f92f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d0815836-344d-493c-8794-7af79406d7dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d0815836-344d-493c-8794-7af79406d7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_38d8352b-7ac5-4b7b-a1f9-37d1f4502fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_38d8352b-7ac5-4b7b-a1f9-37d1f4502fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dce838c7-e885-4342-944a-8590e4502ce4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6ad83ba-6cbd-492e-974f-c56a7e314416" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dce838c7-e885-4342-944a-8590e4502ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3798345f-f59d-4f85-8885-30c7fa1ffb3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3295aa75-eca0-4285-9ed5-2c4df028ceca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3798345f-f59d-4f85-8885-30c7fa1ffb3b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3295aa75-eca0-4285-9ed5-2c4df028ceca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4134c41f-73af-4309-879b-e627e7d6fdda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3295aa75-eca0-4285-9ed5-2c4df028ceca" xlink:to="loc_us-gaap_AwardTypeAxis_4134c41f-73af-4309-879b-e627e7d6fdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_195b2696-36a2-4c11-b70f-774a6f862e4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4134c41f-73af-4309-879b-e627e7d6fdda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_195b2696-36a2-4c11-b70f-774a6f862e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_db435b2e-b05d-4ed8-8ff7-a110e995b975" xlink:href="cvs-20201231.xsd#cvs_RestrictedStockUnitsandPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_195b2696-36a2-4c11-b70f-774a6f862e4d" xlink:to="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_db435b2e-b05d-4ed8-8ff7-a110e995b975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f504207a-4197-4093-b3e8-4720e2873eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3295aa75-eca0-4285-9ed5-2c4df028ceca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f504207a-4197-4093-b3e8-4720e2873eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f504207a-4197-4093-b3e8-4720e2873eb1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7033acfa-d8a9-43a4-b775-0ace37030f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7033acfa-d8a9-43a4-b775-0ace37030f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9a3dd517-62c1-4cda-9efc-1ecab1055e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9a3dd517-62c1-4cda-9efc-1ecab1055e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_64acc130-0114-4582-89b5-9a3d18951b3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_64acc130-0114-4582-89b5-9a3d18951b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c5155cfc-b058-4388-a03d-47e81b342bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c5155cfc-b058-4388-a03d-47e81b342bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_39a789ab-be59-4af5-8cb6-2c5071e923db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_09202382-14f8-4d0c-ae5d-b145bba932a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_39a789ab-be59-4af5-8cb6-2c5071e923db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f504207a-4197-4093-b3e8-4720e2873eb1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_10bf4c74-655c-4844-a1b5-a405184b920d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_10bf4c74-655c-4844-a1b5-a405184b920d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_31ab3538-80f1-467c-bb44-af4955d047e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_31ab3538-80f1-467c-bb44-af4955d047e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_202fd588-a7a8-4b44-8869-7d5cda14a2dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_202fd588-a7a8-4b44-8869-7d5cda14a2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0b69c0f6-6352-42d7-b725-29e68bedd29f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0b69c0f6-6352-42d7-b725-29e68bedd29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9b1b59cb-e072-412d-9587-e86d4a2125ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c731d19-9c85-4a22-81c3-6827e2bf55ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9b1b59cb-e072-412d-9587-e86d4a2125ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#StockIncentivePlansStockOptionandSARActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7e8976e6-fa96-4c09-94a5-f539cef9ea8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41d30528-5551-4ec3-91f0-1b6b381ac13e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7e8976e6-fa96-4c09-94a5-f539cef9ea8c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41d30528-5551-4ec3-91f0-1b6b381ac13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6e36bf6f-672a-4641-87e1-1d5448998a66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41d30528-5551-4ec3-91f0-1b6b381ac13e" xlink:to="loc_us-gaap_AwardTypeAxis_6e36bf6f-672a-4641-87e1-1d5448998a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109a4bf1-5bf1-43ff-925d-57250f408868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6e36bf6f-672a-4641-87e1-1d5448998a66" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109a4bf1-5bf1-43ff-925d-57250f408868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member_2eafdf65-3377-4fb0-b3ac-787c9ce89a6a" xlink:href="cvs-20201231.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109a4bf1-5bf1-43ff-925d-57250f408868" xlink:to="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member_2eafdf65-3377-4fb0-b3ac-787c9ce89a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member_457a5522-4727-473e-9319-c7e3615165fe" xlink:href="cvs-20201231.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109a4bf1-5bf1-43ff-925d-57250f408868" xlink:to="loc_cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member_457a5522-4727-473e-9319-c7e3615165fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_6e21a83b-1875-40db-8206-b33da9910615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109a4bf1-5bf1-43ff-925d-57250f408868" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_6e21a83b-1875-40db-8206-b33da9910615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_d77bf9b5-e5e9-4d1e-97d1-40f9a767647f" xlink:href="cvs-20201231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_109a4bf1-5bf1-43ff-925d-57250f408868" xlink:to="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_d77bf9b5-e5e9-4d1e-97d1-40f9a767647f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_41d30528-5551-4ec3-91f0-1b6b381ac13e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_be08844d-93da-4f60-9fce-9ca0b370dcf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_be08844d-93da-4f60-9fce-9ca0b370dcf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_e1b8fadd-963e-4525-b63a-7a511bc45fba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_e1b8fadd-963e-4525-b63a-7a511bc45fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f26335b6-36d6-4b46-94aa-f20f377e85ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f26335b6-36d6-4b46-94aa-f20f377e85ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1ac0899e-98a5-47bd-9ce4-08505550f281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1ac0899e-98a5-47bd-9ce4-08505550f281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_a3d4b9d2-6e43-4ea7-8087-0e9e36450c32" xlink:href="cvs-20201231.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_a3d4b9d2-6e43-4ea7-8087-0e9e36450c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6fe68cbe-fa87-44e1-90ae-721cab8f522b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6fe68cbe-fa87-44e1-90ae-721cab8f522b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_37865414-c6da-44d6-b8a7-566cee8e3582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_37865414-c6da-44d6-b8a7-566cee8e3582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_85e26ff2-a2fb-4007-bd27-0c0172936001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_85e26ff2-a2fb-4007-bd27-0c0172936001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_131c430f-1299-4793-88f4-84965257245a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_131c430f-1299-4793-88f4-84965257245a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_5c97115d-0e0b-47c9-80e3-0112d9a8724e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_5c97115d-0e0b-47c9-80e3-0112d9a8724e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_85fe6b76-3ce6-4357-92bf-47df842bfd26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_fad4de28-f713-42b7-a0d0-4082fa3fc0ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_85fe6b76-3ce6-4357-92bf-47df842bfd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cc11ede9-1a25-4d27-a774-8c1737e2f915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cc11ede9-1a25-4d27-a774-8c1737e2f915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_420c049d-9616-4761-aac9-38a4fae4ec29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_420c049d-9616-4761-aac9-38a4fae4ec29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a591973f-f65d-4905-8711-651f093fe046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a591973f-f65d-4905-8711-651f093fe046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8dd33a5f-b14c-476e-9c41-fbbbcc5a7071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8dd33a5f-b14c-476e-9c41-fbbbcc5a7071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_77d04326-d800-4c50-a2f3-823c778701cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_77d04326-d800-4c50-a2f3-823c778701cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_be44f5e2-6ae0-4ceb-a224-b461f6875826" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e3d864ad-2b9a-4139-b993-23482f9a82ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_be44f5e2-6ae0-4ceb-a224-b461f6875826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4b84b88b-998d-4677-8ca0-5dede36fdde0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_febbacbc-c818-4221-b0a3-b9380e85a322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_febbacbc-c818-4221-b0a3-b9380e85a322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a58d4dc0-0a0d-4609-8353-23ac242bea4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a58d4dc0-0a0d-4609-8353-23ac242bea4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_39a31b2c-786a-4d08-83e5-7cb9d6fc2775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_39a31b2c-786a-4d08-83e5-7cb9d6fc2775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_7af74455-34d6-4b63-b9b6-ec6d1620ff83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_7af74455-34d6-4b63-b9b6-ec6d1620ff83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4749609b-ba24-4e4c-9ed4-bdaf36c61094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4749609b-ba24-4e4c-9ed4-bdaf36c61094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_20b456c2-dad9-4cf8-98aa-3f526551c985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_20b456c2-dad9-4cf8-98aa-3f526551c985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_97509201-cbe3-4969-9343-f3dfbd519040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_97509201-cbe3-4969-9343-f3dfbd519040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1253e5fb-6398-4cf1-9653-8fe1d0cb35b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1253e5fb-6398-4cf1-9653-8fe1d0cb35b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_25c25e43-6a9e-4eb3-aa49-f0a00fc695b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_25c25e43-6a9e-4eb3-aa49-f0a00fc695b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_7b5751a1-07ea-458b-82ef-ec40c6360a3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_75ebcee4-9972-4192-a8b1-2ac60c7be4ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_7b5751a1-07ea-458b-82ef-ec40c6360a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ae8346e6-c67a-4f17-a5e1-10e7cf188e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_486ca560-4f9d-496f-981d-9c14c6f77afe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ae8346e6-c67a-4f17-a5e1-10e7cf188e37" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_486ca560-4f9d-496f-981d-9c14c6f77afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1df47607-04dd-4fef-bd0d-21e4d76f061e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_f70ab769-3a7f-4832-b8dc-923a3e53eb34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1df47607-04dd-4fef-bd0d-21e4d76f061e" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_f70ab769-3a7f-4832-b8dc-923a3e53eb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock_c0cfaff8-3b08-45f1-8118-82b730100bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1df47607-04dd-4fef-bd0d-21e4d76f061e" xlink:to="loc_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock_c0cfaff8-3b08-45f1-8118-82b730100bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7670e03a-52b4-4008-b263-1c2e7762bd41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_0fcdea26-a3cf-4b35-9e2a-93ba44330b71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7670e03a-52b4-4008-b263-1c2e7762bd41" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_0fcdea26-a3cf-4b35-9e2a-93ba44330b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_22121c8b-4078-4a85-8aaf-6241dabd77f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_0fcdea26-a3cf-4b35-9e2a-93ba44330b71" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_22121c8b-4078-4a85-8aaf-6241dabd77f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_3733a8c3-ba4f-44b2-9f0f-23154cb32898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_22121c8b-4078-4a85-8aaf-6241dabd77f8" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_3733a8c3-ba4f-44b2-9f0f-23154cb32898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember_36b008f1-958e-45c9-a0ae-8cedb81b30ae" xlink:href="cvs-20201231.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_3733a8c3-ba4f-44b2-9f0f-23154cb32898" xlink:to="loc_cvs_A2016RepurchaseProgramMember_36b008f1-958e-45c9-a0ae-8cedb81b30ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9b2afcc6-8990-40c3-a700-bb7b9614497e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_0fcdea26-a3cf-4b35-9e2a-93ba44330b71" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9b2afcc6-8990-40c3-a700-bb7b9614497e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3e6096b2-cf34-4b14-95cc-f65cac872578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9b2afcc6-8990-40c3-a700-bb7b9614497e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3e6096b2-cf34-4b14-95cc-f65cac872578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_39accda4-8b8c-4234-937c-edffd60be429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_9b2afcc6-8990-40c3-a700-bb7b9614497e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_39accda4-8b8c-4234-937c-edffd60be429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_de7a224f-39dc-41c5-b08e-8cf0c04de925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_ef208552-b2cf-4b9a-8936-e3a566468fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_de7a224f-39dc-41c5-b08e-8cf0c04de925" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_ef208552-b2cf-4b9a-8936-e3a566468fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityRegulatoryRequirementsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_04bafde9-b5f1-434a-8e27-8ec5794215d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable_20269336-bc6a-44f7-bbd1-3ed30ce3ded3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_04bafde9-b5f1-434a-8e27-8ec5794215d7" xlink:to="loc_us-gaap_StatutoryAccountingPracticesTable_20269336-bc6a-44f7-bbd1-3ed30ce3ded3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c8187f99-fba1-430b-8c2a-4adf581d72ed" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_20269336-bc6a-44f7-bbd1-3ed30ce3ded3" xlink:to="loc_dei_LegalEntityAxis_c8187f99-fba1-430b-8c2a-4adf581d72ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_28ca942b-bb6e-4758-8c80-ccb30a97d278" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c8187f99-fba1-430b-8c2a-4adf581d72ed" xlink:to="loc_dei_EntityDomain_28ca942b-bb6e-4758-8c80-ccb30a97d278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsuranceAndHmoMember_3c2098cc-82a7-4f6d-ab60-8b85bca63be3" xlink:href="cvs-20201231.xsd#cvs_InsuranceAndHmoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_28ca942b-bb6e-4758-8c80-ccb30a97d278" xlink:to="loc_cvs_InsuranceAndHmoMember_3c2098cc-82a7-4f6d-ab60-8b85bca63be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_20269336-bc6a-44f7-bbd1-3ed30ce3ded3" xlink:to="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_e2aa0def-859b-4736-94ad-4abd13a436dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_e2aa0def-859b-4736-94ad-4abd13a436dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_b3dc0067-ba5c-457b-80b2-d3ff1805a89b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_b3dc0067-ba5c-457b-80b2-d3ff1805a89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_062a203f-3b0d-4cc4-9afc-1d24023c97c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_062a203f-3b0d-4cc4-9afc-1d24023c97c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_964df043-0a7e-46bd-aa8d-4d6406758e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_964df043-0a7e-46bd-aa8d-4d6406758e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators_24f8925f-39f2-4864-88c6-69f4a5eebb5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_AssetsHeldByInsuranceRegulators_24f8925f-39f2-4864-88c6-69f4a5eebb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_87b5ed43-7423-4549-8202-1f06cbd3f31e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_f18e9714-5dbd-480b-bd1b-966010dffcbc" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_87b5ed43-7423-4549-8202-1f06cbd3f31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ShareholdersEquityNoncontrollingInterestsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_29793111-5998-47c0-8f3f-206604ddc17b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ced971c0-70a8-4fd2-8fef-28ce44866e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_29793111-5998-47c0-8f3f-206604ddc17b" xlink:to="loc_us-gaap_MinorityInterest_ced971c0-70a8-4fd2-8fef-28ce44866e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20201231.xsd#OtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_eac43062-ef66-4ba3-8eda-10bf9d7d3707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_ebf882aa-7418-4b79-a9e0-662d72c7cfbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_eac43062-ef66-4ba3-8eda-10bf9d7d3707" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_ebf882aa-7418-4b79-a9e0-662d72c7cfbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#OtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1f12fb72-6b8a-4651-b619-a18057fbd1ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_195d9657-80a8-4a0d-8e9b-ba74ee3dfeb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_1f12fb72-6b8a-4651-b619-a18057fbd1ac" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_195d9657-80a8-4a0d-8e9b-ba74ee3dfeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#OtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_cecdf5fb-ad38-4062-9d79-e3341a64b1ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_65e62139-3a3b-41b6-820f-5d0dcb9bd2e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_cecdf5fb-ad38-4062-9d79-e3341a64b1ac" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_65e62139-3a3b-41b6-820f-5d0dcb9bd2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b24ca1a7-8084-46c1-b8ee-f39a70b0f5cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_65e62139-3a3b-41b6-820f-5d0dcb9bd2e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b24ca1a7-8084-46c1-b8ee-f39a70b0f5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b24ca1a7-8084-46c1-b8ee-f39a70b0f5cf" xlink:to="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_4b0e0662-2fbe-4495-9c07-1db4a527c555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_4b0e0662-2fbe-4495-9c07-1db4a527c555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_47fab5ea-cdc2-4fdb-873d-9ec3f889fa7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_47fab5ea-cdc2-4fdb-873d-9ec3f889fa7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_72ce4eb6-16ae-4ad1-915f-ecdb4beb880d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_72ce4eb6-16ae-4ad1-915f-ecdb4beb880d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_6394161a-1921-41dd-89e6-aeef32153275" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_6394161a-1921-41dd-89e6-aeef32153275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_e657aee0-b14e-41d7-88d2-1e3fad8f85dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6fae5337-c037-4909-959e-d38c3b5b3f9a" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_e657aee0-b14e-41d7-88d2-1e3fad8f85dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d4f20cc3-9b84-4793-8236-8d399113ecca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_65e62139-3a3b-41b6-820f-5d0dcb9bd2e7" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d4f20cc3-9b84-4793-8236-8d399113ecca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d4f20cc3-9b84-4793-8236-8d399113ecca" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fc784e55-a06a-4ecf-abab-7f1b1a770c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fc784e55-a06a-4ecf-abab-7f1b1a770c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect_60abc6e7-3955-4471-807a-caa3bd8ca89f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:to="loc_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect_60abc6e7-3955-4471-807a-caa3bd8ca89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b324e3bf-93fd-4e64-b9b7-1747e2ea4408" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_b324e3bf-93fd-4e64-b9b7-1747e2ea4408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_70f1e61f-ddb5-4ad2-aaa3-009cc2ae3064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_70f1e61f-ddb5-4ad2-aaa3-009cc2ae3064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f67cd13f-edc8-4868-b871-806c7ad3e6d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f67cd13f-edc8-4868-b871-806c7ad3e6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_07ed6f9f-1ff0-48b4-b4cf-a1f3d78b22a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_e8698c23-3c2c-4cbc-a30a-dcee75f447c6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_07ed6f9f-1ff0-48b4-b4cf-a1f3d78b22a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_7732c65a-835c-4132-ace7-eed4352bc4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d4f20cc3-9b84-4793-8236-8d399113ecca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_7732c65a-835c-4132-ace7-eed4352bc4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f990e010-bdf1-4390-807c-6fa8b39f228d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d4f20cc3-9b84-4793-8236-8d399113ecca" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f990e010-bdf1-4390-807c-6fa8b39f228d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_ec3de1d7-5b9b-4f74-bce9-f1a35ed724b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_d4f20cc3-9b84-4793-8236-8d399113ecca" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_ec3de1d7-5b9b-4f74-bce9-f1a35ed724b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsLossPerShare" xlink:type="simple" xlink:href="cvs-20201231.xsd#EarningsLossPerShare"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ba6c7ec5-fd2d-47c1-a102-38c7c5e38f6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_817677f8-2302-4d7b-b68d-e0145bfbd69a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ba6c7ec5-fd2d-47c1-a102-38c7c5e38f6a" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_817677f8-2302-4d7b-b68d-e0145bfbd69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsLossPerShareTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#EarningsLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1274f91d-c6e3-4976-baf1-28e8811c7ebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_54c59117-42d4-4e81-a74a-138b8414d319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1274f91d-c6e3-4976-baf1-28e8811c7ebc" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_54c59117-42d4-4e81-a74a-138b8414d319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsLossPerShareDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#EarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3682662d-69ea-4f2b-806f-d862a9792a5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb99cb52-72b6-49d3-9349-c88892058d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3682662d-69ea-4f2b-806f-d862a9792a5d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb99cb52-72b6-49d3-9349-c88892058d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_65dd10cf-5897-4ef6-abb3-be88b2443a27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb99cb52-72b6-49d3-9349-c88892058d1f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_65dd10cf-5897-4ef6-abb3-be88b2443a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ab2d07-f620-4991-a18a-01a1c24e0044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_65dd10cf-5897-4ef6-abb3-be88b2443a27" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ab2d07-f620-4991-a18a-01a1c24e0044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fd6fc78f-1936-405c-9443-e26e0626195d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ab2d07-f620-4991-a18a-01a1c24e0044" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fd6fc78f-1936-405c-9443-e26e0626195d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonEquivalentSharesMember_4d77ad2c-8f1e-4fb6-a0fc-44624e5925ef" xlink:href="cvs-20201231.xsd#cvs_CommonEquivalentSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ab2d07-f620-4991-a18a-01a1c24e0044" xlink:to="loc_cvs_CommonEquivalentSharesMember_4d77ad2c-8f1e-4fb6-a0fc-44624e5925ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1a9529bb-93a4-4f16-b50f-478fb6b22212" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_bb99cb52-72b6-49d3-9349-c88892058d1f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1a9529bb-93a4-4f16-b50f-478fb6b22212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ec60b113-e01b-4e73-89f0-57e665cee257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1a9529bb-93a4-4f16-b50f-478fb6b22212" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ec60b113-e01b-4e73-89f0-57e665cee257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_34dfbcb5-efba-42fd-90ac-8c16489ad029" xlink:href="cvs-20201231.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3682662d-69ea-4f2b-806f-d862a9792a5d" xlink:to="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_34dfbcb5-efba-42fd-90ac-8c16489ad029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e70b7676-81b9-4abf-98ff-f2c6eceee446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_34dfbcb5-efba-42fd-90ac-8c16489ad029" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e70b7676-81b9-4abf-98ff-f2c6eceee446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_09ce04cf-13f6-421b-856b-93b6f6a4ef6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_34dfbcb5-efba-42fd-90ac-8c16489ad029" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_09ce04cf-13f6-421b-856b-93b6f6a4ef6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9f296967-60f7-4376-8786-ea19d231c6f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_34dfbcb5-efba-42fd-90ac-8c16489ad029" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9f296967-60f7-4376-8786-ea19d231c6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_fc7984ae-eaa2-47af-b369-1c98c3e4060a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_34dfbcb5-efba-42fd-90ac-8c16489ad029" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_fc7984ae-eaa2-47af-b369-1c98c3e4060a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_8e197843-24f6-45cf-baf1-f90c9de6a625" xlink:href="cvs-20201231.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3682662d-69ea-4f2b-806f-d862a9792a5d" xlink:to="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_8e197843-24f6-45cf-baf1-f90c9de6a625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a6296b76-f0c8-40f1-a53e-03ff6717970b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_8e197843-24f6-45cf-baf1-f90c9de6a625" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a6296b76-f0c8-40f1-a53e-03ff6717970b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_99775459-fee2-4cd3-a47e-1a08802d8eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_8e197843-24f6-45cf-baf1-f90c9de6a625" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_99775459-fee2-4cd3-a47e-1a08802d8eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_53090384-3665-47dc-86ee-1652de15e913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_8e197843-24f6-45cf-baf1-f90c9de6a625" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_53090384-3665-47dc-86ee-1652de15e913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1d645f7d-cb1a-4d41-9738-a796c36628e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3682662d-69ea-4f2b-806f-d862a9792a5d" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1d645f7d-cb1a-4d41-9738-a796c36628e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_a16c11c7-306d-4002-970b-6acf916d2eba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1d645f7d-cb1a-4d41-9738-a796c36628e4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_a16c11c7-306d-4002-970b-6acf916d2eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_00bd6837-7c9d-4cbf-855c-c8baa711465e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1d645f7d-cb1a-4d41-9738-a796c36628e4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_00bd6837-7c9d-4cbf-855c-c8baa711465e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Reinsurance" xlink:type="simple" xlink:href="cvs-20201231.xsd#Reinsurance"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Reinsurance" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_98a69d42-ae78-4944-97ea-abd9e0c091c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock_199174c8-85b8-45de-82f6-fd704057e41f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_98a69d42-ae78-4944-97ea-abd9e0c091c8" xlink:to="loc_us-gaap_ReinsuranceTextBlock_199174c8-85b8-45de-82f6-fd704057e41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#ReinsuranceTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_392e78d7-37ed-43e9-8f59-07c86b19ef21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_b214b8cb-1726-415f-87a7-2efb5c699965" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_392e78d7-37ed-43e9-8f59-07c86b19ef21" xlink:to="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_b214b8cb-1726-415f-87a7-2efb5c699965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_00eee9b8-1bec-4ec7-b00c-91926c5a76b0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_392e78d7-37ed-43e9-8f59-07c86b19ef21" xlink:to="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_00eee9b8-1bec-4ec7-b00c-91926c5a76b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceTableTextBlock_d93f5613-f7fc-4343-b6dd-b4b3e785b760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectsOfReinsuranceTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_392e78d7-37ed-43e9-8f59-07c86b19ef21" xlink:to="loc_us-gaap_EffectsOfReinsuranceTableTextBlock_d93f5613-f7fc-4343-b6dd-b4b3e785b760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ReinsuranceNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_fecbf32a-3afe-4bcf-bc33-4998843392a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_749468f4-b609-40d1-8092-c87b18994ba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_fecbf32a-3afe-4bcf-bc33-4998843392a0" xlink:to="loc_us-gaap_SubsequentEventTable_749468f4-b609-40d1-8092-c87b18994ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_769dfdbd-bd8f-48bd-af16-51495439b58d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_749468f4-b609-40d1-8092-c87b18994ba2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_769dfdbd-bd8f-48bd-af16-51495439b58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_09674efa-1643-4b04-a485-e89b99264427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_769dfdbd-bd8f-48bd-af16-51495439b58d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_09674efa-1643-4b04-a485-e89b99264427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_087dd1c0-02a6-4d2d-a0bd-65267f564e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_09674efa-1643-4b04-a485-e89b99264427" xlink:to="loc_us-gaap_SubsequentEventMember_087dd1c0-02a6-4d2d-a0bd-65267f564e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_74ea3b1a-9136-4099-900d-99d609607bee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_749468f4-b609-40d1-8092-c87b18994ba2" xlink:to="loc_us-gaap_SubsequentEventLineItems_74ea3b1a-9136-4099-900d-99d609607bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofReinsuranceContractsEnteredInto_87c14767-3c9e-4ed4-b496-198df1684a2a" xlink:href="cvs-20201231.xsd#cvs_NumberofReinsuranceContractsEnteredInto"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_74ea3b1a-9136-4099-900d-99d609607bee" xlink:to="loc_cvs_NumberofReinsuranceContractsEnteredInto_87c14767-3c9e-4ed4-b496-198df1684a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_41b2c945-0256-4b8d-adc7-f89ab5b92a6b" xlink:href="cvs-20201231.xsd#cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_74ea3b1a-9136-4099-900d-99d609607bee" xlink:to="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_41b2c945-0256-4b8d-adc7-f89ab5b92a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ReinsuranceReinsuranceRecoverablesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_9a7fd73a-e3d1-4f8b-bb69-c774953e8b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable_4a94a19f-6343-44d9-92db-04024048dbd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_9a7fd73a-e3d1-4f8b-bb69-c774953e8b7b" xlink:to="loc_us-gaap_CededCreditRiskTable_4a94a19f-6343-44d9-92db-04024048dbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis_9d2575cf-4084-43d0-9a7f-cc4895fed1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_4a94a19f-6343-44d9-92db-04024048dbd9" xlink:to="loc_us-gaap_CededCreditRiskAxis_9d2575cf-4084-43d0-9a7f-cc4895fed1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskAxis_9d2575cf-4084-43d0-9a7f-cc4895fed1b6" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_6d56348a-382e-4791-9dd0-e987cd83cff6" xlink:href="cvs-20201231.xsd#cvs_HartfordLifeAndAccidentInsuranceCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:to="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_6d56348a-382e-4791-9dd0-e987cd83cff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_3e52f0d7-62b2-4e7c-a97f-122aec9e559c" xlink:href="cvs-20201231.xsd#cvs_LincolnLifeAnnuityCompanyOfNewYorkMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:to="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_3e52f0d7-62b2-4e7c-a97f-122aec9e559c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_WellCareHealthPlansMember_941fe80b-3d1a-4318-bc3f-34c512a13c10" xlink:href="cvs-20201231.xsd#cvs_WellCareHealthPlansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:to="loc_cvs_WellCareHealthPlansMember_941fe80b-3d1a-4318-bc3f-34c512a13c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_d4c30a80-5aa0-44a2-bbda-ae7fa70b2284" xlink:href="cvs-20201231.xsd#cvs_VOYARetirementInsuranceAndAnnuityCompanyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:to="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_d4c30a80-5aa0-44a2-bbda-ae7fa70b2284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AllOtherReinsurersMember_477fb4fc-3674-4949-8095-d1f714191904" xlink:href="cvs-20201231.xsd#cvs_AllOtherReinsurersMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_5066ea36-e494-4359-aa3d-d9e3ae34d7d1" xlink:to="loc_cvs_AllOtherReinsurersMember_477fb4fc-3674-4949-8095-d1f714191904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems_ee390f9c-90f9-4083-830a-e47ba3238687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_4a94a19f-6343-44d9-92db-04024048dbd9" xlink:to="loc_us-gaap_CededCreditRiskLineItems_ee390f9c-90f9-4083-830a-e47ba3238687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_d851a6ff-22ef-4ae1-b694-b5b5d3b16f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_ee390f9c-90f9-4083-830a-e47ba3238687" xlink:to="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_d851a6ff-22ef-4ae1-b694-b5b5d3b16f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#ReinsuranceEffectsofReinsuranceDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_12331937-4bf7-4b96-bab1-5094c606385b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_0088705d-1fbc-4878-8a45-73378e867494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_12331937-4bf7-4b96-bab1-5094c606385b" xlink:to="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_0088705d-1fbc-4878-8a45-73378e867494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned_d2c7fe48-d0b4-4db6-8ce4-1bd2bb790067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_0088705d-1fbc-4878-8a45-73378e867494" xlink:to="loc_us-gaap_DirectPremiumsEarned_d2c7fe48-d0b4-4db6-8ce4-1bd2bb790067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned_93f7a239-3ceb-47c1-84d5-50fe80d5a65a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_0088705d-1fbc-4878-8a45-73378e867494" xlink:to="loc_us-gaap_AssumedPremiumsEarned_93f7a239-3ceb-47c1-84d5-50fe80d5a65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned_74165267-9a8b-434b-9d42-4b8b6ef7d6dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CededPremiumsEarned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_0088705d-1fbc-4878-8a45-73378e867494" xlink:to="loc_us-gaap_CededPremiumsEarned_74165267-9a8b-434b-9d42-4b8b6ef7d6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_d3f22edb-387b-4f83-901e-f9021de37b41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_0088705d-1fbc-4878-8a45-73378e867494" xlink:to="loc_us-gaap_PremiumsEarnedNet_d3f22edb-387b-4f83-901e-f9021de37b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_439578c1-2c55-49f7-b6b6-362612f7df39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_12331937-4bf7-4b96-bab1-5094c606385b" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_439578c1-2c55-49f7-b6b6-362612f7df39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_798e40cd-26ff-44f5-8532-37d6b0d08620" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_439578c1-2c55-49f7-b6b6-362612f7df39" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_798e40cd-26ff-44f5-8532-37d6b0d08620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_3abd74e4-e5ed-41a3-b4af-12d1b9d034fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_439578c1-2c55-49f7-b6b6-362612f7df39" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_3abd74e4-e5ed-41a3-b4af-12d1b9d034fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_f1baa0fc-1413-481f-bbf9-e38f6fb8dcff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_439578c1-2c55-49f7-b6b6-362612f7df39" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_f1baa0fc-1413-481f-bbf9-e38f6fb8dcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_a4d235c1-cb8d-4832-905f-56993d17bca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_439578c1-2c55-49f7-b6b6-362612f7df39" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_a4d235c1-cb8d-4832-905f-56993d17bca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cvs-20201231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_aa8da1ba-026a-4ed8-ad37-a948a9e52af8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_00a8ab28-aa55-40b3-af0e-30c4664d3dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_aa8da1ba-026a-4ed8-ad37-a948a9e52af8" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_00a8ab28-aa55-40b3-af0e-30c4664d3dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d4666e1-3f3f-4756-ae14-e1ca35a2368d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_54894501-27b5-4006-a578-d320fdf0ce7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d4666e1-3f3f-4756-ae14-e1ca35a2368d" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_54894501-27b5-4006-a578-d320fdf0ce7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_7d6ac0ca-33bb-4e8c-a7a8-37e5aaf4fa29" xlink:href="cvs-20201231.xsd#cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d4666e1-3f3f-4756-ae14-e1ca35a2368d" xlink:to="loc_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_7d6ac0ca-33bb-4e8c-a7a8-37e5aaf4fa29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases_392636f3-1136-422a-94c6-58a2f8016f02" xlink:href="cvs-20201231.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d4666e1-3f3f-4756-ae14-e1ca35a2368d" xlink:to="loc_cvs_GuarantorObligationsNumberofLeases_392636f3-1136-422a-94c6-58a2f8016f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_294bcddc-eef6-4199-abe3-f5c8bd92db4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuarantyLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d4666e1-3f3f-4756-ae14-e1ca35a2368d" xlink:to="loc_us-gaap_GuarantyLiabilities_294bcddc-eef6-4199-abe3-f5c8bd92db4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0d2c0e68-103c-47ec-b28a-7900af70876b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_94e83e68-f01b-4e23-9d0c-487d6b40d45f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0d2c0e68-103c-47ec-b28a-7900af70876b" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_94e83e68-f01b-4e23-9d0c-487d6b40d45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7bd404d5-adf0-4797-b181-57ed50e42228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_934270c7-9a2a-4efc-b092-ec5dba9731f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7bd404d5-adf0-4797-b181-57ed50e42228" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_934270c7-9a2a-4efc-b092-ec5dba9731f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_2a803977-5ef2-42e4-9385-18a0712fe428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7bd404d5-adf0-4797-b181-57ed50e42228" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_2a803977-5ef2-42e4-9385-18a0712fe428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_56a8b411-6840-4c7f-90c1-3792616fa3db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_27baab94-1124-41ec-867b-c5dc7cbc2058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_56a8b411-6840-4c7f-90c1-3792616fa3db" xlink:to="loc_us-gaap_ConcentrationRiskTable_27baab94-1124-41ec-867b-c5dc7cbc2058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_82f87bc9-6bbc-4118-9418-d025cb121ab0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_27baab94-1124-41ec-867b-c5dc7cbc2058" xlink:to="loc_srt_MajorCustomersAxis_82f87bc9-6bbc-4118-9418-d025cb121ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3f7e9ecb-7d7c-4d66-aa63-4cbfe24a6668" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_82f87bc9-6bbc-4118-9418-d025cb121ab0" xlink:to="loc_srt_NameOfMajorCustomerDomain_3f7e9ecb-7d7c-4d66-aa63-4cbfe24a6668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc.Member_4f274d8b-fe89-4862-84d3-7a1112657332" xlink:href="cvs-20201231.xsd#cvs_AetnaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_3f7e9ecb-7d7c-4d66-aa63-4cbfe24a6668" xlink:to="loc_cvs_AetnaInc.Member_4f274d8b-fe89-4862-84d3-7a1112657332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USFederalGovernmentMember_c81fb11b-a06b-4787-89b8-875c35975e6d" xlink:href="cvs-20201231.xsd#cvs_USFederalGovernmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_3f7e9ecb-7d7c-4d66-aa63-4cbfe24a6668" xlink:to="loc_cvs_USFederalGovernmentMember_c81fb11b-a06b-4787-89b8-875c35975e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e11286fc-a273-4476-b8ab-7e7411bb22e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_27baab94-1124-41ec-867b-c5dc7cbc2058" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e11286fc-a273-4476-b8ab-7e7411bb22e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_08c7883a-8cdc-42c6-819c-67c3cf072147" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e11286fc-a273-4476-b8ab-7e7411bb22e6" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_08c7883a-8cdc-42c6-819c-67c3cf072147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_3944bfcd-a15e-4717-8286-7d7087fb712b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_08c7883a-8cdc-42c6-819c-67c3cf072147" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_3944bfcd-a15e-4717-8286-7d7087fb712b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_63de79da-e650-4a69-9275-0ee07edbdc8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_27baab94-1124-41ec-867b-c5dc7cbc2058" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_63de79da-e650-4a69-9275-0ee07edbdc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_acda3ed8-5f68-4ea2-a645-e8055074923e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_63de79da-e650-4a69-9275-0ee07edbdc8f" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_acda3ed8-5f68-4ea2-a645-e8055074923e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_a81f7bb6-f204-4183-8be7-03ce14fa4258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_acda3ed8-5f68-4ea2-a645-e8055074923e" xlink:to="loc_us-gaap_SalesRevenueNetMember_a81f7bb6-f204-4183-8be7-03ce14fa4258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_4c37ad0d-2314-48af-bce7-46a89f75c4dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_27baab94-1124-41ec-867b-c5dc7cbc2058" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_4c37ad0d-2314-48af-bce7-46a89f75c4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_17215e62-576e-469e-9171-db700c8dce83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_4c37ad0d-2314-48af-bce7-46a89f75c4dc" xlink:to="loc_us-gaap_NumberOfOperatingSegments_17215e62-576e-469e-9171-db700c8dce83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_79be953d-3a14-404a-aa56-d612271e7b1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_4c37ad0d-2314-48af-bce7-46a89f75c4dc" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_79be953d-3a14-404a-aa56-d612271e7b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReportingSummarizedFinancialInformationofSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7ce29578-8c0b-4302-b05f-a906f3676df3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ff47053-b0d4-474a-9fc7-bea74c3be568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7ce29578-8c0b-4302-b05f-a906f3676df3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ff47053-b0d4-474a-9fc7-bea74c3be568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7981e44a-3d63-4334-b918-2d99862f9e00" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ff47053-b0d4-474a-9fc7-bea74c3be568" xlink:to="loc_srt_ConsolidationItemsAxis_7981e44a-3d63-4334-b918-2d99862f9e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9774d527-5f78-4b92-8b4d-0e47c1934537" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_7981e44a-3d63-4334-b918-2d99862f9e00" xlink:to="loc_srt_ConsolidationItemsDomain_9774d527-5f78-4b92-8b4d-0e47c1934537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d02ac021-b51f-4be1-accc-249a3b5b4592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9774d527-5f78-4b92-8b4d-0e47c1934537" xlink:to="loc_us-gaap_OperatingSegmentsMember_d02ac021-b51f-4be1-accc-249a3b5b4592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_bbd0f78c-e275-4904-8107-304053eb5177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9774d527-5f78-4b92-8b4d-0e47c1934537" xlink:to="loc_us-gaap_IntersegmentEliminationMember_bbd0f78c-e275-4904-8107-304053eb5177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_fc39d354-0206-4c04-bbe1-a58a7810c589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_9774d527-5f78-4b92-8b4d-0e47c1934537" xlink:to="loc_us-gaap_CorporateNonSegmentMember_fc39d354-0206-4c04-bbe1-a58a7810c589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3317a933-aba7-4608-86ce-89bb20da1b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ff47053-b0d4-474a-9fc7-bea74c3be568" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3317a933-aba7-4608-86ce-89bb20da1b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ee14efa9-1967-487e-bfd5-95f797e9ebfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3317a933-aba7-4608-86ce-89bb20da1b36" xlink:to="loc_us-gaap_SegmentDomain_ee14efa9-1967-487e-bfd5-95f797e9ebfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_07b11a51-3f93-456e-9318-880e6913b6aa" xlink:href="cvs-20201231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ee14efa9-1967-487e-bfd5-95f797e9ebfd" xlink:to="loc_cvs_PharmacyServicesSegmentMember_07b11a51-3f93-456e-9318-880e6913b6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_b7b1fbdc-d1cd-4027-90d2-dd229e288ac3" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ee14efa9-1967-487e-bfd5-95f797e9ebfd" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_b7b1fbdc-d1cd-4027-90d2-dd229e288ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_c3a438f6-ebc1-468f-b42a-f05d5c681f82" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ee14efa9-1967-487e-bfd5-95f797e9ebfd" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_c3a438f6-ebc1-468f-b42a-f05d5c681f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5ff47053-b0d4-474a-9fc7-bea74c3be568" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_b14f19b5-b33d-4241-90fc-d09f3a1300d1" xlink:href="cvs-20201231.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_b14f19b5-b33d-4241-90fc-d09f3a1300d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_137696d9-842f-4fc5-9bdc-59f1cccf518c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_137696d9-842f-4fc5-9bdc-59f1cccf518c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_76d88ecb-5de0-4a12-91ce-2cac1e8cc4d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_us-gaap_NetInvestmentIncome_76d88ecb-5de0-4a12-91ce-2cac1e8cc4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_694a72e4-4083-4fa5-9b6a-de43df3fb9d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_us-gaap_Revenues_694a72e4-4083-4fa5-9b6a-de43df3fb9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_baf14011-6d3b-4c51-b069-2166f7095bdf" xlink:href="cvs-20201231.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_baf14011-6d3b-4c51-b069-2166f7095bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5bff06e6-db74-4fca-b9b4-b38b6e38b18a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5bff06e6-db74-4fca-b9b4-b38b6e38b18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_bf48990d-98c6-4312-a834-005932186101" xlink:href="cvs-20201231.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2e11e3ae-f293-4a82-bb01-9d5ddac2f157" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_bf48990d-98c6-4312-a834-005932186101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails" xlink:type="simple" xlink:href="cvs-20201231.xsd#SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_19bc59ca-4e71-4bfa-bcec-b4c04694ccab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_19bc59ca-4e71-4bfa-bcec-b4c04694ccab" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ee251d31-3513-40e3-bd10-b6e28c15d7d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_us-gaap_DebtInstrumentAxis_ee251d31-3513-40e3-bd10-b6e28c15d7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f1c0d4a8-dc1c-42c0-a38e-9f84b36f079b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ee251d31-3513-40e3-bd10-b6e28c15d7d4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f1c0d4a8-dc1c-42c0-a38e-9f84b36f079b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TwoThousandEighteenNotesMember_d22f1d82-e7d2-429a-865e-cef750c8c44f" xlink:href="cvs-20201231.xsd#cvs_TwoThousandEighteenNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f1c0d4a8-dc1c-42c0-a38e-9f84b36f079b" xlink:to="loc_cvs_TwoThousandEighteenNotesMember_d22f1d82-e7d2-429a-865e-cef750c8c44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_246ec571-f3cd-492b-a585-b0c42a3a15c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_246ec571-f3cd-492b-a585-b0c42a3a15c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41c7b4b9-756c-4a9d-9438-ee149d1e6388" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_246ec571-f3cd-492b-a585-b0c42a3a15c2" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41c7b4b9-756c-4a9d-9438-ee149d1e6388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RXCrossroadsMember_3483da23-b597-4893-bcb4-774cf6d89e2b" xlink:href="cvs-20201231.xsd#cvs_RXCrossroadsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41c7b4b9-756c-4a9d-9438-ee149d1e6388" xlink:to="loc_cvs_RXCrossroadsMember_3483da23-b597-4893-bcb4-774cf6d89e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_80f19b25-9d18-4073-a180-352085dc5544" xlink:href="cvs-20201231.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_41c7b4b9-756c-4a9d-9438-ee149d1e6388" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_80f19b25-9d18-4073-a180-352085dc5544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a23cb319-0f8d-43e1-a1a7-1859d37463b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a23cb319-0f8d-43e1-a1a7-1859d37463b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a017e82c-7a12-499c-bf30-fa252f749c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a23cb319-0f8d-43e1-a1a7-1859d37463b4" xlink:to="loc_us-gaap_SegmentDomain_a017e82c-7a12-499c-bf30-fa252f749c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_d27d4acb-c2be-460c-bca8-219e59a7ed7b" xlink:href="cvs-20201231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a017e82c-7a12-499c-bf30-fa252f749c8c" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_d27d4acb-c2be-460c-bca8-219e59a7ed7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_e550f9cf-f3bc-423e-95e6-eee51954f7fa" xlink:href="cvs-20201231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a017e82c-7a12-499c-bf30-fa252f749c8c" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_e550f9cf-f3bc-423e-95e6-eee51954f7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_57f0f30c-fa08-4256-ac33-3325fe721c97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_57f0f30c-fa08-4256-ac33-3325fe721c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5e4f15d9-0be5-4906-a040-f029bc72b855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_57f0f30c-fa08-4256-ac33-3325fe721c97" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5e4f15d9-0be5-4906-a040-f029bc72b855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_750327e5-6643-4671-9e64-ae4d8d97d08d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_5e4f15d9-0be5-4906-a040-f029bc72b855" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_750327e5-6643-4671-9e64-ae4d8d97d08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_715af28b-e610-47fb-aa56-40cd974f0f03" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_srt_LitigationCaseAxis_715af28b-e610-47fb-aa56-40cd974f0f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c04c467b-a4f0-4b6e-a15c-7792318123e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_715af28b-e610-47fb-aa56-40cd974f0f03" xlink:to="loc_srt_LitigationCaseTypeDomain_c04c467b-a4f0-4b6e-a15c-7792318123e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_bdc46ce1-dd6a-4106-bde9-20c28b364913" xlink:href="cvs-20201231.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c04c467b-a4f0-4b6e-a15c-7792318123e9" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_bdc46ce1-dd6a-4106-bde9-20c28b364913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_1edc673c-7248-4da9-a013-2ef975bb8ac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_us-gaap_LitigationStatusAxis_1edc673c-7248-4da9-a013-2ef975bb8ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d71f1a23-ff54-4e63-9ce2-91aaa359db68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_1edc673c-7248-4da9-a013-2ef975bb8ac1" xlink:to="loc_us-gaap_LitigationStatusDomain_d71f1a23-ff54-4e63-9ce2-91aaa359db68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_bdf58c09-76bb-4624-8cd7-e865e9c90c21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_d71f1a23-ff54-4e63-9ce2-91aaa359db68" xlink:to="loc_us-gaap_SettledLitigationMember_bdf58c09-76bb-4624-8cd7-e865e9c90c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_91ae72d6-4dd6-4d45-9241-1d69d7cd1a30" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_af38ed61-4a89-4a64-a772-3a498aa802cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_OperatingIncomeLoss_af38ed61-4a89-4a64-a772-3a498aa802cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_805b4449-3dfd-4989-87ca-f321087617a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_805b4449-3dfd-4989-87ca-f321087617a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_fc0bead6-6b98-4e60-ac77-f77e6f3ae66b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_fc0bead6-6b98-4e60-ac77-f77e6f3ae66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_ec053e68-ca60-418a-8d34-3830e890a535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_ec053e68-ca60-418a-8d34-3830e890a535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_057306d0-7bae-4faf-afc9-91fbadc99d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_057306d0-7bae-4faf-afc9-91fbadc99d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreRationalizationCharges_fb3d5bc4-e2c3-4fae-bbbd-94d1ed33d901" xlink:href="cvs-20201231.xsd#cvs_StoreRationalizationCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_cvs_StoreRationalizationCharges_fb3d5bc4-e2c3-4fae-bbbd-94d1ed33d901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_743e64b9-1a3a-4f1b-990f-b798ac324d33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_743e64b9-1a3a-4f1b-990f-b798ac324d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_0e71f281-9b4f-482f-86c8-7009363b0868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_0e71f281-9b4f-482f-86c8-7009363b0868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_b049c3fd-b504-484e-a487-25c6ebfad080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_b049c3fd-b504-484e-a487-25c6ebfad080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_c9d17d7e-5dd6-4253-ae0b-90d8e8e21b85" xlink:href="cvs-20201231.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_c9d17d7e-5dd6-4253-ae0b-90d8e8e21b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9459b3ad-c4a4-44c6-85e6-de65db1862bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9459b3ad-c4a4-44c6-85e6-de65db1862bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_997d6ce2-7c26-44eb-b1b0-095679f10f00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_997d6ce2-7c26-44eb-b1b0-095679f10f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_2f69ef69-a2ed-4bbd-b104-e29b7776bffd" xlink:href="cvs-20201231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_2f69ef69-a2ed-4bbd-b104-e29b7776bffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfUnderPerformingStoresPlannedClosure_d3b6d372-fde0-4612-bf17-b482a5267c7e" xlink:href="cvs-20201231.xsd#cvs_NumberOfUnderPerformingStoresPlannedClosure"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_cvs_NumberOfUnderPerformingStoresPlannedClosure_d3b6d372-fde0-4612-bf17-b482a5267c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3be36799-0120-4931-ac08-6edc66f71269" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0318a349-0163-41a7-896a-2a5c88daed66" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3be36799-0120-4931-ac08-6edc66f71269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>cvs-20201231_g1.jpg
<DESCRIPTION>CVS HEALTH LOGO
<TEXT>
begin 644 cvs-20201231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  < )T# 2(  A$! Q$!_\0
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M>(O@BW@63PU_PLX3?\([?_V@?#O]N&P_L[S/M.S[=Y()\[9Y>[G;CY3\[?\
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&-FB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>cvs-20201231_g2.jpg
<DESCRIPTION>STOCK PERFORMANCE GRAPH
<TEXT>
begin 644 cvs-20201231_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBGD."8XWMED7<<(6DQC>V0#T:BOS4TC_ (.#M9^*W[.OQ@_;N_9M_9 B\5_
M?X,>*UT76?$NH^/&T[6]=5/LYN;O3]/^P21&.*.Z@F"SW,3R(_1&!2N9_P""
MVW_!9SXC^ ?^"//AG]L[_@GC:Q7'A_XQ"/2K;XA7=ZL-WX9%S',&2.U&6:]5
MH+F$MNVP20L<N=M 'ZH(Z2()(V#*PRK Y!%+7YQ?!;_@I_J'_!/?_@B7\/\
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M'Q/^%OP8_P"#OWXV^,OBQ\0] \)Z*D_B&.35?$6K06%JLLEK;[5,LS*@9CG
MSDG-7O'4C?M9_P#!U]X,^./_  2HE36_#GA^[T5_C#X]\$)YFB31QJXU4S7<
M/[B42V9CM]VXB2; &YN: /Z#Z*^6_P!K3_@ICHGP._;"^&?_  3S^"_P[@\<
M?&3XGV\^HVFCW^N'3--T/1X(YY)=0OKI8)W4$6TXBBCB=I&B8$QY4MY':?\
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M'6MQZEX?\4:+:ZMH>HP@[+JSN85FAE&><,CJW/K0!Y_^U!^WI^QE^Q8FF_\
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M87_**#Q1_P!EPU?_ --FDU^?/_!1O_@H1_P3V^)G_!3/XI>+_P#@IA_P2_\
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M?MO_ +$'[1W[.W_!HE\,_A?\1_ &K1>(=!^(4'BSQ1HQM',V@V%Y=:E)&)T
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MW\$:IK7B1+/70ZVZ?8!INFS>3<727-LLB Q%YA/"8S)L&/Z'OV;O W@[X9_
M#P9\/_AY\,[GP7H6D>&;*UT?PA>SF2;1;985$=G(QDDR\2X1OG<94X9AR>CN
M/!OA"[\1P^,;KPIILNKV\?EV^JR6,;7,2<C:LI&Y1R> >YK2H _%K_@OO_P7
M:_8W\*?'6U_X)L>.CXL\3> ].NDN/CW%\.Y(/M.IF)U>+PR+B2>(0QNP#7KQ
MDN$46R[6DF,7KOP)_:Y\(?\ !PO_ ,$U?VC/V?OV7_@#<?#WP/IG@6V\)?#^
MVUK[/"[ZTMK/.D)CMW:&"TA\O3%4*<@/)G "@?J110!_-+K-GJ6O_P#!L=X5
M_P""<.DZ7/-\>4_:*E\./\)%4?V^FHC4KJ[,;6>?-11"ZN9&4( 1E@"#7ZZ_
M'3X?^!?V /\ @@!XA_9K^*/Q#T32[OPQ^R]J?AQKB_U..%-0U1=!EAD2#>09
M&DN6(1%RQ,B@ DBOM5?"7A1/$C>,4\,:>-7>#R7U464?VEHO[AEQN*\#C.*T
M* /QW_X,O?B-X G_ .";7B[X81>-M*/B2W^,6IWLWA_^T(_MJ6SZ;I:I/Y.=
M_E,R.H?&TE&&<J0/HKPG_P %L?\ @CK^WAXD^(O[%G[0^O:=X8N=!U2\T?7?
M!_Q\TFUTNVU@0R-$[VYN)6B?Y@2L;M'<#[WE+@D??U9%SX \!WGB:/QK=^"=
M(EUF( 1:M)IL372 # Q*5WC XZT ?"__  ;X_L$7_P"PK\#/BY;Z;8ZIIG@W
MQY\;];UOX8:'K*2I=6_AE"EKIT\Z3 2)+-#"LF' <Q^26 8E1Z'_ ,%)/^"4
MNK_\%#/&_AKQEIO[=WQC^$:^'=*FLFT[X9>(FLH-0+R[_-F4$;G7[H/I7UY1
M0!X%_P $Y_V&+_\ X)^_!+5/@UJ/[3_Q"^++ZGXJGUH>(_B5JYO;ZV$EM;0?
M9(W).(5^S&0+_>FD/>O)?^"J_P"T_P# /Q)XE\$?\$N]>_:4T+P;K_QLU62V
M\6W4NK6:7&D^&[:VDO+H.MR&B5KWR8K&-)D*RI=S$!O+(K[7HH _$+_@ZV_X
M)V:EJ?["NF_M6>/_ -L/5_%?B?X8ZM&FC:9XML?#^G-=:=>S0P745M]@L;62
M>5)/LLH0LX5(Y<+ELUZI\!O^"IWPW_;V_P"#9[XP>-/'_P 4M)C^(/AC]GKQ
M-X6\?V6H:I$ET^J+H]Q:VURR,P9OMNZ!T(&'FF>-<LA%?K310!_+O\/?B1\/
MK3_@ST\=^!+GQMI2:W<_'B""#2#?Q_:6D^VV%P%\K.[/DQ22=/NH3T%?1W_!
M3KXF?#J__P"#1#X":)8>.]'GO+S3O"%E:6D.HQ-+-<VL1^TPJH;)>+:?,7JF
M/FQ7[]44 ?S*?\%POBC\-?$'_!.3_@E[::%X_P!&O9M)^%MFVJ0VNI12/9K%
MIWA^WE,JJQ,86:WN(B6QAX)%ZHP'U1_P=E7UKI'[0/[$'[4$TOG> -$\<W<^
MJ>*[)3/901O=Z-=1L9(\J1)!!/(F"=ZPN5SM-?N'5+Q!X;\.^+-,?1/%.@V6
MIV4C*9+34+5)HF(.02C@@X(!'% '\_WC']J+X&?&[_@\%^#OQQ^'OCNWG\&W
M?A^*STKQ/>(UI9:FSZ!J4,<EM).$$T4DTBQ1R+\LC\(6!4GTC]J+_@H'HWQE
M_P""W?QA_8G^(7PVUWP#HVC> +W2["/X7^!+I_%GQ3UA;:W:SM=0U#3H3?#3
M"LCR)$KQV[)"GGR%&*C]Q(88K>)8((E1$4*B(N H'   Z"HUT[3UOVU5;&$7
M3Q")KD1#S"@)(4MU(!)..G- '\\7_!OM\7_AQX1_X-]OVU_AGXK\4P:7K%E8
M>+;N[@U%&ACACNO#,%I;JTK@1K)+/')&D1;S'9"%4X./K?\ X,T/$WAS4/\
M@E9KWA>QU^SFU/3OBWJDFH:=%<JT]LDMI8F-Y(P=R*^UMI(PVUL9P:_6:RTW
M3M-$HTZP@MQ/,TTP@B">9(WWG; Y8]R>34U !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;3-%/$\K91U)#*?EZ@@BMGP'^TM\!_BA=7%E\/\ XGZ9JLMI&'N$M9&)C4G
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M7COPSTC2=+_;P\>:'INF6]O91>"-+>*S@@5(D9I&W,$ P">YQS7OM>%^ ?\
ME()X_P#^Q$TK_P!&-0![=_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%9WBRSM(?#=Y+#:QHRPDJRH
M16O6;XQ_Y%B]_P"N!H GL+"Q:QA9K*(DQ*23&.>*E_L[3_\ GQA_[]"C3O\
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MJ* (?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ* (?[.T__ )\8?^_0H_L[3_\
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M&_TW7OB]\=O#/AWPY!:$.TKRFXF:88_Y9HD99G^ZH.20* .K\:?%[4_VZ?\
M@M1XB_X)\ZYKNIP?"KX%_"VV\0>-M TK5)K,>)/$>I-;M9PWKP.KRVD%G-YJ
MP;@CS,&=7"(%U/V!?V@_%_PJ_P""FWQ\_P""4GBSQ3J6M>'O"&B:7XY^$5UK
M>HRWE[8Z)>QPI>:;)/,S22PV]Y,JP%V9UBDV%MJ(J\'^R=X.U'X)_P#!R[^U
M#I?BJ-X4^+WP=\->+/"$LW NK6P2VTVZ53T9DN V5'(7:3ZT?LL>"]5^(_\
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M4G%TV.E2_P#"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
MX%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M0!L45C_ /"#Z1_S\WO_
M (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;4
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M[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\
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M16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\
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M(/I'_/S>_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\
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M!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!6/X'_Y!$O\ U^S?^A5L5C^!_P#D$2_]?LW_ *%0!L4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!CV7_([WO\ UY1?
MS-;%8]E_R.][_P!>47\S6Q0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !6/9?\CO>_]>47\S6Q6/9?\CO>_P#7E%_,T ;%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 8_B7_ )"^C_\ 7Z?_ $$UL5C^)?\ D+Z/_P!?I_\ 036Q0 4444 %%%%
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M0 4444 %%%% !1110 4444 %9OC'_D6+W_K@:TJS?&/_ "+%[_UP- %S3O\
MD'P?]<5_D*FJ'3O^0?!_UQ7^0J:@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "L?P/_P @B7_K]F_]"K8K'\#_ /((E_Z_
M9O\ T*@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#'LO^1WO?^O*+^9K8K'LO^1WO?\ KRB_F:V* "BBB@ HHHH
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M=._Y!\'_ %Q7^0J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'2_%4;PI\7O@[X:\6>$)9N!=6M@EMIMTJGHS)<!LJ.0NTGUH_98\%ZK\1_\
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MV[))ZFM/_A!](_Y^;W_P+:BR_P"1WO?^O*+^9K8H Q_^$'TC_GYO?_ MJ/\
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M;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\
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MX0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^
M?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y
M^;W_ ,"VKX%_X?':1_T;3>_^' ;_ .0J_1*OP+H ^V[G_@L+ITTT,D?[-]RH
MC?+AO';,6&.@/V/Y?K4__#X[2/\ HVF]_P##@-_\A5\.T4 ?J_\ L.?M5Z1^
MV;_PE'_%N;WPW_PC?V+_ )F9KS[1]H^T?],8MFWR/?.[MCGWW_A!](_Y^;W_
M ,"VK\V_^"6/BO\ :*T/_A.]'_9Z^%VC:Y=:@-,^W:MK^K_9[32]GVORR\:_
MO)M^]^$((\LYZBOKD_LK_M&?%?\ >_M'?M8ZM':2?ZSPW\.[<:7; =T:X(,L
MR'T8 X[T =C\5OC%^S9\$8G/Q1^,%GI4R+N-B^J-)=$>H@CW2'\%KS7_ (:3
M\>?%#_1_V8OV8/&6N02<1^(_%=Y_8^G8/_+1#)EYE]@%->I_"K]D']F[X+RK
M?> OA-I<5^K;O[6OHS=WA?NWG3%G4D\G:0/:O2: /FNR_9;_ &L?B@PN/C?^
MTX?#5E)_K- ^&L#Q$ ]OMDY,@.."-I%=;X"_8"_9?^']X-9M/ 1U352V^36-
M?NFO;EW_ +^Z7(5O=0M>ST4 8R^!=&10B3W@4#  NFP!2_\ "#Z1_P _-[_X
M%M6Q10!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@
M6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L4
M4 8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?
M\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C
M_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q3998H(VFGE5$499W;  ]2: .?U
MK0?"7AS2;C7==UJ>TL[2(RW-S/?,J1H.I)KXN^/7[3&L>.O%:0_#W4K_ $_1
M=.N ]D6N&\RY=3Q*X)X'HG8'G)/%S]K/]I7Q#\6?$D_@O3$FL- TVY9%M'.'
MNI%./-DQVS]U>@Z]>GC5 'VQ^R_\9_!_QOT8:%K5W/9^)+.+-U:+=LJ7*#_E
MK$,]/5>J_3!KUS_A!](_Y^;W_P "VK\UM!U[6/#&L6WB#P_J4MI>VDHDMKF!
ML-&P[C_#H1P:^^?V7_C9J?QP^'8U_7-!EM+VTE^SW4XB(@NG Y>(_P#H2_PG
MCTH [#_A!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_
M (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:MBB@#
M'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB@#'_ .$'TC_GYO?_  +:C_A!
M](_Y^;W_ ,"VK8HH HZ5H%EH\CR6LL[%UP?-F+#]:O444 %%%% !1110 444
M4 >=_M>ZW\6/#7[)OQ0\1_ 6"27QUI_P[UNY\%Q16WG,^K1V$S68$?/F$SB/
M"]^G>OB__@GG\ /V"OV&- ^+<]_^U-:?$+X?^/? 'ACQ9X[^(_Q5\5VE_;^(
M+NYDUN"ZN)99L1^4Z6L1\IMQ7)!+$U]W?&GXGZ5\$O@YXL^,^NZ9=7MCX1\,
MW^M7EG8A3//%:V[SO'&&(&]EC(&2!DC)%?CU\6KS]A']HOXBR_'/XG?\&IW[
M1.I>(M3G^VWNH)\-4L?MLSG<TMQ#!>1I+(Q.6,J%F).[))H ^M?^#?C]ICQ=
M^U!^SQ\5O%5EJ&LZC\+=(^//B+3/@5JVOF5KB;PHCQ/:PJ\Q,LD,+2211ER6
M15$).8<#[VKY<_X)%_M-WG[3_P"RO-X@B_8YU7X':)X?\47NB^$/!>HZ$NGH
M-)A*F"2**,"--I:2"1$^Y+;R @'BOJ.@ HHHH **** "BBB@ HHHH *\+\ _
M\I!/'_\ V(FE?^C&KW2O"_ /_*03Q_\ ]B)I7_HQJ /=**** "BBB@ HHHH
M**** "BBB@ K-\8_\BQ>_P#7 UI5F^,?^18O?^N!H N:=_R#X/\ KBO\A4U0
MZ=_R#X/^N*_R%34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5C^!_^01+_P!?LW_H5;%8_@?_ )!$O_7[-_Z%0!L4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C
MV7_([WO_ %Y1?S-;%8]E_P CO>_]>47\S6Q0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !6/9?\CO>_P#7E%_,UL5CV7_(
M[WO_ %Y1?S- &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !111TZT %%>1?%']M_]G_X9ZO\ \(C:^(KCQ3XD9BD/ACP=:G4;UW'\!$?R
M(WL[*?:N5_M;]O;X_G&BZ/I'P;\.S=+O4@NIZW(A[K$,10Y&<A\.IQ@G% 'M
M7Q ^)_P[^%.AMXD^)/C;3-#L5SBXU*\2(.1_"H8Y=O\ 94$GTK\**_8OX?\
M[!WP-\+ZVOC;Q_#J/Q \2G!DU_QS>&_D!Z_)$_[I #]WY25XP:_'2@ HHHH
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M[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U &Q6;XQ_Y%B]_ZX&H?^$'TC_GYO?\ P+:J/B7PEIECH-U=PW%T6CB) >Y8
MC\10!T&G?\@^#_KBO\A4U85EX+TJ6SBE:YO,M$I.+IL=*E_X0?2/^?F]_P#
MMJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8
MHK'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\
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MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P#
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M?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
MMJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\
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MB]_ZX&@"YIW_ "#X/^N*_P A4U0Z=_R#X/\ KBO\A4U !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_@?_D$2_P#7[-_Z
M%6Q6/X'_ .01+_U^S?\ H5 &Q1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% &/9?\CO>_P#7E%_,UL5CV7_([WO_ %Y1
M?S-;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %8]E_R.][_UY1?S-;%8]E_R.][_ ->47\S0!L4444 %%%% !1110 44
M44 %%%% !17DOQ5_;:_9^^%6J_\ "*-XHE\1^(V8I!X8\(VQU&^DD'\&R+Y4
M;V=E-<G_ ,)%^WG\?3M\+^&=)^#WA^;IJ.N!=2UJ1#_$EN,10G&<K)A@<8-
M'M?CSXD> /A=H;>)?B-XSTW1+%,_Z3J=XD*L?[J[B-S?[(R3Z5XM/^VUXH^*
MTSZ3^R#\"-:\: L4'BG5T.F:+&<X+"68!YL=T4*3V)K7\!?L%_!3P_KB^-_B
M;)J?Q$\2\%M;\<7AO=IZXCA;]TB@_=!4E<#!KVN""&VA2VMH5CCC4+'&B@*H
M'   Z"@#Y[_X9/\ CM\;/]+_ &LOVA[R6PEYD\%> =VGZ=CO'+,?WUPOLV".
MQKUOX5_ WX0_!'2?[&^%/P\TS1(2H65[.W'FS =/,E;+R'W9B:ZNB@ HHHH
M***S/$OC3P?X-MOMGBWQ3I^F18R'OKQ(MWTW$9_"@#3HKRZ\_:V^&UY<MIWP
M\TC7O%UTIVF+P]H\DB*W^T[A5 ]QD5%_PEG[5WC7CPY\--!\)VS]+GQ%J1NI
MMOJ(X!A6]FH ]6KX<_:]_:*\5_$OQ9=> (K.ZTK1=)NVC.GW"E);B53CS)1_
MZ"O0=>O3Z-_X9Y\=^*_WGQ8_:"\0ZBC<O8:&$TVW(_NL(\EQ]<&N9^,?["WP
M\U[P64^%6F_V9K=H&DA>:[DD6]/4I(9&.">S#H>O'0 ^+ZMZ#KVL>&-8MO$'
MA_4I;2]M)1);7,#8:-AW'^'0C@TFM:+JWAS5KC0M=T^6TO+24Q7-M.FUXW'4
M$5ZC^R_^R_K'QPU@:YKBRVGAJTEQ=70&&NF'6&(^O]YNBCWP* /8O@)>?&O]
MIGPO<>)/$WQNUS1K:WNC ;;1]&AM5EXSNCN!RWH1CY3]:[ZU_9!^#\LZWOB\
M:UXEN%.1<>(=;FF;/J0I53^(KT;0=!T?PQH]MX?\/Z;%:65I$([:V@7"QJ.P
M_P >I/)KSC]H#]M_]CG]E2V>X_:1_:B\!>"&1-PM?$GBFUM;F0>D<#N))#[*
MI- ':^&OAC\.?!H4^%/ ND:>R])+33XT<_5@,D_4UNU\ :K_ ,'&7[&/C?4I
MO#?[%/P9^-?[16J1R&'9\)/A=?3VD<H[2W-VL"(@[R ,H'/(J _M0_\ !P?^
MTG^[^!'_  3I^%/P*TJ?B'7?CE\1'UB[:(_\M!9:0H:&3'2.7(SC)Q0!^@U<
M=\8OVA_@#^SQH?\ PDWQ\^-_A'P3IVTL+[Q;XCM=.B8#KAKAT!_"OBH_\$I/
M^"E7[0F9OVW_ /@MG\1X[&XYF\*_ +P[9^#X(%/6$7R"2>=#R"9%!P<5V/P>
M_P"#>G_@DQ\)]=_X337/V7K?XB>))&#7GB/XL:Q=>([B[8=&DCO9'MR?I$*
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M  /T4HJKK>MZ-X:T:[\1^(M5MK#3]/M9+F^OKR=8H;>&-2SR.[$!%5026)
M!)K\LC^T1^T;\:O^"]/[,/CS7_%6KZ)\,/&W@3QK=_#[P"_FV_F:7!8D0ZM?
M1$C-Q>$^>D;J#!;BV4A9?.% 'ZKT5\ ^-/B]J?[=/_!:CQ%_P3YUS7=3@^%7
MP+^%MMX@\;:!I6J368\2>(]2:W:SAO7@=7EM(+.;S5@W!'F8,ZN$0+J?L"_M
M!^+_ (5?\%-OCY_P2D\6>*=2UKP]X0T32_'/PBNM;U&6\O;'1+V.%+S39)YF
M:26&WO)E6 NS.L4FPMM1%4 ^ZJ*** "O"_ /_*03Q_\ ]B)I7_HQJ]TKPOP#
M_P I!/'_ /V(FE?^C&H ]THHHH **** "BBB@ HHHH **** "LWQC_R+%[_U
MP-:59OC'_D6+W_K@: +FG?\ (/@_ZXK_ "%35#IW_(/@_P"N*_R%34 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^!_^
M01+_ -?LW_H5;%8_@?\ Y!$O_7[-_P"A4 ;%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 45\"_\%Q?^:7_]QO\ ]L*^!: /
MW<LO^1WO?^O*+^9K8K\"Z* /WTHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "L>R_P"1WO?^O*+^9K8K'LO^1WO?^O*+^9H
MV**** "BBB@ HHKR?XL?MK_L^_";5/\ A%KKQ9)K_B)V*0>&/"EN=0OI)/\
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M_P @^#_KBO\ (5-0!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\
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M &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\
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MX0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^
M?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y
M^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\
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M% !1110 5C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\ U^S?^A4 ;%%%% !1110
M4444 %%%% !1110 454UK7=#\-Z>^K>(=9M+"UC_ -9<WMPL4:_5F( KR/QC
M_P % _V3O"-[_8]M\4X=?U%CMAT[PK:RZE)*WHK0*R9^K"@#V>BOG[_AJ[]H
MSX@'R_@A^Q3XF,#_ '-4\=W\.CQH/[_DL6>1?]TYI?\ A6O_  4&^)'/C?\
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M^+H?\(W_ ,(W]M_Y@GVS[1]H^S_]-HMFWR/?.[MCGP+_ (<=?]7/_P#EE?\
MW;7WU7+_ !<^+GA'X,>$9?%OBV[P!E+2TC(\VZEQPB#^9Z <F@#XA@_X(H>=
MK<^C?\-+X\F%9/,_X0SKGMC[95S_ (<=?]7/_P#EE?\ W;7L/[.O[9\/C/XD
M7>E?%%;73FU5]FD7,7RQ1_-\L#D]^P<]3P<9%?3- !1110 4444 %%%% !11
M10 4444 %%%% !152]\0:#II(U'6[2WQU\^Y5,?F:Q[WXP_"73<_VA\4?#L&
M.TNM0*?U>@#HZ*X6]_:9^ .GY\_XLZ,V/^>%T)?_ $#-95S^V5^SC _DQ_$/
MSY.T=MI5TY/Y18_6@#T/4/#OA_5\_P!JZ%9W6>OVBU1\_F#Z#\JP=1^!7P1U
M?/\ :WP<\*W6>OVCP];/G_OI#7+?\->?#.X_Y _A[Q5J/I]B\-S-G_OH#V_.
MC_AIVZN^-&_9Y^(]QZ/+X=$2'Z,ST 6]1_8\_92U3/VK]G/P6"W4P>'+>(_^
M.(*P=2_X)[?L8ZKG[5\ M(7/7[-+/#Z_\\Y%QU_SBM/_ (7K\7[SC1OV6_$$
MF>GVW5+>V_\ 0LXH_P"%D_M27W_'I^S9860/0WOC""3](U_SF@#EG_X)E?L:
MQ.9='^&M]IKDY+Z?XHU!.?7F<BO(/V\/V+/A9\(?V4O%7CWP=XH\8B:P^P^7
MI]]XIGN+23??6\9WQ.2&P')'/# 'M7T1_:_[9%]Q:^$/ 5CGI]MU"ZEQ]?+%
M>4?MO3?M#:'^S#XE\0_%V]\'W>A6SV#WVFZ):S^;*?M]N(]K3<#$A1CGJ 10
M!\$?!_X/[_*\6>++7Y>'L[.1>OH[C^0_$UZK67X1\7Z-XTTE=6T>;(Z2Q/\
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M*** "BBB@ HHHH *S?&/_(L7O_7 UI5F^,?^18O?^N!H N:=_P @^#_KBO\
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MCX=^.>B?L/?L>:=I.M:;!JOAK3O'FM:KJ&IV%M.JS0[Y8&\L/L9"=@'(Z#H
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M'_OT*/[.T_\ Y\8?^_0H I_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5<_L[3_\
MGQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU6?XH\4>'[SP_=VMKJL3R/$
M0B*>2:W/[.T__GQA_P"_0K.\76-E'X:O'CLXE80G!6, B@ L?%WAJ.RAC?68
M0RQ*"">AQ4O_  F/AC_H-0?]]5-I^GV#6$!-E"285R3&/05-_9VG_P#/C#_W
MZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\ ?H4?
MV=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ
M%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\ SXP_
M]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\
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MO7?M4A7^]Y%H R-_LMGGVI?^&2OVB_B#\_QK_;&UF&"3[^E^ -(@TE8QW47
M#2./=AF@#V+Q+\8OA5X,LSJ/B_XAZ/I5N!GSM1OT@7\W(%>5^(_^"D'[+FF7
M;Z1X.\0ZMXQU%/\ F'>#]"GO)&],,56,Y]GJ[X/_ .">O[)_A2]&L:A\-!XC
MU$D&74?%E[+J,DI]665C'^2"O6=#\'>$/#%@NE>&_"NFZ?:I]RVL;&.*-?HJ
M  4 ?/[_ +6'[4WQ 8Q?";]EBWT*V?\ U6K?$+Q"EOM]-UI#F4?@U)_PK?\
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M+TS5=6A;4_+EC#-%]BBWW#R1MNC=4C;:Z$=:\7/_  7"\7?M'_Z!_P $N_\
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M /PB_P"S-\%/!'@6S,829?#&@06CW '>62- \S<#+.S$]S7J7]G:?_SXP_\
M?H4?V=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C
M#_WZ%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\
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M::U_[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\
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MB_V0/_"1\0?_ !5'_"J/^#EN^^>[_:R_92L"O 2Q\!ZS*K#U)D?(/TK[_HH
M^ #\&?\ @Y1(Q_PVA^S /^Z<ZI_\72_\,\?\'''_ $D5_9__ /#17'_QROOZ
MB@#X!_X9I_X.+;_Y+O\ X*9_ VP"\A['X,/*7]B)), ?2C_AE;_@X?\ ^DK7
MP?\ _#%Q_P#QVOOZB@#X _X8X_X.#)OWTO\ P66^'<+/RT,/[.]BR(3_  J6
MFR0.@)YH_P"&*O\ @X!O/W%S_P %M/!%FAY,]I^S;IDCCV"R3;:^_P"B@#X
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M9B"\2RH"T,@'W98WW1NO\+HP[4 =Y1110 4444 %%%% !1110 4444 %%%%
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M'_A;KEA'@^UMITAQ[*#4%Y\7O^"1,I;_ (6)XO\ CUXL*C=(=;^&7C^YW_\
M?C2UR?84 ?>WB+XQ_"+PAN_X2SXJ>&]+V_>_M'7+>#'UWN*X3Q%^WU^QQX7W
M?VE^T#H,NWK_ &=(]Y^7D*^?PKY<\._M8_\ !#SPK%YEM\+O$48CYQKO[._C
M25L#OB[THDCWZ<'TKKM&_P""NG_!'_P(Z1Z!K]WHI RGV7X!^);; ]?ETE<#
MWH ]6_X>/_ /51_Q0/AOQUXKS]S_ (1WP7=2;_IY@2C_ (;'^,.O?\B!^PI\
M2;G/W/\ A(DM])S]?,9L5P5U_P %W_\ @E58D"]_:?GA+?=$OP_U]<_G851C
M_P"#@?\ X(^/GS?VT]*@]#=^&=7A#?3S+09_"@#TO_A:O_!0KQ)_R!/V5/"/
MAP-]T^(O'"W>WZBU44#PK_P4G\2?\A?XK?"WPTK?] +0KN\9!_V\D G]*\L/
M_!Q#_P $6E)5OV_O"0(/(-C?_P#R/5V+_@X"_P""-$T:RI_P4&\" ,H(#37"
MGGU!BR/H: /1O^&7/VI]?Y\=_M\>(9%;[T7AWPK9Z;M]@R%C^/6C_AWSX-U;
MGQ_^T%\6?$N[[\6K>.)/*/L%C1<#VS7 6G_!?/\ X(WWLWD0_P#!0KX>JV,Y
MFOI8Q^;1@5:_X?M_\$>O^DB'PS_\'H_^)H ]#T7_ ()P_L9:+-]K/P7@OIR<
MR3ZKJEW=,Y]2)92OZ5W/AW]F?]G7PEM;PW\"?"%FZ])8?#ML)/\ OO9N/YUX
M=:_\%P?^"0UY +B+_@HM\* K9P)?%D*-_P!\L01^530?\%LO^"1MQ,L$?_!1
MGX1!G. 7\:VJC\26 'U- 'TY8Z?8:9;BTTVRAMXE^[%!&$4?@.*FKYK_ .'R
M?_!)O_I)!\%/_#CZ=_\ ':L67_!7_P#X)27Z&2#_ (*2_ Q0IP?/^*>E1'\G
MG!- 'T917SU_P]P_X)5_])*?@+_X=S1__DFKW_#TC_@FC_TD'^"G_AT=*_\
MDB@#W>BO#K+_ (*;_P#!.'47,>G_ +?'P:G91EEA^)FEL0/7B>K/_#Q__@GO
M_P!'R?"+_P .+IO_ ,>H ]HKP+]N/]AS_ALW_A%_^+H?\(W_ ,(W]M_Y@GVS
M[1]H^S_]-HMFWR/?.[MCGH8?V_OV%[F)9[?]LCX7R(XRCIX\T\AAZ@B7FIK;
M]NW]B>]F%M9_M=?#661L[8XO&]BS'OT$M 'R7XL_X(R>&_ GA74_''C']KFW
MTW2-&T^:^U74;OP<$BM;:%#)+*[&]^55168GL :^//\ @DU\&M4_X*):YX^\
M(_$;Q9JOPYUG1[U=:\#Z9K?@PB77?"5R[)::@H-TF)%="LT8SY9EAR3Y@K]#
MOVXOVEO!7Q6\'W'P0\$75OJ^B:B(SKU_#('M[V(,'%NI'$D3$*7_ (77*'<K
M.#X3\-?%]U\,?B=HWQ6T2TC?4M&:587;@R6\H"S0,1UC<*N5.1N2-\;HT( .
M[_X<=?\ 5S__ )97_P!VU]]5\?\ QZ_X+L_\$TOV7'TO1?V@/C=J&@>(-7LA
M<6/AJ'P7JU]<SC."L;6MK)$^"",A\<=CQ7E6N?\ !QY\$]2A#? W_@G]^U#X
M\24XM=5L_A7_ &?IC^A:ZO)X]@/J4H _16BOS,'_  68_P""F/Q,U<Z#\'_^
M"2FE^'4DCWV^L_$+XSVTJG/9K32[6>4'ZL*Z?PK\2O\ @NQ\8 K^*?&'P5^'
M%JQYC\,^![R\N%!_Z>-4OU7CU%H?I0!^AE!(4%F. .I-?'OAK]E_]K'Q- 3\
M<?\ @I!XHORRY$.E?9M/$1] =*MK!L?[SN?<UUY_8A^"&KS6.H>//C;XQ\07
M=G&%:?5-:6X,O_;2>.2<#_MKD>M 'LOB7X^?!;P@9(]?^)^BQ2PL5EMX[Y99
M4([&.,LP/X5\[_'O_@MI_P $^/V>C-:^-_CCI$-W%G%I=:I;VTKD=A%*XF8^
MRQD^U=A_PP-_P3_NBR^)/A39>(8)&W26/BS7+_5[1CWS;WL\L./;9CVKN_AA
M\$_V1/@DJK\&/@IX \(A/N#PQX4L[#;]/(B7% 'POXB_X.&#X]15_9-_8Y^+
M_P 2?-DV ^!OA'K.IE5SCS/,GBM(-HZ[MY&/6L*[_;,_X+A?'&Y*?##_ ()6
M_% :;,/DN_&'Q'T+P4;8'NT!\^:09[!MU?I]_P )CX8_Z#4'_?5'_"8^&/\
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M]4 <!\+_ -A[]B[X(B/_ (4U^R-\,O"AAQY;^'/ >GV3 CONAA4D^^<UZB
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M@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4
M:5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^
M&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_
MZ#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &
ME16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/A
MC_H-0?\ ?5 &E6;XQ_Y%B]_ZX&C_ (3'PQ_T&H/^^JS_ !1XH\/WGA^[M;75
M8GD>(A$4\DT ;FG?\@^#_KBO\A4U9%CXN\-1V4,;ZS"&6)003T.*E_X3'PQ_
MT&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:
M@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*
MS?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]
M!J#_ +ZH TJ*JZ?K>DZJ[1Z=?QS,@RP0]!5J@ HHHH **** "BBB@ HHHH *
M*** "OSQ_P""T_\ R>U^P-_V<A_[:5^AU>+_ +17_!/O]EC]JWXD^$/BY\=/
M"7B+5=?\ ZJNI^#;NQ^(FN:;'I-X-@^T0PV5[#$LF$4%MA)&0<ACD ^1/^#G
MKP-K-W^Q7\,OV@+*TFFTOX.?M#>%O%_BGRD+>5I<;SVLLI &?EDNH23V7<3Z
MB'_@Z"\*7OQY_8&^'_[+_@;_ $W7OB]\=O#/AWPY!:$.TKRFXF:88_Y9HD99
MG^ZH.20*_1'Q/X \&>-_ E]\,O&_ARVUO0-4TM].U32M93[7%>VKQF-XIA+N
M\Y60D-OR6R<YS7E7P?\ ^"?/[-GP6\9^'_'NA:7XBUG4/!FF2Z;X#/C#QCJ&
MLQ^%;.1!&\.GI>32+;EHU6(R@&8Q@1F0H M 'R-^R=X.U'X)_P#!R[^U#I?B
MJ-X4^+WP=\->+/"$LW NK6P2VTVZ53T9DN V5'(7:3ZT?LL>"]5^(_\ P<V?
MM,?'W0H'DT+P!\#_  _X'U*]4?NFU*^-AJ0B#=&=([5MP'W=P#8)%?;OQY_9
M1^#O[1.L>'?%_C?3]2L?$WA">>7PIXO\-:S/INJZ29X_+G2*YMV5C%*F%DA?
M=$^U2R$HI&E\!/V=/A!^S/X/N?!7P=\+-I]OJ.JSZKK-[=WTUY?:MJ$Y!FO;
MR[N'>>ZN'P-TLKLV%5<A54  [>BBB@#$E^&GPXGE:>?X?Z([NQ9W?2H26)ZD
MG;R:\9^&/AWP_I/[?/CVPTK0K.V@3P-I92&WM41%)D;)  P,X'Y5] UX7X!_
MY2">/_\ L1-*_P#1C4 >W?V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_V=I_
M_/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%34
M4 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/
MC#_WZ%344 ?AA_P7W_;FNOV!OVHO%OQ!\+V%K?:SJ6J:/::=H=RY6*[C&G6;
MW!?;R%6,$!A]UY$ZY(/8?L@?M?\ P?\ VU?@_:?%SX1ZMN1L1:OI%PX^U:5=
M8RT$RCH>ZL/E=<,/;T'_ (*Y?\&RGB3_ (*K_M>:C^T[J?[??_"%Z=/I]I:Z
M7X27X7_VBMEY5M%%)(;C^U(/,:1H@Q/EK@!%YV[CY=^R?_P:>?&#]@WXF)\:
MOA/_ ,%4?.6-!'K>@7'P8*VNKVN[)@E UHX/4JX&Y&Y'<$ T/VO_ -K_ .#_
M .Q5\'[OXN?%S5MJ+F+2-(MW'VK5;K&5@A4]3W9C\J+EC[^5_P#!&_\ :$\&
M?\%<?BQH6F_'#P^D:RZEJ=IKOAW3-1F@%HL=I<7-HT4B,L@'R1'?D;GC<$8R
M*]+_ &P/^#3'XP?MQ_%B;XO_ !8_X*K;$9#'HFA6_P %R;72+4G(AB!UKD]"
MSD;G;D]@/3/^"1?_  ;,>)/^"4W[7%A^TSIO[?7_  FNFQ:?=6NI^$F^%YTU
M;PR6\L44@N/[4G\MHS*6'[MLJ77C=N$SA"I!PFKIZ-/JC;#8G$8/$0Q%";A.
M#4HR3LXR3NFFM4T]4ULSZSN?^"7=KX:/G?!/]L/XM^%BIS#87GB!-5L(\=,6
M]Q'S^+55E_9Q_P""DW@+)\)_'[X2_$.->D7C[X=C37<#H"VGYR?<]3UKZSHK
MS_[*PD?X?-#_  RDE]U[?@?6?Z]Y]5TQBI8A?]/:%*<O_!CA[3[IH^1)OB/^
MVEX&)7XJ?\$P/"?BBW7_ %VJ^ O$UD_3^[:W,?FM^?:JTO[=_P"R#X<)3X_?
ML;^-?AV4XGN?%GPFS;#U*RP+)O7WQ7V)11]4QU/^'B&_\48R_+E?XC_U@X9Q
M7^]Y3"/G0JU:;^ZHZ\%\H)>1\W^!?VC/^"6GQ5V)X4\??"HR2C$=O?PVVGS/
MGL([A(W)^@S7J-A\ _V;O$=BFIZ/\./#=W;2#]W<64$;(P]F3@T_X@?LM?LU
M_%4.WQ'^ G@_6I)/O7&H>';>28>XD*;U/N"#7DFJ?\$E?V-$OWUGX<>'?$G@
M34)#EK_P5XOO;-P>Q"M(Z+CV4"CFS:GO&$_1N+^YJ7YA['@#%_#6Q.'?:4*=
M=?.49T7\U3?H>K2_LJ_L\S$%_A5IHQ_=WK_)JJR_L>_LW38W_#"W&/[M]<K_
M "DKRO\ X8>_:K\"<_!#_@I1X]@CC_U=MX^T>T\0AQ_=:24(P^H&:/-_X*Z?
M#H_/:_!KXC6:=/+>]TC4)?KG,"YH^OUH?Q:$UYJTE_Y*V_P#_57+L3_N6:X>
M?]V;J49?-U:<:?W5&>E3?L3?LSS#_DG)7G/RZQ=_UE-9UU^P)^S!=9+^!902
MVXD:A*?_ $)C7##]NG]ISP+\OQR_X)L_$6S5.)+CP'J-IXB4C^\%A*$#O@\B
MK6C?\%:?V+);Y-&\>^,==\$:B_33O&?A2]LI!ZY81M&,>[4UFV7WM.?+_B3A
M_P"E)$RX XO<7+#X5UTNM"4*Z];T95%8W-1_X)M_LIZI&8;OP5*R,VXJTRN,
M_1E-8]Y_P2D_8WO=WF> R-QY_P!'M6_]"@->M?#_ /:8_9U^*VQ?AK\=/".N
M22?=@TSQ#;S2@^AC5]RGV(!KMZ[J=2G5CS0::\M3Y?%8/&8&K[+$TY0EVDG%
M_<[,^4=1_P"",/["6I7CZC=?"^SEN'QNEN-"TN4G  YW6A)X'<U6G_X(L_L/
M20M;+\*/#;QL,&.Z\#:/*#]0;3D>U?6]%6<Q\>?\.2/V(8>+3X*?#L=QYWPC
MT&3G\;7I[56O?^"('[%U[()9_@3\'IF485KSX!^')B/Q:VZ>U?9E% 'Q8?\
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M+8^-=1B\3Z9I@TW1$ DEB#7UU!O:X<)$0FX>5YX;&Y<@'D5%>$_\$T?V3/\
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M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
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M_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\
MSXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344
M0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_
M 'Z%344 87B.RLTU7252TB :\(8",<C::U_[.T__ )\8?^_0K-\2_P#(7T?_
M *_3_P"@FMB@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_O
MT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:B@"'^SM/
M_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:
MB@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*/[.T_P#Y
M\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\ ^?&'_OT*
M/[.T_P#Y\8?^_0J:B@"'^SM/_P"?&'_OT*/[.T__ )\8?^_0J:B@"'^SM/\
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MG_\ /C#_ -^A4U% #(K:V@),%NB$]2B 9I]%% !1110 4444 %%%% !1110
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MGO9.SC*VEXZ:K1IIV6J11117N'YT%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%<S\2/C-\*?A!9)?\ Q,\?Z7HJ2J3#'>W0668#KLC&
M7?'^R#45*E.E!RFTDNKT1OAL-B<965'#P<YO913;?HEJR]9?\CO>_P#7E%_,
MUL5XMX/_ &U/V6?%7CZX@TKXT:2AGMTCA>_$EHCN#T#SHB_3GGM7L\4L4\2S
M0R*Z.H9'4Y# ]"#W%11Q.'Q*O1FI+R:?Y'3C\IS7*IJ&-H3I-[*<91;].9(=
M1116QYX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%8]E_P CO>_]>47\S6Q6/9?\CO>_]>47\S0!L4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7R'^WS^W]K7PFUN;X+?!6ZB3
M7(H@=:UMD63["6 (AB4@J9-I!9CD*" !NR5^IO$OCWP-X,B\_P 8>--)TE ,
ME]3U&* 8]<NPK\9_&?BC4?&_B_5/&6KS&2ZU;49KRX=NI>1RY_4U\AQ;FU;
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M_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\
MH-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX
M8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)C
MX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]
M4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H I_\ "8^&/^@U
M!_WU6?XH\4>'[SP_=VMKJL3R/$0B*>2:W/[.T_\ Y\8?^_0K.\76-E'X:O'C
MLXE80G!6, B@ L?%WAJ.RAC?680RQ*"">AQ4O_"8^&/^@U!_WU4VGZ?8-80$
MV4))A7),8]!4W]G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN
M?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_O
MJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@
M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
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M?)Z>O'?VI?\ A:__  57TWB^\%_L_P"IXZG3M<U6'/\ W]7\?H:^J?[.T_\
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M/^^J\Y\5_MG_ +%7@G>OB7]I/X>P2)]^W3Q):2RC_MG&[-^E>>ZM_P %8O\
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MM/\ ^?&'_OT*/[.T_P#Y\8?^_0H_LG /XHN7^*4I?^E-A_K_ ,5P_@5HT?\
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MTKZI_L[3_P#GQA_[]"C^SM/_ .?&'_OT*/[/FMJ\_OB_SBP_UMPLOCRK"O\
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M/_Y\8?\ OT*/[.T__GQA_P"_0K]:/XE*?_"8^&/^@U!_WU1_PF/AC_H-0?\
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M_P!"H V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?_036Q6/XE_Y"^C_ /7Z?_036Q0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% '+?%SX,?#;XY^$W\&?$WPS#J-F6WPEB5EM
MY,<21NN&1O<'D<'()%?*/CW_ ()">$+07.L>$?C7J-I:1#>MIJ&C)<R8]/,2
M2(?CMK[7K-\8_P#(L7O_ %P->;C<GRW,9*6(IJ3[ZI_>FF?6</\ '/%G"U)T
MLLQ<J<'KRVC*-^ZC-22?=I)L\*_9W_X)Q_ OX,ZA:>-=6:Z\3ZU %EMKC555
M;>VDZAXX5XW#L7+X(!&",U]#U#IW_(/@_P"N*_R%35T83!87 TO9T(**\OUZ
MOYGEYUG^<\18OZSF5>56>R<GLNR2LHKR22"BBBNH\<**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKR']O']LSX7?\ !/S]
MDSQI^UO\7S)+I'A'3/.CT^W<+-J-W(ZQ6UG$3P'EF>- 3PH8L?E4FOG[]@C2
M])_:,>P^)W[>?[1'AWQA\;M?LTUJ7X)6/B]#I?P^M7598M/CT5)L2W$*,GG7
M=U'+-YNX*ZH%! /M^BO@'QI\7M3_ &Z?^"U'B+_@GSKFNZG!\*O@7\+;;Q!X
MVT#2M4FLQXD\1ZDUNUG#>O ZO+:06<WFK!N"/,P9U<(@74_8%_:#\7_"K_@I
MM\?/^"4GBSQ3J6M>'O"&B:7XY^$5UK>HRWE[8Z)>QPI>:;)/,S22PV]Y,JP%
MV9UBDV%MJ(J@'W51110 5X7X!_Y2">/_ /L1-*_]&-717_[;'[*6EWT^F:A\
M<M#BN+:9HIXGE;*.I(93\O4$$5X_X0_:B_9\TS]L7QG\4KWXLZ0F@:AX4TVR
ML]2$Y9)+A'<M'@ L" ">0!Q0!]945Y+_ ,-W?LA_]%XT3_OJ3_XBC_AN[]D/
M_HO&B?\ ?4G_ ,10!ZU17DO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]
M]2?_ !% 'K5%>2_\-W?LA_\ 1>-$_P"^I/\ XBC_ (;N_9#_ .B\:)_WU)_\
M10!ZU17DO_#=W[(?_1>-$_[ZD_\ B*/^&[OV0_\ HO&B?]]2?_$4 >M45Y+_
M ,-W?LA_]%XT3_OJ3_XBC_AN[]D/_HO&B?\ ?4G_ ,10!ZU6;XQ_Y%B]_P"N
M!KS?_AN[]D/_ *+QHG_?4G_Q%9WBS]NC]DFX\.7D-O\ '+1Y':$A402DD^P"
M<T >RZ=_R#X/^N*_R%35X_8?MV?LBI8PJ_QVT4$1*""9 1Q_N5-_PW=^R'_T
M7C1/^^I/_B* /6J*\E_X;N_9#_Z+QHG_ 'U)_P#$4?\ #=W[(?\ T7C1/^^I
M/_B* /6J*\E_X;N_9#_Z+QHG_?4G_P 11_PW=^R'_P!%XT3_ +ZD_P#B* /6
MJ*\E_P"&[OV0_P#HO&B?]]2?_$4?\-W?LA_]%XT3_OJ3_P"(H ]:HKR7_AN[
M]D/_ *+QHG_?4G_Q%'_#=W[(?_1>-$_[ZD_^(H ]:HKR7_AN[]D/_HO&B?\
M?4G_ ,11_P -W?LA_P#1>-$_[ZD_^(H ]:HKR7_AN[]D/_HO&B?]]2?_ !%'
M_#=W[(?_ $7C1/\ OJ3_ .(H ]:HKR7_ (;N_9#_ .B\:)_WU)_\11_PW=^R
M'_T7C1/^^I/_ (B@#UJBO)?^&[OV0_\ HO&B?]]2?_$4?\-W?LA_]%XT3_OJ
M3_XB@#UJBO)?^&[OV0_^B\:)_P!]2?\ Q%'_  W=^R'_ -%XT3_OJ3_XB@#U
MJBO)?^&[OV0_^B\:)_WU)_\ $4?\-W?LA_\ 1>-$_P"^I/\ XB@#UJBO)?\
MAN[]D/\ Z+QHG_?4G_Q%'_#=W[(?_1>-$_[ZD_\ B* /6JQ_ _\ R")?^OV;
M_P!"KSW_ (;N_9#_ .B\:)_WU)_\163X-_;F_9+MM+DCN?CCI$;&[E(602J2
M"W!Y3I0![A17DO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q% '
MK5%>2_\ #=W[(?\ T7C1/^^I/_B*/^&[OV0_^B\:)_WU)_\ $4 >M45Y+_PW
M=^R'_P!%XT3_ +ZD_P#B*/\ AN[]D/\ Z+QHG_?4G_Q% 'K5%>2_\-W?LA_]
M%XT3_OJ3_P"(H_X;N_9#_P"B\:)_WU)_\10!ZU17DO\ PW=^R'_T7C1/^^I/
M_B*/^&[OV0_^B\:)_P!]2?\ Q% 'K5%>2_\ #=W[(?\ T7C1/^^I/_B*/^&[
MOV0_^B\:)_WU)_\ $4 >M45Y+_PW=^R'_P!%XT3_ +ZD_P#B*/\ AN[]D/\
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M_P!]2?\ Q%'_  W=^R'_ -%XT3_OJ3_XB@#UJBO)?^&[OV0_^B\:)_WU)_\
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MKHCYC,LSS'.,9+%8ZK*I4EO*3N_^&71+1=#UJBO)?^&[OV0_^B\:)_WU)_\
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M  W=^R'_ -%XT3_OJ3_XB@#UJBO)?^&[OV0_^B\:)_WU)_\ $4?\-W?LA_\
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M/]RIO^&[OV0_^B\:)_WU)_\ $4 >M45Y+_PW=^R'_P!%XT3_ +ZD_P#B*/\
MAN[]D/\ Z+QHG_?4G_Q% 'K5%>2_\-W?LA_]%XT3_OJ3_P"(H_X;N_9#_P"B
M\:)_WU)_\10!ZU17DO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\
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MAI\.)Y6GG^'^B.[L6=WTJ$EB>I)V\FF-\+/ABZ[7^'.@D9S@Z/#_ /$UO44
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MIZL(+*VC@@#MDA$4*N3W. *LT <__P *F^%?_1-/#_\ X)H/_B*/^%3?"O\
MZ)IX?_\ !-!_\17044 <_P#\*F^%?_1-/#__ ()H/_B*/^%3?"O_ *)IX?\
M_!-!_P#$5T%% '/_ /"IOA7_ -$T\/\ _@F@_P#B*/\ A4WPK_Z)IX?_ /!-
M!_\ $5T%% '/_P#"IOA7_P!$T\/_ /@F@_\ B*/^%3?"O_HFGA__ ,$T'_Q%
M=!10!S__  J;X5_]$T\/_P#@F@_^(H_X5-\*_P#HFGA__P $T'_Q%=!10!S_
M /PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,17044 <_\ \*F^
M%?\ T33P_P#^":#_ .(H_P"%3?"O_HFGA_\ \$T'_P 17044 <__ ,*F^%?_
M $33P_\ ^":#_P"(H_X5-\*_^B:>'_\ P30?_$5T%% '/_\ "IOA7_T33P__
M .":#_XBC_A4WPK_ .B:>'__  30?_$5T%% '/\ _"IOA7_T33P__P"":#_X
MBC_A4WPK_P"B:>'_ /P30?\ Q%=!10!S_P#PJ;X5_P#1-/#_ /X)H/\ XBC_
M (5-\*_^B:>'_P#P30?_ !%=!10!S_\ PJ;X5_\ 1-/#_P#X)H/_ (BO$_V"
MOAYX UGX-ZK=:QX&T>[E7QOJ\:R7.F12,$6Y(5064G '0=J^C*YOX6_"GPC\
M'O#L_A?P7#.EI<:E<7T@N)S(WG3/O<Y/;/0=J )/^%3?"O\ Z)IX?_\ !-!_
M\11_PJ;X5_\ 1-/#_P#X)H/_ (BN@HH Y_\ X5-\*_\ HFGA_P#\$T'_ ,11
M_P *F^%?_1-/#_\ X)H/_B*Z"B@#G_\ A4WPK_Z)IX?_ /!-!_\ $4?\*F^%
M?_1-/#__ ()H/_B*Z"B@#G_^%3?"O_HFGA__ ,$T'_Q%'_"IOA7_ -$T\/\
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M:>'_ /P30?\ Q%'_  J;X5_]$T\/_P#@F@_^(KH** .?_P"%3?"O_HFGA_\
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M^(KH** .?_X5-\*_^B:>'_\ P30?_$4?\*F^%?\ T33P_P#^":#_ .(KH**
M.?\ ^%3?"O\ Z)IX?_\ !-!_\11_PJ;X5_\ 1-/#_P#X)H/_ (BN@HH Y_\
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M?_1-/#__ ()H/_B*Z"B@#G_^%3?"O_HFGA__ ,$T'_Q%'_"IOA7_ -$T\/\
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M:>'_ /P30?\ Q%'_  J;X5_]$T\/_P#@F@_^(KH** .?_P"%3?"O_HFGA_\
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M$T\/_P#@F@_^(H_X5-\*_P#HFGA__P $T'_Q%=!10!S_ /PJ;X5_]$T\/_\
M@F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,17044 <_\ \*F^%?\ T33P_P#^":#_
M .(H_P"%3?"O_HFGA_\ \$T'_P 17044 <__ ,*F^%?_ $33P_\ ^":#_P"(
MKR[]M?X;_#O2?V4_'.I:5X"T6VN(=#=HI[?2X4=#N7D,%R#]*]QK$^)'P^\.
M?%7P+J?P[\712OINK6Q@O%@E*.4)!X8=#Q0!S_PT^%GPQN/AQX?GG^'&@N[Z
M):,[OH\!+$PJ222O)K;_ .%3?"O_ *)IX?\ _!-!_P#$5KZ-I5IH.CVFAZ>K
M""RMHX( [9(1%"KD]S@"K- '/_\ "IOA7_T33P__ .":#_XBC_A4WPK_ .B:
M>'__  30?_$5T%% '/\ _"IOA7_T33P__P"":#_XBC_A4WPK_P"B:>'_ /P3
M0?\ Q%=!10!S_P#PJ;X5_P#1-/#_ /X)H/\ XBC_ (5-\*_^B:>'_P#P30?_
M !%=!10!S_\ PJ;X5_\ 1-/#_P#X)H/_ (BC_A4WPK_Z)IX?_P#!-!_\1704
M4 <__P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\17044 9NA^#
M?"'AB9[CPWX4TW3Y)5VRO8V,<1<=<$H!D5I444 %%%% !1110 4444 %%%%
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M?\$B;7XR?%OX>Z-J\7CCX Q^*7TW5--CGAM[F\T$W&]%D!V,OGL%8?, 3@T
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M(98W >*5'5D9& (*GV->@T %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^YYK1H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _,?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKS7Q[^V)^S+\--5D
MT+QC\8])@O(6*SVUJSW3Q,.JN(%?8?8X-8UL10P\>:K-17=M+\SMP.6YCFE7
MV6"HSJR[0BY/[HIL]*HKD?AE\>_@U\9%?_A67Q'TO5Y(UW2VUO<8G1?[S1-A
MU'N5Q775=.K3K0YZ<DUW3NC+%83%X&NZ.)IRA-;QDG%KU3LPHHHJSG"BBB@
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M3@UZA0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[).S5]%<_1VBOF/_ (82_:1_Z26_$_\ \ K/_P")H_X82_:1_P"DEOQ/_P#
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M_@XU_9J?6=)LM16R^!GBN[LC<PI*(+B.YCV2ID':ZG.&'(/3%3_LB:=9:/\
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M)8$]\H*^\?\ AD/XY_\ 1]_C_P#\!+7_ .)H ]\HKP/_ (9#^.?_ $??X_\
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M^#=3_@H=;:-_PE'P7\7Q#QU?:GJL,J>-/#>A7%M>:9I]JK-OGFDF2V\T[?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%>(_P#!0G]O;X(_\$V?V9=3_:D^
M/ES<'1=/U*RL(;&Q :ZO;BYG6,1PJ?OLJ>9,1_<A<]J /;J*H^&/$OA_QIX;
MT_QCX3UBWU'2M6L8KS3-0M) \5S;RH'CE1APRLK!@1U!%7J "BBB@ HHHH *
M*\Q^.?[9W[+/[-?B'3_!_P ;OC?H>@ZWJMH]WIVA2SM-?SVR-M>X6VA5Y?)5
MOE,NW8#P3GBM/X)_M0_LX_M)174_[/OQS\*>-8[&SMKJ^D\+ZY!?+;17#3)"
M9#"S",LUM.NUL,#$P(&* .[HKCOC7^T)\$OV<?#5MXN^.7Q.TCPS8WU_'8Z<
M^J7022^NWSLMK>(9>XF;!(CC5G(!(& :F^#?QR^$7[0G@W_A8'P4^(6F>)-(
M%[-9S7>F7&_[/=1-MEMY4.&AF1N&B<*ZGJ!0!U=%><_'C]K_ /96_9<6VD_:
M2_:)\&^ H[S;]DE\7^(K?3TF+;]H5IW4,3Y<F #GY&]*S?@Q^WE^Q'^T9XH_
MX0?X!_M>?#3QGKGD><-%\,^-[&]O#%MW>8((I6D*8YW!<>] 'K%%%>?_ !^_
M:P_9A_93TS3M:_::_:$\&?#^TU>=X-*N?&/B2VTY+R1%#.D1G=0Y4$$@9P",
M]: /0**Y#X)?'_X'?M*>"!\2_P!GOXN^'/&_AUKN2U77/"VL0WUHTT>-\8EA
M9E++N&1G(S7.^ /VV/V2_BI\11\)_AU^T'X7UC7Y);F*SL+'4U<7TEL2+F.V
MD_U=T\)!$JPLYB*D.%P: /4:*YCXN?&CX3_ 3P<WC_XS?$'2O#>CBZBM4O=5
MNUB6:XE;;%;Q _-+-(WRI$@9W/"@GBF?"#XX?"/X^^%I/&GP:^(6F>(M.@O9
M+.[FTZX#-:74>/,MYT.'@F7(W12!77(R!D4 =516)\0OB3X ^$OA2Y\=?$[Q
MCIV@Z+9(6O-5U6Z6"W@4 DL[L0%  )))P #7C^G?\%3_ /@FKJ^F'6M)_;S^
M$EU9J&+7=OX^L'B 7[WSK*1QWYXH ][HKE/@Q\=/@O\ M&>!(/BC\ OBMX>\
M:>&[F>2&WU[POJ\-]:2R1MMD19869258$$ \'@UU= !1110 45P7[1W[47[/
M7[(?PRN_C'^TO\7=%\&>&[+B74]:NM@=NT<:#+S2'LD:LQ[ UU/@CQGX:^(_
M@O2/B'X,U+[9H^O:7;ZCI-YY+Q^?;3QK+%)LD"LNY&4[6 89P0#Q0!J45#J.
MHZ?H^GSZMJU_#:VEK"TUU=7,H2.&-069V9L!5 !))X %>7?!C]N?]D+]H?Q<
MO@3X)_M">&O$>K36$E]8VFG7V3J%I&X22YM&("W<*LRAI82Z*67)&X9 /5Z*
M*I>(_$GAWP=X?O?%GB[7K+2M*TVU>YU'4]2ND@M[6!%+/+)(Y"HBJ"2S$  $
MDT 7:*\"T7_@J=_P3KUY7DL_VQ? L,8LI+RVEU#65M$O[=!EI;1I]@O% P<P
M&3((QU&??: "BBB@ HHKR_XS?MI_LK_L^?%#P;\$_C#\;M%T;QA\0=7@TSP=
MX8>1YK[4KB:3RX]L,2LZ1E_E\UPL8(.6&#0!ZA1110 445E^,_&WA'X=>&KK
MQEX[\1V>DZ59*&N]0OYQ'#"I( +,> ,D<F@#4HKYYL/^"MW_  2TU3!L?^"B
MWP2=3((_-/Q.TM4#'H"QG"@GW->]>'_$&@>+-#M/$WA;7+/4]-O[=9['4-/N
M4F@N8F&5DCD0E74@Y# D$4 7**** "BBJFO:YI'AC0[WQ+X@U".TL-.M)+F^
MNICA(88U+N['L H)/TH MT5XIH'_  4:_8A\1_LCV/[=UG^T=H%O\)=3BG>P
M\9ZJ9;&"<PS2P21K'<(DQD$D$R^5LWDQG"FO3/A3\4/ OQO^%WAKXT_"[71J
MGAGQ?H%GK?AW4Q;2PB[L+J!)[>;RY561-\<B-M=589P0""* -^BH-3U/3=%T
MZXUC6-0@M+2UA::ZNKF41QPQJ"6=V8@*H ))/  KPZQ_X*>_\$_]3B?4=/\
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M%8@ ]4HJIKVO:%X6T6[\2^)]:M--TZPMWGOK^_N5A@MXE&6DD=R%10 26)
M%<)^S)^UO^SE^V5X)U+XD_LP_%6P\8Z!I6OW&BWFL:7%*+?[= L;RQH\B*)0
M%EC/F1[D.[AC@X /1J**@U/4]-T33;C6=9U""TL[2%IKJZNI5CCAC4%F=V8@
M*H ))/  H GHKPO2/^"F?[ NO2K)I/[5W@^;3Y+O[+%XA74<:1+/NV"--1(^
MR.Q?Y0!*26X&3Q7KG@/XA>!OBEX9C\9_#CQ98:YI$US<V\.IZ7<K-!));SR6
M\RJZDAMDL4B$@XRAH V**** "BBB@ HJIKVO:%X6T2[\2^)]:M--TZPMWN+[
M4+^Y6&"VA0%GDDD<A450"2Q(  R:\4TW_@IS^P%JT2:C9?M6>$CI4DXAA\2R
M7I31I7+;0$U)E%H^6(4$2D,3@9- 'NU%8_@3X@>!_BAX8A\:_#GQ9I^N:/<3
MSPV^J:7=+/!,\,SP2A'4E6VRQNA()&5-;% !1110 4444 %%%>>?'?\ :V_9
M>_9<M;:^_:2_:"\'^ [>\8+:7/B[Q!;Z?',QW857G95).QN <_*?2@#T.BL+
MX<_$WX>?%[PG;>//A;XTTWQ!HMXH:SU72+M9[>=2H8,DB$JP*LI!!P00:W:
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MZ:&-,O[:"%KB*&QL+>$SR1I/-'+<$P,8HT2-I<?XR_MI> OV??\ @Y8U(?\
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M\%:Y^T2]SIZ_!?7?A1KUO<^)?$&J_:8E@LEBLG,UV N3E@6MMA<-'M8'L/\
M@I[XYUW]G7XF_P#!.?XV?ME^*[;2_P#A$O&[VWQ0\87)Q866JSZ D4LDLR_)
M&KW"S$,3C:K'HI- 'U?XN_;Z\?Q?M3>'OV%/AG^S[I^J?%R]^$Q^(/BG3->\
M:2:?HNA:=]K2R$/]H0V-R]S.UTS(JI;A2D;.S+PIXOP)_P %C_#/C+_@G_\
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MGP='K6GZ#JVDV\D#V1(AE:)94D>5B@.=\#$% S1^X>+?CA_P2E^)?[#'Q?\
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M^(ECM/M4>ENGE/\ 8X@9(WE=]S-)$(]BA6+_ #A_P2P_;2_X);_LG?LX0_\
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M=-C<0,8+>XN+HHZV:%=OV591&JERW,_L$_MJ_LE#]K7]MKX/_P#!9OQIX?\
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MN-%M8;6U@=(C"9S/(R_8+&-%BDN @A1G"GWK0/C'\)YO^#K;5K ?$G0EN/\
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M4K)&BV=A'>2/-;- /D=)8_+:.5PZG<=OW3\P?'']O+]G;]LG_@@=K7@3X?\
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MZG8+"0DMI,(\YB&R-PR@!/++?<= !1110 4444 %%%% !1110 4444 %%%%
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M2]0)>:E!91I<3J,8#R ;F' X)/05HT44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>cvs-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cvs="http://www.cvshealth.com/20201231"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cvs-20201231.xsd" xlink:type="simple"/>
    <context id="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i41f59795c714410e9809b7c4aef691c6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ifbc4ad88529244e7ae1cef69ab7110a5_I20210208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-02-08</instant>
        </period>
    </context>
    <context id="ie1244a575f4b4f4185b2f04835a5d5dc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4619659f3e0e4e749c1bfe7929426080_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iacfc4b890d944c33bd862b4eae13875c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3ffa460f969548b583077ff85463f042_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8887a1cd3c8547d681d8baa2a35e51a2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i862fd4d1d6ba4365a8082e4c0ccf9463_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7c05067cc57a462d9ae3f15016cd028d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i371ef8b4f96c4033b7b40dccf03166b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36847bfea20b4065b555edc6977908d0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic4db69fd194a4a0081fed80395cfe996_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i20db3230df8c4812ac4bf0f95ceda745_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i8c716e5b99ef43d2a3c07841be0dc4a4_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ifc9a1b1abab04a16a3b873c907603424_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i1e063d39bee64f188da6a74f7ebdb608_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i193db80c5bda4fb7aa1cd998bea9026b_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i14773d0466f74f54b9cb98d7ad2d00db_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ib83b00b1f6e34feeb9987e580b61bb95_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i99d5436478ce4110b135201c6608ebd8_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ic20621be887c43a9b7de2f03f299252a_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ie900981eb1e84a1ba647ba34d76fbbda_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i1f132d1656cc4ffca90cc7c194f9eb50_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i6a4dfbfbdb0244b189151eb29a59b6ef_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="iae582128ff614e3bac0ec6439e7a73c0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2865692d83ef4ec3beffe7dbbdbd7685_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i479bc088fe574cd9bf70b669ad0bde68_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4b45a4b6f0e34440abe81173dd958f40_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4a8972c93193441eb5d3b821774ebb82_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i633d2d566192435e97ba030a650d9a4d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3bf8771a68c449ef90d36d232f370426_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i771cb7ed20844ad7a8c780839f51c6f0_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1b8647a195fe4759a2c1d965857302cc_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia07f8a9064884f3da3adf7cb16b994ad_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i182c31bd325c4b0db0263ee586306fe4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7748ca57fc424eaa980cac40c30c5207_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6d28dbcffa4047b78489791263cdc3d3_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0a9f1919bc174b95976298b74c0d5023_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="icec68b3996a444c5a769c70fa0b27d4a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9861fabc3eea4b0aa172430d1406d2ce_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i59d331567a29463ba17005a8dac8083d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4ec57ae1fbdf44c086926cdcbb8ce7ad_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib940e469010141009d1f199a133e402f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i579b801fc47647a9ae9d0a9f745b8002_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idaa674d77dad4633b24afc1e676be890_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4ebc196b27e547dd9505449bbc3c149c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if00ea0e1726a4c0693ffda7f4456d2ab_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib3384c22fbbc4007beae52127a1ca929_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic1f2c8e874cd4322964c291da3c8928d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibad41ca6e209411b8aed153ad0ca7b35_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i50b94dc3fa4a45d2a882ca93d2edb4a4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id566ff7b0a4d432094d2dd009bd9325d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibbb5ad828f3d430ab4e4b7789d96ca96_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7c36f74c88e4d1293588b625bef258b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iddbe6826a9f14b02936670ae1a4ac19c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3b1fa3d607d64b19b6e722492150bc46_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4052b450116d44169998570f9d72ad8f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieaaac464404e4f83b7ae4acc339eae78_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac50116896f44c97b2f61f0fa8211ac1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58512c9652124fb18dc047245e08325f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idef7f894733b48a89d8de562546c4dd5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ied30c7ad7aa44d239c4dc814569f41f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if103de66430f477397471c724603a2a4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac8be9403fbc450db4da0a11f9de6385_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i582affc472fa400a9eb5ee9688d05fee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3030715b1c74323bd4bcb2d48199bf3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e943a74976c444798abe05d760b9d08_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9229806f74744b7886032e409d4d844_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i42a1c40357754fa8ab8bff9c11bbc401_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8590a938bc284f1db11c769ad6e3a70d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30d444aa6cdc43d59d7fa44cb8d6c3cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i963da7f6c42a4740a9aef503c045ff0b_I20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201802Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="i5212eadada724019b746b479c60caaf0_I20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201802Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="ibe752e5f0c414274aa8dd851fe81d462_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i48c282f0fbe7448d99f6ba30a60ace6c_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201802Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i1c1af2cb8e024fc0b237288131dfaa08_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02d9906f299f46c78575a0dcc95ab970_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9ea0930652734afeab89b2f4895835b6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8696070d484a40f2bb7a4f689ad3defb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cvs:FixturesEquipmentAndInternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c66b1159478475eadd94b3ae0b2492e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cvs:FixturesEquipmentAndInternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i089b48d85e384c799bd89b63783799f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21bafdeb44cc4054a9d59d8f3c997e60_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i52e60b1b6f4a4dbd88268862a0d22fe5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie669a13e87484bbf8cec205795711fbe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ica9c1a9ce292408681c60506f05c7e71_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id09b24f17a054a62a94b835ed727b119_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5737e6e8f2e848bb890ccfdf89d8addd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if57eea73aa9c452f8b32b1d955f87c9c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i05dc4ee13c7c4d28aec45e6e732ddc48_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6b3de6701614688b86b94e57bba778a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9e7dfa659f1f4a92a32a74b0958212b4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8d08e4488aed40f3ab968e76d61f94ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iddd268c0de8441a3a25145b2c7fdf545_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2d5b621fca784ba2afc687cec988fde8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2e9687452be744e6ae16597342184c4b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1ecd36bf6d9f459da73860d5891edad6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1dbce9db2d76499fa858862f845f972d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaff454c2b91e4d3a845612cd83bc5a37_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:BrazilSubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="i37eb583c6b6d47f3b7c106af8367c133_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i426635a6436f4eceb5ae3bf452f2e8ce_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i313e1434cd644196a894b71f3e4d271b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i300a5c4ae7ad4f77b6e0b97f6f8e0cfb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i987983ae1dcf428e845562a5e086c894_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8807d9a1c6eb4ef7a7bb815b14181f74_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iebbeab317d23464cb721bf23c9554965_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia39c42c0a78e456cb74db342cf62b094_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id4810c04a4634439b6905b74827cb24c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia8b1524b485c49609e399b2a230e04c7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd55880281f749318f4691e88cd97168_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i783b1352f68b40d2b4ac2682bc608521_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i42aa9378a89545c48dee0fc68567b9a5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iad54c820725c447083ff3be1ee37598e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieef46aea24674d5297f52fe96fd3652f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idbe2227ce7b3407291809c1a7fef699c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd5d327d52f54f70913e6c6108027d81_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaad598e9ae7248d4b644c5cafe6a51ca_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if63174233acd4168b88c860a242fb85e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i61b3eabef1e6460cb656982802e37513_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if1a017feef1f44bdbe74396d8046773e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib170695af7314375ae76b557f9da70b3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i33407e182d1347caaf77663336da82fb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i15b2e86a75f2415d8bf8685add0dd173_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i69c3bc4b998f4337814af2804581a932_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5c72ee7a1ff04724b5d9c64969981c00_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9eefd35256b74eb588b983fc0ce03cee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i615e8d8d64e049b2baa6aa868316807d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1e5738b83cac44c8a207d99440f8125c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ice6658f59817451f8226605da85f4b71_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic572f6f25fb641d68b501e02911341dd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i905d30d3d5c2417fa14d71aa765d04ac_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icc535c0378834b1dba6be6c404915f1d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i75ffe98b0bd943648691587a5bd133e0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2ff00ef80a974f5eb5b735f33880f18d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icc9115de5fde4c4880875ae246f420e0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5478933c3dbd44f28b9d5a0b50d6db7f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i883ea853b3fe48ebb9fada798636ba5b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8c68a89f8e4c4e81a8576d27b3744e59_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iee4e7fda3ff44e1cae0013e4824f88ca_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9a9e992c01b8401c841b3eae8f16e94d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i317b21ec3df84f079f10f3a3cb5996c8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9a391b68fb7b4d8f843138cd71f2707b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie48e36cfbbf8422186962d2169fc4edd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie727763f57214c94a1c11e4313718b07_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8f10e0c26b5b4685a3da73b5a6d6cdfe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i98c09f3cf15740fcb2085a4ea7a6b757_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id31407870d8c4fbe93fa0ef67d5f1bd1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaceaf6ce0c0649e59587194b8562c088_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic2c64df3e01c472b98a154efeaba9606_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9d705300d5f44592abe5c5834931363a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i637cbce7eef743f392772d2447f3fb0f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i03cfffc1fd2442cb99a34979e3c58111_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6948fd96583f49168479c7bb034889d2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9a2861a5e8ba4e20bd8eaceed653d6dd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i19549f30d57c482c9aefda9c7a91347c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2700a9f4cb9448a3ad808275ab50ef5c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9db376e2f088449494413724fca2e556_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i647cd1db2a7b4b81b35d2e32684b1fd1_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i92201227633d42428e8654713a1183c3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i013b860d7dc4425abe6f741f311f6b69_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i691b329bada44592bc51fab7186d983a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibbecb39a71a1469892eb85b5117dd313_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2bbabdb50ce14e3e9d0aa6b2731c0077_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i521a13bc74694ab2bcde000a0cfa3d7b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8edc8623a1824b2192d1cd1f2197d2df_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iee713b77e09b40658fff6dc3733ade2a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifa5cde79d4cc48c894fc26a3d00d4c4c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8cbb8e25253e442da025fb09f9ffb8fc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2c61f360659541ec934371fdc19fdbfe_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8c5fc5617f60483f850c62403eee0116_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9ace05bc406f4b35bd7d939aba14ba8d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9f39b6fd2b4740dcb546b4ea89d46660_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i36564f45ec67407d93ad909645376841_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia751108dc0164471ae32975e51995a36_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3c87d411f5b34673b9973adc00d3637d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4bcade8977e24f33a1be8dd5bbb6e4ae_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0afe948f657f4d75a79b6884ce991c1e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i50ea2b4a55ee4369beeefd0c2170a8cf_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9be25d61dc7c486faee71c20d5fbb1f8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7219da47c7214a83bc6666bb4b2abb50_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2c3e56e0202f45e1ad53f61ac55f0d3b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9e56f64001404d73b3c695a3b5ae8845_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibda6ee66f0de4117add908957e89dd30_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i138a42c6cd5e4913b5eb2ad3288f6b8a_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="iacafa6a2e9244f43ab295d89abdb066f_D20201022-20201022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-22</startDate>
            <endDate>2020-10-22</endDate>
        </period>
    </context>
    <context id="ia508c5dcbe174753b2ea381d7ec1a3bc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30eb50f669aa417d98981c15d603526d_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ia29ce83052be481eb35a86ede34ef887_D20140101-20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="i6fe88e3b7af243da9625e02cfbb5d718_I20141031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2014-10-31</instant>
        </period>
    </context>
    <context id="i80d59f9f341b4a83b98d2b3b1b87310e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i59ea7852fec74a64bb6d3f7c2754512d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1a0cfcdaf6c54b489a9c3eea04ed3a37_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idcf15c27df834ce98c7f1da46d42a14a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3267481b2aa4488bb857353dc51ca8f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i373b58235285416bb437fdca972f274b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i343f3e71f5b546c7ac384b8289428e7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4dc57d39a4f04908be65c7bad08c6849_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8168693bd43e42ad9a06d56bbef64902_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieb3ef261af8c4ac5882b054e927e2644_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i8966d06a68154d9b9a82e87fc68f00cd_I20181128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:AetnaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-28</instant>
        </period>
    </context>
    <context id="i2bda1e1ef73b4b7b83d6f7ff5925839f_D20181128-20181128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:AetnaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-28</startDate>
            <endDate>2018-11-28</endDate>
        </period>
    </context>
    <context id="ie8f88d1feca14fab9af82ff64e292817_D20181128-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:AetnaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-28</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i1d28d9feed044ba598796ea48b01c29b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cvs:AetnaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6292fcfab69c48809cd6df0bbb16e7ba_D20200731-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-31</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i686d61205fb142b1bc16e360c062d7f1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie10ef6a4cf20405a8bbbdaffe804df04_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:BrazilSubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="i15adb3671036492cbdf9d10285213988_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:DrogariaOnofreLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i69096b9bb0844234beb55f386ccdbcdd_D20180102-20180102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:RXCrossroadsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-02</startDate>
            <endDate>2018-01-02</endDate>
        </period>
    </context>
    <context id="i7c5ea305571c4ec78c8dbf812bcf4b08_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:RXCrossroadsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i46cc0ed8444447369f7ffb60b023dfe9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4b98a93f0276459b890b573fb626a088_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id67b9d5fd1cd48469659ac7a217ebce6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id2ac54c8ef3a4dbaa343b9df3e53741c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9da7e2dfa74045cdb18889001920c71c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5230461e9b449448da7c51080282d09_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if36ae6ba3e364496829160fdbe5c179f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf17d2d7ffb9462082227dfa17b3344b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2508af2bd58e4d89a5c41fbe25a234da_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8ce489ea7924f6db3a93eaaae428baa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a19c71845964210be53c6d425920e0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2afaaa9709c42e3912403cd458a7e31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if3c9a60aa719471988bfddae88c14375_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaa76c57927554320b220d6cae72d2d1e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iadc8ca1db091488bb75ef590d4ae4d16_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i16e6f0f08a7b48b197075141b6b6b948_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7862ac46b00d47789bc1df87115c0653_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaa2411561ccf4d0b8a1929416700eb6e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9f07a8fe7175442fbcc819fecef5c309_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ecf8dcd90f14826a44fd5403301707d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i676e7b8c5a05475e91e66c6e8684f644_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i70ae98000fd546eea670504ba0d63d0a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4c483eeffe6d4d83b95ee855c212d24f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7ed3ea2d008c4900b6da8ca08af14359_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iac96be526caf4447bbf555aac1a17ecd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2862acbf1b084e6790226fec4b8bacae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id096a5fb170740c39d0deca267bf7d45_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i994b426c1b84462e8430c20afa88eb28_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if373b00647a647d492b359b2cc518799_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e506a799edf42b6a5cab4f7c3320e36_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a9206a1aaa548579a9355991549eb38_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibdd643de24674532b6eb565b63aa23ac_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie6781fba553a4bf7935fdce6921489c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6ec62eeb545418f935cd6789b8f043a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a5f6618b0fa465f9f1f9beb794efccb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i387442e37b5e42a49e054c4423e257a8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b8d4e422a0b456caf45c84c95a13c63_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib60bdc4640d3430dba09cf14bed10e42_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29175412719d4ae0bbdcfa90a2791097_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i443be5ac12ab477899d6c78b902bfd1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3350229ccf0473d9d352076764201b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2808c5a9454a47638feaed23f05ffd75_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9ded9eecf3545abad11c717bcf28ef4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99bc2416240a4a1ebcd6963cab1df746_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01cb405c32b64ca890eabde91b0981d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1c5b042ce36e4d5f8c31048f338d0da0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5431d9662eca4651a20170ff92cb9ea6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iafd0d1d240b7439788501063223cefba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7dc8b1810ba64a5fa3916ea6c09b3e81_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i63fa7e4e54554cac9b950e535b9ca5a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1643fa3fa2c44337b623c38b9b1c7cc9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i32903e0797f349ad863b6da5b59eb0d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic485b0b1dfd5472cb9fc36c196433b4e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8e442f3b9594715b2fb6548ebca61e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01033fcb93704a4391a3e7fbe27e7af2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3682b33721ec4514903d622b539be8a7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8cb4368415fd4f45ae4f3029eb9e6097_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i88e6a24a77d9465bad6519907e24343a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i09f545523cd149f2a426aa336810452a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i822d645dd6e24c729f04ce2895f1a93f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i062d253ff7ef401a835b48533522c00e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ide073f4bb27c48c7840435bb8f104221_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie0bc39dee46c4714ac0b0fab972c4ccf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i473b0c0209924e7cb5e5f5f0cb1e4669_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69e2a8048cc94bfa86c33501b14cf008_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic55e9a14e25049ec9335dfd7e9cc5e2c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d53390437704160bfb47a2ae8120e70_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79abeff81ecb4f2ba2b425357fdac880_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7deafc4a256c48d8ad86736b4e5311e4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6510e58a12864cabbb5f5d397cdcc6e0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1e8f84bde226406fb2371bdc5972636d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib4aea11f47ef497bb4cfae564490a9ff_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia03d8280e504476eac041f0e93f83065_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i94e42d46c2d6436ca7b0109d263897d7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4a3f3595ae134cc981ca1d3c18836706_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0bb8e2da802b450082ce3f9ebeddbb9f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icb976174df584566912d1ce975916216_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1e03fbfce9af49f1aa6114c65a6c2f53_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i76d11217f0a44658a8c9c461abf28597_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i971973c567634c73ab4ea2e84ce6b0dd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0c310256123047cd9dfe888f312658ec_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i88616ec7a1ad44c3a2a4dd7cd79f5196_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1a4cbded6e7742669126ef8fc6075ffd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie2c70dda95db46be820b218ae77d9e96_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id96a55c4463044b5bf44723d5c1ccf62_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i877d4580f0694cb4be370136b4865d7a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i08f62f5e177e435b841ab3f7d3b09c13_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic98ccfb571144f1c97c0ad662c696d05_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0daf6c04fb1344edb25e56b236c0dc57_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib258da2c83ef4d81899c8b052d2499ba_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idf33732bb1b44dafa8da81b701b2c146_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieed1e5fc77c944bf8c6cb12c1362e77f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i45581d71f4fc45f68574e3690202b39e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i47f137d0f6d243babd97d6cefb992373_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1b85ad0009a8404f91f09c0c56c9e0a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7d7ca48c598f45cb8d641ff3cfd83dc3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibb6ec27882864945abe2ffe9bd523656_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4463ae62a9024501b5a957f93ffd509c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5f180321401b43afb4ccf64eefc9ed72_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieae65b64f43641bd80854962068ff2bf_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="icef7b09090ab4ce78a8ecf8b2b4586e1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i739d9512c32a42c2bc64e5f94d64b6a8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i851d4aa7d40b44b789763f7863bce518_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i439d5bbe06ca42518920801c888d40c2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia8dd6959068f4e5490c721fc82461ad7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idc5fbdda1ccb46f0bf05959e53345921_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3489e4cdcead49faa7307339be45ea56_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i054b8f52f436443db1807cf26d0d4567_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i458385d44006411896bb4794dbc65c9b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if9f2ffe7a0ba474fb811572f2e0ea7e0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4508cc8f56f04ee9a7567e40b8da3c28_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id19caab13c4e4bc38082d1bdf6bc13ea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7e22f02c654244d596daa5e51b729587_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c4a870a8354489ab03c6ca49ffdd338_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i344a6a9cd51e4e43b0ca2ddc7cb48feb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60bdcc978cfc484baf04fe7970cd32e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3a9c7ec5cd043a1b1452b0017077321_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i535e58cf8ebd41cb8d7240e4b1e35f50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ddc060d200a4e2aa0952f43df4f21a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e8fea1acd9244a5a882955ae4ed486a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ice331df2b98e46fea9be5f51151c8e6b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8a89f2686564b389cdb4fe8539d10e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8edb5e9988eb4dcfadaa6febf64f603c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7a5669faf591465099f3db3909bf4908_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2db80d0e7344f35840de60bfea8a22a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ide99961030a64271a6dfda0a74b2fd14_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie311d074225743679534438cd7b7490f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8564e44c4d0940d883bb0a3d95fd9e7e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i61b53e87d1454d1f831fd5c70d5c60fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia77b398de41746a9bea32d7c8add5469_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iadfe4530ccf44844a620422f79befd12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia44caf607a4b4de3b75eb6df51116b96_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id18c3b096aa54a56ab5aebddae95e201_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i150ad433496a404098a477e3ea7c9713_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6bfb0024ebcf4bc0a0df96fc6053933d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05c28a6dc98643f2af8af4f866a43aeb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie0e0cef498104e4498bc6b4cb58dea9c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48f0fd6cea0b4f2ea1af31f0b858cf48_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4ed896778474633bf168b8f5368a64d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i37858238ff4b4357b90cb98696708c18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba2f946e677c41e6a1dd57f66196e517_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i81b92da379164d05a04e73b67319b43e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia4de0232daf44e89b664bfe4fd000aeb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ed66fb799214fc2bf98dc256cfdda0d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie604f7e6063c410db0270a579e5c2e1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i824ec462d55041558ba9c29476131800_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i427b6fb3db3448e2808f061a08c25372_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9ec6476033e246a18cda5819f01ab27f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8539ee32c9a54080a31d12e525e306c0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4dad6865b2654a9b907c9347d91993df_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i78f5a494a7494280953e08b74b394c16_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9710be21b74c4c1599f063414aaf6404_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if9d5661cc4d149c7b8bb9325f15773b2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i56d284138b914afab3d80a561bb6eb39_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8d9f485c9030494899f777cd715f8fa7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1085bdeb3b104e208f4620803d5c8e4d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7e2f247e22d446e691e08e44f6068a66_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibf6bb670dc3c4e049ca389440de1255e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if1419625a52b4c7f99601b13d3fffd3b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i49d58ae32a674ec7a25b0cab1c107c50_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7fe5b5a213bc48a9a839453f8eec37aa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifdd142883292428c9379bdc65620fa8e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7d59fc608e9943a9a082f64bd8966e7d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i10d143f8d4624b888878df58de333010_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i84acf5a3b4b74531b1bc2f9b3cebfa9f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i14c435d7631b4ba8ada299ff02b1fa00_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i27193b7a6df549ac80433361247ff541_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie1e2ac0b66c2497880c1e0d940d086ae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i099b6050d3584f5fb00e807ed1227a99_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaee970ac587c4ba29630fb7caf93ece4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i89a55680a0a4433a9c10cba73488c4a4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib79362fb767e403b8719ea6a27dfc263_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6ee3a9120196416f8296ed0519c6e205_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i917d8b2ba01740e38b71a44126058fb3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i909a12cdf2aa40dda0c82baf62b9869d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia22f84d3693548b99878a1e34770cf19_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib1c603ece9bf403fb66246ce8f442203_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i67c1ffa9b4a64076853256c4949fc411_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iee9c609f9b8541b4a685e9d0fd26d249_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7980aa14ee0540c882652c696d24ce39_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9553185d57414893ad62b80064c4476b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb48192210564ac4a732e153ced3f314_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i43a7de1365ad4a64915e5f9da6e4dd39_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2c1a17b1b7b4bc6b1eed4e29b39070f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i60f83ba007004358b8f859c6f7774937_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i488b7e7f18e24adab3814dcb16ac304c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie354c2c65a4c4f7abcb39006882cccc7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2bacd808153c4072ae90e6431d9f3e8b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9af5df3294d4476b83876447a5baef98_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i244c2d6efb77428f9129af9df189e973_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3c34bf51a0004f2da4f3173e1abb80a8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i89a12d5819e147e7bc86f9b529bb3c15_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i281d455fefd94775a95b6168db361569_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if101d6a0ae7e4064a00c572a41fb9b2d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5b578dc25944a4fbe4f6a957829e2d8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i04dac01b07d44177a2aaf98a61848abf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id19a4d6575054945aa1e86e5f0871e33_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib042e1b736b6487fa6a695c2e0d0ef4e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id59f0110266f4824ba6157134876f465_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6557af605d654a8e8081d5968b6b3548_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i100418be515a4d90809febbdcf54309f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib991f27f97f044478758250bf930edc1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i57f9fd12efa94170971353c862b9029d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6543aefea2e4d4f81c09b28b2913051_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5cf3dd46c89b44d5bdbd281a784aaa95_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6180b9fbac5241d0a8dc3af2706fcd51_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6438f449279451c82fc37e0afbb67db_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i28d236f896774150b7f1bc5f4da496b8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia8ddf588ddb0403491b152484f71c14c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i871f5afdae7444e99dd2730c1cf0cee9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibee9411da7c14a77a36a1bac009e2718_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4fe2ce5da7414160ae14468a18322af4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff428bc79a6944198cdd6baa0d71d0b1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0c958b1240244ab49139ba6f5f3c28d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a35d7e4fc984bbd812c51700e1979e2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia00b03bec0a84260b8fe2013746a2f95_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i280afee039b24b5c9a7ca13a82b422e7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib0e7bd646c054ce0b4531b2eb42e4c6c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie69e76ed83f946baa094f2cc5d6eed7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7305113d58334ee181e867ee40fba5ea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i460c17b4dd6047799d283a4d6ac8e89e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i03b2619a7c974ff2a2f5ae867e8f37e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i151d6d04ea0b4c4d8082b77226a45d78_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i24eb76bad3d44b72b3d464f255226436_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibc128aa047224725a06bd6f71841db12_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i54973a0f47c84614ac6eac855bff8c4a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic4c1904e935648538c8d82dcc767f325_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9bb3afb7703f41758890d49de4633ba9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i42c5a9f858b74f68b1093b16815b1cce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9cfe1fb048044ccaa0da17032f0b6155_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff5a46ba7a27414b9d1202b7ad24b91e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i844180dee7354a88a31506e0b8d33a2d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i19b103cf575b42eba2237027ca0840ed_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia86e094601974260bb883cef037fa44f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ide3c87bc14d942c99faa1f30e965d4f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i65c51381aa1a459fa5e530ac9f5de9f2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i91b1952fb7784e7f9e6499530764f7ad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c56d1167edd4939801f422a336b0abc_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2f780e49e5ac454294cb92045dbbedba_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i328ef57235b84be59c08ccc5a5935e02_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5423b7aeb71b4180a07350c4973d0d2f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i015c0f06a5d5429bb1541c67f66811a0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i052772f862ef450c8eb33c1ce00be32b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i115aa53eff704e2796feb2dab7050983_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibc25230039c44ea89e091836ed33b5f4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8c1e3b4bd52240c6a3a87ca6634cc223_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i19aec03053a346be962dfd329ffc858e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iedba146ac9454388b30cd9e975a457e9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i21b8848a0b0848d0b1ef073195fcf232_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i412092e3efa64b64bfb4e908a7aecf6f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f1c041ab6e1476e81c0a2cce0548fb0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4e630250890a4d9da4b21f7c24765041_D20180401-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i890b640f721945cabfe705407b55dc08_D20180701-20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="i81f108a20d3a4e71b79be5b539cf2fb3_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i821644c913b3489eb143ff3327e94045_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84badfbc307d4be689f1bf6c6f45530f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ba3c6a5d60545c7aa5e44bfe6800541_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i67ce92b07cf64792b2f3329459fc557a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id50415e8993440b4b0cc0fa2104abfda_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibc0b012207df4d0a9822ad6163fa473c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75becaee1c754117a23d47d9390aa79a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i72cdd4168bda4feba177b3eb839e391b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id2e3c68b19214ed09360896c5196bd2e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i591aef778e8f4b08a9c034e1f397fd90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:AboveMarketLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i491553d39bb44be899dcfc0772b9b2d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:AboveMarketLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i21fdbe08c4894113b384b8256579df43_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i584138b84e0c44e79759aa9dc3e98131_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie44e4bdd6e20403284243fce9600ca50_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id2c72804fb3f40038ae0de7cee82c6ea_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie01b8cdceadc4bdc8efc4a1dccc006f8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i63d8ba5cb3cf4c23924e487351249b95_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icbfa84e1dd6d488fb10bc33f97246d8f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d00c64ee40f49f090f5ef6179642e56_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie6f52fb91cf7425c82f7676b531c4967_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:AboveMarketLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i34f48c975e2748a8ab2b5a10d3e41319_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:AboveMarketLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icdcdd6decfad41b9858abc5ec839199a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i13bbb4efccc14c5c82049f643d62aa08_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idc7172c9ddcb4248bce1ae1aa4280d25_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i029b000534014642b4477f76ec44b138_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i70084b42bcb34cf790dad3c2e153d003_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ib071f664e4424c34825859add41556cc_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icbd9a72694e74fb1953ac9de25db565c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib0a759204965465a8c57fcb74fea946b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a55f9c69cd1488f89f0c37551af36cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2e2b65bba50242fd9c8370770a4be117_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iab2819dc76894f5995f2436bdfa0b59f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="idf1e85cb6e5d4ed281db988a9eb5b755_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie2689c30da3241379d3461455317d9fb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iadc52b1e6e6f4e7e82de9d1c0a987c54_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if59595395c854ba7b06e3bf1c79b2167_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3dc84e117e964242bed54b2fad5b0376_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i39ca9c0893574888b90454ef444cf1b0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icb51aad0627040f1899c9ab4dbda4d6f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia44aee29de0d4077a6f00b78e9d6263e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJuly2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i88f639376b55490690a36f10a9be2811_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJuly2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id01a6d6a45694726a6f06c733cf6bd6f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i59044fa83a6d4afea18e5166e0f463e8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i82faa3a8c7e745008aa3175817187e10_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if2e6fb4f07b74b628115f0ccc6d9da66_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1dc856455e7b400ab7c24c5df6647e6f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a9b18d3bdf747699de43dbe6ce0bd3a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3b59429fddec4142a6db54bed9ab055a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5d340447641846a9a431c822fbec5ddc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i676ade2029cd42ddb0666570247f7159_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic6a6f27fcb634d5a8284be453046e3da_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i63be7ab398194c9282444fbe7e010250_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id602ed76bb1141efaf6bf5a490a87c42_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2c0d5087b6064f70b84a0c6522dde077_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b68adadc076455fb9d9fe54b81b2afb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie4f845bef7bb4551b019ead11e5321e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i51052298202549029f99a9aa30364e50_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i556ba81c12d2465ab03865c19ccdd639_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ed4c4a68c7f4d81b36909b27c56373c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i171c4fd932814c18abf98b03dd0d5aa6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0047ef3047aa4d01b3b1461ca8ad2376_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i734cf172fc0a4bb394897c043bd538c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i186e6bd3f8c243f290f2d7379452ca08_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icecaee365bf9466885c2e04672491901_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if2942eb9beaf4f7cb5866f52e34c56a2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0e657c55e1f64967b1ffeccd58ae062b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e950cbfa319445c8d4b8cb106e4f1ce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i53be593e004440969eaadd34053626fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f30d489cf5246259fd164aec13a5624_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibd43c50e8ca4414ea2cecb99247ff8e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0573e87a0f0c42ed97784d5b5ea32460_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7dde33d57ede4cd2b5f5a4f7c72f3c92_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i97fa105db68d4c46a1f39c9e528fa813_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if1ea528658e74bf787c41152af9d8121_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2694eec161064921894d65f27aa8ab17_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibb4bb36351fe4c6f9d1a0eae2a188257_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79094d4adfd5425ea0d62b733c026eca_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie6fd5b2064a242a6b820eafdcbbe9428_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if4dacf9fff2540b993923fdc63acc6b3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8450bfd94fac484aba4e77c9fc4efd2f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5874afefc4a74dd6ad08f344c1f53ec9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9dd4c17f4c144cf297f7e26ae28bd94d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i866a5d43855e486f8cc0c68a5b4620bb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i08df6665d2524a33a4be6561924aefca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i24c2a1537a164fc5874c6fa1eea075b4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idddb1de105474de39bd0e7760adec57d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie92a12c2190d4335847859245937972b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4ca0fb7a5b484776ba687c307ef197ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point3PercentAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i050c35f0329b4b58a86438fbafa04846_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point3PercentAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibe8c3f3d18834cf7b9b94d15988c16aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ica41313a27ea4d7ca02bb73da16225a1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0bb1c419c09e4bb19d54039c47abe8e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie8e397dcb8d14af0a33b647343c389f2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5a1d49c0ec7e47f4a5602ea8cc802eef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic5782efa7db249b6b23113dc33fb76a7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i212780690b054480b1d4b16a1ce55e8f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point75PercentAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82893487b53a40c3a443264c005a3544_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point75PercentAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i014f1a1c658f4a5e88082091afbc10b5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point875PercentFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28e1dfeab22c474fbf87dbcc1a78ae98_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point875PercentFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3262bc6e373b449b95e2a2364d10c2ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id20e06cc938d415a953c7aa4bdf9cc8b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8948ebc60ee549319fa423f9c9ca71ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i133831fe5f40404ebaf46e33ca52ac9b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i353b9ef71c8f47328eb48db1a68abf98_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib9bdbcde47724dd2a5dc223d8b0d9fb9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic196591389f249e3a85fa825d6428142_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia7d67544c4ed4204b542c36dc455c469_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2552168ebcaf4d87b5f4441f01768b71_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7d273705308749c995ee3575c0e5b372_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i867a6232fb7244249412521e5001679b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if44fd76e6acf41a9b3352d5c1ce68f96_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1044e6b95e9d4af7a0760d5a5f5c5d96_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point7PercentAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84cdd9e17651455894397e2cc826487c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point7PercentAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4a05340b9e204506b8228431b5765c0a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ad9df9ebf4746febbda2d5944fecaa3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1fa943d2d2b64256b7f438c6bd342aa4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d024add61ae4a83bd4faf2b2187bffd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iacb0304ddc414bc9ba515d05b822e59f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i063d082f54bf4a70a10b63c68204c506_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib365a66162e74ae1a131e17260d3c309_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic58975dfc3894919a505a5a72c8de2e1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4bb283ec93234091a925868aa3c3d104_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia4515473601e42ccb48a414ff823ea6f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icb5c311b199b423a93de6b1490f41256_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f477f50197a44379a3e15ab264fb450_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7a9f776493394d3aa1b9afef76079abb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i38882d76fbd94254a2babd6873e24f9e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e5d522c3502448f88a84c21bcdd8997_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ff770766b8f4090a02e18b7734a5a58_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iea2cca2aa63645ea8d47444ec2a4b2ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6f4c74c7d7384526865bf4ee6224633b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia69df1d43019455c8f2e992b4d61f9cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic6471700783d4a9ba371feacbe010756_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i436a5971435f44fba2581c308d881259_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2a81421b67049b4b9bda55d847576dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay122021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib876b3c3e46f46e0981a6a45069067a3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay122021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie9c68e7d2e424fc59a03e33749acacea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay182022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i624a08d2669d4bc19ebfeec612b82b2b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay182022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8809cf477a8743d9bb985128a2794821_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay172023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibbb693e747254191aa459c5a8372bb85_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay172023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic05b162415354eb4a957e1d4b5f6f6c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia57b5877fbea405eb22d66a6eaf931b6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iab6686fec59a41f4a0c718105fed5c6d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i07faa68d499941c1be4ba68ed832a9f1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f6bebf211ae4518a4a23f58e6f388a0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i95fd067686e94117b1c847c8a8c039eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8c5eaacbdf242339dd3eee02265fbc6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f88871020ec4730bb5d033335c7942c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3459ed386a61404c94e9479d6015ffbe_I20201216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-16</instant>
        </period>
    </context>
    <context id="i99166279d10146f28c4d4195c226385f_I20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-21</instant>
        </period>
    </context>
    <context id="iad8877d2fdd8467888b253ca40d5a80b_I20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-21</instant>
        </period>
    </context>
    <context id="i88e8304eaa26409d8a604190defc89b5_I20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-21</instant>
        </period>
    </context>
    <context id="i94f9c1f9d7704805bcabb81136732a71_D20200821-20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-08-21</endDate>
        </period>
    </context>
    <context id="i445f32d7eda447d4a2c49f251b316594_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3625DueApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0f587ced64ac42339b971d523874e02d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes375DueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i459a1521a0b34aa48757c591eb7efefc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4125DueApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iaffd5e9b361c427a883e24208cf16157_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes425DueApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id5a40055293c4fe79da45605991de624_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3754da4dc0974763892869cfb72c7345_I20190815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-15</instant>
        </period>
    </context>
    <context id="ie91d7fd162c249529beb9e9eb9f7e7a7_I20190815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-15</instant>
        </period>
    </context>
    <context id="idb2dc5274bad4e428d1e8ae87786fedc_I20190815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-15</instant>
        </period>
    </context>
    <context id="ifaa8ac73798d48a8aaab4ac171cb2721_D20190815-20190815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-08-15</startDate>
            <endDate>2019-08-15</endDate>
        </period>
    </context>
    <context id="i95a7e367f856452c8f2160336066176a_D20190701-20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="i3267d33afe6d45e6b4528df8d62df448_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibca2e87104be46389dc5a70a0864d1a3_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id9f05d6d28af4ae0878d9c571f979793_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i28dabe1fc51c4dfa95740ee0bce67f39_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9f5ce01da4b6464cad8f27d28f832fe6_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i854b7b5601cc4ad2ae0c167f72910032_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3512931fe12944039d4fea37efaabf11_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i00d2c3f9c025419cb3e6849ea5f357fd_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i55b3bd8ed75a4dcba9f7489cefb5e348_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ib154687a8b3a4739af34791842da6702_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i6e0292e851e64435a7435abc06f22dd9_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i3f4b2227a9a84f6aaa20022126390e84_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i19a7d9778cad44b39b5aedbba6e986eb_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="iacb6befda8dc4cad8d7d488e77940523_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i77619d991c0342398aac18ff9a3beda1_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ie86e314ed8c34b84b73378a6b9f4d9fb_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i93c1191afd7245a2b1def8168a0950e2_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i2792f74c0d9748799688efc0b0fec153_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i7f532518f6a74de889d917417c28eeb3_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cvs:FloatingRateNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="ice888eb6a699499fa3f39bf466abe7a3_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i4fdb87438a4048388482de54f9117c58_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i57fd64714a6f4ea08771d23076bbabd4_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i55a729e2dd93487da789a270476d9892_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="ia4b13a24dc9745c6846d0092832bf57b_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i128e4692b13144ff870ee0ffea794d65_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="ia712a987f9e947c89a37cdc4169dac3b_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i9e401817f81448f2a9b9b27b7cc53de0_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i56de586fcbb34f1fa9240dc169c67a55_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="id05aab78eef84ae1b36d242d69f4a389_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ida8160947ef6494a8204e68ccf558244_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie19b4a92f0034466b0dafc7eef0ed131_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d0605006d2241649165adc7e5b9f2ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if6fb4454708b484d80f98d957fdbae70_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i199b7cb664dd42c0a4101ffbc59daa25_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9b7e0181861a4c0d9e8c70427c9ed30b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5907cfcab6b4aef941e6f756054404d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd81358eeafb4757a5e163b51db96a44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i94f76249fb9a452d9893743b90cf37d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60b124872b654d26a4229c8094209469_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee2b654be581464a9cfbd3f508f399e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06e5a033c28d4981a2fdc1ff5bb4e842_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2be7ba94d39d477293bb398aeeeb21bc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie06fb4df6a36490395db8159ed91e626_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i92ca0b1a966a481bb230964303d892b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i467e9f5dc8e842b6afcb7be67ac32c9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idebaa114561f4d728604bd981df6517f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5925ffc572454ec9a71d0ef8eb29f390_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01c474448dea429dae5ca6e183b910fc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1552a4f21d8e47278630c328c2dde9c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6d60e6812854952a3585905fbbea41b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d8204427c844531b278a523b96a7dff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e87124deec94812a64890f3add780e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i93b5aeda1e154dd9b1c23b1da20f6ee4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id02d21e453d54dae81874530cd9f89dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i377d5f59a8274903ba535a34426c2ccb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0dcfb37002f247639c8eb485fc992007_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01e14729da7b4279abc81f285bf7a165_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iabe4e2d60e78403dbc51a597cc767f01_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieea92042d53540819af2bae5cd60cb85_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic6007e672e02407bbd8bad0315a61ffa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75d0265957df4b58acf5ac2bed8460f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if507a4fe145e42b493db61571bfd2376_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i83dbe71df09344f38b1a756f97f3b8a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10c5293ad9994caab33673ec66c3cf31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54427a144ab54136af97359d16305c28_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i788a8b0a6104485c88fb58913f9c1b1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69a36f8e3e0747b5b5d40f18f897e44b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d20ef997413454bb5220829c7a405ef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i24b8f1f9efa947c7bffb894e3104cd7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i353f05ec97dd4a7dad6e03d980c8825e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ec36398a8c3460a872ca7a5eec4975a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7d49739667e46e7a8df15497979d8ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8202fb48582644a489621cd494e8d6ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib225d997939f4bb2bd5ea1d2988d1cb4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if874ae14e12a45bca74664b04f2b5666_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0638d5f10c8d47228bce923194d15629_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff889270d69a4541aec6168c327f2898_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if371687561d646ad8eeab5f4be3e9b99_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieabe9e784e6e48c1aa447f7436dba5ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5d02faf330be4175b93e19bf97c5db9e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6302fcfa13ad4d1ea6a72dfe007f13bc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5ac1eab026c440588dfa8abb8de73fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i67d5ae7d8fcc4926bcf462116cd3f590_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib1bf3a33ce5e49e09483d3f1eb323c91_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b5b3546e61842e19f00e5e719d97b10_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd3b8f30c29d437ab39023c671b9f5d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i83f10752832a454a8ce347de35c34a61_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id3677d20c08e4c8ebbebcb282e4db114_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i86f58868e0964cd2b2796c0808009103_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b548029e62747ba94fd53b47736ecd4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i58de51b364c74e4a85531407fafb309d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85c43bf5e0d844b89bae1a96c978b4f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife531059d400455c8d2de1200f45d2b3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06bafa8c2cdf4929affc318e38df023e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29f1e9cab7554879b559a825763f064c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied8b9a81bd694cde82356583d0495b4a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb86f9a64a874a4aa21ee0d29a5c45c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f1fcbaf310f4df8bd8906a1f02317be_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i080509f1feb54ebcb46eeaa383e8546f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8654f2977f3d468dae935f3fbfbecf0b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if218f96f5bc7440190bb6d1d32469556_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i729a6c49903d4b309e624c0dbef3b76a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1312f09b0894768af1a8551fc6e5b03_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i91c8af184e30405da562adf6b2f53803_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05d08625a5eb4640bd0ccc35f6f0113e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic5abb09cdc094ad4b2a7a7bb44a3a237_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f89a175a9a14d3e920a746200d35fac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd90fa404f7c46ff85d4bc45bbb37cdd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie8a130cfef55481ab1428a6385d3f85a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5df5acb6d9c14d45b450813208569404_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9298abceed34f2693a1b4f218cd1ae5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i189e4eb5f8f84310ab30e1e16b049ded_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id53b84ef08da4bc0be96eeacb61d6fdf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2a7783ec39f44c7f950de140ee30ccd3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5bae567789f14a93a57bf38399d526bc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5622e8a9b4b94311af248826e87e3fdf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i307b2fc7ef7b489dace816f6d69b35b4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9f44abef5a694fda9c5e4cad71fe5401_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3c01a675083b46ebafe2d3f0f7ee1ab3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id8826db7d3214cdb93b22d4439751850_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i84c926b8e33449989a08783eb00e7643_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i32101714f9f94576810cf6f379fe4387_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iae61a996efae4295867c0dfb1a39a3f2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7622f52a58534a658e934f69b4a9f3fd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7cc20f88214b4a889d0644a52d5a3199_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i87158720186e40a988f7d80acf1e290f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic2a42438d1164e93a25bd2d16276f08b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9913ee60876d48f9a437df7a194a8925_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7e944506a5e748718a30ff6c9042ae2c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i656d5ceb239c4aa6a6bacdc5506c6402_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2cc901a60d9e43c0aa6809d88598eebe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i13907d2d75304f7ba2882e4c00e7720c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i069fbff796464b2d9a15554368b9f668_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i074b986b3d7d4aa2ac22c8e670376a66_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie2a5a8651a074b198c987dc214b0dd2b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iead9829071b4481ab63cea328f7f1f8e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9f27c04d6477464c8445d1e603a5b16a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5ee6557a5cac41d48e5c01b08eaaeb97_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if9aa9e3cb8794b4aa342f889f8401d1e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i39362337f3b44b66bccad215f1c8e8c0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9ad099eb0d7146c38442e0cb9d3a8402_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ide54b78ac8dd45638fb5a4471bfa5d00_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i846c67b9e9c6476ba16d4a96de44df37_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i19f7ea30687c4c7c906cfa2a0496f916_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i13374b6df9b64f6aaa07708acc7d5634_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i90458e77c8d04c8b86fc7590c59d6025_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2d0070b3fe1244aa932248485abfe70a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie317f789360640fb822133fe59211131_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idc128ee345d848ff9eea0ec8c49afc99_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iced38e2fa6484ee9861a8081d056eb1e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if9945b71b67144ecb9f14a84d87ddc66_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i24a8700c68594e30b441940e80331370_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i147b83dbf4614f9c9108afea3b976504_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie1029d4685304d2cb2982ca56bfc846b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2f7b664efcce4edeb2d0be08f0af7e83_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i146ec2efe7f44c0fbbf0805c2207957f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifb71646c58d7445aa5f321233e70747d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i621fa421235e47879a3c82d1e7761526_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie182b182c1e04b5a95f77614cf852dcb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i174d4a2984ab43e49d4c93870e670a82_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iab99963cfd9c4db0b3ea89aeae5f9c86_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i14643b42fd4744918e6578d8405012b6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i457edd129a59445180d32544cd427fce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if81393ad83d44ce4a232212a8aed80bb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i79605292953547d9b320dae3bf8430ac_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibbb7812c80d64641a6de43f21593e322_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2c89457d6192440fa11287d12cc947df_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i80a9f79f4ffe48d1860759d3460e04e8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id82b6a24ba2c4189832ac5c9b3270e8f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i52a9e0dcc4a04df6ac84ab2839ff962f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id3e054a6e4684760a1317f79ac480b98_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0ee306bddc4f4d6b8934f74c4545ea7c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ida6f1c68de9d434f969f54fdf8aba608_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i54a2fed1212f490e95fe213e7e4ba150_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i237d341b67b849d18d2ee8b7d61ffa52_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i107d385134dc41aea1a97e0c5d0f5916_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1fa9c507902c4d0b8fa4479a7c0ed322_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i646a4d5e671b48e3b5e208d65353fdf0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ife78fc80a60a4e48b19bed5974ae5428_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i190a83693cb04cfb8d75c0ceecbbe1ba_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib1d6b4017f5149b3ae49f0bd1da1940d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ife7c0d3bc5f844c3ab8218065d78c108_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i39bb7917bc994f0eaf005fd0617cde55_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i958b9417031b48e7a2cb6c08607b666b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie0dca0fdd1cc4f1c87ec37e91a251807_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5ba1a93762424cd3b76c4ca89d3b3cf3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i706c321b809b483b98aa21c73cf16796_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5510c8c02acc41eb892b3be5a2a9b1b8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i81dde339dd0248afbe29f4dc19b3c9be_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic8aef86038c9426ca7436114946db2b5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4fb8ea69d9ee452abf1af74b33433c67_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idddcc030b53a42e4be0825c74db753da_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i09e3fae81cff499099d524e5745e57cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie58dc0862dea4aa2b787686a9637e9e1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i709a7a961b39422984ed1bd0a5689686_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic8c098e2a62d48dba96b79e8a470d8af_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id2e47c4a3e474047b5600f55bf95c1ac_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i832b22dba7494ed582da21d8a190e7d9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i82cc1b96c4d540878bf6fe77d08690d5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic46f812ae4a24778b7506bc4bb600bf2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icc6b13b774c2451ebf395531a720b68e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic1dd8da2c561447490c876b5d1d43462_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i47492e5b6b204ea7abaea7eee818a880_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateInvestmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib81821bf724343ffbd656554419d3a89_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia6f4539d5aa54233a40a81686c5e751a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifab6770f74fb4affaa6da71827532dca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4862415f867402e89af424bb29735c0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4ee76c7bbbad45d3a4d8ec0ad4b5a14b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i27e3f6392d84488594d582d44fa7d68a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iac73a717d5c74326808abd0309a3a07d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i51951ef33f584792b1899fbe7522c0e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvs:CVSHealth2017IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i368dc3028c9348a7b6752c5b2a1288cc_I20181128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvs:AetnaInc2010StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-28</instant>
        </period>
    </context>
    <context id="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i942a3f87081143089686acdf7d4ee185_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idedbaa2d1d234783b888c78eec015afe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibf6ce0645a6645f6b71865a0cd2f6305_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie367a51e740f4a3da15af04b3bf0109a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i42d6f09ef96442c986984d00a0124904_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iec4fd22ebfb24fdd8219d715c4eefaf5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic0df88ade3c94c729995bbc859b11248_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i32362d8d9c104060a8a8caf80210e039_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib3218ac52d8e4abb8d070125f07b4ed6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d4c72ed7d1844239059f054fea52735_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i840a4dd4fea34ef1a604ab9891347d56_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8044667803dd4f4e94f81a063416a4a6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4c18060ad0f74b60bd700240ae354b4a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:ShareBasedPaymentArrangementOptionGrantedIn2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i93f5bc2c5d2246fa87aab2340bdaa368_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i17808cc9c8d54c05a246d77b12f95dfa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01826b36b4634f7c8bf2af0872e7548a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i14abdf015f0f4b9db4fe52c587222dc0_I20161102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-11-02</instant>
        </period>
    </context>
    <context id="i2dd8180c25fb4a8481234de8c71c1147_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i999deb1ae4c9461bbcddbc5f7a24ed43_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if989d485536c470f8ae4b36308072658_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="id7eb47ba380c4e5e8af029b7a1dcec29_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i76b1b2868c2745ef9a27492b7d5c0054_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ia62846c7391548e195bd48645f91d3f9_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ice5dfe6468064630ab677c3f80d083bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f0e3ad72e674d79b9416210fc264e80_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie31822396a9a497fb994c84f0ccd13ff_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i34d3860039e94245ab240f1f07b53dc4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifcf2440c1d0e4e17ac229c0445e4203e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9a22940c170b4cf68098d8a1d7db4b07_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1b47b478e9b74d6283da9fb27e389a6f_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i4c96fa94b27d4a2c824b3844e3c8037b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i443408ee77904553aa013c58c381a6e4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i57fe03ab102c4593846e42c9794bcb06_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0602d4ebfef644a18655290e8ece6717_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i060f98498d204f6d8a753045e2d7c203_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic1125996cace4e93a47589d739fbafd1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5594c4b0291247d29cdc2fcc74572eb4_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i9aaef92229504806b1ba8f864dfcc385_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac55eea462b842aab63a774c5b13738c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia21d4a25030943aa870bf85489fc686b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic509b8303359462cb2a1c66d8ff1c410_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i218673f1547f4d87ad2718881dec2f7c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i62fa0632829f46fcb2cb4d4b11969265_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic2c5e7b4689046d383454e690de48a8f_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie55d01130f004e38a1138732a5796669_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ea3441f923f4cad82455098c9eac4f3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2cf5ea89c34f444085bba9feb6d80c49_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i19bfa54afd084b37b88cf9c88401e61d_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia39a6a5feda9465cae5cb3ef31577007_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie67e69bf0ba04460ad30b2bfb023aa77_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia10ab0fc32f0402bbbaa42ba5ce15209_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i77138741f151409593c0f08b724a0e30_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i2e098044ef0e47c5bb1938a83a8faa41_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i544dec88053840f8844b00845a1e6704_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i708551cc4c814f7ba31ad03e5c460a9b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib26f4f89c2814e789be0ba11239b5764_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i44c7450a0d11477499c9bec9bf025a94_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic4a8d6916f6844c2903a012a996567fe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia66f0a48333c4fb8a9fae0a1c2df0fca_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="icc86caed1ec14c06a5264c5b07d25d2c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvs:CommonEquivalentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id456c1b6d71e415f8fae0b19939047b5_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i283d40b1ef884f6cb9ca2441e0955fad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:HartfordLifeAndAccidentInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5a32e023950437daba697bb6436ecc3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:HartfordLifeAndAccidentInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if1061114a7fd4ccdb4a85fb5f0f28ab9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:LincolnLifeAnnuityCompanyOfNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa18411dccbb43738f7c59758dc47e91_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:LincolnLifeAnnuityCompanyOfNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i09460a20d53d4ad4afdab3735a3cc179_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:WellCareHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i81a6a522a6904da1983e84571970a6af_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:WellCareHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4a0994e7abf542478298de546eeea26a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:VOYARetirementInsuranceAndAnnuityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc0de1362c31442e9830179e9cf9ff8a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:VOYARetirementInsuranceAndAnnuityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i974ce0ed0b7041fc865280b9d6ba0727_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:AllOtherReinsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8177202559374cd1b60b07d956cf5c08_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:AllOtherReinsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6e2f1b217f52446cb6e5188fdcdf3a24_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4fad3343a4d04d8eb3071527460cb5cf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i970d47a28d574ba6aa6a095102442465_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i02d01cae12ae4fcfa5db05cc7acbdce2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:AetnaInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i11b7b7dd14d4443089c85a899cf72296_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i74221d409dca4f35b040b2ed0b77e999_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7d5bd822a20345d1b479f13bc043f886_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i875e15f3f4444bf9a8d68faf00b3a90d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i93d64ebea36e4de88c24cd1d6157c5e8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie9f90001385946838987a8d0b03205b3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i027f2373425b4cd295e0f10e2e0aa39a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i67879d9b5c0743d68fc0bf8c41903fae_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id4c1b7e8f9d543768b0ff3135e5a5f0b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if1058e7e5067441cb02129bfd0cc9dad_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i451e6007601e4a3f8f2a01973945700b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:RXCrossroadsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i356e04bbc2764550a470b9863ec4eece_I20180309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:TwoThousandEighteenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-03-09</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="store">
        <measure>cvs:store</measure>
    </unit>
    <unit id="clinic">
        <measure>cvs:clinic</measure>
    </unit>
    <unit id="member">
        <measure>cvs:member</measure>
    </unit>
    <unit id="patient">
        <measure>cvs:patient</measure>
    </unit>
    <unit id="people">
        <measure>cvs:people</measure>
    </unit>
    <unit id="segment">
        <measure>cvs:Segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="payment">
        <measure>cvs:payment</measure>
    </unit>
    <unit id="state">
        <measure>cvs:state</measure>
    </unit>
    <unit id="security">
        <measure>cvs:security</measure>
    </unit>
    <unit id="reinsuranceagreement">
        <measure>cvs:reinsuranceAgreement</measure>
    </unit>
    <unit id="lease">
        <measure>cvs:lease</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF80L2ZyYWc6ZGRmMGIwMjEwODA0NDRlNGIxMDUxNTJhOTRjN2Q0OGEvdGFibGU6NWVjOWRiYjNiYjViNGJkZTg2MzAzMDkzZjJhYzUwMjQvdGFibGVyYW5nZTo1ZWM5ZGJiM2JiNWI0YmRlODYzMDMwOTNmMmFjNTAyNF8zLTEtMS0xLTA_d10da047-1161-4885-afe6-92f05234d9b8">0000064803</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF80L2ZyYWc6ZGRmMGIwMjEwODA0NDRlNGIxMDUxNTJhOTRjN2Q0OGEvdGFibGU6NWVjOWRiYjNiYjViNGJkZTg2MzAzMDkzZjJhYzUwMjQvdGFibGVyYW5nZTo1ZWM5ZGJiM2JiNWI0YmRlODYzMDMwOTNmMmFjNTAyNF81LTEtMS0xLTA_e186270e-d737-4f6e-b029-93c25f4933f7">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF80L2ZyYWc6ZGRmMGIwMjEwODA0NDRlNGIxMDUxNTJhOTRjN2Q0OGEvdGFibGU6NWVjOWRiYjNiYjViNGJkZTg2MzAzMDkzZjJhYzUwMjQvdGFibGVyYW5nZTo1ZWM5ZGJiM2JiNWI0YmRlODYzMDMwOTNmMmFjNTAyNF82LTEtMS0xLTA_e5214161-5e97-489c-b29b-dc21f8bd7b24">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF80L2ZyYWc6ZGRmMGIwMjEwODA0NDRlNGIxMDUxNTJhOTRjN2Q0OGEvdGFibGU6NWVjOWRiYjNiYjViNGJkZTg2MzAzMDkzZjJhYzUwMjQvdGFibGVyYW5nZTo1ZWM5ZGJiM2JiNWI0YmRlODYzMDMwOTNmMmFjNTAyNF83LTEtMS0xLTA_42095482-0f82-4415-b77b-ab235dca2d7f">false</dei:AmendmentFlag>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8yMTMzL2ZyYWc6YjcxNDcyZGMxNGI4NDcwM2E4ZTk0NWU3MmNmZTYwNGYvdGFibGU6ZmFhYzQxZmI0OTY3NDNiMWE1MjA4ZDkxNmJjMjdjM2EvdGFibGVyYW5nZTpmYWFjNDFmYjQ5Njc0M2IxYTUyMDhkOTE2YmMyN2MzYV8yLTEtMS0xLTMwNjE_7e343810-80b2-4092-a247-5c76377bfc20">us-gaap:ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8yMTMzL2ZyYWc6YjcxNDcyZGMxNGI4NDcwM2E4ZTk0NWU3MmNmZTYwNGYvdGFibGU6ZmFhYzQxZmI0OTY3NDNiMWE1MjA4ZDkxNmJjMjdjM2EvdGFibGVyYW5nZTpmYWFjNDFmYjQ5Njc0M2IxYTUyMDhkOTE2YmMyN2MzYV8yLTEtMS0xLTMwNjE_b2ab09e6-de12-4f56-9a15-189682067250">us-gaap:ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8yMTMzL2ZyYWc6YjcxNDcyZGMxNGI4NDcwM2E4ZTk0NWU3MmNmZTYwNGYvdGFibGU6ZmFhYzQxZmI0OTY3NDNiMWE1MjA4ZDkxNmJjMjdjM2EvdGFibGVyYW5nZTpmYWFjNDFmYjQ5Njc0M2IxYTUyMDhkOTE2YmMyN2MzYV8yLTEtMS0xLTMwNjE_e463e76d-94f3-45b3-aba1-401ade0a3af5">us-gaap:ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE0LTAtMS0xLTIwNjc3_acac4981-50db-4f80-84d2-20cb232e7d72">us-gaap:AccountingStandardsUpdate201602Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTAtMS0xLTIwNjc4_147575f9-abf3-431a-a93a-0c6a87ecc03d">us-gaap:AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="ibe752e5f0c414274aa8dd851fe81d462_D20170101-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTUvZnJhZzpjMDFlMWI5NzgyMDg0ZWJjOGUxMWQ3NzYxNDM3NzVkOS90YWJsZTozYTlhODU0OWM3NDU0MzBkODhiZDIxYTRjNTU3NDBlZC90YWJsZXJhbmdlOjNhOWE4NTQ5Yzc0NTQzMGQ4OGJkMjFhNGM1NTc0MGVkXzItMS0xLTEtMTcwMDU_8a9dfaa4-a24a-41fa-84a8-b5098c460208">us-gaap:AccountingStandardsUpdate201409Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i48c282f0fbe7448d99f6ba30a60ace6c_D20170101-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTUvZnJhZzpjMDFlMWI5NzgyMDg0ZWJjOGUxMWQ3NzYxNDM3NzVkOS90YWJsZTozYTlhODU0OWM3NDU0MzBkODhiZDIxYTRjNTU3NDBlZC90YWJsZXJhbmdlOjNhOWE4NTQ5Yzc0NTQzMGQ4OGJkMjFhNGM1NTc0MGVkXzMtMS0xLTEtMTcwMDU_42df80c9-83b5-4cde-a368-ddc6f8cee619">us-gaap:AccountingStandardsUpdate201802Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9e7dfa659f1f4a92a32a74b0958212b4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2OTY1ODE1NjM0NzI_a2f5f276-1187-4a37-84f0-e7ca761d6280">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9e7dfa659f1f4a92a32a74b0958212b4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzE4ODc_a2f5f276-1187-4a37-84f0-e7ca761d6280">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8xMzc1_96d11335-b6e5-4772-8d7e-cb84acf0d29b">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8xMzc2_291fd670-4ef9-4ee9-9296-67a9bc16623b">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8yMTc_25ba1d14-97a0-4505-b19a-5bf4dfcc245c">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8yMTc_f16db495-64ce-400b-916f-f4fddfe021f6">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8xMzc3_615db032-20f9-4bd6-ad6c-894b249c287b">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8xMzc4_e4d44dd8-ea01-4dee-b5a6-1ee0ed347922">001-01011</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8xMzc5_8f63e1d6-fa55-4df7-bf83-3ed199862cc0">CVS HEALTH CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6ZDllNTBiNDJiOTE3NDU5ZjhhNmY1YjQ4ZmI2Y2VhYTEvdGFibGVyYW5nZTpkOWU1MGI0MmI5MTc0NTlmOGE2ZjViNDhmYjZjZWFhMV8wLTAtMS0xLTA_9f7fc6ab-0262-4f35-800d-29f43f3c8ad8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6ZDllNTBiNDJiOTE3NDU5ZjhhNmY1YjQ4ZmI2Y2VhYTEvdGFibGVyYW5nZTpkOWU1MGI0MmI5MTc0NTlmOGE2ZjViNDhmYjZjZWFhMV8wLTEtMS0xLTA_a64a35de-3d22-4578-a6a4-381f2cc6d300">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MTY2MDM5Y2QwZjI2NDVhOWE1YzQ0Y2RmOGVlMzY5MmYvdGFibGVyYW5nZToxNjYwMzljZDBmMjY0NWE5YTVjNDRjZGY4ZWUzNjkyZl8wLTAtMS0xLTA_e855857d-2b27-45be-b084-a31a5ac3c4c3">One CVS Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MTY2MDM5Y2QwZjI2NDVhOWE1YzQ0Y2RmOGVlMzY5MmYvdGFibGVyYW5nZToxNjYwMzljZDBmMjY0NWE5YTVjNDRjZGY4ZWUzNjkyZl8wLTEtMS0xLTA_8a16bfe5-0cdf-4061-8f1d-d3a3e616ee5d">Woonsocket,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MTY2MDM5Y2QwZjI2NDVhOWE1YzQ0Y2RmOGVlMzY5MmYvdGFibGVyYW5nZToxNjYwMzljZDBmMjY0NWE5YTVjNDRjZGY4ZWUzNjkyZl8wLTItMS0xLTA_3ac0a6ae-52a8-432f-8178-8ee367fde74f">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MTY2MDM5Y2QwZjI2NDVhOWE1YzQ0Y2RmOGVlMzY5MmYvdGFibGVyYW5nZToxNjYwMzljZDBmMjY0NWE5YTVjNDRjZGY4ZWUzNjkyZl8wLTMtMS0xLTA_1b29cfc5-bd15-4594-bb2d-9484079ac787">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6Y2QzZmUzYjI1YTI1NDA2Y2EwZDhmNzczNjY0MDQyYTMvdGFibGVyYW5nZTpjZDNmZTNiMjVhMjU0MDZjYTBkOGY3NzM2NjQwNDJhM18wLTEtMS0xLTA_2f844f8e-1b3b-4e6b-89f5-dd6b31c6d14c">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6Y2QzZmUzYjI1YTI1NDA2Y2EwZDhmNzczNjY0MDQyYTMvdGFibGVyYW5nZTpjZDNmZTNiMjVhMjU0MDZjYTBkOGY3NzM2NjQwNDJhM18wLTItMS0xLTA_75de1f65-0206-41a8-b70d-15fabdf20e08">765-1500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MGEzNzdkNmVhZWM0NDk0NmI2YTBiZjJkY2I3ZjViZmUvdGFibGVyYW5nZTowYTM3N2Q2ZWFlYzQ0OTQ2YjZhMGJmMmRjYjdmNWJmZV8yLTAtMS0xLTA_c96499ba-2754-4640-b25d-5dd22d0e8cf6">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MGEzNzdkNmVhZWM0NDk0NmI2YTBiZjJkY2I3ZjViZmUvdGFibGVyYW5nZTowYTM3N2Q2ZWFlYzQ0OTQ2YjZhMGJmMmRjYjdmNWJmZV8yLTEtMS0xLTA_015e3764-51c4-4f3f-abaa-63e8befe905e">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MGEzNzdkNmVhZWM0NDk0NmI2YTBiZjJkY2I3ZjViZmUvdGFibGVyYW5nZTowYTM3N2Q2ZWFlYzQ0OTQ2YjZhMGJmMmRjYjdmNWJmZV8yLTItMS0xLTA_286262ef-21a1-4f57-85bc-89f1b037eed5">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF8wLTUtMS0xLTA_68e9c390-a7f6-4322-b712-05efc277474c">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF8xLTctMS0xLTA_49b45ad6-36eb-4bd9-a948-5659d728b27a">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF8yLTUtMS0xLTA_cb6c04c0-056c-40f2-b4bb-4cb446f848f0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF8zLTUtMS0xLTA_589a3fa3-4303-4392-82d8-f193b75e2ab9">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF81LTAtMS0xLTA_e5d8b1c7-ddec-4d6d-9386-263d4307e0f2">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF82LTctMS0xLTA_99e99e0d-7c07-45da-b014-6d07af3f0a09">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF83LTctMS0xLTA_e20a0cd6-7432-4d69-9d9f-5d37fe5ec9af">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF85LTctMS0xLTE5Mzg4_a478dc0e-8d50-43f1-a0ab-a78bd63ac607">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGFibGU6MWM0MjYyOTAwMTBlNGRiZTliZDc0N2Q2MjQzYjI3MjQvdGFibGVyYW5nZToxYzQyNjI5MDAxMGU0ZGJlOWJkNzQ3ZDYyNDNiMjcyNF85LTQtMS0xLTA_1a22288b-8522-4c89-91fc-d1a3a109062e">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i41f59795c714410e9809b7c4aef691c6_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl81OTk_c83d0b4a-7456-4cb5-9be7-8b5e5e1bcd80"
      unitRef="usd">84719366378</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ifbc4ad88529244e7ae1cef69ab7110a5_I20210208"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl84NjU_5662beed-190a-4dd6-b153-5e91484da1b9"
      unitRef="shares">1311354926</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xL2ZyYWc6OGJkNjVhNGNkN2JjNDcxZmE2NThiNmM2YTljNDhlM2YvdGV4dHJlZ2lvbjo4YmQ2NWE0Y2Q3YmM0NzFmYTY1OGI2YzZhOWM0OGUzZl8xMzgx_a7656bb5-4857-4710-a03e-26432b5caaeb">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following materials are incorporated by reference into this Form 10-K:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Information contained in the definitive proxy statement for CVS Health Corporation&#x2019;s 2021 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year ended December 31, 2020 (the &#x201c;Proxy Statement&#x201d;), is incorporated by reference in Parts III and IV to the extent described therein.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1244a575f4b4f4185b2f04835a5d5dc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMy0xLTEtMS0w_7088fe52-c46c-40d9-b90c-4f52446cdbc7"
      unitRef="usd">190688000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4619659f3e0e4e749c1bfe7929426080_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMy0zLTEtMS0w_a89ae496-45cb-4774-a4e3-919fabf576eb"
      unitRef="usd">185236000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacfc4b890d944c33bd862b4eae13875c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMy01LTEtMS0w_4d0ad08d-ef2c-4369-91b4-c743220f07f2"
      unitRef="usd">183910000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:PremiumsEarnedNet
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNC0xLTEtMS0w_4664306f-c906-4407-8afb-a18fa0b76ed5"
      unitRef="usd">69364000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNC0zLTEtMS0w_ead1f5a4-ea47-4aa0-9cde-a9dbe2fa0f49"
      unitRef="usd">63122000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNC01LTEtMS0w_1d1149ab-6391-4952-b182-eadddc4380b1"
      unitRef="usd">8184000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8887a1cd3c8547d681d8baa2a35e51a2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNS0xLTEtMS0w_596c5c22-5cc3-4bb2-845f-f7925c35bd29"
      unitRef="usd">7856000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i862fd4d1d6ba4365a8082e4c0ccf9463_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNS0zLTEtMS0w_a776c302-87e6-44e6-8ee0-14d607868587"
      unitRef="usd">7407000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c05067cc57a462d9ae3f15016cd028d_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNS01LTEtMS0w_96e00fae-ce77-41a5-8f34-5698e818e08b"
      unitRef="usd">1825000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNi0xLTEtMS0w_80ab37b0-6b2b-46c9-ac02-2e68454dd34a"
      unitRef="usd">798000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNi0zLTEtMS0w_ea2108d8-0867-4315-9fa0-03d3d0cfb834"
      unitRef="usd">1011000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNi01LTEtMS0w_8acd8e33-86ac-46d3-be65-21434354a2a4"
      unitRef="usd">660000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNy0xLTEtMS0w_bf55b031-7cf3-4070-8e2b-a05b675d5144"
      unitRef="usd">268706000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNy0zLTEtMS0w_01e3ab2b-a098-4966-88a8-c66f51af51a8"
      unitRef="usd">256776000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfNy01LTEtMS0w_3dacc44a-5acf-4660-bcbf-b90924857778"
      unitRef="usd">194579000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfOS0xLTEtMS0w_14525226-6a40-4a85-ade0-296ef187f248"
      unitRef="usd">163981000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfOS0zLTEtMS0w_0b60b6e6-9cc6-46a5-8421-04f784606c88"
      unitRef="usd">158719000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfOS01LTEtMS0w_b63e9a2e-dc7b-4366-8357-277d9a00033c"
      unitRef="usd">156447000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTAtMS0xLTEtMA_086d8487-20eb-4f97-b378-437ed6e83490"
      unitRef="usd">55679000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTAtMy0xLTEtMA_fcce39f6-2073-4b90-80a8-e5d1aaf4e596"
      unitRef="usd">52529000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTAtNS0xLTEtMA_23243b64-9b84-4777-8685-15d9fe81d1cc"
      unitRef="usd">6594000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTEtMS0xLTEtMA_8c804133-2650-48b9-a985-eb92a75e91f6"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTEtMy0xLTEtMA_e2dd8091-dfbf-42aa-988d-84d67f4a06bb"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTEtNS0xLTEtMA_a921c00f-2fbf-40df-b713-a770b08a567e"
      unitRef="usd">6149000000</us-gaap:GoodwillImpairmentLoss>
    <cvs:OperatingExpensesExcludingGoodwillImpairments
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTItMS0xLTEtMA_fce528da-7a8a-4b56-aade-a3681e8762a8"
      unitRef="usd">35135000000</cvs:OperatingExpensesExcludingGoodwillImpairments>
    <cvs:OperatingExpensesExcludingGoodwillImpairments
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTItMy0xLTEtMA_5bb83529-94b8-4b24-915b-0bfd2f5c701a"
      unitRef="usd">33541000000</cvs:OperatingExpensesExcludingGoodwillImpairments>
    <cvs:OperatingExpensesExcludingGoodwillImpairments
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTItNS0xLTEtMA_c7f814e2-c5b4-4346-a43c-0b7a6e613e39"
      unitRef="usd">21368000000</cvs:OperatingExpensesExcludingGoodwillImpairments>
    <us-gaap:CostsAndExpenses
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTMtMS0xLTEtMA_e0d60756-ce8a-40e3-be66-105ab782c3f5"
      unitRef="usd">254795000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTMtMy0xLTEtMA_f6f89a03-8a7d-471a-8edf-42cf2a759bae"
      unitRef="usd">244789000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTMtNS0xLTEtMA_8b034346-6977-4946-b9d5-8c7c88ea3fe8"
      unitRef="usd">190558000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTQtMS0xLTEtMA_2b1c2b39-e903-49ba-bf3e-3448f4bd8716"
      unitRef="usd">13911000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTQtMy0xLTEtMA_54b98a80-eea4-40c3-a9e3-456b55538106"
      unitRef="usd">11987000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTQtNS0xLTEtMA_acd074a2-2e51-40c5-bee2-68619fdfa225"
      unitRef="usd">4021000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTUtMS0xLTEtMA_a8ce887a-a9e2-4217-aa01-36fba7c10d3c"
      unitRef="usd">2907000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTUtMy0xLTEtMA_10e1d301-f0cf-495b-8e37-b948057b772c"
      unitRef="usd">3035000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTUtNS0xLTEtMA_54a756ab-20e5-474e-8bc9-fde5dd41d614"
      unitRef="usd">2619000000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTYtMS0xLTEtMA_f071d68a-bbdb-4f06-9dd0-52d3c7eb8761"
      unitRef="usd">-1440000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTYtMy0xLTEtMA_ffa688d4-0159-4bd0-9eb8-80bdb78ec03f"
      unitRef="usd">-79000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTYtNS0xLTEtMA_70d2dcbc-a9cd-4f87-9539-0e30adbc1790"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTctMS0xLTEtMA_433fa6f1-d1ed-4135-9230-9b7b76c534e4"
      unitRef="usd">206000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTctMy0xLTEtMA_59e41072-47ea-464f-8ff5-e180b3ab59ab"
      unitRef="usd">124000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTctNS0xLTEtMA_b69d51f9-1b85-4044-b7c9-32fc9d2ce407"
      unitRef="usd">4000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTgtMS0xLTEtMA_5e24f72a-60c7-4856-bd95-5aa6357f5283"
      unitRef="usd">9770000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTgtMy0xLTEtMA_d7a85b8d-0f52-428c-97b0-bfa96c82b092"
      unitRef="usd">8997000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTgtNS0xLTEtMA_b081e483-c4a7-4d91-baf5-36f870368cfe"
      unitRef="usd">1406000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTktMS0xLTEtMA_f7dd085c-1e43-457b-b2d4-e7f967d9c42f"
      unitRef="usd">2569000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTktMy0xLTEtMA_e87feee9-9c3f-479a-84ff-ad023dd4f942"
      unitRef="usd">2366000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMTktNS0xLTEtMA_292ebc83-9ab7-4c0c-be22-78ea9677f8f3"
      unitRef="usd">2002000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjAtMS0xLTEtMA_cda17fea-7d15-451d-8b54-ad7bbd61e288"
      unitRef="usd">7201000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjAtMy0xLTEtMA_0521c654-5344-4077-8347-ebf606ddd7ae"
      unitRef="usd">6631000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjAtNS0xLTEtMA_6eae977c-12b4-4c8e-ba69-a4432612bbf8"
      unitRef="usd">-596000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjEtMS0xLTEtMA_d6e6b0ea-d6bc-4079-b00f-3c62cc9feb5a"
      unitRef="usd">-9000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjEtMy0xLTEtMA_49612bc8-69e1-4140-8ee7-3500ccfc36cd"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjEtNS0xLTEtMA_e85d6cd1-366c-4e78-918a-a7d419e22e41"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjItMS0xLTEtMA_3edeb1a8-76ad-4e2e-bc92-a15709e691d0"
      unitRef="usd">7192000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjItMy0xLTEtMA_7dfd08bf-50bf-4f6f-8487-4cceba28a3a5"
      unitRef="usd">6631000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjItNS0xLTEtMA_1911c967-9fda-4829-a95a-4e7d5af1ed1d"
      unitRef="usd">-596000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjMtMS0xLTEtMA_263d434f-8170-421d-83af-97dc5ac1fff2"
      unitRef="usd">13000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjMtMy0xLTEtMA_3bb7afd4-f292-451f-a4b3-0b4509db99d8"
      unitRef="usd">-3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjMtNS0xLTEtMA_2584c35b-3aa0-4848-aafe-c75889d37196"
      unitRef="usd">-2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjQtMS0xLTEtMA_c9b12151-a16d-4fc3-a925-8b7693955a13"
      unitRef="usd">7179000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjQtMy0xLTEtMA_b4503f95-bb44-4843-94ab-0a15cc5c95aa"
      unitRef="usd">6634000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjQtNS0xLTEtMA_a1b8181d-616a-4d77-8ba5-21cb2712f1f6"
      unitRef="usd">-594000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjctMS0xLTEtMA_c7882d2c-679b-4c56-8f43-2a01c14a1b52"
      unitRef="usdPerShare">5.49</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjctMy0xLTEtMA_aaa03f32-fd71-4525-aa54-db7d5d6a6b1d"
      unitRef="usdPerShare">5.10</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjctNS0xLTEtMA_93e9460d-eb80-4da6-8403-dc9106b2d26e"
      unitRef="usdPerShare">-0.57</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjgtMS0xLTEtMA_65661061-e549-487b-8130-a712364d6e62"
      unitRef="usdPerShare">-0.01</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjgtMy0xLTEtMA_1ae0418b-6270-4909-8e14-2a61643e0e5f"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjgtNS0xLTEtMA_905ecbe7-e0d8-49dc-970c-01b2e99c6a8d"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjktMS0xLTEtMA_1efb2490-3122-49c2-a3cc-dde218f2059b"
      unitRef="usdPerShare">5.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjktMy0xLTEtMA_cbabe04f-5e6a-43aa-87b1-cf55aebdb45d"
      unitRef="usdPerShare">5.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMjktNS0xLTEtMA_94076329-0a09-47e5-a39d-e109af425a4d"
      unitRef="usdPerShare">-0.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzAtMS0xLTEtMA_6899e612-7d38-41e9-a407-14d51430040f"
      unitRef="shares">1309000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzAtMy0xLTEtMA_c6335f20-6046-4e26-a558-edf5972a5a93"
      unitRef="shares">1301000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzAtNS0xLTEtMA_fb70dd46-8e35-4e99-a422-12e432b08c70"
      unitRef="shares">1044000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzItMS0xLTEtMA_ec4fa5a2-2622-469d-8d3b-651fe105a302"
      unitRef="usdPerShare">5.47</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzItMy0xLTEtMA_e2a7ee7e-1b6d-46e4-a11e-51b9dcf97900"
      unitRef="usdPerShare">5.08</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzItNS0xLTEtMA_fd0cc01d-eac4-4939-a086-08a62b87197b"
      unitRef="usdPerShare">-0.57</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzMtMS0xLTEtMA_187e614b-406a-43e2-b2d3-44e5a2ee65d3"
      unitRef="usdPerShare">-0.01</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzMtMy0xLTEtMA_8335cfd4-e078-4f11-8f36-b4f1f824cf12"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzMtNS0xLTEtMA_6b4beb7b-d598-4c24-8116-7a9348767ed5"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzQtMS0xLTEtMA_16c5a74a-e964-4431-bae1-74a43d55055f"
      unitRef="usdPerShare">5.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzQtMy0xLTEtMA_e02323a0-adcc-4b57-8f30-ff91f17679a3"
      unitRef="usdPerShare">5.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzQtNS0xLTEtMA_3bb86572-f2b0-4b17-8d10-be713afe95e3"
      unitRef="usdPerShare">-0.57</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzUtMS0xLTEtMA_b5ff59d4-97fe-43a1-8150-f6b639130ac2"
      unitRef="shares">1314000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzUtMy0xLTEtMA_f1aa1846-4587-496a-81b0-b9c1efd22512"
      unitRef="shares">1305000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzUtNS0xLTEtMA_9e509213-630e-4158-aea5-6ca7570d4c2d"
      unitRef="shares">1044000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzYtMS0xLTEtMA_1e58bcb8-a219-4f17-b9e3-08c4e24ab24f"
      unitRef="usdPerShare">2.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzYtMy0xLTEtMA_5684cba1-8523-4f6f-b519-62d87dcc863a"
      unitRef="usdPerShare">2.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF85Ny9mcmFnOjhjNjBjMzViZTY3ODQxZmRiMjQyYjNmM2Q1MDNjZTllL3RhYmxlOmM0MDg3MzRiNzE2NTQ5NTViZDE3Y2U2YTA3YjY4N2FlL3RhYmxlcmFuZ2U6YzQwODczNGI3MTY1NDk1NWJkMTdjZTZhMDdiNjg3YWVfMzYtNS0xLTEtMA_f669f478-30ae-494c-bb64-09f30724b500"
      unitRef="usdPerShare">2.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzItMS0xLTEtMA_3edeb1a8-76ad-4e2e-bc92-a15709e691d0"
      unitRef="usd">7192000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzItMy0xLTEtMA_7dfd08bf-50bf-4f6f-8487-4cceba28a3a5"
      unitRef="usd">6631000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzItNS0xLTEtMA_1911c967-9fda-4829-a95a-4e7d5af1ed1d"
      unitRef="usd">-596000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzQtMS0xLTEtMA_3ba3226a-ab19-4d5e-9379-ee5be9f97bae"
      unitRef="usd">440000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzQtMy0xLTEtMA_b522810e-33cc-4d33-afe2-19508e8694ac"
      unitRef="usd">677000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzQtNS0xLTEtMA_83242673-f8c0-41c4-9ed9-755fe66c9c33"
      unitRef="usd">97000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzUtMS0xLTEtMA_73992999-93d9-4d83-a91a-9a5fa1455ccd"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzUtMy0xLTEtMA_2ed0aac1-ce99-499a-92f1-b80b7f9ede1f"
      unitRef="usd">162000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzUtNS0xLTEtMA_57de81bc-b76f-491c-a185-a00c07444572"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzYtMS0xLTEtMA_81c49058-5427-47c0-92a7-0a9a1d98ee29"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzYtMy0xLTEtMA_3bff7a6c-5b9d-4f2c-af0c-4ef1229cb813"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzYtNS0xLTEtMA_602d9532-2ec5-45a4-8c65-046136431c8e"
      unitRef="usd">330000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzctMS0xLTEtMA_f97bd2ba-b8cd-4e1a-a7f0-07ee9ca84c05"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzctMy0xLTEtMA_1e509cc2-9177-42a1-a8b3-99a13fbb005e"
      unitRef="usd">-111000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzctNS0xLTEtMA_0f699c31-7d7e-4408-aeb2-af5a5e29c8fa"
      unitRef="usd">124000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzgtMS0xLTEtMA_3416bc4d-f53c-4c08-8f57-8bd75737468f"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzgtMy0xLTEtMA_1bf5fc46-92b0-48a4-8c67-a9d7e4180bb5"
      unitRef="usd">917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzgtNS0xLTEtMA_66c37c9c-fc3e-42d1-8b00-72d3a9f4e36e"
      unitRef="usd">274000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzktMS0xLTEtMA_5bf08791-a936-43fa-a5d1-409cc9927a7c"
      unitRef="usd">7587000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzktMy0xLTEtMA_b68d8513-7236-4f90-a97f-1d9089bbc433"
      unitRef="usd">7548000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzktNS0xLTEtMA_7738de94-0144-4be7-9c44-29ffd2000ee0"
      unitRef="usd">-322000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzEwLTEtMS0xLTA_ca764c0b-3ae0-4732-b39a-78786ac67846"
      unitRef="usd">13000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzEwLTMtMS0xLTA_dfacb3f1-2d71-4c78-a82c-bda7828d9c45"
      unitRef="usd">-3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzEwLTUtMS0xLTA_32b5029e-50b8-476b-8053-0f460ede8b8d"
      unitRef="usd">-2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzExLTEtMS0xLTA_62e88b31-5024-4fad-9c5d-77bcde32e347"
      unitRef="usd">7574000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzExLTMtMS0xLTA_f65634a6-edf5-44cd-8766-791e69cdfb15"
      unitRef="usd">7551000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDAvZnJhZzo1YjhjYWY0ZDJiNjA0YzlmYTRmYWZjMzlmZGZiOTNhOS90YWJsZTozNGZiYWQ2YWY3OGU0YWJjYTYwNTVlMGY0YWVhNTdkMC90YWJsZXJhbmdlOjM0ZmJhZDZhZjc4ZTRhYmNhNjA1NWUwZjRhZWE1N2QwXzExLTUtMS0xLTA_ddd9d92e-e206-4842-a3c9-64e26d455be8"
      unitRef="usd">-320000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMtMS0xLTEtMA_617c4e50-7a35-4483-bdcc-d804eb569ece"
      unitRef="usd">7854000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMtMy0xLTEtMA_90924d1e-1d78-4cdd-991c-5ae392b706da"
      unitRef="usd">5683000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQtMS0xLTEtMA_27b8f8db-77a3-40a5-ba00-f140ead7993b"
      unitRef="usd">3000000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQtMy0xLTEtMA_d21254f9-e9cb-424c-987f-f96b82c17143"
      unitRef="usd">2373000000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzUtMS0xLTEtMA_0f2e4ce8-4b92-4deb-baad-792d302b1113"
      unitRef="usd">21742000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzUtMy0xLTEtMA_eb36f716-79bf-49d6-a297-ccd4ea06148e"
      unitRef="usd">19617000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzYtMS0xLTEtMA_f85555c6-2354-4557-a4a3-8eb4074a20fb"
      unitRef="usd">18496000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzYtMy0xLTEtMA_a2c35c2c-354d-4e16-9fb4-52af1e0d11ab"
      unitRef="usd">17516000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzctMS0xLTEtMA_8714f085-9d74-4665-9839-1734c5593a9a"
      unitRef="usd">5277000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzctMy0xLTEtMA_e2d8d68f-1a76-4870-86fd-6ab6c49820db"
      unitRef="usd">5113000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzgtMS0xLTEtMA_b9093761-dc3c-4fe0-8f62-25cbe888060d"
      unitRef="usd">56369000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzgtMy0xLTEtMA_b65c9b30-0003-49c7-bdd7-030573042362"
      unitRef="usd">50302000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzktMS0xLTEtMA_2ca5bbf1-7e2d-45c8-8de8-5adcacb778ee"
      unitRef="usd">20812000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzktMy0xLTEtMA_a9d298b7-9864-4940-984b-4aa174f74f17"
      unitRef="usd">17314000000</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzEwLTEtMS0xLTA_505e0764-9d0c-4e1a-a864-91c0398c382b"
      unitRef="usd">12606000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzEwLTMtMS0xLTA_83eb2ae3-2e25-4513-9142-f2e39a469449"
      unitRef="usd">12044000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzExLTEtMS0xLTA_cbc2b2f2-0373-44f3-9b54-cb74f39be00c"
      unitRef="usd">20729000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzExLTMtMS0xLTA_73f87535-4b0e-42bf-9009-ac6a0f6bc305"
      unitRef="usd">20860000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzEyLTEtMS0xLTA_8856b16f-c960-49ff-889a-dc84c28f0fc1"
      unitRef="usd">79552000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzEyLTMtMS0xLTA_e85f5e81-8b64-4f6e-8c23-5ca4ccafc90a"
      unitRef="usd">79749000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzEzLTEtMS0xLTA_b1abccc8-328e-4997-b26e-6617d314d1a2"
      unitRef="usd">31142000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzEzLTMtMS0xLTA_fbb1b43e-cb0b-400b-9bca-e77a42bb3db7"
      unitRef="usd">33121000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:SeparateAccountAssets
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE0LTEtMS0xLTA_ddeacab4-e9d0-4c5a-8d33-8bef8780dbcc"
      unitRef="usd">4881000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE0LTMtMS0xLTA_8f3e6d65-e74b-4176-baa1-044beb2a0768"
      unitRef="usd">4459000000</us-gaap:SeparateAccountAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE1LTEtMS0xLTA_0afc2b04-2e9f-4ae4-9991-2ac6b2049693"
      unitRef="usd">4624000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE1LTMtMS0xLTA_86b5ce90-8cb6-43f0-8b06-2510cc9ea17f"
      unitRef="usd">4600000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE2LTEtMS0xLTA_c1008a0d-1cda-4807-9f04-cae160ce8ccf"
      unitRef="usd">230715000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE2LTMtMS0xLTA_55d0ad0e-62e9-4250-93c4-1540a6484338"
      unitRef="usd">222449000000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE5LTEtMS0xLTA_5e717915-1dda-4778-ad60-dcb1b0fec045"
      unitRef="usd">11138000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzE5LTMtMS0xLTA_87861a1c-2b1c-4d57-801d-05fd4e6b8311"
      unitRef="usd">10492000000</us-gaap:AccountsPayableTradeCurrent>
    <cvs:PharmacyClaimsandDiscountsPayableCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIwLTEtMS0xLTA_53e948b4-a11a-45bc-88dc-d49a3c275e51"
      unitRef="usd">15795000000</cvs:PharmacyClaimsandDiscountsPayableCurrent>
    <cvs:PharmacyClaimsandDiscountsPayableCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIwLTMtMS0xLTA_1baca93c-fa87-44dd-a1b2-dc4ec440c654"
      unitRef="usd">13601000000</cvs:PharmacyClaimsandDiscountsPayableCurrent>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIxLTEtMS0xLTA_4e78c373-0614-4116-9a3a-57b1041c4d83"
      unitRef="usd">7936000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIxLTMtMS0xLTA_da8ef50f-e13a-426a-8e5c-9de8f37a9609"
      unitRef="usd">6879000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:OtherPolicyholderFunds
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIyLTEtMS0xLTA_fe3ffc2b-c5bc-477a-b8e9-e1e39c200f9c"
      unitRef="usd">4270000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:OtherPolicyholderFunds
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIyLTMtMS0xLTA_170e20aa-10cd-4563-ac81-be9b133cbc51"
      unitRef="usd">2991000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIzLTEtMS0xLTA_b1c5eb1d-86de-4d21-aead-9b0bdf575bf9"
      unitRef="usd">14243000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzIzLTMtMS0xLTA_c324d84c-7f7e-4409-b1a5-9b3b240ccee2"
      unitRef="usd">12133000000</us-gaap:AccruedLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI0LTEtMS0xLTA_652e7d67-3020-4f29-83d1-ed7696d7f408"
      unitRef="usd">1557000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI0LTMtMS0xLTA_ba73f567-a647-4b74-812f-d24c1bf25de5"
      unitRef="usd">1830000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI1LTEtMS0xLTA_d47cccb8-464d-453c-9ebf-1bedc9ff34d7"
      unitRef="usd">1638000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI1LTMtMS0xLTA_fb542fd9-1301-4c4f-9930-09e1f252a680"
      unitRef="usd">1596000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI3LTEtMS0xLTA_49be91c6-a577-4107-8fb3-3e394b87e55a"
      unitRef="usd">5440000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI3LTMtMS0xLTA_bfeabce0-0027-4aab-8c9e-ee75db3a8341"
      unitRef="usd">3781000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI4LTEtMS0xLTA_ab47996d-be99-4d34-abf1-c15df6c233c0"
      unitRef="usd">62017000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI4LTMtMS0xLTA_7847357f-f1a2-4604-bc5e-4ab0528f32f2"
      unitRef="usd">53303000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI5LTEtMS0xLTA_360daf77-09a9-4be9-9c48-0ee7065e3a88"
      unitRef="usd">18757000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzI5LTMtMS0xLTA_51967e69-1f3f-473b-a409-3385272461c2"
      unitRef="usd">18926000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMwLTEtMS0xLTA_40496f2d-2d44-42b0-9916-a97543f3f655"
      unitRef="usd">59207000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMwLTMtMS0xLTA_139c906e-9878-447c-aca5-bd1cfe417ca5"
      unitRef="usd">64699000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMxLTEtMS0xLTA_0f724970-088d-428b-8010-2a01555047c9"
      unitRef="usd">6794000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMxLTMtMS0xLTA_1ec85955-0781-4959-a5a6-7593f1926d64"
      unitRef="usd">7294000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:SeparateAccountsLiability
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMyLTEtMS0xLTA_124d62fe-4bc5-4cf2-b37e-aeae43296702"
      unitRef="usd">4881000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMyLTMtMS0xLTA_f77ec6a8-a012-4ab8-b82b-8e349d23fbcc"
      unitRef="usd">4459000000</us-gaap:SeparateAccountsLiability>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMzLTEtMS0xLTA_e73152cd-d0bf-4cea-8c71-a7ba73415a56"
      unitRef="usd">7007000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzMzLTMtMS0xLTA_3336d9fc-e615-4414-bd32-58b7d507ef10"
      unitRef="usd">7436000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM0LTEtMS0xLTA_6ab82cce-74ea-418f-86e9-a980c18eacef"
      unitRef="usd">2351000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM0LTMtMS0xLTA_b3ea4c6e-a9e6-4fd4-80d9-3b3c544a3292"
      unitRef="usd">2162000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM1LTEtMS0xLTA_544cad90-275e-4431-b506-a971a111ad8b"
      unitRef="usd">161014000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM1LTMtMS0xLTA_ec04e78d-5b0b-428c-aa3c-c211f9912e74"
      unitRef="usd">158279000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM2LTEtMS0xLTA_af957eaa-a0e1-487f-80ca-3cbd0a558d86"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM2LTMtMS0xLTA_288d7695-c7b9-4bbe-99c1-7eba647857ae"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzU3_b800f890-3106-4efa-bf50-96c502904ee1"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzU3_ee025347-8390-4d7e-8bf6-1bbd12ae55f2"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzY1_617d709f-fac6-4a59-8590-51eb69b03b55"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzY1_be2e39af-0c82-41e2-bf5d-65fb91b8cb65"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzcw_8e63a96d-c0db-470b-8796-71b7de0b49b7"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzcw_c0b07ad7-e7cc-444b-9730-1c4e4199f94f"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzcw_e3f977e9-c43c-47c7-bf92-116c8fb38058"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjo1MDdhMDQ2YzIwODc0OTcyOTdkNDQ4NWI1MjVlNjgxZl8xNjQ5MjY3NDQxNzcw_f95fbd4d-8d12-43fa-81f0-2e887f95ec01"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTEtMS0xLTA_ef51cbf1-d0c2-461d-bc22-e864e34b44b8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzM5LTMtMS0xLTA_aa78e1e3-89e8-4449-98ff-fb7ae54f0b35"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTQx_545deb20-485b-4af0-b51d-60780b23c05f"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTQx_d4bdcc1d-e5a9-4343-8553-e131bb9f31ce"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTUw_9de9e30f-36ae-494c-ba13-d49d967e5b3d"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTUw_c9bdcd9f-b3dc-46a8-b931-76961f608a8b"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxODg4_331c0608-9db6-494b-96c3-2b2c8ebd4a0c"
      unitRef="shares">1733000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTEz_587aae3e-1e75-44e4-bd0c-ac51759d247b"
      unitRef="shares">1310000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTI1_2c6a8a9e-8cfe-4faf-914e-91e6ad13b37c"
      unitRef="shares">1727000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjpmODI1YWI3ZGQzZjU0YjA3OTM1MDhiYmYwYjhlMTk5N18xNjQ5MjY3NDQxOTMz_99192a4e-84e1-4e49-815d-854bb5f235d8"
      unitRef="shares">1302000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTEtMS0xLTA_2fa4a73d-c9ee-4d4c-9185-4d0b8f656393"
      unitRef="usd">46513000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQwLTMtMS0xLTA_3f92b207-b576-4a03-a765-83c924ab957d"
      unitRef="usd">45972000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoyOTMwMTMwMjEzNzE0OThlODQwMjMzMTIzYWQzZjJhMF8xNjQ5MjY3NDQxNzU0_34b06697-c910-4b97-b82c-d166c06d005d"
      unitRef="shares">423000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoyOTMwMTMwMjEzNzE0OThlODQwMjMzMTIzYWQzZjJhMF8xNjQ5MjY3NDQxNzM4_77b7a6ec-b809-47f2-86ad-553db8ae673d"
      unitRef="shares">425000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQxLTEtMS0xLTA_38c0abf6-603d-492d-8203-165ae624296f"
      unitRef="usd">28178000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQxLTMtMS0xLTA_03294cb8-ea26-4bd1-af6e-aff53c2e623e"
      unitRef="usd">28235000000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQyLTEtMS0xLTA_1c1f7f5f-f31f-4a99-a83f-643b049ebb07"
      unitRef="usd">49640000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQyLTMtMS0xLTA_3574e78c-4a7e-495c-b7ef-bc527db56325"
      unitRef="usd">45108000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQzLTEtMS0xLTA_e831b9e8-e89d-458b-a1d6-4f534c4a971b"
      unitRef="usd">1414000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQzLTMtMS0xLTA_85d4cea3-6abd-4e5f-8435-4af8fb0c5965"
      unitRef="usd">1019000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ0LTEtMS0xLTA_5e515a3d-3ddd-4c66-9e65-283733f4d55d"
      unitRef="usd">69389000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ0LTMtMS0xLTA_6b69332b-0b40-4db2-aa0a-f158d98c4077"
      unitRef="usd">63864000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ1LTEtMS0xLTA_92073843-1bed-4995-bdd2-04b6a65da388"
      unitRef="usd">312000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ1LTMtMS0xLTA_4f108bf4-1c76-413a-b712-be5094143bd7"
      unitRef="usd">306000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ2LTEtMS0xLTA_5feb225a-b9d8-41f4-85e7-80ecb7ffe4ef"
      unitRef="usd">69701000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ2LTMtMS0xLTA_2d97738a-eb12-4972-a04d-3b776961ac8d"
      unitRef="usd">64170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ3LTEtMS0xLTA_41adb6d1-ff6b-404f-bada-9c4fd71552f2"
      unitRef="usd">230715000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDMvZnJhZzowY2UzZDhjNWVmNzc0NjAyYjgyYTQ3NDcyMTZlMWI0Yi90YWJsZToxOTIxNWU4ODIzMTI0ZWViYTFlOTNmNWE0YzEzZDU3Yi90YWJsZXJhbmdlOjE5MjE1ZTg4MjMxMjRlZWJhMWU5M2Y1YTRjMTNkNTdiXzQ3LTMtMS0xLTA_5a49f343-57d2-4225-ae68-3f88017d1c0b"
      unitRef="usd">222449000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProceedsFromCustomers
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMtMS0xLTEtMA_916c728b-7127-4f3b-934a-8cd7b578e0ce"
      unitRef="usd">264327000000</us-gaap:ProceedsFromCustomers>
    <us-gaap:ProceedsFromCustomers
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMtMy0xLTEtMA_3148f932-9e16-40c1-9ecd-fa4680265fae"
      unitRef="usd">248393000000</us-gaap:ProceedsFromCustomers>
    <us-gaap:ProceedsFromCustomers
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMtNS0xLTEtMA_cc889e55-aad6-4ebc-9948-9607157fcd45"
      unitRef="usd">186519000000</us-gaap:ProceedsFromCustomers>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzQtMS0xLTEtMA_e4c98613-61d0-4347-bc43-e8685be707ca"
      unitRef="usd">158636000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzQtMy0xLTEtMA_472e4c3e-6cbc-47cf-a324-6a7ded1f1969"
      unitRef="usd">149655000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzQtNS0xLTEtMA_fe6051b2-e58d-49ef-9661-7316c2d7dc01"
      unitRef="usd">148981000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzUtMS0xLTEtMA_76cd9db1-1440-4b62-a486-219303280e8c"
      unitRef="usd">55124000000</cvs:PaymentsforInsuranceBenefits>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzUtMy0xLTEtMA_1153190b-d821-4799-b286-a1978faf51b6"
      unitRef="usd">52242000000</cvs:PaymentsforInsuranceBenefits>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzUtNS0xLTEtMA_a0e82ce5-b750-4e39-bdca-efc2d5d60e22"
      unitRef="usd">6897000000</cvs:PaymentsforInsuranceBenefits>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzYtMS0xLTEtMA_1b4ad823-5fd9-4be7-bac0-7e8419f02377"
      unitRef="usd">29763000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzYtMy0xLTEtMA_1a35c7eb-a72f-453a-ab2a-e0c41722aab8"
      unitRef="usd">28932000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzYtNS0xLTEtMA_48d0cda6-3235-4da7-8114-2548621c3521"
      unitRef="usd">17234000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzctMS0xLTEtMA_1c08b1fb-3234-4e65-94d4-edac550e91cf"
      unitRef="usd">894000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzctMy0xLTEtMA_971b624e-acbd-445d-a653-89a4f78636fe"
      unitRef="usd">955000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzctNS0xLTEtMA_7b228937-913a-46de-ae93-053cc9fe5b80"
      unitRef="usd">644000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:InterestPaidNet
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzgtMS0xLTEtMA_3d87ce02-427b-4187-92ce-0a10bee4acda"
      unitRef="usd">2904000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzgtMy0xLTEtMA_995a6102-3724-427c-be66-5548787d945a"
      unitRef="usd">2954000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzgtNS0xLTEtMA_ad891c55-4a8f-456b-ae23-f95f1573f88f"
      unitRef="usd">2803000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzktMS0xLTEtMA_4019e3ce-2769-4a56-9aa7-b27a27ea8c5f"
      unitRef="usd">2929000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzktMy0xLTEtMA_bb1e3d01-fc18-4a69-8da3-f458be042a72"
      unitRef="usd">2717000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzktNS0xLTEtMA_eb7b4238-3048-41ed-b9d2-f016a8dcfe65"
      unitRef="usd">2383000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzEwLTEtMS0xLTA_9ad8cdd7-52ff-4a52-a57d-4f789e91aa1d"
      unitRef="usd">15865000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzEwLTMtMS0xLTA_0f08cd9e-b4a4-4d50-9d2f-49a32c68be68"
      unitRef="usd">12848000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzEwLTUtMS0xLTA_92e11a25-d0dc-4e0a-9401-2eced3712099"
      unitRef="usd">8865000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzEzLTEtMS0xLTA_fd76d942-cd0d-4a79-9a0b-1c7c14faacec"
      unitRef="usd">6467000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzEzLTMtMS0xLTA_18179cfe-f2dc-459b-8866-ef3f67872c79"
      unitRef="usd">7049000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzEzLTUtMS0xLTA_fb3ae9c4-f59f-41b4-8d19-39074ba5954f"
      unitRef="usd">817000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE0LTEtMS0xLTA_048b1a2b-1195-4c26-83e1-e6a72b8eaa5b"
      unitRef="usd">9639000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE0LTMtMS0xLTA_2b46c4f6-7c9c-47dd-a4ec-887cbeeec21c"
      unitRef="usd">7534000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE0LTUtMS0xLTA_ef09fa88-96af-42db-9a71-95659c2dabbc"
      unitRef="usd">692000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE1LTEtMS0xLTA_aa834688-ca9c-4488-bac7-803c9bc92a93"
      unitRef="usd">2437000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE1LTMtMS0xLTA_2b36ce50-6462-4459-b7a2-361ce6914931"
      unitRef="usd">2457000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE1LTUtMS0xLTA_ca6cda71-0b38-4fc4-88fb-01e08ba2f6a9"
      unitRef="usd">2037000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE2LTEtMS0xLTA_44f8825b-8760-47f0-a320-bd117cb693c7"
      unitRef="usd">101000000</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE2LTMtMS0xLTA_bd781b6a-ed82-4a4b-b08f-547ecc111eee"
      unitRef="usd">5000000</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE2LTUtMS0xLTA_541b60d6-82ea-4021-b543-4069bfd8bb9c"
      unitRef="usd">0</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE3LTEtMS0xLTA_8e85cbe9-bbf4-49dc-bd6c-9ee76254bba9"
      unitRef="usd">866000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE3LTMtMS0xLTA_a107de0b-d22f-49ff-9034-3c0868123941"
      unitRef="usd">444000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE3LTUtMS0xLTA_65e7c63d-b010-4e2a-8697-9ecb8ea533f0"
      unitRef="usd">42226000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE4LTEtMS0xLTA_29e0312d-f6d7-4baa-81f0-2d19c33d17be"
      unitRef="usd">840000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE4LTMtMS0xLTA_e68c19c2-b954-408f-8fa6-e7a37f66c6e0"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE4LTUtMS0xLTA_8bec95f0-a642-4473-b1a4-32968d368a42"
      unitRef="usd">832000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE5LTEtMS0xLTA_c4a91000-dd5e-4807-9a1b-97108ecc36ab"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE5LTMtMS0xLTA_df819d79-1e0e-4bd3-9502-1e6d7f6cfeb6"
      unitRef="usd">-42000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzE5LTUtMS0xLTA_e0de93d8-f256-48fd-8292-1d7bacb23e27"
      unitRef="usd">-21000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzIwLTEtMS0xLTA_405101e8-ef6f-4ef5-b088-20d862ad1105"
      unitRef="usd">-5534000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzIwLTMtMS0xLTA_5290dbef-1742-4111-923c-03b17c81c18c"
      unitRef="usd">-3339000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzIwLTUtMS0xLTA_7de25b6f-15bd-4a83-8e5b-14c4fd7fcb76"
      unitRef="usd">-43285000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzIzLTEtMS0xLTA_2766220e-1024-44fb-8f71-fbb39e9b5c8a"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzIzLTMtMS0xLTA_42db853e-acee-412c-8ed9-bb1bcadf0e87"
      unitRef="usd">-720000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzIzLTUtMS0xLTA_01608fe9-ab57-46ac-ab5b-c3af9b165cad"
      unitRef="usd">-556000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI0LTEtMS0xLTA_5e9ac7e3-8750-459b-bbb7-541c5890d0f8"
      unitRef="usd">9958000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI0LTMtMS0xLTA_1d196906-6220-4570-87eb-7328991c4694"
      unitRef="usd">3736000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI0LTUtMS0xLTA_57ad5532-cf4c-488c-b9fe-ddb41ef7cbf0"
      unitRef="usd">44343000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI1LTEtMS0xLTA_5ed82076-9a69-4d18-a573-a2c370a7c3ba"
      unitRef="usd">15631000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI1LTMtMS0xLTA_7e915dd4-f768-4f30-8b9f-5a1ac41a15b3"
      unitRef="usd">8336000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI1LTUtMS0xLTA_ce4530a5-16db-40bd-ae3d-2dbf4b215a3d"
      unitRef="usd">5522000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI2LTEtMS0xLTA_0b46d4da-7b9f-42b4-9a3d-7ab886ef8edd"
      unitRef="usd">7000000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI2LTMtMS0xLTA_9bdd4481-edb0-40ad-9288-e0f32d68fda1"
      unitRef="usd">25000000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI2LTUtMS0xLTA_27f97ba9-9465-4a69-af14-9c3ccf4bb292"
      unitRef="usd">-446000000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsOfDividends
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI4LTEtMS0xLTA_e586f8a9-d96c-4b9e-9423-ffc2a971cb48"
      unitRef="usd">2624000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI4LTMtMS0xLTA_dca2369c-f6e1-433b-94bd-1b5cb39c8811"
      unitRef="usd">2603000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI4LTUtMS0xLTA_082c2ae1-dca7-4b90-bfcd-f21f4a4ec38b"
      unitRef="usd">2038000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI5LTEtMS0xLTA_fd6a06c1-b5b3-4fcb-a105-7f33a3f2739b"
      unitRef="usd">264000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI5LTMtMS0xLTA_5374cfba-e2e5-45d7-bb8b-ed5887469b7a"
      unitRef="usd">210000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzI5LTUtMS0xLTA_d5e9556b-e69d-42cc-9b77-015d7324c0b9"
      unitRef="usd">242000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMwLTEtMS0xLTA_e8cc4ccd-729f-48c7-9621-df5237238499"
      unitRef="usd">88000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMwLTMtMS0xLTA_9f1befb0-c63f-430a-9ae8-de0ac133b305"
      unitRef="usd">112000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMwLTUtMS0xLTA_f33a301d-a39c-47cc-833d-95b1447ffab2"
      unitRef="usd">97000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMxLTEtMS0xLTA_fc38f3b7-7d9a-41a6-961c-61db83811c64"
      unitRef="usd">-27000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMxLTMtMS0xLTA_edb1c3c7-d483-4c87-b0d5-a10c114c593b"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMxLTUtMS0xLTA_348e3e88-f563-4f5f-9fb0-92fa4398af90"
      unitRef="usd">1000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMyLTEtMS0xLTA_1f21fe01-5c02-41f1-85b9-57b1f0eac5ed"
      unitRef="usd">-8155000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMyLTMtMS0xLTA_5d24c81f-8cbd-4340-bffc-80e49702a4ea"
      unitRef="usd">-7850000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMyLTUtMS0xLTA_71add6b8-b915-430c-ba4c-79bc6c6a85a9"
      unitRef="usd">36819000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMzLTEtMS0xLTA_fc6e1f77-07bd-4ebf-8b85-c88830d3ca21"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMzLTMtMS0xLTA_bd4fce45-2a50-4ae0-acea-4c59591f0cdf"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzMzLTUtMS0xLTA_3f9e473d-7ca9-40c4-91e3-bcce4e98720f"
      unitRef="usd">-4000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM0LTEtMS0xLTA_f42dd76a-2dd5-4f90-b1c5-d6e062b703a0"
      unitRef="usd">2176000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM0LTMtMS0xLTA_29050b2e-9c7a-4090-b3f8-f5f0cd10a7ce"
      unitRef="usd">1659000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM0LTUtMS0xLTA_bbf0ec0a-ba82-4b41-9b6c-3045f4c7a924"
      unitRef="usd">2395000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM1LTEtMS0xLTA_28bf55b7-5d7e-4698-851f-9da66a672233"
      unitRef="usd">5954000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM1LTMtMS0xLTA_e67e2e7b-7345-4e81-923c-0bc56efb6295"
      unitRef="usd">4295000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i20db3230df8c4812ac4bf0f95ceda745_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM1LTUtMS0xLTA_d86aa8f6-cd53-48af-841f-b7b8321708bd"
      unitRef="usd">1900000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM2LTEtMS0xLTA_c53aadf3-8d5e-4d1d-ad73-01a304ce8856"
      unitRef="usd">8130000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM2LTMtMS0xLTA_6ed17a22-a149-4585-aa9d-72732b2c4f02"
      unitRef="usd">5954000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTplZmFiNGI4MTk1YzE0YWJiYTNhYTI5OGUxZThmOGIxOC90YWJsZXJhbmdlOmVmYWI0YjgxOTVjMTRhYmJhM2FhMjk4ZTFlOGY4YjE4XzM2LTUtMS0xLTA_1e80cece-9b1b-4fe1-97ef-373a7086c7f6"
      unitRef="usd">4295000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ProfitLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzMtMS0xLTEtMA_3edeb1a8-76ad-4e2e-bc92-a15709e691d0"
      unitRef="usd">7192000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzMtMy0xLTEtMA_7dfd08bf-50bf-4f6f-8487-4cceba28a3a5"
      unitRef="usd">6631000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzMtNS0xLTEtMA_8d6d3df7-8317-41d9-bed7-5bed420d24c3"
      unitRef="usd">-596000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzUtMS0xLTEtMA_3617b5af-8cd8-41a8-950e-3fe2da258f23"
      unitRef="usd">4441000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzUtMy0xLTEtMA_1673bba8-9d2c-48ad-bb9f-f3d73197851b"
      unitRef="usd">4371000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzUtNS0xLTEtMA_2063779e-2354-477c-8660-00761ee70670"
      unitRef="usd">2718000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzYtMS0xLTEtMA_9a64ea68-68d2-4d78-abb4-8a3fb3ea3094"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzYtMy0xLTEtMA_a200bb29-1ee1-4ed9-90f4-76093497aa8d"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzYtNS0xLTEtMA_0d696957-0e41-498c-a96f-a28418ebc08c"
      unitRef="usd">6149000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzgtMS0xLTEtMA_56760175-3ae0-43af-a676-7ae5c5fdf401"
      unitRef="usd">400000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzgtMy0xLTEtMA_3143b16c-374d-4f3d-972d-a330dc677486"
      unitRef="usd">453000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzgtNS0xLTEtMA_e2245b90-0d85-40fd-a632-cb8b5842bef2"
      unitRef="usd">280000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzktMS0xLTEtMA_101dd34e-e3fd-495d-87eb-72bb40e014e7"
      unitRef="usd">-269000000</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzktMy0xLTEtMA_02fcadef-0aa5-4312-a9c0-618f6d08f18b"
      unitRef="usd">205000000</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzktNS0xLTEtMA_c56b778e-505b-492c-a906-737383f378ef"
      unitRef="usd">86000000</us-gaap:DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzEwLTEtMS0xLTA_f2595eac-44c7-4912-ac80-ada27908ed36"
      unitRef="usd">-1440000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzEwLTMtMS0xLTA_532a35c4-51d7-47f2-9501-54f6c308aaab"
      unitRef="usd">-79000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzEwLTUtMS0xLTA_35d2461f-f9c7-4fc1-9ce1-76da7757c6be"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzExLTEtMS0xLTA_dbba0319-4c03-42b7-95b8-76cbf18f2b7e"
      unitRef="usd">-570000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzExLTMtMS0xLTA_13dd3c50-0984-4c13-8348-4c5bc953c283"
      unitRef="usd">-654000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzExLTUtMS0xLTA_9ae3ad9e-8278-4aee-9780-74d11d4c8f45"
      unitRef="usd">87000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzEyLTEtMS0xLTA_58e56d86-38b1-4cd7-8b05-dd4e1c9374aa"
      unitRef="usd">-72000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzEyLTMtMS0xLTA_17a3e8d5-a108-4f58-adcb-81015efa542f"
      unitRef="usd">-264000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzEyLTUtMS0xLTA_82b463ec-cadc-4c33-a626-5f92a3fe285d"
      unitRef="usd">-253000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE0LTEtMS0xLTA_17ea04fe-2219-4b15-8fe2-c101d2adb868"
      unitRef="usd">1510000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE0LTMtMS0xLTA_23939d3e-20f1-4d85-8780-84197d1f369b"
      unitRef="usd">2158000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE0LTUtMS0xLTA_d839eddd-84a0-4e01-a103-d9eebd3e9975"
      unitRef="usd">1139000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE1LTEtMS0xLTA_e113e440-7285-48df-b8eb-6b225fcda64e"
      unitRef="usd">973000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE1LTMtMS0xLTA_20b63fd9-46cf-4a2c-91d8-bd23256c17cb"
      unitRef="usd">1075000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE1LTUtMS0xLTA_f5f912e0-d837-4f1e-bab6-696dc1e8dc4d"
      unitRef="usd">1153000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE2LTEtMS0xLTA_55b366b5-2e2b-4116-8dc3-66ae548aef77"
      unitRef="usd">-364000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE2LTMtMS0xLTA_549ac684-a965-4e82-b662-886bc6f1f6f8"
      unitRef="usd">614000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE2LTUtMS0xLTA_9e934f02-7273-4bfa-9392-4277308c5703"
      unitRef="usd">3000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE3LTEtMS0xLTA_d77ee65b-133d-4945-b0b6-d0f2717489b1"
      unitRef="usd">2769000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE3LTMtMS0xLTA_6cabfce0-28ad-4203-bf93-18ab4b269f8d"
      unitRef="usd">3550000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE3LTUtMS0xLTA_0e8b865d-0d60-48fa-980b-0c5b1a555d9f"
      unitRef="usd">2329000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE4LTEtMS0xLTA_743880eb-e14e-4989-9533-40048374fd52"
      unitRef="usd">-231000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE4LTMtMS0xLTA_eff5da63-b67b-4ed3-900c-27b361a52027"
      unitRef="usd">320000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE4LTUtMS0xLTA_6b9c1277-b52a-4fd7-a49b-288ec582c54e"
      unitRef="usd">-311000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE5LTEtMS0xLTA_c813deb6-05ca-4e0d-bbd5-f3d7afd605e6"
      unitRef="usd">2740000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE5LTMtMS0xLTA_d98848d8-c72b-40f8-a7ac-46057d52bd61"
      unitRef="usd">1476000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzE5LTUtMS0xLTA_49c45a64-b4e4-4827-a349-e47bca6d8c31"
      unitRef="usd">165000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzIwLTEtMS0xLTA_2c105afc-e0bb-4166-9c73-1dc3509c28d6"
      unitRef="usd">15865000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzIwLTMtMS0xLTA_e171ace1-f2d2-4667-96dc-a06f24e4844a"
      unitRef="usd">12848000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMDkvZnJhZzozOTg5YjI4YmE1MTE0MGIzYTA0Y2ZmMTJjNTU3OWQzNi90YWJsZTo5MjFiZTM4ZDg4MDQ0NDQ4OGU2ZWNjMzUxZDA2NzlhZC90YWJsZXJhbmdlOjkyMWJlMzhkODgwNDQ0NDg4ZTZlY2MzNTFkMDY3OWFkXzIwLTUtMS0xLTA_eb27d124-d1d9-442f-87d4-7793be87c318"
      unitRef="usd">8865000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SharesOutstanding
      contextRef="i8c716e5b99ef43d2a3c07841be0dc4a4_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtMS0xLTEtMA_887e5719-a51c-45c7-ad9f-00b444b8a275"
      unitRef="shares">1712000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="ifc9a1b1abab04a16a3b873c907603424_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtMi0xLTEtMA_bd15f8ed-fb13-4a71-9515-093b89ab0d04"
      unitRef="shares">-698000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1e063d39bee64f188da6a74f7ebdb608_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNC0xLTEtMA_16e4fa08-10b4-4101-b231-c5805bb1fb2a"
      unitRef="usd">32096000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifc9a1b1abab04a16a3b873c907603424_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNS0xLTEtMA_d59bffe9-db14-4325-ad7d-ad2ea667f60f"
      unitRef="usd">-37796000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i193db80c5bda4fb7aa1cd998bea9026b_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNi0xLTEtMA_00c99425-043b-47a2-95cf-03406baae617"
      unitRef="usd">43556000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i14773d0466f74f54b9cb98d7ad2d00db_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNy0xLTEtMA_3a38c2de-d1a0-4a1c-ba8b-cde1fdfb13df"
      unitRef="usd">-165000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib83b00b1f6e34feeb9987e580b61bb95_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtOC0xLTEtMA_b6a39168-518b-4a6c-b60c-852cdffd7a5c"
      unitRef="usd">37691000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99d5436478ce4110b135201c6608ebd8_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtOS0xLTEtMA_79243c1d-6a73-4b12-aa52-ead9a162b4e4"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i20db3230df8c4812ac4bf0f95ceda745_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtMTAtMS0xLTA_21cd0722-815d-49b7-874f-f953717d5c07"
      unitRef="usd">37695000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic20621be887c43a9b7de2f03f299252a_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtNi0xLTEtNjA3_b62a2af9-95ac-469a-99b0-0b1c81ab2257"
      unitRef="usd">-6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie900981eb1e84a1ba647ba34d76fbbda_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtNy0xLTEtNjA3_8230c267-f94f-4e54-a63d-5204ca4b2869"
      unitRef="usd">-7000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f132d1656cc4ffca90cc7c194f9eb50_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtOC0xLTEtNjA3_999f653d-544c-4faf-9bce-c39d61c7b44d"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6a4dfbfbdb0244b189151eb29a59b6ef_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtMTAtMS0xLTYwNw_add9a4c1-8090-4e76-b88c-ee5d313958e8"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="iae582128ff614e3bac0ec6439e7a73c0_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtNi0xLTEtMA_d5db607b-568f-42b7-b6d4-5692ddceaa30"
      unitRef="usd">-594000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtOC0xLTEtMA_9ad223c4-5510-43a8-9e85-b82cabf1268e"
      unitRef="usd">-594000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2865692d83ef4ec3beffe7dbbdbd7685_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtOS0xLTEtMA_b5fccb3a-3382-4a5f-96be-50fe4ee561fa"
      unitRef="usd">-2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzQtMTAtMS0xLTA_d5fcbb2d-6e3b-4829-8d0a-c05bca9fe38d"
      unitRef="usd">-596000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i479bc088fe574cd9bf70b669ad0bde68_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzUtNy0xLTEtMA_a4f36910-0b46-4227-8b9c-6c35cabba2dd"
      unitRef="usd">274000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzUtOC0xLTEtMA_45c2ab0b-f70e-4131-8d73-0d4e1c1be0da"
      unitRef="usd">274000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzUtMTAtMS0xLTA_7ddfe897-085c-4a60-9f34-edbf7d16ddc7"
      unitRef="usd">274000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i4b45a4b6f0e34440abe81173dd958f40_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctMi0xLTEtNjMw_d50a71af-940e-4010-aa72-0c9b28bd1abf"
      unitRef="shares">274000000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i4a8972c93193441eb5d3b821774ebb82_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctNC0xLTEtNjMw_16fe42b0-ede0-4629-a559-5776601a1fa9"
      unitRef="usd">12923000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i4b45a4b6f0e34440abe81173dd958f40_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctNS0xLTEtNjMw_93c25e5e-9e62-4262-89b5-b26bec99477d"
      unitRef="usd">9561000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctOC0xLTEtNjMw_a1b8a581-bc8a-4ed9-996d-9aa8735242b7"
      unitRef="usd">22484000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctMTAtMS0xLTYzNQ_c3384f1c-4eda-4903-89e4-8ba64c1ab364"
      unitRef="usd">22484000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i633d2d566192435e97ba030a650d9a4d_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzYtMS0xLTEtMA_f042239f-050c-4928-a598-ac089474ae9a"
      unitRef="shares">8000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4a8972c93193441eb5d3b821774ebb82_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzYtNC0xLTEtMA_04f10832-781d-4849-96a6-73e822af4437"
      unitRef="usd">421000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzYtOC0xLTEtMA_80ff30f0-d036-40d3-b8e5-d79e2d32f152"
      unitRef="usd">421000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzYtMTAtMS0xLTA_0e5c2651-00ee-4bf2-b232-c9fe00a95eb2"
      unitRef="usd">421000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="i4b45a4b6f0e34440abe81173dd958f40_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctMi0xLTEtMA_7e7fe2a3-8e1a-42e9-8ece-9da8b40d2dee"
      unitRef="shares">1000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i4b45a4b6f0e34440abe81173dd958f40_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctNS0xLTEtMA_065a8a3f-8af2-4885-a8c1-8ca7428e8223"
      unitRef="usd">-7000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctOC0xLTEtMA_fec9e366-c993-4c21-958c-aeef9af57ee1"
      unitRef="usd">-7000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctMTAtMS0xLTA_381971fd-ba5b-412a-b9ba-1a0ddba9bcc9"
      unitRef="usd">-7000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="iae582128ff614e3bac0ec6439e7a73c0_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzgtNi0xLTEtMA_f1eaac42-599d-4efc-b91b-3d96d2d731de"
      unitRef="usd">2045000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i45e52bfc4db3464ba96249d75c704f0a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzgtOC0xLTEtMA_c5d24405-0eba-4920-a758-2d2c119c6628"
      unitRef="usd">2045000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzgtMTAtMS0xLTA_d067b1ef-442a-4204-a97d-6663a0d63e2e"
      unitRef="usd">2045000000</us-gaap:DividendsCommonStock>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i2865692d83ef4ec3beffe7dbbdbd7685_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTktMS0xLTYyMQ_f46cfc8b-222f-4ef0-b8d5-058c0b8c850d"
      unitRef="usd">329000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTEwLTEtMS02MjE_f9fd82dd-fced-474a-97e6-a22ef1b0407d"
      unitRef="usd">329000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i2865692d83ef4ec3beffe7dbbdbd7685_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzktOS0xLTEtMA_156fb14d-433d-4a22-9ae7-a7c1e08a54d6"
      unitRef="usd">-13000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzktMTAtMS0xLTA_470beb11-3939-4364-9440-55d34f3452b9"
      unitRef="usd">-13000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i3bf8771a68c449ef90d36d232f370426_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTEtMS0xLTA_df8d5b1e-3974-4b20-9223-a96cb79ebebb"
      unitRef="shares">1720000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i771cb7ed20844ad7a8c780839f51c6f0_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTItMS0xLTA_2514b134-4d79-4553-bfd8-476a7b592485"
      unitRef="shares">-425000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b8647a195fe4759a2c1d965857302cc_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTQtMS0xLTA_54335d89-aefe-4dc2-abf8-9c0a58c71b35"
      unitRef="usd">45440000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i771cb7ed20844ad7a8c780839f51c6f0_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTUtMS0xLTA_fd8f0b5e-3919-4188-a448-6bbe6f9716ac"
      unitRef="usd">-28228000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia07f8a9064884f3da3adf7cb16b994ad_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTYtMS0xLTA_0a69a8f0-43bb-4351-8459-2815b3669976"
      unitRef="usd">40911000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i182c31bd325c4b0db0263ee586306fe4_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTctMS0xLTA_4ebdc84f-2861-4cd4-83f7-124f5253e59e"
      unitRef="usd">102000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7748ca57fc424eaa980cac40c30c5207_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTgtMS0xLTA_37aaa462-6d33-41ac-81d8-82a7aa630c82"
      unitRef="usd">58225000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d28dbcffa4047b78489791263cdc3d3_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTktMS0xLTA_6bd4a2d8-bdba-444d-8b17-836eb728efa4"
      unitRef="usd">318000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTEwLTEtMS0w_24716ef3-487a-4846-83c9-bbaa4e3fc20f"
      unitRef="usd">58543000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0a9f1919bc174b95976298b74c0d5023_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTYtMS0xLTA_31eb6726-7a91-438f-87a5-53f124c07aa8"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icec68b3996a444c5a769c70fa0b27d4a_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTgtMS0xLTA_f472468a-9d67-42d2-bc8d-2f8e09cf383e"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9861fabc3eea4b0aa172430d1406d2ce_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTEwLTEtMS0w_01bbd745-65a4-4dca-9dbe-9b32284c852d"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i59d331567a29463ba17005a8dac8083d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEyLTYtMS0xLTA_26b4b9ec-783f-44ae-89bc-ffa839db3a7c"
      unitRef="usd">6634000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4ec57ae1fbdf44c086926cdcbb8ce7ad_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEyLTgtMS0xLTA_126ccb36-400e-457e-b4da-4ebc19a6aec5"
      unitRef="usd">6634000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib940e469010141009d1f199a133e402f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEyLTktMS0xLTA_3f59256b-864c-4213-8691-3d4f47638c2e"
      unitRef="usd">-3000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEyLTEwLTEtMS0w_77bcb6a0-d480-4d53-92eb-4188319c6f74"
      unitRef="usd">6631000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i579b801fc47647a9ae9d0a9f745b8002_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEzLTctMS0xLTA_56a8fd3e-e290-4fa8-8998-adf7b9586a80"
      unitRef="usd">917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4ec57ae1fbdf44c086926cdcbb8ce7ad_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEzLTgtMS0xLTA_a78bd4dd-d766-41c7-b456-f85720b0f8fa"
      unitRef="usd">917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEzLTEwLTEtMS0w_2d3dc5d1-0172-42e9-8839-92277e14b8a3"
      unitRef="usd">917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idaa674d77dad4633b24afc1e676be890_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTEtMS0xLTA_22380353-05fb-4d71-8998-ba03148e0a9a"
      unitRef="shares">7000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4ebc196b27e547dd9505449bbc3c149c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTItMS0xLTA_79572c17-8c16-4874-aa6a-341e8dd7db9e"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if00ea0e1726a4c0693ffda7f4456d2ab_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTQtMS0xLTA_5a2c956a-7097-44be-a189-7313063ea5ee"
      unitRef="usd">532000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4ec57ae1fbdf44c086926cdcbb8ce7ad_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTgtMS0xLTA_37fcb297-1e29-47a3-8512-9fbdab5ed9d0"
      unitRef="usd">532000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTEwLTEtMS0w_27fbbd42-e7d7-41d1-af5b-c76381205ff5"
      unitRef="usd">532000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="i4ebc196b27e547dd9505449bbc3c149c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTItMS0xLTA_eb3c5e68-7726-4b79-b649-2ab124a852a1"
      unitRef="shares">2000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i4ebc196b27e547dd9505449bbc3c149c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTUtMS0xLTA_2f2dd26c-e7f9-4dda-9316-d5984a87a00a"
      unitRef="usd">7000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i4ec57ae1fbdf44c086926cdcbb8ce7ad_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTgtMS0xLTA_ba7bc357-4b0f-4914-bef5-5331e8cec41a"
      unitRef="usd">7000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTEwLTEtMS0w_ca68eabe-90b2-49eb-b7e7-3dad16bad14f"
      unitRef="usd">7000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="i59d331567a29463ba17005a8dac8083d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE3LTYtMS0xLTA_1e05dc3d-5cd2-451f-a052-4f0241a59083"
      unitRef="usd">2615000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i4ec57ae1fbdf44c086926cdcbb8ce7ad_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE3LTgtMS0xLTA_19e306bd-5649-4128-aacc-74854db372a1"
      unitRef="usd">2615000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE3LTEwLTEtMS0w_6e7af525-d187-4338-a97d-b3cafb39fc84"
      unitRef="usd">2615000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="ib940e469010141009d1f199a133e402f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE5LTktMS0xLTA_859025c6-ecd0-4352-8051-21cc1725176b"
      unitRef="usd">-9000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE5LTEwLTEtMS0w_99f694ae-2596-422e-ae82-9cf5d080c6f9"
      unitRef="usd">-9000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="ib3384c22fbbc4007beae52127a1ca929_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTEtMS0xLTA_9051dafc-2d3b-45a4-9bbf-286b445d201b"
      unitRef="shares">1727000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="ic1f2c8e874cd4322964c291da3c8928d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTItMS0xLTA_2435051f-4ce3-42cb-9703-f4ace175a146"
      unitRef="shares">-425000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibad41ca6e209411b8aed153ad0ca7b35_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTQtMS0xLTA_f68504a9-4624-4e2a-a2d6-ed8227e1917d"
      unitRef="usd">45972000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1f2c8e874cd4322964c291da3c8928d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTUtMS0xLTA_1621828b-14e0-446f-a93d-fbdd43a45fa7"
      unitRef="usd">-28235000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i50b94dc3fa4a45d2a882ca93d2edb4a4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTYtMS0xLTA_98f1bde6-41c3-48c9-a656-615be182db16"
      unitRef="usd">45108000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id566ff7b0a4d432094d2dd009bd9325d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTctMS0xLTA_ef2c4ca5-d53c-48a7-a82e-65d193fce248"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibbb5ad828f3d430ab4e4b7789d96ca96_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTgtMS0xLTA_2586179f-f8fc-4573-a5c6-bd1066fc9b66"
      unitRef="usd">63864000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7c36f74c88e4d1293588b625bef258b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTktMS0xLTA_02c390c8-ce67-4364-bd64-45700c14ba07"
      unitRef="usd">306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTEwLTEtMS0w_81ac5e42-facb-4335-8d31-000bfedfcfd0"
      unitRef="usd">64170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iddbe6826a9f14b02936670ae1a4ac19c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIxLTYtMS0xLTA_42dade65-73ce-4d63-97f4-7e32c3a17957"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b1fa3d607d64b19b6e722492150bc46_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIxLTgtMS0xLTA_32d4e5bd-5a8c-4d84-b303-bf8b9b056f6f"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4052b450116d44169998570f9d72ad8f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIxLTEwLTEtMS0w_7ff207ab-7e1e-417a-81db-3755b3334986"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ieaaac464404e4f83b7ae4acc339eae78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIyLTYtMS0xLTA_ef51f163-bb12-4bc5-ae6a-ac47fa6bd057"
      unitRef="usd">7179000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iac50116896f44c97b2f61f0fa8211ac1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIyLTgtMS0xLTA_7a980b56-cedd-47e8-b17f-6a38a51dea80"
      unitRef="usd">7179000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i58512c9652124fb18dc047245e08325f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIyLTktMS0xLTA_fc842a3b-e633-4a53-a90e-508d62f48c40"
      unitRef="usd">13000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIyLTEwLTEtMS0w_6793318c-5261-4cb2-9bcb-a48849db4b06"
      unitRef="usd">7192000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idef7f894733b48a89d8de562546c4dd5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIzLTctMS0xLTA_feeac7c3-3851-4cee-9906-3453f218cb98"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iac50116896f44c97b2f61f0fa8211ac1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIzLTgtMS0xLTA_c2a6aa76-f40f-47af-a13d-412fe48b45b7"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIzLTEwLTEtMS0w_c891babf-2543-4117-9a21-d74b2f1da7a3"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ied30c7ad7aa44d239c4dc814569f41f9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTEtMS0xLTA_c2700f6d-1cea-424a-b55c-bf5743a28752"
      unitRef="shares">6000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if103de66430f477397471c724603a2a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTItMS0xLTA_5852c8da-7472-4465-9b6a-1e4830d46909"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iac8be9403fbc450db4da0a11f9de6385_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTQtMS0xLTA_257c52a8-5b09-4880-9f25-4b0697e3ff7e"
      unitRef="usd">541000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iac50116896f44c97b2f61f0fa8211ac1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTgtMS0xLTA_f516c586-e8e7-4ba0-ba7f-57ff2bbc2dc5"
      unitRef="usd">541000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTEwLTEtMS0w_ed2477b1-a303-4881-8870-d73b041b74b0"
      unitRef="usd">541000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="if103de66430f477397471c724603a2a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTItMS0xLTA_9b8cebe1-0b8a-4e47-b179-f53a706dfa00"
      unitRef="shares">2000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="if103de66430f477397471c724603a2a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTUtMS0xLTA_2e6555ea-9d89-4f6a-9188-aec0ac5db97e"
      unitRef="usd">57000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="iac50116896f44c97b2f61f0fa8211ac1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTgtMS0xLTA_caf596b2-0a48-42b7-bdfe-7eeca6306d34"
      unitRef="usd">57000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTEwLTEtMS0w_1ef18408-8a30-4786-99ca-6e4f7bb73f3b"
      unitRef="usd">57000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="ieaaac464404e4f83b7ae4acc339eae78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI2LTYtMS0xLTA_c20710c8-aa16-4b86-b6e5-a0430fe8eb1a"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="iac50116896f44c97b2f61f0fa8211ac1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI2LTgtMS0xLTA_d6dd5e94-2423-4441-ad8b-41036f5beb45"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI2LTEwLTEtMS0w_bcbb10fe-a2be-40ae-94c8-25bc0b9468cd"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i58512c9652124fb18dc047245e08325f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI3LTktMS0xLTA_9ecf3645-9128-42bf-a8c5-93f05856cc8c"
      unitRef="usd">-7000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI3LTEwLTEtMS0w_9c547cfe-58d7-4dfa-ae42-ba92e52d2211"
      unitRef="usd">-7000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i582affc472fa400a9eb5ee9688d05fee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTEtMS0xLTA_7e715c0b-73c1-4a92-9a7a-31ecc8734791"
      unitRef="shares">1733000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="ie3030715b1c74323bd4bcb2d48199bf3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTItMS0xLTA_db94551e-003e-40b1-974c-609d700a26b3"
      unitRef="shares">-423000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e943a74976c444798abe05d760b9d08_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTQtMS0xLTA_01d38a2b-d2f4-401a-a290-0c4d6573dc03"
      unitRef="usd">46513000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie3030715b1c74323bd4bcb2d48199bf3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTUtMS0xLTA_7ff7c6fa-bb8f-45ab-b419-bb5be4433372"
      unitRef="usd">-28178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic9229806f74744b7886032e409d4d844_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTYtMS0xLTA_3be1d002-0047-4486-96ef-13787764e00d"
      unitRef="usd">49640000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i42a1c40357754fa8ab8bff9c11bbc401_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTctMS0xLTA_475288f1-c4cf-4405-9376-5e1be98c1d90"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8590a938bc284f1db11c769ad6e3a70d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTgtMS0xLTA_e10652ef-dddf-4447-a8a3-3515e61cc075"
      unitRef="usd">69389000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i30d444aa6cdc43d59d7fa44cb8d6c3cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTktMS0xLTA_8610272b-6b45-4cad-ab06-4a9553eb5247"
      unitRef="usd">312000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTEwLTEtMS0w_8f05007b-b6f2-4c1a-bf5f-f439822a8ca4"
      unitRef="usd">69701000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzEyNg_0bf798c6-0eb4-4ca3-9f33-9baad8ade9fe"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzEyNg_31fa1019-cac1-4448-b975-959cc6b438b7"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzEyNg_a3c69594-9346-435d-8c87-1e99bf13f866"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzIzNg_5f8f45d3-a1eb-4a00-bfef-1ba91b1712b1"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzIzNg_c481ae89-0c97-452a-9b3b-d94c7dff5d71"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzIzNg_f96be4f3-730f-402e-a2d6-f7c419ee137c"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <us-gaap:CommonStockValue
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzUxMw_ae9435f2-f6c7-4915-8a90-7d30058bc199"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzUxMw_ce28d1db-787f-4351-8cc6-955866b5d297"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzUxMw_f48c3587-bf65-4307-b871-e44ad84d1c07"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i963da7f6c42a4740a9aef503c045ff0b_I20180101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzcxOQ_10889b9b-cabc-4b03-8a67-ac101c5948bb"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5212eadada724019b746b479c60caaf0_I20180101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4Xzk3OA_bd82f588-d256-40cf-98c9-f2930f4410d7"
      unitRef="usd">-7000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5212eadada724019b746b479c60caaf0_I20180101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzEwMjE_82c56a0f-7ce6-4c50-91d0-e6ee48da7103"
      unitRef="usd">7000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0a9f1919bc174b95976298b74c0d5023_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzIxOTkwMjMyNTc1NjU_31eb6726-7a91-438f-87a5-53f124c07aa8"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDA1_cff3389d-f69f-4167-8b73-510c45973322">Significant Accounting Policies &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business&#160; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation (&#x201c;CVS Health&#x201d;), together with its subsidiaries (collectively, the &#x201c;Company&#x201d;), has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 105 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. The Company also serves an estimated 34 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#x201c;PDP&#x201d;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) pandemic has severely impacted the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#x2019;s businesses, operating results, cash flows and financial condition in the year ended December 31, 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 28, 2018 (the &#x201c;Aetna Acquisition Date&#x201d;), the Company acquired Aetna Inc. (&#x201c;Aetna&#x201d;). As a result of the acquisition of Aetna (the &#x201c;Aetna Acquisition&#x201d;), the Company added the Health Care Benefits segment. Certain aspects of Aetna&#x2019;s operations, including products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products, are included in the Company&#x2019;s Corporate/Other segment. The consolidated financial statements reflect Aetna&#x2019;s results subsequent to the Aetna Acquisition Date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has four reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other, which are described below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment provides a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) and private health insurance exchanges and other sponsors of health benefit plans throughout the United States. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2020, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Care Benefits segment is one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#x2019; compensation administrative services through its Coventry Health Care Workers&#x2019; Compensation business (&#x201c;Workers&#x2019; Compensation business&#x201d;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d; For periods prior to the Aetna Acquisition Date, the Health Care Benefits segment was comprised only of the Company&#x2019;s SilverScript&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; PDP business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform with the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash included in other current assets on the consolidated balance sheets represents amounts held in escrow accounts in connection with certain recent acquisitions. Restricted cash included in other assets on the consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#x2018;&#x2018;Fair Value&#x2019;&#x2019; for additional information on how the Company estimates the fair value of these investments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#x2019;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments consist primarily of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#x2019;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#x2019;s investments through its review or prior to receiving the limited partnership&#x2019;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using a discounted future cash flow analysis in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#x201c;FHLBB&#x201d;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net investment income on the Company&#x2019;s investments is recorded when earned and is reflected in the Company&#x2019;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#x2019; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#x2019;s net income (as long as the contract&#x2019;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#x2019; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#x2019; accounts through a charge to benefit costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized capital gains and losses on investments supporting large case pensions&#x2019; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#x2019; accounts. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#x2019; equity, net of tax, as a component of accumulated other comprehensive income. Unrealized capital gains and losses on investments supporting large case pensions&#x2019; experience-rated products are credited directly to contract holders&#x2019; accounts. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#x2019;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net is composed of the following at December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for credit losses was $358&#160;million as of December&#160;31, 2020. When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days. The Company&#x2019;s allowance for doubtful accounts was $319&#160;million as of December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reinsurance Recoverables &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#x2019;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2020, the Company&#x2019;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Contract Acquisition Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Insurance products included in the Health Care Benefits segment are cancelable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. Acquisition costs for certain long-duration insurance contracts are deferred and are recorded as other current assets or other assets on the consolidated balance sheets and are amortized over the estimated life of the contracts. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations. At December&#160;31, 2020 and 2019, the balance of deferred acquisition costs was $546 million and $271 million, respectively, comprised primarily of commissions paid on Medicare Supplement products within the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 1 to 40 years for buildings, building improvements and leasehold improvements and 3 to 10 years for fixtures, equipment and internally developed &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consists of the following at December&#160;31, 2020 and 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,890)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense (which includes the amortization of property and equipment under finance or capital leases) totaled $2.1 billion, $1.9 billion and $1.7 billion for the years ended December&#160;31, 2020, 2019 and 2018, respectively. See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Right-of-Use Assets and Lease Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#x2019;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about right-of-use assets and lease liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently if necessary, as further described below. See Note 5 &#x2018;&#x2018;Goodwill and Other Intangibles&#x2019;&#x2019; for additional information about goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#x201c;VOBA&#x201d;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Other than VOBA, definite-lived intangible assets are amortized using the straight-line method. VOBA is amortized over the expected life of the acquired contracts in proportion to estimated premiums. Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently if necessary, as further described in &#x201c;Long-Lived Asset Impairment&#x201d; below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 5 &#x2018;&#x2018;Goodwill and Other Intangibles&#x2019;&#x2019; for additional information about intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Asset Impairment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted and without interest charges). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#x2019;s estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the asset group&#x2019;s carrying value that exceeds the asset group&#x2019;s estimated future cash flows (discounted and with interest charges). There were no material impairment charges recognized on long-lived assets in the year ended December&#160;31, 2020. During the year ended December 31, 2019, the Company recorded store rationalization charges of $231 million, primarily related to operating lease right-of-use asset impairment charges. See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about the right-of-use asset impairment charges. During the year ended December 31, 2018, the Company recognized a $43 million long-lived asset impairment charge, primarily related to the impairment of property and equipment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of both 2020 and 2019, the Company performed its required annual goodwill impairment tests and concluded there were no goodwill impairments as of the testing dates or during the years ended December&#160;31, 2020 and 2019. See Note 5 &#x2018;&#x2018;Goodwill and Other Intangibles&#x2019;&#x2019; for additional information about goodwill impairment charges recorded during the year ended December 31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value. There were no impairment losses recognized on indefinite-lived intangible assets in any of the years ended December&#160;31, 2020, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#x2019;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Costs Payable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#x2019;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#x2019;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#x201c;IBNR&#x201d;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#x2019;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#x2019;s estimate of IBNR in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#x201c;completion factors.&#x201d; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within six months of the date of service, but it can take up to 48 months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#x2019;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#x2019;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#x2019;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#x2019;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#x2019;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#x2019;s business. The health status of the Company&#x2019;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#x2019;s health care cost trend rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2020; however, actual claim payments may differ from the Company&#x2019;s estimates. A worsening (or improvement) of the Company&#x2019;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2020 would cause these estimates to change in the near term, and such a change could be material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#x2019;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#x2019;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#x2019;s health care costs payable, see Note 7 &#x2018;&#x2018;Health Care Costs Payable.&#x2019;&#x2019; The Company&#x2019;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Insurance Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unpaid Claims&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#x2019;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#x2019;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#x2019;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#x2019;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#x2019;s estimate of unpaid claims IBNR in 2020. As of December&#160;31, 2020, unpaid claims balances of $532 million and $1.5 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2019, unpaid claims balances of $704 million and $1.8 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Future Policy Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future policy benefits consist primarily of reserves for limited payment pension and annuity contracts and long-term care insurance contracts. Reserves for limited payment pension and annuity contracts are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality, retirement, expense and interest rate experience. Such assumptions generally vary by plan, year of issue and policy duration. Assumed interest rates on such contracts ranged from 3.3% to 11.3% in the year ended December 31, 2020 and from 3.5% to 11.3% in the year ended December 31, 2019. The Company periodically reviews mortality assumptions against both industry standards and its experience. Reserves for long-duration long-term care contracts represent the Company&#x2019;s estimate of the present value of future benefits to be paid to or on behalf of policyholders less the present value of future net premiums. The assumed interest rate on such contracts was 5.1% in both the years ended December 31, 2020 and 2019. The Company&#x2019;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity and interest rate assumptions. As of December&#160;31, 2020, future policy benefits &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;balances of $462 million and $5.5 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2019, future policy benefits balances of $508 million and $5.6 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Premium Deficiency Reserves&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is considered in the calculation of premium deficiency losses for short-duration contracts. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#x2019;s method of acquiring, servicing and measuring the profitability of such contracts. As of December&#160;31, 2020 and 2019, the Company established a premium deficiency reserve of $11 million and $4 million, respectively, related to Medicaid products in the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policyholders&#x2019; Funds&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Policyholders&#x2019; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus  interest credited thereon, net of experience-rated adjustments. In 2020, interest rates for pension and annuity investment contracts ranged from 4.1% to 5.1%. In 2019, interest rates for pension and annuity investment contracts ranged from 3.5% to 5.2%. Reserves for contracts subject to experience rating reflect the Company&#x2019;s rights as well as the rights of policyholders and plan participants. The Company also holds funds for health savings accounts (&#x201c;HSAs&#x201d;) on behalf of members associated with high deductible health plans. These amounts are held to pay for qualified health care expenses incurred by these members. The HSA balances were approximately $2.7 billion and $2.2 billion at December&#160;31, 2020 and 2019, respectively, and are reflected in other current assets with a corresponding liability in policyholders&#x2019; funds. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Policyholders&#x2019; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#x2019; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Self-Insurance Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is self-insured for certain losses related to general liability, workers&#x2019; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#x2019;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#x2019;s historical claims experience. At December&#160;31, 2020 and 2019, self-insurance liabilities totaled $927 million and $856 million, respectively, and were recorded as accrued expenses on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation and Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and losses from foreign currency transactions and the effects of foreign currency remeasurements were not material in the years ended December&#160;31, 2020 or 2018. On July 1, 2019, the Company sold its Brazilian subsidiary, Drogaria Onofre Ltda. (&#x201c;Onofre&#x201d;) for an immaterial amount. The Company recorded a loss on the divestiture, which included the elimination of the subsidiary&#x2019;s $154 million cumulative translation adjustment from accumulated other comprehensive income during the year ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment sells prescription drugs directly through its mail service dispensing pharmacies and indirectly through the Company&#x2019;s retail pharmacy network. The Company&#x2019;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the dispensing of prescription drugs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions dispensed indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#x201c;Drug Discounts&#x201d; and &#x201c;Guarantees&#x201d; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#x201c;retail co-payments&#x201d;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Pharmacy Services segment:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenues generated from prescription drugs sold by mail service dispensing pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenues generated from prescription drugs sold by third party pharmacies in the Company&#x2019;s retail pharmacy network and associated administrative fees are recognized at the Company&#x2019;s point-of-sale, which is when the claim is adjudicated by the Company&#x2019;s online claims processing system and the Company has transferred control of the prescription drug and performed all of its performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Drug Discounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records revenue net of manufacturers&#x2019; rebates earned by its clients based on their plan members&#x2019; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#x2019; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#x2019; rebate amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Retail Pharmacy&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer returns are not material to the Company&#x2019;s operating results or financial condition. Sales taxes are not included in revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Loyalty and Other Programs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customer loyalty program, ExtraCare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, consists of two components, ExtraSavings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also offers a subscription-based membership program, CarePass&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long-term Care&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of Long-term Care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#x2019;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Walk-In Medical Clinics&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For services provided by the Company&#x2019;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which reflect contracted rates per employee and the number of covered employees &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recorded in the Company&#x2019;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Premium Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#x201c;MLR&#x201d;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#x201c;ACA&#x201d;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#x2019;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#x2019;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#x2019;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting for Medicare Part D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues include insurance premiums earned by the Company&#x2019;s PDPs, which are determined based on the PDP&#x2019;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by major source in each segment for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;70,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;171,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;75,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;85,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;56,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;140,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;66,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(41,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;165,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;86,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;256,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;88,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;52,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;134,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;64,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(33,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;164,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;134,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;83,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(33,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;194,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;87,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;47,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;134,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;program. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Certain prior year amounts have been reclassified for consistency with the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2020 and 2019, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Products Sold&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for cost of products sold as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#x2019;s mail service dispensing pharmacies and indirectly through the Company&#x2019;s retail pharmacy network, (ii) shipping and handling costs, and (iii) the operating costs of the Company&#x2019;s mail service dispensing pharmacies and client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#x2019; benefit plans from the Company&#x2019;s mail service dispensing pharmacies, net of any volume-related or other discounts (see &#x201c;Vendor Allowances and Purchase Discounts&#x201d; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#x2019;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of products sold includes: the cost of merchandise sold during the reporting period, including prescription drug costs, and the related purchasing costs, warehousing and delivery costs (including depreciation and amortization) and actual and estimated inventory losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Vendor Allowances and Purchase Discounts &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for vendor allowances and purchase discounts as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#x2019;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Pharmacy Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vendor allowances received by the Retail/LTC segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon purchase volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#x2019;s consolidated financial statements in any of the periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Reform&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Insurer Fee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since January 1, 2014, the ACA has imposed an annual premium-based health insurer fee (&#x201c;HIF&#x201d;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company has been required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In the years ended December&#160;31, 2020 and 2018, operating expenses included $1.0 billion and $157 million, respectively, related to the Company&#x2019;s share of the HIF. There was no expense related to the HIF in 2019, since there was a one-year suspension of the HIF for 2019. In December 2019, the HIF was repealed for calendar years after 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Adjustment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#x2019;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Corridor&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#x201c;HHS&#x201d;) based on their ratio of allowable costs to target costs (as defined by the ACA). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#x2019;s temporary risk corridor program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Company received the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December&#160;31, 2020. After considering offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $307 million and after-tax income of $223&#160;million during the year ended December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2019, the Company did not record any ACA risk corridor receivables because payment was uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $461 million, $396 million and $364 million in 2020, 2019 and 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2OTY1ODE1NjM0NzI_a2f5f276-1187-4a37-84f0-e7ca761d6280"&gt;three&lt;/span&gt; to five years) using the straight-line method. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Tax Cuts and Jobs Act (the &#x201c;TCJA&#x201d;) was enacted on December 22, 2017. Among numerous changes to existing tax laws, the TCJA permanently reduced the federal corporate income tax rate from 35% to 21% effective January 1, 2018. The effects of changes in tax rates on deferred tax balances are required to be taken into consideration in the period in which the changes are enacted, regardless of when they are effective. As&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a result of the reduction of the corporate income tax rate under the TCJA, the Company estimated the revaluation of its net deferred tax liabilities and recorded a provisional income tax benefit of approximately $1.5&#160;billion for year ended December 31, 2017. In 2018, the Company completed its process of determining the TCJA&#x2019;s final impact and recorded an additional income tax benefit of $100 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#x2019;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors defined benefit pension plans (&#x201c;pension plans&#x201d;) and other postretirement employee benefit plans (&#x201c;OPEB plans&#x201d;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit cost (income) for the Company&#x2019;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit cost (income) are included in other income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings (Loss) per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings (loss) per share is computed using the two-class method. The Company calculates basic earnings (loss) per share based on the weighted average number of common shares outstanding for the period. See Note 14 &#x2018;&#x2018;Earnings (Loss) Per Share&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shares Held in Trust&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains grantor trusts, which held approximately one million shares of its common stock at both December&#160;31, 2020 and 2019. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#x2019;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities - Primary Beneficiary&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2014, the Company and Cardinal Health, Inc. (&#x201c;Cardinal&#x201d;) established Red Oak Sourcing, LLC (&#x201c;Red Oak&#x201d;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own 50%. The Red Oak arrangement has an initial term of 10 years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Retail/LTC segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardinal is required to pay the Company 39 quarterly payments beginning in October 2014. As milestones are met, the quarterly payments increase. The Company received from Cardinal $183 million during each of the years ended December&#160;31, 2020, 2019 and 2018. The payments reduce the Company&#x2019;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold. Revenues associated with Red Oak expenses reimbursed by Cardinal for the years ended December&#160;31, 2020, 2019 and 2018, and amounts due to or due from Cardinal at December&#160;31, 2020 and 2019 were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities - Other Variable Interest Holder&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Hedge fund and private equity investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Real estate partnerships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is not the primary beneficiary of these VIEs because the nature of the Company&#x2019;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#x2019;s income or losses in net income (loss).&#160;The Company&#x2019;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total amount of other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2020 and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedge fund investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $56 million, $32 million and $45 million in the years ended December&#160;31, 2020, 2019 and 2018, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $77 million, $96 million and $135 million for pharmaceutical inventory purchases during the years ended December&#160;31, 2020, 2019 and 2018, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2020 and 2019, the Company made charitable contributions of&#160;$50&#160;million and $30 million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#x2018;n Things and Bob&#x2019;s Stores, each of which subsequently filed for bankruptcy. The Company&#x2019;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees. See &#x201c;Lease Guarantees&#x201d; in Note 16 &#x2018;&#x2018;Commitments and Contingencies&#x2019;&#x2019; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the results of discontinued operations for the year ended December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Results from discontinued operations were immaterial for the years ended December 31, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 326). This standard requires the use of a forward-looking expected credit loss impairment model for trade and other receivables, held-to-maturity debt securities, loans and other instruments. This standard also requires impairments and recoveries for available-for-sale debt securities to be recorded through an allowance account and revises certain disclosure requirements. The Company adopted this new accounting standard on January 1, 2020. The Company adopted the credit loss impairment model on a modified retrospective basis and recorded a $3 million cumulative effect adjustment to reduce retained earnings as of the adoption date. The Company adopted the available-for-sale debt security impairment model on a prospective &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;basis. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and other - Internal-Use Software &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 350-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; This standard requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in Topic 350-40 to determine which implementation costs to capitalize as assets. The Company adopted this new accounting guidance on January 1, 2020 on a prospective basis. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows, financial condition or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification (&#x201c;ASC&#x201d;) 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows, financial condition or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#x2019;s consolidated operating results, cash flows, financial condition and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfStores
      contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzE4Mg_a0dbde93-734f-4ef8-bc36-ba5480cf9454"
      unitRef="store">9900</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxNw_0f42dee4-d1a2-4926-937c-b4860890906d"
      unitRef="clinic">1100</cvs:NumberofWalkInMedicalClinics>
    <cvs:NumberOfPlanMembers
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzMwMA_bdb41c6a-3fe2-4b71-8b24-49ee5f98eded"
      unitRef="member">105000000</cvs:NumberOfPlanMembers>
    <cvs:NumberofPatientsServedperYear
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzM3Nw_38dbc3da-122e-4518-94fd-2f9796c370c5"
      unitRef="patient">1000000</cvs:NumberofPatientsServedperYear>
    <cvs:NumberOfPeopleServed
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQ3Nw_ac029b0d-8f0e-4971-8196-4124a7b6dd5e"
      unitRef="people">34000000</cvs:NumberOfPeopleServed>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTU0_01eef069-657e-46e5-9ef3-84992c77919d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has four reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other, which are described below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment provides a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) and private health insurance exchanges and other sponsors of health benefit plans throughout the United States. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2020, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Care Benefits segment is one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#x2019; compensation administrative services through its Coventry Health Care Workers&#x2019; Compensation business (&#x201c;Workers&#x2019; Compensation business&#x201d;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d; For periods prior to the Aetna Acquisition Date, the Health Care Benefits segment was comprised only of the Company&#x2019;s SilverScript&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; PDP business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIwOTg_422e2df1-6c37-4c37-829f-6a7f475c4f62"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfStores
      contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzM3NTQ_d9b28e95-fdb1-4b83-9f1a-c114d76262f4"
      unitRef="store">9900</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzM3ODk_b5607a25-a137-4a2d-ad8f-3e87ef32ba3a"
      unitRef="clinic">1100</cvs:NumberofWalkInMedicalClinics>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDA3_e1dea56a-9716-440a-afe5-75624e5f6abf">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDIz_761ff74e-be40-4b84-af0e-a2932c3fcf77">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform with the current year presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTU1_a690f670-03c9-4a5a-912a-5f16db756e35">Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTQy_a959a07d-b093-446e-b251-515470e028ca">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash included in other current assets on the consolidated balance sheets represents amounts held in escrow accounts in connection with certain recent acquisitions. Restricted cash included in other assets on the consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTMz_e4fe8f16-b275-422b-a942-baae837a6227">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzEtMS0xLTEtMA_617c4e50-7a35-4483-bdcc-d804eb569ece"
      unitRef="usd">7854000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzEtMy0xLTEtMA_90924d1e-1d78-4cdd-991c-5ae392b706da"
      unitRef="usd">5683000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzEtNS0xLTEtMA_68d8746f-9a9d-4c4e-ba15-3f6d8ed14abc"
      unitRef="usd">4059000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzItMS0xLTEtMA_f9e6a436-836b-4157-bd41-3ad334a49269"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzItMy0xLTEtMA_bea9c1d0-6365-4dd8-b004-4e540f64af45"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzItNS0xLTEtMA_7604a648-5891-43e1-acc8-2ce78b54d75f"
      unitRef="usd">6000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzMtMS0xLTEtMA_9cad9521-3593-4f6a-b932-dd9f9f13bf78"
      unitRef="usd">276000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzMtMy0xLTEtMA_533afffa-ad39-4e8f-ac2d-c610d1621254"
      unitRef="usd">271000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzMtNS0xLTEtMA_8c2d0723-3822-4485-9410-237f01b9558e"
      unitRef="usd">230000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzQtMS0xLTEtMA_144fce41-4c83-4383-9f4c-566d31bae2b0"
      unitRef="usd">8130000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzQtMy0xLTEtMA_621d14c9-5036-4d39-afbf-c4c002e4f068"
      unitRef="usd">5954000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo2Zjg4NGZiYzY0NjY0MDkyYWFlNTM0M2YwYTA2MTZhYi90YWJsZXJhbmdlOjZmODg0ZmJjNjQ2NjQwOTJhYWU1MzQzZjBhMDYxNmFiXzQtNS0xLTEtMA_378bbf65-ef4a-4b8b-a700-f9ec1930369b"
      unitRef="usd">4295000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTk5_5a90bafd-6455-4ce1-91fe-6d1ab31f6628">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#x2018;&#x2018;Fair Value&#x2019;&#x2019; for additional information on how the Company estimates the fair value of these investments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#x2019;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments consist primarily of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#x2019;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#x2019;s investments through its review or prior to receiving the limited partnership&#x2019;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using a discounted future cash flow analysis in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#x201c;FHLBB&#x201d;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net investment income on the Company&#x2019;s investments is recorded when earned and is reflected in the Company&#x2019;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#x2019; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#x2019;s net income (as long as the contract&#x2019;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#x2019; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#x2019; accounts through a charge to benefit costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized capital gains and losses on investments supporting large case pensions&#x2019; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#x2019; accounts. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#x2019; equity, net of tax, as a component of accumulated other comprehensive income. Unrealized capital gains and losses on investments supporting large case pensions&#x2019; experience-rated products are credited directly to contract holders&#x2019; accounts. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDQw_01c9014f-74c6-4981-831a-1a13b4d30de7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#x2019;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTYz_75c32d8c-e95d-4b9d-9c9f-8073a721b999">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTYy_16d70ab6-746a-48cc-9abd-65353dc62b90">Accounts receivable, net is composed of the following at December&#160;31, 2020 and 2019:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzEtMS0xLTEtMA_96e5fa16-ae2e-4841-9c16-de47258571b0"
      unitRef="usd">7101000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzEtMy0xLTEtMA_9daf0c54-b232-4a4e-a721-acc941fe9a79"
      unitRef="usd">6717000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <cvs:VendorandManufacturerReceivables
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzItMS0xLTEtMA_e4e1d7a8-9e9d-4ac8-86b0-8deeeb53a30e"
      unitRef="usd">9815000000</cvs:VendorandManufacturerReceivables>
    <cvs:VendorandManufacturerReceivables
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzItMy0xLTEtMA_4c117aa9-7459-40b0-a42f-cddfcf404682"
      unitRef="usd">7856000000</cvs:VendorandManufacturerReceivables>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzMtMS0xLTEtMA_74b2469d-1090-4c01-913d-bdade8b4dcc2"
      unitRef="usd">2628000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzMtMy0xLTEtMA_bb5b9c50-7ec8-42bb-aba6-c9f9c9a26227"
      unitRef="usd">2663000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzQtMS0xLTEtMA_c51ab0f9-5f49-4b9c-a7b0-835bae57e44b"
      unitRef="usd">2198000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzQtMy0xLTEtMA_c6595779-ad4f-4003-9775-aab645204fdd"
      unitRef="usd">2381000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzUtMS0xLTEtMA_c47f7917-75cf-4c51-9fd0-ca99d1b5f791"
      unitRef="usd">21742000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZmYzODMyY2ExYWY0ODIxYjg2ZmU3MzIxMTRhZDA1Yy90YWJsZXJhbmdlOjhmZjM4MzJjYTFhZjQ4MjFiODZmZTczMjExNGFkMDVjXzUtMy0xLTEtMA_ebda0f6d-635c-4ac6-b90f-de1e2bbbd130"
      unitRef="usd">19617000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MjQ1MzM_4a972593-144a-4fd8-ac64-a234152358a4"
      unitRef="usd">358000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzU0OTc1NTgzMDI4MzY_b3c9d7da-50e6-4abd-9d16-53d7f94090c5"
      unitRef="usd">319000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDE4_5a09d129-7842-4596-aeba-0303a3666c4a">Inventories Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ReinsuranceAccountingPolicy
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDI3_7f0c737d-9df5-445a-89ef-8c4c9aeb61a5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reinsurance Recoverables &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#x2019;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2020, the Company&#x2019;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReinsuranceAccountingPolicy>
    <us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTI3_eab0673f-f987-431b-bd00-84ad71087823">Health Care Contract Acquisition CostsInsurance products included in the Health Care Benefits segment are cancelable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. Acquisition costs for certain long-duration insurance contracts are deferred and are recorded as other current assets or other assets on the consolidated balance sheets and are amortized over the estimated life of the contracts. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations.</us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy>
    <us-gaap:DeferredPolicyAcquisitionCosts
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIwNTAy_d7602e7e-54fa-4695-b2aa-0c39ae7cf1ec"
      unitRef="usd">546000000</us-gaap:DeferredPolicyAcquisitionCosts>
    <us-gaap:DeferredPolicyAcquisitionCosts
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIwNTA5_cccaa52a-7f63-4457-9358-ff995c3c73a3"
      unitRef="usd">271000000</us-gaap:DeferredPolicyAcquisitionCosts>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDQ4_9774c54a-5237-4d36-bfdd-2c3007717ecc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 1 to 40 years for buildings, building improvements and leasehold improvements and 3 to 10 years for fixtures, equipment and internally developed &lt;/span&gt;&lt;/div&gt;software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i02d9906f299f46c78575a0dcc95ab970_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxMDEz_8aedd29b-bfd8-4ddb-ad8f-a6ffe3922915">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9ea0930652734afeab89b2f4895835b6_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxMDE5_0babba13-7bf3-4ebc-832e-2efd86e6f794">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8696070d484a40f2bb7a4f689ad3defb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxMDk2_4285c40e-cb89-40b4-b10c-ec349c8f682c">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1c66b1159478475eadd94b3ae0b2492e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxMTAy_970046aa-cc13-44fc-a79e-933b7639fbfd">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDU1_ce4f9680-a863-478f-8267-1e0ad86f28b3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consists of the following at December&#160;31, 2020 and 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,890)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i089b48d85e384c799bd89b63783799f0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzEtMS0xLTEtMA_6b360884-8213-46c8-903d-809048b0e58a"
      unitRef="usd">2134000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i21bafdeb44cc4054a9d59d8f3c997e60_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzEtMy0xLTEtMA_75b9cc1b-294c-4312-86e0-6d1b563a85c9"
      unitRef="usd">1981000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i52e60b1b6f4a4dbd88268862a0d22fe5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzItMS0xLTEtMA_752bea1a-1b20-438c-8720-9a64b9630e7e"
      unitRef="usd">3950000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie669a13e87484bbf8cec205795711fbe_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzItMy0xLTEtMA_9b9e8f25-9531-42c6-8f04-153d27af6056"
      unitRef="usd">3541000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ica9c1a9ce292408681c60506f05c7e71_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzMtMS0xLTEtMA_64456834-b166-4003-b418-6fc0b6bea156"
      unitRef="usd">13125000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id09b24f17a054a62a94b835ed727b119_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzMtMy0xLTEtMA_17576931-1745-4e2f-b3de-ee2f8830b055"
      unitRef="usd">12401000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5737e6e8f2e848bb890ccfdf89d8addd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzQtMS0xLTEtMA_1548b648-d06f-40c8-8d81-c29175776085"
      unitRef="usd">6077000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if57eea73aa9c452f8b32b1d955f87c9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzQtMy0xLTEtMA_f88399bb-8c30-495f-8cb9-15cb774e7e9c"
      unitRef="usd">5611000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i05dc4ee13c7c4d28aec45e6e732ddc48_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzUtMS0xLTEtMA_5e57ae82-7380-4cdd-809f-d9457e505220"
      unitRef="usd">6020000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib6b3de6701614688b86b94e57bba778a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzUtMy0xLTEtMA_57d66e85-4701-4dec-b970-e1f1f8c53e39"
      unitRef="usd">5400000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzYtMS0xLTEtMA_4f060742-1ef5-4ad2-afb6-1cf31e15789e"
      unitRef="usd">31306000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzYtMy0xLTEtMA_5451ae7a-bdc8-401c-b57f-225d6b8d8a57"
      unitRef="usd">28934000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzctMS0xLTEtMA_4638e520-1f74-4c59-974e-01248586c208"
      unitRef="usd">18700000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzctMy0xLTEtMA_1d5c106c-3e4b-4319-a10e-a860c74510ac"
      unitRef="usd">16890000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzgtMS0xLTEtMA_998334d2-5e64-4be2-990f-061d6811c448"
      unitRef="usd">12606000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTozOWI4ZGZjZjc0YWE0MTRkYTk0MWU5ZDU2YzBiY2JiMy90YWJsZXJhbmdlOjM5YjhkZmNmNzRhYTQxNGRhOTQxZTlkNTZjMGJjYmIzXzgtMy0xLTEtMA_24a44d5f-bf13-463d-8ac8-34f098fa830c"
      unitRef="usd">12044000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxNjc3_0cd4903f-7f21-45e0-a6af-caa710fcbaff"
      unitRef="usd">2100000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxNzIw_d20e9a2b-4085-4848-ad12-bd5744efbd5f"
      unitRef="usd">1900000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3Mjk5OTc_b4c6b89c-f94c-4604-bc58-da122b564e0f"
      unitRef="usd">1700000000</us-gaap:Depreciation>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDAx_96555e15-b1b4-407a-a7e5-297057b3967a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Right-of-Use Assets and Lease Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#x2019;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.&lt;/span&gt;&lt;/div&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about right-of-use assets and lease liabilities.</us-gaap:LesseeLeasesPolicyTextBlock>
    <cvs:LesseeOperatingAndFinanceLeasesRenewalTerm
      contextRef="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIyODcy_73067bfc-970e-4bcb-8643-964e058bf750">P5Y</cvs:LesseeOperatingAndFinanceLeasesRenewalTerm>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTU3_0cda6aa8-31d9-42a2-ae12-023b17ee0a28">Goodwill The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently if necessary, as further described below.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTI4_ae60c6b6-9388-4afc-b313-aacdb45671f3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#x201c;VOBA&#x201d;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Other than VOBA, definite-lived intangible assets are amortized using the straight-line method. VOBA is amortized over the expected life of the acquired contracts in proportion to estimated premiums. Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently if necessary, as further described in &#x201c;Long-Lived Asset Impairment&#x201d; below.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDUw_6e0a493a-8f70-40a5-b4e3-c871d424886e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Asset Impairment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted and without interest charges). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#x2019;s estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the asset group&#x2019;s carrying value that exceeds the asset group&#x2019;s estimated future cash flows (discounted and with interest charges). There were no material impairment charges recognized on long-lived assets in the year ended December&#160;31, 2020. During the year ended December 31, 2019, the Company recorded store rationalization charges of $231 million, primarily related to operating lease right-of-use asset impairment charges. See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about the right-of-use asset impairment charges. During the year ended December 31, 2018, the Company recognized a $43 million long-lived asset impairment charge, primarily related to the impairment of property and equipment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of both 2020 and 2019, the Company performed its required annual goodwill impairment tests and concluded there were no goodwill impairments as of the testing dates or during the years ended December&#160;31, 2020 and 2019. See Note 5 &#x2018;&#x2018;Goodwill and Other Intangibles&#x2019;&#x2019; for additional information about goodwill impairment charges recorded during the year ended December 31, 2018.&lt;/span&gt;&lt;/div&gt;Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <cvs:StoreRationalizationCharges
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjMzOTc0MjY_a18383e4-86aa-470f-bbba-aceef86c3d7b"
      unitRef="usd">0</cvs:StoreRationalizationCharges>
    <cvs:StoreRationalizationCharges
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzI3MzMy_0857ce25-167c-4afc-ae14-881c8a972b4e"
      unitRef="usd">231000000</cvs:StoreRationalizationCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjMzOTc1Njc_373c55c5-57e3-4bf8-9158-c0bce70ef29e"
      unitRef="usd">43000000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MTkyNzU_1503ba47-e2b4-4cf5-9b29-8e338670dd07"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MTkyNzU_1a34321f-a753-48c9-804d-3ceb077a5e24"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzI4OTU3_18c43e98-a296-4e28-a436-b49ad9bdef8a"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzI4OTU3_838de5e2-46be-468a-80f7-1a11e1783682"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzI4OTU3_88487aac-9c26-4046-94a2-3d2dccbac281"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:PolicyholderAccountsPolicy
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTc4_41224446-9a30-43db-bb32-3d9a7959c67b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#x2019;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.&lt;/span&gt;&lt;/div&gt;</us-gaap:PolicyholderAccountsPolicy>
    <us-gaap:HealthCareCostsPolicyPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDU2_93d3e9b9-7916-49c1-86c8-62510b58fc00">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Costs Payable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#x2019;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#x2019;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#x201c;IBNR&#x201d;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#x2019;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#x2019;s estimate of IBNR in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#x201c;completion factors.&#x201d; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within six months of the date of service, but it can take up to 48 months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#x2019;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#x2019;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#x2019;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#x2019;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#x2019;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#x2019;s business. The health status of the Company&#x2019;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#x2019;s health care cost trend rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2020; however, actual claim payments may differ from the Company&#x2019;s estimates. A worsening (or improvement) of the Company&#x2019;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2020 would cause these estimates to change in the near term, and such a change could be material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#x2019;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#x2019;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#x2019;s health care costs payable, see Note 7 &#x2018;&#x2018;Health Care Costs Payable.&#x2019;&#x2019; The Company&#x2019;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.&lt;/span&gt;&lt;/div&gt;</us-gaap:HealthCareCostsPolicyPolicyTextBlock>
    <cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid
      contextRef="i9e7dfa659f1f4a92a32a74b0958212b4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzMzMTY3_2aba46ee-a84b-4581-8ec2-cd02d19d0a61">P6M</cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid>
    <cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid
      contextRef="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzMzMjE2_41dc24cd-2e79-4e0c-8f98-59727891be5c">P48M</cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid>
    <us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTg2_fe053d63-3d74-4afc-853b-657d7a9ce2c4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Insurance Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unpaid Claims&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#x2019;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#x2019;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#x2019;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#x2019;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#x2019;s estimate of unpaid claims IBNR in 2020. As of December&#160;31, 2020, unpaid claims balances of $532 million and $1.5 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2019, unpaid claims balances of $704 million and $1.8 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Future Policy Benefits&lt;/span&gt;&lt;/div&gt;Future policy benefits consist primarily of reserves for limited payment pension and annuity contracts and long-term care insurance contracts. Reserves for limited payment pension and annuity contracts are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality, retirement, expense and interest rate experience. Such assumptions generally vary by plan, year of issue and policy duration. Assumed interest rates on such contracts ranged from 3.3% to 11.3% in the year ended December 31, 2020 and from 3.5% to 11.3% in the year ended December 31, 2019. The Company periodically reviews mortality assumptions against both industry standards and its experience. Reserves for long-duration long-term care contracts represent the Company&#x2019;s estimate of the present value of future benefits to be paid to or on behalf of policyholders less the present value of future net premiums. The assumed interest rate on such contracts was 5.1% in both the years ended December 31, 2020 and 2019. The Company&#x2019;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity and interest rate assumptions.</us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy>
    <cvs:LiabilityforUnpaidClaims
      contextRef="i8d08e4488aed40f3ab968e76d61f94ae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQwMzUw_01b47111-8cbc-41b7-be72-e27e7c1822a4"
      unitRef="usd">532000000</cvs:LiabilityforUnpaidClaims>
    <cvs:LiabilityforUnpaidClaims
      contextRef="iddd268c0de8441a3a25145b2c7fdf545_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQwMzU3_9d24a709-21c1-4b49-82cf-40ad1781cf7d"
      unitRef="usd">1500000000</cvs:LiabilityforUnpaidClaims>
    <cvs:LiabilityforUnpaidClaims
      contextRef="i2d5b621fca784ba2afc687cec988fde8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQwNDk4_e32b83a5-0f06-4623-96d6-0380c77d874a"
      unitRef="usd">704000000</cvs:LiabilityforUnpaidClaims>
    <cvs:LiabilityforUnpaidClaims
      contextRef="i2e9687452be744e6ae16597342184c4b_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQwNTA1_9c950590-45c6-4bf2-941b-b9c14795c91d"
      unitRef="usd">1800000000</cvs:LiabilityforUnpaidClaims>
    <cvs:LimitedPaymentsContracts
      contextRef="i9e7dfa659f1f4a92a32a74b0958212b4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQxMzU4_e1181e69-2158-40f6-928f-3da39ddc1b31"
      unitRef="number">0.033</cvs:LimitedPaymentsContracts>
    <cvs:LimitedPaymentsContracts
      contextRef="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQxMzY0_4e1570d0-ba85-45ec-8b19-8d048df8b11e"
      unitRef="number">0.113</cvs:LimitedPaymentsContracts>
    <cvs:LimitedPaymentsContracts
      contextRef="i1ecd36bf6d9f459da73860d5891edad6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzA1NzM_5a2de318-c812-4df0-a5bd-1b085c7fbd0d"
      unitRef="number">0.035</cvs:LimitedPaymentsContracts>
    <cvs:LimitedPaymentsContracts
      contextRef="i1dbce9db2d76499fa858862f845f972d_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzA1OTA_6fe64d7a-dd87-486a-b534-b604bb3de015"
      unitRef="number">0.113</cvs:LimitedPaymentsContracts>
    <cvs:AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQxODM1_238f5c91-727e-400f-8724-bc5f1ec79f36"
      unitRef="number">0.051</cvs:AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts>
    <cvs:AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQxODM1_91c0138f-c9ef-4322-ac8d-12c450fbd44b"
      unitRef="number">0.051</cvs:AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i8d08e4488aed40f3ab968e76d61f94ae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQyMTMw_3a81b1c9-de26-444c-9324-c01f0db2b459"
      unitRef="usd">462000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="iddd268c0de8441a3a25145b2c7fdf545_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQyMTM3_516ba0ab-0e60-463d-b8dc-baa62a815f58"
      unitRef="usd">5500000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i2d5b621fca784ba2afc687cec988fde8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQyMjg3_e0f85e8e-6e4c-423d-bb74-1ed0e04cdc73"
      unitRef="usd">508000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i2e9687452be744e6ae16597342184c4b_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQyMjk0_63442200-cb7e-4ffc-b85c-9a4e6f7cb60d"
      unitRef="usd">5600000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <cvs:InsurancePremiumDeficiencyReservePolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTgx_557bd336-25d9-4c6e-92ce-0fb79988372f">Premium Deficiency ReservesThe Company evaluates its insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is considered in the calculation of premium deficiency losses for short-duration contracts. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#x2019;s method of acquiring, servicing and measuring the profitability of such contracts.</cvs:InsurancePremiumDeficiencyReservePolicyTextBlock>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQzMTg5_d9f320e9-f525-4df3-bf98-cdc7bfee46f2"
      unitRef="usd">11000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQzMTk2_6cdbcb83-0e73-4044-85c6-ee3cd7669480"
      unitRef="usd">4000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:AllocationsToPolicyholdersPolicies
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDI5_8d593347-b954-4446-869c-448f75cd9071">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policyholders&#x2019; Funds&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Policyholders&#x2019; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus  interest credited thereon, net of experience-rated adjustments. In 2020, interest rates for pension and annuity investment contracts ranged from 4.1% to 5.1%. In 2019, interest rates for pension and annuity investment contracts ranged from 3.5% to 5.2%. Reserves for contracts subject to experience rating reflect the Company&#x2019;s rights as well as the rights of policyholders and plan participants. The Company also holds funds for health savings accounts (&#x201c;HSAs&#x201d;) on behalf of members associated with high deductible health plans. These amounts are held to pay for qualified health care expenses incurred by these members. The HSA balances were approximately $2.7 billion and $2.2 billion at December&#160;31, 2020 and 2019, respectively, and are reflected in other current assets with a corresponding liability in policyholders&#x2019; funds. &lt;/span&gt;&lt;/div&gt;Policyholders&#x2019; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#x2019; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets.</us-gaap:AllocationsToPolicyholdersPolicies>
    <cvs:PensionAndAnnuityInvestmentContractsInterest
      contextRef="i9e7dfa659f1f4a92a32a74b0958212b4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQzNzAw_7e3a702a-153d-4214-9970-4b91706aa263"
      unitRef="number">0.041</cvs:PensionAndAnnuityInvestmentContractsInterest>
    <cvs:PensionAndAnnuityInvestmentContractsInterest
      contextRef="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQzNzA2_f1393506-ed42-42b8-8afd-a90fa8c729b6"
      unitRef="number">0.051</cvs:PensionAndAnnuityInvestmentContractsInterest>
    <cvs:PensionAndAnnuityInvestmentContractsInterest
      contextRef="i1ecd36bf6d9f459da73860d5891edad6_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzAyODU_238f745e-8223-47b4-b3aa-7f987ce63dcc"
      unitRef="number">0.035</cvs:PensionAndAnnuityInvestmentContractsInterest>
    <cvs:PensionAndAnnuityInvestmentContractsInterest
      contextRef="i1dbce9db2d76499fa858862f845f972d_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzAyOTI_34b04459-820a-45c7-86ea-0a3a9d30f28b"
      unitRef="number">0.052</cvs:PensionAndAnnuityInvestmentContractsInterest>
    <cvs:HeathSavingsAccountBalance
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQ0MjU1_47050374-1c64-4e76-8d6e-16f5bab80f90"
      unitRef="usd">2700000000</cvs:HeathSavingsAccountBalance>
    <cvs:HeathSavingsAccountBalance
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQ0MjYy_0b487829-7ffb-427f-b954-05b807971937"
      unitRef="usd">2200000000</cvs:HeathSavingsAccountBalance>
    <us-gaap:SelfInsuranceReservePolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDQ3_0d37ce60-bb58-436b-a162-91721429f511">Self-Insurance LiabilitiesThe Company is self-insured for certain losses related to general liability, workers&#x2019; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#x2019;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#x2019;s historical claims experience.</us-gaap:SelfInsuranceReservePolicyTextBlock>
    <us-gaap:SelfInsuranceReserve
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQ1Mzcw_4060bfd5-d28f-4794-a939-8155335f8ad3"
      unitRef="usd">927000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQ1Mzc3_1a4956b8-b32a-4a13-b126-acd99d14bba0"
      unitRef="usd">856000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDA4_b1489c18-19be-4344-8f70-ffc5e52d9f76">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation and Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income (loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iaff454c2b91e4d3a845612cd83bc5a37_D20190701-20190701"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzQ2NzAy_fe37828d-a430-4f7b-969e-1b5144fa7a7e"
      unitRef="usd">154000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTk1_58eeea71-583a-4f56-9821-066ac0fc429c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment sells prescription drugs directly through its mail service dispensing pharmacies and indirectly through the Company&#x2019;s retail pharmacy network. The Company&#x2019;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the dispensing of prescription drugs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions dispensed indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#x201c;Drug Discounts&#x201d; and &#x201c;Guarantees&#x201d; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#x201c;retail co-payments&#x201d;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Pharmacy Services segment:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenues generated from prescription drugs sold by mail service dispensing pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenues generated from prescription drugs sold by third party pharmacies in the Company&#x2019;s retail pharmacy network and associated administrative fees are recognized at the Company&#x2019;s point-of-sale, which is when the claim is adjudicated by the Company&#x2019;s online claims processing system and the Company has transferred control of the prescription drug and performed all of its performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Drug Discounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records revenue net of manufacturers&#x2019; rebates earned by its clients based on their plan members&#x2019; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#x2019; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#x2019; rebate amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Retail Pharmacy&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer returns are not material to the Company&#x2019;s operating results or financial condition. Sales taxes are not included in revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Loyalty and Other Programs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customer loyalty program, ExtraCare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, consists of two components, ExtraSavings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also offers a subscription-based membership program, CarePass&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long-term Care&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of Long-term Care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#x2019;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Walk-In Medical Clinics&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For services provided by the Company&#x2019;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which reflect contracted rates per employee and the number of covered employees &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recorded in the Company&#x2019;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Premium Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#x201c;MLR&#x201d;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#x201c;ACA&#x201d;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#x2019;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#x2019;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#x2019;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting for Medicare Part D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues include insurance premiums earned by the Company&#x2019;s PDPs, which are determined based on the PDP&#x2019;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by major source in each segment for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;70,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;171,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;75,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;85,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;56,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;140,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;66,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(41,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;165,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;86,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;256,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;88,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;52,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;134,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;64,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(33,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;164,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;134,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;83,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(33,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;194,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;87,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;47,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;134,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;program. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Certain prior year amounts have been reclassified for consistency with the current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2020 and 2019, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTY2_a6427d56-232b-4f52-8b77-ddbd8161a3d3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by major source in each segment for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;70,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;171,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;75,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;85,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;56,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;140,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;66,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(41,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;165,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;86,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;256,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;88,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;52,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;134,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;64,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(33,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;164,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;134,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;83,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(33,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;194,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;87,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;47,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;134,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;program. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Certain prior year amounts have been reclassified for consistency with the current period presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37eb583c6b6d47f3b7c106af8367c133_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMtMS0xLTEtMA_1aadb1f7-79ac-4564-b4c5-1bc02071e568"
      unitRef="usd">141116000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i426635a6436f4eceb5ae3bf452f2e8ce_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMtMy0xLTEtMA_47d77f33-da4d-44d3-afad-850a3704cb73"
      unitRef="usd">70176000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i313e1434cd644196a894b71f3e4d271b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMtNS0xLTEtMA_0d6fb73c-bb15-4fd1-a55b-e5c4c688a572"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i300a5c4ae7ad4f77b6e0b97f6f8e0cfb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMtNy0xLTEtMA_3373a893-b8db-4f65-b0dc-93e04489e69a"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i987983ae1dcf428e845562a5e086c894_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMtOS0xLTEtMA_02d4cc1e-f6a3-4c76-80e7-20fb86b70515"
      unitRef="usd">-40003000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8807d9a1c6eb4ef7a7bb815b14181f74_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMtMTEtMS0xLTA_5fb96f27-eac6-43b2-bcd2-598608c7a940"
      unitRef="usd">171289000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebbeab317d23464cb721bf23c9554965_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQtMS0xLTEtMA_430559f1-6911-4730-952d-bc177bda09ba"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia39c42c0a78e456cb74db342cf62b094_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQtMy0xLTEtMA_78fc36d5-5fad-4c67-979a-d70ddc3ba5fa"
      unitRef="usd">19655000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4810c04a4634439b6905b74827cb24c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQtNS0xLTEtMA_003875ac-f6ed-4d0c-a95c-79165be5f11b"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8b1524b485c49609e399b2a230e04c7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQtNy0xLTEtMA_30b097e0-f8c0-498f-b1ba-659b1a4fff60"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd55880281f749318f4691e88cd97168_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQtOS0xLTEtMA_c643e9d4-ed1d-4e2a-b9f9-7b8afbd83d49"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i783b1352f68b40d2b4ac2682bc608521_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQtMTEtMS0xLTA_75521c51-5c28-4f4e-8b76-b213109d7f41"
      unitRef="usd">19655000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42aa9378a89545c48dee0fc68567b9a5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzUtMS0xLTEtMA_55dbd325-1a09-4a70-beec-e478b85a7ef0"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad54c820725c447083ff3be1ee37598e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzUtMy0xLTEtMA_3ee8876c-5dd3-4a5a-b7f5-e58eff394710"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieef46aea24674d5297f52fe96fd3652f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzUtNS0xLTEtMA_5403c702-6b67-45dd-8470-9f6663a09804"
      unitRef="usd">69301000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idbe2227ce7b3407291809c1a7fef699c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzUtNy0xLTEtMA_3c99fea2-6abb-4d94-b934-7fec1d6e90e5"
      unitRef="usd">63000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd5d327d52f54f70913e6c6108027d81_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzUtOS0xLTEtMA_3585e459-cfa4-4029-806d-c5060d932078"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaad598e9ae7248d4b644c5cafe6a51ca_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzUtMTEtMS0xLTA_f6a69894-f642-4afd-8adc-5fd8b42c01ef"
      unitRef="usd">69364000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzYtMS0xLTEtMA_8f610992-2670-4424-9e29-4b5b84c4e92a"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzYtMy0xLTEtMA_db993e4b-9f17-4a9a-aa96-24d9d049c68f"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzYtNS0xLTEtMA_5392fabd-272b-4a95-8ded-1955df2e3ddf"
      unitRef="usd">483000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzYtNy0xLTEtMA_79cb0803-666a-4baf-a699-7531e34d6737"
      unitRef="usd">315000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzYtOS0xLTEtMA_24b3fbcd-ab02-47a8-966d-b3fd127259f1"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzYtMTEtMS0xLTA_8ed42f05-25fb-4cb1-8747-54b34bedfb9c"
      unitRef="usd">798000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61b3eabef1e6460cb656982802e37513_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzctMS0xLTEtMA_54024b9e-2860-4079-9c21-e78dc3920381"
      unitRef="usd">822000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1a017feef1f44bdbe74396d8046773e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzctMy0xLTEtMA_1a6e5511-c321-4dea-84b8-3e3f409c9c01"
      unitRef="usd">1367000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib170695af7314375ae76b557f9da70b3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzctNS0xLTEtMA_5aa28c4f-9d91-42b5-994a-bfd26f5908be"
      unitRef="usd">5683000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33407e182d1347caaf77663336da82fb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzctNy0xLTEtMA_9cf14a02-aa5a-4f17-9362-58e5042ce3c1"
      unitRef="usd">48000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15b2e86a75f2415d8bf8685add0dd173_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzctOS0xLTEtMA_950e695e-1469-4150-ad3a-8c3ac01fcd8c"
      unitRef="usd">-320000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69c3bc4b998f4337814af2804581a932_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzctMTEtMS0xLTA_9390c098-916d-4563-918f-e83af6a8bcb8"
      unitRef="usd">7600000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzgtMS0xLTEtMA_218baa3b-d4bd-431e-953d-939fbed4130a"
      unitRef="usd">141938000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzgtMy0xLTEtMA_4f695125-544d-4bd4-9f61-ff3911a780e7"
      unitRef="usd">91198000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzgtNS0xLTEtMA_94dbbc6a-abb8-4cb0-a17e-d7b086183896"
      unitRef="usd">75467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzgtNy0xLTEtMA_9763c613-c2e9-42c3-a0aa-83dbe4d4af52"
      unitRef="usd">426000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzgtOS0xLTEtMA_6ca82945-79ab-4d16-a7a9-04f0cc8657b3"
      unitRef="usd">-40323000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzgtMTEtMS0xLTA_9d2bce85-fb48-439c-bf61-ba241c96f45c"
      unitRef="usd">268706000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5c72ee7a1ff04724b5d9c64969981c00_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzExLTEtMS0xLTA_6cfe4090-e69a-46fb-bb0b-0294bcac5c9c"
      unitRef="usd">85045000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9eefd35256b74eb588b983fc0ce03cee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzEyLTEtMS0xLTA_78f18563-20d8-4b29-9862-8388490f7cb4"
      unitRef="usd">56071000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i615e8d8d64e049b2baa6aa868316807d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzEzLTEtMS0xLTA_9c4f1958-e1d4-4e4d-b6a3-a2b96abf639a"
      unitRef="usd">822000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE0LTEtMS0xLTA_80c02901-ba24-4580-a0c0-adc4262a567c"
      unitRef="usd">141938000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e5738b83cac44c8a207d99440f8125c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE4LTEtMS0xLTA_5d4cd995-5db2-49a7-b34e-76da1257f8ea"
      unitRef="usd">140896000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice6658f59817451f8226605da85f4b71_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE4LTMtMS0xLTA_ab6f731b-2384-4908-96a8-d32e95b6b4e0"
      unitRef="usd">66442000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic572f6f25fb641d68b501e02911341dd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE4LTUtMS0xLTA_edb68950-adc3-447c-b20a-4e8988739a54"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i905d30d3d5c2417fa14d71aa765d04ac_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE4LTctMS0xLTA_df2edb93-2f6a-4432-903f-fd9ace09d6fa"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc535c0378834b1dba6be6c404915f1d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE4LTktMS0xLTA_c2efee71-f4df-437f-ac21-8b3fe4fd49b7"
      unitRef="usd">-41413000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75ffe98b0bd943648691587a5bd133e0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE4LTExLTEtMS0w_55e5db6b-1e19-4b5d-9555-4f25eea9b9ee"
      unitRef="usd">165925000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ff00ef80a974f5eb5b735f33880f18d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE5LTEtMS0xLTA_b0f8a808-8c39-4a2d-bb48-b1966e89ed29"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc9115de5fde4c4880875ae246f420e0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE5LTMtMS0xLTA_538ecf82-721c-4f5e-8522-7b74975e35f8"
      unitRef="usd">19422000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5478933c3dbd44f28b9d5a0b50d6db7f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE5LTUtMS0xLTA_dc07aae4-d9b7-4166-adae-8757b53e30a6"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i883ea853b3fe48ebb9fada798636ba5b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE5LTctMS0xLTA_4fd7eda0-454a-4267-a337-1f79e6eae9c2"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c68a89f8e4c4e81a8576d27b3744e59_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE5LTktMS0xLTA_fe374543-8564-4724-b18b-afbf85a517ae"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee4e7fda3ff44e1cae0013e4824f88ca_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzE5LTExLTEtMS0w_b0c6874b-ffd1-4a30-abc7-bf8b4cb2b27f"
      unitRef="usd">19422000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a9e992c01b8401c841b3eae8f16e94d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIwLTEtMS0xLTA_0d3be75e-8630-43d3-b267-fdff0aea6c03"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i317b21ec3df84f079f10f3a3cb5996c8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIwLTMtMS0xLTA_8d3386c7-4f5d-4791-81d8-e47af06d427b"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a391b68fb7b4d8f843138cd71f2707b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIwLTUtMS0xLTA_020839c2-4977-4838-a7f4-2489dea24509"
      unitRef="usd">63031000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie48e36cfbbf8422186962d2169fc4edd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIwLTctMS0xLTA_11a35dc1-beeb-480a-879f-1859750aa010"
      unitRef="usd">91000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie727763f57214c94a1c11e4313718b07_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIwLTktMS0xLTA_f3ff4657-420b-4510-bd93-036420f81b48"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f10e0c26b5b4685a3da73b5a6d6cdfe_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIwLTExLTEtMS0w_ce86c453-4659-4001-83f4-cb182e26451e"
      unitRef="usd">63122000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIxLTEtMS0xLTA_46be0bcb-8dd8-4d94-8cd3-c678efa08d5d"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIxLTMtMS0xLTA_b4d25b17-548a-487d-a312-30e92f10c96d"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIxLTUtMS0xLTA_27cd018c-7376-482c-82a3-af4e12282e8b"
      unitRef="usd">599000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIxLTctMS0xLTA_b3b6a16e-deee-4198-a210-7b8c6c7ff95a"
      unitRef="usd">412000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIxLTktMS0xLTA_94fbee50-f229-4837-8397-25793474e1b5"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIxLTExLTEtMS0w_1ed7ea89-fc82-4c90-a329-512aa841e1a3"
      unitRef="usd">1011000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98c09f3cf15740fcb2085a4ea7a6b757_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIyLTEtMS0xLTA_1910947a-e2eb-4f67-91be-f15bbef6e8d3"
      unitRef="usd">595000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id31407870d8c4fbe93fa0ef67d5f1bd1_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIyLTMtMS0xLTA_dee6562c-8301-4b5c-bf2e-93b5c934f87c"
      unitRef="usd">744000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaceaf6ce0c0649e59587194b8562c088_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIyLTUtMS0xLTA_9ca54563-07d4-4571-83fd-8e8c0d1562c3"
      unitRef="usd">5974000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic2c64df3e01c472b98a154efeaba9606_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIyLTctMS0xLTA_7ababbdc-57a7-4cee-befa-4ba45a1ccbc1"
      unitRef="usd">9000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d705300d5f44592abe5c5834931363a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIyLTktMS0xLTA_1240fc2a-b676-4018-9ad1-2161a525c8c1"
      unitRef="usd">-26000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i637cbce7eef743f392772d2447f3fb0f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIyLTExLTEtMS0w_569c38bb-36cf-4f5f-befd-b747626b3b9e"
      unitRef="usd">7296000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIzLTEtMS0xLTA_4b09fcdf-8486-4722-aa59-931859fe1d7a"
      unitRef="usd">141491000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIzLTMtMS0xLTA_a99a41b2-5f91-40c9-9154-89fc68991ee1"
      unitRef="usd">86608000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIzLTUtMS0xLTA_745b1aac-3ce1-4bde-8792-106ca6d50d7f"
      unitRef="usd">69604000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIzLTctMS0xLTA_773de77e-1ae3-4ca4-bd35-a9db60d2e800"
      unitRef="usd">512000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIzLTktMS0xLTA_8d9284f6-02a5-4a12-bcb6-fe342a01da4d"
      unitRef="usd">-41439000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzIzLTExLTEtMS0w_1d2d2ef4-c79c-4cb2-aedd-946822dc4e53"
      unitRef="usd">256776000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i03cfffc1fd2442cb99a34979e3c58111_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzI2LTEtMS0xLTA_31e17619-7e70-4973-8d79-126a4dd5b3ec"
      unitRef="usd">88755000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6948fd96583f49168479c7bb034889d2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzI3LTEtMS0xLTA_aa85bacf-6285-4b0c-9d7d-8efab19d6be2"
      unitRef="usd">52141000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9a2861a5e8ba4e20bd8eaceed653d6dd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzI4LTEtMS0xLTA_1affa67d-2ec0-48a3-985c-d3c2d71f1c62"
      unitRef="usd">595000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzI5LTEtMS0xLTA_cd693de9-0a3d-4967-a2f1-890331f634b1"
      unitRef="usd">141491000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19549f30d57c482c9aefda9c7a91347c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMzLTEtMS0xLTg5Mw_b5243715-bd6b-4963-98be-08d93171f515"
      unitRef="usd">134216000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2700a9f4cb9448a3ad808275ab50ef5c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMzLTMtMS0xLTg5Mw_e41ef279-5072-49d0-a3ad-4c780deb67f2"
      unitRef="usd">64179000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9db376e2f088449494413724fca2e556_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMzLTUtMS0xLTg5Mw_74e010ba-672e-4fd3-a1ca-50b72af1647d"
      unitRef="usd">164000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i647cd1db2a7b4b81b35d2e32684b1fd1_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMzLTctMS0xLTg5Mw_4aa22203-7794-4896-aa7d-cfd0eb715bc6"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92201227633d42428e8654713a1183c3_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMzLTktMS0xLTg5Mw_d19d38f9-efa4-4f12-ada2-9ef6666769d7"
      unitRef="usd">-33714000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i013b860d7dc4425abe6f741f311f6b69_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzMzLTExLTEtMS04OTM_a3972eda-872c-4961-8c6a-b54eaa9ee45c"
      unitRef="usd">164845000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i691b329bada44592bc51fab7186d983a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM0LTEtMS0xLTg5Mw_19477bc5-36cb-4794-a677-4a614cc41eac"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbecb39a71a1469892eb85b5117dd313_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM0LTMtMS0xLTg5Mw_d282033e-38ec-4e5b-a7ea-d10c80c6d180"
      unitRef="usd">19055000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bbabdb50ce14e3e9d0aa6b2731c0077_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM0LTUtMS0xLTg5Mw_d803c66b-3927-48ee-9754-3fcc9cf53e5a"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i521a13bc74694ab2bcde000a0cfa3d7b_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM0LTctMS0xLTg5Mw_1b6bf068-7991-4abb-a38a-3ab8cb71d9e6"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8edc8623a1824b2192d1cd1f2197d2df_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM0LTktMS0xLTg5Mw_114e5f3b-c83b-49fb-b791-3cf12cd9b5d7"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee713b77e09b40658fff6dc3733ade2a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM0LTExLTEtMS04OTM_b60870bb-c907-42bb-8763-ca5478e7ffe4"
      unitRef="usd">19055000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa5cde79d4cc48c894fc26a3d00d4c4c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM1LTEtMS0xLTg5Mw_81a99de8-11c2-42f5-8578-fff8b484d297"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8cbb8e25253e442da025fb09f9ffb8fc_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM1LTMtMS0xLTg5Mw_698eb390-d578-421c-8738-1c1ce08ea27c"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c61f360659541ec934371fdc19fdbfe_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM1LTUtMS0xLTg5Mw_606ff353-1beb-44fa-9a6e-089612665c25"
      unitRef="usd">8180000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c5fc5617f60483f850c62403eee0116_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM1LTctMS0xLTg5Mw_40cf1a87-1a4f-4620-880b-f0151057f5e9"
      unitRef="usd">4000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ace05bc406f4b35bd7d939aba14ba8d_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM1LTktMS0xLTg5Mw_6612f535-63ad-4f3e-989d-c6654e590289"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f39b6fd2b4740dcb546b4ea89d46660_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM1LTExLTEtMS04OTM_18d91b39-0768-48e4-95c0-5e8222e7c356"
      unitRef="usd">8184000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM2LTEtMS0xLTg5Mw_2c32818f-8386-4c4f-8394-db27f77a2b61"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM2LTMtMS0xLTg5Mw_dd5e6b97-2d52-4e92-8e36-db1d7eab1769"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM2LTUtMS0xLTg5Mw_5cc571b0-b185-4355-b3a9-0f89ac487696"
      unitRef="usd">58000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM2LTctMS0xLTg5Mw_08f01f8c-c239-4ec7-a3eb-3aa7bc77228f"
      unitRef="usd">602000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM2LTktMS0xLTg5Mw_386f2df6-74ce-45fd-a5c6-17632a2ac679"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM2LTExLTEtMS04OTM_c57766e0-d1d9-484e-82ee-6dc12f819c6d"
      unitRef="usd">660000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c87d411f5b34673b9973adc00d3637d_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM3LTEtMS0xLTg5Mw_e2a1dbb1-54dc-4013-ab3e-fadfef5e3dbc"
      unitRef="usd">520000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4bcade8977e24f33a1be8dd5bbb6e4ae_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM3LTMtMS0xLTg5Mw_95f193b1-eb2c-4aa0-a209-fb6219f46b4b"
      unitRef="usd">755000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0afe948f657f4d75a79b6884ce991c1e_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM3LTUtMS0xLTg5Mw_3c26f8f0-6d5b-4aeb-8099-5a77bee46050"
      unitRef="usd">560000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i50ea2b4a55ee4369beeefd0c2170a8cf_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM3LTctMS0xLTg5Mw_b6dc95cc-14ba-4a1e-a57c-5207568aa6be"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9be25d61dc7c486faee71c20d5fbb1f8_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM3LTktMS0xLTg5Mw_a951e114-7527-418d-82ae-06ff4059e8ee"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7219da47c7214a83bc6666bb4b2abb50_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM3LTExLTEtMS04OTM_65333c47-44ee-4a8e-84de-42b9dd4c482d"
      unitRef="usd">1835000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM4LTEtMS0xLTg5Mw_a466c862-79f9-4476-8890-289c5a55f2a3"
      unitRef="usd">134736000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM4LTMtMS0xLTg5Mw_27a0d49c-9c93-479a-80a0-95a239ff0d76"
      unitRef="usd">83989000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM4LTUtMS0xLTg5Mw_8ccbde46-42ca-46f5-8e20-d94b2ab5dcd0"
      unitRef="usd">8962000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM4LTctMS0xLTg5Mw_6200eb43-1ce9-48b9-b9b0-a6dcda353789"
      unitRef="usd">606000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM4LTktMS0xLTg5Mw_35dd5eff-837d-4086-80e0-8e4e2bfa44b7"
      unitRef="usd">-33714000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzM4LTExLTEtMS04OTM_2719273f-fc54-4eee-be8b-339b144e9aff"
      unitRef="usd">194579000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c3e56e0202f45e1ad53f61ac55f0d3b_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQxLTEtMS0xLTg5Nw_77e08f9c-16b0-4360-a54d-760723c83643"
      unitRef="usd">87167000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e56f64001404d73b3c695a3b5ae8845_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQyLTEtMS0xLTg5Nw_1dea41dd-b309-4c0d-b842-4ea9fb0765b5"
      unitRef="usd">47049000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibda6ee66f0de4117add908957e89dd30_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQzLTEtMS0xLTg5Nw_27e10e0e-6958-47d3-9b18-2593f8023901"
      unitRef="usd">520000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTphMmRhNDJhNzdhMTg0MmI2YmRjMTZhMTg4ODg3MWUyZi90YWJsZXJhbmdlOmEyZGE0MmE3N2ExODQyYjZiZGMxNmExODg4ODcxZTJmXzQ0LTEtMS0xLTg5Nw_19d7ad2d-eee0-4b77-a4fb-d883300dcd44"
      unitRef="usd">134736000000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDI4_285eaf46-1025-4dbc-a0a4-3f41682323d7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2020 and 2019, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToyN2JjZDc3YmNkYjA0YzcxYTM2OWFiOWMxMjg1ZDQ0MC90YWJsZXJhbmdlOjI3YmNkNzdiY2RiMDRjNzFhMzY5YWI5YzEyODVkNDQwXzEtMS0xLTEtMA_96e5fa16-ae2e-4841-9c16-de47258571b0"
      unitRef="usd">7101000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToyN2JjZDc3YmNkYjA0YzcxYTM2OWFiOWMxMjg1ZDQ0MC90YWJsZXJhbmdlOjI3YmNkNzdiY2RiMDRjNzFhMzY5YWI5YzEyODVkNDQwXzEtMy0xLTEtMA_9daf0c54-b232-4a4e-a721-acc941fe9a79"
      unitRef="usd">6717000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToyN2JjZDc3YmNkYjA0YzcxYTM2OWFiOWMxMjg1ZDQ0MC90YWJsZXJhbmdlOjI3YmNkNzdiY2RiMDRjNzFhMzY5YWI5YzEyODVkNDQwXzItMS0xLTEtMA_a64d45f0-32ac-4917-90b7-a200fab09f08"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToyN2JjZDc3YmNkYjA0YzcxYTM2OWFiOWMxMjg1ZDQ0MC90YWJsZXJhbmdlOjI3YmNkNzdiY2RiMDRjNzFhMzY5YWI5YzEyODVkNDQwXzItMy0xLTEtMA_4af146e5-6019-4702-a9e6-b1a6bc355e3d"
      unitRef="usd">73000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzEtMS0xLTEtMA_1c19dca6-0cf3-4281-a09c-de14aa1dde25"
      unitRef="usd">73000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzEtMy0xLTEtMA_0a076eab-d346-47de-8c7d-2bb5aee46294"
      unitRef="usd">67000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzMtMS0xLTEtMA_0e9aab5b-9155-4bbb-9c6c-ed1fc1e100db"
      unitRef="usd">357000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzMtMy0xLTEtMA_9e599549-1178-49bf-9283-250a2a18109d"
      unitRef="usd">365000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractWithCustomerLiabilityRedemptionAndBreakage
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzQtMS0xLTEtMA_799a495d-d0e0-46a4-8276-dd42992dbcf4"
      unitRef="usd">359000000</cvs:ContractWithCustomerLiabilityRedemptionAndBreakage>
    <cvs:ContractWithCustomerLiabilityRedemptionAndBreakage
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzQtMy0xLTEtMA_d6f3105a-23f7-40ee-985d-4bdec02550ef"
      unitRef="usd">359000000</cvs:ContractWithCustomerLiabilityRedemptionAndBreakage>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzUtMS0xLTEtMA_ccf76068-2cf2-47ef-83e2-236192e0f522"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTplNTMwOTVmZGI1ZWQ0M2QyYjhkM2QwOTI3Y2U2M2ZmNi90YWJsZXJhbmdlOmU1MzA5NWZkYjVlZDQzZDJiOGQzZDA5MjdjZTYzZmY2XzUtMy0xLTEtMA_d75ba377-0a2e-4be1-a849-f9159af47e41"
      unitRef="usd">73000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTM3_ba132f85-97bd-465c-a334-78ed79b7882e">&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Products Sold&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for cost of products sold as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#x2019;s mail service dispensing pharmacies and indirectly through the Company&#x2019;s retail pharmacy network, (ii) shipping and handling costs, and (iii) the operating costs of the Company&#x2019;s mail service dispensing pharmacies and client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#x2019; benefit plans from the Company&#x2019;s mail service dispensing pharmacies, net of any volume-related or other discounts (see &#x201c;Vendor Allowances and Purchase Discounts&#x201d; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#x2019;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;Cost of products sold includes: the cost of merchandise sold during the reporting period, including prescription drug costs, and the related purchasing costs, warehousing and delivery costs (including depreciation and amortization) and actual and estimated inventory losses.</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTY3_38eaba55-b08d-4c42-a232-9159f0ecb676">&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Vendor Allowances and Purchase Discounts &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for vendor allowances and purchase discounts as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#x2019;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Pharmacy Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;Vendor allowances received by the Retail/LTC segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon purchase volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#x2019;s consolidated financial statements in any of the periods presented.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <cvs:PharmacyRebatePeriod
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzY1NTU2_f3cac2be-4dff-403d-b8cb-69889d0c3360">P30D</cvs:PharmacyRebatePeriod>
    <us-gaap:HealthCareEntitiesPolicyPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDMx_7f241ef1-0bbb-4b6d-866a-b70985076d40">&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Reform&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Insurer Fee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since January 1, 2014, the ACA has imposed an annual premium-based health insurer fee (&#x201c;HIF&#x201d;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company has been required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In the years ended December&#160;31, 2020 and 2018, operating expenses included $1.0 billion and $157 million, respectively, related to the Company&#x2019;s share of the HIF. There was no expense related to the HIF in 2019, since there was a one-year suspension of the HIF for 2019. In December 2019, the HIF was repealed for calendar years after 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Adjustment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#x2019;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Corridor&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#x201c;HHS&#x201d;) based on their ratio of allowable costs to target costs (as defined by the ACA). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#x2019;s temporary risk corridor program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Company received the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December&#160;31, 2020. After considering offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $307 million and after-tax income of $223&#160;million during the year ended December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2019, the Company did not record any ACA risk corridor receivables because payment was uncertain.&lt;/span&gt;&lt;/div&gt;</us-gaap:HealthCareEntitiesPolicyPolicyTextBlock>
    <cvs:HealthInsurerFee
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzEwNzM_98e65cc7-4269-445f-bd1b-93f5d729beb2"
      unitRef="usd">1000000000.0</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzExMzc_689767c4-82f0-4cac-99b1-cf7fe6cd4bbd"
      unitRef="usd">157000000</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzY4MjMw_57bb4fd7-cc19-4ef6-9c6b-005dbd653c43"
      unitRef="usd">0</cvs:HealthInsurerFee>
    <us-gaap:GainContingencyUnrecordedAmount
      contextRef="i138a42c6cd5e4913b5eb2ad3288f6b8a_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MDM4MTg_541197b2-97fc-47b8-9fd2-10efbf466fa4"
      unitRef="usd">313000000</us-gaap:GainContingencyUnrecordedAmount>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="iacafa6a2e9244f43ab295d89abdb066f_D20201022-20201022"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MDM4NTU_3c0f91c9-23d3-42f1-8c97-f1d8833a652b"
      unitRef="usd">313000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax
      contextRef="ia508c5dcbe174753b2ea381d7ec1a3bc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MjgwODc_e9840c15-c8c8-42b3-936c-28320ea2225e"
      unitRef="usd">307000000</cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax>
    <cvs:FormerGainContingencyRecognizedInCurrentPeriodNetOfTax
      contextRef="ia508c5dcbe174753b2ea381d7ec1a3bc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MDM5Mjc_a41333d1-7b55-4b43-9058-d88a14fdcdd8"
      unitRef="usd">223000000</cvs:FormerGainContingencyRecognizedInCurrentPeriodNetOfTax>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDQy_643ae02f-a8fb-4c6b-a35f-37c189398d63">Advertising Costs Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $461 million, $396 million and $364 million in 2020, 2019 and 2018, respectively.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzY5Mzg5_0e1a408d-72b6-4851-a921-f49ac1479069"
      unitRef="usd">461000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzY5Mzkz_3b5a43d3-df77-4c9c-8409-4d9d84f3df5d"
      unitRef="usd">396000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzY5NDAw_67183176-35a0-4f7d-8e70-9b2bd6b37e70"
      unitRef="usd">364000000</us-gaap:AdvertisingExpense>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDIw_0f422597-8df9-4abe-b8dd-4ea152b5c193">Stock-Based CompensationStock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2OTY1ODE1NjM0NzI_a2f5f276-1187-4a37-84f0-e7ca761d6280"&gt;three&lt;/span&gt; to five years) using the straight-line method.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2OTY1ODE1NjM0Nzk_691b4819-b028-4d40-9831-49efada44469">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDIx_f9a4c8f8-093c-4023-bd28-82415496e280">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Tax Cuts and Jobs Act (the &#x201c;TCJA&#x201d;) was enacted on December 22, 2017. Among numerous changes to existing tax laws, the TCJA permanently reduced the federal corporate income tax rate from 35% to 21% effective January 1, 2018. The effects of changes in tax rates on deferred tax balances are required to be taken into consideration in the period in which the changes are enacted, regardless of when they are effective. As&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a result of the reduction of the corporate income tax rate under the TCJA, the Company estimated the revaluation of its net deferred tax liabilities and recorded a provisional income tax benefit of approximately $1.5&#160;billion for year ended December 31, 2017. In 2018, the Company completed its process of determining the TCJA&#x2019;s final impact and recorded an additional income tax benefit of $100 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#x2019;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit
      contextRef="i30eb50f669aa417d98981c15d603526d_D20170101-20171231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjMzOTgzMDE_cd15098e-dda1-463e-86be-e0f5be1dcd81"
      unitRef="usd">1500000000</us-gaap:TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit>
    <us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzcxMjU0_93240894-1857-458f-b228-1c9400e8ec0e"
      unitRef="usd">-100000000</us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTI5_a7fde9a1-26fb-40d2-b502-4dc279ce5c8d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors defined benefit pension plans (&#x201c;pension plans&#x201d;) and other postretirement employee benefit plans (&#x201c;OPEB plans&#x201d;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit cost (income) for the Company&#x2019;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended &lt;/span&gt;&lt;/div&gt;period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit cost (income) are included in other income in the consolidated statements of operations.</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTcy_266db162-804c-4cde-8239-be75e8413bf1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings (Loss) per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings (loss) per share is computed using the two-class method. The Company calculates basic earnings (loss) per share based on the weighted average number of common shares outstanding for the period. See Note 14 &#x2018;&#x2018;Earnings (Loss) Per Share&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <cvs:SharesHeldInTrustPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDMy_4788d7b2-0d38-46e5-b4cf-3f5a84ff2ea7">Shares Held in TrustThe Company maintains grantor trusts, which held approximately one million shares of its common stock at both December&#160;31, 2020 and 2019. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding.</cvs:SharesHeldInTrustPolicyTextBlock>
    <us-gaap:CommonStockSharesHeldInEmployeeTrustShares
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc0MDA3_0e165a54-c14b-4ebb-af60-e59a3d23c7dd"
      unitRef="shares">1000000</us-gaap:CommonStockSharesHeldInEmployeeTrustShares>
    <us-gaap:CommonStockSharesHeldInEmployeeTrustShares
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc0MDA3_bcaa8b9b-cb98-4497-84ba-5c49d76b0fee"
      unitRef="shares">1000000</us-gaap:CommonStockSharesHeldInEmployeeTrustShares>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTMw_41bb6433-c6ee-4d45-9f9f-3af52b420520">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#x2019;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities - Primary Beneficiary&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2014, the Company and Cardinal Health, Inc. (&#x201c;Cardinal&#x201d;) established Red Oak Sourcing, LLC (&#x201c;Red Oak&#x201d;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own 50%. The Red Oak arrangement has an initial term of 10 years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Retail/LTC segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardinal is required to pay the Company 39 quarterly payments beginning in October 2014. As milestones are met, the quarterly payments increase. The Company received from Cardinal $183 million during each of the years ended December&#160;31, 2020, 2019 and 2018. The payments reduce the Company&#x2019;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold. Revenues associated with Red Oak expenses reimbursed by Cardinal for the years ended December&#160;31, 2020, 2019 and 2018, and amounts due to or due from Cardinal at December&#160;31, 2020 and 2019 were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities - Other Variable Interest Holder&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Hedge fund and private equity investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Real estate partnerships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is not the primary beneficiary of these VIEs because the nature of the Company&#x2019;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#x2019;s income or losses in net income (loss).&#160;The Company&#x2019;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="ia29ce83052be481eb35a86ede34ef887_D20140101-20141231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc1MjQ0_5a34840c-8e08-4576-87f0-81de61ba8382"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cvs:Initialcontractualterm
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzU0OTc1NTgzMDI4OTk_448e01e9-ae53-487f-a3be-5a7d72d643e9">P10Y</cvs:Initialcontractualterm>
    <cvs:NumberOfQuarterlyPaymentsFromVariableInterestEntity
      contextRef="i6fe88e3b7af243da9625e02cfbb5d718_I20141031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2MDU5_1c789561-e722-4529-a1a1-104b3f211bac"
      unitRef="payment">39</cvs:NumberOfQuarterlyPaymentsFromVariableInterestEntity>
    <cvs:ProceedsFromVariableInterestEntity
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2MTk5_261ca473-9aa6-4104-aeb2-f230782a076d"
      unitRef="usd">183000000</cvs:ProceedsFromVariableInterestEntity>
    <cvs:ProceedsFromVariableInterestEntity
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2MTk5_c7ed2626-d4cd-4832-b686-2947c03e340c"
      unitRef="usd">183000000</cvs:ProceedsFromVariableInterestEntity>
    <cvs:ProceedsFromVariableInterestEntity
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2MTk5_f929ce3f-af24-41c8-81f1-1c97dc32d4f4"
      unitRef="usd">183000000</cvs:ProceedsFromVariableInterestEntity>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDQ2_d9c4e750-7c53-40e7-9333-4c63f105a2fc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total amount of other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2020 and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedge fund investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:LongTermInvestments
      contextRef="i80d59f9f341b4a83b98d2b3b1b87310e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzEtMS0xLTEtMA_5451396b-2f9f-43af-aff3-73138832e99f"
      unitRef="usd">342000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i59ea7852fec74a64bb6d3f7c2754512d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzEtMy0xLTEtMA_c8e9e6cf-b4d9-4015-b4db-d65ed51251ac"
      unitRef="usd">271000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i1a0cfcdaf6c54b489a9c3eea04ed3a37_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzItMS0xLTEtMA_1f76c1fa-be5d-4664-a150-50473641718a"
      unitRef="usd">547000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="idcf15c27df834ce98c7f1da46d42a14a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzItMy0xLTEtMA_9982a05d-707d-4b4d-8725-ed0d5d45cebd"
      unitRef="usd">538000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i3267481b2aa4488bb857353dc51ca8f9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzMtMS0xLTEtMA_9b9a2690-bd43-4e5c-b6ee-257b396b6506"
      unitRef="usd">200000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i373b58235285416bb437fdca972f274b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzMtMy0xLTEtMA_0155d126-b934-44bf-b8f4-6a64a45904a8"
      unitRef="usd">212000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i343f3e71f5b546c7ac384b8289428e7c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzQtMS0xLTEtMA_d2bde341-eb69-407d-9d07-5484de7f33c8"
      unitRef="usd">1089000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i4dc57d39a4f04908be65c7bad08c6849_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZToxMDlkZGE3ZTU3MGE0NWFjOTgzZjRiMWUzNWFkNDcxYi90YWJsZXJhbmdlOjEwOWRkYTdlNTcwYTQ1YWM5ODNmNGIxZTM1YWQ0NzFiXzQtMy0xLTEtMA_4124c557-f1f4-45b3-a39c-b2852bec8e21"
      unitRef="usd">1021000000</us-gaap:LongTermInvestments>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDYw_465bcb58-761e-4cb3-9305-b1472b0513f8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $56 million, $32 million and $45 million in the years ended December&#160;31, 2020, 2019 and 2018, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $77 million, $96 million and $135 million for pharmaceutical inventory purchases during the years ended December&#160;31, 2020, 2019 and 2018, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2020 and 2019, the Company made charitable contributions of&#160;$50&#160;million and $30 million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4NTQx_56b208e9-dae4-4222-a7a4-b5bfd04a448c"
      unitRef="usd">56000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4NTQ1_0a1285ac-edf0-4bfd-9c95-68c5712d302a"
      unitRef="usd">32000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4NTUy_9a08364c-fac4-4a78-b301-a9b70bb6672a"
      unitRef="usd">45000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i8168693bd43e42ad9a06d56bbef64902_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4ODUy_e341220b-4131-4e0c-b9ed-563f79c07a9c"
      unitRef="state">4</us-gaap:NumberOfStatesInWhichEntityOperates>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4ODkw_d7a9eeb5-9845-4086-926c-ca1110acbb81"
      unitRef="usd">77000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4ODk0_37f716fe-7819-48e4-8455-8d0636329c8f"
      unitRef="usd">96000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc4OTAx_912edf8d-e883-4d51-aa04-ebb840bf13da"
      unitRef="usd">135000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzIxOTkwMjM0MDc2NTE_aa8825d9-6da6-4dae-a3a7-f92c8efdbdcc"
      unitRef="usd">50000000</cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity>
    <cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc5MzIy_1750fd80-1eb3-4026-8750-f747a97de7a5"
      unitRef="usd">30000000</cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity>
    <us-gaap:DiscontinuedOperationsPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTUz_5a77cb4e-4fb6-4f4d-814c-6c10c03ecbb4">Discontinued OperationsIn connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#x2018;n Things and Bob&#x2019;s Stores, each of which subsequently filed for bankruptcy. The Company&#x2019;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees.</us-gaap:DiscontinuedOperationsPolicyTextBlock>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg4MDM3_ba8e03b4-9f07-419d-aedd-d355346f9a88">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZjRiNDE4Nzk0NWI0MTRmOTYxNjY0NDIwODZlZDYwYy90YWJsZXJhbmdlOjhmNGI0MTg3OTQ1YjQxNGY5NjE2NjQ0MjA4NmVkNjBjXzEtMS0xLTEtMA_b98f3f6a-7cf9-48af-b4eb-7cc9cba64eae"
      unitRef="usd">-12000000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZjRiNDE4Nzk0NWI0MTRmOTYxNjY0NDIwODZlZDYwYy90YWJsZXJhbmdlOjhmNGI0MTg3OTQ1YjQxNGY5NjE2NjQ0MjA4NmVkNjBjXzItMS0xLTEtMA_ca8d840f-11bf-4e84-84c7-44f200a6779f"
      unitRef="usd">3000000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90YWJsZTo4ZjRiNDE4Nzk0NWI0MTRmOTYxNjY0NDIwODZlZDYwYy90YWJsZXJhbmdlOjhmNGI0MTg3OTQ1YjQxNGY5NjE2NjQ0MjA4NmVkNjBjXzMtMS0xLTEtMA_899b57ab-50d6-4c7b-9427-282213dd1038"
      unitRef="usd">-9000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzg3OTc2_1edb8b32-5915-4814-854f-5fe5d684b3e6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 326). This standard requires the use of a forward-looking expected credit loss impairment model for trade and other receivables, held-to-maturity debt securities, loans and other instruments. This standard also requires impairments and recoveries for available-for-sale debt securities to be recorded through an allowance account and revises certain disclosure requirements. The Company adopted this new accounting standard on January 1, 2020. The Company adopted the credit loss impairment model on a modified retrospective basis and recorded a $3 million cumulative effect adjustment to reduce retained earnings as of the adoption date. The Company adopted the available-for-sale debt security impairment model on a prospective &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;basis. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and other - Internal-Use Software &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 350-40): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; This standard requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in Topic 350-40 to determine which implementation costs to capitalize as assets. The Company adopted this new accounting guidance on January 1, 2020 on a prospective basis. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows, financial condition or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification (&#x201c;ASC&#x201d;) 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows, financial condition or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#x2019;s consolidated operating results, cash flows, financial condition and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ieb3ef261af8c4ac5882b054e927e2644_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzEwOTk1MTE3MzI2Mjc_b4048791-3932-4458-a85b-11f56ff6b97f"
      unitRef="usd">3000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzU2Mzc_e24f3fee-5352-49ff-b6c1-cef12c84134e">Acquisitions and Divestitures &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisition of Aetna&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On the Aetna Acquisition Date, the Company acquired 100% of the outstanding shares and voting interests of Aetna for a combination of cash and stock. Under the terms of the merger agreement, Aetna shareholders received $145.00 in cash and 0.8378 CVS Health shares for each Aetna share. The transaction valued Aetna at approximately $212 per share or approximately $70 billion. Including the assumption of Aetna&#x2019;s debt, the total value of the transaction was approximately $78 billion. The Company financed the cash portion of the purchase price through a combination of cash on hand and by issuing approximately $45 billion of new debt, including senior notes and term loans. The Company acquired Aetna to help improve the consumer health care experience by combining Aetna&#x2019;s health care benefits products and services with CVS Health&#x2019;s more than 9,900 retail locations, approximately 1,100 walk-in medical clinics and integrated pharmacy capabilities with the goal of becoming the new, trusted front door to health care.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction has been accounted for using the acquisition method of accounting which requires, among other things, the assets acquired and liabilities assumed to be recognized at their fair values at the date of acquisition. The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments (current and long-term)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt (current and long-term)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s assessment of the fair value of assets acquired and liabilities assumed was finalized during the fourth quarter of 2019. Measurement period adjustments to assets acquired and liabilities assumed during the&#160;year ended&#160;December 31, 2019&#160;primarily were due to additional information received related to certain intangible asset valuations and contingencies and the related impact on the accounting for income taxes and goodwill. There were no material income statement measurement period adjustments recorded during the&#160;year ended&#160;December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidated Results of Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s consolidated operating results for the year ended December&#160;31, 2018, included $5.6 billion of revenues and $146 million of income before income tax provision associated with the operating results of Aetna from the Aetna Acquisition Date to December&#160;31, 2018. During the year ended December 31, 2018, the Company incurred transaction costs of $147 million associated with the Aetna Acquisition that were recorded within operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following unaudited pro forma information presents a summary of the Company&#x2019;s combined operating results for the year ended December&#160;31, 2018 as if the Aetna acquisition and the related financing transactions had occurred on January 1, 2018. The following pro forma financial information is not necessarily indicative of the Company&#x2019;s operating results as they would have been had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including differences between the assumptions used to prepare the pro forma financial information, basic shares outstanding and dilutive equivalents, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share from continuing operations attributable to CVS Health &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pro forma results for the year ended December&#160;31, 2018 include adjustments related to the following purchase accounting and acquisition-related items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Elimination of intercompany transactions between CVS Health and Aetna;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Elimination of estimated foregone interest income associated with (i) cash assumed to have been used to partially fund the Aetna Acquisition and (ii) adjusting the amortized cost of Aetna&#x2019;s investment portfolio to fair value as of the completion of the Aetna Acquisition;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Elimination of historical intangible asset, deferred acquisition cost and capitalized software amortization expense and addition of amortization expense based on the values of identified intangible assets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Additional interest expense from (i) the long-term debt issued to partially fund the Aetna Acquisition and (ii) the amortization of the fair value adjustment to assumed long-term debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Additional depreciation expense related to the adjustment of Aetna&#x2019;s property and equipment to fair value;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Adjustments to align CVS Health&#x2019;s and Aetna&#x2019;s accounting policies;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Elimination of transaction related costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Tax effects of the adjustments noted above.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of Workers&#x2019; Compensation Business&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 31, 2020, the Company sold its Workers&#x2019; Compensation business for approximately $850&#160;million. The results of this business have historically been reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $269 million in the year ended December&#160;31, 2020, which is reflected as a reduction in operating expenses in the Company&#x2019;s consolidated statement of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of Brazilian Subsidiary&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 1, 2019, the Company sold its Brazilian subsidiary, Onofre, for an immaterial amount. Onofre operated 50 retail pharmacy stores, the results of which historically had been reported within the Retail/LTC segment. The Company recorded a pre-tax loss on the divestiture of $205 million in the year ended December 31, 2019, which primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#x2019;s consolidated statement of operations within the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of RxCrossroads Subsidiary&lt;/span&gt;&lt;/div&gt;On January 2, 2018, the Company sold its RxCrossroads subsidiary, the results of which had historically been reported within the Retail/LTC segment, to McKesson Corporation for $725 million. The Company recorded a pre-tax loss on the divestiture of $86 million in the year ended December 31, 2018 which was reflected in operating expenses in the Company&#x2019;s consolidated statement of operations within the Retail/LTC segment.</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzExMg_4630f83b-26a1-45b5-b060-981f44de83a6"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzI3Nw_90d5349f-ad70-42c0-a1d7-7e70cb9073c8"
      unitRef="usdPerShare">145.00</us-gaap:BusinessAcquisitionSharePrice>
    <cvs:BusinessCombinationPerShareExchangeRatio
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzI5Mg_5959060a-94e8-4cd6-8a58-4c63d82d65fe"
      unitRef="usdPerShare">0.8378</cvs:BusinessCombinationPerShareExchangeRatio>
    <cvs:BusinessCombinationAcquisitionValuePerSharesAcquired
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzM4MQ_2b914438-64d6-4e38-9ccf-07684011906f"
      unitRef="usdPerShare">212</cvs:BusinessCombinationAcquisitionValuePerSharesAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2bda1e1ef73b4b7b83d6f7ff5925839f_D20181128-20181128"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzQxMQ_7e6e59fa-2b58-42b5-bb1c-f461ea4cb183"
      unitRef="usd">70000000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <cvs:BusinessCombinationAcquisitionAssignedValueOfAcquiree
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzUxMA_70bcfca0-9890-453f-b47d-c51775086312"
      unitRef="usd">78000000000</cvs:BusinessCombinationAcquisitionAssignedValueOfAcquiree>
    <us-gaap:LongTermDebt
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzY0MQ_25d103cf-4602-43b1-9d71-71adaa1ec4db"
      unitRef="usd">45000000000</us-gaap:LongTermDebt>
    <us-gaap:NumberOfStores
      contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzg3MQ_a0dbde93-734f-4ef8-bc36-ba5480cf9454"
      unitRef="store">9900</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzkwNg_0f42dee4-d1a2-4926-937c-b4860890906d"
      unitRef="clinic">1100</cvs:NumberofWalkInMedicalClinics>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzU2NDU_66b72676-08d6-479d-8c93-6c3d1a5e7da6">The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments (current and long-term)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt (current and long-term)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzEtMS0xLTEtMA_d94f4c57-9ae1-46ca-a4a4-f6dc4c19b95c"
      unitRef="usd">6565000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzItMS0xLTEtMA_a8be9a1f-ba22-4375-bc81-89a0046de5e9"
      unitRef="usd">4094000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzMtMS0xLTEtMA_d7a49563-d99f-43bb-8675-07c5d2bc46ad"
      unitRef="usd">3894000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzQtMS0xLTEtMA_f37c2009-ec97-40c0-a0ea-80fd75b3e8ab"
      unitRef="usd">17984000000</cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments>
    <us-gaap:Goodwill
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzUtMS0xLTEtMA_a79f15ff-4624-4e67-a84f-eb60c276a78e"
      unitRef="usd">47755000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzYtMS0xLTEtMA_7df8cc95-0c7e-4783-955e-25bf15ff1ca5"
      unitRef="usd">22571000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzctMS0xLTEtMA_9ad46191-3201-4e66-93b6-b06e56f41209"
      unitRef="usd">8249000000</cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzgtMS0xLTEtMA_1e09777f-6832-4863-bcc1-1f5e9e0fa96a"
      unitRef="usd">111112000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzktMS0xLTEtMA_6af22f3b-3a81-4d71-b5df-b381d929d877"
      unitRef="usd">5302000000</cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzEwLTEtMS0xLTA_96ba5bd7-fa58-4fdd-a3d1-a01783740172"
      unitRef="usd">9940000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzExLTEtMS0xLTA_6cfc735b-3ee1-4979-b022-97a0a49b5abb"
      unitRef="usd">8098000000</cvs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzEyLTEtMS0xLTA_e6ce5b93-ce83-4ceb-8fe1-efeb6ffc1c35"
      unitRef="usd">4608000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzEzLTEtMS0xLTA_3da94794-c212-4c83-b1d5-7b3e546b13a8"
      unitRef="usd">13078000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzE0LTEtMS0xLTA_1487ba56-fc2a-4238-9a0a-c592d82bd69e"
      unitRef="usd">41026000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzE1LTEtMS0xLTA_15bad4db-0774-456e-8f23-df970486c09d"
      unitRef="usd">320000000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest
      contextRef="i8966d06a68154d9b9a82e87fc68f00cd_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTpkYmJmZGM0YjE2OWY0ZTg4ODgwY2Y2ODBiM2M1ZTk4ZS90YWJsZXJhbmdlOmRiYmZkYzRiMTY5ZjRlODg4ODBjZjY4MGIzYzVlOThlXzE2LTEtMS0xLTA_67abc7a9-8881-4671-9730-847bceaf7cd5"
      unitRef="usd">69766000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="ie8f88d1feca14fab9af82ff64e292817_D20181128-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzIwODQ_554f46ba-e43e-4236-8179-a3a71aaec86c"
      unitRef="usd">5600000000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="ie8f88d1feca14fab9af82ff64e292817_D20181128-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzIxMDM_69824231-6779-4a75-8379-4c3e8d7440f7"
      unitRef="usd">146000000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="i1d28d9feed044ba598796ea48b01c29b_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzIzMzY_1e77070d-ab9f-4e67-b687-fed96df80a25"
      unitRef="usd">147000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzU2NDA_e521a1b8-71ef-435a-8224-a2b9ee9d044a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following unaudited pro forma information presents a summary of the Company&#x2019;s combined operating results for the year ended December&#160;31, 2018 as if the Aetna acquisition and the related financing transactions had occurred on January 1, 2018. The following pro forma financial information is not necessarily indicative of the Company&#x2019;s operating results as they would have been had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including differences between the assumptions used to prepare the pro forma financial information, basic shares outstanding and dilutive equivalents, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per share from continuing operations attributable to CVS Health &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTo4M2JlMWMxNjhiNTY0OWI4YWQwN2MzYTI4ODgwNzUwMC90YWJsZXJhbmdlOjgzYmUxYzE2OGI1NjQ5YjhhZDA3YzNhMjg4ODA3NTAwXzItMS0xLTEtMA_01bc2de0-8c90-4e71-80ca-c8099f953b1a"
      unitRef="usd">243232000000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTo4M2JlMWMxNjhiNTY0OWI4YWQwN2MzYTI4ODgwNzUwMC90YWJsZXJhbmdlOjgzYmUxYzE2OGI1NjQ5YjhhZDA3YzNhMjg4ODA3NTAwXzMtMS0xLTEtMA_d3278028-dadf-4fbd-a54b-d5bd834bbf58"
      unitRef="usd">1152000000</us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTo4M2JlMWMxNjhiNTY0OWI4YWQwN2MzYTI4ODgwNzUwMC90YWJsZXJhbmdlOjgzYmUxYzE2OGI1NjQ5YjhhZDA3YzNhMjg4ODA3NTAwXzQtMS0xLTEtMA_2a2f93e6-4a15-4edd-9e0a-5391b43a083f"
      unitRef="usdPerShare">0.89</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90YWJsZTo4M2JlMWMxNjhiNTY0OWI4YWQwN2MzYTI4ODgwNzUwMC90YWJsZXJhbmdlOjgzYmUxYzE2OGI1NjQ5YjhhZDA3YzNhMjg4ODA3NTAwXzUtMS0xLTEtMA_1bd9ac02-5c3f-46b8-abf0-eafc4e193b6e"
      unitRef="usdPerShare">0.88</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i6292fcfab69c48809cd6df0bbb16e7ba_D20200731-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzIxOTkwMjMyNjMxMDY_df6d95dd-9e68-489c-9bb7-9f25b45d26c7"
      unitRef="usd">850000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i686d61205fb142b1bc16e360c062d7f1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzc2OTY1ODE0MDIxNDQ_20714f19-f14a-44ff-abd4-88c1373c17c2"
      unitRef="usd">-269000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:NumberOfStores
      contextRef="ie10ef6a4cf20405a8bbbdaffe804df04_I20190701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzQ2MzA_c03138ea-d4a2-4165-b42e-2c65e9a252b5"
      unitRef="store">50</us-gaap:NumberOfStores>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i15adb3671036492cbdf9d10285213988_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzQ3OTg_25964665-6a3a-43e1-8e47-7cfe4fc2fc09"
      unitRef="usd">-205000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i69096b9bb0844234beb55f386ccdbcdd_D20180102-20180102"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzUzMDk_de622593-5f31-42a2-8bf7-ff0ee7e26212"
      unitRef="usd">725000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i7c5ea305571c4ec78c8dbf812bcf4b08_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjcvZnJhZzo0N2U4YWY4Mjk0MWQ0ODkzODFkODk0ZDc3ZDE5MmY0MC90ZXh0cmVnaW9uOjQ3ZThhZjgyOTQxZDQ4OTM4MWQ4OTRkNzdkMTkyZjQwXzIxOTkwMjMyNjMzMDY_24c6e5ed-2d30-403a-a92d-adcbe7d8d671"
      unitRef="usd">-86000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MTM_4fe1bd5b-b3ab-4276-8b51-25ed8aab987f">Investments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020 and 2019, the Company held investments of $524 million and $537 million, respectively, related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract. The conversion occurred prior to the Aetna Acquisition. These investments are included in the total investments of large case pensions supporting non-experience-rated products. Although these investments are not accounted for as Separate Accounts assets, they are legally segregated and are not subject to claims that arise out of the Company&#x2019;s business and only support future policy benefits obligations under that group annuity contract. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Effective January 1, 2020, the Company adopted the available-for-sale debt security impairment model under ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments -Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; (Topic 326). The new impairment model requires the write down of amortized cost through an allowance for credit losses, rather than through a reduction of the amortized cost basis of the available-for-sale debt security. There was no allowance for credit losses recorded on available-for-sale debt securities at December&#160;31, 2020. As the Company adopted the new available-for-sale debt security impairment model on a prospective basis, there was no allowance for credit losses recorded on available-for-sale debt securities at December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results.&#160;At December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses and at December&#160;31, 2019, debt securities with a fair value of $965 million, gross unrealized capital gains of $83 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities at December&#160;31, 2020 are shown below by contractual maturity.&#160;&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mortgage-Backed and Other Asset-Backed Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s residential mortgage-backed securities at December&#160;31, 2020 were issued by the Government National Mortgage Association, the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation and carry agency guarantees and explicit or implicit guarantees by the U.S. Government.&#160;At December&#160;31, 2020, the Company&#x2019;s residential mortgage-backed securities had an average credit quality rating of AAA and a weighted average duration of 2.4 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States. Significant market observable inputs used to value these securities include loss severity and probability of default.&#160;At December&#160;31, 2020, these securities had an average credit quality rating of AAA and a weighted average duration of 6.1 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card receivables, home equity loans and commercial loans). Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default.&#160;At December&#160;31, 2020, these securities had an average credit quality rating of AA and a weighted average duration of 1.1 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at December&#160;31, 2020 and 2019 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt; Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt; Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt; Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#x2019;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#x2019;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#x2019;s current prospects for recovery. As of December&#160;31, 2020, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting experience-&lt;br/&gt;rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting remaining&lt;br/&gt;products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2020 and 2019, the Company had the following activity in its mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#x2019;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 1 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Represents loans of superior quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 2 to 4 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 5 and 6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represent loans where credit risk is not substantial, but these loans warrant management&#x2019;s close attention.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based upon the Company&#x2019;s assessments at December&#160;31, 2020 and 2019, the amortized cost basis of the Company&#x2019;s mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020 scheduled mortgage loan principal repayments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the years ended December 31, 2020, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital gains are net of yield-related impairment losses on debt securities of $49 million for the year ended December&#160;31, 2020. There were no credit-related losses on debt securities in the year ended December&#160;31, 2020. Net realized capital gains are net of other-than-temporary impairment (&#x201c;OTTI&#x201d;) losses on debt securities of $24 million for the year ended December 31, 2019. There were no material OTTI losses on debt securities for the year ended December 31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net investment income includes $42 million, $44 million and $4 million for the years ended December 31, 2020, 2019 and 2018, respectively, related to investments supporting experience-rated products. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capital gains and losses recognized during the year ended December 31, 2020 related to investments in equity securities held as of December 31, 2020 were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available for sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2020, 2019 and subsequent to the Aetna Acquisition Date in 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <cvs:TotalInvestmentsTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MjY_dd3e879e-1db1-4b72-b1a1-201265587c04">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:TotalInvestmentsTableTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="i46cc0ed8444447369f7ffb60b023dfe9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzItMS0xLTEtMA_8648fbd3-a93e-4ad4-bd64-40294b01ea14"
      unitRef="usd">2774000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i46cc0ed8444447369f7ffb60b023dfe9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzItMy0xLTEtMA_f79f7b14-4be5-423d-b645-55e3df5d9d08"
      unitRef="usd">18414000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i46cc0ed8444447369f7ffb60b023dfe9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzItNS0xLTEtMA_32a31413-c9b6-4c61-a054-6c6e5c4f9955"
      unitRef="usd">21188000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i4b98a93f0276459b890b573fb626a088_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzItNy0xLTEtMA_4835a9cd-ec0d-4885-9bd3-423ed3d886d6"
      unitRef="usd">2251000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i4b98a93f0276459b890b573fb626a088_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzItOS0xLTEtMA_11c99a24-72f2-4161-9142-5c27195afdec"
      unitRef="usd">14671000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i4b98a93f0276459b890b573fb626a088_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzItMTEtMS0xLTA_63c087f9-1a29-493a-b016-a1ed74f910ab"
      unitRef="usd">16922000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="id67b9d5fd1cd48469659ac7a217ebce6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzMtMS0xLTEtMA_a4c52691-da97-4eb5-ac1e-df04304c49a7"
      unitRef="usd">226000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="id67b9d5fd1cd48469659ac7a217ebce6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzMtMy0xLTEtMA_db2db764-13e7-4bb7-aa4f-dd7a08a00876"
      unitRef="usd">821000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="id67b9d5fd1cd48469659ac7a217ebce6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzMtNS0xLTEtMA_4e72ac5e-08eb-48ea-9e24-ba858d8e2258"
      unitRef="usd">1047000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="id2ac54c8ef3a4dbaa343b9df3e53741c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzMtNy0xLTEtMA_0ab52796-279e-43e5-80c4-5a48dd8169fc"
      unitRef="usd">122000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="id2ac54c8ef3a4dbaa343b9df3e53741c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzMtOS0xLTEtMA_82ccb48a-ff33-436e-8a1d-54826fcaad16"
      unitRef="usd">1091000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="id2ac54c8ef3a4dbaa343b9df3e53741c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzMtMTEtMS0xLTA_465b79a9-29e2-465c-a4ad-ae88cc219903"
      unitRef="usd">1213000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i9da7e2dfa74045cdb18889001920c71c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzQtMS0xLTEtMA_a7edc7c8-b633-470c-a9ba-f6673c04168a"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i9da7e2dfa74045cdb18889001920c71c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzQtMy0xLTEtMA_fb26d540-0cf9-4ad8-bce3-3c5755047d46"
      unitRef="usd">1577000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i9da7e2dfa74045cdb18889001920c71c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzQtNS0xLTEtMA_166f2124-7bfb-40bb-9a9e-141a73211b79"
      unitRef="usd">1577000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ib5230461e9b449448da7c51080282d09_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzQtNy0xLTEtMA_c4aef8cc-3a79-4f14-9a34-6f8638361db4"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ib5230461e9b449448da7c51080282d09_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzQtOS0xLTEtMA_659856ef-32e9-4b6c-a3c3-dbb2a9766cbf"
      unitRef="usd">1552000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ib5230461e9b449448da7c51080282d09_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzQtMTEtMS0xLTA_af85ce81-eb61-43d0-8731-df6c7c452c49"
      unitRef="usd">1552000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzUtMS0xLTEtMA_0d442db2-31c8-4024-aa93-c37265aee1c6"
      unitRef="usd">3000000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzUtMy0xLTEtMA_e7a33b23-c302-4756-8a36-ee52946a776b"
      unitRef="usd">20812000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzUtNS0xLTEtMA_f86db9ce-7c07-4da4-81aa-4f80123b84cc"
      unitRef="usd">23812000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzUtNy0xLTEtMA_a3a2c141-db70-4114-ab58-5d365f9ece88"
      unitRef="usd">2373000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzUtOS0xLTEtMA_77bd9216-980b-4dac-96ce-3e0735ed7a63"
      unitRef="usd">17314000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowMmJiOTZjNmY3MmI0ZTVmYTYxZjc3MzUyNzY3YmNjMC90YWJsZXJhbmdlOjAyYmI5NmM2ZjcyYjRlNWZhNjFmNzczNTI3NjdiY2MwXzUtMTEtMS0xLTA_070e6517-239e-4c18-b1d8-f3fcc0b39160"
      unitRef="usd">19687000000</us-gaap:Investments>
    <us-gaap:RestrictedInvestmentsAtFairValue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEzNA_03fc4234-de99-4c7d-ba0c-5f9f9b858f95"
      unitRef="usd">524000000</us-gaap:RestrictedInvestmentsAtFairValue>
    <us-gaap:RestrictedInvestmentsAtFairValue
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzE0MQ_ea6cdeca-3c7e-4ff3-abc7-427629964dac"
      unitRef="usd">537000000</us-gaap:RestrictedInvestmentsAtFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4Mjc_6528f4a2-e281-45c6-9ec4-19c319b52707">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Effective January 1, 2020, the Company adopted the available-for-sale debt security impairment model under ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments -Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; (Topic 326). The new impairment model requires the write down of amortized cost through an allowance for credit losses, rather than through a reduction of the amortized cost basis of the available-for-sale debt security. There was no allowance for credit losses recorded on available-for-sale debt securities at December&#160;31, 2020. As the Company adopted the new available-for-sale debt security impairment model on a prospective basis, there was no allowance for credit losses recorded on available-for-sale debt securities at December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results.&#160;At December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses and at December&#160;31, 2019, debt securities with a fair value of $965 million, gross unrealized capital gains of $83 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzMtNS0xLTEtMTEzNA_c1257545-6b66-409d-9ff5-ea753979fd34"
      unitRef="usd">2341000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzMtMy0xLTEtMA_fa8cf7d2-866f-4d51-8bb6-97fd08f23623"
      unitRef="usd">128000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzMtNS0xLTEtMA_a4b34937-b393-499f-939e-38a35b385849"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzMtNy0xLTEtMA_fc728133-5cae-418d-bd1f-0e4280ddfeab"
      unitRef="usd">2469000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzQtNS0xLTEtMTEzNA_768f1d34-85bb-4865-9708-6667b15d95e8"
      unitRef="usd">2556000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzQtMy0xLTEtMA_ba637936-83ed-4b9f-a059-e5d13c434a88"
      unitRef="usd">172000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzQtNS0xLTEtMA_f0a83a60-3229-4d39-ba71-8246668c4882"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzQtNy0xLTEtMA_82262999-6367-4369-85c1-0e3adb1897cf"
      unitRef="usd">2728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzUtNS0xLTEtMTEzNA_47809627-0662-444d-a01d-ce0130259972"
      unitRef="usd">7879000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzUtMy0xLTEtMA_13f13330-a3a3-4249-a2a5-62cf8cc00a90"
      unitRef="usd">1023000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzUtNS0xLTEtMA_bfdc2e42-c0ef-4c49-bfbe-86b05e2e3064"
      unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzUtNy0xLTEtMA_c8d8d623-0f7a-48a9-8afc-66976f746f45"
      unitRef="usd">8894000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzYtNS0xLTEtMTEzNA_0086c75d-c66c-423a-bef4-c157b290dde3"
      unitRef="usd">2595000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzYtMy0xLTEtMA_c5b7c350-b79d-4325-b775-d708fcc69a97"
      unitRef="usd">324000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzYtNS0xLTEtMA_804c3052-42a0-4475-bca9-4c9c601e1015"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzYtNy0xLTEtMA_d4341eff-7fea-4c14-8afa-8ff09c23776f"
      unitRef="usd">2918000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzctNS0xLTEtMTEzNA_41841331-4fc4-4911-917d-62552cd17f9e"
      unitRef="usd">673000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzctMy0xLTEtMA_78d56d17-deb2-48f2-82b5-bfc9baed031f"
      unitRef="usd">32000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzctNS0xLTEtMA_0d9c2077-96d2-497f-8ef1-4ada3906c04f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzctNy0xLTEtMA_40457892-adf8-4029-a74c-3b3fc6c8a5db"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzgtNS0xLTEtMTEzNA_d9ab6a64-af97-4b73-bd25-a48252428f92"
      unitRef="usd">962000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzgtMy0xLTEtMA_e5874ca7-4a34-4880-97a2-9917d3e33257"
      unitRef="usd">84000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzgtNS0xLTEtMA_35562dc5-d85f-47e9-b2f3-a94ae50e0136"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzgtNy0xLTEtMA_342058e9-caf8-4aaf-89c2-473a67e63cc7"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzktNS0xLTEtMTEzNA_58d286b6-7b37-49f0-91a8-a64d522c8e73"
      unitRef="usd">2369000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzktMy0xLTEtMA_0816eb63-b80a-4af9-84cf-76d2db3d090a"
      unitRef="usd">36000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzktNS0xLTEtMA_ecb5949a-d1ae-4908-b9c3-1228d23b2ec9"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzktNy0xLTEtMA_fbad9ea6-f760-4f9e-8444-f740dc1d50bd"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ic2afaaa9709c42e3912403cd458a7e31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzEwLTUtMS0xLTExMzQ_071086b8-4cda-43d5-97fe-abd2c9985d7b"
      unitRef="usd">21000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic2afaaa9709c42e3912403cd458a7e31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzEwLTMtMS0xLTA_607d9be9-f400-4c84-931f-2ccb109224c2"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic2afaaa9709c42e3912403cd458a7e31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzEwLTUtMS0xLTA_467d4bd5-9218-4bc0-b7f7-4be37af19ab0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic2afaaa9709c42e3912403cd458a7e31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzEwLTctMS0xLTA_d1188fd4-d164-41c1-9498-46af5caa7e2d"
      unitRef="usd">25000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzExLTUtMS0xLTExMzk_74fb10de-0901-4114-8617-6fa097e208b2"
      unitRef="usd">19396000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzExLTMtMS0xLTA_71886b95-6b39-48a6-83b2-5c93c7455376"
      unitRef="usd">1803000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzExLTUtMS0xLTA_4414e1c9-6e20-4fad-acbb-90b267f4729f"
      unitRef="usd">11000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzExLTctMS0xLTA_0f649a0f-450a-46d0-98ce-110caf6fc3d4"
      unitRef="usd">21188000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE1LTUtMS0xLTExNDI_f9f8f60a-47a3-4774-9788-40a9210565ae"
      unitRef="usd">1791000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE1LTMtMS0xLTA_445c2c90-8dad-4f1f-8fea-2e9926356737"
      unitRef="usd">62000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE1LTUtMS0xLTA_c749b904-13f3-4415-98da-2afb1caa47f0"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE1LTctMS0xLTA_34cdad35-9c20-451f-a832-cf84dce5d7e0"
      unitRef="usd">1852000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE2LTUtMS0xLTExNDI_2c74b41e-48ce-43c4-ac53-f094811652b4"
      unitRef="usd">2202000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE2LTMtMS0xLTA_06d46a6c-7804-4fe0-bca7-962595b71fae"
      unitRef="usd">108000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE2LTUtMS0xLTA_c9c99f16-b2cd-42c2-bb32-d051d3f5f5fa"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE2LTctMS0xLTA_54df960c-cc76-4b19-8986-4df26a07c406"
      unitRef="usd">2309000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE3LTUtMS0xLTExNDI_6cad7906-7724-497e-b45a-fab4b5175b9e"
      unitRef="usd">7167000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE3LTMtMS0xLTA_81f50761-a078-4323-93c8-693ce639d4f6"
      unitRef="usd">573000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE3LTUtMS0xLTA_32550256-9d6b-4865-bf7c-3a628f87f929"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE3LTctMS0xLTA_ed80c49a-5915-4ef8-9dc2-8be91eaaed8f"
      unitRef="usd">7737000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE4LTUtMS0xLTExNDI_afa1e72f-a678-4fdc-9d92-9eee67c10a9d"
      unitRef="usd">2149000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE4LTMtMS0xLTA_136e2697-c85b-484f-bd5a-cc99ebf3a767"
      unitRef="usd">200000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE4LTUtMS0xLTA_09ede9a1-e47b-47b8-898f-13fa9ac448c8"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE4LTctMS0xLTA_854be920-ea55-4b8b-b293-2f6d75c8a538"
      unitRef="usd">2348000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE5LTUtMS0xLTExNDI_baa1bc6a-80db-4314-8798-9a0c802e2713"
      unitRef="usd">508000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE5LTMtMS0xLTA_f5fd8ea2-7b64-4ffd-963c-ef06482d879d"
      unitRef="usd">25000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE5LTUtMS0xLTA_fce4ea08-b1dd-4dec-a0e5-5c0ac08aa134"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzE5LTctMS0xLTA_f993e9e3-4996-4e47-ae93-f9c79d3850dd"
      unitRef="usd">533000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIwLTUtMS0xLTExNDI_3399d14f-36dd-449c-8141-5cdb232d1b45"
      unitRef="usd">654000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIwLTMtMS0xLTA_c19f5736-7674-4498-9270-0d8e18caba55"
      unitRef="usd">46000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIwLTUtMS0xLTA_03a25157-5acf-4ef3-b396-9c6c10f9ecb0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIwLTctMS0xLTA_77337ca7-5ce6-4aa0-a13f-0c0f3dd02a85"
      unitRef="usd">700000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIxLTUtMS0xLTExNDI_da140a54-35e4-47af-bf05-3f9b335b7355"
      unitRef="usd">1397000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIxLTMtMS0xLTA_030db6a7-7967-4fa1-9e65-e1e95d266ac2"
      unitRef="usd">13000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIxLTUtMS0xLTA_7f57ac90-a211-4c40-b33e-8c11b036e42f"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIxLTctMS0xLTA_1405e756-e266-4042-9b98-aa5c7ce9b214"
      unitRef="usd">1405000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i9f07a8fe7175442fbcc819fecef5c309_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIyLTUtMS0xLTExNDI_241bcee7-46db-4db0-ae12-7c2dc45f3c4d"
      unitRef="usd">30000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9f07a8fe7175442fbcc819fecef5c309_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIyLTMtMS0xLTA_b375dbda-94e6-4e83-a792-88d8acd90b5e"
      unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9f07a8fe7175442fbcc819fecef5c309_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIyLTUtMS0xLTA_d6d21e13-92b9-4fa3-913a-a2642a9c54a7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9f07a8fe7175442fbcc819fecef5c309_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIyLTctMS0xLTA_82175cf0-d0f0-475a-a1d7-39b5afb7f470"
      unitRef="usd">38000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIzLTUtMS0xLTExNDI_2a3793cc-fc34-4a2e-baf7-dad1c78b5fb1"
      unitRef="usd">15898000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIzLTMtMS0xLTA_d9783e18-c523-4370-b91f-827a0b2a5ca8"
      unitRef="usd">1035000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIzLTUtMS0xLTA_0749790c-6e49-495a-9a73-e007a2f60410"
      unitRef="usd">11000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo3YTNmMGQ0MjE4MzA0MTIzYjIzZDkzYmViMWE5ZTNlYy90YWJsZXJhbmdlOjdhM2YwZDQyMTgzMDQxMjNiMjNkOTNiZWIxYTllM2VjXzIzLTctMS0xLTA_aa8218a8-8690-4c1c-ad5a-e725612de298"
      unitRef="usd">16922000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzIxOTkwMjMyNjgwNDg_ef5f73da-0dd3-414f-8285-b28bd3e11b13"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEwNDQ_654cc5ed-6c99-492f-82c7-7ed677f40198"
      unitRef="usd">919000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEwODI_18144ba4-878b-4717-ad11-165460732bff"
      unitRef="usd">135000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEwODk_d45bcf5a-527b-4be7-8ca9-8a10b24e7a18"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2ecf8dcd90f14826a44fd5403301707d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzExNzM_943643c3-ba3e-44f8-b8f6-7ca1e99b7478"
      unitRef="usd">965000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2ecf8dcd90f14826a44fd5403301707d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEyMTE_91675451-b709-458b-b6a7-a64e4ef1db00"
      unitRef="usd">83000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2ecf8dcd90f14826a44fd5403301707d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEyNTM_dbc6f691-20fe-4a5d-8a6c-2f2770894ef8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MzE_86fe17ec-54a5-4234-a28f-c7e3c50fa8c4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities at December&#160;31, 2020 are shown below by contractual maturity.&#160;&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzItMS0xLTEtMA_fbf2c0fb-2c27-4b35-ad1f-e00e627d70ae"
      unitRef="usd">1276000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzItMy0xLTEtMA_eca607d5-fecd-47be-a834-1d7ae9405d12"
      unitRef="usd">1291000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzMtMS0xLTEtMA_93291ef1-f7c1-437f-845c-965311b9de75"
      unitRef="usd">6346000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzMtMy0xLTEtMA_ed72d453-e27e-4fd9-81ca-465c73750a65"
      unitRef="usd">6698000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzQtMS0xLTEtMA_88e12cd4-a052-4f4a-9586-beff0789d485"
      unitRef="usd">3748000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzQtMy0xLTEtMA_e7d0876d-ab8d-46d2-8b59-8e18978f9520"
      unitRef="usd">4121000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzUtMS0xLTEtMA_4eac8034-0468-41b8-91f1-6e2dba89fc75"
      unitRef="usd">4022000000</cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzUtMy0xLTEtMA_08265e83-d72e-4c3b-b9c6-5514ee20807c"
      unitRef="usd">4924000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzYtMS0xLTEtMA_3cff4d66-edb0-407e-8308-9bf08b11d02b"
      unitRef="usd">673000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzYtMy0xLTEtMA_f49ed962-2d94-4d81-a9be-148b7d7f175d"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzctMS0xLTEtMA_07c17a51-bdfa-4505-b13f-a491e129e08e"
      unitRef="usd">962000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzctMy0xLTEtMA_2d0a4285-d8be-418e-8b5a-b81b1c6b5acf"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzgtMS0xLTEtMA_14272890-c998-4e4b-bf4d-13dbfda69fc3"
      unitRef="usd">2369000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzgtMy0xLTEtMA_35370964-f1c4-4f67-bd5c-f9bc5873bab3"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzktMS0xLTEtMA_8ca1bdda-95a0-4544-92c5-4dad083b6081"
      unitRef="usd">19396000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZToyN2IxYjAxYzY3Y2Y0ZDgzOThkZTA1YTgyOWQ3Y2ZhYi90YWJsZXJhbmdlOjI3YjFiMDFjNjdjZjRkODM5OGRlMDVhODI5ZDdjZmFiXzktMy0xLTEtMA_28aad065-af3b-441a-8b4d-12e63101a737"
      unitRef="usd">21188000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities
      contextRef="i676e7b8c5a05475e91e66c6e8684f644_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzIyMzk_bb156071-027e-4a28-8dba-14f19cecb3b3">P2Y4M24D</cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities>
    <cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities
      contextRef="i70ae98000fd546eea670504ba0d63d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzI1ODc_0a172d70-829e-412e-a3d0-885e4ab605d7">P6Y1M6D</cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities>
    <cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities
      contextRef="i4c483eeffe6d4d83b95ee855c212d24f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzMwMTA_be8cebb1-5ad1-4752-a57e-2b771d75e77c">P1Y1M6D</cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities>
    <us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MzI_a22757de-6fde-43f2-8faf-5c1e9eb25c34">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at December&#160;31, 2020 and 2019 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt; Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt; Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt; Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting experience-&lt;br/&gt;rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting remaining&lt;br/&gt;products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtMS0xLTEtMA_42812586-59df-458c-a7a4-1b96175bf366"
      unitRef="security">32</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtMy0xLTEtMA_cb1ffbb5-e7bf-4443-9492-c346ae35f627"
      unitRef="usd">205000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtNS0xLTEtMA_db964fe0-4bcc-4ded-abbe-7b892a3f9741"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtNy0xLTEtMA_064b0b5c-ff3c-41b0-8900-d71aab314bb7"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtOS0xLTEtMA_21c3c087-820f-4e96-9a2f-1ebf3fb15710"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtMTEtMS0xLTA_a6f945a9-639f-469f-aabd-11d30583d4a8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtMTMtMS0xLTA_169ea7de-b9ec-4904-b258-d74b17dfab79"
      unitRef="security">32</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtMTUtMS0xLTA_6b6627ea-02d0-45b7-8f62-8ebf21aa0572"
      unitRef="usd">205000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i3af54fa0b17a4eeeb0c115bb1ae7e504_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzQtMTctMS0xLTA_694a0c18-2b5f-4b59-ba44-5feacfa6bc73"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtMS0xLTEtMA_a8813031-e855-432e-b677-8737ca64798b"
      unitRef="security">49</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtMy0xLTEtMA_d96231a0-5c2b-4f57-be95-0741966b7965"
      unitRef="usd">83000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtNS0xLTEtMA_2a621b5a-41db-4a66-bbef-05b93d6e3129"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtNy0xLTEtMA_3e24d3d9-bc1c-4460-a1b3-6c704f5a8493"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtOS0xLTEtMA_23e24ea3-9abe-4c8c-b829-d674c31e65c4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtMTEtMS0xLTA_b6f0978f-ed79-4015-a4ba-8898d3cefc8c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtMTMtMS0xLTA_11993778-370f-46ec-b6ab-f7d69e921038"
      unitRef="security">49</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtMTUtMS0xLTA_22240681-abfc-4ee7-9c57-02d0d8403063"
      unitRef="usd">83000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i02672ac3c0df4fdaac5a6b8e47270ecc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzUtMTctMS0xLTA_d2eaf29f-97af-448c-b7c2-16a3ffee1f0c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtMS0xLTEtMA_550c2502-3688-4c68-9b9c-5f13fa4c2be8"
      unitRef="security">145</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtMy0xLTEtMA_f2a86c5e-3cfa-4023-a899-b0e400964836"
      unitRef="usd">155000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtNS0xLTEtMA_755f18b9-91c9-4ac9-8dda-80eefb537866"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtNy0xLTEtMA_1fbad2e9-f12f-41f9-9982-22b790687f05"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtOS0xLTEtMA_17374c62-f953-460f-b686-95e1cc84171c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtMTEtMS0xLTA_16fdfa1a-90f3-4e8e-a35c-462b078403e2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtMTMtMS0xLTA_52d8cd40-6e70-467b-8c91-fbd3d551595e"
      unitRef="security">147</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtMTUtMS0xLTA_529ad857-f956-4213-b676-1428919e9300"
      unitRef="usd">155000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="if36ae6ba3e364496829160fdbe5c179f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzYtMTctMS0xLTA_ec766eea-08d3-4836-867e-c72e59441810"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctMS0xLTEtMA_939905c9-75e8-427e-98fb-923be4667c1a"
      unitRef="security">41</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctMy0xLTEtMA_bf860b52-7822-4cde-a2c9-385ea18bc587"
      unitRef="usd">69000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctNS0xLTEtMA_040ed471-20a1-4e70-a00d-60e6aea53938"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctNy0xLTEtMA_80e0ff11-3941-44db-967b-ba9db3bf34a0"
      unitRef="security">5</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctOS0xLTEtMA_975f9eb4-ed28-48d5-b100-6640b2b7027c"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctMTEtMS0xLTA_ecc938d9-94b8-477b-bd38-86d33b815a30"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctMTMtMS0xLTA_7616530f-fcf0-473d-a089-3065dd482faa"
      unitRef="security">46</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctMTUtMS0xLTA_6aa961b7-703d-4e8b-9c59-cd867a22c49f"
      unitRef="usd">74000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iaf17d2d7ffb9462082227dfa17b3344b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzctMTctMS0xLTA_c0ac1197-a598-4472-9e46-c711d1dd8609"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtMS0xLTEtMA_4f019339-407b-42ba-b727-8688cb826070"
      unitRef="security">23</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtMy0xLTEtMA_d4b5f02e-4cb3-47b7-a1d7-b5ca7932adac"
      unitRef="usd">26000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtNS0xLTEtMA_cad0bf5d-0363-47a6-a928-018f90912f86"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtNy0xLTEtMA_f49851b5-dc95-44fd-a478-430d8fda0c28"
      unitRef="security">3</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtOS0xLTEtMA_0fbb481e-7c31-4a68-8c7a-eb9940eb260c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtMTEtMS0xLTA_8c14d3c8-57f6-46ab-ae6e-3dad6cb8e08c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtMTMtMS0xLTA_4925eee9-5116-417d-952a-cca3f25349b8"
      unitRef="security">26</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtMTUtMS0xLTA_c81c940c-1c24-46c2-8394-933896180677"
      unitRef="usd">26000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzgtMTctMS0xLTA_7f5e3670-8626-4b59-8c91-89210802daf5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktMS0xLTEtMA_29ffc6f6-c82a-4e9a-ad4c-8bdb6dba6783"
      unitRef="security">22</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktMy0xLTEtMA_9f4d060f-7847-462f-9df5-bf1ca1051ea7"
      unitRef="usd">75000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktNS0xLTEtMA_11e125ec-4fd5-48fa-af6d-e1e38e4f8e1f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktNy0xLTEtMA_498d70a9-7443-45d7-9868-4cdd1c21c7a6"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktOS0xLTEtMA_0806da98-e2ad-4eae-a6dc-da15e57bd08d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktMTEtMS0xLTA_56c37097-e63e-49cf-b027-d8b2d195485e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktMTMtMS0xLTA_2ab7a1bc-137a-4f0e-bec9-37ae93109606"
      unitRef="security">22</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktMTUtMS0xLTA_586bc4bb-4d46-4147-a659-21ae326f9d74"
      unitRef="usd">75000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzktMTctMS0xLTA_574a5145-0472-4746-91b6-e05e170c6ef9"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTEtMS0xLTA_85a2c5d8-4751-4c1b-80b5-7d0488518c90"
      unitRef="security">156</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTMtMS0xLTA_6c63c255-0c56-4d7d-92eb-fbc7e081ddeb"
      unitRef="usd">256000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTUtMS0xLTA_023dd851-93ca-4df0-b1eb-806f6b37f19a"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTctMS0xLTA_4bb85fef-e5d5-4154-a5f0-18000155778e"
      unitRef="security">49</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTktMS0xLTA_77cf8ccf-1d6e-4aed-a830-a5727daa5022"
      unitRef="usd">41000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTExLTEtMS0w_3eed5de3-7b4f-4496-95ad-451ba3be672c"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTEzLTEtMS0w_f9a430bb-c487-469c-a440-280ee5af6c8d"
      unitRef="security">205</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTE1LTEtMS0w_308dca11-520a-42e2-9158-75504fa3f956"
      unitRef="usd">297000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzEwLTE3LTEtMS0w_d9bc2969-045d-46e3-ae64-86a667fd021c"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTEtMS0xLTA_cace02ba-5699-4e13-8897-ee6374a590c4"
      unitRef="security">468</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTMtMS0xLTA_0f625de6-318b-472c-a2e1-cb428a0eb837"
      unitRef="usd">869000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTUtMS0xLTA_81086dd6-cf3c-48cd-82a6-6e23889bde32"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTctMS0xLTA_36934914-db61-42a8-947d-6946181355de"
      unitRef="security">59</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTktMS0xLTA_703a6b1e-0e13-4be8-ad8c-172eb663b48a"
      unitRef="usd">46000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTExLTEtMS0w_0faf84f0-6c77-4731-93e6-85616fbe5beb"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTEzLTEtMS0w_ffb782a6-f16a-4e1c-aec9-7a948ea1f497"
      unitRef="security">527</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTE1LTEtMS0w_6390b48f-ea39-47f5-881e-82b4d197728d"
      unitRef="usd">915000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzExLTE3LTEtMS0w_00e2f4dd-6436-424c-8f01-c1f6ef126c94"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTEtMS0xLTA_87c92971-0d13-4320-9bc1-0a10399b8b7c"
      unitRef="security">52</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTMtMS0xLTA_bd9780de-8917-4d2d-96be-bd4f96c9790b"
      unitRef="usd">168000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTUtMS0xLTA_3953ddf6-8f4c-40a2-87e6-d1e1bd4af4d3"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTctMS0xLTA_bf218856-519d-4844-ab51-ffa41699a414"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTktMS0xLTA_a0c21f35-adb5-42cd-898c-810b0681b001"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTExLTEtMS0w_8ebaec85-d563-4a14-b276-dcdbefcfb744"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTEzLTEtMS0w_de45632c-60b9-495a-b7c8-41566b26a974"
      unitRef="security">52</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTE1LTEtMS0w_d124e38a-fea1-4b67-9a66-06b4dde089f5"
      unitRef="usd">168000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i4e2e059e059447e4b13be1b5e1d0cb9c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE1LTE3LTEtMS0w_cbd5a035-16a6-44b8-8203-8db262151ef1"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTEtMS0xLTA_fc96e2e9-5338-491d-a23f-5886e2d6d37e"
      unitRef="security">66</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTMtMS0xLTA_e7b65bdf-2658-445f-ac39-4afeb65250ae"
      unitRef="usd">115000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTUtMS0xLTA_59713b98-3c0f-43e8-953a-996bce9b772d"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTctMS0xLTA_c13d86c1-0fb6-468a-ae9d-26496c4df119"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTktMS0xLTA_9b14664d-6751-4511-8e30-84e8a1389e61"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTExLTEtMS0w_cd529200-94fa-42a2-8d37-946e65036e30"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTEzLTEtMS0w_66058a56-15e5-4ad8-b595-890880c0d64f"
      unitRef="security">68</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTE1LTEtMS0w_f860fcc3-f7a2-4162-9e7f-7f692dfebf45"
      unitRef="usd">120000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="if3c9a60aa719471988bfddae88c14375_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE2LTE3LTEtMS0w_7b8b49e5-e1ac-499e-8828-de1bc4f7ce10"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTEtMS0xLTA_bcbf9506-21bc-41d0-86de-46dcafe3c064"
      unitRef="security">181</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTMtMS0xLTA_d37f7285-2345-4be2-88cd-1bfd906ea634"
      unitRef="usd">305000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTUtMS0xLTA_720a920f-f146-4e2c-98a5-b092fbf51fac"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTctMS0xLTA_9891a545-6176-4963-be5c-f121c019e95b"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTktMS0xLTA_e2ed23d9-22e4-43a0-a6f2-f9227a34922b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTExLTEtMS0w_959531eb-1c83-450c-b6c8-d663b89d4150"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTEzLTEtMS0w_18a746b7-0448-4b43-a44d-0b1d77bbcf14"
      unitRef="security">183</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTE1LTEtMS0w_e97068cd-f108-48db-b8d3-829a74e911f6"
      unitRef="usd">305000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iaa76c57927554320b220d6cae72d2d1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE3LTE3LTEtMS0w_0f97fc80-f5be-4ce8-812c-04a873d6566c"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTEtMS0xLTA_39b12e9e-ba89-4b08-afd5-6d348b40b795"
      unitRef="security">39</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTMtMS0xLTA_301d251c-25c3-4564-ace2-824fa5925bd0"
      unitRef="usd">75000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTUtMS0xLTA_bf034373-b73f-47a1-bee1-45899eaf11aa"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTctMS0xLTA_d4cec547-3234-4ebc-b4ea-8180429ae8ba"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTktMS0xLTA_cafb974e-1cc1-45be-a005-d823e5611e33"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTExLTEtMS0w_37e8dc1f-693b-4139-894d-7f7a11bd11c4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTEzLTEtMS0w_8d985d5d-c5cd-4941-8dcc-fdce29f3fe43"
      unitRef="security">39</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTE1LTEtMS0w_ae917944-1afb-43ff-8c0c-85545c8d9b5b"
      unitRef="usd">75000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iadc8ca1db091488bb75ef590d4ae4d16_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE4LTE3LTEtMS0w_fa8ee60d-e3d4-4dce-95b5-8d83bd013e41"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTEtMS0xLTA_245fd56a-3632-4bee-a64d-12fc7d492896"
      unitRef="security">30</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTMtMS0xLTA_f47265a1-8015-40f8-948c-27f61f821b05"
      unitRef="usd">16000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTUtMS0xLTA_2cf33108-7b92-464f-9a4f-ca56af033523"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTctMS0xLTA_b537ae05-9aa5-4e99-a78a-55d3e820fdd3"
      unitRef="security">9</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTktMS0xLTA_d24ecbc1-68f0-4339-b5b8-a2d74fb4777f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTExLTEtMS0w_e64f94f9-f2e9-4368-8530-57dba2ff44d0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTEzLTEtMS0w_bd35be3e-f505-4176-b22c-5086d585d3fc"
      unitRef="security">39</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTE1LTEtMS0w_3210a9c2-6d6f-4dc8-88d6-012edd3eb6a3"
      unitRef="usd">16000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i16e6f0f08a7b48b197075141b6b6b948_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzE5LTE3LTEtMS0w_780c5b02-8766-4e45-a97d-1e88ca0140b2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTEtMS0xLTExMDU_8ac876b4-e00c-4c75-9d86-ef8e737562f4"
      unitRef="security">16</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTMtMS0xLTExMDU_c0e6478d-866f-45af-9ecb-dcd59c0d0041"
      unitRef="usd">49000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTUtMS0xLTExMDU_1350a5cb-d3d9-4d7b-97e3-1191c39e62d0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTctMS0xLTExMDU_a1ca3402-f2b3-4982-96af-7992cf4e584f"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTktMS0xLTExMDU_77da021d-641e-47af-a7b9-68639fa454ce"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTExLTEtMS0xMTA1_41f503fd-9824-4dbc-a50e-4b1c6283065c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTEzLTEtMS0xMTA1_64535fbb-9191-4f43-aa13-5e14a5f04779"
      unitRef="security">16</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTE1LTEtMS0xMTA1_92e59fd3-8f40-44a0-8b15-ee6a9474aad2"
      unitRef="usd">49000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7862ac46b00d47789bc1df87115c0653_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTE3LTEtMS0xMTA1_fc12ce3d-64b7-4e67-a8e0-ceae1a9ca9ea"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTEtMS0xLTA_16a796cb-871a-4bb1-aa9a-a637025b8adf"
      unitRef="security">138</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTMtMS0xLTA_b9216b4b-2f82-47e1-a879-7e3b42dc934b"
      unitRef="usd">254000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTUtMS0xLTA_0ca6d39f-4f31-46d5-a557-0c6d231dd83b"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTctMS0xLTA_03fea508-fed6-4bcc-89e2-01afe824f5d7"
      unitRef="security">187</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTktMS0xLTA_c3936ff2-3d1b-4159-9ecc-a9f0028cced7"
      unitRef="usd">182000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTExLTEtMS0w_ef61aa63-7d87-477e-8e7e-b581d2d1bcf4"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTEzLTEtMS0w_2c919f33-9216-4cd7-9ce4-17ac8f536ea9"
      unitRef="security">325</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTE1LTEtMS0w_d41cfa7a-b1c2-4985-b3ab-b66aacb7dc1e"
      unitRef="usd">436000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iaa2411561ccf4d0b8a1929416700eb6e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIwLTE3LTEtMS0w_ad336a47-9f72-4d05-ac13-34f6b7b53740"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTEtMS0xLTA_fcb3a33a-ff77-4fba-8f76-1a8449177ea5"
      unitRef="security">522</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTMtMS0xLTA_76bb6460-4329-4a7e-9fd1-bc4baad1616f"
      unitRef="usd">982000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTUtMS0xLTA_d879f9da-d77e-4b1a-bcb1-745a443dd267"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTctMS0xLTA_30f76960-d0d5-46a3-ac93-9a48b5988d96"
      unitRef="security">200</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTktMS0xLTA_595f0a77-d90e-4ef3-a28b-f013a6ad8d69"
      unitRef="usd">187000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTExLTEtMS0w_5183c176-d121-46e3-a76c-7b1b93775331"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTEzLTEtMS0w_7cded46e-ba45-4341-ad5c-870d5027e533"
      unitRef="security">722</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTE1LTEtMS0w_378d9b42-d5ab-44c5-b4d4-d17ed550dc04"
      unitRef="usd">1169000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1OTk5MzhkMzgwZWY0MGMxOWIyNzM5MmMwYzQzNGZjNS90YWJsZXJhbmdlOjU5OTkzOGQzODBlZjQwYzE5YjI3MzkyYzBjNDM0ZmM1XzIyLTE3LTEtMS0w_91f33866-9abf-4e56-845c-8066e971b6c4"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzMtMS0xLTEtMA_54d4b443-b641-45f0-ba79-e9041a345934"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzMtMy0xLTEtMA_7c6f4d3f-bd45-4697-ab6e-affbb5cfb69e"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzMtNS0xLTEtMA_c0d0f3c3-e3bb-4fc2-bc3e-3f29d086eabb"
      unitRef="usd">9000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzMtNy0xLTEtMA_daee8d10-9feb-4894-aa74-6876ce4cf952"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzMtOS0xLTEtMA_1528e00f-ff2a-449d-9dab-7e9100ac426e"
      unitRef="usd">9000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzMtMTEtMS0xLTA_e1e30465-9b72-4875-bc84-148f8589be37"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzQtMS0xLTEtMA_be8c5805-32e1-464a-9aef-b7935c159a24"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzQtMy0xLTEtMA_9a7195ca-f7a6-4b39-bdda-0efedb42e083"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzQtNS0xLTEtMA_7b6f3770-4146-4295-a918-0792f7f1e7bf"
      unitRef="usd">300000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzQtNy0xLTEtMA_da01697c-f2b4-4a41-8070-a148d1c68443"
      unitRef="usd">4000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzQtOS0xLTEtMA_4532222f-214c-40e6-ba09-ed4ddbcc503c"
      unitRef="usd">300000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzQtMTEtMS0xLTA_0567d91e-e046-438a-8186-ff1745cf5ca8"
      unitRef="usd">4000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzUtMS0xLTEtMA_36c2cb1d-a62c-48e7-b69e-876386900865"
      unitRef="usd">4000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzUtMy0xLTEtMA_63aae4b7-c2b1-4bdd-a539-21f53405a724"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzUtNS0xLTEtMA_1a192fb5-1c68-4c38-8980-6b2387e26a0a"
      unitRef="usd">165000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzUtNy0xLTEtMA_11bbeb68-9b85-4094-8b97-7d380bcdfaf4"
      unitRef="usd">4000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzUtOS0xLTEtMA_13f0e5d6-dc7a-4100-9500-4d0931bb6a9a"
      unitRef="usd">169000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzUtMTEtMS0xLTA_febf5705-904b-4e55-8f24-1fabd1bff26e"
      unitRef="usd">4000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzYtMS0xLTEtMA_785df94d-e068-484d-afce-f0156b6d66ba"
      unitRef="usd">3000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzYtMy0xLTEtMA_ee9ff35f-cce1-456b-bd39-2977fe53de80"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzYtNS0xLTEtMA_c7873ed0-f5ab-4cbb-a3c7-1457910cc24a"
      unitRef="usd">36000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzYtNy0xLTEtMA_be608823-5c29-4ffd-aee1-5023bae44fd4"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzYtOS0xLTEtMA_607888cb-4bc4-4804-b00b-2455fe6cc69a"
      unitRef="usd">39000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzYtMTEtMS0xLTA_3f0b4cd3-9a36-4fe4-8550-ecad77b5a9d0"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="iac96be526caf4447bbf555aac1a17ecd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzctMS0xLTEtMA_9473a863-a2aa-4565-a13d-9c8a7af1e51b"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="iac96be526caf4447bbf555aac1a17ecd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzctMy0xLTEtMA_d070aaba-25f4-4486-9b38-4909a094e0dd"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i2862acbf1b084e6790226fec4b8bacae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzctNS0xLTEtMA_3e34f13c-a693-410b-aa9c-f13e8331e033"
      unitRef="usd">26000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i2862acbf1b084e6790226fec4b8bacae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzctNy0xLTEtMA_8284e7f8-f00b-40dd-b74a-b63a970742af"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzctOS0xLTEtMA_e373f135-f7a4-478f-97c3-c86fa0a28779"
      unitRef="usd">26000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i2508af2bd58e4d89a5c41fbe25a234da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzctMTEtMS0xLTA_fb2a91a4-a517-492b-bfd2-af257c7c8340"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="id096a5fb170740c39d0deca267bf7d45_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzgtMS0xLTEtMA_f6fa41ee-f214-49c3-a5fe-245241148a4b"
      unitRef="usd">2000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="id096a5fb170740c39d0deca267bf7d45_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzgtMy0xLTEtMA_297f4210-8749-4ae3-8fad-504f52286b0f"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i994b426c1b84462e8430c20afa88eb28_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzgtNS0xLTEtMA_c0a0c7f7-acbc-42ab-936c-886cabae3e7f"
      unitRef="usd">73000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i994b426c1b84462e8430c20afa88eb28_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzgtNy0xLTEtMA_49ade2b5-0d1f-4e93-a956-d8fa5dd25431"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzgtOS0xLTEtMA_a2e9fa80-f820-4f22-8b34-4c1bb653ee22"
      unitRef="usd">75000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ic8ce489ea7924f6db3a93eaaae428baa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzgtMTEtMS0xLTA_bed485da-9ab4-4b34-90d3-eae4c534714b"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="if373b00647a647d492b359b2cc518799_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzktMS0xLTEtMA_8ed653af-d2b5-418c-96de-649095e8a241"
      unitRef="usd">5000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="if373b00647a647d492b359b2cc518799_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzktMy0xLTEtMA_4a3b586b-8796-401c-bc78-0ba594ded72e"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i6e506a799edf42b6a5cab4f7c3320e36_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzktNS0xLTEtMA_dde46c57-ee3a-4229-bbbe-b7c48396c56e"
      unitRef="usd">292000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i6e506a799edf42b6a5cab4f7c3320e36_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzktNy0xLTEtMA_0d7c392d-53e7-4ba4-a434-c8571bbe7f1c"
      unitRef="usd">2000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzktOS0xLTEtMA_ef50ca9f-4b12-4e17-aec5-b346a0c8b242"
      unitRef="usd">297000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i1a19c71845964210be53c6d425920e0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzktMTEtMS0xLTA_bc02beee-3b97-4d88-900a-e29266c7f9a8"
      unitRef="usd">2000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzEwLTEtMS0xLTA_20f6de12-e011-4f78-81b2-9c824658b8d9"
      unitRef="usd">14000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i369f28cfdeb5415b8e941cabf0f84fd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzEwLTMtMS0xLTA_3f43164e-aa94-4bc5-9b52-116af20be12e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzEwLTUtMS0xLTA_2d73b64b-3c2b-4a28-a2d1-d0fd1337ad47"
      unitRef="usd">901000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7ed3ea2d008c4900b6da8ca08af14359_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzEwLTctMS0xLTA_2ea287b4-ae1f-4a60-9921-9a66a434910d"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzEwLTktMS0xLTA_88a39a78-1828-488c-b09d-8460b23efee0"
      unitRef="usd">915000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo5NzRhOWRiMmZkZTE0MGQ4ODNiZDMyNDUzZTlkMzE5Mi90YWJsZXJhbmdlOjk3NGE5ZGIyZmRlMTQwZDg4M2JkMzI0NTNlOWQzMTkyXzEwLTExLTEtMS0w_ccd7c06a-1ea1-44c5-ba37-1805986b1d30"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:ActivityInMortgageLoanPortfolioTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4NDI_abfa28e5-89ba-499c-877d-2fd07dc9578e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2020 and 2019, the Company had the following activity in its mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020 scheduled mortgage loan principal repayments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ActivityInMortgageLoanPortfolioTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i1a9206a1aaa548579a9355991549eb38_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo0ZGZmZjEzOTVjMGE0M2NjOTM1MWVmNTM0YTY4ZGQ1Zi90YWJsZXJhbmdlOjRkZmZmMTM5NWMwYTQzY2M5MzUxZWY1MzRhNjhkZDVmXzEtMS0xLTEtMA_4dc8d2f2-ac9e-4408-a9be-8816790e27cf"
      unitRef="usd">63000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="ibdd643de24674532b6eb565b63aa23ac_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo0ZGZmZjEzOTVjMGE0M2NjOTM1MWVmNTM0YTY4ZGQ1Zi90YWJsZXJhbmdlOjRkZmZmMTM5NWMwYTQzY2M5MzUxZWY1MzRhNjhkZDVmXzEtMy0xLTEtMA_4b37ada6-82e0-424b-a641-f5c149720cf9"
      unitRef="usd">131000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i1a9206a1aaa548579a9355991549eb38_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo0ZGZmZjEzOTVjMGE0M2NjOTM1MWVmNTM0YTY4ZGQ1Zi90YWJsZXJhbmdlOjRkZmZmMTM5NWMwYTQzY2M5MzUxZWY1MzRhNjhkZDVmXzItMS0xLTEtMA_b0287014-6948-4c5b-8a1c-bb6185bac362"
      unitRef="usd">187000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="ibdd643de24674532b6eb565b63aa23ac_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo0ZGZmZjEzOTVjMGE0M2NjOTM1MWVmNTM0YTY4ZGQ1Zi90YWJsZXJhbmdlOjRkZmZmMTM5NWMwYTQzY2M5MzUxZWY1MzRhNjhkZDVmXzItMy0xLTEtMA_2abc933f-4e1a-4de6-b9ad-7a39abf73473"
      unitRef="usd">234000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i1a9206a1aaa548579a9355991549eb38_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo0ZGZmZjEzOTVjMGE0M2NjOTM1MWVmNTM0YTY4ZGQ1Zi90YWJsZXJhbmdlOjRkZmZmMTM5NWMwYTQzY2M5MzUxZWY1MzRhNjhkZDVmXzMtMS0xLTEtMA_d2c27d1a-d261-4560-9ab3-028fc2ed6b8e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="ibdd643de24674532b6eb565b63aa23ac_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo0ZGZmZjEzOTVjMGE0M2NjOTM1MWVmNTM0YTY4ZGQ1Zi90YWJsZXJhbmdlOjRkZmZmMTM5NWMwYTQzY2M5MzUxZWY1MzRhNjhkZDVmXzMtMy0xLTEtMA_1a7f7ca2-97de-45eb-bf23-bcbc9f13f80e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MjI_9f5ad8b0-be28-4454-810a-48fde436d44f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based upon the Company&#x2019;s assessments at December&#160;31, 2020 and 2019, the amortized cost basis of the Company&#x2019;s mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie6781fba553a4bf7935fdce6921489c1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtMS0xLTEtNTA4MQ_ea61db33-b758-4bef-bcac-3c6163a5c98e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib6ec62eeb545418f935cd6789b8f043a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtMy0xLTEtNTA4MQ_ee693972-e944-4c94-b93a-28f797b19651"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8a5f6618b0fa465f9f1f9beb794efccb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtNS0xLTEtNTA4MQ_01130018-8923-4e34-85aa-f5d1d842878f"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i387442e37b5e42a49e054c4423e257a8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtNy0xLTEtNTA4MQ_f14054de-2faf-4f48-8b5d-29f77ab67d8c"
      unitRef="usd">22000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2b8d4e422a0b456caf45c84c95a13c63_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtOS0xLTEtNTA4MQ_0d9908e6-6f68-4a9e-8917-f7373369d2d1"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib60bdc4640d3430dba09cf14bed10e42_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtMTEtMS0xLTUwODE_b88a09e0-58c5-44f1-9bec-a73d2328c3e6"
      unitRef="usd">37000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i29175412719d4ae0bbdcfa90a2791097_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzMtMTMtMS0xLTUwODE_2e81859c-912e-4b5b-b171-f0e3ef820b0e"
      unitRef="usd">59000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i443be5ac12ab477899d6c78b902bfd1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtMS0xLTEtNTA4MQ_3b1c59e4-1bc9-49b2-9d32-fdf509633e77"
      unitRef="usd">46000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if3350229ccf0473d9d352076764201b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtMy0xLTEtNTA4MQ_7bf9e5a7-9fad-49c1-8cc9-a85c9234c660"
      unitRef="usd">96000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2808c5a9454a47638feaed23f05ffd75_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtNS0xLTEtNTA4MQ_6d4e2a1b-57f0-4242-8556-8599c697683d"
      unitRef="usd">91000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia9ded9eecf3545abad11c717bcf28ef4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtNy0xLTEtNTA4MQ_e9d51daf-3e2f-4589-8f55-20cbd6a26fbf"
      unitRef="usd">124000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i99bc2416240a4a1ebcd6963cab1df746_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtOS0xLTEtNTA4MQ_9e1e89d9-1302-4899-802b-0a6abe7c3def"
      unitRef="usd">101000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i01cb405c32b64ca890eabde91b0981d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtMTEtMS0xLTUwODE_9825cac4-c540-4d68-a621-d0d495797555"
      unitRef="usd">494000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1c5b042ce36e4d5f8c31048f338d0da0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzQtMTMtMS0xLTUwODE_8620bd1e-26d7-4389-b9a1-ce8b928e2dc7"
      unitRef="usd">952000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i5431d9662eca4651a20170ff92cb9ea6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtMS0xLTEtNTA4MQ_68883046-ea29-4cc6-b32a-9267f918dea9"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iafd0d1d240b7439788501063223cefba_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtMy0xLTEtNTA4MQ_5d684639-2b9a-489a-9aa9-20da66b79b58"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7dc8b1810ba64a5fa3916ea6c09b3e81_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtNS0xLTEtNTA4MQ_2a6efda2-3bcb-4118-bcbf-4acbadcadb89"
      unitRef="usd">3000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i63fa7e4e54554cac9b950e535b9ca5a5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtNy0xLTEtNTA4MQ_ad5f5fc0-0d53-4aa7-9870-4e5ce232370b"
      unitRef="usd">4000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1643fa3fa2c44337b623c38b9b1c7cc9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtOS0xLTEtNTA4MQ_cd0062c8-4d95-424e-90be-f0b11ac1557b"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i32903e0797f349ad863b6da5b59eb0d9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtMTEtMS0xLTUwODE_1e9d7d44-e722-4f03-ad74-cc63abd3ac26"
      unitRef="usd">29000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic485b0b1dfd5472cb9fc36c196433b4e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzUtMTMtMS0xLTUwODE_8a54d946-6289-494f-86f0-36ac5387586b"
      unitRef="usd">36000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib8e442f3b9594715b2fb6548ebca61e8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtMS0xLTEtNTA4MQ_08e74fe9-b508-479b-83a8-28a31e426c4a"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i01033fcb93704a4391a3e7fbe27e7af2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtMy0xLTEtNTA4MQ_d2c94d1e-2310-497a-9c7c-abafb2648e91"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3682b33721ec4514903d622b539be8a7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtNS0xLTEtNTA4MQ_9af32ffd-42ff-463b-a759-1bd2ce3e614c"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8cb4368415fd4f45ae4f3029eb9e6097_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtNy0xLTEtNTA4MQ_4f3dc693-39b0-4bd2-87be-0286a96ac778"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i88e6a24a77d9465bad6519907e24343a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtOS0xLTEtNTA4MQ_b3486a19-7caf-46db-8228-98befbc163ee"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i09f545523cd149f2a426aa336810452a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtMTEtMS0xLTUwODE_411dffa2-4754-40e5-b7bf-b804c6e3ab2d"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i822d645dd6e24c729f04ce2895f1a93f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzYtMTMtMS0xLTUwODE_5957152b-4833-4d94-95e3-894f04622a4e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i062d253ff7ef401a835b48533522c00e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctMS0xLTEtNTA4MQ_8822550d-4f74-47c1-8f37-58e8121cb4fa"
      unitRef="usd">46000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ide073f4bb27c48c7840435bb8f104221_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctMy0xLTEtNTA4MQ_d7e67c1f-6a74-4b00-8aa9-758dcedcec81"
      unitRef="usd">96000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie0bc39dee46c4714ac0b0fab972c4ccf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctNS0xLTEtNTA4MQ_47dc4ec7-296e-4514-bc34-5b2cea437ac9"
      unitRef="usd">94000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i473b0c0209924e7cb5e5f5f0cb1e4669_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctNy0xLTEtNTA4MQ_c359042c-b1f0-4e96-91fc-d0df58a7513b"
      unitRef="usd">150000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i69e2a8048cc94bfa86c33501b14cf008_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctOS0xLTEtNTA4MQ_a4c88db0-5216-42d4-b57b-48023fa6342d"
      unitRef="usd">101000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic55e9a14e25049ec9335dfd7e9cc5e2c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctMTEtMS0xLTUwODE_61854c07-9ca1-4fcb-a238-93c81aadae03"
      unitRef="usd">560000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzctMTMtMS0xLTUwODE_9651ed05-7bc7-49f0-8d5f-7fecb1fe4733"
      unitRef="usd">1047000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i79abeff81ecb4f2ba2b425357fdac880_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEwLTMtMS0xLTUwODQ_261b63d2-c908-4d4a-88fa-e020f68a0d86"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7deafc4a256c48d8ad86736b4e5311e4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEwLTUtMS0xLTUwODQ_774b5d8d-6959-4aa4-8c8f-ef1f59497186"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6510e58a12864cabbb5f5d397cdcc6e0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEwLTctMS0xLTUwODQ_ee0d19e3-52ec-4396-9ffb-9222cdf71023"
      unitRef="usd">15000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1e8f84bde226406fb2371bdc5972636d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEwLTktMS0xLTUwODQ_b295b60a-7910-4887-bef9-16e40be10829"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib4aea11f47ef497bb4cfae564490a9ff_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEwLTExLTEtMS01MDg0_db35d02e-0508-4ce7-8844-8e714689dc22"
      unitRef="usd">43000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia03d8280e504476eac041f0e93f83065_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEwLTEzLTEtMS01MDg0_091ecd3c-4578-4fc8-abc2-de6486542a4e"
      unitRef="usd">58000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i94e42d46c2d6436ca7b0109d263897d7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzExLTMtMS0xLTUwODQ_9f50875d-ded1-4228-b9f8-11a2cc1cfa3f"
      unitRef="usd">93000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4a3f3595ae134cc981ca1d3c18836706_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzExLTUtMS0xLTUwODQ_7223ab3b-ac89-41b1-b5b9-f2270ac314ae"
      unitRef="usd">93000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0bb8e2da802b450082ce3f9ebeddbb9f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzExLTctMS0xLTUwODQ_04c89343-06fd-42c1-bd38-78e7f2c857af"
      unitRef="usd">206000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="icb976174df584566912d1ce975916216_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzExLTktMS0xLTUwODQ_301798bf-b45c-494a-95ae-9ad525c96cf3"
      unitRef="usd">140000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1e03fbfce9af49f1aa6114c65a6c2f53_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzExLTExLTEtMS01MDg0_e2b1a5f4-81b5-4290-9bb5-129baa5558e3"
      unitRef="usd">611000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i76d11217f0a44658a8c9c461abf28597_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzExLTEzLTEtMS01MDg0_140704d3-293d-45d9-9e90-c79ab663174a"
      unitRef="usd">1143000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i971973c567634c73ab4ea2e84ce6b0dd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEyLTMtMS0xLTUwODQ_a4453bea-c364-42ee-aefb-5652f8ec1328"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0c310256123047cd9dfe888f312658ec_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEyLTUtMS0xLTUwODQ_c9c6b35d-f5d3-4b5c-9c4b-0e81304c9bd3"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i88616ec7a1ad44c3a2a4dd7cd79f5196_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEyLTctMS0xLTUwODQ_76acf58b-9030-4edd-92e5-bac7e0f9936a"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1a4cbded6e7742669126ef8fc6075ffd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEyLTktMS0xLTUwODQ_a514b47c-be2d-43fb-a00d-b99c7a092fdf"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie2c70dda95db46be820b218ae77d9e96_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEyLTExLTEtMS01MDg0_5467bb64-c3c2-408b-9330-6d410cb444ee"
      unitRef="usd">12000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id96a55c4463044b5bf44723d5c1ccf62_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEyLTEzLTEtMS01MDg0_106026b2-88c9-4162-9edd-31aae728c598"
      unitRef="usd">12000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i877d4580f0694cb4be370136b4865d7a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEzLTMtMS0xLTUwODQ_127e24f6-cf31-4801-ac1e-1b727b9c0e81"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i08f62f5e177e435b841ab3f7d3b09c13_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEzLTUtMS0xLTUwODQ_70fd1003-a890-4a57-9d8c-2e82f9d497b7"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic98ccfb571144f1c97c0ad662c696d05_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEzLTctMS0xLTUwODQ_3b2cee69-1ca0-412e-af89-0948ee76b3fc"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0daf6c04fb1344edb25e56b236c0dc57_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEzLTktMS0xLTUwODQ_c04acac3-eb89-4526-b7e3-a7e59af0a1b6"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib258da2c83ef4d81899c8b052d2499ba_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEzLTExLTEtMS01MDg0_16cf1ac0-4b60-4d5c-9fe5-22e9cb08c7f2"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="idf33732bb1b44dafa8da81b701b2c146_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzEzLTEzLTEtMS01MDg0_f846215a-900c-4b67-b3bb-4055229db4fe"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ieed1e5fc77c944bf8c6cb12c1362e77f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzE0LTMtMS0xLTUwODQ_64a85fe7-9945-4d5f-bb10-c2fdee5d78e7"
      unitRef="usd">93000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i45581d71f4fc45f68574e3690202b39e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzE0LTUtMS0xLTUwODQ_e377a1da-7f5f-42f9-859b-4c774788fb44"
      unitRef="usd">93000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i47f137d0f6d243babd97d6cefb992373_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzE0LTctMS0xLTUwODQ_2d785337-fe4d-4d93-afc7-8b5e7e7a8cfc"
      unitRef="usd">221000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1b85ad0009a8404f91f09c0c56c9e0a5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzE0LTktMS0xLTUwODQ_c8a800d8-983d-40d2-9f43-73915b83ea34"
      unitRef="usd">140000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7d7ca48c598f45cb8d641ff3cfd83dc3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzE0LTExLTEtMS01MDg0_726107d1-a46f-42ac-9d2f-e895697cf7fe"
      unitRef="usd">666000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ibb6ec27882864945abe2ffe9bd523656_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTo1YjBiNjA1ODY3OGM0YTE1OGQ2YmY3MmU2Y2U0MGJjMi90YWJsZXJhbmdlOjViMGI2MDU4Njc4YzRhMTU4ZDZiZjcyZTZjZTQwYmMyXzE0LTEzLTEtMS01MDg0_5537fc66-8ef9-421d-8112-0bf22c080bb4"
      unitRef="usd">1213000000</us-gaap:MortgageLoansOnRealEstate>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths
      contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzEtMS0xLTEtMA_7966a039-ce45-40aa-8537-c3b9d7c0561b"
      unitRef="usd">226000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo
      contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzItMS0xLTEtMA_2ddeacac-8b39-4784-a146-0aa0f773570e"
      unitRef="usd">147000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree
      contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzMtMS0xLTEtMA_603af48e-870b-4f6b-b914-cb18a5d7cfa9"
      unitRef="usd">121000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour
      contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzQtMS0xLTEtMA_dc34ea04-6ed0-4f41-ba37-3998b1d58454"
      unitRef="usd">172000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive
      contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzUtMS0xLTEtMA_ce928a99-097a-4446-bdbb-e9db5ce46dc2"
      unitRef="usd">93000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive
      contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzYtMS0xLTEtMA_b11623fc-7725-4472-a1d5-b9b56d279a5f"
      unitRef="usd">288000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet
      contextRef="i9d53390437704160bfb47a2ae8120e70_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTpkNmMxMjk1YmQzMDY0MDE4Yjg0MGQ3NTYzOGI4MDNhNi90YWJsZXJhbmdlOmQ2YzEyOTViZDMwNjQwMThiODQwZDc1NjM4YjgwM2E2XzctMS0xLTEtMA_74436f8c-cb50-4b56-ad2f-bb0c9312d5a5"
      unitRef="usd">1047000000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:InvestmentIncomeTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MzQ_2e581d67-57f1-4da0-8df1-b0dc75ce178e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the years ended December 31, 2020, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital gains are net of yield-related impairment losses on debt securities of $49 million for the year ended December&#160;31, 2020. There were no credit-related losses on debt securities in the year ended December&#160;31, 2020. Net realized capital gains are net of other-than-temporary impairment (&#x201c;OTTI&#x201d;) losses on debt securities of $24 million for the year ended December 31, 2019. There were no material OTTI losses on debt securities for the year ended December 31, 2018.&lt;/span&gt;&lt;/div&gt;(2)Net investment income includes $42 million, $44 million and $4 million for the years ended December 31, 2020, 2019 and 2018, respectively, related to investments supporting experience-rated products.</us-gaap:InvestmentIncomeTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i4463ae62a9024501b5a957f93ffd509c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzEtMS0xLTEtMA_e19eeeeb-f5cc-42c8-9ac9-067bb56cc95e"
      unitRef="usd">598000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i5f180321401b43afb4ccf64eefc9ed72_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzEtMy0xLTEtMA_47f82bb9-a622-47a5-b913-44fbede22373"
      unitRef="usd">589000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ieae65b64f43641bd80854962068ff2bf_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzEtNS0xLTEtMTIwOA_2f1b7dfe-59f6-4295-83b7-7c83231c3342"
      unitRef="usd">61000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="icef7b09090ab4ce78a8ecf8b2b4586e1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzItMS0xLTEtMA_6e3a3904-b1b2-4586-984e-6649bb60f7f6"
      unitRef="usd">60000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i739d9512c32a42c2bc64e5f94d64b6a8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzItMy0xLTEtMA_1fd13bff-a1dc-425e-a065-7129296522b2"
      unitRef="usd">71000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i851d4aa7d40b44b789763f7863bce518_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzItNS0xLTEtMTIwOA_c1b62570-6da4-4d22-90dd-f0974725a319"
      unitRef="usd">6000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i439d5bbe06ca42518920801c888d40c2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzMtMS0xLTEtMA_dd796717-a885-40be-af8a-13c2d153e031"
      unitRef="usd">123000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ia8dd6959068f4e5490c721fc82461ad7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzMtMy0xLTEtMA_03694a54-2943-4cc8-8405-dbfd7718b8e6"
      unitRef="usd">194000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="idc5fbdda1ccb46f0bf05959e53345921_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzMtNS0xLTEtMTIwOA_731558ec-58cc-4f07-8867-e82cc17da22a"
      unitRef="usd">593000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzQtMS0xLTEtMA_6379dc87-6d4c-470e-b2f2-a82311a9753e"
      unitRef="usd">781000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzQtMy0xLTEtMA_9d545d77-2c49-43c6-81e2-cc1905d72868"
      unitRef="usd">854000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzQtNS0xLTEtMTIwOA_b7866a8b-0428-45b6-8760-f199927b7221"
      unitRef="usd">660000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzUtMS0xLTEtMA_2f40a9e9-3428-44bf-833c-b4ce4897f2a3"
      unitRef="usd">35000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzUtMy0xLTEtMA_31411c38-0f59-4b28-9c03-beac8b090845"
      unitRef="usd">42000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzUtNS0xLTEtMTIwOA_dcc93b58-deb6-42a9-a887-961c1408c559"
      unitRef="usd">3000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzYtMS0xLTEtMA_aa8a4b4e-1746-4b34-a79d-550b295811b9"
      unitRef="usd">746000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzYtMy0xLTEtMA_369508a1-3f53-412f-a45a-1fe80b09e005"
      unitRef="usd">812000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzYtNS0xLTEtMTIwOA_9788e3c9-0651-4d55-9fef-db8e011b5291"
      unitRef="usd">657000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzctMS0xLTEtMA_dc95e5fc-772d-45fe-ad46-0f30239bed19"
      unitRef="usd">52000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzctMy0xLTEtMA_755e8239-feb0-46ca-8144-7610443aaacc"
      unitRef="usd">199000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzctNS0xLTEtMTIwOA_522e68be-0714-4448-8228-15990d40e1fb"
      unitRef="usd">3000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:InvestmentIncomeNet
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzgtMS0xLTEtMA_26a12c69-6d8c-4bc3-be79-7445322f8991"
      unitRef="usd">798000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzgtMy0xLTEtMA_263a3f0b-fa98-46ab-ba35-c957af0d7e11"
      unitRef="usd">1011000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTowOTcwYjI1MDZmMWE0MTMzODZiYjM5ZmEwYzM5ZTczOC90YWJsZXJhbmdlOjA5NzBiMjUwNmYxYTQxMzM4NmJiMzlmYTBjMzllNzM4XzgtNS0xLTEtMTIxNQ_755a8fa5-8b76-4fa8-92fd-ac0036f18557"
      unitRef="usd">660000000</us-gaap:InvestmentIncomeNet>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzIxOTkwMjMyNjczNTA_4395e9c3-c0c4-4330-a78d-909c4a79b904"
      unitRef="usd">-49000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzIxOTkwMjMyNjc5MzU_be15d859-5a77-446f-ba0f-37a9699ef636"
      unitRef="usd">0</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzIxOTkwMjMyNjc0MjM_28d1db15-54a7-4364-9b73-d73ea8640c7e"
      unitRef="usd">-24000000</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzU5NTM_5e871851-f7c6-41c8-aac0-3dcb0e5e1514"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:InvestmentIncomeNet
      contextRef="i3489e4cdcead49faa7307339be45ea56_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzYwNjQ_be705036-ba4d-4f4f-b929-3b5fb1448d0a"
      unitRef="usd">42000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i054b8f52f436443db1807cf26d0d4567_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzYwNzE_357e641b-9509-4c17-8042-47993041f78a"
      unitRef="usd">44000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i458385d44006411896bb4794dbc65c9b_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzEwOTk1MTE2MzY5Nzg_99eee749-6503-47ac-936c-1706f86de110"
      unitRef="usd">4000000</us-gaap:InvestmentIncomeNet>
    <cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90ZXh0cmVnaW9uOjBjY2E1OThhZjZkMDRlZGI5OTM2OTZmOGI3MTAxM2Q0XzY4MjM_458d9c0d-4d47-4c5a-a8f4-9fa92c44572b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available for sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2020, 2019 and subsequent to the Aetna Acquisition Date in 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzEtMS0xLTEtMA_94661ee3-7a64-46a9-a4d3-1b083fab7110"
      unitRef="usd">3913000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzEtMy0xLTEtMA_0032c344-26da-4f77-b6e6-414b2e310b7f"
      unitRef="usd">4773000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzEtNS0xLTEtMTI2MA_513b3e49-8b4b-4a63-b127-d75af8c09f3c"
      unitRef="usd">389000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzItMS0xLTEtMA_788bae4d-e61b-45b1-82b2-4f8843210f1b"
      unitRef="usd">80000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzItMy0xLTEtMA_28790ebe-1c6c-419c-b4ce-17ffc328c31a"
      unitRef="usd">146000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzItNS0xLTEtMTI2MA_ee1d0523-f2c5-412a-8409-9cf0756500a7"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzMtMS0xLTEtMA_64d14424-c50b-452f-abfb-6641d1b0fd85"
      unitRef="usd">-62000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzMtMy0xLTEtMA_51f13340-51b7-421e-939d-7fa6b3796b24"
      unitRef="usd">-17000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzAvZnJhZzowY2NhNTk4YWY2ZDA0ZWRiOTkzNjk2ZjhiNzEwMTNkNC90YWJsZTozMDg3M2RjNDZhYzU0MzEzOWZjOTBmZTM5MDRmNGY5ZC90YWJsZXJhbmdlOjMwODczZGM0NmFjNTQzMTM5ZmM5MGZlMzkwNGY0ZjlkXzMtNS0xLTEtMTI2MA_54a80701-c52b-4990-8abf-7550ca18f652"
      unitRef="usd">-2000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzExMDE4_c5a02de3-684c-435a-80bc-7f54b4eeb790">Fair Value&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;In this note, the Company provides details on the fair value of financial assets and liabilities and how it determines those fair values.&#160;The Company presents this information for those financial instruments that are measured at fair value for which the change in fair value impacts net income (loss) attributable to CVS Health or other comprehensive income separately from other financial assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments Measured at Fair Value on the Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s financial instruments are measured at fair value on the consolidated balance sheets.&#160;The fair values of these instruments are based on valuations that include inputs that can be classified within one of three levels of a hierarchy established by GAAP.&#160;&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#x201c;valuation inputs&#x201d;) that qualifies a financial asset or liability for each level:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Unadjusted quoted prices for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Valuation inputs other than Level 1 that are based on observable market data.&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Developed from unobservable data, reflecting the Company&#x2019;s assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities are classified based upon the lowest level of input that is significant to the valuation.&#160;When quoted prices in active markets for identical assets and liabilities are available, the Company uses these quoted market prices to determine the fair value of financial assets and liabilities and classifies these assets and liabilities in Level 1.&#160;In other cases where a quoted market price for identical assets and liabilities in an active market is either not available or not observable, the Company estimates fair value using valuation methodologies based on available and observable market information or by using a matrix pricing model.&#160;These financial assets and liabilities are classified in Level 2.&#160;If quoted market prices are not available, the Company determines fair value using broker quotes or an internal analysis of each investment&#x2019;s financial performance and cash flow projections.&#160;Thus, financial assets and liabilities may be classified in Level 3 even though there may be some significant inputs that may be observable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of the valuation methodologies used for the Company&#x2019;s financial assets and liabilities that are measured at fair value, including the general classification of such assets and liabilities pursuant to the valuation hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. When quoted prices are available in an active market, cash equivalents are classified in Level 1 of the fair value hierarchy. Fair values of cash equivalent instruments that do not trade on a regular basis in active markets are classified as Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Where quoted prices are available in an active market, debt securities are classified in Level 1 of the fair value hierarchy.&#160;The Company&#x2019;s&#160;Level 1 debt securities consist primarily of U.S. Treasury securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s Level 2 debt securities are obtained using models, such as matrix pricing, which use quoted market prices of debt securities with similar characteristics or discounted cash flows to estimate fair value. The Company reviews these prices to ensure they are based on observable market inputs that include quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets and inputs that are observable that are not prices (such as interest rates and credit risks). The Company also reviews the methodologies and the assumptions used to calculate prices from these observable inputs. On a quarterly basis, the Company selects a sample of its Level 2 debt securities&#x2019; prices and compares them to prices provided by a secondary source. Variances over a specified threshold are identified and reviewed to confirm the price provided by the primary source represents an appropriate estimate of fair value. In addition, the Company&#x2019;s internal investment team consistently compares the prices obtained for select Level 2 debt securities to the team&#x2019;s own independent estimates of fair value for those securities.&#160;The Company obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December&#160;31, 2020 or 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also values certain debt securities using Level 3 inputs.&#160;For Level 3 debt securities, fair values are determined by outside brokers or, in the case of certain private placement securities, are priced internally.&#160;Outside brokers determine the value of these debt securities through a combination of their knowledge of the current pricing environment and market flows.&#160;The Company did not have any broker quoted debt securities for the years ended December&#160;31, 2020 and 2019. For some private placement securities, the Company&#x2019;s internal staff determines the value of these debt securities by analyzing spreads of corporate and sector indices as well as interest spreads of comparable public bonds.&#160;Examples of these private placement Level 3 debt securities include certain U.S. and foreign securities and certain tax-exempt municipal securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company currently has two classifications of equity securities:&#160;those that are publicly traded and those that are privately placed.&#160;Publicly-traded equity securities are classified in Level 1 because quoted prices are available for these securities in an active market.&#160;For privately placed equity securities, there is no active market; therefore, these securities are classified in Level 3 because the Company prices these securities through an internal analysis of each investment&#x2019;s financial statements and cash flow projections. Significant unobservable inputs consist of earnings and revenue multiples, discount for lack of marketability and comparability adjustments. An increase or decrease in any of these unobservable inputs would have resulted in a change in the fair value measurement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no financial liabilities measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2020 or 2019. Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;States, &lt;br/&gt;municipalities&lt;br/&gt; and political &lt;br/&gt;subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;br/&gt;corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;preferred&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized and unrealized capital gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in earnings&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2020 was $4 million during the year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;br/&gt;corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;preferred&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized and unrealized capital gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in earnings&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross transfers into Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments Not Measured at Fair Value on the Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information regarding the valuation of cost method investments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts Measured at Fair Value on the Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets relate to the Company&#x2019;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Net investment income and capital gains and losses on Separate Accounts assets accrue directly to such contract holders.&#160;The assets of each account are legally segregated and are not subject to claims arising from the Company&#x2019;s other businesses.&#160;Deposits, withdrawals, net investment income and realized and unrealized capital gains and losses on Separate Accounts assets are not reflected in the consolidated statements of operations, shareholders&#x2019; equity or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets include debt and equity securities.&#160;The valuation methodologies used for these assets are similar to the methodologies described above in this Note 4 &#x2018;&#x2018;Fair Value.&#x2019;&#x2019;&#160;Separate Accounts assets also include investments in common/collective trusts that are carried at fair value. Common/collective trusts invest in other investment funds otherwise known as the underlying funds. The Separate Accounts&#x2019; interests in the common/collective trust funds are based on the fair values of the investments of the underlying funds and therefore are classified in Level 2. The assets in the underlying funds primarily consist of equity securities. Investments in common/collective trust funds are valued at their respective net asset value (&#x201c;NAV&#x201d;) per share/unit on the valuation date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts financial assets at December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $29 million of other receivables at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December 31, 2020 and 2019, the Company had no gross transfers of Separate Accounts financial assets into or out of Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Offsetting Financial Assets and Liabilities&lt;/span&gt;&lt;/div&gt;Certain financial assets and liabilities are offset in the Company&#x2019;s consolidated balance sheets or are subject to master netting arrangements or similar agreements with the applicable counterparty. Financial assets subject to offsetting and enforceable master netting arrangements were $2 million as of December 31, 2020. Financial liabilities subject to offsetting and enforceable master netting arrangements were $3 million as of December 31, 2019.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzExMDEx_b7c545ca-0a7f-4f04-95ec-35df1cfbccfd">Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2020 and 2019 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if9f2ffe7a0ba474fb811572f2e0ea7e0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzItMS0xLTEtMA_9f711256-4b4a-4481-aaaa-8352055d7788"
      unitRef="usd">4210000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4508cc8f56f04ee9a7567e40b8da3c28_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzItMy0xLTEtMA_2abaa062-2869-4794-b03c-fa478e7627b4"
      unitRef="usd">3869000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id19caab13c4e4bc38082d1bdf6bc13ea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzItNS0xLTEtMA_4e81f966-d5d1-4182-9449-f3ca10da7a8f"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7e22f02c654244d596daa5e51b729587_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzItNy0xLTEtMA_60648591-1343-484a-8342-bd78e9d7aa5f"
      unitRef="usd">8079000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2c4a870a8354489ab03c6ca49ffdd338_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzQtMS0xLTEtMA_17382e17-fdc1-4f3f-833f-71e615a90fd9"
      unitRef="usd">2370000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i344a6a9cd51e4e43b0ca2ddc7cb48feb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzQtMy0xLTEtMA_56224da5-b1ba-4609-ae94-3258ff8279f5"
      unitRef="usd">99000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i60bdcc978cfc484baf04fe7970cd32e6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzQtNS0xLTEtMA_1d15f08c-3aa4-473f-9a30-f60c81049437"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie3a9c7ec5cd043a1b1452b0017077321_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzQtNy0xLTEtMA_7df5d963-12d5-4de3-b71c-b182350bca6a"
      unitRef="usd">2469000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i535e58cf8ebd41cb8d7240e4b1e35f50_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzUtMS0xLTEtMA_7dd37ac1-6856-4e2c-8df5-dbb8b806bf90"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ddc060d200a4e2aa0952f43df4f21a9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzUtMy0xLTEtMA_84ff948b-dd08-4e0c-a799-bfa0428a23da"
      unitRef="usd">2727000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5e8fea1acd9244a5a882955ae4ed486a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzUtNS0xLTEtMA_bac76adc-9854-4eab-a6a6-29d7eda42829"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ice331df2b98e46fea9be5f51151c8e6b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzUtNy0xLTEtMA_511b1ca1-bc18-47b3-9633-324124d4364c"
      unitRef="usd">2728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic8a89f2686564b389cdb4fe8539d10e8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzYtMS0xLTEtMA_56bb8415-cf6a-4e26-ab31-62258396566e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8edb5e9988eb4dcfadaa6febf64f603c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzYtMy0xLTEtMA_fd3e5fb7-1c38-4269-a822-09ceb142b1a5"
      unitRef="usd">8842000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7a5669faf591465099f3db3909bf4908_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzYtNS0xLTEtMA_44ef6511-a453-46d8-8c08-826fcfdb43e1"
      unitRef="usd">52000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib2db80d0e7344f35840de60bfea8a22a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzYtNy0xLTEtMA_4b2c1ef8-08e6-493d-8555-c33a9b536c40"
      unitRef="usd">8894000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ide99961030a64271a6dfda0a74b2fd14_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzctMS0xLTEtMA_5ec3c5c9-9938-4d32-99bd-3ee5b4f019c4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie311d074225743679534438cd7b7490f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzctMy0xLTEtMA_1bcb4c2f-4a43-4387-a9b7-09c02a501771"
      unitRef="usd">2918000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8564e44c4d0940d883bb0a3d95fd9e7e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzctNS0xLTEtMA_022045a5-5d5c-4135-a2e5-4e5ddd794b9f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i61b53e87d1454d1f831fd5c70d5c60fb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzctNy0xLTEtMA_959a808d-016e-409b-91b8-c42e342d2c5b"
      unitRef="usd">2918000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia77b398de41746a9bea32d7c8add5469_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzgtMS0xLTEtMA_11f8d187-e5b4-424e-9ac1-4976dba78023"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iadfe4530ccf44844a620422f79befd12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzgtMy0xLTEtMA_02ad91ab-390b-4f10-86ec-56827099d680"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia44caf607a4b4de3b75eb6df51116b96_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzgtNS0xLTEtMA_7ea3d46f-cc43-4533-afbb-6c201966dbec"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id18c3b096aa54a56ab5aebddae95e201_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzgtNy0xLTEtMA_36430706-33cf-44af-9a07-243f29c270e4"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i150ad433496a404098a477e3ea7c9713_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzktMS0xLTEtMA_2db74c03-1373-482d-ab16-d299695d0c89"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6bfb0024ebcf4bc0a0df96fc6053933d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzktMy0xLTEtMA_15244496-52b0-47c8-92f5-04bb254c2593"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i05c28a6dc98643f2af8af4f866a43aeb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzktNS0xLTEtMA_f5c40f73-11c5-4830-bdc0-8e3a38be84d7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie0e0cef498104e4498bc6b4cb58dea9c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzktNy0xLTEtMA_207b3c14-6422-4119-84a3-fc2e5c7ac0a6"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i48f0fd6cea0b4f2ea1af31f0b858cf48_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEwLTEtMS0xLTA_cf4dcac8-9d73-483e-9ec8-be97b895df9d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib4ed896778474633bf168b8f5368a64d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEwLTMtMS0xLTA_6aed8fb0-a7ac-4594-a4b0-75c982274d6b"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i37858238ff4b4357b90cb98696708c18_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEwLTUtMS0xLTA_35011c50-1758-4670-ae9c-03e2ce38789e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iba2f946e677c41e6a1dd57f66196e517_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEwLTctMS0xLTA_8b044ca3-7b8c-422a-b2ff-438739733403"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i81b92da379164d05a04e73b67319b43e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzExLTEtMS0xLTA_6c55405b-187c-4a87-81c1-7608d3b2ba79"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia4de0232daf44e89b664bfe4fd000aeb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzExLTMtMS0xLTA_dff9f1ea-2bb1-4cff-8872-d42988affdca"
      unitRef="usd">24000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4ed66fb799214fc2bf98dc256cfdda0d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzExLTUtMS0xLTA_4dd47a3c-f89b-419a-a759-adb7623dbc14"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie604f7e6063c410db0270a579e5c2e1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzExLTctMS0xLTA_af8123b4-1005-421f-ac85-334308037b1a"
      unitRef="usd">25000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if9f2ffe7a0ba474fb811572f2e0ea7e0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEyLTEtMS0xLTA_9f5014c9-cde1-48b0-9ccf-643548061d1f"
      unitRef="usd">2370000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4508cc8f56f04ee9a7567e40b8da3c28_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEyLTMtMS0xLTA_a80f62d3-0a2c-4112-a769-fe6ea75c2052"
      unitRef="usd">18764000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id19caab13c4e4bc38082d1bdf6bc13ea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEyLTUtMS0xLTA_7946a3e9-7847-4ecb-a693-c0ffc42908b1"
      unitRef="usd">54000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7e22f02c654244d596daa5e51b729587_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEyLTctMS0xLTA_b499c8fe-da29-407b-9b4c-2e5177549ff9"
      unitRef="usd">21188000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if9f2ffe7a0ba474fb811572f2e0ea7e0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEzLTEtMS0xLTA_1fc9fba9-1df8-436d-aec8-e9c3a6e4a460"
      unitRef="usd">17000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i4508cc8f56f04ee9a7567e40b8da3c28_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEzLTMtMS0xLTA_04179dbd-be90-44f0-884c-233cf665901a"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id19caab13c4e4bc38082d1bdf6bc13ea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEzLTUtMS0xLTA_0b940db4-cb99-4d4c-ad18-29fef24bcdd0"
      unitRef="usd">30000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7e22f02c654244d596daa5e51b729587_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzEzLTctMS0xLTA_cdd1f5a5-31a2-4b8a-8a06-77a5925874b2"
      unitRef="usd">47000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if9f2ffe7a0ba474fb811572f2e0ea7e0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE0LTEtMS0xLTA_d02fd5c5-a08e-4a71-92a3-1d695faae986"
      unitRef="usd">6597000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4508cc8f56f04ee9a7567e40b8da3c28_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE0LTMtMS0xLTA_fb0fe952-a462-4862-b2a1-f4ac6c9db55b"
      unitRef="usd">22633000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id19caab13c4e4bc38082d1bdf6bc13ea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE0LTUtMS0xLTA_fea349cb-7207-4d87-bd0d-e1bc73f64d6c"
      unitRef="usd">84000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7e22f02c654244d596daa5e51b729587_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE0LTctMS0xLTA_e6da550b-cfa9-4fb0-aae1-363e922633fa"
      unitRef="usd">29314000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i824ec462d55041558ba9c29476131800_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE3LTEtMS0xLTA_1c6abd73-d7d8-4ef1-8632-3e1480e22261"
      unitRef="usd">3397000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i427b6fb3db3448e2808f061a08c25372_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE3LTMtMS0xLTA_95b54da8-e01f-481b-96fd-2b70eb5a7af0"
      unitRef="usd">2286000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9ec6476033e246a18cda5819f01ab27f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE3LTUtMS0xLTA_8cba8661-62a0-4894-9dda-1e56cfd1e0e3"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE3LTctMS0xLTA_c26f94cc-5b07-4906-8842-f392a39362f3"
      unitRef="usd">5683000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8539ee32c9a54080a31d12e525e306c0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE5LTEtMS0xLTA_c7b0d4ea-bbef-4c55-911b-6a06a0111b9f"
      unitRef="usd">1785000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4dad6865b2654a9b907c9347d91993df_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE5LTMtMS0xLTA_866b1f22-6444-4c1d-9885-c75136abac11"
      unitRef="usd">67000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i78f5a494a7494280953e08b74b394c16_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE5LTUtMS0xLTA_309859da-d48a-4454-861b-2670cf81cade"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9710be21b74c4c1599f063414aaf6404_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzE5LTctMS0xLTA_1e145344-5df5-4a5b-aa28-d4643306a1e2"
      unitRef="usd">1852000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if9d5661cc4d149c7b8bb9325f15773b2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIwLTEtMS0xLTA_75caeed4-0264-4c72-bf7c-5dfbc191aeeb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i56d284138b914afab3d80a561bb6eb39_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIwLTMtMS0xLTA_fb336c00-7582-46f2-a107-45c19fed34d9"
      unitRef="usd">2309000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8d9f485c9030494899f777cd715f8fa7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIwLTUtMS0xLTA_ad4e61cb-2dd3-4ccd-985e-a7b8a3e21822"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1085bdeb3b104e208f4620803d5c8e4d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIwLTctMS0xLTA_55e527fe-3b41-4ed5-85f0-9c195f0830a3"
      unitRef="usd">2309000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7e2f247e22d446e691e08e44f6068a66_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIxLTEtMS0xLTA_4dea33b3-25ff-4260-abdc-17feec13414c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibf6bb670dc3c4e049ca389440de1255e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIxLTMtMS0xLTA_dc39a0d7-7081-4b2b-bd97-04b0eda2c3b8"
      unitRef="usd">7700000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if1419625a52b4c7f99601b13d3fffd3b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIxLTUtMS0xLTA_25d06da9-6d54-4dbc-9fc4-8b91b9c1249b"
      unitRef="usd">37000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i49d58ae32a674ec7a25b0cab1c107c50_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIxLTctMS0xLTA_673ac561-fba5-4330-890c-abea51a06c47"
      unitRef="usd">7737000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7fe5b5a213bc48a9a839453f8eec37aa_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIyLTEtMS0xLTA_733341a3-360d-4e68-ae4b-3edf8cfb067f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifdd142883292428c9379bdc65620fa8e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIyLTMtMS0xLTA_fa44c8cf-de27-49a4-9856-dd914bc1553f"
      unitRef="usd">2348000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7d59fc608e9943a9a082f64bd8966e7d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIyLTUtMS0xLTA_7f6ec279-d3ff-42e8-b8b7-9a67d8005eaa"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i10d143f8d4624b888878df58de333010_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIyLTctMS0xLTA_13ceef73-becf-4a97-a8f8-05a82467d596"
      unitRef="usd">2348000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i84acf5a3b4b74531b1bc2f9b3cebfa9f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIzLTEtMS0xLTA_8e44b7c2-75e9-4457-a659-8906c0ff1d9f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i14c435d7631b4ba8ada299ff02b1fa00_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIzLTMtMS0xLTA_2fe34af6-5e58-4c6e-b751-1848859fd4fd"
      unitRef="usd">533000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i27193b7a6df549ac80433361247ff541_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIzLTUtMS0xLTA_e06b5e85-26e3-4e55-ae3d-31557941b6b0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie1e2ac0b66c2497880c1e0d940d086ae_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzIzLTctMS0xLTA_7620bd85-3ee5-4933-b800-dd97183caf38"
      unitRef="usd">533000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i099b6050d3584f5fb00e807ed1227a99_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI0LTEtMS0xLTA_9ced34bd-345a-4a26-b138-c0ae55ee0c90"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaee970ac587c4ba29630fb7caf93ece4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI0LTMtMS0xLTA_4871dff7-c68d-4523-b926-8f1997103d13"
      unitRef="usd">700000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i89a55680a0a4433a9c10cba73488c4a4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI0LTUtMS0xLTA_256e98b0-980c-4d8e-98ec-335f79e1383e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib79362fb767e403b8719ea6a27dfc263_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI0LTctMS0xLTA_8ec564ff-14e4-4505-a9e9-bf7c43604b69"
      unitRef="usd">700000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6ee3a9120196416f8296ed0519c6e205_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI1LTEtMS0xLTA_c1f12456-3dd7-4a28-96d6-0197d5b56de2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i917d8b2ba01740e38b71a44126058fb3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI1LTMtMS0xLTA_896f0df2-608c-4dc7-9ca5-e355105e32ca"
      unitRef="usd">1405000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i909a12cdf2aa40dda0c82baf62b9869d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI1LTUtMS0xLTA_121fd8d1-9e0c-4ef1-a2ac-6c8acaecb615"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia22f84d3693548b99878a1e34770cf19_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI1LTctMS0xLTA_51c972a9-9148-415b-aa91-934b22d043d2"
      unitRef="usd">1405000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib1c603ece9bf403fb66246ce8f442203_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI2LTEtMS0xLTA_04e87abb-3fc9-4747-b24f-3b1014606285"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i67c1ffa9b4a64076853256c4949fc411_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI2LTMtMS0xLTA_bd6e947a-e602-411e-8c6d-108a1577875b"
      unitRef="usd">26000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iee9c609f9b8541b4a685e9d0fd26d249_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI2LTUtMS0xLTA_1d4919d0-abfc-48e2-9afd-fe66566b5a28"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7980aa14ee0540c882652c696d24ce39_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI2LTctMS0xLTA_590591d6-1211-4aa2-b146-8904b8ac5b92"
      unitRef="usd">38000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i824ec462d55041558ba9c29476131800_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI3LTEtMS0xLTA_c955acea-1e91-4730-99d3-272e02a8cb07"
      unitRef="usd">1785000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i427b6fb3db3448e2808f061a08c25372_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI3LTMtMS0xLTA_d600febc-ec97-4ae5-a358-57281ce1cc3f"
      unitRef="usd">15088000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9ec6476033e246a18cda5819f01ab27f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI3LTUtMS0xLTA_f920ccb8-1000-4320-8dec-18e096750a34"
      unitRef="usd">49000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI3LTctMS0xLTA_8876a7de-768b-489d-a078-83373a205fec"
      unitRef="usd">16922000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i824ec462d55041558ba9c29476131800_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI4LTEtMS0xLTA_08cfeeec-87e2-48eb-9c86-b755dbc86954"
      unitRef="usd">34000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i427b6fb3db3448e2808f061a08c25372_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI4LTMtMS0xLTA_b4bc1c6f-d057-4d23-8b22-f8a23b8062b2"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9ec6476033e246a18cda5819f01ab27f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI4LTUtMS0xLTA_3cbe8a88-8016-4160-861b-6fff31084dff"
      unitRef="usd">39000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI4LTctMS0xLTA_baa0a3a8-9258-4a9c-967c-c1a307e9d592"
      unitRef="usd">73000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i824ec462d55041558ba9c29476131800_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI5LTEtMS0xLTA_e7253084-47cf-48c5-a164-8f1ce3875ed6"
      unitRef="usd">5216000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i427b6fb3db3448e2808f061a08c25372_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI5LTMtMS0xLTA_31df646d-4392-465a-8226-791412b40fe5"
      unitRef="usd">17374000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9ec6476033e246a18cda5819f01ab27f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI5LTUtMS0xLTA_c63617f6-1000-4aa6-8966-a2d0e194add0"
      unitRef="usd">88000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTplN2FmZDJmZTVlY2M0NjhiOGFiYTZjYjJkYTViMzk3YS90YWJsZXJhbmdlOmU3YWZkMmZlNWVjYzQ2OGI4YWJhNmNiMmRhNWIzOTdhXzI5LTctMS0xLTA_64726f5f-549b-4144-b28a-4975e591a624"
      unitRef="usd">22678000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzU0OTc1NTgxNTQ2MTk_07845073-497f-4b61-877b-58db98c6a269">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;States, &lt;br/&gt;municipalities&lt;br/&gt; and political &lt;br/&gt;subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;br/&gt;corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;preferred&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized and unrealized capital gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in earnings&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;br/&gt;corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;preferred&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized and unrealized capital gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in earnings&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross transfers into Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i1085bdeb3b104e208f4620803d5c8e4d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzEtMS0xLTEtNTIyNg_8df80b1e-1210-43a4-976c-583165aa6bd2"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i49d58ae32a674ec7a25b0cab1c107c50_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzEtMy0xLTEtNTIyNg_0766bc04-d2d9-4545-a06c-251659202940"
      unitRef="usd">37000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i9553185d57414893ad62b80064c4476b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzEtNS0xLTEtNTIyNg_00ad5702-1b48-441c-a808-4c5a6b967dd6"
      unitRef="usd">39000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i7980aa14ee0540c882652c696d24ce39_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzEtNy0xLTEtNTIyNg_7f6ee45c-5b00-419d-ab24-017e265197c5"
      unitRef="usd">12000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzEtOS0xLTEtNTIyNg_d7647bbf-fc01-4b4f-a85b-edc8105e44ba"
      unitRef="usd">88000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="ieb48192210564ac4a732e153ced3f314_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzMtMS0xLTEtNTIyNg_b171f48d-b048-4136-b002-4f9fb6a72638"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzMtMy0xLTEtNTIyNg_435749a0-f1d1-4a7b-966c-d8f1b211be4b"
      unitRef="usd">-11000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzMtNS0xLTEtNTIyNg_ac33a919-24c7-4c99-8e02-d6eda526cfd5"
      unitRef="usd">-3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzMtNy0xLTEtNTIyNg_d58cc4e5-cc81-45bd-9f96-da1ff1323651"
      unitRef="usd">18000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzMtOS0xLTEtNTIyNg_2bb94483-e113-4571-829e-78f7b997fd37"
      unitRef="usd">4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ieb48192210564ac4a732e153ced3f314_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzQtMS0xLTEtNTIyNg_21d63dc6-018b-40c8-bccf-0bee7bce9371"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzQtMy0xLTEtNTIyNg_b4298ad2-2ae7-4a28-a7cc-b50f450c8dcb"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzQtNS0xLTEtNTIyNg_395bd35a-cae8-4b70-b4cc-6bcd5a0ab854"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzQtNy0xLTEtNTIyNg_63cd24f3-5338-40de-ad1d-1f86327b3ac8"
      unitRef="usd">-5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzQtOS0xLTEtNTIyNg_edcc49f6-a5a7-4e2a-92c9-69e1bbb5f7e2"
      unitRef="usd">-5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="ieb48192210564ac4a732e153ced3f314_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzUtMS0xLTEtNTIyNg_65aa1208-e18c-4b78-bdb6-2b68f09ebbce"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzUtMy0xLTEtNTIyNg_25aa0347-3d82-4c22-902c-e3bb2e60ecd3"
      unitRef="usd">27000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzUtNS0xLTEtNTIyNg_39b63cdb-63e0-479b-b659-5654f495baab"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzUtNy0xLTEtNTIyNg_dd404977-a350-47ed-b8c0-8bc028d0c777"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzUtOS0xLTEtNTIyNg_7c04e864-a24f-4383-9703-6eea1d703591"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="ieb48192210564ac4a732e153ced3f314_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzYtMS0xLTEtNTIyNg_529f301d-885e-4664-bf6e-5da14ec1a749"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzYtMy0xLTEtNTIyNg_11c3a933-712b-4bd6-97c5-77283f83a513"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzYtNS0xLTEtNTIyNg_b5d909cb-7b1e-42a6-920f-7b9d4bbdc915"
      unitRef="usd">9000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzYtNy0xLTEtNTIyNg_363028ec-b336-413e-b5e7-a924f7014413"
      unitRef="usd">24000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzYtOS0xLTEtNTIyNg_4b78b579-e6f5-41e5-b12b-54fe9d41b2a1"
      unitRef="usd">33000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="ieb48192210564ac4a732e153ced3f314_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzctMS0xLTEtNTIyNg_59c4f32f-5ead-4fb3-a6b6-1ed999be8e80"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzctMy0xLTEtNTIyNg_993f61dd-d59e-469a-94fb-f4213a3289a1"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzctNS0xLTEtNTIyNg_5be050f0-932f-4a9b-8a0d-bfbf1c6dabbd"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzctNy0xLTEtNTIyNg_bcf1fc27-d322-4aa6-b929-8db859bacd9e"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzctOS0xLTEtNTIyNg_60354691-3fd2-4036-8adc-3c46c240b18e"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="ieb48192210564ac4a732e153ced3f314_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzgtMS0xLTEtNTIyNg_5e2bae14-8f7c-45ff-a577-ca66a9bee573"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i2605dd2d8cb34ea7ba887d982e558288_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzgtMy0xLTEtNTIyNg_92661447-bae2-41c3-b9ad-072f7cc96ebe"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i5956e1d28e4d4a94b5ca223c3aa760d6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzgtNS0xLTEtNTIyNg_ee2304cb-db46-448a-b60f-3e03dfe3770e"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="icbcc5e37e1544fc3bcdaf7b91bc9f8a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzgtNy0xLTEtNTIyNg_4a2ecb78-0cd0-43e3-b7b3-01de45fb5d71"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzgtOS0xLTEtNTIyNg_7a5c6d84-7986-4c90-9e53-c164f54700ed"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ice331df2b98e46fea9be5f51151c8e6b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzktMS0xLTEtNTIyNg_36894318-2a26-472a-95d2-9a8afbb1172c"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ib2db80d0e7344f35840de60bfea8a22a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzktMy0xLTEtNTIyNg_3e6b8f73-2a50-45d8-ae6a-fde0ba8f46dc"
      unitRef="usd">52000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i43a7de1365ad4a64915e5f9da6e4dd39_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzktNS0xLTEtNTIyNg_266f76a7-f6fa-4622-b9d7-d1d336089bd0"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ie604f7e6063c410db0270a579e5c2e1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzktNy0xLTEtNTIyNg_77adf5ac-f5d3-47db-9862-6301c7982d5f"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i7e22f02c654244d596daa5e51b729587_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTphYWM2MDAzYzgzZmM0OGY0OGFiNzllMDk1NTAyNjVjMC90YWJsZXJhbmdlOmFhYzYwMDNjODNmYzQ4ZjQ4YWI3OWUwOTU1MDI2NWMwXzktOS0xLTEtNTIyNg_bc762556-10ab-4d6b-83ca-cd5bc5e3010d"
      unitRef="usd">84000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2Xzc2OTY1ODE0MDkwNjc_ebc3915b-73f7-4757-be20-7bae8d16b9dd"
      unitRef="usd">-4000000</us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ic2c1a17b1b7b4bc6b1eed4e29b39070f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzEtMS0xLTEtMA_e95a19ed-08c3-43ec-9b04-d022e34821a4"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i60f83ba007004358b8f859c6f7774937_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzEtMy0xLTEtMA_9f5f0adc-c9ef-4628-bea3-49a1717913a3"
      unitRef="usd">67000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i488b7e7f18e24adab3814dcb16ac304c_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzEtNS0xLTEtMA_514fdca8-57ee-4d7b-ac38-3865f0580f07"
      unitRef="usd">54000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ie354c2c65a4c4f7abcb39006882cccc7_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzEtNy0xLTEtMA_90108b2a-9527-436e-a8d8-a3c171e4d73b"
      unitRef="usd">7000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i2bacd808153c4072ae90e6431d9f3e8b_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzEtOS0xLTEtMA_79888682-8230-4377-8468-d59a3e012077"
      unitRef="usd">131000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i9af5df3294d4476b83876447a5baef98_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzMtMS0xLTEtMA_e12d98d6-cebd-49bf-81d3-e72644d34432"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i244c2d6efb77428f9129af9df189e973_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzMtMy0xLTEtMA_f7142316-6813-40ec-b211-993f2930f6f6"
      unitRef="usd">-33000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzMtNS0xLTEtMA_f743e325-beba-40cf-93bb-3183cc8a2fb0"
      unitRef="usd">13000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzMtNy0xLTEtMA_1b6c0076-5e32-45c9-ab0c-55162f063144"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzMtOS0xLTEtMA_5b8fe4c2-f2cd-44d1-bb98-4bd311f907c5"
      unitRef="usd">-20000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i9af5df3294d4476b83876447a5baef98_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzQtMS0xLTEtMA_486768e2-b02a-40a9-8292-df6b6bc5170e"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i244c2d6efb77428f9129af9df189e973_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzQtMy0xLTEtMA_4bb72281-dd4d-4309-af37-70378b8f1d78"
      unitRef="usd">18000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzQtNS0xLTEtMA_3f379676-c547-46f0-ae35-6e091229430d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzQtNy0xLTEtMA_365edac1-8607-4219-87e9-25a45e3318ee"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzQtOS0xLTEtMA_b2beed9a-a282-49b6-b137-ffdfe627f517"
      unitRef="usd">23000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i9af5df3294d4476b83876447a5baef98_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzUtMS0xLTEtMA_db21f9d9-9975-4965-b8ca-c48293957487"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i244c2d6efb77428f9129af9df189e973_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzUtMy0xLTEtMA_91732837-14e5-48e1-aeb3-18827ddfcdeb"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzUtNS0xLTEtMA_1caddfcc-9db2-4bb5-9452-6373e1720895"
      unitRef="usd">13000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzUtNy0xLTEtMA_0f05b955-dd3a-4431-9e01-368a64eca121"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzUtOS0xLTEtMA_c22945a5-f801-46e5-b374-89e48c8bc6d1"
      unitRef="usd">18000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i9af5df3294d4476b83876447a5baef98_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzYtMS0xLTEtMA_e6df9015-ba11-43e9-a8ad-0c2aa1b8c0b6"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i244c2d6efb77428f9129af9df189e973_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzYtMy0xLTEtMA_8e59e107-ab6e-46ef-ad7c-066043aa9074"
      unitRef="usd">6000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzYtNS0xLTEtMA_778b58b1-2a9c-492d-8b00-0b2e0e154e9a"
      unitRef="usd">41000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzYtNy0xLTEtMA_230d5a8e-69b6-4c6d-b413-1c65fcda8fe2"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzYtOS0xLTEtMA_8a77d57f-09fc-4a55-8c40-1030345a7bf6"
      unitRef="usd">47000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i9af5df3294d4476b83876447a5baef98_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzctMS0xLTEtMA_2d189481-0208-4f0a-a654-c516f6ce8753"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i244c2d6efb77428f9129af9df189e973_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzctMy0xLTEtMA_4b33f0cc-a576-43c1-8da0-5322cacd401b"
      unitRef="usd">12000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzctNS0xLTEtMA_ca4ddfcc-dc4a-4ffc-80e3-2789819d4e82"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzctNy0xLTEtMA_f4c2bc7e-0e6f-4028-a7ec-f58382a25eee"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzctOS0xLTEtMA_ecaeb76a-f6c7-4857-b0a6-403f3c389707"
      unitRef="usd">13000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i9af5df3294d4476b83876447a5baef98_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzgtMS0xLTEtMA_ebf62fb2-e8e4-4986-8fce-e694a36dfb00"
      unitRef="usd">-4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i244c2d6efb77428f9129af9df189e973_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzgtMy0xLTEtMA_e3905008-a472-48a6-8be6-fa456a4d6b4b"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="idcd7678b7c944f4c9b63362df5fc1254_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzgtNS0xLTEtMA_0c9f5d87-83bb-449f-850f-e31b80e50cc1"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i14d479f020b74f3786dd0d273d9b9293_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzgtNy0xLTEtMA_07897e1b-eea4-41fe-acd7-36f2ba28d662"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="ifeb339cae494434eb8e433cc3968a848_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzgtOS0xLTEtMA_5884afe8-e754-4d74-8fa2-6b21833c8936"
      unitRef="usd">-4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i10d143f8d4624b888878df58de333010_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzktMS0xLTEtMA_b61ac64f-f605-488f-aa52-0e11a9ba78ef"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i49d58ae32a674ec7a25b0cab1c107c50_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzktMy0xLTEtMA_7abfe62d-a382-4973-a3ba-00f46300c3a1"
      unitRef="usd">37000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i9553185d57414893ad62b80064c4476b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzktNS0xLTEtMA_f0de2c37-7008-4a45-97fe-d491af1f6021"
      unitRef="usd">39000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i7980aa14ee0540c882652c696d24ce39_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzktNy0xLTEtMA_174a5922-5e89-4f03-b418-6e0edde3fb7e"
      unitRef="usd">12000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpjMDg3NWRjYjdlMDU0MWM5OGY3YjQ3NGE4ZDEzZmY0MC90YWJsZXJhbmdlOmMwODc1ZGNiN2UwNTQxYzk4ZjdiNDc0YThkMTNmZjQwXzktOS0xLTEtMA_0f439dd2-d873-4293-9be4-4484b7618ab5"
      unitRef="usd">88000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i3c34bf51a0004f2da4f3173e1abb80a8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpkNjgzOGZiNGJmOTg0ZTgzOWVlNzU5M2I2NzZmZjBmZS90YWJsZXJhbmdlOmQ2ODM4ZmI0YmY5ODRlODM5ZWU3NTkzYjY3NmZmMGZlXzEtMS0xLTEtNTI5Ng_4ebf5f52-e4bf-46f2-987c-790d833b4920"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i89a12d5819e147e7bc86f9b529bb3c15_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpkNjgzOGZiNGJmOTg0ZTgzOWVlNzU5M2I2NzZmZjBmZS90YWJsZXJhbmdlOmQ2ODM4ZmI0YmY5ODRlODM5ZWU3NTkzYjY3NmZmMGZlXzEtMS0xLTEtMA_6690f030-68d1-4ed6-94dc-10b8ac91ad32"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i3c34bf51a0004f2da4f3173e1abb80a8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpkNjgzOGZiNGJmOTg0ZTgzOWVlNzU5M2I2NzZmZjBmZS90YWJsZXJhbmdlOmQ2ODM4ZmI0YmY5ODRlODM5ZWU3NTkzYjY3NmZmMGZlXzItMS0xLTEtNTI5Ng_1cf31bfa-d950-451e-9d74-cf8e41377e7c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i89a12d5819e147e7bc86f9b529bb3c15_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpkNjgzOGZiNGJmOTg0ZTgzOWVlNzU5M2I2NzZmZjBmZS90YWJsZXJhbmdlOmQ2ODM4ZmI0YmY5ODRlODM5ZWU3NTkzYjY3NmZmMGZlXzItMS0xLTEtMA_01b098de-97f7-45d1-93ea-f0f9f2bda8e7"
      unitRef="usd">4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i3c34bf51a0004f2da4f3173e1abb80a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpkNjgzOGZiNGJmOTg0ZTgzOWVlNzU5M2I2NzZmZjBmZS90YWJsZXJhbmdlOmQ2ODM4ZmI0YmY5ODRlODM5ZWU3NTkzYjY3NmZmMGZlXzMtMS0xLTEtNTI5Ng_94fe0583-e82c-4866-8f3d-11343f4efd2b"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i89a12d5819e147e7bc86f9b529bb3c15_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTpkNjgzOGZiNGJmOTg0ZTgzOWVlNzU5M2I2NzZmZjBmZS90YWJsZXJhbmdlOmQ2ODM4ZmI0YmY5ODRlODM5ZWU3NTkzYjY3NmZmMGZlXzMtMS0xLTEtMA_2f7d2066-0511-4030-9f10-419ac64a8017"
      unitRef="usd">-4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzExMDE1_55db5dfe-1afa-4bde-8d56-4add8fc66eb1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;(1)It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information regarding the valuation of cost method investments.</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i281d455fefd94775a95b6168db361569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzQtMS0xLTEtMA_c7d66712-1989-4c53-8997-e7e92e3f291f"
      unitRef="usd">1047000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="if101d6a0ae7e4064a00c572a41fb9b2d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzQtMy0xLTEtMA_eac43f8b-2693-41b9-8216-a95fb740c75e"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="if5b578dc25944a4fbe4f6a957829e2d8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzQtNS0xLTEtMA_466d7881-6787-4e01-85e3-364fbbb8b0c9"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i04dac01b07d44177a2aaf98a61848abf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzQtNy0xLTEtMA_27e0ece1-ac3e-4526-9022-1ddd7ac8b6d3"
      unitRef="usd">1070000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="id19a4d6575054945aa1e86e5f0871e33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzQtOS0xLTEtMA_caa9fa07-f6e1-408e-bf88-d40e3abc1020"
      unitRef="usd">1070000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i281d455fefd94775a95b6168db361569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzUtMS0xLTEtMA_68d1ddfd-2882-4b01-997c-6d0539809a12"
      unitRef="usd">145000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i281d455fefd94775a95b6168db361569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzgtMS0xLTEtMA_d6ff5032-0aa7-4cce-b715-d97111b90d03"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="if101d6a0ae7e4064a00c572a41fb9b2d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzgtMy0xLTEtMA_5be8e9e9-fc99-48fa-826d-8132a7fb6684"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="if5b578dc25944a4fbe4f6a957829e2d8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzgtNS0xLTEtMA_fc86895e-7fb4-472d-b277-9a84d0c566c0"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i04dac01b07d44177a2aaf98a61848abf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzgtNy0xLTEtMA_8be67263-8154-4adb-b833-35422cad9e73"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="id19a4d6575054945aa1e86e5f0871e33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzgtOS0xLTEtMA_3318bf70-1ba7-4952-a8e8-5c196402b9a5"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i281d455fefd94775a95b6168db361569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzktMS0xLTEtMA_31b18b6a-8942-4dfa-8ab5-4c2a073c838a"
      unitRef="usd">322000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="if101d6a0ae7e4064a00c572a41fb9b2d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzktMy0xLTEtMA_6f4f5305-8a65-4fe6-a5bd-3b7310921403"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="if5b578dc25944a4fbe4f6a957829e2d8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzktNS0xLTEtMA_d5cf3fc8-8c55-4f75-a45a-1fd59a897965"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i04dac01b07d44177a2aaf98a61848abf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzktNy0xLTEtMA_d0b09bbb-3208-45f2-ae83-4b317980684a"
      unitRef="usd">371000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="id19a4d6575054945aa1e86e5f0871e33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzktOS0xLTEtMA_6ea63ac7-cff5-4846-a618-3a2e2b829092"
      unitRef="usd">371000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i281d455fefd94775a95b6168db361569_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzEwLTEtMS0xLTA_5ddb4b82-70c1-4697-b831-6d6a7316f66b"
      unitRef="usd">64647000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if101d6a0ae7e4064a00c572a41fb9b2d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzEwLTMtMS0xLTA_df9f38ac-c325-4c1f-974b-0956b3373af8"
      unitRef="usd">75940000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if5b578dc25944a4fbe4f6a957829e2d8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzEwLTUtMS0xLTA_86b8364a-de11-4787-8182-d06d18857630"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i04dac01b07d44177a2aaf98a61848abf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzEwLTctMS0xLTA_536eac07-eb7f-4d0e-8019-93cbc3f82ffb"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id19a4d6575054945aa1e86e5f0871e33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzEwLTktMS0xLTA_98c8562d-3870-4002-9750-c47b504bc00c"
      unitRef="usd">75940000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ib042e1b736b6487fa6a695c2e0d0ef4e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE0LTEtMS0xLTUzMjM_8e9bbafc-2725-4576-b054-6cb3f86e2855"
      unitRef="usd">1213000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="id59f0110266f4824ba6157134876f465_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE0LTMtMS0xLTUzMjM_bbe1c8f9-82ac-440c-a530-ee07876e08a1"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i6557af605d654a8e8081d5968b6b3548_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE0LTUtMS0xLTUzMjM_e50cd0d7-99cb-46a8-8f25-38c5cd262a02"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i100418be515a4d90809febbdcf54309f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE0LTctMS0xLTUzMjM_91789bb8-5ddd-40b1-807a-c886511d3d46"
      unitRef="usd">1239000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ib991f27f97f044478758250bf930edc1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE0LTktMS0xLTUzMjM_18e584c8-6efb-4e25-931e-24238eed8ede"
      unitRef="usd">1239000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ib042e1b736b6487fa6a695c2e0d0ef4e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE1LTEtMS0xLTUzMjM_4edb3bf9-76da-4c40-babd-803fd16473fc"
      unitRef="usd">149000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ib042e1b736b6487fa6a695c2e0d0ef4e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE4LTEtMS0xLTUzMjM_44bee085-231d-4146-91ea-857acf8075cb"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="id59f0110266f4824ba6157134876f465_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE4LTMtMS0xLTUzMjM_ca996949-2c35-4d2c-8932-12c32b805151"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i6557af605d654a8e8081d5968b6b3548_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE4LTUtMS0xLTUzMjM_77a94b5e-bae8-496a-a085-82b2e55115a4"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i100418be515a4d90809febbdcf54309f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE4LTctMS0xLTUzMjM_2f18c49d-7449-4547-afed-66e33cfde03b"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ib991f27f97f044478758250bf930edc1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE4LTktMS0xLTUzMjM_525ab0cc-ef52-4e65-96dc-8129666c8cdd"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ib042e1b736b6487fa6a695c2e0d0ef4e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE5LTEtMS0xLTUzMjM_6a08578c-42db-4172-8d6a-d51140427999"
      unitRef="usd">372000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="id59f0110266f4824ba6157134876f465_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE5LTMtMS0xLTUzMjM_75bd4fba-ffba-4a63-8584-f579c797da7f"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i6557af605d654a8e8081d5968b6b3548_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE5LTUtMS0xLTUzMjM_7a6dee22-8e20-4b53-a23f-1eee5c038640"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i100418be515a4d90809febbdcf54309f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE5LTctMS0xLTUzMjM_a7978e70-89f0-4184-89e3-4791ba76d5b9"
      unitRef="usd">392000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ib991f27f97f044478758250bf930edc1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzE5LTktMS0xLTUzMjM_8d6ed9bb-c418-43cf-b7fa-105184c56d33"
      unitRef="usd">392000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib042e1b736b6487fa6a695c2e0d0ef4e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzIwLTEtMS0xLTUzMjM_01ff142e-e5b3-4ce1-8c98-7427f091b98e"
      unitRef="usd">68480000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id59f0110266f4824ba6157134876f465_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzIwLTMtMS0xLTUzMjM_4b5bbf03-68e1-4c8a-a301-5937cd2f5046"
      unitRef="usd">74306000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6557af605d654a8e8081d5968b6b3548_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzIwLTUtMS0xLTUzMjM_59f3ba28-1e24-4d9c-952d-208c3447aa6e"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i100418be515a4d90809febbdcf54309f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzIwLTctMS0xLTUzMjM_b95869dc-225f-42d1-be65-aeb53d37f0d3"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib991f27f97f044478758250bf930edc1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTowYjYxMGNlOTc0OTI0MDg4ODljZmJkMjdmOTExMGZmZC90YWJsZXJhbmdlOjBiNjEwY2U5NzQ5MjQwODg4OWNmYmQyN2Y5MTEwZmZkXzIwLTktMS0xLTUzMjM_578ad9bf-4c62-4ff7-a028-90f67bacc12b"
      unitRef="usd">74306000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzExMDEy_ba9b5e5f-a976-42f3-a213-d9182e2be2c2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts financial assets at December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $29 million of other receivables at December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock>
    <us-gaap:SeparateAccountAssets
      contextRef="i57f9fd12efa94170971353c862b9029d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItMS0xLTEtMA_5aca846e-9c9a-41d6-9987-f9b6dd5d4d43"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib6543aefea2e4d4f81c09b28b2913051_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItMy0xLTEtMA_6f226ee9-156b-4f86-8b38-81be9bf06b9b"
      unitRef="usd">186000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5cf3dd46c89b44d5bdbd281a784aaa95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItNS0xLTEtMA_d08741a9-6616-42f1-9c60-e72701d6564b"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i6180b9fbac5241d0a8dc3af2706fcd51_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItNy0xLTEtMA_c7ee7345-86ad-40a7-adec-76ac256bfa6b"
      unitRef="usd">188000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="id6438f449279451c82fc37e0afbb67db_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItOS0xLTEtMA_f12e9d6f-e05f-4e50-9336-74a92ab8c877"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i28d236f896774150b7f1bc5f4da496b8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItMTEtMS0xLTA_e7d540ab-41f9-49cf-894a-70ee55935bcc"
      unitRef="usd">143000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia8ddf588ddb0403491b152484f71c14c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItMTMtMS0xLTA_1aea6561-7602-4f61-aa22-78022e2f1fe0"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i871f5afdae7444e99dd2730c1cf0cee9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzItMTUtMS0xLTA_ee450717-a895-4d2b-bca3-9185a113844c"
      unitRef="usd">145000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ibee9411da7c14a77a36a1bac009e2718_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtMS0xLTEtMA_39212496-98af-4c53-98f0-a5916eb78ce2"
      unitRef="usd">1465000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i4fe2ce5da7414160ae14468a18322af4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtMy0xLTEtMA_06e39a5b-9a62-4b79-a218-f8980086af30"
      unitRef="usd">2634000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iff428bc79a6944198cdd6baa0d71d0b1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtNS0xLTEtMA_b240e795-d151-4b59-8e50-35364c07416c"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i0c958b1240244ab49139ba6f5f3c28d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtNy0xLTEtMA_84c2f2e0-04f0-495c-812c-f7556d2541bb"
      unitRef="usd">4099000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i1a35d7e4fc984bbd812c51700e1979e2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtOS0xLTEtMA_7b949e82-2628-4bec-811f-4870d72c1992"
      unitRef="usd">1224000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia00b03bec0a84260b8fe2013746a2f95_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtMTEtMS0xLTA_0b47d035-6c89-4594-9cda-2700b11c041a"
      unitRef="usd">2589000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i280afee039b24b5c9a7ca13a82b422e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtMTMtMS0xLTA_a2f2b7d8-a6c8-49ba-8579-19d5acdc406d"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib0e7bd646c054ce0b4531b2eb42e4c6c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzMtMTUtMS0xLTA_84af7dd5-9cc1-4ba1-a967-a56f80fb8a72"
      unitRef="usd">3813000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie69e76ed83f946baa094f2cc5d6eed7c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtMS0xLTEtMA_d1177b22-2694-4173-b450-8a456b6f565f"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i7305113d58334ee181e867ee40fba5ea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtMy0xLTEtMA_48439101-8ad2-4297-88cd-670c84e80723"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i460c17b4dd6047799d283a4d6ac8e89e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtNS0xLTEtMA_ddb56351-96d3-4355-976a-dfe88d19c480"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i03b2619a7c974ff2a2f5ae867e8f37e9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtNy0xLTEtMA_d26ea3fe-2eb7-4bb7-a3bc-cf5ecd26ac76"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i151d6d04ea0b4c4d8082b77226a45d78_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtOS0xLTEtMA_8c49b657-b8da-4937-9289-cc6e1b4f4506"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i24eb76bad3d44b72b3d464f255226436_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtMTEtMS0xLTA_7cb78493-4daf-44c1-b9ed-86a759a540e0"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ibc128aa047224725a06bd6f71841db12_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtMTMtMS0xLTA_2d7c35f7-a188-423a-aa3b-9a5126e3351d"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i54973a0f47c84614ac6eac855bff8c4a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzQtMTUtMS0xLTA_59043808-62f4-4239-833d-0ba36fe00410"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic4c1904e935648538c8d82dcc767f325_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtMS0xLTEtMA_e9b92b91-6c2f-44c0-baf3-2750ba693576"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i9bb3afb7703f41758890d49de4633ba9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtMy0xLTEtMA_c42f4764-1dc8-40ea-a0aa-62d2d03282b1"
      unitRef="usd">563000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i42c5a9f858b74f68b1093b16815b1cce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtNS0xLTEtMA_5b67ae50-01ec-4fbf-a783-0ba94b32ad27"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i9cfe1fb048044ccaa0da17032f0b6155_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtNy0xLTEtMA_6b21de57-6dd4-4600-962f-169d8daf919f"
      unitRef="usd">563000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iff5a46ba7a27414b9d1202b7ad24b91e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtOS0xLTEtMA_c4bbfa64-4a9d-4e12-a6a0-79822851dfbe"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i844180dee7354a88a31506e0b8d33a2d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtMTEtMS0xLTA_8d6c50ce-0eb0-417f-81a1-fa4fbd350b18"
      unitRef="usd">499000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i19b103cf575b42eba2237027ca0840ed_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtMTMtMS0xLTA_667cc9f6-e9e5-4992-8c08-a71422ec184b"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia86e094601974260bb883cef037fa44f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzUtMTUtMS0xLTA_42cb95fe-c308-4517-89bf-7cb4ad6fef64"
      unitRef="usd">499000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if9f2ffe7a0ba474fb811572f2e0ea7e0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtMS0xLTEtMA_d849eed7-7092-4f33-83c1-6c883e019d5b"
      unitRef="usd">1467000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i4508cc8f56f04ee9a7567e40b8da3c28_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtMy0xLTEtMA_6a2ab1b1-4433-452e-b64e-287995939316"
      unitRef="usd">3385000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="id19caab13c4e4bc38082d1bdf6bc13ea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtNS0xLTEtMA_a56fea4e-6248-41fe-a416-04b4c83a2199"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i7e22f02c654244d596daa5e51b729587_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtNy0xLTEtMA_f4098678-97b8-4eb0-86c2-8ca182d931ed"
      unitRef="usd">4852000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i824ec462d55041558ba9c29476131800_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtOS0xLTEtMA_f09f9978-2248-43d9-b785-f704e02ced28"
      unitRef="usd">1226000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i427b6fb3db3448e2808f061a08c25372_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtMTEtMS0xLTA_9960fcf6-c78b-4c3d-8aea-c43a368f0d36"
      unitRef="usd">3233000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i9ec6476033e246a18cda5819f01ab27f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtMTMtMS0xLTA_85157085-232b-476b-b409-f639cf3d34db"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i7d8c98a9702e49129c36c9e4ba15bda9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90YWJsZTo0NTE5ZWJmZTk4MjM0NDEyYjU5YjhiNmQ0ZWI4YWMwOC90YWJsZXJhbmdlOjQ1MTllYmZlOTgyMzQ0MTJiNTliOGI2ZDRlYjhhYzA4XzYtMTUtMS0xLTA_d890d2c4-0fe0-4a4c-9bab-9e0dd11e9957"
      unitRef="usd">4459000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ide3c87bc14d942c99faa1f30e965d4f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzIxOTkwMjMyNzE2Mjk_55b82151-f52c-4d2a-ac91-8228feede386"
      unitRef="usd">29000000</us-gaap:SeparateAccountAssets>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i65c51381aa1a459fa5e530ac9f5de9f2_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzIxOTkwMjMyNzE2NTY_f9448eef-10d1-48d8-9675-8adabbb2e133"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i91b1952fb7784e7f9e6499530764f7ad_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzIxOTkwMjMyNzE2NTY_fedbe1d3-2795-4717-aaaa-fd27ad8531f9"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:DerivativeCollateralObligationToReturnSecurities
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzEwOTk1MTE2NDM0NjQ_8775f6b8-185b-42c4-9f1c-5f07f66c0bd0"
      unitRef="usd">2000000</us-gaap:DerivativeCollateralObligationToReturnSecurities>
    <us-gaap:DerivativeLiabilityCollateralRightToReclaimCashOffset
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzMvZnJhZzo1NmI1N2JlYjYxM2E0ZmZjOGY3NjIyMzg3NGU1ODEwNi90ZXh0cmVnaW9uOjU2YjU3YmViNjEzYTRmZmM4Zjc2MjIzODc0ZTU4MTA2XzEwOTg0_d55f32e1-4847-4fae-9dbd-2467b2754064"
      unitRef="usd">3000000</us-gaap:DerivativeLiabilityCollateralRightToReclaimCashOffset>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzcxNzc_cf4458f1-b523-4811-952d-11cd051ac67e">Goodwill and Other Intangibles&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment realignment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture of Workers&#x2019; Compensation business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2020, the decrease in the carrying amount of goodwill was primarily driven by the divestiture of the Workers&#x2019; Compensation business, partially offset by goodwill associated with immaterial acquisitions. During the year ended December&#160;31, 2019, the increase in the carrying amount of goodwill was primarily driven by purchase accounting adjustments associated with the Aetna Acquisition. See Note 2 &#x2018;&#x2018;Acquisitions and Divestitures&#x2019;&#x2019; for further discussion regarding the Workers&#x2019; Compensation business divestiture and the Aetna Acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, the Company also realigned the composition of its segments to correspond with changes to its operating model and to reflect how the Chief Operating Decision Maker (the &#x201c;CODM&#x201d;) reviews information and manages the business. As a result of this realignment, the Company reallocated the associated goodwill balance to the Pharmacy Services and Health Care Benefits segments based on a relative fair value approach. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill Impairment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of both 2020 and 2019, the Company performed its required annual impairment tests of goodwill. The results of these impairment tests indicated that there was no impairment of goodwill. At both December&#160;31, 2020 and 2019, cumulative goodwill impairments were $6.1 billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The LTC reporting unit has experienced industry-wide challenges that have impacted management&#x2019;s ability to grow the business at the rate that was originally estimated when the Company acquired Omnicare, Inc. (&#x201c;Omnicare&#x201d;) in 2015. Those challenges include lower client retention rates, lower occupancy rates in skilled nursing facilities, the deteriorating financial health of numerous skilled nursing facility customers which resulted in a number of customer bankruptcies in 2018, and continued facility reimbursement pressures. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the update of its current and long-term forecasts in June 2018, management determined that there were indicators that the LTC reporting unit&#x2019;s goodwill may be impaired and, accordingly, management performed an interim goodwill impairment test as of June 30, 2018. The results of that interim impairment test showed that the fair value of the LTC reporting unit was lower than the carrying value, resulting in a $3.9 billion pre-tax goodwill impairment charge in the second quarter of 2018. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2018, the Company performed its required annual impairment tests of goodwill and concluded there was no impairment of goodwill or trade names. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2018, the LTC reporting unit missed its forecast primarily due to operational issues and customer liquidity issues, including one significant customer bankruptcy. Additionally, LTC management submitted updated projected financial results which showed significant additional deterioration primarily due to continued industry and operational challenges including lower occupancy rates in skilled nursing facilities, significant deterioration in the financial health of numerous skilled nursing facility customers and continued facility reimbursement pressures. Based on these updated projections, management determined that there were indicators that the LTC reporting unit&#x2019;s goodwill may be further impaired and, accordingly, management performed an interim goodwill impairment test during the fourth quarter of 2018. The results of that interim impairment test showed that the fair value of the LTC reporting unit was lower than the carrying value, resulting in an additional $2.2 billion pre-tax goodwill impairment charge in the fourth quarter of 2018. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the remaining goodwill balance in the LTC reporting unit was $431 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s intangible assets as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions, except weighted average life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks (indefinite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships and covenants not to compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of Business Acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,481)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks (indefinite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships and covenants not to compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of Business Acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,038)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for intangible assets totaled $2.3 billion, $2.4 billion and $1.0 billion for the years ended December 31, 2020, 2019 and 2018, respectively. The projected annual amortization expense for the Company&#x2019;s intangible assets for the next five&#160;years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzcxNzk_830bcf1c-a5d9-43f8-8fe9-446286d96c4a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment realignment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase accounting adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture of Workers&#x2019; Compensation business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i1c56d1167edd4939801f422a336b0abc_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEtMS0xLTEtMA_4f243c72-6c4f-45f7-ae35-4d8a19224ced"
      unitRef="usd">23388000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2f780e49e5ac454294cb92045dbbedba_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEtMy0xLTEtMA_d4c0fe5c-37ae-4eba-825a-7d76f8b3e3e7"
      unitRef="usd">10806000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i328ef57235b84be59c08ccc5a5935e02_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEtNS0xLTEtMA_ab4f38a5-3ee9-4234-8fe4-3ed60a5e2863"
      unitRef="usd">44484000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEtNy0xLTEtMA_99f5d881-9129-452d-b518-4bda2a5c9ab6"
      unitRef="usd">78678000000</us-gaap:Goodwill>
    <us-gaap:GoodwillTransfers
      contextRef="i5423b7aeb71b4180a07350c4973d0d2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzItMS0xLTEtMA_ab89ec4a-a88a-4f0e-a549-2230ecb1d20f"
      unitRef="usd">194000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i015c0f06a5d5429bb1541c67f66811a0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzItMy0xLTEtMA_7cb13d88-2552-4754-ac69-0401577c1217"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i052772f862ef450c8eb33c1ce00be32b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzItNS0xLTEtMA_e25d66a7-2db7-43ab-8922-35370321223f"
      unitRef="usd">-194000000</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillTransfers
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzItNy0xLTEtMA_78cda02d-2baa-4b46-9965-2b6e4343e2c2"
      unitRef="usd">0</us-gaap:GoodwillTransfers>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i5423b7aeb71b4180a07350c4973d0d2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzMtMS0xLTEtMA_c6cea720-6174-4976-8cef-cd87532be297"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i015c0f06a5d5429bb1541c67f66811a0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzMtMy0xLTEtMA_3f966c6d-97df-4044-980b-28cf2564b548"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i052772f862ef450c8eb33c1ce00be32b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzMtNS0xLTEtMA_74245589-1ec5-4f9a-94fb-7494818120c0"
      unitRef="usd">1071000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzMtNy0xLTEtMA_60faf03f-1421-49f2-9df1-3978cd8a9e27"
      unitRef="usd">1071000000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i5423b7aeb71b4180a07350c4973d0d2f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzQtMS0xLTEtMA_56c76da7-8579-4d17-8bf9-abd1fa6594e3"
      unitRef="usd">1000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i015c0f06a5d5429bb1541c67f66811a0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzQtMy0xLTEtMA_d168c5e9-4c9e-4797-9aa0-85273081c567"
      unitRef="usd">-1000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i052772f862ef450c8eb33c1ce00be32b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzQtNS0xLTEtMA_8778db97-08f4-4d6b-bb6c-938e14f7af3c"
      unitRef="usd">0</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzQtNy0xLTEtMA_84a7ab67-e471-476a-ac2c-218a49c27fba"
      unitRef="usd">0</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="i115aa53eff704e2796feb2dab7050983_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzYtMS0xLTEtMA_6755286c-8891-4b31-8efb-1a646f638070"
      unitRef="usd">23581000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibc25230039c44ea89e091836ed33b5f4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzYtMy0xLTEtMA_de350619-f71d-473e-a3e8-87cbaa7658a0"
      unitRef="usd">10807000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8c1e3b4bd52240c6a3a87ca6634cc223_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzYtNS0xLTEtMA_6a5f6ab7-3cd8-458e-9d23-ac2abce21072"
      unitRef="usd">45361000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzYtNy0xLTEtMA_1d8de532-89e3-4982-807d-bf9874856ec9"
      unitRef="usd">79749000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i19aec03053a346be962dfd329ffc858e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzctMS0xLTEtMA_637be21f-307c-4ed0-a4b3-80690cfc170e"
      unitRef="usd">34000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iedba146ac9454388b30cd9e975a457e9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzctMy0xLTEtMA_91990cce-7363-4e9a-8c92-a16425b117c6"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i21b8848a0b0848d0b1ef073195fcf232_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzctNS0xLTEtMA_5c44e9c8-ac1a-4c3a-b300-fc7a5363233d"
      unitRef="usd">274000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzctNy0xLTEtMA_87d60858-87e0-4935-bb2c-25ad6f05739c"
      unitRef="usd">308000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i19aec03053a346be962dfd329ffc858e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzgtMS0xLTEtMA_aac1d919-8007-4a7e-a156-fd5754899444"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="iedba146ac9454388b30cd9e975a457e9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzgtMy0xLTEtMA_842773fc-16f4-4a44-a313-585f1a508c62"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i21b8848a0b0848d0b1ef073195fcf232_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzgtNS0xLTEtMA_d1c79b11-a34b-4d70-9d75-5d6b3d4159d2"
      unitRef="usd">505000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzgtNy0xLTEtMA_ad1a38a2-22ba-48ec-bb68-89dbf07d668c"
      unitRef="usd">505000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:Goodwill
      contextRef="i412092e3efa64b64bfb4e908a7aecf6f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEwLTEtMS0xLTA_15472f8d-153e-46dd-aaef-ba5d7460b179"
      unitRef="usd">23615000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1c1af2cb8e024fc0b237288131dfaa08_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEwLTMtMS0xLTA_a81f09f6-052a-45bf-86c2-caac78f5563a"
      unitRef="usd">10807000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0f1c041ab6e1476e81c0a2cce0548fb0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEwLTUtMS0xLTA_09bb4e02-ccd5-430f-bfa6-193c172fd9ec"
      unitRef="usd">45130000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2ZGU2YWI2OTk4NTY0NjEzYjA0ZTY3MmVlMzMyYTdhMy90YWJsZXJhbmdlOjZkZTZhYjY5OTg1NjQ2MTNiMDRlNjcyZWUzMzJhN2EzXzEwLTctMS0xLTA_441cf1ee-854b-4b1b-92c9-10242e71430f"
      unitRef="usd">79552000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzIxOTkwMjMyNzk4MjM_1573def0-7441-4cf2-a529-9740ac6bfcf1"
      unitRef="usd">6100000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzIxOTkwMjMyNzk4MjM_e0f6c120-c8c1-49a6-821e-d918e7e2cc83"
      unitRef="usd">6100000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4e630250890a4d9da4b21f7c24765041_D20180401-20180630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzIxOTkwMjMyNzgxNDM_6c2d843f-df3d-484c-923e-231e226d00e1"
      unitRef="usd">3900000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i890b640f721945cabfe705407b55dc08_D20180701-20180930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzIxOTkwMjMyNzk1NTA_dc619779-01b1-4e3a-8c91-68e6a337f6af"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i81f108a20d3a4e71b79be5b539cf2fb3_D20181001-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzIxOTkwMjMyNzkzOTQ_bd5f2690-7de0-41c6-954c-06c2ef82b427"
      unitRef="usd">2200000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i821644c913b3489eb143ff3327e94045_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzIxOTkwMjMyNzk1Mzk_4bc8c5ae-7ac3-4b06-8cd0-0dc1ed9f2b9f"
      unitRef="usd">431000000</us-gaap:Goodwill>
    <cvs:FinitelivedandindefinitelivedintangibleassetsTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzcxNzQ_31b91e6a-9096-4f44-98c5-4fd910ce2e93">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s intangible assets as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions, except weighted average life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks (indefinite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships and covenants not to compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of Business Acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,481)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks (indefinite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships and covenants not to compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of Business Acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,038)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:FinitelivedandindefinitelivedintangibleassetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzItMS0xLTEtMA_266c67f6-332f-4c4d-bdf7-d160f2cdadb5"
      unitRef="usd">10498000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzItNS0xLTEtMA_238d46e4-1044-4431-b4d3-c6a3c78e033c"
      unitRef="usd">10498000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i84badfbc307d4be689f1bf6c6f45530f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzMtMS0xLTEtMA_2558f878-a4d3-4722-b6fb-f219439bdd49"
      unitRef="usd">24952000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i84badfbc307d4be689f1bf6c6f45530f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzMtMy0xLTEtMA_b015df07-7caa-40c6-81b6-2e8c392a6035"
      unitRef="usd">8923000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i84badfbc307d4be689f1bf6c6f45530f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzMtNS0xLTEtMA_a1e849ed-e23c-4247-b635-6e367cbdf82e"
      unitRef="usd">16029000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i0ba3c6a5d60545c7aa5e44bfe6800541_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzMtNy0xLTEtMA_e00c0614-01e1-49db-bf50-89795a3b231e">P14Y10M24D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i67ce92b07cf64792b2f3329459fc557a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzQtMS0xLTEtMA_c27f4e42-d5bd-4ad6-a1d6-4e8ea14950dd"
      unitRef="usd">1060000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i67ce92b07cf64792b2f3329459fc557a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzQtMy0xLTEtMA_92da6508-aeb7-4a3d-a175-08a002766983"
      unitRef="usd">739000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i67ce92b07cf64792b2f3329459fc557a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzQtNS0xLTEtMA_b48bbf34-3fa9-4f4e-875f-9d143e6227a9"
      unitRef="usd">321000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="id50415e8993440b4b0cc0fa2104abfda_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzQtNy0xLTEtMA_7a8668f5-1ed8-4119-bc6e-ef2529b3681d">P3Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibc0b012207df4d0a9822ad6163fa473c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzUtMS0xLTEtMA_ca51503a-fb3a-48d9-91dd-3b6219c2c8ea"
      unitRef="usd">4203000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibc0b012207df4d0a9822ad6163fa473c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzUtMy0xLTEtMA_48ec29ae-459a-4083-8dc0-3e382ed62e81"
      unitRef="usd">440000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibc0b012207df4d0a9822ad6163fa473c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzUtNS0xLTEtMA_2f8bf9bc-27f8-4288-9da9-bc8a689e1dbf"
      unitRef="usd">3763000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i75becaee1c754117a23d47d9390aa79a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzUtNy0xLTEtMA_4f0236b1-3800-4663-8876-7b5a5af9b8ba">P20Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i72cdd4168bda4feba177b3eb839e391b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzYtMS0xLTEtMA_8be2093e-0ea3-4d24-88b4-93ba902b2771"
      unitRef="usd">590000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i72cdd4168bda4feba177b3eb839e391b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzYtMy0xLTEtMA_f12b303f-ffa9-4bf0-bdf4-fad140f33b4b"
      unitRef="usd">119000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i72cdd4168bda4feba177b3eb839e391b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzYtNS0xLTEtMA_aaefe6f7-e217-4379-b9b8-05f9334e34bd"
      unitRef="usd">471000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="id2e3c68b19214ed09360896c5196bd2e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzYtNy0xLTEtMA_e8f09e6f-ebfa-47fc-b02e-70a9a23ec135">P20Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i591aef778e8f4b08a9c034e1f397fd90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzctMS0xLTEtMA_1b2d895a-7312-4486-90fd-f6f1e4ef887b"
      unitRef="usd">320000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i591aef778e8f4b08a9c034e1f397fd90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzctMy0xLTEtMA_e4fe2094-e405-48a4-9fd1-625492003e4f"
      unitRef="usd">260000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i591aef778e8f4b08a9c034e1f397fd90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzctNS0xLTEtMA_c31f5f10-0244-4cb5-9302-469d64c943bb"
      unitRef="usd">60000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i491553d39bb44be899dcfc0772b9b2d0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzctNy0xLTEtMA_8b9a74ce-d809-4a53-b20e-f89a7c061c5e">P7Y8M12D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzgtMS0xLTEtMA_bcb28c1b-e952-40d3-a9b0-4dde081a6eaa"
      unitRef="usd">41623000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzgtMy0xLTEtMA_a490bd5c-bc3b-4f4f-aed0-80fa316f0eda"
      unitRef="usd">10481000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzgtNS0xLTEtMA_0958dfcf-b5dc-4981-8aec-0874a3e74787"
      unitRef="usd">31142000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzgtNy0xLTEtMA_5c88af4d-d15a-41fb-9bbd-37a25d024a2c">P15Y2M12D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzExLTEtMS0xLTA_fc1044ff-65ae-4fc2-b9bb-0c021c94ba33"
      unitRef="usd">10498000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzExLTUtMS0xLTA_24815eb1-62b7-4cd2-8a0b-a8ee0029b134"
      unitRef="usd">10498000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i21fdbe08c4894113b384b8256579df43_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEyLTEtMS0xLTA_f28a9668-7925-4d6d-973b-2d869dc8d78f"
      unitRef="usd">25447000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i21fdbe08c4894113b384b8256579df43_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEyLTMtMS0xLTA_ba56cf81-36ce-48e4-888d-c4932c235221"
      unitRef="usd">8128000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i21fdbe08c4894113b384b8256579df43_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEyLTUtMS0xLTA_c37d1304-a3db-406f-9cf1-3df274f988cb"
      unitRef="usd">17319000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i584138b84e0c44e79759aa9dc3e98131_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEyLTctMS0xLTA_8f3e9862-c691-49e1-b221-d19c06b4fc45">P14Y9M18D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie44e4bdd6e20403284243fce9600ca50_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEzLTEtMS0xLTA_166ac20a-5489-4879-892c-efca0265d34a"
      unitRef="usd">1060000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie44e4bdd6e20403284243fce9600ca50_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEzLTMtMS0xLTA_9dfd3812-ed99-4097-9c49-8c635b300eb5"
      unitRef="usd">386000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie44e4bdd6e20403284243fce9600ca50_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEzLTUtMS0xLTA_89fbca86-36bd-4b4c-8538-a15ba3f9b3b1"
      unitRef="usd">674000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="id2c72804fb3f40038ae0de7cee82c6ea_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzEzLTctMS0xLTA_6600d264-2901-4be9-8fa0-94c5e66273fe">P3Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie01b8cdceadc4bdc8efc4a1dccc006f8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE0LTEtMS0xLTA_97bd08cd-2502-479d-a041-389cceae70ac"
      unitRef="usd">4200000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie01b8cdceadc4bdc8efc4a1dccc006f8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE0LTMtMS0xLTA_0b8706a6-7185-469f-ab55-91c88d9548eb"
      unitRef="usd">229000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie01b8cdceadc4bdc8efc4a1dccc006f8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE0LTUtMS0xLTA_a87d8b12-677f-4b1f-8e6b-c23159f2254d"
      unitRef="usd">3971000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i63d8ba5cb3cf4c23924e487351249b95_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE0LTctMS0xLTA_488ce357-9d15-4aaf-8245-382bc88c49a7">P20Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icbfa84e1dd6d488fb10bc33f97246d8f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE1LTEtMS0xLTA_cd77c113-896c-4ae6-bf04-d32194cdd861"
      unitRef="usd">590000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icbfa84e1dd6d488fb10bc33f97246d8f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE1LTMtMS0xLTA_73af072d-cceb-458c-81e7-549182e821d3"
      unitRef="usd">63000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icbfa84e1dd6d488fb10bc33f97246d8f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE1LTUtMS0xLTA_29100147-84cd-459c-9748-46da52505c18"
      unitRef="usd">527000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i9d00c64ee40f49f090f5ef6179642e56_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE1LTctMS0xLTA_66cbe99f-2aa8-4cf3-9d2a-5333c3760e6f">P20Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie6f52fb91cf7425c82f7676b531c4967_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE2LTEtMS0xLTA_3ef65dfa-9aae-44b7-9483-bff3f7fc54f4"
      unitRef="usd">364000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie6f52fb91cf7425c82f7676b531c4967_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE2LTMtMS0xLTA_4379686b-aaf5-4481-8f15-6ecac93a0237"
      unitRef="usd">232000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie6f52fb91cf7425c82f7676b531c4967_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE2LTUtMS0xLTA_63ab13d4-bb1a-4ad5-9544-59d5fb156ba3"
      unitRef="usd">132000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i34f48c975e2748a8ab2b5a10d3e41319_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE2LTctMS0xLTA_f83f923f-2d5f-473a-ba47-e6560b67f586">P8Y1M6D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE3LTEtMS0xLTA_35146bbe-f5d8-4f60-98c6-f221d5f68f5d"
      unitRef="usd">42159000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE3LTMtMS0xLTA_f7f4d6a5-50fc-45d2-9b6b-f575622242fc"
      unitRef="usd">9038000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE3LTUtMS0xLTA_e6f766fe-80c0-44f5-bd53-d3ec52c71dee"
      unitRef="usd">33121000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTplYzA0ZGZhMWRmZjY0YjI0YWU5MGMwMWFjZjY5ZTYwZi90YWJsZXJhbmdlOmVjMDRkZmExZGZmNjRiMjRhZTkwYzAxYWNmNjllNjBmXzE3LTctMS0xLTA_cc3a4862-d85c-402a-bb7e-85b5f17f7fd5">P15Y1M6D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzY5Nzg_2bad6232-d1a0-4868-b2c1-b8db7fbb4b35"
      unitRef="usd">2300000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzY5ODI_f388f14c-ebac-4001-96fe-3d6fa3721095"
      unitRef="usd">2400000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzY5ODk_c337f771-32e6-47f9-8eb4-6b96feb6279d"
      unitRef="usd">1000000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90ZXh0cmVnaW9uOjhiMzYyZGVjM2U1OTQ4YWVhNGQ2MjA4NDgzZWUyMTE0XzcxNzY_5729f99f-1702-4c7c-8d52-00a051f15bfd">The projected annual amortization expense for the Company&#x2019;s intangible assets for the next five&#160;years is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2MzkzNDg0YTQ4ZTA0NzAxOWNjZTc5NWE0ODRhZWZkOC90YWJsZXJhbmdlOjYzOTM0ODRhNDhlMDQ3MDE5Y2NlNzk1YTQ4NGFlZmQ4XzEtMS0xLTEtMA_4089336a-3960-40eb-bb4d-5c817a8c10f8"
      unitRef="usd">2249000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2MzkzNDg0YTQ4ZTA0NzAxOWNjZTc5NWE0ODRhZWZkOC90YWJsZXJhbmdlOjYzOTM0ODRhNDhlMDQ3MDE5Y2NlNzk1YTQ4NGFlZmQ4XzItMS0xLTEtMA_ed8f2246-6318-4f42-95c6-35e9874dcc8c"
      unitRef="usd">1842000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2MzkzNDg0YTQ4ZTA0NzAxOWNjZTc5NWE0ODRhZWZkOC90YWJsZXJhbmdlOjYzOTM0ODRhNDhlMDQ3MDE5Y2NlNzk1YTQ4NGFlZmQ4XzMtMS0xLTEtMA_1b772683-77a2-4f14-a9c2-37757802b535"
      unitRef="usd">1812000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2MzkzNDg0YTQ4ZTA0NzAxOWNjZTc5NWE0ODRhZWZkOC90YWJsZXJhbmdlOjYzOTM0ODRhNDhlMDQ3MDE5Y2NlNzk1YTQ4NGFlZmQ4XzQtMS0xLTEtMA_53346899-9493-40f1-a534-6a585ffd52f0"
      unitRef="usd">1770000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMzYvZnJhZzo4YjM2MmRlYzNlNTk0OGFlYTRkNjIwODQ4M2VlMjExNC90YWJsZTo2MzkzNDg0YTQ4ZTA0NzAxOWNjZTc5NWE0ODRhZWZkOC90YWJsZXJhbmdlOjYzOTM0ODRhNDhlMDQ3MDE5Y2NlNzk1YTQ4NGFlZmQ4XzUtMS0xLTEtMA_e7baa017-a135-475d-92a8-87c4a1115c60"
      unitRef="usd">1718000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NjI_bb310ba4-dd5f-455d-ac34-64c6d1c5ca9d">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted ASU 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 842) (&#x201c;ASC 842&#x201d;) on January 1, 2019 on a modified retrospective basis. As a result, the Company&#x2019;s lease disclosures as of and for the years ended December 31, 2020 and 2019 are reported under ASC 842. Comparative financial information for the year ended December 31, 2018 has not been restated and continues to be reported under ASC 840, the lease accounting standard in effect for that period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disclosure Subsequent to the Adoption of the New Lease Accounting Standard (ASU 2016-02) &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of 15 to 25 years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of 3 to 10 years&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the years ended December&#160;31, 2020 and 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for interest portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for principal portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases as of December&#160;31, 2020 and 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except remaining lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,729&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,860&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,757&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,926&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,395&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,522&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Future operating lease payments have not been reduced by minimum sublease rentals of $306 million due in the future under noncancelable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.3 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale-Leaseback Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a guarantee of lease payments, in connection with the sale-leaseback transactions. Proceeds from sale-leaseback transactions totaled $101 million and $5 million in the years ended December 31, 2020 and 2019, respectively. Gains from sale-leaseback transactions totaled $3 million in the year ended December 31, 2020.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no material gains from sale-leaseback transactions in the year ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Store Rationalization Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2019, the Company performed a review of its retail stores and determined it would close 46 underperforming retail pharmacy stores during the second quarter of 2019. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Accordingly, an interim long-lived asset impairment test was performed. The results of the impairment test indicated that the fair value of each store asset group was lower than the carrying value. The fair value was determined using a discounted cash flow method based on estimated sublease income. In the three months ended March 31, 2019, the Company recorded a store rationalization charge of $135 million, primarily related to these operating lease right-of-use asset impairment charges, which was recorded within operating expenses in the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2019, in connection with its annual budgeting process, the Company performed an updated review of its retail stores and determined it would close an additional 22 underperforming retail pharmacy stores during the first quarter of 2020. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Accordingly, an interim long-lived asset impairment test was performed. The results of the impairment test indicated that the fair value of each store asset group was lower than the carrying value. The fair value was determined using a discounted cash flow method based on estimated sublease income. In the three months ended September&#160;30, 2019, the Company recorded a store rationalization charge of $96 million, primarily related to these operating lease right-of-use asset impairment charges, which was recorded within operating expenses in the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comparative Disclosure Prior to the Adoption of the New Lease Accounting Standard (ASU 2016-02)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s net rental expense for operating leases for the&#160;year ended December&#160;31, 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimum rentals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent rentals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rental expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total rental expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NjM_524184ff-8f78-4af8-aac9-e917c8ab7cc7">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted ASU 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 842) (&#x201c;ASC 842&#x201d;) on January 1, 2019 on a modified retrospective basis. As a result, the Company&#x2019;s lease disclosures as of and for the years ended December 31, 2020 and 2019 are reported under ASC 842. Comparative financial information for the year ended December 31, 2018 has not been restated and continues to be reported under ASC 840, the lease accounting standard in effect for that period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disclosure Subsequent to the Adoption of the New Lease Accounting Standard (ASU 2016-02) &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of 15 to 25 years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of 3 to 10 years&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the years ended December&#160;31, 2020 and 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for interest portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for principal portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases as of December&#160;31, 2020 and 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except remaining lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,729&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,860&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,757&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,926&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,395&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,522&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Future operating lease payments have not been reduced by minimum sublease rentals of $306 million due in the future under noncancelable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.3 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale-Leaseback Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a guarantee of lease payments, in connection with the sale-leaseback transactions. Proceeds from sale-leaseback transactions totaled $101 million and $5 million in the years ended December 31, 2020 and 2019, respectively. Gains from sale-leaseback transactions totaled $3 million in the year ended December 31, 2020.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no material gains from sale-leaseback transactions in the year ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Store Rationalization Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2019, the Company performed a review of its retail stores and determined it would close 46 underperforming retail pharmacy stores during the second quarter of 2019. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Accordingly, an interim long-lived asset impairment test was performed. The results of the impairment test indicated that the fair value of each store asset group was lower than the carrying value. The fair value was determined using a discounted cash flow method based on estimated sublease income. In the three months ended March 31, 2019, the Company recorded a store rationalization charge of $135 million, primarily related to these operating lease right-of-use asset impairment charges, which was recorded within operating expenses in the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2019, in connection with its annual budgeting process, the Company performed an updated review of its retail stores and determined it would close an additional 22 underperforming retail pharmacy stores during the first quarter of 2020. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Accordingly, an interim long-lived asset impairment test was performed. The results of the impairment test indicated that the fair value of each store asset group was lower than the carrying value. The fair value was determined using a discounted cash flow method based on estimated sublease income. In the three months ended September&#160;30, 2019, the Company recorded a store rationalization charge of $96 million, primarily related to these operating lease right-of-use asset impairment charges, which was recorded within operating expenses in the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comparative Disclosure Prior to the Adoption of the New Lease Accounting Standard (ASU 2016-02)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s net rental expense for operating leases for the&#160;year ended December&#160;31, 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimum rentals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent rentals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rental expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total rental expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <cvs:LesseeOperatingAndFinanceLeasesTermOfContract
      contextRef="icdcdd6decfad41b9858abc5ec839199a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzcxNQ_af461f9b-982b-4542-a92c-9ad2b2898bf1">P15Y</cvs:LesseeOperatingAndFinanceLeasesTermOfContract>
    <cvs:LesseeOperatingAndFinanceLeasesTermOfContract
      contextRef="i13bbb4efccc14c5c82049f643d62aa08_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzcyMQ_f06b9f14-dd7f-4392-8c20-ae2927d5fce6">P25Y</cvs:LesseeOperatingAndFinanceLeasesTermOfContract>
    <cvs:LesseeOperatingAndFinanceLeasesTermOfContract
      contextRef="idc7172c9ddcb4248bce1ae1aa4280d25_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzg1MQ_22215cbb-1644-4090-93a2-43ad4d5e91b5">P3Y</cvs:LesseeOperatingAndFinanceLeasesTermOfContract>
    <cvs:LesseeOperatingAndFinanceLeasesTermOfContract
      contextRef="i029b000534014642b4477f76ec44b138_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzg1Nw_68b4c8aa-faa5-4f74-9d04-a0239be491e6">P10Y</cvs:LesseeOperatingAndFinanceLeasesTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NjU_46fa2f80-9845-495b-9c07-c26d4e527225">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the years ended December&#160;31, 2020 and 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for interest portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for principal portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzEtMS0xLTEtMA_820fba4b-4244-4c19-81ce-b66887c9c619"
      unitRef="usd">2670000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzEtMy0xLTEtNDU1_a8b921b4-1dcf-45b3-8637-c48df061bd0d"
      unitRef="usd">2720000000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzMtMS0xLTEtMA_de173554-e012-44a4-8cd1-ff5f0dc4f3c9"
      unitRef="usd">56000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzMtMy0xLTEtNDU1_49f1c32e-0891-47ce-bf07-9ffc834f247c"
      unitRef="usd">38000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzQtMS0xLTEtMA_099d6d61-84fd-43d4-9394-c6c917ba505e"
      unitRef="usd">58000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzQtMy0xLTEtNDU1_cc69f342-d161-4794-87c0-f123df9d280b"
      unitRef="usd">44000000</us-gaap:FinanceLeaseInterestExpense>
    <cvs:FinanceLeaseCost
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzUtMS0xLTEtMA_ee559a6c-674c-4f75-afac-683af5022052"
      unitRef="usd">114000000</cvs:FinanceLeaseCost>
    <cvs:FinanceLeaseCost
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzUtMy0xLTEtNDU1_356aefae-45e9-4f22-9339-97fa7a92d539"
      unitRef="usd">82000000</cvs:FinanceLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzYtMS0xLTEtMA_84882e3b-be70-484a-883c-627ecfe2cfc8"
      unitRef="usd">22000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzYtMy0xLTEtNDU1_3b78e14c-57bb-45a9-bec5-c0a3d98c75f9"
      unitRef="usd">24000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzctMS0xLTEtMA_a255f7ac-725c-4052-a28f-7e1f3b1ffe3a"
      unitRef="usd">599000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzctMy0xLTEtNDU1_c886bfd6-3801-4a6d-b727-6499f03e72e6"
      unitRef="usd">581000000</us-gaap:VariableLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzgtMS0xLTEtMA_00ea2fb5-bdbc-4331-995d-92d64d527285"
      unitRef="usd">55000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzgtMy0xLTEtNDU1_d24a793c-a039-463b-b1e6-6acb3bba9483"
      unitRef="usd">50000000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzktMS0xLTEtMA_9b05e6a8-a16e-432c-91ce-9ec6ced942d1"
      unitRef="usd">3350000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo1OWQ5Y2RiZDUxNTM0MzUwYmIzMWRiYTgzZDUyYjkwMi90YWJsZXJhbmdlOjU5ZDljZGJkNTE1MzQzNTBiYjMxZGJhODNkNTJiOTAyXzktMy0xLTEtNDU1_6491003a-4124-4c14-83d6-061d84e5f9c1"
      unitRef="usd">3357000000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzItMS0xLTEtMA_e991ac0d-75b9-489e-9ce3-db974d2596f0"
      unitRef="usd">2724000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzItMy0xLTEtNDc4_a894d5ee-e430-4c0f-b1fa-18b9ae731a0f"
      unitRef="usd">2701000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzMtMS0xLTEtMA_11936a71-b230-4ce3-942e-60d503b7d359"
      unitRef="usd">58000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzMtMy0xLTEtNDc4_de3290fa-f62e-41bc-b900-e0a30d452499"
      unitRef="usd">44000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzQtMS0xLTEtMA_cf85b18b-e7df-414b-9e62-2235763c7d80"
      unitRef="usd">34000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzQtMy0xLTEtNDc4_1781988e-7d89-4c4f-833d-c056e7515153"
      unitRef="usd">26000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzYtMS0xLTEtMA_5ce4445d-a3ed-47d9-90d3-d2f966384920"
      unitRef="usd">1679000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzYtMy0xLTEtNDc4_8173f4ff-5dee-462b-934d-49c8e9b19000"
      unitRef="usd">1824000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzctMS0xLTEtMA_435fac33-78ea-4dec-8471-14cad79acf5d"
      unitRef="usd">313000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo2NjU5NDZkMmFiMGY0MjI3OWM1OWNiODFjM2ZkYjU1Mi90YWJsZXJhbmdlOjY2NTk0NmQyYWIwZjQyMjc5YzU5Y2I4MWMzZmRiNTUyXzctMy0xLTEtNDc4_f18cf519-2840-4efa-967b-f961da8187c9"
      unitRef="usd">283000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <cvs:LesseeLeaseTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NTk_0eb4767a-933b-4c60-ba25-f244106d28cd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases as of December&#160;31, 2020 and 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except remaining lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,729&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,860&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,757&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,926&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,395&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,522&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:LesseeLeaseTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzItMS0xLTEtMA_d36ab2a1-ec7c-4faa-899c-04d54efc53e4"
      unitRef="usd">20729000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzItMy0xLTEtNTEy_f42da14b-5498-4df4-9acf-ca49ff147148"
      unitRef="usd">20860000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzQtMS0xLTEtMA_3176bbcb-093e-4386-8502-892f8da1a582"
      unitRef="usd">1638000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzQtMy0xLTEtNTEy_b8aad93c-6f7c-46cb-b93e-aa7707c7baa9"
      unitRef="usd">1596000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzUtMS0xLTEtMA_4bfbbd08-1f19-415a-b436-33ce0cc9498f"
      unitRef="usd">18757000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzUtMy0xLTEtNTEy_27af33f0-230f-4c58-b3bd-e86bcb4e4e72"
      unitRef="usd">18926000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzYtMS0xLTEtMA_f1e60d7f-fd24-4d82-9c79-985974e8f0a8"
      unitRef="usd">20395000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzYtMy0xLTEtNTEy_baa14bff-be04-4c31-b7af-be0925ccf1fc"
      unitRef="usd">20522000000</us-gaap:OperatingLeaseLiability>
    <cvs:FinanceLeaseRightOfUseAssetGross
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzktMS0xLTEtMA_1312ec8c-dadf-44ff-9252-52d91886f122"
      unitRef="usd">1107000000</cvs:FinanceLeaseRightOfUseAssetGross>
    <cvs:FinanceLeaseRightOfUseAssetGross
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzktMy0xLTEtNTEy_fd65b58e-6860-4a47-af1e-5e4a5d2882e5"
      unitRef="usd">790000000</cvs:FinanceLeaseRightOfUseAssetGross>
    <cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzEwLTEtMS0xLTA_dca94209-996a-4cbe-959d-dbe251aaa184"
      unitRef="usd">106000000</cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation>
    <cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzEwLTMtMS0xLTUxMg_9c23247a-290e-4dbc-95a5-d4a10a4926dc"
      unitRef="usd">38000000</cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation>
    <cvs:FinanceLeaseRightOfUseAssetNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzExLTEtMS0xLTA_9d1a1d96-137d-49b5-8d80-788c690fe774"
      unitRef="usd">1001000000</cvs:FinanceLeaseRightOfUseAssetNet>
    <cvs:FinanceLeaseRightOfUseAssetNet
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzExLTMtMS0xLTUxMg_d842a24c-c80b-4ee7-ad65-afc7f14f7c1e"
      unitRef="usd">752000000</cvs:FinanceLeaseRightOfUseAssetNet>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzEzLTEtMS0xLTA_4d22a635-d68a-4c12-a5cf-2d80e3a8aeb2"
      unitRef="usd">33000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzEzLTMtMS0xLTUxMg_5c862be1-7b0c-465f-9fe7-cc40dccb1e79"
      unitRef="usd">27000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE0LTEtMS0xLTA_398278d6-7157-40c0-a6d0-b3cf1e8ad912"
      unitRef="usd">1050000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE0LTMtMS0xLTUxMg_0576ac29-ab8b-4fa9-b20d-d2582ffe23c7"
      unitRef="usd">781000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE1LTEtMS0xLTA_e66c16d4-7c79-4e28-968f-151538da92fe"
      unitRef="usd">1083000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE1LTMtMS0xLTUxMg_b6f99cb6-853b-4759-b046-ac9c6650b3fe"
      unitRef="usd">808000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE4LTEtMS0xLTA_952e938e-95a0-493f-bf7d-b2edda3c9390">P13Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE4LTMtMS0xLTUyMQ_08a1e856-28ee-4309-92b1-ec5f6e3b6e1c">P13Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE5LTEtMS0xLTA_a041b996-cab3-425a-ab7e-eedaa3278eac">P20Y3M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzE5LTMtMS0xLTUyMQ_6c48b784-da49-4d02-ab80-a60a97d42b2c">P20Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzIyLTEtMS0xLTA_13cecf60-3c27-4099-bb22-37328f142a70"
      unitRef="number">0.045</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzIyLTMtMS0xLTUyMQ_bfbb80b4-d47c-4c43-8b22-f9716e966daf"
      unitRef="number">0.046</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzIzLTEtMS0xLTA_46d37a3f-3aaf-4381-939b-567d8b3bcc5b"
      unitRef="number">0.056</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTphN2ZiM2Y0MWVjMTQ0M2I1OTQzNDU3NTY2NmFiYjU4MC90YWJsZXJhbmdlOmE3ZmIzZjQxZWMxNDQzYjU5NDM0NTc1NjY2YWJiNTgwXzIzLTMtMS0xLTUyMQ_359a8ea2-6e08-4d6a-8a9e-b27d81ce3526"
      unitRef="number">0.067</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NTY_a1f8f30b-6abf-4d7a-9159-e8cdd43c91b9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Future operating lease payments have not been reduced by minimum sublease rentals of $306 million due in the future under noncancelable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.3 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NjA_e7f358b0-7d45-4565-a0f0-fac4727446ce">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,747)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Future operating lease payments have not been reduced by minimum sublease rentals of $306 million due in the future under noncancelable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.3 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzEtMS0xLTEtMA_99141321-2b05-40fb-b506-d6bff40cc321"
      unitRef="usd">100000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzEtMy0xLTEtMA_b7e96381-3b63-4b48-a24c-6c9194fadab8"
      unitRef="usd">2688000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <cvs:LesseeLiabilityPaymentsYearOne
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzEtNS0xLTEtMA_83047e78-1ec2-44d5-b3fb-3f760add3cbf"
      unitRef="usd">2788000000</cvs:LesseeLiabilityPaymentsYearOne>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzItMS0xLTEtMA_ee6b8df0-bc58-4ad3-b9e3-141a1a8d17e3"
      unitRef="usd">98000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzItMy0xLTEtMA_73d8d122-5cee-4d29-9d4d-be936c943939"
      unitRef="usd">2583000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <cvs:LesseeLiabilityPaymentsDueYearTwo
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzItNS0xLTEtMA_180189fe-d231-4598-9f23-b13961f09f99"
      unitRef="usd">2681000000</cvs:LesseeLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzMtMS0xLTEtMA_6bcb67a5-85d3-41f0-a75e-bd72415be6ec"
      unitRef="usd">96000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzMtMy0xLTEtMA_82fa941b-d8aa-405a-8f46-3f04358067e9"
      unitRef="usd">2496000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <cvs:LesseeLiabilityPaymentsDueYearThree
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzMtNS0xLTEtMA_726a1609-6c6c-4da8-85e1-76ec47e6c220"
      unitRef="usd">2592000000</cvs:LesseeLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzQtMS0xLTEtMA_4875065d-6d55-4546-9ad7-e3d51f766752"
      unitRef="usd">95000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzQtMy0xLTEtMA_aec9a1b4-5673-4145-8e39-6dadcc6b2bf3"
      unitRef="usd">2269000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <cvs:LesseeLiabilityPaymentsDueYearFour
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzQtNS0xLTEtMA_352d3cd7-4e7f-4fd1-ba20-ad056e671b6c"
      unitRef="usd">2364000000</cvs:LesseeLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzUtMS0xLTEtMA_32db5195-fccc-4145-a103-720b808631cb"
      unitRef="usd">95000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzUtMy0xLTEtMA_feff16ff-8824-4327-ad1c-46898b058e9a"
      unitRef="usd">2089000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <cvs:LesseeLiabilityPaymentsDueYearFive
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzUtNS0xLTEtMA_768141b6-bb19-478b-8536-dc44249ffe5a"
      unitRef="usd">2184000000</cvs:LesseeLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzYtMS0xLTEtMA_ba228a7f-5729-4959-b2b3-aa3ec89b2d02"
      unitRef="usd">1328000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzYtMy0xLTEtMA_2acb985a-4594-4c94-971f-1db944ca0799"
      unitRef="usd">15017000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <cvs:LesseeLiabilityPaymentsDueAfterYearFive
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzYtNS0xLTEtMA_84c81476-75ba-4c3c-b023-e95f351ff6f9"
      unitRef="usd">16345000000</cvs:LesseeLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzctMS0xLTEtMA_12b00960-7e06-487b-8acc-7b98cac33927"
      unitRef="usd">1812000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzctMy0xLTEtMA_f3ded2f8-6124-4215-a425-53242c0fee40"
      unitRef="usd">27142000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <cvs:LesseeLiabilityPaymentsDue
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzctNS0xLTEtMA_fb8cf953-1740-46ec-ae4c-156960c2a15b"
      unitRef="usd">28954000000</cvs:LesseeLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzgtMS0xLTEtMA_1e8bb604-ff2f-4a6c-a44e-f8837072925c"
      unitRef="usd">729000000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzgtMy0xLTEtMA_cc318040-b6eb-45f0-99c4-2b48ff28c1ed"
      unitRef="usd">6747000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <cvs:LesseeLiabilityUndiscountedExcessAmount
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzgtNS0xLTEtMA_4770a0ea-02dd-4adc-a1da-fbeab3d5d2fd"
      unitRef="usd">7476000000</cvs:LesseeLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzktMS0xLTEtMA_4f99c4a8-a281-48f9-a1f9-fbe2b5c59572"
      unitRef="usd">1083000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzktMy0xLTEtMA_1189726f-244a-4681-8974-b0b1fb09f1cd"
      unitRef="usd">20395000000</us-gaap:OperatingLeaseLiability>
    <cvs:LeaseLiability
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo5YWZkODQ3ZDUxZDM0NTg3YjE2OWM5MzA5ZWMyZDQxYS90YWJsZXJhbmdlOjlhZmQ4NDdkNTFkMzQ1ODdiMTY5YzkzMDllYzJkNDFhXzktNS0xLTEtMA_13530e53-4707-4e2d-9f0a-67f2a25f0f75"
      unitRef="usd">21478000000</cvs:LeaseLiability>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzIzODI_4b1b4546-b265-405c-a415-1733c024c385"
      unitRef="usd">306000000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <cvs:OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzI2OTA_541b61f4-35ff-4237-b4bf-807c0ef87534"
      unitRef="usd">2300000000</cvs:OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzM1MDk_d6e6544d-7dc7-43a8-84ca-9b897ddde931"
      unitRef="usd">101000000</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzEwOTk1MTE2MzU3ODE_368ff538-c868-43ce-a308-d081ddd3276a"
      unitRef="usd">5000000</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzIxOTkwMjMyNjY2NzM_6de7f26c-3b5e-4685-98d0-5f70a2de20a8"
      unitRef="usd">3000000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzIxOTkwMjMyNjcwMzU_2ec71e7f-9880-4f13-89d6-8fb8abafe060"
      unitRef="usd">0</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <cvs:NumberOfUnderPerformingStoresPlannedClosure
      contextRef="i70084b42bcb34cf790dad3c2e153d003_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzM2Njg_1f286a97-cf1a-4832-90b8-0a82a11b4240"
      unitRef="store">46</cvs:NumberOfUnderPerformingStoresPlannedClosure>
    <cvs:StoreRationalizationCharges
      contextRef="i70084b42bcb34cf790dad3c2e153d003_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzQzMTc_e845af78-b611-4bed-aaea-994ffaa528a5"
      unitRef="usd">135000000</cvs:StoreRationalizationCharges>
    <cvs:NumberOfUnderPerformingStoresPlannedClosure
      contextRef="ib071f664e4424c34825859add41556cc_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzQ2NjQ_ec3d36d8-c1f6-4ca2-8666-167945ae1185"
      unitRef="store">22</cvs:NumberOfUnderPerformingStoresPlannedClosure>
    <cvs:StoreRationalizationCharges
      contextRef="ib071f664e4424c34825859add41556cc_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzUzMTY_0ac4a114-0e29-4faf-97ce-77420170e047"
      unitRef="usd">96000000</cvs:StoreRationalizationCharges>
    <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90ZXh0cmVnaW9uOmYxMTY3M2IwMjI4YTRkY2E5MTMzMGIyNjNkM2Y5NWEwXzc5NjE_d9871d2c-fd6e-454b-92aa-e58b3cc30344">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s net rental expense for operating leases for the&#160;year ended December&#160;31, 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.158%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Minimum rentals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent rentals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rental expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total rental expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
    <us-gaap:OperatingLeasesRentExpenseMinimumRentals
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo0MGZjNDBiODIwMGQ0MzFmODE0OWM5MTllZTE0Zjg2ZC90YWJsZXJhbmdlOjQwZmM0MGI4MjAwZDQzMWY4MTQ5YzkxOWVlMTRmODZkXzEtMS0xLTEtMA_c47d5946-4146-4fd4-8af6-dd1ae0394288"
      unitRef="usd">2528000000</us-gaap:OperatingLeasesRentExpenseMinimumRentals>
    <us-gaap:OperatingLeasesRentExpenseContingentRentals
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo0MGZjNDBiODIwMGQ0MzFmODE0OWM5MTllZTE0Zjg2ZC90YWJsZXJhbmdlOjQwZmM0MGI4MjAwZDQzMWY4MTQ5YzkxOWVlMTRmODZkXzItMS0xLTEtMA_d580815f-eccd-4b74-a1f0-06e60179bcdd"
      unitRef="usd">28000000</us-gaap:OperatingLeasesRentExpenseContingentRentals>
    <cvs:OperatingLeasesRentExpenseGross
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo0MGZjNDBiODIwMGQ0MzFmODE0OWM5MTllZTE0Zjg2ZC90YWJsZXJhbmdlOjQwZmM0MGI4MjAwZDQzMWY4MTQ5YzkxOWVlMTRmODZkXzMtMS0xLTEtMA_cef13b04-376a-4753-94d0-04ed3a8bc2e4"
      unitRef="usd">2556000000</cvs:OperatingLeasesRentExpenseGross>
    <us-gaap:OperatingLeasesRentExpenseSubleaseRentals1
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo0MGZjNDBiODIwMGQ0MzFmODE0OWM5MTllZTE0Zjg2ZC90YWJsZXJhbmdlOjQwZmM0MGI4MjAwZDQzMWY4MTQ5YzkxOWVlMTRmODZkXzQtMS0xLTEtMA_d9453226-7f16-4365-bb65-12feb09b4774"
      unitRef="usd">21000000</us-gaap:OperatingLeasesRentExpenseSubleaseRentals1>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDIvZnJhZzpmMTE2NzNiMDIyOGE0ZGNhOTEzMzBiMjYzZDNmOTVhMC90YWJsZTo0MGZjNDBiODIwMGQ0MzFmODE0OWM5MTllZTE0Zjg2ZC90YWJsZXJhbmdlOjQwZmM0MGI4MjAwZDQzMWY4MTQ5YzkxOWVlMTRmODZkXzUtMS0xLTEtMA_0352b884-228e-4603-91f3-3822594d0e85"
      unitRef="usd">2535000000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzQxODA_6c85ec78-a897-430c-a4c3-4958b298a344">Health Care Costs Payable&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is information about incurred and cumulative paid health care claims development as of December&#160;31, 2020, net of reinsurance, and the total IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for information on how the Company estimates IBNR reserves and health care costs payable as well as changes to those methodologies, if any. The Company&#x2019;s estimate of IBNR liabilities is primarily based on trend and completion factors. Claim frequency is not used in the calculation of the Company&#x2019;s liability. In addition, it is impracticable to disclose claim frequency information for health care claims due to the Company&#x2019;s inability to gather consistent claim frequency information across its multiple claims processing systems. Any claim frequency count disclosure would not be comparable across the Company&#x2019;s different claim processing systems and would not be consistent from period to period based on the volume of claims processed through each system. As a result, health care claim count frequency is not included in the disclosures below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information about incurred and paid health care claims development for the year ended December 31, 2019 is presented as required unaudited supplemental information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Incurred Health Care Claims,&lt;br/&gt;Net of Reinsurance&lt;br/&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Date of Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Health Care Claims,&lt;br/&gt;Net of Reinsurance&lt;br/&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Date of Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All outstanding liabilities for health care costs payable prior to 2019, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total outstanding liabilities for health care costs payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, the Company&#x2019;s liabilities for IBNR plus expected development on reported claims totaled approximately $6.1 billion. Substantially all of the Company&#x2019;s liabilities for IBNR plus expected development on reported claims at December&#160;31, 2020 related to the current calendar year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the December&#160;31, 2020 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-duration health care costs payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance lines other than short duration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Aetna Acquisition on November 28, 2018, the Company&#x2019;s health care costs payable balance was immaterial and related to unpaid pharmacy claims for its SilverScript PDP. The following table shows the components of the change in health care costs payable during the years ended December 31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of period &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification from pharmacy claims and discounts payable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;As of the Aetna Acquisition Date, the Company reclassified $776 million of the Pharmacy Services segment&#x2019;s unpaid retail pharmacy claims to third parties from pharmacy claims and discounts payable to health care costs payable as the third party liability was incurred to support the Health Care Benefits segment&#x2019;s insured members.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the years ended December&#160;31, 2020, 2019 and 2018 in the table above exclude (i) $11 million, $4 million and $16 million, respectively, for a premium deficiency reserve related to the Company&#x2019;s Medicaid products, (ii) $41 million, $41 million and $4 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and (iii) $221 million, $285 million and $22 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimates of prior years&#x2019; health care costs payable decreased by $429 million and $524 million in 2020 and 2019, respectively, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#x2019;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year. This development does not directly correspond to an increase in the Company&#x2019;s operating results as these reductions were offset by estimated current period health care costs when the Company established the estimate of the current year health care costs payable.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock>
    <us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzQxODI_910c60a1-9837-44e7-9866-188f1ab1c63c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information about incurred and paid health care claims development for the year ended December 31, 2019 is presented as required unaudited supplemental information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Incurred Health Care Claims,&lt;br/&gt;Net of Reinsurance&lt;br/&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Date of Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Health Care Claims,&lt;br/&gt;Net of Reinsurance&lt;br/&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Date of Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All outstanding liabilities for health care costs payable prior to 2019, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total outstanding liabilities for health care costs payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="icbd9a72694e74fb1953ac9de25db565c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzMtMS0xLTEtMA_46d8b80f-f2c4-4b6b-87f5-a9db3a142748"
      unitRef="usd">51426000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ib0a759204965465a8c57fcb74fea946b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzMtMy0xLTEtMA_223058ee-1d6a-4d79-806d-b41fcbf5f542"
      unitRef="usd">51056000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i2a55f9c69cd1488f89f0c37551af36cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzQtMy0xLTEtMA_669f9c32-5abe-45d8-9fed-23a7cd2c10d4"
      unitRef="usd">54529000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzUtMy0xLTEtMA_5f777c81-1d57-49e4-8de4-524f170982d2"
      unitRef="usd">105585000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="icbd9a72694e74fb1953ac9de25db565c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzEwLTEtMS0xLTA_9df873a3-4473-471a-bdf7-5d0b03accc8d"
      unitRef="usd">44987000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ib0a759204965465a8c57fcb74fea946b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzEwLTMtMS0xLTA_f52ba57a-9d55-4c48-99e1-aa51d9192164"
      unitRef="usd">50394000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i2a55f9c69cd1488f89f0c37551af36cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzExLTMtMS0xLTA_ceebf706-9528-4fa1-a1a6-370c60535089"
      unitRef="usd">47567000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzEyLTMtMS0xLTA_c749b92f-dfa6-4a25-bd79-58c2b11ddc36"
      unitRef="usd">97961000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzEzLTMtMS0xLTA_dbdcb389-a5de-4bc8-a88d-80824ca691ae"
      unitRef="usd">144000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo3YmRmOGM1YmZmYWQ0ZjVjYjQ4YWQ1Mzg2ODMyOWU1Ny90YWJsZXJhbmdlOjdiZGY4YzViZmZhZDRmNWNiNDhhZDUzODY4MzI5ZTU3XzE0LTMtMS0xLTA_54178be9-d00e-48fd-8389-5f79c8cb7062"
      unitRef="usd">7768000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="i0f1c041ab6e1476e81c0a2cce0548fb0_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzE3NTI_2d00a976-57f4-42de-93fe-0c4c674ae1e2"
      unitRef="usd">6100000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzQxODM_fdc2ccfe-1746-4314-b418-0c3b62390d70">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the December&#160;31, 2020 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-duration health care costs payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance lines other than short duration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo0NDVjMWJhZDlmNTk0MDJlYjZhNjQ1Y2I1ZjdjMjA3NC90YWJsZXJhbmdlOjQ0NWMxYmFkOWY1OTQwMmViNmE2NDVjYjVmN2MyMDc0XzEtMS0xLTEtMA_54178be9-d00e-48fd-8389-5f79c8cb7062"
      unitRef="usd">7768000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo0NDVjMWJhZDlmNTk0MDJlYjZhNjQ1Y2I1ZjdjMjA3NC90YWJsZXJhbmdlOjQ0NWMxYmFkOWY1OTQwMmViNmE2NDVjYjVmN2MyMDc0XzItMS0xLTEtMA_b079dafa-8ffc-42c5-a35f-e9b1c064b2c2"
      unitRef="usd">10000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo0NDVjMWJhZDlmNTk0MDJlYjZhNjQ1Y2I1ZjdjMjA3NC90YWJsZXJhbmdlOjQ0NWMxYmFkOWY1OTQwMmViNmE2NDVjYjVmN2MyMDc0XzMtMS0xLTEtMA_e02d0360-4e93-4076-9c61-09f23781f753"
      unitRef="usd">11000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo0NDVjMWJhZDlmNTk0MDJlYjZhNjQ1Y2I1ZjdjMjA3NC90YWJsZXJhbmdlOjQ0NWMxYmFkOWY1OTQwMmViNmE2NDVjYjVmN2MyMDc0XzQtMS0xLTEtMA_74a05dea-d9da-4a72-a449-059b0368385f"
      unitRef="usd">147000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTo0NDVjMWJhZDlmNTk0MDJlYjZhNjQ1Y2I1ZjdjMjA3NC90YWJsZXJhbmdlOjQ0NWMxYmFkOWY1OTQwMmViNmE2NDVjYjVmN2MyMDc0XzUtMS0xLTEtMA_ef03db72-f297-4f73-b43e-c65c591c3425"
      unitRef="usd">7936000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzQxODQ_1ff4ffbb-db5c-475d-879d-c3cd44a19d03">The following table shows the components of the change in health care costs payable during the years ended December 31, 2020, 2019 and 2018:&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of period &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification from pharmacy claims and discounts payable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;As of the Aetna Acquisition Date, the Company reclassified $776 million of the Pharmacy Services segment&#x2019;s unpaid retail pharmacy claims to third parties from pharmacy claims and discounts payable to health care costs payable as the third party liability was incurred to support the Health Care Benefits segment&#x2019;s insured members.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the years ended December&#160;31, 2020, 2019 and 2018 in the table above exclude (i) $11 million, $4 million and $16 million, respectively, for a premium deficiency reserve related to the Company&#x2019;s Medicaid products, (ii) $41 million, $41 million and $4 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and (iii) $221 million, $285 million and $22 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEtMS0xLTEtMA_28e71a67-f140-4c7b-a658-622264ef319a"
      unitRef="usd">6879000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEtMy0xLTEtMA_cf1b7f00-9d6a-4104-8697-85829a4c3548"
      unitRef="usd">6147000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i2e2b65bba50242fd9c8370770a4be117_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEtNS0xLTEtMTUzMw_ca324eed-8db3-407b-8059-11a0319b0443"
      unitRef="usd">5000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzItMS0xLTEtMA_3d30aef8-10d6-4b6f-ba91-bfb1275be76a"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzItMy0xLTEtMA_bf659b73-ff74-4030-8925-bd6dd4c604fd"
      unitRef="usd">4000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i2e2b65bba50242fd9c8370770a4be117_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzItNS0xLTEtMTUzMw_4bd3e94f-cf58-481f-8b71-7e8d67c7ecf2"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzMtMS0xLTEtMA_808564f5-a4fb-42a8-92d6-69502484b0eb"
      unitRef="usd">6874000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzMtMy0xLTEtMA_3dc2fd92-98e7-4c87-998b-91e02f3e27fe"
      unitRef="usd">6143000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i2e2b65bba50242fd9c8370770a4be117_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzMtNS0xLTEtMTUzMw_8d68e7ea-bdc8-420a-8019-83253864f5fb"
      unitRef="usd">5000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzQtMS0xLTEtMA_d1c5e323-3bdf-4767-83ab-ff75288ee2eb"
      unitRef="usd">414000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzQtMy0xLTEtMA_c35d13ac-fb17-4e62-a020-8bd54a0f9608"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzQtNS0xLTEtMTUzMw_3cfd0223-4a8b-4b57-9325-0fcbe8cdcf0f"
      unitRef="usd">5357000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification
      contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzUtMS0xLTEtMA_c80e8c64-cfe0-49fc-a5e6-6303224d483d"
      unitRef="usd">0</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification
      contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzUtMy0xLTEtMA_1d5c3a12-c0f7-4829-9719-60567362d268"
      unitRef="usd">0</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification
      contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzUtNS0xLTEtMTUzOA_d7238db6-e1e2-4cac-8640-f380114185ae"
      unitRef="usd">776000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzctMS0xLTEtMA_2e1ee4d4-9934-41bb-866e-c282295a5a48"
      unitRef="usd">55835000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzctMy0xLTEtMA_3387bdb2-0c5e-467f-8c78-96172f50f012"
      unitRef="usd">52723000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzctNS0xLTEtMTUzMw_2e84ea56-8c38-4f6f-85bb-7d907d4d808b"
      unitRef="usd">6594000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzgtMS0xLTEtMA_fa591501-c520-45a9-9f04-d56c374f29db"
      unitRef="usd">-429000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzgtMy0xLTEtMA_e3afe50b-c076-4230-8f08-0bc3adbcef10"
      unitRef="usd">-524000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzgtNS0xLTEtMTUzMw_9cb0086b-c404-487b-8664-066f5186f032"
      unitRef="usd">-42000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzktMS0xLTEtMA_c5b7596e-7958-46d7-9ad4-cc153aa4bb74"
      unitRef="usd">55406000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzktMy0xLTEtMA_d1f48c0e-ec67-44ca-bdd0-61f9f5774e1a"
      unitRef="usd">52199000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzktNS0xLTEtMTUzMw_75c04bdd-6f46-4ab3-8b7e-31ecea76f540"
      unitRef="usd">6552000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzExLTEtMS0xLTA_77318733-5e88-495d-bc1e-ae4c849be85e"
      unitRef="usd">48770000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzExLTMtMS0xLTA_0feed5f6-c8ca-43fa-8571-82c8f35a1a0e"
      unitRef="usd">46158000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzExLTUtMS0xLTE1MzM_bf41b668-2024-4c93-9598-c608cd761e0e"
      unitRef="usd">6303000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEyLTEtMS0xLTA_b121d8c8-e35c-429b-8849-460cdf0d75da"
      unitRef="usd">6009000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEyLTMtMS0xLTA_dad855d4-7881-479a-bae1-5444a0163e76"
      unitRef="usd">5314000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEyLTUtMS0xLTE1MzM_87e6b972-90ed-4c31-a270-76a7d8aa415b"
      unitRef="usd">260000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEzLTEtMS0xLTA_3ef13c0d-3dd4-42bb-ad30-dd48f15b4115"
      unitRef="usd">54779000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEzLTMtMS0xLTA_ef50341c-3d4e-487b-89c4-432be89bbc9b"
      unitRef="usd">51472000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i9d88421ed5684917b4ef0ec6460f95e6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzEzLTUtMS0xLTE1MzM_f4b9997f-c881-471f-8102-cc9c0e0d1243"
      unitRef="usd">6563000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE0LTEtMS0xLTA_d9f320e9-f525-4df3-bf98-cdc7bfee46f2"
      unitRef="usd">11000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE0LTMtMS0xLTA_6cdbcb83-0e73-4044-85c6-ee3cd7669480"
      unitRef="usd">4000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE0LTUtMS0xLTE1MzM_5d5cf548-77c3-48a7-a45d-ae4c0d555898"
      unitRef="usd">16000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE1LTEtMS0xLTA_5dc50a86-0a1a-4fb1-b6e8-78578f8dcf5b"
      unitRef="usd">7926000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE1LTMtMS0xLTA_5fd2f710-0330-4425-8d01-1fd19dd0fec3"
      unitRef="usd">6874000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE1LTUtMS0xLTE1MzM_d201f3ba-eae9-4237-a42c-369cd44ca589"
      unitRef="usd">6143000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE2LTEtMS0xLTA_e8ba4083-492e-4b57-82ed-63898bbf032b"
      unitRef="usd">10000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE2LTMtMS0xLTA_67c252cc-8cea-4457-b699-dfd150e315c4"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE2LTUtMS0xLTE1MzM_f7952aae-5908-48f4-a6f5-8e24eb46470e"
      unitRef="usd">4000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE3LTEtMS0xLTA_22de718f-4975-4a1b-8e1b-6fb999bea697"
      unitRef="usd">7936000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE3LTMtMS0xLTA_6d3e3d9e-4de9-4920-9d03-88a4722629a1"
      unitRef="usd">6879000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90YWJsZTphYjc4ZmQ1ZTYyMTc0M2ZjODRmMGI1MWNkZjJhMTRiYi90YWJsZXJhbmdlOmFiNzhmZDVlNjIxNzQzZmM4NGYwYjUxY2RmMmExNGJiXzE3LTUtMS0xLTE1MzM_bf152ca9-53da-4498-8987-6d50454a528a"
      unitRef="usd">6147000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzEwOTk1MTE2MzIxMjc_e23926ee-b29a-481c-a0e7-e3b98a016810"
      unitRef="usd">776000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzI5NDM_d9f320e9-f525-4df3-bf98-cdc7bfee46f2"
      unitRef="usd">11000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i2cd7de8880194de2bc24cc7db6ac3c5d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzI5NTA_6cdbcb83-0e73-4044-85c6-ee3cd7669480"
      unitRef="usd">4000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ic206ed87b8dc4cdfbc44e7d91db63cdd_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzEwOTk1MTE2MzIwNjY_5d5cf548-77c3-48a7-a45d-ae4c0d555898"
      unitRef="usd">16000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i21b8848a0b0848d0b1ef073195fcf232_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzIxOTkwMjMyNjA0MDI_8f764331-756d-4fa8-ba60-795551d60061"
      unitRef="usd">41000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i052772f862ef450c8eb33c1ce00be32b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzMwNjQ_5ad64813-8f99-4c92-8591-43ae52f55c9c"
      unitRef="usd">41000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="iab2819dc76894f5995f2436bdfa0b59f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzEwOTk1MTE2MzIwODg_bd0b90aa-9f7e-44ce-8488-c0d54f40004e"
      unitRef="usd">4000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="idf1e85cb6e5d4ed281db988a9eb5b755_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzIxOTkwMjMyNjAzOTg_3344f79c-97c9-4ec6-ae1e-1b8b7fb111cd"
      unitRef="usd">221000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="ie2689c30da3241379d3461455317d9fb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzMyNDU_eda6a2a3-b6fb-471d-bbdb-368cdb0efcd8"
      unitRef="usd">285000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="iadc52b1e6e6f4e7e82de9d1c0a987c54_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzEwOTk1MTE2MzIxMTQ_cabf8734-a72e-4e96-97fd-6b4184b65552"
      unitRef="usd">22000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i78ffeb8a0f1649ba9584aa0e2224ab72_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzM0ODU_fa591501-c520-45a9-9f04-d56c374f29db"
      unitRef="usd">-429000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="idaa2a9eb8b32425f8562f7ed3357a12f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDUvZnJhZzpiYmRkMDRkYWQ2ZDk0YzIxODM5MmNlZDQ3NzJkNTZmNy90ZXh0cmVnaW9uOmJiZGQwNGRhZDZkOTRjMjE4MzkyY2VkNDc3MmQ1NmY3XzM4NDgyOTA3MDE4NDk_e3afe50b-c076-4230-8f08-0bc3adbcef10"
      unitRef="usd">-524000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzgyNDYzMzcyMjY5MTU_91572412-5fee-4c5d-a365-bd11c81ce22e">Borrowings and Credit Agreements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.125% senior notes due March 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Floating rate notes due March 2020 (2.515% at December 31, 2019)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due July 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.35% senior notes due March 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Floating rate notes due March 2021 (0.950% and 2.605% at December 31, 2020 and 2019, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due May 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.45% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.7% senior notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.875% senior notes due February 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for a summary of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;maturities of the Company&#x2019;s finance lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper and Back-up Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have any commercial paper outstanding as of December 31, 2020 or 2019. In connection with its commercial paper program, the Company maintains a $1.0 billion 364-day unsecured back-up revolving credit facility, which expires on May&#160;12, 2021, a $1.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 18, 2022, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 17, 2023 and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2024. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#x2019;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of December&#160;31, 2020 and 2019, there were no borrowings outstanding under any of the Company&#x2019;s back-up credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Federal Home Loan Bank of Boston (&#x201c;FHLBB&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the Aetna Acquisition Date, a subsidiary of the Company is a member of the FHLBB. As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of December&#160;31, 2020 was approximately $925 million. At both December&#160;31, 2020 and 2019, there were no outstanding advances from the FHLBB.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 16, 2020, the Company issued $750&#160;million aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027 and $1.25&#160;billion aggregate principal amount of 1.875% unsecured senior notes due February 28, 2031 for total proceeds of approximately $1.99&#160;billion, net of discounts and underwriting fees. The $750&#160;million aggregate principal amount of 1.3% unsecured senior notes represent a further issuance of the Company&#x2019;s 1.3% unsecured senior notes due August 21, 2027 initially issued in an aggregate principal amount of $1.5&#160;billion on August 21, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 21, 2020, the Company issued $1.5&#160;billion aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027, $1.25&#160;billion aggregate principal amount of 1.75% unsecured senior notes due August 21, 2030 and $1.25&#160;billion aggregate principal amount of 2.7% unsecured senior notes due August 21, 2040 (collectively, the &#x201c;August 2020 Notes&#x201d;) for total proceeds of approximately $3.97&#160;billion, net of discounts and underwriting fees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 31, 2020, the Company issued $750&#160;million aggregate principal amount of 3.625% unsecured senior notes due April 1, 2027, $1.5&#160;billion aggregate principal amount of 3.75% unsecured senior notes due April 1, 2030, $1.0&#160;billion aggregate principal amount of 4.125% unsecured senior notes due April 1, 2040 and $750&#160;million aggregate principal amount of 4.25% unsecured senior notes due April 1, 2050 (collectively, the &#x201c;March 2020 Notes&#x201d;) for total proceeds of approximately $3.95&#160;billion, net of discounts and underwriting fees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds of these offerings were used for general corporate purposes, which may include working capital, capital expenditures, as well as the repurchase and/or repayment of indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the March 2020 Notes. In connection with the issuance of the March 2020 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $7&#160;million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $5&#160;million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 13 &#x2018;&#x2018;Other Comprehensive Income&#x2019;&#x2019; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2019 Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 15, 2019, the Company issued $1.0 billion aggregate principal amount of 2.625% unsecured senior notes due August 15, 2024, $750 million aggregate principal amount of 3% unsecured senior notes due August 15, 2026 and $1.75 billion aggregate principal amount of 3.25% unsecured senior notes due August 15, 2029 (collectively, the &#x201c;2019 Notes&#x201d;) for total proceeds of approximately $3.46 billion, net of discounts and underwriting fees. The net proceeds of the 2019 Notes were used to repay certain of the Company&#x2019;s outstanding debt.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in July 2019, the Company entered into several interest rate swap and treasury lock transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the 2019 Notes. In connection with the issuance of the 2019 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $25 million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $18 million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the 2019 Notes. See Note 13 &#x2018;&#x2018;Other Comprehensive Income&#x2019;&#x2019; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Early Extinguishments of Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, the Company purchased $4.5&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $113&#160;million of its 4.0% senior notes due 2023, $1.4&#160;billion of its 3.7% senior notes due 2023, $1.0&#160;billion of its 4.1% senior notes due 2025 and $2.0&#160;billion of its 4.3% senior notes due 2028. In connection with the purchase of such senior notes, the Company paid a premium of $619&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $45&#160;million of unamortized deferred financing costs and incurred $10&#160;million in fees, for a total loss on early extinguishment of debt of $674&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, the Company purchased $4.0 billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $1.3&#160;billion of its 3.125% senior notes due 2020, $723&#160;million of its floating rate notes due 2020, $328&#160;million of its 4.125% senior notes due 2021, $297&#160;million of 4.125% senior notes due 2021 issued by Aetna, $413&#160;million of 5.45% senior notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna, and $962&#160;million of its 3.35% senior notes due 2021. In connection with the purchase of such senior notes, the Company paid a premium of $76 million in excess of the aggregate principal amount of the senior notes that were purchased, incurred $8 million in fees and recognized a net gain of $5 million on the write-off of net unamortized deferred financing premiums, for a net loss on early extinguishment of debt of $79 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Covenants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s back-up revolving credit facilities, unsecured senior notes and unsecured floating rate notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#x2019;s debt maturities in the event of a downgrade in the Company&#x2019;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of December&#160;31, 2020, the Company was in compliance with all of its debt covenants.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzg1MDI_fce932ec-9f05-4508-ac0a-ab1a446e47b6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.125% senior notes due March 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Floating rate notes due March 2020 (2.515% at December 31, 2019)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due July 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.35% senior notes due March 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Floating rate notes due March 2021 (0.950% and 2.605% at December 31, 2020 and 2019, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due May 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.45% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.7% senior notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.875% senior notes due February 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;68,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,781)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if59595395c854ba7b06e3bf1c79b2167_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzctMC0xLTEtMC90ZXh0cmVnaW9uOjI1NzVhNjRjNjRhNzQ5MTY5NTNiYTk4MDViZDgwOTY3XzEwOTk1MTE2Mjc4MjA_0a430a26-4bc7-47d9-8233-eab89e390787"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if59595395c854ba7b06e3bf1c79b2167_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzctMS0xLTEtMA_6f7d1a4e-8789-4b57-ab7e-e564a86a4ffc"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3dc84e117e964242bed54b2fad5b0376_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzctMy0xLTEtMA_11cee9fb-aa74-4aba-8bfa-fc563c6213ff"
      unitRef="usd">723000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i39ca9c0893574888b90454ef444cf1b0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzgtMC0xLTEtMC90ZXh0cmVnaW9uOjI1OTYzYzI3Nzk4NDQwOThhZTBiZGMxZjU1MTgxNzRhXzEwOTk1MTE2Mjc4ODQ_4ebbd23c-d335-403d-a323-95251a954373"
      unitRef="number">0.02515</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icb51aad0627040f1899c9ab4dbda4d6f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzgtMS0xLTEtMA_4b763cea-1969-476f-a7f2-edecfd1d4b11"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i39ca9c0893574888b90454ef444cf1b0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzgtMy0xLTEtMA_93a89d37-70c6-47fb-a8d0-fec807f89f2e"
      unitRef="usd">277000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia44aee29de0d4077a6f00b78e9d6263e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzktMC0xLTEtMC90ZXh0cmVnaW9uOjI1Y2FmMDdiNDI4NDRiNGRhNDBkNGJhMzYzM2M2MWVmXzEwOTk1MTE2Mjc4MTU_11bee481-7808-4d64-92d9-d0dae4ef49f2"
      unitRef="number">0.028</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia44aee29de0d4077a6f00b78e9d6263e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzktMS0xLTEtMA_3fa0f974-6ff1-4470-801e-4b5521ed6df4"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i88f639376b55490690a36f10a9be2811_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzktMy0xLTEtMA_982ca5ba-3a9c-42b2-9d6a-42e27edcf287"
      unitRef="usd">2750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id01a6d6a45694726a6f06c733cf6bd6f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjphOGVmNmFjOGZhMzU0MGIxOWU4NWM2MDI5YWRlMTZhMl8xMDk5NTExNjI3ODE4_3f5f3069-2d0d-4eeb-83ec-00e8ed4f69ef"
      unitRef="number">0.0335</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id01a6d6a45694726a6f06c733cf6bd6f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEwLTEtMS0xLTA_9505bb59-158d-421d-9db2-a920d7e6d62f"
      unitRef="usd">2038000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i59044fa83a6d4afea18e5166e0f463e8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEwLTMtMS0xLTA_0747888e-72c5-430c-80a4-5f73c71c93e6"
      unitRef="usd">2038000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i82faa3a8c7e745008aa3175817187e10_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjpjM2Y2NzRjZDM1NWQ0Y2FlYTBmNzM2ZDQ2YjIxODUwZl8xMDk5NTExNjI3ODcz_afc6a305-373f-4228-a4b4-406cc7241a03"
      unitRef="number">0.00950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if2e6fb4f07b74b628115f0ccc6d9da66_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzExLTAtMS0xLTAvdGV4dHJlZ2lvbjpjM2Y2NzRjZDM1NWQ0Y2FlYTBmNzM2ZDQ2YjIxODUwZl8xMDk5NTExNjI3ODg1_e43a5e6d-b475-44ae-9dd5-ef0073f8e3c3"
      unitRef="number">0.02605</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i82faa3a8c7e745008aa3175817187e10_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzExLTEtMS0xLTA_cd6c66f2-05aa-4d59-89cf-e054c19a8790"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if2e6fb4f07b74b628115f0ccc6d9da66_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzExLTMtMS0xLTA_f1f22d79-18b6-43b3-a707-6bacab34c20b"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1dc856455e7b400ab7c24c5df6647e6f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjozOGQxMzg1ZjQ5Mzc0OTViYmI2NDFiN2MyNGRiOTRlMF8xMDk5NTExNjI3ODE4_b45402ec-57ab-4fba-9e34-5130c356b11b"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1dc856455e7b400ab7c24c5df6647e6f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEyLTEtMS0xLTA_61a5a0f7-6b71-48af-bd3e-3b7335a0be85"
      unitRef="usd">222000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6a9b18d3bdf747699de43dbe6ce0bd3a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEyLTMtMS0xLTA_39260c7f-cac1-4bd5-a15f-77ec29d6368b"
      unitRef="usd">222000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3b59429fddec4142a6db54bed9ab055a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEzLTAtMS0xLTAvdGV4dHJlZ2lvbjplNjZjYWEyYTQ1Nzg0MzBlYjVmMzUwZWQ5OTBmOTBjN18xMDk5NTExNjI3ODE5_2be08f96-659e-4de8-8b19-a3fc94467399"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3b59429fddec4142a6db54bed9ab055a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEzLTEtMS0xLTA_c7636b63-2d7b-4772-863f-55cf9771c0e5"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5d340447641846a9a431c822fbec5ddc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzEzLTMtMS0xLTA_0d4812ff-7c52-410e-a735-a0aa5fe14b2d"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i676ade2029cd42ddb0666570247f7159_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWIyMGYxMjQ5MGE0MjNhODNkOWYwYjc5YzNmNDU3YV8xMDk5NTExNjI3ODE5_1eefb8d6-9354-4eb2-a8e0-9996eeaef24e"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i676ade2029cd42ddb0666570247f7159_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE0LTEtMS0xLTA_22818c74-3031-4dc6-9e59-55399cac0b0d"
      unitRef="usd">203000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic6a6f27fcb634d5a8284be453046e3da_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE0LTMtMS0xLTA_7eb9e74e-26c1-4f1e-b200-2ff355114a44"
      unitRef="usd">203000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i63be7ab398194c9282444fbe7e010250_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE1LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MWRiYTAxNjExYzM0YjZiYTA5OWMwYTgxODIzMTZlNF8xMDk5NTExNjI3ODE3_6549bcb7-de39-49b1-903f-5c4e8657df74"
      unitRef="number">0.0545</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i63be7ab398194c9282444fbe7e010250_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE1LTEtMS0xLTA_bbeaea99-4eeb-4381-bd32-bfc7539fe95d"
      unitRef="usd">187000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id602ed76bb1141efaf6bf5a490a87c42_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE1LTMtMS0xLTA_421843fc-d6bb-4a3c-a027-0670958f013a"
      unitRef="usd">187000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2c0d5087b6064f70b84a0c6522dde077_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE3LTAtMS0xLTAvdGV4dHJlZ2lvbjoxZTBmOWNhYmMwM2M0NzAwYmUwODc4ODczNGU4ZjM3MV8xNjQ5MjY3NDQxNzAz_4810fc02-bf9d-4a28-9829-551d3e9b4c5c"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2c0d5087b6064f70b84a0c6522dde077_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE3LTEtMS0xLTA_59e33d96-e2d1-41b5-8a46-7d3960d52338"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5b68adadc076455fb9d9fe54b81b2afb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE3LTMtMS0xLTA_8f9c62e7-39ad-44e0-a99f-eaf86979ab07"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie4f845bef7bb4551b019ead11e5321e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE4LTAtMS0xLTAvdGV4dHJlZ2lvbjo2N2YwMDljNjQxNWE0YmY1YmZjZDIyZTg3N2ZhMTI2M18xNjQ5MjY3NDQxNzEw_a8ee90a7-c7fb-492a-b52c-de5001a341fb"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie4f845bef7bb4551b019ead11e5321e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE4LTEtMS0xLTA_1520fbf9-d891-4eea-a9ce-b00ff9bc6916"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i51052298202549029f99a9aa30364e50_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE4LTMtMS0xLTA_47b4ed83-35ad-41e9-b8f7-dab2a8688115"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i556ba81c12d2465ab03865c19ccdd639_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE5LTAtMS0xLTAvdGV4dHJlZ2lvbjpmODBlNGNjMjA0ZjE0ZWU2YTFhZjQzODkwMmUzZTIwZF8xNjQ5MjY3NDQxNzA5_043ffa4c-04cd-42b5-9835-32ce4a439b88"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i556ba81c12d2465ab03865c19ccdd639_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE5LTEtMS0xLTA_09d370ae-a825-4fee-8976-763beedf6f26"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0ed4c4a68c7f4d81b36909b27c56373c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzE5LTMtMS0xLTA_4180715a-eea8-4a3a-969d-c8c1fa48eefb"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i171c4fd932814c18abf98b03dd0d5aa6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIwLTAtMS0xLTAvdGV4dHJlZ2lvbjpiYTdmN2Y3NjNkMTI0N2FmODllYWQ4N2VmZDg3ODEyNF8xNjQ5MjY3NDQxNzA5_cbef8380-45be-4362-b3fe-88370db98c1a"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i171c4fd932814c18abf98b03dd0d5aa6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIwLTEtMS0xLTA_728c7117-cbc4-4fbf-a973-6fdcc41cceb9"
      unitRef="usd">399000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0047ef3047aa4d01b3b1461ca8ad2376_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIwLTMtMS0xLTA_216cc232-99da-408d-b6d2-e9b2b25c15d4"
      unitRef="usd">399000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i734cf172fc0a4bb394897c043bd538c6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIxLTAtMS0xLTAvdGV4dHJlZ2lvbjoyZTg0NWE2NjJhYmY0MDgwOTkwNWFlZTdkZDFjN2I5OF8xNjQ5MjY3NDQxNzA0_68f29769-da99-498f-848b-7a2134a3863f"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i734cf172fc0a4bb394897c043bd538c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIxLTEtMS0xLTA_999561e2-b624-4cf8-ac56-f65c098aa757"
      unitRef="usd">2336000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i186e6bd3f8c243f290f2d7379452ca08_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIxLTMtMS0xLTA_80472e90-ba41-4c4e-a453-a1246ae0c0af"
      unitRef="usd">6000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icecaee365bf9466885c2e04672491901_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIyLTAtMS0xLTAvdGV4dHJlZ2lvbjo0ZDYyMDdiZTY2MmI0NjIxOGE3M2Y4OTMxOWQ2ODU5Ml8xNjQ5MjY3NDQxNzAz_4b89945b-adfe-495c-9874-45fe4a40fc1c"
      unitRef="number">0.028</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icecaee365bf9466885c2e04672491901_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIyLTEtMS0xLTA_8d6b8565-45de-4139-bb46-6c795853a972"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if2942eb9beaf4f7cb5866f52e34c56a2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIyLTMtMS0xLTA_572e0b5d-971c-44c0-84d6-49758430d0ad"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0e657c55e1f64967b1ffeccd58ae062b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIzLTAtMS0xLTAvdGV4dHJlZ2lvbjphZDA2N2Y2MzM5Y2M0OWQzYjIyMmNkMjY2YjE4ZDc1N18xNjQ5MjY3NDQxNzAz_a3250ea7-e926-4326-a00a-869ee5cab845"
      unitRef="number">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0e657c55e1f64967b1ffeccd58ae062b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIzLTEtMS0xLTA_232e7586-d215-438c-8e25-d4310ed4ef73"
      unitRef="usd">414000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8e950cbfa319445c8d4b8cb106e4f1ce_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzIzLTMtMS0xLTA_2d9d0e53-ddb3-499e-bb9d-2648f46dcb73"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i53be593e004440969eaadd34053626fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI1LTAtMS0xLTAvdGV4dHJlZ2lvbjo4MWYwODQyYmQyOTE0ZGRjYjgwNmFkOTE1YmYyOWM4Ml8xNjQ5MjY3NDQxNzA5_8aa29822-68a8-4f16-a353-55f80d39e83f"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i53be593e004440969eaadd34053626fb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI1LTEtMS0xLTA_bd518ffd-fc9e-4cbb-84a2-e687beb62695"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3f30d489cf5246259fd164aec13a5624_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI1LTMtMS0xLTA_68fa01fe-500a-4eba-a94b-6087c6deaa3f"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibd43c50e8ca4414ea2cecb99247ff8e7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI2LTAtMS0xLTE2MzgvdGV4dHJlZ2lvbjo3MTM0OTExNjUyM2Y0OTZjYTQzOTg3NzVkYjAxMWUxMl8xNjQ5MjY3NDQxNzA5_41f492f0-3484-47db-afc7-c84daa019602"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibd43c50e8ca4414ea2cecb99247ff8e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI2LTEtMS0xLTE2NDI_786eced9-7798-4c24-b870-0a028e03a0ce"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0573e87a0f0c42ed97784d5b5ea32460_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI2LTMtMS0xLTE2NDI_447164fe-ea44-42dc-a83f-2bdf3c91077b"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7dde33d57ede4cd2b5f5a4f7c72f3c92_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI2LTAtMS0xLTAvdGV4dHJlZ2lvbjpkNmNiMTU2MGQ2NGU0YzJmYThlM2FmMmJmZjgwZDIzM18xNjQ5MjY3NDQxNzA3_6725456e-3835-436e-b992-387d5bb00dc4"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7dde33d57ede4cd2b5f5a4f7c72f3c92_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI2LTEtMS0xLTA_ae9e5f27-4339-4bea-b3d7-db3210d2916b"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i97fa105db68d4c46a1f39c9e528fa813_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI2LTMtMS0xLTA_77e36a61-1996-4ae9-a3bd-8dc8ebd11467"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if1ea528658e74bf787c41152af9d8121_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI3LTAtMS0xLTAvdGV4dHJlZ2lvbjo1Y2U4YTJkMGJmYjk0ZmY1OWJlZDgyZGQ2OWU2MmQ3M18xNjQ5MjY3NDQxNzAz_f2739af3-5f01-4eca-b6c3-f6dfec3f87bf"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if1ea528658e74bf787c41152af9d8121_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI3LTEtMS0xLTA_b955d108-e831-41eb-9e61-f1df9cb09503"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2694eec161064921894d65f27aa8ab17_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI3LTMtMS0xLTA_0e9662b6-44a6-4cb2-b711-aba4097b312f"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibb4bb36351fe4c6f9d1a0eae2a188257_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI4LTAtMS0xLTAvdGV4dHJlZ2lvbjowZWE3YmI2MWMzNzg0OWNiYTMxMWNkYTNlN2VjZjAxY18xNjQ5MjY3NDQxNzA2_967c7c3a-04d1-4a35-83a6-639ab5565997"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibb4bb36351fe4c6f9d1a0eae2a188257_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI4LTEtMS0xLTA_80961288-4762-4ad4-82a0-6f63754754fb"
      unitRef="usd">950000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i79094d4adfd5425ea0d62b733c026eca_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI4LTMtMS0xLTA_7cb25597-7205-4e6e-b3fa-c97f321c4c39"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie6fd5b2064a242a6b820eafdcbbe9428_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI5LTAtMS0xLTAvdGV4dHJlZ2lvbjoxM2U4ZGJmYzcyOWE0OTkzODdiMWYzYzRjMGQwNDBmMV8xNjQ5MjY3NDQxNzA3_3e7fcc7b-8e43-438a-bfdd-b9f79aede312"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie6fd5b2064a242a6b820eafdcbbe9428_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI5LTEtMS0xLTA_bde3c94d-1465-4c8c-83b4-fc6e1b551f1c"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if4dacf9fff2540b993923fdc63acc6b3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzI5LTMtMS0xLTA_7bf43725-fd98-43f3-9f7a-59c7c97c38c0"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8450bfd94fac484aba4e77c9fc4efd2f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMwLTAtMS0xLTAvdGV4dHJlZ2lvbjozMmRmZDM0NDQ3ZWY0Nzc0OWQxMmI3MjUxOGM3OWJkY18xNjQ5MjY3NDQxNzA3_6661b335-2551-4705-a1c2-0f10124b73d1"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8450bfd94fac484aba4e77c9fc4efd2f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMwLTEtMS0xLTA_cc531d09-dce2-4666-9132-d5fdb70ee2f4"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5874afefc4a74dd6ad08f344c1f53ec9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMwLTMtMS0xLTA_9abfd0b1-f3b2-4725-93c0-7fe0deb1546d"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9dd4c17f4c144cf297f7e26ae28bd94d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMxLTAtMS0xLTAvdGV4dHJlZ2lvbjo5YTBkZGJjYjQyNzA0NDAxOWM4OGRlMjRlNzMyMGQ4Nl8xNjQ5MjY3NDQxNzAx_d454eff0-af94-462d-abb8-85b0f28c52a4"
      unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9dd4c17f4c144cf297f7e26ae28bd94d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMxLTEtMS0xLTA_f89557f6-0066-4406-a28b-67474f19a7fa"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i866a5d43855e486f8cc0c68a5b4620bb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMxLTMtMS0xLTA_712816c9-3ebd-4118-9ff0-c0e48a25126f"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i08df6665d2524a33a4be6561924aefca_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMyLTAtMS0xLTE2NDgvdGV4dHJlZ2lvbjo5MmYwNDU2OWQxMDE0NGQzYjA5MTQzNjFlYWU2NTVlMl8xNjQ5MjY3NDQxNzA3_0ce75747-0746-46d5-a488-b49756cc5251"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i08df6665d2524a33a4be6561924aefca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMyLTEtMS0xLTE2NDg_92c375e0-958c-4cbd-8831-77db2ed134b3"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i24c2a1537a164fc5874c6fa1eea075b4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMyLTMtMS0xLTE2NDg_ececff0b-c3be-47c6-a138-b06bcd8b19b3"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idddb1de105474de39bd0e7760adec57d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjowZGQ2YjhlNGMwMTA0ZjI0YjYzYzE3Y2YyNmRhMzg0MV8xNjQ5MjY3NDQxNzA1_a6d263ad-0f7e-4181-9eb5-7696eb86a71d"
      unitRef="number">0.0625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idddb1de105474de39bd0e7760adec57d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMyLTEtMS0xLTA_549b7b60-d033-436e-8f96-b5076a2897a6"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie92a12c2190d4335847859245937972b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMyLTMtMS0xLTA_1696807f-86d9-4dfd-ba0e-5804026eebc2"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4ca0fb7a5b484776ba687c307ef197ce_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM0LTAtMS0xLTE2NTIvdGV4dHJlZ2lvbjozMjZhMTUzZmE3M2E0NjU0YmVmZGFlMWRiNzY5NTU4MF8xNjQ5MjY3NDQxNzA1_1458eba7-0033-4aaf-8d12-716e5fb5efb4"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4ca0fb7a5b484776ba687c307ef197ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM0LTEtMS0xLTE2NTI_cc62c425-4cb4-4338-a939-a99d14db34d2"
      unitRef="usd">2250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i050c35f0329b4b58a86438fbafa04846_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM0LTMtMS0xLTE2NTI_0186f1ef-209f-4112-9752-c91dac7c0ead"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibe8c3f3d18834cf7b9b94d15988c16aa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjpiYmU0ZWVmNWE3NGI0OGU1OWI2YTc1MmQyMzZjOGI2OV8xNjQ5MjY3NDQxNzA0_fc0d6e69-4929-49f8-bf4c-7d23048a7ee0"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibe8c3f3d18834cf7b9b94d15988c16aa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMzLTEtMS0xLTA_f240d250-3448-4397-9392-19a3e84338e8"
      unitRef="usd">7050000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ica41313a27ea4d7ca02bb73da16225a1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzMzLTMtMS0xLTA_dc06df2d-c06f-464c-b5f4-8a9904f520a6"
      unitRef="usd">9000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0bb1c419c09e4bb19d54039c47abe8e8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjowYWMyZmY2ZDVhMzM0NWQxYWJiZDZlZmZjYzRiYzkyNV8xNjQ5MjY3NDQxNzA3_a65ae8b0-76a0-4316-9f04-b3139b6e6037"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0bb1c419c09e4bb19d54039c47abe8e8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM0LTEtMS0xLTA_060e987a-4816-434b-bb7c-0528c89c3f69"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie8e397dcb8d14af0a33b647343c389f2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM0LTMtMS0xLTA_d7211ff6-a9b1-47e4-ada5-66496d9e80be"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5a1d49c0ec7e47f4a5602ea8cc802eef_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM3LTAtMS0xLTE2NTYvdGV4dHJlZ2lvbjpmZjYzNzExOTgzYmU0NjVmOTRmMTZhMDc5ZmJhNWFhMl8xNjQ5MjY3NDQxNzA2_010be136-5596-4570-af7b-20ea8bd9d6e0"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5a1d49c0ec7e47f4a5602ea8cc802eef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM3LTEtMS0xLTE2NTY_bfd6bdaa-9458-425c-a004-219ddf0c1e36"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic5782efa7db249b6b23113dc33fb76a7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM3LTMtMS0xLTE2NTY_085d9134-a3ec-42cc-8421-33e8f7127618"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i212780690b054480b1d4b16a1ce55e8f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM4LTAtMS0xLTE2NTYvdGV4dHJlZ2lvbjoyZWVjZjJlMDhkNzc0Y2I5Yjg2MTRmNzhjNzQ5OThhM18xNjQ5MjY3NDQxNzA3_d594dc28-ed7b-404d-90dd-6d95dce884a1"
      unitRef="number">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i212780690b054480b1d4b16a1ce55e8f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM4LTEtMS0xLTE2NTY_7d67fd9d-2992-47eb-a7ee-dfe2dd4f51cc"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i82893487b53a40c3a443264c005a3544_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM4LTMtMS0xLTE2NTY_c28e4caa-17f1-4d23-9883-1beec4f2cb54"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i014f1a1c658f4a5e88082091afbc10b5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQwLTAtMS0xLTY1OTUvdGV4dHJlZ2lvbjpkZGRkZmY4ZTdkZTY0ZjAyODRjMDNmMDczZDE1ZjdmZV8yMTk5MDIzMjU1NTk5_bb58cee9-53bc-402e-ad57-ea2f1ba23075"
      unitRef="number">0.01875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i014f1a1c658f4a5e88082091afbc10b5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQwLTEtMS0xLTY2MDA_a3eb03ad-bc70-4334-8e73-97bab01182ad"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i28e1dfeab22c474fbf87dbcc1a78ae98_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQwLTMtMS0xLTY2MDA_2a6570ff-c825-4bef-b6b7-46473c1c4312"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3262bc6e373b449b95e2a2364d10c2ee_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM1LTAtMS0xLTAvdGV4dHJlZ2lvbjoyZjJlMjQ5YTY3YmI0MWEwYTY1YjUyM2YxYzg2ZjBmM18xNjQ5MjY3NDQxNzA3_97ec334c-c175-470a-8faf-2a4eb6cc965b"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3262bc6e373b449b95e2a2364d10c2ee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM1LTEtMS0xLTA_d128635c-6582-41b7-909f-144de072061c"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id20e06cc938d415a953c7aa4bdf9cc8b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM1LTMtMS0xLTA_f20476a9-7619-42b4-a787-3b6adbdabe25"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8948ebc60ee549319fa423f9c9ca71ae_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5OTE3ZDQzMGJkZTc0NzM4YjMwOTJiMTgwZDdjZWFlNF8xMDk5NTExNjI3ODE5_3943b3a7-27a6-4598-b320-db9c4cf4a137"
      unitRef="number">0.06625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8948ebc60ee549319fa423f9c9ca71ae_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM2LTEtMS0xLTA_b71825d0-2de3-456c-9f75-44453c631c1b"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i133831fe5f40404ebaf46e33ca52ac9b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM2LTMtMS0xLTA_49f0e521-71bc-4f71-a773-dca07bdcf7ca"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i353b9ef71c8f47328eb48db1a68abf98_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjo1ZDdmMjE1YzcxODY0OTcxYmM4Y2JlMTMwZmFlMmNmM18xMDk5NTExNjI3ODIx_46558b3e-4ff1-45aa-8a97-0a74def25975"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i353b9ef71c8f47328eb48db1a68abf98_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM3LTEtMS0xLTA_fc3eadeb-3a2f-4438-ad32-065d77f76bf5"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib9bdbcde47724dd2a5dc223d8b0d9fb9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM3LTMtMS0xLTA_6608fa07-7e8f-4cdb-9f41-92d44a29de77"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic196591389f249e3a85fa825d6428142_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM4LTAtMS0xLTAvdGV4dHJlZ2lvbjoxOTljNzYwNmVhZWM0OTI4OWIyNWNmYTA1ZjcyNzFkZV8xMDk5NTExNjI3ODE4_14f08dde-7437-4bf7-b2b7-6b7f51fd5dda"
      unitRef="number">0.0478</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic196591389f249e3a85fa825d6428142_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM4LTEtMS0xLTA_ce73c233-578c-44f4-a929-94a620efd236"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia7d67544c4ed4204b542c36dc455c469_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM4LTMtMS0xLTA_dd74e312-bc84-45f7-80cd-45b7b072ae27"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2552168ebcaf4d87b5f4441f01768b71_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM5LTAtMS0xLTAvdGV4dHJlZ2lvbjoyMDI2NWMzY2E4ZTE0ZjYwYTFjOTgzMzJmZTZlN2ZlN18xMDk5NTExNjI3ODI0_c781ceae-5977-4736-9a88-589cbb2d3cdc"
      unitRef="number">0.06125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2552168ebcaf4d87b5f4441f01768b71_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM5LTEtMS0xLTA_e508c8a1-c282-4a5a-ba42-500c1c4d05f6"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7d273705308749c995ee3575c0e5b372_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzM5LTMtMS0xLTA_8bf6d4f3-8f1f-43ff-94f3-8d8b0dd8e44a"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i867a6232fb7244249412521e5001679b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ0LTAtMS0xLTE2NjAvdGV4dHJlZ2lvbjo4YTgyNDNmYTUxNzM0OWNhYWUxNjg4M2NjOGJmODljZV8xMDk5NTExNjI3ODIw_9cbd8d65-a2b4-420f-b3e9-aac5847d62e9"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i867a6232fb7244249412521e5001679b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ0LTEtMS0xLTE2NjA_1776dff0-82ae-4eaf-8f9b-811205d07279"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if44fd76e6acf41a9b3352d5c1ce68f96_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ0LTMtMS0xLTE2NjA_0fffd866-c2e3-4688-a347-9c2272fa3462"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1044e6b95e9d4af7a0760d5a5f5c5d96_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ1LTAtMS0xLTE2NjAvdGV4dHJlZ2lvbjo3Y2ZhM2M2MDZhZGI0MTUxOGNjY2RkYWNhNzJmMmMyNF8xMDk5NTExNjI3ODE3_370259c7-9006-4ec4-b862-d9be55f3e612"
      unitRef="number">0.027</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1044e6b95e9d4af7a0760d5a5f5c5d96_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ1LTEtMS0xLTE2NjA_c5680b34-c7ad-477f-8a66-0558b596b047"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i84cdd9e17651455894397e2cc826487c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ1LTMtMS0xLTE2NjA_dacd1240-fdf5-44f6-8dd7-7d29e343edf7"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4a05340b9e204506b8228431b5765c0a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQwLTAtMS0xLTAvdGV4dHJlZ2lvbjphM2E1Y2E2Zjk0ODY0NDlkYTc1ZTAyOTg4ZGUwMjM3MF8xMDk5NTExNjI3ODE2_9182fce4-1bde-4db9-a5b9-26e0cd96e906"
      unitRef="number">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4a05340b9e204506b8228431b5765c0a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQwLTEtMS0xLTA_b5d08da1-19a8-495d-b7ef-499a9f8720b2"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3ad9df9ebf4746febbda2d5944fecaa3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQwLTMtMS0xLTA_c44b8688-526f-4c7d-8beb-9434451d42c4"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1fa943d2d2b64256b7f438c6bd342aa4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQxLTAtMS0xLTAvdGV4dHJlZ2lvbjoyNTcyOWRjYzVlNDI0YzI0OTdjM2NhNDZjNWE5MmVmNl8xMDk5NTExNjI3ODE0_f19caa8f-4e97-4e7f-aa04-11e6901639e1"
      unitRef="number">0.045</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1fa943d2d2b64256b7f438c6bd342aa4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQxLTEtMS0xLTA_be489fe8-61dc-4df7-be1f-4247aab2e9f4"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6d024add61ae4a83bd4faf2b2187bffd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQxLTMtMS0xLTA_06c1f978-ca68-4475-80c2-c8cc2813c5eb"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iacb0304ddc414bc9ba515d05b822e59f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQyLTAtMS0xLTAvdGV4dHJlZ2lvbjozMTU5ZTc2NjJmMjI0YmVmYjdjNTc0NDAyODdkZGVmNl8xMDk5NTExNjI3ODIz_ee8dc6e6-0912-4d3e-b692-5adf32d0626f"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iacb0304ddc414bc9ba515d05b822e59f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQyLTEtMS0xLTA_00aa0f1b-adc2-4daa-ac6c-262e31d8b4d4"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i063d082f54bf4a70a10b63c68204c506_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQyLTMtMS0xLTA_84facd23-03a8-4e63-85f7-a6752db65317"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib365a66162e74ae1a131e17260d3c309_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQzLTAtMS0xLTAvdGV4dHJlZ2lvbjplM2NlZGUwOGMxMWY0MDQyYWQ1MWEwYTY5YTFmMDZjN18xMDk5NTExNjI3ODE5_4d937e94-0cab-490c-a354-256b096b5416"
      unitRef="number">0.053</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib365a66162e74ae1a131e17260d3c309_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQzLTEtMS0xLTA_6eeae75c-2980-4bda-a5bf-1a67e4c71a12"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic58975dfc3894919a505a5a72c8de2e1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQzLTMtMS0xLTA_55876277-4e60-4820-b5e5-5e38e971b003"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4bb283ec93234091a925868aa3c3d104_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ0LTAtMS0xLTAvdGV4dHJlZ2lvbjo0YTJhMDkwNmMwNTY0MWM3Yjk2MTZjMmU1NTk1NTE2Zl8xMDk5NTExNjI3ODE4_ae86d911-28a1-4932-979c-86e24810a278"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4bb283ec93234091a925868aa3c3d104_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ0LTEtMS0xLTA_de8efa2c-ffef-4d3e-b1bd-3cedb5ec5b54"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia4515473601e42ccb48a414ff823ea6f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ0LTMtMS0xLTA_8184ecc8-6515-469a-8aa7-6c42eda2154e"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icb5c311b199b423a93de6b1490f41256_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ1LTAtMS0xLTAvdGV4dHJlZ2lvbjowYTFkNjhiM2M3ODc0Y2Q2ODZkOTA5NmY4YTgzNjY3N18xMDk5NTExNjI3ODE5_e30cd8fc-284f-42d0-aa79-fa5547a60471"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icb5c311b199b423a93de6b1490f41256_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ1LTEtMS0xLTA_cf03f7c0-ebb0-49e7-b0d2-0a2592ce2578"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2f477f50197a44379a3e15ab264fb450_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ1LTMtMS0xLTA_c9f71be6-9206-4833-b445-2d48b774da9b"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7a9f776493394d3aa1b9afef76079abb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ2LTAtMS0xLTAvdGV4dHJlZ2lvbjo5Mzg2ZTk2ZWVjNTA0MGM1YWFkZGNkOTc2MDQyMzEyN18xMDk5NTExNjI3ODIx_b6b0afaa-8e88-418b-80d6-6bce0e0218f6"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7a9f776493394d3aa1b9afef76079abb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ2LTEtMS0xLTA_0c3ac47e-63a1-43c9-81d3-9885406bb435"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i38882d76fbd94254a2babd6873e24f9e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ2LTMtMS0xLTA_74fd3d90-7da6-467d-8323-dd7ffe0d07f8"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8e5d522c3502448f88a84c21bcdd8997_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ3LTAtMS0xLTAvdGV4dHJlZ2lvbjozZTlhNGJjZjZhMjM0ZjBmOWRlYzUzZjZhYzc5NDU2Nl8xMDk5NTExNjI3ODE4_4d3a2ab3-2347-4a36-a2a0-74993bd61d9a"
      unitRef="number">0.0505</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8e5d522c3502448f88a84c21bcdd8997_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ3LTEtMS0xLTA_91a928d1-b59d-4d78-83b8-b963f2790e23"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6ff770766b8f4090a02e18b7734a5a58_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ3LTMtMS0xLTA_5efb8c95-c44f-4acb-9da4-8afe72381eeb"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iea2cca2aa63645ea8d47444ec2a4b2ad_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU0LTAtMS0xLTE2NjQvdGV4dHJlZ2lvbjpjNTMwMmMxZjA0ZDM0MzVmYWEwMDBkMzBmOGEzYmU5Nl8xMDk5NTExNjI3ODE4_ccb0a357-d8ad-4146-a4d6-8f2c21a0c4c4"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iea2cca2aa63645ea8d47444ec2a4b2ad_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU0LTEtMS0xLTE2NjQ_d3ed497d-58f8-428d-9eff-f4a129eaa095"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6f4c74c7d7384526865bf4ee6224633b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU0LTMtMS0xLTE2NjQ_3d9d4c9a-8497-4a00-b474-71d11a4628f2"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ4LTEtMS0xLTA_adb10bf6-b971-4111-b8d3-613cbe5eb1da"
      unitRef="usd">1083000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ4LTMtMS0xLTA_9f01a857-4475-4784-91ce-2d565486e2b0"
      unitRef="usd">808000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia69df1d43019455c8f2e992b4d61f9cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ5LTEtMS0xLTA_a10c2c82-8133-4f7e-b776-db43068384f4"
      unitRef="usd">326000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic6471700783d4a9ba371feacbe010756_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzQ5LTMtMS0xLTA_3652adcb-c4fa-428c-8f5c-73ec6d376c95"
      unitRef="usd">279000000</us-gaap:DebtInstrumentCarryingAmount>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUwLTEtMS0xLTA_e145dbea-3094-426a-907d-446350d631b5"
      unitRef="usd">65318000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUwLTMtMS0xLTA_b5dc9e1a-e6ab-4f55-b052-c6c84ad05990"
      unitRef="usd">69246000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUxLTEtMS0xLTA_ffe04e30-665f-47ba-bcc2-59d74c1db26a"
      unitRef="usd">238000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUxLTMtMS0xLTA_e833a4d6-5649-47c3-8dd6-8144aa93d2fd"
      unitRef="usd">262000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUyLTEtMS0xLTA_4aed2700-417f-4a48-ae3f-cb518c469271"
      unitRef="usd">909000000</cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet>
    <cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUyLTMtMS0xLTA_c361d13f-ef6a-4ed5-b188-0911397c9e74"
      unitRef="usd">1028000000</cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUzLTEtMS0xLTA_732e48b0-112c-414c-b600-45b36e7fbd84"
      unitRef="usd">64647000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzUzLTMtMS0xLTA_f1fec528-cf9b-485c-a748-6f2863d56b49"
      unitRef="usd">68480000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU2LTEtMS0xLTA_d89b3fe3-4c48-4009-8a58-949b6ebe73f6"
      unitRef="usd">5440000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU2LTMtMS0xLTA_0fff9adc-11cf-4bb0-b97d-ce9f49416bc7"
      unitRef="usd">3781000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU3LTEtMS0xLTA_43f3a1a6-2679-437b-91e6-7768bac413a3"
      unitRef="usd">59207000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTplNzdhODdiZjc0ZDM0NWRmYTRjM2ZlMDhmZTk5ZTBhYy90YWJsZXJhbmdlOmU3N2E4N2JmNzRkMzQ1ZGZhNGMzZmUwOGZlOTllMGFjXzU3LTMtMS0xLTA_0a5aa792-cf31-4431-91e5-9e0fbdc9782c"
      unitRef="usd">64699000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzg1MDc_32b17fef-af8c-44c7-9e69-f8e2e3c3eb22">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for a summary of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;maturities of the Company&#x2019;s finance lease liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzEtMS0xLTEtMA_945a748d-d5bd-4d28-803e-37b03629d10c"
      unitRef="usd">5405000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzItMS0xLTEtMA_4936f0ea-a0c3-4738-81d7-566c67763aa0"
      unitRef="usd">4154000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzMtMS0xLTEtMA_373295c6-acde-4dbc-8db9-73d8403d6b08"
      unitRef="usd">4055000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzQtMS0xLTEtMA_f6b151d7-11af-44cc-bc7a-39746456ffa5"
      unitRef="usd">2706000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzUtMS0xLTEtMA_0dd75aa5-bbc3-46f0-93f6-66565b6ce966"
      unitRef="usd">3785000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzYtMS0xLTEtMA_b0ff1a7c-58ac-464a-b906-e2d45db4aa0f"
      unitRef="usd">44130000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzctMS0xLTEtMA_79953f25-bd15-4a31-aa81-7396eef7b348"
      unitRef="usd">64235000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzgtMS0xLTEtMA_adb10bf6-b971-4111-b8d3-613cbe5eb1da"
      unitRef="usd">1083000000</us-gaap:FinanceLeaseLiability>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90YWJsZTowMzdhZDhkNmRhMTM0ODdmYjIzOTYzNzFlMWRlNGYyMS90YWJsZXJhbmdlOjAzN2FkOGQ2ZGExMzQ4N2ZiMjM5NjM3MWUxZGU0ZjIxXzktMS0xLTEtMA_b3275831-2d15-4b4b-ae27-c5f4fd17c00d"
      unitRef="usd">65318000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <us-gaap:ShortTermBorrowings
      contextRef="i436a5971435f44fba2581c308d881259_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzQ4NA_f9ff6670-0b40-451b-b438-6e5d46917062"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic2a81421b67049b4b9bda55d847576dc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzc0MA_1830fb0f-4951-4c54-9998-ed1eb18f64b3"
      unitRef="usd">1000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ib876b3c3e46f46e0981a6a45069067a3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzc0Mw_e68cab50-a443-4978-968f-b713ee542c6a">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie9c68e7d2e424fc59a03e33749acacea_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzgyOA_47d9e42d-1bf3-4c56-bba2-81e3e36793f7"
      unitRef="usd">1000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i624a08d2669d4bc19ebfeec612b82b2b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzU0OTc1NTgxNjY5MTA_1afc910e-c27a-4efb-89f4-ac43c57dbc44">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8809cf477a8743d9bb985128a2794821_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzkxOA_21439427-b549-46cc-9681-ce350599c3f1"
      unitRef="usd">2000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ibbb693e747254191aa459c5a8372bb85_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzU0OTc1NTgxNjg4ODE_8acef578-d68d-4968-b42f-1bbe7029cbc7">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic05b162415354eb4a957e1d4b5f6f6c4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzEwMTE_3f1477ed-b453-4e97-9ad2-6a19803e37cd"
      unitRef="usd">2000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ia57b5877fbea405eb22d66a6eaf931b6_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzU0OTc1NTgxNjY5MTE_a67aefce-c211-427b-8fdc-70575577f08e">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="iab6686fec59a41f4a0c718105fed5c6d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzEzMTU_ed58df64-46ff-4d35-bc17-14d4c2b116f3"
      unitRef="number">0.0003</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:ShortTermBorrowings
      contextRef="i07faa68d499941c1be4ba68ed832a9f1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzEzNjg_4e284a48-acf4-454b-a36e-62f696143d1d"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i3f6bebf211ae4518a4a23f58e6f388a0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzEzNjg_b60e9af9-d66d-4496-a569-2554a76a12d7"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM0ODg_4ea4d36d-ec53-4202-b735-7b2e07004b44"
      unitRef="usd">925000000</us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable>
    <us-gaap:ShortTermBorrowings
      contextRef="i95fd067686e94117b1c847c8a8c039eb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM1MjI_e06041d7-1331-49a7-8c50-09a6cfb736db"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia8c5eaacbdf242339dd3eee02265fbc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzM1MTI_cb287d69-3f6e-4795-a59f-ce8c642b7fe0"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia8c5eaacbdf242339dd3eee02265fbc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzM1MzU_55572e56-7e2b-4787-98b2-f848f556af4b"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5f88871020ec4730bb5d033335c7942c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzM2MDg_2cc58c61-41fa-4c2c-87e6-6a4ad6d26c69"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5f88871020ec4730bb5d033335c7942c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzM2MzY_2abaa016-2f41-4d50-874f-72ed97d8e218"
      unitRef="number">0.01875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzM2NTM_069130b7-a3f8-48f9-90eb-bbd38bca69a2"
      unitRef="usd">1990000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3459ed386a61404c94e9479d6015ffbe_I20201216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzgyNDYzMzcyMjY5MDI_971b1307-eece-404d-adb6-50630f55d5db"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia8c5eaacbdf242339dd3eee02265fbc6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDIxNjk_55572e56-7e2b-4787-98b2-f848f556af4b"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3459ed386a61404c94e9479d6015ffbe_I20201216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzM5NjQ_d625ae2e-11f6-4df1-95f3-e231cf5113ad"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i99166279d10146f28c4d4195c226385f_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzIxOTkwMjMyNzQwNjM_116a85e0-6270-4040-8e39-26449babc5c9"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i99166279d10146f28c4d4195c226385f_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTEwNzI_116a85e0-6270-4040-8e39-26449babc5c9"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3459ed386a61404c94e9479d6015ffbe_I20201216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTEwOTE_d625ae2e-11f6-4df1-95f3-e231cf5113ad"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iad8877d2fdd8467888b253ca40d5a80b_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTExMTE_7823e59b-0eaf-461b-b86e-429b4b875b5b"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iad8877d2fdd8467888b253ca40d5a80b_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTExMzI_3727b1ab-b8ad-4200-a6d6-29bf18ae7c68"
      unitRef="number">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i88e8304eaa26409d8a604190defc89b5_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTExNTM_15ed2c5e-9f6c-4cc5-aa81-321888f281d0"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i88e8304eaa26409d8a604190defc89b5_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTExNzM_799fdd10-e23c-45a1-9291-aa3d02c1de12"
      unitRef="number">0.027</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i94f9c1f9d7704805bcabb81136732a71_D20200821-20200821"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzE2NDkyNjc0NTExOTM_8a1cd679-8e10-4e8f-ae7c-dd1a72019010"
      unitRef="usd">3970000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i445f32d7eda447d4a2c49f251b316594_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM1MDM_f4b93bd9-81fc-4c55-afb0-e2924f98ea29"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i445f32d7eda447d4a2c49f251b316594_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM1MjQ_c1919730-cf8b-4ea4-a5e3-5693d129c844"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0f587ced64ac42339b971d523874e02d_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM1NDU_c7017788-6dd1-49e3-afe8-9d3faacbb847"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0f587ced64ac42339b971d523874e02d_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM1NjU_19af21f9-1168-4196-ad69-c48edad14820"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i459a1521a0b34aa48757c591eb7efefc_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM1ODU_5030f743-a02a-445a-b701-13c2cd8c8246"
      unitRef="usd">1000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i459a1521a0b34aa48757c591eb7efefc_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM2MDY_f83dd3a4-5cf1-4f16-ad12-1c24938d961f"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iaffd5e9b361c427a883e24208cf16157_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM2Mjc_cd914c85-8921-44b3-a665-fa4d21432208"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iaffd5e9b361c427a883e24208cf16157_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM2NDc_f3f8b4af-6784-41a4-9da6-f5876e28138a"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="id5a40055293c4fe79da45605991de624_D20200101-20200331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM2Njg_8e7a4203-c3be-44c0-a8e5-b8e6a678974b"
      unitRef="usd">3950000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="id5a40055293c4fe79da45605991de624_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM2OTQ_097f0b68-9bed-4b01-aacd-6f5779705de6"
      unitRef="usd">7000000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id5a40055293c4fe79da45605991de624_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4NDgyOTA3MTM4MTA_4ed5bfb0-6f7a-4792-81ae-36c4e17444c3"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3754da4dc0974763892869cfb72c7345_I20190815"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM2MzU_efaa0554-6503-465c-9288-5fa895858603"
      unitRef="usd">1000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3754da4dc0974763892869cfb72c7345_I20190815"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM2Njg_aa6edc57-3f84-4f9d-8b7b-8bad11f2bd26"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie91d7fd162c249529beb9e9eb9f7e7a7_I20190815"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM3MTU_f5987389-d0c4-43e4-915d-d97408182cbc"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie91d7fd162c249529beb9e9eb9f7e7a7_I20190815"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM3NDg_98511d1a-bd03-4aed-bc25-9f811fbdb1f3"
      unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idb2dc5274bad4e428d1e8ae87786fedc_I20190815"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM3OTg_9657b81f-69bb-4374-9160-3b8e8587068b"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idb2dc5274bad4e428d1e8ae87786fedc_I20190815"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM4MzE_9d17d0b6-b18e-46e1-82d4-7fe1608e905e"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="ifaa8ac73798d48a8aaab4ac171cb2721_D20190815-20190815"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzM5NDY_d5e063be-f134-468a-9c76-30aa0b2153fb"
      unitRef="usd">3460000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i95a7e367f856452c8f2160336066176a_D20190701-20190731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzQ1ODc_2b3d5da7-e4ad-42c0-a35b-ed0c2dc1c35f"
      unitRef="usd">25000000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i95a7e367f856452c8f2160336066176a_D20190701-20190731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzQ2ODE_0236c279-9b59-4962-b014-6e2dc76d420f"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i3267d33afe6d45e6b4528df8d62df448_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDMzNDE_e2a0d8fe-f220-460a-93b8-4e6965f08f1a"
      unitRef="usd">4500000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ibca2e87104be46389dc5a70a0864d1a3_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDMzNTU_01e9070b-cb69-47d7-be9d-f3ccbbdd06a1"
      unitRef="usd">113000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0e657c55e1f64967b1ffeccd58ae062b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDMzNjk_e8050a13-e9c7-4b12-989a-10b7620ab0d3"
      unitRef="number">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="id9f05d6d28af4ae0878d9c571f979793_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDMzNzU_7ccd8b03-d935-48f2-a738-f10348355594"
      unitRef="usd">1400000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i734cf172fc0a4bb394897c043bd538c6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDMzODk_9ddcb8b6-ab2c-46b8-9084-e8942e931575"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i28dabe1fc51c4dfa95740ee0bce67f39_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDMzOTU_104a26b6-7757-4ee8-85c9-0b0d4d163398"
      unitRef="usd">1000000000.0</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibb4bb36351fe4c6f9d1a0eae2a188257_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0MDk_e3873c2e-dd57-4c59-b934-fd8172c21f36"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i9f5ce01da4b6464cad8f27d28f832fe6_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0MTU_4da0b8fc-a2ce-421c-8f39-36f1a678f311"
      unitRef="usd">2000000000.0</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i854b7b5601cc4ad2ae0c167f72910032_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0Mjk_cc25488c-2d24-4605-a660-d5150f038f6c"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i3512931fe12944039d4fea37efaabf11_D20201201-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0MzU_fdc8c39a-ffbc-42db-973e-9e75ba63bfed"
      unitRef="usd">-619000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i3512931fe12944039d4fea37efaabf11_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0NTk_2104b717-276e-49c3-9c63-be2d3fb79064"
      unitRef="usd">45000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="i3512931fe12944039d4fea37efaabf11_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0NDc_f3b17a9e-b23c-4853-b411-c517cf5190db"
      unitRef="usd">10000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i3512931fe12944039d4fea37efaabf11_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDM0NzE_4e7ae48f-3b73-404f-a47c-cd6599093fc6"
      unitRef="usd">-674000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i00d2c3f9c025419cb3e6849ea5f357fd_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQxNTk_cd38a1f2-c687-4fd2-abcd-26583294200a"
      unitRef="usd">6000000000.0</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i55b3bd8ed75a4dcba9f7489cefb5e348_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQxNzM_992750ec-d932-430a-a8b5-8701b946c9af"
      unitRef="usd">723000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib154687a8b3a4739af34791842da6702_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQxODc_f75e1ff0-d2bc-4df9-ad0c-33bd08a0e0fc"
      unitRef="number">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i6e0292e851e64435a7435abc06f22dd9_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQxOTM_d59558c5-940b-4eee-bbdd-c7039d91c884"
      unitRef="usd">2300000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3f4b2227a9a84f6aaa20022126390e84_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyMDc_0dcf5de7-fe5b-439e-b772-1e8bafadbc55"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i19a7d9778cad44b39b5aedbba6e986eb_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyMTM_a9152dd0-aafb-49ab-b5fe-4b4d109d2e15"
      unitRef="usd">3000000000.0</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iacb6befda8dc4cad8d7d488e77940523_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyMjc_9b0a76ef-c536-40ae-90f5-90a1e17df813"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i77619d991c0342398aac18ff9a3beda1_D20200801-20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyMzM_9e59dbfb-43f8-4cad-bff6-56489bb993a2"
      unitRef="usd">-706000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i77619d991c0342398aac18ff9a3beda1_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyNDc_ed1d4755-3fa5-4821-9362-907f91712bd5"
      unitRef="usd">47000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="i77619d991c0342398aac18ff9a3beda1_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyNzQ_ccdb2cee-63b6-4e61-814f-9e87fa3d7aa0"
      unitRef="usd">13000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i77619d991c0342398aac18ff9a3beda1_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQyNjA_e0631aab-2b5c-427e-99f0-70d3124889e1"
      unitRef="usd">-766000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ie86e314ed8c34b84b73378a6b9f4d9fb_D20190801-20190831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDI0NzI_17e99162-43c4-458a-81b6-4954f5f351ea"
      unitRef="usd">4000000000.0</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i93c1191afd7245a2b1def8168a0950e2_D20190801-20190831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQzMDA_530ca064-6fa2-45e0-8a59-6b68d47a094d"
      unitRef="usd">1300000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2792f74c0d9748799688efc0b0fec153_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQzMjE_1ad0d30f-67fe-4a80-bfc1-c07d57fa3858"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i7f532518f6a74de889d917417c28eeb3_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQzNDI_2f17d007-0552-4509-a8ad-72566ffc7b52"
      unitRef="usd">723000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ice888eb6a699499fa3f39bf466abe7a3_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQzNjk_dc77b050-0cc8-4b41-9f0d-c87e7ca00108"
      unitRef="usd">328000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4fdb87438a4048388482de54f9117c58_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQzOTA_1477bd8b-d9d4-4e98-8273-0e0d3f2e6bf5"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i57fd64714a6f4ea08771d23076bbabd4_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQ0MTE_fca43b52-d09e-4c30-9374-8a84bea8c052"
      unitRef="usd">297000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i55a729e2dd93487da789a270476d9892_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQ0MzI_76ef155d-cbb8-48c6-8682-5688e4888195"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ia4b13a24dc9745c6846d0092832bf57b_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQ0NTM_2e5fa967-6b9c-4b39-bb9d-eafb6185b234"
      unitRef="usd">413000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i128e4692b13144ff870ee0ffea794d65_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQ0NzM_8ecbac69-5eed-4794-b373-0a09e80301cc"
      unitRef="number">0.0545</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ia712a987f9e947c89a37cdc4169dac3b_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQ0OTM_5661026c-c3c7-409d-aefe-98e030525611"
      unitRef="usd">962000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9e401817f81448f2a9b9b27b7cc53de0_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDQ1MTM_698aac16-4e31-4dd3-b89e-9ad708118b35"
      unitRef="number">0.0335</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i56de586fcbb34f1fa9240dc169c67a55_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDI1NDQ_4d060845-82ad-41a7-9031-217b38ca7f07"
      unitRef="usd">-76000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="i56de586fcbb34f1fa9240dc169c67a55_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDI1NTA_aea185ac-d5b0-48c4-a1d7-1bf92813f6b0"
      unitRef="usd">8000000</cvs:DebtExtinguishmentFees>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i56de586fcbb34f1fa9240dc169c67a55_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDI1NTY_b87f288c-b991-4d8a-a0a9-41604f6bb25e"
      unitRef="usd">5000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i56de586fcbb34f1fa9240dc169c67a55_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNDgvZnJhZzpjMTE5ZjIzMzQ4ODI0MmNlYmI4NmZhODUxNTBhNDhhMy90ZXh0cmVnaW9uOmMxMTlmMjMzNDg4MjQyY2ViYjg2ZmE4NTE1MGE0OGEzXzMyOTg1MzQ5MDI1NjI_70e89ef8-4a90-4cf7-a3c7-d7fd2af3c967"
      unitRef="usd">-79000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDYz_95ad5489-7dfb-4475-bb20-9b952ddc9056">Pension Plans and Other Postretirement Benefits&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company sponsors several active 401(k) savings plans that cover all employees who meet plan eligibility requirements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company makes matching contributions consistent with the provisions of the respective plans. At the participant&#x2019;s option, account balances, including the Company&#x2019;s matching contribution, can be invested among various investment options under each plan. The CVS Health Future Fund 401(k) Plan offers the Company&#x2019;s common stock fund as an investment option. The Company also maintains nonqualified, unfunded deferred compensation plans for certain key employees. The plans provide participants the opportunity to defer portions of their eligible compensation and for certain nonqualified plans, participants receive matching contributions equivalent to what they could have received under the CVS Health Future Fund 401(k) Plan absent certain restrictions and limitations under the Internal Revenue Code. The Company&#x2019;s contributions under its defined contribution plans were $520 million, $550 million and $334 million in the years ended December 31, 2020, 2019 and 2018, respectively. The Company&#x2019;s contributions for the years ended December&#160;31, 2019 and 2018 include contributions to the Aetna 401(k) Plan subsequent to the Aetna Acquisition Date. On January 1, 2020, the Aetna 401(k) Plan was merged into the CVS Health Future Fund 401(k) Plan. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Benefit Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 28, 2018, the Company completed the Aetna Acquisition. Aetna sponsors a tax-qualified defined benefit pension plan that was frozen in 2010. Aetna also sponsors a nonqualified supplemental pension plan that was frozen in 2007. Aetna&#x2019;s pension plan benefit obligations and the fair value of plan assets were remeasured as of the Aetna Acquisition Date. The Company also sponsors several other defined benefit pension plans that are unfunded nonqualified supplemental retirement plans. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension Benefit Obligation and Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables outline the change in pension benefit obligation and plan assets over the specified periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the pension benefit obligation during the years ended December&#160;31, 2020 and 2019 was primarily driven by the change in the discount rate during each respective period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2020 and 2019 for the pension plans consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets reflected in other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities reflected in accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities reflected in other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Periodic Benefit Cost (Income)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of net periodic benefit cost (income) for the years ended December&#160;31, 2020, 2019 and 2018 are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Components of net periodic benefit cost (income):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension Plan Assumptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a series of actuarial assumptions to determine its benefit obligation and net periodic benefit cost (income), the most significant of which include discount rates and expected return on plan assets assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Discount Rates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The discount rate is determined using a yield curve as of the annual measurement date. The yield curve consists of a series of individual discount rates, with each discount rate corresponding to a single point in time, based on high-quality bonds. Projected benefit payments are discounted to the measurement date using the corresponding rate from the yield curve that is consistent with the maturity profile of the expected liability cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Return on Plan Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected long-term rate of return on plan assets is determined by using the plan&#x2019;s target allocation and return expectations based on many factors including forecasted long-term capital market real returns and the inflationary outlook on a plan by plan basis. See &#x201c;Pension Plan Assets&#x201d; below for additional details regarding the pension plan assets as of December 31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also considers other assumptions including mortality, interest crediting rate, termination and retirement rates and cost of living adjustments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the Aetna Acquisition Date, the Company&#x2019;s pension plan assets primarily include debt and equity securities held in separate accounts, common/collective trusts and real estate investments. The valuation methodologies used to value these debt and equity securities and common/collective trusts are similar to the methodologies described in Note 4 &#x201c;Fair Value.&#x201d; Pension plan assets also include investments in other assets that are carried at fair value. The following is a description of the valuation methodologies used to value real estate investments and these additional investments, including the general classification pursuant to the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Real Estate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Real estate investments are valued by independent third party appraisers. The appraisals comply with the Uniform Standards of Professional Appraisal Practice, which include, among other things, the income, cost, and sales comparison approaches to estimating property value. Therefore, these investments are classified in Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Private equity and hedge fund limited partnerships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Private equity and hedge fund limited partnerships are carried at fair value which is estimated using the NAV per unit as reported by the administrator of the underlying investment fund as a practical expedient to fair value. Therefore, these investments have been excluded from the fair value table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2020 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Domestic real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Common/collective trusts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pension investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The assets in the underlying funds of common/collective trusts consist of $84 million of equity securities and $182 million of debt securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $142 million of other receivables as well as $624 million of private equity limited partnership investments and $214 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2019 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Domestic real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Common/collective trusts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pension investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The assets in the underlying funds of common/collective trusts consist of $137 million of equity securities and $151 million of debt securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $540 million of private equity limited partnership investments and $184 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balance of Level 3 pension plan assets during 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S. corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balance of Level 3 pension plan assets during 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S. corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s pension plan invests in a diversified mix of assets designed to generate returns that will enable the plan to meet its future benefit obligations. The risk of unexpected investment and actuarial outcomes is regularly evaluated. This evaluation is performed through forecasting and assessing ranges of investment outcomes over short- and long-term horizons and by assessing the pension plan&#x2019;s liability characteristics. Complementary investment styles and strategies are utilized by professional investment management firms to further improve portfolio and operational risk characteristics. Public and private equity investments are used primarily to increase overall plan returns. Real estate investments are viewed favorably for their diversification benefits and above-average dividend generation. Fixed income investments provide diversification benefits and liability hedging attributes that are desirable, especially in falling interest rate environments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020, target investment allocations for the Company&#x2019;s pension plan were: 20% in equity securities, 68% in fixed income and debt securities, 6% in real estate, 3% in private equity limited partnerships and 3% in hedge funds. Actual asset allocations may differ from target allocations due to tactical decisions to overweight or underweight certain assets or as a result of normal fluctuations in asset values. Asset allocations are consistent with stated investment policies and, as a general rule, periodically rebalanced back to target asset allocations. Asset allocations and investment performance are formally reviewed periodically throughout the year by the pension plan&#x2019;s Investment Subcommittee. Forecasting of asset and liability growth is performed at least annually.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally contributes to its tax-qualified pension plan based on minimum funding requirements determined under applicable federal laws and regulations. Employer contributions related to the nonqualified supplemental pension plans generally represent payments to retirees for current benefits. The Company contributed $25 million, $25 million and $12 million to its pension plans during 2020, 2019 and 2018, respectively. No contributions are required for the tax-qualified pension plan in 2021. The Company expects to make an immaterial amount of contributions for all other pension plans in 2021. The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026-2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Multiemployer Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover its union-represented employees. The risks of participating in these multiemployer plans are different from single-employer pension plans in the following respects: (i) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (ii) if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers, and (iii) if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the applicable plan, which is referred to as a withdrawal liability. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None of the multiemployer pension plans in which the Company participates are individually significant to the Company. The Company&#x2019;s contributions to multiemployer pension plans were $19 million, $18 million and $18 million in 2020, 2019 and 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides postretirement health care and life insurance benefits to certain retirees who meet eligibility requirements. During 2018, the Company acquired additional OPEB plans in connection with the Aetna Acquisition. The Company&#x2019;s funding policy is generally to pay covered expenses as they are incurred. For retiree medical plan accounting, the Company reviews external data and its own historical trends for health care costs to determine the health care cost trend rates. As of December&#160;31, 2020 and 2019, the Company&#x2019;s other postretirement benefits had an accumulated postretirement benefit obligation of $226 million and $246 million, respectively. Net periodic benefit costs related to these other postretirement benefits were $12 million, $7 million and $2 million in 2020, 2019 and 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026-2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Pursuant to various collective bargaining agreements, the Company also contributes to multiemployer health and welfare plans that cover certain union-represented employees. The plans provide postretirement health care and life insurance benefits to certain employees who meet eligibility requirements. The Company&#x2019;s contributions to multiemployer health and welfare plans totaled $54 million, $57 million and $58 million in 2020, 2019 and 2018, respectively.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExMTk_041c263f-5c4a-4e0d-85d3-7956a014393b"
      unitRef="usd">520000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExMjM_3b483fbc-3083-4937-ad8c-4f83377260bb"
      unitRef="usd">550000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExMzA_46a4531a-114b-4634-85cd-7dbda31daeaf"
      unitRef="usd">334000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDU4_0e4e030d-2048-490f-911f-7aba46c3bebf">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables outline the change in pension benefit obligation and plan assets over the specified periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDcy_fe4f4d05-a501-46cc-967e-e37d364353d4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables outline the change in pension benefit obligation and plan assets over the specified periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzItMS0xLTEtMA_c6942f53-e926-43dc-ae10-f18f3fd4aa4e"
      unitRef="usd">6239000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ida8160947ef6494a8204e68ccf558244_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzItMy0xLTEtMA_a8d48415-8acf-422b-9d3b-95412f2c92f0"
      unitRef="usd">5841000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzQtMS0xLTEtMA_4b64ced7-6563-4142-a15c-b7c02cf8a4d7"
      unitRef="usd">168000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzQtMy0xLTEtMA_c5865076-308d-4081-b56f-074ecf2d8000"
      unitRef="usd">225000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzUtMS0xLTEtMA_f5c93ec0-c593-4c26-b631-6ad7c0fffd91"
      unitRef="usd">-413000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzUtMy0xLTEtMA_111c55c1-c851-40f4-ba18-ce8bb6f19e9d"
      unitRef="usd">-530000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzYtMS0xLTEtMA_278ea5a1-7b8b-442e-b848-6aa6d188c691"
      unitRef="usd">358000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzYtMy0xLTEtMA_fba42cd2-3f2a-4437-94a1-eb50de0b9200"
      unitRef="usd">357000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzctMS0xLTEtMA_e2207ded-c6f8-4b08-b34f-3ca78425adeb"
      unitRef="usd">6462000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzctMy0xLTEtMA_e93fd035-9015-4711-9f55-8696e86d416c"
      unitRef="usd">6239000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzEwLTEtMS0xLTA_a2baa7ec-39e8-4d2b-bce9-77403a06e7f4"
      unitRef="usd">6395000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ida8160947ef6494a8204e68ccf558244_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzEwLTMtMS0xLTA_beb9fa91-476d-4c54-a926-e45d89229cd9"
      unitRef="usd">5663000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzEyLTEtMS0xLTA_e1f74d0a-85c2-47c6-a522-d06bf921f17d"
      unitRef="usd">783000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzEyLTMtMS0xLTA_8588bc56-7f6e-4178-b54f-ae870feaba97"
      unitRef="usd">1064000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzEzLTEtMS0xLTA_19589502-6ea5-4658-b244-bb6692b3164b"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzEzLTMtMS0xLTA_5d1a06a5-dc8a-4f43-affd-c5f93b002a79"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzE0LTEtMS0xLTA_ed0479be-a9f8-481b-955c-c6de3dd37e9f"
      unitRef="usd">358000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzE0LTMtMS0xLTA_ecf4875f-9848-4cea-9ed3-35d2a8743b27"
      unitRef="usd">357000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzE1LTEtMS0xLTA_f80e4165-e0df-4e3b-8e12-e75c9f3be17a"
      unitRef="usd">6845000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzE1LTMtMS0xLTA_427e541d-c400-4ee4-89b6-0fd62d60a180"
      unitRef="usd">6395000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzE3LTEtMS0xLTA_a13cc03f-6416-48b3-b37d-dbf3d69014c4"
      unitRef="usd">383000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo1MWRjY2IyZTAxMTM0OGYxOWUxMThmNDdiNzAyZmMxZi90YWJsZXJhbmdlOjUxZGNjYjJlMDExMzQ4ZjE5ZTExOGY0N2I3MDJmYzFmXzE3LTMtMS0xLTA_2fe69ea6-1381-41ee-bd75-b551b2254ae3"
      unitRef="usd">156000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDcz_2e86a49d-7e11-4e81-9c2e-a553f9a8192b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2020 and 2019 for the pension plans consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets reflected in other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities reflected in accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities reflected in other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzEtMS0xLTEtMA_23e191a5-42fa-4dba-a5a2-f2ddd99e7337"
      unitRef="usd">744000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzEtMy0xLTEtMA_07c3521e-5dc8-4d2f-ba1d-051fdd2d93c1"
      unitRef="usd">494000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzItMS0xLTEtMA_4f95cbae-19ed-4c6b-96eb-6174bbe284c4"
      unitRef="usd">76000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzItMy0xLTEtMA_a9aec4fd-3e4a-4555-a031-f4f484901122"
      unitRef="usd">25000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzMtMS0xLTEtMA_6142f055-b9fd-4208-bfeb-24b75b39a56d"
      unitRef="usd">285000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzMtMy0xLTEtMA_a75c333e-0cc1-4026-b254-06a593a3595a"
      unitRef="usd">313000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzQtMS0xLTEtMA_d7c5500e-98b9-4d61-bb27-765df46fe674"
      unitRef="usd">383000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="id05aab78eef84ae1b36d242d69f4a389_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo3N2NlOTM2MzVkNWI0MjQzYTNjN2Q1N2FkYTU3ODBmNy90YWJsZXJhbmdlOjc3Y2U5MzYzNWQ1YjQyNDNhM2M3ZDU3YWRhNTc4MGY3XzQtMy0xLTEtMA_a4159896-06a6-42da-a81b-0a3b72d8fe97"
      unitRef="usd">156000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDc0_58b94f78-1ab3-454e-a679-3e8e79e50182">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of net periodic benefit cost (income) for the years ended December&#160;31, 2020, 2019 and 2018 are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Components of net periodic benefit cost (income):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzItMS0xLTEtMA_2885dd58-2234-4fcf-9bed-08cdbf0f78bd"
      unitRef="usd">168000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzItMy0xLTEtMA_f6f8ff72-47c0-47ac-bb30-a32f082320e1"
      unitRef="usd">225000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzItNS0xLTEtMA_edbb97fc-0005-4114-94af-7930a6632525"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzMtMS0xLTEtMA_465e481f-d178-4d6b-86d8-e8b69cc63079"
      unitRef="usd">388000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzMtMy0xLTEtMA_0badc51d-65d8-4b82-912a-41d3f4c9b4c8"
      unitRef="usd">357000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzMtNS0xLTEtMA_8069db49-f518-4c68-af55-2f54559aaf65"
      unitRef="usd">33000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzQtMS0xLTEtMA_893e0579-d433-4c63-9d16-e8bd2dee027c"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzQtMy0xLTEtMA_bf2f62f8-ff45-41df-9b90-9fe04236ac0c"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzQtNS0xLTEtMA_23167549-7c3f-4e42-9c2f-a3ddc2861dc3"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzYtMS0xLTEtMA_19ebbbd0-578b-456b-9af7-dad1596a03c3"
      unitRef="usd">-218000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzYtMy0xLTEtMA_381ff18f-584a-4c6a-a074-cf2c4500ea41"
      unitRef="usd">-131000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphODJhNmVmZmUzZWM0ODE5YmVmZWM4ZmE2OTg2ZWEwYy90YWJsZXJhbmdlOmE4MmE2ZWZmZTNlYzQ4MTliZWZlYzhmYTY5ODZlYTBjXzYtNS0xLTEtMA_58cd0561-3e2b-4134-8bee-6a8116db04b5"
      unitRef="usd">-6000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDY2_ed0cf6f9-7eca-4486-a8f7-7b658399a7f5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpjYjRjYzBkNmEzZGM0MjIxODFhZjMwZTFhZmVmNWQ5MC90YWJsZXJhbmdlOmNiNGNjMGQ2YTNkYzQyMjE4MWFmMzBlMWFmZWY1ZDkwXzEtMS0xLTEtMA_a5200901-f8ce-4d2b-b03b-1ec6a72f78c8"
      unitRef="number">0.025</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpjYjRjYzBkNmEzZGM0MjIxODFhZjMwZTFhZmVmNWQ5MC90YWJsZXJhbmdlOmNiNGNjMGQ2YTNkYzQyMjE4MWFmMzBlMWFmZWY1ZDkwXzEtMy0xLTEtMA_a24b0d25-e534-44c0-9024-183aff108097"
      unitRef="number">0.032</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo5NjY5MzBmNDIzNTk0YmViYjA0ZmJiN2JjMGUzNzc1My90YWJsZXJhbmdlOjk2NjkzMGY0MjM1OTRiZWJiMDRmYmI3YmMwZTM3NzUzXzEtMS0xLTEtMA_bcd1dd4d-e5bc-4c44-b4e4-d2125f2a7353"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo5NjY5MzBmNDIzNTk0YmViYjA0ZmJiN2JjMGUzNzc1My90YWJsZXJhbmdlOjk2NjkzMGY0MjM1OTRiZWJiMDRmYmI3YmMwZTM3NzUzXzEtMy0xLTEtMA_a2526a41-c308-40c9-b56a-f40599041129"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo5NjY5MzBmNDIzNTk0YmViYjA0ZmJiN2JjMGUzNzc1My90YWJsZXJhbmdlOjk2NjkzMGY0MjM1OTRiZWJiMDRmYmI3YmMwZTM3NzUzXzEtNS0xLTEtMA_07bd24bf-1244-4c43-8903-5b8051b165e0"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo5NjY5MzBmNDIzNTk0YmViYjA0ZmJiN2JjMGUzNzc1My90YWJsZXJhbmdlOjk2NjkzMGY0MjM1OTRiZWJiMDRmYmI3YmMwZTM3NzUzXzItMS0xLTEtMA_2f43017d-c416-449d-bf03-0e005b05485b"
      unitRef="number">0.063</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo5NjY5MzBmNDIzNTk0YmViYjA0ZmJiN2JjMGUzNzc1My90YWJsZXJhbmdlOjk2NjkzMGY0MjM1OTRiZWJiMDRmYmI3YmMwZTM3NzUzXzItMy0xLTEtMA_225cd486-fa86-4398-a93b-e9c4c3638c15"
      unitRef="number">0.065</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTo5NjY5MzBmNDIzNTk0YmViYjA0ZmJiN2JjMGUzNzc1My90YWJsZXJhbmdlOjk2NjkzMGY0MjM1OTRiZWJiMDRmYmI3YmMwZTM3NzUzXzItNS0xLTEtMA_47afc15d-4038-4a00-a302-34ab509a9e7e"
      unitRef="number">0.066</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDc1_06dd66f5-0a1a-4930-b1ac-1dd4fcab43df">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2020 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Domestic real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Common/collective trusts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pension investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The assets in the underlying funds of common/collective trusts consist of $84 million of equity securities and $182 million of debt securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $142 million of other receivables as well as $624 million of private equity limited partnership investments and $214 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2019 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Domestic real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Common/collective trusts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pension investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The assets in the underlying funds of common/collective trusts consist of $137 million of equity securities and $151 million of debt securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $540 million of private equity limited partnership investments and $184 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie19b4a92f0034466b0dafc7eef0ed131_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEtMS0xLTEtMA_b1fb18e7-e771-407c-a861-53786dd969ac"
      unitRef="usd">118000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9d0605006d2241649165adc7e5b9f2ca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEtMy0xLTEtMA_0ab89b30-34f0-446c-aeac-c702fb7e3a8b"
      unitRef="usd">81000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if6fb4454708b484d80f98d957fdbae70_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEtNS0xLTEtMA_768e85a5-25fa-419b-b336-15bed9112c33"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i199b7cb664dd42c0a4101ffbc59daa25_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEtNy0xLTEtMA_8c46a297-8544-4ddb-b227-63ff56450796"
      unitRef="usd">199000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9b7e0181861a4c0d9e8c70427c9ed30b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzMtMS0xLTEtMA_efba05cb-76e8-45a3-b967-d5fe55efb9ef"
      unitRef="usd">575000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib5907cfcab6b4aef941e6f756054404d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzMtMy0xLTEtMA_3345fe38-dcee-48e2-824f-8eb63798d6f0"
      unitRef="usd">36000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icd81358eeafb4757a5e163b51db96a44_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzMtNS0xLTEtMA_600671b9-ac61-47a5-80ca-7e245becc7dc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i94f76249fb9a452d9893743b90cf37d9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzMtNy0xLTEtMA_1beee20f-de61-4981-9fa8-ca702180a910"
      unitRef="usd">611000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i60b124872b654d26a4229c8094209469_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzQtMS0xLTEtMA_f2858e5c-de87-46df-bd0b-31e01c297eab"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iee2b654be581464a9cfbd3f508f399e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzQtMy0xLTEtMA_cd049727-d0e0-46de-810a-ba3bdef7f32e"
      unitRef="usd">170000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i06e5a033c28d4981a2fdc1ff5bb4e842_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzQtNS0xLTEtMA_c10e12ec-e46f-48ee-90a1-8d67fd6cd2e0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2be7ba94d39d477293bb398aeeeb21bc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzQtNy0xLTEtMA_927f7280-1184-4f2a-8d90-59e0702e0517"
      unitRef="usd">170000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie06fb4df6a36490395db8159ed91e626_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzUtMS0xLTEtMA_287e9fda-15f9-4bc1-9eda-4fca485e59ce"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i92ca0b1a966a481bb230964303d892b0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzUtMy0xLTEtMA_3a40a443-48bf-4507-b134-f2bfea0f6aa9"
      unitRef="usd">2006000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i467e9f5dc8e842b6afcb7be67ac32c9d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzUtNS0xLTEtMA_081f7edc-32a5-4638-a5d8-bf2decfd22ca"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idebaa114561f4d728604bd981df6517f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzUtNy0xLTEtMA_3e119c66-be53-40df-8452-2ca5fb592060"
      unitRef="usd">2006000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5925ffc572454ec9a71d0ef8eb29f390_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzYtMS0xLTEtMA_efb89c64-f633-401d-b2e4-4657d19dc947"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i01c474448dea429dae5ca6e183b910fc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzYtMy0xLTEtMA_98b5e0aa-eca2-409c-a505-509fbc3051d8"
      unitRef="usd">167000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1552a4f21d8e47278630c328c2dde9c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzYtNS0xLTEtMA_edce3774-6b55-4d21-930d-1a705338c8ae"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id6d60e6812854952a3585905fbbea41b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzYtNy0xLTEtMA_e401b54a-a712-4e02-805e-368a165feea5"
      unitRef="usd">167000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9d8204427c844531b278a523b96a7dff_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzctMS0xLTEtMA_d2ca8b99-f544-42b2-91c2-ec5b3bef692a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5e87124deec94812a64890f3add780e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzctMy0xLTEtMA_03cd6723-8e0f-4a5a-8cf0-9d8bab67e8ab"
      unitRef="usd">287000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i93b5aeda1e154dd9b1c23b1da20f6ee4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzctNS0xLTEtMA_bc19343a-ea8b-4e76-9204-2ba5cd7535b2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id02d21e453d54dae81874530cd9f89dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzctNy0xLTEtMA_3bfd8e7b-9b5d-44a8-ba2a-bf7d8f0510c0"
      unitRef="usd">287000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i377d5f59a8274903ba535a34426c2ccb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzgtMS0xLTEtMA_a8238516-f6f5-4a31-bc44-c7c2ab6959dc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0dcfb37002f247639c8eb485fc992007_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzgtMy0xLTEtMA_8a5035c5-b1c2-4a93-9d38-829dbbd7862c"
      unitRef="usd">83000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i01e14729da7b4279abc81f285bf7a165_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzgtNS0xLTEtMA_6ba710ba-a25e-4f27-97f8-e66764f27f80"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iabe4e2d60e78403dbc51a597cc767f01_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzgtNy0xLTEtMA_30e031fe-4552-4e38-9092-923c45c1b581"
      unitRef="usd">83000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieea92042d53540819af2bae5cd60cb85_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzktMS0xLTEtMA_d93c2972-556c-496c-9b3c-6b66e81d0f4d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic6007e672e02407bbd8bad0315a61ffa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzktMy0xLTEtMA_f8fc4791-3e30-443d-b3c4-0d47d5427cb1"
      unitRef="usd">133000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i75d0265957df4b58acf5ac2bed8460f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzktNS0xLTEtMA_189eaf9a-0601-48b3-9e6c-6c303061475a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if507a4fe145e42b493db61571bfd2376_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzktNy0xLTEtMA_e34e0052-e9fa-434c-8f05-7f4bbdb25037"
      unitRef="usd">133000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i83dbe71df09344f38b1a756f97f3b8a9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEwLTEtMS0xLTA_bc21b439-159a-4357-9721-d540c38fb535"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i10c5293ad9994caab33673ec66c3cf31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEwLTMtMS0xLTA_b967c690-c9d6-4c3b-a1e5-9b5fbae68556"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i54427a144ab54136af97359d16305c28_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEwLTUtMS0xLTA_eb35acf3-c1f8-49e5-a478-a4a9d47c1be5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i788a8b0a6104485c88fb58913f9c1b1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEwLTctMS0xLTA_42c14fb8-e61c-48aa-b20f-1a803456a07a"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i69a36f8e3e0747b5b5d40f18f897e44b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzExLTEtMS0xLTA_a0208c59-b094-4a14-9b2f-4747f52f2330"
      unitRef="usd">575000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8d20ef997413454bb5220829c7a405ef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzExLTMtMS0xLTA_8293089b-7c7b-411a-bfca-3d76e27ff78b"
      unitRef="usd">2887000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i24b8f1f9efa947c7bffb894e3104cd7a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzExLTUtMS0xLTA_86b6fadc-3e20-4860-b6fa-97cb84f81408"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i353f05ec97dd4a7dad6e03d980c8825e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzExLTctMS0xLTA_ed8ef088-e303-4955-a2a7-0bf13f5ef7de"
      unitRef="usd">3462000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3ec36398a8c3460a872ca7a5eec4975a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEzLTEtMS0xLTA_09712cf4-4cd7-4ed3-8668-0de721efd97c"
      unitRef="usd">1046000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id7d49739667e46e7a8df15497979d8ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEzLTMtMS0xLTA_749cc5e4-919a-4e07-ab18-6943d3af4846"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8202fb48582644a489621cd494e8d6ed_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEzLTUtMS0xLTA_fcd4fa72-4a80-49cd-9d40-282d3f7c05ac"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib225d997939f4bb2bd5ea1d2988d1cb4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzEzLTctMS0xLTA_2ce3d718-0897-4e32-9034-d2fa5e8ea992"
      unitRef="usd">1046000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if874ae14e12a45bca74664b04f2b5666_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE0LTEtMS0xLTA_4d1b2bb6-26d6-43bd-9de5-85c7f1e01b23"
      unitRef="usd">537000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0638d5f10c8d47228bce923194d15629_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE0LTMtMS0xLTA_a8f32f1d-2e40-4e99-96e4-41e0627db1ce"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iff889270d69a4541aec6168c327f2898_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE0LTUtMS0xLTA_dc58890b-5341-4a12-b38c-069756298db2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if371687561d646ad8eeab5f4be3e9b99_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE0LTctMS0xLTA_18e10110-1ca2-44c2-9df3-40da9759b663"
      unitRef="usd">537000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieabe9e784e6e48c1aa447f7436dba5ec_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE1LTEtMS0xLTA_03939233-a184-4588-90ff-6dfe20cfc6af"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5d02faf330be4175b93e19bf97c5db9e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE1LTMtMS0xLTA_1744b974-6a0c-4d45-a9ab-a86c00ee9fcf"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6302fcfa13ad4d1ea6a72dfe007f13bc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE1LTUtMS0xLTA_258dc9cb-9f46-4b56-8278-258ccefcb2a7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if5ac1eab026c440588dfa8abb8de73fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE1LTctMS0xLTA_40e34a41-c7c8-47fc-bf10-afb1f1171b7d"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i67d5ae7d8fcc4926bcf462116cd3f590_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE2LTEtMS0xLTA_e73f2339-b755-40b4-9acd-aa7293e80631"
      unitRef="usd">1598000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib1bf3a33ce5e49e09483d3f1eb323c91_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE2LTMtMS0xLTA_39820a31-e233-4f94-a740-8e1e062453d2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6b5b3546e61842e19f00e5e719d97b10_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE2LTUtMS0xLTA_01a5422c-5eef-4970-808f-160c1231a423"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icd3b8f30c29d437ab39023c671b9f5d5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE2LTctMS0xLTA_3bcaef36-5e05-4e12-9404-ba4fd59be5d3"
      unitRef="usd">1598000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i83f10752832a454a8ce347de35c34a61_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE4LTEtMS0xLTA_520cbb86-e8c9-4b27-bc03-57e96110076b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id3677d20c08e4c8ebbebcb282e4db114_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE4LTMtMS0xLTA_6fa8ffdb-ec3a-41a0-9c37-9b29317476b6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i86f58868e0964cd2b2796c0808009103_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE4LTUtMS0xLTA_08a4f404-4a49-40c2-8487-cd4a9c75df9f"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1b548029e62747ba94fd53b47736ecd4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE4LTctMS0xLTA_43c5082d-8487-4183-a48d-900660d66044"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i58de51b364c74e4a85531407fafb309d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE5LTEtMS0xLTA_13151902-36f9-4626-bf33-e0435b57b305"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i85c43bf5e0d844b89bae1a96c978b4f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE5LTMtMS0xLTA_71233c21-4ee4-4c0a-bde5-a3c80231cd47"
      unitRef="usd">266000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ife531059d400455c8d2de1200f45d2b3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE5LTUtMS0xLTA_f87c52c4-8db6-4ca2-9ef7-d91f7860b2a2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i06bafa8c2cdf4929affc318e38df023e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzE5LTctMS0xLTA_b05b3483-fce4-4b70-b41a-016bf2de56d8"
      unitRef="usd">266000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i29f1e9cab7554879b559a825763f064c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIwLTEtMS0xLTA_6839eeb8-c659-4853-a591-0c489aeda9b7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ied8b9a81bd694cde82356583d0495b4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIwLTMtMS0xLTA_8e365b87-66b8-40b8-850a-e3f40746f5bc"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifb86f9a64a874a4aa21ee0d29a5c45c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIwLTUtMS0xLTA_4b62da50-6c35-49d3-8d10-04cb4450f255"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7f1fcbaf310f4df8bd8906a1f02317be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIwLTctMS0xLTA_e77c1578-d600-4c39-b2e0-7ce983d3481d"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i080509f1feb54ebcb46eeaa383e8546f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIxLTEtMS0xLTA_780d8110-f863-407e-a4b5-7962f8b3e677"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8654f2977f3d468dae935f3fbfbecf0b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIxLTMtMS0xLTA_b56d78eb-9bae-4a69-a838-7a39aa42dfb5"
      unitRef="usd">263000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if218f96f5bc7440190bb6d1d32469556_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIxLTUtMS0xLTA_582c76aa-3e8d-42dc-8867-e43824bddba8"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i729a6c49903d4b309e624c0dbef3b76a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIxLTctMS0xLTA_7980425f-6708-4bfb-8080-8b00e0830cb2"
      unitRef="usd">606000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie1312f09b0894768af1a8551fc6e5b03_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIyLTEtMS0xLTA_df7fcdb6-20dd-471b-834e-4799b0ca988a"
      unitRef="usd">2291000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i91c8af184e30405da562adf6b2f53803_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIyLTMtMS0xLTA_f28d07a7-b638-4baa-9b7a-d08a9acbf4cd"
      unitRef="usd">3231000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i05d08625a5eb4640bd0ccc35f6f0113e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIyLTUtMS0xLTA_81dd0225-ac89-4a00-9fac-2ba1a719e408"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic5abb09cdc094ad4b2a7a7bb44a3a237_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpiYzk0NWJjZGU2ZjU0YTk3YTA5MzE5ZjgyMjlmZWE4Yi90YWJsZXJhbmdlOmJjOTQ1YmNkZTZmNTRhOTdhMDkzMTlmODIyOWZlYThiXzIyLTctMS0xLTA_95f860e1-2f6f-4be5-b84b-378449c11cab"
      unitRef="usd">5865000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount
      contextRef="i7f89a175a9a14d3e920a746200d35fac_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzYyMDM_9e951060-c803-47f2-9e3f-b9f3ea6db00d"
      unitRef="usd">84000000</us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount>
    <us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount
      contextRef="icd90fa404f7c46ff85d4bc45bbb37cdd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzYyMzE_33aff0d0-a5a7-490b-9717-8082c4b080d2"
      unitRef="usd">182000000</us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie8a130cfef55481ab1428a6385d3f85a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzIxOTkwMjMyNzY0MTc_1a8bf4ea-ae88-4ecb-917c-7c3ca4b943d2"
      unitRef="usd">142000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5df5acb6d9c14d45b450813208569404_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzYyNjQ_4a5c7aeb-ab63-429a-9999-394438346ef8"
      unitRef="usd">624000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia9298abceed34f2693a1b4f218cd1ae5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzYzMjE_479e19b0-6f4e-4621-8731-2791f8e36d02"
      unitRef="usd">214000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i189e4eb5f8f84310ab30e1e16b049ded_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEtMS0xLTEtMA_99d8393f-7e27-4e0f-92b6-ba03fa436b3b"
      unitRef="usd">92000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id53b84ef08da4bc0be96eeacb61d6fdf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEtMy0xLTEtMA_ab7bc462-33d9-4780-987a-ec84e1ae161b"
      unitRef="usd">65000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2a7783ec39f44c7f950de140ee30ccd3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEtNS0xLTEtMA_7b282e7c-ceb0-4557-a3b5-cabfed9359ff"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5bae567789f14a93a57bf38399d526bc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEtNy0xLTEtMA_908d5a0d-301b-438c-a7b2-38275d4ba10f"
      unitRef="usd">157000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5622e8a9b4b94311af248826e87e3fdf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzMtMS0xLTEtMA_83abf321-796f-49a4-b513-e18b527c2f5f"
      unitRef="usd">592000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i307b2fc7ef7b489dace816f6d69b35b4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzMtMy0xLTEtMA_99470d53-9308-4932-83ef-e75182d294a0"
      unitRef="usd">31000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9f44abef5a694fda9c5e4cad71fe5401_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzMtNS0xLTEtMA_6f7255aa-fce6-42b3-ac5a-db195d547212"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3c01a675083b46ebafe2d3f0f7ee1ab3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzMtNy0xLTEtMA_48abc11d-c912-4097-87dd-32743e3713cf"
      unitRef="usd">623000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id8826db7d3214cdb93b22d4439751850_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzQtMS0xLTEtMA_7ba1d989-a4f0-4208-b95a-80a03b41b89d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i84c926b8e33449989a08783eb00e7643_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzQtMy0xLTEtMA_3bb626ce-b34f-400b-928e-16a89da0c7b4"
      unitRef="usd">157000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i32101714f9f94576810cf6f379fe4387_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzQtNS0xLTEtMA_dd82b253-5f84-44bb-90a5-9eca876df185"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iae61a996efae4295867c0dfb1a39a3f2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzQtNy0xLTEtMA_485050b4-d1af-4f47-bc6f-55fafeaffe51"
      unitRef="usd">157000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7622f52a58534a658e934f69b4a9f3fd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzUtMS0xLTEtMA_ecb1ea70-ac7a-4725-9e9c-6d2d6995fcdd"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7cc20f88214b4a889d0644a52d5a3199_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzUtMy0xLTEtMA_16a0f1fd-1f31-49b5-bc35-d9064a697ba1"
      unitRef="usd">1849000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i87158720186e40a988f7d80acf1e290f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzUtNS0xLTEtMA_5bc5e7ee-8661-4f42-977a-18ac4c3781f0"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic2a42438d1164e93a25bd2d16276f08b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzUtNy0xLTEtMA_250a27ab-8c00-4909-aebb-4bdc9e726932"
      unitRef="usd">1850000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9913ee60876d48f9a437df7a194a8925_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzYtMS0xLTEtMA_6d1aac4f-bc3d-403d-b46b-5d596fed7166"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7e944506a5e748718a30ff6c9042ae2c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzYtMy0xLTEtMA_3a9b6369-ed5c-4e32-8170-807eb398a9aa"
      unitRef="usd">178000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i656d5ceb239c4aa6a6bacdc5506c6402_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzYtNS0xLTEtMA_74dc2c42-f976-4964-933f-d46db178b20d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2cc901a60d9e43c0aa6809d88598eebe_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzYtNy0xLTEtMA_ada87595-f8ef-442d-8de2-6c99d39aeb85"
      unitRef="usd">178000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i13907d2d75304f7ba2882e4c00e7720c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzctMS0xLTEtMA_72d9f6a2-36a1-494d-b84d-57b8e1778c3f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i069fbff796464b2d9a15554368b9f668_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzctMy0xLTEtMA_290e0d35-af9a-4693-a56a-ae0d0bca9be0"
      unitRef="usd">385000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i074b986b3d7d4aa2ac22c8e670376a66_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzctNS0xLTEtMA_ae5ae793-1e5b-435b-89d3-5ccff410f449"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie2a5a8651a074b198c987dc214b0dd2b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzctNy0xLTEtMA_f5666ef1-01f5-47c2-bf83-3f9ab7d3c64a"
      unitRef="usd">385000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iead9829071b4481ab63cea328f7f1f8e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzgtMS0xLTEtMA_e9fcc4af-05bc-4086-99ce-9cf399d4d73c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9f27c04d6477464c8445d1e603a5b16a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzgtMy0xLTEtMA_5452560a-73cf-4773-bf10-9f23d8bf6e8b"
      unitRef="usd">89000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5ee6557a5cac41d48e5c01b08eaaeb97_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzgtNS0xLTEtMA_5299be38-fa74-484e-b6b2-e687996cbbd9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if9aa9e3cb8794b4aa342f889f8401d1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzgtNy0xLTEtMA_ea8cf886-0b1b-4a12-8fee-3ed1e76b383c"
      unitRef="usd">89000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i39362337f3b44b66bccad215f1c8e8c0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzktMS0xLTEtMA_33a2694b-9ba0-4673-91b0-988010cc2525"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9ad099eb0d7146c38442e0cb9d3a8402_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzktMy0xLTEtMA_1fc2f023-fa22-456c-a4a6-e06ca4e82051"
      unitRef="usd">150000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ide54b78ac8dd45638fb5a4471bfa5d00_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzktNS0xLTEtMA_159356fb-fad6-4c65-b90e-ce2d105fcbc7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i846c67b9e9c6476ba16d4a96de44df37_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzktNy0xLTEtMA_3c583176-4a88-42f3-9ca3-3add0b227cd3"
      unitRef="usd">150000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i19f7ea30687c4c7c906cfa2a0496f916_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEwLTEtMS0xLTA_bb838899-63a7-4502-b52c-56dd110a7c22"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i13374b6df9b64f6aaa07708acc7d5634_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEwLTMtMS0xLTA_be50f4dd-06bd-40f9-a7fc-51522f3d0383"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i90458e77c8d04c8b86fc7590c59d6025_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEwLTUtMS0xLTA_abb02097-76ab-4c26-8667-417a264f20c4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2d0070b3fe1244aa932248485abfe70a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEwLTctMS0xLTA_ef51b1b3-29b5-4299-abb1-dcbd36616d73"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie317f789360640fb822133fe59211131_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzExLTEtMS0xLTA_e1841500-1021-4a99-96ff-8cf3a7fd7801"
      unitRef="usd">592000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idc128ee345d848ff9eea0ec8c49afc99_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzExLTMtMS0xLTA_1ada5601-7e2e-4115-a363-a14157d6b778"
      unitRef="usd">2844000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iced38e2fa6484ee9861a8081d056eb1e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzExLTUtMS0xLTA_f41946e8-a6fe-4c01-9d8d-d7492c15d5cd"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if9945b71b67144ecb9f14a84d87ddc66_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzExLTctMS0xLTA_ea95ef90-4998-4261-8e60-74189b8a84e4"
      unitRef="usd">3437000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i24a8700c68594e30b441940e80331370_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEzLTEtMS0xLTA_6983e4b5-46eb-4760-b152-ed24579c5054"
      unitRef="usd">931000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i147b83dbf4614f9c9108afea3b976504_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEzLTMtMS0xLTA_615ecc50-fa59-4c02-b7de-6cc4b6d1fe2c"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie1029d4685304d2cb2982ca56bfc846b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEzLTUtMS0xLTA_19e98e50-326e-410e-8f9e-1bdc0af03f90"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2f7b664efcce4edeb2d0be08f0af7e83_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzEzLTctMS0xLTA_cae481ec-c03f-4afc-bcfa-d0c08dda2728"
      unitRef="usd">932000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i146ec2efe7f44c0fbbf0805c2207957f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE0LTEtMS0xLTA_dfc300b0-3c53-461d-8953-7fce51c7328c"
      unitRef="usd">481000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifb71646c58d7445aa5f321233e70747d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE0LTMtMS0xLTA_6601af23-7b28-4497-a992-ba8c42447005"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i621fa421235e47879a3c82d1e7761526_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE0LTUtMS0xLTA_54cfaaf6-a09b-4bd2-9f9e-21bb5e7f40bc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie182b182c1e04b5a95f77614cf852dcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE0LTctMS0xLTA_b46cbaff-2e72-4e2b-bfa7-49c3dcd2e8fe"
      unitRef="usd">481000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i174d4a2984ab43e49d4c93870e670a82_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE1LTEtMS0xLTA_6d3dec62-f3a2-4ddd-b403-770fd6dd8e37"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iab99963cfd9c4db0b3ea89aeae5f9c86_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE1LTMtMS0xLTA_3432ca7b-04e5-45c0-a047-01bf1069c80f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i14643b42fd4744918e6578d8405012b6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE1LTUtMS0xLTA_140d2df2-4704-4bd5-bd34-51a7e6bfc3bb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i457edd129a59445180d32544cd427fce_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE1LTctMS0xLTA_1a16f384-1312-45a7-b845-8698ba1b1cb0"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if81393ad83d44ce4a232212a8aed80bb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE2LTEtMS0xLTA_204e016f-375c-41f8-b71d-d45726a3a6e3"
      unitRef="usd">1437000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i79605292953547d9b320dae3bf8430ac_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE2LTMtMS0xLTA_c71c667e-5c67-44af-a0f8-7ee40cef3429"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibbb7812c80d64641a6de43f21593e322_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE2LTUtMS0xLTA_0be52315-751d-48eb-8003-25668e150e8a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2c89457d6192440fa11287d12cc947df_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE2LTctMS0xLTA_3bfef242-5ca9-45d1-b949-0853f21535d8"
      unitRef="usd">1438000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i80a9f79f4ffe48d1860759d3460e04e8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE4LTEtMS0xLTA_ef83074a-fe28-4fe0-bf83-3607ed0ae418"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id82b6a24ba2c4189832ac5c9b3270e8f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE4LTMtMS0xLTA_840159eb-a15b-4c03-b002-3dc01c34ed3c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i52a9e0dcc4a04df6ac84ab2839ff962f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE4LTUtMS0xLTA_5e56f628-3556-4635-8cbf-7b4732f2f36a"
      unitRef="usd">353000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id3e054a6e4684760a1317f79ac480b98_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE4LTctMS0xLTA_eb62ee51-fd33-4c8a-b0f3-4d8249a210c0"
      unitRef="usd">353000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0ee306bddc4f4d6b8934f74c4545ea7c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE5LTEtMS0xLTA_34de9c6d-df01-474c-a6f5-627ca38ef613"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ida6f1c68de9d434f969f54fdf8aba608_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE5LTMtMS0xLTA_5fb7df08-a681-474e-8e91-9056abc0a3e7"
      unitRef="usd">288000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i54a2fed1212f490e95fe213e7e4ba150_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE5LTUtMS0xLTA_34f6e2d1-89f4-4f45-890f-50a8f595e68d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i237d341b67b849d18d2ee8b7d61ffa52_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzE5LTctMS0xLTA_1cc295de-9679-4498-acd4-450e3c53d9aa"
      unitRef="usd">288000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i107d385134dc41aea1a97e0c5d0f5916_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIwLTEtMS0xLTA_44bae813-7a09-4d47-9fa4-e2a7c4df40f4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1fa9c507902c4d0b8fa4479a7c0ed322_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIwLTMtMS0xLTA_922c91b3-1ae4-4cc6-9a1a-d5cffa6f476c"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i646a4d5e671b48e3b5e208d65353fdf0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIwLTUtMS0xLTA_13065489-5123-4cca-bd77-cf0cee1b7b79"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ife78fc80a60a4e48b19bed5974ae5428_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIwLTctMS0xLTA_945d3e80-a495-40d3-9a0a-b9fc87c40603"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i190a83693cb04cfb8d75c0ceecbbe1ba_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIxLTEtMS0xLTA_5f0a7d53-4452-4d8c-84cf-cff5a2d5da93"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib1d6b4017f5149b3ae49f0bd1da1940d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIxLTMtMS0xLTA_cfc7f1bc-74b5-418b-8134-000bed44c086"
      unitRef="usd">286000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ife7c0d3bc5f844c3ab8218065d78c108_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIxLTUtMS0xLTA_08e6258c-a53f-4aba-9d62-181f2e1cfd2c"
      unitRef="usd">353000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i39bb7917bc994f0eaf005fd0617cde55_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIxLTctMS0xLTA_6f4e3e34-16ad-48b8-b6cb-4f292f2dfc02"
      unitRef="usd">639000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i958b9417031b48e7a2cb6c08607b666b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIyLTEtMS0xLTA_c29d5d46-eccf-40f5-ab3d-47be6fa51a19"
      unitRef="usd">2121000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie0dca0fdd1cc4f1c87ec37e91a251807_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIyLTMtMS0xLTA_ba3fc3c0-b473-46ab-b77a-83a4ad206cc5"
      unitRef="usd">3196000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5ba1a93762424cd3b76c4ca89d3b3cf3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIyLTUtMS0xLTA_61328f29-4683-4a3c-87ef-cc7413f7577a"
      unitRef="usd">354000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i706c321b809b483b98aa21c73cf16796_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTozZTE4MmY2YjMwN2E0NGJhYjNiODUwYTkyZWE2OWY5MC90YWJsZXJhbmdlOjNlMTgyZjZiMzA3YTQ0YmFiM2I4NTBhOTJlYTY5ZjkwXzIyLTctMS0xLTA_c4ac861b-95e9-4215-8a03-337ceac3c965"
      unitRef="usd">5671000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount
      contextRef="i5510c8c02acc41eb892b3be5a2a9b1b8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzY3MjQ_4d6a749c-c552-4b26-ac56-98cb0e0e6954"
      unitRef="usd">137000000</us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount>
    <us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount
      contextRef="i81dde339dd0248afbe29f4dc19b3c9be_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzY3NTI_bf66decb-bb46-43a3-b3f9-0e4e17af4aa6"
      unitRef="usd">151000000</us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic8aef86038c9426ca7436114946db2b5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzY3ODU_4cb0277a-f313-4e9c-8f1c-2588ec2e7b3f"
      unitRef="usd">540000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4fb8ea69d9ee452abf1af74b33433c67_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzY4NDI_a104c131-8812-4519-af32-936f5acbf61c"
      unitRef="usd">184000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDY4_bacc8f02-172c-42b6-ac3e-4f379914477f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balance of Level 3 pension plan assets during 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S. corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balance of Level 3 pension plan assets during 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S. corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i52a9e0dcc4a04df6ac84ab2839ff962f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzItMS0xLTEtMA_947861c8-9293-4f1e-b26d-40b19c271c12"
      unitRef="usd">353000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i87158720186e40a988f7d80acf1e290f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzItMy0xLTEtMA_b323a6c9-16bb-47cd-b930-56aba3709b2f"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5ba1a93762424cd3b76c4ca89d3b3cf3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzItNS0xLTEtMA_61b9b7ab-a371-4926-a250-77e3616ff610"
      unitRef="usd">354000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="idddcc030b53a42e4be0825c74db753da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzMtMS0xLTEtMA_b7f673f3-b48a-4cfd-a0f0-8e0200ded17d"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="i09e3fae81cff499099d524e5745e57cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzMtMy0xLTEtMA_09c3b0e9-38a2-43b0-a868-c8f56182cf86"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="ie58dc0862dea4aa2b787686a9637e9e1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzMtNS0xLTEtMA_fb13fdbe-6c06-45c7-b904-5b4537cb529a"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="idddcc030b53a42e4be0825c74db753da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzQtMS0xLTEtMA_415567c6-e145-4a85-8186-e59492dfbe6d"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="i09e3fae81cff499099d524e5745e57cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzQtMy0xLTEtMA_a8b184c0-f8b7-4ee7-8f98-d99d78593613"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="ie58dc0862dea4aa2b787686a9637e9e1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzQtNS0xLTEtMA_28a6b4e5-85b6-4a76-8341-b541aed7bc7e"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="idddcc030b53a42e4be0825c74db753da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzUtMS0xLTEtMA_4241e81b-e18e-4344-be40-510d681652f1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="i09e3fae81cff499099d524e5745e57cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzUtMy0xLTEtMA_5139b843-070d-488e-9567-3460e635b976"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="ie58dc0862dea4aa2b787686a9637e9e1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzUtNS0xLTEtMA_78c81e98-fc30-4d3f-a946-a9c6ed226031"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i86f58868e0964cd2b2796c0808009103_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzYtMS0xLTEtMA_dcb95653-1920-49c9-b97f-2c8f16f08cde"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i467e9f5dc8e842b6afcb7be67ac32c9d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzYtMy0xLTEtMA_d4b462f9-c69e-4374-962e-3a95e6b3ea2e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i05d08625a5eb4640bd0ccc35f6f0113e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTphM2ViZjBhYzg4MzA0OGE2ODc1YTMxOTc1Mzg0MGQyMC90YWJsZXJhbmdlOmEzZWJmMGFjODgzMDQ4YTY4NzVhMzE5NzUzODQwZDIwXzYtNS0xLTEtMA_db222c06-5e32-484c-8f1a-72901b9bfc59"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i709a7a961b39422984ed1bd0a5689686_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzItMS0xLTEtNTg3MQ_f9ba286a-0e19-4715-b752-7a8790f37ddd"
      unitRef="usd">425000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic8c098e2a62d48dba96b79e8a470d8af_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzItMy0xLTEtNTg3MQ_51ac0d6f-8ede-481b-be6a-6ba475a24739"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id2e47c4a3e474047b5600f55bf95c1ac_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzItNS0xLTEtNTg3MQ_5bbc556a-dcf4-4a96-a376-d03ccee6297c"
      unitRef="usd">430000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="i832b22dba7494ed582da21d8a190e7d9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzMtMS0xLTEtNTg3MQ_864f8c72-3fa6-4cd0-861b-dea2f76d70cf"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="i82cc1b96c4d540878bf6fe77d08690d5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzMtMy0xLTEtNTg3MQ_09da1983-d11a-4431-b0f1-3444c16e6dc2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="ic46f812ae4a24778b7506bc4bb600bf2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzMtNS0xLTEtNTg3MQ_166a49d6-cddd-42b8-86cf-b8b29b123c2b"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="i832b22dba7494ed582da21d8a190e7d9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzQtMS0xLTEtNTg3MQ_45da6595-fb47-4a82-98a7-fa0dff047902"
      unitRef="usd">77000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="i82cc1b96c4d540878bf6fe77d08690d5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzQtMy0xLTEtNTg3MQ_670df743-b2f5-4143-8d42-96b3f6b60728"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="ic46f812ae4a24778b7506bc4bb600bf2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzQtNS0xLTEtNTg3MQ_ca3790e7-3c07-4991-b2df-ed6ddb64f54a"
      unitRef="usd">82000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="i832b22dba7494ed582da21d8a190e7d9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzUtMS0xLTEtNTg3MQ_5f4dc794-3b9e-4109-bf40-e32d8fa4b6d6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="i82cc1b96c4d540878bf6fe77d08690d5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzUtMy0xLTEtNTg3MQ_03790344-285e-44f1-83a9-05418ddc6a00"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="ic46f812ae4a24778b7506bc4bb600bf2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzUtNS0xLTEtNTg3MQ_9a3ae2b3-3be1-49d5-b9a7-936a0620b96d"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i52a9e0dcc4a04df6ac84ab2839ff962f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzYtMS0xLTEtNTg3MQ_e8e45976-06a8-4015-a38a-e0bf9242ffb2"
      unitRef="usd">353000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i87158720186e40a988f7d80acf1e290f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzYtMy0xLTEtNTg3MQ_b131ea26-b4ed-41ea-ba24-fb421dcd90b4"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5ba1a93762424cd3b76c4ca89d3b3cf3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpkM2RjZDg3ZDhiYzY0MzFiYmMzMmVmNjU1OTU1MTVjYy90YWJsZXJhbmdlOmQzZGNkODdkOGJjNjQzMWJiYzMyZWY2NTU5NTUxNWNjXzYtNS0xLTEtNTg3MQ_5ffee53e-3ffd-4f84-ac02-5a41163b0494"
      unitRef="usd">354000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="icc6b13b774c2451ebf395531a720b68e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzg0NTk_9cfb88b5-afb0-408c-8edb-fc2636d8e34a"
      unitRef="number">0.20</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ic1dd8da2c561447490c876b5d1d43462_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzg0ODQ_1b26a4d6-5bb6-4b63-a16c-7e704446c18b"
      unitRef="number">0.68</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i47492e5b6b204ea7abaea7eee818a880_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzg1MDc_6b955e97-b7d5-4884-855a-fd0e2e55d23a"
      unitRef="number">0.06</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ib81821bf724343ffbd656554419d3a89_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzg1MjY_571cce00-ca4a-4dce-bee8-50fe2d786b6f"
      unitRef="number">0.03</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ia6f4539d5aa54233a40a81686c5e751a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzg1NzI_d763182b-9229-4a4d-a18f-4dc942cd3e2a"
      unitRef="number">0.03</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzk0ODc_e6ecf3e7-bbc1-4a0f-aa52-5afd15f3b6de"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzk0OTE_64e2c436-1a53-4663-9637-3d9fbb8820b5"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5Xzk0OTg_467bf798-667f-42ea-8e14-f5f704cfb6ab"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDYx_69e023ee-e5dd-4970-82b2-4d5830b8bca7">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2020: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026-2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026-2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZToyYzU0OWNjYzllNmQ0ZWZmYjFmYWY4NTRhM2UyM2MzNi90YWJsZXJhbmdlOjJjNTQ5Y2NjOWU2ZDRlZmZiMWZhZjg1NGEzZTIzYzM2XzEtMS0xLTEtMA_34818847-4814-4e02-850a-ec33e068347d"
      unitRef="usd">423000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZToyYzU0OWNjYzllNmQ0ZWZmYjFmYWY4NTRhM2UyM2MzNi90YWJsZXJhbmdlOjJjNTQ5Y2NjOWU2ZDRlZmZiMWZhZjg1NGEzZTIzYzM2XzItMS0xLTEtMA_61057dc1-5684-40c7-bc58-3adc7997c482"
      unitRef="usd">376000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZToyYzU0OWNjYzllNmQ0ZWZmYjFmYWY4NTRhM2UyM2MzNi90YWJsZXJhbmdlOjJjNTQ5Y2NjOWU2ZDRlZmZiMWZhZjg1NGEzZTIzYzM2XzMtMS0xLTEtMA_50300aba-d132-4981-b180-797ab0a9e745"
      unitRef="usd">375000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZToyYzU0OWNjYzllNmQ0ZWZmYjFmYWY4NTRhM2UyM2MzNi90YWJsZXJhbmdlOjJjNTQ5Y2NjOWU2ZDRlZmZiMWZhZjg1NGEzZTIzYzM2XzQtMS0xLTEtMA_6a34faeb-7842-4ec8-a93a-337b698715a4"
      unitRef="usd">375000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZToyYzU0OWNjYzllNmQ0ZWZmYjFmYWY4NTRhM2UyM2MzNi90YWJsZXJhbmdlOjJjNTQ5Y2NjOWU2ZDRlZmZiMWZhZjg1NGEzZTIzYzM2XzUtMS0xLTEtMA_76f7f3c2-3032-4c89-9217-29fc3b823055"
      unitRef="usd">375000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZToyYzU0OWNjYzllNmQ0ZWZmYjFmYWY4NTRhM2UyM2MzNi90YWJsZXJhbmdlOjJjNTQ5Y2NjOWU2ZDRlZmZiMWZhZjg1NGEzZTIzYzM2XzYtMS0xLTEtMA_d44e16c9-6287-459d-8d59-2358518ba139"
      unitRef="usd">1807000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEwOTgy_0ed4a1b0-4101-4b2c-872b-d88748da2804"
      unitRef="usd">19000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="i2270603a17114abf97a35a1b9795ccfd_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEwOTg2_99efca21-1ce3-4b9b-a63d-5426dcaae3ea"
      unitRef="usd">18000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="i2ceb1d26f1c343e19ea58ef6d201f0a5_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEwOTkz_da385283-dd9f-4e9d-bf6b-9d80994dfb9a"
      unitRef="usd">18000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExNjY1_596ac223-03c9-44d0-a2c7-8a5b751577d3"
      unitRef="usd">226000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ib4862415f867402e89af424bb29735c0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExNjcy_141beec8-594a-420a-8061-ae8a034d2eb7"
      unitRef="usd">246000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i4ee76c7bbbad45d3a4d8ec0ad4b5a14b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExNzY5_085d7d6c-d3aa-411e-aabd-bef2c1568ccb"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i27e3f6392d84488594d582d44fa7d68a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExNzcz_e05be6cf-6ae6-403e-9bd4-d59f0ee850d3"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iac73a717d5c74326808abd0309a3a07d_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzExNzgw_4aa1f4c6-4613-467b-9ab5-af8f91b5c0d4"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpmMmM0ODc2M2U0NmY0MzE2YjVlNmRlMmVkOTMxMzZiOC90YWJsZXJhbmdlOmYyYzQ4NzYzZTQ2ZjQzMTZiNWU2ZGUyZWQ5MzEzNmI4XzEtMS0xLTEtMA_7337f7c4-3c80-4866-a9b8-64d67039bc62"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpmMmM0ODc2M2U0NmY0MzE2YjVlNmRlMmVkOTMxMzZiOC90YWJsZXJhbmdlOmYyYzQ4NzYzZTQ2ZjQzMTZiNWU2ZGUyZWQ5MzEzNmI4XzItMS0xLTEtMA_2cd95dc4-a4a6-4495-8cb5-d4b585a5d6f4"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpmMmM0ODc2M2U0NmY0MzE2YjVlNmRlMmVkOTMxMzZiOC90YWJsZXJhbmdlOmYyYzQ4NzYzZTQ2ZjQzMTZiNWU2ZGUyZWQ5MzEzNmI4XzMtMS0xLTEtMA_55de620f-acf7-4a9f-b715-c2cb8a6647da"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpmMmM0ODc2M2U0NmY0MzE2YjVlNmRlMmVkOTMxMzZiOC90YWJsZXJhbmdlOmYyYzQ4NzYzZTQ2ZjQzMTZiNWU2ZGUyZWQ5MzEzNmI4XzQtMS0xLTEtMA_c02f9139-6e0e-43c1-adb5-2848adcebc02"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpmMmM0ODc2M2U0NmY0MzE2YjVlNmRlMmVkOTMxMzZiOC90YWJsZXJhbmdlOmYyYzQ4NzYzZTQ2ZjQzMTZiNWU2ZGUyZWQ5MzEzNmI4XzUtMS0xLTEtMA_7e7a2d79-a214-4556-a51d-3d4d2b94aa9e"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="ifab6770f74fb4affaa6da71827532dca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90YWJsZTpmMmM0ODc2M2U0NmY0MzE2YjVlNmRlMmVkOTMxMzZiOC90YWJsZXJhbmdlOmYyYzQ4NzYzZTQ2ZjQzMTZiNWU2ZGUyZWQ5MzEzNmI4XzYtMS0xLTEtMA_dfd892cd-126c-4f19-949f-eb3e82d7a195"
      unitRef="usd">61000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="i4ee76c7bbbad45d3a4d8ec0ad4b5a14b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDA3_725c7c99-a162-4409-ba63-fd8225c196ee"
      unitRef="usd">54000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="i27e3f6392d84488594d582d44fa7d68a_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDEx_fdbbfb90-804d-4955-84cd-fb5e8b50445f"
      unitRef="usd">57000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="iac73a717d5c74326808abd0309a3a07d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNTQvZnJhZzo0OGM0NzMxMTliZmE0MzM0ODQ0ODM0MjA3MzIxMTE3OS90ZXh0cmVnaW9uOjQ4YzQ3MzExOWJmYTQzMzQ4NDQ4MzQyMDczMjExMTc5XzEyNDE4_3a84c32c-591e-490c-a54f-6ba727b82fe4"
      unitRef="usd">58000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQzOTQ_0b4d8c5a-92f8-4de5-ae48-90a57343326f">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(535)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(564)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The TCJA was enacted on December 22, 2017. Among numerous changes to existing tax laws, the TCJA permanently reduced the federal corporate income tax rate from 35% to 21% effective on January 1, 2018. The effects of changes in tax rates on deferred tax balances are required to be taken into consideration in the period in which the changes are enacted, regardless of when they are effective. As a result of the reduction of the corporate income tax rate under the TCJA, the Company estimated the revaluation of its net deferred tax liabilities and recorded a provisional income tax benefit of approximately $1.5 billion for &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;year ended December 31, 2017. In 2018, the Company completed its process of determining the TCJA&#x2019;s final impact and recorded an additional income tax benefit of $100 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of the statutory income tax rate to the Company&#x2019;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of the Tax Cuts and Jobs Act&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurer fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basis difference upon disposition of subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of the Company&#x2019;s deferred income tax assets and liabilities as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and rents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debts and other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and capital loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll tax deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and rents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company had net operating and capital loss carryovers of $568 million, which expire between 2021 and 2040. The Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and the Company&#x2019;s recent operating results. The Company established a valuation allowance of $454 million because it does not consider it more likely than not that these deferred tax assets will be recovered.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2020, 2019 and 2018 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of statutes of limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The increase in the balance of unrecognized tax benefits during 2018 was mainly due to the Aetna Acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and most of its subsidiaries are subject to U.S. federal income tax as well as income tax of numerous state and local jurisdictions. The Company participated in the Compliance Assurance Process through 2019, which is a program made available by the U.S. Internal Revenue Service (&#x201c;IRS&#x201d;) to certain qualifying large taxpayers, under which participants work collaboratively with the IRS to identify and resolve potential tax issues through open, cooperative and transparent interaction prior to the annual filing of their federal income tax returns. The IRS has completed its examinations of the Company&#x2019;s consolidated U.S. federal income tax returns for tax years 2013 and 2018. The IRS has substantially completed its examinations of the Company&#x2019;s consolidated U.S. federal income tax returns for tax years 2014 through 2017 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its subsidiaries are also currently under income tax examinations by a number of state and local tax authorities. As of December&#160;31, 2020, no examination has resulted in any proposed adjustments that would result in a material change to the Company&#x2019;s operating results, financial condition or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all material state and local income tax matters have been concluded for fiscal years through 2014. Certain state exams are likely to be concluded and certain state statutes of limitations will lapse in 2021, but the change in the balance of the Company&#x2019;s uncertain tax positions is projected to be immaterial. In addition, it is reasonably possible that the Company&#x2019;s unrecognized tax benefits could change within the next twelve months due to the anticipated conclusion of various examinations with the IRS for various years. An estimate of the range of the possible change cannot be made at this time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records interest expense related to unrecognized tax benefits and penalties in the income tax provision. The Company accrued interest expense of approximately $34 million, $49 million and $19 million in 2020, 2019 and 2018, respectively. The Company had approximately $121 million and $173 million accrued for interest and penalties as of December&#160;31, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the total amount of unrecognized tax benefits that, if recognized, would affect the Company&#x2019;s effective income tax rate is approximately $651 million, after considering the federal benefit of state income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQzOTY_78a759ed-9554-484e-8675-c6b4aae4322f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(535)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(564)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzItMS0xLTEtMA_be2df563-368e-4692-8385-f4238dfc77d6"
      unitRef="usd">2615000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzItMy0xLTEtMA_3f264655-1bd8-4bfd-8800-b722a0366eee"
      unitRef="usd">2450000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzItNS0xLTEtMA_a408c619-49b5-44e2-a422-700ca02fc8c6"
      unitRef="usd">1480000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzMtMS0xLTEtMA_914e4381-ae92-4fbe-9292-f74be94590b5"
      unitRef="usd">518000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzMtMy0xLTEtMA_889212bb-b84b-4db2-b962-d251c8a91773"
      unitRef="usd">565000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzMtNS0xLTEtMA_2c5200a9-e830-43e9-a1be-95ab129e0f89"
      unitRef="usd">499000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzQtMS0xLTEtMA_e8797d70-fd0f-4d12-ad3b-73983a9ea5d9"
      unitRef="usd">3133000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzQtMy0xLTEtMA_4bea0e78-e255-4f95-9cb9-daa29725a55b"
      unitRef="usd">3015000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzQtNS0xLTEtMA_9606b023-e508-4c62-a9a7-77c4b91d27d1"
      unitRef="usd">1979000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzYtMS0xLTEtMA_93b6e1e5-b546-422f-88a3-47c4ffaf951d"
      unitRef="usd">-450000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzYtMy0xLTEtMA_82dfdb3e-2490-4c40-9724-32df1c5ff762"
      unitRef="usd">-535000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzYtNS0xLTEtMA_b54edfef-f089-4ce5-a83b-94def3777746"
      unitRef="usd">22000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzctMS0xLTEtMA_c7357fd2-0f12-43fe-afda-813f1f8b2a8b"
      unitRef="usd">-114000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzctMy0xLTEtMA_07c43e43-4611-49da-97b4-0ef65ef32af0"
      unitRef="usd">-114000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzctNS0xLTEtMA_11592f86-c535-4ecb-a67c-c0c978598f72"
      unitRef="usd">1000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzgtMS0xLTEtMA_d38f09d3-bc1f-4bb3-b951-7709e361fb0d"
      unitRef="usd">-564000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzgtMy0xLTEtMA_8d7cb873-bd7a-4364-b062-412fc0968eaa"
      unitRef="usd">-649000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzgtNS0xLTEtMA_a32eb60b-8cac-476e-8d12-c8d8de7c0439"
      unitRef="usd">23000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzktMS0xLTEtMA_77ce4696-cb02-4d72-862d-f224a4451000"
      unitRef="usd">2569000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzktMy0xLTEtMA_bf1eb7e8-763d-4842-95b1-1e06d6116bfc"
      unitRef="usd">2366000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpiNjQyNTMyN2U5YmU0NGQ2YjFjMDI4MmY5NzdjYjRjNC90YWJsZXJhbmdlOmI2NDI1MzI3ZTliZTQ0ZDZiMWMwMjgyZjk3N2NiNGM0XzktNS0xLTEtMA_3e0b4bc3-6e4a-4f43-b814-c1767e26a103"
      unitRef="usd">2002000000</us-gaap:IncomeTaxExpenseBenefit>
    <cvs:TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzc1NQ_849b4b50-13bd-4898-8849-cde75baf9dcc"
      unitRef="usd">-1500000000</cvs:TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense>
    <us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzkyMw_b9481248-a78d-41b6-a536-a7f5f66c2d40"
      unitRef="usd">-100000000</us-gaap:TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQzOTE_3eceae67-7e80-406a-b082-cd927a297f77">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of the statutory income tax rate to the Company&#x2019;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of the Tax Cuts and Jobs Act&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurer fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basis difference upon disposition of subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzEtMS0xLTEtMA_cab8ae3b-5b61-4cf9-a91c-330a3f626e9f"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzEtMy0xLTEtMA_053b3ea0-f27e-48b8-a380-998e0fa28448"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzEtNS0xLTEtMA_dadcf7ba-fb61-47c0-ac16-036eb98c462d"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzItMS0xLTEtMA_2bd8c425-79bf-44bf-8e21-69224b3a5ea9"
      unitRef="number">0.032</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzItMy0xLTEtMA_c90f136c-7178-4a2c-915b-af58641b9f96"
      unitRef="number">0.040</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzItNS0xLTEtMA_1c49d99e-aca3-416c-bcb4-af0ea0a948e6"
      unitRef="number">0.277</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzMtMS0xLTEtMA_308dce3c-9303-4c6b-806e-4ab0f0ae940f"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzMtMy0xLTEtMA_c7671b6e-1538-4ff6-95a7-c91ad27364f3"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzMtNS0xLTEtMA_25dd13e3-6eac-4d2e-80d2-9b4c608bf5f2"
      unitRef="number">-0.071</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent>
    <cvs:HealthInsurerFeeTaxEffectPercent
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzQtMS0xLTEtMA_7c3c2f96-06bb-4534-bf3c-1f1bf30d14ac"
      unitRef="number">0.022</cvs:HealthInsurerFeeTaxEffectPercent>
    <cvs:HealthInsurerFeeTaxEffectPercent
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzQtMy0xLTEtMA_3a4acefb-1f73-41ef-82df-abef8d24bfa6"
      unitRef="number">0</cvs:HealthInsurerFeeTaxEffectPercent>
    <cvs:HealthInsurerFeeTaxEffectPercent
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzQtNS0xLTEtMA_6e3c3f67-e161-4b85-8cb8-2de8688355aa"
      unitRef="number">0.022</cvs:HealthInsurerFeeTaxEffectPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzUtMS0xLTEtMA_26d88b4f-809c-45c9-9de8-9a6bd66b9548"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzUtMy0xLTEtMA_347c364c-5d1c-4c05-bdb2-68db880dce15"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzUtNS0xLTEtMA_6387634c-1dcb-495f-82e1-8660670e72c5"
      unitRef="number">0.895</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzYtMS0xLTEtMA_32b62329-a1f9-43e2-9429-c58ba720ba7d"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzYtMy0xLTEtMA_3d814d87-7d5d-4162-825e-66136fd7f796"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzYtNS0xLTEtMA_d32d0f80-0161-4cfb-8502-b2d85c9105a5"
      unitRef="number">0.050</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzctMS0xLTEtMA_02063aff-e719-4a26-8549-6abed1eea129"
      unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzctMy0xLTEtMA_651f41b8-a01a-4dcb-a511-08421cb5e0b4"
      unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzctNS0xLTEtMA_3fb93326-4446-4a69-a68d-b596e3d0a718"
      unitRef="number">0.041</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzgtMS0xLTEtMA_fe03f73b-edc1-4ff3-b95e-e8ef4187a05c"
      unitRef="number">0.263</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzgtMy0xLTEtMA_01357108-23e6-4d27-ab69-04830bb10ef0"
      unitRef="number">0.263</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTozNWQwMDhhODllYTY0Zjk2OGY3YWQzMGNkMzNhYzFkZi90YWJsZXJhbmdlOjM1ZDAwOGE4OWVhNjRmOTY4ZjdhZDMwY2QzM2FjMWRmXzgtNS0xLTEtMA_78713954-0825-401a-ba92-4ab63bd5b7aa"
      unitRef="number">1.424</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQzODc_543246c1-21e2-4142-b2ee-a832c75edf1e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of the Company&#x2019;s deferred income tax assets and liabilities as of December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and rents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debts and other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and capital loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll tax deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and rents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,603)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzItMS0xLTEtMA_95e5938d-0d53-44bf-bbd5-a8421f250039"
      unitRef="usd">5742000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzItMy0xLTEtMA_a7ece961-e196-41c9-b35a-88aee06425f8"
      unitRef="usd">5731000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzMtMS0xLTEtMA_8be6e90e-350d-4142-b95d-685f174a4a84"
      unitRef="usd">80000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzMtMy0xLTEtMA_545a169f-ce84-4ebe-adf1-aaf0f73c5220"
      unitRef="usd">23000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzQtMS0xLTEtMA_cec22008-0fc2-4ac9-a647-2a315f859d59"
      unitRef="usd">238000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzQtMy0xLTEtMA_e020a912-5a73-4fe7-a8e1-934f7e8a3922"
      unitRef="usd">191000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzUtMS0xLTEtMA_ef18f77d-a822-493d-b1ee-5a8457dfe922"
      unitRef="usd">395000000</cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances>
    <cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzUtMy0xLTEtMA_1c936135-743e-4029-a98d-e8da9cd855d4"
      unitRef="usd">294000000</cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzYtMS0xLTEtMA_d0b8840a-5f55-4bb3-a96a-b7f68e24d6c9"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzYtMy0xLTEtMA_4dad1f8c-6c5d-4c8c-8aa1-3f0ec38e2370"
      unitRef="usd">47000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzctMS0xLTEtMA_87c0b47a-feb6-4449-a3da-af5d9e0d688d"
      unitRef="usd">568000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzctMy0xLTEtMA_c6d3c931-569c-4c6f-9558-83afd3a06aae"
      unitRef="usd">480000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzgtMS0xLTEtMA_788893c1-9f6f-4a47-9a33-f99b336ab4d1"
      unitRef="usd">43000000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzgtMy0xLTEtMA_2653de83-3b77-4959-b4f6-215fe62dce85"
      unitRef="usd">36000000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzktMS0xLTEtMA_84fe76b0-2381-4cc3-8ca7-d9ef72257d53"
      unitRef="usd">489000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzktMy0xLTEtMA_0f5aa1ff-0b99-4ddb-8150-42ee29b72c81"
      unitRef="usd">430000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <cvs:DeferredTaxAssetsPayrollTaxDeferral
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzEwLTEtMS0xLTA_18273ebc-9359-486b-b553-4c77d7b6cc96"
      unitRef="usd">173000000</cvs:DeferredTaxAssetsPayrollTaxDeferral>
    <cvs:DeferredTaxAssetsPayrollTaxDeferral
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzEwLTMtMS0xLTA_93a6128e-8552-4117-b506-901e71f7f43f"
      unitRef="usd">0</cvs:DeferredTaxAssetsPayrollTaxDeferral>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzExLTEtMS0xLTA_2e39ad07-f7a0-46b2-8816-48c5643a485e"
      unitRef="usd">500000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzExLTMtMS0xLTA_8193e9cd-58fe-4ef0-9b41-e1e0781a57dc"
      unitRef="usd">451000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzEyLTEtMS0xLTA_b1139b23-b845-4f8d-a9b4-20e6fa706a4e"
      unitRef="usd">454000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzEyLTMtMS0xLTA_1947ef87-8744-44db-925b-14a0127faecd"
      unitRef="usd">374000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzEzLTEtMS0xLTA_ba77dea2-fe1c-455d-a55a-7c9bff4d286f"
      unitRef="usd">7774000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzEzLTMtMS0xLTA_c46b3c1a-d9e3-47fc-9918-13775f7b3d26"
      unitRef="usd">7309000000</us-gaap:DeferredTaxAssetsNet>
    <cvs:DeferredTaxLiabilitiesRetirementBenefits
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE1LTEtMS0xLTE2MDIx_85d21d08-b6c0-4bf7-a13d-365ac373505c"
      unitRef="usd">-29000000</cvs:DeferredTaxLiabilitiesRetirementBenefits>
    <cvs:DeferredTaxLiabilitiesRetirementBenefits
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE1LTMtMS0xLTE2MDIx_e79334f8-8538-4d2d-b9e3-cc58567f4095"
      unitRef="usd">0</cvs:DeferredTaxLiabilitiesRetirementBenefits>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE1LTEtMS0xLTA_a97b1a6f-f9ed-45e5-a8a9-0eb92e242f54"
      unitRef="usd">421000000</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE1LTMtMS0xLTA_7ffccd90-12ff-48b3-b187-b9d6f4c8edd9"
      unitRef="usd">289000000</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE3LTEtMS0xLTE2MDI3_30f33073-4f30-4ab3-b488-e1e873d38d96"
      unitRef="usd">5368000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE3LTMtMS0xLTE2MDI3_1101097f-ffc7-4007-9168-e6b726baa686"
      unitRef="usd">5464000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <cvs:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE2LTEtMS0xLTA_35b8867f-19ed-447b-a2d3-8259da378cf8"
      unitRef="usd">8750000000</cvs:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <cvs:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE2LTMtMS0xLTA_35fc0406-f536-46a3-b4ea-a39810312524"
      unitRef="usd">8850000000</cvs:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE3LTEtMS0xLTA_88667517-7abb-4946-8e79-4c9aeff2e1ae"
      unitRef="usd">14568000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE3LTMtMS0xLTA_2c2ffb71-1d36-4175-a70a-2648e18514bc"
      unitRef="usd">14603000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE4LTEtMS0xLTA_7e538ca6-aaa3-4107-a41d-08ba780d810b"
      unitRef="usd">6794000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpjOTRiOTZhODJlY2U0ZDQ5YTRkZjU0YjIzMGZiZWMzYy90YWJsZXJhbmdlOmM5NGI5NmE4MmVjZTRkNDlhNGRmNTRiMjMwZmJlYzNjXzE4LTMtMS0xLTA_578eb3e6-1379-4649-8a95-64286b00f442"
      unitRef="usd">7294000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzEzMjY_87c0b47a-feb6-4449-a3da-af5d9e0d688d"
      unitRef="usd">568000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzE2NTQ_b1139b23-b845-4f8d-a9b4-20e6fa706a4e"
      unitRef="usd">454000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQzOTk_a0de1fc2-16ce-439b-89a3-4f8bebb6bc73">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2020, 2019 and 2018 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of statutes of limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzEtMS0xLTEtMA_2ff420cf-e4d1-44e4-a368-e463551020cd"
      unitRef="usd">655000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzEtMy0xLTEtMA_58e026a9-ace1-4cfc-a708-478672776083"
      unitRef="usd">661000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i20db3230df8c4812ac4bf0f95ceda745_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzEtNS0xLTEtMA_a5995949-66ae-4c62-85c6-660929b9515d"
      unitRef="usd">344000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzItMS0xLTEtMA_7303b035-ae74-4f52-ba5c-56636b79efd3"
      unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzItMy0xLTEtMA_75b39435-6329-4213-8aa5-f3a94b39fd06"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzItNS0xLTEtMA_dd1d5fe0-250d-4766-859c-9ccc92060d16"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzMtMS0xLTEtMA_531aa8e3-826c-426f-a41f-c46c6f4d9ee4"
      unitRef="usd">182000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzMtMy0xLTEtMA_fb30ac5c-f197-469d-afb7-902a6112d018"
      unitRef="usd">115000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzMtNS0xLTEtMA_631e97a0-1f08-4e03-be3f-7613397cf7fe"
      unitRef="usd">324000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzQtMS0xLTEtMA_85067183-d53f-4583-8c51-2bba2726c9d0"
      unitRef="usd">56000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzQtMy0xLTEtMA_24afbbfa-bba1-4893-a80e-756750fd9881"
      unitRef="usd">111000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzQtNS0xLTEtMA_3fb112c6-924d-4044-9f6c-9ecea753444d"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzUtMS0xLTEtMA_2315c046-dea6-4795-9c3e-a84858b34bd1"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzUtMy0xLTEtMA_4626fda2-b156-4103-aa8c-07f49ee09b20"
      unitRef="usd">7000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzUtNS0xLTEtMA_76fdf916-1207-4ff0-90e2-9bb850ea73f0"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzYtMS0xLTEtMA_d9e2a77e-fce1-40be-b8a3-851c44cf98ab"
      unitRef="usd">14000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzYtMy0xLTEtMA_9a38d0ff-45e5-43bc-99b2-da51f40bbe5e"
      unitRef="usd">7000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzYtNS0xLTEtMA_842775f1-aec2-4950-9756-3f04180cc1d3"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzctMS0xLTEtMA_546b9363-2ac0-4961-ab13-dadcf573c14e"
      unitRef="usd">768000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzctMy0xLTEtMA_2f79ca14-cf52-461d-a752-84be6e0600e9"
      unitRef="usd">655000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic4db69fd194a4a0081fed80395cfe996_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90YWJsZTpkOGQxODcyOTEyZTc0ZGJhOWVhZjA5OGYzNjk4MTYxYS90YWJsZXJhbmdlOmQ4ZDE4NzI5MTJlNzRkYmE5ZWFmMDk4ZjM2OTgxNjFhXzctNS0xLTEtMA_32599dee-7a96-4ec6-9a68-41ed46cce1eb"
      unitRef="usd">661000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQwMjA_4fa9ba20-1479-4f94-84d7-0d56f47ae9f4"
      unitRef="usd">34000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQwMjQ_6ee50a76-f79a-4f4d-97da-50deb9761ddb"
      unitRef="usd">49000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQwMzE_dd5a05d3-0c38-4b68-b7bc-99ef0030e646"
      unitRef="usd">19000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQwOTY_d4fe4df9-928a-4b1c-85af-b8ccef67df41"
      unitRef="usd">121000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQxMDM_c7b81f2e-7127-4328-9fde-870923440cca"
      unitRef="usd">173000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjAvZnJhZzowNmM3ZGM4OGMwMzQ0YTE0YTdkYmJiZDEyYWM2YmZjZS90ZXh0cmVnaW9uOjA2YzdkYzg4YzAzNDRhMTRhN2RiYmJkMTJhYzZiZmNlXzQzMjE_e97082f8-3a8a-4cba-9262-0ab955526bf3"
      unitRef="usd">651000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4MzY_26545c4f-3bb1-40a3-ac2d-a59088f121b9">Stock Incentive Plans&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The terms of the CVS Health 2017 Incentive Compensation Plan (&#x201c;ICP&#x201d;) provide for grants of annual incentive and long-term performance awards to executive officers and other officers and employees of the Company or any subsidiary of the Company, as well as equity compensation to outside directors of CVS Health. Payment of such annual incentive and long-term performance awards will be in cash, stock, other awards or other property, at the discretion of the Management Planning and Development Committee (the &#x201c;MP&amp;amp;D Committee&#x201d;) of CVS Health&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). The ICP allows for a maximum of 58 million shares of CVS Health common stock to be reserved and available for grants. As of December&#160;31, 2020, there were approximately 38 million shares of CVS Health common stock available for future grants under the ICP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the Aetna Acquisition Date, approximately 22 million shares of Aetna common stock subject to awards outstanding under the Amended Aetna Inc. 2010 Stock Incentive Plan (&#x201c;SIP&#x201d;) were assumed by CVS Health. In addition, in accordance with the merger agreement, shares which were available for future issuance under the SIP were converted into approximately 32 million shares of CVS Health common stock reserved and available for issuance pursuant to future awards. Subsequent to the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;expiration of the SIP on May 21, 2020, the ICP is the only compensation plan under which the Company grants stock options, restricted stock and other stock-based awards to its employees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzE4ODc_a2f5f276-1187-4a37-84f0-e7ca761d6280"&gt;three&lt;/span&gt; to five years) using the straight-line method. The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and stock appreciation rights (&#x201c;SARs&#x201d;) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Stock-based compensation for the&#160;year ended December&#160;31, 2018 includes $14 million and $27 million associated with accelerated vesting of SARs and restricted stock replacement awards, respectively, issued to Aetna employees who were terminated subsequent to the Aetna Acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ESPP&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) provides for the purchase of up to 60 million shares of CVS Health common stock. Under the ESPP, eligible employees may purchase common stock at the end of each six&#160;month offering period at a purchase price equal to 90% of the lower of the fair market value on the first day or the last day of the offering period. During 2020, approximately 3 million shares of common stock were purchased under the provisions of the ESPP at an average price of $53.85 per share. As of December&#160;31, 2020, approximately 34 million shares of common stock were available for issuance under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock-based compensation associated with the ESPP is estimated on the date of grant (the first day of the six&#160;month offering period) using the Black-Scholes option pricing model.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health stock at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected volatility is estimated based on the historical volatility of CVS Health&#x2019;s daily stock price over the previous six&#160;month period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected life is based on the semi-annual purchase period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units and Performance Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s restricted stock units and performance stock units are considered nonvested share awards and require no payment from the employee. The fair value of the restricted stock units is based on the market price of CVS Health common stock on the grant date and is recognized on a straight-line basis over the vesting period. For each restricted stock unit granted, employees receive one share of common stock, net of taxes, at the end of the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s performance stock units contain performance vesting conditions in addition to a service vesting condition. Vesting of the Company&#x2019;s performance stock units is dependent upon the degree to which the Company achieves its performance goals, which are generally set for a three-year performance period and are approved at the time of grant by the MP&amp;amp;D Committee. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of performance stock units granted with service and performance vesting conditions is based on the market price of CVS Health common stock on the grant date and is recognized over the vesting period. Certain of the performance stock units also contain a market vesting condition based on the performance of CVS Health common stock relative to a comparator group. The fair value of these performance stock units is determined using a Monte Carlo simulation as of the grant date and is recognized over the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 28, 2018, the Company completed the Aetna Acquisition. All unvested Aetna performance stock unit and restricted stock unit awards as of the Aetna Acquisition Date were converted into replacement CVS Health restricted stock awards. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, there was $493 million of total unrecognized compensation cost related to the Company&#x2019;s restricted stock units and performance stock units that are expected to vest. These costs are expected to be recognized over a weighted-average period of 2.3 years. The total fair value of restricted stock units vested during 2020, 2019 and 2018 was $229 million, $265 million and $262 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In thousands, except weighted average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year, nonvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year, nonvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options and SARs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All stock option grants are awarded at fair value on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. Stock options granted generally become exercisable over a four-year period from the grant date. Stock options granted through 2018 generally expire seven years after the grant date. Stock options granted subsequent to 2018 generally expire ten years after the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 28, 2018, the Company completed the Aetna Acquisition. All unvested Aetna SARs outstanding as of the Aetna Acquisition Date were converted into replacement CVS Health SARs. The replacement SARs granted will be settled in CVS Health common stock, net of taxes, based on the appreciation of the stock price on the exercise date over the market price on the date of grant. The fair value of SARs is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. SARs generally become exercisable over a three-year period from the grant date. SARs generally expire ten years after the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from stock options exercised (including ESPP)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for taxes for net share settlement of equity awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value of stock options and SARs exercised &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of stock options and SARs vested &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option and SAR is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dividend yield is based on annual dividends paid and the fair market value of CVS Health stock at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected volatility is estimated based on the historical volatility of CVS Health&#x2019;s daily stock price over a period equal to the expected life of each option or SAR grant after adjustments for infrequent events such as stock splits.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options or SARs being valued.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected life represents the number of&#160;years the options or SARs are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The increase in the weighted-average grant date fair value in 2018 was due to the issuance of the replacement SARs in connection with the Aetna Acquisition in the year ended December 31, 2018. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, unrecognized compensation expense related to unvested stock options and SARs totaled $45 million, which the Company expects to be recognized over a weighted-average period of 1.8 years. After considering anticipated forfeitures, the Company expects approximately 10 million of the unvested stock options and SARs to vest over the requisite service period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s stock option and SAR activity for the&#160;year ended December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;thousands, except weighted average exercise price and remaining contractual term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at end of year and expected to vest in the future&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.78&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i51951ef33f584792b1899fbe7522c0e5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzYzOQ_4e58d23d-ef3e-4f4a-8df7-8d19a0955be5"
      unitRef="shares">58000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i51951ef33f584792b1899fbe7522c0e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzEwMjA_d5a4f825-160c-44b0-bf46-fde799dfcf0e"
      unitRef="shares">38000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i368dc3028c9348a7b6752c5b2a1288cc_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzExNDk_dc9109c8-565e-4b55-83c7-2ddffc22ac9b"
      unitRef="shares">22000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i368dc3028c9348a7b6752c5b2a1288cc_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzE0NTI_24cbff38-f329-4fe9-8a13-d33e6e89b2c4"
      unitRef="shares">32000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib336f1e5863040f88e2ccac2747f8c1e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzE4OTM_691b4819-b028-4d40-9831-49efada44469">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4MzQ_8edd9942-3731-407c-baa4-0cde4d3a52d6">The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2020, 2019 and 2018:&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and stock appreciation rights (&#x201c;SARs&#x201d;) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Stock-based compensation for the&#160;year ended December&#160;31, 2018 includes $14 million and $27 million associated with accelerated vesting of SARs and restricted stock replacement awards, respectively, issued to Aetna employees who were terminated subsequent to the Aetna Acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzEtMS0xLTEtMA_3afaf223-016d-4d18-b5e4-20d2acfadb7f"
      unitRef="usd">71000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzEtMy0xLTEtMA_10e9b588-361f-48ae-af9c-647ac80a214a"
      unitRef="usd">76000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzEtNS0xLTEtMA_ec9b36ce-2db6-440c-ade8-9617cf2a1037"
      unitRef="usd">70000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzItMS0xLTEtMA_3f4b4138-4028-46f7-b41a-7c9d915df5db"
      unitRef="usd">329000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idedbaa2d1d234783b888c78eec015afe_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzItMy0xLTEtMA_a7558256-fddc-4823-a55f-b038d9aecab2"
      unitRef="usd">377000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibf6ce0645a6645f6b71865a0cd2f6305_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzItNS0xLTEtMA_0f8b7fb9-2b0b-484f-92f2-51ede3a75132"
      unitRef="usd">210000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzMtMS0xLTEtMA_f7498c50-ee78-4add-985b-f9f6faa92b3c"
      unitRef="usd">400000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzMtMy0xLTEtMA_c5ebd2da-53e0-4126-9ff0-76d098705183"
      unitRef="usd">453000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTpmOTEyZDI5NjUzMGI0ZDc1YWI3MjM1MWQxZDIyZTA3ZC90YWJsZXJhbmdlOmY5MTJkMjk2NTMwYjRkNzVhYjcyMzUxZDFkMjJlMDdkXzMtNS0xLTEtMA_bd90fa78-de74-43d9-b036-00405dc829d9"
      unitRef="usd">280000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
      contextRef="ie367a51e740f4a3da15af04b3bf0109a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzIxNjU_811be6d2-f42c-43be-832d-c3ad9da268a9"
      unitRef="usd">14000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
      contextRef="i42d6f09ef96442c986984d00a0124904_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzIxNzI_61d721fe-6ec2-416a-ad26-daf79838e0e2"
      unitRef="usd">27000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="iec4fd22ebfb24fdd8219d715c4eefaf5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzI0MDg_84d00265-08c0-4397-b616-5bc87a948bc6"
      unitRef="shares">60000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzI1ODE_ec1b1326-9da6-4525-a3b8-9718b357a16c"
      unitRef="number">0.90</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzI3MDQ_2d716a48-7fc4-4b50-943f-fe9bca06aa4d"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <cvs:StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzI4MDE_d51fc14a-838a-4238-ab5c-adb42b6b3214"
      unitRef="usdPerShare">53.85</cvs:StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="iec4fd22ebfb24fdd8219d715c4eefaf5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzI4Mzk_81115a23-8ed0-465c-ac0e-2bcaf5166281"
      unitRef="shares">34000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4MjY_25f3826f-a948-4ad0-b651-f2f694ad41c0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health stock at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected volatility is estimated based on the historical volatility of CVS Health&#x2019;s daily stock price over the previous six&#160;month period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected life is based on the semi-annual purchase period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzEtMS0xLTEtMA_c70a8ab6-027b-4570-8949-1d5556e4834f"
      unitRef="number">0.0146</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic0df88ade3c94c729995bbc859b11248_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzEtMy0xLTEtMA_207f79d6-d988-4d83-87e6-c2e92d418133"
      unitRef="number">0.0170</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i32362d8d9c104060a8a8caf80210e039_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzEtNS0xLTEtMA_2216c532-174d-474d-bb2b-9299c66f3de9"
      unitRef="number">0.0145</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzItMS0xLTEtMA_83b2016b-48f2-4298-ab9b-8225a8cb39a9"
      unitRef="number">0.3721</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ic0df88ade3c94c729995bbc859b11248_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzItMy0xLTEtMA_bfa4f2ae-a323-4ede-8c5c-4a1ae6918c7c"
      unitRef="number">0.2796</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i32362d8d9c104060a8a8caf80210e039_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzItNS0xLTEtMA_fa13aad5-a71e-4f80-a6e2-ef0bbea06565"
      unitRef="number">0.2802</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzMtMS0xLTEtMA_76aa10e1-f0b9-48ac-813a-8c386ad5c645"
      unitRef="number">0.0081</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic0df88ade3c94c729995bbc859b11248_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzMtMy0xLTEtMA_8b79216c-57ef-4c3c-af79-ff2e6cacf384"
      unitRef="number">0.0227</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i32362d8d9c104060a8a8caf80210e039_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzMtNS0xLTEtMA_9615bf75-78b3-4a56-813a-75f5598b8b6d"
      unitRef="number">0.0187</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzQtMS0xLTEtMA_37dd4eee-7c21-4bcd-ac13-bb62c18ef5fd">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic0df88ade3c94c729995bbc859b11248_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzQtMy0xLTEtMA_bf053da5-f1f1-45a8-b9c5-8680c32a44e6">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i32362d8d9c104060a8a8caf80210e039_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzQtNS0xLTEtMA_8cdbf333-8942-4ec9-a986-04d69cf742f5">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzUtMS0xLTEtMA_43725172-0451-43ab-8cbd-a83b3b1e2e96"
      unitRef="usdPerShare">13.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic0df88ade3c94c729995bbc859b11248_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzUtMy0xLTEtMA_98d8983c-2c9f-4b3d-a5db-46d322abd877"
      unitRef="usdPerShare">10.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i32362d8d9c104060a8a8caf80210e039_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo5ODI4ZDVkZjM5MjY0MzY5OGI2MGQ4OTFhM2ZmYzM3OS90YWJsZXJhbmdlOjk4MjhkNWRmMzkyNjQzNjk4YjYwZDg5MWEzZmZjMzc5XzUtNS0xLTEtMA_e3a37593-88bb-4830-a7e6-e77edb2825ea"
      unitRef="usdPerShare">12.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="ib3218ac52d8e4abb8d070125f07b4ed6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU0OTE_076673bb-9480-43c6-bccf-da764a3be88f"
      unitRef="usd">493000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU3MTM_2fe37d7b-ffb7-41e8-9827-f873beb37010">P2Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU3OTY_6140cd81-f655-45cc-a556-321f8e0b284e"
      unitRef="usd">229000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="idedbaa2d1d234783b888c78eec015afe_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU4MDA_7d504374-0bb3-40ad-beb3-a90c3f18a707"
      unitRef="usd">265000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ibf6ce0645a6645f6b71865a0cd2f6305_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU4MDc_47e9bffc-59aa-45ce-a857-073e4a91ad80"
      unitRef="usd">262000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4Mjg_bd8f0330-7a98-48de-8c82-4513af267a60">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In thousands, except weighted average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year, nonvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,793)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year, nonvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i8d4c72ed7d1844239059f054fea52735_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzEtMS0xLTEtMA_ace5b8ca-d3f0-4b08-aef2-8cebd98c270c"
      unitRef="shares">13125000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i8d4c72ed7d1844239059f054fea52735_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzEtMy0xLTEtMA_b965375a-3298-4ba9-be1e-59ef59e657c0"
      unitRef="usdPerShare">61.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzItMS0xLTEtMA_4ed4cc87-9b00-4f30-af17-cad0586885c6"
      unitRef="shares">6849000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzItMy0xLTEtMA_93a25252-fbd8-48f7-803e-080d9c7cd0ea"
      unitRef="usdPerShare">58.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzMtMS0xLTEtMA_38940eae-844a-4d1d-9a2b-26ef4e98756b"
      unitRef="shares">3793000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzMtMy0xLTEtMA_a2243d43-594b-442e-a350-1b4feb3132d9"
      unitRef="usdPerShare">60.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzQtMS0xLTEtMA_483bf563-5ff0-4d6a-b490-7210ed1c1640"
      unitRef="shares">1357000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i0fbe4c0a89cc4ec89e32e54b53d554e6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzQtMy0xLTEtMA_c9404b7d-95ba-4e22-8b19-4b803b89a51b"
      unitRef="usdPerShare">59.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ib3218ac52d8e4abb8d070125f07b4ed6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzUtMS0xLTEtMA_a3f68f86-48a0-41ae-8a51-e8b47743c8cb"
      unitRef="shares">14824000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib3218ac52d8e4abb8d070125f07b4ed6_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTplM2JmMzE5NzA5ZDk0MGIwYTc2NDk5MjMyZTRmMmM4MC90YWJsZXJhbmdlOmUzYmYzMTk3MDlkOTQwYjBhNzY0OTkyMzJlNGYyYzgwXzUtMy0xLTEtMA_1e903989-764a-4b8b-95f3-87c89ed5eb99"
      unitRef="usdPerShare">58.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i840a4dd4fea34ef1a604ab9891347d56_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU0OTc1NTgxNDg4NDU_f8752a0f-5233-482c-916c-2380d5fb563a">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i8044667803dd4f4e94f81a063416a4a6_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzYzODg_1a9fde3f-c07e-46fd-a95d-594fad8fb2f5">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i4c18060ad0f74b60bd700240ae354b4a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzY0NTA_70a5d6a0-5e67-43c4-806e-fa2c710c5c43">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i93f5bc2c5d2246fa87aab2340bdaa368_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzU0OTc1NTgxNDg4NDY_55dd0912-ec3a-4693-a73d-7e7ae999aabb">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i93f5bc2c5d2246fa87aab2340bdaa368_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzcxNDI_cfbf2d23-fb71-4edd-bb38-2d11a04361c7">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4Mjk_1f5b8760-a619-47f9-abb7-3243783eee9b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from stock options exercised (including ESPP)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for taxes for net share settlement of equity awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value of stock options and SARs exercised &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of stock options and SARs vested &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzEtMS0xLTEtMA_8daa2974-a9b5-4d6f-85a7-93df08bb0864"
      unitRef="usd">264000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzEtMy0xLTEtMA_de86810f-63fa-4049-a9eb-f57f91601689"
      unitRef="usd">210000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzEtNS0xLTEtMA_1fbccea9-2237-4652-bdb1-986e9a2311c6"
      unitRef="usd">242000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzItMS0xLTEtMA_2f6166e7-e303-4c98-9337-35315bd598e5"
      unitRef="usd">88000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzItMy0xLTEtMA_bb16fe87-cd6c-42b0-990d-24a97854cc14"
      unitRef="usd">112000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzItNS0xLTEtMA_336f8400-49fb-44b0-918a-ada8e6a47569"
      unitRef="usd">97000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzMtMS0xLTEtMA_0cfdad83-e096-46e6-8c9c-cc2133bf0ce2"
      unitRef="usd">24000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzMtMy0xLTEtMA_1e554c5d-8677-4ea4-8aeb-57adef3d8af2"
      unitRef="usd">30000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzMtNS0xLTEtMA_3694ac4d-0c34-4341-833f-72df6010b7d1"
      unitRef="usd">79000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzQtMS0xLTEtMA_77319a18-35b9-4777-8675-68f1bb92318b"
      unitRef="usd">252000000</cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue>
    <cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue
      contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzQtMy0xLTEtMA_173b26f7-1792-4877-ab2e-5e1e967b6d99"
      unitRef="usd">467000000</cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue>
    <cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue
      contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo0YWE2NTdiZDNlZjg0YTkxODM2N2VhMjY1MWVmMTc5MS90YWJsZXJhbmdlOjRhYTY1N2JkM2VmODRhOTE4MzY3ZWEyNjUxZWYxNzkxXzQtNS0xLTEtMA_96cb93ea-17e5-4377-8ecb-d9b37e1824e7"
      unitRef="usd">324000000</cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4MTk_eac359b7-f326-4878-904f-5750fd7d9605">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option and SAR is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dividend yield is based on annual dividends paid and the fair market value of CVS Health stock at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected volatility is estimated based on the historical volatility of CVS Health&#x2019;s daily stock price over a period equal to the expected life of each option or SAR grant after adjustments for infrequent events such as stock splits.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options or SARs being valued.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected life represents the number of&#160;years the options or SARs are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzEtMS0xLTEtMA_5604d36b-631e-460f-aba0-26a890a718d3"
      unitRef="number">0.0342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzEtMy0xLTEtMA_7d421d79-6b25-40f3-ac28-1d36ef5674eb"
      unitRef="number">0.0368</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzEtNS0xLTEtMA_d86fe39c-2883-4762-bfcd-71d674c25727"
      unitRef="number">0.0276</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzItMS0xLTEtMA_6a8514f2-6a9c-48ec-aa11-9858972f5f01"
      unitRef="number">0.2522</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzItMy0xLTEtMA_36a1336a-e098-4df3-b061-9b5a52cde173"
      unitRef="number">0.2176</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzItNS0xLTEtMA_2f3dbf9e-1c53-4ca9-a68d-bbd80e349664"
      unitRef="number">0.2127</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzMtMS0xLTEtMA_45ef7d1f-7bc1-4d21-9de6-cd4ddb466384"
      unitRef="number">0.0061</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzMtMy0xLTEtMA_ff03d586-6974-4bba-a660-c8cf89237467"
      unitRef="number">0.0056</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzMtNS0xLTEtMA_825b0a3a-bd66-4917-abe1-921679e26c21"
      unitRef="number">0.0277</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzQtMS0xLTEtMA_b27c5d93-196c-4ff1-ace1-30c515d397f5">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzQtMy0xLTEtMA_ab8a657e-4966-48b3-8be3-992c55baa5f4">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzQtNS0xLTEtMA_5fbaa7ea-7635-41e4-8d08-aa967983003d">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzUtMS0xLTEtMA_05c3d790-c254-4087-a3f2-3399b207045a"
      unitRef="usdPerShare">8.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i942a3f87081143089686acdf7d4ee185_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzUtMy0xLTEtMA_6ead59b1-90bd-4e87-b926-59c5ca37c8c5"
      unitRef="usdPerShare">6.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia364a09b66ae495f92af39c797e7dd33_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4YzQwM2U4Mjg0Njk0NTRlYjZiOTRlNGFmZWNhYzI2Mi90YWJsZXJhbmdlOjhjNDAzZTgyODQ2OTQ1NGViNmI5NGU0YWZlY2FjMjYyXzUtNS0xLTEtMA_59e938c4-a9bb-43bc-8591-c02719f8cd94"
      unitRef="usdPerShare">24.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg0NjM_45f103ab-fbb8-4ae0-9dbc-4130987d1797"
      unitRef="usd">45000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg1NDQ_7df3796e-b411-4570-9792-e680ae5c7d03">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <cvs:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber
      contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg2MjU_ff4be79d-5969-4959-91d0-55d56a742caa"
      unitRef="shares">10000000</cvs:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5Xzg4MjU_5bf8b7ad-bbbc-43c9-85e1-7f42d686eba2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s stock option and SAR activity for the&#160;year ended December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;thousands, except weighted average exercise price and remaining contractual term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,601)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(941)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at end of year and expected to vest in the future&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.78&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i01826b36b4634f7c8bf2af0872e7548a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzEtMS0xLTEtMA_10dd62f1-c165-4388-870c-4e12e5cd6e35"
      unitRef="shares">23902000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i01826b36b4634f7c8bf2af0872e7548a_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzEtMy0xLTEtMA_22d74182-2c00-469c-aa0e-f22957f4e3c6"
      unitRef="usdPerShare">69.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzItMS0xLTEtMA_4a59035c-43da-4ec0-859e-19c9eb22e555"
      unitRef="shares">4759000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzItMy0xLTEtMA_a696cdb2-7516-44c8-851d-f7a96bb271df"
      unitRef="usdPerShare">58.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzMtMS0xLTEtMA_9da2c60e-8a36-43e1-aa61-4d8515042bb0"
      unitRef="shares">2601000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzMtMy0xLTEtMA_3b08cc2e-e8a3-46e1-a543-b0d3b4a07af5"
      unitRef="usdPerShare">52.95</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzQtMS0xLTEtMA_9dc5e8f7-3de4-45de-97c8-3f4e1d409930"
      unitRef="shares">1164000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzQtMy0xLTEtMA_d733758e-0b13-4a25-9a03-0e99d1ec851c"
      unitRef="usdPerShare">57.61</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzUtMS0xLTEtMA_143a0957-c422-4d4c-9850-34f374390043"
      unitRef="shares">941000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzUtMy0xLTEtMA_a41b7188-af75-41d5-9d54-da063d565af6"
      unitRef="usdPerShare">83.34</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzYtMS0xLTEtMA_49f6204e-178d-47d4-ba97-05630938234b"
      unitRef="shares">23955000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzYtMy0xLTEtMA_691a43fe-0bd1-416a-bbe8-3cfcc9c73f10"
      unitRef="usdPerShare">69.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzYtNS0xLTEtMA_e8186946-ceb3-44aa-90b3-aaff5a0feb30">P4Y10M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzYtNy0xLTEtMA_2d72f981-405e-4f61-9eec-96a0eab03ccf"
      unitRef="usd">185487000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzctMS0xLTEtMA_3cb9e044-dc5b-4db5-b61a-c8712a7e98e1"
      unitRef="shares">13545000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzctMy0xLTEtMA_3195fb1e-f8eb-43fc-af0b-7b38f7d761ab"
      unitRef="usdPerShare">78.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzctNS0xLTEtMA_e25e87b0-31f0-496a-9d46-3fbdda092d6c">P2Y9M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzctNy0xLTEtMA_8a3682ed-50ff-4c52-8c2e-50107283be3f"
      unitRef="usd">78289000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzgtMS0xLTEtMA_e64bbf37-2bea-4ea2-bfca-f0ff9f063a28"
      unitRef="shares">23448000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzgtMy0xLTEtMA_6097375a-e5dd-48e2-8713-cadccfe0262a"
      unitRef="usdPerShare">69.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i4bc5195f4a764d74ba3a39d7b3069441_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzgtNS0xLTEtMA_73731be3-7974-49c7-8dd1-36089825ed6e">P4Y9M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i17808cc9c8d54c05a246d77b12f95dfa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90YWJsZTo4Yzk4NjE3ZDgyYjE0YzdhODUwNWRlNzIwMjViNWEyYi90YWJsZXJhbmdlOjhjOTg2MTdkODJiMTRjN2E4NTA1ZGU3MjAyNWI1YTJiXzgtNy0xLTEtMA_0b3a16f8-a83b-45ac-abcc-05821b5f432e"
      unitRef="usd">180102000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzQxNzA_7b8b021f-b435-415b-921a-febfff834aaf">Shareholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following share repurchase program has been authorized by the Board:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In billions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Authorization&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Remaining as of&lt;br/&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2, 2016 (&#x201c;2016 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2020, 2019 and 2018, the Company did not repurchase any shares of common stock pursuant to the 2016 Repurchase Program.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quarterly cash dividend declared by the Board was $0.50 per share in 2020 and 2019. CVS Health has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#x2019;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Regulatory Requirements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 28, 2018, the Company completed the Aetna Acquisition. Aetna&#x2019;s insurance business operations are conducted through subsidiaries that principally consist of HMOs and insurance companies. The Company&#x2019;s HMO and insurance subsidiaries report their financial statements in accordance with accounting practices prescribed by state regulatory authorities which may differ from GAAP. The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2020, 2019 and 2018 for the Company&#x2019;s insurance and HMO subsidiaries were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory net income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;NM&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated statutory capital and surplus&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Statutory net income of the Company&#x2019;s insurance and HMO subsidiaries for the year ended December 31, 2018 (which includes Aetna and its subsidiaries from November 28, 2018 to December 31, 2018) is not material (&#x201c;NM&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s insurance and HMO subsidiaries paid $3.1 billion of gross dividends to the Company for the year ended December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, HMOs and insurance companies are subject to further regulations that, among other things, may require those companies to maintain certain levels of equity and restrict the amount of dividends and other distributions that may be paid to their equity holders. In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies. At December&#160;31, 2020, these amounts were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated minimum statutory surplus required by regulators&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments on deposit with regulatory bodies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated maximum dividend distributions permitted in 2021 without prior regulatory approval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2020 and 2019, noncontrolling interests were $312 million and $306 million, respectively, primarily related to third party interests in the Company&#x2019;s operating entities.&#160;The noncontrolling entities&#x2019; share is included in total shareholders&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; equity on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzQxNjc_b1fdc09a-e51d-4bb0-8152-bb288436d2b0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following share repurchase program has been authorized by the Board:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In billions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Authorization&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Remaining as of&lt;br/&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2, 2016 (&#x201c;2016 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i14abdf015f0f4b9db4fe52c587222dc0_I20161102"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo4YjMxNTM0MjFlNDU0ZmUzOWNmY2MzMjIxZWI5MDhmYy90YWJsZXJhbmdlOjhiMzE1MzQyMWU0NTRmZTM5Y2ZjYzMyMjFlYjkwOGZjXzEtMS0xLTEtMA_b6e06b68-ef33-4e3c-b937-9de50fea45b1"
      unitRef="usd">15000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i2dd8180c25fb4a8481234de8c71c1147_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo4YjMxNTM0MjFlNDU0ZmUzOWNmY2MzMjIxZWI5MDhmYy90YWJsZXJhbmdlOjhiMzE1MzQyMWU0NTRmZTM5Y2ZjYzMyMjFlYjkwOGZjXzEtMy0xLTEtMA_ba7dce60-a7d0-4140-8233-d1be358125a1"
      unitRef="usd">13900000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i999deb1ae4c9461bbcddbc5f7a24ed43_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_077707cd-2fba-4f5d-b394-fd68abf6c632"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_121cc61f-9e20-4a9b-bf96-9bdca474dc1f"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="if989d485536c470f8ae4b36308072658_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_182f1c34-d2aa-48e4-81be-55b123c47f2d"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="id7eb47ba380c4e5e8af029b7a1dcec29_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_4767a0e0-0749-4148-aa97-48ee23139caa"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_5bb5a8f1-1f2c-4d59-9f6e-2c030d527a66"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="id7eb47ba380c4e5e8af029b7a1dcec29_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_6c74c54d-94ed-4c50-8c00-ea422ad97745"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i41f59795c714410e9809b7c4aef691c6_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_6edea0f4-3c4b-43ea-b167-8b9ae53d8af0"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i999deb1ae4c9461bbcddbc5f7a24ed43_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_763ba24a-450b-43e3-9c1e-ef504ab66b3d"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i76b1b2868c2745ef9a27492b7d5c0054_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_9390a2d1-d056-46be-983b-4e09ae5d0f99"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_9c3c556a-23dd-4ae8-8a19-99cd6f053c57"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="ia62846c7391548e195bd48645f91d3f9_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_ac2a19cf-65aa-48f0-9ba8-d6cf407806f0"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i41f59795c714410e9809b7c4aef691c6_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIwMjc_db58ed4f-aee6-4868-bff6-709c71bafc3f"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo1NzZjMDM3MjEwNzk0ZTgwOWExYjRiYWI1NDgwM2MyNS90YWJsZXJhbmdlOjU3NmMwMzcyMTA3OTRlODA5YTFiNGJhYjU0ODAzYzI1XzEtMS0xLTEtMTE2MTc_e1cff4f2-acf6-40ac-b144-29c381de5f00"
      unitRef="usd">3667000000</us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount>
    <us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo1NzZjMDM3MjEwNzk0ZTgwOWExYjRiYWI1NDgwM2MyNS90YWJsZXJhbmdlOjU3NmMwMzcyMTA3OTRlODA5YTFiNGJhYjU0ODAzYzI1XzEtMy0xLTEtMTEyNzk_37b43fba-0e10-4383-954a-dc1257e719fd"
      unitRef="usd">2842000000</us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="ice5dfe6468064630ab677c3f80d083bf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo1NzZjMDM3MjEwNzk0ZTgwOWExYjRiYWI1NDgwM2MyNS90YWJsZXJhbmdlOjU3NmMwMzcyMTA3OTRlODA5YTFiNGJhYjU0ODAzYzI1XzItMS0xLTEtMTEyODM_747b66db-e0e4-4742-a906-9ace31462b64"
      unitRef="usd">13238000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="i3f0e3ad72e674d79b9416210fc264e80_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo1NzZjMDM3MjEwNzk0ZTgwOWExYjRiYWI1NDgwM2MyNS90YWJsZXJhbmdlOjU3NmMwMzcyMTA3OTRlODA5YTFiNGJhYjU0ODAzYzI1XzItMy0xLTEtMTEyNzk_0045217e-cae1-4315-9852-8dd017b9132d"
      unitRef="usd">10975000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="ie31822396a9a497fb994c84f0ccd13ff_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZTo1NzZjMDM3MjEwNzk0ZTgwOWExYjRiYWI1NDgwM2MyNS90YWJsZXJhbmdlOjU3NmMwMzcyMTA3OTRlODA5YTFiNGJhYjU0ODAzYzI1XzItNS0xLTEtMTEyODY_fc92dc21-35bf-473d-83e2-14dde18b8be3"
      unitRef="usd">10084000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="i34d3860039e94245ab240f1f07b53dc4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzIxOTkwMjMyNjIwODE_18fdd7f4-1e9b-421d-89bb-e97cda189ccc"
      unitRef="usd">3100000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:StatutoryAccountingPracticesDisclosureTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzQxNjI_ca43db22-5e40-4edc-a845-ccd950505ebb">At December&#160;31, 2020, these amounts were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated minimum statutory surplus required by regulators&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments on deposit with regulatory bodies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated maximum dividend distributions permitted in 2021 without prior regulatory approval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StatutoryAccountingPracticesDisclosureTextBlock>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZToyZDAxZWVjZjVjYjg0ZWE2OTgzMGY2OTcyMjEyYTk0Mi90YWJsZXJhbmdlOjJkMDFlZWNmNWNiODRlYTY5ODMwZjY5NzIyMTJhOTQyXzEtMS0xLTEtMA_6f1267ec-680b-4c7a-b01f-06a11d390eaf"
      unitRef="usd">5395000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
    <us-gaap:AssetsHeldByInsuranceRegulators
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZToyZDAxZWVjZjVjYjg0ZWE2OTgzMGY2OTcyMjEyYTk0Mi90YWJsZXJhbmdlOjJkMDFlZWNmNWNiODRlYTY5ODMwZjY5NzIyMTJhOTQyXzItMS0xLTEtMA_448efa6f-8870-4fba-9c2c-1306f82abb94"
      unitRef="usd">712000000</us-gaap:AssetsHeldByInsuranceRegulators>
    <us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90YWJsZToyZDAxZWVjZjVjYjg0ZWE2OTgzMGY2OTcyMjEyYTk0Mi90YWJsZXJhbmdlOjJkMDFlZWNmNWNiODRlYTY5ODMwZjY5NzIyMTJhOTQyXzMtMS0xLTEtMA_5c065120-e4a8-45fe-b2aa-0ef0dc07ea11"
      unitRef="usd">2900000000</us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval>
    <us-gaap:MinorityInterest
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzY1OTcwNjk3NzIyNjk_92073843-1bed-4995-bdd2-04b6a65da388"
      unitRef="usd">312000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjkvZnJhZzphMGZlYjA2YmQ5YTI0NDYyYjY0OTExYzlkZGU2NTE3Mi90ZXh0cmVnaW9uOmEwZmViMDZiZDlhMjQ0NjJiNjQ5MTFjOWRkZTY1MTcyXzY1OTcwNjk3NzIyODE_4f108bf4-1c76-413a-b712-be5094143bd7"
      unitRef="usd">306000000</us-gaap:MinorityInterest>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90ZXh0cmVnaW9uOjIxOTY0YjVjZjI2NjRlZWFiYjRmZjc0ODZiYjJiNjE2XzE1MTY_1c96aff1-5c04-4cfb-87c8-2bb2bec74213">Other Comprehensive Income&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income in 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($497, $927 and $132 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($31, $(105) and $1 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(7), $(25) and $465 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(35), $(20) and $(19) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(30), $162 and $(178) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($7, $(12) and $11 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of year accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of year accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive loss represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Reflects the adoption of ASU 2018-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement Reporting Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Topic 220); Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;during the year ended December 31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify approximately $13 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90ZXh0cmVnaW9uOjIxOTY0YjVjZjI2NjRlZWFiYjRmZjc0ODZiYjJiNjE2XzE1MTk_28431518-4293-428a-b384-ea2b9db7c7ac">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income in 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($497, $927 and $132 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($31, $(105) and $1 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(7), $(25) and $465 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(35), $(20) and $(19) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(30), $162 and $(178) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($7, $(12) and $11 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of year accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of year accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive loss represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Reflects the adoption of ASU 2018-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Statement Reporting Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Topic 220); Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;during the year ended December 31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify approximately $13 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifcf2440c1d0e4e17ac229c0445e4203e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMtMS0xLTEtMA_d6f83408-5a9c-4d42-a1f6-5f32c7b16ba0"
      unitRef="usd">774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a22940c170b4cf68098d8a1d7db4b07_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMtMy0xLTEtMA_c3bd6724-a2be-4d82-afab-894864bfe95f"
      unitRef="usd">97000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b47b478e9b74d6283da9fb27e389a6f_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMtNS0xLTEtMA_e2a431b4-a3b8-4e6e-8d6e-64e2c15a201a"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i4c96fa94b27d4a2c824b3844e3c8037b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzQtMC0xLTEtMC90ZXh0cmVnaW9uOmNhMzFkZmIzMTlkNzQ3NGRiZDU0NTg1ZWIyMDFkMWZiXzY1OTcwNjk3NjY3NTg_35656b4f-5f08-479b-ad56-00424065ce30"
      unitRef="usd">497000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i443408ee77904553aa013c58c381a6e4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzQtMC0xLTEtMC90ZXh0cmVnaW9uOmNhMzFkZmIzMTlkNzQ3NGRiZDU0NTg1ZWIyMDFkMWZiXzY1OTcwNjk3NjY3Njk_18fc0c52-122c-4a7f-8d11-fd6bdc5ab41b"
      unitRef="usd">927000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i57fe03ab102c4593846e42c9794bcb06_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzQtMC0xLTEtMC90ZXh0cmVnaW9uOmNhMzFkZmIzMTlkNzQ3NGRiZDU0NTg1ZWIyMDFkMWZiXzY1OTcwNjk3NjY3NzY_ed0a4137-1793-47ef-a078-ab9eafd9b71f"
      unitRef="usd">132000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4c96fa94b27d4a2c824b3844e3c8037b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzQtMS0xLTEtMA_21a76a8a-e22d-4957-bbf4-0bc6147e1511"
      unitRef="usd">415000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i443408ee77904553aa013c58c381a6e4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzQtMy0xLTEtMA_75daa015-2823-48ca-8e8e-35f50c5858b8"
      unitRef="usd">763000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i57fe03ab102c4593846e42c9794bcb06_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzQtNS0xLTEtMA_2c249641-4430-40ba-ae44-4a580308124e"
      unitRef="usd">97000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i4c96fa94b27d4a2c824b3844e3c8037b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzUtMC0xLTEtMC90ZXh0cmVnaW9uOjgyY2NmMDg2MTljNTQ0Mjg5MGI4ZDQxMzIwN2U3MDdkXzY1OTcwNjk3NjY3OTU_c39805b8-417c-427a-b93f-42d73fbcebfc"
      unitRef="usd">31000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i443408ee77904553aa013c58c381a6e4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzUtMC0xLTEtMC90ZXh0cmVnaW9uOjgyY2NmMDg2MTljNTQ0Mjg5MGI4ZDQxMzIwN2U3MDdkXzY1OTcwNjk3NjY3ODU_a3f97222-3f96-4bdc-9d0c-c072312e68c1"
      unitRef="usd">-105000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i57fe03ab102c4593846e42c9794bcb06_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzUtMC0xLTEtMC90ZXh0cmVnaW9uOjgyY2NmMDg2MTljNTQ0Mjg5MGI4ZDQxMzIwN2U3MDdkXzY1OTcwNjk3NjY3OTE_ac12a4dd-8900-40bb-93f0-026d37c3f95e"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4c96fa94b27d4a2c824b3844e3c8037b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzUtMS0xLTEtMA_9fb0c607-4e66-4c1a-9630-69c4116171ab"
      unitRef="usd">-25000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i443408ee77904553aa013c58c381a6e4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzUtMy0xLTEtMA_a7fbe144-7410-445b-8331-76568cfa3a40"
      unitRef="usd">86000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i57fe03ab102c4593846e42c9794bcb06_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzUtNS0xLTEtMA_c5dcc39e-543a-4356-b790-37cc63093cef"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4c96fa94b27d4a2c824b3844e3c8037b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzYtMS0xLTEtMA_5555bb8a-93d4-4f25-b4d0-22f7676a295f"
      unitRef="usd">440000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i443408ee77904553aa013c58c381a6e4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzYtMy0xLTEtMA_76deef47-d3f7-48cf-b0b3-e4a51be5e7f9"
      unitRef="usd">677000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i57fe03ab102c4593846e42c9794bcb06_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzYtNS0xLTEtMA_e44e078f-808d-4069-bc8c-a5611dfe76c0"
      unitRef="usd">97000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0602d4ebfef644a18655290e8ece6717_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzctMS0xLTEtMA_3172744c-1ead-4671-ad55-5f195d5fa378"
      unitRef="usd">1214000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifcf2440c1d0e4e17ac229c0445e4203e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzctMy0xLTEtMA_338f46ce-a2a2-4faa-bb72-e3482cfaf81c"
      unitRef="usd">774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a22940c170b4cf68098d8a1d7db4b07_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzctNS0xLTEtMA_ff339ccb-ee0a-4e7c-99c7-9106b2ee05f3"
      unitRef="usd">97000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i060f98498d204f6d8a753045e2d7c203_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEwLTEtMS0xLTA_83184aa2-b948-472b-b5bb-7f9a370bea7e"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1125996cace4e93a47589d739fbafd1_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEwLTMtMS0xLTA_dada9a02-ca3a-43ce-8021-149feb1c45f8"
      unitRef="usd">-158000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5594c4b0291247d29cdc2fcc74572eb4_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEwLTUtMS0xLTA_0c3e891f-1dfc-44f9-80f8-e60f45c4d4c4"
      unitRef="usd">-129000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9aaef92229504806b1ba8f864dfcc385_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzExLTEtMS0xLTA_8c028892-8289-4155-9a4f-6edb12ca330a"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iac55eea462b842aab63a774c5b13738c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzExLTMtMS0xLTA_0f01720f-bbb2-4fa4-bbd4-00c953299ce3"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia21d4a25030943aa870bf85489fc686b_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzExLTUtMS0xLTA_2e91e771-649d-46c3-8c0b-a1615e0cca4c"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9aaef92229504806b1ba8f864dfcc385_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEyLTEtMS0xLTA_83e9f9f1-f8b2-499a-8ce0-ea831077d824"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iac55eea462b842aab63a774c5b13738c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEyLTMtMS0xLTA_8cca8dc7-9c94-4248-a3d4-c974c35aaf63"
      unitRef="usd">-154000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia21d4a25030943aa870bf85489fc686b_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEyLTUtMS0xLTA_55f875d6-74e0-4dea-ab9d-e4b56164abf6"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9aaef92229504806b1ba8f864dfcc385_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEzLTEtMS0xLTA_8f32e440-5e7d-4f97-a54f-e1ad80470905"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iac55eea462b842aab63a774c5b13738c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEzLTMtMS0xLTA_59ab3c1f-96fa-4a29-be3d-6f15132d143a"
      unitRef="usd">162000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia21d4a25030943aa870bf85489fc686b_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzEzLTUtMS0xLTA_fefd8c27-7cfe-4994-9741-9654caac35e1"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic509b8303359462cb2a1c66d8ff1c410_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE0LTEtMS0xLTA_0e127e2f-27e5-4397-9f7f-864d1104b1b2"
      unitRef="usd">7000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i060f98498d204f6d8a753045e2d7c203_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE0LTMtMS0xLTA_0204bb39-08c0-4bf8-851c-1fe5bc9176d2"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1125996cace4e93a47589d739fbafd1_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE0LTUtMS0xLTA_7cd6bf0e-a034-4093-9a14-1046478cf707"
      unitRef="usd">-158000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i218673f1547f4d87ad2718881dec2f7c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE3LTEtMS0xLTA_c019e658-55b2-4ba8-9f4d-db0fc5851cae"
      unitRef="usd">279000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i62fa0632829f46fcb2cb4d4b11969265_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE3LTMtMS0xLTA_ed2297d1-a648-43d5-893b-f244754d86a9"
      unitRef="usd">312000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2c5e7b4689046d383454e690de48a8f_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE3LTUtMS0xLTA_729a78f5-2968-4fb9-9e26-8bec3ae2062b"
      unitRef="usd">-15000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect
      contextRef="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE4LTEtMS0xLTA_a52852dc-c80a-4761-8fb9-0a9bba84deb4"
      unitRef="usd">0</us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect>
    <us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect
      contextRef="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE4LTMtMS0xLTA_52fa2760-1232-4145-8daa-0c5ae9d516c0"
      unitRef="usd">0</us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect>
    <us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect
      contextRef="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE4LTUtMS0xLTA_dbb182bc-c835-4307-aa6a-216fca07ef92"
      unitRef="usd">-3000000</us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE5LTAtMS0xLTAvdGV4dHJlZ2lvbjphYmI5MTc4NTVlODU0ZTI3YjZjZDZlYzA1N2RkMGZiZl82NTk3MDY5NzY2Nzc0_900753d2-ce89-4e89-a0b4-87b4d7b31caa"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE5LTAtMS0xLTAvdGV4dHJlZ2lvbjphYmI5MTc4NTVlODU0ZTI3YjZjZDZlYzA1N2RkMGZiZl82NTk3MDY5NzY2Nzgy_8b843e5d-5f63-43d8-9ffd-26d31811a5f0"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE5LTAtMS0xLTAvdGV4dHJlZ2lvbjphYmI5MTc4NTVlODU0ZTI3YjZjZDZlYzA1N2RkMGZiZl82NTk3MDY5NzY2Nzg5_4e182705-27e3-497a-91a1-55b213450e74"
      unitRef="usd">465000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE5LTEtMS0xLTA_1cb6328f-c485-4899-bd3b-f8145c44b1de"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE5LTMtMS0xLTA_6ad11b9c-c14f-4dfb-a4f5-d2caa49d9a6f"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzE5LTUtMS0xLTA_782487d1-b2d1-4cda-ac7c-555278257591"
      unitRef="usd">344000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIwLTAtMS0xLTAvdGV4dHJlZ2lvbjplY2ViMjdkY2U4MzA0ODkwOTNiNDg5M2JkNjU1YWNlMl82NTk3MDY5NzY2Nzg0_997132d4-dfbb-4da7-92a1-771dc7a6feef"
      unitRef="usd">-35000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIwLTAtMS0xLTAvdGV4dHJlZ2lvbjplY2ViMjdkY2U4MzA0ODkwOTNiNDg5M2JkNjU1YWNlMl82NTk3MDY5NzY2Nzky_c234a458-d60a-4957-8f0f-e06ac2270b99"
      unitRef="usd">-20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIwLTAtMS0xLTAvdGV4dHJlZ2lvbjplY2ViMjdkY2U4MzA0ODkwOTNiNDg5M2JkNjU1YWNlMl82NTk3MDY5NzY2ODAw_58be0045-fef6-4553-9c16-f6677eddc0d2"
      unitRef="usd">-19000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIwLTEtMS0xLTA_cee61e3c-e6ab-4a92-950f-dbd00e8537a8"
      unitRef="usd">26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIwLTMtMS0xLTA_c75c253f-ac4c-4b25-ad2b-767635a956b8"
      unitRef="usd">15000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIwLTUtMS0xLTA_3d545bff-65bc-4d84-9fdc-cecee6d3e8b5"
      unitRef="usd">14000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8ac1477504f1473ea3b9e582934c4547_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIxLTEtMS0xLTA_573d3072-f7d5-43f5-b55a-3d2c4181c900"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icb5911e5cbd147aaa6b111d6309cee85_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIxLTMtMS0xLTA_2f8c400e-457e-462a-bdeb-58c285ee6475"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3e896822695e48ac8b5501049fe023d6_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIxLTUtMS0xLTA_c736f33a-5c0f-497d-a7d4-d6b81d7d2671"
      unitRef="usd">330000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie55d01130f004e38a1138732a5796669_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIyLTEtMS0xLTA_3cb3054b-d648-48c9-996c-f6c94d0f7b53"
      unitRef="usd">248000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i218673f1547f4d87ad2718881dec2f7c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIyLTMtMS0xLTA_105c8cbf-5349-46b2-8c71-d858c63c72c0"
      unitRef="usd">279000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i62fa0632829f46fcb2cb4d4b11969265_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzIyLTUtMS0xLTA_a6b01480-bed1-4b23-8153-9a45c12e3df7"
      unitRef="usd">312000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ea3441f923f4cad82455098c9eac4f3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI1LTEtMS0xLTA_b00b643b-8f2f-4fb6-875c-5d59d2c0a814"
      unitRef="usd">-38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2cf5ea89c34f444085bba9feb6d80c49_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI1LTMtMS0xLTA_27ad476e-297b-4450-a23c-68d158115321"
      unitRef="usd">-149000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19bfa54afd084b37b88cf9c88401e61d_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI1LTUtMS0xLTA_62438afa-d102-4c1e-95fe-17686f3216a4"
      unitRef="usd">-21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect
      contextRef="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI2LTEtMS0xLTA_2cd84892-58bf-4961-a939-380fb4efc719"
      unitRef="usd">0</us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect>
    <us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect
      contextRef="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI2LTMtMS0xLTA_c40a2eae-ebb9-4a33-8e54-640c78b0db70"
      unitRef="usd">0</us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect>
    <us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect
      contextRef="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI2LTUtMS0xLTA_8682a200-a698-4dca-ae1d-35bcf87eadcc"
      unitRef="usd">-4000000</us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI3LTAtMS0xLTAvdGV4dHJlZ2lvbjplM2JkNWIwODNmNjI0OTQ1YmJmODA4MjZmZWYyMDhjMV82NTk3MDY5NzY2Nzcz_5fdab4ef-6b3e-4829-ba88-f47262fc6c5e"
      unitRef="usd">-30000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI3LTAtMS0xLTAvdGV4dHJlZ2lvbjplM2JkNWIwODNmNjI0OTQ1YmJmODA4MjZmZWYyMDhjMV82NTk3MDY5NzY2Nzgw_7df3e7f0-a091-426c-9201-a1727626f00a"
      unitRef="usd">162000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI3LTAtMS0xLTAvdGV4dHJlZ2lvbjplM2JkNWIwODNmNjI0OTQ1YmJmODA4MjZmZWYyMDhjMV82NTk3MDY5NzY2Nzg5_655a778c-5cc2-4f89-a644-b356b3f46d3e"
      unitRef="usd">-178000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI3LTEtMS0xLTA_ac3857c6-55a0-476c-b5d6-1f305dca015a"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI3LTMtMS0xLTA_f904ad15-7df8-42db-b644-b7d75dbc2293"
      unitRef="usd">120000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI3LTUtMS0xLTA_4eca5a4e-d7af-4a73-ae72-e64e8b1a3a04"
      unitRef="usd">-132000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjZGExMjIzY2NlM2Y0NGQzYmVhMDNmMGMwM2ZjY2ZkZF82NTk3MDY5NzY2Nzc1_cf18b873-a376-4cd4-a160-7c17bd1809b9"
      unitRef="usd">7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjZGExMjIzY2NlM2Y0NGQzYmVhMDNmMGMwM2ZjY2ZkZF82NTk3MDY5NzY2Nzgz_c72d124f-74ff-44dd-b4f7-f99a4514b4e6"
      unitRef="usd">-12000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI4LTAtMS0xLTAvdGV4dHJlZ2lvbjpjZGExMjIzY2NlM2Y0NGQzYmVhMDNmMGMwM2ZjY2ZkZF82NTk3MDY5NzY2Nzg5_b7c6bdfe-e7b0-4052-9a14-4d59d6e732cc"
      unitRef="usd">11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI4LTEtMS0xLTA_317a0d55-3641-4417-995b-fd5ab5d25593"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI4LTMtMS0xLTA_ecbb3879-69ff-4b38-9120-fd6d430c6f1c"
      unitRef="usd">9000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI4LTUtMS0xLTA_fae7f6da-3b21-44c6-be42-62a2ff9050f3"
      unitRef="usd">-8000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3856bb0e5942434882afdb525656c1c2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI5LTEtMS0xLTA_48ecf4be-41b2-4d81-bbd7-e85d5931e188"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i82958ed2c3014a56b2ba95b09afccf6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI5LTMtMS0xLTA_52cab899-1bfe-4453-a7dc-a3ee18c184b6"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i670b295342754c2ba8cf0e0f8c56e771_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzI5LTUtMS0xLTA_23588eec-e32e-41e8-bcea-73d4b96252a3"
      unitRef="usd">-124000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia39a6a5feda9465cae5cb3ef31577007_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMwLTEtMS0xLTA_0934ae0b-7ec6-4f79-a033-530c716d8b3f"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ea3441f923f4cad82455098c9eac4f3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMwLTMtMS0xLTA_f393a183-a638-4695-9b9b-4b2517170679"
      unitRef="usd">-38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2cf5ea89c34f444085bba9feb6d80c49_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMwLTUtMS0xLTA_7c15c0ad-ea1b-4ec2-bde0-82c33a9fbbcc"
      unitRef="usd">-149000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie67e69bf0ba04460ad30b2bfb023aa77_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMyLTEtMS0xLTA_82afa36d-3823-4bc6-a17b-a0ede7aa328d"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia10ab0fc32f0402bbbaa42ba5ce15209_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMyLTMtMS0xLTA_1b81fa3e-a1fb-4823-a4da-7d8ab1d11001"
      unitRef="usd">102000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i77138741f151409593c0f08b724a0e30_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMyLTUtMS0xLTA_d21e9752-e97e-45b2-805a-f4956e895b66"
      unitRef="usd">-165000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect
      contextRef="i2e098044ef0e47c5bb1938a83a8faa41_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMzLTEtMS0xLTA_1526bdb8-0625-4954-a455-5d50633ca9c0"
      unitRef="usd">0</us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect>
    <us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect
      contextRef="i544dec88053840f8844b00845a1e6704_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMzLTMtMS0xLTA_86d2dd12-7f66-4fd0-b30d-4a51732ab36f"
      unitRef="usd">0</us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect>
    <us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect
      contextRef="i708551cc4c814f7ba31ad03e5c460a9b_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzMzLTUtMS0xLTA_1a1d48ca-adf7-4d3e-9e3c-692a1d0e9427"
      unitRef="usd">-7000000</us-gaap:TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzM0LTEtMS0xLTA_3416bc4d-f53c-4c08-8f57-8bd75737468f"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzM0LTMtMS0xLTA_1bf5fc46-92b0-48a4-8c67-a9d7e4180bb5"
      unitRef="usd">917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzM0LTUtMS0xLTA_66c37c9c-fc3e-42d1-8b00-72d3a9f4e36e"
      unitRef="usd">274000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib26f4f89c2814e789be0ba11239b5764_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzM1LTEtMS0xLTA_d52355d4-e2f9-4034-8d5f-f479d561a0fb"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie67e69bf0ba04460ad30b2bfb023aa77_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzM1LTMtMS0xLTA_4e0780c7-3138-4a61-90ec-d2578b3c779c"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia10ab0fc32f0402bbbaa42ba5ce15209_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90YWJsZTowODAzMTllOTdhNGM0MmI4YTFkYTY3NWFmNWJjZGM2Ni90YWJsZXJhbmdlOjA4MDMxOWU5N2E0YzQyYjhhMWRhNjc1YWY1YmNkYzY2XzM1LTUtMS0xLTA_85685ca9-5297-4953-b04b-a12169157e94"
      unitRef="usd">102000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="ie55d01130f004e38a1138732a5796669_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNzUvZnJhZzoyMTk2NGI1Y2YyNjY0ZWVhYmI0ZmY3NDg2YmIyYjYxNi90ZXh0cmVnaW9uOjIxOTY0YjVjZjI2NjRlZWFiYjRmZjc0ODZiYjJiNjE2XzExODY_e2e3412c-24d5-4bfe-9af0-89f96bd0d166"
      unitRef="usd">13000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90ZXh0cmVnaW9uOjJhYTMwYjM0ZGE0MjQwZGM4OWM2ZWI3NzVmMWZjMTFjXzEzMTI_2b3fad80-bcd0-4507-b0f0-6c3a2c29972b">Earnings (Loss) Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings (loss) per share is computed using the two-class method. For periods in which the Company reports net income, diluted earnings per share is determined by using the weighted average number of common and dilutive common equivalent shares outstanding during the period, unless the effect is antidilutive. SARs and options to purchase 15 million and 17&#160;million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the years ended December&#160;31, 2020 and 2019, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, options to purchase 13 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share, for the year ended December&#160;31, 2018. In addition, due to the loss from continuing operations attributable to CVS Health in the year ended December 31, 2018, 3 million potentially dilutive common equivalent shares were excluded from the calculation of diluted earnings per share, as the impact of these shares was antidilutive for that period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings (loss) per share from continuing operations for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings (loss) per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(596)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings (loss) per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per share from continuing operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.57)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i44c7450a0d11477499c9bec9bf025a94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90ZXh0cmVnaW9uOjJhYTMwYjM0ZGE0MjQwZGM4OWM2ZWI3NzVmMWZjMTFjXzM3Mw_634768e6-80d0-4fb8-a6e9-b2b31c326975"
      unitRef="shares">15000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic4a8d6916f6844c2903a012a996567fe_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90ZXh0cmVnaW9uOjJhYTMwYjM0ZGE0MjQwZGM4OWM2ZWI3NzVmMWZjMTFjXzY1OTcwNjk3NjgwMjQ_85bf51d4-a076-4105-8768-cca65b32747e"
      unitRef="shares">17000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia66f0a48333c4fb8a9fae0a1c2df0fca_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90ZXh0cmVnaW9uOjJhYTMwYjM0ZGE0MjQwZGM4OWM2ZWI3NzVmMWZjMTFjXzcyMw_555bea70-7129-4468-aecd-400b7df6eebf"
      unitRef="shares">13000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icc86caed1ec14c06a5264c5b07d25d2c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90ZXh0cmVnaW9uOjJhYTMwYjM0ZGE0MjQwZGM4OWM2ZWI3NzVmMWZjMTFjXzk4Nw_0b9124dc-a55d-472a-a5dc-ba6137246510"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90ZXh0cmVnaW9uOjJhYTMwYjM0ZGE0MjQwZGM4OWM2ZWI3NzVmMWZjMTFjXzEzMTM_ffa4a6a9-e95e-47b0-b84f-88263b786314">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings (loss) per share from continuing operations for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings (loss) per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(596)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings (loss) per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per share from continuing operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.57)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzItMS0xLTEtMA_cda17fea-7d15-451d-8b54-ad7bbd61e288"
      unitRef="usd">7201000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzItMy0xLTEtMA_0521c654-5344-4077-8347-ebf606ddd7ae"
      unitRef="usd">6631000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzItNS0xLTEtMA_96890304-6350-4e0e-8dad-af3d5021289b"
      unitRef="usd">-596000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzMtMS0xLTEtMA_f8bf3f97-767d-4f45-aaba-0cebd7a35eb8"
      unitRef="usd">0</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzMtMy0xLTEtMA_5316344b-234d-4c8e-be94-6da255c94ccd"
      unitRef="usd">5000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzMtNS0xLTEtMA_9a6f7cd6-6a7f-440b-9f38-e0efaa4ec7cf"
      unitRef="usd">3000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzQtMS0xLTEtMA_e3969c3c-012d-4518-9831-fdf563ea8a0f"
      unitRef="usd">13000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzQtMy0xLTEtMA_13633cd6-25c1-4b7b-8503-5fa1b1344e1e"
      unitRef="usd">-3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzQtNS0xLTEtMA_489c025c-5b59-44e8-8465-60b7dde7405e"
      unitRef="usd">-2000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzUtMS0xLTEtMA_aedd2958-38b9-4690-895f-3474353f0da3"
      unitRef="usd">7188000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzUtMy0xLTEtMA_6f387338-732b-45a1-8c92-31b411d55140"
      unitRef="usd">6629000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzUtNS0xLTEtMA_330c5b10-1ae8-4164-a900-4dd8f808ae3d"
      unitRef="usd">-597000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzgtMS0xLTEtMA_6899e612-7d38-41e9-a407-14d51430040f"
      unitRef="shares">1309000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzgtMy0xLTEtMA_c6335f20-6046-4e26-a558-edf5972a5a93"
      unitRef="shares">1301000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzgtNS0xLTEtMA_fb70dd46-8e35-4e99-a422-12e432b08c70"
      unitRef="shares">1044000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzktMS0xLTEtMA_841ba298-0657-419b-a46d-307590a762ac"
      unitRef="shares">5000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzktMy0xLTEtMA_4dff1ced-d5e4-4b9d-8da4-893c16b0a358"
      unitRef="shares">4000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzktNS0xLTEtMA_bbb1f13e-ac52-4fed-85db-07a5df29da37"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzEwLTEtMS0xLTA_b5ff59d4-97fe-43a1-8150-f6b639130ac2"
      unitRef="shares">1314000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzEwLTMtMS0xLTA_f1aa1846-4587-496a-81b0-b9c1efd22512"
      unitRef="shares">1305000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzEwLTUtMS0xLTA_9e509213-630e-4158-aea5-6ca7570d4c2d"
      unitRef="shares">1044000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzEzLTEtMS0xLTA_c7882d2c-679b-4c56-8f43-2a01c14a1b52"
      unitRef="usdPerShare">5.49</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzEzLTMtMS0xLTA_aaa03f32-fd71-4525-aa54-db7d5d6a6b1d"
      unitRef="usdPerShare">5.10</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzEzLTUtMS0xLTA_93e9460d-eb80-4da6-8403-dc9106b2d26e"
      unitRef="usdPerShare">-0.57</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzE0LTEtMS0xLTA_ec4fa5a2-2622-469d-8d3b-651fe105a302"
      unitRef="usdPerShare">5.47</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzE0LTMtMS0xLTA_e2a7ee7e-1b6d-46e4-a11e-51b9dcf97900"
      unitRef="usdPerShare">5.08</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODEvZnJhZzoyYWEzMGIzNGRhNDI0MGRjODljNmViNzc1ZjFmYzExYy90YWJsZTpjZGRlODU2MDlmOGY0MGI1YmVjYjZiMmRiNzc2ZGEwNy90YWJsZXJhbmdlOmNkZGU4NTYwOWY4ZjQwYjViZWNiNmIyZGI3NzZkYTA3XzE0LTUtMS0xLTA_fd0cc01d-eac4-4939-a086-08a62b87197b"
      unitRef="usdPerShare">-0.57</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:ReinsuranceTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90ZXh0cmVnaW9uOmE3NjdmYmE1Y2U0YzRmOWQ4MmVmY2MyNDVkMzUyNjVmXzIzMDM_e95f3b12-6b7c-4d9f-9b02-b685b129d54d">Reinsurance&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#x2019;s primary liability as the direct insurer of the risks reinsured.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 30, 2018, the Company completed the sale of Aetna&#x2019;s standalone Medicare Part D prescription drug plans to a subsidiary of WellCare Health Plans, Inc. (&#x201c;WellCare&#x201d;), effective December 31, 2018. In connection with that sale, subsidiaries of WellCare and Aetna entered into reinsurance agreements under which WellCare ceded to Aetna 100% of the insurance risk related to the divested standalone Medicare Part D prescription drug plans for the 2019 PDP plan year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company entered into two four-year reinsurance agreements with an unrelated reinsurer that allow it to reduce required capital and provide collateralized excess of loss reinsurance coverage on a portion of the Health Care Benefits segment&#x2019;s group Commercial Insured business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reinsurer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hartford Life and Accident Insurance Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lincoln Life &amp;amp; Annuity Company of New York&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;WellCare Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VOYA Retirement Insurance and Annuity Company &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of reinsurance on benefit costs for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There is not a material difference between premiums on a written basis versus an earned basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has various agreements with unrelated reinsurers that do not qualify for reinsurance accounting under GAAP, and consequently are accounted for using deposit accounting. The Company entered into these contracts to reduce the risk of catastrophic loss which in turn reduces the Company&#x2019;s capital and surplus requirements. Total deposit assets and liabilities related to reinsurance agreements that do not qualify for reinsurance accounting under GAAP were not material as of December&#160;31, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReinsuranceTextBlock>
    <cvs:NumberofReinsuranceContractsEnteredInto
      contextRef="id456c1b6d71e415f8fae0b19939047b5_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90ZXh0cmVnaW9uOmE3NjdmYmE1Y2U0YzRmOWQ4MmVmY2MyNDVkMzUyNjVmXzkxMg_6ab5ee69-1df3-4f35-8bd7-55938097071c"
      unitRef="reinsuranceagreement">2</cvs:NumberofReinsuranceContractsEnteredInto>
    <cvs:FourYearsReinsuranceAgreementWithUnrelatedInsurer
      contextRef="id456c1b6d71e415f8fae0b19939047b5_D20210101-20210131"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90ZXh0cmVnaW9uOmE3NjdmYmE1Y2U0YzRmOWQ4MmVmY2MyNDVkMzUyNjVmXzU0OTc1NTgxNDEyMDc_00b29eaa-cf9a-4f6b-b015-d094613a2eb0">P4Y</cvs:FourYearsReinsuranceAgreementWithUnrelatedInsurer>
    <us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90ZXh0cmVnaW9uOmE3NjdmYmE1Y2U0YzRmOWQ4MmVmY2MyNDVkMzUyNjVmXzIzMTA_57b7214c-f23d-4fb6-a302-04818513d853">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reinsurer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hartford Life and Accident Insurance Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lincoln Life &amp;amp; Annuity Company of New York&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;WellCare Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VOYA Retirement Insurance and Annuity Company &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i283d40b1ef884f6cb9ca2441e0955fad_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzItMS0xLTEtMA_017b7eaf-1fc7-4d54-9104-5608b5f60067"
      unitRef="usd">2364000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="ib5a32e023950437daba697bb6436ecc3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzItMy0xLTEtMA_2ced14d0-126a-44ef-8d7a-ff837721b4d8"
      unitRef="usd">3085000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="if1061114a7fd4ccdb4a85fb5f0f28ab9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzMtMS0xLTEtMA_d39df03f-bb60-4f21-91c8-8241748ffc19"
      unitRef="usd">406000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="iaa18411dccbb43738f7c59758dc47e91_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzMtMy0xLTEtMA_de0d1c24-cb84-444c-b8d9-b47fa6048078"
      unitRef="usd">413000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i09460a20d53d4ad4afdab3735a3cc179_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzQtMS0xLTEtMA_7fda18e7-0213-426b-ac7c-11d7081941fc"
      unitRef="usd">13000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i81a6a522a6904da1983e84571970a6af_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzQtMy0xLTEtMA_67da0f98-69be-40d4-8196-e690a258b4cb"
      unitRef="usd">355000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i4a0994e7abf542478298de546eeea26a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzUtMS0xLTEtMA_d7ac99a7-1c89-4fd6-a175-861d40e60938"
      unitRef="usd">170000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="ifc0de1362c31442e9830179e9cf9ff8a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzUtMy0xLTEtMA_1f05227f-59c3-4368-8495-f8c52ffe43fe"
      unitRef="usd">175000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i974ce0ed0b7041fc865280b9d6ba0727_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzYtMS0xLTEtMA_2115798d-0b36-4f98-9570-0393cbec8d89"
      unitRef="usd">102000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i8177202559374cd1b60b07d956cf5c08_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzYtMy0xLTEtMA_4c5dfb97-694e-41e3-a612-fe1998caef79"
      unitRef="usd">103000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzctMS0xLTEtMA_f1f87114-2ca5-4629-af21-b976a43967f2"
      unitRef="usd">3055000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowZjIyYmNhODVmODg0ZjkxODYyM2UzOGU4NjA5MzU3ZS90YWJsZXJhbmdlOjBmMjJiY2E4NWY4ODRmOTE4NjIzZTM4ZTg2MDkzNTdlXzctMy0xLTEtMA_fdba6e66-3aae-47ee-8a80-a04ef75bc2e1"
      unitRef="usd">4131000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90ZXh0cmVnaW9uOmE3NjdmYmE1Y2U0YzRmOWQ4MmVmY2MyNDVkMzUyNjVmXzIzMDc_1a992277-ca93-40d4-9ff4-85d04feb5522">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock>
    <us-gaap:DirectPremiumsEarned
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzEtMS0xLTEtMA_f2b017b4-ff34-436e-a755-507a324a23ab"
      unitRef="usd">69711000000</us-gaap:DirectPremiumsEarned>
    <us-gaap:DirectPremiumsEarned
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzEtMy0xLTEtMA_f893813b-e806-4082-b5db-11ca7ba98fe8"
      unitRef="usd">62968000000</us-gaap:DirectPremiumsEarned>
    <us-gaap:DirectPremiumsEarned
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzEtNS0xLTEtMjA5Ng_2a624f78-2532-49d9-bde2-d464dc95a6d9"
      unitRef="usd">8365000000</us-gaap:DirectPremiumsEarned>
    <us-gaap:AssumedPremiumsEarned
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzItMS0xLTEtMA_15a503b1-f1ec-4d3d-ad50-a3ddde14c6e6"
      unitRef="usd">478000000</us-gaap:AssumedPremiumsEarned>
    <us-gaap:AssumedPremiumsEarned
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzItMy0xLTEtMA_fa2f2093-36e9-4bcb-a418-8c51f4a6d320"
      unitRef="usd">2108000000</us-gaap:AssumedPremiumsEarned>
    <us-gaap:AssumedPremiumsEarned
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzItNS0xLTEtMjA5Ng_56266ae1-c48d-43fd-baf2-c8db5fcd4c5f"
      unitRef="usd">38000000</us-gaap:AssumedPremiumsEarned>
    <us-gaap:CededPremiumsEarned
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzMtMS0xLTEtMA_5700f981-6510-46fe-bc4b-6a083dae86da"
      unitRef="usd">825000000</us-gaap:CededPremiumsEarned>
    <us-gaap:CededPremiumsEarned
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzMtMy0xLTEtMA_ee798ff3-d77b-4ea6-bcdf-427e5f3f3992"
      unitRef="usd">1954000000</us-gaap:CededPremiumsEarned>
    <us-gaap:CededPremiumsEarned
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzMtNS0xLTEtMjA5Ng_692bc9d0-913e-4872-a706-3244192ce3e4"
      unitRef="usd">219000000</us-gaap:CededPremiumsEarned>
    <us-gaap:PremiumsEarnedNet
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzQtMS0xLTEtMA_48a49e3b-e0dd-4c2e-bb71-841919ef6f02"
      unitRef="usd">69364000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzQtMy0xLTEtMA_26c3d939-9dcd-486d-b412-0307b6e09617"
      unitRef="usd">63122000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTpiMTc4MTg3ZGQ4ODg0NjVkOTIxZWU5MTg4YzY0ZTFmNS90YWJsZXJhbmdlOmIxNzgxODdkZDg4ODQ2NWQ5MjFlZTkxODhjNjRlMWY1XzQtNS0xLTEtMjA5Ng_c4c007f2-c11a-4759-b573-ecb744fb85cb"
      unitRef="usd">8184000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:EffectsOfReinsuranceTableTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90ZXh0cmVnaW9uOmE3NjdmYmE1Y2U0YzRmOWQ4MmVmY2MyNDVkMzUyNjVmXzIzMDE_1ea2804b-5dd8-42e4-bb07-bdc642e8102f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of reinsurance on benefit costs for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EffectsOfReinsuranceTableTextBlock>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredGross
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzEtMS0xLTEtMA_ab56abe2-7e09-4ec0-8f3a-46cd8f273cbc"
      unitRef="usd">56077000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredGross>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredGross
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzEtMy0xLTEtMA_fbfcf726-3237-4b64-9ad8-f379a0f149e5"
      unitRef="usd">52592000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredGross>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredGross
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzEtNS0xLTEtMjEwMg_ff246903-7492-4cdd-9f02-ff0e38e9a7d5"
      unitRef="usd">6773000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredGross>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzItMS0xLTEtMA_a3cf7f11-eab8-4987-9670-040bc2f1f6fa"
      unitRef="usd">329000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzItMy0xLTEtMA_ed63d90d-ac04-4b45-a67a-f3c76b49fe82"
      unitRef="usd">1562000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzItNS0xLTEtMjEwMg_384e53ac-3f7b-4b88-ad88-fa220bb4d687"
      unitRef="usd">32000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzMtMS0xLTEtMA_d4391678-ec5e-4618-a4ad-19b37c77e2c8"
      unitRef="usd">727000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzMtMy0xLTEtMA_227ea516-4dac-4c75-9281-36614db2884b"
      unitRef="usd">1625000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzMtNS0xLTEtMjEwMg_ca9ca9ea-dd21-4560-b949-051782cf8844"
      unitRef="usd">211000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzQtMS0xLTEtMA_5486a7be-83c9-423f-8322-7b7389667296"
      unitRef="usd">55679000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzQtMy0xLTEtMA_7a1636dd-2fe7-4e00-a24e-8df949bcec0c"
      unitRef="usd">52529000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xODQvZnJhZzphNzY3ZmJhNWNlNGM0ZjlkODJlZmNjMjQ1ZDM1MjY1Zi90YWJsZTowMjBkYjRmYjA1MDc0M2I0OTJlMzM5ODVmYzFiNjhmYS90YWJsZXJhbmdlOjAyMGRiNGZiMDUwNzQzYjQ5MmUzMzk4NWZjMWI2OGZhXzQtNS0xLTEtMjEwMg_53eb520d-ebca-4f72-8409-791f0cfb8d1b"
      unitRef="usd">6594000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzMyMDE1_1f9f67bd-639d-4b09-922b-82ec78d74b0f">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;COVID-19&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic continues to evolve. We believe COVID-19&#x2019;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#x2019;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has the following significant guarantee arrangements at December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;ASC Claim Funding Accounts - The Company has arrangements with certain banks for the processing of claim payments for its ASC customers. The banks maintain accounts to fund claims of the Company&#x2019;s ASC customers. The customer is &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;responsible for funding the amount paid by the bank each day. In these arrangements, the Company guarantees that the banks will not sustain losses if the responsible ASC customer does not properly fund its account. The aggregate maximum exposure under these arrangements is generally limited to $250 million. The Company can limit its exposure to these guarantees by suspending the payment of claims for ASC customers that have not adequately funded the amount paid by the bank. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Separate Accounts Assets - Certain Separate Accounts assets associated with the large case pensions business in the Corporate/Other segment represent funds maintained as a contractual requirement to fund specific pension annuities that the Company has guaranteed. Minimum contractual obligations underlying the guaranteed benefits in these Separate Accounts were approximately $1.4 billion at both December&#160;31, 2020 and 2019. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information on Separate Accounts. Contract holders assume all investment and mortality risk and are required to maintain Separate Accounts balances at or above a specified level. The level of required funds is a function of the risk underlying the Separate Account&#x2019;s investment strategy. If contract holders do not maintain the required level of Separate Accounts assets to meet the annuity guarantees, the Company would establish an additional liability. Contract holders&#x2019; balances in the Separate Accounts at December&#160;31, 2020 exceeded the value of the guaranteed benefit obligation. As a result, the Company was not required to maintain any additional liability for its related guarantees at December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#x2019;s Stores and Linens &#x2018;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#x2019;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#x2019;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of December&#160;31, 2020, the Company guaranteed 76 such store leases (excluding the lease guarantees related to Linens &#x2018;n Things, which have been recorded as a liability on the consolidated balance sheets), with the maximum remaining lease term extending through 2030.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#x2019;s assessments generally are based on a formula relating to the Company&#x2019;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#x201c;Penn Treaty&#x201d;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#x2019;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#x2019;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s total guaranty fund assessments liability was $78 million and $84 million at December&#160;31, 2020 and 2019, respectively, and was recorded in accrued expenses on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; CMS, state insurance and health and welfare departments, state attorneys general, the U.S. Drug Enforcement Administration (the &#x201c;DEA&#x201d;) and other governmental authorities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#x2019;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#x2019;s financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#x2019;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Usual and Customary Pricing Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#x2019;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;PBM Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is facing multiple lawsuits, including several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#x201c;CIDs&#x201d;) and &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;other requests for documents and information from, and is being investigated by, Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Behnke v. CVS Caremark Corporation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#x2019;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#x2019;s PBM. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Controlled Substances Litigation, Audits and Subpoenas&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re National Prescription Opiate Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the U.S. Department of Justice (the &#x201c;DOJ&#x201d;) served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations in connection with an investigation concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The Company has been cooperating with the government with respect to this subpoena.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Prescription Processing Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ex rel.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Bassan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; v. Omnicare, Inc. and CVS Health Corp. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ex rel.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Mohajer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; v. Omnicare, Inc. and CVS Health Corp. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#x2019;s Office for the Southern District of New York (the &#x201c;SDNY&#x201d;) filed complaints-in-intervention in these two previously sealed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; cases. With respect to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bassan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint, all states and Washington, D.C. have declined to intervene at this time. The government&#x2019;s investigation related to these complaints included the previously disclosed CID that the Company received in October 2015 from the SDNY concerning the Company&#x2019;s Omnicare pharmacies&#x2019; cycle fill process for assisted living facilities. The complaints allege that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mohajer &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;relators have amended their complaint to include claims based on similar theories related to certain skilled nursing facilities. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#x2019;s Omnicare pharmacies&#x2019; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena..&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2016, the Company received a CID from the U.S. Attorney&#x2019;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#x2019;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Provider Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;whom the Company does not have a contract (&#x201c;out-of-network providers&#x201d;). Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#x2019;s post-payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;CMS Actions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS regularly audits the Company&#x2019;s performance to determine its compliance with CMS&#x2019;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#x2019;s and other companies&#x2019; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#x2019; medical records to determine whether those records support the related diagnosis codes that determine the members&#x2019; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#x201c;RADV&#x201d;) audits of various Medicare Advantage plans, including certain of the Company&#x2019;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#x2019;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#x201c;HHS-OIG&#x201d;) also is auditing the Company&#x2019;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#x2019;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#x2019;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#x2019;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#x2019;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange-related or other audits by CMS, HHS-OIG or otherwise, including audits of the Company&#x2019;s MLR rebates, methodology and/or reports, could be material and could adversely affect the Company&#x2019;s operating results, cash flows and/or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicare and Medicaid CIDs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#x2019;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the Company received a CID from the Office of the Washington Attorney General, Medicaid Fraud Control Division, on behalf of the State of Washington and all other states, as well as the District of Columbia, Puerto Rico and the U.S. Virgin Islands. The investigation involves, among other things, possible retention of overpayments and possible submission of false claims for Medicaid reimbursement relating to drugs prescribed by providers who were excluded by the applicable federal and/or state Medicaid programs. The Company is cooperating with the government with respect to this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stockholder Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in February 2019, multiple class action complaints, as well as a derivative complaint were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#x2019;s LTC business unit. Since filing, several of the cases have been consolidated, and the first-filed federal case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Miami Fire Fighters&#x2019; and Police Officers&#x2019; Retirement Trust, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Anarkat&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), was recently dismissed with prejudice. The Company and its current and former officers and directors are defending themselves against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August and September 2020, two ERISA class actions were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna, and several current and former executives, directors and/or members of Aetna&#x2019;s Compensation and Talent Management Committee: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Radcliffe v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flaim v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#x2019;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#x2019;s LTC business unit. The district court consolidated the actions and the Company has moved to dismiss the amended and consolidated class action complaint. The Company also received a related document request pursuant to ERISA &#xa7; 104(b), to which the Company has responded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Legal and Regulatory Proceedings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#x2019;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#x2019;s operating results. The Company will continue to defend contract awards it receives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#x2019;s and the rest of the health care and related benefits industry&#x2019;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#x2019; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a leading national health care company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#x2019;s businesses, changes to or clarifications of the Company&#x2019;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;federal government, withholding of premium payments to the Company by government agencies, assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i) future enactment of new health care or other laws or regulations; (ii) the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii) pending or future federal or state government investigations of one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv) pending or future government audits, investigations or enforcement actions against the Company; (v) adverse developments in any pending &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit against the Company, whether sealed or unsealed, or in any future &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit that may be filed against the Company; or (vi) adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzY0Ng_7dd9f703-3c95-497a-9a73-93bb30b28d2d"
      unitRef="usd">250000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzExOTg_45309032-c7e9-4306-8f72-c466e0e9d9da"
      unitRef="usd">1400000000</cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts>
    <cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzExOTg_4d23f9e1-1ce9-47ec-bfa8-832481015cd0"
      unitRef="usd">1400000000</cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts>
    <cvs:GuarantorObligationsNumberofLeases
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzI4Nzc_91396640-2781-4dcf-bbda-ee2918c03f82"
      unitRef="lease">76</cvs:GuarantorObligationsNumberofLeases>
    <us-gaap:GuarantyLiabilities
      contextRef="i371ef8b4f96c4033b7b40dccf03166b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzU4Nzk_949f6b3d-9b98-421e-adb0-80eb34932edd"
      unitRef="usd">78000000</us-gaap:GuarantyLiabilities>
    <us-gaap:GuarantyLiabilities
      contextRef="i36847bfea20b4065b555edc6977908d0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTAvZnJhZzoxMDM4MWRmMGY3OGQ0MWU1YTViZjAxODgxZDRiNjQyNy90ZXh0cmVnaW9uOjEwMzgxZGYwZjc4ZDQxZTVhNWJmMDE4ODFkNGI2NDI3XzU4ODY_b850b149-6c76-48e2-9ac4-5160a02110d0"
      unitRef="usd">84000000</us-gaap:GuarantyLiabilities>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzU3MDg_933a180f-a647-480e-a4de-7889c849455f">Segment Reporting&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has three operating segments, Pharmacy Services, Retail/LTC and Health Care Benefits, as well as a Corporate/Other segment. The Company&#x2019;s segments maintain separate financial information, and the CODM evaluates the segments&#x2019; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#x2019;s segments based on adjusted operating income which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#x2019;s business nor reflect the Company&#x2019;s underlying business performance. See the reconciliation of consolidated operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#x2019;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020 and 2019, revenues from the federal government accounted for 14% and 13%, respectively, of the Company&#x2019;s consolidated total revenues, primarily related to contracts with CMS for coverage of Medicare-eligible individuals within the Health Care Benefits segment. Revenues from the federal government were less than 10% of the Company&#x2019;s consolidated revenues in 2018. In 2018, approximately 9.8% of the Company&#x2019;s consolidated revenues were from Aetna, which was a Pharmacy Services segment client. On the Aetna Acquisition Date, Aetna became a wholly-owned subsidiary of CVS Health. Subsequent to the Aetna Acquisition Date, transactions with Aetna continue to be reported within the Pharmacy Services segment, but are eliminated in the Company&#x2019;s consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&#160;&lt;br/&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(708)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(856)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;Total revenues of the Pharmacy Services segment include approximately $10.9 billion, $11.5 billion and $11.4 billion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;of retail co-payments for 2020, 2019 and 2018, respectively. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information about retail co-payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related transaction and integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Gain) loss on divestiture of subsidiary &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receipt of fully reserved ACA risk corridor receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Store rationalization charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income on financing for the Aetna Acquisition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#x2019;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.   &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2020, 2019 and 2018, acquisition-related transaction and integration costs relate to the Aetna Acquisition. In 2018, acquisition-related integration costs also relate to the acquisition of Omnicare. The acquisition-related transaction and integration costs are reflected in the Company&#x2019;s consolidated statements of operations in operating expenses within the Corporate/Other segment and the Retail/LTC segment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#x2019; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#x2019;s consolidated statement of operations within the Health Care Benefits segment. In 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income. In 2018, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of the Company&#x2019;s RxCrossroads subsidiary for $725&#160;million on January 2, 2018. The losses on divestiture of subsidiary are reflected in the Company&#x2019;s consolidated statements of operations in operating expenses within the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2020, the Company received $313&#160;million owed to it under the ACA&#x2019;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#x2019;s consolidated statement of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2019, the store rationalization charges relate to the planned closure of 46 underperforming retail pharmacy stores in the second quarter of 2019 and the planned closure of 22 underperforming retail pharmacy stores in the first quarter of 2020. The store rationalization charges primarily relate to operating lease right-of-use asset impairment charges and are reflected in the Company&#x2019;s consolidated statement of operations in operating expenses within the Retail/LTC segment.   &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2018, the goodwill impairments relate to the LTC reporting unit within the Retail/LTC segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2018, impairment of long-lived assets primarily relates to the impairment of property and equipment within the Retail/LTC segment and is reflected in operating expenses in the Company&#x2019;s consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2018, the Company recorded interest income of $536 million on the proceeds of the $40 billion of unsecured senior notes it issued in March 2018 to partially fund the Aetna Acquisition. All amounts are for the periods prior to the close of the Aetna Acquisition, which occurred on November 28, 2018, and were recorded within the Corporate/Other segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzQx_e40b1bae-851f-4ab4-b563-769a91cac303"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6e2f1b217f52446cb6e5188fdcdf3a24_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzcxMTg_b84a9d8b-5d62-45d9-b898-e51e0d3326b9"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4fad3343a4d04d8eb3071527460cb5cf_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzcxMjM_707433a9-3e3b-4ee1-894b-bf04fd5bab64"
      unitRef="number">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i970d47a28d574ba6aa6a095102442465_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzU0OTc1NTgxNjEyMTU_b1f0826c-ebae-49b4-8d44-eada4426713b"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i02d01cae12ae4fcfa5db05cc7acbdce2_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIwMDY_acd6d803-ec8f-4a91-8870-1a620b116332"
      unitRef="number">0.098</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzU3MDM_c72dc9af-9eaf-41e8-87ac-cee7e311e988">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.018%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&#160;&lt;br/&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(708)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(856)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;Total revenues of the Pharmacy Services segment include approximately $10.9 billion, $11.5 billion and $11.4 billion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;of retail co-payments for 2020, 2019 and 2018, respectively. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information about retail co-payments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzItMS0xLTEtMA_cb2ebc1d-0f64-4287-a8de-372fb9c1881c"
      unitRef="usd">132663000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzItMy0xLTEtMA_e0a9da3c-8f0d-4a7e-91ea-a4540aaf72f6"
      unitRef="usd">60208000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzItNS0xLTEtMA_a9febfcc-0b0f-41f2-b669-97bc0a32d566"
      unitRef="usd">74926000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzItNy0xLTEtMA_d7cdf7a0-c761-4819-8ea1-25742ed4ea3f"
      unitRef="usd">111000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzItMTEtMS0xLTA_b2c9ad38-aaf3-48fa-8522-06493a981e67"
      unitRef="usd">267908000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11b7b7dd14d4443089c85a899cf72296_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtMS0xLTEtMTg4MQ_ba5953fd-1df8-4c06-9c38-6b58a958853b"
      unitRef="usd">9275000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74221d409dca4f35b040b2ed0b77e999_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtMy0xLTEtMTg4MQ_189bae10-fed8-4404-a8d6-c24e7c95e06f"
      unitRef="usd">30990000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d5bd822a20345d1b479f13bc043f886_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtNS0xLTEtMTg4MQ_47f4a746-0271-47cd-8998-280d581957f7"
      unitRef="usd">58000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtOS0xLTEtMTg4MQ_d4514283-9db2-44d2-8ce2-bfc884138afb"
      unitRef="usd">-40323000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtMS0xLTEtMA_8f610992-2670-4424-9e29-4b5b84c4e92a"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtMy0xLTEtMA_db993e4b-9f17-4a9a-aa96-24d9d049c68f"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtNS0xLTEtMA_5392fabd-272b-4a95-8ded-1955df2e3ddf"
      unitRef="usd">483000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtNy0xLTEtMA_79cb0803-666a-4baf-a699-7531e34d6737"
      unitRef="usd">315000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtOS0xLTEtMA_24b3fbcd-ab02-47a8-966d-b3fd127259f1"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzMtMTEtMS0xLTA_24a2c441-5cc4-44c9-aaff-d9a2c5fdaa09"
      unitRef="usd">798000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzQtMS0xLTEtMA_58497f92-b549-4f4e-bafa-ccc190b246ba"
      unitRef="usd">141938000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzQtMy0xLTEtMA_a9ef9c96-e605-407e-a59b-084a1ae6520b"
      unitRef="usd">91198000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzQtNS0xLTEtMA_e0e6ddae-ec80-4348-abdb-993c9c46bb80"
      unitRef="usd">75467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzQtNy0xLTEtMA_cfacf59b-776f-477a-98e6-acf6223ef992"
      unitRef="usd">426000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzQtOS0xLTEtMA_f2ade516-09ef-4053-bc0e-62ec1b96023c"
      unitRef="usd">-40323000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzQtMTEtMS0xLTA_56fbc0ce-16c7-4b68-84b9-5aa758371d37"
      unitRef="usd">268706000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzUtMS0xLTEtMA_a07ab2e5-eee2-4e1d-9e8d-ead0da921517"
      unitRef="usd">5688000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzUtMy0xLTEtMA_090bc3b0-e437-494b-94dc-6ea6e0888c60"
      unitRef="usd">6146000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzUtNS0xLTEtMA_ee3e7758-7a97-490e-a5fd-3456ddd369a9"
      unitRef="usd">6188000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzUtNy0xLTEtMA_33f3ada2-c0b4-4254-9d28-1aab9ec7ead2"
      unitRef="usd">-1306000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzUtOS0xLTEtMA_087c40ff-da09-4cb7-9429-a94a65508009"
      unitRef="usd">-708000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzUtMTEtMS0xLTA_20e5d505-6316-46be-9825-c65f2a621e6a"
      unitRef="usd">16008000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzYtMS0xLTEtMA_8f6769e2-5295-4f96-bf68-4d8b27c1ffcc"
      unitRef="usd">612000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6f3fe7c4f4bb491983cdbbcd16f040b3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzYtMy0xLTEtMA_92c5c508-7d2b-4f4a-b5d4-5efa72cf8e00"
      unitRef="usd">1801000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3f07f4e42abc44e1a00bb4463807f4ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzYtNS0xLTEtMA_7f0ece49-8cc6-4149-b92c-f747f6bf5ad1"
      unitRef="usd">1832000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i62292e2dfc244402a8034c9118fdd238_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzYtNy0xLTEtMA_7c30b750-4e50-4985-b69b-e65addf6e25d"
      unitRef="usd">196000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib10d6c1ff1b54485b4c18d8a9885f0d4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzYtOS0xLTEtMA_ae4e756f-523c-4375-b1c6-859fe22fa7d2"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzYtMTEtMS0xLTA_b66f5c3c-cfa7-4c89-b23f-170a2bd4db62"
      unitRef="usd">4441000000</us-gaap:DepreciationDepletionAndAmortization>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzktMS0xLTEtMA_94cbb91d-f63e-4f8e-b4cc-5548f51c875a"
      unitRef="usd">130428000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzktMy0xLTEtMA_317dfe14-a080-44c8-b8bc-8cb0c508f4cb"
      unitRef="usd">56258000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzktNS0xLTEtMA_a6a6fa21-0ad2-4a3e-8195-d41fad737981"
      unitRef="usd">68979000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzktNy0xLTEtMA_dd8294ce-8c3d-4aa0-aa54-7386f42ae27f"
      unitRef="usd">100000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzktMTEtMS0xLTA_7cab36fc-ea7c-40fe-a7e4-08719f8fade7"
      unitRef="usd">255765000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i875e15f3f4444bf9a8d68faf00b3a90d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTEtMS0xLTE4OTA_7e2dc9c1-f6f8-457b-8fb9-95fcd0d7be7e"
      unitRef="usd">11063000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93d64ebea36e4de88c24cd1d6157c5e8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTMtMS0xLTE4OTA_73e4c287-2e52-45d2-803d-b000468ddf6f"
      unitRef="usd">30350000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9f90001385946838987a8d0b03205b3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTUtMS0xLTE4OTA_91e65e5e-5ad4-4545-920f-179438991c5b"
      unitRef="usd">26000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTktMS0xLTE4OTA_ed295ca5-fe8d-4eb7-97b3-2546c05be2e2"
      unitRef="usd">-41439000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEwLTEtMS0xLTA_fa8b438e-4921-42c2-b820-b02cdec1d8bd"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEwLTMtMS0xLTA_4ee940c5-6763-4e61-9f7b-03fb1b05798a"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEwLTUtMS0xLTA_6ee42fdb-ffcd-4db9-9cfc-80a74ead7045"
      unitRef="usd">599000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEwLTctMS0xLTA_cd7025bb-3ead-4012-9307-89f7238e6642"
      unitRef="usd">412000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEwLTktMS0xLTA_723f5089-f86a-4c1f-85aa-9da46229c869"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEwLTExLTEtMS0w_b8f59ce7-75ba-40ef-8bea-3dfadf4f84a0"
      unitRef="usd">1011000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTEtMS0xLTA_bd3f67e8-44c4-4249-b741-ace671cc1270"
      unitRef="usd">141491000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTMtMS0xLTA_b5680843-7bcf-4931-8030-fdd1df13384e"
      unitRef="usd">86608000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTUtMS0xLTA_f92ef8ac-6c05-4d33-bb95-340614d81182"
      unitRef="usd">69604000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTctMS0xLTA_645d9703-aa9a-45fe-bde0-00e6a00eedb3"
      unitRef="usd">512000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTktMS0xLTA_5f677a1f-e304-44c4-97a4-8adff707572a"
      unitRef="usd">-41439000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzExLTExLTEtMS0w_3daf8fef-3a94-4e0f-bd1f-deaa2d20663a"
      unitRef="usd">256776000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEyLTEtMS0xLTA_b630ab82-2ddd-4236-9420-1cdaabcef44f"
      unitRef="usd">5129000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEyLTMtMS0xLTA_1317a024-2a24-4bed-b11d-9dd5be32bf74"
      unitRef="usd">6705000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEyLTUtMS0xLTA_518cfd12-cf2e-4ac6-8021-89aea8181b81"
      unitRef="usd">5202000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEyLTctMS0xLTA_8103e3ef-ace8-4863-81ed-d0983c42df41"
      unitRef="usd">-1000000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEyLTktMS0xLTA_1358ae0f-7578-449f-b336-6c1637ab344b"
      unitRef="usd">-697000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEyLTExLTEtMS0w_33427fba-4f81-44e8-aea3-2d7afbdb2450"
      unitRef="usd">15339000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEzLTEtMS0xLTA_8363790b-ef90-46a0-971a-c1f5a4506dca"
      unitRef="usd">766000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9d6e75ada00b4605953319e63fc8c8c4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEzLTMtMS0xLTA_746a329f-0976-466d-b7c9-7e0df5eeeda1"
      unitRef="usd">1723000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia52c225f120b4c3fb46eebd167c0b7ae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEzLTUtMS0xLTA_8eb18607-b43a-4b3e-9f78-bd5ef4275330"
      unitRef="usd">1721000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib683132ac8e749aba9597ed569d5ea37_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEzLTctMS0xLTA_eabae611-e04c-4627-998f-bdda7e3c98de"
      unitRef="usd">161000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i29bbc519faa54d2697c4b5eee52efbaa_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEzLTktMS0xLTA_31678cd9-2de9-4e99-8c47-a1e9da029fe7"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzEzLTExLTEtMS0w_c01b3ef5-ac9c-4caa-b9d1-658d99d1097e"
      unitRef="usd">4371000000</us-gaap:DepreciationDepletionAndAmortization>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE2LTEtMS0xLTA_017a0fd1-b5eb-4e20-89d7-b6f58816c078"
      unitRef="usd">130012000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE2LTMtMS0xLTA_36833839-3104-4198-86a7-54e1f82cd8e9"
      unitRef="usd">54999000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE2LTUtMS0xLTA_ec7ca21b-b49d-4ff2-b98f-1448c609fde1"
      unitRef="usd">8904000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE2LTctMS0xLTA_90717c36-f553-4c39-8f56-f124d8d86116"
      unitRef="usd">4000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE2LTExLTEtMS0w_5c87d8ca-1841-49b8-8b1a-9b5171756d5e"
      unitRef="usd">193919000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i027f2373425b4cd295e0f10e2e0aa39a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTEtMS0xLTE4OTc_94d39d34-9aca-49d4-9649-abe13f94391a"
      unitRef="usd">4724000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67879d9b5c0743d68fc0bf8c41903fae_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTMtMS0xLTE4OTc_8a02f157-d6fc-4181-a113-5597a15a52dc"
      unitRef="usd">28990000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4c1b7e8f9d543768b0ff3135e5a5f0b_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTUtMS0xLTE4OTc_b21c3b0c-c56d-4c52-8514-5b1ad9333b64"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTktMS0xLTE4OTc_6faf1b40-9e91-4414-a188-4544f1808d64"
      unitRef="usd">-33714000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE3LTEtMS0xLTA_1e0879e2-5b9a-485d-b996-6e5220e523f6"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE3LTMtMS0xLTA_f3bccff6-413e-47ad-865b-11ad969cb279"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE3LTUtMS0xLTA_4c7ac5cc-d1f9-46c9-8469-bade26c48e00"
      unitRef="usd">58000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE3LTctMS0xLTA_1235bd89-416c-488d-a74a-daa90373adc0"
      unitRef="usd">602000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE3LTktMS0xLTA_83af842e-065a-4b11-9726-fac63bff1a76"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE3LTExLTEtMS0w_8fbeb7a5-47c3-421e-9698-fd86bbba5c7e"
      unitRef="usd">660000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE4LTEtMS0xLTA_7b52dc1e-7b1e-4b30-bc5e-cc650f26799d"
      unitRef="usd">134736000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE4LTMtMS0xLTA_4d87ec2c-a035-46ba-945a-bb73c747e588"
      unitRef="usd">83989000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE4LTUtMS0xLTA_4d9b5aa8-aadf-49b3-826a-d5847a73de71"
      unitRef="usd">8962000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE4LTctMS0xLTA_4efbc770-4d59-4f5f-834b-87e063148944"
      unitRef="usd">606000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE4LTktMS0xLTA_a0635ddf-ecbb-4569-aa3c-277e3c23d4eb"
      unitRef="usd">-33714000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE4LTExLTEtMS0w_7c4941bf-8bc0-46b9-af4d-8dd3c3854a7b"
      unitRef="usd">194579000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTEtMS0xLTA_f4bb288d-559d-486a-bcc1-55477c72e09e"
      unitRef="usd">4955000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTMtMS0xLTA_ad197305-9d61-4c00-ab2c-8bda63f46745"
      unitRef="usd">7403000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTUtMS0xLTA_7f536ba2-e2d4-45f9-98b0-719c57d00ead"
      unitRef="usd">528000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTctMS0xLTA_e58a5c66-db38-45fd-abf9-4970f9de0329"
      unitRef="usd">-856000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTktMS0xLTA_064fd1d6-180d-477f-b92a-3fe9136f6926"
      unitRef="usd">-769000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzE5LTExLTEtMS0w_203ad57a-8900-4709-b392-aee98e37b503"
      unitRef="usd">11261000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzIwLTEtMS0xLTA_e2da6bb1-e7bd-47e0-91b8-d4116a706ebd"
      unitRef="usd">710000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i36564f45ec67407d93ad909645376841_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzIwLTMtMS0xLTA_f5933fe6-f0a7-46d4-8046-15903a08d281"
      unitRef="usd">1698000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i26fb15d93ba740aca5eda633a2448dcd_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzIwLTUtMS0xLTA_4728dfab-84be-442d-950a-1978aebc2cf7"
      unitRef="usd">172000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia751108dc0164471ae32975e51995a36_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzIwLTctMS0xLTA_d5ee4051-6506-4832-9824-f0cf6e835b9f"
      unitRef="usd">138000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="icb250f29cda74b2bb24d133faa6ef859_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzIwLTktMS0xLTA_fbdad40d-dd37-46dc-9b35-896cf68dde05"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTo4MmEwYjkwM2U1MTk0ZjkwYTRjMzQ2MTNlYWEyOTA2OC90YWJsZXJhbmdlOjgyYTBiOTAzZTUxOTRmOTBhNGMzNDYxM2VhYTI5MDY4XzIwLTExLTEtMS0w_0541287a-0682-457b-9a85-5d27fb28f064"
      unitRef="usd">2718000000</us-gaap:DepreciationDepletionAndAmortization>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="if63174233acd4168b88c860a242fb85e_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzI1MDU_0b455d80-cc34-4784-9dd8-fc876372b429"
      unitRef="usd">10900000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i9d16a3a5e12a4ac69be41615cd4c75ed_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzI1MDk_4706c5cb-cc71-43d3-b3d6-10b35fd8c78e"
      unitRef="usd">11500000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i241bbca6b28e4cec846eb1953c8343d7_D20180101-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzI1MTY_f6ab68a7-ca30-469c-b33d-83f6d3c67c23"
      unitRef="usd">11400000000</cvs:NetRevenuesRetailCoPayments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzU3MDU_4f55c9ab-051a-4c82-ba4b-45f22c23da76">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related transaction and integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Gain) loss on divestiture of subsidiary &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receipt of fully reserved ACA risk corridor receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Store rationalization charges &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of long-lived assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income on financing for the Aetna Acquisition &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(8)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#x2019;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.   &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2020, 2019 and 2018, acquisition-related transaction and integration costs relate to the Aetna Acquisition. In 2018, acquisition-related integration costs also relate to the acquisition of Omnicare. The acquisition-related transaction and integration costs are reflected in the Company&#x2019;s consolidated statements of operations in operating expenses within the Corporate/Other segment and the Retail/LTC segment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#x2019; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#x2019;s consolidated statement of operations within the Health Care Benefits segment. In 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income. In 2018, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of the Company&#x2019;s RxCrossroads subsidiary for $725&#160;million on January 2, 2018. The losses on divestiture of subsidiary are reflected in the Company&#x2019;s consolidated statements of operations in operating expenses within the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2020, the Company received $313&#160;million owed to it under the ACA&#x2019;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#x2019;s consolidated statement of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2019, the store rationalization charges relate to the planned closure of 46 underperforming retail pharmacy stores in the second quarter of 2019 and the planned closure of 22 underperforming retail pharmacy stores in the first quarter of 2020. The store rationalization charges primarily relate to operating lease right-of-use asset impairment charges and are reflected in the Company&#x2019;s consolidated statement of operations in operating expenses within the Retail/LTC segment.   &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2018, the goodwill impairments relate to the LTC reporting unit within the Retail/LTC segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2018, impairment of long-lived assets primarily relates to the impairment of property and equipment within the Retail/LTC segment and is reflected in operating expenses in the Company&#x2019;s consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(8)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2018, the Company recorded interest income of $536 million on the proceeds of the $40 billion of unsecured senior notes it issued in March 2018 to partially fund the Aetna Acquisition. All amounts are for the periods prior to the close of the Aetna Acquisition, which occurred on November 28, 2018, and were recorded within the Corporate/Other segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzEtMS0xLTEtMA_e80af6a9-a16d-4a86-8275-ec383706b1cc"
      unitRef="usd">13911000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzEtMy0xLTEtMA_5ddc43db-dab4-49cd-b114-983571b570e3"
      unitRef="usd">11987000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzEtNS0xLTEtMA_a89c4c74-e25f-4a55-b432-d010a3f3feb3"
      unitRef="usd">4021000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzItMS0xLTEtMA_a318e32c-95a1-4c67-9bc5-7064e20a4b67"
      unitRef="usd">2341000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzItMy0xLTEtMA_1f140631-ce1c-47a0-843d-674803369f87"
      unitRef="usd">2436000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzItNS0xLTEtMA_86804177-82b4-41bd-9519-373efdaa48d5"
      unitRef="usd">1006000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzMtMS0xLTEtMA_7cdb169c-9d90-41d5-aa17-adc6585b98a0"
      unitRef="usd">332000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzMtMy0xLTEtMA_2ba0666f-2acf-4f9a-b37e-1e847ad73fa0"
      unitRef="usd">480000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzMtNS0xLTEtMA_190b30a9-e4a5-4717-8d74-6a3edd481971"
      unitRef="usd">492000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtMS0xLTEtNjI1OQ_622f72ab-7310-4939-a18e-2197e1b8981b"
      unitRef="usd">269000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtMy0xLTEtNjI1OQ_5eaeb186-3d81-42a5-bd90-2c2f1255aa99"
      unitRef="usd">-205000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtNS0xLTEtNjI1OQ_55bf3333-389b-405b-b2b8-ffd3267dd903"
      unitRef="usd">-86000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtMS0xLTEtMjYzMw_45198185-5a69-4af3-8b65-eb2a0f92e8c5"
      unitRef="usd">307000000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtMy0xLTEtMjYzNw_a321b3f3-a56c-4bd9-b78c-0f91b801ee1a"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtNS0xLTEtMjY0MQ_0b8ac302-2555-4dbe-b5a8-cf5833051bb3"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <cvs:StoreRationalizationCharges
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtMS0xLTEtMA_ecbd2666-6ba3-4949-b2dd-8c00694b582c"
      unitRef="usd">0</cvs:StoreRationalizationCharges>
    <cvs:StoreRationalizationCharges
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtMy0xLTEtMA_afd96f1d-9b67-4a6c-85a3-650d54ff0104"
      unitRef="usd">231000000</cvs:StoreRationalizationCharges>
    <cvs:StoreRationalizationCharges
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzQtNS0xLTEtMA_3e9d2f1d-b94e-4bfe-8b17-dc0d69799373"
      unitRef="usd">0</cvs:StoreRationalizationCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzYtMS0xLTEtMA_80fe7343-0a0f-40df-b77f-f364429b41fd"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzYtMy0xLTEtMA_7f1e3bc0-1125-4d1d-9f1c-455acd838108"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if1058e7e5067441cb02129bfd0cc9dad_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzYtNS0xLTEtMA_2abb458c-e874-4589-8f5a-9ca9fb464f55"
      unitRef="usd">6149000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzctMS0xLTEtMA_6614de97-88bd-466b-9be1-5a0c05aceb90"
      unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzctMy0xLTEtMA_c1102dfb-6009-416c-afe5-33047f44eafb"
      unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzctNS0xLTEtMA_373c55c5-57e3-4bf8-9158-c0bce70ef29e"
      unitRef="usd">43000000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzgtMS0xLTEtMA_bfbc37de-2f17-4304-8926-abe7dc695526"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzgtMy0xLTEtMA_d641aa4c-428f-4c1f-82ff-35a4856ef9f7"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzgtNS0xLTEtMA_8c4d79b9-4c59-4fe7-9dda-86abc1a34d43"
      unitRef="usd">-536000000</us-gaap:InterestIncomeExpenseNet>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzktMS0xLTEtMA_369e2367-3ad6-493b-b466-8f23fef0d0a2"
      unitRef="usd">16008000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzktMy0xLTEtMA_33427fba-4f81-44e8-aea3-2d7afbdb2450"
      unitRef="usd">15339000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90YWJsZTpjMmE3YmM0MWIwZGU0MDc2YjFjNGVhMmU0OTI5NWJkYS90YWJsZXJhbmdlOmMyYTdiYzQxYjBkZTQwNzZiMWM0ZWEyZTQ5Mjk1YmRhXzktNS0xLTEtMA_203ad57a-8900-4709-b392-aee98e37b503"
      unitRef="usd">11261000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i6292fcfab69c48809cd6df0bbb16e7ba_D20200731-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzMwOTA_19850f02-0368-43e5-9619-18b5f656bed0"
      unitRef="usd">850000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i451e6007601e4a3f8f2a01973945700b_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzMxMTc_0621e2ed-be0c-4297-9737-ccc4e70cbb83"
      unitRef="usd">725000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainContingencyUnrecordedAmount
      contextRef="i138a42c6cd5e4913b5eb2ad3288f6b8a_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzY1OTcwNjk3NzkyNTc_541197b2-97fc-47b8-9fd2-10efbf466fa4"
      unitRef="usd">313000000</us-gaap:GainContingencyUnrecordedAmount>
    <cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax
      contextRef="ia508c5dcbe174753b2ea381d7ec1a3bc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzc5MDk_e9840c15-c8c8-42b3-936c-28320ea2225e"
      unitRef="usd">307000000</cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax>
    <cvs:NumberOfUnderPerformingStoresPlannedClosure
      contextRef="i70084b42bcb34cf790dad3c2e153d003_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzcwNzU_803f80f5-2335-4d4e-8d9a-93691afc9264"
      unitRef="store">46</cvs:NumberOfUnderPerformingStoresPlannedClosure>
    <cvs:NumberOfUnderPerformingStoresPlannedClosure
      contextRef="ib071f664e4424c34825859add41556cc_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzIxOTkwMjMyNzcwNzk_03041368-d6f0-4108-9ba6-392fe097afbf"
      unitRef="store">22</cvs:NumberOfUnderPerformingStoresPlannedClosure>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i3ffa460f969548b583077ff85463f042_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzY1OTcwNjk3NzYwMDM_8c4d79b9-4c59-4fe7-9dda-86abc1a34d43"
      unitRef="usd">-536000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i356e04bbc2764550a470b9863ec4eece_I20180309"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xOTYvZnJhZzpjYmVhN2UxNzQyYjc0NjZkYWY1MGY0NTFiNjE0ZWM2Zi90ZXh0cmVnaW9uOmNiZWE3ZTE3NDJiNzQ2NmRhZjUwZjQ1MWI2MTRlYzZmXzU0MzY_a40aa4af-77fa-47e2-b821-e088501db10e"
      unitRef="usd">40000000000</us-gaap:DebtInstrumentFaceAmount>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTUtMS0xLTA_2e6555ea-9d89-4f6a-9188-aec0ac5db97e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTUtMS0xLTA_2e6555ea-9d89-4f6a-9188-aec0ac5db97e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTItMS0xLTA_2435051f-4ce3-42cb-9703-f4ace175a146"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTItMS0xLTA_2435051f-4ce3-42cb-9703-f4ace175a146"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTItMS0xLTA_9b8cebe1-0b8a-4e47-b179-f53a706dfa00"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTItMS0xLTA_9b8cebe1-0b8a-4e47-b179-f53a706dfa00"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctMi0xLTEtMA_7e7fe2a3-8e1a-42e9-8ece-9da8b40d2dee"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctMi0xLTEtMA_7e7fe2a3-8e1a-42e9-8ece-9da8b40d2dee"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTItMS0xLTA_eb3c5e68-7726-4b79-b649-2ab124a852a1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTItMS0xLTA_eb3c5e68-7726-4b79-b649-2ab124a852a1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTItMS0xLTA_2514b134-4d79-4553-bfd8-476a7b592485"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTItMS0xLTA_2514b134-4d79-4553-bfd8-476a7b592485"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtMi0xLTEtMA_bd15f8ed-fb13-4a71-9515-093b89ab0d04"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtMi0xLTEtMA_bd15f8ed-fb13-4a71-9515-093b89ab0d04"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctNS0xLTEtMA_065a8a3f-8af2-4885-a8c1-8ca7428e8223"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctNS0xLTEtMA_065a8a3f-8af2-4885-a8c1-8ca7428e8223"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTUtMS0xLTA_1621828b-14e0-446f-a93d-fbdd43a45fa7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTUtMS0xLTA_1621828b-14e0-446f-a93d-fbdd43a45fa7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTItMS0xLTA_db94551e-003e-40b1-974c-609d700a26b3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTItMS0xLTA_db94551e-003e-40b1-974c-609d700a26b3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTUtMS0xLTA_7ff7c6fa-bb8f-45ab-b419-bb5be4433372"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTUtMS0xLTA_7ff7c6fa-bb8f-45ab-b419-bb5be4433372"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTUtMS0xLTA_fd8f0b5e-3919-4188-a448-6bbe6f9716ac"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTUtMS0xLTA_fd8f0b5e-3919-4188-a448-6bbe6f9716ac"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTUtMS0xLTA_2f2dd26c-e7f9-4dda-9316-d5984a87a00a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTUtMS0xLTA_2f2dd26c-e7f9-4dda-9316-d5984a87a00a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNS0xLTEtMA_d59bffe9-db14-4325-ad7d-ad2ea667f60f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNS0xLTEtMA_d59bffe9-db14-4325-ad7d-ad2ea667f60f"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Treasury shares include 1 million shares held in trust for each of the years ended December 31, 2020, 2019 and 2018. Treasury stock includes $29 million related to shares held in trust for each of the years ended December 31, 2020, 2019 and 2018. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTUtMS0xLTA_2e6555ea-9d89-4f6a-9188-aec0ac5db97e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTItMS0xLTA_2435051f-4ce3-42cb-9703-f4ace175a146"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI1LTItMS0xLTA_9b8cebe1-0b8a-4e47-b179-f53a706dfa00"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctMi0xLTEtMA_7e7fe2a3-8e1a-42e9-8ece-9da8b40d2dee"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTItMS0xLTA_eb3c5e68-7726-4b79-b649-2ab124a852a1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTItMS0xLTA_2514b134-4d79-4553-bfd8-476a7b592485"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtMi0xLTEtMA_bd15f8ed-fb13-4a71-9515-093b89ab0d04"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzctNS0xLTEtMA_065a8a3f-8af2-4885-a8c1-8ca7428e8223"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTUtMS0xLTA_1621828b-14e0-446f-a93d-fbdd43a45fa7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTItMS0xLTA_db94551e-003e-40b1-974c-609d700a26b3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTUtMS0xLTA_7ff7c6fa-bb8f-45ab-b419-bb5be4433372"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTUtMS0xLTA_fd8f0b5e-3919-4188-a448-6bbe6f9716ac"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE2LTUtMS0xLTA_2f2dd26c-e7f9-4dda-9316-d5984a87a00a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNS0xLTEtMA_d59bffe9-db14-4325-ad7d-ad2ea667f60f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzM_31160ea5-6d2c-45c8-9a99-af0ebb300cb8"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTYtMS0xLTA_31eb6726-7a91-438f-87a5-53f124c07aa8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTYtMS0xLTA_31eb6726-7a91-438f-87a5-53f124c07aa8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzIxOTkwMjMyNTc1NjU_31eb6726-7a91-438f-87a5-53f124c07aa8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzIxOTkwMjMyNTc1NjU_31eb6726-7a91-438f-87a5-53f124c07aa8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTEwLTEtMS0w_01bbd745-65a4-4dca-9dbe-9b32284c852d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTEwLTEtMS0w_01bbd745-65a4-4dca-9dbe-9b32284c852d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTgtMS0xLTA_f472468a-9d67-42d2-bc8d-2f8e09cf383e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTgtMS0xLTA_f472468a-9d67-42d2-bc8d-2f8e09cf383e"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzI_0e9483fe-dba2-4c15-a9ca-3961fe592c5e" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzI_0e9483fe-dba2-4c15-a9ca-3961fe592c5e" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09, </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, which resulted in a reduction to retained earnings of $13 million and the adoption of ASU 2018-02, </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, which resulted in a reduction to accumulated other comprehensive income of $7 million and an increase to retained earnings of $7 million, each during the year ended December 31, 2018.</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of ASU 2016-02, </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 842), which resulted in an increase to retained earnings of $178 million during the year ended December 31, 2019.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTYtMS0xLTA_31eb6726-7a91-438f-87a5-53f124c07aa8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzI_0e9483fe-dba2-4c15-a9ca-3961fe592c5e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzIxOTkwMjMyNTc1NjU_31eb6726-7a91-438f-87a5-53f124c07aa8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzI_0e9483fe-dba2-4c15-a9ca-3961fe592c5e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTEwLTEtMS0w_01bbd745-65a4-4dca-9dbe-9b32284c852d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzI_0e9483fe-dba2-4c15-a9ca-3961fe592c5e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzExLTgtMS0xLTA_f472468a-9d67-42d2-bc8d-2f8e09cf383e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzI_0e9483fe-dba2-4c15-a9ca-3961fe592c5e"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTQtMS0xLTA_5a2c956a-7097-44be-a189-7313063ea5ee"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTQtMS0xLTA_5a2c956a-7097-44be-a189-7313063ea5ee"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTQtMS0xLTA_f68504a9-4624-4e2a-a2d6-ed8227e1917d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTQtMS0xLTA_f68504a9-4624-4e2a-a2d6-ed8227e1917d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTQtMS0xLTA_257c52a8-5b09-4880-9f25-4b0697e3ff7e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTQtMS0xLTA_257c52a8-5b09-4880-9f25-4b0697e3ff7e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTQtMS0xLTA_54335d89-aefe-4dc2-abf8-9c0a58c71b35"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTQtMS0xLTA_54335d89-aefe-4dc2-abf8-9c0a58c71b35"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNC0xLTEtMA_16e4fa08-10b4-4101-b231-c5805bb1fb2a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNC0xLTEtMA_16e4fa08-10b4-4101-b231-c5805bb1fb2a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTQtMS0xLTA_01d38a2b-d2f4-401a-a290-0c4d6573dc03"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTQtMS0xLTA_01d38a2b-d2f4-401a-a290-0c4d6573dc03"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzYtNC0xLTEtMA_04f10832-781d-4849-96a6-73e822af4437"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzYtNC0xLTEtMA_04f10832-781d-4849-96a6-73e822af4437"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzE_a591683a-1aec-44ff-a7e0-6cf45389822a" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzE_a591683a-1aec-44ff-a7e0-6cf45389822a" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock and capital surplus includes the par value of common stock of $17 million as of December 31, 2020, 2019 and 2018.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzE1LTQtMS0xLTA_5a2c956a-7097-44be-a189-7313063ea5ee"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzE_a591683a-1aec-44ff-a7e0-6cf45389822a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzIwLTQtMS0xLTA_f68504a9-4624-4e2a-a2d6-ed8227e1917d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzE_a591683a-1aec-44ff-a7e0-6cf45389822a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI0LTQtMS0xLTA_257c52a8-5b09-4880-9f25-4b0697e3ff7e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzE_a591683a-1aec-44ff-a7e0-6cf45389822a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzEwLTQtMS0xLTA_54335d89-aefe-4dc2-abf8-9c0a58c71b35"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzE_a591683a-1aec-44ff-a7e0-6cf45389822a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzMtNC0xLTEtMA_16e4fa08-10b4-4101-b231-c5805bb1fb2a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzE_a591683a-1aec-44ff-a7e0-6cf45389822a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzI4LTQtMS0xLTA_01d38a2b-d2f4-401a-a290-0c4d6573dc03"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzE_a591683a-1aec-44ff-a7e0-6cf45389822a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90YWJsZTo2YzBjMjEwNGJkNWQ0ZjRjYmYwYzg0NjY2OTdlMDI2Ny90YWJsZXJhbmdlOjZjMGMyMTA0YmQ1ZDRmNGNiZjBjODQ2NjY5N2UwMjY3XzYtNC0xLTEtMA_04f10832-781d-4849-96a6-73e822af4437"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMTIvZnJhZzo1Y2I0NjYxNDFhZWI0NTZkOWYwZjVmYjRiMDMxYTUyOC90ZXh0cmVnaW9uOjVjYjQ2NjE0MWFlYjQ1NmQ5ZjBmNWZiNGIwMzFhNTI4XzExMzE_a591683a-1aec-44ff-a7e0-6cf45389822a"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217395757736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 08, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,719,366,378<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,311,354,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following materials are incorporated by reference into this Form 10-K:</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information contained in the definitive proxy statement for CVS Health Corporation&#8217;s 2021 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year ended December 31, 2020 (the &#8220;Proxy Statement&#8221;), is incorporated by reference in Parts III and IV to the extent described therein.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217389920728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 69,364,000,000<span></span>
</td>
<td class="nump">$ 63,122,000,000<span></span>
</td>
<td class="nump">$ 8,184,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">798,000,000<span></span>
</td>
<td class="nump">1,011,000,000<span></span>
</td>
<td class="nump">660,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">268,706,000,000<span></span>
</td>
<td class="nump">256,776,000,000<span></span>
</td>
<td class="nump">194,579,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">163,981,000,000<span></span>
</td>
<td class="nump">158,719,000,000<span></span>
</td>
<td class="nump">156,447,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="nump">55,679,000,000<span></span>
</td>
<td class="nump">52,529,000,000<span></span>
</td>
<td class="nump">6,594,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,149,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OperatingExpensesExcludingGoodwillImpairments', window );">Operating expenses</a></td>
<td class="nump">35,135,000,000<span></span>
</td>
<td class="nump">33,541,000,000<span></span>
</td>
<td class="nump">21,368,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">254,795,000,000<span></span>
</td>
<td class="nump">244,789,000,000<span></span>
</td>
<td class="nump">190,558,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">13,911,000,000<span></span>
</td>
<td class="nump">11,987,000,000<span></span>
</td>
<td class="nump">4,021,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">2,907,000,000<span></span>
</td>
<td class="nump">3,035,000,000<span></span>
</td>
<td class="nump">2,619,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">1,440,000,000<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="num">(206,000,000)<span></span>
</td>
<td class="num">(124,000,000)<span></span>
</td>
<td class="num">(4,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax provision</a></td>
<td class="nump">9,770,000,000<span></span>
</td>
<td class="nump">8,997,000,000<span></span>
</td>
<td class="nump">1,406,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">2,569,000,000<span></span>
</td>
<td class="nump">2,366,000,000<span></span>
</td>
<td class="nump">2,002,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">7,201,000,000<span></span>
</td>
<td class="nump">6,631,000,000<span></span>
</td>
<td class="num">(596,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">7,192,000,000<span></span>
</td>
<td class="nump">6,631,000,000<span></span>
</td>
<td class="num">(596,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="num">(13,000,000)<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to CVS Health</a></td>
<td class="nump">$ 7,179,000,000<span></span>
</td>
<td class="nump">$ 6,634,000,000<span></span>
</td>
<td class="num">$ (594,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income (loss) from continuing operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 5.49<span></span>
</td>
<td class="nump">$ 5.10<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare', window );">Loss from discontinued operations attributable to CVS Health (in dollars per share)</a></td>
<td class="num">(0.01)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 5.48<span></span>
</td>
<td class="nump">$ 5.10<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic shares outstanding (in shares)</a></td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">1,301<span></span>
</td>
<td class="nump">1,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income (loss) from continuing operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 5.47<span></span>
</td>
<td class="nump">$ 5.08<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Loss from discontinued operations attributable to CVS Health (in dollars per share)</a></td>
<td class="num">(0.01)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 5.46<span></span>
</td>
<td class="nump">$ 5.08<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted shares outstanding (in shares)</a></td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">1,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible List]</a></td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services</a></td>
<td class="nump">$ 190,688,000,000<span></span>
</td>
<td class="nump">$ 185,236,000,000<span></span>
</td>
<td class="nump">$ 183,910,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Products and Services</a></td>
<td class="nump">$ 7,856,000,000<span></span>
</td>
<td class="nump">$ 7,407,000,000<span></span>
</td>
<td class="nump">$ 1,825,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingExpensesExcludingGoodwillImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses, Excluding Goodwill Impairments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingExpensesExcludingGoodwillImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121551570&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217384936328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 7,192<span></span>
</td>
<td class="nump">$ 6,631<span></span>
</td>
<td class="num">$ (596)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized investment gains</a></td>
<td class="nump">440<span></span>
</td>
<td class="nump">677<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net cash flow hedges</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="nump">330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and other postretirement benefits</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">395<span></span>
</td>
<td class="nump">917<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">7,587<span></span>
</td>
<td class="nump">7,548<span></span>
</td>
<td class="num">(322)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Comprehensive (income) loss attributable to noncontrolling interests</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss) attributable to CVS Health</a></td>
<td class="nump">$ 7,574<span></span>
</td>
<td class="nump">$ 7,551<span></span>
</td>
<td class="num">$ (320)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217390072824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7,854.0<span></span>
</td>
<td class="nump">$ 5,683.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">3,000.0<span></span>
</td>
<td class="nump">2,373.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">21,742.0<span></span>
</td>
<td class="nump">19,617.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">18,496.0<span></span>
</td>
<td class="nump">17,516.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,277.0<span></span>
</td>
<td class="nump">5,113.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">56,369.0<span></span>
</td>
<td class="nump">50,302.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">20,812.0<span></span>
</td>
<td class="nump">17,314.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,606.0<span></span>
</td>
<td class="nump">12,044.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">20,729.0<span></span>
</td>
<td class="nump">20,860.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">79,552.0<span></span>
</td>
<td class="nump">79,749.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">31,142.0<span></span>
</td>
<td class="nump">33,121.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,881.0<span></span>
</td>
<td class="nump">4,459.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">4,624.0<span></span>
</td>
<td class="nump">4,600.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">230,715.0<span></span>
</td>
<td class="nump">222,449.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">11,138.0<span></span>
</td>
<td class="nump">10,492.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PharmacyClaimsandDiscountsPayableCurrent', window );">Pharmacy claims and discounts payable</a></td>
<td class="nump">15,795.0<span></span>
</td>
<td class="nump">13,601.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable</a></td>
<td class="nump">7,936.0<span></span>
</td>
<td class="nump">6,879.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPolicyholderFunds', window );">Policyholders&#8217; funds</a></td>
<td class="nump">4,270.0<span></span>
</td>
<td class="nump">2,991.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">14,243.0<span></span>
</td>
<td class="nump">12,133.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="nump">1,557.0<span></span>
</td>
<td class="nump">1,830.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,638.0<span></span>
</td>
<td class="nump">1,596.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">5,440.0<span></span>
</td>
<td class="nump">3,781.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">62,017.0<span></span>
</td>
<td class="nump">53,303.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">18,757.0<span></span>
</td>
<td class="nump">18,926.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">59,207.0<span></span>
</td>
<td class="nump">64,699.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">6,794.0<span></span>
</td>
<td class="nump">7,294.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="nump">4,881.0<span></span>
</td>
<td class="nump">4,459.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="nump">7,007.0<span></span>
</td>
<td class="nump">7,436.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">2,351.0<span></span>
</td>
<td class="nump">2,162.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">161,014.0<span></span>
</td>
<td class="nump">158,279.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital', window );">Common stock, par value $0.01: 3,200 shares authorized; 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus</a></td>
<td class="nump">46,513.0<span></span>
</td>
<td class="nump">45,972.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost: 423 and 425 shares at December 31, 2020 and 2019</a></td>
<td class="num">(28,178.0)<span></span>
</td>
<td class="num">(28,235.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">49,640.0<span></span>
</td>
<td class="nump">45,108.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">1,414.0<span></span>
</td>
<td class="nump">1,019.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="nump">69,389.0<span></span>
</td>
<td class="nump">63,864.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">312.0<span></span>
</td>
<td class="nump">306.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">69,701.0<span></span>
</td>
<td class="nump">64,170.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 230,715.0<span></span>
</td>
<td class="nump">$ 222,449.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PharmacyClaimsandDiscountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Claims and Discounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PharmacyClaimsandDiscountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of par value plus amounts in excess of par value or issuance value for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStocksIncludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPolicyholderFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPolicyholderFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641442&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121638699&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641442&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=121638699&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641442&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217398034504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">3,200,000,000<span></span>
</td>
<td class="nump">3,200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">1,733,000,000<span></span>
</td>
<td class="nump">1,727,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">1,310,000,000<span></span>
</td>
<td class="nump">1,302,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">423,000,000<span></span>
</td>
<td class="nump">425,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217394277784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCustomers', window );">Cash receipts from customers</a></td>
<td class="nump">$ 264,327,000,000<span></span>
</td>
<td class="nump">$ 248,393,000,000<span></span>
</td>
<td class="nump">$ 186,519,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies', window );">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</a></td>
<td class="num">(158,636,000,000)<span></span>
</td>
<td class="num">(149,655,000,000)<span></span>
</td>
<td class="num">(148,981,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsforInsuranceBenefits', window );">Insurance benefits paid</a></td>
<td class="num">(55,124,000,000)<span></span>
</td>
<td class="num">(52,242,000,000)<span></span>
</td>
<td class="num">(6,897,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToSuppliersAndEmployees', window );">Cash paid to other suppliers and employees</a></td>
<td class="num">(29,763,000,000)<span></span>
</td>
<td class="num">(28,932,000,000)<span></span>
</td>
<td class="num">(17,234,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromInterestAndDividendsReceived', window );">Interest and investment income received</a></td>
<td class="nump">894,000,000<span></span>
</td>
<td class="nump">955,000,000<span></span>
</td>
<td class="nump">644,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="num">(2,904,000,000)<span></span>
</td>
<td class="num">(2,954,000,000)<span></span>
</td>
<td class="num">(2,803,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="num">(2,929,000,000)<span></span>
</td>
<td class="num">(2,717,000,000)<span></span>
</td>
<td class="num">(2,383,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">15,865,000,000<span></span>
</td>
<td class="nump">12,848,000,000<span></span>
</td>
<td class="nump">8,865,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturities of investments</a></td>
<td class="nump">6,467,000,000<span></span>
</td>
<td class="nump">7,049,000,000<span></span>
</td>
<td class="nump">817,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(9,639,000,000)<span></span>
</td>
<td class="num">(7,534,000,000)<span></span>
</td>
<td class="num">(692,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(2,437,000,000)<span></span>
</td>
<td class="num">(2,457,000,000)<span></span>
</td>
<td class="num">(2,037,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity', window );">Proceeds from sale-leaseback transactions</a></td>
<td class="nump">101,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions (net of cash acquired)</a></td>
<td class="num">(866,000,000)<span></span>
</td>
<td class="num">(444,000,000)<span></span>
</td>
<td class="num">(42,226,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from sale of subsidiaries and other assets</a></td>
<td class="nump">840,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">832,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">42,000,000<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(5,534,000,000)<span></span>
</td>
<td class="num">(3,339,000,000)<span></span>
</td>
<td class="num">(43,285,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net repayments of short-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(720,000,000)<span></span>
</td>
<td class="num">(556,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">9,958,000,000<span></span>
</td>
<td class="nump">3,736,000,000<span></span>
</td>
<td class="nump">44,343,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(15,631,000,000)<span></span>
</td>
<td class="num">(8,336,000,000)<span></span>
</td>
<td class="num">(5,522,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities', window );">Derivative settlements</a></td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="num">(25,000,000)<span></span>
</td>
<td class="nump">446,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(2,624,000,000)<span></span>
</td>
<td class="num">(2,603,000,000)<span></span>
</td>
<td class="num">(2,038,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">264,000,000<span></span>
</td>
<td class="nump">210,000,000<span></span>
</td>
<td class="nump">242,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes related to net share settlement of equity awards</a></td>
<td class="num">(88,000,000)<span></span>
</td>
<td class="num">(112,000,000)<span></span>
</td>
<td class="num">(97,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(27,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(8,155,000,000)<span></span>
</td>
<td class="num">(7,850,000,000)<span></span>
</td>
<td class="nump">36,819,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,000,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">2,176,000,000<span></span>
</td>
<td class="nump">1,659,000,000<span></span>
</td>
<td class="nump">2,395,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">5,954,000,000<span></span>
</td>
<td class="nump">4,295,000,000<span></span>
</td>
<td class="nump">1,900,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">8,130,000,000<span></span>
</td>
<td class="nump">5,954,000,000<span></span>
</td>
<td class="nump">4,295,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Reconciliation of net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">7,192,000,000<span></span>
</td>
<td class="nump">6,631,000,000<span></span>
</td>
<td class="num">(596,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Reconciliation of net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,441,000,000<span></span>
</td>
<td class="nump">4,371,000,000<span></span>
</td>
<td class="nump">2,718,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,149,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">453,000,000<span></span>
</td>
<td class="nump">280,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">(Gain) loss on sale of subsidiaries</a></td>
<td class="num">(269,000,000)<span></span>
</td>
<td class="nump">205,000,000<span></span>
</td>
<td class="nump">86,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">1,440,000,000<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(570,000,000)<span></span>
</td>
<td class="num">(654,000,000)<span></span>
</td>
<td class="nump">87,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other noncash items</a></td>
<td class="nump">72,000,000<span></span>
</td>
<td class="nump">264,000,000<span></span>
</td>
<td class="nump">253,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(1,510,000,000)<span></span>
</td>
<td class="num">(2,158,000,000)<span></span>
</td>
<td class="num">(1,139,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(973,000,000)<span></span>
</td>
<td class="num">(1,075,000,000)<span></span>
</td>
<td class="num">(1,153,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">364,000,000<span></span>
</td>
<td class="num">(614,000,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable and pharmacy claims and discounts payable</a></td>
<td class="nump">2,769,000,000<span></span>
</td>
<td class="nump">3,550,000,000<span></span>
</td>
<td class="nump">2,329,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="num">(231,000,000)<span></span>
</td>
<td class="nump">320,000,000<span></span>
</td>
<td class="num">(311,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">2,740,000,000<span></span>
</td>
<td class="nump">1,476,000,000<span></span>
</td>
<td class="nump">165,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">$ 15,865,000,000<span></span>
</td>
<td class="nump">$ 12,848,000,000<span></span>
</td>
<td class="nump">$ 8,865,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsforInsuranceBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Insurance Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsforInsuranceBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToSuppliersAndEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to suppliers for goods and services provided and to employees for services provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToSuppliersAndEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash receipts from customers during the current period which are usually for sales of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInterestAndDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for dividends and interest on the entity's equity and debt investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3337-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInterestAndDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from principal payment received from sales-type and direct financing leases classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 230<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121551529&amp;loc=SL120154370-112784<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217390269272">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th" colspan="2"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Shares</div></th>
<th class="th" colspan="2"><div>Treasury Shares</div></th>
<th class="th" colspan="2"><div>Common Stock and Capital Surplus</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th" colspan="2">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th">
<div>Accumulated Other Comprehensive Income (Loss) </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Total CVS Health Shareholders' Equity</div></th>
<th class="th" colspan="2">
<div>Total CVS Health Shareholders' Equity </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2017</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,712<span></span>
</td>
<td class="num">(698)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance at Dec. 31, 2017</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 37,695<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (37,796)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 32,096<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 43,556<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (165)<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
<td class="nump">$ 37,691<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(596)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(594)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(594)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (Note 13)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Common shares issued to acquire Aetna (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Common shares issued to acquire Aetna</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,561<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">421<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,045)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,045)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,045)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisition of noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other decreases in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2018</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,720<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance at Dec. 31, 2018</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 58,543<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,228)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">45,440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">40,911<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,225<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">us-gaap:AccountingStandardsUpdate201602Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (Note 13)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">532<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other decreases in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,727<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 64,170<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">45,972<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">45,108<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,864<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 7,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (Note 13)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">541<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other decreases in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,733<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 69,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,178)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 46,513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 49,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 312<span></span>
</td>
</tr>
<tr><td colspan="18"></td></tr>
<tr><td colspan="18"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Treasury shares include 1 million shares held in trust for each of the years ended December 31, 2020, 2019 and 2018. Treasury stock includes $29 million related to shares held in trust for each of the years ended December 31, 2020, 2019 and 2018. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Common stock and capital surplus includes the par value of common stock of $17 million as of December 31, 2020, 2019 and 2018.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, which resulted in a reduction to retained earnings of $13 million and the adoption of ASU 2018-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, which resulted in a reduction to accumulated other comprehensive income of $7 million and an increase to retained earnings of $7 million, each during the year ended December 31, 2018.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 842), which resulted in an increase to retained earnings of $178 million during the year ended December 31, 2019.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling interest, Other Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217396829448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity (Parentheticals) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesHeldinTrust', window );">Treasury shares held in trust (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueSharesHeldInTrust', window );">Treasury shares held in trust</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="nump">64,170<span></span>
</td>
<td class="nump">$ 58,543<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 37,695<span></span>
</td>
<td class="nump">69,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Decrease to accumulated other comprehensive income</a></td>
<td class="num">(1,019)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,414)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Increase to retained earnings</a></td>
<td class="nump">$ 45,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">us-gaap:AccountingStandardsUpdate201613Member<span></span>
</td>
<td class="text">us-gaap:AccountingStandardsUpdate201602Member<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member', window );">Accounting Standards Update 2014-09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">us-gaap:AccountingStandardsUpdate201409Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201802Member', window );">Accounting Standards Update 2018-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Decrease to accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Increase to retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">us-gaap:AccountingStandardsUpdate201802Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="nump">$ 45,108<span></span>
</td>
<td class="nump">$ 40,911<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 43,556<span></span>
</td>
<td class="nump">$ 49,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings | Accounting Standards Update 2018-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2014-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, which resulted in a reduction to retained earnings of $13 million and the adoption of ASU 2018-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">, which resulted in a reduction to accumulated other comprehensive income of $7 million and an increase to retained earnings of $7 million, each during the year ended December 31, 2018.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 842), which resulted in an increase to retained earnings of $178 million during the year ended December 31, 2019.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesHeldinTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Held in Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesHeldinTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueSharesHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Shares Held In Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueSharesHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201802Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201802Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388662184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company&#8221;), has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 105 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. The Company also serves an estimated 34 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic has severely impacted the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition in the year ended December 31, 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2018 (the &#8220;Aetna Acquisition Date&#8221;), the Company acquired Aetna Inc. (&#8220;Aetna&#8221;). As a result of the acquisition of Aetna (the &#8220;Aetna Acquisition&#8221;), the Company added the Health Care Benefits segment. Certain aspects of Aetna&#8217;s operations, including products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products, are included in the Company&#8217;s Corporate/Other segment. The consolidated financial statements reflect Aetna&#8217;s results subsequent to the Aetna Acquisition Date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other, which are described below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#8220;Public Exchanges&#8221;) and private health insurance exchanges and other sponsors of health benefit plans throughout the United States. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2020, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; For periods prior to the Aetna Acquisition Date, the Health Care Benefits segment was comprised only of the Company&#8217;s SilverScript</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> PDP business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash included in other current assets on the consolidated balance sheets represents amounts held in escrow accounts in connection with certain recent acquisitions. Restricted cash included in other assets on the consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,130&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,954&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,295&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; for additional information on how the Company estimates the fair value of these investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#8217;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist primarily of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#8217;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#8217;s investments through its review or prior to receiving the limited partnership&#8217;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using a discounted future cash flow analysis in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment income on the Company&#8217;s investments is recorded when earned and is reflected in the Company&#8217;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#8217; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#8217;s net income (as long as the contract&#8217;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#8217; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#8217; accounts through a charge to benefit costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#8217; equity, net of tax, as a component of accumulated other comprehensive income. Unrealized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net is composed of the following at December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,617&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $358&#160;million as of December&#160;31, 2020. When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days. The Company&#8217;s allowance for doubtful accounts was $319&#160;million as of December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance Recoverables </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2020, the Company&#8217;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Contract Acquisition Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance products included in the Health Care Benefits segment are cancelable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. Acquisition costs for certain long-duration insurance contracts are deferred and are recorded as other current assets or other assets on the consolidated balance sheets and are amortized over the estimated life of the contracts. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations. At December&#160;31, 2020 and 2019, the balance of deferred acquisition costs was $546 million and $271 million, respectively, comprised primarily of commissions paid on Medicare Supplement products within the Health Care Benefits segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 1 to 40 years for buildings, building improvements and leasehold improvements and 3 to 10 years for fixtures, equipment and internally developed </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consists of the following at December&#160;31, 2020 and 2019: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,934&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,700)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,044&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense (which includes the amortization of property and equipment under finance or capital leases) totaled $2.1 billion, $1.9 billion and $1.7 billion for the years ended December&#160;31, 2020, 2019 and 2018, respectively. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about finance leases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right-of-Use Assets and Lease Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#8217;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about right-of-use assets and lease liabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently if necessary, as further described below. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about goodwill. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#8220;VOBA&#8221;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Other than VOBA, definite-lived intangible assets are amortized using the straight-line method. VOBA is amortized over the expected life of the acquired contracts in proportion to estimated premiums. Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently if necessary, as further described in &#8220;Long-Lived Asset Impairment&#8221; below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about intangible assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Asset Impairment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted and without interest charges). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the asset group&#8217;s carrying value that exceeds the asset group&#8217;s estimated future cash flows (discounted and with interest charges). There were no material impairment charges recognized on long-lived assets in the year ended December&#160;31, 2020. During the year ended December 31, 2019, the Company recorded store rationalization charges of $231 million, primarily related to operating lease right-of-use asset impairment charges. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about the right-of-use asset impairment charges. During the year ended December 31, 2018, the Company recognized a $43 million long-lived asset impairment charge, primarily related to the impairment of property and equipment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of both 2020 and 2019, the Company performed its required annual goodwill impairment tests and concluded there were no goodwill impairments as of the testing dates or during the years ended December&#160;31, 2020 and 2019. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about goodwill impairment charges recorded during the year ended December 31, 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value. There were no impairment losses recognized on indefinite-lived intangible assets in any of the years ended December&#160;31, 2020, 2019 or 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Costs Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#8217;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#8220;IBNR&#8221;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#8217;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of IBNR in 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#8220;completion factors.&#8221; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within six months of the date of service, but it can take up to 48 months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#8217;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#8217;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#8217;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#8217;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#8217;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#8217;s business. The health status of the Company&#8217;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#8217;s health care cost trend rate.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2020; however, actual claim payments may differ from the Company&#8217;s estimates. A worsening (or improvement) of the Company&#8217;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2020 would cause these estimates to change in the near term, and such a change could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#8217;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#8217;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#8217;s health care costs payable, see Note 7 &#8216;&#8216;Health Care Costs Payable.&#8217;&#8217; The Company&#8217;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Insurance Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unpaid Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#8217;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#8217;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#8217;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#8217;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of unpaid claims IBNR in 2020. As of December&#160;31, 2020, unpaid claims balances of $532 million and $1.5 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2019, unpaid claims balances of $704 million and $1.8 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Policy Benefits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits consist primarily of reserves for limited payment pension and annuity contracts and long-term care insurance contracts. Reserves for limited payment pension and annuity contracts are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality, retirement, expense and interest rate experience. Such assumptions generally vary by plan, year of issue and policy duration. Assumed interest rates on such contracts ranged from 3.3% to 11.3% in the year ended December 31, 2020 and from 3.5% to 11.3% in the year ended December 31, 2019. The Company periodically reviews mortality assumptions against both industry standards and its experience. Reserves for long-duration long-term care contracts represent the Company&#8217;s estimate of the present value of future benefits to be paid to or on behalf of policyholders less the present value of future net premiums. The assumed interest rate on such contracts was 5.1% in both the years ended December 31, 2020 and 2019. The Company&#8217;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity and interest rate assumptions. As of December&#160;31, 2020, future policy benefits </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">balances of $462 million and $5.5 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2019, future policy benefits balances of $508 million and $5.6 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Premium Deficiency Reserves</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is considered in the calculation of premium deficiency losses for short-duration contracts. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#8217;s method of acquiring, servicing and measuring the profitability of such contracts. As of December&#160;31, 2020 and 2019, the Company established a premium deficiency reserve of $11 million and $4 million, respectively, related to Medicaid products in the Health Care Benefits segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policyholders&#8217; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus  interest credited thereon, net of experience-rated adjustments. In 2020, interest rates for pension and annuity investment contracts ranged from 4.1% to 5.1%. In 2019, interest rates for pension and annuity investment contracts ranged from 3.5% to 5.2%. Reserves for contracts subject to experience rating reflect the Company&#8217;s rights as well as the rights of policyholders and plan participants. The Company also holds funds for health savings accounts (&#8220;HSAs&#8221;) on behalf of members associated with high deductible health plans. These amounts are held to pay for qualified health care expenses incurred by these members. The HSA balances were approximately $2.7 billion and $2.2 billion at December&#160;31, 2020 and 2019, respectively, and are reflected in other current assets with a corresponding liability in policyholders&#8217; funds. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policyholders&#8217; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#8217; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Self-Insurance Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is self-insured for certain losses related to general liability, workers&#8217; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#8217;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#8217;s historical claims experience. At December&#160;31, 2020 and 2019, self-insurance liabilities totaled $927 million and $856 million, respectively, and were recorded as accrued expenses on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses from foreign currency transactions and the effects of foreign currency remeasurements were not material in the years ended December&#160;31, 2020 or 2018. On July 1, 2019, the Company sold its Brazilian subsidiary, Drogaria Onofre Ltda. (&#8220;Onofre&#8221;) for an immaterial amount. The Company recorded a loss on the divestiture, which included the elimination of the subsidiary&#8217;s $154 million cumulative translation adjustment from accumulated other comprehensive income during the year ended December 31, 2019.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment sells prescription drugs directly through its mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network. The Company&#8217;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the dispensing of prescription drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions dispensed indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#8220;Drug Discounts&#8221; and &#8220;Guarantees&#8221; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#8220;retail co-payments&#8221;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Pharmacy Services segment:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by mail service dispensing pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by third party pharmacies in the Company&#8217;s retail pharmacy network and associated administrative fees are recognized at the Company&#8217;s point-of-sale, which is when the claim is adjudicated by the Company&#8217;s online claims processing system and the Company has transferred control of the prescription drug and performed all of its performance obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Drug Discounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue net of manufacturers&#8217; rebates earned by its clients based on their plan members&#8217; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#8217; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#8217; rebate amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retail Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer returns are not material to the Company&#8217;s operating results or financial condition. Sales taxes are not included in revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loyalty and Other Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer loyalty program, ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consists of two components, ExtraSavings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-term Care</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of Long-term Care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#8217;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-In Medical Clinics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided by the Company&#8217;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which reflect contracted rates per employee and the number of covered employees </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded in the Company&#8217;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Premium Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#8220;MLR&#8221;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#8220;ACA&#8221;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#8217;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#8217;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#8217;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Medicare Part D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include insurance premiums earned by the Company&#8217;s PDPs, which are determined based on the PDP&#8217;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.334%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">171,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">140,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41,413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">165,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1) </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">52,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">134,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">64,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">164,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">134,736&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">83,989&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,714)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">194,579&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">134,736&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">program. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Certain prior year amounts have been reclassified for consistency with the current period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020 and 2019, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for cost of products sold as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#8217;s mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network, (ii) shipping and handling costs, and (iii) the operating costs of the Company&#8217;s mail service dispensing pharmacies and client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#8217; benefit plans from the Company&#8217;s mail service dispensing pharmacies, net of any volume-related or other discounts (see &#8220;Vendor Allowances and Purchase Discounts&#8221; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#8217;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold includes: the cost of merchandise sold during the reporting period, including prescription drug costs, and the related purchasing costs, warehousing and delivery costs (including depreciation and amortization) and actual and estimated inventory losses. </span></div><div><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vendor Allowances and Purchase Discounts </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for vendor allowances and purchase discounts as follows: </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#8217;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Pharmacy Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vendor allowances received by the Retail/LTC segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon purchase volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#8217;s consolidated financial statements in any of the periods presented. </span></div><div><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurer Fee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2014, the ACA has imposed an annual premium-based health insurer fee (&#8220;HIF&#8221;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company has been required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In the years ended December&#160;31, 2020 and 2018, operating expenses included $1.0 billion and $157 million, respectively, related to the Company&#8217;s share of the HIF. There was no expense related to the HIF in 2019, since there was a one-year suspension of the HIF for 2019. In December 2019, the HIF was repealed for calendar years after 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#8217;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Corridor</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) based on their ratio of allowable costs to target costs (as defined by the ACA). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company received the $313&#160;million it was owed under the ACA&#8217;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December&#160;31, 2020. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $307 million and after-tax income of $223&#160;million during the year ended December&#160;31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2019, the Company did not record any ACA risk corridor receivables because payment was uncertain.</span></div><div><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $461 million, $396 million and $364 million in 2020, 2019 and 2018, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2OTY1ODE1NjM0NzI_a2f5f276-1187-4a37-84f0-e7ca761d6280">three</span> to five years) using the straight-line method. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Tax Cuts and Jobs Act (the &#8220;TCJA&#8221;) was enacted on December 22, 2017. Among numerous changes to existing tax laws, the TCJA permanently reduced the federal corporate income tax rate from 35% to 21% effective January 1, 2018. The effects of changes in tax rates on deferred tax balances are required to be taken into consideration in the period in which the changes are enacted, regardless of when they are effective. As</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a result of the reduction of the corporate income tax rate under the TCJA, the Company estimated the revaluation of its net deferred tax liabilities and recorded a provisional income tax benefit of approximately $1.5&#160;billion for year ended December 31, 2017. In 2018, the Company completed its process of determining the TCJA&#8217;s final impact and recorded an additional income tax benefit of $100 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#8217;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors defined benefit pension plans (&#8220;pension plans&#8221;) and other postretirement employee benefit plans (&#8220;OPEB plans&#8221;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit cost (income) for the Company&#8217;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit cost (income) are included in other income in the consolidated statements of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings (Loss) per Common Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (loss) per share is computed using the two-class method. The Company calculates basic earnings (loss) per share based on the weighted average number of common shares outstanding for the period. See Note 14 &#8216;&#8216;Earnings (Loss) Per Share&#8217;&#8217; for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares Held in Trust</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains grantor trusts, which held approximately one million shares of its common stock at both December&#160;31, 2020 and 2019. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Primary Beneficiary</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company and Cardinal Health, Inc. (&#8220;Cardinal&#8221;) established Red Oak Sourcing, LLC (&#8220;Red Oak&#8221;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own 50%. The Red Oak arrangement has an initial term of 10 years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Retail/LTC segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal is required to pay the Company 39 quarterly payments beginning in October 2014. As milestones are met, the quarterly payments increase. The Company received from Cardinal $183 million during each of the years ended December&#160;31, 2020, 2019 and 2018. The payments reduce the Company&#8217;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold. Revenues associated with Red Oak expenses reimbursed by Cardinal for the years ended December&#160;31, 2020, 2019 and 2018, and amounts due to or due from Cardinal at December&#160;31, 2020 and 2019 were immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Other Variable Interest Holder</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hedge fund and private equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Real estate partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not the primary beneficiary of these VIEs because the nature of the Company&#8217;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#8217;s income or losses in net income (loss).&#160;The Company&#8217;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total amount of other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2020 and 2019 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge fund investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate partnerships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $56 million, $32 million and $45 million in the years ended December&#160;31, 2020, 2019 and 2018, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $77 million, $96 million and $135 million for pharmaceutical inventory purchases during the years ended December&#160;31, 2020, 2019 and 2018, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020 and 2019, the Company made charitable contributions of&#160;$50&#160;million and $30 million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2020 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#8216;n Things and Bob&#8217;s Stores, each of which subsequently filed for bankruptcy. The Company&#8217;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees. See &#8220;Lease Guarantees&#8221; in Note 16 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the results of discontinued operations for the year ended December&#160;31, 2020. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results from discontinued operations were immaterial for the years ended December 31, 2019 and 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 326). This standard requires the use of a forward-looking expected credit loss impairment model for trade and other receivables, held-to-maturity debt securities, loans and other instruments. This standard also requires impairments and recoveries for available-for-sale debt securities to be recorded through an allowance account and revises certain disclosure requirements. The Company adopted this new accounting standard on January 1, 2020. The Company adopted the credit loss impairment model on a modified retrospective basis and recorded a $3 million cumulative effect adjustment to reduce retained earnings as of the adoption date. The Company adopted the available-for-sale debt security impairment model on a prospective </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and other - Internal-Use Software </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 350-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This standard requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in Topic 350-40 to determine which implementation costs to capitalize as assets. The Company adopted this new accounting guidance on January 1, 2020 on a prospective basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#8217;s consolidated operating results, cash flows, financial condition and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217387926456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Acquisitions and Divestitures</a></td>
<td class="text">Acquisitions and Divestitures <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition of Aetna</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the Aetna Acquisition Date, the Company acquired 100% of the outstanding shares and voting interests of Aetna for a combination of cash and stock. Under the terms of the merger agreement, Aetna shareholders received $145.00 in cash and 0.8378 CVS Health shares for each Aetna share. The transaction valued Aetna at approximately $212 per share or approximately $70 billion. Including the assumption of Aetna&#8217;s debt, the total value of the transaction was approximately $78 billion. The Company financed the cash portion of the purchase price through a combination of cash on hand and by issuing approximately $45 billion of new debt, including senior notes and term loans. The Company acquired Aetna to help improve the consumer health care experience by combining Aetna&#8217;s health care benefits products and services with CVS Health&#8217;s more than 9,900 retail locations, approximately 1,100 walk-in medical clinics and integrated pharmacy capabilities with the goal of becoming the new, trusted front door to health care.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction has been accounted for using the acquisition method of accounting which requires, among other things, the assets acquired and liabilities assumed to be recognized at their fair values at the date of acquisition. The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.988%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments (current and long-term)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,112&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt (current and long-term)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s assessment of the fair value of assets acquired and liabilities assumed was finalized during the fourth quarter of 2019. Measurement period adjustments to assets acquired and liabilities assumed during the&#160;year ended&#160;December 31, 2019&#160;primarily were due to additional information received related to certain intangible asset valuations and contingencies and the related impact on the accounting for income taxes and goodwill. There were no material income statement measurement period adjustments recorded during the&#160;year ended&#160;December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated operating results for the year ended December&#160;31, 2018, included $5.6 billion of revenues and $146 million of income before income tax provision associated with the operating results of Aetna from the Aetna Acquisition Date to December&#160;31, 2018. During the year ended December 31, 2018, the Company incurred transaction costs of $147 million associated with the Aetna Acquisition that were recorded within operating expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma information presents a summary of the Company&#8217;s combined operating results for the year ended December&#160;31, 2018 as if the Aetna acquisition and the related financing transactions had occurred on January 1, 2018. The following pro forma financial information is not necessarily indicative of the Company&#8217;s operating results as they would have been had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including differences between the assumptions used to prepare the pro forma financial information, basic shares outstanding and dilutive equivalents, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share data</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,152&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share from continuing operations attributable to CVS Health </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share from continuing operations attributable to CVS Health</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pro forma results for the year ended December&#160;31, 2018 include adjustments related to the following purchase accounting and acquisition-related items:</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elimination of intercompany transactions between CVS Health and Aetna;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elimination of estimated foregone interest income associated with (i) cash assumed to have been used to partially fund the Aetna Acquisition and (ii) adjusting the amortized cost of Aetna&#8217;s investment portfolio to fair value as of the completion of the Aetna Acquisition;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elimination of historical intangible asset, deferred acquisition cost and capitalized software amortization expense and addition of amortization expense based on the values of identified intangible assets;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Additional interest expense from (i) the long-term debt issued to partially fund the Aetna Acquisition and (ii) the amortization of the fair value adjustment to assumed long-term debt.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Additional depreciation expense related to the adjustment of Aetna&#8217;s property and equipment to fair value;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjustments to align CVS Health&#8217;s and Aetna&#8217;s accounting policies;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elimination of transaction related costs; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Tax effects of the adjustments noted above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Workers&#8217; Compensation Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, the Company sold its Workers&#8217; Compensation business for approximately $850&#160;million. The results of this business have historically been reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $269 million in the year ended December&#160;31, 2020, which is reflected as a reduction in operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Brazilian Subsidiary</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2019, the Company sold its Brazilian subsidiary, Onofre, for an immaterial amount. Onofre operated 50 retail pharmacy stores, the results of which historically had been reported within the Retail/LTC segment. The Company recorded a pre-tax loss on the divestiture of $205 million in the year ended December 31, 2019, which primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#8217;s consolidated statement of operations within the Retail/LTC segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of RxCrossroads Subsidiary</span></div>On January 2, 2018, the Company sold its RxCrossroads subsidiary, the results of which had historically been reported within the Retail/LTC segment, to McKesson Corporation for $725 million. The Company recorded a pre-tax loss on the divestiture of $86 million in the year ended December 31, 2018 which was reflected in operating expenses in the Company&#8217;s consolidated statement of operations within the Retail/LTC segment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217387956152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,314&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,687&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, the Company held investments of $524 million and $537 million, respectively, related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract. The conversion occurred prior to the Aetna Acquisition. These investments are included in the total investments of large case pensions supporting non-experience-rated products. Although these investments are not accounted for as Separate Accounts assets, they are legally segregated and are not subject to claims that arise out of the Company&#8217;s business and only support future policy benefits obligations under that group annuity contract. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,898&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective January 1, 2020, the Company adopted the available-for-sale debt security impairment model under ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments -Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 326). The new impairment model requires the write down of amortized cost through an allowance for credit losses, rather than through a reduction of the amortized cost basis of the available-for-sale debt security. There was no allowance for credit losses recorded on available-for-sale debt securities at December&#160;31, 2020. As the Company adopted the new available-for-sale debt security impairment model on a prospective basis, there was no allowance for credit losses recorded on available-for-sale debt securities at December 31, 2019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results.&#160;At December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses and at December&#160;31, 2019, debt securities with a fair value of $965 million, gross unrealized capital gains of $83 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at December&#160;31, 2020 are shown below by contractual maturity.&#160;&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage-Backed and Other Asset-Backed Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s residential mortgage-backed securities at December&#160;31, 2020 were issued by the Government National Mortgage Association, the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation and carry agency guarantees and explicit or implicit guarantees by the U.S. Government.&#160;At December&#160;31, 2020, the Company&#8217;s residential mortgage-backed securities had an average credit quality rating of AAA and a weighted average duration of 2.4 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States. Significant market observable inputs used to value these securities include loss severity and probability of default.&#160;At December&#160;31, 2020, these securities had an average credit quality rating of AAA and a weighted average duration of 6.1 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card receivables, home equity loans and commercial loans). Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default.&#160;At December&#160;31, 2020, these securities had an average credit quality rating of AA and a weighted average duration of 1.1 years.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at December&#160;31, 2020 and 2019 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/> Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/> Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/> Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. As of December&#160;31, 2020, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting experience-<br/>rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting remaining<br/>products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2020 and 2019, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon the Company&#8217;s assessments at December&#160;31, 2020 and 2019, the amortized cost basis of the Company&#8217;s mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 scheduled mortgage loan principal repayments were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the years ended December 31, 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital gains are net of yield-related impairment losses on debt securities of $49 million for the year ended December&#160;31, 2020. There were no credit-related losses on debt securities in the year ended December&#160;31, 2020. Net realized capital gains are net of other-than-temporary impairment (&#8220;OTTI&#8221;) losses on debt securities of $24 million for the year ended December 31, 2019. There were no material OTTI losses on debt securities for the year ended December 31, 2018.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net investment income includes $42 million, $44 million and $4 million for the years ended December 31, 2020, 2019 and 2018, respectively, related to investments supporting experience-rated products. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital gains and losses recognized during the year ended December 31, 2020 related to investments in equity securities held as of December 31, 2020 were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available for sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2020, 2019 and subsequent to the Aetna Acquisition Date in 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388157224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;In this note, the Company provides details on the fair value of financial assets and liabilities and how it determines those fair values.&#160;The Company presents this information for those financial instruments that are measured at fair value for which the change in fair value impacts net income (loss) attributable to CVS Health or other comprehensive income separately from other financial assets and liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s financial instruments are measured at fair value on the consolidated balance sheets.&#160;The fair values of these instruments are based on valuations that include inputs that can be classified within one of three levels of a hierarchy established by GAAP.&#160;&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities are classified based upon the lowest level of input that is significant to the valuation.&#160;When quoted prices in active markets for identical assets and liabilities are available, the Company uses these quoted market prices to determine the fair value of financial assets and liabilities and classifies these assets and liabilities in Level 1.&#160;In other cases where a quoted market price for identical assets and liabilities in an active market is either not available or not observable, the Company estimates fair value using valuation methodologies based on available and observable market information or by using a matrix pricing model.&#160;These financial assets and liabilities are classified in Level 2.&#160;If quoted market prices are not available, the Company determines fair value using broker quotes or an internal analysis of each investment&#8217;s financial performance and cash flow projections.&#160;Thus, financial assets and liabilities may be classified in Level 3 even though there may be some significant inputs that may be observable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the valuation methodologies used for the Company&#8217;s financial assets and liabilities that are measured at fair value, including the general classification of such assets and liabilities pursuant to the valuation hierarchy.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. When quoted prices are available in an active market, cash equivalents are classified in Level 1 of the fair value hierarchy. Fair values of cash equivalent instruments that do not trade on a regular basis in active markets are classified as Level 2.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Where quoted prices are available in an active market, debt securities are classified in Level 1 of the fair value hierarchy.&#160;The Company&#8217;s&#160;Level 1 debt securities consist primarily of U.S. Treasury securities.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s Level 2 debt securities are obtained using models, such as matrix pricing, which use quoted market prices of debt securities with similar characteristics or discounted cash flows to estimate fair value. The Company reviews these prices to ensure they are based on observable market inputs that include quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets and inputs that are observable that are not prices (such as interest rates and credit risks). The Company also reviews the methodologies and the assumptions used to calculate prices from these observable inputs. On a quarterly basis, the Company selects a sample of its Level 2 debt securities&#8217; prices and compares them to prices provided by a secondary source. Variances over a specified threshold are identified and reviewed to confirm the price provided by the primary source represents an appropriate estimate of fair value. In addition, the Company&#8217;s internal investment team consistently compares the prices obtained for select Level 2 debt securities to the team&#8217;s own independent estimates of fair value for those securities.&#160;The Company obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December&#160;31, 2020 or 2019. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also values certain debt securities using Level 3 inputs.&#160;For Level 3 debt securities, fair values are determined by outside brokers or, in the case of certain private placement securities, are priced internally.&#160;Outside brokers determine the value of these debt securities through a combination of their knowledge of the current pricing environment and market flows.&#160;The Company did not have any broker quoted debt securities for the years ended December&#160;31, 2020 and 2019. For some private placement securities, the Company&#8217;s internal staff determines the value of these debt securities by analyzing spreads of corporate and sector indices as well as interest spreads of comparable public bonds.&#160;Examples of these private placement Level 3 debt securities include certain U.S. and foreign securities and certain tax-exempt municipal securities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company currently has two classifications of equity securities:&#160;those that are publicly traded and those that are privately placed.&#160;Publicly-traded equity securities are classified in Level 1 because quoted prices are available for these securities in an active market.&#160;For privately placed equity securities, there is no active market; therefore, these securities are classified in Level 3 because the Company prices these securities through an internal analysis of each investment&#8217;s financial statements and cash flow projections. Significant unobservable inputs consist of earnings and revenue multiples, discount for lack of marketability and comparability adjustments. An increase or decrease in any of these unobservable inputs would have resulted in a change in the fair value measurement. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no financial liabilities measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2020 or 2019. Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,764&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,374&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,678&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2020 were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/> and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2020 was $4 million during the year ended December 31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers into Level 3</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers out of Level 3</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Not Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information regarding the valuation of cost method investments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Net investment income and capital gains and losses on Separate Accounts assets accrue directly to such contract holders.&#160;The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses.&#160;Deposits, withdrawals, net investment income and realized and unrealized capital gains and losses on Separate Accounts assets are not reflected in the consolidated statements of operations, shareholders&#8217; equity or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets include debt and equity securities.&#160;The valuation methodologies used for these assets are similar to the methodologies described above in this Note 4 &#8216;&#8216;Fair Value.&#8217;&#8217;&#160;Separate Accounts assets also include investments in common/collective trusts that are carried at fair value. Common/collective trusts invest in other investment funds otherwise known as the underlying funds. The Separate Accounts&#8217; interests in the common/collective trust funds are based on the fair values of the investments of the underlying funds and therefore are classified in Level 2. The assets in the underlying funds primarily consist of equity securities. Investments in common/collective trust funds are valued at their respective net asset value (&#8220;NAV&#8221;) per share/unit on the valuation date.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts financial assets at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,459&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $29 million of other receivables at December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2020 and 2019, the Company had no gross transfers of Separate Accounts financial assets into or out of Level 3.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offsetting Financial Assets and Liabilities</span></div>Certain financial assets and liabilities are offset in the Company&#8217;s consolidated balance sheets or are subject to master netting arrangements or similar agreements with the applicable counterparty. Financial assets subject to offsetting and enforceable master netting arrangements were $2 million as of December 31, 2020. Financial liabilities subject to offsetting and enforceable master netting arrangements were $3 million as of December 31, 2019.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217387909208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangibles</a></td>
<td class="text">Goodwill and Other Intangibles<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,678&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment realignment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture of Workers&#8217; Compensation business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,552&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the decrease in the carrying amount of goodwill was primarily driven by the divestiture of the Workers&#8217; Compensation business, partially offset by goodwill associated with immaterial acquisitions. During the year ended December&#160;31, 2019, the increase in the carrying amount of goodwill was primarily driven by purchase accounting adjustments associated with the Aetna Acquisition. See Note 2 &#8216;&#8216;Acquisitions and Divestitures&#8217;&#8217; for further discussion regarding the Workers&#8217; Compensation business divestiture and the Aetna Acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, the Company also realigned the composition of its segments to correspond with changes to its operating model and to reflect how the Chief Operating Decision Maker (the &#8220;CODM&#8221;) reviews information and manages the business. As a result of this realignment, the Company reallocated the associated goodwill balance to the Pharmacy Services and Health Care Benefits segments based on a relative fair value approach. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of both 2020 and 2019, the Company performed its required annual impairment tests of goodwill. The results of these impairment tests indicated that there was no impairment of goodwill. At both December&#160;31, 2020 and 2019, cumulative goodwill impairments were $6.1 billion.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LTC reporting unit has experienced industry-wide challenges that have impacted management&#8217;s ability to grow the business at the rate that was originally estimated when the Company acquired Omnicare, Inc. (&#8220;Omnicare&#8221;) in 2015. Those challenges include lower client retention rates, lower occupancy rates in skilled nursing facilities, the deteriorating financial health of numerous skilled nursing facility customers which resulted in a number of customer bankruptcies in 2018, and continued facility reimbursement pressures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the update of its current and long-term forecasts in June 2018, management determined that there were indicators that the LTC reporting unit&#8217;s goodwill may be impaired and, accordingly, management performed an interim goodwill impairment test as of June 30, 2018. The results of that interim impairment test showed that the fair value of the LTC reporting unit was lower than the carrying value, resulting in a $3.9 billion pre-tax goodwill impairment charge in the second quarter of 2018. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2018, the Company performed its required annual impairment tests of goodwill and concluded there was no impairment of goodwill or trade names. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the LTC reporting unit missed its forecast primarily due to operational issues and customer liquidity issues, including one significant customer bankruptcy. Additionally, LTC management submitted updated projected financial results which showed significant additional deterioration primarily due to continued industry and operational challenges including lower occupancy rates in skilled nursing facilities, significant deterioration in the financial health of numerous skilled nursing facility customers and continued facility reimbursement pressures. Based on these updated projections, management determined that there were indicators that the LTC reporting unit&#8217;s goodwill may be further impaired and, accordingly, management performed an interim goodwill impairment test during the fourth quarter of 2018. The results of that interim impairment test showed that the fair value of the LTC reporting unit was lower than the carrying value, resulting in an additional $2.2 billion pre-tax goodwill impairment charge in the fourth quarter of 2018. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the remaining goodwill balance in the LTC reporting unit was $431 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s intangible assets as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except weighted average life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,923)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(739)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,481)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,142&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,038)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets totaled $2.3 billion, $2.4 billion and $1.0 billion for the years ended December 31, 2020, 2019 and 2018, respectively. The projected annual amortization expense for the Company&#8217;s intangible assets for the next five&#160;years is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,842&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217387967752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 842) (&#8220;ASC 842&#8221;) on January 1, 2019 on a modified retrospective basis. As a result, the Company&#8217;s lease disclosures as of and for the years ended December 31, 2020 and 2019 are reported under ASC 842. Comparative financial information for the year ended December 31, 2018 has not been restated and continues to be reported under ASC 840, the lease accounting standard in effect for that period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disclosure Subsequent to the Adoption of the New Lease Accounting Standard (ASU 2016-02) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of 15 to 25 years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of 3 to 10 years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2020 and 2019 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for interest portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows paid for principal portion of finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December&#160;31, 2020 and 2019 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except remaining lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,729</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,860</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,757</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,926</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,395</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,522</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,747)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $306 million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.3 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Transactions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a guarantee of lease payments, in connection with the sale-leaseback transactions. Proceeds from sale-leaseback transactions totaled $101 million and $5 million in the years ended December 31, 2020 and 2019, respectively. Gains from sale-leaseback transactions totaled $3 million in the year ended December 31, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material gains from sale-leaseback transactions in the year ended December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Store Rationalization Charges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2019, the Company performed a review of its retail stores and determined it would close 46 underperforming retail pharmacy stores during the second quarter of 2019. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Accordingly, an interim long-lived asset impairment test was performed. The results of the impairment test indicated that the fair value of each store asset group was lower than the carrying value. The fair value was determined using a discounted cash flow method based on estimated sublease income. In the three months ended March 31, 2019, the Company recorded a store rationalization charge of $135 million, primarily related to these operating lease right-of-use asset impairment charges, which was recorded within operating expenses in the Retail/LTC segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2019, in connection with its annual budgeting process, the Company performed an updated review of its retail stores and determined it would close an additional 22 underperforming retail pharmacy stores during the first quarter of 2020. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Accordingly, an interim long-lived asset impairment test was performed. The results of the impairment test indicated that the fair value of each store asset group was lower than the carrying value. The fair value was determined using a discounted cash flow method based on estimated sublease income. In the three months ended September&#160;30, 2019, the Company recorded a store rationalization charge of $96 million, primarily related to these operating lease right-of-use asset impairment charges, which was recorded within operating expenses in the Retail/LTC segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparative Disclosure Prior to the Adoption of the New Lease Accounting Standard (ASU 2016-02)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s net rental expense for operating leases for the&#160;year ended December&#160;31, 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.158%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum rentals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent rentals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total rental expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 842) (&#8220;ASC 842&#8221;) on January 1, 2019 on a modified retrospective basis. As a result, the Company&#8217;s lease disclosures as of and for the years ended December 31, 2020 and 2019 are reported under ASC 842. Comparative financial information for the year ended December 31, 2018 has not been restated and continues to be reported under ASC 840, the lease accounting standard in effect for that period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disclosure Subsequent to the Adoption of the New Lease Accounting Standard (ASU 2016-02) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of 15 to 25 years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of 3 to 10 years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2020 and 2019 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for interest portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows paid for principal portion of finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December&#160;31, 2020 and 2019 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except remaining lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,729</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,860</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,757</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,926</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,395</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,522</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,747)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $306 million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.3 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Transactions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a guarantee of lease payments, in connection with the sale-leaseback transactions. Proceeds from sale-leaseback transactions totaled $101 million and $5 million in the years ended December 31, 2020 and 2019, respectively. Gains from sale-leaseback transactions totaled $3 million in the year ended December 31, 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material gains from sale-leaseback transactions in the year ended December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Store Rationalization Charges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2019, the Company performed a review of its retail stores and determined it would close 46 underperforming retail pharmacy stores during the second quarter of 2019. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Accordingly, an interim long-lived asset impairment test was performed. The results of the impairment test indicated that the fair value of each store asset group was lower than the carrying value. The fair value was determined using a discounted cash flow method based on estimated sublease income. In the three months ended March 31, 2019, the Company recorded a store rationalization charge of $135 million, primarily related to these operating lease right-of-use asset impairment charges, which was recorded within operating expenses in the Retail/LTC segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2019, in connection with its annual budgeting process, the Company performed an updated review of its retail stores and determined it would close an additional 22 underperforming retail pharmacy stores during the first quarter of 2020. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Accordingly, an interim long-lived asset impairment test was performed. The results of the impairment test indicated that the fair value of each store asset group was lower than the carrying value. The fair value was determined using a discounted cash flow method based on estimated sublease income. In the three months ended September&#160;30, 2019, the Company recorded a store rationalization charge of $96 million, primarily related to these operating lease right-of-use asset impairment charges, which was recorded within operating expenses in the Retail/LTC segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparative Disclosure Prior to the Adoption of the New Lease Accounting Standard (ASU 2016-02)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s net rental expense for operating leases for the&#160;year ended December&#160;31, 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.158%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum rentals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent rentals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total rental expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388020040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock', window );">Health Care Costs Payable</a></td>
<td class="text">Health Care Costs Payable<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is information about incurred and cumulative paid health care claims development as of December&#160;31, 2020, net of reinsurance, and the total IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for information on how the Company estimates IBNR reserves and health care costs payable as well as changes to those methodologies, if any. The Company&#8217;s estimate of IBNR liabilities is primarily based on trend and completion factors. Claim frequency is not used in the calculation of the Company&#8217;s liability. In addition, it is impracticable to disclose claim frequency information for health care claims due to the Company&#8217;s inability to gather consistent claim frequency information across its multiple claims processing systems. Any claim frequency count disclosure would not be comparable across the Company&#8217;s different claim processing systems and would not be consistent from period to period based on the volume of claims processed through each system. As a result, health care claim count frequency is not included in the disclosures below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about incurred and paid health care claims development for the year ended December 31, 2019 is presented as required unaudited supplemental information.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.031%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Incurred Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,585&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative Paid Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,961&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding liabilities for health care costs payable prior to 2019, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outstanding liabilities for health care costs payable, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,768&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, the Company&#8217;s liabilities for IBNR plus expected development on reported claims totaled approximately $6.1 billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at December&#160;31, 2020 related to the current calendar year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the December&#160;31, 2020 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-duration health care costs payable, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines other than short duration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total health care costs payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Aetna Acquisition on November 28, 2018, the Company&#8217;s health care costs payable balance was immaterial and related to unpaid pharmacy claims for its SilverScript PDP. The following table shows the components of the change in health care costs payable during the years ended December 31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,357&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from pharmacy claims and discounts payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of the Aetna Acquisition Date, the Company reclassified $776 million of the Pharmacy Services segment&#8217;s unpaid retail pharmacy claims to third parties from pharmacy claims and discounts payable to health care costs payable as the third party liability was incurred to support the Health Care Benefits segment&#8217;s insured members.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the years ended December&#160;31, 2020, 2019 and 2018 in the table above exclude (i) $11 million, $4 million and $16 million, respectively, for a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $41 million, $41 million and $4 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and (iii) $221 million, $285 million and $22 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $429 million and $524 million in 2020 and 2019, respectively, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year. This development does not directly correspond to an increase in the Company&#8217;s operating results as these reductions were offset by estimated current period health care costs when the Company established the estimate of the current year health care costs payable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI http://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217386473208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings and Credit Arrangements</a></td>
<td class="text">Borrowings and Credit Agreements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.125% senior notes due March 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating rate notes due March 2020 (2.515% at December 31, 2019)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8% senior notes due July 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.35% senior notes due March 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating rate notes due March 2021 (0.950% and 2.605% at December 31, 2020 and 2019, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due May 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.45% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% senior notes due July 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.75% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7% senior notes due March 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.875% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,318&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,781)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,318&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for a summary of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">maturities of the Company&#8217;s finance lease liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any commercial paper outstanding as of December 31, 2020 or 2019. In connection with its commercial paper program, the Company maintains a $1.0 billion 364-day unsecured back-up revolving credit facility, which expires on May&#160;12, 2021, a $1.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 18, 2022, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 17, 2023 and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2024. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of December&#160;31, 2020 and 2019, there were no borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the Aetna Acquisition Date, a subsidiary of the Company is a member of the FHLBB. As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of December&#160;31, 2020 was approximately $925 million. At both December&#160;31, 2020 and 2019, there were no outstanding advances from the FHLBB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020, the Company issued $750&#160;million aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027 and $1.25&#160;billion aggregate principal amount of 1.875% unsecured senior notes due February 28, 2031 for total proceeds of approximately $1.99&#160;billion, net of discounts and underwriting fees. The $750&#160;million aggregate principal amount of 1.3% unsecured senior notes represent a further issuance of the Company&#8217;s 1.3% unsecured senior notes due August 21, 2027 initially issued in an aggregate principal amount of $1.5&#160;billion on August 21, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2020, the Company issued $1.5&#160;billion aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027, $1.25&#160;billion aggregate principal amount of 1.75% unsecured senior notes due August 21, 2030 and $1.25&#160;billion aggregate principal amount of 2.7% unsecured senior notes due August 21, 2040 (collectively, the &#8220;August 2020 Notes&#8221;) for total proceeds of approximately $3.97&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2020, the Company issued $750&#160;million aggregate principal amount of 3.625% unsecured senior notes due April 1, 2027, $1.5&#160;billion aggregate principal amount of 3.75% unsecured senior notes due April 1, 2030, $1.0&#160;billion aggregate principal amount of 4.125% unsecured senior notes due April 1, 2040 and $750&#160;million aggregate principal amount of 4.25% unsecured senior notes due April 1, 2050 (collectively, the &#8220;March 2020 Notes&#8221;) for total proceeds of approximately $3.95&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds of these offerings were used for general corporate purposes, which may include working capital, capital expenditures, as well as the repurchase and/or repayment of indebtedness.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the March 2020 Notes. In connection with the issuance of the March 2020 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $7&#160;million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $5&#160;million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 13 &#8216;&#8216;Other Comprehensive Income&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 15, 2019, the Company issued $1.0 billion aggregate principal amount of 2.625% unsecured senior notes due August 15, 2024, $750 million aggregate principal amount of 3% unsecured senior notes due August 15, 2026 and $1.75 billion aggregate principal amount of 3.25% unsecured senior notes due August 15, 2029 (collectively, the &#8220;2019 Notes&#8221;) for total proceeds of approximately $3.46 billion, net of discounts and underwriting fees. The net proceeds of the 2019 Notes were used to repay certain of the Company&#8217;s outstanding debt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in July 2019, the Company entered into several interest rate swap and treasury lock transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the 2019 Notes. In connection with the issuance of the 2019 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $25 million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $18 million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the 2019 Notes. See Note 13 &#8216;&#8216;Other Comprehensive Income&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company purchased $4.5&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $113&#160;million of its 4.0% senior notes due 2023, $1.4&#160;billion of its 3.7% senior notes due 2023, $1.0&#160;billion of its 4.1% senior notes due 2025 and $2.0&#160;billion of its 4.3% senior notes due 2028. In connection with the purchase of such senior notes, the Company paid a premium of $619&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $45&#160;million of unamortized deferred financing costs and incurred $10&#160;million in fees, for a total loss on early extinguishment of debt of $674&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, the Company purchased $4.0 billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $1.3&#160;billion of its 3.125% senior notes due 2020, $723&#160;million of its floating rate notes due 2020, $328&#160;million of its 4.125% senior notes due 2021, $297&#160;million of 4.125% senior notes due 2021 issued by Aetna, $413&#160;million of 5.45% senior notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna, and $962&#160;million of its 3.35% senior notes due 2021. In connection with the purchase of such senior notes, the Company paid a premium of $76 million in excess of the aggregate principal amount of the senior notes that were purchased, incurred $8 million in fees and recognized a net gain of $5 million on the write-off of net unamortized deferred financing premiums, for a net loss on early extinguishment of debt of $79 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities, unsecured senior notes and unsecured floating rate notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of December&#160;31, 2020, the Company was in compliance with all of its debt covenants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217385325576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Plans and Other Postretirement Benefits</a></td>
<td class="text">Pension Plans and Other Postretirement Benefits<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company sponsors several active 401(k) savings plans that cover all employees who meet plan eligibility requirements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes matching contributions consistent with the provisions of the respective plans. At the participant&#8217;s option, account balances, including the Company&#8217;s matching contribution, can be invested among various investment options under each plan. The CVS Health Future Fund 401(k) Plan offers the Company&#8217;s common stock fund as an investment option. The Company also maintains nonqualified, unfunded deferred compensation plans for certain key employees. The plans provide participants the opportunity to defer portions of their eligible compensation and for certain nonqualified plans, participants receive matching contributions equivalent to what they could have received under the CVS Health Future Fund 401(k) Plan absent certain restrictions and limitations under the Internal Revenue Code. The Company&#8217;s contributions under its defined contribution plans were $520 million, $550 million and $334 million in the years ended December 31, 2020, 2019 and 2018, respectively. The Company&#8217;s contributions for the years ended December&#160;31, 2019 and 2018 include contributions to the Aetna 401(k) Plan subsequent to the Aetna Acquisition Date. On January 1, 2020, the Aetna 401(k) Plan was merged into the CVS Health Future Fund 401(k) Plan. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2018, the Company completed the Aetna Acquisition. Aetna sponsors a tax-qualified defined benefit pension plan that was frozen in 2010. Aetna also sponsors a nonqualified supplemental pension plan that was frozen in 2007. Aetna&#8217;s pension plan benefit obligations and the fair value of plan assets were remeasured as of the Aetna Acquisition Date. The Company also sponsors several other defined benefit pension plans that are unfunded nonqualified supplemental retirement plans. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Benefit Obligation and Plan Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables outline the change in pension benefit obligation and plan assets over the specified periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,239&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the pension benefit obligation during the years ended December&#160;31, 2020 and 2019 was primarily driven by the change in the discount rate during each respective period.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2020 and 2019 for the pension plans consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets reflected in other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities reflected in accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities reflected in other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Cost (Income)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) for the years ended December&#160;31, 2020, 2019 and 2018 are shown below:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of net periodic benefit cost (income):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plan Assumptions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a series of actuarial assumptions to determine its benefit obligation and net periodic benefit cost (income), the most significant of which include discount rates and expected return on plan assets assumptions. </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discount Rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate is determined using a yield curve as of the annual measurement date. The yield curve consists of a series of individual discount rates, with each discount rate corresponding to a single point in time, based on high-quality bonds. Projected benefit payments are discounted to the measurement date using the corresponding rate from the yield curve that is consistent with the maturity profile of the expected liability cash flows.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Return on Plan Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected long-term rate of return on plan assets is determined by using the plan&#8217;s target allocation and return expectations based on many factors including forecasted long-term capital market real returns and the inflationary outlook on a plan by plan basis. See &#8220;Pension Plan Assets&#8221; below for additional details regarding the pension plan assets as of December 31, 2020 and 2019.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also considers other assumptions including mortality, interest crediting rate, termination and retirement rates and cost of living adjustments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plan Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Aetna Acquisition Date, the Company&#8217;s pension plan assets primarily include debt and equity securities held in separate accounts, common/collective trusts and real estate investments. The valuation methodologies used to value these debt and equity securities and common/collective trusts are similar to the methodologies described in Note 4 &#8220;Fair Value.&#8221; Pension plan assets also include investments in other assets that are carried at fair value. The following is a description of the valuation methodologies used to value real estate investments and these additional investments, including the general classification pursuant to the fair value hierarchy.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Real estate investments are valued by independent third party appraisers. The appraisals comply with the Uniform Standards of Professional Appraisal Practice, which include, among other things, the income, cost, and sales comparison approaches to estimating property value. Therefore, these investments are classified in Level 3.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private equity and hedge fund limited partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Private equity and hedge fund limited partnerships are carried at fair value which is estimated using the NAV per unit as reported by the administrator of the underlying investment fund as a practical expedient to fair value. Therefore, these investments have been excluded from the fair value table below.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2020 were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,231&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $84 million of equity securities and $182 million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $142 million of other receivables as well as $624 million of private equity limited partnership investments and $214 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2019 were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,196&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,671&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $137 million of equity securities and $151 million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $540 million of private equity limited partnership investments and $184 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balance of Level 3 pension plan assets during 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. corporate<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balance of Level 3 pension plan assets during 2019 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. corporate<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pension plan invests in a diversified mix of assets designed to generate returns that will enable the plan to meet its future benefit obligations. The risk of unexpected investment and actuarial outcomes is regularly evaluated. This evaluation is performed through forecasting and assessing ranges of investment outcomes over short- and long-term horizons and by assessing the pension plan&#8217;s liability characteristics. Complementary investment styles and strategies are utilized by professional investment management firms to further improve portfolio and operational risk characteristics. Public and private equity investments are used primarily to increase overall plan returns. Real estate investments are viewed favorably for their diversification benefits and above-average dividend generation. Fixed income investments provide diversification benefits and liability hedging attributes that are desirable, especially in falling interest rate environments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020, target investment allocations for the Company&#8217;s pension plan were: 20% in equity securities, 68% in fixed income and debt securities, 6% in real estate, 3% in private equity limited partnerships and 3% in hedge funds. Actual asset allocations may differ from target allocations due to tactical decisions to overweight or underweight certain assets or as a result of normal fluctuations in asset values. Asset allocations are consistent with stated investment policies and, as a general rule, periodically rebalanced back to target asset allocations. Asset allocations and investment performance are formally reviewed periodically throughout the year by the pension plan&#8217;s Investment Subcommittee. Forecasting of asset and liability growth is performed at least annually.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally contributes to its tax-qualified pension plan based on minimum funding requirements determined under applicable federal laws and regulations. Employer contributions related to the nonqualified supplemental pension plans generally represent payments to retirees for current benefits. The Company contributed $25 million, $25 million and $12 million to its pension plans during 2020, 2019 and 2018, respectively. No contributions are required for the tax-qualified pension plan in 2021. The Company expects to make an immaterial amount of contributions for all other pension plans in 2021. The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2020: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiemployer Pension Plans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover its union-represented employees. The risks of participating in these multiemployer plans are different from single-employer pension plans in the following respects: (i) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (ii) if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers, and (iii) if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the applicable plan, which is referred to as a withdrawal liability. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the multiemployer pension plans in which the Company participates are individually significant to the Company. The Company&#8217;s contributions to multiemployer pension plans were $19 million, $18 million and $18 million in 2020, 2019 and 2018, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Postretirement Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides postretirement health care and life insurance benefits to certain retirees who meet eligibility requirements. During 2018, the Company acquired additional OPEB plans in connection with the Aetna Acquisition. The Company&#8217;s funding policy is generally to pay covered expenses as they are incurred. For retiree medical plan accounting, the Company reviews external data and its own historical trends for health care costs to determine the health care cost trend rates. As of December&#160;31, 2020 and 2019, the Company&#8217;s other postretirement benefits had an accumulated postretirement benefit obligation of $226 million and $246 million, respectively. Net periodic benefit costs related to these other postretirement benefits were $12 million, $7 million and $2 million in 2020, 2019 and 2018, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2020: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:86.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Pursuant to various collective bargaining agreements, the Company also contributes to multiemployer health and welfare plans that cover certain union-represented employees. The plans provide postretirement health care and life insurance benefits to certain employees who meet eligibility requirements. The Company&#8217;s contributions to multiemployer health and welfare plans totaled $54 million, $57 million and $58 million in 2020, 2019 and 2018, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388112808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,979&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(535)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(564)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(649)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The TCJA was enacted on December 22, 2017. Among numerous changes to existing tax laws, the TCJA permanently reduced the federal corporate income tax rate from 35% to 21% effective on January 1, 2018. The effects of changes in tax rates on deferred tax balances are required to be taken into consideration in the period in which the changes are enacted, regardless of when they are effective. As a result of the reduction of the corporate income tax rate under the TCJA, the Company estimated the revaluation of its net deferred tax liabilities and recorded a provisional income tax benefit of approximately $1.5 billion for </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year ended December 31, 2017. In 2018, the Company completed its process of determining the TCJA&#8217;s final impact and recorded an additional income tax benefit of $100 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of the statutory income tax rate to the Company&#8217;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of the Tax Cuts and Jobs Act</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurer fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis difference upon disposition of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of the Company&#8217;s deferred income tax assets and liabilities as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debts and other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and capital loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll tax deferral</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(454)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,309&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,368)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,568)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,603)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,794)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,294)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company had net operating and capital loss carryovers of $568 million, which expire between 2021 and 2040. The Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and the Company&#8217;s recent operating results. The Company established a valuation allowance of $454 million because it does not consider it more likely than not that these deferred tax assets will be recovered.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2020, 2019 and 2018 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of statutes of limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the balance of unrecognized tax benefits during 2018 was mainly due to the Aetna Acquisition.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and most of its subsidiaries are subject to U.S. federal income tax as well as income tax of numerous state and local jurisdictions. The Company participated in the Compliance Assurance Process through 2019, which is a program made available by the U.S. Internal Revenue Service (&#8220;IRS&#8221;) to certain qualifying large taxpayers, under which participants work collaboratively with the IRS to identify and resolve potential tax issues through open, cooperative and transparent interaction prior to the annual filing of their federal income tax returns. The IRS has completed its examinations of the Company&#8217;s consolidated U.S. federal income tax returns for tax years 2013 and 2018. The IRS has substantially completed its examinations of the Company&#8217;s consolidated U.S. federal income tax returns for tax years 2014 through 2017 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries are also currently under income tax examinations by a number of state and local tax authorities. As of December&#160;31, 2020, no examination has resulted in any proposed adjustments that would result in a material change to the Company&#8217;s operating results, financial condition or liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all material state and local income tax matters have been concluded for fiscal years through 2014. Certain state exams are likely to be concluded and certain state statutes of limitations will lapse in 2021, but the change in the balance of the Company&#8217;s uncertain tax positions is projected to be immaterial. In addition, it is reasonably possible that the Company&#8217;s unrecognized tax benefits could change within the next twelve months due to the anticipated conclusion of various examinations with the IRS for various years. An estimate of the range of the possible change cannot be made at this time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records interest expense related to unrecognized tax benefits and penalties in the income tax provision. The Company accrued interest expense of approximately $34 million, $49 million and $19 million in 2020, 2019 and 2018, respectively. The Company had approximately $121 million and $173 million accrued for interest and penalties as of December&#160;31, 2020 and 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the total amount of unrecognized tax benefits that, if recognized, would affect the Company&#8217;s effective income tax rate is approximately $651 million, after considering the federal benefit of state income taxes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388092968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Incentive Plans</a></td>
<td class="text">Stock Incentive Plans<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the CVS Health 2017 Incentive Compensation Plan (&#8220;ICP&#8221;) provide for grants of annual incentive and long-term performance awards to executive officers and other officers and employees of the Company or any subsidiary of the Company, as well as equity compensation to outside directors of CVS Health. Payment of such annual incentive and long-term performance awards will be in cash, stock, other awards or other property, at the discretion of the Management Planning and Development Committee (the &#8220;MP&amp;D Committee&#8221;) of CVS Health&#8217;s Board of Directors (the &#8220;Board&#8221;). The ICP allows for a maximum of 58 million shares of CVS Health common stock to be reserved and available for grants. As of December&#160;31, 2020, there were approximately 38 million shares of CVS Health common stock available for future grants under the ICP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the Aetna Acquisition Date, approximately 22 million shares of Aetna common stock subject to awards outstanding under the Amended Aetna Inc. 2010 Stock Incentive Plan (&#8220;SIP&#8221;) were assumed by CVS Health. In addition, in accordance with the merger agreement, shares which were available for future issuance under the SIP were converted into approximately 32 million shares of CVS Health common stock reserved and available for issuance pursuant to future awards. Subsequent to the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expiration of the SIP on May 21, 2020, the ICP is the only compensation plan under which the Company grants stock options, restricted stock and other stock-based awards to its employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xNjMvZnJhZzpiNGYxZjRmMzdjYTU0MTJmYjMzYzE4NjU0NDk1OGE4OS90ZXh0cmVnaW9uOmI0ZjFmNGYzN2NhNTQxMmZiMzNjMTg2NTQ0OTU4YTg5XzE4ODc_a2f5f276-1187-4a37-84f0-e7ca761d6280">three</span> to five years) using the straight-line method. The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights (&#8220;SARs&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the ESPP.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Stock-based compensation for the&#160;year ended December&#160;31, 2018 includes $14 million and $27 million associated with accelerated vesting of SARs and restricted stock replacement awards, respectively, issued to Aetna employees who were terminated subsequent to the Aetna Acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Employee Stock Purchase Plan (&#8220;ESPP&#8221;) provides for the purchase of up to 60 million shares of CVS Health common stock. Under the ESPP, eligible employees may purchase common stock at the end of each six&#160;month offering period at a purchase price equal to 90% of the lower of the fair market value on the first day or the last day of the offering period. During 2020, approximately 3 million shares of common stock were purchased under the provisions of the ESPP at an average price of $53.85 per share. As of December&#160;31, 2020, approximately 34 million shares of common stock were available for issuance under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock-based compensation associated with the ESPP is estimated on the date of grant (the first day of the six&#160;month offering period) using the Black-Scholes option pricing model.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health&#8217;s daily stock price over the previous six&#160;month period.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life is based on the semi-annual purchase period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units and Performance Stock Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s restricted stock units and performance stock units are considered nonvested share awards and require no payment from the employee. The fair value of the restricted stock units is based on the market price of CVS Health common stock on the grant date and is recognized on a straight-line basis over the vesting period. For each restricted stock unit granted, employees receive one share of common stock, net of taxes, at the end of the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s performance stock units contain performance vesting conditions in addition to a service vesting condition. Vesting of the Company&#8217;s performance stock units is dependent upon the degree to which the Company achieves its performance goals, which are generally set for a three-year performance period and are approved at the time of grant by the MP&amp;D Committee. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of performance stock units granted with service and performance vesting conditions is based on the market price of CVS Health common stock on the grant date and is recognized over the vesting period. Certain of the performance stock units also contain a market vesting condition based on the performance of CVS Health common stock relative to a comparator group. The fair value of these performance stock units is determined using a Monte Carlo simulation as of the grant date and is recognized over the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2018, the Company completed the Aetna Acquisition. All unvested Aetna performance stock unit and restricted stock unit awards as of the Aetna Acquisition Date were converted into replacement CVS Health restricted stock awards. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, there was $493 million of total unrecognized compensation cost related to the Company&#8217;s restricted stock units and performance stock units that are expected to vest. These costs are expected to be recognized over a weighted-average period of 2.3 years. The total fair value of restricted stock units vested during 2020, 2019 and 2018 was $229 million, $265 million and $262 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In thousands, except weighted average grant date fair value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,849&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,793)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,357)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,824&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options and SARs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All stock option grants are awarded at fair value on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. Stock options granted generally become exercisable over a four-year period from the grant date. Stock options granted through 2018 generally expire seven years after the grant date. Stock options granted subsequent to 2018 generally expire ten years after the grant date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2018, the Company completed the Aetna Acquisition. All unvested Aetna SARs outstanding as of the Aetna Acquisition Date were converted into replacement CVS Health SARs. The replacement SARs granted will be settled in CVS Health common stock, net of taxes, based on the appreciation of the stock price on the exercise date over the market price on the date of grant. The fair value of SARs is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. SARs generally become exercisable over a three-year period from the grant date. SARs generally expire ten years after the grant date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from stock options exercised (including ESPP)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes for net share settlement of equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of stock options and SARs exercised </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of stock options and SARs vested </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option and SAR is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is based on annual dividends paid and the fair market value of CVS Health stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health&#8217;s daily stock price over a period equal to the expected life of each option or SAR grant after adjustments for infrequent events such as stock splits.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options or SARs being valued.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life represents the number of&#160;years the options or SARs are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the weighted-average grant date fair value in 2018 was due to the issuance of the replacement SARs in connection with the Aetna Acquisition in the year ended December 31, 2018. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, unrecognized compensation expense related to unvested stock options and SARs totaled $45 million, which the Company expects to be recognized over a weighted-average period of 1.8 years. After considering anticipated forfeitures, the Company expects approximately 10 million of the unvested stock options and SARs to vest over the requisite service period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s stock option and SAR activity for the&#160;year ended December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands, except weighted average exercise price and remaining contractual term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,164)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(941)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,955&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.86</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,487&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,545&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at end of year and expected to vest in the future</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,448&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.78</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217386460568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase program has been authorized by the Board:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2016 (&#8220;2016 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020, 2019 and 2018, the Company did not repurchase any shares of common stock pursuant to the 2016 Repurchase Program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly cash dividend declared by the Board was $0.50 per share in 2020 and 2019. CVS Health has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Requirements</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 28, 2018, the Company completed the Aetna Acquisition. Aetna&#8217;s insurance business operations are conducted through subsidiaries that principally consist of HMOs and insurance companies. The Company&#8217;s HMO and insurance subsidiaries report their financial statements in accordance with accounting practices prescribed by state regulatory authorities which may differ from GAAP. The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2020, 2019 and 2018 for the Company&#8217;s insurance and HMO subsidiaries were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory net income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated statutory capital and surplus</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Statutory net income of the Company&#8217;s insurance and HMO subsidiaries for the year ended December 31, 2018 (which includes Aetna and its subsidiaries from November 28, 2018 to December 31, 2018) is not material (&#8220;NM&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s insurance and HMO subsidiaries paid $3.1 billion of gross dividends to the Company for the year ended December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, HMOs and insurance companies are subject to further regulations that, among other things, may require those companies to maintain certain levels of equity and restrict the amount of dividends and other distributions that may be paid to their equity holders. In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies. At December&#160;31, 2020, these amounts were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:88.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated minimum statutory surplus required by regulators</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments on deposit with regulatory bodies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated maximum dividend distributions permitted in 2021 without prior regulatory approval</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 and 2019, noncontrolling interests were $312 million and $306 million, respectively, primarily related to third party interests in the Company&#8217;s operating entities.&#160;The noncontrolling entities&#8217; share is included in total shareholders</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> equity on the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217387995992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Income</a></td>
<td class="text">Other Comprehensive Income<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income in 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.529%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($497, $927 and $132 pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($31, $(105) and $1 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(7), $(25) and $465 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(35), $(20) and $(19) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(30), $162 and $(178) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($7, $(12) and $11 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of year accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of year accumulated other comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive loss represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of ASU 2018-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Income Statement Reporting Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Topic 220); Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">during the year ended December 31, 2018.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify approximately $13 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217390696472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) Per Share</a></td>
<td class="text">Earnings (Loss) Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (loss) per share is computed using the two-class method. For periods in which the Company reports net income, diluted earnings per share is determined by using the weighted average number of common and dilutive common equivalent shares outstanding during the period, unless the effect is antidilutive. SARs and options to purchase 15 million and 17&#160;million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the years ended December&#160;31, 2020 and 2019, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, options to purchase 13 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share, for the year ended December&#160;31, 2018. In addition, due to the loss from continuing operations attributable to CVS Health in the year ended December 31, 2018, 3 million potentially dilutive common equivalent shares were excluded from the calculation of diluted earnings per share, as the impact of these shares was antidilutive for that period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings (loss) per share from continuing operations for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings (loss) per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(596)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,629&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings (loss) per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share from continuing operations:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.57)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217386470152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceDisclosuresAbstract', window );"><strong>Reinsurance Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceTextBlock', window );">Reinsurance</a></td>
<td class="text">Reinsurance<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured.</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2018, the Company completed the sale of Aetna&#8217;s standalone Medicare Part D prescription drug plans to a subsidiary of WellCare Health Plans, Inc. (&#8220;WellCare&#8221;), effective December 31, 2018. In connection with that sale, subsidiaries of WellCare and Aetna entered into reinsurance agreements under which WellCare ceded to Aetna 100% of the insurance risk related to the divested standalone Medicare Part D prescription drug plans for the 2019 PDP plan year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company entered into two four-year reinsurance agreements with an unrelated reinsurer that allow it to reduce required capital and provide collateralized excess of loss reinsurance coverage on a portion of the Health Care Benefits segment&#8217;s group Commercial Insured business.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reinsurer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hartford Life and Accident Insurance Company</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Life &amp; Annuity Company of New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WellCare Health Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOYA Retirement Insurance and Annuity Company </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,954)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,184&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of reinsurance on benefit costs for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,594&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is not a material difference between premiums on a written basis versus an earned basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has various agreements with unrelated reinsurers that do not qualify for reinsurance accounting under GAAP, and consequently are accounted for using deposit accounting. The Company entered into these contracts to reduce the risk of catastrophic loss which in turn reduces the Company&#8217;s capital and surplus requirements. Total deposit assets and liabilities related to reinsurance agreements that do not qualify for reinsurance accounting under GAAP were not material as of December&#160;31, 2020 or 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI http://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217386796232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the following significant guarantee arrangements at December&#160;31, 2020:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ASC Claim Funding Accounts - The Company has arrangements with certain banks for the processing of claim payments for its ASC customers. The banks maintain accounts to fund claims of the Company&#8217;s ASC customers. The customer is </span></div><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">responsible for funding the amount paid by the bank each day. In these arrangements, the Company guarantees that the banks will not sustain losses if the responsible ASC customer does not properly fund its account. The aggregate maximum exposure under these arrangements is generally limited to $250 million. The Company can limit its exposure to these guarantees by suspending the payment of claims for ASC customers that have not adequately funded the amount paid by the bank. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Separate Accounts Assets - Certain Separate Accounts assets associated with the large case pensions business in the Corporate/Other segment represent funds maintained as a contractual requirement to fund specific pension annuities that the Company has guaranteed. Minimum contractual obligations underlying the guaranteed benefits in these Separate Accounts were approximately $1.4 billion at both December&#160;31, 2020 and 2019. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information on Separate Accounts. Contract holders assume all investment and mortality risk and are required to maintain Separate Accounts balances at or above a specified level. The level of required funds is a function of the risk underlying the Separate Account&#8217;s investment strategy. If contract holders do not maintain the required level of Separate Accounts assets to meet the annuity guarantees, the Company would establish an additional liability. Contract holders&#8217; balances in the Separate Accounts at December&#160;31, 2020 exceeded the value of the guaranteed benefit obligation. As a result, the Company was not required to maintain any additional liability for its related guarantees at December&#160;31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of December&#160;31, 2020, the Company guaranteed 76 such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the consolidated balance sheets), with the maximum remaining lease term extending through 2030.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total guaranty fund assessments liability was $78 million and $84 million at December&#160;31, 2020 and 2019, respectively, and was recorded in accrued expenses on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CMS, state insurance and health and welfare departments, state attorneys general, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;) and </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other requests for documents and information from, and is being investigated by, Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re National Prescription Opiate Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the U.S. Department of Justice (the &#8220;DOJ&#8221;) served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations in connection with an investigation concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The Company has been cooperating with the government with respect to this subpoena.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Mohajer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed complaints-in-intervention in these two previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cases. With respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint, all states and Washington, D.C. have declined to intervene at this time. The government&#8217;s investigation related to these complaints included the previously disclosed CID that the Company received in October 2015 from the SDNY concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The complaints allege that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mohajer </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relators have amended their complaint to include claims based on similar theories related to certain skilled nursing facilities. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena..</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">whom the Company does not have a contract (&#8220;out-of-network providers&#8221;). Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#8217;s post-payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#8220;HHS-OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange-related or other audits by CMS, HHS-OIG or otherwise, including audits of the Company&#8217;s MLR rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the Company received a CID from the Office of the Washington Attorney General, Medicaid Fraud Control Division, on behalf of the State of Washington and all other states, as well as the District of Columbia, Puerto Rico and the U.S. Virgin Islands. The investigation involves, among other things, possible retention of overpayments and possible submission of false claims for Medicaid reimbursement relating to drugs prescribed by providers who were excluded by the applicable federal and/or state Medicaid programs. The Company is cooperating with the government with respect to this investigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. Since filing, several of the cases have been consolidated, and the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), was recently dismissed with prejudice. The Company and its current and former officers and directors are defending themselves against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, two ERISA class actions were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna, and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The district court consolidated the actions and the Company has moved to dismiss the amended and consolidated class action complaint. The Company also received a related document request pursuant to ERISA &#167; 104(b), to which the Company has responded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health care company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">federal government, withholding of premium payments to the Company by government agencies, assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i) future enactment of new health care or other laws or regulations; (ii) the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii) pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv) pending or future government audits, investigations or enforcement actions against the Company; (v) adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi) adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388096312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Pharmacy Services, Retail/LTC and Health Care Benefits, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the CODM evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliation of consolidated operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020 and 2019, revenues from the federal government accounted for 14% and 13%, respectively, of the Company&#8217;s consolidated total revenues, primarily related to contracts with CMS for coverage of Medicare-eligible individuals within the Health Care Benefits segment. Revenues from the federal government were less than 10% of the Company&#8217;s consolidated revenues in 2018. In 2018, approximately 9.8% of the Company&#8217;s consolidated revenues were from Aetna, which was a Pharmacy Services segment client. On the Aetna Acquisition Date, Aetna became a wholly-owned subsidiary of CVS Health. Subsequent to the Aetna Acquisition Date, transactions with Aetna continue to be reported within the Pharmacy Services segment, but are eliminated in the Company&#8217;s consolidated financial statements. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,608&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,604&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,714)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(769)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Total revenues of the Pharmacy Services segment include approximately $10.9 billion, $11.5 billion and $11.4 billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of retail co-payments for 2020, 2019 and 2018, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information about retail co-payments.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related transaction and integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of fully reserved ACA risk corridor receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store rationalization charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on financing for the Aetna Acquisition </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,261&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.   </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, 2019 and 2018, acquisition-related transaction and integration costs relate to the Aetna Acquisition. In 2018, acquisition-related integration costs also relate to the acquisition of Omnicare. The acquisition-related transaction and integration costs are reflected in the Company&#8217;s consolidated statements of operations in operating expenses within the Corporate/Other segment and the Retail/LTC segment.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment. In 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income. In 2018, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of the Company&#8217;s RxCrossroads subsidiary for $725&#160;million on January 2, 2018. The losses on divestiture of subsidiary are reflected in the Company&#8217;s consolidated statements of operations in operating expenses within the Retail/LTC segment.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the Company received $313&#160;million owed to it under the ACA&#8217;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2019, the store rationalization charges relate to the planned closure of 46 underperforming retail pharmacy stores in the second quarter of 2019 and the planned closure of 22 underperforming retail pharmacy stores in the first quarter of 2020. The store rationalization charges primarily relate to operating lease right-of-use asset impairment charges and are reflected in the Company&#8217;s consolidated statement of operations in operating expenses within the Retail/LTC segment.   </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2018, the goodwill impairments relate to the LTC reporting unit within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2018, impairment of long-lived assets primarily relates to the impairment of property and equipment within the Retail/LTC segment and is reflected in operating expenses in the Company&#8217;s consolidated statement of operations. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2018, the Company recorded interest income of $536 million on the proceeds of the $40 billion of unsecured senior notes it issued in March 2018 to partially fund the Aetna Acquisition. All amounts are for the periods prior to the close of the Aetna Acquisition, which occurred on November 28, 2018, and were recorded within the Corporate/Other segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217405391912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Policy</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Pharmacy Services, Retail/LTC, Health Care Benefits and Corporate/Other, which are described below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services and medical spend management. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#8220;Public Exchanges&#8221;) and private health insurance exchanges and other sponsors of health benefit plans throughout the United States. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2020, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; For periods prior to the Aetna Acquisition Date, the Health Care Benefits segment was comprised only of the Company&#8217;s SilverScript</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> PDP business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash included in other current assets on the consolidated balance sheets represents amounts held in escrow accounts in connection with certain recent acquisitions. Restricted cash included in other assets on the consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; for additional information on how the Company estimates the fair value of these investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#8217;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist primarily of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#8217;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#8217;s investments through its review or prior to receiving the limited partnership&#8217;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using a discounted future cash flow analysis in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment income on the Company&#8217;s investments is recorded when earned and is reflected in the Company&#8217;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#8217; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#8217;s net income (as long as the contract&#8217;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#8217; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#8217; accounts through a charge to benefit costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#8217; equity, net of tax, as a component of accumulated other comprehensive income. Unrealized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceAccountingPolicy', window );">Reinsurance Recoverables</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance Recoverables </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2020, the Company&#8217;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy', window );">Health Care Contract Acquisition Costs</a></td>
<td class="text">Health Care Contract Acquisition CostsInsurance products included in the Health Care Benefits segment are cancelable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. Acquisition costs for certain long-duration insurance contracts are deferred and are recorded as other current assets or other assets on the consolidated balance sheets and are amortized over the estimated life of the contracts. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 1 to 40 years for buildings, building improvements and leasehold improvements and 3 to 10 years for fixtures, equipment and internally developed </span></div>software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Right-of-Use Assets and Lease Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right-of-Use Assets and Lease Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#8217;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.</span></div>See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about right-of-use assets and lease liabilities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">Goodwill The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently if necessary, as further described below.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#8220;VOBA&#8221;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Other than VOBA, definite-lived intangible assets are amortized using the straight-line method. VOBA is amortized over the expected life of the acquired contracts in proportion to estimated premiums. Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently if necessary, as further described in &#8220;Long-Lived Asset Impairment&#8221; below.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Long-Lived Asset Impairment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Asset Impairment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted and without interest charges). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted and with interest charges). If required, an impairment loss is recorded for the portion of the asset group&#8217;s carrying value that exceeds the asset group&#8217;s estimated future cash flows (discounted and with interest charges). There were no material impairment charges recognized on long-lived assets in the year ended December&#160;31, 2020. During the year ended December 31, 2019, the Company recorded store rationalization charges of $231 million, primarily related to operating lease right-of-use asset impairment charges. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about the right-of-use asset impairment charges. During the year ended December 31, 2018, the Company recognized a $43 million long-lived asset impairment charge, primarily related to the impairment of property and equipment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of both 2020 and 2019, the Company performed its required annual goodwill impairment tests and concluded there were no goodwill impairments as of the testing dates or during the years ended December&#160;31, 2020 and 2019. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about goodwill impairment charges recorded during the year ended December 31, 2018.</span></div>Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderAccountsPolicy', window );">Separate Accounts</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses. Deposits, withdrawals and net investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareCostsPolicyPolicyTextBlock', window );">Health Care Costs Payable</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Costs Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#8217;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#8220;IBNR&#8221;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#8217;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of IBNR in 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#8220;completion factors.&#8221; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within six months of the date of service, but it can take up to 48 months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#8217;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#8217;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#8217;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#8217;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#8217;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#8217;s business. The health status of the Company&#8217;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#8217;s health care cost trend rate.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2020; however, actual claim payments may differ from the Company&#8217;s estimates. A worsening (or improvement) of the Company&#8217;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2020 would cause these estimates to change in the near term, and such a change could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#8217;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#8217;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#8217;s health care costs payable, see Note 7 &#8216;&#8216;Health Care Costs Payable.&#8217;&#8217; The Company&#8217;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy', window );">Other Insurance Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Insurance Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unpaid Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#8217;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#8217;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#8217;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#8217;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of unpaid claims IBNR in 2020. As of December&#160;31, 2020, unpaid claims balances of $532 million and $1.5 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2019, unpaid claims balances of $704 million and $1.8 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Policy Benefits</span></div>Future policy benefits consist primarily of reserves for limited payment pension and annuity contracts and long-term care insurance contracts. Reserves for limited payment pension and annuity contracts are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality, retirement, expense and interest rate experience. Such assumptions generally vary by plan, year of issue and policy duration. Assumed interest rates on such contracts ranged from 3.3% to 11.3% in the year ended December 31, 2020 and from 3.5% to 11.3% in the year ended December 31, 2019. The Company periodically reviews mortality assumptions against both industry standards and its experience. Reserves for long-duration long-term care contracts represent the Company&#8217;s estimate of the present value of future benefits to be paid to or on behalf of policyholders less the present value of future net premiums. The assumed interest rate on such contracts was 5.1% in both the years ended December 31, 2020 and 2019. The Company&#8217;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity and interest rate assumptions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock', window );">Premium Deficiency Reserves</a></td>
<td class="text">Premium Deficiency ReservesThe Company evaluates its insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is considered in the calculation of premium deficiency losses for short-duration contracts. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#8217;s method of acquiring, servicing and measuring the profitability of such contracts.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocationsToPolicyholdersPolicies', window );">Policyholders' Funds</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policyholders&#8217; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus  interest credited thereon, net of experience-rated adjustments. In 2020, interest rates for pension and annuity investment contracts ranged from 4.1% to 5.1%. In 2019, interest rates for pension and annuity investment contracts ranged from 3.5% to 5.2%. Reserves for contracts subject to experience rating reflect the Company&#8217;s rights as well as the rights of policyholders and plan participants. The Company also holds funds for health savings accounts (&#8220;HSAs&#8221;) on behalf of members associated with high deductible health plans. These amounts are held to pay for qualified health care expenses incurred by these members. The HSA balances were approximately $2.7 billion and $2.2 billion at December&#160;31, 2020 and 2019, respectively, and are reflected in other current assets with a corresponding liability in policyholders&#8217; funds. </span></div>Policyholders&#8217; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#8217; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReservePolicyTextBlock', window );">Self-Insurance Liabilities</a></td>
<td class="text">Self-Insurance LiabilitiesThe Company is self-insured for certain losses related to general liability, workers&#8217; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#8217;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#8217;s historical claims experience.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation and Transactions and Translations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income (loss).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment sells prescription drugs directly through its mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network. The Company&#8217;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the dispensing of prescription drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions dispensed indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#8220;Drug Discounts&#8221; and &#8220;Guarantees&#8221; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#8220;retail co-payments&#8221;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Pharmacy Services segment:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by mail service dispensing pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by third party pharmacies in the Company&#8217;s retail pharmacy network and associated administrative fees are recognized at the Company&#8217;s point-of-sale, which is when the claim is adjudicated by the Company&#8217;s online claims processing system and the Company has transferred control of the prescription drug and performed all of its performance obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Drug Discounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue net of manufacturers&#8217; rebates earned by its clients based on their plan members&#8217; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#8217; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#8217; rebate amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retail Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer returns are not material to the Company&#8217;s operating results or financial condition. Sales taxes are not included in revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loyalty and Other Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer loyalty program, ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consists of two components, ExtraSavings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-term Care</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of Long-term Care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#8217;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-In Medical Clinics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided by the Company&#8217;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which reflect contracted rates per employee and the number of covered employees </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded in the Company&#8217;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Premium Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#8220;MLR&#8221;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#8220;ACA&#8221;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#8217;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#8217;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#8217;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Medicare Part D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include insurance premiums earned by the Company&#8217;s PDPs, which are determined based on the PDP&#8217;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.334%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">171,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">140,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41,413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">165,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1) </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">52,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">134,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">64,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">164,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">134,736&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">83,989&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,714)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">194,579&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">134,736&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">program. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Certain prior year amounts have been reclassified for consistency with the current period presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020 and 2019, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Products Sold</a></td>
<td class="text"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for cost of products sold as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#8217;s mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network, (ii) shipping and handling costs, and (iii) the operating costs of the Company&#8217;s mail service dispensing pharmacies and client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#8217; benefit plans from the Company&#8217;s mail service dispensing pharmacies, net of any volume-related or other discounts (see &#8220;Vendor Allowances and Purchase Discounts&#8221; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#8217;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div>Cost of products sold includes: the cost of merchandise sold during the reporting period, including prescription drug costs, and the related purchasing costs, warehousing and delivery costs (including depreciation and amortization) and actual and estimated inventory losses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Vendor Allowances and Purchase Discounts</a></td>
<td class="text"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vendor Allowances and Purchase Discounts </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for vendor allowances and purchase discounts as follows: </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#8217;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Pharmacy Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div>Vendor allowances received by the Retail/LTC segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon purchase volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#8217;s consolidated financial statements in any of the periods presented.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock', window );">Health Care Reform</a></td>
<td class="text"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurer Fee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2014, the ACA has imposed an annual premium-based health insurer fee (&#8220;HIF&#8221;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company has been required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In the years ended December&#160;31, 2020 and 2018, operating expenses included $1.0 billion and $157 million, respectively, related to the Company&#8217;s share of the HIF. There was no expense related to the HIF in 2019, since there was a one-year suspension of the HIF for 2019. In December 2019, the HIF was repealed for calendar years after 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#8217;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Corridor</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) based on their ratio of allowable costs to target costs (as defined by the ACA). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company received the $313&#160;million it was owed under the ACA&#8217;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December&#160;31, 2020. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $307 million and after-tax income of $223&#160;million during the year ended December&#160;31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2019, the Company did not record any ACA risk corridor receivables because payment was uncertain.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">Advertising Costs Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $461 million, $396 million and $364 million in 2020, 2019 and 2018, respectively.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text">Stock-Based CompensationStock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzMTc2MGM0MTdhZDQzMzA5NGQzN2IyNDIwMjI1NzQ4L3NlYzpjMzE3NjBjNDE3YWQ0MzMwOTRkMzdiMjQyMDIyNTc0OF8xMjEvZnJhZzo2YjRiNGVkNWIxOTk0ZmE4ODI4NjUyMWFmNjVmZDVhYi90ZXh0cmVnaW9uOjZiNGI0ZWQ1YjE5OTRmYTg4Mjg2NTIxYWY2NWZkNWFiXzc2OTY1ODE1NjM0NzI_a2f5f276-1187-4a37-84f0-e7ca761d6280">three</span> to five years) using the straight-line method.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Tax Cuts and Jobs Act (the &#8220;TCJA&#8221;) was enacted on December 22, 2017. Among numerous changes to existing tax laws, the TCJA permanently reduced the federal corporate income tax rate from 35% to 21% effective January 1, 2018. The effects of changes in tax rates on deferred tax balances are required to be taken into consideration in the period in which the changes are enacted, regardless of when they are effective. As</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a result of the reduction of the corporate income tax rate under the TCJA, the Company estimated the revaluation of its net deferred tax liabilities and recorded a provisional income tax benefit of approximately $1.5&#160;billion for year ended December 31, 2017. In 2018, the Company completed its process of determining the TCJA&#8217;s final impact and recorded an additional income tax benefit of $100 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#8217;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit (OPEB) Plans</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors defined benefit pension plans (&#8220;pension plans&#8221;) and other postretirement employee benefit plans (&#8220;OPEB plans&#8221;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit cost (income) for the Company&#8217;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended </span></div>period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit cost (income) are included in other income in the consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings (Loss) per Common Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings (Loss) per Common Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (loss) per share is computed using the two-class method. The Company calculates basic earnings (loss) per share based on the weighted average number of common shares outstanding for the period. See Note 14 &#8216;&#8216;Earnings (Loss) Per Share&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_SharesHeldInTrustPolicyTextBlock', window );">Shares Held in Trust</a></td>
<td class="text">Shares Held in TrustThe Company maintains grantor trusts, which held approximately one million shares of its common stock at both December&#160;31, 2020 and 2019. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Primary Beneficiary</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company and Cardinal Health, Inc. (&#8220;Cardinal&#8221;) established Red Oak Sourcing, LLC (&#8220;Red Oak&#8221;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own 50%. The Red Oak arrangement has an initial term of 10 years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Retail/LTC segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal is required to pay the Company 39 quarterly payments beginning in October 2014. As milestones are met, the quarterly payments increase. The Company received from Cardinal $183 million during each of the years ended December&#160;31, 2020, 2019 and 2018. The payments reduce the Company&#8217;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold. Revenues associated with Red Oak expenses reimbursed by Cardinal for the years ended December&#160;31, 2020, 2019 and 2018, and amounts due to or due from Cardinal at December&#160;31, 2020 and 2019 were immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Other Variable Interest Holder</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hedge fund and private equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Real estate partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not the primary beneficiary of these VIEs because the nature of the Company&#8217;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#8217;s income or losses in net income (loss).&#160;The Company&#8217;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Related Party Transactions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $56 million, $32 million and $45 million in the years ended December&#160;31, 2020, 2019 and 2018, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $77 million, $96 million and $135 million for pharmaceutical inventory purchases during the years ended December&#160;31, 2020, 2019 and 2018, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020 and 2019, the Company made charitable contributions of&#160;$50&#160;million and $30 million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2020 and 2019.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsPolicyTextBlock', window );">Discontinued Operations</a></td>
<td class="text">Discontinued OperationsIn connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#8216;n Things and Bob&#8217;s Stores, each of which subsequently filed for bankruptcy. The Company&#8217;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements Recently Adopted and Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 326). This standard requires the use of a forward-looking expected credit loss impairment model for trade and other receivables, held-to-maturity debt securities, loans and other instruments. This standard also requires impairments and recoveries for available-for-sale debt securities to be recorded through an allowance account and revises certain disclosure requirements. The Company adopted this new accounting standard on January 1, 2020. The Company adopted the credit loss impairment model on a modified retrospective basis and recorded a $3 million cumulative effect adjustment to reduce retained earnings as of the adoption date. The Company adopted the available-for-sale debt security impairment model on a prospective </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and other - Internal-Use Software </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 350-40): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This standard requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in Topic 350-40 to determine which implementation costs to capitalize as assets. The Company adopted this new accounting guidance on January 1, 2020 on a prospective basis. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company is currently evaluating the effect that implementation of this standard will have on the Company&#8217;s consolidated operating results, cash flows, financial condition and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Insurance Premium Deficiency Reserve [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InsurancePremiumDeficiencyReservePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_SharesHeldInTrustPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares Held In Trust [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_SharesHeldInTrustPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocationsToPolicyholdersPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining amounts of income and expenses allocated to policyholders and contract holders, excluding the method for determining dividends payable to policyholders and accounting policies pertaining to separate accounts for variable annuity contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6483535&amp;loc=d3e16392-158451<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocationsToPolicyholdersPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35755530&amp;loc=d3e11264-158415<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareCostsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for  accruing health care costs for a prepaid health care service provider.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 405<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491204&amp;loc=d3e4879-115612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareCostsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for all health care policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 405<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491204&amp;loc=d3e4879-115612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareEntitiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for contracts reported in separate accounts, including the extent and terms of minimum guarantees, basis of presentation for separate account assets and liabilities and related separate account activity, the liability valuation method and assumptions used in valuing each type of policyholder and contract holder account maintained by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27758-158548<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6816-158387<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27830-158548<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReservePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReservePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14754-158437<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14784-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217395425832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of reconciliation of cash and cash equivalents</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,130&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,954&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,295&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of accounts receivable, net</a></td>
<td class="text">Accounts receivable, net is composed of the following at December&#160;31, 2020 and 2019:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,617&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consists of the following at December&#160;31, 2020 and 2019: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,934&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,700)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,044&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of disaggregation of revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.334%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">171,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">140,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41,413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">165,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1) </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">52,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">134,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">64,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">164,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">134,736&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">83,989&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(33,714)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">194,579&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">134,736&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">program. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Certain prior year amounts have been reclassified for consistency with the current period presentation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of contract with customer assets and liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020 and 2019, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of variable interest entities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total amount of other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2020 and 2019 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge fund investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate partnerships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of discontinued operations</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759159-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5747-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6228884-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388132552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of fair value of assets acquired and liabilities assumed</a></td>
<td class="text">The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.988%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments (current and long-term)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,112&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,940&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt (current and long-term)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consideration transferred</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of pro forma financial information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma information presents a summary of the Company&#8217;s combined operating results for the year ended December&#160;31, 2018 as if the Aetna acquisition and the related financing transactions had occurred on January 1, 2018. The following pro forma financial information is not necessarily indicative of the Company&#8217;s operating results as they would have been had the acquisition been effected on the assumed date, nor is it necessarily an indication of trends in future results for a number of reasons, including differences between the assumptions used to prepare the pro forma financial information, basic shares outstanding and dilutive equivalents, cost savings from operating efficiencies, potential synergies, and the impact of incremental costs incurred in integrating the businesses.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share data</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,152&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share from continuing operations attributable to CVS Health </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share from continuing operations attributable to CVS Health</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217398177672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsTableTextBlock', window );">Total investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,314&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,687&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Debt securities available for sale</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,898&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Effective January 1, 2020, the Company adopted the available-for-sale debt security impairment model under ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments -Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 326). The new impairment model requires the write down of amortized cost through an allowance for credit losses, rather than through a reduction of the amortized cost basis of the available-for-sale debt security. There was no allowance for credit losses recorded on available-for-sale debt securities at December&#160;31, 2020. As the Company adopted the new available-for-sale debt security impairment model on a prospective basis, there was no allowance for credit losses recorded on available-for-sale debt securities at December 31, 2019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results.&#160;At December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses and at December&#160;31, 2019, debt securities with a fair value of $965 million, gross unrealized capital gains of $83 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Fair value of debt securities by contractual maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at December&#160;31, 2020 are shown below by contractual maturity.&#160;&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock', window );">Debt securities in an unrealized capital loss position</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at December&#160;31, 2020 and 2019 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/> Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/> Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/> Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting experience-<br/>rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting remaining<br/>products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock', window );">Activity in mortgage loan portfolio</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2020 and 2019, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2020 scheduled mortgage loan principal repayments were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock', window );">Mortgage loan internal credit rating</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon the Company&#8217;s assessments at December&#160;31, 2020 and 2019, the amortized cost basis of the Company&#8217;s mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeTextBlock', window );">Net investment income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the years ended December 31, 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital gains are net of yield-related impairment losses on debt securities of $49 million for the year ended December&#160;31, 2020. There were no credit-related losses on debt securities in the year ended December&#160;31, 2020. Net realized capital gains are net of other-than-temporary impairment (&#8220;OTTI&#8221;) losses on debt securities of $24 million for the year ended December 31, 2019. There were no material OTTI losses on debt securities for the year ended December 31, 2018.</span></div>(2)Net investment income includes $42 million, $44 million and $4 million for the years ended December 31, 2020, 2019 and 2018, respectively, related to investments supporting experience-rated products.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock', window );">Proceeds and related gross realized capital gains and losses from the sale of debt securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available for sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2020, 2019 and subsequent to the Aetna Acquisition Date in 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Table representing activities in mortgage loan portfolio during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ActivityInMortgageLoanPortfolioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item includes total investments, both current and long-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217530882280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair value of financial assets and liabilities</a></td>
<td class="text">Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2020 and 2019 were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,764&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,374&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,678&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Changes in level 3 financial assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2020 were as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:40.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.897%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/> and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers into Level 3</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers out of Level 3</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Carrying value and estimated fair value of certain financial instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div>(1)It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information regarding the valuation of cost method investments.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock', window );">Separate account financial assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts financial assets at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,459&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $29 million of other receivables at December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of asset supporting separate account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641442&amp;loc=d3e19393-158473<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121639652&amp;loc=d3e7104-158389<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121638699&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217399072712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Change in goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,678&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment realignment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture of Workers&#8217; Compensation business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,552&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock', window );">Other intangible assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s intangible assets as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except weighted average life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,923)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(739)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,623&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,481)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,142&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,159&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,038)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,121&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated annual pretax amortization for other acquired intangible assets over the next five years</a></td>
<td class="text">The projected annual amortization expense for the Company&#8217;s intangible assets for the next five&#160;years is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,842&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the cost, accumulated amortization and net balance of intangibles assets and amortization period, in total and by major class. Finite-lived intangible assets have a stated useful life over which their gross carrying value is amortized. Indefinite intangible assets have a projected indefinite period of benefit (hence are not amortized).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388021688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease costs and supplemental cash flow information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2020 and 2019 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for interest portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows paid for principal portion of finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLeaseTableTextBlock', window );">Supplemental balance sheet information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December&#160;31, 2020 and 2019 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except remaining lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,729</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,860</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,757</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,926</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,395</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,522</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of operating lease liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,747)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $306 million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.3 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Maturities of financing lease liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,747)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $306 million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.3 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock', window );">Lessee, Operating Lease, Disclosure</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s net rental expense for operating leases for the&#160;year ended December&#160;31, 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.158%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum rentals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent rentals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total rental expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLeaseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLeaseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 1,3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12069-110248<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121549808&amp;loc=d3e36991-112694<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388586216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock', window );">Information about incurred and paid health care claims development</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about incurred and paid health care claims development for the year ended December 31, 2019 is presented as required unaudited supplemental information.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.031%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Incurred Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,585&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative Paid Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,961&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding liabilities for health care costs payable prior to 2019, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outstanding liabilities for health care costs payable, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,768&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of liability for unpaid claims and claims adjustment expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the December&#160;31, 2020 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-duration health care costs payable, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines other than short duration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total health care costs payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock', window );">Components of change in health care costs payable</a></td>
<td class="text">The following table shows the components of the change in health care costs payable during the years ended December 31, 2020, 2019 and 2018:<div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,357&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification from pharmacy claims and discounts payable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">As of the Aetna Acquisition Date, the Company reclassified $776 million of the Pharmacy Services segment&#8217;s unpaid retail pharmacy claims to third parties from pharmacy claims and discounts payable to health care costs payable as the third party liability was incurred to support the Health Care Benefits segment&#8217;s insured members.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the years ended December&#160;31, 2020, 2019 and 2018 in the table above exclude (i) $11 million, $4 million and $16 million, respectively, for a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $41 million, $41 million and $4 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and (iii) $221 million, $285 million and $22 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217387865544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Carrying value of long-term debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.125% senior notes due March 2020</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating rate notes due March 2020 (2.515% at December 31, 2019)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8% senior notes due July 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.35% senior notes due March 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating rate notes due March 2021 (0.950% and 2.605% at December 31, 2020 and 2019, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due May 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.45% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% senior notes due July 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.75% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7% senior notes due March 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.875% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,318&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,781)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of maturities of long-term debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,055&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,318&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for a summary of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">maturities of the Company&#8217;s finance lease liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217398074936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock', window );">Schedule of changes in benefit obligations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables outline the change in pension benefit obligation and plan assets over the specified periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,239&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Schedule of changes in plan assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables outline the change in pension benefit obligation and plan assets over the specified periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,239&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Schedule of assets (liabilities) recognized in Balance Sheet</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2020 and 2019 for the pension plans consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets reflected in other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities reflected in accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities reflected in other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of net periodic benefit cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) for the years ended December&#160;31, 2020, 2019 and 2018 are shown below:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of net periodic benefit cost (income):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Weighted average assumptions used in determining benefit obligations and net benefit costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of changes in fair value of plan assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2020 were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,231&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $84 million of equity securities and $182 million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $142 million of other receivables as well as $624 million of private equity limited partnership investments and $214 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2019 were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,196&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,671&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $137 million of equity securities and $151 million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $540 million of private equity limited partnership investments and $184 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock', window );">Schedule of change in level 3 plan assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balance of Level 3 pension plan assets during 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. corporate<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balance of Level 3 pension plan assets during 2019 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. corporate<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of expected future benefits payments</a></td>
<td class="text">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2020: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2020: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:86.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026-2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of defined benefit plan asset investment. Includes, but is not limited to, fair value of category of plan asset and its level within fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217398076728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of components of income tax expense (benefit)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,979&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(535)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(564)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(649)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of effective income tax rate reconciliation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of the statutory income tax rate to the Company&#8217;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of the Tax Cuts and Jobs Act</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurer fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis difference upon disposition of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax assets and liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of the Company&#8217;s deferred income tax assets and liabilities as of December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debts and other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and capital loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll tax deferral</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(454)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,309&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,368)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,568)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,603)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,794)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,294)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of unrecognized tax benefits roll forward</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2020, 2019 and 2018 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of statutes of limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397839032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-based compensation</a></td>
<td class="text">The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2020, 2019 and 2018:<div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights (&#8220;SARs&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the ESPP.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Stock-based compensation for the&#160;year ended December&#160;31, 2018 includes $14 million and $27 million associated with accelerated vesting of SARs and restricted stock replacement awards, respectively, issued to Aetna employees who were terminated subsequent to the Aetna Acquisition.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule ESPP valuation assumptions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health&#8217;s daily stock price over the previous six&#160;month period.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life is based on the semi-annual purchase period.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">RSU and performance share unit activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In thousands, except weighted average grant date fair value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,125&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,849&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,793)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,357)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,824&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock', window );">Cash proceeds received and tax benefit from share-based payment awards</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from stock options exercised (including ESPP)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes for net share settlement of equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of stock options and SARs exercised </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of stock options and SARs vested </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of valuation assumptions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option and SAR is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is based on annual dividends paid and the fair market value of CVS Health stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health&#8217;s daily stock price over a period equal to the expected life of each option or SAR grant after adjustments for infrequent events such as stock splits.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options or SARs being valued.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life represents the number of&#160;years the options or SARs are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock', window );">Schedule of stock options and stock appreciation rights award activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s stock option and SAR activity for the&#160;year ended December&#160;31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands, except weighted average exercise price and remaining contractual term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,601)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,164)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(941)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,955&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.86</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,487&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,545&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.79</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at end of year and expected to vest in the future</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,448&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.78</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217386445272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Share repurchase programs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase program has been authorized by the Board:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2016 (&#8220;2016 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock', window );">Statutory accounting practices disclosure</a></td>
<td class="text">At December&#160;31, 2020, these amounts were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:88.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated minimum statutory surplus required by regulators</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments on deposit with regulatory bodies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated maximum dividend distributions permitted in 2021 without prior regulatory approval</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.23(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24790-158529<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24746-158529<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 55<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82848697&amp;loc=d3e24959-158530<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82848697&amp;loc=d3e24938-158530<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388103144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income in 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.529%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($497, $927 and $132 pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($31, $(105) and $1 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(7), $(25) and $465 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(35), $(20) and $(19) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(30), $162 and $(178) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($7, $(12) and $11 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of year accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of year accumulated other comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive loss represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of ASU 2018-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Income Statement Reporting Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Topic 220); Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">during the year ended December 31, 2018.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify approximately $13 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217386419896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of basic and diluted earnings (loss) per share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings (loss) per share from continuing operations for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings (loss) per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(596)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,629&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings (loss) per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,044&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per share from continuing operations:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.57)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217385247832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceDisclosuresAbstract', window );"><strong>Reinsurance Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock', window );">Schedule of reinsurance recoverables</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reinsurer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hartford Life and Accident Insurance Company</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,085&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Life &amp; Annuity Company of New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WellCare Health Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOYA Retirement Insurance and Annuity Company </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock', window );">Schedule of direct, assumed and ceded premiums earned</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,954)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,184&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectsOfReinsuranceTableTextBlock', window );">Schedule of impact of reinsurance on benefit costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of reinsurance on benefit costs for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,594&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the supplemental schedule of reinsurance information. Reinsurance schedule includes, but is not limited to, the type of insurance, gross amount of premiums, premiums ceded to other entities, premiums assumed from other entities, net amount of premium revenue, and the percentage of the premiums assumed to net premium revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectsOfReinsuranceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effects of reinsurance, for example, but not limited to, disclosure of direct, assumed, and ceded insurance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectsOfReinsuranceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=99380617&amp;loc=SL75241803-196195<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217386476328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summarized financial information of segments</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,608&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,604&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,714)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,714)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(856)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(769)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Total revenues of the Pharmacy Services segment include approximately $10.9 billion, $11.5 billion and $11.4 billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of retail co-payments for 2020, 2019 and 2018, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information about retail co-payments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of operating earnings to net income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related transaction and integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of fully reserved ACA risk corridor receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store rationalization charges </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on financing for the Aetna Acquisition </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(8)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,261&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.   </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, 2019 and 2018, acquisition-related transaction and integration costs relate to the Aetna Acquisition. In 2018, acquisition-related integration costs also relate to the acquisition of Omnicare. The acquisition-related transaction and integration costs are reflected in the Company&#8217;s consolidated statements of operations in operating expenses within the Corporate/Other segment and the Retail/LTC segment.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction in operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment. In 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income. In 2018, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of the Company&#8217;s RxCrossroads subsidiary for $725&#160;million on January 2, 2018. The losses on divestiture of subsidiary are reflected in the Company&#8217;s consolidated statements of operations in operating expenses within the Retail/LTC segment.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the Company received $313&#160;million owed to it under the ACA&#8217;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2019, the store rationalization charges relate to the planned closure of 46 underperforming retail pharmacy stores in the second quarter of 2019 and the planned closure of 22 underperforming retail pharmacy stores in the first quarter of 2020. The store rationalization charges primarily relate to operating lease right-of-use asset impairment charges and are reflected in the Company&#8217;s consolidated statement of operations in operating expenses within the Retail/LTC segment.   </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2018, the goodwill impairments relate to the LTC reporting unit within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2018, impairment of long-lived assets primarily relates to the impairment of property and equipment within the Retail/LTC segment and is reflected in operating expenses in the Company&#8217;s consolidated statement of operations. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2018, the Company recorded interest income of $536 million on the proceeds of the $40 billion of unsecured senior notes it issued in March 2018 to partially fund the Aetna Acquisition. All amounts are for the periods prior to the close of the Aetna Acquisition, which occurred on November 28, 2018, and were recorded within the Corporate/Other segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217400567160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br> shares in Millions, people in Millions, member in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 22, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2019 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>store </div>
<div>people </div>
<div>Segment </div>
<div>member </div>
<div>clinic </div>
<div>patient </div>
<div>state </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th">
<div>Jan. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2014 </div>
<div>payment</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfPlanMembers', window );">Number of plan members | member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofPatientsServedperYear', window );">Number of patients served per year | patient</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfPeopleServed', window );">Number of people served | people</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCosts', window );">Deferred acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 546,000,000<span></span>
</td>
<td class="nump">$ 271,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000,000<span></span>
</td>
<td class="nump">1,900,000,000<span></span>
</td>
<td class="nump">$ 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreRationalizationCharges', window );">Store rationalization charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">231,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment of long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,149,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets, indefinite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts', window );">Assumed interest rates on long-duration group life and long-term care contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HeathSavingsAccountBalance', window );">HSA balances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000,000<span></span>
</td>
<td class="nump">$ 2,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">927,000,000<span></span>
</td>
<td class="nump">856,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (49,640,000,000)<span></span>
</td>
<td class="num">(45,108,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PharmacyRebatePeriod', window );">Pharmacy rebate period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthInsurerFee', window );">Health insurer fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">157,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 461,000,000<span></span>
</td>
<td class="nump">$ 396,000,000<span></span>
</td>
<td class="nump">364,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit', window );">TCJA tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit', window );">Benefit of revaluation of net DTL due to TCJA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesHeldInEmployeeTrustShares', window );">Common stock, shares held in trust (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">VIE, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_Initialcontractualterm', window );">Initial contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity', window );">Number of quarterly payments from VIE | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ProceedsFromVariableInterestEntity', window );">Proceeds from VIE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,000,000<span></span>
</td>
<td class="nump">$ 183,000,000<span></span>
</td>
<td class="nump">183,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,000,000<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty', window );">Other revenues from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,000,000<span></span>
</td>
<td class="nump">96,000,000<span></span>
</td>
<td class="nump">135,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity', window );">Charitable contribution to CVS Health Foundation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Pre-tax income recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,770,000,000<span></span>
</td>
<td class="nump">8,997,000,000<span></span>
</td>
<td class="nump">1,406,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember', window );">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables [Member] | Settled Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingencyUnrecordedAmount', window );">Gain contingency, unrecorded amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 313,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Amount awarded from other party</a></td>
<td class="nump">$ 313,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax', window );">Former gain contingency, recognized in current period, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax', window );">Former gain contingency, recognized in current period, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cvs_HeartlandHealthcareServicesMember', window );">Heartland Healthcare Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which entity operates | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Cumulative translation adjustment from AOCI eliminated upon divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(154,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherInsuranceLiabilitiesMember', window );">Other Insurance Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityforUnpaidClaims', window );">Liability for unpaid claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532,000,000<span></span>
</td>
<td class="nump">704,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">462,000,000<span></span>
</td>
<td class="nump">508,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherLongTermInsuranceLiabilitiesMember', window );">Other Long-Term Insurance Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityforUnpaidClaims', window );">Liability for unpaid claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="nump">1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000,000<span></span>
</td>
<td class="nump">$ 5,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid', window );">Period after date of service a claim is paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LimitedPaymentsContracts', window );">Assumed interest rates on limited payment pension contracts on large case pension business (in hundredths)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PensionAndAnnuityInvestmentContractsInterest', window );">Interest rate for pension and annuity investment contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building, building improvements and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Fixtures, equipment and internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm', window );">Lease renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid', window );">Period after date of service a claim is paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LimitedPaymentsContracts', window );">Assumed interest rates on limited payment pension contracts on large case pension business (in hundredths)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.30%<span></span>
</td>
<td class="nump">11.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PensionAndAnnuityInvestmentContractsInterest', window );">Interest rate for pension and annuity investment contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building, building improvements and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Fixtures, equipment and internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">ASU 2016-13 | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_BrazilSubsidiaryMember', window );">Brazil Subsidiary | Discontinued Operations, Disposed of by Sale | Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Cumulative translation adjustment from AOCI eliminated upon divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of stores | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofWalkInMedicalClinics', window );">Number of walk-in medical clinics | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreRationalizationCharges', window );">Store rationalization charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,000,000<span></span>
</td>
<td class="nump">$ 135,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,149,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC | Brazil Subsidiary | Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of stores | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Premium deficiency reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assumed Interest Rates On Long Duration Group Life And Long Term Care Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Gain Contingency, Recognized in Current Period, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Gain Contingency, Recognized in Current Period, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care Costs Payable, Period After Date Of Services Claims Are Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthInsurerFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthInsurerFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HeathSavingsAccountBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Heath Savings Account Balance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HeathSavingsAccountBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_Initialcontractualterm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Initial Contractual Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_Initialcontractualterm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating And Finance Leases, Renewal Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeOperatingAndFinanceLeasesRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityforUnpaidClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total liability on the balance sheet for unpaid claims for both short-duration and long-duration insurance contracts after reinsurance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityforUnpaidClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LimitedPaymentsContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum assumed interest rates on limited payment contracts on large case pensions business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LimitedPaymentsContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPeopleServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of People Served</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPeopleServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPlanMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Plan Members</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPlanMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Quarterly Payments From Variable Interest Entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofPatientsServedperYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Patients Served per Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofPatientsServedperYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofWalkInMedicalClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Walk In Medical Clinics</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofWalkInMedicalClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PensionAndAnnuityInvestmentContractsInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pension And Annuity Investment Contracts Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PensionAndAnnuityInvestmentContractsInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PharmacyRebatePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Rebate Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PharmacyRebatePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ProceedsFromVariableInterestEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Variable Interest Entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ProceedsFromVariableInterestEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Charitable Contribution To Non-Profit Entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreRationalizationCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Store Rationalization Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreRationalizationCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesHeldInEmployeeTrustShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common stock held in a trust that has been set up specifically to accumulate stock for the sole purpose of distribution to participating employees but not yet earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=109244457&amp;loc=d3e16701-113920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesHeldInEmployeeTrustShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred policy acquisition cost capitalized on contract remaining in force.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121638524&amp;loc=SL117422543-158416<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121638524&amp;loc=SL117422543-158416<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121640538&amp;loc=d3e32546-158582<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121638166&amp;loc=d3e11522-158419<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingencyUnrecordedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingencyUnrecordedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121643868&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI http://asc.fasb.org/extlink&amp;oid=121639165&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121643868&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2A<br> -Subparagraph (SAB Topic 5.EE.Q2(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=SL116722634-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cvs_HeartlandHealthcareServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cvs_HeartlandHealthcareServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherInsuranceLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherInsuranceLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherLongTermInsuranceLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherLongTermInsuranceLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_BrazilSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_BrazilSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217387874744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Restricted Cash (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7,854<span></span>
</td>
<td class="nump">$ 5,683<span></span>
</td>
<td class="nump">$ 4,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash (included in other current assets)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash (included in other assets)</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</a></td>
<td class="nump">$ 8,130<span></span>
</td>
<td class="nump">$ 5,954<span></span>
</td>
<td class="nump">$ 4,295<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397680776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 7,101.0<span></span>
</td>
<td class="nump">$ 6,717.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_VendorandManufacturerReceivables', window );">Vendor and manufacturer receivables</a></td>
<td class="nump">9,815.0<span></span>
</td>
<td class="nump">7,856.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAtCarryingValue', window );">Premium receivables</a></td>
<td class="nump">2,628.0<span></span>
</td>
<td class="nump">2,663.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">2,198.0<span></span>
</td>
<td class="nump">2,381.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total accounts receivable, net</a></td>
<td class="nump">21,742.0<span></span>
</td>
<td class="nump">19,617.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, allowance for credit loss</a></td>
<td class="nump">$ 358.0<span></span>
</td>
<td class="nump">$ 319.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VendorandManufacturerReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vendor and Manufacturer Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VendorandManufacturerReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397351752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Property Plant and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 31,306.0<span></span>
</td>
<td class="nump">$ 28,934.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(18,700.0)<span></span>
</td>
<td class="num">(16,890.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,606.0<span></span>
</td>
<td class="nump">12,044.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">2,134.0<span></span>
</td>
<td class="nump">1,981.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">3,950.0<span></span>
</td>
<td class="nump">3,541.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Fixtures and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">13,125.0<span></span>
</td>
<td class="nump">12,401.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">6,077.0<span></span>
</td>
<td class="nump">5,611.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 6,020.0<span></span>
</td>
<td class="nump">$ 5,400.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217393198232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 267,908<span></span>
</td>
<td class="nump">$ 255,765<span></span>
</td>
<td class="nump">$ 193,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">798<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">660<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">268,706<span></span>
</td>
<td class="nump">256,776<span></span>
</td>
<td class="nump">194,579<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember', window );">Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">171,289<span></span>
</td>
<td class="nump">165,925<span></span>
</td>
<td class="nump">164,845<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember', window );">Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">19,655<span></span>
</td>
<td class="nump">19,422<span></span>
</td>
<td class="nump">19,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PremiumsMember', window );">Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">69,364<span></span>
</td>
<td class="nump">63,122<span></span>
</td>
<td class="nump">8,184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">7,600<span></span>
</td>
<td class="nump">7,296<span></span>
</td>
<td class="nump">1,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">132,663<span></span>
</td>
<td class="nump">130,428<span></span>
</td>
<td class="nump">130,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">141,938<span></span>
</td>
<td class="nump">141,491<span></span>
</td>
<td class="nump">134,736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Pharmacy network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">85,045<span></span>
</td>
<td class="nump">88,755<span></span>
</td>
<td class="nump">87,167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Mail choice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">56,071<span></span>
</td>
<td class="nump">52,141<span></span>
</td>
<td class="nump">47,049<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">822<span></span>
</td>
<td class="nump">595<span></span>
</td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">141,116<span></span>
</td>
<td class="nump">140,896<span></span>
</td>
<td class="nump">134,216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">822<span></span>
</td>
<td class="nump">595<span></span>
</td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">60,208<span></span>
</td>
<td class="nump">56,258<span></span>
</td>
<td class="nump">54,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">91,198<span></span>
</td>
<td class="nump">86,608<span></span>
</td>
<td class="nump">83,989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">70,176<span></span>
</td>
<td class="nump">66,442<span></span>
</td>
<td class="nump">64,179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">19,655<span></span>
</td>
<td class="nump">19,422<span></span>
</td>
<td class="nump">19,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">1,367<span></span>
</td>
<td class="nump">744<span></span>
</td>
<td class="nump">755<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">74,926<span></span>
</td>
<td class="nump">68,979<span></span>
</td>
<td class="nump">8,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">483<span></span>
</td>
<td class="nump">599<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">75,467<span></span>
</td>
<td class="nump">69,604<span></span>
</td>
<td class="nump">8,962<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">69,301<span></span>
</td>
<td class="nump">63,031<span></span>
</td>
<td class="nump">8,180<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,683<span></span>
</td>
<td class="nump">5,974<span></span>
</td>
<td class="nump">560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">315<span></span>
</td>
<td class="nump">412<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">426<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(40,323)<span></span>
</td>
<td class="num">(41,439)<span></span>
</td>
<td class="num">(33,714)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(40,003)<span></span>
</td>
<td class="num">(41,413)<span></span>
</td>
<td class="num">(33,714)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">$ (320)<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PremiumsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PremiumsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217398657144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Contract Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables (included in accounts receivable, net)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,101<span></span>
</td>
<td class="nump">$ 6,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities (included in accrued expenses)</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Change in Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Balance at December 31, 2019</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance', window );">Rewards earnings and gift card issuances</a></td>
<td class="nump">357<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage', window );">Redemption and breakage</a></td>
<td class="num">(359)<span></span>
</td>
<td class="num">(359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Balance at December 31, 2020</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer Liability Redemption And Breakage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractWithCustomerLiabilityRedemptionAndBreakage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217398967208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Variable Interest Entities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">$ 20,812<span></span>
</td>
<td class="nump">$ 17,314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">1,089<span></span>
</td>
<td class="nump">1,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Hedge fund investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Private equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">547<span></span>
</td>
<td class="nump">538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Real estate partnerships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 212<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_RealEstateFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_RealEstateFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397863864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Discontinued Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Loss from discontinued operations</a></td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax benefit</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="num">$ (9)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217484437896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 28, 2018 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 02, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>store </div>
<div>clinic</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2019 </div>
<div>store</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on divestiture, pretax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="num">$ (205)<span></span>
</td>
<td class="num">$ (86)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax', window );">Loss on sale of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="num">(205)<span></span>
</td>
<td class="num">(86)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_AetnaInc.Member', window );">Aetna Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business acquisition, share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_BusinessCombinationPerShareExchangeRatio', window );">Per share exchange ratio | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired', window );">The assigned value per share of acquiree (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree', window );">Assigned value of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">New debt issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Revenue of acquiree since acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Income of acquiree since acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Business acquisition transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of stores | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofWalkInMedicalClinics', window );">Number of walk-in medical clinics | clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_RXCrossroadsMember', window );">RX Crossroads</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on divestiture, pretax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Brazil Subsidiary | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of stores | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | RX Crossroads | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on divestiture, pretax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (86)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Coventry Health Care Workers Compensation Business | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on divestiture, pretax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Drogaria onofre Ltda. [Member] | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on divestiture, pretax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Acquisition Assigned Value Of Acquiree</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationAcquisitionValuePerSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The assigned value per share of the acquiree company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationAcquisitionValuePerSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationPerShareExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Per Share Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationPerShareExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofWalkInMedicalClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Walk In Medical Clinics</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofWalkInMedicalClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cvs_AetnaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cvs_AetnaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_RXCrossroadsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_RXCrossroadsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_BrazilSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_BrazilSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_DrogariaOnofreLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_DrogariaOnofreLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217398520696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Nov. 28, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 79,552<span></span>
</td>
<td class="nump">$ 79,749<span></span>
</td>
<td class="nump">$ 78,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_AetnaInc.Member', window );">Aetna Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments', window );">Investments (current and long-term)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,249<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet', window );">Health care costs payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt', window );">Debt (current and long-term)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,078<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest', window );">Total consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,766<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Liability for Unpaid Claims and Claims Adjustment Expense, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cvs_AetnaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cvs_AetnaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217395693576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Divestitures - Pro Forma (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Total revenues | $</a></td>
<td class="nump">$ 243,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax', window );">Income from continuing operations | $</a></td>
<td class="nump">$ 1,152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Basic earnings per share from continuing operations attributable to CVS Health (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Diluted earnings per share from continuing operations attributable to CVS Health (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397876760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Total Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 2,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">20,812<span></span>
</td>
<td class="nump">17,314<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">23,812<span></span>
</td>
<td class="nump">19,687<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember', window );">Debt securities available for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">2,774<span></span>
</td>
<td class="nump">2,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">18,414<span></span>
</td>
<td class="nump">14,671<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">21,188<span></span>
</td>
<td class="nump">16,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">226<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">821<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">1,047<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">1,577<span></span>
</td>
<td class="nump">1,552<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">$ 1,577<span></span>
</td>
<td class="nump">$ 1,552<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217485363832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsAtFairValue', window );">Investments related to 2012 contract conversion</a></td>
<td class="nump">$ 524<span></span>
</td>
<td class="nump">$ 537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities', window );">Weighted average duration of securities</a></td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities', window );">Weighted average duration of securities</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities', window );">Weighted average duration of securities</a></td>
<td class="text">1 year 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedInvestmentsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate value of all restricted investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12.6(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=d3e611133-123010<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Footnote 11(c)))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedInvestmentsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397073800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">$ 19,396,000,000<span></span>
</td>
<td class="nump">$ 15,898,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1,803,000,000<span></span>
</td>
<td class="nump">1,035,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(11,000,000)<span></span>
</td>
<td class="num">(11,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">21,188,000,000<span></span>
</td>
<td class="nump">16,922,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Debt Securities, Available-for-sale, Allowance for Credit Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,341,000,000<span></span>
</td>
<td class="nump">1,791,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">128,000,000<span></span>
</td>
<td class="nump">62,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,469,000,000<span></span>
</td>
<td class="nump">1,852,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,556,000,000<span></span>
</td>
<td class="nump">2,202,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">172,000,000<span></span>
</td>
<td class="nump">108,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,728,000,000<span></span>
</td>
<td class="nump">2,309,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">7,879,000,000<span></span>
</td>
<td class="nump">7,167,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1,023,000,000<span></span>
</td>
<td class="nump">573,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(8,000,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">8,894,000,000<span></span>
</td>
<td class="nump">7,737,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,595,000,000<span></span>
</td>
<td class="nump">2,149,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">324,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="num">(1,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,918,000,000<span></span>
</td>
<td class="nump">2,348,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">673,000,000<span></span>
</td>
<td class="nump">508,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">32,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">705,000,000<span></span>
</td>
<td class="nump">533,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">962,000,000<span></span>
</td>
<td class="nump">654,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">84,000,000<span></span>
</td>
<td class="nump">46,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,046,000,000<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,369,000,000<span></span>
</td>
<td class="nump">1,397,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">36,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,403,000,000<span></span>
</td>
<td class="nump">1,405,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">21,000,000<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">38,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">135,000,000<span></span>
</td>
<td class="nump">83,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 919,000,000<span></span>
</td>
<td class="nump">$ 965,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available For Sale, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217395411000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities by Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet', window );">Less than one year</a></td>
<td class="nump">$ 1,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet', window );">One year through five years</a></td>
<td class="nump">6,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet', window );">After five years through ten years</a></td>
<td class="nump">3,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet', window );">Greater than ten years</a></td>
<td class="nump">4,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Gross Amortized Cost</a></td>
<td class="nump">19,396<span></span>
</td>
<td class="nump">$ 15,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than one year</a></td>
<td class="nump">1,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">One year through five years</a></td>
<td class="nump">6,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">After five years through ten years</a></td>
<td class="nump">4,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than ten years</a></td>
<td class="nump">4,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">21,188<span></span>
</td>
<td class="nump">16,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Gross Amortized Cost</a></td>
<td class="nump">673<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">705<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Gross Amortized Cost</a></td>
<td class="nump">962<span></span>
</td>
<td class="nump">654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Gross Amortized Cost</a></td>
<td class="nump">2,369<span></span>
</td>
<td class="nump">1,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 2,403<span></span>
</td>
<td class="nump">$ 1,405<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available For Sale, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217390106200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>security</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">468<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">527<span></span>
</td>
<td class="nump">722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 869<span></span>
</td>
<td class="nump">$ 982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">915<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 205<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 256<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397141016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">915<span></span>
</td>
<td class="nump">$ 1,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217386572232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Mortgage Loans (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans', window );">New mortgage loans</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid', window );">Mortgage loans fully repaid</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateForeclosures', window );">Mortgage loans foreclosed</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pertains to amount of mortgage loans fully repaid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateLoansFullyRepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateForeclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateForeclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateNewMortgageLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217391385768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Mortgage Loans Credit Ratings Indicator (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 1,047<span></span>
</td>
<td class="nump">$ 1,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">560<span></span>
</td>
<td class="nump">666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">952<span></span>
</td>
<td class="nump">1,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">494<span></span>
</td>
<td class="nump">611<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Column G))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=cvs_Category1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=cvs_Category1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=cvs_Category2To4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=cvs_Category2To4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=cvs_Categories5and6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=cvs_Categories5and6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=cvs_Category7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=cvs_Category7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388471816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Mortgage Loan Principal Repayments (Details) - Commercial Real Estate<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet', window );">Total</a></td>
<td class="nump">$ 1,047<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217484366056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Net Investment Income (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 781,000,000<span></span>
</td>
<td class="nump">$ 854,000,000<span></span>
</td>
<td class="nump">$ 660,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInvestmentExpense', window );">Investment expenses</a></td>
<td class="num">(35,000,000)<span></span>
</td>
<td class="num">(42,000,000)<span></span>
</td>
<td class="num">(3,000,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentIncomeExcludingCapitalGainsorLosses', window );">Net investment income (excluding net realized capital gains or losses)</a></td>
<td class="nump">746,000,000<span></span>
</td>
<td class="nump">812,000,000<span></span>
</td>
<td class="nump">657,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized capital gains</a></td>
<td class="nump">52,000,000<span></span>
</td>
<td class="nump">199,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">798,000,000<span></span>
</td>
<td class="nump">1,011,000,000<span></span>
</td>
<td class="nump">660,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Credit-related impairment loss (reversal of loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Yield-related impairment loss</a></td>
<td class="num">(49,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">OTTI losses, investments, portion recognized in earnings, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">42,000,000<span></span>
</td>
<td class="nump">44,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">598,000,000<span></span>
</td>
<td class="nump">589,000,000<span></span>
</td>
<td class="nump">61,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">60,000,000<span></span>
</td>
<td class="nump">71,000,000<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 123,000,000<span></span>
</td>
<td class="nump">$ 194,000,000<span></span>
</td>
<td class="nump">$ 593,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentIncomeExcludingCapitalGainsorLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Income, Excluding Capital Gains or Losses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentIncomeExcludingCapitalGainsorLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInvestmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the generation of investment income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInvestmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217530885960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Realized Gains (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales</a></td>
<td class="nump">$ 3,913<span></span>
</td>
<td class="nump">$ 4,773<span></span>
</td>
<td class="nump">$ 389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Gross realized capital gains</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Gross realized capital losses</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217396252248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Fair Value Measurements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 21,188<span></span>
</td>
<td class="nump">$ 16,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,469<span></span>
</td>
<td class="nump">1,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,728<span></span>
</td>
<td class="nump">2,309<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">8,894<span></span>
</td>
<td class="nump">7,737<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,918<span></span>
</td>
<td class="nump">2,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">705<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,403<span></span>
</td>
<td class="nump">1,405<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">8,079<span></span>
</td>
<td class="nump">5,683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">21,188<span></span>
</td>
<td class="nump">16,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">29,314<span></span>
</td>
<td class="nump">22,678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">4,210<span></span>
</td>
<td class="nump">3,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,370<span></span>
</td>
<td class="nump">1,785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">6,597<span></span>
</td>
<td class="nump">5,216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">3,869<span></span>
</td>
<td class="nump">2,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">18,764<span></span>
</td>
<td class="nump">15,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">22,633<span></span>
</td>
<td class="nump">17,374<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,469<span></span>
</td>
<td class="nump">1,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,370<span></span>
</td>
<td class="nump">1,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,728<span></span>
</td>
<td class="nump">2,309<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,727<span></span>
</td>
<td class="nump">2,309<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">8,894<span></span>
</td>
<td class="nump">7,737<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">8,842<span></span>
</td>
<td class="nump">7,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,918<span></span>
</td>
<td class="nump">2,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,918<span></span>
</td>
<td class="nump">2,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">705<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">705<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,403<span></span>
</td>
<td class="nump">1,405<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,403<span></span>
</td>
<td class="nump">1,405<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217396220680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Changes in Level 3 Financial Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci', window );">Change in unrealized capital losses included in OCI associated with Level 3 financial assets</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers out of Level 3, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers out of Level 3, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers out of Level 3, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers out of Level 3, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Equity securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers out of Level 3, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(24)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers out of Level 3, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217502864872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Gross Transfers Into (Out Of) Level 3 (Details) - Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Net transfers out of Level 3</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="num">$ (4.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Gross transfers into Level 3</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Gross transfers out of Level 3</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Net transfers out of Level 3</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="num">$ (4.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217501578504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Carrying Value and Fair Value Classified by Level (Details) - Nonrecurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">$ 1,047<span></span>
</td>
<td class="nump">$ 1,213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts without a fixed maturity</a></td>
<td class="nump">322<span></span>
</td>
<td class="nump">372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">64,647<span></span>
</td>
<td class="nump">68,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">1,070<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts without a fixed maturity</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">75,940<span></span>
</td>
<td class="nump">74,306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated Fair Value | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">75,940<span></span>
</td>
<td class="nump">74,306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated Fair Value | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated Fair Value | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">1,070<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts without a fixed maturity</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts With Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of mortgage loans held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgagesHeldForSaleFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217390010744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Separate Accounts Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 4,881.0<span></span>
</td>
<td class="nump">$ 4,459.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,852.0<span></span>
</td>
<td class="nump">4,459.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Gross transfers into (out of) level 3</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">29.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">188.0<span></span>
</td>
<td class="nump">145.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,099.0<span></span>
</td>
<td class="nump">3,813.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">563.0<span></span>
</td>
<td class="nump">499.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,467.0<span></span>
</td>
<td class="nump">1,226.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,465.0<span></span>
</td>
<td class="nump">1,224.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,385.0<span></span>
</td>
<td class="nump">3,233.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">186.0<span></span>
</td>
<td class="nump">143.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2,634.0<span></span>
</td>
<td class="nump">2,589.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">563.0<span></span>
</td>
<td class="nump">499.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Gross transfers into (out of) level 3</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Separate Accounts, financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Gross transfers into (out of) level 3</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641442&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121638699&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_CommonAndCollectiveTrustsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=cvs_CommonAndCollectiveTrustsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_SeparateAccountFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=cvs_SeparateAccountFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388037992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Offsetting Financial Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAbstract', window );"><strong>Offsetting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCollateralObligationToReturnSecurities', window );">Derivative assets subject to offsetting and enforceable master netting arrangements</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset', window );">Derivative liabilities subject to offsetting and enforceable master netting arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCollateralObligationToReturnSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to return securities collateral under master netting arrangements that have not been offset against derivative assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226016-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCollateralObligationToReturnSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of right to receive cash collateral under master netting arrangements offset against derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=117331979&amp;loc=d3e41228-113958<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217392577704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles - Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="nump">$ 79,749<span></span>
</td>
<td class="nump">$ 78,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Segment realignment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestiture of Workers&#8217; Compensation business</a></td>
<td class="num">(505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="nump">79,552<span></span>
</td>
<td class="nump">79,749<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember', window );">Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="nump">23,581<span></span>
</td>
<td class="nump">23,388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Segment realignment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestiture of Workers&#8217; Compensation business</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="nump">23,615<span></span>
</td>
<td class="nump">23,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="nump">10,807<span></span>
</td>
<td class="nump">10,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Segment realignment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestiture of Workers&#8217; Compensation business</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="nump">10,807<span></span>
</td>
<td class="nump">10,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="nump">45,361<span></span>
</td>
<td class="nump">44,484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Segment realignment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(194)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Purchase accounting adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestiture of Workers&#8217; Compensation business</a></td>
<td class="num">(505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="nump">$ 45,130<span></span>
</td>
<td class="nump">$ 45,361<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillOtherIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillOtherIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217407524072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Cumulative goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,100,000,000<span></span>
</td>
<td class="nump">$ 6,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 6,149,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 78,678,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,552,000,000<span></span>
</td>
<td class="nump">79,749,000,000<span></span>
</td>
<td class="nump">78,678,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,149,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">10,806,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,807,000,000<span></span>
</td>
<td class="nump">10,807,000,000<span></span>
</td>
<td class="nump">10,806,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC | Long-Term Care Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairments</a></td>
<td class="nump">2,200,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">431,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 44,484,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,130,000,000<span></span>
</td>
<td class="nump">$ 45,361,000,000<span></span>
</td>
<td class="nump">$ 44,484,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217484455272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles - Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets, Trademarks</a></td>
<td class="nump">$ 10,498<span></span>
</td>
<td class="nump">$ 10,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(10,481)<span></span>
</td>
<td class="num">(9,038)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross</a></td>
<td class="nump">41,623<span></span>
</td>
<td class="nump">42,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">$ 31,142<span></span>
</td>
<td class="nump">$ 33,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">15 years 2 months 12 days<span></span>
</td>
<td class="text">15 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 2,341<span></span>
</td>
<td class="nump">$ 2,436<span></span>
</td>
<td class="nump">$ 1,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer contracts/relationships and covenants not to compete</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">24,952<span></span>
</td>
<td class="nump">25,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(8,923)<span></span>
</td>
<td class="num">(8,128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">$ 16,029<span></span>
</td>
<td class="nump">$ 17,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">14 years 10 months 24 days<span></span>
</td>
<td class="text">14 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">$ 1,060<span></span>
</td>
<td class="nump">$ 1,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(739)<span></span>
</td>
<td class="num">(386)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">$ 321<span></span>
</td>
<td class="nump">$ 674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ProviderNetworksMember', window );">Provider networks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">$ 4,203<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(440)<span></span>
</td>
<td class="num">(229)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">$ 3,763<span></span>
</td>
<td class="nump">$ 3,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ValueOfBusinessAcquiredMember', window );">Value of Business Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(119)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">$ 471<span></span>
</td>
<td class="nump">$ 527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_AboveMarketLeasesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">$ 364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(260)<span></span>
</td>
<td class="num">(232)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">8 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherAcquiredIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherAcquiredIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period before the next renewal or extension (both explicit and implicit) for intangible assets that have been renewed or extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ProviderNetworksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ProviderNetworksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ValueOfBusinessAcquiredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ValueOfBusinessAcquiredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_AboveMarketLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_AboveMarketLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217385182280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 2,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">1,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">1,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">1,770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">2025</a></td>
<td class="nump">$ 1,718<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217390588680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity', window );">Proceeds from sale-leaseback transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,000,000<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Gains from sale-leaseback transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreRationalizationCharges', window );">Store rationalization charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 231,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfUnderPerformingStoresPlannedClosure', window );">Number of under performing stores, planned closure | store</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreRationalizationCharges', window );">Store rationalization charges</a></td>
<td class="nump">$ 96,000,000<span></span>
</td>
<td class="nump">$ 135,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Distribution centers and Corporate Offices | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeOperatingAndFinanceLeasesTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Distribution centers and Corporate Offices | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeOperatingAndFinanceLeasesTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeOperatingAndFinanceLeasesTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeOperatingAndFinanceLeasesTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeOperatingAndFinanceLeasesTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating And Finance Leases, Term Of Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeOperatingAndFinanceLeasesTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfUnderPerformingStoresPlannedClosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Under Performing Stores, Planned Closure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfUnderPerformingStoresPlannedClosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreRationalizationCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Store Rationalization Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreRationalizationCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from principal payment received from sales-type and direct financing leases classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 230<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121551529&amp;loc=SL120154370-112784<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleAndLeasebackTransactionGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121606570&amp;loc=SL77919786-209982<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleAndLeasebackTransactionGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217385364904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Summary of the Components of Net Lease Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 2,670<span></span>
</td>
<td class="nump">$ 2,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FinanceLeaseCost', window );">Total finance lease costs</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease costs</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">599<span></span>
</td>
<td class="nump">581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Less: sublease income</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total rental expense, net</a></td>
<td class="nump">$ 3,350<span></span>
</td>
<td class="nump">$ 3,357<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217501588728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows paid for operating leases</a></td>
<td class="nump">$ 2,724<span></span>
</td>
<td class="nump">$ 2,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows paid for interest portion of finance leases</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows paid for principal portion of finance leases</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>Right-of-use assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">1,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance leases</a></td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">$ 283<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217399286344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 20,729<span></span>
</td>
<td class="nump">$ 20,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,638<span></span>
</td>
<td class="nump">1,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">18,757<span></span>
</td>
<td class="nump">18,926<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">20,395<span></span>
</td>
<td class="nump">20,522<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Finance leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FinanceLeaseRightOfUseAssetGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,107<span></span>
</td>
<td class="nump">790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation', window );">Accumulated depreciation</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FinanceLeaseRightOfUseAssetNet', window );">Property and equipment, net</a></td>
<td class="nump">1,001<span></span>
</td>
<td class="nump">752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term debt</a></td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">781<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 1,083<span></span>
</td>
<td class="nump">$ 808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted average remaining lease term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">13 years 3 months 18 days<span></span>
</td>
<td class="text">13 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">20 years 3 months 18 days<span></span>
</td>
<td class="text">20 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LeasesWeightedAverageDiscountRateAbstract', window );"><strong>Weighted average discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Assets And Liabilities, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, Accumulated Depreciation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseRightOfUseAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseRightOfUseAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseRightOfUseAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseRightOfUseAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LeasesWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases, Weighted Average Discount Rate [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LeasesWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Assets And Liabilities, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217484369720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Operating and Finance Lease Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">1,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(729)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">1,083<span></span>
</td>
<td class="nump">$ 808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">2,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">2,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">2,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">2,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">2,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">15,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">27,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(6,747)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">20,395<span></span>
</td>
<td class="nump">$ 20,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsYearOne', window );">2021</a></td>
<td class="nump">2,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">2,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">2,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">2,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">2,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">16,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">28,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(7,476)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">21,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Future noncancelable subleases, future minimum payments</a></td>
<td class="nump">306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife', window );">Leases, amount due in excess of remaining estimated economic life</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Leases Liabilities Payments Due [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217385190056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Rental Expense (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals', window );">Minimum rentals</a></td>
<td class="nump">$ 2,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseContingentRentals', window );">Contingent rentals</a></td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OperatingLeasesRentExpenseGross', window );">Rental expense</a></td>
<td class="nump">2,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1', window );">Less: sublease income</a></td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Total rental expense, net</a></td>
<td class="nump">$ 2,535<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingLeasesRentExpenseGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Leases, Rent Expense, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingLeasesRentExpenseGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseContingentRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increases or decreases in lease payments that result from changes occurring after the inception of the lease in the factors (other than the passage of time) on which lease payments are based, except that any escalation of minimum lease payments relating to increases in construction or acquisition cost of the leased property or for increases in some measure of cost or value during the construction or preconstruction period, are excluded from contingent rentals. Contingent rentals also may include amounts for which the triggering events have not yet occurred or the specified targets for which have not yet been achieved (such as sales based percentage rent), but which events are considered probable of occurring or which specified targets are considered probable of being achieved.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121549808&amp;loc=d3e36991-112694<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 40<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556591&amp;loc=d3e36728-112689<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 25<br> -Paragraph 35<br> -URI http://asc.fasb.org/extlink&amp;oid=121614528&amp;loc=d3e35050-112683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseContingentRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseMinimumRentals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121595440&amp;loc=d3e34039-112682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseMinimumRentals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of sublease rental income recognized during the period that reduces the entity's rent expense incurred under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseSubleaseRentals1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217398384520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details) - Health Insurance Product Line - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Health Care Claims,Net of Reinsurance</a></td>
<td class="nump">$ 105,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Health Care Claims,Net of Reinsurance</a></td>
<td class="nump">97,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented', window );">All outstanding liabilities for health care costs payable prior to 2019, net of reinsurance</a></td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Total outstanding liabilities for health care costs payable, net of reinsurance</a></td>
<td class="nump">7,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Health Care Claims,Net of Reinsurance</a></td>
<td class="nump">51,056<span></span>
</td>
<td class="nump">$ 51,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Health Care Claims,Net of Reinsurance</a></td>
<td class="nump">50,394<span></span>
</td>
<td class="nump">$ 44,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Health Care Claims,Net of Reinsurance</a></td>
<td class="nump">54,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Health Care Claims,Net of Reinsurance</a></td>
<td class="nump">$ 47,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClaimsDevelopmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClaimsDevelopmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217387803896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Health Care Costs Payable - Narrative (Details)<br> $ in Billions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</a></td>
<td class="nump">$ 6.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671321-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671317-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397457752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Health Care Costs Payable - Reconciliation of Health Care Net Incurred and Paid Claims Development to Health Care Costs Payable Liability (Details) - Health Insurance Product Line - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems', window );"><strong>Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration health care costs payable, net of reinsurance</a></td>
<td class="nump">$ 7,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Reinsurance recoverables</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Premium deficiency reserve</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem', window );">Insurance lines other than short duration</a></td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Total health care costs payable</a></td>
<td class="nump">$ 7,936<span></span>
</td>
<td class="nump">$ 6,879<span></span>
</td>
<td class="nump">$ 6,147<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reconciling item for the reconciliation of the liability in the disclosure of claims development (in excess of) less than the liability for unpaid claims and claims adjustment expense for short-duration insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217391290440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Reconciliation of Health Care Costs Payable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of period, net</a></td>
<td class="nump">$ 6,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification', window );">Reclassification from pharmacy claims and discounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of period, net</a></td>
<td class="nump">7,936<span></span>
</td>
<td class="nump">$ 6,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">221<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, beginning of period</a></td>
<td class="nump">6,879<span></span>
</td>
<td class="nump">6,147<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Less: Reinsurance recoverables</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of period, net</a></td>
<td class="nump">6,874<span></span>
</td>
<td class="nump">6,143<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquisitions, net</a></td>
<td class="nump">414<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification', window );">Reclassification from pharmacy claims and discounts payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Add: Components of incurred health care costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">55,835<span></span>
</td>
<td class="nump">52,723<span></span>
</td>
<td class="nump">6,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(429)<span></span>
</td>
<td class="num">(524)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred health care costs</a></td>
<td class="nump">55,406<span></span>
</td>
<td class="nump">52,199<span></span>
</td>
<td class="nump">6,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">48,770<span></span>
</td>
<td class="nump">46,158<span></span>
</td>
<td class="nump">6,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="nump">6,009<span></span>
</td>
<td class="nump">5,314<span></span>
</td>
<td class="nump">260<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total claims paid</a></td>
<td class="nump">54,779<span></span>
</td>
<td class="nump">51,472<span></span>
</td>
<td class="nump">6,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Add: Premium deficiency reserve</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of period, net</a></td>
<td class="nump">7,926<span></span>
</td>
<td class="nump">6,874<span></span>
</td>
<td class="nump">6,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Add: Reinsurance recoverables</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, end of period</a></td>
<td class="nump">$ 7,936<span></span>
</td>
<td class="nump">$ 6,879<span></span>
</td>
<td class="nump">$ 6,147<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of unpaid retail pharmacy claims to third parties from pharmacy claims and discounts payable to health care costs payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217391709272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Schedule of Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 15, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 64,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liabilities</a></td>
<td class="nump">1,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LongtermDebtGrossAndLeaseObligation', window );">Total debt principal</a></td>
<td class="nump">65,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premiums</a></td>
<td class="nump">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet', window );">Debt discounts and deferred financing costs</a></td>
<td class="num">(909)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,028)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Long-term debt and lease obligations</a></td>
<td class="nump">64,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="num">(5,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,781)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">$ 59,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.125% senior notes due March 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.8% senior notes due July 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.35% senior notes due March 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due May 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.45% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due July 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due November 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.7% senior notes due March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.8% senior notes due June 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4% senior notes due December 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.375% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.625% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due November 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5% senior notes due December 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.1% senior notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due July 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.875% senior notes due June 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3% senior notes due August 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.625% senior notes due April 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.25% senior notes due June 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.3% senior notes due August 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.3% senior notes due March 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 7,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.25% senior notes due August 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.75% senior notes due April 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.75% senior notes due August 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.875% senior notes due February 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.875% senior notes due July 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.625% senior notes due June 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.75% senior notes due December 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.78% senior notes due March 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.125% senior notes due September 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due April 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.7% senior notes due August 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.75% senior notes due May 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.5% senior notes due May 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due November 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.3% senior notes due December 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due March 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.125% senior notes due July 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due August 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.05% senior notes due March 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% senior notes due April 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Notes Payable | Floating rate notes due March 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.515%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Notes Payable | Floating rate notes due March 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">0.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.605%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other Debt Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongtermDebtGrossAndLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Gross And Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongtermDebtGrossAndLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.125DueMarch2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.125DueMarch2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJuly2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJuly2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.125June2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.125June2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point625PercentApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point625PercentApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point3PercentAugust2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point3PercentAugust2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point75PercentApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point75PercentApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point75PercentAugust2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point75PercentAugust2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point875PercentFebruary2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point875PercentFebruary2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point125PercentApril2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point125PercentApril2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point7PercentAugust2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point7PercentAugust2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point25PercentApril2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point25PercentApril2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217502467656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Debt Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 5,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">4,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">4,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">2,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">3,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">44,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">64,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liabilities</a></td>
<td class="nump">1,083<span></span>
</td>
<td class="nump">$ 808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LongtermDebtGrossAndLeaseObligation', window );">Total debt principal</a></td>
<td class="nump">$ 65,318<span></span>
</td>
<td class="nump">$ 69,246<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongtermDebtGrossAndLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Gross And Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongtermDebtGrossAndLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217392277336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Short-term Borrowings (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 09, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable', window );">Federal home loan bank advances maximum amount available</a></td>
<td class="nump">$ 925,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cvs_TwoThousandEighteenNotesMember', window );">2018 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Back-Up Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.03%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility, Expiring May 12, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">364 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility, Expiring May 18, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility, Expiring May 17, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 2,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility, Expiring May 16, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 2,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember', window );">Federal Home Loan Bank Advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of maximum advances or credit lines available from the Federal Home Loan Bank (FHLB).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6479118&amp;loc=d3e64650-112822<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22 (b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_TwoThousandEighteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_TwoThousandEighteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_BackUpCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_BackUpCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay122021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay122021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay182022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay182022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay172023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay172023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay162024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay162024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217389621624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Long-Term Borrowings (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 21, 2020</div></th>
<th class="th"><div>Aug. 15, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 16, 2020</div></th>
<th class="th"><div>Nov. 28, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt</a></td>
<td class="nump">$ 3,970,000,000<span></span>
</td>
<td class="nump">$ 3,460,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,950,000,000<span></span>
</td>
<td class="nump">$ 1,990,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities', window );">Proceeds from derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="num">$ (446,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Loss on net cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost', window );">Premium paid in excess of debt principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 619,000,000<span></span>
</td>
<td class="nump">$ 706,000,000<span></span>
</td>
<td class="nump">$ 76,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Gain on write off of unamortized deferred financing premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,000,000)<span></span>
</td>
<td class="num">(47,000,000)<span></span>
</td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtExtinguishmentFees', window );">Debt extinguishment fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">674,000,000<span></span>
</td>
<td class="nump">766,000,000<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,440,000,000<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,235,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,235,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.3% senior notes due August 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.875%, senior notes due February 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.75% senior notes due August 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.7% senior notes due August 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.625% senior notes due April 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.75% senior notes due April 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due April 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% senior notes due April 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.625% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3% senior notes due August 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.25% senior notes due August 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="nump">1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Outstanding Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000,000<span></span>
</td>
<td class="nump">$ 6,000,000,000.0<span></span>
</td>
<td class="nump">$ 4,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4% senior notes due December 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000,000<span></span>
</td>
<td class="nump">$ 723,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414,000,000<span></span>
</td>
<td class="nump">1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.7% senior notes due March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="nump">$ 2,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,336,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,336,000,000<span></span>
</td>
<td class="nump">6,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.1% senior notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="nump">$ 3,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.3% senior notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.125% senior notes due March 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">723,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due May 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 328,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 222,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 222,000,000<span></span>
</td>
<td class="nump">222,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 297,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 203,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 203,000,000<span></span>
</td>
<td class="nump">203,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.45% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 413,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187,000,000<span></span>
</td>
<td class="nump">187,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.35% senior notes due March 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 962,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,038,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,038,000,000<span></span>
</td>
<td class="nump">$ 2,038,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Notes Payable | Floating rate notes due March 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.515%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 277,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=cvs_FloatingRateNotesMember', window );">Floating Rate Notes | Floating rate notes due March 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 723,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cvs_AetnaInc.Member', window );">Aetna Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt', window );">Assumed debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,098,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtExtinguishmentFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Extinguishment Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtExtinguishmentFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1875DueFebruary2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1875DueFebruary2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3625DueApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3625DueApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes375DueApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes375DueApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4125DueApril2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4125DueApril2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes425DueApril2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes425DueApril2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_OutstandingSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_OutstandingSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes43Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes43Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.125DueMarch2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.125DueMarch2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=cvs_FloatingRateNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=cvs_FloatingRateNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cvs_AetnaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cvs_AetnaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217398546520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Defined contribution plan, employer contributions</a></td>
<td class="nump">$ 520.0<span></span>
</td>
<td class="nump">$ 550.0<span></span>
</td>
<td class="nump">$ 334.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">25.0<span></span>
</td>
<td class="nump">25.0<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution', window );">Multiemployer plans, plan contributions</a></td>
<td class="nump">19.0<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation</a></td>
<td class="nump">6,462.0<span></span>
</td>
<td class="nump">6,239.0<span></span>
</td>
<td class="nump">5,841.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">$ (218.0)<span></span>
</td>
<td class="num">(131.0)<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">68.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Real Estate Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Private equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Hedge Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution', window );">Multiemployer plans, plan contributions</a></td>
<td class="nump">$ 54.0<span></span>
</td>
<td class="nump">57.0<span></span>
</td>
<td class="nump">58.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation</a></td>
<td class="nump">226.0<span></span>
</td>
<td class="nump">246.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 12.0<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by multiemployer pension plan from all employers participating in multiemployer pension plan determined to be individually insignificant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450678-114947<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlanPensionInsignificantPlanContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217398370824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation, beginning of year</a></td>
<td class="nump">$ 6,239<span></span>
</td>
<td class="nump">$ 5,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial loss</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefit payments</a></td>
<td class="num">(358)<span></span>
</td>
<td class="num">(357)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation, end of year</a></td>
<td class="nump">6,462<span></span>
</td>
<td class="nump">6,239<span></span>
</td>
<td class="nump">5,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">6,395<span></span>
</td>
<td class="nump">5,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">783<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefit payments</a></td>
<td class="num">(358)<span></span>
</td>
<td class="num">(357)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">6,845<span></span>
</td>
<td class="nump">6,395<span></span>
</td>
<td class="nump">$ 5,663<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract', window );"><strong>Assets (liabilities) recognized on the consolidated balance sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Non-current assets reflected in other assets</a></td>
<td class="nump">744<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities reflected in accrued expenses</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Non-current liabilities reflected in other long-term liabilities</a></td>
<td class="num">(285)<span></span>
</td>
<td class="num">(313)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Net assets</a></td>
<td class="nump">$ 383<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217386501080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Costs (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">$ 168<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(388)<span></span>
</td>
<td class="num">(357)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net actuarial loss</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost (income)</a></td>
<td class="num">$ (218)<span></span>
</td>
<td class="num">$ (131)<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397448184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Assumptions used to determine benefit obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Assumptions used to determine net benefit costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on plan assets</a></td>
<td class="nump">6.30%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217395068392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 6,845<span></span>
</td>
<td class="nump">$ 6,395<span></span>
</td>
<td class="nump">$ 5,663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2,291<span></span>
</td>
<td class="nump">2,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3,231<span></span>
</td>
<td class="nump">3,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="nump">430<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5,865<span></span>
</td>
<td class="nump">5,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Cash and cash equivalents | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Cash and cash equivalents | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Cash and cash equivalents | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Cash and cash equivalents | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Debt securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">575<span></span>
</td>
<td class="nump">592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Debt securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2,887<span></span>
</td>
<td class="nump">2,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Debt securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Debt securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3,462<span></span>
</td>
<td class="nump">3,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.s. government securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">575<span></span>
</td>
<td class="nump">592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.s. government securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.s. government securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.s. government securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">611<span></span>
</td>
<td class="nump">623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">States, municipalities and political subdivisions | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">States, municipalities and political subdivisions | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">States, municipalities and political subdivisions | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">States, municipalities and political subdivisions | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. corporate securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. corporate securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2,006<span></span>
</td>
<td class="nump">1,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. corporate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. corporate securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2,006<span></span>
</td>
<td class="nump">1,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Residential mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Residential mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">287<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Residential mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Residential mortgage-backed securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">287<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Commercial mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Commercial mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Commercial mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Commercial mortgage-backed securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other asset-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other asset-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other asset-backed securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Redeemable preferred securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Redeemable preferred securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Redeemable preferred securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Redeemable preferred securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Equity securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,598<span></span>
</td>
<td class="nump">1,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Equity securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Equity securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Equity securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,598<span></span>
</td>
<td class="nump">1,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. Domestic | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. Domestic | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. Domestic | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. Domestic | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">537<span></span>
</td>
<td class="nump">481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">537<span></span>
</td>
<td class="nump">481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Domestic real estate | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Domestic real estate | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Domestic real estate | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Domestic real estate | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other investments | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other investments | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other investments | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other investments | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">606<span></span>
</td>
<td class="nump">639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Real estate | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Real estate | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Real estate | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">353<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Real estate | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Derivatives | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Derivatives | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Derivatives | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Derivatives | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts, Equity Securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount', window );">Plan assets, investment within plan asset category, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts, Equity Securities | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount', window );">Plan assets, investment within plan asset category, amount</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts, Debt Securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount', window );">Plan assets, investment within plan asset category, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts, Debt Securities | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount', window );">Plan assets, investment within plan asset category, amount</a></td>
<td class="nump">182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Private equity investments | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">624<span></span>
</td>
<td class="nump">540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Hedge fund investments | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other receivables | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment within defined benefit plan asset category.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_RedeemablePreferredSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_RedeemablePreferredSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_EquitySecuritiesDomesticRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_EquitySecuritiesDomesticRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDerivativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDerivativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217394033688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">$ 6,395<span></span>
</td>
<td class="nump">$ 5,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">6,845<span></span>
</td>
<td class="nump">6,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld', window );">Actual return on plan assets</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements', window );">Purchases, sales and settlements</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels', window );">Transfers out of Level 3</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember', window );">Real estate | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">353<span></span>
</td>
<td class="nump">425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld', window );">Actual return on plan assets</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements', window );">Purchases, sales and settlements</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels', window );">Transfers out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld', window );">Actual return on plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements', window );">Purchases, sales and settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels', window );">Transfers out of Level 3</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(A)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(B)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan, for assets transferred into (out of) Level 3 of fair value hierarchy. Includes, but is not limited to, transfer due to change in observability of significant inputs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(C)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217388823064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2022</a></td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2023</a></td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2024</a></td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2025</a></td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2026-2030</a></td>
<td class="nump">1,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2021</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2022</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2023</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2024</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2025</a></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2026-2030</a></td>
<td class="nump">$ 61<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217384910440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Provision (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 2,615<span></span>
</td>
<td class="nump">$ 2,450<span></span>
</td>
<td class="nump">$ 1,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">565<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current taxes</a></td>
<td class="nump">3,133<span></span>
</td>
<td class="nump">3,015<span></span>
</td>
<td class="nump">1,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(450)<span></span>
</td>
<td class="num">(535)<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income taxes</a></td>
<td class="num">(564)<span></span>
</td>
<td class="num">(649)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">$ 2,569<span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="nump">$ 2,002<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397656440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense', window );">Provisional benefit of revaluation of net DTL due to TCJA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit', window );">Benefit of revaluation of net DTL due to TCJA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss and capital loss carryforwards</a></td>
<td class="nump">$ 568<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">454<span></span>
</td>
<td class="nump">374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Income tax penalties and interest expense</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Income tax penalties and interest accrued</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">$ 651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts and Jobs Act, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217385364904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Tax Rate Reconciliation (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax benefit</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">27.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent', window );">Effect of the Tax Cuts and Jobs Act</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.071)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthInsurerFeeTaxEffectPercent', window );">Health insurer fee</a></td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses', window );">Goodwill impairments</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">89.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness', window );">Basis difference upon disposition of subsidiary</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">26.30%<span></span>
</td>
<td class="nump">26.30%<span></span>
</td>
<td class="nump">142.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthInsurerFeeTaxEffectPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tax effect of the health care reform's non-tax deductible health insurer fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthInsurerFeeTaxEffectPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397269576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent', window );">Lease and rents</a></td>
<td class="nump">$ 5,742.0<span></span>
</td>
<td class="nump">$ 5,731.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory</a></td>
<td class="nump">80.0<span></span>
</td>
<td class="nump">23.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Employee benefits</a></td>
<td class="nump">238.0<span></span>
</td>
<td class="nump">191.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances', window );">Bad debts and other allowances</a></td>
<td class="nump">395.0<span></span>
</td>
<td class="nump">294.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits', window );">Retirement benefits</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">47.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss and capital loss carryforwards</a></td>
<td class="nump">568.0<span></span>
</td>
<td class="nump">480.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income</a></td>
<td class="nump">43.0<span></span>
</td>
<td class="nump">36.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Insurance reserves</a></td>
<td class="nump">489.0<span></span>
</td>
<td class="nump">430.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DeferredTaxAssetsPayrollTaxDeferral', window );">Payroll tax deferral</a></td>
<td class="nump">173.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">500.0<span></span>
</td>
<td class="nump">451.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(454.0)<span></span>
</td>
<td class="num">(374.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred income tax assets</a></td>
<td class="nump">7,774.0<span></span>
</td>
<td class="nump">7,309.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DeferredTaxLiabilitiesRetirementBenefits', window );">Retirement benefits</a></td>
<td class="num">(29.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestments', window );">Investments</a></td>
<td class="num">(421.0)<span></span>
</td>
<td class="num">(289.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Lease and rents</a></td>
<td class="num">(5,368.0)<span></span>
</td>
<td class="num">(5,464.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(8,750.0)<span></span>
</td>
<td class="num">(8,850.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(14,568.0)<span></span>
</td>
<td class="num">(14,603.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liabilities</a></td>
<td class="num">$ (6,794.0)<span></span>
</td>
<td class="num">$ (7,294.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredTaxAssetsPayrollTaxDeferral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Payroll Tax Deferral</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredTaxAssetsPayrollTaxDeferral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Depreciation and Amortization - Amount of deferred tax liability attributable to taxable temporary differences from depreciation and amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredTaxLiabilitiesRetirementBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Retirement Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredTaxLiabilitiesRetirementBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397798040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 655<span></span>
</td>
<td class="nump">$ 661<span></span>
</td>
<td class="nump">$ 344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to the current year</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions based on tax positions related to prior years</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions for tax positions of prior years</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(111)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Expiration of statutes of limitation</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="nump">$ 768<span></span>
</td>
<td class="nump">$ 655<span></span>
</td>
<td class="nump">$ 661<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217484262440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Nov. 28, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 453<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued employee stock purchase plan (in shares)</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased', window );">Average purchase price of shares purchased (in dollars per share)</a></td>
<td class="nump">$ 53.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember', window );">Employee Stock Options and Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation not yet recognized, period for recognition</a></td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Compensation not yet recognized, options</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber', window );">Expected to vest (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsandPerformanceShareUnitsMember', window );">Restricted Stock Units and Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 329<span></span>
</td>
<td class="nump">377<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Compensation not yet recognized, other than options</a></td>
<td class="nump">$ 493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation not yet recognized, period for recognition</a></td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested in period, fair value</a></td>
<td class="nump">$ 229<span></span>
</td>
<td class="nump">$ 265<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Accelerated compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Accelerated compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock percent</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cvs_CVSHealth2017IncentiveCompensationPlanMember', window );">CVS Health 2017 Incentive Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="nump">58,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">38,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cvs_AetnaInc2010StockIncentivePlanMember', window );">Aetna Inc 2010 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Capital shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsandPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsandPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cvs_CVSHealth2017IncentiveCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cvs_CVSHealth2017IncentiveCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cvs_AetnaInc2010StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cvs_AetnaInc2010StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397703272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Valuation and Assumptions (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">1.46%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">1.45%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">37.21%<span></span>
</td>
<td class="nump">27.96%<span></span>
</td>
<td class="nump">28.02%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.81%<span></span>
</td>
<td class="nump">2.27%<span></span>
</td>
<td class="nump">1.87%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 13.85<span></span>
</td>
<td class="nump">$ 10.51<span></span>
</td>
<td class="nump">$ 12.26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember', window );">Employee Stock Options and Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">3.42%<span></span>
</td>
<td class="nump">3.68%<span></span>
</td>
<td class="nump">2.76%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">25.22%<span></span>
</td>
<td class="nump">21.76%<span></span>
</td>
<td class="nump">21.27%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.61%<span></span>
</td>
<td class="nump">0.56%<span></span>
</td>
<td class="nump">2.77%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 8.78<span></span>
</td>
<td class="nump">$ 6.27<span></span>
</td>
<td class="nump">$ 24.55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397353288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Restricted Stock Activity (Details) - Restricted Stock Units and Performance Share Units<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of period (in shares) | shares</a></td>
<td class="nump">13,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">6,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(3,793)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(1,357)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of period (in shares) | shares</a></td>
<td class="nump">14,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average grant date fair value (in dollars per share)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 61.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">58.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">60.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">59.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 58.12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsandPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsandPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217392076728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Stock Option and SAR Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from stock options exercised (including ESPP)</a></td>
<td class="nump">$ 264,000<span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
<td class="nump">$ 242,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes for net share settlement of equity awards</a></td>
<td class="nump">$ 88,000<span></span>
</td>
<td class="nump">112,000<span></span>
</td>
<td class="nump">97,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member', window );">Stock options granted prior to 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member', window );">Stock options granted in 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember', window );">Employee Stock Options and Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from stock options exercised (including ESPP)</a></td>
<td class="nump">$ 264,000<span></span>
</td>
<td class="nump">210,000<span></span>
</td>
<td class="nump">242,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes for net share settlement of equity awards</a></td>
<td class="nump">88,000<span></span>
</td>
<td class="nump">112,000<span></span>
</td>
<td class="nump">97,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of stock options and SARs exercised</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">79,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue', window );">Fair value of stock options and SARs vested</a></td>
<td class="nump">$ 252,000<span></span>
</td>
<td class="nump">$ 467,000<span></span>
</td>
<td class="nump">$ 324,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at beginning of year (in shares)</a></td>
<td class="nump">23,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares granted (in shares)</a></td>
<td class="nump">4,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares exercised (in shares)</a></td>
<td class="num">(2,601)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares forfeited (in shares)</a></td>
<td class="num">(1,164)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Shares expired (in shares)</a></td>
<td class="num">(941)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at end of year (in shares)</a></td>
<td class="nump">23,955<span></span>
</td>
<td class="nump">23,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding at beginning of year ($ per share)</a></td>
<td class="nump">$ 69.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, granted ($ per share)</a></td>
<td class="nump">58.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, exercised ($ per share)</a></td>
<td class="nump">52.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, forfeited ($ per share)</a></td>
<td class="nump">57.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, expired ($ per share)</a></td>
<td class="nump">83.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding at end of year ($ per share)</a></td>
<td class="nump">$ 69.62<span></span>
</td>
<td class="nump">$ 69.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average contractual term, outstanding at end of year</a></td>
<td class="text">4 years 10 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic value outstanding at end of year</a></td>
<td class="nump">$ 185,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares exercisable at end of year (in shares)</a></td>
<td class="nump">13,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price exercisable at end of year ($ per share)</a></td>
<td class="nump">$ 78.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term exercisable at end of year</a></td>
<td class="text">2 years 9 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value exercisable at end of year</a></td>
<td class="nump">$ 78,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Shares vested at end of year and expected to vest in the future (in shares)</a></td>
<td class="nump">23,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price vested at end of year and expected to vest in the future ($ per share)</a></td>
<td class="nump">$ 69.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term vested at end of year and expected to vest in the future</a></td>
<td class="text">4 years 9 months 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value vested at end of year and expected to vest in the future</a></td>
<td class="nump">$ 180,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217386794536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Repurchases (Details) - 2016 Repurchase Program - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 02, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining as of December 31, 2020</a></td>
<td class="nump">$ 13,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217395425832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Dividends (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Cash dividend declared (USD per share)</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217399030920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Regulatory Requirements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount', window );">Combined statutory net income</a></td>
<td class="nump">$ 3,667<span></span>
</td>
<td class="nump">$ 2,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired', window );">Estimated minimum statutory surplus required by regulators</a></td>
<td class="nump">5,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldByInsuranceRegulators', window );">Investments on deposit with regulatory bodies</a></td>
<td class="nump">712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval', window );">Estimated maximum dividend distributions permitted in 2021 without prior regulatory approval</a></td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cvs_InsuranceAndHmoMember', window );">Insurance and HMO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance', window );">Combined statutory capital and surplus</a></td>
<td class="nump">13,238<span></span>
</td>
<td class="nump">$ 10,975<span></span>
</td>
<td class="nump">$ 10,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries', window );">Dividends paid</a></td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldByInsuranceRegulators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of cash and investment securities on deposit with state regulatory authorities in connection with capital requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=75763970&amp;loc=SL75763979-209797<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldByInsuranceRegulators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of dividends that can be declared or paid without approval of regulatory agency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net income for the period determined using accounting principles prescribed or permitted by insurance regulators.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cvs_InsuranceAndHmoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cvs_InsuranceAndHmoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217387938488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Noncontrolling Interests (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217389511432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,170<span></span>
</td>
<td class="nump">$ 64,170<span></span>
</td>
<td class="nump">$ 58,543<span></span>
</td>
<td class="nump">$ 37,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">$ (18)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">917<span></span>
</td>
<td class="nump">274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,701<span></span>
</td>
<td class="nump">64,170<span></span>
</td>
<td class="nump">58,543<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Net unrealized investment gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">415<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(86)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="nump">677<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">497<span></span>
</td>
<td class="nump">927<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Net cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect', window );">Adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="nump">330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Amount expected to be reclassified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Pension and OPEB plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect', window );">Adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="num">(132)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="num">(178)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="num">(165)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect', window );">Adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,414<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accumulated other comprehensive income (AOCI) for reclassification to retained earnings of tax effect from remeasurement of deferred tax pursuant to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL116659650-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217398363656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumeratorForEarningsPerShareCalculationAbstract', window );"><strong>Numerator for earnings (loss) per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">$ 7,201<span></span>
</td>
<td class="nump">$ 6,631<span></span>
</td>
<td class="num">$ (596)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted', window );">Income allocated to participating securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income (loss) from continuing operations attributable to CVS Health</a></td>
<td class="nump">$ 7,188<span></span>
</td>
<td class="nump">$ 6,629<span></span>
</td>
<td class="num">$ (597)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings (loss) per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares, basic (in shares)</a></td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">1,301<span></span>
</td>
<td class="nump">1,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares, diluted (in shares)</a></td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">1,305<span></span>
</td>
<td class="nump">1,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings (loss) per share from continuing operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Earnings (loss) per share from continuing operations, basic (USD per share)</a></td>
<td class="nump">$ 5.49<span></span>
</td>
<td class="nump">$ 5.10<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Earnings (loss) per share from continuing operations, diluted (USD per share)</a></td>
<td class="nump">$ 5.47<span></span>
</td>
<td class="nump">$ 5.08<span></span>
</td>
<td class="num">$ (0.57)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of EPS (in shares)</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_CommonEquivalentSharesMember', window );">Common Equivalent Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of EPS (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DenominatorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DenominatorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumeratorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Numerator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumeratorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_CommonEquivalentSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvs_CommonEquivalentSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397636712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance - Narrative (Details) - Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jan. 31, 2021 </div>
<div>reinsuranceAgreement</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofReinsuranceContractsEnteredInto', window );">Number of reinsurance contracts entered into</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer', window );">Four years reinsurance agreement with unrelated insurer</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This line item represents the four years of a reinsurance agreement with an unrelated insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofReinsuranceContractsEnteredInto">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reinsurance contracts entered into with an unrelated insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofReinsuranceContractsEnteredInto</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217390079576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Reinsurance - Reinsurance Recoverables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">$ 3,055<span></span>
</td>
<td class="nump">$ 4,131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_HartfordLifeAndAccidentInsuranceCompanyMember', window );">Hartford Life and Accident Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">2,364<span></span>
</td>
<td class="nump">3,085<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_LincolnLifeAnnuityCompanyOfNewYorkMember', window );">Lincoln Life &amp; Annuity Company of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_WellCareHealthPlansMember', window );">WellCare Health Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_VOYARetirementInsuranceAndAnnuityCompanyMember', window );">VOYA Retirement Insurance and Annuity Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_AllOtherReinsurersMember', window );">All Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">$ 103<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, policy benefits and policy reserves. Excludes premiums paid under reinsurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21409-158489<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99380617&amp;loc=SL75241803-196195<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_HartfordLifeAndAccidentInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_HartfordLifeAndAccidentInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_LincolnLifeAnnuityCompanyOfNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_LincolnLifeAnnuityCompanyOfNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_WellCareHealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_WellCareHealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_VOYARetirementInsuranceAndAnnuityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_VOYARetirementInsuranceAndAnnuityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_AllOtherReinsurersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_AllOtherReinsurersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217399232648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance - Effects of Reinsurance (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract', window );"><strong>Premiums Earned, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DirectPremiumsEarned', window );">Direct</a></td>
<td class="nump">$ 69,711<span></span>
</td>
<td class="nump">$ 62,968<span></span>
</td>
<td class="nump">$ 8,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssumedPremiumsEarned', window );">Assumed</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">2,108<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededPremiumsEarned', window );">Ceded</a></td>
<td class="num">(825)<span></span>
</td>
<td class="num">(1,954)<span></span>
</td>
<td class="num">(219)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Net premiums</a></td>
<td class="nump">69,364<span></span>
</td>
<td class="nump">63,122<span></span>
</td>
<td class="nump">8,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract', window );"><strong>Policyholder Benefits and Claims Incurred, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross', window );">Direct</a></td>
<td class="nump">56,077<span></span>
</td>
<td class="nump">52,592<span></span>
</td>
<td class="nump">6,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed', window );">Assumed</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">1,562<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded', window );">Ceded</a></td>
<td class="num">(727)<span></span>
</td>
<td class="num">(1,625)<span></span>
</td>
<td class="num">(211)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet', window );">Net benefit costs</a></td>
<td class="nump">$ 55,679<span></span>
</td>
<td class="nump">$ 52,529<span></span>
</td>
<td class="nump">$ 6,594<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssumedPremiumsEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earned premiums assumed from other entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssumedPremiumsEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededPremiumsEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earned premiums ceded to other entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84167274&amp;loc=d3e27175-158546<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededPremiumsEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectPremiumsEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectPremiumsEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of policy benefits and costs incurred for policies assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reduction of provision for policy benefits and costs incurred for policies ceded.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217390033352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor obligations, maximum exposure</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts', window );">Contractual obligations underlying the guaranteed benefits</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_GuarantorObligationsNumberofLeases', window );">Number of leases guaranteed | lease</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuarantyLiabilities', window );">Guaranty liabilities</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the contractual obligation to maintain the required level of funding in Separate Accounts necessary to fund specific guaranteed pensions annuities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_GuarantorObligationsNumberofLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Number of Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_GuarantorObligationsNumberofLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuarantyLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121555860&amp;loc=d3e11019-110243<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121555860&amp;loc=d3e11049-110243<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuarantyLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217397611080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details) - Segment<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cvs_AetnaInc.Member', window );">Aetna Inc. | Customer Concentration Risk | Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage ("Less than" - 2018 Federal Government)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cvs_USFederalGovernmentMember', window );">US Federal Government | Customer Concentration Risk | Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage ("Less than" - 2018 Federal Government)</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cvs_AetnaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cvs_AetnaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cvs_USFederalGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cvs_USFederalGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217390184824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Summarized Financial Information of Segments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">$ 267,908<span></span>
</td>
<td class="nump">$ 255,765<span></span>
</td>
<td class="nump">$ 193,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">798<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">660<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">268,706<span></span>
</td>
<td class="nump">256,776<span></span>
</td>
<td class="nump">194,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">16,008<span></span>
</td>
<td class="nump">15,339<span></span>
</td>
<td class="nump">11,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,441<span></span>
</td>
<td class="nump">4,371<span></span>
</td>
<td class="nump">2,718<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">132,663<span></span>
</td>
<td class="nump">130,428<span></span>
</td>
<td class="nump">130,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">141,938<span></span>
</td>
<td class="nump">141,491<span></span>
</td>
<td class="nump">134,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">5,688<span></span>
</td>
<td class="nump">5,129<span></span>
</td>
<td class="nump">4,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">766<span></span>
</td>
<td class="nump">710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NetRevenuesRetailCoPayments', window );">Co-payments</a></td>
<td class="nump">10,900<span></span>
</td>
<td class="nump">11,500<span></span>
</td>
<td class="nump">11,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">60,208<span></span>
</td>
<td class="nump">56,258<span></span>
</td>
<td class="nump">54,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">91,198<span></span>
</td>
<td class="nump">86,608<span></span>
</td>
<td class="nump">83,989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">6,146<span></span>
</td>
<td class="nump">6,705<span></span>
</td>
<td class="nump">7,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,801<span></span>
</td>
<td class="nump">1,723<span></span>
</td>
<td class="nump">1,698<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">74,926<span></span>
</td>
<td class="nump">68,979<span></span>
</td>
<td class="nump">8,904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">483<span></span>
</td>
<td class="nump">599<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">75,467<span></span>
</td>
<td class="nump">69,604<span></span>
</td>
<td class="nump">8,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">6,188<span></span>
</td>
<td class="nump">5,202<span></span>
</td>
<td class="nump">528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,832<span></span>
</td>
<td class="nump">1,721<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(40,323)<span></span>
</td>
<td class="num">(41,439)<span></span>
</td>
<td class="num">(33,714)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(40,323)<span></span>
</td>
<td class="num">(41,439)<span></span>
</td>
<td class="num">(33,714)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">(708)<span></span>
</td>
<td class="num">(697)<span></span>
</td>
<td class="num">(769)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">9,275<span></span>
</td>
<td class="nump">11,063<span></span>
</td>
<td class="nump">4,724<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">30,990<span></span>
</td>
<td class="nump">30,350<span></span>
</td>
<td class="nump">28,990<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">315<span></span>
</td>
<td class="nump">412<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">426<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">(1,306)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="num">(856)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
<td class="nump">$ 138<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NetRevenuesRetailCoPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Revenues, Retail CoPayments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NetRevenuesRetailCoPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140217396874904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation of Operating Earnings to Net Income (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 02, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 09, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (GAAP measure)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,911,000,000<span></span>
</td>
<td class="nump">$ 11,987,000,000<span></span>
</td>
<td class="nump">$ 4,021,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,341,000,000<span></span>
</td>
<td class="nump">2,436,000,000<span></span>
</td>
<td class="nump">1,006,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Acquisition-related transaction and integration costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332,000,000<span></span>
</td>
<td class="nump">480,000,000<span></span>
</td>
<td class="nump">492,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) loss on divestiture of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(269,000,000)<span></span>
</td>
<td class="nump">205,000,000<span></span>
</td>
<td class="nump">86,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries', window );">Receipt of fully reserved ACA risk corridor receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(307,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreRationalizationCharges', window );">Store rationalization charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">231,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,149,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment of long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income on financing for the Aetna Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(536,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,008,000,000<span></span>
</td>
<td class="nump">$ 15,339,000,000<span></span>
</td>
<td class="nump">11,261,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember', window );">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables [Member] | Settled Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingencyUnrecordedAmount', window );">Gain contingency, unrecorded amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 313,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax', window );">Former gain contingency, recognized in current period, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreRationalizationCharges', window );">Store rationalization charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,000,000<span></span>
</td>
<td class="nump">$ 135,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,149,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfUnderPerformingStoresPlannedClosure', window );">Number of under performing stores, planned closure | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_RXCrossroadsMember', window );">RX Crossroads</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) loss on divestiture of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(725,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_RXCrossroadsMember', window );">RX Crossroads | Retail/ LTC | Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) loss on divestiture of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember', window );">Coventry Health Care Workers Compensation Business | Health Care Benefits | Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) loss on divestiture of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=cvs_TwoThousandEighteenNotesMember', window );">2018 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Gain Contingency, Recognized in Current Period, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfUnderPerformingStoresPlannedClosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Under Performing Stores, Planned Closure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfUnderPerformingStoresPlannedClosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreRationalizationCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Store Rationalization Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreRationalizationCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in allowance for credit loss on accounts receivable, from recovery.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingencyUnrecordedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingencyUnrecordedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_RXCrossroadsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_RXCrossroadsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_TwoThousandEighteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_TwoThousandEighteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>136
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M3U;K9YO-&@DS;62R,08&B4C7O^QUXX@]@XYWP,#?&/CO#.BA-P0;@^"]0?N
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M   8    >&PO=V]R:W-H965T<R]S:&5E=#0N>&ULK9IM;]LX$L>_"N$K#KM
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MZMO3LW<G;%A<V'RULGMF+ZB80-7N[,ES<*Z8KS&.-2_OW!V )H%3=Q]*\FB
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MJKJ&JKJ&A&2[0_(IB4CL4T!R<$\?PICG)]=[75CPEM6IHH#M<Y(SZK\#&!X
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MJJK=,M..W?1*C>2@'J)L"Y7(_(#-@X#&@=IRK%B0+%N"&S?]R&9&LJ8]-5R
MMM:>$UY@LU!,;!;0N-D A&4#H#;0;JF$T5A:E0U$3:UK^ 'U^*-8F0/J\[PL
M-CU^2W,%5FA!,P-14_,:4D ]IMCI@V@<].N 1LK]D38Z@!ZRY+G5IAK8R)&G
MEUYG?1,$:^P!]>#CO#!8UP"I3)V48G<+A#-R;"E@9["-2Z GM7OG!A6_8W6!
M;6LP0".$Y&;2)%W=.BD4MQW;MN25SR!<W3RIA%MC*"VKMWV<]^E9SINJ1%M(
MKF]M(H<Y6,K4+WW4O'N6FG.%: R[D%.-:^'H#_9CL :04(\@3WP_V<0Y+WWS
MG$$Q <F^K?D^,OA^_C/G[<M]1,%MF.4J\R<&^9ML\$#(^K >IQJF&(5-7M="
MG^CJ7D: S?VB&G,B/9+KU6.6,G8GINMB*;EO4!O],2JYW>I%-5=0#3I6!50#
M2:3'=<_M-%$;^(VA!)ZF?8AF!J*F73N;?GI@]JI]#3)#205)QQX JA$?TB.^
M%_<^J W='"S5OZL^1-<&33MZ'X/HIEMJX(CTP/'U>Q_#@!V]#VH#S*Y]'U3C
M2Z3'EZ_3^R %@FQEK&/<;KPT*-O1_>A';SJFAJ](#P7[MS](@3R1"^7VIQ_9
MS$C6M*>&I$B/!5[82* V9AC('9">IJEW#2N0?K_L.6W$6%E4%;M>'FIE:9M*
MT488=-:W$:B&.D@/17JT$2I3)Z78!E:PH2?![#,%V4!^D:*B8?T ;GE$;TE'
M/X#:.WBV,_9:JX%!N+H?4 J'EH2A;WMX8:H0!87OFU.W3>7BD2OAJB\]!IPK
M1&'+5<\E7 --;/U!B(YKD(?U(._%$-T@OQ=$A]@(T7$-[[ >WO6"Z%BQO0?'
M4C+?8 6X@YZ<2[VHY@JJKHT;O/,*5P^NG@O1<1M]8?GE[;0/T<Q U+2KQG%8
M#ZM>%:+C-AB37OA=*$BL#AMJN(;U".C%$!VWL9)CRZ\G^A!=&S3M@.@&T4VW
MU& -Z\%:$Z%6P'7=#6Y-$-TP8 =$QXH7F1VVU< -&_82?]LV9=P5NTXR]L&*
MW4<9H1N4[4#H^M&;CJF1(>[W)M6,T+$"U"'7MN7*W(ML9B1KVE.C/:R',2]$
MZ+@-&>3^:JZG:1[#J%&%K=^^>@9"Y[OW[9IJMS><H(=E1*J@8@A=HKHTZ*Q'
MZ':-=&P]$C$C=*6IDU)L Z&//0O*MK;)&/IN[0-?&K3L0-\*Z;;KR*^'KDW"
MU>A;)7SLREO]4P49M*$\Y93NPB,9#BG(,.PHP#;'?LT[-4*RGW,P[-3 ]55:
M@1BFBC8!@U-@59Q;WCY8TBC@LS]/-UD.%DD**/&7HM OJ<BUC,\T&O \$QBW
MRK6B)Q00@+]C>@?J0469+,?,P!LTKH9-:7'L-$_^A 9S2D$!&\&__S5"T'U?
M_IN'#W&X"'T2YV"G8Y@E4>B'-!-4WOORGU""!(%X?TLBIESQL0V[>J>;R3NG
MR0R;;LHT/C5P-=8@;K-?GH[.BM/1M<.YX]:L2CR2:",6;7^7E5V_@5X5$2*.
MP1M]JS.\AI2V :@I7Q*=&KCNZ()_,U381<HCN>)XKJ;W>\N#B:SW)_-OXA=\
MO\\-L0?6^ #<T4<:,]<LTF0%)GS5(US^4Y@OP41\D,"Z5G  GI8A2T66I9N(
M)RW+4L*N@DWQ 1/+X71[.)R6A\,+[^+:N\Q_+;7GWX1/!Q8ZV)ZUKCY*  .F
MW3I)A57J8]E?DW7H V;<_B&C]2.292*WM_(G-.5:@:_D9WFF.2LL[7GNNX?=
M9$=2TMW#<6=X#5^0F#\3J*/;?Q7+05$+@DW*O;&M!^IRP.?_6WL?=&=+X797
MN/VVP#VE+T<VVE=:W4=;MD16)O;3=*R<3<.=[UM8_CV(3^,R(%*\/%96W:Z^
MOSL5'RY)]\_@X;GJ_@4\O%3=OX*'UZK[M_#PD^K^%WAXI[I_8J/#.QLIGK#U
MBCW!RB<V>V(KGSCLB?B8:5C[H_@X\1-)'\(X Q%=,-]8[SQ60=+B>[_B(D_6
MXG.@^R1GLUG\7%(2T)03L.>+A"T3Y04?H/KJ\O@?4$L#!!0    ( /@U4%+T
MZ87Y[@4  *L9   8    >&PO=V]R:W-H965T<R]S:&5E=#@N>&ULO5EK;]LV
M%/TKA%=L,>#$(BW)CSD&',?).C18$#?;AV(?&(FVM4JB2])Q NS'[U*2)3]H
MVGTL0%%+U'V<>R[%PU#]%1>?Y9PQA5Z2.)67M;E2BUZS*8,Y2ZB\X N6PI,I
M%PE5<"MF3;D0C(:94Q(WB>/XS81&:6W0S\;NQ:#/ERJ.4G8OD%PF"16O5RSF
MJ\L:KJT''J+97.F!YJ"_H#,V8>IQ<2_@KEE&":.$I3+B*1)L>ED;XMXM\;1#
M9O%GQ%9RXQKI4IXX_ZQOWH>7-4<C8C$+E Y!X>>9C5@<ZTB XTL1M%;FU(Z;
MU^OH-UGQ4,P3E6S$X[^B4,TO:YT:"MF4+F/UP%>_L:*@#&# 8YG]CU:%K5-#
MP5(JGA3.@"")TOR7OA1$G.) "@>RX^#Z!QQ:A4-KQP&W#CBXA8-[:@:O</!V
M,[@''/S"P3_5H5TXM+-FY>QFK;FFB@[Z@J^0T-8035]D_<V\H2-1JJ?B1 EX
M&H&?&HQX*GD<A52Q$$T4_, \4Q+Q*9K,J6!S'H=,R%_0^,LR4J_H[!X&4S5G
M*@IH+.OH'#U.KM'9NSJ2VEZB*$5W41S#/),-]&[SMM]4@%CG;08%NJL<'3F
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M$T=$F]?=6K;&T>;[M^\=*?4QM#2%-4 /-MV69763@AK=RGB*;96; K"3FFJ
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M>ILHH4AKDB 9.&8GQIYCO')]0ERY%68;BRRB)[X.X$ JTZ3M%)\Y_8F9QJ-
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M7*^ZNI5CHP8_L.+W__%@_SU\6*?K#7,+_&*Z".L.@SCG8LJ:N0.QTWUHJ'G
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M8O%_N0MU(/PR-?/]4/;TP %AJ 3\ZO+"9ZN'^S:>\@#>VCZ;'DRIN-/!PG%
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M4 ,M$@9O.,XYA41]07BT@N6D9S"%!(\=GE)L5*-*C00&YZ+-?=#+*7L-MSA
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M%08&._ '?1@,]8_VLE/ N&M KQ>S& ;/8C'VGLLA@Z0#K#OD'"= ?U6+]\Y
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MY5B&?3HK#&Q\<:YO(PH(]'DCD;19(%C'/CK(OM9E/>:SVKSADMV@IK G77R
M!0(THQ3(.6J44\JU/CC+(8^2NGYT(;Q^? \Z?QB:'D?%5K5NH9Z+LC1AV&1'
M.UI*CGK4CFL<\Q+!""-'K"ETNO68\R3RL9L;]L@.D_M,D0'":C*C!)1#X-K4
MF '0DF8D&/08 \$T9OY>K"IV*U(G)J>$WPGISY9)AN3*EMQWBN3+",9=Q_X0
MF'O#T@Z9!"XDK#" ]&^7MT!%$]@/7NMCV?B1T:+1":D5KB$PG)>-R_46G5V/
M'-C55GTLDJKU8!!:0;NT#I9H6#> 3 CB2TI^,Y-EJNH":36.CT*R"T'>#+OK
M2BWNL,ADXVT;RV&U5IN,__!85NI[.;<P^>\EI>0"_JILM"LKGI?*%UC/(6-O
M?.JEA<9)@SAA#BE89-6(F%).(W2/63./2_9+02D,U\ >X-<6,?RP:FJ*&#)*
MOMOGY!%E=12F%L:-X>)$D9(VJ=8.>;3O;)6#TFF.)%21<;095>L4T/,5; K#
M+ #O#H(W--F+U%@S.M%RJ_*,!&ZT9QP,C&<$9\6ABK74) ";F_FCVJ>[=E3H
MW!1 T,>@@X<6*,\&X9AD>B#_A)4>T"2H(1@UZ";1:/,*5@F^<_X#[D'TOI0:
M W7F3K@F11QU#S;R(>%F9'6/,,[$7A0H(B]/[,S!J^ST_95#0<,)KO';))?2
MI=. ()5D,C.I&ZV"&5%<VR$=4BJ("*G8K4#5KBB*'B>:A,L1Z[ ^U)7W^H,:
M_^@2*8?VCT#//>OU"#JNV:P ;3YIUGM  &!C,TGTA9BYF!(,+TV>8'F!"=V1
M >8\I3)E9Q@D35/.&F#D$'=^Z='O+G&:7,08\D#W6TU)(D<4K<!Q>6D=3.I;
MH>YSD6T<!08=-?+E4G=1W$FM"N(5U67]+3GWKNR=(K?\3I :_<PZ&S#FLL:#
MX# G1&$VHF4<TJ@9%43)[6D9GK2RLN+K=;?@^:@ T0/A*N#?* V[X4,J57I/
M:W[B$3I4&"R*S" 6PJ7(\XY[[_1%@R9ONZ]7N4S9"AP<R//# SE2KQPWG.T1
ME#9ASV&-L@WD#20M8$'0-SS7KN(/+\2#@&C!=G4!6M^CI#QCQW2X.HSE8[[Z
M+7# 76UAUM6]ZN7I9@UE2+747UI+;R*DD0=0H4PRLP&MV\2(!-J04+)+]MEV
M>F$[#88YD?*M1,J]-&@TJ[18[3C!L533H+3/WY"=P*[9J,+?)?'*O$*=!<,Q
MCTTC;J;1W2LPF52?2N,3OGNEZVVSG%CHWGK+T$YERZ9*+DFF(74!!E:Z*"T*
ML,E=G5<2S2%HDDM2!4CU&W8R$G,%US:?:)Y02"$V+]DU3C;%Y)MJ)IFPUZ3&
M0VMP8XS>JQKR"7)L8,K E9$]]W8J>LL&NZ+%L<E+@M[N!26 GA0[J_VCI7Q<
M2:%Q4;&"UE*/U_<?"9F#.N%_8W3GRHT@>&G+#N "($V"O#PG)^',TJ4,#M]?
M5 7L#JG>'%V!_\"2( HG\!L'B]D2?@G(T2NX6@23^=(L,WU?1"YS@REET0LL
M+ KB^80MEPV1*$B Z"T: N"S\9RM?]TKO,&%0UFO,GDG2YI@VW\>S6&B^+LP
M([<AI>SY6FB_"!9)Q*817BP3=#1]I]Y27H:+WMVOHC2I,+"S4[K:\(UXL0([
M$MD8B?EDVKD&C[(3.GUB[S"8)+/>W2]4NB2XG>@)0IW$O;M?12;$S@1+<(Q"
MZR-]$Y3FU"*E'QV-_L)%,)\E;)JP* S"Q<+%-J]A.&\HQA.6S"V]']@LF"[G
M\!M%P2R.$40)WBV#.$SZP 24GP)F',2&5! M9AU@3H/9(GX6,,-@OIBRV=R3
M]P)0\F> &4^6O;O'X3D/YI,)B^=X ?^>A&><+'IWSX3G-(X[U\^#)S+J7S\-
MFB& <=J[>S(T9RR,6+PX@DVCPG :3 "1R9*%LV 912/8C),6FTLVCQML3L'3
M(9#".< <80F$#%+G"U.ZI$!5NDAE_35%>^=A!^7:K-:N](I)^M$<_:0_=S@D
M!-D9>6(S$W@G-K(H3(@Q@<2WB1A-)48'#D*DJ?T,*Q"(WKG\M\T0ZZ*Y3?E>
M(LT-Y+:E.2(@R@MDBM)C"MQ-MN$&.0_#"W8>7X"#8$FGZ8GC ZYS__=\>D%_
MGVL-8B]]',Q9['N76YY[;YO^2^@?)<@0<'0KJBJWN5;+[L6P%SS[HGE1KG&-
M"'F=<IH-Z,Q$>)3?$(\M=84?(J90V/'$WH&S:W&$@AD1N9&U6X@\)CY F4HE
MI0]46CR*0U.J))1M14Z58H#M" [AQ0^)@]Y3X7OYU]K'8_F.<Y3/M@^,0#.T
MC"G:.UZ$<?@76 9B,&Q1>QY-+IYK(%XV,F51[!D&.$6?.#3LFL3Y#*P@\=!^
MGLR[)H&P/P^C,7N(?8-0=>4ITYC$>3+LU@YT,32+4SX)4521MC9:X8Y.UQ;/
M#0,7[?*]BY['2R"G<41-J=G?QX9WHQIC=O/H-^T*J2,+!-;1AH8J-AL_&O6S
MJO[$\:B1K3>4B:M89OZ*Q3_<<&A/,HQMZ-!2<OQL%8XFS5;#$Y8ZS?D=.L%'
M!T(*.E7IF'W>:NC&3?5#,T%/7G]FK71-?NLE^\GF2."P0:&H/4C1YQU\MU?P
M;CYI?H<Y"1I@F$S9SU?7G;\?V\4M(K4I;S?"R?T&OV,$P!-5#[0511ND!S8=
MF.44_L>V",!!\SB*!AWB>4A_/ZIB\P+K?B;[FB7!#*8\GP;+9#+H9!\/7?D)
M"49A?%2"D?$4]'M,@LO_%Q*<CTAP&=%?7X*+(%E,V#R!!<)L*$'S^/^>\Q\)
MXE-%<=QLE&%E#-<I_B;B\%B/J=N@\;TPFV%>[8I*L;B5UN[=E%O:2X&.=9%+
M:[A8,*-BYZT0Z*Z$RY=FK^R/7\RZ3JD8A4;Z&1Q#VFYNN3TN]"UNZX><2WM2
M1HL-U\VAAO8X M6%P8$,YX!<F9.J;N0_<]IT2,OF,UK0YJ#=+>H7T7.N-W9#
M8V^^1:!MNJQ.FQ2M$3);UT6&>\X0>\S>$!#=X:<5=I\N96I%=<([>[S 01HW
M[B# 8.T06>X_9RM,M) ];\,,MTE;')C)!+3A >NQ<J],%!].NSVKB17KE1!%
MYPRJP*.>3AJ&JCO"=.K@D@T=G4+:)85/CV67 A?]K(Q(FC0:5'E453Q--6@[
MDQJ$B,5R93;ZAW+\TC#?5':Y(68/GVQPDPG<T09Q6=FLT>U5ES6IB;9+<RYW
M.$=)^V=N[WB $WOD'7?9!,X#3W/L52E1)YCG9YK?<SR94!P5R=,2V*>*RDZE
M/9DO1Z*Z5] &,:F],%\?X $*=!=6G,ZZ;4%?:>^DPYB1-B<&S,X,^4U*7?HQ
MP.CI*:>L//1IT1QHL"CM=C/GN%8HQY6ZLU5J61KWEO3<6^M#+GNN[+AD<;.U
M/07>NEP8"'2Y4P5^E9,;,X?D$9(D[WC$$4.Y.=;1#-"N.#SH&&]#C^\E" @W
M-?&S#I()O,/S"X39FC;94-2#2;G9NNVZLH7)*$-VT,ZQE&YH:D[Q^**QC_I,
MN7,;9N/GU E(SYXM@P-:[9DC?X-E"+E/3U*9-U&:EO<A#'I7VQ2-V1R"-V'9
M':;_^?IK<WX>C,I8TU5=0$BV FM!CY8X9D7#<X3/2ZB';8>)W=/3ZM-O3U5]
M<:$8]NJ]H2G4X572S1\QIWX_*!0F,UA!!S.O$)@$D^42<\LH@3?315NZC8,%
MY*3#?+.I1CUR==04FU1R%H]>)]XV"5X;T6!V]P--86Y*X(MI9\()U:TI38YF
MU"**XUZ+9+K\CISRPP/Y*-!!M&S*0^CFR9% "!62MOO&D04![+E+]>XQJ2W'
M@Q&#L@ P\ 2LT^H=/V/JK+@OV2_K-;RG%+1=<U^W>8FW>!C[MN_*^U)R)R"S
MP^]!<4<6N# ?339/FT].K\V7EFUS\[WJ3Y 88CS.Q1JZ3B[GTS-(R>@;4'-3
MJ3U]=[E25:5V=+D5')P6-H#W:P4!R=[@ ,V'N&__ U!+ P04    " #X-5!2
M2SDMI( )  "A&@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6S-66MS
MV[@5_2L8U=.Q9QA)?.B5V)ZQG>YN.DWB2=S-ATX_0"0D84T""@#:47]]SP5(
M2K)EQ\WV]44"2>#BWH-S#R[!TWMM;NU*",>^5:6R9[V5<^O7@X'-5Z+BMJ_7
M0N')0IN*.UR:Y<"NC>"%'U25@V0X' \J+E7O_-3?NS;GI[IVI53BVC!;5Q4W
MFTM1ZONS7MQK;WR2RY6C&X/STS5?BL_"_75];7 UZ*P4LA+*2JV8$8NSWD7\
M^C*C_K[#KU+<VYTVHTCF6M_2Q;OBK#<DAT0I<D<6./[NQ)4H2S($-[XV-GO=
ME#1PM]U:_\G'CECFW(HK77Z1A5N=]:8]5H@%KTOW2=__(IIX1F0OUZ7UO^P^
M]!VE/9;7UNFJ&0P/*JG"/__6X+ S8#I\8D#2#$B\WV$B[^5;[OCYJ='WS%!O
M6*.&#]6/AG-2T:)\=@9/)<:Y\Y^U+NYE63*N"O;1K81A[Y3C:BGGI6 7U@IG
M3P<.,U'_0=Y8O0Q6DR>LQ@E[KY5;6?8G58ABW\  +G9^)JV?E\FS%M^*O,_2
M.&+),!D^8R_MXDZ]O?0E<3^*F+V5-B^UK8U@?[N86V? GK\_,VW639OY:;,?
M@?L@T,_:HY1];=<\%V<]Y*05YD[TOC,)ZQ[[E&32,M[F)-,+AOXL7Z$WNDH5
M+KDQ&ZF6C%>Z5HYZ+5LC\PVS8HDT=0P2X;MO!#>6"5IYAG43U1P>M&OGG4J&
M\>PUG *CRQ+):=GUBB/'\@W[)!R7Y8#](GCI5NR*8PENM.-PEY=<Y8)Q]]!J
M/&5'+$FC=$J->!A-AV,TLBS*IAD:DVDTGDS9Y\9/B%<IE\JWXUG&_OB':1(G
M;]@Q+DZZJ^O:  :+^?*<HO;Q%[\A)6F@[?JU_W$TG,3-;P#].#YA\:-^SX0Q
MHR!&TSB$,&'9*$K',9O,HDDV8Q?YUUI:Z3Q>Z=;M9)*Q=#@%9^^$==(1:;%"
M7Z"&PEC?:_*&7>D*0FZYU\)Y;4$D^SB(X]%P=-+\/NTH5M'C/8Y'+=X3PGL4
MQ2D]@L.C4<+>UH9 :RGQ%",BWZ,0.=8%<+^ <_?<LK618*PL-ZPP"%P1$;V=
M?13HUDN0B-B:&R=Y65(2+" "9+";D5NK<\D=_+^7H*5$NCAAT!_TV"Y+_V4Q
MQ[,0LU2_/^;U=VCZT'.:YT(XQ7?YU$=N"/9!.\&2P(7QF^9OCW64NSLT:R%M
MD24!6-3&D[^ @M:VV;N7W!0M+"_BY>XJTJ1/>-V@O464K'&U8;RTNLUS$8;G
M>*3#0 )6 IM&N"QS&H\- EIKU>#42B >45=4089[<"M=B""MCJ984'W!5A!2
M/_]*B@7[V'7&PDN/P7M^2XI ?2CR9/CFZN/;][X9OSF!G3NJ-T"$4&?Y@@53
M5%QQ[P7&M>#TL4E!LN$M*H_ <6CXCJCM0T$/2IU[!M#]'4)L1;Q)=41$73HQ
M_HP-1>8B+/RN(E\*)19[$%)I5#!R&S.6G&HMMN#2L#M>UIAUO3::YZO^=OMY
M!_^D\2J\DS4(QA3L:XUL!&"(;JXQZ=[.L1\?L";,,#GY8P3H87#!E:J1G7([
MB0.C[&Y.]=D-[ 0<;2,6E(P/ATA5R!8_B"'16_A\5'JW\Y[E"Q<<?WK_BU#>
M576#5+<26WN6W=,\1^-^S.9AFPP._^7F"DZOM?$,JY4$_>",^ 8DI, R%N0Q
M!,!L7J&8]+MY68K 9@I@Q>]"E#G%%"A&,S8IB=7&?-)MB Y+TS"[2\V   /!
M13!'2&@CEU)Y]:2\K8+>K(3:S\J\69R/E0*B1D2H 5#7'3<IT=[NT@*Z"*A&
M%+>V>X% .LL:L:&" ;AY*</&[O#G)0<.0-/#4YWG->8'G_UMLFIO@2@<4;6Q
MA.*"YQ2RI$%A-R)UUTT6+Q":RDGL5R$'L-2JKH31M7W*U*:IWB%U $+FJX9H
M?G60)!@_#P1O^R&%U*VIURZ7P4DJ;"+/EUR3L-<8VUDW0E9S3.E7CE'Q1]4J
MQ.$GC72_;].I7A>T4(W@Y35$#MW)9JG5\A6BK$BV1<X#T]F?:R6:F;?,"'C@
M]>-!#M!/DQW:V.[1 8IVW.J87O$-F[?9YA.VB/PFYK>*<K,W_S;)N<*,M#C5
MH:3Q&<NXSV8?23H,!>*!7(>OK:6'!BST?"?472%K:HH#24AY$ B'<0\V=#\V
M:N:G&YX#1VE_UN8V+>$KQ[\=C K$-\NN3+ BIVUJ1R-#A,^I:%C1?X]NMI3T
M&5B\1 \9O1D8CGQ5O!+[9=)"4\5PV-<#*%?2VL;GEK>[=5'M-[%FM]:*(D%B
M-#M8EVFE1+0%I5%X&C5Z0K-HL,9B)Y4+T)JP?Y2>&\A[4<A@GXA*;NZ0U=;S
M2CK*])!]!1S4OPFOMELI:;D8Q*%AW.[$O)MC5XX\4QZ$NY6'5OA]N+LH/)).
M"O6'Y''7Q7V_&GK^7K7\5P7OLJT\PO;] '.J6_]+4M:6OO\)22N^ES#_CP*G
M=CE\E/23'Q"[IZ*]\$$^\3)I!)U'DAN/2MS&[!/A'65IW!Y*] ^<"]UXC[H-
MEM.C0P<HC<AV5)%;2SQ8XH?]/WP\$J&ZR\4:/OI31N+,'7(;*)5R(=C/1J,P
MN\B;@A*//^#]]4O;U]N](?F%B[>6'8/GJ-X1LWA5HOHL3L);?#:CXY/V**"[
M]6%PP:Y:$:3$I,,P.PA5/IQ;R76;M'@GY52Y*NV"+N'=CMXILV@V2MCQ-)HE
MZ0F+Q]$PF;$XP^YW(_*5TJ5>;NCH9#QDQY-T=L+2)&9I?\BNC;Y#"6N8$LX?
M5+,L2H8I.\ZR(7I%DW&*\-#QUY:[EVV=>M$6FZ,9K,8QK&:3./0.YS,I8#E.
MQC"$>2?]27/.=,2R.!HG*1K'!,$T)GRP0'&6,!2C23BJ^9\".HJR;$* QLD4
M@$ZB-/: 3@\ FD['B) .B9X$E'!("/9HUD+T/4#'6,A1,MG#<YS!3IK H31A
M4[RW=( F43R:$:"S:)A./9XI?(\)SYA=5)2'_PB["+W'*"O\8<+CM'%D$3Y
M3=)632*ZRCIM(>2.8GC5WGC1N61S ->DW]1+V5KX;P;E)HCK=A=OBB3^E-\O
MDX"VIQ+?'';-N]9#Z=4AR(S=/R:%IS&=O45)-J,+$#*:9L1(\!7-V#<S-">3
M(35'U(RG[-#9]6#GLP&HN/0?1_"20,=(X0M"=[?[_G(1/CMLNX>/-^\AV1+^
ME6*!H</^9-1C)GP0"1=.K_U'"+P4@_>^B>H 1*0.>+[0VK47-$'W5>K\GU!+
M P04    " #X-5!2L]?LO8H+  "L/P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970Q-"YX;6SM6_UOV[@9_E>(K!L2P'4DV?)'^@&DZ;K=<+<53>_NAV$8:(FV
MB9-$E922^O[Z/2])R9+CN$UWP#"<\H,42>3[^;P?).&7]TK_8K9"5.QSGA7F
MU=FVJLJKRTN3;$7.S5B5HL"7M=(YK_"H-Y>FU(*G=E*>749!,+O,N2S.7K^T
M[][KUR]5766R$.\U,W6><[U[(S)U_^HL/&M>?)";;44O+E^_+/E&W(KJQ_*]
MQM-E2R65N2B,5 738OWJ[#J\>A/3>#O@)RGN3>=_1IJLE/J%'KY+7YT%))#(
M1%(1!8[;G;@164:$(,8G3_.L94D3N_\WU-]9W:'+BAMQH[*?95IM7YTMSE@J
MUKS.J@_J_J_"ZV,%3%1F[)7=N[$A!B>UJ53N)T."7!;NSC][.W0F+()')D1^
M0F3E=HRLE&]YQ5^_U.J>:1H-:O2/5=7.AG"R(*?<5AI?)>95K[\74,F\O*Q
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MHIP4Z@1$60,G9)U]N%A5[OFW"WFC"A\UV6[40MR)+8M4WLF43-;7P-BLTL>
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MQV<.6,U#I4K[>^R5JBJ5VW^W@B-UT@!\7RM5-0_$H/V!_NO_ %!+ P04
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MQU=,^U\T_!>K-NY7A(6R5I7N$L;F0M,"/%\J99LOI*#]6>GA/U!+ P04
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MC?]>UELF 6Q?,=VI<J-X;@W7SW GHX8+$7WNV@Y;:?@P/PJ>IQ!0FZ(228-
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MCP&O9_NG@U>#T7\,?I\(C'@R]H>!,?YOP>A_(S#&430-QL/R9!1)_W=@=*?
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M*U&FY&=X9)3::8U$SW+)*<^40IUCF*[N2_D=J*KTO)A%5KG,."*FR?<8[;H
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MIAWB$!&8.TG(EF#;X *!OU@F5 I[%)TU?JZ SJE%&-J-_(9$C"VRW W!!0*
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MQT*"*,$&=43(G;#45OO0B&$GVH%RJ0?I6-"<*1\I\7H:C5!50P5J+S<=Y U
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MM4*$6)J ]RL#-!(?:(/N0^/;_P)02P,$%     @ ^#504L?!X?@M#@  C2X
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MM%( KSQ_8, $?NCJ5B=Q N@Q6. PKMD=Q#9^BC^JI'Q@45=.8 ,@2:-$<:(
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M:MI[X.)*0*!$)O,9QZ8X* 15\2GD3 QC6 [N;C"PK1WN=M+ ":;I)*=#]4%
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M34W]IFT^J0MN.H*#M2[[M2TERZ_@!-0:BP(3!QBD*NJL*+"7Q3,/&S/0<R*
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M;"]W;W)K<VAE971S+W-H965T,C N>&ULI5AM;]LX$OXKA"_8[0*&+<MY;9,
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M:0XZ6$$TF9R=C(2+/RO$CV!KOLHO;0BVXM="H0 =+<#\RMK0?9"!_K>=Z_\
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ML-SAA2HM$^#WC3&^V_ %_9OWXE]02P,$%     @ ^#504J$=S_\Y)@  2'L
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M@<5%I O10K&V""J $+2?X^0&K#BD&J*YVCC:*% 2""B62$7N6C-3)SX>-6'
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M1 OP?F:@COJ&$+1G85__%U!+ P04    " #X-5!2 "+WCII<  "#60$ &0
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MCQF&N/KU6B4%'0K*B!VHN&#7M*C6@KZ"BF2!!XRD5>#!T7O:)>T/T5,>_&%
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M0 E%]C>X6[-SLGCF%]_*?W[ '_V*/Q+F5#\5CIPOU8<9V8+P?W= UG[[@K*
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M<>)+,NL]0GM8?$9O4#PADK!+#@Z@?5>P>VX%XJ@Q#RP,_0T]!5)%MC;8=8X
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M3 ,T(5+"5^Y#0 CVC[SU]B,Y0L(<T8G-\>BN;P<%.1*\"FX@5;21A?7"8"^
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M#E?H%DK*T-]CX'?#*AS>T,<MF*[Q0A$">)XQ@3=[31"BS5/-KN%_B[^> K9
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M%1#IMB.>D&TDB!)/D<M+4\VYNQ891*2H+&,FZ<8DD"W!<?3+'D?_Q:M?6KM
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MBJ'4N(Z+AY!9+E?IFJ&:CW-5+ E-9\7!WV.(]SOE]/%":EP=W)<1)VTDEBW
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MUVMM@<1@EB^P]32( 'GME;>*J$K"SS1+"M2\L)L+@=7=-^$57V?S\_EL/K^
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M9.?S\/KY[&2N>X6K??GF9?;J_!P.^\VK\^P-;.@%'O4I+-]OXSF\'P[@ F@
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M!BE9XK5 /@HD'BHP:%]H7[V>-@H_3)\"I[T.3]FZ4XO)K7&9?A%ZLP-XU70
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MHOBK0@ YJTL$[$Y[<96=O1R#ZR\O/&KO- ;MG;_TF+VG:R$1H"_)=_%YJ>7
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M 7R_:IJM_@-?@-$CFMZ?_U]02P,$%     @ ^#504E!0AGOB"0  &QT  !D
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MQ%3W):Y[,,W&?OVZ:0Q"L+U="Z0@11NPOFP:,SP0@O%[Z,5_ 5!+ P04
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MYPHO>79R ><+BX1I%V)@_[_![#]02P,$%     @ ^#504I3=1:6:#   ;BL
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M&)">.UXH[JNH4J4ALCI/XF0=I:V88']=T$T,VY;U;)X\)"7S;,'H'LQG=;2
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MY(SE8-NP:%,,(L2>BOZ!>#IP>6)<W?:\MAR='$.WXZR0HD$_>M)QQ*X53-G
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M=>K@:,SL.\-^UX0 '+!)*9_R#C8$8,9'\3CP(8&DN N0N5!_<[!]*(Z/HB)
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MI@%XORB*:G-#"W2?V+[^+U!+ P04    " #X-5!2V0K^(7<'  !?&   &0
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M+W-H965T,S$N>&ULQ5=+<]LV$/XK.VJG(\^P(@&^'5LSLI,F.23UQ&Y\Z/0
M49"$!"04 +*L_OHNP(?C6%9\ZT4$R,4^OOUV%SK;*?W5K#FW<%_+QIR/UM9N
M3L/05&M>,S-1&][@EZ72-;.XU:O0;#1G"W^HEB&-HBRLF6A&TS/_[DI/S]36
M2M'P*PUF6]=,[R^X5+OS$1GU+SZ)U=JZ%^'T;,-6_)K;OS97&G?AH&4A:MX8
MH1K0?'D^FI'3B\S)>X'/@N_,=VMPD<R5^NHV[Q?GH\@YQ"6OK-/ \'''+[F4
M3A&Z\:W3.1I,NH/?KWOM?_C8,98Y,_Q2R5NQL.OS43&"!5^RK;2?U.X=[^))
MG;Y*2>-_8=?)1B.HML:JNCN,'M2B:9_LOL/A)0=H=X!ZOUM#WLO7S++IF58[
MT$X:M;F%#]6?1N=$XY)R;35^%7C.3M\JM=@)*8$U"_C3KKF&]XUES4K,)3<P
MOF'N>7(66C3FCH15I_BB54R?44PH?%"-71MXTRSXXK&"$+T<7*6]JQ?TJ,;7
MO)I 3 *@$8V.Z(N'T&.O+WY)Z ]!P\P8;@V\%J:2RFPUA[]G<V,U$NB?(V:3
MP6SBS2;/F+U<HR$.HH%5Y\ A<(_J<)5Z:C:LXN<C+$7#]1T?37V%@3# ^A(#
MM01,*53>I'$V_99IO1?-"EBMMHUU4KTK,-^#X2NL.@M8\5Y\SYDVP%T6 7/
MZSF2I,^#!X]&I#Q%")&@4F*M&;A:,RR9:@^?N&5"AO".,VG7<,D0SAMEF80+
M)EE3<6#V1ZVD@%^!QD%<N 6)@B+*<)$D05(DN,B+(,L+N.[\Q%XDQ:KQ:U(F
M\-LO!27T%8QQ<S+LKK8:83!HKZI<U#[^Q1>L,'?0#'+]DP113KK?MB[&Y 3(
M$[DC890NB+0@;0@Y)&D09P3R,LB3$F;5MZTPPGJ\X@>W:9Y '!7(OSMNK+".
M@)BA6VQN7!LOE;^"2U5C7S;,M[;YUB!!S-,@QFF4GG2_SSN*6?1X9R3M\<X=
MWFE 8O<)'4Y3"D>XGP[<3X]ROP52/-0:\[5VJ ".*[I!7BZ51,*[/%K7I XR
MW\'$FGV'FGEJ&A].]H6\#H#?5WQC8>>[/18$N^,:AQ=(L>3P5BM,PJRJMO56
M,O?Y(X[5VU[6Z[W1;(%S%6<NC 76U%(TPO+?)69[<=+"GY2.]WT.AU<?PQE<
M^HF ?E;86UU',J'FTK/ K,7&>+<K=<<;YDC=* M6X0LDB^5 DZ#$1(Z+H*0Q
MDCD+(EH"228EW/!JW2BI5GO'^2R"<1Z7)Q!3 O$D@BNM[L0"[3;<^@L#) &-
M8A@G281209[%&!X*?F9RZ_EZT7/2\UQC^&F)6@E!K0G6E)=N^1 C+&.:H2*T
MFT_RKD$@ TF0T1@78P=!01P^F""24"#IA+8U]K\"F@9)DCM "2T0T#R(B0>T
M. !H7&08H:ON9P%U.% '>U#V$/T,T P3F=+\$9Y9@GIBB@[%%(H)>0"4!B0M
M':!E$,6%QS-&WXG#DQPI\&PH\.QH7;[!CE5[YK.FV:)-'$^6W;M)HZWXMVU7
M;K H[RGK0WE:EPAY.WX:?H^S"+/9#J)#O>*H3X>'I6L@&ZV^X.7PP=E'7O)[
MUV#Y, 9_WDIZR1\\]HW)=.W*/)Z3V!*(:[X!Q8F &R1V4"2.V<A[7!*_3'"9
MYY%;IFZ) _)0KL+OKH%(Z96_[!KPXZZ]$0YOA_OTK+U&/HBWE_$/3*\$^B?Y
M$H]&DQS;L6XON.W&JHV_5,Z5Q?KQRS7^)^#:">#WI5*VWS@#P[^,Z7]02P,$
M%     @ ^#504FA3ES'S!@  :A<  !D   !X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL[5AM;]LV$/XK!R\=$L"U]2XY2P*DZ8H5:+>@[;H/PS!0,FT3E425
MI)JFOWYWI*38B:VTVS[6'T29+P_OY;GCB6<W4GW0&\X-?*[*6I]/-L8TI_.Y
M+C:\8GHF&U[CR$JJBAG\J]9SW2C.EG915<X#STOF%1/UY.+,]EVKBS/9FE+4
M_%J!;JN*J=MGO)0WYQ-_TG>\$>N-H8[YQ5G#UOPM-[\WUPK_S0>4I:AXK86L
M0?'5^>32/WV6T7P[X;W@-WKK'4B37,H/].?E\GSBD4"\Y(4A!(;-)W[%RY*
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M8H:47-,&7+]7RFX?2$'_]>?Z'U!+ P04    " #X-5!2D_YM$^D%  "%$0
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M$;&(^9IBL*HN\_;2QNR=JXQ&['( Z:F8?&:#JZ<-(RL10^KQ=$VT<1TI<Y.
MGTLI4(BL#(1#84Q49! ?A"K%P";B&0($5ZN,17S%&3QFDHNEFI/O4HC2.$8=
MC%O@PYZ1VYK-(?EY9>S&O1',6_,T1:G!5B^,2C(DP<AQ9W#U1Z%G R?-0%%-
M(@A58@<A<1R?7$<ZIY+3F,1"*>+9+O%=JV:1T1?T+\2QZX?G^#D][^3/0.>*
M<S#R J?DOM.D89$Y^4"Y),\TSHUO&X^Z- E&[LP'+8+ +>2-H;[I7*9$M,B2
M:>@2>V0%'KE+LEB\@-DC2"')%[DN+.SC_U[E>B1KZQAZ?BG9AQP3E"A-=:[
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M@%XWZ13/U_"P-'2:!N4IY-&^.1&##DW9<GA?1C5^$+=/SBA6G:.L<E"65<=
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MIUL4?HY2-[11^-\JNY\]#4 "[6# QAVKL2G"  M*9C<F=A%V9]MDTZI\#8M
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M/*71 OR_T-JM;\C YA7-^?]02P,$%     @ ^#504D8Q1DE3 P  W@<  !D
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ME:7WP$]+>H!1NPMT7BAENX43Z)_T]5=02P,$%     @ ^#504A/DT ?< P
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M#<,  &%("I:6[U6IC+EFB9=.IRSU@CBE3UQ?!5[DI]?L*O.GURQ(/1^J?R^
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MLKJ[J=76_L1@H>I:;>SE6G @$"W ^Z6".]H;8M#_YN35_P%02P,$%     @
M^#504GM>?"Z_#   DD$  !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL
MQ5QM;]LX$OXK1' '=($DMMZE11H@39HZW60;U&WOPV(_T!)M\ZH7EZ*2>K$_
M?H>4;-H61:GMU;<?MK9%#F<XP^<9#JE</!?L<[DDA*.O69J7+T^6G*]^'8W*
M>$DR7)X7*Y+#DWG!,LSA*UN,RA4C.)&=LG1DC\?^*,,T/[F\D+\]LLN+HN(I
MS<DC0V6599BM7Y&T>'YY8IUL?GA/%TLN?AA=7JSP@DP)_[AZ9/!MM)62T(SD
M)2URQ,C\Y<F5]>M#Y(@.LL4G2I[+G<](F#(KBL_BRUWR\F0L-"(IB;D0@>&?
M)W)-TE1( CV^-$)/MF.*CKN?-])OI?%@S R7Y+I(_T,3OGQY$IZ@A,QQE?+W
MQ?.$- 9Y0EY<I*7\/WINVHY/4%R5O,B:SJ!!1O/Z7_RUF8B=#K;5T<%N.MB'
M'?R.#D[3P1DZ@MMT<(=V\)H.WD$'/^KHX#<=_,,1@HX.0=,A&*I2V'0(AW:(
MF@[100?+[7+<>..Y\= QK*VS!WO;VKC;:OF[L\O&X9;T^*B.11G(-YCCRPM6
M/",FVH,\\4&N!MD?XI?F8N%..8.G%/KQRRE=Y'1.8YQS=!7'195SFB_08Y'2
MF)(2G:'?,6-8K"[TXH9P3-/R%U0N,8.'-$</-$UA 9:G:$6*54KV?\M(-B-L
M][>+$0>MQ=BCN-'P5:VAW:'ANYB?(]L^1?;8'G^<WJ 7__I%(^7:+.5ME9ZC
ML26D6%$C!::7$8VH&[.H*5F=(V>\)THCY;59R@-F(,7JDW)KEG)#XHV4[>1(
MLVIO3,D"0);7;HBA,XU7X$OXJ>28D]J-FE'?#!Y536:7K,EP66'W/-P-EQ)T
M2WD[7(JKZ?Y;3XSA?!-CIDB]-TNYJA9# N-AP*K9F++":Q$&^U)&@!1;N+"W
M<&%+L<YWPL4?]] !W7&2E7\:AG.VPSER.+=CN-\KB1_%'*U2G#=P4J*_FT^Z
M]5(+]*5 D;4\75IC[V+TI-'"W6KA#M6B63RH).R))(!Y#*T)9J!1\TBGDJM1
M2?ZG5\O;JN4-5:N&WD:IOYOO.E6\EBJ.J]?"WVKA#]0"0*=@',^D)A)WA*<:
M"-(IX[>4Z= EV.H2&'6Y(7/"&$P!CK]4M*0R-8R+DNMPZ;:6Y>T,[[G^@6-J
M-&RWM .C"\.MPF&/PI!MQQ0+174JAJT9LIMQ6SJVFUJ1ONDD;)EC!:VF>_9$
M6WLBHSU303V(27MP2O_"M0> &A9:;KB-6EH?VM5N83N'<U^;99*U9XTU5LG1
MV&C/7;;"E(GX%0&>%OGB+*5BC>&R)/JH:B2:3.IO,M$T<1V3AZR=A,\RVO2F
M*))GR,80W1JG-\3J-Z2WR433Q+?<R&B*(B/+_@;WT)SC?$$%_M3N.86?8 \'
M60\GM=^T=MJMY="RL[?)I&DR)/H4^5EF]KLJ83L-P0:&$<BMN%A8P+&PHF0D
M)E6]T-""%=4*I70.AN=)_1!Z9"B&E SP+^<,]L=Z)YLU\,ZM\;^U^>$W]]N?
M T6]EIE[)],KV)@#^<=Z &FZ[V-S!T3JVMIFX+,4&5MF-IZ25(1@"4X!7<$;
M>$938* .M=M$'&WT/M2ZW33T#GEJ7VG%W9:9O-^+#5T.(08Y3 Z)G%Y7OS5M
M9V[DNQV3W&;U,]>SQJ%18\7PEIGB'X%+,ARO(=N8P6H0&1@M].O:+,@9HP2O
M2U.0*A:WS#0^(3CER]K[D O-B3;WLC2\.^X*U3:=MQ!'P_C>80CM&Z1HW#+S
M^%7R1!B'# IR^\[\J9&Q:X_K:ZGYC::I$VESK8G5IG%G$VMZLVQ%Y[:9SC]<
MO[U"'']%Y.N*Y"5!+V8D!X+@VAUG(VS/7YX9+FS%PK:9A5_5 ]=Y\Q-.JQK*
MX6M..+KY<(^2BB!>(*&S;E=MMXFUG1KN*[>SR3/SZG619:!,R8OX\^FFV+,D
MJ: BQ%D%5/0"/M4/?H$DOW/S?VNW>=$Z" YCDWT+%'7:9@+Z=/?Z%!7/.>P6
MEW0E4"*&+ $O= OS;8\L;WP^-K*9K=C,-K/9':0B%*=;3J[@LV!J[<R915EC
MN?,T 9BMR,L>NI7\4F$&&J5KU!0-2C1G189@0N4F5U-(J,L1MF9K&76X4?&3
M;>:G1U;$A"1*!^U$M?G)"@^3Y2;4!C>=V&T>:S?=-TN1F&WFGM<U_#1F023D
M)9;G&"5ZID DC*3 ;0E,-^-KK<E!2[E62M!8W&[IV'J#VRU=SVBOXD?;S(_O
M^!*B"W".Y-6/6-UFO$"?,VE:=M"-IJ7EF,U6+&J;6?0:4)'6!1&YX.FLDB /
MJ'[]:8J:K.&VJ/*DLP)@M^EPPT&'-FN(T\@'CN)-Q\R;CXR<"=JD>5QDL+\G
M<;'(Z5_Z_933WKI&&S<=ZJQI&T:1UJ<335O+'1L384?1L6.FXX_GTW-T0T3H
M;;:3C7O$CFI293A'4\*>*&Q#3M'5]15Z3\O/Z+I@C"8%0^])3.B3<'6)_GB0
MQ<D_9?&+\Q1"^AY@?Z'Q\;ZVBI^=XU1A=\JP9@I\ [L$&<,P#,GC]2FJ<A$%
M+!&UD$PHH"MT-U+WTC[+B*&.HE+'S']7<E2$G[%40F)*(7&F"S]>.>W]7Y\Z
MBD$=,X.*4V08>]&:*+581/(45XR)^*JW+:=H1N:B8@:+2[N4-)PZ-J;XCJ)6
MQTRMWZFPR$YA<70IW.97VS;/L")-QTR:L!X93^5RE"M3%C<V:](4Y8JFG/ H
MRTH1A&,F")5VU<=Q8L*?ES1>(IARRM>H@&F7#_ZN6VCGO(W['65T5P&^:P9\
M" X"D]%X'W;;DJW3>H^"D__"#D!3-]P?3&&O:QUCVET%GV[/]J;*JK0^TM;;
M5:/)U;OK.T12FM%<YB75"AHET*L$WU3:D^-;M[^8Z+:W.V>6=[C#K3E/T[9C
M';D*RUTSEM?)V-VV4G7?5:G:E[]S6.8>Q9T*>ETS]&X,6"/ 4B"F%:8)BE-,
M,^V.U&V#JJ=/B=]HF@9C8RW"5?CK]N!O)6((K<2TK%%3A] KK#DG\SL4;C?U
MS)4W5^&O:\;?.F[N17'Y@R@N?W,$*1QVCX+#KL)AUXS#WQI!;<35%(8:CVC:
MAN8ZC:=@VNN!Z<$QY+5K65Z7RKJV?H_*"NP]<Z+]0'.:59G!;9["<>\H:;"G
MH-,S0^>C3((0GG-8"8DH/POJKE,0A.N(0;1$(GZT7C"+]U$&B=C2M(@\!<->
M3W[<?7@$C%;OLV4Q!ZV::YC;@R+92!S9HAB79/M\5I4P1EG*VM\2-JV,)*"M
M]M92CW+.N:,_5^KMYQDK<=[.W0DS:=SM3HM<]ALS18:)\[P2<$!SP?9REHS'
M:#V#N5W':#W]>LU5;..9V>9*;).03%U@A70?FO2(<7IKCI[B$\_,)PT20&K[
MJJ)I GK!=JCY),ZF6?%$Z@*D/-0D$(K+0I2@=QZ9%%%TXQV%;CQ%-YZ9;CZ6
M9%ZE]8&MN+W#1)H/T2;N.'%I+?E2T577M9D>Z9;TD4%17_&+;^87Y:);^E50
M37FJ5).*2G3)<9JN44*>2 J6)*@LYASBC9AT4(3A'V5WX"M6\<V[@Q_T3H_T
M_A7D*SKRS7SQ@+_V<*FOZ,(_2M;N*P#V>[)VL: 1["[)L^$0I$>(US^;._?8
M>LX:?I#<>\2[83^[^PH\?3-X_G_9O4<YR^JB]^_HN#]!"M1]\Y'#_Y;?>P;K
MO";3V\\VFZLHQ>\YL!_([SUB^M=3H,@CZ"&/&IU^%K\'BD&"HS!(H!@D^*D,
MTB/=[3_X#12%!(,HY"<P?*"H)S@*]02*>@(S:_RH?\S2!QS,!XJ4@IZ\??I1
MW.#WSRP'?+13N'P]GY.8GZ*&M<",JZ18B3KF*7S:%#)-.NQ<J@Z.XA^%W8$9
M%H?<2OLM:-^F.C.>- 0*3 ,S"KYB^"^:HFDU*VE",5O#U-_0LCXEJ4"O=[(L
M7[_B! ]614FD"V9K-,4I$:OIQPOHH4+:<'P,!X4*44-S$>?G%="OFY'W+UT9
M2ZZAPN70C)PRKM(1NO]P;9H&!9ZA<Y1Y5T@9#GT11;[C51\+Z=]ANPW;;YU$
M4><<*NP,A]X4@K3]\QD5+^4D, 4IJE\O$SK5G[1*M0OJEM6IE$+)T(R2W_K:
MP4W8/J?4WP]YK6G9<S\D5, :FM/=@3?Q)V'[9D[?'?IPYPV4 6!;+PJ1JOT@
M])G"7.%O&!UC744*0"-SJOH-Z^HZ:E]#\;K>FE& &ID!M;EKHHY4'EF15#%'
MPE*3B0K[HJ/4RB,%CE%/K9R1C$)F*5[ @!%R>65;OJ&F?0^H?5/$TE\EUK34
MGYWJ1.IO"XUV7I\6?ZW@ 7"#YB7L2>;0=7PN$CY6_P& ^@LO5O*-ZEG!>9')
MCTN"$\)$ W@^+PJ^^2)>TM[^&8;+?P!02P,$%     @ ^#504ISY4I/3 @
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MCKCX]0AW85ARYHX25R:T0,XX\2PS:]&S22, [V+"*K-OH(PS90)@+V9>919
M:#']?0KA>EQ[7AF6Q!X)%CU#10+LY02?W).;<9Y, OWES)Y9 JOE=,\LA[<&
MAR5Q4'+>:F"^G."3^P;.L"&3, /(F=VR!%;+Z6Y9>M_(0/;&C$]&$;4W9CPR
MA55?D@#2<H)9[DG2D$F3G5?.9K;,$B@JIUMFZ9I=+IP9U*?2TIY]O'7UI0?
M+,-@7N7%4UXGR"P'HZ^ FFIFBZP DFJZ158>BVR_MKGRB>SW:V*/J&=J4<!<
M]4[O9B@7G13;C\0>$</V [%')%"/?U& 877I&QK*?:.".9[8(^)N#UR10#V[
M7@IXKL*.WAX$XXR6 HBKF5^]4(!;%<9M<#RX_M6>R8<E<5!RWFK M0I;8$\"
MQKDIU7ES>&:SJX"I:KK95<-F=U@2!R7G+SP#M'78ZOH&P;!ITD!J/;.=U8!6
M/=W.:@\#[0G9HW'>$O-H>J8$#23589)Z4C T*6N G)[9M&K@G9YN6K5O3<&.
MOZNQ%Q0\DKX1 .S4879^RBI3E >7&OVX2_=IUL8J>/\#X_3,EE0#Z_0[;;3I
MX27=84D<E)QWH7/^XM*--NTR\'N&*'$&LT^'&77N*(^.4HG[WDE'W:,88;3V
MWECCC 9&G5,::.YC&JAS3@-=<% #N8"L\X.0G1^_$#-L"6.O,)BASGD-%"9O
M*$,C3]*@SH$.-/>)#M0YTH$N.-.!0AA]R\^@)@YKK*9W#G.@B4 >YTTPZISV
M0',?]T"=\Q[H@@,?:)C)(S1Q6&,UO7/6 X6Y'$K)X.&;[NDU//,2 CX[VC9]
M$>&M+#^C#G%2XI/9S[BQ3V4G9=DYS+TWQ:8]%%]&[='LP['GTZ^GD_<?V^/F
MUN^WS8G\]I X5',XSO\Y*39IG;*=>:RK1!^:I;_B<$#^\*7*G]HCXU_SJLKW
M[<>M21Y,T0CJOS_F>?7VI;G Z?]3</,_4$L#!!0    ( /@U4%*>-T/ 4 ,
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M7O2=KH-F,"=+IA_$^@>4!>4)QH*I_!>M2UO/0?%2:9&68)-!2GGQ)*\E$34
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M\B#'@FR8?A#;S]CE,[9\F6#*/6';Q08>9!NE1=V!C8.:\O9-7KISV .$DP.
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M.RAM@-DOA-"[B17H_V3)'U!+ P04    " #X-5!2;/['R-$%  "9&0  &0
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M5/4U4]T8N2N/ZTMIX/!?7F[A"Y I&P#/UU*:EQO[!=!\4\Y_ %!+ P04
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MS/BK@]8G\/G:&-IO/$'S'1O_!E!+ P04    " #X-5!2[ ,P;4L#   <#0
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MJ#  _7S%N7H=F -R\4$T^0]02P,$%     @ ^#504LYS*<'V @  S D  !D
M  !X;"]W;W)K<VAE971S+W-H965T-34N>&ULO59;3]LP%/XK1Q$/(%%RZP50
M6PG:34,:&Z)B/$Q[<)/3QL*).]MMX=_OV$G3,M' )L%+X\OYOG/YZF/WUU(]
MZ S1P&,N"CWP,F,6Y[ZODPQSID_D @O:F4F5,T-3-??U0B%+'2@7?A0$73]G
MO/"&?;=VHX9]N32"%WBC0"_SG*FG2Q1R/?!";[-PR^>9L0O^L+]@<YR@N5O<
M*)KY-4O*<RPTEP4HG V\B_!\%,86X"Q^<%SKG3'85*92/MC)53KP AL1"DR,
MI6#T6>$(A;!,%,?OBM2K?5K@[GC#_MDE3\E,F<:1%/<\-=G ._4@Q1E;"G,K
MUU^P2JAC^1(IM/N%=6G;(>-DJ8W,*S!%D/.B_++'JA [@*BS!Q!5@.@O0-C>
M X@K@*N<7T;FTAHSPX9])=>@K#6QV8&KC4-3-KRP,DZ,HEU..#.\*E:H#>EB
M-+3@&U.*V;K"X1@-XT(?T>K=9 R'!T=P +R :RX$U5_W?4/N+8F?5*XN2U?1
M'E=A!->R,)F&3T6*Z7,"G^*N@X\VP5]&C8QC3$X@#H\A"J+@A8!&;X:'9PWA
MQ'4M8\<7[^6;&IA@LE3<<-3'<+&B$K*IP!:=MY9F N'G5P+!E<%<_VIPV:Y=
MMIW+]AOD4RB8P12,M E%D%"Q%1T3.UBAL@?O)=%*!QWGP![ZU; 3M?O^:K>.
M+]C$O=KF6>2=.O).8^2WJ'E*<7,F()?*S*EIM*8L>: ,=%W#AA)U:T?=CU*E
M5[OL->9V[YH')<*H[I07I$M[K*AKR=G>Y$HUFHDC>$*F-+2I9.XD16U(V5-3
MF4[KF$\;J4<RSU$E_RW'6>WG[*/D"(-MDPO>2Y!7F+N5(F&I"'1?TR/<Z<QA
M(_5WDZ$"IC6:?U(BC+8>H@_38MLDP_C=M&AF#IT6;Y#"W[DOZ4\_=\\(37UR
M69CRZJQ7ZZ?*A;N@_:UY^<ZY9FK."PT"9P0-3GK4]53Y="@G1B[<[3N5ANYR
M-\SHN87*&M#^3$JSF5@']0-N^ =02P,$%     @ ^#504A+*Z;]S!@  !B8
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MZ.^?BT+]/*A>!=J]^C7^#U!+ P04    " #X-5!2PS$J_4\$  #U$P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6R]F%MOVS84@/\*(?2A!=)()'6Q
M"MM ZJ!;@04+DK9[IFW:(B*)'DG'S7[]J$M$N1(Y;]#ZDH@2SX4\YWP\YOS$
MQ9/,*%7@>Y&7<N%E2AT^^+[<9+0@\IH?:*F_[+@HB-)#L??E05"RK86*W$=!
M$/L%8:6WG-?O[L5RSH\J9R6]%T >BX*(EX\TYZ>%![W7%P]LGZGJA;^<'\B>
M/E+U]7 O],COM&Q904O)> D$W2V\&_AAA<-*H)[QC=&3[#V#:BEKSI^JP>?M
MP@LJCVA.-ZI20?2_9[JB>5YITG[\V2KU.IN58/_Y5?NG>O%Z,6LBZ8KG?["M
MRA;>S -;NB/'7#WPTZ^T75!4Z=OP7-9_P:F9F\0>V!REXD4KK#TH6-G\)]_;
MC>@)P- B@%H!=*D ;@5PO=#&LWI9MT21Y5SP$Q#5;*VM>JCWII;6JV%E%<9'
M)?17IN74\G/Y3*72<5$2O >W=*W (]T<!5.,2K!^ 7=$5:,7\/:6*L)R^4[/
M^_IX"]Z^>0?> %:".Y;G.B)R[BOM4*76W[3&/S;&D<7X+=U< PRO  I0,"*^
MNE@<IN?BOMZ&;B]0MQ>HUH<M^FX*+A3[BV[!BDOE4(@[A;A6&%H4_D:E!"HC
M)> E!2^4B+$]:G1$M8ZJZIZ7$"7QW'\>L1QVED.GY=];>]JZX,=]!G:Z6.HW
MHV%JE,4]%V(<6ER(.A<BIPLW.T5%SV[GBJ*EW9-HX E.PMFX)W'G2>STY!?-
MM\J7.A).Z_' >A@@-&X]Z:PG_V"=ZRQPY59C.QG8ABE.31":BDB&R1+-4LL&
MS3H79\[$_T28 -](?J2.I$\[9>D$29\.5XM2.+X,&!B8!5.F?:OM+.]CVV;"
M'E+A_Y#YK=*SY(/(MB6&:1!-E/RMHC,'4A1:'# ,A&X(?N&*Y*/V\, >@G V
M^R'C1Z;!.+55)32$A&Y$/E#)MOK<8R0'57'N==?R?DTV3[I&97<$.@H"&A+"
M:)J#!1JD03?3ZI/:N'FE>X+FG+[2#83*=,,&)"OW.>T^@*W.@]$X#*D7)]BR
MO89Z<!KLP2'W^M;;'!A.B@);G1KJP0FP!PWWH!M\4X9DB,<DB,;7BPP=D9N.
MUDI$0P[VS34Q&)D484N:(,-*Y&;EBA<%%9O_7(2HU]Q-U-TA@S;D1MN$$4=#
MRJ6QA7'(, ZY&7=I$:)A ]BWWB; 2)<868X'9-B(W&R\J B1X2+Z:5Q$0R["
MP-85(P-&Y :CO0I'.L"^O38*PUE)$%B<,BA$,W?CI#+=(Q IJ?IWY6?HB-*)
M?EP9GF$WSR:,-1["#>$X'=]6;.B&W72[M/[PL/<[,]^$?F06Q&EB<=* $;O!
M>%$%XMYOWI\&13S2(8:!Y<S!AHK8345K!;9RD<U>&X;A+!@.3F>_=R=378C=
M$;%GI00YW6FQX#K1\J*Y8VH&BA_J:YHU5XH7]6-&R9:*:H+^ON-<O0ZJFY_N
MIF_Y-U!+ P04    " #X-5!2CK)8 ^$(  !@/P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970U."YX;6R]6UUOXS86_2N"T8<6:&.)%/51) %V,NAN@79W,,&T
MSXK-Q,+(DE>2D[;8'[^2K?&5>,DK4F/T9<9VCJC#:^J<ZR/Q]JVJ/S<[*5OO
MCWU1-G>K7=L>?EROF\U.[K/FICK(LOO+<U7OL[9[6[^LFT,ML^WIH'VQ9KX?
MK?=97J[N;T^??:CO;ZMC6^2E_%![S7&_S^H_W\FB>KM;!:LO'WS,7W9M_\'Z
M_O:0O<A'V7XZ?*B[=^O+*-M\+\LFKTJOEL]WJW\$/SX$?M@?<8+\ELNW9O3:
MZ^?R5%6?^S<_;^]6?D])%G+3]F-DW7^O\D$613]41^2_PZBKRTG[ \>OOXS^
MTVGVW6R>LD8^5,7O^;;=W:V2E;>5S]FQ:#]6;_^2PXQ$/]ZF*IK3O][;&1OQ
ME;<Y-FVU'P[N&.SS\OQ_]L=0B=$!+#4<P(8#F.T!?#B GR9Z9G::UONLS>YO
MZ^K-JWMT-UK_XE2;T]'=;/*R_QX?V[K[:]X=U][_7+[*INV^F+;Q?O ^E=U:
M*/*_Y-;[I6H:[T/5Y*=J?_M>MEE>--]YWWAYZ?V:%T7W<7.[;CL._4CKS7"^
M=^?S,</YWLO-C<>#[SWF,__3XWOOVV^^:^3F6.?MGYK1'JQ'"U)RM'57ETMQ
MV*4X[#0\-PS_[^/^2=9>]>P]G@?-94,,RR_#\M.PH<.PWWN_R*[@[2XKO8!Y
M^ZIL=XWW/X^HS;OS6:+36?KK]?4^C)+;]>NX?A@C&+M@)O3#"_UP ?U_=BNG
M[3YVFD&(V:7*!#"DDRC]!,1E L)Y C-$A::,L<(48V)3J:,+TXA<@#]E>>W]
MEA5'22R[^#)83$X;!M,N-MVTSP.*T9222/V","9-#--.+DP3:Z;Z=:4CFV@N
M!X4KA@1)K.>:7KBFEEQUG%)TPC00"BF,"8)1E2>L A]TW2>7CB+EI' %([<(
MR-FB4:V7TC#P9)J^4@D-)C+4 20\8*Z,[9?4,/:$M,H90X2!,_A#0!O$S'<W
M<./HP@L0.1(S90?R']#Z_^GF\<9[J5YE7?9]PQ?=I+TQ '$.Q#5--P M#:*_
MQ7:'TXR_<<[4PF.,,(AB /H=T )^1>,=SC3FARY&"C*= >AZ0 O[ N<-L&;C
M:F.,L=J@ZT'Z]=[+0(^9?VWW'48<7[W,5]U# PI&7>"4+>@\HW5^F0,SK-_J
MJB(A4[*C+IV6>-J"&19H314U0F^L(N@XXU?S8 ;ZRV;T=[$',]Q,H^\'0PR&
MP4#1&=UO?Y4%,]Q6(\X49,H9S(+19F%EP<,8@N*&(:9Z@@\PV@<>VZYV71'W
MQS+?Y(>.YDE'LW+K':K^S28KO.;XM,U?\P;_3)^>%;2;)=?T909"R^@.^EJ^
MS' C':H_5C28R-!B<I!V3DO[%7UY.!.UVC40@]=QD'M.R_T"7^98R%&U-1B3
MJ')0>TZ',E:^S$=9#-UK+_!ECKOJA*M3UW7>AA\&'*2?T]*_S);YO.QK(":R
M(/N<EGW:ECD6;5Q$C F80=HY2#NG0Q475^8@RIP6Y>6NS.=[<0W$X"(<])S3
MO?A7N3+''3?B3$&FG,$J.&T55JX\C$&YL@9BJ&<(+A#2+G#Z6;RIZD-5=T6T
M^U4<@D*'P37=-P0Y#>GF^5KN&VHZZ%!MLW6@Q%1YD/!P29Z^+)#&>;GZ8Y.$
M3&<P2M3=(_4YIII&/50C:1UHI+)3MB#L(9W06#EP"'H<TJWV @<.-5VU0(L-
M@[AO<+40=#ZT3]'M]3*<UW@2,B4+&A_:!NE:4IHX'%=1D[\8JPA"'M+ABHL'
M"Y!@,2/!BSU8X*9:O9.F@1BN>P&J+ISC=/LU)>;3%@W$H+8"#$,X!NI:;@RW
MR"HW##$HDP G$#/-?%7+_*6T,U\!\BS":YJO&-V(=+\3N<1\!6Z40_5>@ ;#
M#7>9!&BW6)*I+[)>H8G,U2E@B.E6,.BY< _5YYABI49W&C488[5!S@4=P5@9
MKP 1%K:W+NUU$C?.Z(:P!A,;#",":8_LXW-[B8RP9JMK2@,QK*D(9#VR3<^U
MI+ HQZ'*2H,QU1"4.Z*3$Q?3C4!S(\>;E=:+*<*=M"I:)&1*&-0\<L[/'5;4
M?)9"0J:<P2@BQPA=RTT0OVH';A1DRFWTC KM 1]EDV]EV>99T16N;E^R%_G#
M4[;YW)&U,N((Q#J*KVG$$2AKY'YC<HD11[A;9FJJI<%PTP(!+8^6A.B+C#C"
M&3F:@N:Y%OT,8E#XV#U%GV$::UIRU8@U&),1QR#P,9W&V#V7!<(<V][ M'\R
M"W?/>.H8$QAN=L0@][%]7FXOFS'6<54V2<B4+$A];)N7:TEIGBU$-=0D**8:
M@IK'=(#B8L0QZ'#L>,O2?C%1??50!^O6.QX]C^@<F3NLJ/E$A81,.8-1Q(ZI
MN99;,IM DY I-_" F/: AVJ_E_5FL0\GH-4)_7"AHP\G(*R)^XW()3Z<X/Z9
MJ4&N!F.ZM!.0\F1)G+[(AQ,<EJNKB(1,9P "G[BGZ7-,-9$XJK:FDS=5&_0]
MH8,9*Q].0)<3VSN6UM*9X(8Z5G]B:C"AH05)0.T3^]3<X1GI>:4G(5.RH/2)
M;6BN)85U&M=0D[F8:CAZS)S.4UQ\. $93AQO4MHO)MQ6HV^'@DP?8 <U3YUC
M<_L5E<X_L4)"IIS!*%+'Y%S++9CU81(RY08>D-(>\)]VUY4NZUBU3OZ;@D:G
M](.%COZ;@J"F2_;VN/MOJFF;A=I;ZT#<\'Q0"B*>+LG4%SEPJHG5U;13@S'O
M*0%U3]US]3FR6+?Q<ZX:$&>&8#$%>4_I6,;*AE.0Y=1^^X^E<J:XG69XO>E
MH6'RH_T_]BFZ@VQJ'E94PSH-)C!MK0K\\<X@VRQ=^\"]KTE54O7) ATJY*;=
M.OYH@Y%/1RM.^Y;\T38@WWD?D.W.)=]B%Q")44B/]@'YSMFZP^8E?SY?UV$,
M5T2_5QMX.T;L>GXAOAX1/XQ1Y6H]VOW<[SW_-:M?\K+Q"OG<'>/?]&%,?=[-
M?7[35H?3ANBGJFVK_>GE3F9;6?> [N_/5=5^>=/OL;YLJK__/U!+ P04
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MD=OP8P[M@#Y^#/JX3;70-6" &A\.:AR@QH?8[.,VG!RNQ'O;?</N]]F8<ID
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M;0R@BY_EF#;><4SKV!*- 84QGK3MY8R N/A$M:J?,WIOY<6 QO@X-!Y:HL5
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M,6!.@#.G$Q6KE@)@1.#"\PQ,C[7K"=9%Q4+&B0%V AP[G:A8O10 * ('SB<
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M/WC88RL ,\+%_M)@@\EZA\ET4,'TRVPFAM %58%7 N=5I^IZA26 ,L*!UQ*
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MD3,$"C)T&03=MG #2KE$9.-_DS-HD4ZX/W[/_L/73K4\"0LW6OV12UQ/@W'
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M:JSS$4US;B:*U[9=+;C2S<\.2WV?@3  O;[D7.TF9H/NADS_ E!+ P04
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MC;/<';CO;K189F?68Z&U2+++!253*JV!>3X30K_>V&/PXF>/X;]02P,$%
M  @ ^#504LZ$VS3H!0  %R@  !D   !X;"]W;W)K<VAE971S+W-H965T-CDN
M>&ULO9I9;]LX$,>_"F'TH0':V.)ENW ,Y&AW S38HD&[#XM]8&PZ%JK#%6FG
M!?;#+W5$HY.1 D$OB24/A\/YRS]R**Z>PNB'VDNIT2_?"]3%9*_UX<-TJC9[
MZ0MU'AYD8+[9A9$OM+F,'J?J$$FQ31KYWA3/9GSJ"S>8K%?)O2_1>A4>M><&
M\DN$U-'W1?3[2GKAT\7$F3S?^.H^[G5\8[I>'<2CO)?ZV^%+9*ZFN9>MZ\M
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MEX9XDL)RR6\=6A_ _MH8VAM^G+K7L_@)4$L#!!0    ( /@U4%(GC0N"O 0
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MRF)>SU;U0K*-_K1_85(-"OHV5_,HYI6 >KYF3.X7E8)VPIW\!U!+ P04
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M:]*Q)H=8HS[6Y"TKCH-^5MRQXD.L<1\K?O._PC@\^X?E[SQ56_6NF5KS2H/
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MOPJR]J*3UMK&>:R22&VZ:9/:K6KV\&+:"^)<8C0,&9"FVZ??@5W7=1RW;VS
M=W]^=X>!R5[IWR8#L.0A%]),@\S:[7D8FC2#G)DSM06)7]9*Y\QB5V]"L]7
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M /L58+\SZ ]<,IE"#>^\(^Q!I3KH#/LB5]KR?\SO [@ZM?M53]7Z=(>3,&/
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M9X#?UTK9QXZ;H+KKS?X#4$L#!!0    ( /@U4%*V0NJ%#0,  *\(   9
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M U T4O'RX*P)2EKM__&?0R).'*+T@D-T<(BN=8@/#K$-=$]FPWK "L\F@N^
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M,=#/UYRKEX$Y';6GX=E?4$L#!!0    ( /@U4%)!*U(P,@0  'D2   9
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M=,UJ,T$_WPBA7@?F]&$X;5K^ E!+ P04    " #X-5!2M^:+LFT"   V!@
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M?EAA8P?M#'!_I90]3!R@_:O(_P)02P,$%     @ ^#504GM=0-P? P  XPH
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M4+]2(O0!V)]QKE83W><T?>W@'U!+ P04    " #X-5!2W%XBK48"  "<!
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ME@SW>+ZV4I96@P31/OPXR%K"PCVEN(L![;>/9S&7$*-M\_$4]M(7I1L0-V.
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M.JO1H&D?5OM@D@M8D\19Q\ @[8]?VPEQ.H 9VL(#V([ON1\^G-@>;+EXSE<
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ME5]1W,L4'<DS<U,QYU+RQ#170-52Z GJ^8*KTU_9T0ZJV['1_U!+ P04
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MNQIK(,IM!840V@&R=R?RA?WYVNH#G+CRQ9.SHE@\P4/P\P=W"*EG'9.V50#
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MP@CH]U/.U69@'#27@J/_ %!+ P04    " #X-5!26MO]Q&P$  !X$   &0
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MKU[2W>"^M\5@"P\$X7O -A[P2/B'DY'3AXP9C1,IK\/^,ZT09&O!#AX(PO.
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MU]WAEXO^_"]U\W7W'E?_ U!+ P04    " #X-5!28=X<DQ<$  "7$0  &0
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M:1Y1O 4H3A0_YAOI9Z[TMCP_C('N0)@ ?7_/N7H],3]0O8M9_0=02P,$%
M  @ ^#504FWKO+#( @  X0D  !D   !X;"]W;W)K<VAE971S+W-H965T.34N
M>&ULO99=;YLP%(;_BH5ZT4I;P9! 6A&DI=FT2JL6M>IV,>W"A9-@U>#,=IKN
MW\\& G3A(]K%;H)M>,]SCLEY<;CGXEFF  J]9BR7<RM5:GMMVS).(2/RDF\A
MUW?67&1$Z:G8V'(K@"2%*&.VZSB^G1&:6U%8K*U$%/*=8C2'E4!REV5$_%X
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M>L 40+Y?4BKV#35 4SQ._@%02P,$%     @ ^#504E.@Q#M. P  H D  !D
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MI1M:>UGJCQ009H&^7W"NG@8F0/?9L_H)4$L#!!0    ( /@U4%+H"VJ@'00
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M?%^J<FP_ NV^/XL0'((Y5&@^]H%Z@X#3#O&&_1*TF_LL#BT+<,JB9&S.]S8
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MXNM/K#*HI?7%/)/F+UI78X,&BI=2\;P2!@1Y6I3_Z4NU$#4!TCHB0"H!LB>
MHR,"8240GBL050+1N0*M2L"8WBQM-PLWI(KV;P5?(Z%'@S9]85;?2,-ZI84.
ME(D2\#8%.=6?*![_0)^+F!7:8VB<T4*B#\@\_W /+DC0 \\A+B4UGAV]Z&N&
M:)&@T60\1E=#IFB:R?<@]6TR1%?OWJ-WJ(GDG HF45J@;T6JY#4\A.O'-,M
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MTX&@%.79:WFC^,(<+CYSI7AN+N>,)DSH ?!^RKG:W.@)MB?@_?\ 4$L#!!0
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M[YWV<4UP3H09H+]?<JY>&V:"]M>)Z;]02P,$%     @ ^#504GQ[;08O P
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M1IV!*=W2-SQ^HL7"-1G/0IN6Q0T+TR2BM!O,]YD0^FUB#VC:SLD?4$L#!!0
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MR=+\<$5)1+DV4+\O&)/;$[U ]?W&Y;]02P,$%     @ ^#504F$1B8,[ @
M]00  !H   !X;"]W;W)K<VAE971S+W-H965T,3 U+GAM;'U4;6_:,!#^*U8T
M::W$2$B =56(5&#3*G43@G7[,.V#20YB8<>I[9"R7[^S$R*V ?D0^WSW//?<
M^26NI=KI',"05\$+/?%R8\I[W]=I#H+JOBRA0,]&*D$-FFKKZU(!S1Q(<#\,
M@K$O*"N\)'9K"Y7$LC*<%;!01%="4'68 I?UQ!MXQX4EV^;&+OA)7-(MK, \
MEPN%EM^Q9$Q H9DLB(+-Q'L8W,^&-MX%?&=0ZY,YL96LI=Q9XS&;>($5!!Q2
M8QDH#GN8 >>6"&6\M)Q>E]("3^=']D^N=JQE337,)/_!,I-/O#N/9+"A%3=+
M67^&MIZ1Y4LEU^Y/ZC8V\$A::2-%"T8%@A7-2%_;/IP !N,+@+ %A/\"[BX
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MICF^2Z!L /HW4IJC88]^]](E?P!02P,$%     @ ^#504GGW TA@ @  X0<
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MI.OG0CVQJO07Z%I9O([],,<G%FAG@-\W2MGGB=N@?;0M_@502P,$%     @
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M99"F+BQK^B^ ]0 Z7QN#N\*/WOBG*?X 4$L#!!0    ( /@U4%(/V#0Q50<
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MS(P-T@:8^Q,A]&ICI[AB:N__!U!+ P04    " #X-5!2N*8R!F(#  !+"P
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MI9=YH"(U/C;J@9]^)T- L;%7\D9VO^#48U/ML3Q*Q=N!K,<M9?T__C$D8D*
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M/H11>_'XNVK"W0D[(LSY> W"L#/ (%@HAH@97Q&/O*_6Q=L]T.!P D#2.5$
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #X-5!22HD19!L(  #[3   #P
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M:82T,6+6QERM_!7B4FV-]7@4#.EBQ*P+&',&@?$(Z6+$K N,.::82!<C9EW
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MQP 4+O.,N//C7@#U8Y[NZ@ 4KOZ,N-/D7@"]5*[UU$4 "M=_1MR)<NC1BXL
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M   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-VTE.&U$81>&M("^
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M5>\(T#NJWA&@=U2](T#O:'XL >@=5>\(T#NJWA&@=U2](T#OJ'I'@-Y1]8X
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MN^K= 7IWU;L#].ZJ=P?HW57O#M"[J]X=H'=7O3M [ZYZ=X#>7?7N +V[B74
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M+,Y(%F<FBS.4]5^GLKZ/X_X?QR_7N*_:X34_6?[EX>8G4$L! A0#%     @
M^#504@=!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " #X-5!2ZT)>Z.X    K @  $0
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M965T-"YX;6Q02P$"% ,4    " #X-5!2E]M O>X"  !T"@  &
M    @(%2(@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @
M^#504LX1JX_'"0  HB\  !@              ("!=B4  'AL+W=O<FMS:&5E
M=',O<VAE970V+GAM;%!+ 0(4 Q0    ( /@U4%(6^ &5_@H  ($Y   8
M          " @7,O  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M    " #X-5!2].F%^>X%  "K&0  &               @(&G.@  >&PO=V]R
M:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ ^#504HY9@_G%)P  3X<
M !@              ("!RT   'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+
M 0(4 Q0    ( /@U4%(!R5++N0H  "(>   9              " @<9H  !X
M;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ ^#504FR*2WD@
M$0  ]C8  !D              ("!MG,  'AL+W=O<FMS:&5E=',O<VAE970Q
M,2YX;6Q02P$"% ,4    " #X-5!2IV*$KX 1  "4.P  &0
M@($-A0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( /@U
M4%)+.2VD@ D  *$:   9              " @<26  !X;"]W;W)K<VAE971S
M+W-H965T,3,N>&UL4$L! A0#%     @ ^#504K/7[+V*"P  K#\  !D
M         ("!>Z   'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
M    " #X-5!27#4:!AH)  !B&@  &0              @($\K   >&PO=V]R
M:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( /@U4%+BOC)K80T  +TQ
M   9              " @8VU  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL
M4$L! A0#%     @ ^#504O\J&Z%>%   "T(  !D              ("!)<,
M 'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #X-5!21 K/
M)>4*  !T'   &0              @(&ZUP  >&PO=V]R:W-H965T<R]S:&5E
M=#$X+GAM;%!+ 0(4 Q0    ( /@U4%+'P>'X+0X  (TN   9
M  " @=;B  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @
M^#504FEMT,\=!P  YQ$  !D              ("!.O$  'AL+W=O<FMS:&5E
M=',O<VAE970R,"YX;6Q02P$"% ,4    " #X-5!2_2T2SL8%  "A$0  &0
M            @(&.^   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4
M Q0    ( /@U4%*_2<):O 0  ' ,   9              " @8O^  !X;"]W
M;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ ^#504MOOBK!4!@
M_PX  !D              ("!?@,! 'AL+W=O<FMS:&5E=',O<VAE970R,RYX
M;6Q02P$"% ,4    " #X-5!2H1W/_SDF  !(>P  &0              @($)
M"@$ >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( /@U4%)+
M#?&($0X  !<K   9              " @7DP 0!X;"]W;W)K<VAE971S+W-H
M965T,C4N>&UL4$L! A0#%     @ ^#504@ B]XZ:7   @UD! !D
M     ("!P3X! 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /@U4%*R2I/'-@4  '$,   9              "
M@8R_ 0!X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ ^#50
M4FA3ES'S!@  :A<  !D              ("!^<0! 'AL+W=O<FMS:&5E=',O
M<VAE970S,BYX;6Q02P$"% ,4    " #X-5!2%3P:6S\&   )$@  &0
M        @($CS $ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0
M   ( /@U4%*3_FT3Z04  (41   9              " @9G2 0!X;"]W;W)K
M<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ ^#504NLY?5N0"0  9B0
M !D              ("!N=@! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q0
M2P$"% ,4    " #X-5!2G(6!0_L%  !B#P  &0              @(& X@$
M>&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( /@U4%(*Q5YI
M4P@  )L8   9              " @;+H 0!X;"]W;W)K<VAE971S+W-H965T
M,S<N>&UL4$L! A0#%     @ ^#504@!\$W@K P  ] 8  !D
M ("!//$! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " #X
M-5!25ZC7D-8%  "N$0  &0              @(&>] $ >&PO=V]R:W-H965T
M<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( /@U4%)&,49)4P,  -X'   9
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M970T-"YX;6Q02P$"% ,4    " #X-5!2;(0&K+T"  #7!P  &0
M    @(% '@( >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    (
M /@U4%+)/;P:8@,  #@-   9              " @30A @!X;"]W;W)K<VAE
M971S+W-H965T-#8N>&UL4$L! A0#%     @ ^#504HDIR-(O"0  LT   !D
M             ("!S20" 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"
M% ,4    " #X-5!2GC=#P% #  !."@  &0              @($S+@( >&PO
M=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( /@U4%(<DN"5]0(
M .L*   9              " @;HQ @!X;"]W;W)K<VAE971S+W-H965T-#DN
M>&UL4$L! A0#%     @ ^#504FZRP<Z, @  U08  !D              ("!
MYC0" 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " #X-5!2
M;/['R-$%  "9&0  &0              @(&I-P( >&PO=V]R:W-H965T<R]S
M:&5E=#4Q+GAM;%!+ 0(4 Q0    ( /@U4%(H3X8S" 0  %\.   9
M      " @;$] @!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%
M  @ ^#504B 8%RJT @  TP8  !D              ("!\$$" 'AL+W=O<FMS
M:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " #X-5!2[ ,P;4L#   <#0
M&0              @(';1 ( >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+
M 0(4 Q0    ( /@U4%+.<RG!]@(  ,P)   9              " @5U( @!X
M;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ ^#504A+*Z;]S
M!@  !B8  !D              ("!BDL" 'AL+W=O<FMS:&5E=',O<VAE970U
M-BYX;6Q02P$"% ,4    " #X-5!2PS$J_4\$  #U$P  &0
M@($T4@( >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( /@U
M4%*.LE@#X0@  & _   9              " @;I6 @!X;"]W;W)K<VAE971S
M+W-H965T-3@N>&UL4$L! A0#%     @ ^#504N._+%&T!@  D2\  !D
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M=#8S+GAM;%!+ 0(4 Q0    ( /@U4%(L%EFSE0(  "T'   9
M  " @9%W @!X;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @
M^#504L:J3$F["0  J4T  !D              ("!77H" 'AL+W=O<FMS:&5E
M=',O<VAE970V-2YX;6Q02P$"% ,4    " #X-5!2K>\(@F0'   /*P  &0
M            @(%/A ( >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4
M Q0    ( /@U4%(?:<03R (  $L(   9              " @>J+ @!X;"]W
M;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ ^#504H[B:RB.!
M AD  !D              ("!Z8X" 'AL+W=O<FMS:&5E=',O<VAE970V."YX
M;6Q02P$"% ,4    " #X-5!2SH3;-.@%   7*   &0              @(&N
MDP( >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( /@U4%+&
M'/U;.0(  $D%   9              " @<V9 @!X;"]W;W)K<VAE971S+W-H
M965T-S N>&UL4$L! A0#%     @ ^#504B>-"X*\!   !Q8  !D
M     ("!/9P" 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /@U4%+1[R*T00,  /<)   9              "
M@;*Q @!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ ^#50
M4K9"ZH4- P  KP@  !D              ("!*K4" 'AL+W=O<FMS:&5E=',O
M<VAE970W-RYX;6Q02P$"% ,4    " #X-5!2L"7/1><#   9#P  &0
M        @(%NN ( >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0
M   ( /@U4%)!*U(P,@0  'D2   9              " @8R\ @!X;"]W;W)K
M<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @ ^#504K?FB[)M @  -@8
M !D              ("!]< " 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q0
M2P$"% ,4    " #X-5!2>UU W!\#  #C"@  &0              @(&9PP(
M>&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    ( /@U4%+<7B*M
M1@(  )P$   9              " @>_& @!X;"]W;W)K<VAE971S+W-H965T
M.#(N>&UL4$L! A0#%     @ ^#504H\/0-\@ P  30D  !D
M ("!;,D" 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q02P$"% ,4    " #X
M-5!2J+1I4X(%  "M&   &0              @('#S ( >&PO=V]R:W-H965T
M<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( /@U4%*?;W ?T@T   UP   9
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M970X.2YX;6Q02P$"% ,4    " #X-5!26MO]Q&P$  !X$   &0
M    @(&=]P( >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;%!+ 0(4 Q0    (
M /@U4%*S^M$\_0(  &P(   9              " @4#\ @!X;"]W;W)K<VAE
M971S+W-H965T.3$N>&UL4$L! A0#%     @ ^#504BSE!\NX @  4 @  !D
M             ("!=/\" 'AL+W=O<FMS:&5E=',O<VAE970Y,BYX;6Q02P$"
M% ,4    " #X-5!2(4'ME-H.   :A@  &0              @(%C @, >&PO
M=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0    ( /@U4%)AWAR3%P0
M )<1   9              " @701 P!X;"]W;W)K<VAE971S+W-H965T.30N
M>&UL4$L! A0#%     @ ^#504FWKO+#( @  X0D  !D              ("!
MPA4# 'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6Q02P$"% ,4    " #X-5!2
M4WUYH0D#  !("@  &0              @('!& , >&PO=V]R:W-H965T<R]S
M:&5E=#DV+GAM;%!+ 0(4 Q0    ( /@U4%)3H,0[3@,  * )   9
M      " @0$< P!X;"]W;W)K<VAE971S+W-H965T.3<N>&UL4$L! A0#%
M  @ ^#504O:0_"F  P   @T  !D              ("!AA\# 'AL+W=O<FMS
M:&5E=',O<VAE970Y."YX;6Q02P$"% ,4    " #X-5!2Z MJH!T$  #0#P
M&0              @($](P, >&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+
M 0(4 Q0    ( /@U4%)].0.3<0,  .\*   :              " @9$G P!X
M;"]W;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4 Q0    ( /@U4%+5I1 ^
M1 8   T?   :              " @3HK P!X;"]W;W)K<VAE971S+W-H965T
M,3 Q+GAM;%!+ 0(4 Q0    ( /@U4%)2EWWQ'00  *D0   :
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M,3 V+GAM;%!+ 0(4 Q0    ( /@U4%+Z\!\T9@,  , )   :
M  " @75% P!X;"]W;W)K<VAE971S+W-H965T,3 W+GAM;%!+ 0(4 Q0    (
M /@U4%(J0;2T!@(  '4$   :              " @1-) P!X;"]W;W)K<VAE
M971S+W-H965T,3 X+GAM;%!+ 0(4 Q0    ( /@U4%(/V#0Q50<  -\I   :
M              " @5%+ P!X;"]W;W)K<VAE971S+W-H965T,3 Y+GAM;%!+
M 0(4 Q0    ( /@U4%(A+IH&G 0  ,,1   :              " @=Y2 P!X
M;"]W;W)K<VAE971S+W-H965T,3$P+GAM;%!+ 0(4 Q0    ( /@U4%+&_^?;
M10(  #4%   :              " @;)7 P!X;"]W;W)K<VAE971S+W-H965T
M,3$Q+GAM;%!+ 0(4 Q0    ( /@U4%)U>Q*>+0,  ,$+   :
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M,3$V+GAM;%!+ 0(4 Q0    ( /@U4%)BM/(LF08  $8<   :
M  " @3QN P!X;"]W;W)K<VAE971S+W-H965T,3$W+GAM;%!+ 0(4 Q0    (
M /@U4%(8D=;550(  $(,   -              "  0UU P!X;"]S='EL97,N
M>&UL4$L! A0#%     @ ^#504I>*NQS     $P(   L              ( !
MC7<# %]R96QS+RYR96QS4$L! A0#%     @ ^#504DJ)$60;"   ^TP   \
M             ( !=G@# 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( /@U
M4%(A<?>R.P,  *Q$   :              "  ;Z  P!X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /@U4%)&M$XJCP(  .U!   3
M          "  3&$ P!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !] 'T
*="(  /&& P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>972</ContextCount>
  <ElementCount>797</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>230</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>15</UnitCount>
  <MyReports>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010002 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020003 - Statement - Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030004 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040005 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060007 - Statement - Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070008 - Statement - Consolidated Statements of Shareholders' Equity (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210121002 - Disclosure - Acquisitions and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionsandDivestitures</Role>
      <ShortName>Acquisitions and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210171003 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210301004 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210381005 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210441006 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210521007 - Disclosure - Health Care Costs Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayable</Role>
      <ShortName>Health Care Costs Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210581008 - Disclosure - Borrowings and Credit Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditArrangements</Role>
      <ShortName>Borrowings and Credit Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210641009 - Disclosure - Pension Plans and Other Postretirement Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210731010 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210801011 - Disclosure - Stock Incentive Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlans</Role>
      <ShortName>Stock Incentive Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210861012 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210921013 - Disclosure - Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncome</Role>
      <ShortName>Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210951014 - Disclosure - Earnings (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsLossPerShare</Role>
      <ShortName>Earnings (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210981015 - Disclosure - Reinsurance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Reinsurance</Role>
      <ShortName>Reinsurance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>211031016 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>211051017 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>230033001 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>230133002 - Disclosure - Acquisitions and Divestitures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionsandDivestituresTables</Role>
      <ShortName>Acquisitions and Divestitures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/AcquisitionsandDivestitures</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>230183003 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Investments</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>230313004 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/FairValue</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230393005 - Disclosure - Goodwill and Other Intangibles (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables</Role>
      <ShortName>Goodwill and Other Intangibles (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230453006 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Leases</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230533007 - Disclosure - Health Care Costs Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableTables</Role>
      <ShortName>Health Care Costs Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/HealthCareCostsPayable</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230593008 - Disclosure - Borrowings and Credit Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables</Role>
      <ShortName>Borrowings and Credit Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/BorrowingsandCreditArrangements</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230653009 - Disclosure - Pension Plans and Other Postretirement Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230743010 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230813011 - Disclosure - Stock Incentive Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansTables</Role>
      <ShortName>Stock Incentive Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/StockIncentivePlans</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230873012 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/ShareholdersEquity</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230933013 - Disclosure - Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</Role>
      <ShortName>Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncome</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230963014 - Disclosure - Earnings (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsLossPerShareTables</Role>
      <ShortName>Earnings (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsLossPerShare</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230993015 - Disclosure - Reinsurance (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ReinsuranceTables</Role>
      <ShortName>Reinsurance (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Reinsurance</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>231063016 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SegmentReporting</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>240044001 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>240054002 - Disclosure - Significant Accounting Policies - Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails</Role>
      <ShortName>Significant Accounting Policies - Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>240064003 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails</Role>
      <ShortName>Significant Accounting Policies - Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>240074004 - Disclosure - Significant Accounting Policies - Property Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails</Role>
      <ShortName>Significant Accounting Policies - Property Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>240084005 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails</Role>
      <ShortName>Significant Accounting Policies - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>240094006 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240104007 - Disclosure - Significant Accounting Policies - Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails</Role>
      <ShortName>Significant Accounting Policies - Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240114008 - Disclosure - Significant Accounting Policies - Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails</Role>
      <ShortName>Significant Accounting Policies - Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240144009 - Disclosure - Acquisitions and Divestitures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails</Role>
      <ShortName>Acquisitions and Divestitures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240154010 - Disclosure - Acquisitions and Divestitures - Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Acquisitions and Divestitures - Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240164011 - Disclosure - Acquisitions and Divestitures - Pro Forma (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails</Role>
      <ShortName>Acquisitions and Divestitures - Pro Forma (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240194012 - Disclosure - Investments - Schedule of Total Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails</Role>
      <ShortName>Investments - Schedule of Total Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240204013 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240214014 - Disclosure - Investments - Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails</Role>
      <ShortName>Investments - Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240224015 - Disclosure - Investments - Debt Securities by Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails</Role>
      <ShortName>Investments - Debt Securities by Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240234016 - Disclosure - Investments - Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails</Role>
      <ShortName>Investments - Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240244017 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails</Role>
      <ShortName>Investments - Unrealized Loss Position Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240254018 - Disclosure - Investments - Mortgage Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails</Role>
      <ShortName>Investments - Mortgage Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240264019 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails</Role>
      <ShortName>Investments - Mortgage Loans Credit Ratings Indicator (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240274020 - Disclosure - Investments - Schedule of Mortgage Loan Principal Repayments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails</Role>
      <ShortName>Investments - Schedule of Mortgage Loan Principal Repayments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240284021 - Disclosure - Investments - Net Investment Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails</Role>
      <ShortName>Investments - Net Investment Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240294022 - Disclosure - Investments - Realized Gains (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails</Role>
      <ShortName>Investments - Realized Gains (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240324023 - Disclosure - Fair Value - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails</Role>
      <ShortName>Fair Value - Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240334024 - Disclosure - Fair Value - Changes in Level 3 Financial Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails</Role>
      <ShortName>Fair Value - Changes in Level 3 Financial Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240344025 - Disclosure - Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details</Role>
      <ShortName>Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240354026 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails</Role>
      <ShortName>Fair Value - Carrying Value and Fair Value Classified by Level (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240364027 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails</Role>
      <ShortName>Fair Value - Separate Accounts Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240374028 - Disclosure - Fair Value - Offsetting Financial Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueOffsettingFinancialLiabilitiesDetails</Role>
      <ShortName>Fair Value - Offsetting Financial Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240404029 - Disclosure - Goodwill and Other Intangibles - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangibles - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240414030 - Disclosure - Goodwill and Other Intangibles - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangibles - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240424031 - Disclosure - Goodwill and Other Intangibles - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangibles - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240434032 - Disclosure - Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240464033 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240474034 - Disclosure - Leases - Summary of the Components of Net Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails</Role>
      <ShortName>Leases - Summary of the Components of Net Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240484035 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240494036 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240504037 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Operating and Finance Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240514038 - Disclosure - Leases - Rental Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesRentalExpenseDetails</Role>
      <ShortName>Leases - Rental Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240544039 - Disclosure - Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails</Role>
      <ShortName>Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240554040 - Disclosure - Health Care Costs Payable - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails</Role>
      <ShortName>Health Care Costs Payable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240564041 - Disclosure - Health Care Costs Payable - Reconciliation of Health Care Net Incurred and Paid Claims Development to Health Care Costs Payable Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails</Role>
      <ShortName>Health Care Costs Payable - Reconciliation of Health Care Net Incurred and Paid Claims Development to Health Care Costs Payable Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240574042 - Disclosure - Health Care Costs Payable - Reconciliation of Health Care Costs Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails</Role>
      <ShortName>Health Care Costs Payable - Reconciliation of Health Care Costs Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240604043 - Disclosure - Borrowings and Credit Arrangements - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240614044 - Disclosure - Borrowings and Credit Arrangements - Debt Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Debt Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240624045 - Disclosure - Borrowings and Credit Arrangements - Short-term Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Short-term Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240634046 - Disclosure - Borrowings and Credit Arrangements - Long-Term Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Long-Term Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240664047 - Disclosure - Pension Plans and Other Postretirement Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240674048 - Disclosure - Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240684049 - Disclosure - Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240694050 - Disclosure - Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240704051 - Disclosure - Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240714052 - Disclosure - Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240724053 - Disclosure - Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240754054 - Disclosure - Income Taxes - Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes - Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240764055 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240774056 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Effective Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240784057 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240794058 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240824059 - Disclosure - Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails</Role>
      <ShortName>Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240834060 - Disclosure - Stock Incentive Plans - Valuation and Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails</Role>
      <ShortName>Stock Incentive Plans - Valuation and Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240844061 - Disclosure - Stock Incentive Plans - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails</Role>
      <ShortName>Stock Incentive Plans - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240854062 - Disclosure - Stock Incentive Plans - Stock Option and SAR Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails</Role>
      <ShortName>Stock Incentive Plans - Stock Option and SAR Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240884063 - Disclosure - Shareholders' Equity - Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails</Role>
      <ShortName>Shareholders' Equity - Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240894064 - Disclosure - Shareholders' Equity - Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails</Role>
      <ShortName>Shareholders' Equity - Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240904065 - Disclosure - Shareholders' Equity - Regulatory Requirements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails</Role>
      <ShortName>Shareholders' Equity - Regulatory Requirements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240914066 - Disclosure - Shareholders' Equity - Noncontrolling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails</Role>
      <ShortName>Shareholders' Equity - Noncontrolling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240944067 - Disclosure - Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails</Role>
      <ShortName>Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240974068 - Disclosure - Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsLossPerShareDetails</Role>
      <ShortName>Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsLossPerShareTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>241004069 - Disclosure - Reinsurance - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ReinsuranceNarrativeDetails</Role>
      <ShortName>Reinsurance - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>241014070 - Disclosure - Reinsurance - Reinsurance Recoverables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails</Role>
      <ShortName>Reinsurance - Reinsurance Recoverables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>241024071 - Disclosure - Reinsurance - Effects of Reinsurance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails</Role>
      <ShortName>Reinsurance - Effects of Reinsurance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>241044072 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/CommitmentsandContingencies</ParentRole>
      <Position>114</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>241074073 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>241084074 - Disclosure - Segment Reporting - Summarized Financial Information of Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails</Role>
      <ShortName>Segment Reporting - Summarized Financial Information of Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="cvs-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>241094075 - Disclosure - Segment Reporting - Reconciliation of Operating Earnings to Net Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails</Role>
      <ShortName>Segment Reporting - Reconciliation of Operating Earnings to Net Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="cvs-20201231.htm">cvs-20201231.htm</File>
    <File>cvs-20201231.xsd</File>
    <File>cvs-20201231_cal.xml</File>
    <File>cvs-20201231_def.xml</File>
    <File>cvs-20201231_lab.xml</File>
    <File>cvs-20201231_pre.xml</File>
    <File>exhibit1051-2020.htm</File>
    <File>exhibit1052-2020.htm</File>
    <File>exhibit211-2020.htm</File>
    <File>exhibit231-2020.htm</File>
    <File>exhibit311-2020.htm</File>
    <File>exhibit312-2020.htm</File>
    <File>exhibit321-2020.htm</File>
    <File>exhibit322-2020.htm</File>
    <File>exhibit422-2020.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cvs-20201231_g1.jpg</File>
    <File>cvs-20201231_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>142
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cvs-20201231.htm": {
   "axisCustom": 2,
   "axisStandard": 42,
   "contextCount": 972,
   "dts": {
    "calculationLink": {
     "local": [
      "cvs-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cvs-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "cvs-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20201231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 1195,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 9,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 13
   },
   "keyCustom": 119,
   "keyStandard": 678,
   "memberCustom": 121,
   "memberStandard": 92,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover Page",
     "role": "http://www.cvshealth.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210121002 - Disclosure - Acquisitions and Divestitures",
     "role": "http://www.cvshealth.com/role/AcquisitionsandDivestitures",
     "shortName": "Acquisitions and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i36847bfea20b4065b555edc6977908d0_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794058 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)",
     "role": "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i20db3230df8c4812ac4bf0f95ceda745_I20171231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240824059 - Disclosure - Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
     "shortName": "Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240834060 - Disclosure - Stock Incentive Plans - Valuation and Assumptions (Details)",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails",
     "shortName": "Stock Incentive Plans - Valuation and Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "ifb7debeb99e74881ab3f936d5f087219_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i8d4c72ed7d1844239059f054fea52735_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844061 - Disclosure - Stock Incentive Plans - Restricted Stock Activity (Details)",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
     "shortName": "Stock Incentive Plans - Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i8d4c72ed7d1844239059f054fea52735_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromStockOptionsExercised",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854062 - Disclosure - Stock Incentive Plans - Stock Option and SAR Activity (Details)",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
     "shortName": "Stock Incentive Plans - Stock Option and SAR Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i8044667803dd4f4e94f81a063416a4a6_D20200101-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i14abdf015f0f4b9db4fe52c587222dc0_I20161102",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240884063 - Disclosure - Shareholders' Equity - Repurchases (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails",
     "shortName": "Shareholders' Equity - Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i14abdf015f0f4b9db4fe52c587222dc0_I20161102",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsPayableAmountPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894064 - Disclosure - Shareholders' Equity - Dividends (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails",
     "shortName": "Shareholders' Equity - Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsPayableAmountPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904065 - Disclosure - Shareholders' Equity - Regulatory Requirements (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails",
     "shortName": "Shareholders' Equity - Regulatory Requirements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240914066 - Disclosure - Shareholders' Equity - Noncontrolling Interests (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails",
     "shortName": "Shareholders' Equity - Noncontrolling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i36847bfea20b4065b555edc6977908d0_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944067 - Disclosure - Other Comprehensive Income (Details)",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
     "shortName": "Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i1b47b478e9b74d6283da9fb27e389a6f_I20171231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210171003 - Disclosure - Investments",
     "role": "http://www.cvshealth.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974068 - Disclosure - Earnings (Loss) Per Share (Details)",
     "role": "http://www.cvshealth.com/role/EarningsLossPerShareDetails",
     "shortName": "Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "id456c1b6d71e415f8fae0b19939047b5_D20210101-20210131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberofReinsuranceContractsEnteredInto",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reinsuranceagreement",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004069 - Disclosure - Reinsurance - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails",
     "shortName": "Reinsurance - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "id456c1b6d71e415f8fae0b19939047b5_D20210101-20210131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberofReinsuranceContractsEnteredInto",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reinsuranceagreement",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014070 - Disclosure - Reinsurance - Reinsurance Recoverables (Details)",
     "role": "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails",
     "shortName": "Reinsurance - Reinsurance Recoverables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DirectPremiumsEarned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241024071 - Disclosure - Reinsurance - Effects of Reinsurance (Details)",
     "role": "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails",
     "shortName": "Reinsurance - Effects of Reinsurance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DirectPremiumsEarned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241044072 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241074073 - Disclosure - Segment Reporting - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241084074 - Disclosure - Segment Reporting - Summarized Financial Information of Segments (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
     "shortName": "Segment Reporting - Summarized Financial Information of Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "if63174233acd4168b88c860a242fb85e_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:AdjustedOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241094075 - Disclosure - Segment Reporting - Reconciliation of Operating Earnings to Net Income (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
     "shortName": "Segment Reporting - Reconciliation of Operating Earnings to Net Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationIntegrationRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210301004 - Disclosure - Fair Value",
     "role": "http://www.cvshealth.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210381005 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210441006 - Disclosure - Leases",
     "role": "http://www.cvshealth.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210521007 - Disclosure - Health Care Costs Payable",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayable",
     "shortName": "Health Care Costs Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210581008 - Disclosure - Borrowings and Credit Arrangements",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditArrangements",
     "shortName": "Borrowings and Credit Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210641009 - Disclosure - Pension Plans and Other Postretirement Benefits",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits",
     "shortName": "Pension Plans and Other Postretirement Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210731010 - Disclosure - Income Taxes",
     "role": "http://www.cvshealth.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210801011 - Disclosure - Stock Incentive Plans",
     "role": "http://www.cvshealth.com/role/StockIncentivePlans",
     "shortName": "Stock Incentive Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010002 - Statement - Consolidated Statements of Operations",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210861012 - Disclosure - Shareholders' Equity",
     "role": "http://www.cvshealth.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210921013 - Disclosure - Other Comprehensive Income",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncome",
     "shortName": "Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210951014 - Disclosure - Earnings (Loss) Per Share",
     "role": "http://www.cvshealth.com/role/EarningsLossPerShare",
     "shortName": "Earnings (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210981015 - Disclosure - Reinsurance",
     "role": "http://www.cvshealth.com/role/Reinsurance",
     "shortName": "Reinsurance",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211031016 - Disclosure - Commitments and Contingencies",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211051017 - Disclosure - Segment Reporting",
     "role": "http://www.cvshealth.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230033001 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230133002 - Disclosure - Acquisitions and Divestitures (Tables)",
     "role": "http://www.cvshealth.com/role/AcquisitionsandDivestituresTables",
     "shortName": "Acquisitions and Divestitures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230183003 - Disclosure - Investments (Tables)",
     "role": "http://www.cvshealth.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020003 - Statement - Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230313004 - Disclosure - Fair Value (Tables)",
     "role": "http://www.cvshealth.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230393005 - Disclosure - Goodwill and Other Intangibles (Tables)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables",
     "shortName": "Goodwill and Other Intangibles (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230453006 - Disclosure - Leases (Tables)",
     "role": "http://www.cvshealth.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230533007 - Disclosure - Health Care Costs Payable (Tables)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableTables",
     "shortName": "Health Care Costs Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230593008 - Disclosure - Borrowings and Credit Arrangements (Tables)",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables",
     "shortName": "Borrowings and Credit Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230653009 - Disclosure - Pension Plans and Other Postretirement Benefits (Tables)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables",
     "shortName": "Pension Plans and Other Postretirement Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230743010 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.cvshealth.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230813011 - Disclosure - Stock Incentive Plans (Tables)",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansTables",
     "shortName": "Stock Incentive Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230873012 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230933013 - Disclosure - Other Comprehensive Income (Tables)",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables",
     "shortName": "Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - Consolidated Balance Sheets",
     "role": "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230963014 - Disclosure - Earnings (Loss) Per Share (Tables)",
     "role": "http://www.cvshealth.com/role/EarningsLossPerShareTables",
     "shortName": "Earnings (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230993015 - Disclosure - Reinsurance (Tables)",
     "role": "http://www.cvshealth.com/role/ReinsuranceTables",
     "shortName": "Reinsurance (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231063016 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.cvshealth.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberOfPlanMembers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "member",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240044001 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberOfPlanMembers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "member",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240054002 - Disclosure - Significant Accounting Policies - Restricted Cash (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails",
     "shortName": "Significant Accounting Policies - Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "ic4db69fd194a4a0081fed80395cfe996_I20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064003 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
     "shortName": "Significant Accounting Policies - Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:VendorandManufacturerReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074004 - Disclosure - Significant Accounting Policies - Property Plant and Equipment (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails",
     "shortName": "Significant Accounting Policies - Property Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084005 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
     "shortName": "Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i8807d9a1c6eb4ef7a7bb815b14181f74_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094006 - Disclosure - Significant Accounting Policies - Contract Balances (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
     "shortName": "Significant Accounting Policies - Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104007 - Disclosure - Significant Accounting Policies - Variable Interest Entities (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails",
     "shortName": "Significant Accounting Policies - Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i343f3e71f5b546c7ac384b8289428e7c_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040005 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114008 - Disclosure - Significant Accounting Policies - Discontinued Operations (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails",
     "shortName": "Significant Accounting Policies - Discontinued Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfBusiness",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144009 - Disclosure - Acquisitions and Divestitures - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
     "shortName": "Acquisitions and Divestitures - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i8966d06a68154d9b9a82e87fc68f00cd_I20181128",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240154010 - Disclosure - Acquisitions and Divestitures - Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Acquisitions and Divestitures - Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i8966d06a68154d9b9a82e87fc68f00cd_I20181128",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i3ffa460f969548b583077ff85463f042_D20180101-20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164011 - Disclosure - Acquisitions and Divestitures - Pro Forma (Details)",
     "role": "http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails",
     "shortName": "Acquisitions and Divestitures - Pro Forma (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i3ffa460f969548b583077ff85463f042_D20180101-20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240194012 - Disclosure - Investments - Schedule of Total Investments (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails",
     "shortName": "Investments - Schedule of Total Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedInvestmentsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204013 - Disclosure - Investments - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedInvestmentsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240214014 - Disclosure - Investments - Debt Securities (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
     "shortName": "Investments - Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240224015 - Disclosure - Investments - Debt Securities by Maturity (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
     "shortName": "Investments - Debt Securities by Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234016 - Disclosure - Investments - Unrealized Loss Position (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
     "shortName": "Investments - Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244017 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
     "shortName": "Investments - Unrealized Loss Position Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050006 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ActivityInMortgageLoanPortfolioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i1a9206a1aaa548579a9355991549eb38_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240254018 - Disclosure - Investments - Mortgage Loans (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
     "shortName": "Investments - Mortgage Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ActivityInMortgageLoanPortfolioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i1a9206a1aaa548579a9355991549eb38_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i9d53390437704160bfb47a2ae8120e70_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264019 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
     "shortName": "Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i9d53390437704160bfb47a2ae8120e70_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i9d53390437704160bfb47a2ae8120e70_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274020 - Disclosure - Investments - Schedule of Mortgage Loan Principal Repayments (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails",
     "shortName": "Investments - Schedule of Mortgage Loan Principal Repayments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i9d53390437704160bfb47a2ae8120e70_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284021 - Disclosure - Investments - Net Investment Income (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
     "shortName": "Investments - Net Investment Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294022 - Disclosure - Investments - Realized Gains (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails",
     "shortName": "Investments - Realized Gains (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324023 - Disclosure - Fair Value - Fair Value Measurements (Details)",
     "role": "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
     "shortName": "Fair Value - Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i7e22f02c654244d596daa5e51b729587_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334024 - Disclosure - Fair Value - Changes in Level 3 Financial Assets (Details)",
     "role": "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
     "shortName": "Fair Value - Changes in Level 3 Financial Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i3dee70a63b4243fbbc3573e0e856978b_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240344025 - Disclosure - Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)",
     "role": "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
     "shortName": "Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i3c34bf51a0004f2da4f3173e1abb80a8_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i281d455fefd94775a95b6168db361569_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354026 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "role": "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
     "shortName": "Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i281d455fefd94775a95b6168db361569_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364027 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)",
     "role": "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
     "shortName": "Fair Value - Separate Accounts Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i7e22f02c654244d596daa5e51b729587_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i8c716e5b99ef43d2a3c07841be0dc4a4_I20171231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060007 - Statement - Consolidated Statements of Shareholders' Equity",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
     "shortName": "Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i8c716e5b99ef43d2a3c07841be0dc4a4_I20171231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeCollateralObligationToReturnSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240374028 - Disclosure - Fair Value - Offsetting Financial Liabilities (Details)",
     "role": "http://www.cvshealth.com/role/FairValueOffsettingFinancialLiabilitiesDetails",
     "shortName": "Fair Value - Offsetting Financial Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeCollateralObligationToReturnSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i36847bfea20b4065b555edc6977908d0_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404029 - Disclosure - Goodwill and Other Intangibles - Goodwill (Details)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
     "shortName": "Goodwill and Other Intangibles - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i03910d29701c40fb994e5e5ebe1e0b09_D20190101-20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillTransfers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414030 - Disclosure - Goodwill and Other Intangibles - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
     "shortName": "Goodwill and Other Intangibles - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:FinitelivedandindefinitelivedintangibleassetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240424031 - Disclosure - Goodwill and Other Intangibles - Intangible Assets (Details)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangibles - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:FinitelivedandindefinitelivedintangibleassetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240434032 - Disclosure - Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails",
     "shortName": "Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464033 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:SaleAndLeasebackTransactionGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474034 - Disclosure - Leases - Summary of the Components of Net Lease Cost (Details)",
     "role": "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails",
     "shortName": "Leases - Summary of the Components of Net Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484035 - Disclosure - Leases - Supplemental Cash Flow Information (Details)",
     "role": "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:LesseeLeaseTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494036 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:LesseeLeaseTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:FinanceLeaseRightOfUseAssetGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504037 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)",
     "role": "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Operating and Finance Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "cvs:TreasuryStockSharesHeldinTrust",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i36847bfea20b4065b555edc6977908d0_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldinTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070008 - Statement - Consolidated Statements of Shareholders' Equity (Parentheticals)",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
     "shortName": "Consolidated Statements of Shareholders' Equity (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "cvs:TreasuryStockSharesHeldinTrust",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i36847bfea20b4065b555edc6977908d0_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldinTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i3ffa460f969548b583077ff85463f042_D20180101-20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesRentExpenseMinimumRentals",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514038 - Disclosure - Leases - Rental Expense (Details)",
     "role": "http://www.cvshealth.com/role/LeasesRentalExpenseDetails",
     "shortName": "Leases - Rental Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i3ffa460f969548b583077ff85463f042_D20180101-20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesRentExpenseMinimumRentals",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544039 - Disclosure - Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
     "shortName": "Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i0f1c041ab6e1476e81c0a2cce0548fb0_I20201231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240554040 - Disclosure - Health Care Costs Payable - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
     "shortName": "Health Care Costs Payable - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i0f1c041ab6e1476e81c0a2cce0548fb0_I20201231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564041 - Disclosure - Health Care Costs Payable - Reconciliation of Health Care Net Incurred and Paid Claims Development to Health Care Costs Payable Liability (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails",
     "shortName": "Health Care Costs Payable - Reconciliation of Health Care Net Incurred and Paid Claims Development to Health Care Costs Payable Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "ic5fc35a7a6e442eda14cf38dd4b653c6_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i36847bfea20b4065b555edc6977908d0_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574042 - Disclosure - Health Care Costs Payable - Reconciliation of Health Care Costs Payable (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
     "shortName": "Health Care Costs Payable - Reconciliation of Health Care Costs Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i3ffa460f969548b583077ff85463f042_D20180101-20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240604043 - Disclosure - Borrowings and Credit Arrangements - Schedule of Debt (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
     "shortName": "Borrowings and Credit Arrangements - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedPremium",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614044 - Disclosure - Borrowings and Credit Arrangements - Debt Maturities (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails",
     "shortName": "Borrowings and Credit Arrangements - Debt Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624045 - Disclosure - Borrowings and Credit Arrangements - Short-term Borrowings (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails",
     "shortName": "Borrowings and Credit Arrangements - Short-term Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i94f9c1f9d7704805bcabb81136732a71_D20200821-20200821",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634046 - Disclosure - Borrowings and Credit Arrangements - Long-Term Borrowings (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
     "shortName": "Borrowings and Credit Arrangements - Long-Term Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i94f9c1f9d7704805bcabb81136732a71_D20200821-20200821",
      "decimals": "-7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664047 - Disclosure - Pension Plans and Other Postretirement Benefits - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Significant Accounting Policies",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "id05aab78eef84ae1b36d242d69f4a389_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674048 - Disclosure - Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanInterestCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684049 - Disclosure - Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Costs (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i7aeede48bef44c0c9654202b6dd800f2_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694050 - Disclosure - Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240704051 - Disclosure - Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "ie1312f09b0894768af1a8551fc6e5b03_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "id05aab78eef84ae1b36d242d69f4a389_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714052 - Disclosure - Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "ie58dc0862dea4aa2b787686a9637e9e1_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724053 - Disclosure - Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i91d6cbf6f31540a9aa149b65e2c3d5f4_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754054 - Disclosure - Income Taxes - Income Tax Provision (Details)",
     "role": "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails",
     "shortName": "Income Taxes - Income Tax Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i3ffa460f969548b583077ff85463f042_D20180101-20181231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764055 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i3ffa460f969548b583077ff85463f042_D20180101-20181231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240774056 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)",
     "role": "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails",
     "shortName": "Income Taxes - Effective Tax Rate Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i5353e59c2c9c4f55a2d3f0cdbe3b16f3_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240784057 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20201231.htm",
      "contextRef": "i371ef8b4f96c4033b7b40dccf03166b8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 230,
   "tag": {
    "cvs_A2016RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Repurchase Program [Member]",
        "label": "2016 Repurchase Program [Member]",
        "terseLabel": "2016 Repurchase Program"
       }
      }
     },
     "localname": "A2016RepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ActivityInMortgageLoanPortfolioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table representing activities in mortgage loan portfolio during the period.",
        "label": "Activity in mortgage loan portfolio [Table Text Block]",
        "verboseLabel": "Activity in mortgage loan portfolio"
       }
      }
     },
     "localname": "ActivityInMortgageLoanPortfolioTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_AdjustedOperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Operating Income (Loss)",
        "label": "Adjusted Operating Income (Loss)",
        "totalLabel": "Adjusted operating income",
        "verboseLabel": "Adjusted operating income (loss)"
       }
      }
     },
     "localname": "AdjustedOperatingIncomeLoss",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_AetnaInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aetna Inc. [Member]",
        "label": "Aetna Inc. [Member]",
        "verboseLabel": "Aetna Inc."
       }
      }
     },
     "localname": "AetnaInc.Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_AetnaInc2010StockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aetna Inc 2010 Stock Incentive Plan [Member]",
        "label": "Aetna Inc 2010 Stock Incentive Plan [Member]",
        "terseLabel": "Aetna Inc 2010 Stock Incentive Plan"
       }
      }
     },
     "localname": "AetnaInc2010StockIncentivePlanMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_AllOtherReinsurersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Other Reinsurers [Member]",
        "label": "All Other Reinsurers [Member]",
        "terseLabel": "All Other"
       }
      }
     },
     "localname": "AllOtherReinsurersMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assumed Interest Rates On Long Duration Group Life And Long Term Care Contracts",
        "label": "Assumed Interest Rates On Long Duration Group Life And Long Term Care Contracts",
        "terseLabel": "Assumed interest rates on long-duration group life and long-term care contracts"
       }
      }
     },
     "localname": "AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_BackUpCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Back-Up Credit Facilities [Member]",
        "label": "Back-Up Credit Facilities [Member]",
        "terseLabel": "Back-Up Credit Facilities"
       }
      }
     },
     "localname": "BackUpCreditFacilitiesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_BrazilSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brazil Subsidiary [Member]",
        "label": "Brazil Subsidiary [Member]",
        "terseLabel": "Brazil Subsidiary"
       }
      }
     },
     "localname": "BrazilSubsidiaryMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_BusinessCombinationAcquisitionAssignedValueOfAcquiree": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Acquisition Assigned Value Of Acquiree",
        "label": "Business Combination Acquisition Assigned Value Of Acquiree",
        "terseLabel": "Assigned value of acquiree"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionAssignedValueOfAcquiree",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_BusinessCombinationAcquisitionValuePerSharesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The assigned value per share of the acquiree company.",
        "label": "Business Combination Acquisition Value Per Shares Acquired",
        "terseLabel": "The assigned value per share of acquiree (in dollars per share)"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionValuePerSharesAcquired",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cvs_BusinessCombinationPerShareExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Per Share Exchange Ratio",
        "label": "Business Combination, Per Share Exchange Ratio",
        "terseLabel": "Per share exchange ratio"
       }
      }
     },
     "localname": "BusinessCombinationPerShareExchangeRatio",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssets",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "terseLabel": "Health care costs payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentLiabilitiesLiabilityforUnpaidClaimsandClaimsAdjustmentExpenseNet",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "terseLabel": "Debt (current and long-term)",
        "verboseLabel": "Assumed debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments",
        "terseLabel": "Investments (current and long-term)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInvestments",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_CVSHealth2017IncentiveCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CVS Health 2017 Incentive Compensation Plan [Member]",
        "label": "CVS Health 2017 Incentive Compensation Plan [Member]",
        "terseLabel": "CVS Health 2017 Incentive Compensation Plan"
       }
      }
     },
     "localname": "CVSHealth2017IncentiveCompensationPlanMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee [Abstract]",
        "label": "Cash Flow, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_Categories5and6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Categories 5 and 6",
        "label": "Categories 5 and 6 [Member]",
        "terseLabel": "5 and 6"
       }
      }
     },
     "localname": "Categories5and6Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 1 [Member].",
        "label": "Category 1 [Member]",
        "terseLabel": "1"
       }
      }
     },
     "localname": "Category1Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category2To4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].",
        "label": "Category 2 to 4 [Member]",
        "terseLabel": "2 to 4"
       }
      }
     },
     "localname": "Category2To4Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Category 7",
        "label": "Category 7 [Member]",
        "terseLabel": "7"
       }
      }
     },
     "localname": "Category7Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CommonAndCollectiveTrustsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.",
        "label": "Common and Collective Trusts [Member]",
        "terseLabel": "Common/collective trusts"
       }
      }
     },
     "localname": "CommonAndCollectiveTrustsMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CommonEquivalentSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Equivalent Shares [Member]",
        "label": "Common Equivalent Shares [Member]",
        "terseLabel": "Common Equivalent Shares"
       }
      }
     },
     "localname": "CommonEquivalentSharesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.",
        "label": "Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance",
        "terseLabel": "Rewards earnings and gift card issuances"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ContractWithCustomerLiabilityRedemptionAndBreakage": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer Liability Redemption And Breakage",
        "label": "Contract With Customer Liability Redemption And Breakage",
        "negatedTerseLabel": "Redemption and breakage"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRedemptionAndBreakage",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the contractual obligation to maintain the required level of funding in Separate Accounts necessary to fund specific guaranteed pensions annuities.",
        "label": "Contractual Obligations To Maintain Levels Of Separate Accounts",
        "terseLabel": "Contractual obligations underlying the guaranteed benefits"
       }
      }
     },
     "localname": "ContractualObligationsToMaintainLevelsOfSeparateAccounts",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_CoventryHealthCareWorkersCompensationBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coventry Health Care Workers Compensation Business",
        "label": "Coventry Health Care Workers Compensation Business [Member]",
        "terseLabel": "Coventry Health Care Workers Compensation Business"
       }
      }
     },
     "localname": "CoventryHealthCareWorkersCompensationBusinessMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings",
        "label": "Credit Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings",
        "terseLabel": "Credit-related impairment loss (reversal of loss)"
       }
      }
     },
     "localname": "CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtAndEquitySecuritiesAvailableForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)",
        "label": "Debt And Equity Securities Available For Sale [Member]",
        "terseLabel": "Debt securities available for sale"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesAvailableForSaleMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DebtExtinguishmentFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Extinguishment Fees",
        "label": "Debt Extinguishment Fees",
        "terseLabel": "Debt extinguishment fees"
       }
      }
     },
     "localname": "DebtExtinguishmentFees",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net",
        "label": "Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Debt discounts and deferred financing costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available For Sale, Amortized Cost, Net",
        "label": "Debt Securities, Available For Sale, Amortized Cost, Net",
        "terseLabel": "Amortized Cost",
        "totalLabel": "Gross Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities",
        "label": "Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities",
        "terseLabel": "Weighted average duration of securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Debt securities, maturity, without single maturity date, unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date, fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DeferredTaxAssetsPayrollTaxDeferral": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Payroll Tax Deferral",
        "label": "Deferred Tax Assets, Payroll Tax Deferral",
        "terseLabel": "Payroll tax deferral"
       }
      }
     },
     "localname": "DeferredTaxAssetsPayrollTaxDeferral",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances",
        "terseLabel": "Bad debts and other allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DeferredTaxLiabilitiesDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Depreciation and Amortization - Amount of deferred tax liability attributable to taxable temporary differences from depreciation and amortization",
        "label": "Deferred Tax Liabilities, Depreciation and Amortization",
        "negatedTerseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DeferredTaxLiabilitiesRetirementBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Retirement Benefits",
        "label": "Deferred Tax Liabilities, Retirement Benefits",
        "terseLabel": "Retirement benefits"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRetirementBenefits",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Common Collective Trust, Debt Securities [Member]",
        "label": "Defined Benefit Plan, Common Collective Trust, Debt Securities [Member]",
        "terseLabel": "Common/collective trusts, Debt Securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Common Collective Trust, Equity Securities [Member]",
        "label": "Defined Benefit Plan, Common Collective Trust, Equity Securities [Member]",
        "terseLabel": "Common/collective trusts, Equity Securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DenominatorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator For Earnings Per Share Calculation [Abstract]",
        "label": "Denominator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Denominator for earnings (loss) per share calculation:"
       }
      }
     },
     "localname": "DenominatorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DrogariaOnofreLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Drogaria onofre Ltda.",
        "label": "Drogaria onofre Ltda. [Member]",
        "terseLabel": "Drogaria onofre Ltda. [Member]"
       }
      }
     },
     "localname": "DrogariaOnofreLtdaMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method",
        "label": "ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares (in shares)"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method",
        "label": "ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_EmployeeStockOptionsandStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Options and Stock Appreciation Rights [Member]",
        "label": "Employee Stock Options and Stock Appreciation Rights [Member]",
        "terseLabel": "Employee Stock Options and Stock Appreciation Rights"
       }
      }
     },
     "localname": "EmployeeStockOptionsandStockAppreciationRightsMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_EquitySecuritiesDomesticRealEstateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about ownership interests or the right to acquire ownership interests in domestic real estate whose ownership interest is represented by shares of common or preferred stock (which is neither mandatorily redeemable no redeemable at the option of the holder), convertible securities, stock rights, or stock warrants categorized by other type.",
        "label": "Equity Securities Domestic Real Estate [Member]",
        "terseLabel": "Domestic real estate"
       }
      }
     },
     "localname": "EquitySecuritiesDomesticRealEstateMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]",
        "label": "Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]",
        "terseLabel": "Net realized and unrealized capital gains (losses):"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Assets And Liabilities, Lessee [Abstract]",
        "label": "Finance Lease, Assets And Liabilities, Lessee [Abstract]",
        "terseLabel": "Finance leases:"
       }
      }
     },
     "localname": "FinanceLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Cost",
        "label": "Finance Lease Cost",
        "totalLabel": "Total finance lease costs"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "cvs_FinanceLeaseRightOfUseAssetNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, Accumulated Depreciation",
        "label": "Finance Lease, Right-Of-Use Asset, Accumulated Depreciation",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedDepreciation",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FinanceLeaseRightOfUseAssetGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "cvs_FinanceLeaseRightOfUseAssetNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, Gross",
        "label": "Finance Lease, Right-Of-Use Asset, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetGross",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FinanceLeaseRightOfUseAssetNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, Net",
        "label": "Finance Lease, Right-Of-Use Asset, Net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetNet",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the cost, accumulated amortization and net balance of intangibles assets and amortization period, in total and by major class. Finite-lived intangible assets have a stated useful life over which their gross carrying value is amortized. Indefinite intangible assets have a projected indefinite period of benefit (hence are not amortized).",
        "label": "Finite lived and indefinite lived intangible assets [Table Text Block]",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "FinitelivedandindefinitelivedintangibleassetsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixtures, Equipment And Internally Developed Software [Member]",
        "label": "Fixtures, Equipment And Internally Developed Software [Member]",
        "terseLabel": "Fixtures, equipment and internally developed software"
       }
      }
     },
     "localname": "FixturesEquipmentAndInternallyDevelopedSoftwareMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FloatingRateNotesDueMarch2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Notes Due March 2020 [Member]",
        "label": "Floating Rate Notes Due March 2020 [Member]",
        "terseLabel": "Floating rate notes due March 2020"
       }
      }
     },
     "localname": "FloatingRateNotesDueMarch2020Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FloatingRateNotesDueMarch2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Notes Due March 2021 [Member]",
        "label": "Floating Rate Notes Due March 2021 [Member]",
        "terseLabel": "Floating rate notes due March 2021"
       }
      }
     },
     "localname": "FloatingRateNotesDueMarch2021Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FloatingRateNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Notes",
        "label": "Floating Rate Notes [Member]",
        "terseLabel": "Floating Rate Notes"
       }
      }
     },
     "localname": "FloatingRateNotesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Gain Contingency, Recognized in Current Period, Before Tax",
        "label": "Former Gain Contingency, Recognized in Current Period, Before Tax",
        "terseLabel": "Former gain contingency, recognized in current period, before tax"
       }
      }
     },
     "localname": "FormerGainContingencyRecognizedInCurrentPeriodBeforeTax",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Gain Contingency, Recognized in Current Period, Net of Tax",
        "label": "Former Gain Contingency, Recognized in Current Period, Net of Tax",
        "terseLabel": "Former gain contingency, recognized in current period, net of tax"
       }
      }
     },
     "localname": "FormerGainContingencyRecognizedInCurrentPeriodNetOfTax",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This line item represents the four years of a reinsurance agreement with an unrelated insurer.",
        "label": "Four Years Reinsurance Agreement With Unrelated Insurer",
        "terseLabel": "Four years reinsurance agreement with unrelated insurer"
       }
      }
     },
     "localname": "FourYearsReinsuranceAgreementWithUnrelatedInsurer",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_FrontStoreRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Front Store Revenue [Member]",
        "label": "Front Store Revenue [Member]",
        "terseLabel": "Front Store"
       }
      }
     },
     "localname": "FrontStoreRevenueMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_GuarantorObligationsNumberofLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor Obligations, Number of Leases",
        "label": "Guarantor Obligations, Number of Leases",
        "terseLabel": "Number of leases guaranteed"
       }
      }
     },
     "localname": "GuarantorObligationsNumberofLeases",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_HartfordLifeAndAccidentInsuranceCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hartford Life And Accident Insurance Company [Member]",
        "label": "Hartford Life And Accident Insurance Company [Member]",
        "terseLabel": "Hartford Life and Accident Insurance Company"
       }
      }
     },
     "localname": "HartfordLifeAndAccidentInsuranceCompanyMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HealthCareBenefitsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Benefits Segment [Member]",
        "label": "Health Care Benefits Segment [Member]",
        "terseLabel": "Health Care Benefits"
       }
      }
     },
     "localname": "HealthCareBenefitsSegmentMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Costs Payable, Period After Date Of Services Claims Are Paid",
        "label": "Health Care Costs Payable, Period After Date Of Services Claims Are Paid",
        "terseLabel": "Period after date of service a claim is paid"
       }
      }
     },
     "localname": "HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_HealthInsurerFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.",
        "label": "Health Insurer Fee",
        "terseLabel": "Health insurer fee"
       }
      }
     },
     "localname": "HealthInsurerFee",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_HealthInsurerFeeTaxEffectPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the tax effect of the health care reform's non-tax deductible health insurer fee.",
        "label": "Health Insurer Fee Tax Effect, Percent",
        "terseLabel": "Health insurer fee"
       }
      }
     },
     "localname": "HealthInsurerFeeTaxEffectPercent",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_HeartlandHealthcareServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heartland Healthcare Services [Member]",
        "label": "Heartland Healthcare Services [Member]",
        "terseLabel": "Heartland Healthcare Services"
       }
      }
     },
     "localname": "HeartlandHealthcareServicesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HeathSavingsAccountBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heath Savings Account Balance",
        "label": "Heath Savings Account Balance",
        "terseLabel": "HSA balances"
       }
      }
     },
     "localname": "HeathSavingsAccountBalance",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_Initialcontractualterm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entity, Initial Contractual Term",
        "label": "Initial contractual term",
        "terseLabel": "Initial contractual term"
       }
      }
     },
     "localname": "Initialcontractualterm",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_InsuranceAndHmoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance and HMO subsidiaries [Member].",
        "label": "Insurance and HMO [Member]",
        "terseLabel": "Insurance and HMO"
       }
      }
     },
     "localname": "InsuranceAndHmoMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_InsurancePremiumDeficiencyReservePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance Premium Deficiency Reserve [Policy Text Block]",
        "label": "Insurance Premium Deficiency Reserve [Policy Text Block]",
        "terseLabel": "Premium Deficiency Reserves"
       }
      }
     },
     "localname": "InsurancePremiumDeficiencyReservePolicyTextBlock",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts With Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts With Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts with a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts without a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithoutFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentIncomeExcludingCapitalGainsorLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Income, Excluding Capital Gains or Losses",
        "label": "Investment Income, Excluding Capital Gains or Losses",
        "totalLabel": "Net investment income (excluding net realized capital gains or losses)"
       }
      }
     },
     "localname": "InvestmentIncomeExcludingCapitalGainsorLosses",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LeasesWeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases, Weighted Average Discount Rate [Abstract]",
        "label": "Leases, Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "LeasesWeightedAverageDiscountRateAbstract",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_LesseeLeaseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Lease [Table Text Block]",
        "label": "Lessee, Lease [Table Text Block]",
        "terseLabel": "Supplemental balance sheet information"
       }
      }
     },
     "localname": "LesseeLeaseTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Leases Liabilities Payments Due [Abstract]",
        "label": "Lessee, Leases Liabilities Payments Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LesseeLeasesLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_LesseeLiabilityPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due",
        "label": "Lessee, Liability, Payments, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDue",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due After Year Five",
        "label": "Lessee, Liability, Payments, Due After Year Five",
        "totalLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due Year Five",
        "label": "Lessee, Liability, Payments, Due Year Five",
        "totalLabel": "2025"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueYearFive",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due Year Four",
        "label": "Lessee, Liability, Payments, Due Year Four",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due Year Three",
        "label": "Lessee, Liability, Payments, Due Year Three",
        "totalLabel": "2023"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due Year Two",
        "label": "Lessee, Liability, Payments, Due Year Two",
        "totalLabel": "2022"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Year One",
        "label": "Lessee, Liability, Payments, Year One",
        "totalLabel": "2021"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsYearOne",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Undiscounted Excess Amount",
        "label": "Lessee, Liability, Undiscounted Excess Amount",
        "negatedTotalLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeOperatingAndFinanceLeasesRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating And Finance Leases, Renewal Term",
        "label": "Lessee, Operating And Finance Leases, Renewal Term",
        "terseLabel": "Lease renewal term"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasesRenewalTerm",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_LesseeOperatingAndFinanceLeasesTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating And Finance Leases, Term Of Contract",
        "label": "Lessee, Operating And Finance Leases, Term Of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasesTermOfContract",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "terseLabel": "Benefit costs recorded in other insurance liabilities"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of unpaid retail pharmacy claims to third parties from pharmacy claims and discounts payable to health care costs payable.",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Reclassification",
        "terseLabel": "Reclassification from pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReclassification",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LiabilityforUnpaidClaims": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total liability on the balance sheet for unpaid claims for both short-duration and long-duration insurance contracts after reinsurance.",
        "label": "Liability for Unpaid Claims",
        "terseLabel": "Liability for unpaid claims"
       }
      }
     },
     "localname": "LiabilityforUnpaidClaims",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LimitedPaymentsContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum assumed interest rates on limited payment contracts on large case pensions business.",
        "label": "Limited Payments Contracts",
        "terseLabel": "Assumed interest rates on limited payment pension contracts on large case pension business (in hundredths)"
       }
      }
     },
     "localname": "LimitedPaymentsContracts",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_LincolnLifeAnnuityCompanyOfNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lincoln Life &amp; Annuity Company Of New York [Member]",
        "label": "Lincoln Life &amp; Annuity Company Of New York [Member]",
        "terseLabel": "Lincoln Life &amp; Annuity Company of New York"
       }
      }
     },
     "localname": "LincolnLifeAnnuityCompanyOfNewYorkMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_LongTermCareReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Care Reporting Unit [Member]",
        "label": "Long-Term Care Reporting Unit [Member]",
        "terseLabel": "Long-Term Care Reporting Unit"
       }
      }
     },
     "localname": "LongTermCareReportingUnitMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_LongtermDebtGrossAndLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Gross And Lease Obligation",
        "label": "Long-term Debt, Gross And Lease Obligation",
        "terseLabel": "Total debt principal",
        "totalLabel": "Total debt principal"
       }
      }
     },
     "localname": "LongtermDebtGrossAndLeaseObligation",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.",
        "label": "Mortgage Loans [Member]",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal After Year Five",
        "label": "Mortgage Loans On Real Estate Collections Of Principal After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Year Five",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Year Four",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Year Three",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Year Two",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateLoansFullyRepaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertains to amount of mortgage loans fully repaid.",
        "label": "Mortgage Loans on Real Estate, Loans Fully Repaid",
        "terseLabel": "Mortgage loans fully repaid"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLoansFullyRepaid",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Year Of Origination",
        "label": "Mortgage Loans On Real Estate Year Of Origination [Axis]",
        "terseLabel": "Mortgage Loans On Real Estate Year Of Origination [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationAxis",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Year Of Origination",
        "label": "Mortgage Loans On Real Estate Year Of Origination [Domain]",
        "terseLabel": "Mortgage Loans On Real Estate Year Of Origination [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationDomain",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_NetRevenuesRetailCoPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Revenues, Retail CoPayments",
        "label": "Net Revenues, Retail CoPayments",
        "terseLabel": "Co-payments"
       }
      }
     },
     "localname": "NetRevenuesRetailCoPayments",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling interest, Other Period Increase (Decrease)",
        "label": "Noncontrolling interest, Other Period Increase (Decrease)",
        "terseLabel": "Other decreases in noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollinginterestOtherPeriodIncreaseDecrease",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NumberOfPeopleServed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of People Served",
        "label": "Number Of People Served",
        "terseLabel": "Number of people served"
       }
      }
     },
     "localname": "NumberOfPeopleServed",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfPlanMembers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Plan Members",
        "label": "Number Of Plan Members",
        "terseLabel": "Number of plan members"
       }
      }
     },
     "localname": "NumberOfPlanMembers",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfQuarterlyPaymentsFromVariableInterestEntity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Quarterly Payments From Variable Interest Entity",
        "label": "Number Of Quarterly Payments From Variable Interest Entity",
        "terseLabel": "Number of quarterly payments from VIE"
       }
      }
     },
     "localname": "NumberOfQuarterlyPaymentsFromVariableInterestEntity",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfUnderPerformingStoresPlannedClosure": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Under Performing Stores, Planned Closure",
        "label": "Number of Under Performing Stores, Planned Closure",
        "terseLabel": "Number of under performing stores, planned closure"
       }
      }
     },
     "localname": "NumberOfUnderPerformingStoresPlannedClosure",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofPatientsServedperYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Patients Served per Year",
        "label": "Number of Patients Served per Year",
        "terseLabel": "Number of patients served per year"
       }
      }
     },
     "localname": "NumberofPatientsServedperYear",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofReinsuranceContractsEnteredInto": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reinsurance contracts entered into with an unrelated insurer.",
        "label": "Number of Reinsurance Contracts Entered Into",
        "terseLabel": "Number of reinsurance contracts entered into"
       }
      }
     },
     "localname": "NumberofReinsuranceContractsEnteredInto",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofWalkInMedicalClinics": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Walk In Medical Clinics",
        "label": "Number of Walk In Medical Clinics",
        "terseLabel": "Number of walk-in medical clinics"
       }
      }
     },
     "localname": "NumberofWalkInMedicalClinics",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumeratorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator For Earnings Per Share Calculation [Abstract]",
        "label": "Numerator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Numerator for earnings (loss) per share calculation:"
       }
      }
     },
     "localname": "NumeratorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life",
        "label": "Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life",
        "terseLabel": "Leases, amount due in excess of remaining estimated economic life"
       }
      }
     },
     "localname": "OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OperatingExpensesExcludingGoodwillImpairments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses, Excluding Goodwill Impairments",
        "label": "Operating Expenses, Excluding Goodwill Impairments",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesExcludingGoodwillImpairments",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
        "label": "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
        "terseLabel": "Operating leases:"
       }
      }
     },
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OperatingLeasesRentExpenseGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesRentalExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeasesRentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases, Rent Expense, Gross",
        "label": "Operating Leases, Rent Expense, Gross",
        "totalLabel": "Rental expense"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseGross",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesRentalExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherAcquiredIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Other Acquired Intangible Assets [Line Items]",
        "terseLabel": "Other Intangible Assets[Line Items]"
       }
      }
     },
     "localname": "OtherAcquiredIntangibleAssetsLineItems",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OtherAcquiredIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Other Acquired Intangible Assets [Table]",
        "terseLabel": "Other Intangible Assets [Table]"
       }
      }
     },
     "localname": "OtherAcquiredIntangibleAssetsTable",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OtherAssetBackedSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.",
        "label": "Other Asset-Backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "OtherAssetBackedSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherInsuranceLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Current",
        "label": "Other Insurance Liabilities, Current",
        "terseLabel": "Other insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesCurrent",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherInsuranceLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities [Member]",
        "label": "Other Insurance Liabilities [Member]",
        "terseLabel": "Other Insurance Liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherInsuranceLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Noncurrent",
        "label": "Other Insurance Liabilities, Noncurrent",
        "terseLabel": "Other long-term insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesNoncurrent",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherLongTermInsuranceLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Long-Term Insurance Liabilities [Member]",
        "label": "Other Long-Term Insurance Liabilities [Member]",
        "terseLabel": "Other Long-Term Insurance Liabilities"
       }
      }
     },
     "localname": "OtherLongTermInsuranceLiabilitiesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OutstandingSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding Senior Notes [Member]",
        "label": "Outstanding Senior Notes [Member]",
        "terseLabel": "Outstanding Senior Notes"
       }
      }
     },
     "localname": "OutstandingSeniorNotesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PaymentsforInsuranceBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Insurance Benefits",
        "label": "Payments for Insurance Benefits",
        "negatedTerseLabel": "Insurance benefits paid"
       }
      }
     },
     "localname": "PaymentsforInsuranceBenefits",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies",
        "label": "Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies",
        "negatedTerseLabel": "Cash paid for inventory and prescriptions dispensed by retail network pharmacies"
       }
      }
     },
     "localname": "PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PensionAndAnnuityInvestmentContractsInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension And Annuity Investment Contracts Interest",
        "label": "Pension And Annuity Investment Contracts Interest",
        "terseLabel": "Interest rate for pension and annuity investment contracts"
       }
      }
     },
     "localname": "PensionAndAnnuityInvestmentContractsInterest",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_PharmacyClaimsandDiscountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Claims and Discounts Payable, Current",
        "label": "Pharmacy Claims and Discounts Payable, Current",
        "terseLabel": "Pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "PharmacyClaimsandDiscountsPayableCurrent",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyRebatePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Rebate Period",
        "label": "Pharmacy Rebate Period",
        "terseLabel": "Pharmacy rebate period"
       }
      }
     },
     "localname": "PharmacyRebatePeriod",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_PharmacyRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Revenue [Member]",
        "label": "Pharmacy Revenue [Member]",
        "terseLabel": "Pharmacy"
       }
      }
     },
     "localname": "PharmacyRevenueMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PharmacyServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Services Segment [Member]",
        "label": "Pharmacy Services Segment [Member]",
        "terseLabel": "Pharmacy Services"
       }
      }
     },
     "localname": "PharmacyServicesSegmentMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PremiumDeficiencyReserveLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.",
        "label": "Premium Deficiency Reserve Liability",
        "terseLabel": "Add: Premium deficiency reserve",
        "verboseLabel": "Premium deficiency reserve"
       }
      }
     },
     "localname": "PremiumDeficiencyReserveLiability",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "label": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues from external customers",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums [Member]",
        "label": "Premiums [Member]",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.",
        "label": "Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]",
        "verboseLabel": "Proceeds and related gross realized capital gains and losses from the sale of debt securities"
       }
      }
     },
     "localname": "ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_ProceedsFromVariableInterestEntity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Variable Interest Entity",
        "label": "Proceeds From Variable Interest Entity",
        "terseLabel": "Proceeds from VIE"
       }
      }
     },
     "localname": "ProceedsFromVariableInterestEntity",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ProviderNetworksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired in a business combination or other transaction. This item represents the value ascribed to the relationships with the acquiree's physicians, hospitals and other health care providers network.",
        "label": "Provider networks [Member]",
        "terseLabel": "Provider networks"
       }
      }
     },
     "localname": "ProviderNetworksMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RXCrossroadsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RX Crossroads [Member]",
        "label": "RX Crossroads [Member]",
        "terseLabel": "RX Crossroads"
       }
      }
     },
     "localname": "RXCrossroadsMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RedeemablePreferredSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Preferred Securities [Member]",
        "label": "Redeemable Preferred Securities [Member]",
        "terseLabel": "Redeemable preferred securities"
       }
      }
     },
     "localname": "RedeemablePreferredSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Charitable Contribution To Non-Profit Entity",
        "label": "Related Party Transaction, Charitable Contribution To Non-Profit Entity",
        "terseLabel": "Charitable contribution to CVS Health Foundation"
       }
      }
     },
     "localname": "RelatedPartyTransactionCharitableContributionToNonProfitEntity",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_RestrictedStockUnitsandPerformanceShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units and Performance Share Units [Member]",
        "label": "Restricted Stock Units and Performance Share Units [Member]",
        "terseLabel": "Restricted Stock Units and Performance Share Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsandPerformanceShareUnitsMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RetailLongTermCareSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail Long-Term Care Segment [Member]",
        "label": "Retail Long-Term Care Segment [Member]",
        "terseLabel": "Retail/ LTC"
       }
      }
     },
     "localname": "RetailLongTermCareSegmentMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RevolvingCreditFacilityExpiringMay122021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Expiring May 12, 2021",
        "label": "Revolving Credit Facility, Expiring May 12, 2021 [Member]",
        "terseLabel": "Revolving Credit Facility, Expiring May 12, 2021"
       }
      }
     },
     "localname": "RevolvingCreditFacilityExpiringMay122021Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RevolvingCreditFacilityExpiringMay162024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Expiring May 16, 2024 [Member]",
        "label": "Revolving Credit Facility, Expiring May 16, 2024 [Member]",
        "terseLabel": "Revolving Credit Facility, Expiring May 16, 2024"
       }
      }
     },
     "localname": "RevolvingCreditFacilityExpiringMay162024Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RevolvingCreditFacilityExpiringMay172023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Expiring May 17, 2023 [Member]",
        "label": "Revolving Credit Facility, Expiring May 17, 2023 [Member]",
        "terseLabel": "Revolving Credit Facility, Expiring May 17, 2023"
       }
      }
     },
     "localname": "RevolvingCreditFacilityExpiringMay172023Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RevolvingCreditFacilityExpiringMay182022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Expiring May 18, 2022 [Member]",
        "label": "Revolving Credit Facility, Expiring May 18, 2022 [Member]",
        "terseLabel": "Revolving Credit Facility, Expiring May 18, 2022"
       }
      }
     },
     "localname": "RevolvingCreditFacilityExpiringMay182022Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "label": "Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations:"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_SalesChannelOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Channel, Other [Member]",
        "label": "Sales Channel, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "SalesChannelOtherMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.",
        "label": "Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]",
        "verboseLabel": "Mortgage loan internal credit rating"
       }
      }
     },
     "localname": "ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_SeniorNotes13DueAugust2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.3%, Due August 2027",
        "label": "Senior Notes, 1.3%, Due August 2027 [Member]",
        "terseLabel": "1.3% senior notes due August 2027"
       }
      }
     },
     "localname": "SeniorNotes13DueAugust2027Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes175DueAugust2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.75%, Due August 2030",
        "label": "Senior Notes, 1.75%, Due August 2030 [Member]",
        "terseLabel": "1.75% senior notes due August 2030"
       }
      }
     },
     "localname": "SeniorNotes175DueAugust2030Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1875DueFebruary2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.875%, Due February 2031",
        "label": "Senior Notes, 1.875%, Due February 2031 [Member]",
        "terseLabel": "1.875%, senior notes due February 2031"
       }
      }
     },
     "localname": "SeniorNotes1875DueFebruary2031Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1Point3PercentAugust2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1 Point 3 Percent, August 2027",
        "label": "Senior Notes, 1 Point 3 Percent, August 2027 [Member]",
        "terseLabel": "1.3% senior notes due August 2027"
       }
      }
     },
     "localname": "SeniorNotes1Point3PercentAugust2027Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1Point75PercentAugust2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1 Point 75 Percent, August 2030",
        "label": "Senior Notes, 1 Point 75 Percent, August 2030 [Member]",
        "terseLabel": "1.75% senior notes due August 2030"
       }
      }
     },
     "localname": "SeniorNotes1Point75PercentAugust2030Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1Point875PercentFebruary2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1 Point 875 Percent, February 2031",
        "label": "Senior Notes, 1 Point 875 Percent, February 2031 [Member]",
        "terseLabel": "1.875% senior notes due February 2031"
       }
      }
     },
     "localname": "SeniorNotes1Point875PercentFebruary2031Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.125June2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.125%, June 2021 [Member]",
        "label": "Senior Notes, 2.125%, June 2021 [Member]",
        "terseLabel": "2.125% senior notes due June 2021"
       }
      }
     },
     "localname": "SeniorNotes2.125June2021Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.625DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "label": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "terseLabel": "2.625% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes2.625DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.75DueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.75%, Due December 2022 [Member]",
        "label": "Senior Notes, 2.75%, Due December 2022 [Member]",
        "terseLabel": "2.75% senior notes due December 2022"
       }
      }
     },
     "localname": "SeniorNotes2.75DueDecember2022Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.75DueNovember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.75%, Due November 2022 [Member]",
        "label": "Senior Notes, 2.75%, Due November 2022 [Member]",
        "terseLabel": "2.75% senior notes due November 2022"
       }
      }
     },
     "localname": "SeniorNotes2.75DueNovember2022Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.875DueJune2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "label": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "terseLabel": "2.875% senior notes due June 2026"
       }
      }
     },
     "localname": "SeniorNotes2.875DueJune2026Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.8DueJuly2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.8%, Due July 2020 [Member]",
        "label": "Senior Notes, 2.8%, Due July 2020 [Member]",
        "terseLabel": "2.8% senior notes due July 2020"
       }
      }
     },
     "localname": "SeniorNotes2.8DueJuly2020Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.8DueJune2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "label": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "terseLabel": "2.8% senior notes due June 2023"
       }
      }
     },
     "localname": "SeniorNotes2.8DueJune2023Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes27DueAugust2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.7%, Due August 2040",
        "label": "Senior Notes, 2.7%, Due August 2040 [Member]",
        "terseLabel": "2.7% senior notes due August 2040"
       }
      }
     },
     "localname": "SeniorNotes27DueAugust2040Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2Point7PercentAugust2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2 Point 7 Percent, August 2040",
        "label": "Senior Notes, 2 Point 7 Percent, August 2040 [Member]",
        "terseLabel": "2.7% senior notes due August 2040"
       }
      }
     },
     "localname": "SeniorNotes2Point7PercentAugust2040Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.125DueMarch2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.125%, Due March 2020 [Member]",
        "label": "Senior Notes, 3.125%, Due March 2020 [Member]",
        "terseLabel": "3.125% senior notes due March 2020"
       }
      }
     },
     "localname": "SeniorNotes3.125DueMarch2020Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.25DueAugust2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "label": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "terseLabel": "3.25% senior notes due August 2029"
       }
      }
     },
     "localname": "SeniorNotes3.25DueAugust2029Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.35DueMarch2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.35%, Due March 2021 [Member]",
        "label": "Senior Notes, 3.35%, Due March 2021 [Member]",
        "terseLabel": "3.35% senior notes due March 2021"
       }
      }
     },
     "localname": "SeniorNotes3.35DueMarch2021Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.375DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "label": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "terseLabel": "3.375% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes3.375DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueJuly2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due July 2022 [Member]",
        "label": "Senior Notes, 3.5%, Due July 2022 [Member]",
        "terseLabel": "3.5% senior notes due July 2022"
       }
      }
     },
     "localname": "SeniorNotes3.5DueJuly2022Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueNovember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "label": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "terseLabel": "3.5% senior notes due November 2024"
       }
      }
     },
     "localname": "SeniorNotes3.5DueNovember2024Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.7DueMarch2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.7%, Due March 2023 [Member]",
        "label": "Senior Notes, 3.7%, Due March 2023 [Member]",
        "terseLabel": "3.7% senior notes due March 2023"
       }
      }
     },
     "localname": "SeniorNotes3.7DueMarch2023Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueAugust2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "label": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "terseLabel": "3.875% senior notes due August 2047"
       }
      }
     },
     "localname": "SeniorNotes3.875DueAugust2047Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueJuly2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "label": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "terseLabel": "3.875% senior notes due July 2025"
       }
      }
     },
     "localname": "SeniorNotes3.875DueJuly2025Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3625DueApril2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.625%, Due April 2027",
        "label": "Senior Notes, 3.625%, Due April 2027 [Member]",
        "terseLabel": "3.625% senior notes due April 2027"
       }
      }
     },
     "localname": "SeniorNotes3625DueApril2027Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes375DueApril2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.75%, Due April 2030",
        "label": "Senior Notes, 3.75%, Due April 2030 [Member]",
        "terseLabel": "3.75% senior notes due April 2030"
       }
      }
     },
     "localname": "SeniorNotes375DueApril2030Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3DueAugust2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3%, Due August 2026 [Member]",
        "label": "Senior Notes, 3%, Due August 2026 [Member]",
        "terseLabel": "3% senior notes due August 2026"
       }
      }
     },
     "localname": "SeniorNotes3DueAugust2026Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3Point625PercentApril2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3 Point 625 Percent, April 2027",
        "label": "Senior Notes, 3 Point 625 Percent, April 2027 [Member]",
        "terseLabel": "3.625% senior notes due April 2027"
       }
      }
     },
     "localname": "SeniorNotes3Point625PercentApril2027Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3Point75PercentApril2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3 Point 75 Percent, April 2030",
        "label": "Senior Notes, 3 Point 75 Percent, April 2030 [Member]",
        "terseLabel": "3.75% senior notes due April 2030"
       }
      }
     },
     "localname": "SeniorNotes3Point75PercentApril2030Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueJune2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due June 2021 [Member]",
        "label": "Senior Notes, 4.125%, Due June 2021 [Member]",
        "terseLabel": "4.125% senior notes due June 2021"
       }
      }
     },
     "localname": "SeniorNotes4.125DueJune2021Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueMay2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due May 2021 [Member]",
        "label": "Senior Notes, 4.125%, Due May 2021 [Member]",
        "terseLabel": "4.125% senior notes due May 2021"
       }
      }
     },
     "localname": "SeniorNotes4.125DueMay2021Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueNovember2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents senior notes due 2042 with a coupon rate of 4.125%.",
        "label": "Senior Notes, 4.125%, Due November 2042 [Member]",
        "terseLabel": "4.125% senior notes due November 2042"
       }
      }
     },
     "localname": "SeniorNotes4.125DueNovember2042Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.1DueMarch2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "label": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "terseLabel": "4.1% senior notes due March 2025"
       }
      }
     },
     "localname": "SeniorNotes4.1DueMarch2025Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.3DueMarch2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "label": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "terseLabel": "4.3% senior notes due March 2028"
       }
      }
     },
     "localname": "SeniorNotes4.3DueMarch2028Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.5DueMay2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "label": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "terseLabel": "4.5% senior notes due May 2042"
       }
      }
     },
     "localname": "SeniorNotes4.5DueMay2042Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due December 2022 [Member]",
        "label": "Senior Notes, 4.75%, Due December 2022 [Member]",
        "terseLabel": "4.75% senior notes due December 2022"
       }
      }
     },
     "localname": "SeniorNotes4.75DueDecember2022Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueMarch2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "label": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "terseLabel": "4.75% senior notes due March 2044"
       }
      }
     },
     "localname": "SeniorNotes4.75DueMarch2044Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.78DueMarch2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "label": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "terseLabel": "4.78% senior notes due March 2038"
       }
      }
     },
     "localname": "SeniorNotes4.78DueMarch2038Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.875DueJuly2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "label": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "terseLabel": "4.875% senior notes due July 2035"
       }
      }
     },
     "localname": "SeniorNotes4.875DueJuly2035Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4125DueApril2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due April 2040",
        "label": "Senior Notes, 4.125%, Due April 2040 [Member]",
        "terseLabel": "4.125% senior notes due April 2040"
       }
      }
     },
     "localname": "SeniorNotes4125DueApril2040Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes425DueApril2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.25%, Due April 2050",
        "label": "Senior Notes, 4.25%, Due April 2050 [Member]",
        "terseLabel": "4.25% senior notes due April 2050"
       }
      }
     },
     "localname": "SeniorNotes425DueApril2050Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes43Due2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.3%, Due 2028",
        "label": "Senior Notes, 4.3%, Due 2028 [Member]",
        "terseLabel": "4.3% senior notes due 2028"
       }
      }
     },
     "localname": "SeniorNotes43Due2028Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4DueDecember2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4%, Due December 2023 [Member]",
        "label": "Senior Notes, 4%, Due December 2023 [Member]",
        "terseLabel": "4% senior notes due December 2023"
       }
      }
     },
     "localname": "SeniorNotes4DueDecember2023Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4Point125PercentApril2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4 Point 125 Percent, April 2040",
        "label": "Senior Notes, 4 Point 125 Percent, April 2040 [Member]",
        "terseLabel": "4.125% senior notes due April 2040"
       }
      }
     },
     "localname": "SeniorNotes4Point125PercentApril2040Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4Point25PercentApril2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4 Point 25 Percent, April 2050",
        "label": "Senior Notes, 4 Point 25 Percent, April 2050 [Member]",
        "terseLabel": "4.25% senior notes due April 2050"
       }
      }
     },
     "localname": "SeniorNotes4Point25PercentApril2050Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.05DueMarch2048Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "label": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "terseLabel": "5.05% senior notes due March 2048"
       }
      }
     },
     "localname": "SeniorNotes5.05DueMarch2048Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.125DueJuly2045Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "label": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "terseLabel": "5.125% senior notes due July 2045"
       }
      }
     },
     "localname": "SeniorNotes5.125DueJuly2045Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.3DueDecember2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "label": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "terseLabel": "5.3% senior notes due December 2043"
       }
      }
     },
     "localname": "SeniorNotes5.3DueDecember2043Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.45DueJune2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents senior notes due 2021 with a coupon rate of 5.45%.",
        "label": "Senior Notes, 5.45%, Due June 2021 [Member]",
        "terseLabel": "5.45% senior notes due June 2021"
       }
      }
     },
     "localname": "SeniorNotes5.45DueJune2021Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.75DueMay2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "label": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "terseLabel": "5.75% senior notes due May 2041"
       }
      }
     },
     "localname": "SeniorNotes5.75DueMay2041Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5DueDecember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5%, Due December 2024 [Member]",
        "label": "Senior Notes, 5%, Due December 2024 [Member]",
        "terseLabel": "5% senior notes due December 2024"
       }
      }
     },
     "localname": "SeniorNotes5DueDecember2024Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.125DueSeptember2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "label": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "terseLabel": "6.125% senior notes due September 2039"
       }
      }
     },
     "localname": "SeniorNotes6.125DueSeptember2039Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.25DueJune2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "label": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "terseLabel": "6.25% senior notes due June 2027"
       }
      }
     },
     "localname": "SeniorNotes6.25DueJune2027Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.625DueJune2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "label": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "terseLabel": "6.625% senior notes due June 2036"
       }
      }
     },
     "localname": "SeniorNotes6.625DueJune2036Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.75DueDecember2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "label": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "terseLabel": "6.75% senior notes due December 2037"
       }
      }
     },
     "localname": "SeniorNotes6.75DueDecember2037Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeparateAccountFinancialAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separate Account, Financial Assets",
        "label": "Separate Account, Financial Assets [Member]",
        "terseLabel": "Separate Accounts, financial assets"
       }
      }
     },
     "localname": "SeparateAccountFinancialAssetsMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value",
        "terseLabel": "Fair value of stock options and SARs vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ShareBasedPaymentArrangementOptionGrantedIn2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Option, Granted In 2019 [Member]",
        "label": "Share-Based Payment Arrangement, Option, Granted In 2019 [Member]",
        "terseLabel": "Stock options granted in 2019"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementOptionGrantedIn2019Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Option, Granted Prior To 2019 [Member]",
        "label": "Share-Based Payment Arrangement, Option, Granted Prior To 2019 [Member]",
        "terseLabel": "Stock options granted prior to 2019"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementOptionGrantedPriorTo2019Member",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number",
        "terseLabel": "Expected to vest (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_SharesHeldInTrustPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Held In Trust [Policy Text Block]",
        "label": "Shares Held In Trust [Policy Text Block]",
        "terseLabel": "Shares Held in Trust"
       }
      }
     },
     "localname": "SharesHeldInTrustPolicyTextBlock",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased",
        "label": "Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased",
        "terseLabel": "Average purchase price of shares purchased (in dollars per share)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cvs_StoreRationalizationCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails": {
       "order": 1.0,
       "parentTag": "cvs_AdjustedOperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Store Rationalization Charges",
        "label": "Store Rationalization Charges",
        "verboseLabel": "Store rationalization charges"
       }
      }
     },
     "localname": "StoreRationalizationCharges",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_SupportingExperienceRatedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supporting discontinued and experience-rated products.",
        "label": "Supporting Experience Rated Products [Member]",
        "terseLabel": "Supporting experience- rated products"
       }
      }
     },
     "localname": "SupportingExperienceRatedProductsMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SupportingRemainingProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities in an unrealized capital loss position supporting remaining products.",
        "label": "Supporting Remaining Products [Member]",
        "terseLabel": "Supporting remaining products"
       }
      }
     },
     "localname": "SupportingRemainingProductsMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Cuts and Jobs Act, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense",
        "label": "Tax Cuts and Jobs Act, Incomplete Accounting, Change in Tax Rate, Provisional Income Tax Expense",
        "negatedTerseLabel": "Provisional benefit of revaluation of net DTL due to TCJA"
       }
      }
     },
     "localname": "TaxCutsAndJobsActIncompleteAccountingChangeInTaxRateProvisionalIncomeTaxExpense",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TotalInvestmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Axis]",
        "terseLabel": "Total Investments [Axis]"
       }
      }
     },
     "localname": "TotalInvestmentsAxis",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Domain]",
        "terseLabel": "Total Investments [Domain]"
       }
      }
     },
     "localname": "TotalInvestmentsDomain",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Line Items]",
        "terseLabel": "Total Investments [Line Items]"
       }
      }
     },
     "localname": "TotalInvestmentsLineItems",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Table]",
        "terseLabel": "Total Investments [Table]"
       }
      }
     },
     "localname": "TotalInvestmentsTable",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes total investments, both current and long-term.",
        "label": "Total Investments [Table Text Block]",
        "verboseLabel": "Total investments"
       }
      }
     },
     "localname": "TotalInvestmentsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchase of treasury shares, net of ESPP issuances (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockSharesHeldinTrust": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Held in Trust",
        "label": "Treasury Stock, Shares, Held in Trust",
        "terseLabel": "Treasury shares held in trust (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesHeldinTrust",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchase of treasury shares, net of ESPP issuances"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TreasuryStockValueSharesHeldInTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Shares Held In Trust",
        "label": "Treasury Stock, Value, Shares Held In Trust",
        "terseLabel": "Treasury shares held in trust"
       }
      }
     },
     "localname": "TreasuryStockValueSharesHeldInTrust",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TwoThousandEighteenNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Eighteen Notes [Member]",
        "label": "Two Thousand Eighteen Notes [Member]",
        "terseLabel": "2018 Senior Notes"
       }
      }
     },
     "localname": "TwoThousandEighteenNotesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Department of Health and Human Services, ACA Risk Corridor Receivables",
        "label": "U.S. Department of Health and Human Services, ACA Risk Corridor Receivables [Member]",
        "terseLabel": "U.S. Department of Health and Human Services, ACA Risk Corridor Receivables [Member]"
       }
      }
     },
     "localname": "USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_USFederalGovernmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Federal Government",
        "label": "US Federal Government [Member]",
        "terseLabel": "US Federal Government"
       }
      }
     },
     "localname": "USFederalGovernmentMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_VOYARetirementInsuranceAndAnnuityCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VOYA Retirement Insurance And Annuity Company [Member]",
        "label": "VOYA Retirement Insurance And Annuity Company [Member]",
        "terseLabel": "VOYA Retirement Insurance and Annuity Company"
       }
      }
     },
     "localname": "VOYARetirementInsuranceAndAnnuityCompanyMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ValueOfBusinessAcquiredMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value Of Business Acquired [Member]",
        "label": "Value Of Business Acquired [Member]",
        "terseLabel": "Value of Business Acquired"
       }
      }
     },
     "localname": "ValueOfBusinessAcquiredMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_VendorandManufacturerReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor and Manufacturer Receivables",
        "label": "Vendor and Manufacturer Receivables",
        "terseLabel": "Vendor and manufacturer receivables"
       }
      }
     },
     "localname": "VendorandManufacturerReceivables",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_WeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Lease Term [Abstract]",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_WellCareHealthPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "WellCare Health Plans [Member]",
        "label": "WellCare Health Plans [Member]",
        "terseLabel": "WellCare Health Plans"
       }
      }
     },
     "localname": "WellCareHealthPlansMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period Five",
        "label": "Year Of Origination Period Five [Member]",
        "terseLabel": "2016"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period Four",
        "label": "Year Of Origination Period Four [Member]",
        "terseLabel": "2017"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFourMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period One",
        "label": "Year Of Origination Period One [Member]",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "YearOfOriginationPeriodOneMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period Three",
        "label": "Year Of Origination Period Three [Member]",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "YearOfOriginationPeriodThreeMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period Two",
        "label": "Year Of Origination Period Two [Member]",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "YearOfOriginationPeriodTwoMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPriorToPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Prior To Period Five",
        "label": "Year Of Origination Prior To Period Five [Member]",
        "terseLabel": "Prior"
       }
      }
     },
     "localname": "YearOfOriginationPriorToPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings",
        "label": "Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings",
        "terseLabel": "Yield-related impairment loss"
       }
      }
     },
     "localname": "YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20201231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r975",
      "r976",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r978"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r973"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r980"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r975",
      "r976",
      "r977"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r974"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r635",
      "r636",
      "r645",
      "r646",
      "r971",
      "r982"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r635",
      "r636",
      "r645",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r221",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r247",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r221",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r247",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r174",
      "r182",
      "r299",
      "r558",
      "r559",
      "r560",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r174",
      "r182",
      "r299",
      "r558",
      "r559",
      "r560",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r174",
      "r182",
      "r299",
      "r558",
      "r559",
      "r560",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r257",
      "r412",
      "r416",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r512",
      "r518",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r772",
      "r887",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r512",
      "r518",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r772",
      "r887",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "auth_ref": [
      "r954",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r981",
      "r983"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of real estate property.",
        "label": "Real Estate, Type of Property [Axis]",
        "terseLabel": "Real Estate, Type of Property [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]",
        "terseLabel": "Mortgage Loans on Real Estate [Line Items]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "auth_ref": [
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Land and any structures permanently fixed to it.",
        "label": "Real Estate [Domain]",
        "terseLabel": "Real Estate [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateScheduleTable": {
     "auth_ref": [
      "r956",
      "r985"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]",
        "terseLabel": "Mortgage Loans on Real Estate [Table]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateScheduleTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r257",
      "r412",
      "r416",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r254",
      "r412",
      "r414",
      "r773",
      "r884",
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r254",
      "r412",
      "r414",
      "r773",
      "r884",
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r451",
      "r512",
      "r518",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r772",
      "r887",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r451",
      "r512",
      "r518",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r772",
      "r887",
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock": {
     "auth_ref": [
      "r864",
      "r984"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the supplemental schedule of reinsurance information. Reinsurance schedule includes, but is not limited to, the type of insurance, gross amount of premiums, premiums ceded to other entities, premiums assumed from other entities, net amount of premium revenue, and the percentage of the premiums assumed to net premium revenue.",
        "label": "SEC Schedule, 12-17, Insurance Companies, Reinsurance [Text Block]",
        "terseLabel": "Schedule of direct, assumed and ceded premiums earned"
       }
      }
     },
     "localname": "SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AboveMarketLeasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases acquired as part of a real property acquisition at above market lease rate.",
        "label": "Above Market Leases [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "AboveMarketLeasesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "Accounting Standards Update 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "ASU 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201802Member": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2018-02 Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.",
        "label": "Accounting Standards Update 2018-02 [Member]",
        "terseLabel": "Accounting Standards Update 2018-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201802Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r178",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r599",
      "r600",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r30",
      "r61"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r26",
      "r48",
      "r259",
      "r260"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net",
        "totalLabel": "Total accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r90",
      "r96",
      "r97",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Pension and OPEB plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r59",
      "r359"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r85",
      "r96",
      "r97",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r96",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r96",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r51",
      "r93",
      "r95",
      "r96",
      "r832",
      "r900",
      "r904"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "negatedLabel": "Decrease to accumulated other comprehensive income",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r92",
      "r96",
      "r97",
      "r171",
      "r172",
      "r173",
      "r642",
      "r895",
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r178",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r597",
      "r598",
      "r599",
      "r600",
      "r775",
      "r776",
      "r777",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Reconciliation of net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r567"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r521",
      "r550",
      "r563"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocationsToPolicyholdersPolicies": {
     "auth_ref": [
      "r157",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining amounts of income and expenses allocated to policyholders and contract holders, excluding the method for determining dividends payable to policyholders and accounting policies pertaining to separate accounts for variable annuity contracts.",
        "label": "Allocations to Policyholders, Policies [Policy Text Block]",
        "terseLabel": "Policyholders' Funds"
       }
      }
     },
     "localname": "AllocationsToPolicyholdersPolicies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r263",
      "r302",
      "r304",
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts Receivable, allowance for credit loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": {
     "auth_ref": [
      "r305"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails": {
       "order": 9.0,
       "parentTag": "cvs_AdjustedOperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Recovery",
        "negatedTerseLabel": "Receipt of fully reserved ACA risk corridor receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r150",
      "r343",
      "r350"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails": {
       "order": 6.0,
       "parentTag": "cvs_AdjustedOperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Antidilutive securities excluded from computation of EPS (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r92",
      "r96",
      "r97",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r282",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r161",
      "r229",
      "r242",
      "r249",
      "r294",
      "r635",
      "r645",
      "r693",
      "r783",
      "r828"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r27",
      "r28",
      "r80",
      "r161",
      "r294",
      "r635",
      "r645",
      "r693"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r669"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldByInsuranceRegulators": {
     "auth_ref": [
      "r931"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of cash and investment securities on deposit with state regulatory authorities in connection with capital requirements.",
        "label": "Assets Held by Insurance Regulators",
        "terseLabel": "Investments on deposit with regulatory bodies"
       }
      }
     },
     "localname": "AssetsHeldByInsuranceRegulators",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssumedPremiumsEarned": {
     "auth_ref": [
      "r846",
      "r862",
      "r916",
      "r919"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PremiumsEarnedNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earned premiums assumed from other entities.",
        "label": "Assumed Premiums Earned",
        "terseLabel": "Assumed"
       }
      }
     },
     "localname": "AssumedPremiumsEarned",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r276",
      "r279",
      "r810"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r276",
      "r278",
      "r809"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r276",
      "r280",
      "r811"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r276",
      "r277",
      "r808"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r268",
      "r272",
      "r314",
      "r791"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Debt securities",
        "totalLabel": "Total",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]",
        "terseLabel": "Number of Securities"
       }
      }
     },
     "localname": "AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r522",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building, building improvements and leasehold improvements",
        "verboseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Distribution centers and Corporate Offices"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r507",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r507",
      "r513",
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Business acquisition transaction costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "auth_ref": [
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Basic earnings per share from continuing operations attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "auth_ref": [
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Diluted earnings per share from continuing operations attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Schedule of pro forma financial information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Business acquisition, share price (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax": {
     "auth_ref": [
      "r618",
      "r619"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax",
        "terseLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r618",
      "r619"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r623"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r626",
      "r627",
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred in acquisition"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails": {
       "order": 5.0,
       "parentTag": "cvs_AdjustedOperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "verboseLabel": "Acquisition-related transaction and integration costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Income of acquiree since acquisition date"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Revenue of acquiree since acquisition date"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": {
     "auth_ref": [
      "r622"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest",
        "totalLabel": "Total consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy": {
     "auth_ref": [
      "r157",
      "r865"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.",
        "label": "Deferred Policy Acquisition Costs, Policy [Policy Text Block]",
        "terseLabel": "Health Care Contract Acquisition Costs"
       }
      }
     },
     "localname": "CapitalizationOfDeferredPolicyAcquisitionCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r24",
      "r55",
      "r152"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r33",
      "r153",
      "r157",
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r142",
      "r152",
      "r156"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "totalLabel": "Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r142",
      "r694"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries": {
     "auth_ref": [
      "r168"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.",
        "label": "SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries",
        "terseLabel": "Dividends paid"
       }
      }
     },
     "localname": "CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.",
        "label": "Cash Proceeds Received and Tax Benefit from Share-based Payment Awards [Table Text Block]",
        "terseLabel": "Cash proceeds received and tax benefit from share-based payment awards"
       }
      }
     },
     "localname": "CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CededCreditRiskAxis": {
     "auth_ref": [
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reinsurer or group of reinsurers of concentrated credit risk arising from a reinsurance arrangement.",
        "label": "Ceded Credit Risk, Reinsurer [Axis]",
        "terseLabel": "Ceded Credit Risk, Reinsurer [Axis]"
       }
      }
     },
     "localname": "CededCreditRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededCreditRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Ceded Credit Risk [Line Items]",
        "terseLabel": "Ceded Credit Risk [Line Items]"
       }
      }
     },
     "localname": "CededCreditRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededCreditRiskReinsurerDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.",
        "label": "Ceded Credit Risk, Reinsurer [Domain]",
        "terseLabel": "Ceded Credit Risk, Reinsurer [Domain]"
       }
      }
     },
     "localname": "CededCreditRiskReinsurerDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CededCreditRiskTable": {
     "auth_ref": [
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.",
        "label": "Ceded Credit Risk [Table]",
        "terseLabel": "Ceded Credit Risk [Table]"
       }
      }
     },
     "localname": "CededCreditRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededPremiumsEarned": {
     "auth_ref": [
      "r846",
      "r861",
      "r913",
      "r914",
      "r917",
      "r919"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PremiumsEarnedNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earned premiums ceded to other entities.",
        "label": "Ceded Premiums Earned",
        "negatedTerseLabel": "Ceded"
       }
      }
     },
     "localname": "CededPremiumsEarned",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClaimsDevelopmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Claims Development [Line Items]",
        "terseLabel": "Claims Development [Line Items]"
       }
      }
     },
     "localname": "ClaimsDevelopmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r394",
      "r395",
      "r396",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r281",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage Backed Securities [Member]",
        "terseLabel": "Commercial mortgage-backed securities"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialRealEstateMember": {
     "auth_ref": [
      "r311",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property that is solely used for business purposes.",
        "label": "Commercial Real Estate [Member]",
        "terseLabel": "Commercial Real Estate"
       }
      }
     },
     "localname": "CommercialRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r71",
      "r370",
      "r794",
      "r839"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r367",
      "r368",
      "r369",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Capital shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock).",
        "label": "Common Stock Including Additional Paid in Capital [Member]",
        "terseLabel": "Common Stock and Capital Surplus"
       }
      }
     },
     "localname": "CommonStockIncludingAdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r171",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesHeldInEmployeeTrustShares": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common stock held in a trust that has been set up specifically to accumulate stock for the sole purpose of distribution to participating employees but not yet earned.",
        "label": "Common Stock, Shares Held in Employee Trust, Shares",
        "terseLabel": "Common stock, shares held in trust (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesHeldInEmployeeTrustShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r47",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStocksIncludingAdditionalPaidInCapital": {
     "auth_ref": [
      "r47",
      "r49",
      "r392"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of par value plus amounts in excess of par value or issuance value for common stock issued.",
        "label": "Common Stocks, Including Additional Paid in Capital",
        "terseLabel": "Common stock, par value $0.01: 3,200 shares authorized; 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus"
       }
      }
     },
     "localname": "CommonStocksIncludingAdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "terseLabel": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r100",
      "r102",
      "r103",
      "r114",
      "r801",
      "r853"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss) attributable to CVS Health"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r100",
      "r102",
      "r113",
      "r633",
      "r657",
      "r800",
      "r852"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r112",
      "r122",
      "r799",
      "r850"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r210",
      "r211",
      "r257",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r210",
      "r211",
      "r257",
      "r690",
      "r691",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r210",
      "r211",
      "r257",
      "r690",
      "r691",
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r210",
      "r211",
      "r257",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage (\"Less than\" - 2018 Federal Government)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r208",
      "r210",
      "r211",
      "r212",
      "r690",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r210",
      "r211",
      "r257",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r157",
      "r644",
      "r648",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of contract with customer assets and liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r399",
      "r401",
      "r413"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables (included in accounts receivable, net)",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r399",
      "r400",
      "r413"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "periodEndLabel": "Balance at December 31, 2020",
        "periodStartLabel": "Balance at December 31, 2019",
        "terseLabel": "Contract liabilities (included in accrued expenses)"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r412",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r412",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateAndOtherMember": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate and Other [Member]",
        "terseLabel": "Corporate/ Other"
       }
      }
     },
     "localname": "CorporateAndOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r251",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate/ Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r118",
      "r773"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Products Sold"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r162",
      "r593",
      "r603"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r162",
      "r593",
      "r603",
      "r605"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r162",
      "r593",
      "r603"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r209",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer contracts/relationships and covenants not to compete"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Borrowings and Credit Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r39",
      "r41",
      "r42",
      "r784",
      "r786",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r42",
      "r381",
      "r786",
      "r823"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total",
        "verboseLabel": "Amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r706",
      "r708"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt face amount",
        "verboseLabel": "Debt issued in acquisition"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r687"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r69",
      "r164",
      "r388",
      "r389",
      "r390",
      "r391",
      "r705",
      "r706",
      "r708",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r705",
      "r708"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premiums"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r273",
      "r314",
      "r322",
      "r323"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "negatedTerseLabel": "Debt Securities, Available-for-sale, Allowance for Credit Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r289",
      "r320",
      "r325"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Fair Value, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r289",
      "r320"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "terseLabel": "Unrealized Losses, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": {
     "auth_ref": [
      "r318"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions",
        "terseLabel": "Number of Securities, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r289",
      "r320",
      "r325"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "verboseLabel": "Fair Value, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r289",
      "r320"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "verboseLabel": "Unrealized Losses, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "auth_ref": [
      "r318"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Number of Securities, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Gain",
        "terseLabel": "Gross realized capital gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Loss",
        "negatedTerseLabel": "Gross realized capital losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Debt securities available for sale"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r285",
      "r316",
      "r325"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r286",
      "r317"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss",
        "totalLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r287",
      "r318"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "totalLabel": "Number of Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r162",
      "r594",
      "r603"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r150",
      "r162",
      "r594",
      "r603",
      "r604",
      "r605"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r44",
      "r45",
      "r586",
      "r785",
      "r822"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r571",
      "r572"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredPolicyAcquisitionCosts": {
     "auth_ref": [
      "r837",
      "r866",
      "r867",
      "r868",
      "r898",
      "r930"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force.",
        "label": "Deferred Policy Acquisition Cost",
        "terseLabel": "Deferred acquisition costs"
       }
      }
     },
     "localname": "DeferredPolicyAcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r162",
      "r594",
      "r603"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r591",
      "r592"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r591",
      "r592"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r588"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r591",
      "r592"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss and capital loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r591",
      "r592"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "auth_ref": [
      "r591",
      "r592"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "terseLabel": "Employee benefits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits",
        "terseLabel": "Retirement benefits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent": {
     "auth_ref": [
      "r591",
      "r592"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent",
        "terseLabel": "Lease and rents"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": {
     "auth_ref": [
      "r591",
      "r592"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves",
        "terseLabel": "Insurance reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r587"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance",
        "verboseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r572",
      "r588"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Liabilities, Investments",
        "negatedLabel": "Investments"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r591",
      "r592"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Lease and rents"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r441",
      "r498"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld": {
     "auth_ref": [
      "r456",
      "r498"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r428",
      "r467",
      "r492",
      "r498",
      "r499"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Amortization of net actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r426",
      "r449"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "totalLabel": "Net assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]",
        "terseLabel": "Assets (liabilities) recognized on the consolidated balance sheet"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r37",
      "r426",
      "r427",
      "r449",
      "r498",
      "r782",
      "r826"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Non-current assets reflected in other assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r475",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected long-term rate of return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Benefit obligation, end of year",
        "periodStartLabel": "Benefit obligation, beginning of year",
        "terseLabel": "Benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r436",
      "r504"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefit payments"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r478",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in benefit obligation:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in plan assets:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated trust, responsible for collective investment and reinvestment of asset from employee benefit plan maintained by more than one employer, in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Common Collective Trust [Member]",
        "verboseLabel": "Common/collective trusts"
       }
      }
     },
     "localname": "DefinedBenefitPlanCommonCollectiveTrustMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r443",
      "r452",
      "r454",
      "r496",
      "r498",
      "r499"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions",
        "verboseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDerivativeMember": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or other contract with one or more underlyings, notional amount or payment provision or both; can be settled net by means outside contract or delivery of asset; and with minimal or no initial net investment, in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Derivative [Member]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DefinedBenefitPlanDerivativeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember": {
     "auth_ref": [
      "r452",
      "r454",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity, not domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities, Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesNonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember": {
     "auth_ref": [
      "r452",
      "r454",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities, US [Member]",
        "terseLabel": "U.S. Domestic"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2026-2030"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r428",
      "r466",
      "r491",
      "r498",
      "r499"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r440",
      "r452",
      "r454",
      "r455",
      "r498"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r426",
      "r449",
      "r498"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r428",
      "r432",
      "r465",
      "r490",
      "r498",
      "r499"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r463",
      "r488",
      "r498",
      "r499"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "terseLabel": "Net periodic benefit cost",
        "totalLabel": "Net periodic benefit cost (income)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r445",
      "r504"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefit payments"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock": {
     "auth_ref": [
      "r452",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of defined benefit plan asset investment. Includes, but is not limited to, fair value of category of plan asset and its level within fair value hierarchy.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Table Text Block]",
        "terseLabel": "Schedule of change in level 3 plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsCategoryTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment within defined benefit plan asset category.",
        "label": "Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount",
        "terseLabel": "Plan assets, investment within plan asset category, amount"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r451",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Target investment allocations"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements": {
     "auth_ref": [
      "r457",
      "r498"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement",
        "verboseLabel": "Purchases, sales and settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanPurchasesSalesAndSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRealEstateMember": {
     "auth_ref": [
      "r452",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property composed of building, land and land improvement; in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Real Estate [Member]",
        "terseLabel": "Real estate"
       }
      }
     },
     "localname": "DefinedBenefitPlanRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels": {
     "auth_ref": [
      "r458",
      "r498"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan, for assets transferred into (out of) Level 3 of fair value hierarchy. Includes, but is not limited to, transfer due to change in observability of significant inputs.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3",
        "terseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "DefinedBenefitPlanTransfersBetweenMeasurementLevels",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Assumptions used to determine benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Assumptions used to determine net benefit costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r484",
      "r485",
      "r486",
      "r487",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Defined contribution plan, employer contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r150",
      "r357"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r150",
      "r224"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCollateralObligationToReturnSecurities": {
     "auth_ref": [
      "r82",
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to return securities collateral under master netting arrangements that have not been offset against derivative assets.",
        "label": "Derivative, Collateral, Obligation to Return Securities",
        "terseLabel": "Derivative assets subject to offsetting and enforceable master netting arrangements"
       }
      }
     },
     "localname": "DerivativeCollateralObligationToReturnSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueOffsettingFinancialLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset": {
     "auth_ref": [
      "r81",
      "r658"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to receive cash collateral under master netting arrangements offset against derivative liabilities.",
        "label": "Derivative Liability, Collateral, Right to Reclaim Cash, Offset",
        "terseLabel": "Derivative liabilities subject to offsetting and enforceable master netting arrangements"
       }
      }
     },
     "localname": "DerivativeLiabilityCollateralRightToReclaimCashOffset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueOffsettingFinancialLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r157",
      "r166",
      "r659",
      "r660",
      "r661",
      "r662",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DirectPremiumsEarned": {
     "auth_ref": [
      "r846",
      "r860",
      "r915",
      "r918"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PremiumsEarnedNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Direct Premiums Earned",
        "terseLabel": "Direct"
       }
      }
     },
     "localname": "DirectPremiumsEarned",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r412",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock Incentive Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r15",
      "r110",
      "r848"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "terseLabel": "Loss from discontinued operations"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share",
        "terseLabel": "Loss from discontinued operations attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share",
        "terseLabel": "Loss from discontinued operations attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax": {
     "auth_ref": [
      "r3",
      "r5",
      "r7"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a discontinued operation.",
        "label": "Discontinued Operation, Provision for Loss (Gain) on Disposal, before Income Tax",
        "negatedLabel": "Loss on sale of subsidiary",
        "terseLabel": "(Gain) loss on sale of subsidiaries"
       }
      }
     },
     "localname": "DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r7",
      "r15",
      "r18",
      "r573",
      "r602",
      "r610"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "negatedTerseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsPolicyTextBlock": {
     "auth_ref": [
      "r9",
      "r22",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.",
        "label": "Discontinued Operations, Policy [Policy Text Block]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DiscontinuedOperationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r507",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r392",
      "r813"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedTerseLabel": "Common stock dividends"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends Payable, Amount Per Share",
        "terseLabel": "Cash dividend declared (USD per share)"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DomesticCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r271",
      "r452",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, US [Member]",
        "terseLabel": "U.S. corporate securities",
        "verboseLabel": "U.S. corporate securities"
       }
      }
     },
     "localname": "DomesticCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r115",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r188",
      "r190",
      "r193",
      "r194",
      "r195",
      "r199",
      "r200",
      "r802",
      "r854"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Net income (loss) attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "verboseLabel": "Basic earnings (loss) per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings (loss) per share from continuing operations:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r115",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r190",
      "r193",
      "r194",
      "r195",
      "r199",
      "r200",
      "r802",
      "r854"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Net income (loss) attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted earnings (loss) per share:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r157",
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings (Loss) per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r694"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r574"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r574",
      "r606"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r574",
      "r606"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Percent",
        "terseLabel": "Basis difference upon disposition of subsidiary"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": {
     "auth_ref": [
      "r574",
      "r606"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent",
        "terseLabel": "Goodwill impairments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r574",
      "r606"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r574",
      "r606"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent": {
     "auth_ref": [
      "r574"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to Tax Cuts and Jobs Act.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent",
        "terseLabel": "Effect of the Tax Cuts and Jobs Act"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_EffectsOfReinsuranceTableTextBlock": {
     "auth_ref": [
      "r921"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effects of reinsurance, for example, but not limited to, disclosure of direct, assumed, and ceded insurance.",
        "label": "Effects of Reinsurance [Table Text Block]",
        "terseLabel": "Schedule of impact of reinsurance on benefit costs"
       }
      }
     },
     "localname": "EffectsOfReinsuranceTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Compensation not yet recognized, period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r551"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation not yet recognized, other than options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r551"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation not yet recognized, options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r176",
      "r185",
      "r187",
      "r203",
      "r299",
      "r387",
      "r392",
      "r558",
      "r559",
      "r560",
      "r599",
      "r600",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r701",
      "r895",
      "r896",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r56",
      "r141",
      "r157",
      "r293",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r685"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r34",
      "r40",
      "r291",
      "r824",
      "r949",
      "r950",
      "r951"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r292"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of debt",
        "verboseLabel": "Aggregate principal of debt extinguished"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci": {
     "auth_ref": [
      "r679"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.",
        "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI",
        "terseLabel": "Change in unrealized capital losses included in OCI associated with Level 3 financial assets"
       }
      }
     },
     "localname": "FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r669",
      "r670",
      "r671",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r674",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Changes in level 3 financial assets"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r669",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r669",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Carrying value and estimated fair value of certain financial instruments"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r498",
      "r670",
      "r745",
      "r746",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r669",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r669",
      "r670",
      "r672",
      "r673",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).",
        "label": "Fair Value, Inputs, Level 1, 2 and 3 [Member]",
        "terseLabel": "Total Fair Value, Inputs, Level 1, 2 and 3"
       }
      }
     },
     "localname": "FairValueInputsLevel12And3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r452",
      "r454",
      "r459",
      "r498",
      "r670",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r452",
      "r454",
      "r459",
      "r498",
      "r670",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r498",
      "r670",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "auth_ref": [
      "r454",
      "r668",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "terseLabel": "Fair Value Measured at Net Asset Value Per Share"
       }
      }
     },
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r675"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Included in earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r676"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Included in other comprehensive income"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "auth_ref": [
      "r677"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "auth_ref": [
      "r677"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "negatedTerseLabel": "Sales"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "auth_ref": [
      "r677"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "auth_ref": [
      "r678"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details": {
       "order": 1.0,
       "parentTag": "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "terseLabel": "Gross transfers into Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net",
        "terseLabel": "Transfers out of Level 3, net",
        "totalLabel": "Net transfers out of Level 3",
        "verboseLabel": "Gross transfers into (out of) level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r678"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details": {
       "order": 2.0,
       "parentTag": "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "negatedTerseLabel": "Gross transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r674"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r498",
      "r745",
      "r746",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r669",
      "r670",
      "r672",
      "r673",
      "r680",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r681",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable": {
     "auth_ref": [
      "r67",
      "r792",
      "r814"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of maximum advances or credit lines available from the Federal Home Loan Bank (FHLB).",
        "label": "Federal Home Loan Bank, Advances, General Debt Obligations, Maximum Amount Available",
        "terseLabel": "Federal home loan bank advances maximum amount available"
       }
      }
     },
     "localname": "FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FederalHomeLoanBankAdvancesMember": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings from the Federal Home Loan Bank, which are primarily used to cover shortages in the required reserve balance and also in times of liquidity shortages. The member institution executes a promissory note, which is generally collateralized by government securities to the Federal Reserve or loans.",
        "label": "Federal Home Loan Bank Advances [Member]",
        "terseLabel": "Federal Home Loan Bank Advances"
       }
      }
     },
     "localname": "FederalHomeLoanBankAdvancesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r719",
      "r724",
      "r736"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "cvs_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r721",
      "r730"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows paid for interest portion of finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r718",
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LeaseLiability",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total finance lease liabilities",
        "totalLabel": "Total finance lease liabilities",
        "verboseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r718"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Maturities of financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r718"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsYearOne",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r720",
      "r730"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows paid for principal portion of finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r719",
      "r724",
      "r736"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "cvs_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r733",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r732",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r282",
      "r283",
      "r303",
      "r307",
      "r308",
      "r309",
      "r310",
      "r319",
      "r321",
      "r324",
      "r325",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average period before the next renewal or extension (both explicit and implicit) for intangible assets that have been renewed or extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Weighted Average Period before Next Renewal or Extension",
        "terseLabel": "Weighted Average Life (years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-lived intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r344",
      "r345",
      "r349",
      "r353",
      "r774",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r349",
      "r778"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-lived intangible assets, gross carrying amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r344",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r349",
      "r774"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Finite-lived intangible assets, net carrying amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r271",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation not domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, Non-US [Member]",
        "terseLabel": "Foreign securities"
       }
      }
     },
     "localname": "ForeignCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r157",
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation and Transactions and Translations"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Fixtures and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainContingencyUnrecordedAmount": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.",
        "label": "Gain Contingency, Unrecorded Amount",
        "terseLabel": "Gain contingency, unrecorded amount"
       }
      }
     },
     "localname": "GainContingencyUnrecordedAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r150",
      "r643"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails": {
       "order": 7.0,
       "parentTag": "cvs_AdjustedOperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "(Gain) loss on divestiture of subsidiary",
        "terseLabel": "Gain (loss) on divestiture, pretax"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r150",
      "r383",
      "r384"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r383",
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.",
        "label": "Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost",
        "negatedTerseLabel": "Premium paid in excess of debt principal"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r329",
      "r331",
      "r781"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance, end of the period",
        "periodStartLabel": "Balance, beginning of the period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r333"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Goodwill and Other Intangibles"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r157",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r157",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r332",
      "r337"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Cumulative goodwill impairments"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r150",
      "r330",
      "r335",
      "r340"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails": {
       "order": 8.0,
       "parentTag": "cvs_AdjustedOperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairments",
        "verboseLabel": "Impairments"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillOtherIncreaseDecrease": {
     "auth_ref": [
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Other Increase (Decrease)",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "GoodwillOtherIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r336",
      "r615"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Purchase accounting adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Segment realignment"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r334"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Divestiture of Workers\u2019 Compensation business"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Guarantor obligations, maximum exposure"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuarantyLiabilities": {
     "auth_ref": [
      "r373",
      "r374",
      "r793",
      "r844"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.",
        "label": "Guaranty Liabilities",
        "terseLabel": "Guaranty liabilities"
       }
      }
     },
     "localname": "GuarantyLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareCostsPolicyPolicyTextBlock": {
     "auth_ref": [
      "r958"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for  accruing health care costs for a prepaid health care service provider.",
        "label": "Health Care Costs, Policy [Policy Text Block]",
        "terseLabel": "Health Care Costs Payable"
       }
      }
     },
     "localname": "HealthCareCostsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HealthCareEntitiesPolicyPolicyTextBlock": {
     "auth_ref": [
      "r958"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for all health care policies.",
        "label": "Health Care Entities, Policy [Policy Text Block]",
        "terseLabel": "Health Care Reform"
       }
      }
     },
     "localname": "HealthCareEntitiesPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HealthInsuranceProductLineMember": {
     "auth_ref": [
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product line consisting of insurance against loss by illness or injury.",
        "label": "Health Insurance Product Line [Member]",
        "terseLabel": "Health Insurance Product Line"
       }
      }
     },
     "localname": "HealthInsuranceProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgeFundsMember": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in registered hedge funds.",
        "label": "Hedge Funds [Member]",
        "terseLabel": "Hedge Funds",
        "verboseLabel": "Hedge fund investments"
       }
      }
     },
     "localname": "HedgeFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r150",
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets, indefinite-lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Asset Impairment"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r117",
      "r151",
      "r180",
      "r181",
      "r182",
      "r183",
      "r191",
      "r195",
      "r632"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income (loss) from continuing operations attributable to CVS Health"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r165",
      "r229",
      "r241",
      "r245",
      "r248",
      "r251"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Pre-tax income recognized",
        "totalLabel": "Income before income tax provision"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r161",
      "r175",
      "r229",
      "r241",
      "r245",
      "r248",
      "r251",
      "r294",
      "r633",
      "r693"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Income (loss) from continuing operations",
        "verboseLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r107",
      "r115",
      "r175",
      "r180",
      "r181",
      "r182",
      "r183",
      "r190",
      "r193",
      "r194",
      "r795",
      "r797",
      "r802",
      "r847"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Income (loss) from continuing operations attributable to CVS Health (in dollars per share)",
        "verboseLabel": "Earnings (loss) per share from continuing operations, basic (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r107",
      "r115",
      "r175",
      "r180",
      "r181",
      "r182",
      "r183",
      "r190",
      "r193",
      "r194",
      "r195",
      "r802",
      "r847",
      "r850",
      "r854"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Income (loss) from continuing operations attributable to CVS Health (in dollars per share)",
        "verboseLabel": "Earnings (loss) per share from continuing operations, diluted (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r18",
      "r21",
      "r611",
      "r848"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Loss from discontinued operations, net of tax",
        "totalLabel": "Loss from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r507",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r575",
      "r584",
      "r590",
      "r601",
      "r607",
      "r612",
      "r613",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r162",
      "r186",
      "r187",
      "r227",
      "r573",
      "r602",
      "r609",
      "r856"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "totalLabel": "Total",
        "verboseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r104",
      "r157",
      "r569",
      "r570",
      "r584",
      "r585",
      "r589",
      "r595",
      "r959"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "negatedTerseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable and pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInsuranceLiabilities": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in insurance liability balances during the period.",
        "label": "Increase (Decrease) in Insurance Liabilities",
        "terseLabel": "Health care costs payable and other insurance liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r352"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangible assets, Trademarks"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]",
        "terseLabel": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r342",
      "r347"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r108",
      "r223",
      "r704",
      "r707",
      "r804"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r803"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails": {
       "order": 2.0,
       "parentTag": "cvs_AdjustedOperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "verboseLabel": "Interest income on financing for the Aetna Acquisition"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r139",
      "r146",
      "r154"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "negatedTerseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r667"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Amount expected to be reclassified"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalCreditAssessmentAxis": {
     "auth_ref": [
      "r262",
      "r310",
      "r312",
      "r313",
      "r375",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by entity-defined rating.",
        "label": "Internal Credit Assessment [Axis]",
        "terseLabel": "Internal Credit Assessment [Axis]"
       }
      }
     },
     "localname": "InternalCreditAssessmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InternalCreditAssessmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity defined credit risk rating.",
        "label": "Internal Credit Assessment [Domain]",
        "terseLabel": "Internal Credit Assessment [Domain]"
       }
      }
     },
     "localname": "InternalCreditAssessmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r221",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r247",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r25",
      "r77"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r31",
      "r78",
      "r157",
      "r202",
      "r326",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsorLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Gross investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInvestmentExpense": {
     "auth_ref": [
      "r121",
      "r857"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsorLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to the generation of investment income.",
        "label": "Investment Income, Investment Expense",
        "negatedLabel": "Investment expenses"
       }
      }
     },
     "localname": "InvestmentIncomeInvestmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r119",
      "r120"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "totalLabel": "Net investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeTextBlock": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table Text Block]",
        "verboseLabel": "Net investment income"
       }
      }
     },
     "localname": "InvestmentIncomeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r293",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r842"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "verboseLabel": "Fair value of debt securities by contractual maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r291",
      "r779",
      "r812",
      "r952"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r734",
      "r736"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total rental expense, net"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Finance lease cost:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease costs and supplemental cash flow information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Right-of-Use Assets and Lease Liabilities"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of operating lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueAfterYearFive",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r735"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearFive",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearFour",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearThree",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r735"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "auth_ref": [
      "r738"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payments to be received by lessor for operating lease.",
        "label": "Lessor, Operating Lease, Payments to be Received",
        "terseLabel": "Future noncancelable subleases, future minimum payments"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r64",
      "r161",
      "r243",
      "r294",
      "r636",
      "r645",
      "r646",
      "r693"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r54",
      "r161",
      "r294",
      "r693",
      "r788",
      "r836"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r66",
      "r161",
      "r294",
      "r636",
      "r645",
      "r646",
      "r693"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r872",
      "r875"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Health care costs payable, end of period",
        "periodStartLabel": "Health care costs payable, beginning of period",
        "terseLabel": "Total health care costs payable"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.",
        "label": "Liability for Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefits": {
     "auth_ref": [
      "r820",
      "r885",
      "r886",
      "r890",
      "r898"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.",
        "label": "Liability for Future Policy Benefit, before Reinsurance",
        "terseLabel": "Future policy benefits"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "verboseLabel": "Acquisitions, net"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Less: Claims paid"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r874"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r874"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r873"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Add: Components of incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": {
     "auth_ref": [
      "r821",
      "r872",
      "r875"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "periodEndLabel": "Health care costs payable, end of period, net",
        "periodStartLabel": "Health care costs payable, beginning of period, net",
        "terseLabel": "Health care costs payable"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Amount awarded from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r42",
      "r382",
      "r786",
      "r830"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "New debt issued in acquisition"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "negatedTerseLabel": "Current portion of long-term debt",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Long-term debt and lease obligations"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Long-term Debt, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r169",
      "r379"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r169",
      "r379"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r169",
      "r379"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r169",
      "r379"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r169",
      "r379"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r169",
      "r379"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-term Investments",
        "terseLabel": "Long-term",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r69",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r23",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "verboseLabel": "Acquisitions and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r76",
      "r161",
      "r294",
      "r693",
      "r787",
      "r835"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstate": {
     "auth_ref": [
      "r953"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": {
     "auth_ref": [
      "r841"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.",
        "label": "Mortgage Loans on Real Estate, Commercial and Consumer, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateForeclosures": {
     "auth_ref": [
      "r955"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure",
        "terseLabel": "Mortgage loans foreclosed"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateForeclosures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateNewMortgageLoans": {
     "auth_ref": [
      "r955"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan",
        "terseLabel": "New mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNewMortgageLoans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgagesHeldForSaleFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of mortgage loans held-for-sale.",
        "label": "Mortgages Held-for-sale, Fair Value Disclosure",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgagesHeldForSaleFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MultiemployerPlanPensionInsignificantPlanContribution": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by multiemployer pension plan from all employers participating in multiemployer pension plan determined to be individually insignificant.",
        "label": "Multiemployer Plan, Pension, Insignificant, Plan Contribution",
        "terseLabel": "Multiemployer plans, plan contributions"
       }
      }
     },
     "localname": "MultiemployerPlanPensionInsignificantPlanContribution",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r142",
      "r148",
      "r151"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Reconciliation of net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r21",
      "r98",
      "r101",
      "r111",
      "r151",
      "r161",
      "r175",
      "r180",
      "r181",
      "r182",
      "r183",
      "r186",
      "r187",
      "r191",
      "r229",
      "r241",
      "r245",
      "r248",
      "r251",
      "r294",
      "r693",
      "r798",
      "r849"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r98",
      "r101",
      "r186",
      "r187",
      "r638",
      "r656"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net (income) loss attributable to noncontrolling interests",
        "negatedTerseLabel": "Comprehensive (income) loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentIncome": {
     "auth_ref": [
      "r851"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.",
        "label": "Net Investment Income",
        "terseLabel": "Net investment income"
       }
      }
     },
     "localname": "NetInvestmentIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "verboseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r182",
      "r199",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r597",
      "r598",
      "r599",
      "r600",
      "r775",
      "r776",
      "r777",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "verboseLabel": "Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements Recently Adopted and Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r393",
      "r623",
      "r640"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Acquisition of noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r392",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableToBanksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a bank.",
        "label": "Notes Payable to Banks [Member]",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayableToBanksMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which entity operates"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStores": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of stores.",
        "label": "Number of Stores",
        "terseLabel": "Number of stores",
        "verboseLabel": "Number of stores"
       }
      }
     },
     "localname": "NumberOfStores",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OffsettingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offsetting [Abstract]",
        "terseLabel": "Offsetting [Abstract]"
       }
      }
     },
     "localname": "OffsettingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating costs:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r229",
      "r241",
      "r245",
      "r248",
      "r251"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails": {
       "order": 4.0,
       "parentTag": "cvs_AdjustedOperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "netLabel": "Operating income (GAAP measure)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r725",
      "r736"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r718"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LeaseLiability",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r718"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities",
        "verboseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r718"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities",
        "verboseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r722",
      "r730"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows paid for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r717"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r733",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r732",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r377",
      "r712",
      "r713",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.",
        "label": "Lessee, Operating Lease, Disclosure [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Disclosure"
       }
      }
     },
     "localname": "OperatingLeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseContingentRentals": {
     "auth_ref": [
      "r709",
      "r711",
      "r712",
      "r714",
      "r715"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesRentalExpenseDetails": {
       "order": 2.0,
       "parentTag": "cvs_OperatingLeasesRentExpenseGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increases or decreases in lease payments that result from changes occurring after the inception of the lease in the factors (other than the passage of time) on which lease payments are based, except that any escalation of minimum lease payments relating to increases in construction or acquisition cost of the leased property or for increases in some measure of cost or value during the construction or preconstruction period, are excluded from contingent rentals. Contingent rentals also may include amounts for which the triggering events have not yet occurred or the specified targets for which have not yet been achieved (such as sales based percentage rent), but which events are considered probable of occurring or which specified targets are considered probable of being achieved.",
        "label": "Operating Leases, Rent Expense, Contingent Rentals",
        "terseLabel": "Contingent rentals"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseContingentRentals",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesRentalExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseMinimumRentals": {
     "auth_ref": [
      "r710",
      "r714",
      "r715"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesRentalExpenseDetails": {
       "order": 1.0,
       "parentTag": "cvs_OperatingLeasesRentExpenseGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the payments that the lessee is obligated to make or can be required to make in connection with a property under the terms of an agreement classified as an operating lease, excluding contingent rentals and a guarantee by the lessee of the lessor's debt and the lessee's obligation to pay (apart from the rental payments) executory costs such as insurance, maintenance, and taxes.",
        "label": "Operating Leases, Rent Expense, Minimum Rentals",
        "terseLabel": "Minimum rentals"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseMinimumRentals",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesRentalExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r715"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesRentalExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "totalLabel": "Total rental expense, net"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesRentalExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseSubleaseRentals1": {
     "auth_ref": [
      "r714"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesRentalExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesRentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of sublease rental income recognized during the period that reduces the entity's rent expense incurred under operating leases.",
        "label": "Operating Leases, Rent Expense, Sublease Rentals",
        "negatedLabel": "Less: sublease income"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseSubleaseRentals1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesRentalExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r633",
      "r634",
      "r641"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Net unrealized investment gains"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r96",
      "r695",
      "r697",
      "r701"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "OCI before Reclass, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r96",
      "r105",
      "r695",
      "r697",
      "r701"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "negatedTerseLabel": "Loss on net cash flow hedges",
        "verboseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r86",
      "r93"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r99",
      "r102",
      "r105",
      "r112",
      "r387",
      "r695",
      "r700",
      "r701",
      "r799",
      "r850"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income (Note 13)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r91",
      "r93"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r284",
      "r315",
      "r452",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other Debt Obligations"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r151"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other noncash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPolicyholderFunds": {
     "auth_ref": [
      "r843"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.",
        "label": "Other Policyholder Funds",
        "terseLabel": "Policyholders\u2019 funds"
       }
      }
     },
     "localname": "OtherPolicyholderFunds",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r425",
      "r426",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r478",
      "r481",
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.",
        "label": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings",
        "terseLabel": "OTTI losses, investments, portion recognized in earnings, net"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total CVS Health Shareholders' Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted",
        "negatedTerseLabel": "Income allocated to participating securities"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r147",
      "r874"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total claims paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities": {
     "auth_ref": [
      "r167"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow from derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.",
        "label": "Payments for (Proceeds from) Derivative Instrument, Financing Activities",
        "negatedTerseLabel": "Derivative settlements",
        "terseLabel": "Proceeds from derivative instruments"
       }
      }
     },
     "localname": "PaymentsForProceedsFromDerivativeInstrumentFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r126",
      "r129",
      "r167"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Payments for taxes related to net share settlement of equity awards",
        "terseLabel": "Payments for taxes for net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions (net of cash acquired)"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToSuppliersAndEmployees": {
     "auth_ref": [
      "r137",
      "r138",
      "r145"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to suppliers for goods and services provided and to employees for services provided.",
        "label": "Payments to Suppliers and Employees",
        "negatedTerseLabel": "Cash paid to other suppliers and employees"
       }
      }
     },
     "localname": "PaymentsToSuppliersAndEmployees",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r451",
      "r453",
      "r459",
      "r477",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r498",
      "r500",
      "r503",
      "r505",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "verboseLabel": "Pension Plans and Other Postretirement Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r41",
      "r426",
      "r427",
      "r449",
      "r498"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities reflected in accrued expenses"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r43",
      "r426",
      "r427",
      "r449",
      "r498"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Non-current liabilities reflected in other long-term liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r157",
      "r484",
      "r501",
      "r502",
      "r505",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit (OPEB) Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r424",
      "r426",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r478",
      "r481",
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r505",
      "r506",
      "r513",
      "r514",
      "r515",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r478",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r522",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderAccountsPolicy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for contracts reported in separate accounts, including the extent and terms of minimum guarantees, basis of presentation for separate account assets and liabilities and related separate account activity, the liability valuation method and assumptions used in valuing each type of policyholder and contract holder account maintained by the entity.",
        "label": "Policyholder Accounts, Policy [Policy Text Block]",
        "terseLabel": "Separate Accounts"
       }
      }
     },
     "localname": "PolicyholderAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredGross": {
     "auth_ref": [
      "r859"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred.",
        "label": "Policyholder Benefits and Claims Incurred, Direct",
        "terseLabel": "Direct"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r859"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "terseLabel": "Benefit costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet": {
     "auth_ref": [
      "r816",
      "r859"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.",
        "label": "Policyholder Benefits and Claims Incurred, Net",
        "totalLabel": "Net benefit costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Policyholder Benefits and Claims Incurred, Net [Abstract]",
        "terseLabel": "Policyholder Benefits and Claims Incurred, Net [Abstract]"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r796",
      "r846",
      "r863",
      "r920"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums",
        "totalLabel": "Net premiums"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAtCarryingValue": {
     "auth_ref": [
      "r840"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.",
        "label": "Premiums Receivable, Net",
        "terseLabel": "Premium receivables"
       }
      }
     },
     "localname": "PremiumsReceivableAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrivateEquityFundsMember": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments held in private equity funds.",
        "label": "Private Equity Funds [Member]",
        "verboseLabel": "Private equity investments"
       }
      }
     },
     "localname": "PrivateEquityFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromCustomers": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash receipts from customers during the current period which are usually for sales of goods and services.",
        "label": "Proceeds from Customers",
        "terseLabel": "Cash receipts from customers"
       }
      }
     },
     "localname": "ProceedsFromCustomers",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of subsidiary"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from sale of subsidiaries and other assets"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromInterestAndDividendsReceived": {
     "auth_ref": [
      "r136",
      "r144"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for dividends and interest on the entity's equity and debt investments during the current period.",
        "label": "Proceeds from Interest and Dividends Received",
        "terseLabel": "Interest and investment income received"
       }
      }
     },
     "localname": "ProceedsFromInterestAndDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity": {
     "auth_ref": [
      "r805"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from principal payment received from sales-type and direct financing leases classified as investing activity.",
        "label": "Proceeds from Lease Payment, Sales-Type and Direct Financing Leases, Investing Activity",
        "terseLabel": "Proceeds from sale-leaseback transactions"
       }
      }
     },
     "localname": "ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r132",
      "r135",
      "r167"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r167"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Net repayments of short-term debt"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r123",
      "r124",
      "r269"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sales"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r130",
      "r553"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options",
        "verboseLabel": "Cash received from stock options exercised (including ESPP)"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r21",
      "r98",
      "r101",
      "r140",
      "r161",
      "r175",
      "r186",
      "r187",
      "r229",
      "r241",
      "r245",
      "r248",
      "r251",
      "r294",
      "r633",
      "r637",
      "r639",
      "r656",
      "r657",
      "r693",
      "r806"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r59",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r58",
      "r358"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r35",
      "r36",
      "r360",
      "r838"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r57",
      "r157",
      "r360",
      "r960",
      "r961"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r35",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r35",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful life of property plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RealEstateFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in funds that invest in commercial or residential real estate.",
        "label": "Real Estate Funds [Member]",
        "verboseLabel": "Real estate partnerships"
       }
      }
     },
     "localname": "RealEstateFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RealEstateInvestmentMember": {
     "auth_ref": [
      "r948",
      "r949",
      "r950",
      "r951"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents direct equity investments in real estate projects (Land, buildings and improvements owned for income production and capital accretion potential) and certain loans accounted for as real estate investments. For loans accounted for as real estate investments, the entity (lender) has virtually the same risks and rewards as those of owners or joint venture participants. Such arrangements are treated as if the entity actually has an ownership interest in the property. In such arrangements, the entity (lender) participates in expected residual profits, which may be in the form of an equity kicker or a higher than usual effective interest rate. At the outset and during the construction and development of the property, the borrower generally has little or no equity in the property and the entity's (lender's) only source of repayment is the property. The entity (lender) generally (a) agrees to provide substantially all funds to acquire, develop, and construct the property, (b) funds the commitment or origination fees or both, and (c) funds interest during the development and construction of the property.",
        "label": "Real Estate Investment [Member]",
        "terseLabel": "Real Estate Investment"
       }
      }
     },
     "localname": "RealEstateInvestmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r858"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Net realized capital gains"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r157",
      "r261",
      "r265",
      "r266",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r96",
      "r97",
      "r695",
      "r699",
      "r701"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "terseLabel": "Amounts reclassified, pre-tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r96",
      "r97",
      "r105",
      "r695",
      "r699",
      "r701"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive loss, net of tax",
        "verboseLabel": "Cumulative translation adjustment from AOCI eliminated upon divestiture"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "Changes in Accumulated Other Comprehensive Income (Loss) by Component"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r241",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of operating earnings to net income"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r32",
      "r161",
      "r294",
      "r386",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]",
        "terseLabel": "Redeemable preferred securities"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReinsuranceAccountingPolicy": {
     "auth_ref": [
      "r157",
      "r816",
      "r817",
      "r922",
      "r923"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.",
        "label": "Reinsurance Accounting Policy [Policy Text Block]",
        "terseLabel": "Reinsurance Recoverables"
       }
      }
     },
     "localname": "ReinsuranceAccountingPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReinsuranceDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reinsurance Disclosures [Abstract]",
        "terseLabel": "Reinsurance Disclosures [Abstract]"
       }
      }
     },
     "localname": "ReinsuranceDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed": {
     "auth_ref": [
      "r816"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of policy benefits and costs incurred for policies assumed.",
        "label": "Policyholder Benefits and Claims Incurred, Assumed",
        "terseLabel": "Assumed"
       }
      }
     },
     "localname": "ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded": {
     "auth_ref": [
      "r816"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reduction of provision for policy benefits and costs incurred for policies ceded.",
        "label": "Policyholder Benefits and Claims Incurred, Ceded",
        "negatedTerseLabel": "Ceded"
       }
      }
     },
     "localname": "ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Premiums Earned, Net [Abstract]",
        "terseLabel": "Premiums Earned, Net [Abstract]"
       }
      }
     },
     "localname": "ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r818",
      "r870",
      "r872",
      "r875"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "periodEndLabel": "Add: Reinsurance recoverables",
        "periodStartLabel": "Less: Reinsurance recoverables",
        "terseLabel": "Reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses": {
     "auth_ref": [
      "r818",
      "r869",
      "r870",
      "r932"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, policy benefits and policy reserves. Excludes premiums paid under reinsurance contracts.",
        "label": "Reinsurance Recoverable for Paid and Unpaid Claims and Claims Adjustments",
        "terseLabel": "Total reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverablesOnPaidAndUnpaidLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceTextBlock": {
     "auth_ref": [
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.",
        "label": "Reinsurance [Text Block]",
        "terseLabel": "Reinsurance"
       }
      }
     },
     "localname": "ReinsuranceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Reinsurance"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r740"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.",
        "label": "Related Party Transaction, Other Revenues from Transactions with Related Party",
        "terseLabel": "Other revenues from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r271",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by residential real estate mortgage loans.",
        "label": "Residential Mortgage Backed Securities [Member]",
        "terseLabel": "Residential mortgage-backed securities"
       }
      }
     },
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r24",
      "r33",
      "r156"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash (included in other current assets)"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r29",
      "r37",
      "r156",
      "r957"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash (included in other assets)"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedInvestmentsAtFairValue": {
     "auth_ref": [
      "r935",
      "r945"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate value of all restricted investments.",
        "label": "Restricted Investments, at Fair Value",
        "terseLabel": "Investments related to 2012 contract conversion"
       }
      }
     },
     "localname": "RestrictedInvestmentsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r50",
      "r392",
      "r561",
      "r833",
      "r899",
      "r904"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Retained earnings",
        "terseLabel": "Retained earnings",
        "verboseLabel": "Increase to retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r176",
      "r185",
      "r187",
      "r299",
      "r558",
      "r559",
      "r560",
      "r599",
      "r600",
      "r895",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r478",
      "r481",
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r513",
      "r514",
      "r515",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r476",
      "r478",
      "r481",
      "r485",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r513",
      "r514",
      "r515",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r220",
      "r221",
      "r240",
      "r246",
      "r247",
      "r254",
      "r255",
      "r257",
      "r411",
      "r412",
      "r773"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue from Products and Services",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r158",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r158",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Vendor Allowances and Purchase Discounts"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r109",
      "r161",
      "r220",
      "r221",
      "r240",
      "r246",
      "r247",
      "r254",
      "r255",
      "r257",
      "r294",
      "r693",
      "r806"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r731",
      "r736"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r731",
      "r736"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleAndLeasebackTransactionGainLossNet": {
     "auth_ref": [
      "r729",
      "r736",
      "r739"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.",
        "label": "Sale and Leaseback Transaction, Gain (Loss), Net",
        "terseLabel": "Gains from sale-leaseback transactions"
       }
      }
     },
     "localname": "SaleAndLeasebackTransactionGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Mail choice"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Pharmacy network"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r210",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of accounts receivable, net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r96",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of changes in fair value of plan assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "terseLabel": "Schedule of assets (liabilities) recognized in Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Weighted average assumptions used in determining benefit obligations and net benefit costs"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r620",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock": {
     "auth_ref": [
      "r933"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.",
        "label": "Ceded Credit Risk [Table Text Block]",
        "terseLabel": "Schedule of reinsurance recoverables"
       }
      }
     },
     "localname": "ScheduleOfCededCreditRiskByReinsurerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of changes in plan assets"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.",
        "label": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]",
        "terseLabel": "Schedule of changes in benefit obligations"
       }
      }
     },
     "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of components of income tax expense (benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r69",
      "r164",
      "r388",
      "r389",
      "r390",
      "r391",
      "r705",
      "r706",
      "r708",
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Carrying value of long-term debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred tax assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r484",
      "r485",
      "r486",
      "r487",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r16",
      "r19",
      "r20",
      "r21",
      "r363",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of discontinued operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Reconciliation of basic and diluted earnings (loss) per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of effective income tax rate reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r521",
      "r549",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r521",
      "r549",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of expected future benefits payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r669",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Fair value of financial assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Separate Account Investment [Line Items]",
        "terseLabel": "Fair Value, Separate Account Investment [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable": {
     "auth_ref": [
      "r819",
      "r925",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table]",
        "terseLabel": "Fair Value, Separate Account Investment [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock": {
     "auth_ref": [
      "r819",
      "r925",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table Text Block]",
        "verboseLabel": "Separate account financial assets"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r338",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r338",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Change in goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Net Investment Income [Line Items]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "auth_ref": [
      "r119",
      "r120",
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of liability for unpaid claims and claims adjustment expense"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of maturities of long-term debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of net periodic benefit cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "RSU and performance share unit activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r59",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of fair value of assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r229",
      "r232",
      "r244",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r229",
      "r232",
      "r244",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summarized financial information of segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r522",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.",
        "label": "Share-based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]",
        "terseLabel": "Schedule of stock options and stock appreciation rights award activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule ESPP valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r394",
      "r395",
      "r396",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Share repurchase programs"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).",
        "label": "Schedule of Unrealized Loss on Investments [Table Text Block]",
        "verboseLabel": "Debt securities in an unrealized capital loss position"
       }
      }
     },
     "localname": "ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r583",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of unrecognized tax benefits roll forward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r635",
      "r636",
      "r645",
      "r646",
      "r647",
      "r649",
      "r652",
      "r653",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r647",
      "r649",
      "r652",
      "r653",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "terseLabel": "Schedule of variable interest entities"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "verboseLabel": "Estimated annual pretax amortization for other acquired intangible assets over the next five years"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r216",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r257",
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r216",
      "r218",
      "r219",
      "r229",
      "r233",
      "r245",
      "r249",
      "r250",
      "r251",
      "r252",
      "r254",
      "r256",
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r157",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Policy"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self Insurance Reserve",
        "terseLabel": "Self insurance liabilities"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SelfInsuranceReservePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).",
        "label": "Self Insurance Reserve [Policy Text Block]",
        "terseLabel": "Self-Insurance Liabilities"
       }
      }
     },
     "localname": "SelfInsuranceReservePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountAssetCategoryAxis": {
     "auth_ref": [
      "r925",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by separate account asset investment.",
        "label": "Separate Account Asset Category [Axis]",
        "terseLabel": "Separate Account Asset Category [Axis]"
       }
      }
     },
     "localname": "SeparateAccountAssetCategoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeparateAccountAssetCategoryDomain": {
     "auth_ref": [
      "r925",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separate account asset investment.",
        "label": "Separate Account Asset Category [Domain]",
        "terseLabel": "Separate Account Asset Category [Domain]"
       }
      }
     },
     "localname": "SeparateAccountAssetCategoryDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountAssets": {
     "auth_ref": [
      "r827",
      "r924",
      "r925",
      "r928"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset at fair value held for benefit of separate account policyholder.",
        "label": "Separate Account Asset",
        "terseLabel": "Separate accounts assets"
       }
      }
     },
     "localname": "SeparateAccountAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountsLiability": {
     "auth_ref": [
      "r831",
      "r924",
      "r926",
      "r927",
      "r929"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.",
        "label": "Separate Account, Liability",
        "terseLabel": "Separate accounts liabilities"
       }
      }
     },
     "localname": "SeparateAccountsLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.",
        "label": "Share-based Payment Arrangement, Accelerated Cost",
        "terseLabel": "Accelerated compensation cost"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)",
        "verboseLabel": "Weighted-average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested at end of period (in shares)",
        "periodStartLabel": "Unvested at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested at end of year (in dollars per share)",
        "periodStartLabel": "Unvested at beginning of year (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Vested in period, fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "verboseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "verboseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "verboseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Shares exercisable at end of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price exercisable at end of year ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of stock options and SARs exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Shares expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Shares forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Shares granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic value outstanding at end of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r530",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Shares, Outstanding at end of year (in shares)",
        "periodStartLabel": "Shares, Outstanding at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price, outstanding at end of year ($ per share)",
        "periodStartLabel": "Weighted average exercise price, outstanding at beginning of year ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value vested at end of year and expected to vest in the future"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Shares vested at end of year and expected to vest in the future (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price vested at end of year and expected to vest in the future ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r520",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, exercised ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, expired ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, forfeited ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, granted ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r157",
      "r522",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r544",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value exercisable at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term exercisable at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average contractual term, outstanding at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term vested at end of year and expected to vest in the future"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock percent"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock": {
     "auth_ref": [
      "r934"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.",
        "label": "Short-Duration Insurance and Deposit Contracts [Text Block]",
        "terseLabel": "Health Care Costs Payable"
       }
      }
     },
     "localname": "ShortDurationInsuranceAndDepositContractsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2019Member": {
     "auth_ref": [
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2019 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2019 [Member]",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2019Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2020Member": {
     "auth_ref": [
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2020 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2020 [Member]",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2020Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r38",
      "r784",
      "r829"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r40",
      "r789",
      "r790",
      "r825"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Investments",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r726",
      "r736"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease costs"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearAxis": {
     "auth_ref": [
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-duration Insurance Contracts, Accident Year [Axis]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Axis]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearDomain": {
     "auth_ref": [
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-duration Insurance Contracts, Accident Year [Domain]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Domain]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable": {
     "auth_ref": [
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Claims Development [Table]",
        "terseLabel": "Short-duration Insurance Contracts, Claims Development [Table]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock": {
     "auth_ref": [
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Claims Development [Table Text Block]",
        "terseLabel": "Information about incurred and paid health care claims development"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r879"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Cumulative Paid Health Care Claims,Net of Reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": {
     "auth_ref": [
      "r882",
      "r883"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net",
        "verboseLabel": "Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r878"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Incurred Health Care Claims,Net of Reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r880",
      "r881"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Short-duration health care costs payable, net of reinsurance",
        "totalLabel": "Total outstanding liabilities for health care costs payable, net of reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented": {
     "auth_ref": [
      "r880"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented",
        "terseLabel": "All outstanding liabilities for health care costs payable prior to 2019, net of reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem": {
     "auth_ref": [
      "r881"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reconciling item for the reconciliation of the liability in the disclosure of claims development (in excess of) less than the liability for unpaid claims and claims adjustment expense for short-duration insurance contracts, classified as other.",
        "label": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Other Reconciling Item",
        "terseLabel": "Insurance lines other than short duration"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]",
        "terseLabel": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable": {
     "auth_ref": [
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]",
        "terseLabel": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock": {
     "auth_ref": [
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]",
        "terseLabel": "Components of change in health care costs payable"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r8",
      "r216",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r257",
      "r338",
      "r362",
      "r365",
      "r366",
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/AcquisitionsandDivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingSummarizedFinancialInformationofSegmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r74",
      "r171",
      "r172",
      "r173",
      "r176",
      "r185",
      "r187",
      "r203",
      "r299",
      "r387",
      "r392",
      "r558",
      "r559",
      "r560",
      "r599",
      "r600",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r701",
      "r895",
      "r896",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r203",
      "r773"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatutoryAccountingPracticesDisclosureTextBlock": {
     "auth_ref": [
      "r845",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority.",
        "label": "Statutory Accounting Practices Disclosure [Table Text Block]",
        "terseLabel": "Statutory accounting practices disclosure"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatutoryAccountingPracticesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statutory Accounting Practices [Line Items]",
        "terseLabel": "Statutory Accounting Practices [Line Items]"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval": {
     "auth_ref": [
      "r163"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of dividends that can be declared or paid without approval of regulatory agency.",
        "label": "Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval",
        "terseLabel": "Estimated maximum dividend distributions permitted in 2021 without prior regulatory approval"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance": {
     "auth_ref": [
      "r834",
      "r906"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus, Balance",
        "terseLabel": "Combined statutory capital and surplus"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired": {
     "auth_ref": [
      "r907"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus Required",
        "terseLabel": "Estimated minimum statutory surplus required by regulators"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount": {
     "auth_ref": [
      "r834"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net income for the period determined using accounting principles prescribed or permitted by insurance regulators.",
        "label": "Statutory Accounting Practices, Statutory Net Income Amount",
        "terseLabel": "Combined statutory net income"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryNetIncomeAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesTable": {
     "auth_ref": [
      "r845",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail by state, country, or other jurisdiction of domicile in which financial statements are filed reflecting statutory capital and surplus, net income and the differences between financial reports which are in conformity with generally accepted accounting principles and the statutory financial statements which also use state permitted or prescribed accounting practices.",
        "label": "Statutory Accounting Practices [Table]",
        "terseLabel": "Statutory Accounting Practices [Table]"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r46",
      "r47",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Common shares issued to acquire Aetna (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r46",
      "r47",
      "r387",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Shares issued employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r46",
      "r47",
      "r387",
      "r392",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Shares exercised (in shares)",
        "terseLabel": "Stock option activity, stock awards and other (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r74",
      "r387",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Common shares issued to acquire Aetna"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r74",
      "r387",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option activity, stock awards and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining as of December 31, 2020"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r47",
      "r52",
      "r53",
      "r161",
      "r264",
      "r294",
      "r693"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total CVS Health shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r161",
      "r171",
      "r172",
      "r173",
      "r176",
      "r185",
      "r294",
      "r299",
      "r392",
      "r558",
      "r559",
      "r560",
      "r599",
      "r600",
      "r630",
      "r631",
      "r655",
      "r693",
      "r695",
      "r696",
      "r701",
      "r896",
      "r897"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "End of year balance",
        "periodStartLabel": "Beginning of year balance",
        "terseLabel": "Cumulative adjustment to retained earnings as a result of new accounting standard adoption",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r160",
      "r392",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r728",
      "r736"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "terseLabel": "Less: sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r702",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r702",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r702",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r702",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r873"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r873"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "terseLabel": "Prior years",
        "verboseLabel": "Decrease in prior years' healthcare costs payable"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "auth_ref": [
      "r7",
      "r361"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails": {
       "order": 3.0,
       "parentTag": "cvs_AdjustedOperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.",
        "label": "Tangible Asset Impairment Charges",
        "terseLabel": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "TangibleAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofOperatingEarningstoNetIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r595"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) for remeasurement of deferred tax from change in tax rate pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Benefit of revaluation of net DTL due to TCJA"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r608"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Measurement Period Adjustment, Income Tax Expense (Benefit)",
        "terseLabel": "TCJA tax expense (benefit)"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect": {
     "auth_ref": [
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accumulated other comprehensive income (AOCI) for reclassification to retained earnings of tax effect from remeasurement of deferred tax pursuant to Tax Cuts and Jobs Act.",
        "label": "Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect",
        "terseLabel": "Adoption of new accounting standard"
       }
      }
     },
     "localname": "TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r282",
      "r283",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r73",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Shares"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r73",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r73",
      "r394",
      "r397"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost: 423 and 425 shares at December 31, 2020 and 2019"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r178",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r597",
      "r598",
      "r599",
      "r600",
      "r775",
      "r776",
      "r777",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of cost from product sold and service rendered.",
        "label": "Cost, Product and Service [Extensible List]",
        "terseLabel": "Cost, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r452",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r452",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "States, municipalities and political subdivisions",
        "verboseLabel": "States, municipalities and political subdivisions"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r452",
      "r807",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "U.s. government securities"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy": {
     "auth_ref": [
      "r871",
      "r877"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]",
        "terseLabel": "Other Insurance Liabilities"
       }
      }
     },
     "localname": "UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r568",
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Reductions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r580"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r576"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Income tax penalties and interest accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r576"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Income tax penalties and interest expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r579"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r578"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r581"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Expiration of statutes of limitation"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r204",
      "r205",
      "r206",
      "r207",
      "r213",
      "r214",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "VIE, ownership percentage"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r727",
      "r736"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r189",
      "r195"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average diluted shares outstanding (in shares)",
        "totalLabel": "Weighted average shares, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r188",
      "r195"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average basic shares outstanding (in shares)",
        "verboseLabel": "Weighted average shares, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "negatedTerseLabel": "Gain on write off of unamortized deferred financing premiums"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 15
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657190&loc=SL116659633-172590"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3337-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(b))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953659-111524"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=SL6284422-111562"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL6283291-111563"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL82887624-210437"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921835-210448"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82921842-210448"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121647567&loc=SL82922352-210448"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922890-210455"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555860&loc=d3e11019-110243"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555860&loc=d3e11049-110243"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450678-114947"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "40",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244457&loc=d3e16701-113920"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.EE.Q2(f))",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=SL116722634-122817"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759068-111685"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6228884-111685"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5708775-113959"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117332851&loc=SL7495116-110257"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22 (b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121614528&loc=d3e35050-112683"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121595440&loc=d3e34039-112682"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121556591&loc=d3e36728-112689"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121549808&loc=d3e36991-112694"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 1,3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919396-209981"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121606570&loc=SL77919786-209982"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13(3)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=121551529&loc=SL120154370-112784"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6479118&loc=d3e64650-112822"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6816-158387"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639652&loc=d3e7104-158389"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226016-175313"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(7))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.14)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.23(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121638524&loc=SL117422543-158416"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121638524&loc=SL117422543-158416"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121638166&loc=d3e11522-158419"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21409-158489"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14754-158437"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14784-158437"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671315-158438"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671321-158438"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=d3e14931-158439"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=d3e14931-158439"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819541-158441"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884803&loc=SL65671395-207642"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6483535&loc=d3e16392-158451"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24746-158529"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24790-158529"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=82848697&loc=d3e24938-158530"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=82848697&loc=d3e24959-158530"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=84167274&loc=d3e27175-158546"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(a)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(b)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(b)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(b)(3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99379264&loc=d3e27758-158548"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99379264&loc=d3e27830-158548"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6484091&loc=d3e19268-158472"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=SL117422267-158473"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=SL117422267-158473"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121638699&loc=SL117422397-158474"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121638699&loc=SL117422401-158474"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121640538&loc=d3e32546-158582"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=75763970&loc=SL75763979-209797"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "http://asc.fasb.org/topic&trid=2303980"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12.6(c))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611133-123010"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL116659650-108580"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Footnote 11(c)))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Column G))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 6))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29)",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491204&loc=d3e4879-115612"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r972": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r973": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r974": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r975": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r976": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r977": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r978": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r979": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r980": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r981": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r982": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r983": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r984": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "17"
  },
  "r985": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>143
<FILENAME>0000064803-21-000011-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000064803-21-000011-xbrl.zip
M4$L#!!0    ( /@U4%)F1Q8V7@(( ,W(6  0    8W9S+3(P,C Q,C,Q+FAT
M;>R]:WL41[(M_'W_"K_^?#3.2V1FI)\9GP=SV_A8P@9L!K[,$Y$9"8TE-;M;
MPL"O?R-;$C?C;8$;=55WF8&1NJJKJVNMC%@K+Y'__+\OCPZ_>B&+Y6Q^_*^O
M[3_,UU_]W^_^^?_M[?W[^WL_?G5C7DZ/Y/CDJ^L+H1.I7_T^.WGZU<,JR]^^
M:HOYT5</YXO?9B]H;V_UGNOSYZ\6LR=/3[YRQMD/#BZ^!<IHDZE[CI'V *+?
M(Q-PKS;30K.&J_7_Y\FWQ-ED9^U>MBQ[$#+O<?!NK[*X8DMJS?'_J=\6;U,T
M!6RB"MZ;#-4G=J ?[4("[!_[]$2_G7[#X^6W+Y>S?WW]].3D^;???//[[[__
MXW?_C_GBR3?.&/O-O_=_O%^>RA'MS8Z7)W1<Y.OS=RT7)V_>U6C)J_?HB_H^
M9_:,W?/VXM39RY.]I93W/D1__\>3^8MO9L>'LV/IC_2;DP4=+]M\<40G^LCU
M.C;L&7SG.B]Y<5C?WFO_]>).XS=G!]]\Y'(.SJ;W/O+=\_TWYV=<O*'*!Q>^
MN$$]\)&O5%XLW[NV_OY4Z/#DZ3_*_&AUOG7OW+A^Q]\^]HQMSOF;U=%WO^/L
M?[OM#V X7>X](7K^1RC.#_SQWO_\/CHGWL'LXW?Q5X"Y/1<O+O*'K_W^=^F'
MF9;R]C/_[&3KW_G<U>G?'M+QDW]]+<=[O]S_6NDL5+_[YY&<T%?]"GOR/Z>S
M%__Z^OK\^$0;Z=Z#5\_U4\K9;__Z^D1>GGRS^K;??/=?__5?_SR9G1S*=XKA
MW@5R__SF[+5_?G-V99[75]_]L\Y>?+4\>74H__JZSI;/#^G5M\?S8]'/G[W\
MMI\HB[,?9[7*\>I'/7Z@@6(Q*V<?__+DGK1_?3T+/G@)N;B2"[00R%7?3-&6
M[-G&YO]SH]^*L8K<6S8=TU'_:)E]>_-8[^_5=?TV"SJ\<USEY?^35U]_-:MZ
MZ>I_?<4WYB]^=/=>//+[I_79S1>/;^=G=X_V7^\_*&[_]K[9?U"?/K[Q\^O]
MU]?"P>V?7Q^X.Z\.;MSY??_9'7OP^F?XT1\</GK]_-G^ZYO^X-GWSPYNW/2/
M'OYL] J_WWUP[[?]UW6V_^SG5_LW]'T/BKE["\V/[O&K1P]+?'S[WM'^[7ZM
MF[_?O7'-'-RX=WAP^\[+_1N_O#QX\,-3??^S _>SN7O[YHMZ^]:,;_\2#Q[^
M^NSNPWNS1\\.].^OLX/;/_SV^,$3I_?W>O_&;Z\?/_OAZ:/7O^@U?SY_SZ_Z
M6>'X\8.Y??QP/SR^_<-LW_TP.WAXQSPZNG=X]\8C?5^_UX.C_:-;SPX>7'MU
M< M?__C@YLG^??/RQP?7_E.MJ60@[5D;[1X@ACUJ$O>R:R8X#S4S?OV=Z?]%
M0./_^<U[>'Y)>"^RRZW9LM#A(Z'%+7UE.0'\5P#;=P$6B]$E(WLU^;0'+<H>
M&Y?WLB\N-,C>M_3U=_WY;PS:G_3Z\SJ!>REPW7O@!F>A-]P@6<'%7/;8J2"J
MQ=F&7+O@^?J[6X^N$-IKBFM=87M(3R8X_PI._RZ<*DYS '1[IND_ "HE."7>
M(W8^U*)(I/;U=XT.E_(IB!J?-<J[G(PM8!KG#!+T#XL5PR9W1&T^1]3F=Q$]
M%U#?=NUPMUV?+T]NS^?U[N*^+%[,BMQ\J5IB.>-#^7&V/-DLVJ_V'^R_OD#\
MT;/R\N!&>?7X]OY+11KTY]_WW4UX_. W<_#P%[]_='#T^,&CWP]N/WJ#^..C
M6XKHSR\?']TQ=Q\\\@<W#F;[#V_:_6?7X/&-WUX>'/WP;/]9?:;7^0#QYT>/
M'BJB-VX=/7KV<SAX5LR^N_/RT8-?]/Z>_G;WP4WWZ&C_U8%RY]&O^.HMXON_
M'SR[^9\D'CQ:LX>&%74U-WOD-".'DJ)7^%MQYNOO+I#X:3&OI^5D7XY8%I_"
M M\:030MQ\XQ#NA-4K.$08U6,^!6+, +%N#$@JME 3O2IJC*JXI5%K2@&HPT
M %C,$9V)R85UL.!O1/>)!5^>!:*-45*L>QF:WX/ 7H,_J3 W5HV5(4\M#",6
M7"ME?JH&[/C)??7BE19U^<OS2B>#XL'+_0=W7CP^_N'IX]=S^\C=,0?/'BD7
M;CU]K%GYX,'CW^X^?/3[XV>_*E;W9IJ=5SC=O9[-HX<_+#63NT>OOW_654//
M_@?Z68^?W7OVZ.C1[X]>/^G7<G<?U$/]/'?PZOP]__[A*1_5P[O/'C_3[Z0\
MO*;9_V?[^,:]HX/;![/'>M]W;_SL]+WAP'7U\,C_^_5-H]G_G =WE ?%_X<*
M%<BHRLY4UG" FAZ@.H6CJ!APDFIR;XGPIV H>M&X3R?(&B3#1)#U$>3.AP2!
M_UA((866-3[T2.$M[5'VM&=*)$Q2BO'UD@2Q_M,)PI*"D]!Z#RNX!$18*P;;
M!&V%>!9!T@5!TI@)\LLY0?1]-VX=[C^\$PY>/]%SGIC'#W]X=O?V+R_W'_[L
M#UYWXNSK___ZV]W[;PCR^M&#PZ=W;_QB[C[48_K_^Z^__^WNC:>SQS=Z5E#?
M\> 7??W[P\?7/R3(P=.[#V_"P8.?PZ/71<FHW^OVSW!7B;;_[-;3@]O[MM_C
M_NU??U."G)-#L\D#S6XW?OD/4JZ-"+J6I#VPC32 $.YQ,!F+!G]G\'+\4$7Z
MZ?P + Y=T] A"0!KSBTR>4/14)%8)GY<*3_V_\ /<%632LE[Z#GL0:FR1S[B
M7JTE-BPBT>;+\0,_)\%DS6"-8LC--J#LR#M*H)DEH+..X1(Z]/Y36LCWM)1Z
M?7[T7!FQZH&_MEC0\1/I/1#?OWI[RD_TJK]T[7>]]=4_O\JR?YVSOB>[:1+U
MSSG+0JYGF@,%[>#AG9=W5:(^/KH)=V^H;'VF$O+AK:,#S4:/;_SZ]-$LF\?_
M?FK*T:_']#"?:D;1]]U1TOUL'SV[&?2SCAX]> +[SYZX@P=*IH>/W,'#QWK=
M6[-_ORZ:F1[9NS=NVH-G^^;@]9W_D&NAN13WK,6T!^23!HQF]B052M'6Z% -
MR$_^DSJ3)IC?A5D?]46L4*@>O52QH)]8GZFHT,_[046&NH+7-SO4YN#&;_;N
M;87^_@<PJR-Y_$QI</N1WM/!4VWW+_>/'L_V7^O5'W2H?U;'\@LH]$&5I5*G
M_ UHOWE_(&<A319R7&3YD>&G/I+U[7(U4*K@?[4:T?OV1,WBO[Y>SHZ>'_8A
MKM5K3Q>=&^^.-/WCY5+%RC^_>?\29Q__]C//;V$Y/UVL?EL-$WY[SK<S9#_'
MWEY<2%;#21>_S6K_O<UD\=7JAN2C([?7[_R_]T='/GSS=Q<OO7_UYRL^7ORV
M/*'%R0V-IM]=#%0:>_&^M\?>W&9]>ZIU>]Z^_8BS(Q>_7WS(-^\]J(OKG![/
MSA[:Z>K9G[UX)+0\7<AWYP/#W_YR_\;%VR\.7?S>W_]1#%1KA)QR*,D"6",9
M3>94@*3%;$O\SYT5!M&; 3SZLZ'DD_,''_>\>7.A\R.?^#27/18M__! S\%<
M'?SD)]I8GUY%#"X[ $DDMO2'29RL-1163]2>*;HA/5';1\(-?MX3?>\)B-4O
M3MWP $,#BX%57 +Z0*&&6C;0KL\1E2<]X9S]6O7#7CX_G)79>9_,5W5VU*5J
MGSRS7)Q<=-B\Z3.[]G*V_-/NG(]>\<W3>O/!0XTO[\<$59-=!7@QH@2&7"PW
M2=EE<-&@^5A_PH3?Q_"S^=+XZ:GKPH]**\"83<T Q7NN&%6^B48BCRF4CW48
M3OA]%#^\/'ZX-OP^IS]O\ZED\[S_G([R@3VWC? -$1/94GW11Y5J1%N1B=3_
M*>LLN:W(U^<O;F.^UNC>*E2UADS@8R TZ 2**:5EY?Y6Y.LKP6\S<2L5$TQ,
MI82D\<O53.*;#<;&4HW#NA7Y^FKPNZKX^:X?_TD6JSZM-YC4V0M]EN^>NNJB
MH9/YFR?[B=;]#^_O+]Z0X_G1[/ACESW_]G]I8-^[Q#?OW_U?^5R?K#14@Y>C
MJA15F8G!5 TYQML8&<]Z#@:29-_K.7@/][_A<WU$2.J,R!G]ZC%P"$%JB3FE
M;+":_@0&(\_>/H$/(]??> (%*L?<JLU 0,:@;5+U'G,H37)>]1X-1FB]\P1P
M;4_ F<K>>5,;%M!O2NJ\FDK04*12@E5OS_F(V:">0%K;$\"2;)2@+D4:^*JJ
ML9B$8%DT&B@MKNX)?&K2>I.:3C3P]_?<_)_3OD9A?O1\?JR_+M_/8/KZT?SX
M_LF\_+;^+/9%H&DEDV5+3&R ;"3/F'S))D7CP6T/- \6J^3V:DS@J)>/OOK,
M(A&:1:P4-6*T)*Q!U>#6@/-.N[ES7 Y/Z^SXR;5:9WUDD Y_HEF]<WR=GL].
MZ' LT&5?&4T)7 D:)^KN.6=DH6Q<Y*V![IZ<T.Q8ZDU:'"MJR['@ RGY:B#&
MI@TJ .?"&6NBZJK1A+TU^%PKY?3H]+ OY[U[\E06_;R%/.U7>R':V.9'7\!P
M?1'(&#T;P[9%\=!$5$Y@DH"&HV7.5ZBCOC!D/ZDG._X"W=9?!)6<:P ?(6$1
ML%;Q\4$_H$3-3YJFMB=''<R/^Q=?S \/-<[=T4>@SGDL*!5GHE.]C9@*>,J<
MJCBUX<WE[(*CK4'I$]/17WY\[[6Z?A9 -5[>;$W*R=GDH[OM6IT_7\U=6MW!
MI<ZLSTZ7)T?C:=V2C<EHA:V@V@,F;>A,'FJ*C57:; UO_GZ:G*CT%XJK6>^J
MC2&6 JT5U<&EI&(SM"P<S-90Z5+I>V++_\Z62% ;-_6YQ@&PQ6R#AB&7*62.
MTH;+EAT'CF0U%1A;BQ;$,Q4C)8+/DBCY8D8P4C4X![SY\7\($ARWWIGO(0)3
MC@YR3:$D \W0]J'ZI4S8YK%TJ#DXNXI>&DCQ+!IY4E4YQRKK,&P?EE=EW3:/
M+:3,Q2 V"0E*S=R2X1@S5<-5(FX?MAOIWQH T R!@&,SX@' D'I[:Y.O-0=L
ML(5I]@L/X P 4L*<7,G>9H54Q6ZHGE5+I03"^L/V0;K189_- QZ]KZZ&&&UV
MX'O))R;3E]0&4[/ZGZT&?!L!]=PP)4L1"T"6EDWUL3KOFE>9[*YPKLN8<?PB
MDW 4EL))JC,(0#41EH0&?6[!%LVB6P/-U<US6!\XEC%"(IM#$T@ADRNVYA@P
M)&]<*5L#SE#F.:P/.C*I(>7^1!&:K^2IME38QKXFA>K60'>E\QS6V+30%6^Y
M>A<*L.G=J=&+!(S>1&UM6X//IN<YK#-5 18*J15P($0932\>98HW)3B3M@:R
M*YCGL#Y45,=AY=+7CQE(G!#4K66KK:G4XJO?&E0V,,]A?2@9RLUFF[G8!)Q#
M3M%EY 3%U&#<]J TS7-8*V^*E(CL<XX$ "50BKDDT\BP2Q5H:WBSPX/3ZV-+
MQF@;<5$A12JJB&QRX$VU8#1-%!DN6W8<N)"K]S;$1*ZO>F4%SIA 6*GTSH Z
M@F6P@[,MFU\<"]*7Q8IM7)L&;X,QNZBJC!F+)-I"5*]D<'HC6'(&(Q!7:($U
M)E>K@BZ3]5[ N+9]6&YD<'HCV(:4&8U57YMZ=U\FR;4+]@1!7S=N^[#=_.#T
M1H"N1#%!3:E2U33KV0&U8B6FR()Y#-6AAC0@LGE 0=10YZA>2'KYEYJ#"0"9
M50(7"[EL'Z!7.=M@(Y V8X2,J'-1RUM,S+ZU2DD%5% /0[Q]D YGML%FE)7W
M",6YIJT6C$DLU+>;<KVN$V67KZX4Q9AC\9>ID6&;*RC8I^R!=RY'!2K;2KY@
M[M5]M@6:JQN<7A\XK!I&6T@49S)8RTA2;?!43:'$/FP-.$,9G%X?=,&HG:S%
M-P*"H%D-T6FL\]5)Y8NZ(]L W94.3J\/GS[WK;7$AJ#'O;ZGLZM533_7[%W8
MGKBWZ<'I-49#YD 5'3:OD!EB$."4,-<<M6G%K8'L"@:GUXA**KX7LBB( M6Z
M[ ,B1Q=8F@O(6X/*!@:GUQCN*DM$]5NY6>B;]OH8DR&QFI[47I>M06D:G%XK
M;SS;1KY&DVH$MGW]:W(.LK,J< KL6,R=V/(7?74F.(9@K(T5P,:<,X9D6J[)
M:>9NPV7+C@,G1*2M&<"HIFKH.9%H8BC>9R%).((:VX.S+>]VNVVF\C:555/$
M'/O8=$[L6K3--$)GK:;][4/U*@:G-X-EP&!=R;%WFT)CB[482 Z"&%2_VK8/
MRTT,3F\&VRHM-<R0O&= 4D.+58):*(@%:@W;A^W&!Z<W [14;TKJ2\ (H#J?
M%=Z"%D+,#6S+VP?TE0U.;P;09HVO$B-XTWI5SYP@V:)A.1I/CCZZ)^6X ;W"
MP>E-B29DR6!\WRFO[Y@.E0Q9;9T*M,<M#,:#&9S>E+)RU/K$,-?7UQCJ%>%$
M<D2L)C21J]LI8LRQ^(ML82'>>)-L8(VIX)WG"ES854";,S>_-=!<V>#T&L&)
M&B4])<A)52I RD@L)M04#>=JKG"'E6V.CU\$NI*=RVCZL$T"X(2H>L4)F%RA
M(L#60'>5@]-KQ <<];T5?4@I0"-M6,BMY6+M:@*5W1I\-CPXO4;(,&25#AZY
M.(1F*UO-6;WX610-DJ9N#61??G!ZG7M@F:JIB:@OR0%?0ZY)11X4QAJ+/ZON
ML16H7/W@]!I1RM'WZ;\J(]0R)S!]>48+QA<#H35S-H5@58QJJ"B]'?!9WIHO
M#N1W#6SS4[WL\9.?%O-C_;&L0/QC^#L_2V$^KK2HRU^>5P5\]7W=WQV-G(;.
M/V?!YWL6]._, '36"57]DYSF[,P)(JM,+M$4HHNR3Q.K!PH?2PI.0C,%++BD
M201KQ6";H*T0SU:,I8M%"H,L!_X%<52K\(47*J3++U1(ZUMLA"K?7#--T0?
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MZ+&_3G7BTV2+/BD^.9>=N-J* P#C2$&&DJW%5JOSVS)ZLBN&Q9H:BVW-<@#
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M>.)=3*J(V:FA $1F#,D'7TNPA;#E*9ZLE2?WU)?>7/9^Z3$%$Y\\!W1J,3&
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M_AR+-U49>AF$=XZ.I'EP<-Y M)(9(/>:\*3:V1HT#ETU Y[*-RQ(UCD?EEJ
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M#-)*&?#ZLZ%R9=VMZNE")O[^^=0=3-"7I20.?7L6Z,L@H/2Z<>)"HH%W.^T
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M[YRZO-=[IQ9*PB_9E;_.C=F"P5(TW*L2 Y%,22.\J.G%2KZX 6^FM4X"N8E
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MOUX\^_EP&\>:?1YYM"IUN4&!(*E)TMI&GJ&"Q0SS\WXWCLM 8<W[QBEK\Z:
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MS8/^>/W3B[OG]X]8+=[<T@IX%&\E/H4"3M:\%,A3J.>&ZI-J-!FE[V)X^(5
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M;^J 81<K[/!0HTVUW";8,C+HE-%(-BI7$<>E>>YE0+W)XNJ3[-]&=BLE6,7
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M42ZD3N[2-?,A4&[8''M8J=)!M6DS[=YQTMT;I M)SEVZPC@$RJ5/!YRU)9>
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M>"2)M(1%BF!%(!>K);E&M<%0D^Z@6?BF=.BF5M+AX34SXESZ5!!+;_"L2U^
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M8]\SG+_8[=U7\Y?[?Q:V?C<92[\P_>OG?J'-?WWH._B_^<Q'X)\DZM#@W,<
MD23B6""0 .>;;B?^&Z/LD1?@ZP:07][<_G1S.Q_TV'K[Z5= (/MR'%0\%%2+
M$5/CIM*6K'_D<P5L; 7LDC)*HC29RE9G"+CTU0_/YDFQL;373<CYA.M4%X^B
MEWG%7$9/PE%T.DQ@M\FTD00K4'+6<8*\#5X.IA,>A66?\1YUT#K_@ 1DV%(:
MB#8$>W[=]O9D^<E9W@HO7(N5,GT>@<S]&[FXECR]7I84Y+)(Q?GN*ZEXT/37
MN9MO0,-F>;"&?3]5]ALT+)?>LTGKX B)B6VT$40^HR=)CB?^&Z/L8!K@Z5=
MAS:F'M!EO /07 "$J5D'LRD<;)1S!6QL!>R3LMXL5R."7@!SV*B"6+-22=;X
MOAABVXFHLP/WOY6E[^>6?DM(GMUY*M&.+<.,9"1UIF;H>>G)ULKV>=GK#OC)
M@MX5:5D *8'6K"0()36=;R.",RMSVCXM'V6K7X.#7Z^PG![FH?=O)QLEVZ R
M'4H=P[QA0P3(XE59#LK,I14(K4B,M@%8Q5$5H=2JD)1SX]8Q"+,>E)A+*<!9
MD92AUHC2(!@&.H9J<Z7I;PAK\;X#4OZ=B>XO3GY]\_SN]I<'OD75/JUFP*U
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M \_>#5AL4=LP'0*,8X%F<",C) FEB;?9";CU99;G<0D]WXB 7VS'\EV' J>
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MDIL7';_V32M6\X"A:--!-2Y.NB:;]'@#72;D3GM-4RW2%.=QV9+Q0]<6"*H
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MH,@P=CDO%=3=9> 0>T42+IHZ<D :X3+>W;G%,I983WGQ5KF.*R@8>HU*H%G
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M[^7512IP15[MQR/K';N3 Z?'5Y,FWH)UAWPD!XX'DF!PZ%_388H 6I-2CBS
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MPY'*@4+=]SIEX(OD\ >)GR8?]J26^MG1L\Z74J#PCXECL06Y6+33WJ\!<O%
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MDXQ JA+=^?327,\?)L2K-A"N85'\PHAGQT)O*LWZ]CA::JB7)SSV/U=FU';
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M ^K"_R:,G0AXF]:I!1B#.'6Y;!FH](*',M'MI'I517[91"24WE22]901(3L
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M]'W#:1$LS=NPS7\IU.+^LR AO\4%-N;(-DIM"@(A VH=O&5Z5!*,OR!A9S!
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MU#N:J&?-GEYV)&7S_IIK;=??&RPUNFQ21*?9%4Q:V$PH/RR!<NV&CF*I!59
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MPGD%T)+-UT-5%$;1ZQ&Q[DB;M.#-M2Y#TZ<0)ZWV)3":C)!KL6 M!X,I9)D
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M%A=E<<G;E!C ^LFICEUV,I">'[VU\)51YW5X[UH2=970Z<]"4(.=$";_J/U
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M,-]U-;47+!@=VD)T0;],1>(AQ<^D3:6"\Z@QS6Y%;,(M.?Z&UUY94@#\E@0
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M]\+!Y#)PVN_JN\W\%V+\4[;M#A!^#U:T8ACN"CD@%+&:NI+SUZ\H7ICA;;
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MS .-*+U.O)+>0F()8#QD-3]YD(9BXOCX[%/:C"/#6_QT11$*Y?DH$?#_AF7
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M'7<^VPP]-'+"E6T\ER,L6FXZ0$5[CKMI0WZ8YX\SS_WSNQ."ZQRT^HN%J%+
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M7Z\+?P@H20>^9#P=+@(X3-G]3=EKI6\D \F@PZN+FIG,A.-$FQ\0RXW1OB_
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MOE%GS*2,SSHLE?L,;W>MZEM&SJ>5[FAAX\HB"EH5=ET"NV:%&^V@ID];4LH
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M__EV1_VXBI_\3W;P#H[-@^3D84LV3LV3(?D29_)V+#WQK+-T[H&XYU.9P[L
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M8:((]_;PN.*8"N+XZU"UM]U"G(:P-)%TGH_R=EM3&.U>DS4JVT7=* \&L?E
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M3)P:O4G$'(C^*UVHKKV$F6G.FQHP>O)[;,N$LVG7LK@<;4(-"*RBF^\5&//
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M\(-ZL9/&Y?!9&)*FG\!T4=C#<;1OG]$.YH0"$7HK4]2!2F&R,;5#.<:E'*9
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M<D:J^[()-]L._[AMH1-D]G:1Q E0IR/L/MI'R\2#,.="[&G=#/X4W1&.^ZA
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MED) \"A<P<3R3X+Z7:3+10@X(PMH]FI>4KPH%E]P+J!XAOIY)/(G)=]8I)]
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M[J7C<)2Q3J^!5^K6DA&B=C;CTO%X3 :P(87%'7F=X0S-*XM^7+M"4K)U_ID
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M(6E#:E! *AH;YZIL^9E(]BQX&U9"VC5;R4UWR0 8U5:+.OFNNZB;8&=HH8L
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M?SZ<T+.[BA,ZF-?MYE4:7BUL3@OENB44US/QKEK)E- *2GEP_^0IXY;PL*0
MAIA>A&"=3F:(HBZRHD-9(7-'&VGE,U,HA\MB(DY^1XQ^([PU8?M:P$T:VY(8
M44LX57JZ00(<?O;3S\$_/X!2/BL\-9+!X(0567*4CQ!%4PSKJ0M9U*-PLB[+
MT*V/6),99""PJM+55'W"8CIF<<61O82<ZYCT1L_K'Y=DWZ"S$<EK#.O65_0O
MJL2/^<56=:1;5L8([C\]]*CB"&Z9WR-P<4A+W"[RFV B,-Y0(:Q;HIWP9OS1
M*!(<TFTAS(;)A&1=%&YBL+VIU/3J'1>LS3ZFSE]8=7!#6$6:CL9KD6V6G\6U
MK>/DQ^H26AK2"$"#AIPN 1$W>->0$)LEYUT^8_E3231P[=_>5VK_-N_6K[BC
M'H50POM="D(?#2;_!G >I')(?CY]]2^V,O(4RJL>'C=<ELC#J0P]A@\=(SI!
M4\A@@'+DS>3%X!L !JAAYJ>H!,$<^Q24^/?)_1RS@2$J ^0$="[&LH7[$WHY
M;RKBNG=^C61<:K=C84;!J'T0XX./,*9YTU=H226= FL%:>P,PLFL2L$)3PO'
M7?*]"N:8WN'K^19,A>,KKK 32>J=XE0LJYDK[%A1E@D\]'!4Q(D8>N:S"FW<
M&;&YKL%:(XLC,HJ%.B[?W.:T^,2#1L^\W<FT?SKV](/Y_72EO3%>H'QFH'Y2
M"6Y)N9/#?83,V?R&>D)1?$^;2G,?F*^@)$2HYH'X49P3B0B7_7<!1U=#&5VL
M@U^G4Z:?[.=.J-@HR44$[K##GV$Y&^[8NUV$B^QC(B- 3PLIQ)H0_RA1!#Y*
MBCA$U_;12395A/$+08[64?A/']IN?.)%D79-P/48T([Y'N6DT35$ZF4=92(4
MK'1&_(Z2\4=.,9FVM#\.F$2!)YZ IAY-*GN0I'8K:A7XE@8_:0$Z >L8NU-C
MKB.+Y5JMW$^>7SMDT0Y9M&MET0Y'QPT*B@:PA:Z'ZG%!V8Q!7-@!%N_A:#DB
MA0(=%.#((Z&9M A;VV=**OI;*= P#'TH7(9L5BZ R>4BEQEG@"YRENJ<N3E2
M002^P%/.,KTQI:'D'8"@4A91P\.$Z5V!/)'\UR64K,1% X/@HW+#K!<_)'^.
MMA!Y&?,I#1ZGL!C2"GB*D=KJX'K1?D9!.N"HDED9  SZH^FW$((8[FC;_SLY
M_R&:HP(L:M_1P8=60F![R&8IC62VJCE%RWHU8#8DYYC6D\K3M ^\>8,,.:P>
M2Y2X)Z.Z7<UES\<0#DCXK;D?/ZDQ1@ X20>\%@:!.210M;FCRB\W3K:!@"8'
M;WPF&39U-A3"RCI\)(M^H^/RTD6'%5I(>;<[0FOUULP<XWLVOKC-'OHQ&&.,
MD.:#8</*C?3+>]0M_>>SBGO8* #$6GZEY=A/*NW4Q+V#?GN)WDM6EIVI2_ &
M&%O[M$A,?I:6%S;43*/O @1MR(0W^!;Y5@09]I. "QG\0-1=@/ <SS&@J&$T
M0-REU6%'4+. H*(4B@)*O3  HP8J0V2^TP2&BC0 2BXJC#06TMG$@X1"A]0C
MW:BZD#:.585=#,Q!G*@.B<;[32JN'7XO#*TP1F)L0P)\L;RW4#Y27S DMJ>D
M;IAC6JN-YFSK)"&2 J\ESPDVH<76=&[3(*Z17+F,[\+.?;_-:$MEJ9])-X*)
MTB;*^&];,[,S$?3VU J$%6O46VG5#M9K2IU\'UP,?Q_4V&*:8G]<-$A#:_N)
MC"HF/TC4DVBUW:DWP-'Q(-3Z_"-F 0N-@1B7&$B9!$^C3+L,BZ0%.JH\^ FX
M%WL!% CLN'#,R4SACBVR-;384+>?:-)T->F.<N7(,K"B,VG8RZ%M"IL@I6F+
M\YR<*<+1A!NF$C932Z/&V_.J-J#7P#]6Q>T"V"9&SP_A-ITK/,*6VWWK 0MD
MF(2(A5^/+/MFT;4S*-"AKX*#@_EBX3E':''>A.QS_PJ:5IZYB9]C1WP,!["&
M@C6>[Q58X\L,@J&C+5Q&+=.TV-( 4NC+G9+-#*[FV.J5@@+NP<C5CGDZ_) "
M732E?(*X!28Q?6!;IM>P0>3J%IVV^Q&E++O,=3OW1V25]G,V&:5J$0&<K?*@
MHQ LZ4ZDLM[R>#,S UKR/3ER=PU2JZ;! \J$(X$DG+,*2JA"[XPH9/F,79)B
M36I.8Y))HHUAZ *W$:#MH:OR&N7;5S)67(75)B/7L3,F U<9?G/J!U5H#[OD
MS*6)C"\%LTU?.!U5)*!WS)-0.^I5.OWE'5SY%PB $29\:O3B7T*>YVNN</YR
M^E+XPR0SFG'59'"')D%VU#FZ.4$;7"8-9HN:2:QD-RV!KO:K!D@10!V39:19
M>E4@V^8W1FXU6\,!I[^RW'JQ_Q40X?RK48V+82(+-++P$;E\V"-GQQ<E+UOS
M37/G$ PMI5P]S*D$X+\]*?)F >&DX*<5ERY%2K9+T!^.'L,I$=IOG*?3,$^4
M<V0TN%\5_B.^CG_A[[\_L]6PX*65"JTO>R,09("NB'1-R!FFX8<(N[*I(68/
M=^KW1,K4:TO@8?4;*$W\WN":%(<%G<[KT-QU7&?2Z8^,WUAS;&Z7 'K]C*:G
M36>G*)#/F\R/]=HWZ(;C/I"^6M-M&%^]W_@\SJ,9QR+;KR!FP?9+VD?:4"<I
MW7D%I,;.)LC1!@) K2MEK^/(VLX'K.JPK8-_8'\G 62LO#,&O*<(3NMJS@R:
MV\^[0 F'X4[H_@L]Q!2NT[( _N/Y>B![YC\@G(3K\8!A>*99L]^'0O OHD75
M8DWAV3Q>TGD9UJ SS4XQW4#@]$6B998D_M6)JOF0_ R[]?CI5%"U[QT,@K]]
M.;YWI^0U:J4BE4+57":V:EU4FS0SS/07J$'JKJ ]EN/W,C+:XZLA)*#??"OH
MVO'(FCOJ8<+740]E6)71XUXC%4!_GU.O*1(H\8$^%P6N-ONX/_-]1=7 UI2E
MJ>5:\V7\V:7WY6!U %UY5#\/[5#&R1O!5U$&%*D'+R"MRDD6YF9$O!I+Z/"A
M(:U3(;W7(^YVY45>5W@NAQIE>&+.>5 #,4J#^2/FQQ_/V&?ZM2N-TT3O8MZ
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MQ8H8=X'^Y[5X74JD;>! V^+_X^2["XI^L<#9GS_\*]XNUBO5W&R\IWK!?TB
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MND3_;TY6/>_UX$/R\3PG0_I6IV4;SCX?\0]X1PN,"H&>LK'']O,.>U@2?\"
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MSV\K%)W-%ZBXO5\,=Y'J2T'6B@+1R&8&JTC6D]/A?K-/A)N^0:D\Z?C>J"N
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MJ"?RU$>HV(8G/;(<$[J9P?21'*I? 7G3[QR6Q84];*A[BGCKD16K2.% F6&
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MRF+4V=5:!\&QX>(3P,Y[*:J8ULKTCYDS=4TM2(RP5T)-PU-S';FVGI7<E.9
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MTAOQ!/$Q/5T$/#1B+P 'W*!!*-VY");X%<A*@LAEW8S,'/+Y((]17QMD2<S
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M')DFGE^)=YB:3MFZ019=V2>1A5%/RJ(BWK;HQ$2! 7FPL)9"8\]!E^!OORR
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M=Q='_>'>COJ3AV',]TP[8#.WT=IE]1'QV%UD14>\.BX#"=E NM,LJLL2J'>
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MT_&U!W/:FXR4UQ!\;X:&;P(J&,Y;ESTS(%<[CS#Y@V'Q_X%#ME\OLWGVAR_
M<PZ;#G*88+GFG;?X-<J*^_?N>QKL:."/]-CZ]HW&D)@1&M@5..3\U?/SLG]J
MSI;>N0&57/A1"H8'B.?]41[NDXK?I,]2NO825-#-LX33>PE?Q:YU_4$ZYH%D
MF"2==Q@KAI^3MP560O_D8THX4L=NAU<11ZU!F>[P+3)"&P<]4,H7Y#UQ9GOI
M'7;OMKGEJJC6:$N#<=3\?PH^- [S.9S2)3X5_P02NU6W\I_QP0WC[__EW0O_
M?\DGR>5!9V1_^2OX/S1'E&]GA?*!"^58>IY&@'5XKOH:*>LT*S#+)+G,/Y#%
M1;=G)\][)+CM_DG! H:PS15CR@>;:V3-C+F>/O"& 0P?#9=,WEM)0%D/IU?P
MO?$;,!T0PL1_QW>=P  L7"."X9WF)# 3ZI=+V;4UG2'J#.^7(;F>50PGPUTS
MA^;)9?DTKBB:H9LN+OZEMY&@'>&/3%'/X!4,GU_Z'V.T%,47YWYMPW1[MPCV
M AB3--A;ZUJK49$H!\[5-[E?)^XE6J4OA;&].?3AO_[CY.FC%[?RW-><Z,WA
MM,Z!?#++L_/2AS?>WK40A);GJ1Y0$ Y=>%>75<EX6]-\@_EA;]=O],+[B[]E
M:?+R[;]>OSHZ>8Z+H%E 4H)-@W=+:7GT?&"U4'*P^I6I!ZOUV,FMFL&YF4_\
MZMBT8/D--<0-P3W$R 6F/H)=!N^XP+,W+,2J_XQS;^$*TGP/O^35V\(%&PR
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M0X =/51J2S-2GFM<MBP09<M>'8P9S'8XOF)D,L"-\8F^D74!@'!3(<L%+KT
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MC=>M^=UN6]3#H_3*@;=R IF=>:<%T;W2>.(F"']Q3@^@9Q9N JX$4#@/.\>
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MM()-RV,6J0(242L&(OB1\1O%Z879_!>KI%$>TD#[+\ML8XQD*YPA8YI@+LW
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MG++T/@P>@!QM::=02UG6'* X"R*N)6Y"!KH$K(#;)W<:SU.3O/BK5 :JJY\
M* (OB7?_I.!N(&>R\$*2<;AA<!?_G(<K;?; KB= EM^N[1EL]L;VGNSGZ(=W
MZQH!U$$1@)MGWZT!#U$N%P+8)S^8 17_%D]M)9=)XL-,+,E"9(;,03=TFK'Y
M,[-#B?GXR7OFL,4$!)O@(FTL<_('3DI9:68_!B$O;G&!L!TN)CF9@$2-V#5
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MET?U.W9V129=(*;<O&C(1]OU)&<>N$XK+S(8.P(AA^*S->W?!T-9'5'G_(-
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M-!Q;)(F:BYZQ8O9/$O4LF;0[XD%9)<H:4-;@9:^*Z(/H8U]A1NV[[D0?S<N
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M(WJ:,^Z,I9:=6NQUBC50/$ATPT-#HA?5!U\TCTE+JB+L ^(PP/&J,E?$AD2
M?1FXF,RY2OLH3999ZZ2WQZ+&EE"1KIZ<_;H)N#/(K8X"SCJ&5NPB;-X011T
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M1RR?!-?Q!5<5N*\+M55<%G]4E"\RNBM+84YB$K"ZT ,K8U[2NF;OIC:D8AX
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MP68YNT":5Q)[!-X\#K]$G,38WMCB6O!7%#BG8'L<4;*!_ #*([ +02QC&/%
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M-"]66.._?OKT5H]-W7XT9MRQ&N]Y%?+$#8TX@$_;\A25J-VRG_%12,A/$C=
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M0W;/U)(\P% Q3I,P0 ,NF@YY?IMIY&"Z>;\:<N"M@==B2#'C%AX6NMC;:W'
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M&N1%%SF_] S]9747!"J &L[NWC^U_>BVG]'CZ-3;>@AS4ZPLJ->,:U//R18
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MA0)UXYWW,W+-DNH8K5]0?::J7>&30EE*4Y%494+51Z^ACY54@6%Q#?*CM@V
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M".*D_7U=F#,.Y)1H3>.C-:\'_=@9E;[A<[/2S,QT&GRPV"B0POC$2B2 =9J
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M9R_)B[.7'_YB;[-[_9=3=OKA.?N_+]=N\>>CET_>:2R<),J"Q$0"B]2"ILR
M<EY:+E5 >6 A$:Q-OS$>9.N[$Q52VE%20E1CY(F6"#N&HM6:!9[^SP8<D$4Z
MDQ+6$U):,'172&DII'1U0TH4,Q4U): #%L"0P^D[Y].F8D(A(G@TF928:E.]
M@X,L"BGM*"G1F'<PBEIHSI3EBB(I8U2<B60Q,5*1DKHF)55(:>.D=#RUE)Q3
M2@?.P9C</2E8!^E04: %DIC+Z#S+'5=4GJZSK,8%#4K#W2I)>F&24$]0:75Z
M'T-OU!]<57FY%X,P=(.D5;._O)5C<Z$W#+YEKY*('9E.M]4+HT_]P5^MBS.3
M<.8Z8=_JF^=IC+T.X><^#A^_-E=5.#?]\M'U>J;E?%U?S6?7BVFOJB:8W>/Q
M2KZ^6<C"?7-QWZ]UE1B8TTI@"@)[E,?:2[".40A**&Z#1-*9Q'U<M06]79]9
M^N#O!-S7(:D*W#<']ZG^8I(DQ-, PB4KATD7P5#"0!CI@\<1)P,VP3VWK.8-
M::!?X+[TL1=K$"L%[AN#>TW9Q" 0QY9 X"KW1 DQB1J!05(L'/'2.X0SW%5;
MJ]M5RF5>QNIQ>]0;7@Y,SX66#;T0.Z/A6.+LV=B,QHN3R2K]<[)(A93F(J7?
MZY)#"N>UMQ@PRRWCK"!@F!) L*:($H6"<@>'G+<QN=TR[OZ<U#SO;\'P9A5'
MP?""&)[J"(PY3>MCP2N"DX[0&BQ)&#982Q5-3$:'2!@F;<)N]ULK&-X)#&]$
M1A0,+X;AFC@PZ: E+G"PDJ=S.-"$8>\,A)BD ?<"!4(.#D5;Z=OI(1N!\-[&
M.T;]R;B;X>7%1;<3!N-F).'\HMN_"B62T904M@E1G?3?7*_3DYY_?KU*A:OF
MXJK3NF; EIED:E#@T>ND&8*$M*,1R* 8UA$1FMM,$]V6XG;:2'%;[@24UYKX
M5:"\7"C7I(.AW,E@P4@2@7%JP%B2S(ZJ^)D08ZRJ1OAJNHAT*%!N,)37FBY5
MH+Q4*-<4!%,^F5)& "5Y0)4W$A3&#$A:5$&PHYSD\()L$[J()Z]$%QX>71AW
M\*SD0LZ8&HXR%B:#,L?U/1^#W[-@PWKEP]W)F]>KD^CH6>=CQX>>'_XV69)"
M2W/1DIL1"PXIBZ/-M,2 Y1%4FGD&P1O'.0H:NWAPJ/2R!M(4]V0#D;L$M5"0
MNQ[D3K5!GE@K" M@7)Y]R;@'(S@%I0V+4@DJ8C@XU-](32K(W1GD+D$<%.2N
M!;DU*2 M(4I3"3J/=V'")PP'30%QZIR.@5N%<IOS)IVY>Q9/N!$#.:900@:-
M"!E<K\GKM"3'H4F3%K:!@=[7K7[JE70!Y2:PT@+#*G$1<0&0P<B&P(SSYN"0
MM#5JB"^BN!6W.4)0D+L@<FM6O^9&X(1<*@G+\'5@@Q# D_DGE?2:\3%R>4'N
MCB)WG0&!@MS%D%M/(?)*8\<Y,*-R+$_89/43"E'SB+G,3=AC1JY"#8G*[YW_
MO_+SC\SG,'RXV;^]7H?FFOUY74[RLA06>@@+_56W_%FRY0)-ICZ10B<JX@*T
M,1(LD8;(8)3C%0MI<KM[0\E%W@GPKM?R+^!=%+Q3X]]:'*A/ZQ(=5@F\"<'*
MFV1",*YL2*:?D7DD5EOBAF0A%_!NM_%?P+L@>&OV?\@#" E50!'+0Y"#S^.0
M"42$A5'>Q2!X!B]5B]C_S7/Y-]KH3WNZY:K:@4$_1[BJ+DC?ZN^]2 Q@C^<V
MKU,HI+7,92"O)ROYSZO?A\$?]5Y=K^:3F\4L-#87C3W_5)_+J8U7SGL)G,28
M%00!PZ6'G'2@@\;&8)^[(+656/)8SL9/W2RDT#@!4DAAA:0P'2V)(DJDH -8
M9A@PSQ$DVR;1@S:4.)'4B5")%$A;,55(H9#"9H5-(845DL+O4TN!!(P-X>"1
M=\ ",J!97K_@@J<2$Z3UP:':)D-AHHFN+^1ZLX\'=R[;VW&/SUC:A*IRD:N?
M<K.%^OCKT5?CNI@ECKY:QH"BG?^,/8O$7N<@C[?<,)V_XQX.Z7"_'%1;+H^T
MG99H/<PYL[W^XH;Z7^JIXV_2HCWI^9?C%;MZ%5^:P5^A&OS[)KC)*A;C:C[C
MZDO=#1.]%%XS BY95\",U* -LH"==)A%8UQPN2,-$SLXL*@ ?-,3?@K 5P/P
MJ4LE:5RI70P0259/7%M02@@(D48AE21.)O4DVX@U:<Y& 7CS_"(%Q>M&\=0'
M$BTU(=E>$+F.P+!EH#S60#62S!J>%C775W\C8:/4>JU+;EP.W)D9+D=5[$<*
M^F8ZQ3UQ_[WL#,+1=(D*-<U'3:BN(% Z3K A23)@S8$Y(D#1@"$((XE5P1AN
M#PYU6]!%4D%+*4F#<;R9-G$%QTO \50H$,M$8F$!,K$Q,.D]&!9<4@O2V1""
M(]AEH<";TEBJX+B!6:$%K"L$ZU0/A(AT-"H/S#1)#Q!O01N)07.1[2EOK,UN
M.]V0=H[[%GFH2X&+04X$'8V'9H:$@HN\_?<LUK UJN#U9+5>=TTO=ZQY?KU@
MA:[FHRM<UPC&*,I$HBMGLFW!TG=I=TM0B#IMG29&TYRTSFBI.-E15&]4(Q14
M+P_5=<5 A0L<@6""Y-9Q&JPT!*C +@B-F4YKF%'-"ZIW%-6;Z2I=4+UT5$^E
MA3/"^:PED*4*6'0,E(H64.)I90V)PNB,:M24LWK?X@RWTIJ@&Y+8R/?9&@W2
M)X\78]\"#TUI,?V?O!@3KLJ!T>')U46H>E\.@AN]Z/1,SZ5'6_W:\.@Z$7*2
M*WY5J&L^ZB)UF<%85(IP"TH*!$Q&E$=M([ >8^FLT-3)@\.TK$O*$R]>S :"
M>Z5=J NXUPSNJ=JP7BILA8'@55(;AEFP2$7@3 ;G,,8AA(/#996 %&@W$-I+
M5AM?PJ#OS?"L +Y!@)\*$<X2W)$7H$@PP!#!8#FCZ3NA;?3*6NT.$KP5P>3G
M!L%^SX(=E1@?=BK)T?I;+XQRT*-JAF'&,MW?4H7%@;)"*?*UE^2?E\-TA<-$
M3\=A]"KF4JS)*Z7[_IST1.MB0P7%G0T:K(T,F/8NZ0SA0(<@!>',VNPG44(T
MPTM2?)\-C&@4Z*X1NE,I83"2/JT1>%(UEX@1-*(,J$-*9+-1,WQPR+XQ.:-
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MFWL69'G6R367/3]L79B.+V&51H157M_X<FZ6IY#Q?&0\T]$[<"6B2F3LM7#
MK Z)E@F%&!TQ6F)GF<JCDP4IDT5V%+YKS<<J\%T"?&M-^)PA5&@'400,C%*;
MX&L]8,N=I=HIA7$%7W0[6Z/ =R?@NXG!0 6^B\"W5KRA2#IF$W(3CO,\#8W
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MGE@RG92]V9R4*-S*9/1NT64P5O)HI492!XIX4!I9YSC2EB7'HLWES.7$Z4>
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M7@"'7OJ$N*4>&1(T<H$R*J0GRKML-6"UO F^ /E! /ENO8 "Y)L >6[^)Y&
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M*YSWD&2\4L-)+*CC A,B ^=$&F.T4#B9H*@-.A7.NR^<MQ ,5BE1K*P#RXZ
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M7;WRM3/%5"1S7@2E*B6P*U$$15:%02&54E6:\"14CYZ6TR*Z*4S -;G"5U7
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M_/FT,6"Y)#6 - [!_""I\79]=C;3R+%.\*%6?@V9=R/4NJ^K7_Y&#L/5Q6_
M(5?/YO(E$-L9SG$?9#A\\2]V!->:B93Q((T3T"EED@55+640BR0,\SS*E1!#
MG;**JEB%,<MYEK$4W>M F9&J1):7/$PV6D;ODCECZ8'XHB.&^Z"_]F:N[,RU
M%F)0N<%&]GS-&I'7=J3V,&BDAZ%[,+'C3KU!R=5_BAA\1E4!S1)!NHF!*. 9
M#I2K P"^ GYW1 UST+L?.YA,K>E-4?4CB$4.3 A64UE066Q][3"G<48&CQ2]
M1K@7%/=7RX/)R_'7>%CF!%Q!3HG+>% 8R[(,LSHNRYIE(B_2/.6H!I4IK\H\
M'.5!GBB$XQ8_@&Z,*.779DY_T)1_!37UP?&E5Y\.7[S\?%1P)65<5LB-"N!+
ML@JX+.J 9W6MDC*.RRA]]#0:&J)(J)>=9JEX6":@UL1Y@IW>>56455RSHDRQ
M0BW;G^97.,WT**QX5?$H"4"S!(T&1$50)+$*8@6GFZFLSDOVZ"D+-XX3]UG;
MFM6ZF4D-%VI_[+,H LE"CD#@NQL?7485159F81Y*5C#.PCJNJIRS.BM*+A,P
MJ*H]5=P]57R(CUA<I&!9JD# +<2^-RRHHE $2B2L% 4<0 S637+3.QX)L$ZC
M*"U9#J9,JKB4):L2KL(J9F6L]J=YYZ>)MBK(PI!E8)P*$:'54F/E;ZG =$FJ
M/$O*&C@Y<.S+[G@-NX^P2QNJR)Q@.5%JF[Q*$.NW %AZP$A(T8XC(5V);#2P
M06)@%[6,TSC-2@;F85%)^#W/8Y&E+*V^MM5Q"T_SE5;3TW91K\XY@J;]CDY<
MEU$#A#,W_M368C92"+0/V6C<CGW'[2%_O\">$W-USF?D405K8<:%U>LQKH88
M]RO,>3$.8'B=U"#75G/6[E)N4*.-2]L$;HQ#US,%#B;/M-9.BS<WEBXSO.98
M>0[D%FX&0?=2^O+();=;@BX(A!!OKWSW+N?,;)4>#]L-\4=T)!2ZF8LPX 6Z
MO'+0](LXRX-(A:#V@_555,DW=2O<QA0WX>OV5B [FU1Z U2=W4/'B9+R*R#.
ME$5^;]!QRG+[IWMTG#TZSAX=Y^_6H>-78.9[0)P]0L05$=:P*"M6R")5('A$
M7I:5A+]D25XD\$L=WDF?U"V*YB_+17O_(ZRFT/OSFW^_8G_]\M?[O]X+^-M+
MF./O'_Z$[Q[^^X_TKQ=_Q']^_JGY,_YG<[A1Z'V8_OG^Y,-?IZ]/7W_^_>3/
M=__Z]/J7WT_>P+]_O9M]>/WNK_>'O_SS_9^GKSX/L'"R*LG"HF"@GJ*7(Q-%
M4(:)#(JP#%E1A2HM./4W2]A] 8?88^'L.=W7X71Q5/%:JHHQ(5B8,E[*M)1%
MG8BRS%5V-ZUD]YSN+CE=U](BQS:R(JJ"N&0"LTWCH,A4&&38&RA+>)&*\M'3
M:%I^>2>X/0S.W5W/GVQP;!C#WS>;W<:FTAAX414A^#!G$K2Q(LZ*(HMY*..X
M5NE>(=LM-M6#O\G3N%(\XD%4Q2&PJ4($10X_E3QC59DEH<)ZWV1:IN$.-:S<
M-YR]XSNLLJSD4:**G!6LJNI"*!&':5ZF>135E=JK&CMWASW$O:I411VG09DF
M4<!BD05%';(@2A,9Y[S.PC3#.YRR?=/9;WL#?S81^7ZD8X^!LXT-"5Z*"/Y?
MQ67,PB(K(@'$&V9UF(I<Y=%>E=@M-M0#P,D82[,BP2RD+-.]KRL6%4%6B[#*
M4,M -A0ETRC^8BB]/0+.[EYB&995S.HHY^BS #N@9%61I$KF<5Y%4;G7)7;N
M$G>Z1)2G>5:"&A'E+ V8BNN@2J0*%/Q4%$E8A2DF#L=3=F=HY7O7Q#7C8Z/9
MN7N_Q%:_1)[D*D/-6!6LJ*JB#(6H95V4LH"%R[TRL5M\J >$$Z5P9!DK @G:
M'R@3",LKBR@0<8DL*L_"(D44\3#_XH; >[_$[M[A.LV5XGG"P2A@*8B@*HFK
M2)9I6A>Y*,5>E]BY.]SI$J@PE&55!85(PH"5*?;RJLH@2D65YTSEJL3RZVD6
M[?T2W_8&OC5YP7M/Q-8LDU0*IE24B%PP&1=< ?\!;2)/8@F?W T:[Y[QW!GC
MZ4&SI"K-N2KB($\*A.*5E&!2![)D($_2,(WCD)2'^(N#&GM'Q.[>X2I#TS7+
MPRB+6%8459%5)0/:J"J>YP7?*P\[=X<[Y2'-90;&6QHP.+^ P?X'6"\>J*B.
MZD*DB4I*5!Z 2G;H#M^1'X+>G1_DZ8[K$1I"[VRTGN-+'!-?ENQVKYG6-V@;
MM6=:=\BT_O05#U:'69BS.( S!,[%91SPNLJ"2-1)I*(T+TK,IHBF2;C9<^IV
M)L_.Y+?>H4_C(5__K]\_;'_][_;Z>SH+2R.N<AY44A0!"R/06=*\#N(XE<"Z
M9<'3_-'3N)B67Y[>_JVN_T-PASS;TMU)M\/T6EH^,'_)X]W26[QC>N&=$OP\
M4_@#\+)GWF%MY7-[%G<C%B=Z&DZ6%"J-PR"J<X:HMV50YDP%<+*L2(M,Q&'Q
MZ&E43/,1N^S)WJWRM[CJWP1H=7_5O\M5]U)!9"JB,!-!HEB%%2QEP*-088^)
M4.2@ZH1<P%7/ID6Y(U?]@7E?QOMH4,_*6ZJ1>\#M;[!!NRT(=@NE=RMC?ZWV
MO/UFO/W85^/*LD@2)N,@51FH<96*@Q(!M\,LDED118*Q@M+\LKMV5'U'P.T[
M\F3M>>F>E_ZM_'Y[7GH+7MKIR3'CC,FT#JJ:>EI@.PLNBB!A=5@6-2^24! O
M#=D=>_V^(R\E5?L?U -MYR"Z+FT^YYN3KN?C8VJ";H&)6@NUVH.R&8]R3J@I
ME\&N4]@@TF(?4C/E]LEDA3%2=3,4D5LU2_380G$C.)%N0QP;*.\I&_B2-KRO
MWXOD"#:9E6%2!WD=1P%+51CPC->!X#R/PEI4O*X?/8T/1L!#*@L><I.3#I,R
M"F5<YB'H7&%=E9B@ O];J4B%55CB24>E.>D1 ; _Z=N<].=7YT<R#E7)XRI@
M(6:9%*P(N(SBH))ISIBJX5\XZ>A@$Z3>GO3-P8'JFK,L!'NIQ/3V%"1#GM=U
MD8+0J$,6TV$7]K"+_6%_^6&_A+E\B [?O4P.WW^ 9\51Q038IJ4(:FK,DH4L
MJ$1:!))'<5RE&5,AG?MF78$[]]K S>G6VVJ.$&;;8$#QUMHVI44?6.A@\E:I
MR>O%2DVR"6&$9C^:?ZC6IS6XH>8?C:TM-3(JX5UK8B!*K!;KE9-"6O3L$(S0
MKZIME=*+VB,'';YX]NFHS%##C]*@BBJPP,.<!SQ7:8"B(,VKI,QR/NS:74B0
M#"P149*&+"IYD>5Q(HN<1:DHDC3;9>2@WPG29E$'?X"^]4P#$N*U(**8_&IP
MDQO5WH!H=P(M6RH$U8%'VDFCFWPO"1O']C1&B,<6H>YIH5S#4X.FJ<ZL9LD=
MBN+!Q&W3NK5H/MAR'-@&#C>**8S?P ;F](VY5DAG%]3#B-J-6VZE)T (0 [L
MPP%6-^JJ]W1HP 03S#_8$<_XA<$)\?&6W1O'US0^ PMK>3S7S<E7!@#R%%Z@
M>ZY/$ 9R@&!DVK-O?C09]$A?JM.%5#.<8^\Q("&!,) (T&1 ,NU.($*U&Q2^
M#X=)2UQC7X<)''MSNCX=;,0!T+<Y9=AMU:X(GQFK-N&J-"N+:SG<8,VU$84)
MP;J7BLMFUI%7A^&T =/>:$S5)6T0[ ,8?TO=.!O?.^TH5")\JIC!$>"*AH0R
MQ7-%F'/$G/9VIUL6DGV'TZD_78X=[JQ=6&-J2"2G'/Y6*2#*P<%VL*:()4]3
MU5]M".,;X:=N)-%V@3EXP-^(GT[@I?:<5Q=G:%W/+BR3@*W5,.:$*F"P[!WT
MP$#XP\?-0NIS/+L*TJ5*DJR.5%ID20A&1E&H6 @NXISE=2&B:T.ZG"^6$FZ%
ME>[B8VLD^QM+%,_F\F>MA&AA_[N>_CM8S(,3]*\NWKP0%T=Y$F9Y58L !+L*
M6"6JH,A8$I2H::9%5>=I^.AI#?2M]<D-@!?%Q<G!Y&?"GAA2D>8(CG 6%GX"
M+Q)R$0_O';[<+I"-7#C@82 S?<5Z%[%2@N-E]GG-4BGDA/#BEN9C^2N, 9\=
MKV=\B?RSH3G8EVJ\.OAM<0H4B?<;H>U6ZAA^ZRXUDK#ZI):B<0AXEJ';=>%7
MS5L0>1-]-N1IF2WP(B%BGZ(7DZ.*4#:))W:LRKP7-.Y?+(#==.1-[E;9[7-(
MU1YRYT",&M2]A8'Q\X3A8 CS]5/X^EJS:B=6-ECHB'A$:Z$!;H5;,-W<H2UO
M\R:+# 3(*AAA1=Z)7UR3=&#JE=)HS71T6EIO4M.!5O T]BFJ)R Q$2G%(1%&
ML8;KIA.= 3=Q$W#HT$8D]Z&JI]X>63>>@90VV@,19Q],49.HPU+TT1 )^3"@
MOVBUY3Z(FLN8@KVZ7)! UQ+$'=#98NZPW8 J-O^.*BM>R)D:?NE@,GENJ&"$
MEI;H&D4$<4]6V3OA-*R6PTE//BYFP..F^*YS-9OAOTO5G%;K9:OO1SU8WHI_
MPM4A?>'APD<]?!^-=670TPVP)5'3&"@[_OP1-%:"_K K;%'+>4.8Z2-+<W(:
M**EN/BG9UVVTW'8^Y-M.G-2LUKZAQT^\*WG&EZN^$FMGH0?KLX%1)6U, Q]0
M_?UPZ6^!Q+K*6'YZQ]Z7FVSREX L[9!1_Y7=1K\L%O*\F<U JWP%5V]^W,!E
MU;X#^Y'V)CTXW?(X>?/N#XI6\(SS(D@B608LYG' 510'80Q[G"L5\K@8.I'J
M.HTC'M5Q%:<,CJ2H91TQ652Q8")/Y-")9'=ZL@D2N!,D>PO6<.46]!P\/0%:
M(4XS:BG RRNP=+3ZU8$W<P'B3^,;.NCFV@X!#UFQ9,2D]A.H3T(/V:XL4)PW
MC%-7:@2U<PX)1*:V7$;08!K-#00$O*G6@JUQU\8^"VIRI3K="J3@L3E@4([M
M41L?A F!*HF@L825W:XKQ)'#49I3!-DCD;-4'QMUCMP.MIET:]BI4[3P:UPG
M/ *:8X-3QG7RY07)_'J])$D+PE(LFPI-?C5;G(]Q1\>ITP&G=C/&E6O!W7&*
M&W/P;B<VQ> &&N8UJ/TV'SY@D,UXQT$VKP3-''+:,BXCEM5 <QD+HZJ2JF!)
MGF0Y*^)0IM]3?@Y_?\!R]!4[XBH+159E09D41<!X+8(JB9* <]AOEF9Y5'];
M_,0;ZF'=:9K0RGV0S6-^TBN$EX&(G)PMFU.PW= 9!";0DDL%OWY PQ=_IEN
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MX>$7"54FQ '+*@7_*3@(_3H/(AY%*LJ+)"OBFT&5?9G>OC_\;WGX!2MRSD4
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MZ]P[,=U-E0[Q(.R)&+L$WK%&K.3UTLL.7JJ*7!S&3($+ZAOQ/L)UL^QIZ':
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M6^1FYB]8I$"=+O^O7H63 =@Q.D"-G9^UZ@?[PX_8AW7&+WYHJ!-D0%\:EC?
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M$AX4L59)$3"WF^J2'8#M$H#Y&8"%1 '##$/ K0"V.*/(8)90"L;ZB$V0R78
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M *X#N*<.<%M(G.D [OX!;N[I4EPX8JU'S,?LVPZYUX:AB&#IK0P"AUR75QH
MN#N[NCJ ZP!NWP%NZRE''8I]-8JUW'J*A:A41,1&AKBW'+G !+(F.(D#C1KC
M@V.QM3RC#L(Z"-NME6_B_]Q"/M;Z7>L[G+LSSKUOU2@V5/,D$:96(&X)1<X[
MB5)DG%I,@N6A:CW/KL<PK._C[%"N0[F=1+D=S5GKL.WKG0FM1+5 05++Y=N4
M\2@WA4$VAH ,EYK2X.'\V,$Q%?)0J3M[=+\5Q-7NWF8BS6VN &S; 2!KC-%:
M,(,EA=&E&\1K*[[+&[I9=K/L9CE= H#%5\F-XSUV6R+Y]<P"J_17O==Q_*'O
M8>30GTS'?7=9V+0_L\-A'#R[L>;C-M+TNS&Z,>YCC"X3?8'"AW'Z<31^OX\Y
MZ;WOR/>]U5GI=XZ;W3U,7E]+7+7&QZ0(>EB=)RG' 5,/BJ!EW"@3F1>:D'72
M<3M%\)X50=J.*F,D$B6)02HJG/OR,*2#,HA0:7D(PK'H#XZU/E3B,2?2=V-T
M8]S'&%L*0-]S>>;$]@>@EXQ 6=G/^CKT+O5UGD;9,FFX3L%(D9M"&"(U5\8K
MYS#C6IM .\[_\)R?M3F_M5K 94U(4BT0=]@C$U1.NT_6$1.DB_3@6-!#PG>I
M5MFN:*K=&-T8W\"2L3=]9TKUO*Z3_2U];JG.>=%1.\LCQ2[H:.'^!"E8D!NT
MO.R8X-V8(%\H(F=3LA*X'HT>U%]M&3):>!28I[D%,?&2/O8B<MT8W1@[K/MV
MR=>/U!+^A..ENN3KW9<31%M.\$$:%J)!V+* N)$*69H(T@8S1I)DW)&GFGS=
MC=&-\2U4Z2ZLKQNC&V,O9/9=$5'52D$-1"K=1<=U8SS),;YUA-T#.9S_&HU[
MIZ-1F/QMTD3)YL<F7Q<6NP_0W8W1C?&MS''[X)!J@FCOXJ1^K#:W1VI6(T9P
MDQ@.0OG<IMC8F((U7EE#&%>^F-5T8U;3747:O;+(G;3*(9Z*DX_OG*"<*2*0
M"])EHUQVWKF(L Z&$462(.+@&$[^D))MY3#ND-VM [)'"V04%%=K$O?.\.R4
MMD%C396P3N"81 =D>P]D)VT@BYS$1)5! BL*0!9RUU ;$/=*XQ"=5(D>'$M^
M2-2=NV5T.-;AV#?T<SJF9*0):\VY@7\Y88KRY"V-0L@U<*P#JX<'J]_;8*5X
MA -S%DE%(^(I,&2)MX!=3E&;B.0J@-0EMU7!L$.J#JF^0?H"J(>!!$>M<MQI
MXI@(-#(J-7<DU7U$UY>X/L?Q*-C)68=?NX!?OHU?W%I**69(*<,1UT8B:Q5<
M\Q1P=*!..B\/ *LT)?2'#L,Z#-N?6H,&[C6A5$G& J><ZJBEX(HP2XAFGJT!
M8NO7&NP@[2$A[7T;T@(Q@>ED4$P6("T1BFRP%)F8)/RCI GJX)BQ0T6N2V4;
M5RKLP*P#LV]028(PIR4.*GC.J; NRJ0X28R0))TTG0ELWR%L5HV0OWIS\LXR
M _IDL$@KZK,QGR#MI45.\&BMB9$+7]3*0\WOG(VS121[:GE^0!3#:>_U=#2.
M7;;?+=GPH$%2XX -EZZWN01TLJ!=:!F,KKO>=NKD'@(77G)"$L.5@N/-C3$=
MXEFGM%(IQ*TDW'M.HO5;4R=OP8Z'SB+L:-ZYZ!TS5A%+N#3:T.BT<((0%0(C
MZVA?G<2RTX2_X+0+5%/,6$1,1Q!8HG#(JFA1(-AK[&6 LP:!Q1SB1UTYJZ-[
MZIQUP0GL(^&111.PM=)1Q8C'6*F.U^\QR2^XOH+&S$OI4.YUCKB.$1DE.&+)
M>^.38%'8CM<_!9H7%)@\<UX!H^?6@7P?(LS.8I\L"\IU-+_'-+_@+B).NH2E
M1LKDIJ36 9MGVB)FG?:@T 43M^<NZFA^AVE>Q^"UI,P23;FCQ-! ?" )?E*!
MAM31_![3_((_A8 <)Q)SR&N6 XN30TX!]3.?"/7!.)']*1W-/WZ:CU$!FU<J
M8N,XED+#FF7P3#%F0Z2;VO$ZG7[G"'_1"^$DU@H#C_<&@X0/JAW22C+DK>!*
M1Y52Y#NHU#^YW*Z:7+[* _$TZO$F*T G429D([3VVO#DJ03E!&/XB&^:0M!)
M*SL#6F3) Z&)-29$C0CQ%# K":2%T@C 13NN>>[+]X@#VCJ:GVLHWCD=J:""
M1<YIL)B*Y+!))B6G4T?S^TSS"\X':71TS& 4,J5S2CS(*0P@P!,?L8Z6JNUY
M'3N:WV&:IUZ2Q"3H)D9P$KUA.2<V!4],"B[%3D/9=\)?<$' 0:?$!$/$18<X
M3Q89*W/.LY&$2BD\%0?'^A".O"/[1TSVVHODA20J2<PU2UI@+RG'+,:(">DR
MZ_:#MA<S4[!/Q&J%B.4)<4DQTAH[E# 1! N51#0'QX\PKZZCZU:; )#?A/,<
M<)X[)EQ0P3!CG27<61TZ$7Z/J7W!R2"!7R?!!)(EU3^QB(PV<-V!B?,H#*;:
M="+\DZ#YQ(R3*5#'%<?!.\&EX]'";>!22MR)\/M.^(M.!J)##@\W""NI<Q@1
M1T9XC$34E-*H/!.RDN%WB=<_M40'H(]>?_@A3J;G<9A_]$ 07<K#S88(3ISS
M.? 1+K2/7G,9'3&"><TX"W<-@VS:&<"QO)B=RHMR*!T@;09(=,F!0#VCFNB$
M--,2<<_S3X:CX*A*2EGJ).G"'9X"#3,I)$]<1"]!$LF:APT&&\D% U;%[UH%
MHZ/A;=+P8C9"$%$ZHQ -@B(>#44Z,@DT3(**UA$EMZ=-=#2\PS1,97)$ .DZ
M"S1LO14Q6,F8I9SKX->Q('34NGUJ7;#B"^^%(@XC1W+O728$<LR"0I"TL9YK
M(%;0 (3N"/41$ZI5@A ,)(F)Y%P1&QDU2D1!C!&6K6_"[PAUFX2Z8)+'.F&2
MM$>>@K[.HU?(LN@0LU8YKQ2E.AT<2TP[2GW$E.H=%3A1XP.P5$>=HSP0QI*U
M,B8M-JU%THG%]TF_"T9V4&@3#4DBQ7U$7*2 K/ 2@3C,J*46])Q.+'X2-,Q2
MLESB9*017#NA&58J ?5RR1+FM..V#V.(6K",@U2LI(P8!1* W6H>D:8Q(AD\
MH4D3XV4 =BOO'-O2Q=Y_-<V]FI[%<1=X?S/0>*T")R0)Q[A4S!FCF 4I'P<F
MF5I?_^Y<=@\&3&S)0AZI)<$Y@@0/'G%,&+*.1;AL(<4D(@O.@[Y.NYB[QTS9
MW'D;HC9*1<H38Y:XJ$,0SCD9N5TGU+:C[(>G[ 6[N1&)& :4'5TN.V@M1I9B
M@Y*3E)B4 S'<P;&Z>[9?1]D[3-G8IFBX3E*HQ(,25ADGM0:=T1CB24?9^T'9
M"S9VYJE,.F%0'H0#RHX.:6P,@L-5+D;0!04&GGUW7:*C[!VF;(&CI8Y;(>#(
MF31P\C$%["E1V&K?%>W89WI?,-4[&;P1WJ,<* WT3B*R0GD$4KD24N>2;+&+
MIWT*- ]$3D60)/C<!E0FFZMX>(J#2*##)=W1_![3_()YWQI!(B$<*9$+\A$=
MD*8VHIPDQ[$P4<>.YI\$S2O0UH+ERL,/W&KF?.Y\X4![H]8YT<70[SWA+WH*
MI&",>0Y$SV,$;J\CTCS$7++'A%S@1-/<A>Y0LUW2W+<90T_H$=UY9\&;T=0.
M-O7*N-$XQ#&:CBZ>Y<5.1H-^Z#63?=0M73;>@,<#X%M.'U@)X(WKM@;L28?"
MFZ$P7W*+6"YE+HF)E$D&D%A)I+7!B&KC!:C<B5I6-6!7[,X-V#>EC0<.O>A
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M:R-4U"8$MDX:;<<'M\$'/R_Q0:HBP1%'!!*+1EP%AHPC&E%A6-*8,H/)8Z]
MUXW1C;'#&O#3R,JN9K[*X=G%5FUOAQZ/1-'E=>^^L(&7E6X30/*C >5FXH@[
MI9#ER:&@-6,8!Q\XOZ>\[BT03Z>S=V,\YC&*N/*WJ07B:(R]Y3];-E=_D1/0
MVZS5XC9C];M-_EDR:U=@\_+R'";LJ[]G?M,?7MJ"/BL^:7D<ZKGS/+WK<__8
M#].SAL6UOE6#$IY_Q3K G\OIS5]I08^/P ['VV;5!*]Q/@#262-<V,#6?\]F
MD:@7]C0B-X[V/;()9OO,#C[:J\G!WQ86==X?HO8.+B^^6N+Q_^O&\+T5;UTZ
MF8HW&QY2$$*R8 7'RACE$U744L^]5\95\@1\)X;G60B(*@HODHC4<JXLM<(:
M)8#E.)\B"_K@AO<DS G. > J)>Z\MM$IS!-)3A$:;;CI>TIB+V-4DID\/ZE!
M]S8ZUP20PE*<;G%I$=W(N/UA@%OP#.5/MGT3]%H7H17M\LW?_L/"KN@C67;A
M>IC@Q5)84:\_ 5$PP6BA9R<]/[#]\TDO]0>#_,&T-X[3[+:S0Q O+D DM(/I
M5?-A/58_3@YS[^:J EMO>A9[/XW.80.N2E5 ]</D^A?*@/]^\]/"&.YRVHM-
M);?>B>T#40_MT,-XQ6MX+YLKCN@=4)@>Z=M0&.0TQ7]XL$MQ<-S+ N.'_O3J
ML/?QK._/\G%71P7'^[$_/>L/RX&=MWRSWD[CZ6A\=;3B"'H7<7S>GTYZL,#3
M?I8=_:"?>W=?#&!MY_'<Q?&D-QV5&Y1'[H_SV+-1+L9QXL?]B[R5\-P9<.33
ML^KM1?:$NSB S1U?P5_S];.]G_[[>GYIZWLTF8[&,>LL9>X34%!@X#P[N,'S
ML8X6\7$O$(3N/H*TK\H7P,/V;OAZ==8)Z'[0OIO5Q9RTD*9Z635N^?4$;D=O
ME'JO9X_\-!H.HY]VX+ Y.-0;>]'W[^' +B^J,UL$:S@=.-J/$<@9_ERDW_E)
MKP?Z('W'BF8? [C?3Q#+>D=W,1Z=CNWY46\/,8[M&L;]!"<,]S'S$& I5]$"
MZSD'51'8W)D%N'$Q#N$V [5,)OW4AQN?60^(L9/^!"XQH%OFI.5>^\OQN+!#
MF-PH%'*!OQ91]^BZEG5-A[I9NM^^^CG7;LJ(S_I3N.!^C0-L"O#V?K2#3,"3
M;S?3]>8UZ%N7&4N&'#C3<SN&E\$!UJ>Q$JQ&#JB[4DE >H%QAI,$6)6O2_[0
M#GJGHU&89+%DTK R>-#"B5<EB,N=J/A8:WRX0!D(?010"=65 0@L[SDL,G#-
M\WJ_?()W_GCIWT_N*33N'FT-]P.$:Y[Z;_&C'8=*H;@<CF.(\1RVNMG_TWZ:
M@D0+3QSUWF0";1_!_&3&,4NIDWR>R[?H"H:=]E>=_QP< (X_]+-(G>].@8'J
M4ASU7@QG=^APX6+ JT>G0UCHI%>, O84Y)KABGGW\D:'_+NS?A9\\Q'T\CK/
M"Q?N7=CI-(Z'D^OB[LUHLF#A6>KFP02+PGCJC>=)@/X=6,(^N,@<D8EE9P+%
MM3.!XLJ9L.@C6%6A.Q?FSH6\_]WLZIML7'L#K_UQ,/+O]]2)\.?_GF%__M^A
M_<-<OOKK3_C>"_SG'_\A;__Z1<"[SM^^.>4G?YW2EV]>?'K[QUOZ\H\_8=R_
M]__W,WP.8[ZC6D2;N$0$4X%X<!Y9;#EBB1.I*:,LJ&7KC+")^!BT%=3R@)4S
M3+/$HO;1^8#E00]D-'N1+63CRWCP@(B<"2Z-!H/1QV(8R"?>D$H6YRNG4[[#
MUHTNIS4UYJ<J<KY&BAG0TWAT/OO-I.*\#;E-LH@*RL'/,%#61"LW"2.'O7Q5
MRYAP8\VS&X4F8!6G_6'C(<F@5W^28; *G:Y6,;-:%H<)[.? 7DSBL^:''T)_
M AKQU;/^L.Q*^=(R@,*8<_/>$:Y,?+6/O!Z__O51^=62FZ?ZG=)'G-$;?XV/
MR(V_NVU8?:3YS=^\;=3;?\<TOY>YLK5&_4(4PFYD ']1*E.K8MK+7 /PE(JS
M/2NJ5L6>7PPK.H!9#++:MD92\"T[49G:O_%>W++R@^-,VQNL:0UGT9XMGYB%
MY7_K_-EOS%FJ\)JQ!:&YS3"^FYDU09.SWE?ZV_R)PVSQ7K\HT_7Z SL=<+/F
MMFV<H[KSX31K+GR34D:*Q*0=3T9ZCAESRG$<O$^8$2F=?O=B+O=^91#-C0+R
MRSC]J;(@/)+XFM'52_JOO_[\V;.WYR_?O_WK.7[[V7]Z^^:$O@(Q^-4?)S#^
M*8$YXY.?EN)K_GI1OO,2YO26_M8_^?FWOUY^_OO9R>>WXNT?+\3;S[]<O?H9
MYO+S?S[^[^<FM@;^?/[.R"B2)1+92&-N<4^0\?#7$+FB0@M%'#XX5H>@PVPI
ME'=G F>^$,?9P5T'=]?Z)6BN7(J68L"YG.LE1 Q>&J4,U@%GN".F@[M=@[NK
M.=P%FW"NX.8HHXA;'I%5E" 0@@PG*1JK<D7>0T6VE;O_K8JX[;2BMB8IKK1*
M+PNKXTOX,7ZZB,-)G%P34E<D3^U2CM0NB6!?!IZ9 ;)#GJ]!GA=M0<M*'KA(
M&#%J/>*&*&2P4PAX"4[689.P!D%K0RGK_N2E#9I\/G("^VJFWQ'8_1/8G+5S
MFP@';09). [$%:;(FBB1(U8ZS^#06  "8]^>P&Z+D/[6_NM;?1 _7XZ;J,3L
MV9_TXC#SW2^X""I?W4H'A*N\WO-H)?AA'"TP[E[QFE9>P)E+HO8P]^#=0YA(
M?KSE[.TU[LO1N->?3"Z+/SV[,%;X ?/<@!CK=V5W\[A.QID[$^&)^7KK( 0[
M*4$]D\O!-(^<?]-R'\(GJZ=SPPSFSLI5DSSJ_1@'HX\Y,,SV)I?GYS:'\B7X
MT9^5JI2G<?+L>B#$[>'FFSEH5D88?]%GUCEV.L=.Y]C9-<]&Y]AY:HZ=5>KR
M8<]%P/C,/C,OJ=A:Y\GI3)N=EK/U?.C!RS=Y;/C\'R_(G_E=-.<UG[V'/^%S
MT&3H[_2$_GG^\EH^].^DK..//T$[^N\@K^O/G__5?_6/_.=S<?)7^.O/-V\_
M_WG^EB[Y:X@G)G@K$?:)(4XU018;#UR/<&M)")&*S;6<SEG3(=IC0S3/@Y,F
M!6*XY19C31(H-9@9X5,T1A9$6Z-D5(=H]X%H<[L-MEC):!T*+'=\52$B[55
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MX G, ;\3EO%<F0[IB$&P%DHBK1)&FH0HB;.::7IP+*X'2?Y/Q32:R];J^E[
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MB(5O#4CMRZA*?!]F;@LC'Z>90).T=SL>Q5O29KY7SE6\FFQOX,>+*VCYO$;
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M%1BXC[H@=.1!&RL\)\E%*BQE/-B;=*/&1_' V.DOY5H0S0EC!/'D.>*&$&1
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MH*A\H11!#/6L8A(@7S(4TDY<X*)B&8 ?@)\4X(?COV+,OZ0(<C[;H%( \58
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M#M"3!<K)]NZPD5V*L?1>[T:MW.Q]<^AEN&[#==L@UVVH<%>FTX4*UR57%84
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MV@0=M]\Y_\3_GK8IFTLG2IO D_:K)X<SH?QZ?OUSQ<:G="!7_GZ[@]U^8GI
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M6F/$<,]1(3,&!&<T,[^U:U:U<6Z--@A7Z-Y;\;T*W?N#[EQQ *,MQ4DB+*B
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M@ 0^"$,-C\S'K'Q@(KF;L=-9&O0CLD\EIH<BIOV9V@3)L&R5(E%&1H 93BR
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MH\"-XR(V*HCF]2CH9XQFF4Q.CKD0+0=PTAG#K90N08I@U#7Y916R#P+9.2\
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M@E5E8YT!/?,#X/Q91Z,FFAI4-CSWQ$>K"05/4W0\"&^V=O6VIK5 _3.&<V;
MK.+22>XAZ&RMHLPS$07JAU'XFMCSZ)B=6?Q<1JJBLT1%"02B#\3F *3X9#U:
M"1RLW]H5-;'G&0,6;)3&)<&=TI""=EQZ&IQG@5$=9$VL76LLSXQ]I84+4C&2
MO9.DQ/^)L32@5IV<9(ZJ +J1OVL%YTU+!D $X)^]NUKY&^&&1$M0>NDX$SZ
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MZ(]<!]'A1RL*U_O^(*8!&?6/7Y1Q'_8[[=B:]N-Y\Y'AD (H'J6DP*0TWMG
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M" !:^<J 3X0!]Q<504H=SBGEA/ER% JP0)RA^"I(5 *MTK'DW]]]6V-EP,J
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MN%"2H=!?E3^R0G\-H2]B2IHZ)3QP$-G[@)J@2#09J:PVOD+_>4!_*13!O;<
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M%Z@.$G;O+*',<,?MD>NT.GU$1=E7,#[:L'RJ7PXW1"#/G6Y8KO>[J>6&PWY
M;.$'3Q%_TYT(K=SN.80=WL\5D U;IT?M<-0Z38/4.DJ=B&^W^KGU*H74]6DP
M7@:";;<*_ENG>/5OM\GS$U(D:0,/I2:%E(Y'D6F(/@G/5!:W.31R/M.G=]*-
M_='D@U=R4$,CB\SR^ZC=Z?P_[.>[\P&>GAGY-K2?/-N\_\\1#=T_>NY/>_+V
MTSM^^.F=..S^T=[_]/KL\."W+C(/L@>V^].;L[>O GU_\ [V#E[R_YP%_O;@
ML-R'(AN=[G\*'Y(/PC+IB199HWHF-?&)4Z*]2R8RA08Q4L=%YF@A.#IE7<23
M,NPM7*.MK\D-6JE7ENUT9;6FBVJG=04"+X,G/JLLL';OI!$;XUE*&:P#EK"A
M);O8&L,$A*!%<DAS66RM!:P+=)O!F$3:&YQ="<OK!V\>ELR.T8O0S/U.IW\Z
M?'%A0*>][KK!QW9ORL\2>S!YIQ"R;-3,ACK/B7Y,USA8'7<\3"^F+WZ([>%Q
MQWU]T>XU76Z^M$S,>,\?3MMQ=%34D1TZ5DDFR123^T\N[S27EH3,^!K0'2/M
ME9?I#KORVG6W971' _^NVUY_31A8>6/MCE'?=]?:UF?45GVS]GPC9VDM4I/L
ME#N;&[XH^DT[++"IOL2B&;<5I7Y_T+#_"U1 TZ!\:FOW36\J=ZXN"W>C00AH
ML:3! P_#-9W>VOVY/\ _>XTT'!9MICUJ7W.\QL5>7IEY^D0'Y-W.[SO-:.!"
M."YK(=6Q.<_F^^])>_2UCL=T/'Y+,:5N44^:,4%#*:?!(,4Z0N=;UOO(O@O]
MWX2LUQ\3JKV]NR>^;KH7=9.<I($'YICVS&L//BC/4HJ0N/7"4DUS<9(R4YVD
MW^LD_;3W"M__\[=/AY]B9^_5.[KWYYXLWSG\]"M^_C6\?_7Z['WWD%YTDF*;
M7@7V_I?]]CY_=[I_\.M?AV>?X?VGV-Y_%>CAP='GO8-];,&OI_\Y>WV>MKKW
M\D.RTC&;(J$FB+()*1#K*9!(.4\"#&<.5G=J[#.+,57RVQSR4S0;X1U%HJ,@
MI/$F&VF#REIKL$)7\GLJY/?UG/QLEIF6NE'!IES2G SQR2$-6A1S3-M2/79K
M5^G*?I7]-IO]P!BOD\[,) XN.B\,@Q@\4RZ46@:5_9X(^^W/5#_)(,?@#)$Z
M)0)1>X*3:8@P"FE1&IJIWMJ5*XZ-5_9;+Q*H['>##$PA(93D( <!LG8^%(N7
M*F-XP']5]WLR[#>G^U%&C6]V:'*-AJ]*Q)FRF4@$U/T2TJ'P6[M5]:ODM^'D
MQTO];$--*4@*5'.7+$T*!(LVBV1\);\G0GYO9ZI?R1$RRG!BN"BEA[0F!I0I
M!Z@XD2CC5*/JQ\2*D\_O.>UQ0VHL[Z=1ZSP[TO7B9<F2'UV[-VS]?9PS^8\7
M-PCO?7_]IGJ/>H_E>ZSR1$8F=K1<<TR^F<M*3FY0 JO#RZGR1F7/GNYA#;=0
M+*S+,F;!+40 K;P11BM\Y:1W*=NF%C*SD^1H9M>@^N$T57HZVV]ZKR=SS:HV
M<BMM9&\A!LEXM"8J$OX_>U_:W,:1I/U7.ACOAYD(%5U'UB5O,$*V9*\F3&IL
M4Y:E+XHZ14@@P 5 T=2O?[,:  %>$@\0 L#R[%(D&MU=U_/D45F9R4<"UF=B
M6!0D:8[K(0H P6OYEG5EA%L5; 0(/*J4O=; 34;0(TO8F)FQR6IQ THX.R]1
M66 =6&#FD,F: <ZG(LHP08"6ZO*<,5*J.W(K:%99W;/D=,7^ZFH#,42MM/$Z
M6( ,P7HEA.(QRQP8EW #Z%?$KP'BYS:@LBY)C[DD/GF'B ^96.$]$<R($(SC
MV=/BA:@B?W-ASU#YUS933KV&++11,=+(M8BVE/"[B<2O1L#ZDL%,_#.O J5:
M$8F40$ &2YRG@4C)%,]4"090C8!U983;& $Y>2%L< E0$Q"0O$D@4" (JXPS
M<!._0#4"UHD%YC8FI#<YH0U(,@^1H/'/B/?6$/!1,)8MU4%N[?#+B<?6OK+C
MNGDYK\^]4 L];K+'\U69]Y_GI_UE.^OE6Y7Y;L5\O\\[0<$HK4SBQ%->C"%G
MB>&6DYB55SY(5HM"/0Z26( /M-+!FM+!S!P"[S7GAI$8 14A0=$<0O.8:(HV
M,BI)+&JSM<-,98+-98(%N$2KNK!)_##G.Q5(!A8U!A(D: (J4^*2D$0EB@L!
M-4Q1$MM5=6'C26(!#M1*!VM*!S-U02B9H@N,&$61#CA#ZT$G2[AT($NU*9/0
M>I"5"#:7"!;@-JU$L)Y$,.= ]=RG%*TCCAM>8JD4\0SMAIQC3HKK+)G>VN'W
MWE-=O2*3:Q&[_=_C03APPZ\D7-K,_9_E.DD?C,?.IJ]2U*THZO6\IS-ZSK*-
MEEBK)5*4DL2;DI,;#.JK5FHPA:+J'N_F8GR5?9P5XW?&^-SI6J8%-ZAW,$B(
M<9,8<:B?$F8,US'F$)-?7%JIBO$5Q/@J!W16C-\5XW,N2!9<07(@%B4Z >\E
ML2!+_2(M$M.<&BMK^.9F@WS]PC<K].\,_9EXIYE*;Z4D,0I'  0C-N$<"V6<
M@A0<XZP&:SX"_*^RT[$B_:Y(G_,GAK*7*)TDV> <@D)MW@L-!.TT,,'XH");
M1!S"BD9EKKH_\4]<UW?S)3Z*/9'U"[AL)[02UJT(Z^VYP^0J9IQ1I"G'6$EH
M;8DS+A(:N'/,FT"]JH$1ZXK])1\FKS!?+9C/+!"3I$V,:N*\2D4OR<1%'0A5
MBH)PSE(-6SOJ'N=$*K97&-NK[%RLV+X+MN<<BQHG5AJ/4^=L(&!Y),932JCG
MB28F(5FWM0.7D]-5<*\LN#?:IU@1?R?$SZ0Y%S1*9Q)1)6 )@HK$ Q.$!86$
M'IW):7$9H"KV5UBPK[)#L<+\+C"?<R8:IW64.A-J,PIV)R4Q 2AA5% !TFE?
M4CS!Y:3;WT6P/Z:XQ#_3:-1ML?'8(A-O0TZK')HX-X.5HFY%46'>?<@C,Q8,
M(ZA^&@*9.N*4!!(D4UF%9+046SOW,3WJ=N8*(WRE?885X7='^/S):B$R#8$X
MJ='6$.705'242,%Y<"$"91X1?CG^N$)\92&^T8>J*^[OCOLYKV)P, Y7C $<
M2G:T0 Q-@G!MK&$V0C(UR_1C8( U]"]6!K@[ \QEF$;=S@>="$TJ$Z#<$*=3
M(%FB(<<=ERDM+L5298 55O-7VLM8P7YGL,_Y&A/.KM?*$;3:-0$C-?'4H<)/
M119!&*NIOO)TPMIGDEQU7^/^ &_.:3!L^L>CII^;W]+GU&W$DZ:71H\LEG')
MWL>'SXM[-KE[:53IZU;T]>%<&*//BF?/24+11, :14P.B21EP0D5LZ=T:^=R
M;>8: K&R6%^N&W+))DK%_7UP/[-1DK!44HJ6"6B.:@MJ+,8GA2L2I'(0E0=?
M(R$> 06LGY^R4L ]*&#.44F#147/:&)*,1P FXF1-),DF#<T21K"X@Y75@I8
M70I8/T=EI8#[4,#<^6IMK$[,DY0<:O\L)^)0'A"A,O>.FZA4C8=<6PK8N&(X
M%?;W@/U\]1MCP.5D2-(281_+.>OL.%&>,X.S;JQ0*V/T+R@\<J5=E2]ZI:F-
M=UW7"Y<*VWRKI[X_B&E QCUX*G"<8_\84=5,&S[YPJA_]+3,PK#?[<2SB]\D
MMI4;K?_W'0=HM1G_-DH?C0Q$-A$4!V_P/VW0Z#,Q"2&0Y]^_7!%=KWU,9?M;
ML?VG>1>O5\P%!9ED14N./).)<Y(3FAASUCMM4E[T=O3B$/>=-[,K]U;N73CW
M@HW2N"2X4QI2T(Y+3X/S++!2>/ KW%M9=K58=F9*:^=+XO-(G&@3HFN!OWE'
M*,V@!*5!.+:U(RZ?.:H$6PFV$NR"\S%)*9B146I@@-:LBXI[0ZF"T(8T5()=
M$X*=VZ[(-"8>VM)TY<24 TFLSHE$L,QEALIMR04I;"782K"58!^88+4UU#D&
M*5$)-!C#E>1!614YA"1L)=AU(=B9!LLT.&DY)S(96XZDBI(<PY12?RG&)++7
MZ<H#:Y5@*\%6@ETPP483K'%64YZ@A.4%H8)-X!V3/KI*L.M"L'/;;C2#L#%R
M$HT6!+@5Q/H2=0L&O%;,."^W=LRB<AQ_?X)MM^Y^&)4UAO_&SN>=_VE_C/OA
M!S_LG/7I_,4E I.W1P4.4C/JCURWP9$<#IO1V=&!3F_4;_XU/D#P[^D)@B8>
M%V@T([SM-#G\6NK%%)OG*:1#GP;C^1+L2<,IIXWKQ::@M3E)@]2X89/[W6[_
M9/CT4N^G_3YT@P^=WG3J)/9A\DF9*]E*GW94S]; >"9QN+KN:)B>3G_Y,7:&
M1UUW^K33:SO=WG1QSO"9/YYTXNB@L-0V'3/59,-U\OS)Y>WVTH7U-[ZFU;8P
M\MK+=)M=>^UKC[7;1L&=GOKU:\+<[:G?:JN^T5._L:6]$CO7=@J<]H%/.PB.
M3C@')7V%C!NW%052?]"*D:=(2VE0OK6U\[+78 .Z^.GUN7]N- @!95@:+'D8
MOM+IK9T"\UOTZ=HXI+7M/K/GNO\88C9^O4I23 3$'47U8[< 'I."+X( GR5S
MV"+(/#K(@I6"5LY[0UT;<,?I). . 791TY?+B+-[B6NZ7=)B4_3^3WL?/WQY
M]>N[SMZO_SE\M?^!OMO'O]_\U=W[\EKN\I=\[TMYRD^'[_Z\J/?_SE\]WX5W
MAR_IV\.W\M7S/[KXMWSWYK78V__T!=L@4.L_W/WU7??O+R_. C#V]E_*O0_O
M(>%D9\D)FG"9@,J<6*,#T99&(X0'R^E5^;[NI?IOBNND\N+CX45C'>-1&F83
M YVT#T9EZR6WWHO Y+<"D>7W.XQ0V?+>;+G[[+U2EF8J*%$F,@(I*F(A!L*H
M-RY8YJ)8>/ZDY7A"[I]W8:79[:)"?#[KPB-+N+!<3?![,=ZKX]&K7"GO#I3W
M\J*"R +.NL^.1"LI <D2L>5@1L@F 1,:16&H1['6E0YN<Q1K 1I01?XZ(+]L
M"3%/K8FIA#)I1#UJ/%8D1S+--G,?G4EZTTYBC9-';6NYXOK,7AK=6)MYN+VX
M1V3FWGMT5EL&+%$E?,@P@$T\A+LDZM^]J/19R(E*(T@R/! PJF3?$I$P)D!D
M2#EROW"OX'UAMAX^PTJUCYAJEZENU\P'ZT*ZI>Q*UI%3I%DJ2]7FXF:TF:&]
MS6PY(^L,9??4MU>#:Z^(O"I=*@N_TSMN5]E5G]PL.NN:B],QF2 1BGY_U!]V
MVCB00>KB.SZG6:11T8CF[IJ,%)W=XCP.RO'H^ELNQ40LGVW:Z#%63O7-#\;\
MSX/!+*3C0R)^D-PGXC*V]JGKGKC3X=8/YT._.CTR/X(7.W_]%(Q_7IC3,4,D
MU".8\%ESR\ D[P-SKAQ!E9QGU#7'E(CWI/BLN!&S2!PX%R)F ^"M]4F7"'\#
M/%#0?.MA8_5N'G+4CO\OG9Y#]G3=YF5O.!H<MSFMF[W^J)D0;VS<J"ELW+1T
MW."PE-"]G_N]%G9NA-_X:9Q[H_GS(*6YXF3?7OECIMC#MPXZX;QHD4**)&W@
MP0;(4CH>2TF8Z)/P3&5QI1I_C0SYZ732PK:!OR+G'"%)[..[?NKVPZ<U%07O
M_CZ@X?"OGGMCCU]]?,W??GPMWA[^U=G[^.++V_T_"HG#NX_8[H\OO[QZ'E!$
MO(;=_6?\[R\O_ME]_H*]ES)Z&7,BS&5'P,=$3)2* )*HR4&IY-G%U<VU4L+A
M_T12:%A)E[)#@#AI!0=%Z5:34,(>%889'*<'7NO?C$L-;C X+=&FG]NU6X))
MTW"$VD=9M;DLZO&%T'7#82<CUAM_VG1;/T4_SW_CH),&;A .3LM^09//4-.9
M0TUY6WG$!")A'B*3]#3-L(5(P92+'X^'Y5+H#T<-/K0,=)&9T\:.'G-,+.AM
M^0!QIF9;V;M%VBX_)K:VM;;5;&MZ_=4KXJ(O*)(,QN"^<TCM 'GEPM[26H77
M_CR1 *WRT2H#BX@UYFP]1V,L2%Z<B<"97G=5"/)=UE*-N[]9C/IMHF96>TV-
M=W78#8;G1GU^A&/'Z]C=>>RNCXVJ8W?]V.V7\WH;?.KDZEY/S:EF:DG=9.W<
M*^SQ)HOJSB7B:B-K(^_;R,<06]MN LTY1^X1>;<.W;UZ?WNA<8;U&9OUC$<6
MG+;;'XP^N ^IZ?;=9;ON-IW>T$"'-8I6N$W!-L,B2)E3CA:TELY*KY@RT0O%
MI&K3PEP=#S9_1*!W?!C[H\GUBSM.TY4U_-_4C;_T!W^Z;CK;A7K>&89NO^RI
M;4@40O^D_>ZO>]U7Y7G[+^GN\P_PZGGWX[O#_WS:_1@/7^V_P.OXI(N)8#[^
M5+:I3M[RUQ+;+K%=)Z_*O6_V#M\>_GZZQ]_*W?T7)WCGI[^__#X?A1!T5$HS
M3I@MF;:"%,18JTG2R?(D,K<L;^VP)Q06E2YVC>*W*C>M4M]N4T*&41:5HPZ7
M,5 %CM(@-7? LK>>QYMQTW7'ERHM/1 MS=6$=*%4A/"$*RL(,&^)X4P1%#+9
M:Z!!RTVN6U^):5.)27JI30Q<6@ 'V2?("A>U-MPF'DTEIE4DIKG4SZ!4U,8P
MHK31!!)EQ,@DB% XF=X;3X.MQ%2):27Z=@MBHA!=*$< =01@6CON7+;&*6;
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MK"/ HB+6&DVR]2I&&2&"V-JY]YGMVZ[\%2^'71GLT3&85Q*$2SDYGA 4V;!
MK>?&<\L$E:PRV%(9[/2,P53F7*5D"9/*$YP818P7AACFD_69*F_]U@XSBPIU
MKQQ6.6R5.GX;+2QD$2.H8*P'B-)''[EA3AMPSEEY/8?=Y$A>9;9%,-O>3#>+
MU&A@SA*E6!L PE!+4Y0DS35%34TJ\(L^BU?9K;+;*G7\-OD"F*'>9AP2R=&0
MH<[$(%Q&K*@<8M70ELQC,PTMZ)2T $F,<I$ =9HXG "BE0L<E;;L5*NAF<IA
ME<,>-X=%!<)D ,NU!<F"X3D(G:C+WBL=_;=R(%8.6R2'O9KI8IGQ9*/*)-&2
M%R%)2JP0BFAPECMO@M&Z^LDJ@SUZ!N,F<J&RL4JC\2*IUYGY(#-$!U;YKV1M
MJ@SV 'ZRL_2(S]XG'24J7Z6^2;8$;,C$6'!$TY2DM$+Z$% - U%)K)+8XR8Q
M-!UCE@9_>@I4@&6>H5%I(&L6&(3[Y:ZJU+88:ML]HS;FDE-2,30I:<EX@[\Y
MQSG1AG*>>&8Y+:X.1*6W2F_K36]&LRQ=CBYI $C6QLBUH*&DIL%!L55'6RZ1
MO9[I: DDU4P39VQ;>MX3'YP@EAGI&!,&H-71%E4=\\%);$&E,U>:<DH>N[G$
M ;5*YK4Q%,@MP%AT&I4HI[43RC$<"TIMXIJ9F^T_?C6G8*6D^U/2[GR F+"H
M,Z'E3JQQ):.@1#(RF1(G+5/):Q,21T9Z NK>G%2+\ZPN="$G'I)$Z (#G%67
M&( RCAG!N<M0H;LJT)WMNU&5A'72$^M*'E"O;4D@84@VUE!JE,L"K2+^1 FH
MT-U<Z.8,W/B@<158 &9+?77EG:-1LTC]5_;%JS-C6:B=B_KQ'&C2J/U')EFI
M:6F)*=M-0@H%@2+_JE!K6CX"W-)@I?&H?%$.X#Q8)JQW*LLL C>QBMR5 >],
MY!H(//-$"852R-+*0 SC@60MI8I< O-^:P>>4&LK=#<7NLP)&76"'*P![V-9
M Y)I2A.S&FW=!23/K]!=!'3G(CRTMV"3X80K;E#NI@)=AB:OT:@I\<"L;0U=
MSJNVO,'0=91Z*G#VJ3/ %?4&+5_*A ;E>+:+*!Q7H;L00W<NM(%ZT)$*2<K1
M!@+2 K$A.L*1<CUC@0)SQ=*5IHK=#<8N-]3EE"CJR1P-IV"=#HX)9[@'SI.N
MV_:K -O9MCT2*O<Z&N(0MZ@M>T>,U)8P&Z4+,0!5L9JZCP"XGB;MHP(5J(20
MD,ZE8)XGA&V"H&X8;U.%[A+0.]NK-N"RCE&BJ W%4>48<59IXJ3*AF9OG$:%
M63PQ[-X1A:M7\GVE-Z1?7,QE7TN]7\<\2=FD58I&9 NM5]Q"YB'(J%**.E3G
M^/<FG=_G=Z,C8UI[7HQTU/&!:4%05E!B'$CE599*YEJ>\A'@5I><&TQ$:82
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M,_:Z>_N?Z*M??^DBJ#XA$$]>/?\==OE?W=V/+_[9^_DB$ \Z^)S3=[_^A4]
ML.[_#F_?_'6 ;40@/H.]YQ^^O'OS^A2% /W[2_AG[TMX'S* -)D1+[E ,#)&
MT'B*A+$0J60N*)W&I(IX2O%9H<3L,L4O:>L$!4N#46CP1R&MT8EKT%M-0GH[
MPJD8#8[3ULYT(EJN?]6Z0V83,KSDYK@Y6J_4]+[=N@N] 9LS<"-ME&!3-(G9
MJ*366B7*@MI:*?5].I:W&Z4'1-F?X2#%XVYZE:=->]R0^O3>".I#4:2<C):
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M>2J$%P'AN0Q+S")40R):*-0HDG7$!,N)8PJX](SI4I]H];9Y*HX7G;N6>6/
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MN@@(; #B!!-$&IF9D]0$M;AT3178*WR@\<$L_XKAA\#PG"L@LJ"M9PR1"YY
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M:0W]UISNGIY[_TQ3Q@'M%+[N'%ZE=+9J;^-:E;CMB:"M4\)<H3!C6Z=/NOB
M(1J4<UV=MZ0FSI<KB*)@=0P*O.^"TZ.]]\GD_>6#=IW>1C>&I 3EDAI+'40;
M'7C.L@X<M)(46)N_W5 8YV\W%+^](-6IZDGG]*0/_^P]WWVO H\&1"8QBTC
M0""6BT108TV<JTAI0HU8;%].^S55BPJOD)'[Y\IEC&P\^'#F.QNF4!PC<Y;E
M>$FO QU]S3X>T\QB+.(IE[>B*\Y9NK=)K&FI5T"SYLR"# X-%$U15=%HGL1
MS01C>HHQ>QYC]!S$<,!"@=D)$MHP]6Z),?JH,?:)[>T_>X_V("L&(:',HRV2
M1)L+AQ%EDG)"Z*Q<WMKI]2]#[&K7!FI2S6C@4+,I4[$FXGP./[E?_,]7 ^@*
M>738&0XG0)I*^'DO^W'K;YPX5ON] B]4<R;.QC.]J=M!",:B%(VO/IEHA^4M
M?92OI217)Z,"4$CKDK)UNMT\B[$S?GX1Z:69<V)]>.P/R\&6.-%3(C:P_S&U
MNO-,,9Q*[;&J-Y'-\R]V9^^85RY;BKW0W9FR-U7CV^[.C\(E1;AT]4[*[GP3
MS[=KPNOWU7UOJ[[^-'42C[V%%\:\[((L2>F;;J0\A/(7OP68550%>_-K^#9J
MH6&94>,XC<)!TLQKZY/T4EBTJ+,78Y'%Z$1D+="C5M7"\R+K"W[WO8\R<V4I
MT;&DEV%!$2M1-Z2H+Z9LN(=249=O7][%OX-:>-WR7@>Q]JQ%WM=VS@?IT'5Z
M!2"7]LDF_;\&>+>"#V<* )4*X048FSQ#G3X+P76R0$'6 )G%JW:[7SZ]!Q],
MD"X1[8(@X*E"U2Y20F-@*=K,O475#L1E-S.J-5=YE;_;0KX.;<O<,]57MNQE
M;^1Z'SHEIN<9:H*CX2UXX5PTS@+..(\A$3X/G_Z"F!ZE;N=SBBCT48](>?9)
MYZS)KFWQ?@D1VL=7_]3MAT^/#C?A'VSK>\&\96CQ$$NM(I !B$7PX&_1,AH2
M3U9L-0G9Y:AL; R.T_?VHN>9"[),()H.C4-=_Q!U\=.IUC2Q^,]4Q-G4-^.Y
MGWCQOK$+_?32HC[;#$%1V>E- ]S*=LCDDQ+4)MMXVW'KSC:1VI W'*>N.QJF
MI]-??IP>$^[TVMZV-UV,;\-GSG9;MNEXQV5RC'CR_,GE[?;2A2B]\37)MPWH
M:R_3;7;MM:\]UFY+S>_TU*]?$P86WE;&M@57:])8NPUKU%:I;[:TOG$"?B4.
MNMO;BT2$Y+BMJ*9-S/"GQRA]!N5;15B."6:B7: AG/X)Z0@URO;^8GMBS] B
M;;J=G*[--WBC<1IO."]YI+XR+EL[OP[0D&O5@)\G9FK[Q[,V5/,6G;TV-<R:
MCLM<S,AT0+!M7]K5\XB'92^-ZF*Y-"IO)DPQ'HTQ6[2__X:,T?RKQ$T/SR>+
MV:P2KE>/RE5)16[3UVM/(LP?1KC!4KI[6JO:R)5NY&/(V+-?=JW0?/DT;/XU
M,YE):S/?//_433.QKUSW;WT*L)[FNZ.S\N79XOJMK*V9"VGL07KQSV1#;&.<
MFN-3?T?XW6?TW:_O#G;?_''X[N-;^O;C2[SV6F)[3W;?_/(1/Y/O]M^>O.M<
M./5W^-?'W>=_?'IW^.(?O/]P[^,?V+8_#M[M?SK!9_[S]LT>?M;M8C\.__[R
M<CZ5,U<J*)T5$8)G @$B\3%K$M$.R3Q$%[UL4TB 7:5L]$LZXUQ9:I7Z-LD[
M7%==7755-E;9^#"R<2Z3,A<F@DI & 4@ ((1#U&04NPZ:)-PAL/FRL8%F3&K
M!^B]'YYML /DZC[_/(V**WQ5ENCPA_&!IGYO>- YFD9Q?4X]5PY-]OJC<:#:
MX5$:7>]HWLQ<V[>)W #O8O9!4!W!)V5L9CZC1IU!2D$7D4_TE^O)OG685X*_
M%<'OGC-^I#39:$-<H770G!.OLB>YA%X+ZV.$DF84GMC[9SRI*?.7#./;I,S_
MOCB>V^"9W]NIR+XMLF>9]#UE,F:JB0[.$:!!$<.\(CR9("QWB@JYM6.>6"Y6
M(Y=^Q?1&B>:]M"F%,)8'WSG+R[%DRDENDK@(!#AH%,Q"$I6$TL'';'A"RTL]
MH?SRV;;-$<SW,T)6%KY71G12CT:U<C(J*D$&[9Q, #XC<BE^PJZ,Z+QXTBT>
M#\H.]\V!.MTNG^R4CTO;_I3*4:6]MFF]=.*ZKP8O_AFEWK 5RA7+-\'R3!0G
M2@-5# AEJ23SB)[X+"DQ5EOIA"^'51'+,#NE>I9_[UY6^CKNL*9PT,-W?3B]
MD\E]4_?QRA+#3>0Z\G^RW%,=L@*-O_%R4L*"M#E(J5TUN5>-#7Z?-[D#UQD2
M<!*ECP1<5,0Q_ ')),? 2AHCLL$3JA:5BGD57:J;B>+;6-QWAW$UJY>-WIDL
MMSPZ):DA+OE2^%E$1*^6A!I'*==*V9*82XO+2OF] H0J;-=>^%;+^0$1.F<Y
M>S#>9P%$9&?+.:U$C):9V,A ),6Y=G9K1_#+9QHW1[INVH;EU\SF6-(NR62L
M%0#4@Z<AT.PXH^!\CJZ:S6L%Y)FHU<XH9;(D+$5#@#%+?%")I,PEMUXHPV+)
M[407:S6OX=[V?P?]SYV8!DTOC4[Z@T_#NE]]G?SV@7KD $YUS!"ILX9S-,&8
M0FD!6H1J/*\:)[P^9SP[R205CF0O2GWH:(EE,1+A%6?E,#S:T%L[\(33R[M:
MF^,5WTP4W\9XOCN,J_&\;/3.)'JIY\ZM2P3-I;(G;00Q,5 BDC \1<6388A>
MN.SXJCO2*PO;M1&^U:Z^/7CG8X&S\=GZ0+C.J(YS8]"D=D4G-TX9FUCT&=7Q
M)UIMLNA]3!O26OH47$HL:(GFEW9<1-#1"DN=T[9:UNL%Y3DYG"D7RC,B#*4$
ME$(Y;+0BVDLG'8+<>%>.C"_:M%[##>F_IBDF?YH6!W@VS?!?=ZBOD_.:AQB!
M*>.C@YR\8UI[D;P1-@G+_ *T\VI)WYX#WLY;TL8G3JU(A"8G"$0.R $>B!7>
M6<H]UQIU<6GK)O2Z ?4V=O02D%KMZ 5A=R:_,^->4)%);K>X?*;ER#K@<HH,
M:!;"@]_:8:QN0J\1;%<+M=58OCU"Y\.W7<I)94T29YJ T&@GHUI-J,Q6"$@"
M?-S: 5TWH3?#5(X\B8!X9)8S2!$5*T6-54$RJSQ>K*;R6@%Y+G;;9&H1R23Y
M[ CH'(BG/!%-G75<I,#*,:K%F\IKN O]JM22J#O/UPEM:1D*!:T-+BGPU#@;
M*$H"EH75.5I:C>+O@O8P;Q0SSZ.QTA$M&"< 1A%+<R19998@96.T+[%C]S:*
M5]C#O9E O8U1O 2D5J-X0=B=D]1H"7%J@22@DH!Q0&R.C"@NP:+N)? +**FO
M.%51-Y=7%K:KA=IJ%-\>H7-&<1 LR\PHH;QDDPI>$BLHREEEHX)@07B4KO<_
M]K3"*'U,V\=@F90B"NL]@"\!VC'D0+7FWJ*>1:M-O%8X/IW;.K).0T@D&FH)
M."F(YS21;/#S<M(YR+2UH[?U,G:/6UCCN^2*6\?[_9'K7MHS_E9G;Y2'>X.S
M9-Z\_VO!DRN30O,*OT%-G'D_BOPP[TCPP7,3F"?)2E1P:!3$64\)Q)BH84XE
M5^+4V1-U1?JENVT!W!@J*Y[[MU+>9E#>;3PN2^"\ZHQY>/Z;J8@.+/51!N*#
M\.40;B8N14H,S0ZG--,4W3AQL+F\!7KK((5*?97Z5JGCJ\5\5WBQJJYW7ZZ;
M<VM1*TW,(1,O8R!@#2/&I4"HT>!$TJ"-WMH1[ F#>^?073/"N\TS;M.GM8#_
MXLHV5Z?8JK+ 3..1P1B7(9+(I"/ LB?6^TB$=EQ&RL'Q4BI!;O.;>,6F2W:Z
MKF!<*/F[%H(3B,K8/RZUFE>X7%UMY?);N5D'@:XKH%G"J:\);EIRN&1]Q@,_
MXS&$ZRVFF.5-0PM6KOLW-TZOZN):** WLC^5 >US<IRBX:FDEU*F&)35VE(3
MVZ@)9FO!KM750E^,-=#6'GWV/H=2JBMGHF3)LY$#+P<//*&!<A8L>"?$HBIV
MK5Z<1:6I=:*INU6SK*NNKKHJ'*MPO+%P?'TF'#D8)I,O,<$E>7.(G!A'/7$F
M)4JY]4S Y@K'C0U"O'<YRY5V1ZQ*.<M'<;*:LQQ]HB: L<"8\,* -UPJJ6W,
M(!; ^/7\UF(9_O2<^<.-LTH9HBV7!***Q&KA"8]&V1A,U*8< I%/ /0&'[W>
M3!S?)J+H^P*Y1A0M"MJ[9]#V3JJ0#2-"A43 I)*PR."R!BMXX$)RSDI!2\8O
MZVXU[<G*@GIM,%T/?]T%OS/C*P@=F:! G(B>H#F=B0T9X1PSUY"M,:$D+=)/
MQ!5YBS9'-#^FK"C2 !/&&T@T "1MM;3.H1XFDC5,M!4MF9T$NTR16X-=5A;,
MX0S,)I<I5)P$94M)R__/WG<VM95L:_\5%?>^MV:J:*9S\-RBBC$>7Y\:P &/
M#WRA.AIA!8["8/SKW]5[2Z  & 5 @GWF% 9IAT[K67FM2) #_HL",1Y+QY/G
MHFAIJ5]\690%6UJ^B-SM".C 70@R4LPQHYI3SI*/1F+LK5B&H;52NY<+!S]&
MU6XBI?446R1 - /97!FD#?4H)F\QE2(P;I?4TW*%[:K/DXQGT;KGI^-*M7YT
M\KU6K4%["DP3BF(P0+[8*!#-.="PETPXAG%TP,V9EE7IE/6AV]4BVTI[GH=$
MK[5G;9+S5DO$9.X:[;A'6C"-+!'.LF0<<V1C6RK^C/GK<_-;WEU0U"NJ,4^.
M);B;:1MQB IFJ:F7T5:J\WI1\K7J+ %4 Y4<4=@^H.0(?#99C SW(DI)%4OQ
M =I:KJ&/>SEM+5^$:3QBXK0//MK@@9-[#9H7MR1X[S&625<*],J! AY5H(UR
M <,&(BIR031E K*8YP8]!CB;C0I;7_:UK/IQK!L9SZ1 STW'E0+]Z.1[K4!C
MIQ665B)%M,CU#!.R3@ADB-<Z&,%U=!O;E%8-.=:(;M>&_5:Z]3S4>ZU;6ZV"
M=H0BJ50"B9PDI*-TR,-^"9,H%3PWFM\T5;N.9Z)=2P8;;H5WS"<.VVPHCUPK
M)@CEQAE1:=?K1<O7VC77VD<F%#*! ">V%FB9<@&"-'7 BSTW5E7].AZDM>6+
M,)5[EZSFD80@ YRUY AVGK%D%.4RZ+0$ ;W2IN<  3*J3?N@E">$H=R""4 @
M2N02YB@P2@SW(6BYG-Z6*VPL?YZ4.HLN_0BD6NG2RR+>:UU:,9NPHG!8?72(
M"^V1)E$AP0W1-&I* MO8OJ')?.6+7EFR72VJK?3E>2AT)(W6P*X2KI &7@H4
M:CPRBFL$^V,%%5AXHH&]TH4SK%:83E^2+]H$C+WD,7*<N$G8X"1BDD09R6D4
MLM*6UXN21WW1WD5C$J+6 OWZQ$!OIA8)QIAG2N(HTT-HRVOHC)Z_N^7+L(#+
M)&ARAOBD.!5>TZ2DDDXPXKF1JM*+GX;<Z:A>S "U14@6&9N+0W&GD.&:@7*<
M6%+)"Y[XQC:3"P>1K;"9^WE2ZDP^YH<GU4HO7A;Q7NO%N8F\U-(A:Y/(O6D)
MTHD()*.WWC"+*<N6;39=8[SR,:\LW:X6V5:*\3PD>JT82V8=88$CYXA%W :!
MC. <"1-$<D1(9W/QQ1M(]/GPUY?D1F8@+VEOE(A4<6VU==0)2W!@D1-&3*48
MKQ<E7RO&2;-D* /%&"@7<<4L<I8K%*60V$F5A)8;VWJ+/(87>:U:7,YJW!N4
MFR\'?E/%^1?;%&GY"[062+LRA3FK'IG+!UDV9HX0A$OG(DHB:,23Q,AH+U&B
ME #L2@V?;VQSNDG$PA5AEDY,*UYSN(+5"E;GZ,/Y\+A:68T> 6.OK49))1ZD
M%4C@Y!$7@2+CI /(54)22CE-?F/;;&*V2-6\"ETK='V9Z+I:X%JU^GP0.+VV
M\$69E)0I(HT]1IPG@5P0# 46O:!>D1!S\C;;)'3A7)'G!JJS/&.IDUX+!+G1
MP(B9(3A0HS#Q'"=G#(\"_G.11.QP96!<,R"Y-C!ZSRS/!12#%B"786J1<PIP
M!=A"(@K$MB"*=J'WL##^UK.P=?!OJ/^S/7TY_)T/5;W5+\3I[?^%RX:'?' 2
M>38MGK>[]7S!J[*1P#_Q]XMZZ)T.C^G(70.RQ->W6 <4V._=?LL("?H()[SS
M^-1&\Y@(QU<+6"[7R,_3J[ZKYW#ND>M$^PW9!*-]91L7]K*[\=O8I)KU%AI=
MP<G)EU/<_E_7^6W[IK?>><G$MI4DIJ,G1GHK.-:<A*2E](1Z+'VB&@<\^M['
M7MI1G:T6OY\#-L0,1K7Z%;S4;"&6U'K94AQ#[;]G$)_FZIP\(D?I&>2HT:D<
MI$FIZDJ",FL*?,?_/L6^^7?+?C']@[/3.CSG\O@M@!G]3 X./_"C+W^?PACI
MWMD.W]_]^N/XR^?+O<,W^-\_CL3^CZ\GU-D@*0/P(A:D("TU<M03Y'1P*CG'
M'0/PHEO3,?HU!Q(H_+(YT];/Q0:KK5_VUA_LOCM)3.M$N$<19#?@6[#D)LO#
M+,ADF:($FV+KIT/(AEM?=*:99?=92I9+G(S,A12<T PKE9(67 ( <%KLOA[N
MOJYV_Z%V_]N)9PQ$$T40HU$BKI)!.CJ.I,N'P$FJ3  >NS6=6'>U^YDA]$YC
M+8NDW5IL!6 #N]''IHN=&B.;M0S>^2<QQ4G)6[I9Z\3N>?19*&E<;M7NK#D^
M#YL8/P2?_&D,_49LISN,E7_V>_U.'#TO;TJ6=YB%L4,8SQ^-MO_VX@Z*_[[_
MX^A$*&I2#BPG*M<S\LHC'01%&%LL2"+"I0&9@WP#FD:F31(#"+W<2J<4-\YJ
MR;%+ AYDO0H:R#@"^9UG8;+3!RW[$$[1>:=]!N<"SI!M@:#4J-G;A)!\YEZW
MFR 7719])]7OW1L$D^&5+=B_6H)]+W7V\K#6NW 97-)HM"^ZKVZ5RX>BW964
M:#M?05 <",U93AQ\DI574:C(-\IZ/UT/T*KS6;N6R@N5&,2]ACWOQE?#7WX/
M]>YYPUZ^JK<*H:VX:5(%AK%<BZ];N!1A!Z$+@^</OMXJOIJP7I3?:;UEA+[U
M:[Q%;OWNSL=N:4[O]=2?!%RL1+Z!&0K3Q0-?U4$2KOLQ\?JF!O3E6(%KM3O%
M$7G5!^3LY*LVMM^URE/:+"'V]C)YTROQXKJ> ^:3JKGY2^G?JDA,VG$0'4%O
M8,PIQW'P/F%&I'1%6:8;-,5EN3.G98-L/CN\B(U_XAZ,\_2Y9+.TZ=Z/;S]
M#L!'(!L<'^[@_1\[WP^^[)\='WJQ_^4-/MC]>'K\Y?C;P>L)$]K9T8^#P[WB
M^_W=T\;>[@>VM_M&'%%X]X]O)#]O']Y_W/S __UC&#H"_^Z<<*P-8](B9B0H
MH3@Z!)IG0,)KHJSV!"=@D723\F4%CRS#EKX.'.K^4$KOD1#WO*/R5PYBCD!4
M/;QH5\@R$[*\&T66&'2BE$LD&<EQ:9PB([Q$3$2C%8?=U3YW,P&I=#9D>00
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MYE70>&.;K;S5X\61V(.R^(K$%B:Q4<Y.E"9&ZXB F@R(Y#PAS1@P9"QD5(+
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M>_\#I[:>2D:1WV[]P+.= :]FNU.87XYYBA, -?0&[\GW9BX#;X9C/SK?X@U
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MUI\.+)#E.W-@PGGQID;[8LQ&;3N=RSRSXM[R[2//RG>,K'>_FR^UM>L\%WA
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MCO#_T_;%6"3U,$:[6TZQ$V'__AED=(RM:7&0S\N#G)?S(C8:^5]_FLNA=<M
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M#+_G;[VLZ ^;>RV_<]H]FI/1N9N3G<SRO_$V9O!C.,?!6J*,SJ^('D)VO16
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M,6H.C!.9$WJ+H>QK"B6)CXP%PP+Z!FE"^E"CI;A<"!I+3FH;G=94@/?X$DD
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M0L?&V#E$?&2<:*:2S%ZF[$O*WKL9DP%JF'6Z_7L<\&J.W/PPN'H=@[T0% _
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M-$23 Q)4*'EVD1*$N$6YE*B;G:*@68FA/G"C_^/Q<)R)*FL$=7IPYE&@JUT
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M+$CFF6_(O$<7^CA?MOY]H8],9J02D).+"H*#8)6R#DWP!9(O8=(58E)]>I[
M76MASH^@?^/-E'J;"7!,]3_71E7:(6%D14NOH=2(E,AXN1NR\PBB'EY%(;S
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MHQ@(D R%CBS8R&4L#B'9M75AKNH8=V.4O(;Q[TM[NZDQO_+\*J7EABL45@C
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MAUENC/%$[9-ZLID"KA;@;P7PV[.&%HGD$$+B3%L7&.C:JA"+90F3T-X@5PW
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MT\$IIX5AI<[^!%2"A4AV?K11DJ7@M9]C#Z VA+"\G,Q3+$%9SF618(WRT>4
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M0X#:5.)YM_ SRB5=!(\N@972A9@]L:<GZM!&MO5X2\K&4S,?75&RB,1D)HL
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MC[BIQ[==Y%(O<A4<AE>/[KE;VL]*)" Z502W6CI5ZW@ 7<P*;,I*1P5H6K_
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M@JR>]4H();3P7#)E"FE%1AH6BE(L<U Z:$O'.+\1AFU&]/*RLM,15"@Z\^0
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MWFG%4'O!> 3G,2?T87Z5S6V$XX%9^1^W:1"47"#F%2$9#S%E)Y4VVJG$P>L
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MM2]P_PN>#-9^./-0!]U#-KN#YQ]^](CK_R?TZ7.7W/7<R8SX-7LN-;?*^QS
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MD4RIY!E8QYEW%EF.=( "21 ) K6[9TVUH-:"VN,&-8G6.I6C\@4@VN(U3UD
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MXN;N&;%SAKV.2:-%9,X848T$R;REK5BXD" IZT3AA-B&UL>+UB0#2% N"V&
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MS9=L'1?+;&/_W;!X0(<&:PSUG(1TB IT)G6C%(\8.":7P(>26A7]E6:!4V^
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MLE\)#FZ;_AUL^D?SOC[CG4*HAPYDDS&PM-]'H27#+$%;GS37M.E[U9IO/6+
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MXEBT(K-,&XXT006#M8CO,K+LKHJ9!W26L,8\8+WA6GKIM=)@LX]*\AQ0Q>)
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M,94X;;[>DY$O<V&83<[10-$0-IZ[F]0,;[7_;E[[K[\W&;;*?W=@"+3*?ZM
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M#P_B $_6YF;TMG)3^+=[G*!'Q/MWFLG5&/_:C _SNIY%K5P*AH5 1BD(;ED
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MY(OD8=S/57;"8- +GT-_4.'4VQ^.B8X_3\/L]O!#Z/[ S_39O81/JG4W.*@
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M6$_$F?/(@"V/@A4D@78Z6.5Y[/I:&U^/,5YKX[-HXY@9KCE52B2";/04<2/
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M&;]>\?;@$E5:\X^_<W*F\ZU,-N:T%9AJ5Q?Y(C,MM5[&T]YT )@8 >8:8TF
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M[_WX?'IXYJ]W?WR"[[V']_YJ[6Z'<W#+QVD-F4TV4<H0)C* =TXT<B)R6)]
MK0<'W:FTMJD6S$'S6KBX:G![.^!F.+4L:84U(9QA;:26UH>D H^1:#$WW7T-
M;D\#;B,J0H*C<4)KQ"1)B&L;D4W&(\F5]1I;2KC-G*TUN-7@]K;!S3+)+39.
M2ALY6'"&VL2,5T9%%0)C<W</J,'M2<!MC#XP>N.8]!'1X"3*IR21#5$C(XGR
MB5J"F0)PPZL";D\42ES.8,*'Z3J$K)L#2I?1F83Q]U8P?# K=/ ZNK/,0X.2
M7.0>6VV\Y]%K$QF-@CO!@A \RMHQ7@9XW9EPC!-WG&3*BR)M+9-"\+=%RIM@
MB A)9$841F\27]R)KW4KI"=7MA"#LY8&$BCC2C.GM?9*Q^@Q$3;%VE%;$F4;
M.6I6":&IR$<Y@@='C3)DA4C(8::#L=%;1T'9U,V68[6RO:RRN00F*)9<6 D_
MDG2*:"DL]H$FR;"H'8?E4+8QQP$G[51R!E&''2@;3\C01)$@,40&JD@8*!LE
M<WH.2]16;%6Z^QX4O"RSZI#JCF-U?X@GQ^^%]U2N\?L)\'MWW#-)BAOM!48Q
M*O!,0"R1T<*A9)),UAKJF%_;!,EX-7TCZ@8[-8 N*X NO MV#:!/ Z C;]/#
MZ@2:V6U9Q(@3*I%)"2,E S9:84$T P 5-_D&:P"M ;0&T 6W<EQTX_(:0)\$
M0,<B""X8G"P8GR$JCC@+^7 7DPACCD7PFII@UC:I?CT6Z"V=RQ9_%/8>R3CZ
MX&3<\3S_S>PR-DGQJ*>I+_,KBT8<?:_SP;^0?SU)@O0^=Y\DOM0;LIB%G;+5
M3'EX_=W'OV]A#%K^6:7+-JLSSX'?.+1WQYD]HC,C8+DZ\Q 21R:5%01 #R=N
M6; YGX2Y8R[!_F3L(GL6//SD,8!F*S>5FOQF/GJZ\GO>PX^>[L ]/QUK0ER4
M@:+$J8>-RT6D&87MAME@0J;)L+!QD=G=3^:FGN<TR(1-!/.&PSV-ED;S@+'%
MA'*#>2TRRRPR/W:.)0F*DA21C)Z"LR@ML@$\QF"3,IKIB#-K++V9F1R)3*_7
MR>># (P*=BH[FNW&UY(A(!]'SF>%!IT8)VN#NO&R97U)(5HRDTS2U*^7;1J+
M=E$EW]:(A/7;::>DKLI\I[DI5[[J#6Z@GS4AG9]A>UFX3_+&NPK\)@>WT.H/
MZ 8JTK2_K[K^-#>@G>!,RP\XS?C;&^R&F2&J_$YF_;\<(].X)TM9]#P%2J-+
MCL)O 49F@B+"<S#,;:I979<-L_#N]LEQL<-0*1#6'L,V9Q1RDD@DG-?*&O"R
MO5S;E#?=L_OSDVTT/@WI\;((KC? SS@I&O6-P.?"7H\D<))FLV3JB>V"/B=:
M?]KH-;]7IZI! $\SJ739%:!BV8%OV-'%+KN9@"?FWKAW"G79'71*J)-3(;KH
MC %+3FMB'4N&R2 2UH#UYB<YKT*Z;Q%A]W,1=M,B/-#IO_/S% SV [K+OV,W
M'PT>RC*B;T^8R?[VN^/HB2,LQVB#E8@+*I!E3B.CB'9,*$ND7]LT-X7YOP;,
M3*W.M[)#[) $ZL)VSV-_P 55L4,UN[W,&E4PE1=?LX._RV].2>1&8WO0W#MS
M@#R*E/@9FR<6PK53V OE^$MFFA)#AP0WA00.9#,3][]E3&6[V_\<4]CVI.4:
MJ>1YYE7%R'"64(K&>8NEM3RL;=[1HF@$J1-(6!AG UP+8Z2CP_:=0P[?C+,%
M#H)-^14,R),!#L+[=_HDL,3%^BY6[.A M/S7WBRQFBE06^4#3.!?I]K)!R^.
M-G+\]H2.[P+V!4&2)YF5G>4^.Y1I9)W(!ST<ITXZ1@E?VQ1L0XN;@G>920WS
MA/Z,6OTQT/4P [&FL7UQZ?IQGJ,A!)2>(1T#F(DR"Y;'$5$ M"2(E%23.WO!
MWHEI,SAKKR;,QF5AU/RI;S;)'3F3.FS:UQ_"=K,W;',]Y*,,5<_KDJ_RERDC
MI&*5O-,J'N?&^[UE84P?_6FGE9?DLJ1(!5S-'[CHA-B:9[*?BU+O=LV=N6U\
MAA4HU3\S@Y=<+ =9R-XTJ=[9X3$5B6DJ$\KN72X*P^#R"8(23=+ GYQX/$V2
M]\(:]1-ZOH*?=;3*(.EEA*M4PI$]5%+U/IJS;T9J9@6Y]OB&9@]CFKOKLF9#
MRX<QS3T_?]VJC=4LDFOO]=&1U61T;_KQ:S*ZF].RW<QQ?MB]KINQ%5;Q;#BY
M_]GP)R(J6:&JN:<(8_.%^=GOP3?*AGD<,\ISE5U.80X$=:)M\LK&LLN:NX[8
MW][A1]N?SX_.=@58WW"O0['_YPZ,]Q^^?_#^=)<>71S^V&7#[PQJ[L[.P5H_
M/=_[DN]W?KUW!L\#KQV>'7X[VCX1NU_>_3BZ@*O^\&**J,TK;+5U$F&J'.)"
M8:0--X@$(82,7#.>UC;)!E\%-J.74*[_NL<N.G=%]$+0ZO5#E<<A:6U#9-YP
MKZ@Q1CCGM3".$,KU3PY)U%"U E U.E]!L4K*!(F"T;GC@V9(JRB1I]'0P(DF
MC&6H>GINHAJG:IR:!Z<899(&'8PGF&.9=USM;=*8$APQ,S^IUJMQ:OEQ:NP8
M Z5$>L$H(HH'Q/,/YZA#!O8G+V5B(9K"I+J97*MQ:@JGWA1[VT 3&U\[V>5M
MY5;U*^B"OU%ZMM5UIC\/Q:W&_OFQ?X+>33,'JR@S_TVBB%.3*RN,0YI2 7N^
M8R:?!&!J@\Y)?;[R2%X37KT*;[;&BD=BQ<B?=<GR1#-Y./@'B,<0D?;"(VZ)
MC=(0[97/1T VS)RQMQHK7CU6K(1'66/%X[!BS*=,EC!K@T!6D8@X+#2R,E(4
M$W8N6BR%%/EH_ :^V1W^=6-%G;@MB+^;O7.4NC$VFCG5'GO]1CX)N(KN(UM
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M"%8,",;<(,4<E4DAH@Q%7 ,06$<C$I%$(Y63(7.+<;E,H=\:");5#ZJ!8+6
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ML"M&VF.,HN64V@#ZPL7#V@V0)(PRPBO".<'1: S+Y[F-21KB9;6 LMX#'[F
M,42+$T>PWV7&D&B1(U(A[8R-@H6L. ]:P-J->)X%5)(YF%*P7P0N%I AXTE$
M,0G,K0.#GSW,B%'2$4>UU)Z"$L=D+/QKJ%-!@(8+7EFAM08^<@$-,]C20%#
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M#:&-WON#>CRC2H! %D"R^M/9N'697C^/-PVBGU8R6,O2<+\7OQ[#4\%$WT@
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M[W_TMP]?T__Y]OKKSJO=3Y%&Q@GUB/(@$,]=J8U-&&F3C'0!!U*J7]GYL_5
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M=O)SV<::6&%[$P/T[&?1_9*MF$7FHR^HV:]2)XY;F>VM\+^MTC&S@O53;.>
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M1VS>R"^U>:F:1^"KC9M'+AE&NF0O+3NI9.E2& $ 1K8I2FNL3G7<\"M<9WL
M &J10!8+8FP%1]SMO2U0Y827CAL941K4:EH^]!5L>PF--6HITEDE(N;V>I:6
M&^.O2>MO4WJ%<]^;R.W50N"OZ;#:=(.JNT_9YD#>NWKEHJL^;?4.X%*KL2UN
ML99L?6\HWS%M;";CD;!]?>NS&>5]WVJG:OG;8H:EM7F7070I0<_*=K>$JDF0
M6X&M J@?/9YYE._,9*=OVXXV)?9E';8:]MW@7&6A77N?2@7"IS:GA,V 7 .=
M"]^"::F$1,OAQ'CG-(( 5^ ;==GPH-OIALZ_&&3P0('^$UC&O!:,1#MR\@-T
M[:)L+K=3HWWZ@-W'8GF/*FEK&>QA%0N,P>UVU55FEG$VM#%[#6#?CF1UR[!^
M$;/J=!I5Q)H*;9>![^%;[_ALCR?<_'[O]52"&=1[^=5M;2UEZW(.#R( O>V(
MZT5YK^UC;"MJC7JWE##^?%,50/=GV%CM>[)EF_TE;92<F] V'G1MKM!6;EH0
MWF V4#,#J'8W;64/O:M<'S7R&H.IL$E!6^$)F8^&UDY*6W/39"?8-A8O"M]@
MS=/:BZ-_+8\>5]B;#1:OLB3@4PO44XS<>I//9R28I?4A2ZV@-H]QZ@1&@D$-
MM0>S,G;\T %AU'MQ;[> ZJVR>R"6Y;.LREFP26TWRCJ8*>GQOMO<)AOX&,>,
M=Z,^M6748(HS.07VY!ZTHE]7HV$V3@V75+!)F0%=N'8V7)MM3KCVRJ\LC>5>
M&YN='SB4I4QFG!N)WV,Y3[C2(@VS"&2NCMF/C.6VFF',C]=>Q0MFW1M-"F\=
MFZH<'?U&;/X^!FVFJM^KY8UMG"Q--5[/,AH;PX)_M.YKW81@#+2B7&6_/>S5
MRJPE3650)P.S:=1[4ZA1;=I8O\N_B_$)0/=5.<"638Y'S$HU'_,JE]O8-6\#
M@\/GT*/_!-A';2]8#M+TV:RDF)T^V6:(R-CJC9IA>C.%FX[=M>8 S^:2G(Y@
M.\;&=>K433>,EG.^"@EZE<V%"^LGS_;M;)MSWU,D.;.76R 3K]($WTY&ZK/K
ME0ABTW:3W?P7VMG[#?M(#'TE?;M[#>\W?>9F1D*TN[VUX(5I5;:KI.TY5V<2
M6W)SE25(BE53NE9;C&4AUFL:A#8M06V'?-\MU-%DZ\YUO8KO1&E;.<_VI+-M
M<YQ?H)KTA =8@:"9B^'F([J.HI7%6PU1Q(P/'^VKTSY:74"L*5M[9FHUU<Z$
M:'7*J5L5STZ0;@<A5^C0?QX_;P9<XB"*RDL$^VXC[E71OK_>;4>KI6:KWT?C
MW,F+<0E$9X^N[@,AT/K<K*SZYSY@>E# \WJ_HQ?C=_RX%:JQ+0)QF'DEEYJ/
MWACT EH6=3P&DV(SFE<Y.@>+VP^N+#=LS_>'8OQ93'[D5CWM5[.XG!=1%R5"
MJXHT JAL8]TYQV,=C;\I4_%#3*LB!0#&66D&M@?[%A<J[$]/IK[4YJTYGU3)
MZ5:YNQCU7KYY]79_+A^VQ<AOT)UF5M%R)IN:3NI-:^HT^[U],QF*:@Z18U1+
MCL=\!5Z,L@-G9K0;1/_2BDG#T^S=:M:(YVZ&9=.IX%@,\,8'8BA<>U,WD1WD
MM7FV82![([0:8*]EK'6UKV7K7#>!0VW61G65]#,K^MWFMFP<S:Q#.[N-VH4^
M 76*RDNAIY@F!3)B:E4YE_9S(DX<+P.;YK20A6M5"*]9<;R9ACBML;D5_W/;
M2X/PR>>GO==@(LX5F/HY3SY2?@F[#A9"W<VXK@F*^];%9E?54L#[7@FW@L7-
ML+<>T?D2@^]2#X]M/I%GT;ZY5[OIFX\_U7KJ?.G!V>B+6X*7NC[(YHH)7>2@
M=;?EYL.206<M9T*=?5#E2'F_HIO')5R-HI-3.+T3-+DPH$_D4YN4LCB'W7FW
MT0,'*]P"*7V5I>D2K=U4/W'M),X? ?@MV."%^B!+@*+G^BS6X^<7!_TL-J"_
M8JI;,<2P:L5S6E,/9Z(M_I;7N5#FG,@81^BWTLG16>,3YNN*3O3&53']V1F6
M35)W[:YO-U/SG=VOVH2V&WQF=$SMLT)?UWB&C4JAL1 "M;XJX<'%W'-CK6([
M1VI0Y9#UJQN=UXVG^NUZ<+B_NXO?;:Q=GT_+K=/=%W/=T7EY@A2%F:3CS\:E
MJ14EQB:G.&4/2S9\)L?-:S:6%&GT:Q=<KZX?F8RGMH']? ''M'1SKAJV3ERZ
MB+_2\V,_B])["NO;UXD13^WL8M4X$YO.?G:$.YQ_OR[#K-H9X'+@99HEE/9$
M6G2!6CJ<#"K5$S?OLM5_V^?)UHN8-E/!^E73_6:R6]]V;;#IN%-'7?! @-Y@
MMK,8CM(<N43F5AG(W*21E63J7L@Z;.HROV6S0+'RHN6]:@;OWK14O2Z3]UTC
MYR<Q;@5'W,=DLJ69RKZDHC4PJX7^FNCZK6&P@\O&:=RDZ\PU"FS2X=NWLS-S
M\'$KTC^J_CYXK+]5=5"EL8/# +26HUF7 'ZAQ:>!,B:VT$9BSE$Y5<A3\ND
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M4/Z?G5>'O^_TG+\6;@;LJC3JV7!Z=H$EZF8XCZM#6PY^E!]5)H(_ZG*G!Q2
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MPV?%!!ZF9GA%ML1_ZM8*BOIH;!G#LRF >>P</:^&#LMG3K=<W<OX1COA0/O
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M O93N0&="$?EP]9+#*MJZUYQU_F#V#K-\R77>'CH'08U";4T];JL'#4_4$7
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MC?T=A-E@[]DA%GAHCT& 8S(;>^Y:7#_$/T!M^@OTX+DOGOFZBZ56CV*IFY6
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MA[3.#+)F8=>E8:0HE"4VM\T6R[YLW8$)>,>&O9& PA.^.0G $H"0@.=/US-
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MJ43*@\J3&\N ^/WLBZC-_/LB!&;ZYFV1K8&N-I>1GK8U\LRW1E8 G"<PGCO
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MMP^1E6KEB>^=P_-]FNWXQIB-+]0S7?E7J/UG"UTWT"> W./]-H@[0A H_=#
M"(*)),<B&GE#X:@5]4VD1X= \QO> I/]/JNW<&8#'6UI_VE;4(:'?7N @PK2
M%1N"F2,;17.4,_K!L:,+3O 3E-<&ONX3'KGOH8\;;UF,B:]+*R^=T U>JAJC
MXQE$H"US;%KL%N!3EWT*07*?'#* 7=EB^L9J4]S&-Y:UAK2E<[S^.U7>OZJ
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MN?]]<@<S\G_#R>OH?_\?4$L#!!0    ( /@U4%)09H4-T"<  +O@ 0 0
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M:,]<1F8T] F+/_]S"<.@#^8ZJ4+)/>UM>*^]S.8_'<&HTP"8JKAU#!0:[ME
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MDY+^C?JIO4W=@PB:N]ZK6$^@7V6FG&P%7N'I/*HW!>LS:*GR,>+^CNQM+Q1
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MWBG=Q*#]RWCP;G!62?-E$FU>1VI[*H\(=[3<NRQY?61N%+O\$NL5;$)!PO-
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MUXK9GG3E=5$-?M#WQ]81VNY;/I,F5:.4VHJU1M#26?>[BX],,%\\D.5?>EZ
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M]:V_Q5,,$MH6]5!<B.JMWH@RF*I*#C^OM[\>06=C;T;F[F]_^?]02P,$%
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M!0S-+/]?9[/\QW@R&6%$+*(@A*0LJ*(5?>4C:%Y"X9P7:[IX_U<$#*GYT4#
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M9"LWPY6<2]9]7*]F' S)81L47MOJ_C30K41?TO\1I_?(5^B3\SJ"]KYFS[%
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M<E2%O?Y<"TH6X^DOM5VV/(G2MJ7AR(K;2S1'5=Z&%-*5HW'YLV.H;WLJCJS
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M@:[6ZE]6$CW_EF#S_VYR*["7G087)!MC][XOVAZC];21;H<V*#3H/'=HM-:
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M11^J*.*X>/H7/@C4RGRKEV)(S[1?XHU&.3#&?#;$:T:+%T5EK=1HB/11.1'
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M?PKC0O >,:Y[^OZ8+Y]%$F1_,9KUB/CVLWO%.SGWPSX%?.O1/:!M'T3.X3Q
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M:*9&KX@[LXTL9TSJ@&/GK@W2#,2%C'Z9X]QH9ZBEE<I#/OR$S5W,E_ZE7N$
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M%7JJOX0O#<3AO-U;:=(51>*$0\8%$JPE7BE?[&FC8XS.F"KA+-=!/#6.[*R
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MIA[W%XX#%4H2SPP0:I7-+$N&1*MA*7? ]G2,J%H*N\VIO5O+;(18 "[O4SI
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MCY[#Q3LBA1@UX\$17"<5D5)(8KV@Z(QD4,KFJ%1O<>3'9,P=&0(/@3#;J.'
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MI05.%Q%E,< I)[Z4RLS14AZ#L"Q7*32^#LS3L2UZ4\F:56?O*MZKH)8=4CK
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M$(0X!Q:XHR8P8K,4:$;*7.K^4.*S2E8K61)(:\RG-5A.A#!]2;N"-[<8WW3
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M:S*A'91\CT"<RY8XKY,!$2Q E:#S1QB M\OFWZ?X*YR1]'JEV&4L?P7@[1*
MMQ5+:H8T[:+B!Q^ IX11RDB2++KWTN$2[9D& LIXPSA+0M*G2=<= _ >#%NW
MT6P%EO[^\9?)5VC&K6#.T"ZX=:JY, VR<A$EXXE'<Y/( );85$(F@E ,;<R8
M4I62SUT!/O90EVUH,#F #BN8=[]__#A#H[/(Z_VD5."/?O3Q(J3AUV&9RTN4
M/E#%N3<D2!5Q:K)$?***1&FY%(YEVLFUVX%I7> ]:9[UKK\:Z6*3\U(A-;Z8
M-.CS(-ZU4T&H*,'@P''(IH#TZ.E(22)ZSBQ9E="OJG(LW07=$^98_]JKX)&@
MQP7#L_'=&+-DD&QB)/#<=M(I':!\(M0)2YW5RH4JT6)=P#UA@O6NNPH7N=WC
MZ5-DI?@QQ8D0$&C*@@1M,TX$3A4-T499)>_UR61%[,&T.EJL<(W;.:*>RF@8
MLY)D''@Y7,*=70H@/B!.K5*BH4HLU%/)BMB#;%5T>)MK.S>TZA26'TT2QGI-
M,J6>2*\Y"89%XIVR)L2HI5DYYWV261$[T*1W\=^FAMY_UTL Y^44^WVSZ(K\
M<3:)_UI6YU)):L!5D3N>$)VEQ*6V#+$5.B>739U@X;MA/4$N5=#7;3:9@^;8
MA.^_^EGY^GN%;)O;#Z^:=W//6%;+;P7FC?8Z9ZMDANCQ[X1_*2Z<]#)NSL"Y
M_9Z#5N,RD9<S*R06Q6U,1627S4!"R0UC#$GMJAQ''K0:U]V!IPOQXW<?<048
MP:4ZT*NYD2_R_/]G[TV;Y+AQ=>%?A CNRT=9'L]QA,?RE3WOB?NI R1!J>^T
MNG2JNC6C\^M?L'I5]999E<RJ7F)B;+4D9P)XGB0!$@NNCE?O$G_[F,^.<C9&
MVBK!J,C.ID?1NA%'\*XFF[4(B+,474RAS*$GA(YAZ;BLXQG G[53V)7\+=$U
MM\R$MKO=T>R_C\\^'Y]^.*7_2[B\4Q.5I W6VP"D)8$QS= R*U <M,L:8I2;
M9WI;U*--(.C\K-T_EP97NLU-A ZMF'=5[ET]HR7K]M?GY>+\T^=?CK^MU5S=
MT5,+4XMCDV/ -0(1DDMM?BU%;Y5)*N:9"#]4YC?N'R8])A[M,86>V/1LVETJ
M^A>=WJ^GJI2,+ @Z6M:SY@C16 -HK27O;4TUS?09#)7Y[3,X3'I,>)@_H*C[
M4?VNK=#TE.)^W:I0QM6 8"O'UX9#-FB-]MKQ,5FC/%HY) VVMYQO=#\<&DQX
M@?"X;JM;GW+SUQ;G9T]8>[UI)6.3M9DCR,HA$QK7<K(,:(U5V^#-G4%^(QF]
ME5AO!-X;R!-?0HSLLQ&-+UI& H^%+4;20<B%?2A=756!C,F[=Z=^8]LNK5#&
M0-3AVF('TUT9JE2G"%LSEYIY^7960,!80"5>NR5_*1J[C!;87?2W [C)@)VA
M \I#&OQPFG(S5D"JJG24%FP;7F=2*! U?UTI"_15DJR;-5;STO)^L9_5XKD5
M4;;DZ00H[Y&C#YUZW"A28BZ8HP"2&%M3OP+8AKJ5$&,.084@NUP)3:;!&W-G
MP7[V-CX;BMQS9G&CB)7"BLKN4D;!7Z.U!%B:9ZRLLU6+6'R70I_)-'@C\2S8
M=\@Z':7(/=([WD:HF#8]KWG[,34W/ ,:'UQ01:D^4S)V$_N-KOU0[I"J.L;7
MN?<HXD83EV,(F0AL#&UH5F9-JI)@O9)>RU1CGQ;?TZGPQMUYT)_P!&IT2SG$
M6'5% \[IEI/9S.5,AB""3S4'+6@/_L ^^_X=- >W1*[#L=209A$A%9V+21"K
M;\TOK6:'P[9Y)*&R[,X7LX?>?P?<FVV7XZ2I =EW;[:G*NP],O%=38#DVZ1>
M0Q!39I<VQ"(2NPFIODU-VP+V@4U;QIC_T+M?#-'EK6G+-DU;1K&D9QN,;2 ^
M>-I222'(TH:(\VX1:V0WPQ$([86Q)DJ=NZR AT_7+9NV' Y;1R"[UZEIE)UR
M0@:0[*"TNU$/Z&R!+'S4QBMM0NE!P==2'SR*"%O7!X]!<9]3TXK)654VA*XM
MY+$Z0:HE-_=8A)*23=BEY<$KJ0_>A6Q=,)Q[:AI[R;;8W);^Q'%[M@D"(4&V
MOGH4 GW>N.%[C?7!V]!D<O///S7MQPD??RQ6ZZ=/4L_Y^*,GKN8<H<?F-#63
MH_?9I."#J<D@V8I%Z*JBK];YH\%OF;.2$UU1RE0#0;1!X45DWMR49#!BH.**
M57U:F.RMDG/UPRM^/;T?BM7_.>??/,.SXV_T\_&JG>B<+^GW\_8E?JC7?^OZ
M3).)6Z.V!#[G=26W!=3: &6FA0_!5^H^IZB+9H>>8C:&OX\=)N^?%AU<Q\=/
MO]XOV/L]/5^</[ <_4:KU5^?\52J?_#?_+RZH^:1%TGPFN> 2"DPB!Z"=@:B
MBEI*YZSM<XG76:_]WJH< !-'G9W/2Z,>+0MW4N]*K0_+WQ:GGVAY5[W6TS8)
MA9!C-&!850BN!9$F"XF>H\K-.M%#^$J>U.OM*SE<&G5(LGM<O?N5NJN$M,[Q
MIQ[ B=24*!%2R;Q=FZA0*)EX,Y__6Q@H_1OC]TV)60M$[U?@.HGE)I\AZ4PB
M6Z!J6CE5K+QSY0)5HO:JM$GWNQ<I#13F);KK^T'JX!R-33_JJ%A9M:@.LG;-
M;7()@F];@S71EN"EKNKP_(I-->9C[)YXU-69'D6"@Z/TIM-S9&-&)UJW\A01
M#'$0D$A*_K$:%X2F6KKDVTVKQANE9R/!@3BZ1U&CB,JX]O&UL:&">(<C!XJ<
MKEIE=F7V,&?U?F'?Z#DQH+-6@SSU.=T:O=Y^^]J"!EOG89=!^>;HDTV BG^4
MIF(D$QR5+M["Y)J\1!?W,&"??3$=Z^UL*'F4R2JDTHH'++L\)#P$XST(Y&U"
M1!*FSURNKEH=4D[_+*SKZB#O0IF#]Y<WE1,Z^9!(02HR@C&:=\EUII+QR68,
MRO29$M95J[?OX5 H<R#.]J8*3NH0A'<@5!2\X6;DCSLKT*1(!F$E^2YY;Q/(
M_L;M>>'OX*D/J3#Q+E K1^-/R[>L/A8VV$K@A4<7M2.5]^"G''"EURX^]-2
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MVHU>CXHX]ZU.+XX,H>!T6$V<U_&P.X9?Z$K()O)5*LH 4:=.^!DIX_QI0'/
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M&[C/#T"M'D%V@-6R6?(&7,?IE3P <]MTX0"QCZ@5CL#)4EA-""F@"O,UV=^
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MR87+.H'Y>W(*,93%LB*WU-%P#38762M$&:B]N@&=$T8*5PJ.5%)_OPF\Z.1
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M@ J3:-=+=IPYOBRK0Y?5D?3M&"$MVZ;Z($+AT=D&[;FO':"*J6'GGFEPY$.
MT;PP+PLR=1P+>]!IOBRPU@NLG=8=XUIRVVP[[IP>G:_+6<J@2RVTFNJ>4@.
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MM-!&&8CH#0"_Z?^:$^?^ H*Z1F=U-/\PFOW[T?@%$(YF%TGY$6T8*X@M[=5
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M[M3O_OVTBP!I5@J@7X]*C>MH?C=]X@SAUN2D<D'X1*+T2$-9&K:I4OD$6J7
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M771XFC4Y,K;@&3X>44-=SVY#3Y?U5I-A2VOU^S\N/P2TDO[7__C_4$L#!!0
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ME,2[N73<LHKH-'DK!(+\J&YD(= P2V8BR1=E)Q+Z*ZD)?Z."^GUFWT5VS\<
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MJ+;MQ@F&P"RSWYJ^#"EVCNK^].1 F>&;#(<C@3+]JF&KKLVHHRR 1PF8(9_
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M"C12Y)U+<3VV-7\Q>UC4_W"<.NG6P]R+)V^?F3;WA:RE@J*7C/'HG_ F:77
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M3DN#Q:0O'YJ\2;WR8ZFGR('=FZ53LBD?XO.VLUU]?FMMI^DNN$Z#]9<P=.8
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MA&H*;G?,6W5#.TAU.QQ8P)!7*@(+)]OA075SNOCD3[?53TJ'JA;""QC9F@7
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MVG>'/VBDM&:].LVAEM(G./ H;??I PT/PY]#J5JX$( .Q;3I_^P)<_HS2EF
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MZVPI@-*"/"#(;(.B8SFNM3\^;<L_J>A%B%X/5GZ].8 8%5WRO"@H@/AH-[+
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M_ET?H-I'ALY%#J"^!K5FL9*?YAL".K/5VF?D212M.%S03M*R&$,E:=:N4?I
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M3^HQ,@_D 41 V)EF.]J+85QBU',EH8%LY1K_UKN?6@_Q2;!MV9A*G&9SDR;
M-BW4(,5:.C&(_^%Q;JM@292,=!A>"4)B)4,^76[(_OKP$N7NVT*O2YV "(?:
MO8E7 6$(CB9E\@QUG-(34:UIZY0Y.MEV!U7QIM!OT';W 2MKS\D48[M[DYG
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MZ*K@P1>.] ,N!I.6*&6,RL1]Z?W3EBKINPVF#2LO\,GYZMTNF3HT'<863\9
M.3CM$$J*@HVFAS[S12N-!HEP^Z;,MW 8[Z<D/2OI(;H<V69&GI^_K1-_U5G7
M,2%'-N&BV65U]K': 1-%?RCWMP,-:"<6%14HF,0?#*N>SNEM3V^C=I-8@!#R
MX'Q#68IW<F^V4GV=IX=$462*]"?QY3.OK7;+(=C@WK;W857PB!64)#FXO:]@
M<D&_9*NL*C3XKNX7:FGAJ:.9U+45XG1H<73KI[UE?9'G7Y\_;7#G/UZ6"9!%
MZ,_%H524JN2+V-(N_J313H<JI]V<%!; B,ET8";X 1M6ZKEA_']-?91D>KPT
M?KUU]/&?&P8^[%^SH>H>A"_&L8"=9\_I!],C""R@3(,>^4]NC/N++.N*/?P>
M"_@LJL5 ][& 9Y#'_"?W;LG\$K5&NSS&,:]7(95TL\,<=/G'"]N?9&^43D_:
MP*]_D?ZN^Q>Q\,,_SQ-3E04\:(%</Z* !1R%AOOK/_P=Z'D1L9""#F/AP>=C
M*%>2AM">;JWUNLS$B:-B=UU?<WS/$?CA<!\Y0SZ='#ZTD!+B3>B.)\%C]3N]
MD4Z@EED*2?W--[=; C((^S.MY^'+6J!Z<+?M)H_/4S'0/-]Z$+EI5E.LOG1L
MGV;/]L=71%O7<T10PS5&>N85Z6='UGDU_9^Y#EVX\%94&6'OM8-M'2=+P?[\
M=HZ;9&;)M!39OJ807+W0MO8C@-T75V3U^7I'P4H#"Z@#SPOI,?DVR'.=>@-(
M?+56)UP*=7)8V7^A165486\NQK'4?4\A?%PU6G>I18@L<J]%85XC!^1IFW"+
MO]RL&5C,NSS;7\0+J$U]-U'<A=[!G,'()/4#=!AYM<-FGYOT.4KV9@M^-^-'
M;<271!8PGJX\G2V])!LP.V\/*?8S\#MD1#$WI(1V/5:='PHLH3E/BB;=A17X
M;7'' 5^9"BA%\#PYV9;9"WJ2OYM_>+:'$SM>RR?>F[1"N'ISI3-S_O\;E9=P
MF$/0)2?/@O4$:%74EAR*0 =J)*4F/9KN0ADU.NA*-GI1F+9E.FPW^3SF<I+,
MP-S.D2SQII>"T3ZG)0"1 2N-+S!0L[\;EXROZJ&+:Y <ND7&VX+NCP6&ADH/
M!S3IYRSHHY/&1N>+7)U3A-_D5?E^\NQ9*?><[>T+D6JF'"<H-L_:CEOW(,@6
MMK$.F5\K9OMC1J45-6L'Z':AA>:%()]2AFYC\PV-C.>=Y76/8HT^2&O<KM7U
M[U-Z(#+8H$& R:'<AEG 52RH:1Z#)V#UOS86M9&+"8CVR8!M(9,F@S66)3VQ
MAN9%NHU.'7?(^DVU#YSZOI;(AQN^DQUIW^%J^U&:&D'!M./ W74]_:"J6KSA
MV2*DFR(Y*C8?G"-*CM85]MX.]<AUZ^%W\ZVT/:B3TA%P^T )UWCVI51W_\*X
M'%C0'YW/?Y?.IT8ZF$JI(DJW+<*61>)@HC_N"O&OG!C6>JCR %.A&(P?.)HC
MG!NWN8Z_.HF/2;C" CSQXW-=TT9[KTM5Z>*H]H]N=Z.';K 9OYHXO&K) OA[
MJ&M@QW>Z)3C[C*X_I$J;, _[\?UFR%D:+O@(8Y(%U"B:UP"AMHE,93H<],U7
MN$F")5:7"G_@B$^T9QZ6K/@8H'R=*FLXECB#:3-!B9.*ZW4"QCN(WO%HU>F\
M1WIRBH^H6ZBK!I9!A\\?Q9+X.Z9K4*(T-G3?4\D1\UBZ#3$>+X>\_-4UH$<_
M8N'FZSN?2[ -[V^_/DD;JW1R'/=->SB_%?2;/?G8O4OAO.U*ZM^ [6PFBAP,
M**IQ"8 ][YLA!\6/VC68OXC,<V$!R(5[MN=]+RM)&D7LXEUTH.NQ $X0E,@L
M0:N#=<$XNOGH@SF:>8]<9[I?P2M',R6!;R6E8=IN\Z; V0\H R(TUOQU'[3T
MAY(?D^IF.ZO*:RPN)=S9LP- LY?9F0(2?T626;.P32DMS.*]TCU_]G ?N/I^
MU_/"P-5-GC86<,%ADS_S/V<"?Y->9%P2]CBPC\"F\=1$C>/[#N8Y8.'G#3J4
M6(1#ZO!F&=TZ0[T!H_DBGHU XE<[T,57J8Z,8K0*>)PTUV/+%Q)_?HS.\;*L
M@##9"(O)_)JEF!IR2*3ZN-#C)>V]3TRY:L7,CK[V>" ,9_)_H2%"AJAJC)CU
M_GB$T \-^?YM"W=&'Q-+Q68=:[\',@[-GFV.ZPNX.J2,VA]K_4B%YV*,A; %
M&$#"+XF2\.".@F5E\BSU#<397;#W= -XG:+<\U2!;-Z#C;Q3K&Q>W(^YH>D^
MNC=%]USX=9WW)-['8GKI5ZS*#Y[ O\1*H 50>\%)<M9Y4):":;-'[R(_K7^A
M '<8""H?T_[4%K9_Z7/5_AW[4PTZU*^UA>FV@7I421!&=/7N<.Z&XF5'5T2;
M@_5-0B]\>\@H"W"H&_!V?&=I:#?UMMUI0/;Q/K7O7@D'KSP,/F1B;,1(;5(H
MI(NS@(ATC)^"5I==TVY**&$UJLF)R.=%<'7^J%J;%?CRSD'5UBN%G_<-WO5A
MI!E*OZ1#%AB1!?=-3FZ0$-D521"YQX21C?/OY&W8%"'DA2Q.R.?IF_M-AM$:
MPZZ(:2S/),,KD]MF)M0<R:OQ](""!7OC7>3[WWN)MM(@T@EK,Q*8:HB^,"_9
MUZ@ADW]R[X.6;UB_M&-V%H,@'TT?M8.108?=). B6J3\C6?L1KQ'@K(F&^=Q
M6C7^QVX(CM6E!PM__W3!F'O>\]:5/67'7H:Q30Z82K"1G/\+^[E;F4U:K?"U
M![8P%O Q-A_SK3M'Y,+?[;;6_G1=?[M-6WPI#OC[;=K_,N!+8U5R6H9'SB?7
MCNN!SH=CV58<DSL=;)Q:M%G PTL;S%=R0)$GH7F/R^%\9-:[:JM3^[(4]B!^
M&:!4\Y>@]/^S,/]3@._(N,C Y>.G4GP+ZCDOO,Y1[5!O]5M8_,NP#?R[2O<O
M#?RBB=(HL"1E%7,_G;M\:Z#RX;7)2LL%I.TOO9Y*R#*F-YA-N4RO6G6.O]L%
M^I@;IOUW^T>E<7\@_S.RZF]/?O&ON>$?:O]? L3=PQ I$^8,>9M5YG9N%O!Y
M#T,,U]H T*[.,04$"FQT#IC3]*8*$]>(3;?>.7KDP#TVT35PNK$!-'J>+S1$
M1]@,/1(A/& "*V8!Y7/+#L_1XWCR(TQ7?3-YAJZ,N<0",C)PQ@/4Y&K,D$RM
M_YK1]\;:(QLSO_+0AP=5DZ':U:=4A"G>#*/> 5WSD.G.84/&GXJ16_CQ99UF
M+'*MMQO?E(7>(/(J]QY9T%A,I6DP!["2+""49HX>U:^^E8(I(<]T-%[/GV3[
M)$>(V/OZK@Q'T@^VCW1[L(MV""4:V]\%2Y"Z<^YU8V+\0J+J@&(N[X8%A@NG
MRP*B4BES72(_,./QU(N4M'K.W\Q)<,EIC,?\1_C:@&#&[?2/7+H+&'[\9=AX
M(Z&I^"Y!Z_[$!8>%27P-+D\O.))6EZWM?<96S9=CHGE7F#&RDO'SFVAA<8+[
MC/680]$=]F<P)1^,Y5HIVT0":D^=#)L-/_30-2 ,?U%K'$-D$$;]#3F#;,[5
M;NHFHN=Q5UU9 +[A0F1 D(!;ORG@H74O\/+I6"/"Z?U PQ4VZ[]XX5$!W?][
MO4X7B=/<?[?7^2^('/>,XYWP_7+.5-;[5BO'<"8PMU[*T^ZV??"J[J=@YZ>#
M[P>5-?O>;;PKDA-^G@DVSHXM:Y>$+';YBG1\LF(!M@.!BV%4TS+Y=_5!AE:$
MISRYMWA^2^WJG^BG/J:(=&'%; G-VKO*/^A,IIE6WXQN>'C*<%Q[$AYT1[CY
M3L@(<+>"ID7W)F.Z&3(^SB-35+1*5;R>??RMM^GJ\"\EQXV,'%XR]B/'?K4D
MO&ZU0J@CN;O"GR0BLG!FPFW"2J6V_E[Y0/D*O./9=CG:'!4!CA?1KX&W=!DW
MCZ8-4@<159].*2D)%'"DQ[" ;]9TM60K8 G^K^6FV9,>YSCYK!FF5;[O&N/I
M>U+.\%N7.,UF^COQ9#/'&F:ZDH70;_ 2AN9D*3Y5RBB6O.I23[Y@YW+[W5;U
M+7'=)Z+?OXH?3A:8*;@#XIE\<V0.*C\C2D<D_N8,<W@4NZT%!FZT*LI0O).@
M<O@\Q36?@8_9MW)YE-#P*LVI O9H'BFZEG7]P@-K<40PRA?$YJ/$P".D_H2M
ME8R@4 \B3'!FT2'MULZ3W[N05[\W78_:$>"9<"^%V^*-)+A.\?M.%67D,I5Z
M*?VD8+I<-NW$@IO2\!S-?R4'*W2F9[GJR-3@U'&NS[Y[$TXYOHU\DMJHD@EL
MC3&%0,8+0U?::70_3++IO&<A4C^Y_9/R;'],=?\]Y]H63V1LDWJR^$0[3OO
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M*&Z"E]"QPFC9D([.?/S(E*-/@$+]Q@'+.I^-+A@YBSG"5)_MP'/_@(F8S=S
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M]&?T;,(DD6VORM: F_3A(@Q%.3 6I?^P QA?6:OPSWDA\31(6(6\<F M^P'
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MK>!)E S^OVXZRMK8H;2:\%'7,1!(.EZVPR]02<0J\?V;\C@&,41'B@X]9^%
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M+-25LPH_+2D4>CA0=6Z1##(XQ942;J\F.&G43<%W3^!BYBCC2H1I0=8Z=Y2
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MK[&B-P$ZO_*:9$!OJ"(_U.'OXR+XG*M)0A.[=,:8-T*]O4LF1M_6[6@>ZTH
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M/)D6_]G'JQ'QV7=.^V5C0U7V_!!E9H!ZM/OVOB,)\6TW%?8*'3>6<^Z 4"Y
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M&C(A@JYZ3LM?7SM)+%M$=H%LR(KD;-""J>[OGIRX*]CI_MY[2&V 2;_.T*%
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MNOZ.;K["TIUD';JQ51F;<0DWKEU1QOBUUW2[4[RI"!S\P:.AK8U[Y6RZE4"
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M7:8Z1*_;U6;U8D% 1KNI84U4# YC?SZT</#@3_^##8U\5> GI]=?+)#"30N
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M$XH45<[O9%H<V[5^1[>#61#&K7%3+N1M9E6@FU",)\_DM0!?^RB+"6TRE5;
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M'*8:V54#](4*08;59,!-?<V]I"\Z]=#KD8M>\7GJ%A9<(OKCYA%\L)^<M(=
M/264V+L:0L*FH-1P3>-(Z0) S>,\].3$4B+Y?/T^>*216[R\S]$!9$U*6GWU
M^P;%[#'F&YPO%H3Z!*UV2(%<QR74W<0+I3*.W"OPS(S;RB3YO;>9<%OO%UU-
MNS="OHC'J4,6, 1I4QW66*X A9LA/$RF/0W9 ?%*KE92%39;=8;U[">W\)"X
M\H.F<G5[.V&E]=_Q5=I&"Q^?I25<>BCDSBP.A..;6;PGV%G=+JID2HLH5;W7
M\R#0OB<B?YB\(053./QNJJ+F*5QK 7,^>V"^7_54;6)(7GRY^"E_W<\EE;@R
M5!^Z"KK6R;Y^EFK0C044X6M6Y$_&OD$+)>W$'9 TX$OZ4J%54/358AI+A[BD
M?EFI[S<B*DKR*,7W?SE]+D9EG8 W(G-W0B)Q>Z]-L73,82IQFSAA?U.9=[:;
M)V^Y.>*B[)//*OXZ>]KVD8!L2OY2(J/L=R57=O8@&0!9>(:2HA8RQ$-9/)O4
M0D?@  G'Z7\/-J]!$7\\OP/:^VU21U2#JMD278H^?%]B2#$BL=A*3D70#%PY
M\2N K5BO:JHDVZTM5!,J#3J'^9"7@8A7B% 2JIFD1UV/>(D\/;%:&A13E3CJ
M%I3.H^6DPVG]"U_2:#_Y'B3T$?*)3H;$0_PVIG6)F#5NTC _^NK7UA, .@^V
MG9G,R>%CLOC(6<2"4V3&,7__K5]O]X0,HA#H]IM(X1<,MMN-_(AN-V$(DX+'
M)3K/3[;XR/?[NW8/86]+KDX*?G=W[9,;D8OX8/C,VW=W(F@+"VCW9(0MP '%
MK&Y( GIORST200"1U-8J58_MV-Z(8?B\69FZGUI_OR@S<S[0ORJ\Z(?MYR/K
M-A47F-%!< Z& 'N\6TA=H(QJ1/+YZ93.T/BX.2R)J.]54&]L";FE/%;V.?<+
M+&?:(R)$ZOF+F'Y0\7'Q'T(,R23:84"20F;QBE/[>UA2+50Z=&5>+-'69P*E
M@\@Z5Z])ZP_ZM;9>RWO@T95<>2E?;NE=#=J *KA[A26 ;F>G>E? \D!63]:\
M'(#F[G*(O8LTIRH\%Q!Y?FQ0[WHF?Y$$HB"^6_##25/OE'%C83G1<#.(&4L$
M18!687IPR<&0ZN$H4\4Y/&)]Y@QK7$&("HT),N&^T%@YZ[SF1-M^7ML\9Y[&
MJMNW0CA>BDZ$4"YB/D4M3+XD&4'CP3*Y\V/M^!97Y^06<R]BV 6Z%67SQZ-=
MDSN@"W5UZ4,?SGDG'[4[>E1:]+9'IVDHU8UVB/D,Z46W8_ RJUA'61.Y)E2K
MY)8#9?TP2BK):$Y&JE8%%Q5(B1FK6;:;%0P02\<-6%AD'%=K3@"J280$)#>U
MFFV$=!^D-3/.6/<5TA10"2M!D,]-E.M?QSI-ML#+%_B_??ZQ]+TFR5_YE'6>
MNEYYHK33^./WW+]K\0\_.)U!@@#*]W.H)\VH]XO+?*F2G<H]'K)=64<N$V8\
MH):RO%=CSW/ACQY7\W;N=3RD8CI%#T:WN[8*HWK0M0[MP],.SG7CBQ.H XA8
M+Y+\:>V]GK,S_JYGCUT<&*@0"%AR[U.;>=4M==]Z>JY#,(=E]MN+>]B$[H#V
M?$ *-.3>4RQ[R5#U?YZC6&EGG!XV= ^8:D6W7Y@39?&UL^?VME:;$'#95%=:
MI?'C0S[00JL)0"=".C& =D6[$-[A,E"&?HU0=V?F&%M5W)!$J4YM7.@8W;]\
M@1BPX3WC[7KB_%E_.:O]NYI3U==V0-/:M!],=ER[%6;0)8-=+:.^[NWVZLA.
M_X1(GS12S[$M.T:,$G,I6W^5>$FPDE9I5[;8<.%^G>DYYNN?$$%$(6NO/C,;
MZS)ZLU:\"I F-3<?NL=W9G]#ZA>3]-?F^*_W8N6BQL0AJPF%+G[L2'I':.U^
MT\UKPD4,#8K2W.H=QBO_S'GKZ&1N)YX7WC^&WX%04?^!<G;_&^0\4;HTKM><
MP^_V2],G=XZ<^G6_0<= /K?[UN[/8:J[NL47T)3W:+D=T#*=@69CKDP<PP[\
MIT] H8LH-L1K]]\!?28S]'= UTY!MUV"H*[HS@.,>SN@O WJ#HBUR_7W$7'*
M%$.,3JQ(0DDR8!]_.D@Q/">-?>] 8O)R3:Q<4_73Q0P,^!=5S?9\O%1??ODC
M]^#O$KUAO]_KL2FCE(V^5ZV;V; PYPS3K*)/&U .[L2),<XR7\ 9$*)0(KX^
MJCR/4MNU5KP\TC/:Q+O6'A^W.T IPN1[9"N;A]B3P-(.R(I W@$Q=M?N@$A^
MG 35"LY_XXL;82HT!V"Z\&OFU!:TGCMU_54D43%]$N86D*'V5DF6_]D^'50-
MQWKMKQ2VHQ9EEK>* V@6OS9EB6;"Q*&4ORGP H(E#,4,)TJ.,NY>OM_\(2KL
MJR OYE)S??K1CYT!X+[=Y0=<?*P>@H\:,D]49.^ ;FQ$8M\N,<3BNELU?O=:
M84U ^'X21.< WXYMYX2\U'4'M>]#\A9NW_S*5Z];*$>>"N45G^;9;:B^"/4'
M#0%'Z"(WT.S)NC;\BN$!*%&]>K+ /)O:T?C%F*D(?8R,YXVFTX]+;=XL5[O.
M?2H;'ZVQ@"$J."SAFL8M+QSTMT)4&'+F=%N&.3,;?1T;(XEW3JZM$ #XN[%@
MAL$+I \5'*>]6--:0RDMT\NJ[+[#ZZ*)G(@^\%3Z,N=;\+PS&Q%6$MHQ^#P6
MSV\8%@#\KO%/HEBM25<@'9C/30V7FYC#,2TFI'K1&PH".78UH5FJWV*LV[\_
M>M)U_HR6W)-3:;$!A.@'P='L>$>V)>#KV] U5I@@$R/V!!=B7 U9 ,="A6J^
M3>_'G,Q4G;4BA2X+9ZW5W[7/[\@0%3LX?\IQ=O  B :?1I/!JSL@NBEJ#"*"
M.HZP)6<^7M">MB!W;&MA7GYC0:CMM116(UDIEUI>7F.S>9A6B_O$&A1+[^B0
M37BE9-R3:%6^Q.);)&MS(2^PM6##\&"^8.U&WFQ^_!,<NYU;N[ ABS2@CE-V
M-T1JZRLE?G-X[N0X)[7[EL_^MSV\P^UHBOT&1L& 6:F7(P087&3QR0?DH3O.
M4Z#=5"%YZ(T'I4<+4XP-7KJ[>?IGAQ57PW/]E6WA>FRW@^&WTJ3W72Y<MF)(
M.'1Y2DY %M()->L8(M-S*$0/$I,]&%L0 %/+\#DQEND3,1[6\[TPIN.9?-7+
M94L0\@@U@TCH0D?@*'!<^.\%3^PNW$ULLJ<H@'N!5*/@DH(TX<Y >]DW&7A\
M>7GF\)K$5O;]PN [_@<_3 E52BCA%\603T]N!]%W(5%4])HC79BAPLQO01.C
M1VIQ<@"G[62MAZ&B3^J)=<UTJR.Q?<*5UY9Y5;RT;+Y!V>E8.X0]Y!-T%6$-
MQE9Z S-;D5F )NI3"^.(@",QS /)6\8PGP";A;87FBUO7%,1_I#8M1:S9?%B
MC4<RD2DT%CAG='JL[&?*P0Y96UOK"[)N;G[1=SIEPHOCBT&.(!!H@2,1Q&!/
M_,@U%@%=7=$IE(C=RW8Q$+PN+0^HI5QL;U6LRNGRU 5R*#%:5\8#$FT^^^-O
M-\?R#AP9U,:KY-R\2;])LFOVU3")HME2<*L$-I<49B3J(&H:+  )0"<2:H0B
MP1U9J"-0<88-D&ULI9B9*7'/AN9VV$F5'"V2KJYJQX(%W#VC5C&5JT8A1*(.
M+!MFA1L'O%AY\"4K[.:5B9\>%R:-GF@=N(T.UCNZJS29@Q@KB+J,E&!&Z!-X
M48-0R@7M3_=H3JDD=*SAX\W-K/8U<67_*[63ZRW',[ZZ!E1>0P?+?ZZC?=J]
MZC?M,(0Q8R=-O$@N:C^YER$<[/@[BP4P[%P[41/M-P=OVZ[OJA $7G="FU)G
MK'2D-S3T8#!MG9D4_;*KB?.VP2F34$,71<%#MT09</:E1< 2K17@IXL@50&5
M"@+"P)/Y5O^-6T]38>R&@NR@I.58NL%4V:HO=UA+Q6&_@PW<#PZ^[X_CR'K)
MS& =!XS86##*5:-53?",7LWOSH+-)2M;>YQ6PGP*YRZW[$8C9SN\9J;N[&JU
M ?3IF@PSYL,RW$(:6IREZB\I(7,KXPW,$TSEQC]\.5:K+=*SE1W0TK@H/_#]
MY<7(,HGYEG/<>(),RP,<Q?;WZ8G>U6^4*2(JKZB=DD5+9$U2LA*02NC2V7DW
M?U=FL;G6\R)\V&LK/Y_GA<=^J!W-3Y0X[91VTGE9$Q6 ;K]J+%O""&(_;AFJ
M#;K;6/[6E %>NRL,UNOZ*5Z4)F]TQE:Z9<6:'K_^6DDE%JE]@8.I]!\HAOI_
MEH2P.R"XT*=/K#&41"T5'%402^C.5CQ;IWR?7_[G[O5CZX2.8.\\!8[KW!Q)
MVE^V,"@)QFG H\3F%?(DQ;X@;[:G^S[4]:@ZN:GN6,-/'T6%'IR?7T76T'$W
M_NQ)VDB6XOSZE,-B4,4 ,RX"Z36$,-!V"7-5%[8P6+2W/YJRZ7]F= M>]LPC
M9V3FY'?P GKU)15'IM5RQ44RI(/DDQHD9>88@N+/^',OO[<:LMJZ> ]\AFD)
M<%(<.G9 U4L=<T9$3(Q+0>*@[9RG=;C)7.<]Q5+NL[F@)3[QNW<\GHN/I5-H
MDLHMI%^O?S:/V?<%TJ<7[VPE2@_+OSE7Q'4Z6G[\X$Q+74O^VOV,^U4V4-A7
ML?.6H4M?KOY>34MF38$I#AO3$-I"U"DL+0:XHKV)X9\+*^S(U1C9M'VN[?KQ
MRU P'CK=)]]E'-Y]<O5:L8L]UTE*(8T?,*$,>XPASU< !)(!9E->Y,ZQ!$C7
M1CP^MUD!JS,T3:IO?-*FXOZP?H_NT4BSA]Y+,VQ5-#C$H:L=VN$Q$*D6-'6C
M#<5;-\9PI)J2[7-ZFDJAZ/.ALO!J-PGY/>_[Y((T;#Y/!5N";J-K*E8'*0ZT
M=X!-"$6%%DLY:WJ(DED0ZGOOS7+]T2;+P,FI([-=Y>=BU902>$')9.[$[W9P
M%N])NB;0>::*8M %WX<\2_6-J*$_\:T# DB$Q*:>@A?-%D22S=JZEG3%@=.7
MU+DZ^WD^X91!XC_?B8$^78W%B]77)WBEZO/%)X6_N WB?%'!#;!#RNXA9BK.
M'YK*$F>^1NDBP%U-A2D,(2.[A;5;,R1XO :Z\OD3W=J:8_4CG7N_%X-O"!+-
M;H9SA4Z(<2QB:[E7K]*-6=-8;B4FVQS]A01AGOLI80/G+<->G21[N+9KIQND
MGI(4\@T2G2623C._&0PT&F=D'Z9SLOJ^HSX<975N+W5,ZQ-BTI<I*R<[/ ]3
M][XLL1)_IA;)XY5-([F0A$/N/$FT?GU(1DSMDO"JWCGN?NS;#89P/0W$GL0(
MH(-,DER=HF329MS3/]BJ:U[L4E!LF5 <TU2\,NJ&YR^2#TB+ETV^HKNPYSJG
M^'.VG]MM_/LLKML<X^0,91?QYW#"*-2.A!'H(PW:U=P)0B1G269.[B&OTK(4
MC\S<$=%("TS(DW.>?'2.>Z!5B7VE"3N,F1K[L+402CM*M6H/.[-$G(J%[V\9
MJU%%AI3A:^K/O>H5V!*=\;32'^M)D'GY=/9TY:L7CJ?.3Z+&?@?]:0=:&P47
M9:Q-W6C'3Y:BP##U8L1)EWIJ;A&L>&7*Z'ZUUDO!#W/RW\)G"HS>%FZHI:V-
MG^..MF-S/L9,R6>^,%:BGS])(5RNI=9'Z(F/&!\H^H2@N]5%G1FS$*,K.J5Y
M:KZ-+MGW_MJ!ZLS=DUGAD"N0:3@Q;LV2I#T#:4<)306P%(&Z'B-M$43L4B]^
M8A0Z<[JXTH)6/6]2U\73+'9JE]=BK_YJS3^T</V?)NA3=G+CBOYU? <DB/Z4
M)LG*]'!>B1'C "0M4=OGS<!9[*]/8W\9#CJPNI)PS,,U%>-\_],!MAB0#1BB
M%31/8(4Z@!IKU?AH;%Z(/!UG%F4YU@(G.DA]-33-\_(2RWC_UDKS&?7+L= $
M_AYBND/6W;?G/1<M08CAMN%/)Q<,VK")37&],\>H*HFL_5\?7!Y=HDYA6AR"
M2F^<6R$RABO=6M8O#,WBAD;:TDKJ^/?L]_K "&,KPXP981Q M_F&KD4E$+$R
M")4>!?7'^=3'PYWP!$-<W#4J9_6MAW-*,5TN6@3=1X??)=SO%^G]5JS*^1F'
M/\GB"6'?HI]9R) D0O8@QF@W*T?<VO+@T;4XKOG!_!NN=Y^>'>(:K%8?;'(*
MD?K@_E0Q1/==4NX2&RQ'7D?U/*A?9<\U 2LT9<H1+%B0>&G\IQ%$]@8M_6N/
MR^X,D[6)VO%@2<RAY&:[0YG+"-*[]430 OHZ83IK86,UC5)X%CA D;6<T,/Q
M^]45!>2M&&8E!LD[WGQQ=C51!=?PE)QBWF9YY04(U":U\>95N"D,*&(SF\M\
MB%)GC3_ K&&"X>3AO8@MS\JZ*JI]V8)VHBLAKN<='"[3+> ,*_0X^46M)_X)
MUUTQSF?.+0Q#X,Z"=C2*[RUPC]+;<4Q&(J:@R^OMZ,]^GT0I\VL#%JFE P.K
MO1H# P,VBL^;5#F7F,XLWCBZ_#?#+X5WPA9,S@)H-ZH50[&)T/F9JO\=\#T_
M:=S]:'ZP@(V7#NF]J6KQ,<YZ?*I"UN;'U!OD?8";DD1[ D#?(&4 XD).6&AG
MT].$<HWKF=;9)ZZE>2<B?!(R+RNG6CJG^DU[ITRXN%CO:>93Y>QOY4?U$KA8
MW(B-"T#]RYEO#Y92],.T-(_N@'I01ZB"DV7%\J8JVO*/[LTV2VEVIG]1C3R$
MVY#394Q\U?M_;YOS7_07_?^;G./9X=4"#8='0BAVV.FLB\PB4U/W67E)A_'2
MT@.5E1SE%;>T?"]WW2ZBKQ9].6NU=> >/MRD*3&/B!$!T#VYLF,,+Z+)-<+Y
MT5J85(7>H,6H&=5]YD,$^;'4[0\?VB/DS<4?_*_%;_4!U G6-*%J>'6*) ]I
MWP')MAHL/]A;7XPWF7_^TM;(#FU2=6RJP<W/<?&[8^M%K;EPBCVB#!*)KA5:
M)=-M+(,@JW3J<$>N?FK/$/[KM@/_MX=0S1IGP:,6WCK5//WZ-=]JW[9UM44D
M@M:7RXW(T#5>BBWM#F6B/JGU!-)^U%C7*PPMG_ILN^"CC78YP4BSC"0=FI"S
M.Y[L=)=C_Q69G 5"KW8TM$8E"DV\@A0#8EXC,JPEJUT&@U^[P^DFXW9U;B'G
MB"^?RL8F=#3EOCC'[6P9,MR+P>^ :$[,+ F\ ]Z6ED"!A^>US-!LD%"2>IB)
MLB;.S^GY^!%3]R>@I<_P,X/ $7H(J@M=XYL((7(#W'1/I!XUM_%S2*<E93AE
M%0X7< L.B>0I\.?S>MY^9\-,H=)2?&D'!,;!A*;C:!?']-9@M&SF2V-I"FO,
M^?G":#G2BV0;<$);T5)@1?CY^(ESYOM]0<F;+X3,7C4*14+!+&[4:"X/6&0'
MY(M+:I6CXN)<UVT=IXPU2T^&^8U9I5 3KEZ_T-_@[7M(?PC@I'UBIK/4D)9@
M7I8\ZB-*<E+_EU)CXE!'[T5GR5$W$2VON@RFQUB'N4BIQI>#^<?=94";,NI/
M@$9J'A'2YL!M@&'I(LU'6PSRDMZ47=AR;+Z<"4MPN^E$Y?QAJY?R/=]:>I;R
M(O<PEL?T./(00"?Z&_M38"2)IR1-0_YIC?4O8^6<^@7CB!^:2R?C(GW>SXE%
M>-P]NL<2%'3)2:5+.\$4!-@2;;'R2'MJZO,7RW76KC\<)VYE\B/$=MD:57*8
M@=)MVD!3F!4"Y=+O2BW_%VWO&=94]+T+!@&1W@2D!@1$Z5($ 0F*-!$1E%XB
M(EV,2@L2$HKT)BB@($2*H-)["T2ZB(CT)J0@HD D$8U'4YCP^__OS'WNW'F>
MF0_S(?EPGNR<?=9>Y7WW66NO^H8JV1 ;!H8IXN7VZN9")-.T$1X'[=VKK;R'
M*SW)OO:M_AI^=-0^81_4&A O#U20>8D=*9@@0L^S+\DX;W)? __ORF;+E5L6
M!>)^RJY"9B9R_!'_783I*4&2I3D@)Z'-X$$U;":J%3N\*M%?*MU,]+)W[UZ4
M[;&2XL-,RXU)M<B]7;B&SY$$0HB0A%\YJ4B^V;ZEBNUEK[Z*RK5H+3 ZU"1$
MW?'V(S7-+W[&KH<E^T$4,ZDGUXVR*ZJ__4/\:Z]#\=>]K-70GYO[4*:8K,_Y
M;*F8[3K(1B6.,SJJ/V<%3;W **-[]G$ *K0+\)"A!ZWS(E#7Y:"%):.DRCLB
MML66\AJ?53^4O7S8?<IO3#K9[)QWNFIA*MV&@.."(_\,EVHNU+;6J=FUQ918
M79NMS^.-<16V-6FV_J)Z_)52BQ"(X[&91&##H2D4_C6.?*4WVML6LB+QMG%$
MO1+37GAUWGE*B_3)[V5K$)5WF)U+6U+GR*@#.O:_V;+:.%,7N8QJQN[\I9CW
M8SF8VO0[4^&P8XCS<_@9$UE"2N[7OMGZ$X_'<VZ?5C.RA&[L>:K?2"PXIL>V
M]5])#6Y(74K'0Z0L/'A[Q-N8(EOZ^*7;R9#>"\Q[,MJOY0]]@+,KW0]D=TS_
M^W60R;/* DRM<]JW4?AR'$?)Y02('OW*]!R[7%S3\Y,JGQ=ZX:@A*:X,/6-[
M4;B'9\OLKQ5:1.GHU9D?CH&:-WWR\\X*Y4?(?]%6$C:3^*]\]#<ARU]S"5D"
M?X;ZY&<56QMGZI2Z^KJ?$A22]35_C#;R<$,N@3HLX%7Q^R!.*48JPHJFN,A<
MG4>U1L;#R(77TJ,:*:5O_)H2POBF^Y5"9 >41LXKB6KEMT2??GZJX3)PC6+^
M%BO-E("'K-L/D,*#2R4IR/B .B#JFOCT@.:.Y@L;TM>?&TZY!J/'SRPX^3P7
M.G(\SN#;*_US]G93X=M9OJZS\JVM;4E5W=U=3ZQD3K]2+EE*Y7EQR,8$I#98
MB\)78\GVC"LJL^'[H.6>@6M!IS_K:1$#=UV_O=E:L38JP#7A#23W[I7J%H'^
MI*N)$C:'T""$.[G6VPCP6=<P&)+2&)Z8Z.VKJ?2JI/X<@]U3QKS/4U!=.9%^
M44E$)[G]V_^4M(-'&B'GP"W0G<&J\W7,*:R<B0K>0[J EW,W0W]172%2!<3U
M+/^^M:'DV# H:M;%F-Q#Q T*9O4)=@")9-3HLGU:JUHC?U53.51YHA7_IO/4
M<9%ZGN9&^4?F[%YBH*/7 DIY7>6^?KV5;?BI-<_ZK>HK2:7'G]B\ VBF+ ;<
MO$MR(VH=@T.I]X"I"N#]]EOW)^ZH]"^?EKYV-'?E>N4IF.)4?5-QIM<Z/6_@
M<\WD2OX?F5$81-Q4'6Z%WWSH3XG*:#@S@M5H:[T5W>&XGOHI2F7AA:1*O -"
M#A@D"&9Y"^<,>Q_MZC]FNW+J6'1[WOH3'WIQ&3@5).OU?X55;@J.6L) H_S/
M*=K/,TWIGE,F&N)-,=1S4AJ..^K_\D<,CH66>8[=)2!O-M4(G947"&3O*<>,
MXSM(:)H*<^K!'_IQ*#LVT)X'CG;S,"ZNR1*TF5?,^S>O%BV?[5^Z8AK:-]K5
MX:CD!.F[<K:^@U@XC$J&LM/97R.N </K#,4!IO0482_"+LQK5K&MK?W"?VI\
M$UR3V,_ZWSAL<RC.B$<M'I"F.3 G<:U%6^-D<V+5LX;)%Q-'W3>2>O2B'L1<
M*B;LD3:<"A2.'WKWX84AQVM#_:AU>U8\U:+>)6/I)U@AJ4\3B.HO.FD8"AU:
M;G5V'M]3I4^_?U^S9R1@[\S>"XK4<TE#L%AFPD'5DC%3&UXU^G8?Q(NZ@WJ(
ME)]OLS'IU;*91BI\G_%<ZXLD)2L_;:TKU8Y[OM#^B<WB/EJ2:8P08SS'<!L,
M"^;L@\019_$-_"N3,J+;?:?F?1I;;6Z%-I45^#OQC<;I/G;%';Q=":-I(.?F
MNU_N@W9&:1?A6D0^*:5<JUH[_*Z(1_"I6S^33]=6<=U(2C@+6C>V?PEZH"RV
M\0]+JJ.="(2(0PA6V^!6B202W5'?L'5,KTM?7^Y*F6IR^H@-9&XXXGCSDXY(
MD4X_U8?:DU'K*!E BX!^& %.!0MCO*H"C<1S _^XU[?4XJQ"0P(.9;;FC2MP
M2['-/8T[R>Z<CF?R(&>P(%1@ ^ED'P_]^G0;+4MFF%'G&WK*MD8_W_;"SWYY
M-U^;HR+9[\7-*E_?X(]T7^NH!&#670N_21?4;-4,W3UJGJT$7TS7<2U]RP-J
MLXAV&0"O5%!U&2],?"/(?_!0DBU>ZUA(N\ZQW=8<?GC5,O7KT@B]-G=@9PJ]
MBN7C^@PSOPK'4?\Q4IE2B,L9>.P09'F40$U9YTW#U*!X@_M4VQ*O/OO3S&D;
M=4\Q[_W[,Z_''(VO<M4[."Q[K4"7+6(#C,;YIFISK5,49C,3SJ7J*[.\L[<+
M ;P21KU*84D>4H,<,>4$ULNW(:+A@H*3=2&E8M.K/Y1F:@F="6N6I=>O\3FJ
M=VB_3GINN[?I+Y8*^GU)M:JW(=!;?.H.W988&SQC-U.KL1:S3:/E)_/"G_A5
MYGY.L@")N#X"B0T@/Z#;L#L;-#^XBB/PF*9-=VJD9,>_#/DCI?&UZ>7PR0Y:
M.*_TN)1):OE5<=?)9W)?C#M]$^,$+<O3$Z_-_EH5M>N<CRBY<'#VF'M(3<UK
M9T-"UGG_*']YU3AN)3+H!?>W!MYI"+X*U:C9JSI6R9Q;$RRVS]O=:8(G1<@$
MB4SVW,C2%S%]MP/= %VRN7/87FR[E!U(PL/2O25S1E ")FX^]4&BGI]7!E]_
MCU+3$[&!F13LJ7;G2=]JLGZ8F%GV/W4._1^/K/D_/3*1=A7;Y7JC/8DM(,]&
M)LGB*K>Z-8BOB&)GP.0)H[$%3YVH\*,YPZV_.UY12!EJ]GXR]?+^BIF=S1-W
M4]<DCDOFHO&/S>1(%KZ *)$KGGD2?A,L13]+\4?7!_X1G>3O>_UR59U\F?R!
M?$EX-C^T>>2;M9*?W>W_R>V);:)E]T$AL*48JF=;>Q^C$ANHQ04(K%$2ECV!
MGB'Q?XBPTZM)+B7Y-L;2<6$_T9= OXS4> F30[@4M 1&)71],JE/;P9QOGSM
M9,@Y%^L>-]*F8UFB4NJE1M7WY[DXA$(B6<^MMKVMH?,^U-81D[ZVMG:B@$B,
M/J1D7:'^830)])^0-<%"I^ 5-:H/HWZ3X@EML1\YIS5B@R^)HDD/=;AKYY)(
M,$R30I+_244TSZ"&J%%B_UF.JUQ5_V]. ?C_^&&S'Y)3^&2B4N$)SQDVVBA]
M5KUL]=4+MR5QBD^[^D_)YR2''W;WT.1Y</,D0Z9A<!]$5Z]% :10NC=@3IY9
MWQRT"\!OCD .+P$I TR%EC-%\QFO3FFO#E@KRQSBEF3'!O]]S)019F&5T'U0
M90P"L@]Z>Q8+;(!BV?9!_#XT]7W0U'LZZ^K ^]%]4/;4_^[BPN0^B(S/ 11A
M#,45PCZ(R<82W^C)?5 *!ZI?&O5=#B?(^H$ C'G6#&R&&G1%CD-^W<<>7&MN
MV@>MM]$/2F]6T.1K) EJ)Z.V%;;$A>_(JHN L2%./)QX#0URR="OKR;RIO;G
MSWW*SPTEG#J4^^=63.X:]@H*7[L/:N2B"ZLQN>MHA^';U.HY"!Z-XO\R]XL$
MV3'EGZG74#Z^#_+H/&QLW?X7K5/SU0VT^3[9?!F;?_9ET$;0\Y.:PZD7>71B
M07A!GV$0R@Y"#C:@BS40%H8%%R-1BRPBE0ETE7_K4P$@JNX <GWHP8<SU0YD
M^G!6<\7E\=ZZYS9L3K3<V*=1#7-: (L2!3"S70YD(.X,H4=BTW(68X@=_; $
M;%M.?-]QYC28NW52!@%I6;AI+P4/<&K3M8JH&GNZ>>OJ^3U?*YW1!$BT5&*_
M/&O"!\V=$\19@A%%!!%Z(2.FHHS$/NDM(^<Z7[&OSUZY>[S_'ZS6)MG9F>_(
MUI$7@A580BW$#_WO+#2%13?<7/=!E&7(__W27];T_C=+#O[?K"'[MUYV:@ZC
MU,2E=@4(&\#)(21>!TO<CXXLD$*EAYXH"F!N';=VRVD46W;Y@#Z"PF?BR+8Y
M<2B17[!,%!?D9@XG$#,L)X>1<-=LJUY^W^)^F8WM4Z&\C.A*;ZR!&?@16@QU
MQUX$U2^&Q3>BI9#:R#7P87W:/B@1U:HQDK F "R5!^T^*#JTN!0-7HHZ\J)Y
MJ'ZZ*4GPV<^_-3)]04M_T#M0/'1)900MUB?/Q*&:%K(Q6@V!8*E?L9P1Q3CN
M,>G^J-=!=:_2-#=.PCOA#3>R+]ZHKPO=R_H0DC&%A>TNL:]#1B!9D,9"4E8=
M8&R''D1J&-F5)E)$CLG/8!PJQWP"PNNX>X8DLF0>V\KDG@JPUW![<M@1:<Q:
M&B_FQW_V.RQ[X#S->/,;!R@Q-JFL./\/R^/PBW%FYGI(+QM3(=E-86;GSK/W
MGK4.ZD3'[#6;'M=GR;,@=A<F;S7M)F!.9:EF0BWR';3-(*U-S?[H-R075"1H
M397LE%P=0B4IM(5<;&N=Y;%7O[<27?V!5V]"2CA(?NTPL6^3@,[T/LC\N TG
M;A-56%:X1!M!ZE$V23&4,O\9$S7RO?#Q;;"@UXG'L- @'Z6.A79_%W&C,/M[
M#UXI?'Y\^F0JRV[X6-IUEFF"ZM?!!N\"2H)#V,49)H\MY>/XP#Y(A@XCDH+M
M,Q6'IXS@#5<IPM@\.Z-_\TN//GO;P:26+Q:0:\0"Y<#J:ODA+$.VA0*G."!-
M4<,-@LB/*+(76G3[(!7#B8Q^JW@9X&J SPQ*G*%*96?<#]/8:8[;@4VT1K:_
MF58]=C/!]5CM3T^UN%B6/^"ZXSE>@^H7U_IM9WZQ=" :$4;X7CKR:VC&W=CX
MJ\%IXZK?8XX.2V'/=07LG[/F_L$4 IRC60 N>' "R@<B\ZU4@U&-)80N>M*U
M.X&P-^;1-=_G>?F^1J^%^/O" D_0U H>/?P0P]RY+US!NID]<QK*RU1%]1\-
MU3>V@]+D:"/>NE,-=%T"3D@XX W4E?N'E'%9@(+H<1L^Y%T7BW!GWN,5R0[_
M7I*;-_&%&;_R@==D=WO>K3/N.Q><*(+)29@F7%D__^9@KORW!T6@[SOSWT./
M>VQ:/K<L]\_TL5W/.]<"?<R2E9.6"'(6RH.]C1-%SJ+:).C"%8/@UL*=50**
MWRVHFW]C=>19#0ZX.<?N&?R@ULAKX++YN&*\XM]@DQ)3_NDA@\?_QJ Z02BR
MZR1PHJ!I'2U)/X&FUI%_YV1@>(FV=>R>9.^FH]2BB6&ZP!1&_(RH98?4,_5*
ME261T$VVL-Q'@JPYX%^A.[1V*.0*)O_8 C80 IQ03DXA0 X#>W;M4QA)B<1P
MZ_#4\ :2]#Y(Q<&IO>.Z1T@2M+V"!*I=NIVG\P ":/SIWP8O:3&/6 2\04CQ
M$G:%D!\#^A]T#-99#A_J*T3YO7)SBW[CTF-^;L#@#WU^M6341.7@U$-%W! V
M%44VTTK?!S57)YAP:680<6+P=7<@%Z\%>B]V:\K1SJ^-5U8TN"3M;)-%_".A
MUR8?="[\,,:1KPLN*UXX2&]@K;P*XC1-$?EA3:EIWE25^2D**3VC0B[!C)\H
M(SR&Q09%UTR^]DC\ZC9Z*]0O/3+?Y5;FZS^K;*"H)%2@G2UU\^!,'"0_W-RU
M38V 2F)-I 9Q>2;<!AQ^=;M[T&-%?^S:(":RH\E*4O[)B0N=GT->HU*+T#LL
MK\EEQ IYI>22P6&6A\Q!M81++:2'#RE9G>BJ\O8:A"&M[+7=W/]R_);/W PF
MY@RAXHH,Z*)8)J\Y.88Z@NFR,R 89#+9#?I744,+/]4CB\2K@]0-C$+6+MU]
M]'+:?3!4^C3OIN711[?,(I&"""/HBA:3]WL#$^?-V9/B"/B1 _"U$,%6R%'7
MSH)Q=XKL\,;P'''Y2F7E=BCG^*"N@FI><U646AS;/VD3(2\SZH)V9>Z[@X)H
M3C?K?@ZY%^ET!]:#1T'PU?N@II0=-Y;_MV].62\<[FQE0 ?="U-_VY8(ZZUT
M^>=S#N6-I$\-C'6]!87U^SQWV>D8@J3)'6QU\>)2P:+TH)< ZN+,C:"&-J^;
M_XQ#X [7F]1_"G&!_I"@3]'DH(8TI C"EK52^HL(P5Z*7$8-U)P(%EJ!HP?!
M=[)^'&_O[%01O2#]H&)4YZ<9AV'_"\%F4WGZ748Q%E^":YE%B87OLJ^^-3T!
M)\X" 6]+9:VSYGN(6:$S?EE%7=FGE?9@^4M+#F%ZF6;'9/9!F1!\99_60??(
MP,D4*!OV#F3IZ_A;=]3PA"U-\:V<,7DRZTI/Y5CM([X'3GLV?@'*^4-=AW1$
M7$N:.=!J8F0<8 @FC ZA4M;8&,\AMZ')<D*SOR=YD!,X&3W84?CF8/=EP3"C
MP--B-@WBIN[FATY,1Y]LT4O9L/1!LSQ_PGP?*XSV.YIPTHR8$^@FW' 6^ZC[
M#RQE9I"I38MZ&.':@&K$&/OQCZ^%Z+9>1DY(*8U)_2V^G/>AZ97&(Y!I(Z6:
MU- 0@FWM2(/<TEJZ1KA2LCXI#4B;-<]A8DU[B>U3X2C!NF^132Q&K&8[5O0S
M/-O&4:E#M4ES,]= _C9Z29K)<X^,HC[Z9'K*E6Y%_KW <MQ2"-Z^HI5UB43Z
MM1A1M.!Q"Z5Q1,=IY@_BB/7-/.L?(*_WF9=>C2"=&'F8B(,<+)9>)Q"8LVA^
M5 A4U!V 76240RTI*0,0*7CR=XUP!G3GJBW_6E&ACA Z,(7$4WZH/\&C@%T@
M"=.RKK(30X%2-X":_VPYO8;XB3]V(/\90B49N228R@6[>R3"UKUL[1L[0LUW
M<OX$9)YK;'3K/]TSIEHCE&G&Q:+%_>Z04/M,:&L*75B7B!W-.<(<W4,_]#8D
MZV$7C4B[&4,/@)G-7,[2%LU'H8C6EMS,:R MOFV^#$4S[7=8!'((^M-O'W0$
MM5/X#?SO3@)6'8%BS<3JH&:$]=_MI2<!B1"*R^7I/E4X"G^2G)+:)^958/=@
M]-K,SGI;YXE!.7C[85&%SI4-RY0_V4FN@C,00$5E",Q#MV,D(@6!FOZ.W;!;
M+,0;;H@8TR@]KF1GRAD^&&?CS'E%A_V4Y#L]M@T(V?O;K3DL/A<GC9"M0I@U
MDYEU#8!-K=[I"&2C38V7I/!((4A)LKK'^DN'M8N&0F$@UXF^8$82)+!F=^4Q
M]0[ ?P @F@#7?]#!R:4 PMJ;6^2%Y :]OQ%8H>WO95DZS.4C[L23MV]K$'3'
MI.SU[G\693]6<3'KY2@P3@N"\U)C639=H*_ ^I<3%#XY82"BDBZ?@*/>I:BD
MCV5<:.\KT0 [8-R@?ZZN&A>O^-X=$LL6RVP4B*/74: C:P*LI4<QY\ BIO+,
MB>7J=,1!A@$9V <1/10HCX=,^<BS?XS\DV+ULF%UX2MQ3LHMSP5;)N_=EC6=
M#*=.=2QK$-YR_>#:":(YN3.7]D%LO^R7P1< Z?4&]D"D<B/+Q0]2L4(:M1J[
M6K4;7E.>J;6[FHC6B.7W2B>'W5PU!4+Z69&H#P5"!4&6#9C<+4388>:XJ014
M!,BXM/ KZ\%>O^;+E'1U=9AB%]KN5.XFUY&&+YLZ?[U=Q[6Y%B&^^Z"5&:H+
MH]T'"UO<&\:2"^ >@_/.8U'$6#7;(IQM0C3;SQW%: >#C[FOHK*._E6E<"W?
MNAJ$ZK^ NET,7?0E%#Y$ZH<LAZ[.Q]^C*%Z:PC@62-TJ#!NL]OK;-'XW]Z*4
MY<\K8XO'6XZFO>4R?"'XR%0"U6^-.CA$&0I90GLP4DP>%. $3#4F WU3"-5#
MO/H)^R#SA5!DX!UUR0'>QQS?2W)WT.,N;L>S7--_"0*J#:1<FA]"B-$&\1>,
M [.;BG[O6).@_!DZ5>S073A<_GX36OKQO5MRD=43XO)G\6S__ Y)*26S-V49
M !==8IU0>'#ZQS3CB3*CO(^#?I'LW$6[V/NQ%,OY&Y<D];MW,@UQ_@VC2CEA
M[&9SF/XB[^,"SKIV"7ZY>:[&@QH38-.+48(\\1_ =P:YA%1KG]X'$40H/2N(
MJY2DL>&D@AK3N%Q;I1:M,:G>@0_FHEEO1LL?FX%=@![J/PJ=A4]3L#[VR:B6
M'^@W",]>X#)2'JB^O( ).H$N_^8>M3S]SIQ1QI\U_OGCPN5W;PH(ERP_?L"<
M(M*Y68J90Y[,Q.(/:O*P=]AH6L!8 Y(/R/'Z9*H,<%V9_?57,[R8H6 R/MTA
M.L$1ME*N<^;784?P1E+J<4S4^B3]: T!FP'!OYJ'-H^2%"B%SL U<N0>_G=A
M&D(B+%A++]2<:,>8&YEKI]T.+LP=ELI3;.HX;:?7TU%X["&]BR9&MP)\63R'
MHY E!C2=B]Q6558='(D2,=78=H _V+7H[GAL.UTY77>C3>+0=;!_;M$I!Y\G
MM=4[,PAL-P(4"Z48, 4X*;B!AB4:X0^IZ:"RP6 H&> E9O&:]U)<A@ 3<Y8/
M$CG5=L0GTKJ5>FCKQ]HI?Z'8>HOV] #HZ@^7K%(6)1?7&EH3!C(H5M1#P#/\
MA#._K>T\)!@MX/VM^V67LN;M'^K5^4KFJUZ(=KG%!H,%5)!@'$0,A5]LX*8+
MD%4RP]$2\)EA=$MR/![,!XA>PF3'NM.&)E]ZN%D%R;XP#<I32]K+&4_*5CRE
M<'AKC/6@#Q<!+:H&<)#J-,)X:JJ-N#:E$;&;@I:@"P;4ZZ_52'$DC]J>T5V3
M_7*T7=3G8E82*+Z4'X1,HE]GO$%<"Z!T;U)O,HJ98HO YF@W-!F_0+<1:"&&
M57PW$LL::K$(U*Q?;^]^XNG9VSOZF"_RIU_HEV@IY47H(%(:U7_7]/ VM@4R
M@L[<!TD@)8.9W!38#H/XE*Y+,2:0UJI#[RE7U9Q;7EI2EXBKU%GQ]#3,T@2/
M.[0MY3N9&WP MP6,-"RUL :Q-*>)LC""!4YN#FB 70$%F@6<=S"Q'RP:@>:R
MJ@OZ)U!7N3+&OB2BD%_NYFB5G\Y>0C[-R:Z')!!QV6#R)6@:JG&4A3DSSH";
M]T%)ZXQG;;0<03AJV%MO&J,4?LS$@9KEI/X#YN"X)KG1/E/T0]*1%*U3]^YA
MHC@5],_W+:HUAR2$"M+@HB(  NUTD#N'G!(YLKHAJ$^+W)$#=9N9VZEN2MOQ
M$UETMY'9T7(^__.)FG1HI$)"3!;2B=G?Q\GRT!RH?AND+',4UQQ ZD51]JA!
M0 J^),2E\Y-^[QW9X%W"<_&K(_/7E']Q)+5V%5F3\/:Y8!V"9/F>X)9$!L*7
M  ;!([>'F<84Y^+RH#.G=WOG]&.^D>I("X:??UI?>#%YWP*$U#HX#1?7KK7#
M2SM(3#O%5 &XJ/W ,-[#P\M\W2!MO0M U:ZM?-Z26FUM<K=L)P=%!^WR5>JH
M!TG#Y.,,#?_9,_D?,$KV04&XI7$F]\J;0%2K_4/]?1#/]^[=H5A;5P"&QQY-
M\2")GB\R-.G\DFU?RK^G_O/(4_:]9Z=I,U %5+_(/N@6;JF!R9/#4CA/X#5-
M 9Y"M"P,(G[K8Z%;>;)_C0\RY3IYK;QQJ3>[YFCP@(.D4HWV6_CR13[I?)H]
MD_O@E"6#65-C0&((1;Z"7EE@:5W</B@8EN(/Y8$77IF#W>QX//1AZF]D]\=2
MF5?=>[D5N07R-OX"8KX%1J!=YD%W 2=$++YAJ6,(VF'5/[FDC(DB6PT\7AU[
M#2_2DAGVK0UV#ZW<Y5^KJ?H^&4SQ7"K+=K8LVEJS<=3Y+FEI!3O&Z,/BJ\&M
M@JE(=>0(BCQBRMDXWR=)OT_)*F@)J;4CYC1Z 6F^K;3K#SRJG^R#?%,E%:.]
M_NC:".7<3+JY#S)$]:M#0K4 9>Q."<W0G"6&/9895C$_EHJ2HT9S'BXLF,K.
MA6?%$(3G[B \)#MSZU1: M6_AK07G#V>=3UOFN!EH)APKH+)4[8N> 0A<%">
MRO$;^$V!$$9*R(EOUV2 KC#-KFI]3"153BA[ZZU^;]U8_$5M0[;$),9B>"&?
M4]15KH4U+48?!B5(LB/@%J\1JG?^^K!\-1:XBI2'5]@M8 +_(3->?"\GJ3^$
M+@LM?N[]0 K_D/[Z#MMUS6%+3F=& 01?511 ND93HI]GE-$-:&>!%_ <0E1&
M1 ,/'$>H*ZCP/??%Z..SQE6/_GLFC>>-;N<9"(SHO'TD>I<'&0;\82TAR^,0
ML8"J;,I.'<T*X3?'/(J0Z0/.!1"AA[W=,WK%6<#"@C'Q<:Y=8NJ-M\71$+3F
M^]7RHN@H+LW*"XAMYA$7R@K>8!"U1*/B@+#7VRD#%>:,ER:H!L^@-?F9'^J'
M,RK&83ZPX#O+!+%0V;6SBM;^?OF9(G'5XPA03'4Z-M@^!=<10)=.HOA2GP,Q
MY#O@0T#,T#ZH93?GRS1"D:_)Z/OWH- W'E5\#B-Q+1[1/4YFCL"X[[U_7$QN
M%F \V<PH0NW@Z"S26V5L1"<Q$OJTZ*>F(?A)B,AR,%1$S]"_'9"@\%IV)=@Y
M*R@9)<UV3Z^X&_UX/W$J[UQN;E?B:U""VNXNH(C.PH#7T8"R_<YV-!XGNAB<
M>U"21->HPO4F+5_2:-#XE>%:W1%;N9-GX%B;PB'\[H7@XX/CET7;H,N[3)Y5
MF@&J7[SAMVTQ+,54I1$]N@\Z=ENCZA94V-6M;J>]Z/JP]8G5+S,O]WP_2G],
MZSR="*U GJ5P#>0DH'GN1 A*GO>M ""6,Q<EKHY6B;>V-E]?:AP6$7KTYJ[E
M:GK%<S9H"93LAEM*7._H/SCS" ^AB^]1[P)!-7 <4^RH((O9IC,%R;]?HQV*
M!Z])5^;]G.?\&I6N1EM]KW->&_O9ZA;-H!]'=H0!*@M#L$3S]:H,F@_=P%0D
M;V:B9S8"(N[NGF%VO2#]Z]E5[S6'!*E33E[6\J],KG)-X@Y#;FLM0O^SYQ6%
ML #J#@Z?3.O31IP!PMYLKRD6FP.A^K61RV*]'_:V7,YLZW]H&E*(W\C%=':\
MS\7X^-S0]0(?U&-P!E F1R;4!E&2??+,P3XU,E?_N3!\$=VL#YBLAR?/VQG8
MW6K+)GZ=(,TYHS2UIU4]=2JN'-]3?#@T< D09')/A-XC&S#YCP*#7"/%028*
M)[ $B$Q5"CAM_0S_J[:YRM?!\J(D7<FGPG*?=Q4W)F+MJQ!:\Z@[^R! 'S>(
M9=L'^6N)+X9X*\VR@)S =_'&[T:9]R7FU%MK5(IM(QTOAAD/S._D9%5=/L.E
MQ[:%$H'@:\$B?>+(\2(7^E'187"3Y1LD1_ 9:E'^QY8 XNSC8:,[:>'OY.=^
MZ$&;4Q]R*F4[9QLOE!I^<8;/IHD9-62AR-?JN A:H["E70(UB;RV,%S*QZB,
M$ ["H^2^(56D;QZ>-GY9ZA'0(9E&S+^D<VDX.8H##WX6CEK9I<*!W_N@P_^V
M]D%\&Q3EQXC+78!@%'F>1I!NE&,MP\/.(/N761KA,\S'7WL_\26.OTM[F,)3
MF:/!>(,4#L:2[7;CL>3+L5!JX?P(N@QQC#)<]8RB-=3\6*,J)2*J*C[MEF=2
MO+*;KXB,YF+\;CJ(P38/P;]X4)C$4JN74E%TT8HA%/MJ@SXN>:'TH*U1>CA6
MN'(L+ !V-FYE#*9^.EJW-7U1SE=>^@K3&GKT$P3?AI/LT]Z"BM,Y:9JH?@VF
M,GQE%'R$#C.-KP>N[ X_N%+\990C>-K3/M*O8%7V\Y/DM=4?E<6^VCP5^NO_
M-DEI-%.$$XL0/4;R(BX"$>N)M4"("Z/X=ZST!8HFVE>O7:IW)CC,D*;TOM++
MXF=S-.5':G<SEWHMUT$!VE-&I2DG79O1N0^"@0\A[($6 HX?.DH[[[G-#4[5
M?WK[8?O-:<,OS_@^E,V?.?]53"7@F1RI9T$>[(KJU\7B*R#<*'PUI.4N0"./
M#[IWI,#"27<VS2FHQ-^_>&-?!,_3+K<WKR?_]9+U8%==5\V4E.B'X+\?F6*)
M*@DBX_9)I'I0V496D*ZT?/4=G9N^!044P/VAT/,IU#Q&[?JG.WH-O @XH^SW
MY%&Z25M71Z#[GPLZ^1VS#V^S6W9<GGX?%]\-T1@54!-D"E2S,(86B]KU'T5J
MPJ6]*56%?G7P!*C :-EW"0/*RX\O*$"*7=%YOHL_'M]VN+09:.BZ6/J$[1NX
MM9I^U'N2R9W"$L8"X$39=F*4TL^O>ZE"^8&02\]^>5WZ.(^[$I,1 B_7?28S
MT=KT]N>-XMSDE4?!S Z657I0%@;1*UJ$PIT-RB95CA(0CY&D%%_KGF9*(RSG
MZ#9^ZAT/'CIP._).Z,A.+T:_L>Q7+[VA64;,*K#(^3():(R.8N.9"@=[_T@I
M*(!:%TS6(LSJ:['591:XDS#EA+HOK7F$:[XE(TJ<SP6NWE]LN,SR(]/,3R@V
MEB,)1BV:.Q2NJR0Q/^Z#6NWJ7Q7:UIM-,>)6;(YTKTD?$E7*;7AZY7.'-S\H
MUG<=M^("G44%,5RH9QF%IB*+P-X(4XS\N[YM?:4D9%C%:@JCR[FV#VKR^+QJ
M$1)UNJ?+]4N>H<AJ2J%D5#BG 2*&)9]P8*7Z&[25!>V/*JY/CMIS8P=C0@6)
MH=D5Z[(09TQV^-3\S*4GJ^_],S:*P*LVJN]?P++R#Q*M2QC/(,&"R3BR'0K0
M0)&NX:$K#<3#Q?@L+FI\]R>Z#QE-A*3#\F8LYNHT0OW2/>P[+ET\C;D0GF7>
M'/]%>W*2%4.U@="P*N;G!SBZF#GU/J,D8BD"+$JWC%%K8!\J"+O0/< O-G!D
M[:*3\(>IVA!%H>R.TXW*7JYQL4VTBRRE\,($T%00)\DH4AB%1H5@IEA M<>I
ML?WQ\"?XF,H"!A(:F]/LO64$67(ZGM9QRB_Y1[3O&KLE^)0'2[ PNI@@E%&(
M#<4]Q#4W# LN3:O!CM #YE$M&&D* CZ!:K8;&1B8AS/'^]2Z!(;3U9_D5^6(
MQ"F=ID?1A%@WOXS"9Z.D(/Z[W'1I2O4.C' *$CA^3@<WV%W]=F4RX=URVSXH
M%9]Z@5*C_]A"1DL]5-%>]U4\K][7<UE0"Q;]1@B3(4R>I$U4O[2>EA1P97+(
M^8$L-HU^KR9HS_Q>&-ZO_;9K7:9T?M^".N!HZB"&+H7ZE++)<TUAFU5(YNN3
MR\_A#<-A"/&.3PC)2J#@CPTY)T.18M9K+VX5:GSA#W6*%_[>75>1([?X3Y*-
MV=23?$9I'P=+S211_9;A@CE0'A;8]@%GE2J1Z]&40;S8.F \M'PF*1;4MJ!Q
M6Q=VN*:Z$NXF'T@\9)'))OU:V==-T9WVX[_>M=LH6>>^S!]XD^#V%,^V%11L
MW.,1L^UVNYXH8J%W.Z\BW$^1 SP0QP*RA+-D>X: E N33Y&%EUZQO/1F/^27
M81 4T&;!Z_1Z%Z9D&!6Q#RJ_]A*%:]\'24$(A9" R7_*1BX,&HSR0J"&*8IF
M3?H3X24*/P!AJC8B%1'1@"]Y9J!#[N0<_5K W>.>YP,"PO/L[JG<LN!Z_?L;
MUXG7^Z!!3>0D^M>E\ 86^EKWA([L@Q8+"0N9)B=)Y-$+[5/Z-3>\9X<^*'2Q
MT-']0U=TEU+D?[. RY,^780_)6H$)V%#S#GJ&9IUOT!<N.EGW?')5:@C?#S"
M=P<DC% $NHB[B7*:&<-](CW]QVQ[;+A_UI=/GES_*_?BIQJO]Z>('+X0B8/&
M(<4:+TF55<;%00O\T@*C] ?"[ZJ^2UF^;M@J^*>9X:,QMSI;(]:+.>+VY?Y=
M$/OK%X*?<,DLT#X(23<]FCBT')"FH2&;O%+#N])J4U?YHY9;4B[34)'"7OZ_
M"K%!&A"D"0." ][B'@WI_V3;6^J\7@41\S/,_2&;1:"[$UMK&(&SYQ;H.IL'
M^_X7JR_M@["A3#VV.=1 &![]3T:O@7[,:A\T[#BZ#CW\GG@2XU&E>YK-";:N
MA+;O]:S^7\;I*U?O3)#%1[;45NR3ECWO#Q['.*J'YM^X?V1S/L[X#;WVX"T@
M @',L3P+B[$F-,$565R* L8?;F-]R:"/@-]VKU40MN^=P\7M*LVZ?PWYDM68
MMGDR05=1AULBW-)"30J[58+HH+"&G27K$K1(FT2MQ0HJFN*=1<CB=0!"R[=-
M)>?I5VI@+W&3$1%O/+R#]E8G4L4="^9),CK:.LE/3AK?,Q-CT;@<*68_I -'
MXJQ ]5]A\9R<=#EIRHF7062<(QF:IMGZ"E-G4=;3.Z,52I@]?K?%C"S-G:#T
MAEM"_7I^?T,Q!/\-EU' @AR0 &@"6%P#85/M_1EAQ"C#&*_'VA-V%EYIFEA4
M!8T$/*WE^%%TLA(>]24Z6.GSD%#;YCZ(%W)K=ZF! */+0,B;1$&ZB('#=!U&
M(PQ?\@"U'&8!H%ZIKTE/E\-EPQ<_FXWPQF1DE&>W![K EIP=I%[?_SRY(TH+
M9HZ94]L8[7V"+&?C3S]HL<B%N$2)RM(*5^0:6IGR"XK V^6=#ZK\OF??YKSJ
MM':UJ5$W(_6KG.\A//MWWISETAE\I=Q!_SXJW1NP(69!^_N,R) DA"Q>\!!"
M.Q;B-/?8O'.V,F_2 8N+XA-=_>R]Y7"QG3IM1PV_Y34M\61T&WS00D(D&"J$
MQ6= P1A;8D[R@\FD.W>8 MNZ-H1=D=[B-;?&]DB'4RV=G8EWY<%YSOVR8= "
M7),@2;H*U:^)- "LJ)<.FHP -2-3R-$"N3.S&#>:#MV*8I!0CV^;O3/4U61+
M_G8B>XTKI/A51:"+@8YY5%+*V+U_PJPH;,GH0@6 L]%DB_\DJ6&DU]_)DSM2
M3;AKOZT=68A(I)[$."FZ5X9HEC[>R8-G#4T<:G3H+?,W>^>PR,X*C/9$[([7
M^@'4;2! ^G'"\-$!I@J0?X]<T=\.YJ-KE:WUQS:,$BW2QR+=^[F#UG/-\OW>
M<OF$FS1>^]?#TMZ?GYCGX %4$> \87<Y?>LK+#42*A">BKCQ9QK6)3$><BPW
MX$[4!\%QQ5L_[HZJG&TX**<[O@5F-SDHIQH!V(B[H$E"K(?[M*D@@+H\]UM#
MVV,B*B",_^'5\5#=*F\#EZS9"J'[U>G_J'$0(PB^U4B+-%R+"")+9)H>=+[4
MQIRF74$(D363HE_#*]ZZ,]MN>N^#W)[_M0F331IX?^=66YN;LY#"DX)9Y>,Z
M[S+;L0$-*YM4V::#HCZ$/Z,#BR]&MTPF]TE,XG$\VPNEBF2!0GR/AM2Z#<4B
M/U$L@;DVKV]U=X#/^ORJI.R16] R3.Q_GR,%1QQG5"+.TY3I 8PW&"U\C@P0
M/#"]=W4&$7I_^:*H19C(N,12_8]YXYAVU>TGR58W;!P-U-CPN"/8&^>,J>GD
M*%+7NJR$>3<Y)PD5(BDU/B!>5%"B7%GJ^4!B$>P9$^"4!VZ#VMZ[_V9+=MUU
MXX;)Z@OV% ;+T@*T^(!U)G]$%SDJ?89F?I6R\#8K;,3H8TODB&UQ7215K<1-
M7]+O=FLA=[C/(^NA1SY7[E: SRTB5R L;<&_D#N(;NX(;J"LUO;5$L*!PHE+
M9:H4MRO!$S8'*JV.=,F>L+ESHR!:$99;Z3HFP_> )638<H,M<(UEY+1@=+-6
MYH4E1"P9/5CB05"E'[=Q:OM.M]FPKW8=Y"\75?^N=]]C5;TIV3+^0WQ[C?!'
MA/-_"C9[F-R39 \F]V^:]5:[_T\<U6.N^#(PJ5F:?&M&CQ0A%J%QE306$J)6
MF%LR>\M"X5'<JV&S@\V1EQ1!1\93"+X>TL0UBN/X+&V; X:C70'?=>MR0ZF1
M0L3MB4I=WUV-WL]9=Q-;GO]2 D^ET[\PZC%G"0<UXX)TL0ZJ^R<F.[S"G@))
M1 6LE'B,XD3H#B_67JXF97U^'=Q]+@4M')@UFS<P_30*)N1_^486KOQ!?=W+
M0*/;_^:[7J\LN2T/37]>7?W0-,S#EO?A@]E5+L<K)]E_JC"/C-'LF1_V02T=
MI(V#7B9-P 9E=,!4H'L.$E3S5_TX1;R#LWC5LO!!\M?SBH?PNF'92;W;OM2G
MP%_:.>04EGP?LF/\!B$$-!%0DN>K (_1>UL&<G)S/AB/:$CC;JGRHY'1H'?J
M+_Z)G&1!Y ?(,W09"LO-TV("F7) #6%E!2N,G"HL*DPAU44\E?UMJQC&0@Z5
M*R=O3TI(KA47<LC@TXN9/(JTBP@N\@)=IHPF9E-/OTF>> .$#);JME)$)^O>
MUKR<C'[IO>)A<7>XB7?L])$W7T2&^.Z?9-^%IF'; C)0A,A@= MD9XQ<;4_!
M99N<)6Q[P89SMY&G0J4O36G4E]YJ28_I)-WY8N "#N@,)%@?XT@J=4ESUU5)
M!&R9O$VT<Y =#TH-M19H(0\.E8HM0 (:1,8)V'0L_WJ>]/:V[ VOE\]9]B[I
M^D.AB#"OA_X"S1_GY'Z\)T@2H_10O5BJ$XWJO\-41QP@_T*$_%2;8"*N%95D
MHA7#"AC('OSP?"M#^NHT"Y8WV=UP-5>[J/SW96C<NK8N?[97K"*UAC4L@:X)
M<+%\S2301(.QE%GSH!D=W_<UX=!K%C/JI@I!^R !\8\KUP0COJQM7Q@=2]H-
MO3VT]6A<?G'O66=@Q0DSP8I6+' 2.P0[Q%R"\J!\H<L5U,!F<F0UI<-L#L:4
MV^Z3HHS-UWEOVK5+N!1()'A(GVE_)N]WXZJ=M&Z28&G(L-ZK^7&F0-7"C]K;
M%Q]#=N25 C\EZ1I2;H'X2G4NO!K[);9G1>*FG4<.2UG1Q5RHG(PRYE'D)Z8B
MD%MVHF+]G8D]Q<.QV&%>PK6O<RK4IZTM?EJ1^_FDHM:BNJ]%NFU<PM$ GMAM
M,V"47 H#C%:<&\$BX<HL3INL8\?^+M99#$6" 9?D.VF'></"OC#WQL"FGZX8
MLH -2Q8Z^Z!0^Y5J:C:C&Q4DR(T( "0JW;\AA8 ,7T)[]N#H!5>,6A!GXIC,
MO:%/[#%*DPIY-D='#"Z923M8P"7H(C1J&[! 4V&^P[66=M!,D$/=+( 43[!?
M1A'%ZXC'2!B;D'*WQ2#RA.C1])@7I*BPC9$=^00#>?FUJ=9<]5(T:U5F&15(
M 00K>"=4(%=0AY!J\/<:@L-]"L"P7WW@LNPOS;S5H(!+SC&4_.7VJ?+=Z*</
M+6Z-([8$3['&!C/*^@X9T$47J /S]::GX3[J).8YA/5LO3_:/5Y,O=[Q3$>G
M\5/DUE7+45K]?38E83-P!;19@G06#UXQIOJ2(21[<A_O*STM&> !O^/(_-_K
M]B$8'_SC(+6^L^PC*S:2Y@F6_$@42TX^ILHAD#86%RJD'G2*U(%N&0@A3"EY
MGO _Q/D2C@\91%FC,9A_VTR 6D)HR:_Q7*58F3%A_ A_C!9=&K5NSPU@F4<&
MR::X05/%YK["2^3?$P6O^>O>6U,+N5'WI4XYV9SN,$_N[^<J$_MR4!H-B8.*
M,T%('+0%1Q?'X7&#=KXC!6"NO,U!G#C&F+"B&_9JE%"3WVV)[4B*?FI6^&=X
MH2GP*<DB]Q/[KS*Z-($;<1P)'B/8Z;>*S_2]#;=LREPJMBN%+M&?W_[9CN@Y
MW0$[-HRHJ(5C"5QT82C5'8B@G46<)=OA4K$$'6 0\K!/&'"<=@CB\0XIZOW-
M:*M<4)?Q<'<?U4OU7U'\>U=3>)'8R_4637:R!T[L@X8F4]JAH@A^VFVZP:S>
MZGFA90]S8@VJ8TPM)V]E1SEI8=F57HY[OY<A5,8M[S+)&L:RIYQAR-(*(><M
M*<RCJ0^PPD^F0R44IC A%/#5F0(B2^;=PGQ35QP#O8UYQY]P?<U7.E/S]<ZU
MXR5Q<I-D6R:/*#'G&'+)VYB18*K'G P8A IC%/!J**D@![CO<%!MT)K"U$;Q
M#HWTXX[&3M&I@OM-Q[YF2=Q304YU8SP(HW3QO77P:)!)6#5S$DNVM4\K59WM
MDZ+?+GSK;33M2]%\QK=LXJ#G,/9@1W*]]+SN!VQ 1W2^X^=Q)8KBB,<@Q'\R
M&\M"$(-8P+#9RY> SM$/0?,#,U3KCA;RG[3?SR+L+##V"(3-U[$H,=+F,^6=
M0T=*)A8CXV^V/4H1'KCT+^=@QYG20!#,8JHSE_LDR%%#J[S79^_L@VYKB8=$
M1CH;53J.A55]T*A(_ZGO?,):EO!(O2;?&'[N)/LW;!JJ SW<LZI"M$IGH7?(
MTGT<,3*#C';LG3%QBGT%_QYN-1LA;3BXMA1D0[6-C];H.J&BJU^+O-\:I/@D
MMB^>QH=<8F%D%/X%MGDA"1)B'Z^[AAHX1ZRQD3.VNZ2<O35"/.4M2:IV\C]D
MO9$UB\^_?=C1*1Z2CV(9C@W+Z/ZP]#^2'@-LT@XVG*!] G"70>]3B<3-5!,G
MO!88/DIX-UM'=WL1[ (+8[>ZWSYC;%00EOP7B5('ZQA<8G@RLK0P_'4(CAF$
M';D'+]8Q:,^[M>!B4"I%QIB"[53M&TWJOJQ.^.=6+U5VFFF:5#D<5W_5S/G(
MZ!57/YKL,)EJ@.H T\4W\3"ZB/2PBPCXX;)*LA^00W&Y(."L=73R2&<(O]$&
M:J.N]GX_7X[P>YO-=OSE0)=?'L0_64A^A Q@^VH;=4QYYM<DYU+0Q.$::J_A
MN"\GNL"\MJE<I_:0MOD=MD/DNVI[:";/*.T<XC8C#XM_#>:"X#NA'$SI;5,]
M<D=2JS.Y<%20#WYG^$<;;ZCX^;OHY<:W<9AM$2]=HX;5,XV/?^IEHMWICO_I
M<CP %F*1*JPXPHU<34HD+V\/%J4D-@SWE3.U6])L>VOC?<+S+.!?/T<^];H8
MW^=8UOE"\!A9A31*.\@$-H7@"Y!*0!M-P,T+$03XD5NNSNTJ)KXMG&]R_WYF
MH;MNCN@>6[YUW3EYT4L=W"7Z_K64*'C"JWI "U#=34=XR?X9GLP"-T5E(*7I
M@JV 89]IROJ5WCH/6]^[Z;EZ!0GS^GN?'OWX5'#(;5K_'D]MNOWF9'_&V3X>
MUJV?=F\FFVHM0Q[^MKLV4*I@![E"4?(?())^F)P/4^[,/MO>FFS]OALD\%N^
MWI(_-H#F35>A"-*/*C+Y&SH!!YHR/&%F:'F^A>PRJ/-=^)M+S>E>M#USLK>H
M_Q+X]\?VYO,;SV5WV^*^7.6JI!^XU'KZ)0::!0\$F9^ATMB;J[8V@&R]-&\&
MX\'@\'8T$2(0U#$AM8S;<C=L<UU/?79S3X1W/.VF"%^90GZ,8"::[.AA_Q#2
M#GX+7:IABCFU]Q(FE^6#N=ZN0:9,')LM,P)\9+_DZ+>8F5K9^/Y</NMI5#(*
M6X5H(^XQ,-@ V H+S,G6P459F#&ME>%!M,]B'M5*4&>*>GQ6 Q(@XKW-2R4&
M-!.TB2W_)TT;,PX'R33AK+E^YI(<7SMK[N' -I,[J XY7:J9>)G<T)^J+\@-
MWQWY<QFW]"^"WB?3TIKRH9##2GH<=F;^-B@WSYK'&D3+7F'RB-4N'72B:&-Y
MT<VT/M#'(@SD2 "0]@)(L:*HNYS>*@H.!OMD?Q[4NQHMH77RL>KTL85 !H&_
M$PY]B,5W8F5,#0$/8N4^J+F0+E)(#,C&V)%SB%=>$V!B@#M,['LDOW_W XO-
M<>61[S<+-JJB*VS5=*,4>>]O/+&1VP<9D!M(+F1C8C5=AD;02D5R4L)P0,P0
MNBF%"DEJ6[Q]XDSW%Q*Q.,W9UN90KGX7]TF/>%K53\\:L4%I-/DB>#F$^@"P
MIQA0=\GH8?LL.4GR!+.8%@#L>O:D#$E]...AMVYRK_B1OQ^_5*O(845C4Z_%
MSUT@FA63^Z"]&@=@P/K6912T-BPGXH?SF26PL&C3XGH Y<RCI>=UY1#'_.-0
M)7&VW+F4M6S7%1X;AY_5=-DT& >.?'$WU=&6I\6"I1.8RX/*TC3GU?OG!([E
ME.G/'[P7![,A',A8:@S00VGQ(*_^R*BDWV&481S6<1R!_Y**/>P$XJ/4'5S?
MD0WYA0L,3>8X#OG"LXU<2E#]*Q 1!!MA%U#$9;! '5)WFA1!BAER/S+5&K1;
MX5$SJ>60[G)ZZ,H?GESKH3@SGC S\$$?D0M8?*51%%T4C(?$]1W?PK6@TTQ\
M*H&,(2-(\OSNA9[VY)7+!=L;]J<-SHV7O-IPEHYF%Q*]7^"YL8CJOVX23<A9
M01-V=Y)H%L@AY$G@7@7]9LIU, \&]@8H'Z"T&1<?N_AS9<W-0R+TW/+QVK*7
MD2<N.CL9#Z'.HOH'P*U6;R%'4?V&3!X@<1 EA=! ^=8@PLA.:\51 0T>8[+#
M&!V]EDNU]>>M9[Y&?GN1N7Z\[:"!!5JVC]N=-74'%!Y=^ =\#*'YR -A3N%?
M_4!J6-E)7HLU6C,\$8E+RK;RNQXV*!IG!XJ]1T2M0(>8ZHQ*^C7:2>88]D@K
M3A9 $ZCY 3$444<*5X;'Q6F]4S#%(/5:_B'GJ+R):/5 OY_3LKDC3J46_M=A
M&5A\&JI5*QDI8T-#,F<@K>)I!H,D@_.,\HB)D!$C9)VJW8ETA381SY$)@8WG
M-6I)@7M?Z2_/?^;T0PZ"VR '74].5-/%8-1>1BD6-IDF%3#83PDA2M'/ ]!U
MB"14(_MQ_?<P]1?]LCL;/H*']$YS:HTKO3I[&2P >)7;T\*8'U#DZPU+X]0[
MF)XYA,\Z.%.JH)<0>N*<$5$RPMAUC7M*R#HCN7B')%)SX['JO62..&0B<@I,
M=H;)(D>EK ;W05FH-O1.XCV"X$.($,8JH$(KHYS2ZO( FWP"8QD3,*_7=#MW
MI8QGS:>CI^MG^Z/[PT[M?;JH?GN,+<T$U6]N*HL<A$BA H[\TI FM@U_0!X!
M:B"9L]]=IB]DCDP\6D[.!HCZXCL76NR/N7E$AFQ ENR9/ ?9/#!&'9(?B'KK
M+K'CBP_9799V[+#3W,3[X?J?#O^$QTO<&E?"WM0>O)7'E6=;?4,AWJW$:7;8
M>Y1E71<!7[(ODQ?\!I[!Y(8<=)'72O9=H O[2&28^!'SB]1J)H]L'2LZI[J\
M)K_R\.=$Y^=V2$2@G&Z[[3M9D&D1(V,?%+2;"FXK3&R#I?W#]MNB> $76O#6
M3'_19Z0*#4ZQ>*X[)C2G,;,S=6RGZH@<M\R/@C,"0HJ*D):%09:+R %.X9)0
MH9#X!7 +BQ=H"<%][0 <&4F%\B#.DS^FQ=ZYT9LWG-6]%<G+S:U1.6#R5:'9
M@.\%Q\_QV-'_7TZ: *=#R&&3.RSLQ9G$<MO/Z'YDV !X29?JTKE@*@*7L#<8
M?V.0W:HF-O>[)SY-6=L+:G'258&71\+"N+)34?6]_48*_<(Z:_3"/JA"<A_T
MH9B0PW1;^$VS *'DH13>'+H$E)D9L _2@25#_@9 /U73I7'D!2:/!,V4^?9?
MU$X/:ZP(H'R/8!=&V-@+6N.?5::<>?8ZR];<I^_(N.OGR8VV'HDX-9*<XUN)
M2&EP^-3_.75);P6R00+"HV*2@!.#&U^:_45[?;GPC%$R6N;3AWW0VJT(U='/
MF7,38,MIDW-5Y\L#I9S:LO*;.=I;6^)OIBLSM\KCCL:P.0>^X+M'WB4 E'M
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M!C?9G4M2SN.]&9,99WWO7182.8^J?EY9%5Y4594H69?37>=!$'*/Y*JOW,*
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MUR2][M2 1GPV6;+=2HD+'ELQA_=SV0NQWNZ:3>#&=J=>=G#92+O8'BF\MQG
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M[QCF7U_B\E[Z[.I_E-_^A%?JV==<&N.I2A/8__?::']>(FD_8X>X$+FNI-8
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M$X6>43S7L<'FYKN\D!444MB%2LUJQ07??_>)ER6H[K&TZ2#P'#<&'[C$':_
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MXJ1S,[8=V2D#I#:@4:?+M[G8IMYL50*M3@OP6JM)I\G  )UTNB:R37>^IER
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M));K<9F1QT-Y9(8^#_#U,< .Z6V62)M3^'B(3T3IGI&WXG@W\'HXWW+ R?8
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M.<M81F5DUL!HH!QS(\9ONX<'4H?ER,IE6RB+I#AH4!WN:QTLS_6N"V7&H!/
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MP.BS]F'U;PC[\_OCVXW@Q?8#84T5E69WS(,8T5A0]=Y3G<P<Z)[!B,-<!K'
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M;:=M:[F!U"?TIUYG]BR_)R8>L5>7<D9[5T_-,H4(_%;5+#N TE>^K$4&*&A
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M>!7EGX?OMJ(*E*8(P1A'*419BF&.$($D"%A *(X),THMOCS5W!CDF:1 BSJ
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M8!Y&%'*4I2S*D10L'NZ@V\\W-T^=^@K%/KQ-!T"'N.B<8'IE7QW00H-*:K]
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M9J8JPJCF!22!GE\N9V9-GLA*YV1F]8Z.^J' U69OF?(6)5=Z/_T!>)%H2Z(
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MUE)L[FTW<[T3=-[1[X/VD=5+ ['=(I5@!](#0_8^?!],3>2Z_STO\H?M@PE
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M9HZVD &M,9O,VPJTZ>OAM.>UI=W&ES "F:-[$PSF*[#CLX$-6MRFUX3IB]E
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M:2A$&D<*9IG)[ S2%&(F, Q(F"92Q'%&N,M15N]HL]-Z;3 CW:.]:IJ#/AK
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MZ;27CJI=)MJ""V+,L1!B1K*Z#R%5IEMLQE/"4:0$#UTR+TZ,XZ2GIDC9-6.
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M*>HRK0^/VWKK=:M>^W#VGZI**4TYCR".J"D-S1BD*F PQ9PC2;.0AU9.%=_
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MPE>A>BQZ6$9[269J%#]=*=<C!VT ::EC9T=[+)R9"1UI'::QGC7VOYXOWEN
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MKL8%)5) 0S4*(]?LUG\6]U*=*_??XS;K6&OJ[ [L: (.[)%0\6!7S-;U:8W
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M=_?LK^7B27W)+SI.Z&]+'7:QX&:\>SHOGFJ'!6<L$"RE,$VI@+J@(*0IS6'
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M)O,DA3A-F/H\$ZG^&=,\(Q&3L5,ACD.#3,TJ->V>JXV0CFV_#J%H]\%>BLW
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M2912C"!)4PX1B3@DF8@@RZ60<<Y96CK%Q9V4-#7*[!0%"ZVI&P6>AM..XKR
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MNE$(1$FJ\P%T]Y"$IQ!'.24D3E@JG?(HSXN;IA_/&IW!QCW(Z0*Z=L3I#[/
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M+5H#@-QN=)F;CN+!8VO*T+[F=B-C1^4!\0[,U'VH.]T[I@6=]FU/<Q"DPM!
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M-XE=C53@&>Q%G\N=BF%Z61X@$*IEY5[0JW6F/+#U7 /*PXN]5*[[LNN3T:7
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ME^>$LE(6"88(%4QW?\@ACFBJ6TKS,N,9SHE5@)*[Z*G1]4[[;H>BTW\&.@N
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M68+FD,9*0)FDN3;[D GIU:CBT")34T\-1L]Y;(?(<],ZEU(RL()IX($.'V@
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M?1_.0AKU7NN/:L_W86;7E.]UCWX*K2[^_&*NO?Y>5+.(Q!$1"$/&66ZL\T3
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M53E29U$:QW&6,Z^"G#/K3<TF6L-M6@1=-0G#U?8\BCJGN/FQ9R+Q.>[=U%A
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M$P9E8CP^1'&21Y&K8W=VM:GI(VL:NKLFY\D\[\\%I6A@Q6*Q@CL-MM"VP\^
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M5PM-0HR.) DZ)"N%='$$3-Q^[R LJ':Q<)0<F\# !_@\+T)8;G[S9S!+ :7
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M'/-O\-)O_(ZM6?8R0HZ<)*$=D5(:8I74!(+1/#FMHQXOQ[V?AF% :3Z).8*
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M0<-9T\-%.)KN__77.\)[BS\XH@/2LELMYJDXT_U]B-[%7N5W7V%[9;.[R<+
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M)7K3&8*B,89B.FDN1WF9N,P] = B&YD9V"KIPCVT3+MAU0K@#I1U W#I6\A
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M)D1I@BBB)EH%%_$W&-_F >[3S]XS;:G%F&[3J!)MP+[</(^[W(LON*'2EU(
M2I3B!IT_97&;-8+$$*FC.FEFJ[1,?IBL:8LR1M^HQE-!$V>B%Y4F+R%L^LK[
MK_.2FRK,O0N+^>?MS(;+\ *T\ 9#42Y"F:ZE. E)]0UXRWPM:FBJX@(]BLII
MRSA&][BK*:@-_-TURC(IY"%A#(NO))*!(<%[1UBTSD@EG:IS9^O G;!:(4>M
MV.U 43>0[;['^%X[P]%49!]*PDS%,L2726*Y*"6W-E$?%0A594KR3RF;N.3C
M1-O@@9IHPQ(-,K0SW."M4&66O<O(EZ>).&> !"L,S5G)9*M<IAA&WL1E(=-L
M?H_220-N_,O=:[=7\S_Y[]?$5M)E403P1F1B@P"4&*X:"S:A$VF,4R$YQ>J,
MJWV8KHDK1L;&UIA:: !4MZI@NDN;/%/,>4N](#IQ1B3-B5B-X:Z-',6F3'*V
M2A')O11-7$@R-I#&D7RKR:=K6SI+6J E145;9S&X2)0$@>Q$EF.I!5;9W7*N
M'I=_>JRWU'QVNX9@&S U/4O[.9'1N6@T)<!UWUX&Y<4D1A46O-4<0M3USDB.
M@-*3R72/)/L&4'2-B9E"=TU;8\K%6?R#<DZL9V5LF8R"N22LK5(9>XV&B<=I
M50SV'R7=!J+\,@ILOKWTUC?)*H,U/\,R%E9HE"G@/R'!*/3T&=-H*9,KK>R=
M53+ZE*L Y0&:FFG.6*?&;2QM-&!Q^NERV^/EKER)V_PXI*?DM>69=/16X;(J
M:0Z@N&M';HBC3DAC34!?KXI?/2H;S?1EK /?"77> .+?7[RW%\.V>Q+%S21C
M8$)TEKK,Z01BI5%E-Q B>"64KU**L(>6J?NB30>-.Q=VC]-3 U"[-L"SNY3C
MLY3ZI8R+VL_3F^4N@3<+CGL:< E'VG?P HV\^4BT]\SK)+DR52KX'D/DU+7K
MS8"SFF8;0.VGTH_]?/WCVKHK61G#(9'$%<H+/*X[FQ5AC 9!#8I+5@EA[Y(R
MM6?9# */U%([+9,_P,;/EY NYG8_B_'\['Q17O(2\CS.T=D100<O)4FI'&@8
MBD$?<^4^6@(> ]!*EXY_3MK4GF(S<!Q9BPV8P6L<#!HK(7A99D(3+PRRQUR9
M(Y<CB2D[T%%$%&6E<M;'T#EUR^]F$%M3OTT<WM^5]<SXX"B+)6=F.9&V%" H
M90@DJ4.BCBI9Y13U+BG3%M0V!,,CM=1 ;O+O\^5JW8MP-[I!.5J&/ 7"0:)Y
M#\J2P*PDP0?N,W?.\RK;]6U"IJVR;0AC1VFH@:UX'%'.>*;228N"4^7> T7C
M;7.PQ ($EH( 4:F_]"CD3UO"VQ":)T!# U;V^F'8,NW9-2#P;%,4A-N$<L6
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MR\_*LA/2<T^E(59!&5IC%7$)%,$@/H,W-EI;/;H81&F3F>31H/- F#&^'EL
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MK].,V\BEXH)0DPP&I;@"^O'$GF:JI,/8Q)_HYM2#=#9RF'<@+'Y:N3B>CAJ
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M><6"KI)W'4SAQ.,<*F&MCH+:1M[M[W<,"D^IAS*,3$IT62T4YQ6--III] V
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MQ5F=9+((NG!'86_*X&2MO]%62\89MY$-@-3!!$S;H6%,>)U&!UWLH==BVTZ
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M=W \<-\U'0:M:N]DD)M&WCI$\+XX\,%DBS(ZQ":G L?<P$]Z '7()C6F$CK
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MP6<47I<44VER+SR MDY0.18>[L/;2,KI%&_K[V:[K>JVRF0EHH(0%,E,6/+
MDY%@/4MU8&!NE(@PA+A.$#<6(@8@[BCU] "Y^2(L:K_;UPOR7RXJ2QO+#"F3
MMQ(-:.,,*(Q(_@S6[4 )+8M(6K:Y"]U-3R='C=-NL".HJ@/$?5B%Q9K>?-T0
M@T3TMNS@;ET;.JUW_VAKSLX)$[DK8)B(EX.'7! >..<Z:"T*TTTNL,=D8N)%
M<PQ4+3M1<0?P_L?[ORV_XFJQ$>1'VGFVJ9%W^Q$*)R)S$DH]N5*&!Q*P"6 $
M;1_.TT]=D]RNH01."\OI(+0\@3Z[P.G[VO"^RO?W9=W)4CA[?Q'S_.M\7<<S
M7'&EDR.SYR"RJ*<9P8)77(,KL21;DN*AR3G:,/*F=0LZPNCHNNP H2087!,O
MKY:K6D53AP7O,#OE4Q(6!0@?ZCZE$:++'KQA/#!N++]= CA2BNP0ZJ:]@NP&
MG^-KL@-X_K)<X?SCXF&>LK;&1Z\@&9=J_X($3EI)_KZVPJ"79'--PJ@!Q$U[
MR]@-.$?78P?8?(?KVJGJG(1UU03Y94A_8+[#6.3>V$1"*\0"*"8DQ*)H8\!D
M(SGZSKHFPSL&4SAMSXIN4-I&HQU ]7KBTB-\:8M>&)'!9%'K.CB'R$AZV?$Z
M&$Q:IYODAPXE<-HF%MT M8D^)^Y9L2GHWIS]W<-+]D$'Z33$;,FSYI&V!R;)
MT6:9%V=%B.56=O?./A2/O6?:WA*30VQT572P_+W#C/BYG@W_?D7!^_-E^F/+
M#=<FR5@[$+B-WQ$R^1TIU+(0KI+)1=HF_N/#9$W;UV%R'#;070=(O'%?^_W+
MO\]Q141]^O;_L_>FW6W=2+OH+ZI<S,/'Q$GZY*PDSK+=]UWG$Q>&@JW3DNB7
MDISV_?6W0(F23%'2WN0&-^A^>W42#391PP.@JE##[_@%S]=QX<B<-R0BR*G4
M;&961V [";H43.2J:59:9V&\0%XG.;^])&),I<B>X/GX\?4I?YO6ZC)ZFRV=
M_4G5W.<BP;F(P+S(IO!2.&M;;C6$RDY>RR>$R9 '\TETUA,@U\4?5VN)\4VD
M-4='_R0@E" HY;$V]2>FO*,='$-2JFU^Y5.:.@';]$AX#G,'JJ53A(F-]U2R
M,#DG\O)E;9/&R,LG]QZJT>*DE\AXDZZB+]#428[&+ C;1RV=(DS>L1)*\#D(
M"0:K9:Q<).O#(@@O9,W9<TDTF5;X DV=6'>S(&P?M?2$L -,XM_ON_(A#QA=
MBN32!Q)JJLTA#5. *(UUF9%UW-;YF(*+3JJ[^O!1C@Z+#O;$+<\[BDCN:TB\
MU:J@U>"C9J!DLA XSR!#,D$$GAAK\BKS*F6=6)''1\VRI0H[P.2;</6)Q%7_
M\\M_WYQ]">??W&X/#"Z"MDH+3?N<USFZ1>7:^(HN-A-T8#KSE)ODK0VF<%Z,
M3HR,[=>5)FKJ '\O]Y5\^&[!,&HRJRU=.#'6QDL6'$^U1:]5U@;D"9N8 $,)
MG-<+:HN^)DKJ 'QU*UU_?:#_UR]_GBVD).'H^G#.2$;TM0%ON08;9'&&/H2;
M)G4VNXB9U_%I"ZJ#A=\!@)Z5T$(;E+:6 V6I1'V.K#E#M3\NDB,7F='.-6GU
M\RQ%\WH?C<^G2=0PV;B79NTBWGP*EQ_QZNSR-C)P_[QYR_\$?2.&+3!Q XD]
MN#I&)PD3@S0%'5@I:ZAXW77$%[!9L6A5+$S_)W>2L$)GQ1V@%W4NG*&-JT($
MZYV1Y%@9E9OT9?]/Z"0Q!GD-.TF,T' '5_%S]6PE2>Y4(6_?5(N":[H!,D>(
MVDHC<^3)M'D1/J"@M>M RA[H&%C0.D95'2!NTGPD;FP(2F;(K-;H6!\A!CH"
M=$K*A52X3TWLQ>^_H'44JEH6M(Y1<0?P'EA<9FN"I48%/!2L72X+!(?K&TM@
M\5JITGNAX&D4LXZ"SWZ%@F-TV0%"!U7P:!94#K3?>7VH4CIK<%PI4"KPVGV8
MHVO3K72J2JS3*&,]!)V3Z[$#; XK?2R*1%:< %-'"BC./+B2"F!,Z)A'$=OD
M6ORG%;$>@L[I-=D!/+>#KW=<D->9D[41ZD,1R<DE<-8PT-ZD$CDKC#7I_K.;
MG.^H4/40 $Z@JPX0]TK1A!.FU%DJ8'SMS^4-0LA60-!2R!!%2+91/>K!!2^G
M481Z" (GU%T'2!S2H- FD6KS%M":V6IC$$L^%,ATIH><?4FA2='I5#U'3Z$E
MVB$1I(E5V!,J7VAB6*S7NHB:3%H$J" ]1.GI7T:X0KM;D8]VK.J6D^LY.@H/
M>_0<':.<3O'VI*DE%SSIZ!ED96B/(G$7A.$0;$@:)0M1-<GY^CYZCHY"Q#X]
M1\>HIR?(39+&*17+EDL'G->$(YXE."$$>%D\CV03Q]+$8CQ^3O@IU*U.<9D?
M'1;][8D]ATZ]">?IYGS]Y;OE^?FOR]7?8947)ECFG#-@UF,K,XO@<F90D(OL
M518IM!ULVH"I3H[]XV.UR;2R"8#3TR9Z=%G^U]GUIR?,7WW+_;>B6@MR_3$+
M7J3,.0@PO#K+@LS$&((!J05R^I5GMFWNST2,=+599H3H ./J:'C9>[]\QM79
M,K^_#JOK@SL;[:&:?SY5S9]XO9F-3@?=/^F<N_WF3?A\=AW._T%&,%[5J>F/
MDIO());!*0'9<S**'9?@-690VE@E/2^Q;'7NWMDR:38&N@J_S+^E3@=,W]<]
M5<51A?';93J_R9A_N_PEK"[ICUSQA5 F&U0<LM$!%+,2R$DTP'6Q3J.+F-KF
M9C9E;YX[[81PWNZRFPITW_M67#>K>[.\(.8^X>75V1?ZJ+2\P/JG%AAC"9PK
ML'2JTBGK./B:9*/IU/6*L1)"V[C%L3F>Y\;\GPW;%IK?UQ[^ZV:5/@72X,)I
M[X0C [Z0R4,RJ(.BG$\@.++, WK>^.5O0F:ZBB[.;ZMV@YOO:^_4BF#B/VAR
M>W4!%0RYP(@((3$%N1C!>2X%5>_7VIJ1KKJT?)=[9CQ>QN\7?[M?+O%CN,;\
MH<MM@]?7Y[?O>HNL6;9%&K")T\4;R(R.,BK0,CNF2DRI38_S-NS,FS7U'[&%
M]L3.=[F1[M/DR%!?*.1>>AL!0ZR&-SKPR!%L1*0C1W.EVG:OFY:?>8<+_"=L
MI;W1\WT9<;?O&#(84TCVI)/:VLT;!MZS#%EB"2YDKF+;/GO'?/=J-C#A/V';
MC,?+@>]>OUSF!@D7WW+V_OKL_/Q_X?FC(,\F@O(VG2V\M<(K%4#F.KH\< LN
M8 *GDDF&KEK#FM3H[D]R5X]5W21+-%/Z9%="LPXR_U@16_=7WF^7U\NW-]=O
MRVWGE0D:R SZ_(G[QXSGZ2CM8\B111/K 'C.Z6@L-99:/.%&Q^)E*MBFC=AI
MM(]Q)!N2#U'/O*%;K$0(/--5YG@TRL3 1+<-?;MO'S,">>W:QXS1<$^F] L5
M!"0\IY5G(&TN=<*>J"W*.!3K+?THF!3:EE\<6!34=5;D'JC9HRAHC I[0N4+
M509:HG+<&DB>N%$I)@B>)^ B1I^-22P?S6<[N:*@47C8HRAHC'(ZQ=N3JA.=
MK LNISH4B'BR)D.,6@*3CK:N",JXHR7'GEY1T"A$[%,4-$8]/4'NY7%47/(2
M3$1P5GM03J_+EQ7DG)-.IH1H?..[]P7R3M_/GO3ZG4J1/<%ST/ 75X)4ED<P
MAJ"D"FH((5I QZ61:&LSVZ,=C<]1V<D9.2%,#AH_-T9G/0%RQXP@1(DR6@>Z
M2$9"*]6:L1&XCCS8[$5*;>N]]AS=U,GXN5%(&#&Z:8Q:>D+8)&%;EZ(4@HSK
M)&C[*EX,>.<\N%!B"I%'Q+8/LO]3ICOQ_7YT6/2T)R9\<*Z1ZMMS8L$5<T)%
M QP3N:&61!("9V -]TD[K>FZZ_S==0=;G9S]Q\?K$;(5]@3/=[J5'CWX+'3A
MD16?('I%9USPI2:Q(T3#1#(^V:+;>HIM^#I]%[/?S;0O?+[_=+J<#691IX#G
M]5Q;I2!FF4&;R#-JK7/C)BLSI--U;<?UNXG&PN4$QNV$U>HK,;O^)ESFAU^<
MAZNKLW*&.=Z&+*88O3-ZL:G'\!S&[3%R*G0@O\5Z"9H[6:=L%PA6*C ^:JTR
M63J\[=7>,J?BIZ\_A?-PF?#])\3K?ZR6-Y])&W?ME1Q+ :6&9(0')3R':.F.
M\C&44!"Y"&V325X@KA,K_U"\O!#.GD8O/9G>W[R(WI[E->@JG8[%>04VQ_4,
M1P.N, W6VIB+]]&GV!AFN^CJ!&&3 6%0WL)^6ND)9 \[LAHL/UXL;QZZ$2=E
MG+?)@. UT=[40)1T!I!)%8N)GO-C9<<](:X;N!V.AN>0-I5J.H#;7\O56C77
M]\SMX'+3+S,K$5GD8'5MT^2(R:B]!AY-$L(4[GR3\VT$C9V ;S* +(^CK0Z
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M/I:LO&AB5LUM5Z[?_C,R+4KQP%/(=<B\@*"C QX<ZIA#C/Y8-N7\??+:X6:
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MU[')])M]B.W:#)@1L'LILP/ /K&<JN']VS5>7"V"\3YYQ<'X2%N/D^$44]&
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MI&VO]0F *+@Z)8O\]O:K.Q: &AWJ/G9#^!$5/Q0"1)8T!9?%6Q-E=*))LG(
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MC 7'_/8137$F4B9&_^4KRP<I>^_*\@&2[P!!SU8SZV@DT\D#9X682H:!QU2
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MNL5D9)"-KH\.,/86U_-,PIR'B]^6J\V'\ %_"ND?F!\?'N-5D2F!4;H6&[@
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MC9JSY&VR;2*?0PGN[16\![@.5N1Y O;5\G(U(P=+H906; IUZE@4X!G6 MJ
M/,E@;9M=#0?2V]L#> =P':S&,T7K_ O.)$H?K0\@A>3U4";PWEF0)DJO':8L
M3K1J=R]Z>WL/[P&M0]5X?FBM++XB28>+RO#Z_4=<82B;[:).J:/A&FPNLJ[
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M#J#YX/!=,V&4YSJ6#%PQ"2J3+^^+-H!>A6)3"6B:%,3MI&;:\N?N('B\QCJ
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M B+7;6TY*#K%37R:L3@XZU'N0] [=)='&PQTX-#?'UHDR,L*V44H(M2!:[J
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M2 _V,T^3([A%HRUQQB!RA95;RK5<%L!1EI!=<3JW*4\]BNQQJU<;(/QT2NP
MLO?OEFXM>-=;IK>S-[B8?*5_^^O=0LJLBF I2?"Q7A=8+\$):<!EZ3WG$E-J
M<J_2BJ%Q(_CQK@"[ $B'AO(SZ6@'YC=IT6KS=G#]DG!;T>*,=TE(D$DD4"DF
M")(%R G1ZJ*43>841C($,WW=D8\#TQ=LY^28Z<!N'BZ:.N1PO2S).H5:0V"U
ME1]3@1!#!%MXY,%:EER;I:F#D-^7;9P>AB\N'VN.B8,MX<N:_?>KL%@-8@\D
MP]=7J^7%+/_O>5Q>)!*K8-P^JB.*1#_,_ZA%&I1G_106=1SHDG[@IU*05&!8
MB,F@!>E)""1Q#H[9 "G0,9]="LXW>2H=CH6^@JK1[6(D;'1P2CQ7?_$*R[R.
MN_]>"#=E&9=1"H4R%O"R9'(#1@'%M!:X518%!J58D_':1] \[FUI=[@_E?8'
M7$_91R)Q:5GA:'B!G*.N%\P" EDX,.93$@$E,TTV& [)Q+A7I-T9PVCXV-\Z
M_,8Z9NN=U/G#24Z#&]:*L2ES60!S<K5KW$%TZV/.)!NR1)/%J=W^7I!N=B?:
M':0'U^?A$<M\%:8]Y;7,8C;%%^"E,.(ZTO&E:B+#B\S612%"NV4,I\EKFW7T
M=X?S$3!Q9%[[TRR/%;]O_GA]2%DIDM$!G*SSO;BD0RI1ZH)UUH$6,:G09.K5
M,43WE;EV<=MY,@QTD*\.X7INF2_>,V2<0<SKX>B>U60]@2G!Q3H41[@FE3^#
M<M%73MN%18R'D@Y,Y/HX^X-8_:YTZKHNY,/\U1V/@/G-U:+64^%?*R[^3L?B
MIQH;7F*2&>LKNHYU>&FQ=!@F]%!XD!JS%2HV6:\P#/E]Y;9=&,4(N.BVH?3Z
MWK:R?;-/Z#NB=^HB??1GAFD=?9G"H>86;3]T_9&;@#P&RO\P:2A9Y#K5AE,@
MS 1(EVS2*%TQ;1ITGB#HZ#:D>[][VR/MN#5U>2\(2?RI;"-$XS*0TU<ZEIA-
MHU:DIR@:N8EC"$0\Z$0:1/H#7B2?PJ4<//[CF1]KYUX:COUX$E)<6%4\SY ,
M2E#>&HB!HBSAT#G."6YMUBRT<C*WXQKN?^%56$[2Q2R_F4ROZJ7M]V,:M$J:
M#G +2F0ZV-&1:5D5@$M')SU76?(VUU&'T=NI@]H'34\/VFBGN3-S7X>/UWCN
MU]HYL*;C'9_"G#1.U%E58#P&BH=%'9)O"F1G1/#6BZ";W"&T]V 7L]4D5\Q3
M#O(>$V4#JPDN?_JKWJQBKCEU35RN-NI[:#:;$M@8O4]1"[ B&C+)3+F+5!Z2
M<\X+IEWF;<8*#,I&I_YN'^P],UCHU'KNX)+D2)Y??7O\!]8-^T;GS%DJH)VG
M8P&+@1"CA$B'4!1*R2":E$PVY&GD^0@C0O5^DTHGN.G6A'X/GW';#&1EB"(S
M"\407I7W-5UT@9 ;>!(*&5--:F1>(FQ<,'>#H)V0?: Z.X#G3Q2FSK\AKM^&
MWWZITMQVBI5L:@5S 5[7:"NF$WB2#: PR(PP=61>DXCM*8IZ!.2ABK]_[3.(
M%D;>$TH&^7D^JX4%7\.4)+HVQ.7UR(1L;<@B@2L<*0:C(R6PDD I0[+17F@L
M+V1++WUCW#?O)O@85*P=>)LCO?KM"P\/7@L?(X4D01'?W$#4K( B4XDF"B%X
MD^JZH1@8>:/>#Q,I'H:(\[>$Z]69R;#(N:RO )$B&2O!^<) 6S1&)T2A>\RA
M>EB&.@[PAD7_ 2@8M<>@'F>_7WW&1?WG/\\7]_EY'::I/OA7"-Q<WJA<(GD7
MP!(#*%$R>!;HP$O<*.=#9L+O$#CL^=F1!V(->9/56N@=.-/;0KZ-R=3=5E?$
MX]LOE>M:R7=0H2M:%JVQ!AR/OJXC+N!=*5!$,DAFA11EM:GM:<'...ZV.?H>
ME.^,#H4NVKC>!6(N3;Z$NN;M]FAY,UENN,5\,<O_F.7;_W[WJ6C[AG?)?$)6
M:[NY+!39"3I>G#;UJ(NFF%"O3IJ\.P]"_3@^_-2 /[VB^VG$NMDD7UG9R8Y]
M$=YX8\&P8D'):M'6&<# ?:9X(9G29*C;WI2.4ZY\:O"V5>"Q0#U1;%('17BG
M A(305#>$ I$:3SPY%V2J)AA30KK7B9MG/K@_F*&O50T8O=?E=P;G,T_3V9[
MR,XA]]8I"4)5YZ_I&%C7 Q7/DL]H@A%ZAQ1K[P^//)1UZ"2KK> [2+/^Q,G'
M3S6@H$ U?$0RT8B+MV5S(?WV:K5<A5D-K->58)=$O#<4-$-AM6&6$5]!2P0F
M2S&66T\A=0NOMA>5XR5%C=$R/Y7JNLAV'F5O&]L^X/&VS>32>VNUTAX*(KGU
ME"4$91%X8,XQD1UBDS?. ^D=+Z/I *T#J[-??_H4HY=:,L^D4R"-T12$9 IO
M#!)[1HN,7*/G37K-]J1SO-2E Y0.I+X.)DB\4-]]6TV>C=+%9DB14[B4%0=O
MI8-@O4G$JG#8I'YI1_I&GG#>HB:UA68Z<(<OIV'$\)K7-=>7@9M4NQ5 ,I,I
M2F$":F ")J3BN<D"XTAI\W=T]E44/0A6]LZ?#U=<%^'E3@S>]?N7C,5LG+1@
MZ1BI8UH*.*T3)!=#L)PKHW$T;-ZEM*^'SM'0>;#R.NY5^@,GL^75(LS2(4W;
M=__M87J1GJ1GH-ZC.[__9K),TSG]%US>8,B[8'Q6 @):2FJ]4H0A.GM#S!Y9
M8IZG)G,XGR?K^$DO-[]^=YNUYU91ZNYT)%9U1G""XMN2+5-,6U1MNHD>(V;L
MV=*#8>+A])0C)=_MV(>[G!W:FOWP-P9W(@T;L5^ C?2"\)(I@+%(!X1$#ZYH
M#\PF9R+W6 0_/U=R6Q7Z&DF$KPF.D]4?D^4_7WW;?A@7MTB/@JOH4@1N!67.
M=6V8L\&"P!)U,MY[T^0E=2\JNW8^^Z#HZ;;$H74U8B*X7*PNWU]](>=2;_/"
M]);).Y)\M\#/DZO/RY_GBU^O_ZP628;9!)>W+#.&B)Y\,(^8ZO!]"Y&Q!)Y[
M89(.UL1=AO8127>@2?_M/BP'I'GLF7V#@W4L?79PE[$9<[_\CM-[$Q&RET4;
M+J'8VK AE81H<H:HHB11ZVA-D[&2+Y,V]JB\9EYS8*V<0P#W>U@LUN/1#I]2
M\=RO#1[4/4_O:<([ DDL4@20H2"H6!\%DJR34KQS2A("VPQ\;1S>7<4E_K\K
M4M%/7^DOF]8=2SF/<441R)D'Q7(=:.T%)&<C=]ZK&)KT43U&3-?!VCZ8>!"L
M'2OY#@ZT^SS0O[;NI;:4/Y<<R4%F5^HPZ RAML!HKKQ6TD?=9C;L$_2,/('A
M:$6_@)Q#I-XG>+9-L<P;J[ $X(9.6A69@J"<!G0^>HKLE&HS!.1)BOH"T$'Z
M?AE#!PB_/Q1M.Z"9LSGS1$H6@7+;.G(Q,)*/T<)8"N44VB9E9H]2TQUZ#M'T
M\_@Y0.S]8>>WF^Y-$DN0]5')\_5\!>_!,Y;!^TSNVC ;L<E#W5,$C=P8WO@
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M!_PO S&Y'N#Z$6=I<M!@PN=^;9@WOIWI'>AA[\[W+NY][S8[NL%=""X'\E3
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M0.BS \20@NWB"'J#].VTF?E%?S_%M8IF=1\62>[?ZS^_U+$49M#4@F15#]8
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MFU"JHW(%OZ:R,E:P&N6N):ME95529/Q=LZ#-T55IHHN";@;B&\\UW"R*0Z#
M@@7]+:AFNT&+$F#.:C;+4!A'1CU_G:F<-(0WH!6&9987C3T_:SK>M*5Y>R:'
M SZ6*F7YGVLUACT=N.?"HOU.FB;:OBEJ-[G>T8FHPJ!#%&46?IID">Q7 5\
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M&?$78:+J&K\$+^!(!2:DP/&]T44I;IJ<_2!AC(P$+H1YG)V_#Q*M4%V9Q+-
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MXQ;W838C+\C5!%80[+C=X.<82!R1=XO_W1T$/U4(@ #VR;\R]2G1=\%WWQX
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M<NC\<XBAG%NUB54;0CSN?:SZOBZR?[KE.A^:UCE)72Z_XY)2J2<'4\E1%W
M;M?*50S^07I84*9_PK9W3>\]MKM>9YCT4FK4T%#HP7+3)]3,8*UI /SJY_H<
M[0Z/UJMR($U%<3&K2HI[<30?RS2!U/*8DHW9XSI/>'>$!Q$:DR!;7#3PSE?\
M* 4@JD*&KZ?$9P5,,]42XL?@O)/58#"#[2O(+,HV^H5'B%%>4U@DF>YH+X#E
M@H7BUM!4414NT"]<,V%KO7@JA]53K-_5JEF=P,5YE;@:Z'N5.K@H=>B $N '
M>HD+#[.SKK\4#J4FS\0<\P*&HY@S \50M;7<?J$P/.?_&J51<%-)W#C[EC/]
M3 :@TSJ%$X59E6-?P!M\TN\5$$L4AP+RU86585X6,\-"@/7S;'J-X0[6>T8I
M$UCVP2C:7K7<P#D4BFHTE<.B[+'NS&/!/!O_1+;N[6XWD J;6F4-Z-A;QWO;
M!*E'SC27\<[I^)S\*X?[=]CO$C&=S)E-=56B(Q)&E4?&&4;?PTY3MCKSW)W!
M7^Q=Z?5QM2.640Z-'&X@X(:W=TNJ=0?L(_&F@ %TFQ.$]S%P42[$753%C-+?
MO40F#%JA2=QNZL6E(&Y>-D+/>(;-%"9<>48-[:K]X6]*^-W;9WC9K=YVO1D;
M^D3OS]U^#\X=TZ93[+&.&/W#5FDW55 >T?B):1Y%DO4.MPFSZ33KN,.]-[ ,
M'B1JEJ>:RZ/A7-5M]K36FO9KL18.^V8M_)IBX1L<)6>8K3VST\]?;'"2.GOP
M&(3+NL+:)0P,45=?3%&2"0+3F!*23$9'P$>YJ)&=H5GS:NM9_%5@RWEL$K(<
M(Y7*4;^4/_>KU^5K)+O0Y4/V#^:',G![8,,BI.Q@1FAC#;Z6HW#4MZ/P+DMW
MSA'RLHAOL/P#EMUT25KOF?B5L^P$E"$D9ME*M$MU7$X,'@1^6+CS4U.:4@G,
MM0$EFIDI<'ZJT$\6K&7ZJ3MT PT"ITS?*C3#*,&Q"Y= )#Q!VSKHC3IQ8S<N
M+8[>F L$8<"W^! ;8AR8E@CI7:,>V1U>']"C"+;^E\J5L) =/DNSU/Z][5IV
MP6\9$ H=:<+20%T&JYWL^C0;?Z)&V:PE1RN$[WZW*1*\3S?IM5NC/]@W2'0=
M#9=K^6-)K"N+/&P;!33 H6S\M-&MSI%^C?)!Y_YGHS^?4_2%(73@S#@>P6:"
MU]O:X..XX>!(Y/%4'LR/'OAH-@T58 M#7 /7^&] J<O\0@&<  ?BBLY!J[V@
M>^Y<CA XC#H:'' (59I2#D'/<D+ZH;!C7EHTL=$N)XS=J7O61UN[R-6)3+.(
M9T,\ZVOTNQ_W37WPS/S+4I75FL/;Z+Z:""J)EA(G18%$4_X ](K*9\LQ6!?8
M1.6F__%BHF[>" \..0]@9H(LXO1J4[5SAKA2M=8]G3Z"FOM"I%<G4W2AX@4*
MCH'F]PL!9%U44D@&"3E!VTM RLERD[:33&*+@& FFJ6,&8NWZRK8TDY%0IB]
M5"&WI5=6_X+;6(-JQM7+CE7783SK,&/,#?E";Y'9?<;)R[Y9+LXP<NC8#E$U
MC(^OM=@*6,[SOK&<7VQ.RGIYS07F] 4$+"2GR*<80U=:>E?H3T)O+1\BN3<=
M/8HS<<26!8C4J9VO]>B+&F+$:(VX^2CQ#<?+&48\>G=GB\.F[""-:>&LI=$F
M[\)1P_--WL6*YX?-;&X)U#1IN_IA-]*9ZK [*I4\*0%X;2G*315Y'N@N]V 8
MBX!@I5@;S$ C6K\$L^_8CGZP^Q=]8_?G*6Y"?SRU->YI_:^%0"G16%VFATFT
MF^OBYW;NJ,&-QT!\B(?<POA:J'ZV?+?.#C:-4N"2@8?WU$0G*RJLYM41A@\Q
M4D(126S\5%$9>X%>MNNLY/B&>'X]Z''0Q$(?1D8<7EOU'O7O#8*09S#89:31
MJ2EB74<=?=&_HM-UTK?3=:4^4\7!)$MPK]9OO=62#^" L#EG 'EK47!.3:"\
M%Y7?=76:OY69<2Z)[](UJE-GA!V_.H8#D2-@+)VIDDY*2+:,-3%*]9F;UV(^
M+B4&)G?-"D@:@4XZ0+*^'JH>[O6-JG]36':*#.\C<:-URPR@ QX1Z"H2L>#@
M-"'4HTK(:2(,?BS:>H>R[A7GSS0AD))J3I ?95XQLJ/R,<'EN82SPI\4<GK0
MC<\?RLMV<+,>/QD8U\)\U10\[!L%<]M;UD?72[T7G%+&=FX'@>JN)$*"LJ,T
MNX0SIBE>=@.3CSSM&K.JF6W+9>+!D2MCF[U!_89<+@WC)YJ2@:(UCH'5LCJ&
MYIT53.!FI!,Z./'8'XL_9#=E>B&P#V,I4OH?P_%_U>>C=\55/UGLPK?J=MWL
MO3N1EN$5R8X=-*@N<'0W)P\U4;>6KM&Q3K&6CQ.$%+\H$B4@T.AEM<GD[".F
M9%A)L#/U/ES*!7?\JFFT=S4)6*I=ZIQX5*](5)*&"3.(*)!M1DQO<R.6)#K1
M##CBZ? Y4HL)._!0U@E#C?FTXZ<$'%16.>6\4I4SG0'YE1H;2=HRWR"FD_+P
MJ-T3(=?>)<5=P.I,4\JU67\9S1ON0+!BY,V"F%'_:P;09Z+CP(W?N)PK^-4-
M^]YMK*KI:.3V!M30P&"EJ^W:4VUHD9?/=UIN=3?XZD1,<W:E@T7;-F;NN *E
MI, 8O$ 4.@QGDY^C\Y+WCD3%11HZ'!9:F-=W.V\]H6+S>53A*A@PC&=>#GB8
MH*D[7$<>@OIHNZOQBY\$(8&(4MM<:5H[JL2P'5A,/D8+@!'WBA+0*8\;E#\,
M_GFM[0SN@H=HATXU!K/$H@MY49QT#,NDX;TM#_[1(C_ZS^3'".P#@</71DJZ
MJDN?:J5.^CHGHR"-3"9*Q]<[% ')/2D1&X]1G6V3D*GZ'$^KJ1FW;*KK:(8U
MM198G&-!-&OJNB:KTB %S/FXQOFR R0@WPHUG@@G"*[?J'B\A3TJ,A0<K@"9
M$D8*"<S6W/>=;7^ZSX'?,L4V7)HW"G2]=#Y^T*AYDN [.X%"KIPHJKB4G!(#
MC-#1*&5KA;%WGF$1M]0V0HGA7\-F;=^=. [6V>2F3 ??,?:]V<"!2&>[LW/S
M"[/<VO9@5U$?OZY)S7\LG54)LI"*D!-F?'TT,I*!-PYL0QU5(3W2=$Y![T+1
M2O#E/O&!@4YQL<I^)LJY6H?AX3H%Y8#P9R6#HBBS+'(.^JC%2.U.-\1%T! 8
MDCSBIWF;!EM^*HK/B>*Z^M AH1I#L&9-[=$;X'F[M2]Z'U0^Z4]'!T^S/GHD
M+)#E=JUG6OU'C8"ZK+2=24I51U[D.K8, ;=8=%.%H57GI1EQEP>\W7R2+]:=
M'&;QW(,M5]LJK=_^G-5X_H"-6N<^2?L[R@DN53C1UGA7?97.YY\G\0@$X^OU
MBN:ZUX1PJ;4UH>A%?:?:II4G=VUXO@OJG0_//83.:F)D.G]A<RH=ZND(=+D7
MW'JL/E)I3P3_0[,S($<E:]UL)#*LF+4/:^FDM1:AG68<)6F+'73/ 154LG&%
MWJ-Y $24X2DUZ?5^.C7CVY9=9Y9E*)<P[C(V_!QWSRCD*T6U022WCE[JSK)L
M).^KE.,%E*KJ]29U<;=VLR!8U5^1-HRVW"S#63RQ%"A87O?1AF3=^QT;BAA.
M@T+CM"AW/(=+FJ4[E*A5QM:MP 4(Z4Y!AFQI=;\XDQV@M"O)VE5($XB+B 5^
M0%?4=9'F=0\E$-!"?<T]0$@Z1*NTRJ+F6]((@ROD,SB\9''*R^]E+*V,X9E_
M&^X-@&<T#S;#O M^Q<$>5=;/*8;P1=L21V!9[,5^*F+'&T7,6Q?JK?;^-@4&
M,8EGL/&4*$))5.M-NYG#O?'PBE4)OXH+K<72)^@#B+(9"I>0(>0":2-GIWI=
MQ8@$GB*H"WHIS/,*B=/*+?EE;HPN'@Q=N=%ATL(ME=+G4GI/SXGK4"G-!I_M
M0XA.!C$&YU8@S9\")ZO-T 2NV;9D[$J3&NMO]%RK#&>#+ :E"\K-)<_VBUZ>
M[>>;L^UG:[C^S&O.UK@_B6A+G($6)*B>?)UUU1!UI<EM2UND$&N9ZL>4/++&
MP6^P&E&$JL^<5B&=EOFV70VTL7EV5T9?KJGG$GO1ZUD9I+;A5(PMV>J:[30E
MX]N?YT^7DL-:IZ7@)L[0V81-?!>.V';+Q'ERBFX RG^:3>/01BCJ!4GM]JMF
M;O6N47X^3!CJA)/ & %(:C68 +I[5SNF)'-A IDWG: =(+'IC>VM&_A84?7Q
M,J3.TL.DZ%U7K_%FA.5^50\!M5%WK J.=#<M"*_,I?#+\>!56Y5&6B?Y\IO-
MUB<YMGP55\+<$9EF\E[')9 _QH\IS3MYV;#)_+QV\8R3.C8E<'4.%!CPA$HB
M^':*&"]QI<H@B:<S$4WUK>0$K7@ZJL#VY*_2P=WY!%)H+H/HIS- 9E8$^[M[
M!P/\>3@(#G;W]G%*Z\8JFIOE25U0N&\6Q0X[-)7ZEK%!#LI4(T[M:KILU(R+
M720Z6-OFP<)M'@01Q^5MJ^+._+PEGB-Q3?NH(.@@*BGMY+ 3/HXCSAAM;MQL
M[!YE'VZ7D0XK2S9Y24&G=8,<# W;:_1?MF]ALQJR^;SY!;<4.^?@HQ<,#[<[
M.)2MJ6TM0VNU:\V:/9Z4Q,"#(BNE31/$NB6;ULJ ):KFQ]3J1+-PH Q;P&(<
MX\(P+$8(,-P$[EM4RF3C=Q.QUW->==P<^5G,(PL"P^Q8\D2$A1*ZYZT1CGYE
M_?C%1C]NZ\?[+_9^6J]^O'J%B:LOL<J3RX>>!U(2Z2+,XQ'SL,9]I0! )<A$
MZ1Q?,_B/54C8+2AE D9P^QRBF:(P4857N&_.E@50]1$)S>T#5W'&VA>AC-3'
M,F=VK.[T(&1RE0$!VF'U(40B)I%AVD'=+%+D=B0X-C"$&AKTR<E)3??>ZLDB
MG_.(K]3G/BSP@%W!M?P[>M7 N^8=R[ZLJ0PH^(C#73>2@:5=TVN!]44PD\"$
MP+P=$M>4#QFGF"*PJ?NW:W?2^Q2-OM7].X;("B[7#==@<!S'(<0:KBHV)T4X
MK"7(#@U6#O@[S=&\4USS'2QT/27*M@9XR9V&34 )'UV7*#*\:])@T5[!'-#2
M=0/GMM^MPTQV 7M]=;1+"CBI *8IF#>^>6/S['\<5@J7.C..W"R-D9(3O09(
M-A^!K-W;Q4,?<8%!!.%B302A;',T,8RQU5 JG$.!TZRO8\H=%,>W](6W!;54
M3,NAP2QDIZ"V#G.:AUW@1I25NZ^Q0G0OQ$.=DG8%FKWAEC&XBQ8CKKV9+IM9
M=K1A6"+\1,!WE +@,+M.X41$L.$C&#Z9[17'J,<Q.B\]^'M_)6GNL==NY(Z<
M?#-+H0WO%V,'%-P #!DWK$;)CS#(+UDI,*LJ)/^51:T$E38M!&K&6W,J4XI+
M#B*W8M*]D9^G;D5_A.GV0GJZ7F\U(NM"]@?6/.G8RGHV;*WNDG,\O;Y(M&>J
M@UR)?MA7*0Y9@PUOTCA-Z3!2 C(9Y&TQY3(7''%#_SAC#ND.4* Z.T;WM%3B
MVVP)P0);.#;/QS+U>HR1<M=@^*[?'1I, 1(XYT/0)7@'"M9;W OVQ'#&0'KG
M^<DC0D:45!$/,TS21>QS##1-8+B?1KZ2TAU,U33GE^?XS *MN(C+S0TJ(B6E
M.)?0.&;>X/BL#\3<A2:9>YT=F(VWAE<;&/>I[^R=Y1V6@([+ERBK.NYE3=7C
MPVO<XUQ8&'B3'54).70'-ON(T_,9_H1IKO+<]W2Y'(]:%I+Y$F>T%!YXG==9
MF[@2U_DA]D!'.PII//J01MO<479G:"/4OD9>(P^\9%V]03]>79R]/0^.EYRA
MKS _JH6Q9"'<^8\7[RZ0P"^_VFK(X]V]W@$PO,'8&EFCZX8T;3KPFQG1E"+I
M(A9>_)"J&SF\#98$?%IXB7<C#=_X8KB5M;;32%(-)K%&B_//T5=7)*_^:;#6
MB2RT(M%&+5HMTI4?:*Z%.#84\B@40G@1/7)OKT@B&&+?D,B?0")G7O+,ADPV
M9-(D$UVFJ@]T@?0 J@L.!XL^=\%H#3[H-"WNDAN@%(0G6Z(.=+/]*VY_CVK(
MEF0-G!E4YAGZ@+(<4_1R,&_5#*W7>PEC[61P7^^)>P>\4;\?^TRD*9;TO,[2
M]7:L>)C$W >)N:4ZD'(W%/(H%!)\2-035*PV9/+X9/(:4[XO5:+RNR=)(,,_
MX/@]^%." $^9.$SORX3K_GI)(291T038#9%@F^9@>!#M'/A=G4VN\6E8^A#O
M$AADR"-[*VRFOF$_CT]A_4HD^Z*.Q+]<1MEPK_<I99N3^I"3FJE\K8U'ZTX8
M/)\T)((#L3")]S5=GF^Y;A2!!8,ZPP252]N8Y0/GL/6!&E;CU0\6Y9QRVA\6
M@3[GK='V5KQ13QZ7[JM"]X','=/+0@9-"K7) I,RG"FU>!S7P^E42MFK_HW+
MS1O,_N^^'1[OO6K_;.=+W\9),JX2RA6RV8"N*8DKGQT$!X/@$!?KN5FIQ? U
ME '7L]24)1=P=/\"8M)5F*4W,27S$HS36"<9D%2<WF0)Y4 #56&*<Y7/XK**
M)#<QRUMKTM]4GB77*UQBO71ZK1!9ANOPT6+A;%&7=>R(\3K/B@([CQ'J,Z9=
MUCZ8QH6Y!=Y-Y?D=)79694=!0%11IEM7]OM *@DHC1S!6K@X+U38GC>F_'=[
M)"8*I*$!Y(Z!TLFRQV'$)B$OU[.JK/7JG*M*/=#3WY/]OB\I26&U.NW;6,4)
MPK=A&0!U .[8(,Q%= FN!A0A+>*(2M]%M@D%&)X>CZD8 W->A85G CC+& WT
M;@V$6C#8KA$D%X9%U9:15VXMK5P,1G3'Z"VQN(YB\"4U4V',W9SLP^8E;D4V
MKPQ1Q#1E$#/>->I:,E.2FW:>A46OH [V7H]CUX7OVO9#Z<0[,JT [8/,'6V[
M]>[;VCU)LX!24L?J!CA:J^DLE<;8$@YY!LU".G'WOG3[M(8A@J7T/'Q''=2G
MUT(@TFH(J'VSNZZ+5B+<!N/K) @SB%6U'=VWL5D,_,59NZ7&OL+8[[Y9'R*@
M]HPJ(TW!.YJ4N\$+)H3<#91=\LR5DOP?Z1*(V^4"AQ5B_@G=JY 1/PS]NU\+
M6XFBVOQ;$!FS"@'#,A\S 98)#T(T9YEAU4; <WT8A9C'RPQ!UH<A]DX<Q%X7
M[&N"_6,ES9]3J)>:$WR\6R_*\+(H]^61K@%XQ.41,'UZ1F/KT*ZB]E \\-IA
M8;$B2Y,AB*<%NB>)9D&)I**"/R,(S *1RPK$N< *D;&_Z3"3HGX[RT?YILUY
M485$HTN#PEZWA/ A$!D-<+.RJU@AJ-]B-H-;P/ N*^H=Q[>K=P:3?=P_LOOH
M$VH=W-&B@;AG"B:F),B;1\A-AW7B:.Q+NR9^[&"+EC]9M/H#\\@Q?D8/=7FX
M_M &]?4:5T">!<+H=I]W]LM@\Z88AW!-5$;:"![_WZOHFF6L.6?N% F6+)RD
MV"Z 1:.2A^C/<=%-#;DF(,V1=G./O"FORL$7JS8]8?O]-)N;A7<]-J$%;.BK
M) ZPHM>(:%5S-NT?[%()#;*L#SK'QB%;TH4652^2[3X\,$E/+O2LBI([<?#U
MKA^']/P-"N $6"YD322JC3,M/ Q@'94#-_N*P&/D.09"!"$S$2>*7,J)M',T
M?PT,BR-X37Q^!UIR/)WJ"'%)L&#.BEN/Z)K]L?GEP3/=J*2R2,U<PTVENJ3O
M^D#'-!3L.4;:2>Z!%&/''8?^:=OK3*>9A3>=/VINH6VBH/YQR6'%;K8E7)K?
MQ*;;"K^<=4$"]4Z,##AZ^34W>$%-*TL,"%1NT/.XYBM,2 @@_A05=[!V$F6:
M2X0]+4WTMXX*7R: YIVV!;U<X@:-L':PI3]CF;(I2A7ZK %SH#V&1H4QSCKO
M@RX41#QG@%=;2$JK*#>M(]V0UD8%I34H*K+?:O7M?OEZSGC1^K/.J3J<&R5B
M(2>MJ5A*M_0=5ABS&5.&J0>U]>X#KPOC-0IM4=R.20<1&.SF-MT;6-\>;! V
M7#QTV,-X:".VL?^\3P@;\U@O:MF.TW>@.+C^SZ9'U"V94=TW%!Z2)-QVRV>K
M]*9AF89A$01<H<O6H[=4'R %+H'2J;86'GUIEZ 'BM?VP'49P]TXV/M[,UP!
MK'E$%=\W&5TRRVYUL[N;M8YIMX"A=D_8(:JB=0B<S2*E.=I9[-5OQ<B>E,8W
MZI/&QU73 KE)2+4L4&!GA_O<R]WTLLP0*7= QQ.LY4HE"!*7F99K(PTF8,TE
M(G=J>&[(\N2F7_@X[")AFP7>4N,&@BY!.5FS5>%C1#?VO#I!Z\HF'=94P-L&
MIKI"4N8(78G^'.Q)"#K<[V#,EM9F][H[,FY$&5,?3NG#00L@_GSJ,NNN[UH6
M? -6E5;2+K29MKSLG-H3MA_A5."XWL1956 OC<Q.;!"$&M-%ZPW0&;7:P:X@
M:-&\&=-JKW#\]I_O-D73DSN189].)!U((]>JZ=2&>N8KZ6U!B_]T<U\' 6E;
M+<+N#P+/TIO_(#: FO!8UKEEA,-"'4#-&Y@O"3I,'>D')3T"I9&F%5M@(/ Q
M)- 6Q%Z76)V]94:?L:G&RGA)\0FX2WO8HH=+=VG?C&H:4-LL)FGACE!N+B$O
M%]YP[CJPH4JL=<[^S W]?K4G-^K3R1TN.+H^&!9V1W"0Q-XGA?'V*B<F^,7"
M8EL.H!_,9O]"HKGK;F&[CHBA^P#%.:B=6,0]B]%]+#!1<IWT;E42*Q^K&.&$
M\D^Z#- U0G)5XE<*@:#MP2@)5(Y?"[Z[HG[O<2\.QW2N2?LT29,E^@K?&2/
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M1<14>:O,9KTJ_>DU)6#X:N=]&IPSM/_I;>^J[A&-?0?SS[SF ]PO@#/$O*[
MM9*:;EI?B: V!+2 @+*H1XP#-_P"L^XP<?\C!G<J:0N'N1\G+XZY"SWW#-C0
MP!>C 2ETZ0,A-%I _:)2)1FLB$:7FN8.;X XDFQ&'[A"';^JA9)&-C3RY6@$
M(WQ]H!!F%6?_O Q^UBHI)[#_%CX7H77?Z 2EBUX.5G=#!RO1P9NX4*,X 1'>
M'U)XFZ77.U?H>'6C(T'A@;G4NL8CCW"7$F/9$,@7)Y#>P(<ZW2)!2B&"B-PP
MJ<)G*\L;:'[>%2!POOOV\/DK2ES!-*F,,R+HFRK*9NVN=MNN=;K3;+G>.)Z!
M EL0@2+R E=6=V9.4,6'3O0-9J5QJLN6US22G=F"*X$@2]<P0Y2+1:.#($I4
M4]AD6PY>ZQ0;$R9W_&6> 9V8QA8NR-/XZY5E[/>P+&/#H5;B4/WSFJR&1C9<
M%;YV0PP+B,$K0.L#*3A9=>DR?VOPLV0)'QSZEK"4]\-X2&K OP/7Q;$NU1B\
M8O7>=QL:6DA#_6D5_]C]K#:$L(@01--[.G2PL.4(P_HLT])C0Q7S!_43XFY]
MI**G/M %21A7P=W&S=*?L7ZEL"@M5'!G.BZV<219SMP')AD$%IM1>4V.VU!/
M[?%XO0;P&;4.%1;7ANR>Q?842[U!(%7[L=]HFNHA<L4MQ]WP%*N*>'JP0%^G
M,14,8YE=*[&>"UTL@"):A@4&/4SS>)R?(/(U,<2HCZW!VTL(6PU1X J"0:+:
MJ+G@?N@+14P(O)YL-JK@R*F(3O#[(FR67)DD[Y7NQ-B "(B)R(#6I;+HV51R
MV+T/7K=.3,:JJ>&R>J%=O3N'5X5[XS281LD!FK=%44W%ZTLUG,BO\(.9SL=9
M/JWODJ'RM$3\A&R42!?N>4")RNO>/4)R7V-U#['92(?BU7Q)(\:K&HD/AV B
MK)/7!)*VU-.U,MA::UTBAZ'F:'M"Q!9J[+3N2H"1"6\-][89:ZL!GD6O-KQ7
M[@=4Q^))(BIFA$-3$-W/#3+:Z;KI6+A2M-V$=,TU54IQP2>Q':I2Q[IFK^RK
M7KL<;&FY#VQ"=J.2&CM&/O,!N&D<444;L+&S2:S]"]ZSW#'^NP7E9@PTFYK*
M;"JNK0$0=LH!]A"2N++H9]LR\K''EY6M!8?;=8KQ%KJMZ@)8-H"9'4"JIF@T
MV+K>[N3>'CZI%*1K$4=8G@9&<0.]+M<[ME+=0B<%;H-VOS"2U\9P6DE%?GMU
M\:$WNG$WN*:-'(!RAKK##=5+@J4TW9C/7X@*WAO(QG/'B9YH%T_@0SCM@J,X
MR[7%W%#+2M0BW400(2W.>I'L]LC]GS?$L( 8\FSG(YCOXA8XG6;54V(9&YIX
M#)JX_/6I-KD-5^O/LZ&"^8/Z[PHN'%.7C/.;)Z5'>$QA$^_]4N2PN''/TR..
MH]WAT88XOA!Q7&J,?M&Z2H?1)RA 5M8A-MW=5J.2*T*+>KH$TAWR_R->K4=-
MS%MV*4X6PK.L@YO HJ@2O928#RC1KS73R\G!ZFW].G9W,9G\];)"#^IKT<S3
MC*-_?!-K/=[7!VK_.#PY.-0GST?ZQ0MU</SB6$7'^^.3Y_]S^,TFDW3N$E^\
M"WZ[N'IW?GD9_/;S^<?S]S\.:B$'57/Y$T:1IC^QNK#F@.-N,?#.43DAN/IL
M[!6L[NWO+2L\>3$X9<#2,+#=? <6)5&S0K\TO[Q"V+M$W;V,4YH:?>D5PGW&
MH4J$A,ML)EMW<K([/'F!NU?"EI61N;UL["YM[+,R:G]V>+@[/#B<^_'>[G#N
M9PMONWMT].7O>KS[8GCTH+LN^FQ_=W__X(N/]>#Y[O'SY9;@&6T:;QP00 'T
M^8]O#KYQ1YJ4JY=[P9 (R-SO(9>>M"[=GWW&BWW.C7I=D]:8A+_\64:$Q25.
M,Q5OG9^^O?HY.'O_\</[CZ=7%^_?V7/W)Z]B^]*GL8JO[^I]>IOS.GZB\Z):
MFX)^!F_C0@6OX4<8QFI#(*LMY#LUU8M)Q,U,1!>A+LQ@K(AN&^ @7ZVP//??
MY&DLW(;J_L#B76%/Q&7)[JM=!<[>^;F"6V&W\*S*0[B]Y/!TD53#>AHR5O$Z
MR.Q/N'2C(]U+0*?AIS2[371TC;F 8-Z<AIBW3+UB&T=K0T$;"IJC97_X^?3C
M+Z=G_QH$%^_.=C>B;*-A;S3LC8:]_H7;4-U&PUZSAGU\LM&/GLA6G_^_\[-?
MKR[^>?XX]+[9CH>K#_^E<IT&E[O!V[LTG'RM^_.UB-VO:[<:#/U@8_ ^%3H\
M_SR)1W$9G')Q^(]8I9N-08PGU"JTE9#7CRWXJ^_6:]ZMY7(H^[$/JV[9,PK-
M__"'\Z(:?1@/[ZD;_!)/.=H].6HD;.SP>P]^])/(]IF;V"(_1UET!_],RFGR
MP_\'4$L#!!0    ( /@U4%+L5$M_/"L  %OS   4    97AH:6)I=#$P-3(M
M,C R,"YH=&WM75MSV\B5?M]?@7@JB5T%299\'7LR51I9V5&M;V4YF=JGK2;0
M)'N,"], 1#._?L^M+P!!6G9L4QHI#Q.+ !J-[G,_WSG]TY]>O#EY_[]O3Y-Y
M6Q;)VW_\\O+L)+FS=W#PVX.3@X,7[U\DO[Y_]3)YN'__,'EO5=68UM25*@X.
M3E_?2>[,VW;Q[.!@N5SN+Q_LUW9V\/[= 0[U\*"HZT;OYVU^Y^>?\!?XKU;Y
MS__UTY_V]I(7==:5NFJ3S&K5ZCSI&E/-DM]RW7Q(]O;DKI-ZL;)F-F^3H_M'
MA\EOM?U@+A1?;TU;Z)_=.#\=\-\_'=!+?IK4^>KGGW)SD9C\;W?,@X</IOGT
MT?W'A]/[#Y\\>?+TQX>/CX[N/\Z?/,V?3(\F__<$)GD M_,S3;LJ]-_NE*;:
MFVM\_[,G1XOV^=+D[?S9X?W[?[[3NZ_5']L]59A9]8QF"U>G==7"+"R,RO]<
M&WS#0^YR5A>U??;#??K?<[RR-U6E*5;/_OK>E+I)7NME\JXN5?77M(%MV6NT
M-5.^L3'_UL\.<<;TYU(^ <8I3*7=)QT>X7><?IR;B6F3P_O[CX[ZD]TVY0S6
M7-NO/N?#_4>7FO7)/\^37[4JVCG0B%W45B%5;ESK4MD9[.6D;MNZ?';X&-YQ
M=;[EG6Y::[+67&CXF M=*9C%\<QJS82]C7Y,E<,]SQ[ %WV'^3\<G?]9FOR/
MLKI*7JZJ;)XFM)J)J=HZ:>>F2;9_7W+W+S\\!59\[G^AOP^?WTN6!K=W=*?3
MI*X2TS9)O:R2B9ZK8IJH*L=?Y:]Z2M>;;M*8W"AKX)/Q#C6=FL* R&G\F^$5
M\LZDMHG[,;S,32A-EG.3S1/X)CV=:OXBU>"K_JXGME-VE1RF+*K<V*?^QA?P
M3O]I.),&YEG !!?:-CK72;E*LLY:7)/M2Y8F.8E,?O4+G>ER BO^%%]]^#1\
MUJ4&&WX<S\KJ4AE8X2J9=O#GM+:9IDGSAR==U1J<.SS0 C7M)V=5DM6@''+-
M:X8S:^?P45W;J2)9V+HT#:PYC$A$$7T,WK90MJ4=PI_QPZ9U4=3+YB\_/'KZ
M_))L_<AQ]3I3C$OB'3#\X2-@F,/]O_QP^/C^\_7_GO26$%9]70Y\=QZG*>]_
MF]</5=3XRY-DMQ_/M%TA'\.ND%0"7LV[ULD4JYL%[MP$) O_V&Z06RA@ZDJ/
M2B>X%(13"IR2%5V.1M&D:Y.J;I/"E ;Y'@0KCOYVKFRILE4*S)?MI\FQ;BOE
M_CA1R,+V0YJ\?'E"DX19J)+_O MK5[!8*E;,@-ND'EZ/OV%I"N+H"X-22XN<
MKJNI0;XSP.YG%=!NR7?#N__RP\,GS_'SLDPW34**H3<DONOPR?,&!& #K P"
MD::<%08&Y'_C$_4"'FB[RK0K'"37,/]Z09=17+4HLJPN:,AF;A;\Y*RN<YHR
MS1/&*6\Z-:L\-ZQ%AUL[!]&KELKF0&:PL^Y&V-*I ;V1X>9F=;G052-Z>-'9
MID.- AL"7'$,L@H?QH5'Q4.*ZK1<%/6*M/T&)?8:]!(IL4>D/^\'_3GRZ(@^
M!OYL@57PMKJBK](?==8%312K'*8M^ I@M2H3^D5V!+NE;/8WZ(FKI4..-NJ0
MUW6U=X);U)K8)K[5&]_]XU]T%L4W<(4.5#Q9K3$=DF/.]^*EP08F;^']=2X6
MD;L)214XTA%X_QUH.*AJ!;)0-<BC9RRR08< UQD+DK]8H;H!0TG^0JM]IF8:
M[;/XW7"3$_1HFW0%<AG^>@RJJ4W.M;TP(-.)A0PSGC,W@;>/80*?QTY7R;FA
M/50;^>S[4/8X]]_R]U7@[U-D&>0'H'QO/_F-<2YEJ>$EPD5X<^-X!A2F\LR&
M=N%T33+<7<XU_&912ZI*6%QK- YSO=#$'Z3[K,I@B)1\,&!2A?IU 1(E,PM5
MI.!6D<9%+ZO2<%L-=F:&_V#^QR=-=0&,B_^"J8 3:/6\+G*\1W_,]**E*<07
M<+X%F7-SF!H:M>#(9J2!P1<'NV!2F SD#,P-#0+4MR"3[N'M+;EUR5T#CK#5
M]-6- G,#WPPV;J$L>YY5YH50!XO2:&<Z^C4\<^(I'[$JT0Q',8@>:BQ@"]6
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MNQ0WGUJ%OG;YPT:G=^LK!.W-S6LK.=7[)7C451,W0;^!<2])?*NV5=F<CB0
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MVV?&U6%*6#>>54,?]:?]7=T#?LE&^>AP/<H-IJX%=9FHC_UY:\ \)H;8(D4
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MF^Q6)L\ _BH<0XB8F+7E=1&G;*1]PRWP%RN0P*7"@UUP8MX'.T14JB4=^BP
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M!\N@V=UD(&ZBI56C>0,KHFI8/T!22D6DGTB7\+A7&VJ/A20# ;S-\::N2_%
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M"3]W$&*.W7D O QPM->^0*-S;L4#ZF6H@[#F(M!Y8IZ >0GF]*;ZHL'8J4,
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M[GCW?7='<O1J^O-D_OGZ'*U,6:#K7]Y??IR@EN?[M]'$]Z?S*?HP_W2)2"?
M:*ZHT-QP*6CA^^=7+=1:&;,>^/YFL^ELHHY42W\^\ZTIXA=2:M;)3-8:C^P,
MO!G-QC^,7GD>FLJT*IDP*%6,&I:A2G.Q1+<9TU^0YS52$[G>*KY<&10&(4:W
M4GWA=[3^;[@IV'AG9^37WR/?+3):R&P['F7\#O'L78LG&<$)3M@BSS*2DR3I
MTQ[!&8MC1@B-P]]( E[Z(%\K:;,MV+M6R86W8M:!02]<F^&&9V8UP$'P8^M
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M,C R,"YH=&WE6MMRVS@2?=^OP,BUB5.E&W7Q179<E=A.36HN266\2>W3%DB
M$LH4P0% R=JOW], 94F6E,A>9^/QYL$1":#1Z#Y]N@'P]*>+#^=7__QXR49N
MG+&/_WC[Z_MS5FNT6E^ZYZW6Q=4%^_GJMU]9K]F.V)7AN55.Z9QGK=;E[S56
M&SE7#%JMZ73:G':;V@Q;5Y]:)*K7RK2VLBF<J)V=TAO\E5R<_>WTIT:#7>BD
M',O<L<1([J1@I57YD'T1TEZS1J/J=:Z+F5'#D6.==B=B7[2Y5A,>VIURF3R;
MRSEMA>?3EI_D--9B=G8JU(0I\;JF^G$BCSI';9&TDUZGW8]%)-J)B ^ZO>->
M+SWZ5P0E6^@>QE@WR^3KVECEC9&D^0>]3O.P7[B3J1)N-(C:[;_7?->STU3G
M#O,9C \_@YAU8=P,(2_6SNGQ@&0Y>>,:/%/#?. 760O"Y@,2G6DSV&O[?R?4
MTDCY6&6SP<LK-9:6_2ZG[),>\_QEW<(Q#2N-2D-'J_XMH24F\8_3L(A#R,E4
M+N>+BCJTC,N;D8J58]VHV6&KBWB(^AMLL21F:5 "MTGS@Q9]+HU3J4HXH?G)
M:[ONEN^M1V^C'N_K[!+Q=]YD;[7A0 *>;V12.C61[+-*)/MHI%6" IOG@IV/
ME$S9.Y7S/%$\8Q]2F%P:IE-V_OD/]K/DF1LARDU!XN").DN\8V;,C;A[L=<_
M.MFV]J_C;!6N!UA=P84 Q30RF;I!YW .8)63MH-&=%1\_P#<;-6H^6(O.FB?
MK/]]ST8<EC5RHN04).E&RL*P>0E;&@FC.:9S]DZ;,8O:C5^VVQ66/#ZYA[&J
M-TX7/M2?KNTZ3;;->&^YA<E@G_&,7>=ZFDDQE/5@P\IX0D.37",+82*N<MAV
MQLK<F5)B(<A+/D7!JIR-\60(PRE/\ H8'H,SG0[]UCKD,I'6<C.C+F-^+3'O
MDDR+=P+*8,K,YS?,01T299#/T"W'<&@B$"S3D4I&S);T9S%^*HVLA- "QLIF
M2'R40Z<*OD<8%C+Q"I+< JII@65.,$RP>+9LAF<+CNX#P"%9>DM7"W/7/9UI
M-)NE=I6G"#T?8/B=9*6 3+ATR;9UP$&9;,8*>(3 1"#+L@5:*D?9.U,#D$(%
M1D2/,D,'0$3#CWXZZ_5)N!VQ---3.\>/D4-E'<HT\"^]#'I#R_H2#.Q<F35M
MGRT2>MN1<+5BMA=[1YWH\,16OJZR$865#KEKW[[R-GW/N)'>>_"&BC-)5F82
MD(DS94<T@KJ-P2K$+/0LE$TR;4N,([XQ.@MN+(Q.I,!KR_;A-2$!@^":RYMD
MQ/.A9&\0RI_*##VB+F]$_7T9M(CZ(CR%1T4U2A[@0_(9Q?L2JH*729>=)TI7
M)DHQ$:WS+M;0@S*53]B/A)]>_PGA9Y^_VH:?"Q0\0S*C9^AO^[A.R2/AI=U]
M"+%X+.&O:J:0%W1I(  A/5'6$P5ZR=S+H>)I03'+-&5DQCT JL2P<&*]HC!J
M5* ;Z&)UIH3?G=DR1EFGN%&T !72ER?.G"25EE**#QGK\X^G%6S_H!#V97Y0
MP8&\I,PXL2&6Y958I":,"(EN.3_C5RRI(P@+XZ5X3()Z6@"+=P38SB&^AK/=
MR6%GN &B$U3[&,JMSCFQ(+= ()4O!"UNQ-S- )[BL<J4FU&RVC0M@=XCPCL[
MX'6EZU+YX\GVIEI04:+0M7 &)=<DT49X!7PA-)0Y<F8&S*%%%@1FZH(B+^ *
MH%<%^.[Y(BO9BBSLY;+2QS>97:8I"A'LY')4KNL%Q6UFW(&OPN/F&L,#"0/!
M-394,K$NW78-=F%4?MM;4IF6?KOF9?&\ /2Q(8,EYCLEFN!98D%L9YE@YG5W
MT9:H*@Y\RT9,W(-;*#7I)"D-.64I#VR0.M;6X3T=O4"632#HSQ)I!*+W5X>\
M)$8H#>+]3K]*953*TN_C\M7M\ZN@SXC;VW1)3.%Q*(6G4&^)BMYFV*U=RZS:
MU-WI7_^OC7-?[/7_2B5X?^LIQX,K<'\X(N; K2]BFBAF&3R+\"80W".%KE5)
MM]IQ5$I.&WN;M?P+B!R/E7-2?H5 8XV\2.U"03\O9!]  U]9XD/\3_7:/"[D
MGZ6"^CX&RCSQN[]7_X^%]AMLFZDB\<>VT(RV+XF2\%F5<6X+WJGDUY1"0D7@
MDXBO9?RQS7P+?2\D5+5IV/)M( ,N,-#*6R[8BIJJ L(0N!Z%2CWD,8LD9LLQ
MW 1;^<54[+OQL.%YYZCME? ;I*+4(-#J\(?T] "/^N.ORO7UP.<JG^AL(HG4
M<SZL3O%,Q2AR7&1Z)M$Z'>G (7P%6 #"H^2ZYH[N\899\H]_WMU!]SD(7\\8
M$.)\X5[UCP%*:1KP=L8+*P?S'R?@V2+CLX'*O<_\H),)L3/R;75) IG5#=GQ
M<?.HWZ5+,@?EG)B+K^[/FO[^K.7$>ENOV8T.M[:VF]'6MJ])[1XWHX/NHXOM
M-(^/CQ]=:@_*=K8/71;;\N8-)H:K;,'SU[5N;3Z@0M&@4]RP:,.=W5T'!IC\
M[R/?WZ=>((A7$UNU^OLMC"+F2:WKG8Q-25<!T4'=7V0_L_6]G7UOK_W0*]G-
M:>K%7N_P=LF/JL#A3O/_\5WFOL_BMV7IZFSA\QM_3_SATYNKJP]WOHVX!W.U
M"2BUG5#UN%VK1.@3<@$+TUDHFYOV*T .J/Q! ;KV^8 /T-4[^Y4X?>I>^(L9
M^@$?0ZR[H^5KJX?5<ML+PEV*Q3L?.Q4Z?.TU"+<&$[GV^=,B6+Q*[<40'B-B
M2K<^Y!M?3%5_P_=;_DNRL_\ 4$L#!!0    ( /@U4%+S0Z(2X 0  /@3   3
M    97AH:6)I=#,R,2TR,#(P+FAT;=586T_C.!1^WU_A*5J&E9I["KV!Q+8@
M$"P@Z"R:IY43.ZV%8V<<E]+]]7OLI$ IS((6IK-]J!(?G]OG[YR<I/]I>#X8
M?;TX0!.=<W3QY??3XP%J.)YW'0T\;S@:HJ/1'Z<H=OT C106)=-,"LP][^"L
M@1H3K8NNY\UF,W<6N5*-O=&E9TS%'I>RI"[1I+'7-ROP3S'9^Z7_R7'04*;3
MG J-4D6QI@1-2R;&Z)K0\@8Y3KUK((NY8N.)1J$?!NA:JAMVBRNY9IK3O86=
MOE?=]SWKI)](,M_K$W:+&-EML+B]X[=PTHEHO!,3$G>2S&^%:6?;QVE"XM9?
M 03IP?9*I]1S3G<;.1/.A!K_W3AT=UJ%[LT8T9-NX/N_-NS6O7XFA09_"O2K
MR\K,BC%-[[2#.1N+KDVI4:DNQ*GD4G4W?/OK&8F3X9SQ>??SB.6T1&=TABYE
MCL7G9@G'X)14L:S:6+*_*<0$X=G;617R#MCA3-!%"D%H@CZXF["$:12%;K <
M\>/$L1I#[HG46N9=D_=/$CUZ,>1' :; !ZK6%.'@X')T?'@\V!\=GY^] >!Z
M1<OB*=Y+Z3S#M#>8_7!,XF<Q&4TH2JG2+&,I-NT#E52C3"H]00GE<H98"1>F
M 933)&?:- 0F4"J%H*E5F#'8J\'.OA!3S-$E+4 =R0P-_KQ"1Q1SD ^D@M7*
MPY;9O+D1Q;V!S LLYO;Z-P2B0ZER%/C.B0G!&BT@+TD0%00<#VE*\X2JS8U@
MV^]%0=,T'W]AL!V&?J_R;F\"L%E*3OG\P=H4PBBI"2X%WWQN$K,)7$XY14&$
MG2#>2B 65:^TR&(ELQ:N:#I5T&CA" [NT@D68T@\M>D&G2A>BN7QAON(L"#&
MB$4BB%J^!6J""R 2VH[,W<BT2Q2T%RZ_"&90O]+0C4M DE#WY6);YED0OL!?
M!G@*($%[;<P[;J(3K*A 5RXZG8MTTD07BI;,Q&5!&DP8S0!D %RS6XK.,^ H
M@%2C4G.G6=-W#HM8-Y&65IK0TIY)/D<W0LXX)6.ZN=%J]UZ+W#.%7V!"@"\.
MIYGNAJ&[OJH-7&2SK$LMFW+@N"6TX>5]02KZ;<H4-0_ATH#Q0+LM;"D>M+;(
M/;.7V=KJ],PIO!-:T?83XCE!M$;\PAH_)J QY%57@HZF,>RT[>TQN)@I0+<
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MZM4C/_BP4_]7GYGL!Z_#OP!02P,$%     @ ^#504I490";C$P  1U$  !,
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MQO? _Q4MR]^I=ZH4WT-TA]:\96T[OX.H$E@&EMZL_4NVBE^O9SYOQV$>;=?
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M63)RC#TK\)=)7+3%^X^?L]E6Z(EA %88V_#W2M0(!CGV(I!E<>@;QSGG^^W
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M2P$"% ,4    " #X-5!24&:%#= G  "[X $ $               @ &, @@
M8W9S+3(P,C Q,C,Q+GAS9%!+ 0(4 Q0    ( /@U4%(XP,:U%5D  #SD P 4
M              "  8HJ" !C=G,M,C R,#$R,S%?8V%L+GAM;%!+ 0(4 Q0
M   ( /@U4%([N87Y]@D! %[V"P 4              "  =&#" !C=G,M,C R
M,#$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( /@U4%)'__(IQ X  'X/   3
M          "  ?F-"0!C=G,M,C R,#$R,S%?9S$N:G!G4$L! A0#%     @
M^#504DP"4ZTR40$ =M@! !,              ( ![IP) &-V<RTR,#(P,3(S
M,5]G,BYJ<&=02P$"% ,4    " #X-5!2- -"'_5< @!<N!@ %
M    @ %1[@H 8W9S+3(P,C Q,C,Q7VQA8BYX;6Q02P$"% ,4    " #X-5!2
MMUL9;!%N 0"^+A$ %               @ %X2PT 8W9S+3(P,C Q,C,Q7W!R
M92YX;6Q02P$"% ,4    " #X-5!29D:Q/6=   "CWP$ %
M@ &[N0X 97AH:6)I=#$P-3$M,C R,"YH=&U02P$"% ,4    " #X-5!2[%1+
M?SPK  !;\P  %               @ %4^@X 97AH:6)I=#$P-3(M,C R,"YH
M=&U02P$"% ,4    " #X-5!2/5NM=Z,A  "A\ ( $P              @ '"
M)0\ 97AH:6)I=#(Q,2TR,#(P+FAT;5!+ 0(4 Q0    ( /@U4%)E?4F_Q@,
M .$-   3              "  99'#P!E>&AI8FET,C,Q+3(P,C N:'1M4$L!
M A0#%     @ ^#504G="C[T0"   =R8  !,              ( !C4L/ &5X
M:&EB:70S,3$M,C R,"YH=&U02P$"% ,4    " #X-5!2>$]0-2 (  "D)@
M$P              @ '.4P\ 97AH:6)I=#,Q,BTR,#(P+FAT;5!+ 0(4 Q0
M   ( /@U4%+S0Z(2X 0  /@3   3              "  1]<#P!E>&AI8FET
M,S(Q+3(P,C N:'1M4$L! A0#%     @ ^#504I*1;T;O!   2Q,  !,
M         ( !,&$/ &5X:&EB:70S,C(M,C R,"YH=&U02P$"% ,4    " #X
M-5!2E1E )N,3  !'40  $P              @ %09@\ 97AH:6)I=#0R,BTR
=,#(P+FAT;5!+!08     $0 1 %$$  !D>@\    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
